PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Aodah, A; Pavlik, A; Karlage, K; Myrdal, PB				Aodah, Alhassan; Pavlik, Aaron; Karlage, Kelly; Myrdal, Paul B.			Preformulation Studies on Piperlongumine	PLOS ONE			English	Article							CANCER-CELLS; ANOIKIS RESISTANCE; STAT3	Piperlongumine is a natural alkaloid extracted from piper plants which has been used traditionally for the treatment of certain diseases. This compound shows interesting in vitro pharmacological activity such as selective anticancer activity and higher cytotoxicity than methotrexate, cyclophosphamide and adriamycin on breast, colon, and osteosarcoma cancers, respectively. However, the physicochemical properties for this compound have not been well characterized. In this research, preformulation studies for piperlongumine have been performed to determine factors which influence solubility and stability which, in turn, can be used to assist future formulation development. The solubility of piperlongumine in water was found to be approximately 26 mu g/ml. Using 10% polysorbate 80 as a surfactant resulted in a 27 fold increase in solubility. Cosolvents and cyclodextrins afforded concentrations of 1 mg/ml and higher. The pH degradation rate profile for piperlongumine at various temperatures shows significant instability of the drug at pH values >= 7 and 3, and maximum stability around pH 4. It was estimated that it would take approximately 17 weeks for piperlongumine to degrade by 10% at 25 degrees C, pH 4. Additionally, piperlongumine showed marked photo-degradation upon exposure to an ultraviolet light source, especially in aqueous media.	[Aodah, Alhassan; Pavlik, Aaron; Karlage, Kelly; Myrdal, Paul B.] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA	University of Arizona	Aodah, A (corresponding author), Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA.	aaodah@email.arizona.edu						Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Amidon GL, 1979, CHEM STABILITY PHARM, P97; BANERJEE T, 1986, CAN J CHEM, V64, P876, DOI 10.1139/v86-145; Bezerra DP, 2013, EUR J PHARM SCI, V48, P453, DOI 10.1016/j.ejps.2012.12.003; CHATTERJEE A, 1967, TETRAHEDRON, V23, P1769, DOI 10.1016/S0040-4020(01)82575-8; Dhillon H, 2014, TOXICOL REP, V1, P309, DOI 10.1016/j.toxrep.2014.05.011; Fofaria NM, 2016, INT J PHARMACEUT, V498, P12, DOI 10.1016/j.ijpharm.2015.11.045; Fofaria NM, 2015, CARCINOGENESIS, V36, P142, DOI 10.1093/carcin/bgu233; Fofaria NM, 2014, ONCOTARGET, V5, P7051, DOI 10.18632/oncotarget.2251; Fofaria NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094298; Kumar S, 2011, J ACUPUNCT MERIDIAN, V4, P134, DOI 10.1016/S2005-2901(11)60020-4; Lee S.W., 2009, [No title captured], Patent No. [WO20090312373, 20090312373, WO 20090312373]; Li JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09987; MISHRA SS, 1964, J PHARM SCI, V53, P1423, DOI 10.1002/jps.2600531138; Naika R, 2010, PHARMACOPHORE, V1, P141; Niu MS, 2015, CHEM-BIOL INTERACT, V237, P66, DOI 10.1016/j.cbi.2015.05.016; Patel K, 2015, J PHARM SCI-US, V104, P4417, DOI 10.1002/jps.24637; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Roh JL, 2014, ONCOTARGET, V5, P9227, DOI 10.18632/oncotarget.2402; SCHEINER JM, 1981, AM J HOSP PHARM, V38, P1911, DOI 10.1093/ajhp/38.12.1911; Son DJ, 2012, BIOCHEM BIOPH RES CO, V427, P349, DOI 10.1016/j.bbrc.2012.09.061	21	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151707	10.1371/journal.pone.0151707	http://dx.doi.org/10.1371/journal.pone.0151707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982320	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900115
J	Cuevas, RP; Pede, VO; McKinley, J; Velarde, O; Demont, M				Cuevas, Rosa Paula; Pede, Valerien O.; McKinley, Justin; Velarde, Orlee; Demont, Matty			Rice Grain Quality and Consumer Preferences: A Case Study of Two Rural Towns in the Philippines	PLOS ONE			English	Article							APPARENT AMYLOSE CONTENT; HEDONIC PRICE MODEL; MILLED-RICE; GELATINIZATION TEMPERATURE; STARCH; MARKET; AMYLOPECTIN; COOKING; FARMERS; LIPIDS	Hedonic pricing analysis is conducted to determine the implicit values of various attributes in the market value of a good. In this study, hedonic pricing analysis was applied to measure the contribution of grain quality search and experience attributes to the price of rice in two rural towns in the Philippines. Rice samples from respondents underwent quantitative routine assessments of grain quality. In particular, gelatinization temperature and chalkiness, two parameters that are normally assessed through visual scores, were evaluated by purely quantitative means (differential scanning calorimetry and by digital image analysis). Results indicate that rice consumed by respondents had mainly similar physical and chemical grain quality attributes. The respondents' revealed preferences were typical of what has been previously reported for Filipino rice consumers. Hedonic regression analyses showed that grain quality characteristics that affected price varied by income class. Some of the traits or socioeconomic factors that affected price were percent broken grains, gel consistency, and household per capita rice consumption. There is an income effect on rice price and the characteristics that affect price vary between income classes.	[Cuevas, Rosa Paula] Int Rice Res Inst, Grain Qual & Nutr Ctr, DAPO 7777, Manila, Philippines; [Pede, Valerien O.; McKinley, Justin; Velarde, Orlee; Demont, Matty] Int Rice Res Inst, Social Sci Div, DAPO 7777, Manila, Philippines; [Velarde, Orlee] Asian Dev Bank, 6 ADB Ave, Mandaluyong City 1550, Metro Manila, Philippines	CGIAR; International Rice Research Institute (IRRI); Asian Development Bank	McKinley, J (corresponding author), Int Rice Res Inst, Social Sci Div, DAPO 7777, Manila, Philippines.	j.mckinley@irri.org	Cuevas, Rosa Paula/D-3886-2017; Demont, Matty/C-7284-2013; McKinley, Justin/AAU-1130-2020	Cuevas, Rosa Paula/0000-0001-9624-7873; Demont, Matty/0000-0001-9086-5654; McKinley, Justin/0000-0003-3637-2597	Global Rice Science Partnership (GRiSP)	Global Rice Science Partnership (GRiSP)	The cost of data collection and grain quality analysis were covered through funds available from the Global Rice Science Partnership (GRiSP). More information about GRiSP is available at: http://www.grisp.net/main/summary. The funder provided support in the form of salaries for authors [VP, OV, RC] as well as the costs of grain quality tests, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Although one author [OV] is currently affiliated with a multilateral development finance institution, his contributions to this study were carried out while employed by the International Rice Research Institute and his current affiliation with the Asian Development Bank in no way influences the study.	Abansi C. L., 1990, Transactions of the National Academy of Science and Technology, V12, P235; Abansi C.L., 1992, CONSUMER DEMAND RICE; Adair C. R., 1966, RICE BREEDING TESTIN, P19; American Association of Cereal Chemists, 2000, APPR METH AM ASS CER; ANTONIO A A, 1974, Philippine Agriculturist, V58, P17; Ashida K, 2009, CEREAL CHEM, V86, P225, DOI 10.1094/CCHEM-86-2-0225; Bartell KH, 2003, FINE FILIPINO FOOD A; BASON ML, 1993, CEREAL CHEM, V70, P269; Bautista R. C., 2010, BR WELLS RICE RES ST, V581, P220; BRORSEN BW, 1984, AM J AGR ECON, V66, P156, DOI 10.2307/1241032; CAGAMPANG GB, 1973, J SCI FOOD AGR, V24, P1589, DOI 10.1002/jsfa.2740241214; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Calpe C, 2003, 20 SESS INT RIC COMM; Carew R, 2004, CAN J PLANT SCI, V84, P764; Champagne ET, 2010, RICE, V3, P270, DOI 10.1007/s12284-010-9057-4; Champagne ET, 1999, CEREAL CHEM, V76, P764, DOI 10.1094/CCHEM.1999.76.5.764; Chen MH, 2008, J CEREAL SCI, V47, P536, DOI 10.1016/j.jcs.2007.06.013; Chen YR, 2002, COMPUT ELECTRON AGR, V36, P173, DOI 10.1016/S0168-1699(02)00100-X; Codex Alimentarius Commission, 1995, COD STAND RIC; Combris P, 1997, ECON J, V107, P390, DOI 10.1111/j.0013-0133.1997.165.x; Council of the European Eunion, 2003, OFFICIAL J EUROPEAN, V270, P96; Cruz N. Dela, 2000, P15; Cuevas RP, 2010, FUNCT PLANT BIOL, V37, P439, DOI 10.1071/FP09258; Cuevas RP, 2012, GENETIC DIVERSITY IN PLANTS, P285; Dalton TJ, 2004, AGR ECON-BLACKWELL, V31, P149, DOI 10.1016/j.agecon.2004.09.003; Deaton AS., 2008, ECON POLIT WEEKLY, DOI [DOI 10.2139/SSRN.1135253, 10.2139/ssrn.1135253]; DELMUNDO AM, 1981, J TEXTURE STUD, V12, P107; Delwiche SR, 1996, CEREAL CHEM, V73, P257; Demont M, 2012, FOOD QUAL PREFER, V23, P63, DOI 10.1016/j.foodqual.2011.07.005; Deodhar SY, 2004, J INT FOOD AGRIBUS M, V16, P43, DOI 10.1300/J047v16n01_04; Fitzgerald MA, 2003, J AGR FOOD CHEM, V51, P2295, DOI 10.1021/jf020574i; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Fitzgerald MA, 2009, CEREAL CHEM, V86, P492, DOI 10.1094/CCHEM-86-5-0492; Graham R., 2002, PROPOSAL IRRI ESTABL; HAMAKER BR, 1993, CEREAL CHEM, V70, P377; Hulten C.R., 2003, EC POLICY REV, V9, P5; Ikehashi H., 1979, WORKSH CHEM ASP RIC, P223; IRRI, 2006, BREED GRAIN QUAL; ISO, 2007, 664712007 ISO; ISO, 2007, 664722007 ISO; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; Jensen RT, 2008, AM ECON REV, V98, P1553, DOI 10.1257/aer.98.4.1553; Juliano B.O., 1993, GRAIN QUALITY EVALUA; Juliano B.O., 1965, FOOD TECHNOL, V19, P116; Juliano BO, 2009, PHILIPP AGRIC SCI, V92, P106; Juliano BO, 2001, CEREAL FOOD WORLD, V46, P531; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Juliano BO, 1992, CONSUMER DEMAND RICE, P77; JULIANO BVO, 1981, J TEXTURE STUD, V12, P17, DOI 10.1111/j.1745-4603.1981.tb00533.x; KAOSAARD M, 1991, RICE GRAIN MARKETING AND QUALITY ISSUES, P23; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; KUMAR I, 1987, CROP SCI, V27, P1167, DOI 10.2135/cropsci1987.0011183X002700060016x; Laborte AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136562; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lantican FA., 2013, ESTIMATING DEMAND EL; Liang XM, 2002, CEREAL CHEM, V79, P812, DOI 10.1094/CCHEM.2002.79.6.812; LITTLE RR, 1958, CEREAL CHEM, V35, P111; Lusk JL, 2008, EXPT AUCTIONS; Lyman NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072157; MANINGAT CC, 1980, STARKE, V32, P76, DOI 10.1002/star.19800320303; Martin M, 2002, J CEREAL SCI, V36, P285, DOI 10.1006/jcrs.2001.0465; McGrance SJ, 1998, STARCH-STARKE, V50, P158, DOI 10.1002/(SICI)1521-379X(199804)50:4<158::AID-STAR158>3.0.CO;2-7; Minten B, 2013, WORLD DEV, V42, P100, DOI 10.1016/j.worlddev.2012.06.015; MORRISON WR, 1987, J CEREAL SCI, V5, P35, DOI 10.1016/S0733-5210(87)80007-3; Nakamura Y, 2002, STARCH-STARKE, V54, P117, DOI [10.1002/1521-379X(200204)54:3/4<117::AID-STAR117>3.0.CO;2-2, 10.1002/1521-379X(200204)54:3/4&lt;117::AID-STAR117&gt;3.0.CO;2-2]; Nerlove M, 1995, EUR ECON REV, V39, P1697, DOI 10.1016/0014-2921(95)00013-5; NORMAND FL, 1989, CEREAL CHEM, V66, P317; NSO, 2012, 2012 FAM INC EXP SUR; PAGASA, 2011, CLIM CHANG SCEN PHIL; PEREZ CM, 1978, STARKE, V30, P424, DOI 10.1002/star.19780301206; Rachmat R., 2006, Indonesian Journal of Agricultural Science, V7, P27; Reuss R, 2003, STORED GRAINS AUSTR; Rickman J. F., 2002, JIRCAS International Symposium Series, P94; Roferos LT, 2006, PHILIPP AGRIC SCI, V89, P58; Rutsaert P, 2013, REALIZING AFRICA'S RICE PROMISE, P294, DOI 10.1079/9781845938123.0294; Semple RL, 1992, RAS86189 REGNET NAPH, P526; SHAH CH, 1983, ECON DEV CULT CHANGE, V32, P121, DOI 10.1086/451374; Singh N, 2003, FOOD CHEM, V82, P433, DOI 10.1016/S0308-8146(03)00007-4; SLADE L, 1988, CARBOHYD POLYM, V8, P183, DOI 10.1016/0144-8617(88)90002-1; Spiller K, 2012, APPETITE, V59, P100, DOI 10.1016/j.appet.2012.04.007; STANLEY LR, 1991, REV ECON STAT, V73, P537, DOI 10.2307/2109582; Suwannaporn P, 2008, J FOOD PROD MARK, V14, P33, DOI 10.1080/10454440801986348; TASHIRO T, 1991, AUST J AGR RES, V42, P485, DOI 10.1071/AR9910485; Tomlins K, 2007, J SCI FOOD AGR, V87, P1564, DOI 10.1002/jsfa.2889; UNNEVEHR LJ, 1986, AM J AGR ECON, V68, P634, DOI 10.2307/1241547; Vilaplana F, 2012, CARBOHYD POLYM, V88, P103, DOI 10.1016/j.carbpol.2011.11.072; Wang ZG, 2009, J FAC AGR KYUSHU U, V54, P541; Yoshioka Y, 2007, CROP SCI, V47, P2113, DOI 10.2135/cropsci2006.10.0631sc; Zhao XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066218	89	55	58	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150345	10.1371/journal.pone.0150345	http://dx.doi.org/10.1371/journal.pone.0150345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982587	Green Published, gold			2022-12-27	WOS:000372574900037
J	Martinez-Alcantara, B; Martinez-Cuenca, MR; Fernandez, C; Legaz, F; Quinones, A				Martinez-Alcantara, Belen; Martinez-Cuenca, Mary-Rus; Fernandez, Carlos; Legaz, Francisco; Quinones, Ana			Production of N-15-Labelled Liquid Organic Fertilisers Based on Manure and Crop Residue for Use in Fertigation Studies	PLOS ONE			English	Article							NITROGEN; N-15; FECES; AVAILABILITY; SYSTEMS; URINE; SOILS	Large quantities of crop residue and animal manure from agricultural and livestock activities are annually produced worldwide. With proper management, these residues are potentially valuable sources of plant nutrients, mainly N. Recycling such subproducts in sustainably-based agricultural systems can minimise the use of mineral fertilisers, and hence reduce the potential risk of surface and groundwater pollution. Therefore, the purpose of this study was to obtain (small scale) two liquid labelled-organic fertilisers, an animal-and a vegetal-based organic (AO and VO, respectively) fertiliser, to be used as organic N sources in subsequent fertigation studies. Forage maize (Zea mays L.) grown under N-15-labelled fertiliser supply was used as raw material for VO fertiliser production, and also as N-15-labelled sheep feed to obtain N-15-labelled manure. The labelled faeces fraction was used as raw material for the AO fertiliser. The VO fertiliser was obtained after an acidic and an enzyme-driven hydrolysis. The AO fertiliser was obtained after acidic hydrolysis. The VO liquid fertiliser presented an N concentration of 330 mg mu L-1, 85% of total N was organic, while ammonium and nitrate N accounted for 55% and 45% of the mineral nitrogen fraction, respectively. This fertiliser also exhibited high K, Ca and S concentrations and notable values for the remaining macro-and micronutrients. The AO liquid fertiliser had a similar total N concentration (496 mg mu L-1, 82% of total N in an organic form) to that of VO, but its mineral N fraction significantly differed, which came in a predominantly (95%) ammonia form. It also had a high content of N, P, K and other macronutrients, and sufficient Fe, Zn, Mn, Cu and B levels, which suggests its suitability as a potential fertiliser. The percentage of N-15 enrichment in both VO and AO liquid fertilisers exceeded 2% N-15 atom excess, which enabled their use in subsequent assays run to assess nitrogen uptake efficiency.	[Martinez-Alcantara, Belen; Martinez-Cuenca, Mary-Rus; Legaz, Francisco; Quinones, Ana] Inst Valenciano Invest Agr, Dept Citriculture & Vegetable Prod, E-46113 Moncada, Valencia, Spain; [Fernandez, Carlos] Valencian Polytech Univ, Inst Anim Sci & Technol, Valencia, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA)	Quinones, A (corresponding author), Inst Valenciano Invest Agr, Dept Citriculture & Vegetable Prod, E-46113 Moncada, Valencia, Spain.	quinones_ana@gva.es	Fernández, Carlos Javier/I-4027-2015; Quinones, Ana/E-6229-2014; MARTINEZ ALCANTARA, BELEN/AGF-5074-2022; Martinez-Cuenca, Mary-Rus/K-7710-2015	Fernández, Carlos Javier/0000-0002-0368-0158; Quinones, Ana/0000-0002-6096-734X; MARTINEZ ALCANTARA, BELEN/0000-0002-7816-4115; Martinez-Cuenca, Mary-Rus/0000-0002-9017-2951	National Institute of Research and Agrarian and Food Technology [RTA2008-00071-00-00]; European Regional Development Funds	National Institute of Research and Agrarian and Food Technology; European Regional Development Funds(European Commission)	This work was funded by the National Institute of Research and Agrarian and Food Technology (RTA2008-00071-00-00) and the European Regional Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosshard C, 2011, NUTR CYCL AGROECOSYS, V90, P355, DOI 10.1007/s10705-011-9437-1; BREMNER JM, 1996, METHODS SOIL ANAL, V3, P1085; Capulin-Grande J., 2001, Agrociencia (Montecillo), V35, P287; Chantigny MH, 2004, CAN J SOIL SCI, V84, P43, DOI 10.4141/S03-012; Crohn DM, 2006, J ENVIRON QUAL, V35, P658, DOI 10.2134/jeq2005.0132; CROOK EM, 1946, BIOCHEM J, V40, P197, DOI 10.1042/bj0400197; CROUCH IJ, 1993, PLANT GROWTH REGUL, V13, P21, DOI 10.1007/BF00207588; EUROSTAT, 2011, EUR COMM AGR STAT; FAO, 2010, AN PROD HLTH DIV; Flowers RH, 1993, SOIL BIOL BIOCHEM, V15, P193; Gibson L., 2011, BIOMASS MAGAZINE, P701; Govere S, 2011, INT J MODERN ENG RES, V1, P196; Haq Z, 2006, APPL BIOCHEM BIOTECH, V129, P3, DOI 10.1385/ABAB:129:1:3; HE DY, 1994, SOIL SCI, V158, P65, DOI 10.1097/00010694-199407000-00008; IAEA, 1983, GUID US NITR 15 RAD; Jackson-Smith D, 1997, PROGR AGR TECHNOL ST; JENSEN ES, 1994, SOIL BIOL BIOCHEM, V26, P465, DOI 10.1016/0038-0717(94)90178-3; KIRCHMANN H, 1990, J SOIL SCI, V41, P379, DOI 10.1111/j.1365-2389.1990.tb00073.x; Laberge G, 2006, SOIL BIOL BIOCHEM, V38, P1998, DOI 10.1016/j.soilbio.2005.11.023; Langmeier M, 2002, AGRONOMIE, V22, P789, DOI 10.1051/agro:2002044; MARM, 2010, AGR REP; MASON VC, 1979, Z TIERPHYSIOL TIERER, V41, P121; Nolan JV., 1975, P 4 INT S RUM PHYS S, P416; NOWAK P, 1997, WASTE UTILIZATION EF, P1; Powell JM, 2004, AGRON J, V96, P433, DOI 10.2134/agronj2004.0433; Powell JM, 1999, AGRON J, V91, P814, DOI 10.2134/agronj1999.915814x; Powlson D. S., 1993, Nitrogen isotope techniques., P209; RAIGON MD, 1992, ANALUSIS, V20, P483; Sorensen P, 2005, SOIL SCI SOC AM J, V69, P1639, DOI 10.2136/sssaj2004.0364; SORENSEN P, 1994, PLANT SOIL, V162, P31, DOI 10.1007/BF01416087; Sorensen P, 1998, BIOL FERT SOILS, V28, P56, DOI 10.1007/s003740050463; Thirumaran G., 2009, AM EURASIAN J AGRON, V2, P57; Thomsen IK, 1997, PLANT SOIL, V197, P233, DOI 10.1023/A:1004224615075; Tuttobene R, 2009, AGRON SUSTAIN DEV, V29, P557, DOI 10.1051/agro/2009014; Vasanthkumar HHA., 2006, JEEVAMRUT SLURRY PRE, P4; Yacob O, 1980, PLANT SOIL, V57, P237	36	5	6	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150851	10.1371/journal.pone.0150851	http://dx.doi.org/10.1371/journal.pone.0150851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982183	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900054
J	Rajagopalan, V; Zhang, YH; Ojamaa, K; Chen, YF; Pingitore, A; Pol, CJ; Saunders, D; Balasubramanian, K; Towner, RA; Gerdes, AM				Rajagopalan, Viswanathan; Zhang, Youhua; Ojamaa, Kaie; Chen, Yue-feng; Pingitore, Alessandro; Pol, Christine J.; Saunders, Debra; Balasubramanian, Krithika; Towner, Rheal A.; Gerdes, A. Martin			Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects	PLOS ONE			English	Article							ATRIAL-FIBRILLATION INDUCIBILITY; CONGESTIVE-HEART-FAILURE; THYROID-HORMONE ACTION; L-THYROXINE TREATMENT; MYOCARDIAL-INFARCTION; SUBCLINICAL HYPOTHYROIDISM; DILATED CARDIOMYOPATHY; REPLACEMENT THERAPY; RATS; TRIIODOTHYRONINE	Background A large body of evidence suggests that thyroid hormones (THs) are beneficial for the treatment of cardiovascular disorders. We have shown that 3 days of triiodo-L-thyronine (T3) treatment in myocardial infarction (MI) rats increased left ventricular (LV) contractility and decreased myocyte apoptosis. However, no clinically translatable protocol is established for T3 treatment of ischemic heart disease. We hypothesized that low-dose oral T3 will offer safe therapeutic benefits in MI. Methods and Results Adult female rats underwent left coronary artery ligation or sham surgeries. T3 (similar to 6 mu g/kg/day) was available in drinking water ad libitum immediately following MI and continuing for 2 month(s) (mo). Compared to vehicle-treated MI, the oral T3-treated MI group at 2 mo had markedly improved anesthetized Magnetic Resonance Imaging-based LV ejection fraction and volumes without significant negative changes in heart rate, serum TH levels or heart weight, indicating safe therapy. Remarkably, T3 decreased the incidence of inducible atrial tachyarrhythmias by 88% and improved remodeling. These were accompanied by restoration of gene expression involving several key pathways including thyroid, ion channels, fibrosis, sympathetic, mitochondria and autophagy. Conclusions Low-dose oral T3 dramatically improved post-MI cardiac performance, decreased atrial arrhythmias and cardiac remodeling, and reversed many adverse changes in gene expression with no observable negative effects. This study also provides a safe and effective treatment/monitoring protocol that should readily translate to humans.	[Rajagopalan, Viswanathan; Zhang, Youhua; Chen, Yue-feng; Pol, Christine J.; Gerdes, A. Martin] New York Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY 11568 USA; [Ojamaa, Kaie] Feinstein Inst Med Res, Manhasset, NY USA; [Pingitore, Alessandro] CNR Clin Physiol Inst, Pisa, Italy; [Saunders, Debra; Balasubramanian, Krithika; Towner, Rheal A.] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA	New York Institute Technology; Northwell Health; Oklahoma Medical Research Foundation	Rajagopalan, V; Gerdes, AM (corresponding author), New York Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY 11568 USA.	vrajagop@nyit.edu; agerdes@nyit.edu	Pingitore, Alessandro/K-1843-2018	Pingitore, Alessandro/0000-0002-4049-184X; Chen, Yuefeng/0000-0002-5925-2291; Towner, Rheal/0000-0001-7368-8983	National Heart, Lung, And Blood Institute of the National Institutes of Health, Bethesda, MD [R01HL103671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103671] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute of the National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health, Bethesda, MD, under Award Number R01HL103671 (AMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Cerillo AG, 2014, ANN THORAC SURG, V97, P2089, DOI 10.1016/j.athoracsur.2014.01.049; Chen YF, 2008, J MOL CELL CARDIOL, V44, P180, DOI 10.1016/j.yjmcc.2007.09.009; Chen YF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-40; Chen Yue-Feng, 2011, Cardiovasc Pathol, V20, pe189, DOI 10.1016/j.carpath.2010.09.007; Davis PJ, 2002, THYROID, V12, P459, DOI 10.1089/105072502760143827; Dias P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000287; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Files MD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000680; Gerdes AM, 2015, AM J PHYSIOL-HEART C, V308, pH1, DOI 10.1152/ajpheart.00704.2014; Goldman S, 2009, CIRCULATION, V119, P3093, DOI 10.1161/CIRCULATIONAHA.108.834424; Hamilton MA, 1998, AM J CARDIOL, V81, P443, DOI 10.1016/S0002-9149(97)00950-8; Henderson KK, 2009, CIRC-HEART FAIL, V2, P243, DOI 10.1161/CIRCHEARTFAILURE.108.810747; Iervasi G, 2003, CIRCULATION, V107, P708, DOI 10.1161/01.CIR.0000048124.64204.3F; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010; Kenessey A, 2006, J BIOL CHEM, V281, P20666, DOI 10.1074/jbc.M512671200; Khalife WI, 2005, AM J PHYSIOL-HEART C, V289, pH2409, DOI 10.1152/ajpheart.00483.2005; Kishi T, 2015, J CARDIOL, V66, P201, DOI 10.1016/j.jjcc.2015.05.001; Klemperer JD, 1996, ANN THORAC SURG, V61, P1323, DOI 10.1016/0003-4975(96)00102-6; Kobayashi S, 2015, BBA-MOL BASIS DIS, V1852, P252, DOI 10.1016/j.bbadis.2014.05.020; Lesmana R, 2016, ENDOCRINOLOGY, V157, P23, DOI 10.1210/en.2015-1632; Liu YH, 2008, AM J PHYSIOL-HEART C, V294, pH2137, DOI 10.1152/ajpheart.01379.2007; Moruzzi P, 1996, AM J MED, V101, P461, DOI 10.1016/S0002-9343(96)00281-1; Olivares EL, 2007, ENDOCRINOLOGY, V148, P4786, DOI 10.1210/en.2007-0043; Pantos C, 2008, BASIC RES CARDIOL, V103, P308, DOI 10.1007/s00395-008-0697-0; PFEFFER MA, 1985, CIRCULATION, V72, P406, DOI 10.1161/01.CIR.72.2.406; Pingitore A, 2008, J CLIN ENDOCR METAB, V93, P1351, DOI 10.1210/jc.2007-2210; Pingitore A, 2012, ANN MED, V44, P745, DOI 10.3109/07853890.2011.573501; Pol CJ, 2011, ENDOCRINOLOGY, V152, P669, DOI 10.1210/en.2010-0431; Rajagopalan Viswanathan, 2015, Curr Heart Fail Rep, V12, P141, DOI 10.1007/s11897-014-0246-0; Sara JD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002225; Sato Y, 2005, CIRC RES, V97, P550, DOI 10.1161/01.RES.0000181431.04290.bd; Savinova OV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025054; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Suffredini S, 2012, BRIT J PHARMACOL, V165, P1457, DOI 10.1111/j.1476-5381.2011.01627.x; Tseng FY, 2012, J AM COLL CARDIOL, V60, P730, DOI 10.1016/j.jacc.2012.03.047; Wassen FWJS, 2002, ENDOCRINOLOGY, V143, P2812, DOI 10.1210/en.143.7.2812; Weltman NY, 2015, AM J PHYSIOL-HEART C, V309, pH1059, DOI 10.1152/ajpheart.00431.2015; Weltman NY, 2014, MOL MED, V20, P302, DOI 10.2119/molmed.2013.00040; Weltman NY, 2013, ENDOCRINOLOGY, V154, P2542, DOI 10.1210/en.2012-2087; YOUNG WF, 1984, CLIN PHARMACOL THER, V36, P781, DOI 10.1038/clpt.1984.257; Yu XC, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-6; Zhang YH, 2014, J CARD FAIL, V20, P1012, DOI 10.1016/j.cardfail.2014.10.003; Zhang YH, 2013, CIRC-ARRHYTHMIA ELEC, V6, P952, DOI 10.1161/CIRCEP.113.000502; Zucker IH, 2014, CLIN SCI, V126, P695, DOI 10.1042/CS20130294	46	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151413	10.1371/journal.pone.0151413	http://dx.doi.org/10.1371/journal.pone.0151413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981865	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900082
J	Reintjes, R; Das, E; Klemm, C; Richardus, JH; Kessler, V; Ahmad, A				Reintjes, Ralf; Das, Enny; Klemm, Celine; Richardus, Jan Hendrik; Kessler, Verena; Ahmad, Amena			"Pandemic Public Health Paradox": Time Series Analysis of the 2009/10 Influenza A / H1N1 Epidemiology, Media Attention, Risk Perception and Public Reactions in 5 European Countries	PLOS ONE			English	Article							NEWS COVERAGE; OUTBREAK; UNCERTAINTY; NEWSPAPERS	In 2009, influenza A H1N1 caused the first pandemic of the 21st century. Although a vaccine against this influenza subtype was offered before or at the onset of the second epidemic wave that caused most of the fatal cases in Europe, vaccination rates for that season were lower than expected. We propose that the contradiction between high risk of infection and low use of available prevention measures represents a pandemic public health paradox. This research aims for a better understanding of this paradox by exploring the time-dependent interplay among changing influenza epidemiology, media attention, pandemic control measures, risk perception and public health behavior among five European countries (Czech Republic, Denmark, Germany, Spain and the UK). Findings suggest that asynchronicity between media curves and epidemiological curves may potentially explain the pandemic public health paradox; media attention for influenza A H1N1 in Europe declined long before the epidemic reached its peak, and public risk perceptions and behaviors may have followed media logic, rather than epidemiological logic.	[Reintjes, Ralf; Kessler, Verena; Ahmad, Amena] Hamburg Univ Appl Sci, Hamburg, Germany; [Das, Enny] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Klemm, Celine] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands; [Reintjes, Ralf] Univ Tampere, FIN-33101 Tampere, Finland	Hochschule Angewandte Wissenschaft Hamburg; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Reintjes, R (corresponding author), Hamburg Univ Appl Sci, Hamburg, Germany.; Reintjes, R (corresponding author), Univ Tampere, FIN-33101 Tampere, Finland.	Ralf.Reintjes@haw-hamburg.de	Richardus, Jan Hendrik/AAE-1278-2021	Richardus, Jan Hendrik/0000-0003-0564-6313; Klemm, Celine/0000-0001-9178-3669	European Union Seventh Framework Programme (FP7) [278763]	European Union Seventh Framework Programme (FP7)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 278763.	Andersen PH, 2009, EPI NEWS, P27; Bundesministerium fur Gesundheit, 2009, INF BUND ZUM START I; Chang CC, 2012, HEALTH COMMUN, V27, P111, DOI 10.1080/10410236.2011.569004; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Department of Health, 2009, H1N1 SWIN FLU VACC P; Duncan B, 2009, EUROSURVEILLANCE, V14, P15; European Centre for Disease Prevention and Control, 2009, SIT REP INF NOV FLU; European Centre for Disease Prevention and Control, 2010, EUR 2009 INFL PAND T; Fenichel EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058249; FISCHHOFF B, 1985, ISSUES SCI TECHNOL, V2, P83; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Fogarty AS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-181; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goodall C, 2012, J HEALTH COMMUN, V17, P338, DOI 10.1080/10810730.2011.626499; Health Protection Agency, EP REP PAND H1N1 200; Hilton S, 1988, FLASH BUR 287 EUR IN, V8, P177; Hilton S, 1997, J COMMUN, V12, P319; Hilton S, 2011, J EPIDEMIOL COMMUN H, V65, P941, DOI 10.1136/jech.2010.119875; Hine D., 2010, 2009 INFLUENZA PANDE; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Kitzinger J, 1997, EUR J COMMUN, V12, P319, DOI 10.1177/0267323197012003002; Klemm C., 2014, J RISK RES; Klemm C, 2014, ICA C SEATTL US; McCombs ME, 1974, ASS ED JOURN SAN DIE; Mereckiene J, 2012, EUROSURVEILLANCE, V17, P18; Ministerio de Sanidad Politica Social e Igualdad, 2010, AN ACT MAT VAC ANT D; Ministerio de Sanidad y Politica Social, 2009, SWIN FLU VACC 2009; Ministerstvo zdravotnictvi ER, 2009, PRO CESTOVATELE 21 5; Ministerstvo zdravotnictvi ER, 2009, LEK TAM AKT UD PRO Z; Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863; National Board of Health, 2009, AENDR STRAT HANDT IN; National Board of Health, 2009, BEST TID TIL INFL H1; Rachul CM, 2011, CAN J PUBLIC HEALTH, V102, P200, DOI 10.1007/BF03404896; Robert Koch-Institut, 2010, EPIDEMIOL B, P191; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Peralta PS, 2010, REV ESP SALUD PUBLIC, V84, P529, DOI 10.1590/s1135-57272010000500007; Sethi MP R, 2010, PANDEMIC H1N1 SWINE; Sierra Moros J, 2010, REV ESP SALUD PUBLIC, V84, P463; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759; The Gallup Organization, 2010, FLASH EUR 287 EUR IN; Vasterman PLM, 2013, EUR J COMMUN, V28, P436, DOI 10.1177/0267323113486235; Walter D, 2011, VACCINE, V29, P4008, DOI 10.1016/j.vaccine.2011.03.069; World Health Organization, 2009, PAND H1N1 2009 UPD 6; World Health Organization, 2009, CHANG REP REQ PAND H; Yu N., 2011, INT PUBLIC HLTH J, V3, P63	46	51	52	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151258	10.1371/journal.pone.0151258	http://dx.doi.org/10.1371/journal.pone.0151258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982071	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900073
J	Durlik, J; Szewczyk, J; Muszynski, M; Wodniecka, Z				Durlik, Joanna; Szewczyk, Jakub; Muszynski, Marek; Wodniecka, Zofia			Interference and Inhibition in Bilingual Language Comprehension: Evidence from Polish-English Interlingual Homographs	PLOS ONE			English	Article							LEXICAL ACTIVATION; EXECUTIVE CONTROL; WORD RECOGNITION; L2; CONTEXT	The main goal of the present study was to explore the involvement of inhibition in resolution of cross-language activation in bilingual comprehension and a possible modulatory effect of L2 proficiency. We used a semantic relatedness judgment task in L2 English that included Polish-English interlingual homographs and English translations of the Polish homographs' meanings. Based on previous studies using the same paradigm, we expected a strong homograph interference and inhibition of the homographs' Polish meanings translations. In addition, we predicted that participants with lower L2 proficiency would experience greater interference and stronger inhibitory effects. The reported results confirm a strong homograph interference effect. In addition, our results indicate that the scope of inhibition generalized from the homograph's irrelevant meaning to a whole semantic category, indicating the flexibility of the inhibitory mechanisms. Contrary to our expectations, L2 proficiency did not modulate the effects of interference and inhibition, possibly due to a relatively low variability in proficiency within our participant sample.	[Durlik, Joanna; Szewczyk, Jakub; Muszynski, Marek; Wodniecka, Zofia] Jagiellonian Univ, Inst Psychol, Krakow, Poland; [Wodniecka, Zofia] Penn State Univ, University Pk, PA 16802 USA	Jagiellonian University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Durlik, J (corresponding author), Jagiellonian Univ, Inst Psychol, Krakow, Poland.	joanna.durlik@uj.edu.pl	Muszyński, Marek/GNW-5537-2022; Szewczyk, Jakub/D-9882-2012	Szewczyk, Jakub/0000-0003-4464-082X; Muszynski, Marek/0000-0002-9306-1237	FOCUS from Foundation for Polish Science; National Science Centre [N106 366340, 2014/15/N/HS6/04188]; Ministry of Science and Higher Education	FOCUS from Foundation for Polish Science; National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The research was supported by the FOCUS subsidy 4/2009 from Foundation for Polish Science (https://www.fnp.org.pl/), National Science Centre grant N106 366340 (https://ncn.gov.pl/?language=en), both awarded to ZW, and National Science Centre grant 2014/15/N/HS6/04188 (https://ncn.gov.pl/?language=en) awarded to JD. During the work on the paper, ZW was supported by a Mobility Plus Fellowship from Ministry of Science and Higher Education (http://www.nauka.gov.pl/en/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abutalebi J, 2008, LANG COGNITIVE PROC, V23, P557, DOI 10.1080/01690960801920602; Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; BijeljacBabic R, 1997, MEM COGNITION, V25, P447, DOI 10.3758/BF03201121; Blumenfeld HK, 2013, J COGN PSYCHOL, V25, P547, DOI 10.1080/20445911.2013.812093; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Colzato LS, 2008, J EXP PSYCHOL LEARN, V34, P302, DOI 10.1037/0278-7393.34.2.302; Martin M, 2010, BRIT J PSYCHOL, V101, P679, DOI 10.1348/000712609X480571; Dijkstra T, 2000, J MEM LANG, V42, P445, DOI 10.1006/jmla.1999.2697; Dijkstra T., 1998, BILING-LANG COGN, V1, P51, DOI [10.1017/S1366728998000121, DOI 10.1017/S1366728998000121]; Dijkstra T, 2002, BILING LANG COGN, V5; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; Duyck W, 2007, J EXP PSYCHOL LEARN, V33, P663, DOI 10.1037/0278-7393.33.4.663; Elston-Guttler KE, 2005, COGNITIVE BRAIN RES, V25, P57, DOI 10.1016/j.cogbrainres.2005.04.007; Elston-Guttler KE, 2005, J COGNITIVE NEUROSCI, V17, P1593, DOI 10.1162/089892905774597245; Elston-Guttler KE, 2005, J MEM LANG, V52, P256, DOI 10.1016/j.jml.2004.11.002; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Grosjean F., 2006, HDB BILINGUALISM, P32, DOI [10.1002/9780470756997.CH2, DOI 10.1002/9780470756997.CH2]; Kerkhofs R, 2006, BRAIN RES, V1068, P170, DOI 10.1016/j.brainres.2005.10.087; Khare V, 2013, PSYCHOL RES-PSYCH FO, V77, P728, DOI 10.1007/s00426-012-0466-4; Kroll J.F., 2014, OXFORD HDB LANGUAGE, P165, DOI DOI 10.1093/OXFORDHB/9780199735471.013.001; Lemhofer K, 2004, MEM COGNITION, V32, P533, DOI 10.3758/BF03195845; Lemhofer K, 2012, BEHAV RES METHODS, V44, P325, DOI 10.3758/s13428-011-0146-0; Li P, 2006, BEHAV RES METHODS, V38, P202, DOI 10.3758/BF03192770; Macizo P, 2010, J MEM LANG, V63, P232, DOI 10.1016/j.jml.2010.04.002; Mandera P, 2014, BEHAV RES METHODS; Martin MC, 2011, THESIS U GRANADA; Mercier J, 2014, BILING-LANG COGN, V17, P89, DOI 10.1017/S1366728913000084; Pivneva I, 2014, J EXP PSYCHOL LEARN, V40, P787, DOI 10.1037/a0035583; Schwartz AI, 2007, LANG COGNITIVE PROC, V22, P106, DOI 10.1080/01690960500463920; Schwartz AI, 2006, J MEM LANG, V55, P197, DOI 10.1016/j.jml.2006.03.004; Schwartz AI, 2012, CUR ISS PSYCHOL LANG, P131; Sunderman G, 2006, STUD SECOND LANG ACQ, V28, P387, DOI 10.1017/S0272263106060177; Tao L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00123; Van Assche E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00174; Van Assche E, 2009, PSYCHOL SCI, V20, P923, DOI 10.1111/j.1467-9280.2009.02389.x; van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335; van Heuven WJB, 2010, BRAIN RES REV, V64, P104, DOI 10.1016/j.brainresrev.2010.03.002; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584	39	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151430	10.1371/journal.pone.0151430	http://dx.doi.org/10.1371/journal.pone.0151430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977810	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800073
J	Ramos, GD; Bernardi, L; Lauxen, I; Sant'Ana, M; Horwitz, AR; Lamers, ML				Ramos, Grasieli de Oliveira; Bernardi, Lisiane; Lauxen, Isabel; Sant'Ana Filho, Manoel; Horwitz, Alan Rick; Lamers, Marcelo Lazzaron			Fibronectin Modulates Cell Adhesion and Signaling to Promote Single Cell Migration of Highly Invasive Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; COLLECTIVE INVASION; RHO-GTPASES; INTEGRIN; CANCER; ACTIVATION; PLASTICITY; CADHERIN; MICROENVIRONMENT; METASTASIS	Cell migration is regulated by adhesion to the extracellular matrix (ECM) through integrins and activation of small RhoGTPases, such as RhoA and Rac1, resulting in changes to actomyosin organization. During invasion, epithelial-derived tumor cells switch from laminin-enriched basal membrane to collagen and fibronectin-enriched connective tissue. How this switch affects the tumor migration is still unclear. We tested the hypothesis that ECM dictates the invasiveness of Oral Squamous Cell Carcinoma (OSCC). We analyzed the migratory properties of two OSCC lines, a low invasive cell line with high e-cadherin levels (L-inv/HE-cad) or a highly invasive cell line with low e-cadherin levels (H-inv/LE-cad), plated on different ECM components. Compared to laminin, fibronectin induced non-directional collective migration and decreased RhoA activity in L-inv/HE-cad OSCC. For H-inv/LE-cad OSCC, fibronectin increased Rac1 activity and induced smaller adhesions, resulting in a fast single cell migration in both 2D and 3D environments. Consistent with these observations, human OSCC biopsies exhibited similar changes in cell-ECM adhesion distribution at the invasive front of the tumor, where cells encounter fibronectin. Our results indicate that ECM composition might induce a switch from collective to single cell migration according to tumor invasiveness due to changes in cell-ECM adhesion and the resulting signaling pathways that alter actomyosin organization.	[Ramos, Grasieli de Oliveira; Bernardi, Lisiane; Lauxen, Isabel; Sant'Ana Filho, Manoel; Lamers, Marcelo Lazzaron] Univ Fed Rio Grande do Sul, Sch Dent, Basic Res Ctr, Porto Alegre, RS, Brazil; [Ramos, Grasieli de Oliveira; Sant'Ana Filho, Manoel; Lamers, Marcelo Lazzaron] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Horwitz, Alan Rick] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA; [Lamers, Marcelo Lazzaron] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; University of Virginia; Universidade Federal do Rio Grande do Sul	Lamers, ML (corresponding author), Univ Fed Rio Grande do Sul, Sch Dent, Basic Res Ctr, Porto Alegre, RS, Brazil.; Lamers, ML (corresponding author), Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.; Lamers, ML (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil.	marcelo.lamers@ufrgs.br	de Oliveira Ramos, Grasieli/I-3268-2014; LAMERS, MARCELO/A-5291-2013	de Oliveira Ramos, Grasieli/0000-0003-1305-8060; LAMERS, MARCELO/0000-0001-5296-5662	Coordenacao de Pessoal de Nivel Superior (CAPES, Brazil) [9748-13-0, 202188/2014-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [479527/2012-1, 443699/2014-3]; National Institutes of Health (NIH) [GM23244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023244, R01GM023244] Funding Source: NIH RePORTER	Coordenacao de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Coordenacao de Pessoal de Nivel Superior (CAPES, Brazil, #9748-13-0, #202188/2014-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, #479527/2012-1, #443699/2014-3) and National Institutes of Health (NIH, GM23244). FIPE/HCPA - Fundo de Incentivo a Pesquisa e Eventos / Hospital de Clinicas de Porto Alegre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L, 2005, WHO CLASSIFICATION T, P283; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brockbank EC, 2005, BRIT J CANCER, V92, P102, DOI 10.1038/sj.bjc.6602255; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Chen LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040202; Chen QK, 2013, DIFFERENTIATION, V86, P126, DOI 10.1016/j.diff.2013.03.003; Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; HARADA T, 1994, VIRCHOWS ARCH, V424, P257; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Hodgson L., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1411s46, DOI 10.1002/0471143030.CB1411S46]; Huang WC, 2014, CANCER RES, V74, P751, DOI 10.1158/0008-5472.CAN-13-1297; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Kamarajan P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-330; Kosmehl H, 1999, BRIT J CANCER, V81, P1071, DOI 10.1038/sj.bjc.6690809; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518; Nagata M, 2003, INT J CANCER, V106, P683, DOI 10.1002/ijc.11283; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Serres E, 2014, ONCOGENE, V33, P3451, DOI 10.1038/onc.2013.305; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Thiery JP, 2010, B CANCER, V97, P1285, DOI 10.1684/bdc.2010.1206; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; von Schlippe M, 2000, J CELL SCI, V113, P425; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yao XS, 2013, INT J CANCER, V133, P2925, DOI 10.1002/ijc.28312; Yap LF, 2009, ONCOGENE, V28, P2524, DOI 10.1038/onc.2009.105	50	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151338	10.1371/journal.pone.0151338	http://dx.doi.org/10.1371/journal.pone.0151338			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978651	Green Published, gold			2022-12-27	WOS:000372572800062
J	Young, AMH; Donnelly, J; Czosnyka, M; Jalloh, I; Liu, XY; Aries, MJ; Fernandes, HM; Garnett, MR; Smielewski, P; Hutchinson, PJ; Agrawal, S				Young, Adam M. H.; Donnelly, Joseph; Czosnyka, Marek; Jalloh, Ibrahim; Liu, Xiuyun; Aries, Marcel J.; Fernandes, Helen M.; Garnett, Matthew R.; Smielewski, Peter; Hutchinson, Peter J.; Agrawal, Shruti			Continuous Multimodality Monitoring in Children after Traumatic Brain Injury-Preliminary Experience	PLOS ONE			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; BLOOD-FLOW; REACTIVITY	Introduction Multimodality monitoring is regularly employed in adult traumatic brain injury (TBI) patients where it provides physiologic and therapeutic insight into this heterogeneous condition. Pediatric studies are less frequent. Methods An analysis of data collected prospectively from 12 pediatric TBI patients admitted to Addenbrooke's Hospital, Pediatric Intensive Care Unit (PICU) between August 2012 and December 2014 was performed. Patients' intracranial pressure (ICP), mean arterial pressure (MAP), and cerebral perfusion pressure (CPP) were monitored continuously using brain monitoring software ICM+(R)) Pressure reactivity index (PRx) and 'Optimal CPP' (CPPopt) were calculated. Patient outcome was dichotomized into survivors and non-survivors. Results At 6 months 8/12 (66%) of the cohort survived the TBI. The median (+/- IQR) ICP was significantly lower in survivors 13.1 +/- 3.2 mm Hg compared to non-survivors 21.6 +/- 42.9 mm Hg (p = 0.003). The median time spent with ICP over 20 mm Hg was lower in survivors (9.7+ 9.8% vs 60.5 + 67.4% in non-survivors; p = 0.003). Although there was no evidence that CPP was different between survival groups, the time spent with a CPP close (within 10 mm Hg) to the optimal CPP was significantly longer in survivors (90.7 +/- 12.6%) compared with non-survivors (70.6 +/- 21.8%; p = 0.02). PRx provided significant outcome separation with median PRx in survivors being 0.02 +/- 0.19 compared to 0.39 +/- 0.62 in non-survivors (p = 0.02). Conclusion Our observations provide evidence that multi-modality monitoring may be useful in pediatric TBI with ICP, deviation of CPP from CPPopt, and PRx correlating with patient outcome.	[Young, Adam M. H.; Donnelly, Joseph; Czosnyka, Marek; Jalloh, Ibrahim; Liu, Xiuyun; Aries, Marcel J.; Fernandes, Helen M.; Garnett, Matthew R.; Smielewski, Peter; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Acad Neurosurg, Cambridge CB2 2QQ, England; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Dept Pediat Intens Care, Cambridge CB2 2QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Aries, Marcel J.] Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, NL-9700 AB Groningen, Netherlands	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Warsaw University of Technology; University of Groningen	Young, AMH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Acad Neurosurg, Cambridge CB2 2QQ, England.	ay276@cam.ac.uk	Donnelly, Joseph/E-9235-2018; Aries, Marcel/HFF-8727-2022; Liu, Xiuyun/V-4427-2017; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Liu, Xiuyun/0000-0001-9540-4865; Donnelly, Joseph/0000-0002-6502-8069; Smielewski, Peter/0000-0001-5096-3938	Medical Research Council (MRC) [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge; Peter J Hutchinson NIHR Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; NIHR Cambridge BRC; Woolf Fisher Scholarship; MRC [G0601025] Funding Source: UKRI; Medical Research Council [G0601025] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-013, ACF-2014-14-005, 12/35/57] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge; Peter J Hutchinson NIHR Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; NIHR Cambridge BRC; Woolf Fisher Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors gratefully acknowledge financial support as follows: Research support: the Medical Research Council (MRC, Grant Nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: Peter J Hutchinson NIHR Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and NIHR Cambridge BRC. Joseph Donnelly is supported by a Woolf Fisher Scholarship. MC-NIHR BRC. PS and MC have a financial interest in a part of the licensing fee for ICM+, a software licensed by Cambridge Enterprise Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carlson JN, 2015, PEDIAT CRIT CARE MED; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; GUILLAUME J, 1951, REV NEUROL, V84, P131; Haubrich C, 2015, MED ENG PHYS, V37, P175, DOI 10.1016/j.medengphy.2014.11.009; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lang E W, 1995, New Horiz, V3, P400; Langlois JA, 2004, TRAUMATIC BRAIN INJU; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MRC CRASH Trial Collaborators, 2008, BMJ-BRIT MED J, P336; Nordstrom C-H, 2013, CRIT CARE MED, V41, pe3; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Paulson O. B., 1990, BRAIN METAB REV, V2, P161; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roux P Le, 2015, NEUROCRIT CARE; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165	24	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0148817	10.1371/journal.pone.0148817	http://dx.doi.org/10.1371/journal.pone.0148817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978532	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800013
J	Aftab, Z; Robert, T; Wieber, PB				Aftab, Zohaib; Robert, Thomas; Wieber, Pierre-Brice			Balance Recovery Prediction with Multiple Strategies for Standing Humans	PLOS ONE			English	Article							STEP LENGTH; RESPONSES; PERTURBATIONS; OPTIMIZATION; INTEGRATION; MOVEMENTS; STANCE; MODEL; BODY; COST	Human balance recovery from external disturbances is a complex process, and simulating it remains an open challenge. In particular, there still is a need for a comprehensive numerical tool capable of predicting the outcome of a balance perturbation, including in particular the three elementary recovery strategies: ankle, hip and stepping with variable step duration. In order to fill this gap we further developed a previously proposed multiple step balance recovery prediction tool to include the use of the hip strategy and variable step duration. Simulated recovery reactions are compared against observations from different experimental situations from the literature. Reasonable accuracy in terms of step positions and durations were obtained for these different situations using a single set of controller parameters. Moreover, variations in the use of the hip strategy and the step duration between situations were consistent with biomechanical observations. Such a model could be useful to better understand the balance recovery mechanisms, and could also be used to identify potentially hazardous situations.	[Aftab, Zohaib] Univ Cent Punjab, Fac Engn, Lahore, Pakistan; [Robert, Thomas] Univ Lyon, F-69007 Lyon, France; [Robert, Thomas] IFSTTAR, TS2, LBMC, UMR T9406, F-69500 Bron, France; [Robert, Thomas] Univ Lyon 1, LBMC UMR T9406, F-69008 Lyon, France; [Wieber, Pierre-Brice] Univ Grenoble Alpes, LJK Lab Jean Kuntzmann, INRIA Grenoble Rhone Alpes, BIPOP Team, F-38334 Montbonnot St Martin, France	University of Central Punjab; Universite Gustave-Eiffel; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Robert, T (corresponding author), Univ Lyon, F-69007 Lyon, France.; Robert, T (corresponding author), IFSTTAR, TS2, LBMC, UMR T9406, F-69500 Bron, France.; Robert, T (corresponding author), Univ Lyon 1, LBMC UMR T9406, F-69008 Lyon, France.	thomas.robert@ifsttar.fr	Robert, Thomas/I-3465-2012	Robert, Thomas/0000-0002-6502-7082; Aftab, Zohaib/0000-0002-3480-1645	la Region Rhone-Alpes	la Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	Zohaib Aftab held a doctoral fellowship from la Region Rhone-Alpes.	Aftab Z, 2012, SIMULATION DYNAMIQUE; Aftab Z, 2012, P 12 IEEE RAS INT C; Aftab Z, 2012, J BIOMECH, V45, P2804, DOI 10.1016/j.jbiomech.2012.08.038; Atkeson CG, 2007, IEEE-RAS INT C HUMAN, P57, DOI 10.1109/ICHR.2007.4813849; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Chaffin D., 2006, OCCUPATIONAL BIOMECH, V2nd; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cyr MA, 2009, GAIT POSTURE, V29, P628, DOI 10.1016/j.gaitpost.2009.01.011; deGraaf B, 1997, HUM FACTORS, V39, P111, DOI 10.1518/001872097778940614; Diedam H, 2009, P 9 IEEE RAS INT C H; DO MC, 1982, J BIOMECH, V15, P933, DOI 10.1016/0021-9290(82)90011-2; Doke J, 2007, J EXP BIOL, V210, P2390, DOI 10.1242/jeb.02782; Guihard M, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P2587, DOI 10.1109/IRDS.2002.1041660; Heinrich S, 2010, OSTEOPOROSIS INT, V21, P891, DOI 10.1007/s00198-009-1100-1; Herdt A, 2010, ADV ROBOTICS, V24, P719, DOI 10.1163/016918610X493552; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hsiao-Wecksler ET, 2007, CLIN BIOMECH, V22, P574, DOI 10.1016/j.clinbiomech.2007.01.013; King GW, 2005, GAIT POSTURE, V22, P219, DOI 10.1016/j.gaitpost.2004.09.008; Koolen T, 2012, INT J ROBOT RES, V31, P1094, DOI 10.1177/0278364912452673; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; MAKI BE, 1994, INT CONGR SER, V1070, P437; McIlroy WE, 1996, J GERONTOL A-BIOL, V51, pM289, DOI 10.1093/gerona/51A.6.M289; Mille ML, 2003, J NEUROPHYSIOL, V90, P666, DOI 10.1152/jn.00974.2002; Moglo K., 2005, ISB 20 C ASB 29 ANN; Owings TM, 2001, CLIN BIOMECH, V16, P813, DOI 10.1016/S0268-0033(01)00077-8; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Park S, 2004, EXP BRAIN RES, V154, P417, DOI 10.1007/s00221-003-1674-3; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pratt J, 2006, IEEE-RAS INT C HUMAN, P200, DOI 10.1109/ichr.2006.321385; Robert T, 2006, ANAL BIOMECANIQUE MA; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Stephens B, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P4026; Thelen DG, 1997, J GERONTOL A-BIOL, V52, pM8, DOI 10.1093/gerona/52A.1.M8; Tisserand R, 2014, NEUROPHYSIOL CLIN, V44, P133, DOI [10.1016/j.neucli.2013.10.076, DOI 10.1016/J.NEUCLI.2013.10.076]; Vallee P, 2015, COMPUT METHOD BIOMEC, V18, P2074, DOI 10.1080/10255842.2015.1069613; van der Kooij H, 1999, BIOL CYBERN, V80, P299, DOI 10.1007/s004220050527; Wight DL, 2008, J COMPUT NONLIN DYN, V3, DOI 10.1115/1.2815334; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Wu M, 2007, J BIOMECH, V40, P1559, DOI 10.1016/j.jbiomech.2006.07.019; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237	42	12	12	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151166	10.1371/journal.pone.0151166	http://dx.doi.org/10.1371/journal.pone.0151166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974820	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600053
J	Cronin, FM; Segurado, R; McAuliffe, FM; Kelleher, CC; Tremblay, RE				Cronin, Frances M.; Segurado, Ricardo; McAuliffe, Fionnuala M.; Kelleher, Cecily C.; Tremblay, Richard E.			Gestational Age at Birth and 'Body-Mind' Health at 5 Years of Age: A Population Based Cohort Study	PLOS ONE			English	Article							WEIGHT PREMATURE-INFANTS; DIFFICULTIES QUESTIONNAIRE; DEVELOPMENT PROGRAM; EARLY INTERVENTION; PRETERM BIRTH; FOLLOW-UP; CHILDHOOD; LIFE; ADULTHOOD; COUNTRIES	Numerous studies have identified the effects of prematurity on the neonate's physical health, however few studies have explored the effects of prematurity on both the physical and mental health of the child as they develop. Secondary analysis of data from the Millennium Cohort Study, a longitudinal study of infants (n = 18 818, born 2000-2002 in the United Kingdom) was performed. Effects of gestational age at birth on health outcomes at 5 years were measured using parental rating of their children's general health and severity of behavior problems. The association between parent's general health ratings and behavior problem ratings was low: 86% of those reporting serious behavior problems (5% of the sample, n = 764) rated their child as being in excellent, very good, or good health. Still, a gradient of increasing risk of poorer outcome with decreasing gestational age was observed for a composite health measure (poor/fair health and/or serious behavior problems), suggesting an association with prematurity for this composite assessment of health status. The greatest contribution to the childhood composite health measure at 5 years was for children born at 32-36 weeks gestation: population attributable fractions for having poor outcomes was 3.4% (Bonferroni-adjusted 95% confidence interval 1.1%-6.2%), compared to 1% (0.2-2.3) for birth at less than 32 weeks. Results suggest that preterm children, by school entry, are not only at high risk of physical health problems, but also of behavioral health problems. The recognition of, and response to comprehensive health and well-being outcomes related to prematurity are important in order to correctly plan and deliver adequate paediatric health services and policies.	[Cronin, Frances M.; Kelleher, Cecily C.; Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 2, Ireland; [Segurado, Ricardo] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, UCD CSTAR, Dublin 2, Ireland; [McAuliffe, Fionnuala M.] Univ Coll Dublin, Natl Matern Hosp, Sch Med & Med Sci, UCD Obstet & Gynaecol, Dublin 2, Ireland; [Tremblay, Richard E.] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada	University College Dublin; University College Dublin; National Maternity Hospital, Dublin; University College Dublin; Universite de Montreal; Universite de Montreal	Cronin, FM (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 2, Ireland.	fran.cronin@ucd.ie	Tremblay, Richard E./O-1360-2014; kelleher, cecily c/A-4233-2013; Segurado, Ricardo/K-6116-2014	kelleher, cecily c/0000-0001-9548-4914; Segurado, Ricardo/0000-0002-3547-6733	HRB Ireland [HRA_PHS/2011/35]	HRB Ireland	FMC was funded by an HRB Ireland research grant (HRA_PHS/2011/35) awarded to RET. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	American Academy of Child and Adolescent Psychiatry, 2010, GUID BUILD COLL MENT, P1; [Anonymous], USER GUIDE ANAL MCS; [Anonymous], 1996, CHQ USERS MANUAL; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Boisjoli R, 2007, BRIT J PSYCHIAT, V191, P415, DOI 10.1192/bjp.bp.106.030007; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; BROOKSGUNN J, 1994, JAMA-J AM MED ASSOC, V272, P1257, DOI 10.1001/jama.272.16.1257; Castellanos-Ryan N, 2013, BRIT J PSYCHIAT, V203, P188, DOI 10.1192/bjp.bp.112.123182; Chiarella J, 2015, TWIN RES HUM GENET, V18, P623, DOI 10.1017/thg.2015.84; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Eckenrode J, 2010, ARCH PEDIAT ADOL MED, V164, P9, DOI 10.1001/archpediatrics.2009.240; European Foundation for the Care of Newborns and Infants, 2011, EU BENCHM REP 2009 2; Fontaine N, 2008, ARCH GEN PSYCHIAT, V65, P320, DOI 10.1001/archgenpsychiatry.2007.41; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hansen K., 2010, MILLENNIUM COHORT ST; HM Government and Department of Health, 2011, NO HLTH MENT HLTH CR; Hockley C, 2007, MILLENNIUM COHORT ST; Kendell RE, 2001, BRIT J PSYCHIAT, V178, P490, DOI 10.1192/bjp.178.6.490; Ketende S, 2008, MILLIENNIUM COHORT S; Kitzman HJ, 2010, ARCH PEDIAT ADOL MED, V164, P412, DOI 10.1001/archpediatrics.2010.76; Knapp M., 2011, MENTAL HLTH PROMOTIO; Kolko DJ, 2014, J CLIN CHILD ADOLESC, V43, P216, DOI 10.1080/15374416.2013.862804; Larson CP, 2007, PAED CHILD HEALT-CAN, V12, P673, DOI 10.1093/pch/12.8.673; Maughan B, 2005, BRIT J PSYCHIAT, V187, P301, DOI 10.1192/bjp.187.4.301; McCormick MC, 2006, PEDIATRICS, V117, P771, DOI 10.1542/peds.2005-1316; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Natarajan S, 2007, STAT MED, V26, P3229, DOI 10.1002/sim.2779; Norrby U, 2003, SCAND J RHEUMATOL, V32, P101, DOI 10.1080/03009740310000111; Platt MJ, 2008, LANCET, V371, P787, DOI 10.1016/S0140-6736(08)60354-2; Richards M, 2009, CHILDHOOD MENTAL HLT; Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pS1; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Schoon I, 2010, PEDIATRICS, V126, pE73, DOI 10.1542/peds.2009-3282; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; Van Lente E, 2012, INT J PUBLIC HEALTH, V57, P421, DOI 10.1007/s00038-011-0317-x; Vogel JP, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-56; World Health Organization (WHO), 2005, WHO EUR MIN C 2005; Zwicker JG, 2008, PEDIATRICS, V121, pE366, DOI 10.1542/peds.2007-0169	43	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151222	10.1371/journal.pone.0151222	http://dx.doi.org/10.1371/journal.pone.0151222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26975048	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600055
J	Herrmann, KH; Kramer, M; Reichenbach, JR				Herrmann, Karl-Heinz; Kraemer, Martin; Reichenbach, Juergen R.			Time Efficient 3D Radial UTE Sampling with Fully Automatic Delay Compensation on a Clinical 3T MR Scanner	PLOS ONE			English	Article							ULTRASHORT ECHO-TIME; COMPRESSED SENSING RECONSTRUCTION; MAGNETIC-RESONANCE ANGIOGRAPHY; SYSTEM DELAYS; EDDY CURRENTS; SENSITIVITY; CONTRAST; BONE; PULSES	This work's aim was to minimize the acquisition time of a radial 3D ultra-short echo-time (UTE) sequence and to provide fully automated, gradient delay compensated, and therefore artifact free, reconstruction. The radial 3D UTE sequence (echo time 60 mu s) was implemented as single echo acquisition with center-out readouts and improved time efficient spoiling on a clinical 3T scanner without hardware modifications. To assess the sequence parameter dependent gradient delays each acquisition contained a quick calibration scan and utilized the phase of the readouts to detect the actual k-space center. This calibration scan does not require any user interaction. To evaluate the robustness of this automatic delay estimation phantom experiments were performed and 19 in vivo imaging data of the head, tibial cortical bone, feet and lung were acquired from 6 volunteers. As clinical application of this fast 3D UTE acquisition single breath-hold lung imaging is demonstrated. The proposed sequence allowed very short repetition times (TR similar to 1ms), thus reducing total acquisition time. The proposed, fully automated k-phase based gradient delay calibration resulted in accurate delay estimations (difference to manually determined optimal delay -0.13 +/- 0.45 mu s) and allowed unsupervised reconstruction of high quality images for both phantom and in vivo data. The employed fast spoiling scheme efficiently suppressed artifacts caused by incorrectly refocused echoes. The sequence proved to be quite insensitive to motion, flow and susceptibility artifacts and provides oversampling protection against aliasing foldovers in all directions. Due to the short TR, acquisition times are attractive for a wide range of clinical applications. For short T2* mapping this sequence provides free choice of the second TE, usually within less scan time as a comparable dual echo UTE sequence.	[Herrmann, Karl-Heinz; Kraemer, Martin; Reichenbach, Juergen R.] Univ Jena, Jena Univ Hosp, Inst Diagnost & Intervent Radiol, Med Phys Grp, Jena, Germany	Friedrich Schiller University of Jena	Herrmann, KH (corresponding author), Univ Jena, Jena Univ Hosp, Inst Diagnost & Intervent Radiol, Med Phys Grp, Jena, Germany.	karl-heinz.herrmann@med.uni-jena.de	Reichenbach, Jürgen R./B-4333-2011; Krämer, Martin/AAE-7632-2020	Reichenbach, Jürgen R./0000-0002-2640-0630; Krämer, Martin/0000-0002-0173-9830; Herrmann, Karl-Heinz/0000-0003-0757-3525	interdisciplinary Center of Clinical Research (IZKF); University Hospital Jena; Friedrich-Schiller-University Jena; Dissertation Fellowship by the Carl Zeiss Foundation	interdisciplinary Center of Clinical Research (IZKF); University Hospital Jena; Friedrich-Schiller-University Jena; Dissertation Fellowship by the Carl Zeiss Foundation	MK was supported by the interdisciplinary Center of Clinical Research (IZKF), University Hospital Jena, Friedrich-Schiller-University Jena (http://www.izkf.uniklinikum-jena.de/Startseite.html) and by a Dissertation Fellowship by the Carl Zeiss Foundation (http://carl-zeiss-stiftung.de/21-0-Aktuelle-Programme.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, MED PHYS, V40, DOI 10.1118/1.4792672; Anumula S, 2006, MAGN RESON MED, V56, P946, DOI 10.1002/mrm.21050; Atkinson IC, 2009, MAGN RESON MED, V62, P532, DOI 10.1002/mrm.22016; Beatty P.J., 2009, P 17 ANN M ISMRM HAW, P2824; Bracher AK, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120321; Bracher AK, 2011, MAGN RESON MED, V66, P538, DOI 10.1002/mrm.22828; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Carl M, 2011, MAGN RESON MED, V65, P531, DOI 10.1002/mrm.22623; Chan CF, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-17; Chandarana H, 2013, INVEST RADIOL, V48, P10, DOI 10.1097/RLI.0b013e318271869c; Du J, 2013, NMR BIOMED, V26, P489, DOI 10.1002/nbm.2906; Du J, 2011, MAGN RESON IMAGING, V29, P470, DOI 10.1016/j.mri.2010.11.003; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Grodzki DM, 2012, MAGN RESON MED, V67, P510, DOI 10.1002/mrm.23017; Gurney PT, 2006, MAGN RESON MED, V55, P575, DOI 10.1002/mrm.20796; Josan S, 2009, MAGN RESON MED, V61, P1083, DOI 10.1002/mrm.21879; Keil B, 2013, J MAGN RESON, V229, P75, DOI 10.1016/j.jmr.2013.02.001; Kramer M, 2015, MAGN RESON IMAGING, V33, P491, DOI 10.1016/j.mri.2015.01.005; Krug R, 2011, J MAGN RESON IMAGING, V34, P691, DOI 10.1002/jmri.22648; Larkman DJ, 2007, PHYS MED BIOL, V52, pR15, DOI 10.1088/0031-9155/52/7/R01; Larkman DJ, 2006, MAGN RESON MED, V55, P153, DOI 10.1002/mrm.20752; Lee GR, 2013, MAGN RESON MED, V69, P346, DOI 10.1002/mrm.24256; Lee YH, 2012, P INT SOC MAG RESON, V20, P3290; Li C, 2012, MAGN RESON MED, V68, P680, DOI 10.1002/mrm.23267; Lin W, 2009, MAGN RESON MED, V62, P1185, DOI 10.1002/mrm.22089; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Nam S, 2014, J MAGN RESON IMAGING, V39, P179, DOI 10.1002/jmri.24098; Nam S, 2013, MAGN RESON MED, V69, P91, DOI 10.1002/mrm.24234; Peters DC, 2003, MAGNET RESON MED, V50, P1, DOI 10.1002/mrm.10501; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Qian YX, 2008, MAGN RESON MED, V60, P135, DOI 10.1002/mrm.21620; Rad HS, 2011, NMR BIOMED, V24, P855, DOI 10.1002/nbm.1631; Rahmer J, 2006, MAGN RESON MED, V55, P1075, DOI 10.1002/mrm.20868; Rapacchi S, 2014, MAGN RESON MED, V71, P1771, DOI 10.1002/mrm.24842; Rilling G, 2013, MAGN RESON MED, V70, P392, DOI 10.1002/mrm.24471; Robison RK, 2010, MAGN RESON MED, V63, P1683, DOI 10.1002/mrm.22327; Robson MD, 2006, NMR BIOMED, V19, P765, DOI 10.1002/nbm.1100; Robson MD, 2004, CLIN RADIOL, V59, P727, DOI 10.1016/j.crad.2003.11.021; Robson MD, 2003, J COMPUT ASSIST TOMO, V27, P825, DOI 10.1097/00004728-200311000-00001; Schweser F, 2014, P INT SOC MAG RESON, V22, P3133; Waldman A, 2003, NEURORADIOLOGY, V45, P887, DOI 10.1007/s00234-003-1076-z; Wang HF, 2009, IEEE ENG MED BIO, P2672, DOI 10.1109/IEMBS.2009.5334086; Weiger M, 2013, MAGN RESON MED, V70, P328, DOI 10.1002/mrm.24816; Weiger M, 2012, NMR BIOMED, V25, P1144, DOI 10.1002/nbm.2783; Zwart NR, 2012, MAGN RESON MED, V67, P701, DOI 10.1002/mrm.23041	46	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150371	10.1371/journal.pone.0150371	http://dx.doi.org/10.1371/journal.pone.0150371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975051	Green Submitted, gold, Green Published			2022-12-27	WOS:000372570600023
J	Janghra, N; Morgan, JE; Sewry, CA; Wilson, FX; Davies, KE; Muntoni, F; Tinsley, J				Janghra, Narinder; Morgan, Jennifer E.; Sewry, Caroline A.; Wilson, Francis X.; Davies, Kay E.; Muntoni, Francesco; Tinsley, Jonathon			Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXPRESSION PATTERNS; A-UTROPHIN; B-UTROPHIN; MDX MICE; DEFICIENCY; SARCOLEMMA; PATHOLOGY; SEVERITY; THERAPY	Duchenne muscular dystrophy is a severe and currently incurable progressive neuromuscular condition, caused by mutations in the DMD gene that result in the inability to produce dystrophin. Lack of dystrophin leads to loss of muscle fibres and a reduction in muscle mass and function. There is evidence from dystrophin-deficient mouse models that increasing levels of utrophin at the muscle fibre sarcolemma by genetic or pharmacological means significantly reduces the muscular dystrophy pathology. In order to determine the efficacy of utrophin modulators in clinical trials, it is necessary to accurately measure utrophin levels and other biomarkers on a fibre by fibre basis within a biopsy section. Our aim was to develop robust and reproducible staining and imaging protocols to quantify sarcolemmal utrophin levels, sarcolemmal dystrophin complex members and numbers of regenerating fibres within a biopsy section. We quantified sarcolemmal utrophin in mature and regenerating fibres and the percentage of regenerating muscle fibres, in muscle biopsies from Duchenne, the milder Becker muscular dystrophy and controls. Fluorescent immunostaining followed by image analysis was performed to quantify utrophin intensity and beta-dystrogylcan and gamma-sarcoglycan intensity at the sarcolemma. Antibodies to fetal and developmental myosins were used to identify regenerating muscle fibres allowing the accurate calculation of percentage regeneration fibres in the biopsy. Our results indicate that muscle biopsies from Becker muscular dystrophy patients have fewer numbers of regenerating fibres and reduced utrophin intensity compared to muscle biopsies from Duchenne muscular dystrophy patients. Of particular interest, we show for the first time that the percentage of regenerating muscle fibres within the muscle biopsy correlate with the clinical severity of Becker and Duchenne muscular dystrophy patients from whom the biopsy was taken. The ongoing development of these tools to quantify sarcolemmal utrophin and muscle regeneration in muscle biopsies will be invaluable for assessing utrophin modulator activity in future clinical trials.	[Janghra, Narinder; Morgan, Jennifer E.; Sewry, Caroline A.; Muntoni, Francesco] UCL Inst Child Hlth, Dev Neurosci Programme, Dubowitz Neuromuscular Ctr, Mol Neurosci Sect, 30 Guilford St, London WC1N 1EH, England; [Wilson, Francis X.; Tinsley, Jonathon] Summit Therapeut Plc, 85b Pk Dr,Milton Pk, Abingdon OX14 4RY, Oxon, England; [Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 3PT, England	University of London; University College London; University of Oxford	Morgan, JE (corresponding author), UCL Inst Child Hlth, Dev Neurosci Programme, Dubowitz Neuromuscular Ctr, Mol Neurosci Sect, 30 Guilford St, London WC1N 1EH, England.	jennifer.morgan@ucl.ac.uk			Summit Therapeutics and Joining Jack; Great Ormond Street Hospital Children's Charity; GOSH Biomedical Research Centre; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; Medical Research Council; Biomedical Research Centre at GOSH; Summit Therapeutics; Medical Research Council [MC_UU_12021/2, MR/N010698/1] Funding Source: researchfish; Muscular Dystrophy UK [RA3/3073] Funding Source: researchfish; MRC [MC_UU_12021/2, MR/N010698/1] Funding Source: UKRI	Summit Therapeutics and Joining Jack; Great Ormond Street Hospital Children's Charity; GOSH Biomedical Research Centre; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Centre at GOSH; Summit Therapeutics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Muscular Dystrophy UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Summit Therapeutics and Joining Jack ( grant awarded to FM and JEM). JEM is supported by Great Ormond Street Hospital Children's Charity and FM is funded from the GOSH Biomedical Research Centre. This work was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. We gratefully acknowledge the support of the Medical Research Council and of the Biomedical Research Centre at GOSH for their support of the Centre for Neuromuscular Diseases Biobank. JT and FXW are employees of the sponsor (Summit Therapeutics). They were involved in the study design, data analysis, decision to publish, reviewing of the manuscript.	Anthony K, 2011, BRAIN, V134, P3544, DOI 10.1093/brain/awr291; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; Arechavala-Gomeza V, 2010, NEUROPATH APPL NEURO, V36, P265, DOI 10.1111/j.1365-2990.2009.01056.x; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; Belanto JJ, 2014, P NATL ACAD SCI USA, V111, P5723, DOI 10.1073/pnas.1323842111; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; Cirak S, 2011, LANCET; Cirak S, 2012, MOL THER, V20, P462, DOI 10.1038/mt.2011.248; CLERK A, 1993, HISTOCHEM J, V25, P554; Deconinck N, 1998, NEUROMUSCULAR DISORD, V8, P362, DOI 10.1016/S0960-8966(98)00048-0; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Gross JG, 1999, MUSCLE NERVE, V22, P174, DOI 10.1002/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S; Guiraud S, 2015, HUM MOL GENET, V24, P4212, DOI 10.1093/hmg/ddv154; HELLIWELL TR, 1992, NEUROMUSCULAR DISORD, V2, P177, DOI 10.1016/0960-8966(92)90004-P; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Johnson EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043515; Kleopa KA, 2006, HUM MOL GENET, V15, P1623, DOI 10.1093/hmg/ddl083; Koo T, 2013, HUM GENE THER, V24, P479, DOI 10.1089/hum.2012.234; Krag TO, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-31; Li DJ, 2010, J CELL SCI, V123, P2007, DOI 10.1242/jcs.064808; Lin S, 1998, J NEUROPATH EXP NEUR, V57, P780, DOI 10.1097/00005072-199808000-00007; MATSUMURA K, 1993, J CLIN INVEST, V92, P866, DOI 10.1172/JCI116661; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mercuri E, 2013, CURR OPIN PEDIATR, V25, P701, DOI 10.1097/MOP.0b013e328365ace5; MIZUNO Y, 1994, MUSCLE NERVE, V17, P206, DOI 10.1002/mus.880170212; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; Ricotti V, 2015, J NEUROL NEUROSURG P; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; SCOTT OM, 1982, MUSCLE NERVE, V5, P291, DOI 10.1002/mus.880050405; Sewry CA, 2005, NEUROMUSCULAR DISORD, V15, P779, DOI 10.1016/j.nmd.2005.08.002; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Tachi Nobutada, 1993, Acta Paediatrica Japonica (Overseas Edition), V35, P409; Taylor J, 1997, NEUROPATH APPL NEURO, V23, P399; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley J, 2015, J CLIN PHARM; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Torelli S, 2004, NEUROPATH APPL NEURO, V30, P540, DOI 10.1111/j.1365-2990.2004.00561.x; VAINZOF M, 1995, AM J MED GENET, V58, P305, DOI 10.1002/ajmg.1320580403; Vainzof M, 2016, NEUROMUSCUL DISORD; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; Wang ZJ, 2007, MOL THER, V15, P1160, DOI 10.1038/sj.mt.6300161; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; WILSON LA, 1994, NEUROPATH APPL NEURO, V20, P359, DOI 10.1111/j.1365-2990.1994.tb00981.x; Yoshimura M, 2004, MOL THER, V10, P821, DOI 10.1016/j.ymthe.2004.07.025	47	22	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150818	10.1371/journal.pone.0150818	http://dx.doi.org/10.1371/journal.pone.0150818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974331	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600033
J	Lee, CA; Yeh, KS				Lee, Chien-An; Yeh, Kuang-Sheng			The Non-Fimbriate Phenotype Is Predominant among Salmonella enterica Serovar Choleraesuis from Swine and Those Non-Fimbriate Strains Possess Distinct Amino Acid Variations in FimH	PLOS ONE			English	Article							ESCHERICHIA-COLI; TYPE-1 FIMBRIAE; ADHESIVE PROPERTIES; GENOME SEQUENCE; TYPHIMURIUM; EXPRESSION; MUTATIONS; GENES; COLONIZATION; CONSTRUCTION	Although most Salmonella serovars are able to infect a range of animal hosts, some have acquired the ability to cause systemic infections of specific hosts. For example, Salmonella enterica serovar Choleraesuis is primarily associated with systemic infection in swine. Adherence to host epithelial cells is considered a prerequisite for initial infection, and fimbrial appendages on the outer membrane of the bacteria are implicated in this process. Although type 1 fimbriae encoded by the fim gene cluster are commonly found in Salmonella serovars, it is not known whether S. Choleraesuis produces this fimbrial type and if and how fimbriae are involved in pathogenesis. In the present study, we demonstrated that only four out of 120 S. Choleraesuis isolates from pigs with salmonellosis produced type 1 fimbriae as assayed by the yeast agglutination test and electron microscopy. One of the 116 non-type 1 fimbria-producing isolates was transformed with plasmids carrying different fim genes from S. Typhimurium LB5010, a type 1 fimbria-producing strain. Our results indicate that non-type 1 fimbria-producing S. Choleraesuis required only an intact fimH to regain the ability to produce fimbrial appendages. Sequence comparison revealed six amino acid variations between the FimH of the non-type 1 fimbria-producing S. Choleraesuis isolates and those of the type 1 fimbria-producing S. Choleraesuis isolates. S. Choleraesuis that produced type 1 fimbriae contained FimH with an amino acid sequence identical to that of S. Typhimurium LB5010. Site-directed mutagenesis leading to the replacement of the non-conserved residues revealed that a change from glycine to valine at position of 63 (G63V) resulted in a non-type 1 fimbria-producing S. Choleraesuis being able to express type 1 fimbriae on its outer membrane. It is possible that this particular amino acid change prevents this polypeptide from proper interaction with other Fim subunits required for assembly of an intact type 1 fimbrial shaft in S. Choleraesuis; however, it remains to be determined if and how the absence of type 1 fimbriae production is related to the systemic infection of the swine host by S. Choleraesuis.	[Lee, Chien-An; Yeh, Kuang-Sheng] Natl Taiwan Univ, Dept Vet Med, Sch Vet Med, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Yeh, Kuang-Sheng] Natl Taiwan Univ, Vet Hosp, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Yeh, KS (corresponding author), Natl Taiwan Univ, Dept Vet Med, Sch Vet Med, Coll Bioresources & Agr, Taipei 10764, Taiwan.; Yeh, KS (corresponding author), Natl Taiwan Univ, Vet Hosp, Taipei 10764, Taiwan.	ksyeh@ntu.edu.tw	Yeh, Kuang-Sheng/J-7715-2013		Ministry of Science and Technology, Taiwan, R.O.C. [MOST 103-2313-B-002-044]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by Ministry of Science and Technology, Taiwan, R.O.C. under the contract number MOST 103-2313-B-002-044.	Althouse C, 2003, INFECT IMMUN, V71, P6446, DOI 10.1128/IAI.71.11.6446-6452.2003; Anderson RC, 1998, RES VET SCI, V64, P261, DOI 10.1016/S0034-5288(98)90136-9; BULLAS LR, 1983, J BACTERIOL, V156, P471, DOI 10.1128/JB.156.1.471-474.1983; Chattopadhyay S, 2013, MOL BIOL EVOL, V30, P1465, DOI 10.1093/molbev/mst048; Chattopadhyay S, 2012, J BACTERIOL, V194, P5002, DOI 10.1128/JB.00552-12; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Chiu TH, 2005, J FOOD PROTECT, V68, P1575, DOI 10.4315/0362-028X-68.8.1575; Clegg S., 1994, FIMBRIAE ADHESION GE, P105; CLSI, 2011, M10021 CLSI; DUGUID JP, 1976, J MED MICROBIOL, V9, P459, DOI 10.1099/00222615-9-4-459; DUGUID JP, 1957, J PATHOL BACTERIOL, V74, P397, DOI 10.1002/path.1700740218; DUGUID JP, 1966, J PATHOL BACTERIOL, V92, P107, DOI 10.1002/path.1700920113; Dwyer BE, 2011, MICROBIOL-SGM, V157, P3162, DOI 10.1099/mic.0.051425-0; Foley S L, 2008, J Anim Sci, V86, pE173; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Guo AZ, 2009, MICROBIOL-SGM, V155, P1623, DOI 10.1099/mic.0.026286-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hancox LS, 1997, FEMS IMMUNOL MED MIC, V19, P289, DOI 10.1016/S0928-8244(97)00095-3; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Kisiela D, 2005, INFECT IMMUN, V73, P6187, DOI 10.1128/IAI.73.9.6187-6190.2005; Kisiela DI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002733; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Kuzminska-Bajor M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00276; Kuzminska-Bajor M, 2012, VET MICROBIOL, V158, P205, DOI 10.1016/j.vetmic.2012.01.029; Lillington J, 2015, BBA-GEN SUBJECTS, V1850, P554, DOI 10.1016/j.bbagen.2014.07.009; LOCKMAN HA, 1992, INFECT IMMUN, V60, P491, DOI 10.1128/IAI.60.2.491-496.1992; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McFarland KA, 2008, J BACTERIOL, V190, P602, DOI 10.1128/JB.01388-07; OLD DC, 1968, J GEN MICROBIOL, V51, P1; Pires AFA, 2014, PREV VET MED, V116, P120, DOI 10.1016/j.prevetmed.2014.06.009; RUSSELL PW, 1992, J BACTERIOL, V174, P5923, DOI 10.1128/jb.174.18.5923-5935.1992; Schmidt JW, 2012, APPL ENVIRON MICROB, V78, P2716, DOI 10.1128/AEM.07015-11; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; SWENSON DL, 1991, MICROB PATHOGENESIS, V10, P487, DOI 10.1016/0882-4010(91)90115-Q; SWENSON DL, 1994, MOL GEN GENET, V244, P216, DOI 10.1007/BF00283525; Thankavel K, 1999, J BIOL CHEM, V274, P5797, DOI 10.1074/jbc.274.9.5797; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Tinker JK, 2000, INFECT IMMUN, V68, P3305, DOI 10.1128/IAI.68.6.3305-3313.2000; Tinker JK, 2001, J BACTERIOL, V183, P435, DOI 10.1128/JB.183.2.435-442.2001; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Wang KC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-111; YEH KS, 1995, J BACTERIOL, V177, P6861, DOI 10.1128/jb.177.23.6861-6865.1995; Yue M, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00419; Zeiner SA, 2012, INFECT IMMUN, V80, P3289, DOI 10.1128/IAI.00331-12	49	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151126	10.1371/journal.pone.0151126	http://dx.doi.org/10.1371/journal.pone.0151126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974320	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600049
J	Brown, JM; Poirot, E; Hess, KL; Brown, S; Vertucci, M; Hezareh, M				Brown, Joelle M.; Poirot, Eugenie; Hess, Kristen L.; Brown, Stephen; Vertucci, Michele; Hezareh, Marjan			Motivations for Intravaginal Product Use among a Cohort of Women in Los Angeles	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; VAGINAL PRACTICES; HIV ACQUISITION; RISK; PREVALENCE; INFECTION	Objective Intravaginal practices-including behaviors such as intravaginal cleansing and insertion of products-have been linked to a number of adverse reproductive health outcomes, including increased risk for bacterial vaginosis, sexually transmitted infections, and HIV. Currently, little is known about the motivations for intravaginal practices among women in the United States. The objective of this study was to identify and describe motivations for intravaginal washing and intravaginal insertion of products among women of differing ages and racial/ethnic groups. Methods Between 2008 and 2010, we enrolled a convenience sample of sexually active women aged 18-65 years living in Los Angeles recruited through community education and out-reach activities in HIV/AIDS service organizations, women's health clinics, community-based organizations, and HIV testing sites. At the enrollment visit, women completed a self-administered, computer-assisted questionnaire covering demographics, sexual behaviors, intravaginal practices, and motivations for intravaginal practices over the past month and past year. Results We enrolled 141 women; 34% of participants were Caucasian, 40% African American, and 26% Latina. Peri-sexual intravaginal washing was common in all groups, whether to clean up after sex (70%) or to prepare for sex (54%). African American women were more likely to report learning to wash intravaginally from their mothers compared to Latina or Caucasian women (70% vs. 49%, P = 0.04). Sixty-one percent of African American women reported using a douching device over the past year compared to 41% of Latina and 40% of Caucasian women (p = 0.02). Younger women were more likely to report that their male partners wanted them to wash intravaginally than older women (77% vs. 24%, P<0.01), and more likely to report the removal of odors as a motive than older women (65% vs. 40%, P = 0.04). The most commonly used intravaginal products included sexual lubricants, petroleum jelly, body lotions, oils, and wet wipes. Use of these products varied by race, and motives given included increasing lubrication, preparing for sex, smelling good, and preventing sexually transmitted infections. Conclusion Women's intravaginal practices and motivations for these practices differ across race and age. Motivations for use also vary by type of intravaginal product used. Given that some intravaginal practices have been shown to be harmful, interventions, programs and counseling messages to encourage less harmful practices are needed, and should consider underlying motivations that influence women's vaginal practices. Practitioners may use these results to better support women in achieving vaginal health.	[Brown, Joelle M.; Poirot, Eugenie] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Brown, Joelle M.; Hess, Kristen L.; Vertucci, Michele] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Brown, Stephen; Vertucci, Michele; Hezareh, Marjan] AIDS Res Alliance Amer, Los Angeles, CA USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Brown, JM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Brown, JM (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA.	Joelle.Brown@ucsf.edu			California HIV/AIDS Research Program [CR07-LA-582, CR07-ARA-581]; UCLA AIDS Institute [CH05-LA608]; NIH/NIMH [K01 MH100994]; UCSF-CTSI [KL2 TR000143]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH100994] Funding Source: NIH RePORTER	California HIV/AIDS Research Program; UCLA AIDS Institute; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCSF-CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the California HIV/AIDS Research Program (CR07-LA-582; CR07-ARA-581), and the UCLA AIDS Institute (CH05-LA608). JMB received funding from NIH/NIMH grant number K01 MH100994 and support from UCSF-CTSI grant number KL2 TR000143. The study results are solely the responsibility of the authors and do not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide ML, 2013, J ASSOC NURSE AIDS C, V24, P219, DOI 10.1016/j.jana.2012.08.009; American Sexual Health Association, 2014, VAG BACT VAG TRICH; Angeles Mount Saint Mary's University Los, 2015, REP STAT WOM GIRLS C; Annang L, 2006, SEX TRANSM DIS, V33, P215, DOI 10.1097/01.olq.0000205046.11916.c5; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Brown JM, 2013, OBSTET GYNECOL, V121, P773, DOI 10.1097/AOG.0b013e31828786f8; Chandra Anjani, 2005, Vital Health Stat 23, P1; Funkhouser E, 2002, J WOMEN HEALTH GEN-B, V11, P29, DOI 10.1089/152460902753473435; Funkhouser E, 2002, J AM COLL HEALTH, V50, P177, DOI 10.1080/07448480209596024; Gazmararian J A, 2001, Matern Child Health J, V5, P153, DOI 10.1023/A:1011391700314; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hilber AM, 2007, SEX TRANSM INFECT, V83, P505, DOI 10.1136/sti.2007.028597; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hilber AM, 2010, SOC SCI MED, V70, P392, DOI 10.1016/j.socscimed.2009.10.023; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Hutchinson KB, 2007, SEX TRANSM DIS, V34, P671, DOI 10.1097/01.olq.0000258435.34879.da; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Pavlova S I, 2000, Infect Dis Obstet Gynecol, V8, P99, DOI 10.1155/S1064744900000090; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Trabert B, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.085; van de Wijgert JHHM, 2000, J ACQ IMMUN DEF SYND, V24, P62	24	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151378	10.1371/journal.pone.0151378	http://dx.doi.org/10.1371/journal.pone.0151378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967165	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200049
J	Majeed, A; Piah, AM; Yahya, ZR				Majeed, Abdul; Piah, Abd Rahni Mt; Yahya, Zainor Ridzuan			Surface Reconstruction from Parallel Curves with Application to Parietal Bone Fracture Reconstruction	PLOS ONE			English	Article							CRANIOFACIAL RECONSTRUCTION; ALGORITHM	Maxillofacial trauma are common, secondary to road traffic accident, sports injury, falls and require sophisticated radiological imaging to precisely diagnose. A direct surgical reconstruction is complex and require clinical expertise. Bio-modelling helps in reconstructing surface model from 2D contours. In this manuscript we have constructed the 3D surface using 2D Computerized Tomography (CT) scan contours. The fracture part of the cranial vault are reconstructed using GC1 rational cubic Ball curve with three free parameters, later the 2D contours are flipped into 3D with equidistant z component. The constructed surface is represented by contours blending interpolant. At the end of this manuscript a case report of parietal bone fracture is also illustrated by employing this method with a Graphical User Interface (GUI) illustration.	[Majeed, Abdul] Univ Educ, Div Sci & Technol, Town Ship Lahore, Pakistan; [Piah, Abd Rahni Mt] Univ Sains Malaysia, Sch Math Sci, George Town 11800, Malaysia; [Yahya, Zainor Ridzuan] Univ Malaysia Perlis, Inst Engn Math, Pauh Putra Campus, Pauh 02600, Perlis, Malaysia	Universiti Sains Malaysia; Universiti Malaysia Perlis	Majeed, A (corresponding author), Univ Educ, Div Sci & Technol, Town Ship Lahore, Pakistan.	abdulmajeed@ue.edu.pk	Yahya, Zainor/GNH-4483-2022		Ministry of Education of Malaysia; Universiti Sains Malaysia [203/PMATHS/6711365]	Ministry of Education of Malaysia; Universiti Sains Malaysia(Universiti Sains Malaysia)	The authors would like to extend their gratitude to the Ministry of Education of Malaysia and Universiti Sains Malaysia for supporting this work under its Fundamental Research Grant Scheme (FRGS), Account No. 203/PMATHS/6711365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre F, 2008, VIPIMAGE; Ball A. A., 1974, Computer Aided Design, V6, P243, DOI 10.1016/0010-4485(74)90009-8; Bhatt A.D., 2008, COMPUT AIDED DES APP, V5, P194; Butland J, 1980, P COMPUTER GRAPHICS, P409; Cavalcanti MGP, 2014, DENTOMAXILLOFACIAL R; FANG Z., 2005, THESIS DREXEL U; Goodman TNT, 1992, P 5 ASEE INT C ECGDG; Kou XY, 2007, COMPUT AIDED DESIGN, V39, P284, DOI 10.1016/j.cad.2006.12.007; Lian Q, 2006, COMPUT AIDED DESIGN, V38, P507, DOI 10.1016/j.cad.2005.12.001; Ma Z, 2013, MED ENG PHYS, V35, P1819, DOI 10.1016/j.medengphy.2013.05.002; Ma Z, 2012, INT J NUMER METH BIO, V28, P714, DOI 10.1002/cnm.2463; Ma Z, 2010, COMPUT METHOD BIOMEC, V13, P235, DOI 10.1080/10255840903131878; Ma Z, 2009, IMAGAPP 2009: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON COMPUTER IMAGING THEORY AND APPLICATIONS, P135; Magnenat TN, 2000, IEEE T INF TECHNOL B, V4, P137, DOI [10.1109/4233.845206, DOI 10.1109/4233.845206]; Majeed A., 2014, APPL MATH SCI, V8, P3683, DOI DOI 10.12988/AMS.2014.43201; Majeed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122854; Min Kj, 2003, MED IMAGE COMPUTING, P99; Moura DC, 2011, MED ENG PHYS, V33, P924, DOI 10.1016/j.medengphy.2011.03.007; Moura DC, 2009, LECT NOTES COMPUTER; Muller A, 2003, J CRANIOFAC SURG, V14, P899; Park H, 2007, COMPUT AIDED DESIGN, V39, P439, DOI 10.1016/j.cad.2006.12.006; Piah ARM, 2011, SAINS MALAYS, V40, P1173; Pimenta S, 2006, RECONSTRUCTION 3D MO, V1; SAID HB, 1989, ACM T GRAPHIC, V8, P360, DOI 10.1145/77269.77275; Sarfraz M, 2006, COMPUT IMAGING VIS, V32, P528; Sauret V., 2002, IMAGING, V14, P464, DOI [10.1259/img.14.6.140464, DOI 10.1259/IMG.14.6.140464]; Vandermeulen D, 2006, FORENSIC SCI INT, V159, pS164, DOI 10.1016/j.forsciint.2006.02.036; Winslow BD, 2010, BIOMATERIALS, V31, P9373, DOI 10.1016/j.biomaterials.2010.07.078; Wu T, 2006, LECT NOTES COMPUT SC, V4190, P9; Wuyang S., 2010, IM VIS COMP NZ IVCNZ, P1; Yoshimoto F, 2003, COMPUT AIDED DESIGN, V35, P751, DOI 10.1016/S0010-4485(03)00006-X	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149921	10.1371/journal.pone.0149921	http://dx.doi.org/10.1371/journal.pone.0149921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967643	gold, Green Published, Green Submitted			2022-12-27	WOS:000371989200007
J	Yamaguchi, S; Aoyama, T; Ito, A; Nagai, M; Iijima, H; Tajino, J; Zhang, XK; Kiyan, W; Kuroki, H				Yamaguchi, Shoki; Aoyama, Tomoki; Ito, Akira; Nagai, Momoko; Iijima, Hirotaka; Tajino, Junichi; Zhang, Xiangkai; Kiyan, Wataru; Kuroki, Hiroshi			The Effect of Exercise on the Early Stages of Mesenchymal Stromal Cell-Induced Cartilage Repair in a Rat Osteochondral Defect Model	PLOS ONE			English	Article							CONTINUOUS PASSIVE MOTION; ARTICULAR-CARTILAGE; STEM-CELLS; RABBIT; OSTEOARTHRITIS; ADHESION; KNEE; TRANSPLANTATION; PERIOSTEAL; ARTHRITIS	The repair of articular cartilage is challenging owing to the restriction in the ability of articular cartilage to repair itself. Therefore, cell supplementation therapy is possible cartilage repair method. However, few studies have verified the efficacy and safety of cell supplementation therapy. The current study assessed the effect of exercise on early the phase of cartilage repair following cell supplementation utilizing mesenchymal stromal cell (MSC) intra-articular injection. An osteochondral defect was created on the femoral grooves bilaterally of Wistar rats. Mesenchymal stromal cells that were obtained from male Wistar rats were cultured in monolayer. After 4 weeks, MSCs were injected into the right knee joint and the rats were randomized into an exercise or no-exercise intervention group. The femurs were divided as follows: C group (no exercise without MSC injection); E group (exercise without MSC injection); M group (no exercise with MSC injection); and ME group (exercise with MSC injection). At 2, 4, and 8 weeks after the injection, the femurs were sectioned and histologically graded using the Wakitani cartilage repair scoring system. At 2 weeks after the injection, the total histological scores of the M and ME groups improved significantly compared with those of the C group. Four weeks after the injection, the scores of both the M and ME groups improved significantly. Additionally, the scores in the ME group showed a significant improvement compared to those in the M group. The improvement in the scores of the E, M, and ME groups at 8 weeks were not significantly different. The findings indicate that exercise may enhance cartilage repair after an MSC intra-articular injection. This study highlights the importance of exercise following cell transplantation therapy.	[Yamaguchi, Shoki; Iijima, Hirotaka; Tajino, Junichi; Zhang, Xiangkai; Kiyan, Wataru; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Motor Funct Anal, Kyoto, Japan; [Yamaguchi, Shoki; Ito, Akira; Iijima, Hirotaka] Japan Soc Promot Sci, Tokyo, Japan; [Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Dev & Rehabil Motor Funct, Kyoto, Japan; [Ito, Akira] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Nagai, Momoko] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University; Kyoto University; Kyoto University	Kuroki, H (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Motor Funct Anal, Kyoto, Japan.	kuroki.hiroshi.6s@kyoto-u.ac.jp	Iijima, Hirotaka/AAV-9480-2020; Ito, Akira/AAA-4872-2021	Ito, Akira/0000-0002-9645-9777	JSPS KAKENHI [25242055, 25560258];  [26-7304]; Grants-in-Aid for Scientific Research [14J07304] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A Grant-in-Aid for JSPS Research Fellows (number 26-7304), a JSPS KAKENHI Grant-in-Aid for Scientific Research (A) (number 25242055) and JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research (number 25560258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Beckett J, 2012, J ORTHOP RES, V30, P1604, DOI 10.1002/jor.22124; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chan EF, 2012, CARTILAGE, V3, P255, DOI 10.1177/1947603511435272; Clarke HD, 2003, J ARTHROPLASTY, V18, P10, DOI 10.1054/arth.2003.50101; Davis AM, 2013, OSTEOARTHR CARTILAGE, V21, P1414, DOI 10.1016/j.joca.2013.08.013; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Galois L, 2004, OSTEOARTHR CARTILAGE, V12, P779, DOI 10.1016/j.joca.2004.06.008; Gelse K, 2003, ARTHRITIS RHEUM-US, V48, P430, DOI 10.1002/art.10759; Giannini S, 2004, FOOT ANKLE INT, V25, P168, DOI 10.1177/107110070402500311; Gobbi A, 2006, ARTHROSCOPY, V22, P1085, DOI 10.1016/j.arthro.2006.05.016; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Hung BP, 2013, J BIOMED MATER RES A, V101, P3592, DOI 10.1002/jbm.a.34647; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; KREDER HJ, 1994, CLIN ORTHOP RELAT R, P288; Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2; McMahon LA, 2008, REGEN MED, V3, P743, DOI 10.2217/17460751.3.5.743; Nam HY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4309; Nam J, 2011, ARTHRITIS RHEUM-US, V63, P1613, DOI 10.1002/art.30311; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Nishimori M, 2006, J BONE JOINT SURG BR, V88B, P1236, DOI 10.1302/0301-620X.88B9.17810; ODRISCOLL SW, 1984, J BONE JOINT SURG AM, V66A, P1248, DOI 10.2106/00004623-198466080-00014; Orth P, 2012, OSTEOARTHR CARTILAGE, V20, P1161, DOI 10.1016/j.joca.2012.06.008; Peeters CMM, 2013, OSTEOARTHR CARTILAGE, V21, P1465, DOI 10.1016/j.joca.2013.06.025; Ragetly GR, 2010, J MATER SCI-MATER M, V21, P2479, DOI 10.1007/s10856-010-4096-3; RITSILA VA, 1994, CLIN ORTHOP RELAT R, P259; Song JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090858; Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033; Stoddart MJ, 2015, ADV DRUG DELIVER REV, V84, P135, DOI 10.1016/j.addr.2014.08.007; Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x; van Buul GM, 2012, OSTEOARTHR CARTILAGE, V20, P1186, DOI 10.1016/j.joca.2012.06.003; Vijayan S, 2010, INDIAN J ORTHOP, V44, P238, DOI 10.4103/0019-5413.65136; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061; Wondrasch B, 2009, AM J SPORT MED, V37, p88S, DOI 10.1177/0363546509351272; Yamaguchi S, 2013, J ORTHOP RES, V31, P1026, DOI 10.1002/jor.22332	38	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151580	10.1371/journal.pone.0151580	http://dx.doi.org/10.1371/journal.pone.0151580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968036	gold, Green Published			2022-12-27	WOS:000371989200065
J	Bos, EH; Snippe, E; de Jonge, P; Jeronimus, BF				Bos, Elisabeth H.; Snippe, Evelien; de Jonge, Peter; Jeronimus, Bertus F.			Preserving Subjective Wellbeing in the Face of Psychopathology: Buffering Effects of Personal Strengths and Resources	PLOS ONE			English	Article							STRESS SCALES DASS; INDIVIDUAL-DIFFERENCES; DEPRESSIVE SYMPTOMS; POSITIVE PSYCHOLOGY; COMMITMENT THERAPY; MENTAL-HEALTH; SERVICE DOGS; RESILIENCE; HAPPINESS; ANXIETY	Background Many studies on resilience have shown that people can succeed in preserving mental health after a traumatic event. Less is known about whether and how people can preserve subjective wellbeing in the presence of psychopathology. We examined to what extent psychopathology can co-exist with acceptable levels of subjective wellbeing and which personal strengths and resources moderate the association between psychopathology and wellbeing. Methods Questionnaire data on wellbeing (Manchester Short Assessment of Quality of Life/Happiness Index), psychological symptoms (Depression Anxiety Stress Scales), and personal strengths and resources (humor, Humor Style questionnaire; empathy, Empathy Quotient questionnaire; social company; religion; daytime activities, Living situation questionnaire) were collected in a population-based internet study (HowNutsAreTheDutch; N = 12,503). Data of the subset of participants who completed the above questionnaires (n = 2411) were used for the present study. Regression analyses were performed to predict wellbeing from symptoms, resources, and their interactions. Results Satisfactory levels of wellbeing (happiness score 6 or higher) were found in a substantial proportion of the participants with psychological symptoms (58% and 30% of those with moderate and severe symptom levels, respectively). The association between symptoms and wellbeing was large and negative (-0.67, P < .001), but less so in persons with high levels of self-defeating humor and in those with a partner and/or pet. Several of the personal strengths and resources had a positive main effect on wellbeing, especially self-enhancing humor, having a partner, and daytime activities. Conclusions Cultivating personal strengths and resources, like humor, social/animal company, and daily occupations, may help people preserve acceptable levels of wellbeing despite the presence of symptoms of depression, anxiety, and stress.	[Bos, Elisabeth H.; Snippe, Evelien; de Jonge, Peter; Jeronimus, Bertus F.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands	University of Groningen	Bos, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	elske.bos@umcg.nl	Jeronimus, Bertus F/AAC-2877-2020; de Jonge, Peter/L-6395-2013	Jeronimus, Bertus/0000-0003-2826-4537; de Jonge, Peter/0000-0002-0866-6929; Snippe, Evelien/0000-0002-3003-7475	VICI from the Netherlands Organization for Health Research Development (ZonMW) [91812607]	VICI from the Netherlands Organization for Health Research Development (ZonMW)	The work was funded by VICI grant # 91812607 received by PdJ from the Netherlands Organization for Health Research Development (ZonMW; www.zonmw.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Khalek AM, 2006, SOC BEHAV PERSONAL, V34, P139, DOI 10.2224/sbp.2006.34.2.139; Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Allen K, 1996, JAMA-J AM MED ASSOC, V275, P1001, DOI 10.1001/jama.275.13.1001; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 1946, PUBLIC HEALTH REP, V61, P1268; [Anonymous], HAPPINESS SCI YOUR S; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bergsma A, 2011, J HAPPINESS STUD, V12, P793, DOI 10.1007/s10902-010-9227-5; Blonk, 2001, GEDRAGSTHERAPIE, V34, P35, DOI DOI 10.1037/T69646-000]; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Burrows KE, 2008, QUAL HEALTH RES, V18, P1642, DOI 10.1177/1049732308327088; Catalino LI, 2014, EMOTION, V14, P1155, DOI 10.1037/a0038029; CBS, 2015, WELZ NED; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Connor KM, 2003, J TRAUMA STRESS, V16, P487, DOI 10.1023/A:1025762512279; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Duckworth AL, 2005, ANNU REV CLIN PSYCHO, V1, P629, DOI 10.1146/annurev.clinpsy.1.102803.144154; FORDYCE MW, 1988, SOC INDIC RES, V20, P355, DOI 10.1007/BF00302333; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Hayes SC, 2004, BEHAV THER, V35, P639, DOI 10.1016/S0005-7894(04)80013-3; Heintzelman SJ, 2013, PSYCHOL SCI, V24, P991, DOI 10.1177/0956797612465878; Henman LD, 2008, HUMOR, V14, P83; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; IGDA Workgroup, 2003, BRIT J PSYCHIAT, V182, pS37; Jeronimus BF, 2014, J PERS SOC PSYCHOL, V107, P751, DOI 10.1037/a0037009; Kahneman D., 1999, WELL BEING FDN HEDON; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Kendler KS, 2011, PSYCHOL MED, V41, P1143, DOI 10.1017/S0033291710001844; Kendler KS, 2015, PHILOS ISSUES PSYCHI; Keyes CLM, 2007, AM PSYCHOL, V62, P95, DOI 10.1037/0003-066X.62.2.95; Krueger RE, 2006, ANNU REV CLIN PSYCHO, V2, P111, DOI 10.1146/annurev.clinpsy.2.022305.095213; LEWINSOHN PM, 1980, PSYCHOTHER-THEOR RES, V17, P322, DOI 10.1037/h0085929; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Martin RA, 2003, J RES PERS, V37, P48, DOI 10.1016/S0092-6566(02)00534-2; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Mead N, 2010, BRIT J PSYCHIAT, V196, P96, DOI 10.1192/bjp.bp.109.064089; Mezzich JE, 2005, PSYCHOPATHOLOGY, V38, P177, DOI 10.1159/000086086; Nieboer A, 2005, SOC INDIC RES, V73, P313, DOI 10.1007/s11205-004-0988-2; Office for National Statistics, 2015, STAT B; Oishi S, 2007, PERSPECT PSYCHOL SCI, V2, P346, DOI 10.1111/j.1745-6916.2007.00048.x; Palmer BW, 2014, SCHIZOPHR RES, V159, P151, DOI 10.1016/j.schres.2014.07.027; Peeters FPML, 1996, TIJDSCHRIFT PSYCHIAT, V38; Perkins R, 2001, BRIT J PSYCHIAT, V179, P9, DOI 10.1192/bjp.179.1.9; Peterson RA, 2005, J APPL PSYCHOL, V90, P175, DOI 10.1037/0021-9010.90.1.175; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Rafaeli E, 2007, PERS SOC PSYCHOL B, V33, P915, DOI 10.1177/0146167207301009; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Salloum IM, 2011, J EVAL CLIN PRACT, V17, P354, DOI 10.1111/j.1365-2753.2010.01581.x; Sheldon K., 1999, DESIGNING POSITIVE P, P455, DOI [http://dx.doi.org/10.1093/acprof:oso/9780195373585.001.0001, DOI 10.1093/ACPROF:OSO/9780195373585.001.0001]; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Smout MF, 2012, CLIN PSYCHOL-UK, V16, P97, DOI 10.1111/j.1742-9552.2012.00051.x; Snippe E, PROSOCIAL PEOP UNPUB; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Taylor SE, 2006, CURR DIR PSYCHOL SCI, V15, P273, DOI 10.1111/j.1467-8721.2006.00451.x; United Nations Development Programme, 2015, HUM DEV REP 2015; Van Der Krieke L, 2016, INT J METH PSYCH RES, V25, P123, DOI 10.1002/mpr.1495; van Dierendonck D, 2004, PERS INDIV DIFFER, V36, P629, DOI 10.1016/S0191-8869(03)00122-3	64	30	30	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150867	10.1371/journal.pone.0150867	http://dx.doi.org/10.1371/journal.pone.0150867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963923	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000072
J	Kahaki, SMM; Nordin, MJ; Ashtari, AH; Zahra, SJ				Kahaki, Seyed Mostafa Mousavi; Nordin, Md Jan; Ashtari, Amir H.; Zahra, Sophia J.			Invariant Feature Matching for Image Registration Application Based on New Dissimilarity of Spatial Features	PLOS ONE			English	Article							CORNER DETECTION; INTEREST POINTS; SIMILARITY; TRANSFORM; SCALE	An invariant feature matching method is proposed as a spatially invariant feature matching approach. Deformation effects, such as affine and homography, change the local information within the image and can result in ambiguous local information pertaining to image points. New method based on dissimilarity values, which measures the dissimilarity of the features through the path based on Eigenvector properties, is proposed. Evidence shows that existing matching techniques using similarity metrics-such as normalized cross-correlation, squared sum of intensity differences and correlation coefficient-are insufficient for achieving adequate results under different image deformations. Thus, new descriptor's similarity metrics based on normalized Eigenvector correlation and signal directional differences, which are robust under local variation of the image information, are proposed to establish an efficient feature matching technique. The method proposed in this study measures the dissimilarity in the signal frequency along the path between two features. Moreover, these dissimilarity values are accumulated in a 2D dissimilarity space, allowing accurate corresponding features to be extracted based on the cumulative space using a voting strategy. This method can be used in image registration applications, as it overcomes the limitations of the existing approaches. The output results demonstrate that the proposed technique outperforms the other methods when evaluated using a standard dataset, in terms of precision-recall and corner correspondence.	[Kahaki, Seyed Mostafa Mousavi; Nordin, Md Jan; Ashtari, Amir H.; Zahra, Sophia J.] Natl Univ Malaysia UKM, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Kahaki, SMM (corresponding author), Natl Univ Malaysia UKM, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Bangi, Selangor, Malaysia.	kahaki@ukm.edu.my	Kahaki, Seyed Mostafa Mousavi/H-3906-2015; Ashtari, Amir Hossein/E-6134-2011; Nordin, Jan/B-9579-2011	Kahaki, Seyed Mostafa Mousavi/0000-0002-0249-3238; Ashtari, Amir Hossein/0000-0002-1022-8434; Nordin, Jan/0000-0002-7524-5665	Universiti Kebangsaan Malaysia [DIP-2014-018, FRGS/1/2014/ICT07/UKM/02/2]	Universiti Kebangsaan Malaysia	Grants No. DIP-2014-018 and FRGS/1/2014/ICT07/UKM/02/2, Universiti Kebangsaan Malaysia (http://www.ukm.my/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtari AH, 2011, EL ENG INF ICEEI 201; Ashtari AH, 2015, IEEE T IMAGE PROCESS, V24, P3370, DOI 10.1109/TIP.2015.2440763; Awrangieb M, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-5, P1483; Awrangjeb M, 2008, CONTOUR BASED CORNER; Awrangjeb M, 2008, IEEE T IMAGE PROCESS, V17, P2425, DOI 10.1109/TIP.2008.2006441; Awrangjeb M, 2008, IEEE T MULTIMEDIA, V10, P1059, DOI 10.1109/TMM.2008.2001384; BROWN LG, 1992, COMPUT SURV, V24, P325, DOI 10.1145/146370.146374; Brown M, 2002, BRIT MACH VIS C, DOI DOI 10.5244/C.16.23; Cour T, 2007, BALANCED GRAPH MATCH; Dutta A, 2011, PATTERN RECOGN LETT, V32, P712, DOI 10.1016/j.patrec.2010.12.006; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Ge P, 2014, OPT EXPRESS, V22, P13531, DOI 10.1364/OE.22.013531; Gold S, 1996, IEEE T PATTERN ANAL, V18, P377, DOI 10.1109/34.491619; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Hsu WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066656; Hsu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040558; HU XP, 1994, IEEE T PATTERN ANAL, V16, P1041, DOI 10.1109/34.329004; Jung IK, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P538, DOI 10.1109/ICCV.2001.937672; Kahaki SMM, 2014, SENSORS-BASEL, V14, P4126, DOI 10.3390/s140304126; Kang U, 2013, INFORM SCIENCES, V220, P306, DOI 10.1016/j.ins.2012.07.008; Kim T, 2003, IEEE T GEOSCI REMOTE, V41, P1111, DOI 10.1109/TGRS.2003.811994; Lamdan Y., 1988, Second International Conference on Computer Vision (IEEE Cat. No.88CH2664-1), P238, DOI 10.1109/CCV.1988.589995; Lewis AS, 2003, MATH PROGRAM, V97, P155, DOI 10.1007/s10107-003-0441-3; Liu ZX, 2012, IEEE T GEOSCI REMOTE, V50, P514, DOI 10.1109/TGRS.2011.2160645; Lu G., 1999, MULTIMEDIA DATABASE; Maciel J, 2003, IEEE T PATTERN ANAL, V25, P187, DOI 10.1109/TPAMI.2003.1177151; Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Ng ES, 2012, IEEE T IMAGE PROCESS, V21, P3429, DOI 10.1109/TIP.2012.2195012; Olson D.L., 2008, TECHNIQUES, DOI [10.1007/978-3-540-76917-0, DOI 10.1007/978-3-540-76917-0]; Penney GP, 1998, IEEE T MED IMAGING, V17, P586, DOI 10.1109/42.730403; SHAPIRO LS, 1992, IMAGE VISION COMPUT, V10, P283, DOI 10.1016/0262-8856(92)90043-3; SIMON B, 1983, PHYS REV LETT, V51, P2167, DOI 10.1103/PhysRevLett.51.2167; Stottinger J, 2012, IEEE T IMAGE PROCESS, V21, P2681, DOI 10.1109/TIP.2012.2186143; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Sun X, 2001, MULTISPECTRAL IMAGE, P144; UMEYAMA S, 1988, IEEE T PATTERN ANAL, V10, P695, DOI 10.1109/34.6778; Von Neumann J., SOME MATRIX INEQUALI; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Yang DD, 2010, IMAGE VISION COMPUT, V28, P1184, DOI 10.1016/j.imavis.2009.12.003; Yang QX, 2012, IEEE T IMAGE PROCESS, V21, P4410, DOI 10.1109/TIP.2012.2207393; Yoon KJ, 2008, COMPUT VIS IMAGE UND, V112, P173, DOI 10.1016/j.cviu.2008.02.003; YOU J, 1995, INT CONF ACOUST SPEE, P2467, DOI 10.1109/ICASSP.1995.480048; Zhou D, 2004, INT CONTR AUT 2004 W; Zhou DX, 2004, IEEE INT CONF ROBOT, P2730; Zhu Min, 2014, PLOS ONE, V9; Zhu MC, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/157847	49	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0149710	10.1371/journal.pone.0149710	http://dx.doi.org/10.1371/journal.pone.0149710			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985996	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300016
J	Kobayashi, T; Nishijima, T; Teruya, K; Aoki, T; Kikuchi, Y; Oka, S; Gatanaga, H				Kobayashi, Tetsuro; Nishijima, Takeshi; Teruya, Katsuji; Aoki, Takahiro; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy Era	PLOS ONE			English	Article							AVIUM COMPLEX INFECTION; DISEASE; SURVIVAL; COHORT; AIDS	Background Little information is available on the mortality and risk factors associated with death in disseminated non-tuberculous mycobacterial infection (dNTM) in HIV-infected patients in the ART-era. Methods In a single-center study, HIV-infected dNTM with positive NTM culture from sterile sites between 2000 and 2013 were analysed. The clinical characteristics at commencement of anti-mycobacterial treatment (baseline) were compared between those who survived and died. Results Twenty-four patients were analyzed. [The median CD4 27/mu L (range 2-185)]. Mycobacterium avium and M. intracellulare accounted for 20 (83%) and 3 (13%) of isolated NTM. NTM bacteremia was diagnosed in 15 (63%) patients. Seven (29%) patients died, and NTM bacteremia was significantly associated with mortality (p = 0.022). The baseline CD4 count was significantly lower in the non-survivors than the survivors (median 7/mu L versus 49, p = 0.034). Concomitant AIDS-defining diseases or malignancies were not associated with mortality. Immune-reconstitution syndrome (IRS) occurred to 19 (79%) patients (8 paradoxical and 11 unmasking), and prognosis tended to be better in unmasking-IRS than the other patients (n = 13) (p = 0.078). Patients with paradoxical-IRS had marginally lower CD4 count and higher frequency of bacteremia than those with unmasking-IRS (p = 0.051, and 0.059). Treatment with systemic corticosteroids was applied in 63% and 55% of patients with paradoxical and unmasking-IRS, respectively. Conclusion dNTM in HIV-infected patients resulted in high mortality even in the ART-era. NTM bacteremia and low CD4 count were risk factors for death, whereas patients presented with unmasking-IRS had marginally better prognosis. IRS occurred in 79% of the patients, suggesting difficulty in the management of dNTM.	[Kobayashi, Tetsuro; Nishijima, Takeshi; Teruya, Katsuji; Aoki, Takahiro; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Nishijima, T (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	tnishiji@acc.ncgm.go.jp	Kobayashi, Tetsuro/GZG-7054-2022		Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001, H24-AIDS-003]	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant-in Aids for AIDS Research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001; H24-AIDS-003). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; Chou CH, 2011, SCAND J INFECT DIS, V43, P8, DOI 10.3109/00365548.2010.519345; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; HORSBURGH CR, 1991, AM REV RESPIR DIS, V144, P557, DOI 10.1164/ajrccm/144.3_Pt_1.557; HORSBURGH CR, 1994, J INFECT DIS, V170, P573, DOI 10.1093/infdis/170.3.573; Karakousis PC, 2004, LANCET INFECT DIS, V4, P557, DOI 10.1016/S1473-3099(04)01130-2; Laupland KB, 2009, CRIT CARE MED, V37, pS273, DOI 10.1097/CCM.0b013e3181aa6117; LEWIS AG, 1960, ANN INTERN MED, V53, P273, DOI 10.7326/0003-4819-53-2-273; Miguez-Burbano MJ, 2006, INT J INFECT DIS, V10, P47, DOI 10.1016/j.ijid.2004.11.005; Moore RD, 1996, ANN INTERN MED, V124, P633, DOI 10.7326/0003-4819-124-7-199604010-00003; NIGHTINGALE SD, 1992, J INFECT DIS, V165, P1082, DOI 10.1093/infdis/165.6.1082; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Phillips P, 2005, CLIN INFECT DIS, V41, P1483, DOI 10.1086/497269; Ristola MA, 1999, J INFECTION, V39, P61, DOI 10.1016/S0163-4453(99)90104-4; Rossi M, 2001, SWISS MED WKLY, V131, P471; SHAPIRO AL, 1991, OTOLARYNG HEAD NECK, V105, P419, DOI 10.1177/019459989110500312; SLAP GB, 1984, JAMA-J AM MED ASSOC, V252, P1321, DOI 10.1001/jama.252.10.1321; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143	19	21	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151682	10.1371/journal.pone.0151682	http://dx.doi.org/10.1371/journal.pone.0151682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985832	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300111
J	Kole, C; Berdugo, N; Da Silva, C; Ait-Ali, N; Millet-Puel, G; Pagan, D; Blond, F; Poidevin, L; Ripp, R; Fontaine, V; Wincker, P; Zack, DJ; Sahel, JA; Poch, O; Leveillard, T				Kole, Christo; Berdugo, Naomi; Da Silva, Corinne; Ait-Ali, Najate; Millet-Puel, Geraldine; Pagan, Delphine; Blond, Frederic; Poidevin, Laetitia; Ripp, Raymond; Fontaine, Valerie; Wincker, Patrick; Zack, Donald J.; Sahel, Jose-Alain; Poch, Olivier; Leveillard, Thierry			Identification of an Alternative Splicing Product of the Otx2 Gene Expressed in the Neural Retina and Retinal Pigmented Epithelial Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MESSENGER-RNA; PHOTORECEPTOR DEVELOPMENT; MESENCHYMAL TRANSITION; TYROSINASE GENE; CONE SURVIVAL; SEQUENCE; CONSTRUCTION; DEGENERATION; MUTATIONS	To investigate the complexity of alternative splicing in the retina, we sequenced and analyzed a total of 115,706 clones from normalized cDNA libraries from mouse neural retina (66,217) and rat retinal pigmented epithelium (49,489). Based upon clustering the cDNAs and mapping them with their respective genomes, the estimated numbers of genes were 9,134 for the mouse neural retina and 12,050 for the rat retinal pigmented epithelium libraries. This unique collection of retinal of messenger RNAs is maintained and accessible through a web-base server to the whole community of retinal biologists for further functional characterization. The analysis revealed 3,248 and 3,202 alternative splice events for mouse neural retina and rat retinal pigmented epithelium, respectively. We focused on transcription factors involved in vision. Among the six candidates suitable for functional analysis, we selected Otx2S, a novel variant of the Otx2 gene with a deletion within the homeodomain sequence. Otx2S is expressed in both the neural retina and retinal pigmented epithelium, and encodes a protein that is targeted to the nucleus. OTX2S exerts transdominant activity on the tyrosinase promoter when tested in the physiological environment of primary RPE cells. By overexpressing OTX2S in primary RPE cells using an adeno associated viral vector, we identified 10 genes whose expression is positively regulated by OTX2S. We find that OTX2S is able to bind to the chromatin at the promoter of the retinal dehydrogenase 10 (RDH10) gene.	[Kole, Christo; Berdugo, Naomi; Ait-Ali, Najate; Millet-Puel, Geraldine; Pagan, Delphine; Blond, Frederic; Fontaine, Valerie; Sahel, Jose-Alain; Leveillard, Thierry] INSERM, U968, F-75012 Paris, France; [Kole, Christo; Berdugo, Naomi; Ait-Ali, Najate; Millet-Puel, Geraldine; Pagan, Delphine; Blond, Frederic; Fontaine, Valerie; Sahel, Jose-Alain; Leveillard, Thierry] Univ Paris 06, Sorbonne Univ, Inst Vis, UMR S 968, F-75012 Paris, France; [Kole, Christo; Berdugo, Naomi; Ait-Ali, Najate; Millet-Puel, Geraldine; Pagan, Delphine; Blond, Frederic; Fontaine, Valerie; Sahel, Jose-Alain; Leveillard, Thierry] CNRS, UMR 7210, F-75012 Paris, France; [Da Silva, Corinne; Wincker, Patrick] CEA, Ctr Natl Sequencage, GENOSCOPE, Inst Genom, 2 Rue Gaston Cremieux,CP5706, F-91057 Evry, France; [Poidevin, Laetitia; Poch, Olivier] Univ Strasbourg, CNRS, Fac Med, ICube UMR 7357,LBGI, 4 Rue Kirschleger, F-67085 Strasbourg, France; [Ripp, Raymond] Univ Strasbourg, CNRS, IGBMC UMR7104, 1 Rue Laurent Fries BP10142, F-67404 Illkirch Graffenstaden, France; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Wilmer Inst, Baltimore, MD 21287 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University	Leveillard, T (corresponding author), INSERM, U968, F-75012 Paris, France.; Leveillard, T (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Vis, UMR S 968, F-75012 Paris, France.; Leveillard, T (corresponding author), CNRS, UMR 7210, F-75012 Paris, France.	thierry.leveillard@inserm.fr	Léveillard, Thierry/AAR-1804-2020; Sahel, Jose-Alain/F-3172-2017; Kole, Christo/ABE-5654-2020	Léveillard, Thierry/0000-0001-5692-8770; Sahel, Jose-Alain/0000-0002-4831-1153; Kole, Christo/0000-0003-4695-3723; Puel, Geraldine/0000-0003-2387-538X; DA SILVA, Corinne/0000-0002-7618-7831; Blond, Frederic/0000-0002-2314-0570; Berdugo, Naomi/0000-0002-5460-573X; Najate, AIT-ALI/0000-0002-7626-8746	Inserm; Universite Pierre et Marie Curie; Universite de Strasbourg; Labex Lifesenses; Foundation Voir and Entendre; Fondation pour la recherche medicale; NATIONAL EYE INSTITUTE [P30EY001765] Funding Source: NIH RePORTER	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie; Universite de Strasbourg; Labex Lifesenses; Foundation Voir and Entendre; Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Inserm, Universite Pierre et Marie Curie, Universite de Strasbourg, Labex Lifesenses, the Foundation Voir and Entendre and the Fondation pour la recherche medicale.	Agoston Z, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-10; Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Alfano G, 2011, DEVELOPMENT, V138, P261, DOI 10.1242/dev.051037; Aurnhammer C, 2011, HUMAN GENE; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Beby F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011673; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Booij J, 2010, PLOS ONE, V5; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Cao H, 2011, PLOS ONE, V6; CARRIERE C, 1993, MOL CELL BIOL, V13, P7257, DOI 10.1128/MCB.13.12.7257; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chow L, 1998, MECH DEVELOP, V77, P149, DOI 10.1016/S0925-4773(98)00135-X; Comitato A, 2007, HUM MOL GENET, V16, P1699, DOI 10.1093/hmg/ddm118; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Courtois V, 2003, J NEUROCHEM, V84, P840, DOI 10.1046/j.1471-4159.2003.01583.x; Dalkara D, 2009, MOL THER, V17, P2096, DOI 10.1038/mt.2009.181; Delyfer MN, 2013, JOVE-J VIS EXP, DOI 10.3791/50375; Delyfer MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028791; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hao H, 2012, PLOS GENETICS, V8; Henderson RH, 2009, MOL VIS, V15, P2442; Hertel KJ, 2014, SPLICEOSOMAI PREMRNA; Hewitt FC, 2009, J VIROL, V83, P3919, DOI 10.1128/JVI.02466-08; Housset M, 2013, J NEUROSCI, V33, P9890, DOI 10.1523/JNEUROSCI.1099-13.2013; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Kanadia RN, 2008, DEVELOPMENT, V135, P3923, DOI 10.1242/dev.024620; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; Liu MM, 2013, CLIN GENET, V84, P142, DOI 10.1111/cge.12181; Lopez AJ, 1995, DEV BIOL, V172, P396, DOI 10.1006/dbio.1995.8050; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; Mordes D, 2006, MOL VIS, V12, P1259; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nandrot E, 2000, NEUROBIOL DIS, V7, P586, DOI 10.1006/nbdi.2000.0328; Nandrot E, 2006, AM J PHYSIOL-CELL PH, V290, P62; Nandrot EF, 2012, BIOL CELL, V104, P326, DOI 10.1111/boc.201100076; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Ohara O, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e22; Ou JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059247; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; Reichman S, 2010, HUM MOL GENET, V19, P250, DOI 10.1093/hmg/ddp484; Reinisalo M, 2012, MOL VIS, V18, P38; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Smith TPL, 2001, GENOME RES, V11, P626, DOI 10.1101/gr.170101; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Thill G, 2006, GENOME RES, V16, P776, DOI 10.1101/gr.5063306; Vithana EN, 2003, INVEST OPHTH VIS SCI, V44, P4204, DOI 10.1167/iovs.03-0253; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yuan LY, 2005, J NEUROSCI, V25, P748, DOI 10.1523/JNEUROSCI.2399-04.2005	64	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150758	10.1371/journal.pone.0150758	http://dx.doi.org/10.1371/journal.pone.0150758			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985665	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300026
J	Zhou, YY; Shi, LJ; Cui, XL; Wang, SH; Luo, XR				Zhou, Yuanyue; Shi, Lijuan; Cui, Xilong; Wang, Suhong; Luo, Xuerong			Functional Connectivity of the Caudal Anterior Cingulate Cortex Is Decreased in Autism	PLOS ONE			English	Article							RESTING-STATE NETWORK; SPECTRUM DISORDERS; ABNORMALITIES; CHILDREN; ADULTS; ADOLESCENTS; ACTIVATION; ACCUMBENS; BEHAVIOR; REGIONS	The anterior cingulate cortex (ACC) is frequently reported to have functionally distinct subregions that play key roles in different intrinsic networks. However, the contribution of the ACC, which is connected to several cortical areas and the limbic system, to autism is not clearly understood, although it may be involved in dysfunctions across several distinct but related functional domains. By comparing resting-state fMRI data from persons with autism and healthy controls, we sought to identify the abnormalities in the functional connectivity (FC) of ACC sub-regions in autism. The analyses found autism-related reductions in FC between the left caudal ACC and the right rolandic operculum, insula, postcentral gyrus, superior temporal gyrus, and the middle temporal gyrus. The FC (z-scores) between the left caudal ACC and the right insula was negatively correlated with the Stereotyped Behaviors and Restricted Interests scores of the autism group. These findings suggest that the caudal ACC is recruited selectively in the pathomechanism of autism.	[Zhou, Yuanyue; Shi, Lijuan; Cui, Xilong; Luo, Xuerong] Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Zhou, Yuanyue] Hangzhou Seventh Peoples Hosp, Dept Child Psychiat, Hangzhou 310013, Zhejiang, Peoples R China; [Wang, Suhong] Soochow Univ, Affiliated Hosp 3, Dept Neurosci, Changzhou 213003, Peoples R China	Central South University; Soochow University - China	Luo, XR (corresponding author), Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	luoxr@vip.sina.com	Cui, Xilong/HHM-6692-2022		Major State Basic Research Development Program of China (973 Program) [2012CB517901]; Special Health Industry Research of China [201302002]; National Sci-tech Support Plan of China	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Special Health Industry Research of China; National Sci-tech Support Plan of China	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program, no. 2012CB517901), the Special Health Industry Research of China (Research on technology and standards of autism diagnose and control, no. 201302002), the National Sci-tech Support Plan of China (Epidemiological investigation on child and adolescent mental disorders in China).	Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 1996, BRAIN RES REV, V22, P229; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Blakemore SJ, 2006, BRAIN COGNITION, V61, P5, DOI 10.1016/j.bandc.2005.12.013; Bos DJ, 2014, NEUROIMAGE-CLIN, V4, P820, DOI 10.1016/j.nicl.2014.05.007; Cascio CJ, 2014, J CHILD PSYCHOL PSYC, V55, P162, DOI 10.1111/jcpp.12147; Cascio CJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-9; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; Crane L, 2009, AUTISM, V13, P215, DOI 10.1177/1362361309103794; Crone EA, 2006, J NEUROSCI, V26, P11239, DOI 10.1523/JNEUROSCI.2165-06.2006; Delmonte S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00430; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; GAZNICK N, 2013, NICOTINE, V16, P445; Gillberg C, 1996, DEV MED CHILD NEUROL, V38, P191; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, V3rd; Gotham K, 2008, J AM ACAD CHILD PSY, V47, P642, DOI 10.1097/CHI.0b013e31816bffb7; Habas C, 2010, NEURORADIOLOGY, V52, P47, DOI 10.1007/s00234-009-0572-1; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; Lin HY, 2015, J INT NEUROPSYCH SOC, V21, P271, DOI 10.1017/S135561771500020X; Liss M, 2006, AUTISM, V10, P155, DOI 10.1177/1362361306062021; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; RIMLAND B, 1995, J AUTISM DEV DISORD, V25, P61, DOI 10.1007/BF02178168; Shi LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122280; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; Tyszka JM, 2014, CEREB CORTEX, V24, P1894, DOI 10.1093/cercor/bht040; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang DW, 2014, HUM BRAIN MAPP, V35, P2573, DOI 10.1002/hbm.22350; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Wing J. K., 1966, EARLY CHILDHOOD AUTI, P3; Xue G, 2010, NEUROIMAGE, V50, P709, DOI 10.1016/j.neuroimage.2009.12.097; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	52	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151879	10.1371/journal.pone.0151879	http://dx.doi.org/10.1371/journal.pone.0151879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985666	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300146
J	Shen, MQ; Shi, HF				Shen, Minqian; Shi, Haifei			Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; CYTOKINE SIGNALING-3 EXPRESSION; PROTEIN-KINASE PATHWAY; OVARIAN-CANCER CELLS; HEPATITIS-C VIRUS; PROSTATE-CANCER; BREAST-CANCER; SUSTAINED ACTIVATION; UP-REGULATION; LIVER-CANCER	Obesity is a significant risk factor for certain cancers, including hepatocellular carcinoma (HCC). Leptin, a hormone secreted by white adipose tissue, precipitates HCC development. Epidemiology data show that men have a much higher incidence of HCC than women, suggesting that estrogens and its receptors may inhibit HCC development and progression. Whether estrogens antagonize oncogenic action of leptin is uncertain. To investigate potential inhibitory effects of estrogens on leptin-induced HCC development, HCC cell line HepG2 cells were treated with leptin in combination with 17 beta-estradiol (E2), estrogen receptor-alpha (ER-alpha) selective agonist PPT, ER-beta selective agonist DPN, or G protein-coupled ER (GPER) selective agonist G-1. Cell number, proliferation, and apoptosis were determined, and leptin-and estrogen-related intracellular signaling pathways were analyzed. HepG2 cells expressed a low level of ER-beta mRNA, and leptin treatment increased ER-beta expression. E2 suppressed leptin-induced HepG2 cell proliferation and promoted cell apoptosis in a dose-dependent manner. Additionally E2 reversed leptin-induced STAT3 and leptin-suppressed SOCS3, which was mainly achieved by activation of ER-beta. E2 also enhanced ERK via activating ER-alpha and GPER and activated p38/MAPK via activating ER beta. To conclude, E2 and its receptors antagonize the oncogenic actions of leptin in HepG2 cells by inhibiting cell proliferation and stimulating cell apoptosis, which was associated with reversing leptin-induced changes in SOCS3/STAT3 and increasing p38/MAPK by activating ER-beta, and increasing ERK by activating ER-alpha and GPER. Identifying roles of different estrogen receptors would provide comprehensive understanding of estrogenic mechanisms in HCC development and shed light on potential treatment for HCC patients.	[Shen, Minqian; Shi, Haifei] Miami Univ, Dept Biol Cell Mol & Struct Biol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Shi, HF (corresponding author), Miami Univ, Dept Biol Cell Mol & Struct Biol, Oxford, OH 45056 USA.	shih@miamioh.edu	Shen, Minqian/M-2713-2016	Migliaccio, Antimo/0000-0002-4197-2055	Sigma Xi [G2012161930, G20141015719335]; National Institutes of Health [R15 DK090823]; Madalene and George Shetler Diabetes Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK090823] Funding Source: NIH RePORTER	Sigma Xi; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Madalene and George Shetler Diabetes Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by Sigma Xi (G2012161930 and G20141015719335 to M. S.), National Institutes of Health (R15 DK090823 to H. S.) and Madalene and George Shetler Diabetes Research Award to H. S.	Acharya KD, 2012, DEV NEUROBIOL, V72, P1433, DOI 10.1002/dneu.22004; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Alexia C, 2004, BIOCHEM PHARMACOL, V68, P1003, DOI 10.1016/j.bcp.2004.05.029; Altiok N, 2011, ONCOL LETT, V2, P1281, DOI 10.3892/ol.2011.385; Anbalagan M., 2015, MOL CELL ENDOCRINOL; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Canfield S, 2005, J IMMUNOL, V174, P2494, DOI 10.4049/jimmunol.174.5.2494; Chan KKL, 2008, OBSTET GYNECOL, V111, P144, DOI 10.1097/01.AOG.0000296715.07705.e9; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Chu R, 2014, CANCER-AM CANCER SOC, V120, P142, DOI 10.1002/cncr.28383; Ciucci A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101623; CLEMENTI M, 1987, FEBS LETT, V221, P11, DOI 10.1016/0014-5793(87)80343-5; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Dondi D, 2010, ENDOCR-RELAT CANCER, V17, P731, DOI 10.1677/ERC-10-0032; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fazeli M, 2006, J IMMUNOL METHODS, V312, P190, DOI 10.1016/j.jim.2006.03.011; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Hayashida K, 2010, MICROBIOL IMMUNOL, V54, P684, DOI 10.1111/j.1348-0421.2010.00268.x; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; Ho Shuk-Mei, 2003, Reprod Biol Endocrinol, V1, P73, DOI 10.1186/1477-7827-1-73; Hsu IW, 2014, ONCOTARGET, V5, P7917, DOI 10.18632/oncotarget.1421; Ignatov T, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-51; Jammart B, 2013, J VIROL, V87, P5065, DOI 10.1128/JVI.01405-12; Jin J, 2013, MOL CELL BIOCHEM, V381, P267, DOI 10.1007/s11010-013-1710-y; Khan FZ, 2015, WORLD J HEPATOL, V7, P2155, DOI 10.4254/wjh.v7.i18.2155; Komyod W, 2007, MOL CANCER RES, V5, P271, DOI 10.1158/1541-7786.MCR-06-0274; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee J, 2002, BIOCHEM BIOPH RES CO, V298, P765, DOI 10.1016/S0006-291X(02)02562-7; Li SP, 2003, CANCER RES, V63, P3473; Li XP, 2006, MOL CANCER THER, V5, P1290, DOI 10.1158/1535-7163.MCT-05-0348; Liang X, 2013, HORM METAB RES, V45, P423, DOI 10.1055/s-0033-1333751; Lin SJ, 2003, J IMMUNOL, V171, P4708, DOI 10.4049/jimmunol.171.9.4708; Lin T, 2008, TOXICOLOGY, V247, P145, DOI 10.1016/j.tox.2008.02.017; Liu W, 2015, MOL CARCINOG, V14; Liu WH, 2009, J CELL PHYSIOL, V219, P642, DOI 10.1002/jcp.21713; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Marino M, 2014, WORLD J GASTRO ONCOL, V6, P67, DOI 10.4251/wjgo.v6.i3.67; Matsuda Y, 2003, CLIN CANCER RES, V9, P3389; Matsuda Y, 2006, MED MOL MORPHOL, V39, P169, DOI 10.1007/s00795-006-0339-2; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Miceli V, 2011, OMICS, V15, P313, DOI 10.1089/omi.2010.0108; Motylewska E, 2009, CANCER LETT, V276, P68, DOI 10.1016/j.canlet.2008.10.050; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Njei B, 2015, HEPATOLOGY, V61, P191, DOI 10.1002/hep.27388; Otvos L, 2011, BIOPOLYMERS, V96, P117, DOI 10.1002/bip.21377; Persson I, 2000, J STEROID BIOCHEM, V74, P357, DOI 10.1016/S0960-0760(00)00113-8; PORTER LE, 1987, GASTROENTEROLOGY, V92, P735, DOI 10.1016/0016-5085(87)90026-6; Prieto LM, 2008, HORM METAB RES, V40, P311, DOI 10.1055/s-2008-1073141; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shimizu I, 1998, GUT, V42, P112, DOI 10.1136/gut.42.1.112; Signoretti S, 2001, AM J PATHOL, V159, P13, DOI 10.1016/S0002-9440(10)61666-5; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Teng Y, 2015, J BIOL CHEM, V290, P15799, DOI 10.1074/jbc.M115.641167; Teng Y, 2014, MOL CELL ENDOCRINOL, V392, P23, DOI 10.1016/j.mce.2014.05.007; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tong YX, 2015, BIOCHEM BIOPH RES CO, V456, P86, DOI 10.1016/j.bbrc.2014.11.038; VANBEURD.WM, 1974, BIOCHEMISTRY-US, V140, P495, DOI 10.1042/bj1400495; Vanni E, 2014, CLIN LIVER DIS, V18, P191, DOI 10.1016/j.cld.2013.09.001; VanSaun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073054; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wang C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.397; Wang CJ, 2014, MOL MED REP, V10, P3125, DOI 10.3892/mmr.2014.2595; Wei Q, 2015, LAB INVEST; Wei RC, 2011, HUM GENE THER, V22, P1109, DOI 10.1089/hum.2010.219; Wieser V, 2012, DIGEST DIS, V30, P508, DOI 10.1159/000341702; Wu WY, 2014, J INVEST SURG, V27, P197, DOI 10.3109/08941939.2013.873098; Xiong Y, 2014, MOL MED REP, V10, P1649, DOI 10.3892/mmr.2014.2373; Xu ZZ, 2012, CELL SIGNAL, V24, P1658, DOI 10.1016/j.cellsig.2012.04.015; Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307; Yuan JM, 2004, CANCER, V101, P1009, DOI 10.1002/cncr.20427; Zhang Q, 2015, CELL BIOCHEM FUNCT, V33, P134, DOI 10.1002/cbf.3097; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhao LY, 2013, CELL MOL BIOL NOIS S, V59	86	31	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151455	10.1371/journal.pone.0151455	http://dx.doi.org/10.1371/journal.pone.0151455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982332	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900085
J	Sterling, J; Jost, JT; Shrout, PE				Sterling, Joanna; Jost, John T.; Shrout, Patrick E.			Mortality Salience, System Justification, and Candidate Evaluations in the 2012 US Presidential Election	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; CONSERVATIVE SHIFT; THREAT; AUTHORITARIANISM; ATTITUDES; DEATH; IDEOLOGY; LIBERALS; POLITICS; SUPPORT	Experiments conducted during the 2004 and 2008 U.S. presidential elections suggested that mortality salience primes increased support for President George W. Bush and Senator John McCain, respectively. Some interpreted these results as reflecting "conservative shift" following exposure to threat, whereas others emphasized preferences for "charismatic" leadership following exposure to death primes. To assess both hypotheses in the context of a new election cycle featuring a liberal incumbent who was considered to be charismatic, we conducted four experiments shortly before the 2012 election involving President Barack Obama and Governor Mitt Romney. Contrary to earlier studies, there was little evidence that mortality salience, either by itself or in interaction with political orientation, affected overall candidate ratings or voting intentions. However, a significant interaction between mortality salience and system justification in some studies indicated a more circumscribed effect. The failure to "replicate" previous results in the context of this election may be attributable to disagreement among participants as to which of the candidates better represented the societal status quo.	[Sterling, Joanna; Jost, John T.; Shrout, Patrick E.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA	New York University	Sterling, J (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	joanna.sterling@nyu.edu		Jost, John/0000-0002-2844-4645	New York University; NYU Social Justice Lab	New York University; NYU Social Justice Lab	New York University funded this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mark Landau and Sheldon Solomon for sharing their research materials as well as Erin Hennes, two anonymous reviewers, and the NYU Social Justice Lab for their feedback, guidance, and support.	Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Anson J.M., 2009, SOCIAL PSYCHOL BASES, P210, DOI DOI 10.1093/ACPROF:OSO/9780195320916.003.009; Banfield JC, 2010, SOC PSYCHOL PERS SCI, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bonanno GA, 2006, BASIC APPL SOC PSYCH, V28, P311, DOI 10.1207/s15324834basp2804_4; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burke BL, 2013, POLIT PSYCHOL, V20, P1; Cantril H., 1941, PSYCHOL SOCIAL MOVEM; Castano E., 2005, EUR REV SOC PSYCHOL, V16, P221, DOI [10.1080/10463280500436024, DOI 10.1080/10463280500436024]; Castano E, 2011, POLIT PSYCHOL, V32, P601, DOI 10.1111/j.1467-9221.2011.00822.x; Cohen F, 2004, PSYCHOL SCI, V15, P846, DOI 10.1111/j.0956-7976.2004.00765.x; Cohen F., 2005, ANAL SOC ISS PUB POL, V5, P177, DOI [10.1111/j.1530-2415.2005.00063.x, DOI 10.1111/J.1530-2415.2005.00063.X]; Curran PJ, 2009, PSYCHOL METHODS, V14, P81, DOI 10.1037/a0015914; Cutright KM, 2011, J CONSUM RES, V38, P62, DOI 10.1086/658469; de Vyver Van J, 2015, P AER C, P1; DOTY RM, 1991, J PERS SOC PSYCHOL, V61, P629, DOI 10.1037/0022-3514.61.4.629; Echebarria-Echabe A, 2006, EUR J SOC PSYCHOL, V36, P259, DOI 10.1002/ejsp.294; Economou A, 2015, PEACE ECON PEACE SCI, V21, P217, DOI 10.1515/peps-2014-0036; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Fromm Erich, 1941, ESCAPE FREEDOM; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Greenberg J, 1997, ADV EXP SOC PSYCHOL, V29, P61, DOI 10.1016/S0065-2601(08)60016-7; Greenberg J, 2003, PSYCHOL BULL, V129, P376, DOI 10.1037/0033-2909.129.3.376; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Greenberg J., 1986, PUBLIC SELF PRIVATE, P189, DOI [10.1007/978-1-4613-9564-5_10, DOI 10.1007/978-1-4613-9564-5_10]; Hart J, 2014, SOC SCI RES, V46, P1, DOI 10.1016/j.ssresearch.2014.02.005; Hennes EP, 2012, SOC COGNITION, V30, P669, DOI 10.1521/soco.2012.30.6.669; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Huddy L, 2006, HENDR C POL BEH LINC; Jost JT, 2008, PERSPECT PSYCHOL SCI, V3, P126, DOI 10.1111/j.1745-6916.2008.00070.x; JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Jost JT., 2012, HDB THEORIES SOCIAL, P313, DOI [10.4135/9781446249222.n42, DOI 10.4135/9781446249222.N42]; Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823; Kosloff S, 2010, J EXP SOC PSYCHOL, V46, P139, DOI 10.1016/j.jesp.2009.09.002; Landau MJ, 2004, PERS SOC PSYCHOL B, V30, P1136, DOI 10.1177/0146167204267988; McCann SJH, 1997, J PERS SOC PSYCHOL, V73, P160, DOI 10.1037/0022-3514.73.1.160; McCann SJH, 2008, J PERS SOC PSYCHOL, V94, P913, DOI 10.1037/0022-3514.94.5.913; McGregor HA, 1998, J PERS SOC PSYCHOL, V74, P590, DOI 10.1037/0022-3514.74.3.590; Nail PR, 2009, J EXP SOC PSYCHOL, V45, P901, DOI 10.1016/j.jesp.2009.04.013; Nail PR, 2009, SOC JUSTICE RES, V22, P231, DOI 10.1007/s11211-009-0098-z; Pyszczynski, 2004, HDB EXPT EXISTENTIAL, P263; Pyszczynski T., 2003, WAKE 9 11 PSYCHOL TE; Reich Wilhelm, 2007, MASS PSYCHOL FASCISM; SALES SM, 1973, J PERS SOC PSYCHOL, V28, P44, DOI 10.1037/h0035588; SALES SM, 1972, J PERS SOC PSYCHOL, V23, P420, DOI 10.1037/h0033157; SEARS DO, 1980, AM POLIT SCI REV, V74, P670, DOI 10.2307/1958149; SOLOMON S, 1991, ADV EXP SOC PSYCHOL, V24, P93; Thissen D, 2002, J EDUC BEHAV STAT, V27, P77, DOI 10.3102/10769986027001077; Thorisdottir H, 2011, POLIT PSYCHOL, V32, P785, DOI 10.1111/j.1467-9221.2011.00840.x; Ullrich J., 2007, SOC JUSTICE RES, V20, P117, DOI [10.1007/s11211-007-0035-y, DOI 10.1007/S11211-007-0035-Y, 10.1007/s11211-007-0035]; Vail KE, 2009, ANAL SOC ISS PUB POL, V9, P255, DOI 10.1111/j.1530-2415.2009.01190.x; Watson D., 1991, PRELIMINARY MA UNPUB; Weber M, 1925, EC SOC, V1; Weise DR, 2012, EUR PSYCHOL, V17, P63, DOI 10.1027/1016-9040/a000056; Willer R., 2004, CURRENT RES SOCIAL P, V10, P1	58	2	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150556	10.1371/journal.pone.0150556	http://dx.doi.org/10.1371/journal.pone.0150556			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982197	gold, Green Submitted, Green Published			2022-12-27	WOS:000372574900044
J	Antwi-Agyei, P; Peasey, A; Biran, A; Bruce, J; Ensink, J				Antwi-Agyei, Prince; Peasey, Anne; Biran, Adam; Bruce, Jane; Ensink, Jeroen			Risk Perceptions of Wastewater Use for Urban Agriculture in Accra, Ghana	PLOS ONE			English	Article							BEHAVIOR-CHANGE; FOOD SAFETY; IRRIGATION; HYGIENE	Poor food hygiene is a significant risk to public health globally, but especially in low and middle-income countries where access to sanitation, and general hygiene remain poor. Food hygiene becomes even more pertinent when untreated, or poorly treated wastewater is used in agriculture. In such circumstances the WHO recommends the adoption of a multiple-barrier approach that prescribes health protective measures at different entry points along the food chain. This study sought to assess the knowledge and awareness of wastewater use for crop production, its related health risks, and adoption of health protective measures by farmers, market salespersons and consumers using questionnaires and focus group discussions. In the period from September 2012 to August 2013, 490 respondents were interviewed during two cropping seasons. The study found that awareness of the source of irrigation water was low among consumers and street food vendors, though higher among market vendors. In contrast, health risk awareness was generally high among salespersons and consumers, but low among farmers. The study found that consumers did not prioritize health indicators when buying produce from vendors but were motivated to buy produce, or prepared food based on taste, friendship, cost, convenience and freshness of produce. Similarly, farmers' awareness of health risk did not influence their adoption of safer farm practices. The study recommends the promotion of interventions that would result in more direct benefits to both producers and vendors, together with hygiene education and enforcement of food safety byelaws in order to influence behaviour change, and increase the uptake of the multiple-barrier approach.	[Antwi-Agyei, Prince; Biran, Adam; Ensink, Jeroen] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Environm Hlth Grp, Keppel St, London WC1E 7HT, England; [Peasey, Anne] UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England; [Bruce, Jane] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Antwi-Agyei, P (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Environm Hlth Grp, Keppel St, London WC1E 7HT, England.	Princekaagyei@gmail.com		Antwi-Agyei, Prince/0000-0001-6940-2428; Peasey, Anne/0000-0001-7434-2079	Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium through the Department for International Development (DFID); Emory University	Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium through the Department for International Development (DFID); Emory University	The study was funded by the Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium (http://www.shareresearch.org/) through the Department for International Development (DFID). PAA received this funding for this study as part of his PhD scholarship. Fieldwork for this study was also partly supported by the Emory University led SANIPATH project in Accra, Ghana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah M., 2011, INTERNET J FOOD SAFE, V13, P191; AMA, 2007, MED TERM DEV PLAN 20; Amoah P, 2008, THESIS K NKRUMAH U S; Amponsah O, 2015, RESOUR CONSERV RECY, V97, P1, DOI 10.1016/j.resconrec.2015.01.009; Andreasen AlanR., 1995, MARKETING SOCIAL CHA; Antwi-Agyei P, FARM FORK R IN PRESS; Antwi-Agyei P, FAECAL EXPO IN PRESS; Antwi-Agyei P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142346; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; BREWER MS, 1994, J FOOD SAFETY, V14, P63, DOI 10.1111/j.1745-4565.1994.tb00584.x; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; Drechsel P, 2013, MOTIVATING BEHAV CHA; Drechsel P., 2002, URBAN AGR MAGAZINE, V8, P7; Drechsel P., 2006, INFORMAL IRRIGATION; Ensink J, 2006, THESIS LONDON SCH HY; Ensink J. H. J., 2004, Water Policy, V6, P197; Ensink JHJ, 2007, TROP MED INT HEALTH, V12, P2, DOI 10.1111/j.1365-3156.2007.01935.x; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Fung J., 2011, International Journal of Food Safety, Nutrition and Public Health, V4, P152, DOI 10.1504/IJFSNPH.2011.044544; Kar K, 2008, HDB COMMUNITY LED TO; Karg H, 2011, WATER INT, V36, P476, DOI 10.1080/02508060.2011.594684; Keraita B, 2008, THESIS U COPENHAGEN; Keraita B, 2008, J RISK RES, V11, P1047, DOI 10.1080/13669870802380825; Marks D. F., 2004, RES METHODS CLIN HLT; Mertens F, 2015, ECOL SOC, V20, DOI 10.5751/ES-07483-200318; Mertens F, 2012, SOC SCI MED, V75, P643, DOI 10.1016/j.socscimed.2011.10.016; Mutengu S, 2007, PHYS CHEM EARTH, V32, P1195, DOI 10.1016/j.pce.2007.07.019; Ndunda E. N., 2013, African Journal of Agricultural Research, V8, P119; Obuobie E, 2006, IRRIGATED URBAN VEGE; Peasey A., 2002, CRITICAL REV E UNPUB; Pruss-Ustun A., 2006, WORLD HEALTH; Pruss-Ustun A, 2014, TROPICAL MED INT HLT; Qadir M, 2010, AGR WATER MANAGE, V97, P561, DOI 10.1016/j.agwat.2008.11.004; Rheinlander T, 2008, J URBAN HEALTH, V85, P952, DOI 10.1007/s11524-008-9318-3; Scott BE, 2007, HEALTH POLICY PLANN, V22, P216, DOI 10.1093/heapol/czm014; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2006, FOOD SAF RISK ANAL G; World Health Organization, 2006, GUID SAF US WAST EXC, V2	39	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150603	10.1371/journal.pone.0150603	http://dx.doi.org/10.1371/journal.pone.0150603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978778	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000372572800031
J	Ciraci, C; Janczy, JR; Jain, N; Haasken, S; Silva, CPE; Benjamim, CF; Sadler, JJ; Olivier, AK; Iwakura, Y; Shayakhmetov, DM; Sutterwala, FS; Cassel, SL				Ciraci, Ceren; Janczy, John R.; Jain, Nidhi; Haasken, Stefanie; Pecli e Silva, Cyntia; Benjamim, Claudia F.; Sadler, Jeffrey J.; Olivier, Alicia K.; Iwakura, Yoichiro; Shayakhmetov, Dmitry M.; Sutterwala, Fayyaz S.; Cassel, Suzanne L.			Immune Complexes Indirectly Suppress the Generation of Th17 Responses In Vivo	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD4(+) T-CELLS; MICE DEFICIENT; AIRWAY INFLAMMATION; NLRP3 INFLAMMASOME; ADAPTIVE IMMUNITY; DENDRITIC CELLS; RECEPTOR; MACROPHAGES; CASPASE-1	The precise context in which the innate immune system is activated plays a pivotal role in the subsequent instruction of CD4(+) T helper (Th) cell responses. Th1 responses are downregulated when antigen is encountered in the presence of antigen-IgG immune complexes. To assess if Th17 responses to antigen are subject to similar influences in the presence of immune complexes we utilized an inflammatory airway disease model in which immunization of mice with Complete Freund's Adjuvant (CFA) and ovalbumin (Ova) induces a powerful Ova-specific Th1 and Th17 response. Here we show that modification of that immunization with CFA to include IgG-Ova immune complexes results in the suppression of CFA-induced Th17 responses and a concurrent enhancement of Ova-specific Th2 responses. Furthermore, we show the mechanism by which these immune complexes suppress Th17 responses is through the enhancement of IL-10 production. In addition, the generation of Th17 responses following immunization with CFA and Ova were dependent on IL-1 alpha but independent of NLRP3 inflammasome activation. Together these data represent a novel mechanism by which the generation of Th17 responses is regulated.	[Ciraci, Ceren; Janczy, John R.; Jain, Nidhi; Haasken, Stefanie; Pecli e Silva, Cyntia; Sadler, Jeffrey J.; Sutterwala, Fayyaz S.; Cassel, Suzanne L.] Univ Iowa, Carver Coll Med, Inflammat Program, Iowa City, IA USA; [Ciraci, Ceren] Istanbul Tech Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Janczy, John R.; Sutterwala, Fayyaz S.; Cassel, Suzanne L.] Univ Iowa, Carver Coll Med, Grad Program Immunol, Iowa City, IA USA; [Olivier, Alicia K.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA USA; [Sutterwala, Fayyaz S.; Cassel, Suzanne L.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Pecli e Silva, Cyntia; Benjamim, Claudia F.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Yamasaki 2669, Noda, Chiba 2780022, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Shayakhmetov, Dmitry M.] Emory Univ, Dept Med, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Sutterwala, Fayyaz S.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; Istanbul Technical University; University of Iowa; University of Iowa; University of Iowa; Universidade Federal do Rio de Janeiro; Tokyo University of Science; Japan Science & Technology Agency (JST); Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Cassel, SL (corresponding author), Univ Iowa, Carver Coll Med, Inflammat Program, Iowa City, IA USA.; Cassel, SL (corresponding author), Univ Iowa, Carver Coll Med, Grad Program Immunol, Iowa City, IA USA.; Cassel, SL (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA.	suzanne-cassel@uiowa.edu	Benjamim, Claudia/T-5090-2019; Sutterwala, Fayyaz/AAH-5859-2021; Iwakura, Yoichiro/E-5457-2011; ciraci, ceren/ABA-7687-2020; Cassel, Suzanne/AAI-3947-2021	Benjamim, Claudia/0000-0001-6247-9596; Iwakura, Yoichiro/0000-0002-9934-5775; ciraci, ceren/0000-0003-2162-0930; Cassel, Suzanne/0000-0003-2492-1923; Pecli, Cyntia/0000-0003-0129-3514; jain, nidhi/0000-0001-6723-4029	National Institutes of Health [R01 AI104706, T32 AI007485, T32 AI007511]; Asthma and Allergy Foundation of America fellowship; American Lung Association/The American Academy of Allergy; Asthma & Immunology Foundation Allergic Respiratory Disease Award; Bolsista da CAPES Scholarship [2790-14-9]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104706, T32AI007485, R01AI107960, R01AI065429, T32AI007511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asthma and Allergy Foundation of America fellowship; American Lung Association/The American Academy of Allergy; Asthma & Immunology Foundation Allergic Respiratory Disease Award; Bolsista da CAPES Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R01 AI104706 (S.L.C.), T32 AI007485 (J.R.J.), and T32 AI007511 (S.H.); an Asthma and Allergy Foundation of America fellowship (S.L.C.); an American Lung Association/The American Academy of Allergy, Asthma & Immunology Foundation Allergic Respiratory Disease Award (S.L.C.); and a Bolsista da CAPES Scholarship, 2790-14-9 (C.P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CF, 2004, J IMMUNOL, V173, P955, DOI 10.4049/jimmunol.173.2.955; Bandukwala HS, 2007, J EXP MED, V204, P1875, DOI 10.1084/jem.20061134; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciraci C, 2012, MICROBES INFECT, V14, P1263, DOI 10.1016/j.micinf.2012.07.007; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labow M, 1997, J IMMUNOL, V159, P2452; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Sutterwala FS, 1999, J LEUKOCYTE BIOL, V65, P543, DOI 10.1002/jlb.65.5.543; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032	31	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151252	10.1371/journal.pone.0151252	http://dx.doi.org/10.1371/journal.pone.0151252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978520	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800053
J	Feng, JL; Zhu, RD; Chang, C; Yu, L; Cao, F; Zhu, GH; Chen, F; Xia, H; Lv, FD; Zhang, SJ; Sun, L				Feng, Jiliang; Zhu, Ruidong; Chang, Chun; Yu, Lu; Cao, Fang; Zhu, Guohua; Chen, Feng; Xia, Hui; Lv, Fudong; Zhang, Shijie; Sun, Lin			CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR CARCINOMAS; CLINICOPATHOLOGICAL SIGNIFICANCE; POOR-PROGNOSIS; CURATIVE RESECTION; KERATIN 19; DIFFERENTIATION; SYSTEM; CELLS; HETEROZYGOSITY; MARKERS	This retrospective study was designed to investigate the correlation between a novel immunosubtyping method for hepatocellular carcinoma (HCC) and biological behavior of tumor cells. A series of 346 patients, who received hepatectomy at two surgical centers from January 2007 to October 2010, were enrolled in this study. The expressions of cytokeratin 19 (CK19), glypican 3 (GPC3), and CD34 were detected by immunohistochemical staining. The clinical stage was assessed using the sixth edition tumor-node-metastasis (TNM) system (UICC/AJCC, 2010). Vascular invasion comprised both microscopic and macroscopic invasion. The tumor size, lymph node involvement, and metastasis were determined by pathological as well as imaging studies. Recurrence was defined as the appearance of new lesions with radiological features typical of HCC, seen by at least two imaging methods. Survival curves for the patients were plotted using the Kaplan-Meier method, and differences between the curves were assessed using the log-rank test. Significant differences in morphology, histological grading, and TNM staging were observed between groups. Based on the immunohistochemical staining, the enrolled cases were divided into CK19+/GPC3+, CK19-/GPC3+ and CK19-/GPC3- three subtypes. CK19+/GPC3+ HCC has the highest risk of multifocality, microvascular invasion, regional lymph node involvement, and distant metastasis, followed by CK19-/GPC3+ HCC, then CK19-/GPC3-HCC. CK19+/GPC3+ HCC has the shortest recurrence time compared to other immunophenotype HCCs. CK19 and GPC3 expression profiling is an independent prognostic indicator in patients with HCC, and a larger sample size is needed to further investigate the effect of this immunosubtyping model in stratifying the outcome of HCC patients.	[Feng, Jiliang; Yu, Lu; Cao, Fang; Zhu, Guohua] Capital Med Univ, Beijing You An Hosp, Clin Pathol Ctr, Beijing 100069, Peoples R China; [Zhu, Ruidong] Capital Med Univ, Beijing You An Hosp, Surg Ctr, Beijing 100069, Peoples R China; [Chang, Chun] Peking Univ, Hosp 3, Dept Resp Dis, Beijing 100191, Peoples R China; [Chen, Feng] Capital Med Univ, Beijing You An Hosp, Dept Radiol, Beijing 100069, Peoples R China; [Xia, Hui] PLA, Hosp 304, Beijing 100048, Peoples R China; [Lv, Fudong; Zhang, Shijie; Sun, Lin] Capital Med Univ, Dept Pathol, Beijing You An Hosp, Beijing 100069, Peoples R China	Capital Medical University; Capital Medical University; Peking University; Capital Medical University; Capital Medical University	Chang, C (corresponding author), Peking Univ, Hosp 3, Dept Resp Dis, Beijing 100191, Peoples R China.; Lv, FD (corresponding author), Capital Med Univ, Dept Pathol, Beijing You An Hosp, Beijing 100069, Peoples R China.	doudou_1977@163.com; molecularpath@sina.com	zhang, shijie/HGF-0836-2022	feng, jiliang/0000-0002-2027-9737	Basic-Clinical Scientific Research Cooperation Fund, CCMU [15JL66]	Basic-Clinical Scientific Research Cooperation Fund, CCMU	This work was supported by the Basic-Clinical Scientific Research Cooperation Fund, CCMU(No. 15JL66). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118658; Chan ACY, 2013, HPB, V15, P439, DOI 10.1111/j.1477-2574.2012.00617.x; Curado MP, 2010, HEPATOCELLULAR CARCI, V4th, P205; Dorn L, 2009, J CELL MOL MED, V13, P1279, DOI 10.1111/j.1582-4934.2008.00519.x; Feo F, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.08; Fujii T, 2008, HUM PATHOL, V39, P1185, DOI 10.1016/j.humpath.2007.12.010; Gong J, 2015, ONCOL LETT, V9, P1027, DOI 10.3892/ol.2014.2816; Govaere O, 2014, GUT, V63, P674, DOI 10.1136/gutjnl-2012-304351; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Ho M, 2011, EUR J CANCER, V47, P333, DOI 10.1016/j.ejca.2010.10.024; IKEDA K, 1993, CANCER, V71, P19, DOI 10.1002/1097-0142(19930101)71:1<19::AID-CNCR2820710105>3.0.CO;2-I; Khavari DA, 2010, CELL CYCLE, V9, P3880, DOI 10.4161/cc.9.19.13385; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Lee CW, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-136; Li J, 2014, WORLD J GASTROENTERO, V20, P6336, DOI 10.3748/wjg.v20.i20.6336; Lo RCL, 2013, LIVER CANCER, V2, P84, DOI 10.1159/000343844; Mehta Sunali, 2010, Ther Adv Med Oncol, V2, P125, DOI 10.1177/1758834009360519; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Pang A, 2003, CANCER GENET CYTOGEN, V146, P8, DOI 10.1016/S0165-4608(03)00103-1; Piao Z, 1997, CANCER-AM CANCER SOC, V80, P865; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Roskams T, 2010, CLIN LIVER DIS, V14, P705, DOI 10.1016/j.cld.2010.08.003; Rumbajan JM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-608; Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506; Sawada Y, 2015, INT J ONCOL, V46, P28, DOI 10.3892/ijo.2014.2737; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569; Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6; Shirakawa H, 2009, CANCER SCI, V100, P1403, DOI 10.1111/j.1349-7006.2009.01206.x; Su N, 2012, MOL BIOL REP, V39, P351, DOI 10.1007/s11033-011-0745-y; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Wang B, 2013, J AM COLL SURGEONS, V217, P1054, DOI 10.1016/j.jamcollsurg.2013.07.402; Wang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072435; Wong CM, 2002, CLIN CANCER RES, V8, P2266; Wu PC, 1996, AM J PATHOL, V149, P1167; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yeh CT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-324	37	38	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151501	10.1371/journal.pone.0151501	http://dx.doi.org/10.1371/journal.pone.0151501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977595	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800080
J	Weiss, M; Prochazka, J; Schlaghamersky, J; Cizek, L				Weiss, Matthias; Prochazka, Jiri; Schlaghamersky, Jiri; Cizek, Lukas			Fine-Scale Vertical Stratification and Guild Composition of Saproxylic Beetles in Lowland and Montane Forests: Similar Patterns despite Low Faunal Overlap	PLOS ONE			English	Article							COLEOPTERA CARABIDAE; ELEVATIONAL GRADIENT; ALTITUDINAL GRADIENT; IPS-TYPOGRAPHUS; NATIONAL-PARK; COMMUNITY; DIVERSITY; ASSEMBLAGES; MANAGEMENT; TURNOVER	Objective The finer scale patterns of arthropod vertical stratification in forests are rarely studied and poorly understood. Further, there are no studies investigating whether and how altitude affects arthropod vertical stratification in temperate forests. We therefore investigated the fine-scale vertical stratification of diversity and guild structure of saproxylic beetles in temperate lowland and montane forests and compared the resulting patterns between the two habitats. Methods The beetles were sampled with flight intercept traps arranged into vertical transects (sampling heights 0.4, 1.2, 7, 14, and 21 m). A triplet of such transects was installed in each of the five sites in the lowland and in the mountains; 75 traps were used in each forest type. Results 381 species were collected in the lowlands and 236 species in the mountains. Only 105 species (21%) were found at both habitats; in the montane forest as well as in the lowlands, the species richness peaked at 1.2 m, and the change in assemblage composition was most rapid near the ground. The assemblages clearly differed between the understorey (0.4 m, 1.2 m) and the canopy (7 m, 14 m, 21 m) and between the two sampling heights within the understorey, but less within the canopy. The stratification was better pronounced in the lowland, where canopy assemblages were richer than those near the forest floor (0.4 m). In the mountains the samples from 14 and 21 m were more species poor than those from the lower heights. The guild structure was similar in both habitats. Conclusions The main patterns of vertical stratification and guild composition were strikingly similar between the montane and the lowland forest despite the low overlap of their faunas. The assemblages of saproxylic beetles were most stratified near ground. The comparisons of species richness between canopy and understorey may thus give contrasting results depending on the exact sampling height in the understorey.	[Weiss, Matthias; Cizek, Lukas] Acad Sci Czech Republ, Inst Entomol, Biol Ctr CAS, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic; [Weiss, Matthias; Cizek, Lukas] Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Prochazka, Jiri; Schlaghamersky, Jiri] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Masaryk University Brno	Weiss, M (corresponding author), Acad Sci Czech Republ, Inst Entomol, Biol Ctr CAS, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.; Weiss, M (corresponding author), Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	mattweiss@t-online.de	Procházka, Jiří/AAC-9290-2019; Cizek, Lukas/G-7905-2014; Weiss, Matthias/R-6659-2018; Cizek, Lukas/K-7111-2015	Procházka, Jiří/0000-0002-8016-1992; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Weiss, Matthias/0000-0001-9095-0779	Grant Agency of the Czech Academy of Sciences [KJB600960705]; Grant Agency of the University of South Bohemia [04-168/2013/P]; Czech Science Foundation [P504/12/1952]; Ministry of Education, Youth and Sports of the Czech Republic [MSM 0021622416]; Biodiversity of Forest Ecosystems (European Social Fund) [CZ.1.07/2.3.00/20.0064]; state budget of the Czech Republic	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of the University of South Bohemia; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Biodiversity of Forest Ecosystems (European Social Fund); state budget of the Czech Republic	This work was supported by the Grant Agency of the Czech Academy of Sciences (grant No. KJB600960705) (https://www.muni.cz/research/avcr), Grant Agency of the University of South Bohemia (04-168/2013/P), Czech Science Foundation (grant No. P504/12/1952) (http://www.gacr.cz/), Ministry of Education, Youth and Sports of the Czech Republic (Research Plan MSM 0021622416) (http://www.msmt.cz/?lang=2), Biodiversity of Forest Ecosystems (European Social Fund) (grant No. CZ.1.07/2.3.00/20.0064) (http://ec.europa.eu/esf/home.jsp), and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bail JG, 2008, CANOPY ARTHROPOD RES, P327; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P4; Basset Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144110; Bouget C, 2013, BIODIVERS CONSERV, V22, P2111, DOI 10.1007/s10531-013-0531-3; Bouget C, 2011, FOREST ECOL MANAG, V261, P211, DOI 10.1016/j.foreco.2010.10.007; CHAO A, 1984, SCAND J STAT, V11, P265; Chen Y. C., 1995, J CHINESE STAT ASS, V33, P373; Colwell RK, 2013, ESTIMATES STAT ESTIM; Davies ALV, 1999, J BIOGEOGR, V26, P1039, DOI 10.1046/j.1365-2699.1999.00335.x; Duelli P, 2002, ACTA ZOOL ACAD SCI H, V48, P75; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Escobar F, 2007, ECOGRAPHY, V30, P193, DOI [10.1111/j.2007.0906-7590.04818.x, 10.1111/j.0906-7590.2007.04818.x]; Farka J., 2005, CERVENY SEZNAM OHROZ; Floren A, 2014, FOREST ECOL MANAG, V323, P57, DOI 10.1016/j.foreco.2014.03.028; Floren Andreas, 2008, P13; Frazer G.W., 1999, GAP LIGHT ANAL GLA V, P36; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; Gomez-Hernandez M, 2012, BIODIVERS CONSERV, V21, P2247, DOI 10.1007/s10531-011-0180-3; Gossner MM, 2009, EUR J ENTOMOL, V106, P241, DOI 10.14411/eje.2009.032; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hirao T, 2009, ECOL RES, V24, P263, DOI 10.1007/s11284-008-0502-4; Hjalten J, 2007, BASIC APPL ECOL, V8, P364, DOI 10.1016/j.baae.2006.08.003; Horak Jakub, 2009, Klapalekiana, V45, P191; Hulcr J, 2008, ENVIRON ENTOMOL, V37, P1461, DOI 10.1603/0046-225X-37.6.1461; Janik D, 2013, J VEG SCI, V24, P1141, DOI 10.1111/jvs.12018; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jung JK, 2012, J ASIA-PAC ENTOMOL, V15, P487, DOI 10.1016/j.aspen.2012.05.007; Leschen RAB, 2010, HDB ZOOLOGY; Maguire DY, 2014, ENVIRON ENTOMOL, V43, P9, DOI 10.1603/EN13056; Martikainen Petri, 2001, Ecological Bulletins, V49, P205; Meng H, 2013, APPL MICROBIOL BIOT, V97, P2219, DOI 10.1007/s00253-012-4063-7; Miklin J, 2014, J NAT CONSERV, V22, P35, DOI 10.1016/j.jnc.2013.08.002; Muller J, 2008, BIODIVERS CONSERV, V17, P2979, DOI 10.1007/s10531-008-9409-1; Muller J, 2015, ECOGRAPHY, V38, P499, DOI 10.1111/ecog.00908; Parmain G, 2015, B ENTOMOL RES, V105, P101, DOI 10.1017/S0007485314000741; Prochazka J, 2015, MIT SCH GES ENT, V88, P62; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Roberts DW., 2012, LABDSV ORDINATION MU; Robertson HG, 2002, BIODIVERS CONSERV, V11, P1637, DOI 10.1023/A:1016883901065; ROZKOSNY R., 1995, SCI NATUR U MASARYKI, V93, P209; Schlaghamersky Jiri, 2000, Folia Facultatis Scientiarum Naturalium Universitatis Masarykianae Brunensis Biologia, V103, P1; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Schroeder B, 2009, CAN ENTOMOL, V141, P515, DOI 10.4039/n09-022; Sebek P, 2012, ECOL INDIC, V20, P304, DOI 10.1016/j.ecolind.2012.02.033; Seibold S, 2015, CONSERV BIOL, V29, P382, DOI 10.1111/cobi.12427; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Sipos J, 2013, AGR FOREST ENTOMOL, V15, P255, DOI 10.1111/afe.12012; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Stokland JN, 2005, EUR FOREST INST PROC, P207; Su JC, 2001, ENVIRON ENTOMOL, V30, P400, DOI 10.1603/0046-225X-30.2.400; Tanabe S, 2002, ECOL ENTOMOL, V27, P720, DOI 10.1046/j.1365-2311.2002.00469.x; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tykarski P, 2006, FOREST ECOL MANAG, V225, P146, DOI 10.1016/j.foreco.2005.12.034; Ulyshen MD, 2011, FOREST ECOL MANAG, V261, P1479, DOI 10.1016/j.foreco.2011.01.033; Ulyshen MD, 2009, FOREST ECOL MANAG, V257, P653, DOI 10.1016/j.foreco.2008.09.047; Vance CC, 2003, ENVIRON ENTOMOL, V32, P1066, DOI 10.1603/0046-225X-32.5.1066; Vavra JC, 2013, PRIRODA SLEZSKA; Vodka S, 2013, FOREST ECOL MANAG, V304, P33, DOI 10.1016/j.foreco.2013.04.007; VRSKA T., 2006, DYNAMIKA VYVOJE PRAL; Vrska T, 2009, FOREST ECOL MANAG, V258, P347, DOI 10.1016/j.foreco.2009.03.007; Wermelinger B, 2007, J APPL ENTOMOL, V131, P104, DOI 10.1111/j.1439-0418.2006.01128.x; Wermelinger B, 2004, FOREST ECOL MANAG, V202, P67, DOI 10.1016/j.foreco.2004.07.018; Wu J, 2013, FOREST ECOL MANAG, V292, P29, DOI 10.1016/j.foreco.2012.12.004; Yu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069177; Zou Y, 2014, INSECT CONSERV DIVER, V7, P161, DOI 10.1111/icad.12039	70	25	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149506	10.1371/journal.pone.0149506	http://dx.doi.org/10.1371/journal.pone.0149506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978783	gold, Green Published			2022-12-27	WOS:000372572800015
J	Cardoso, MA; Augusto, RA; Bortolini, GA; Oliveira, CSM; Tietzman, DC; Sequeira, LAS; Hadler, MCCM; Peixoto, MDG; Muniz, PT; Vitolo, MR; Lira, PIC; Jaime, PC				Cardoso, Marly A.; Augusto, Rosangela A.; Bortolini, Gisele A.; Oliveira, Cristieli S. M.; Tietzman, Daniela C.; Sequeira, Leopoldina A. S.; Hadler, Maria Claret C. M.; Peixoto, Maria do Rosario G.; Muniz, Pascoal T.; Vitolo, Mrcia R.; Lira, Pedro I. C.; Jaime, Patricia C.		ENFAC Working Grp	Effect of Providing Multiple Micronutrients in Powder through Primary Healthcare on Anemia in Young Brazilian Children: A Multicentre Pragmatic Controlled Trial	PLOS ONE			English	Article							IRON; SUPPLEMENTATION; SPRINKLES; GROWTH; FORTIFICATION; INFLAMMATION; PROVISION; PROGRAM; IMPACT; ZINC	Background Multiple micronutrients in powder (MNP) are recommended by WHO to prevent anemia in young children. However, evidences for its effectiveness in different populations and improvements in other outcomes (e.g. linear growth and vitamin A deficiency) are scarce. Methods A multicentre pragmatic controlled trial was carried out in primary health centres. At study baseline, a control group (CG) of children aged 10- to 14 months (n = 521) was recruited in the routine healthcare for assessing anemia, anthropometric and micronutrient status. At the same time, an intervention group (IG) of infants aged 6- to 8 months (n = 462) was recruited to receive MNP daily in complementary feeding over a period of 60 days. Both study groups were compared when the IG infants reached the age of the CG children at enrolment. Results In CG, the prevalence of anemia [hemoglobin (Hb) < 110 g/L], iron deficiency (ID, plasma ferritin < 12 mu g/L or TfR > 8.3 mg/L), and vitamin A deficiency (VAD, serum retinol < 0.70 mu mol/L) were 23.1%, 37.4%, and 17.4%, respectively. Four to six months after enrolment, when the IG participants had the same age of the controls at the time of testing, the prevalence of anemia, ID and VAD in IG were 14.3%, 30.1% and 7.9%, respectively. Adjusting for city, health centre, maternal education, and age, IG children had a lower likelihood of anemia and VAD [Prevalence Ratio (95% CI) = 0.63 (0.45, 0.88) and 0.45 (0.29, 0.69), respectively] when compared with CG children. The adjusted mean distributions of Hb and length-for-age Z-scores improved by 2 SE in the IG compared to CG children. Conclusions MNP effectively reduced anemia and improved growth and micronutrient status among young Brazilian children.	[Cardoso, Marly A.; Augusto, Rosangela A.; Jaime, Patricia C.] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Bortolini, Gisele A.] Minist Hlth, CGAN, Brasilia, DF, Brazil; [Oliveira, Cristieli S. M.; Muniz, Pascoal T.] Univ Fed Acre, Dept Hlth Sci, Rio Branco, Brazil; [Tietzman, Daniela C.; Vitolo, Mrcia R.] UFCSPA, Porto Alegre, RS, Brazil; [Sequeira, Leopoldina A. S.; Lira, Pedro I. C.] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil; [Hadler, Maria Claret C. M.; Peixoto, Maria do Rosario G.] Univ Fed Goias, Sch Nutr, Goiania, Go, Brazil	Universidade de Sao Paulo; Universidade Federal do Acre (UFAC); Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Pernambuco; Universidade Federal de Goias	Cardoso, MA (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.	marlyac@usp.br	Peixoto, Maria do Rosário G./C-8737-2014; Oliveira, Cristieli/AAS-2493-2020; Cardoso, Marly Augusto/B-8010-2013; Hadler, Maria Claret Costa Monteiro/G-9199-2014; Jaime, Patricia Constante/C-3614-2013; Bortolini, Gisele Ane/AAQ-4954-2020; Jaime, Patricia Constante/N-7268-2019	Peixoto, Maria do Rosário G./0000-0003-1950-0817; Oliveira, Cristieli/0000-0003-4952-7287; Cardoso, Marly Augusto/0000-0003-0973-3908; Hadler, Maria Claret Costa Monteiro/0000-0003-0631-8629; Jaime, Patricia Constante/0000-0003-2291-8536; Jaime, Patricia Constante/0000-0003-2291-8536; Vitolo, Marcia Regina/0000-0001-9137-3854	Ministry of Health of Brazil; Brazilian National Counsel of Technological and Scientific Development, CNPq [552747/2011-4]	Ministry of Health of Brazil; Brazilian National Counsel of Technological and Scientific Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Ministry of Health of Brazil with administrative and financial management by the Brazilian National Counsel of Technological and Scientific Development, CNPq (Grant no. 552747/2011-4). The multiple micronutrients in powder (MNP) used in this study was kindly donated by UNICEF. The views expressed do not necessarily reflect those of the Ministry of Health of Brazil. Neither of the organizations involved in supporting this work had a role in the analysis or interpretation of the data.	Allen LH, 2009, J NUTR, V139, P1022, DOI 10.3945/jn.107.086199; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; [Anonymous], 2009, WHO GLOBAL DATABASE; Assuncao MCF, 2007, REV SAUDE PUBL, V41, P1; Bell KN, 2009, BIRTH DEFECTS RES A, V85, P102, DOI 10.1002/bdra.20504; Burger S., 2003, PROCEDURE ESTIMATE A; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; Vieira RCD, 2010, REV NUTR, V23, P433, DOI 10.1590/S1415-52732010000300011; De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008959.pub2; Dewey KG, 2009, MATERN CHILD NUTR, V5, P283, DOI 10.1111/j.1740-8709.2009.00190.x; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Fundacao Instituto Brasileiro de Geografia e Estatistica (IBGE), 1 RES CENS 2010 POP; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Gomes LF, 2004, ANTIOXID REDOX SIGN, V6, P237, DOI 10.1089/152308604322899305; Hulley SB, 2013, DESIGNING CLIN RES; Jack SJ, 2012, ARCH PEDIAT ADOL MED, V166, P842, DOI 10.1001/archpediatrics.2012.1003; Jordão Regina Esteves, 2009, Rev. paul. pediatr., V27, P90; Loechl CU, 2009, MATERN CHILD NUTR, V5, P33, DOI 10.1111/j.1740-8709.2008.00154.x; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Ministerio da Saude (Brasil), 2010, ESTR NAC PROM AL COM; Sampaio DLB, 2013, J PEDIAT-BRAZIL, V89, P286, DOI 10.1016/j.jped.2012.11.004; Serdula MK, 2013, EUR J CLIN NUTR, V67, P703, DOI 10.1038/ejcn.2013.67; Smuts CM, 2005, J NUTR, V135, p653S, DOI 10.1093/jn/135.3.653S; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Thurnham DI, 2015, J NUTR, V145, p1137S, DOI 10.3945/jn.114.194712; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Villalpando S, 2006, ANN NUTR METAB, V50, P506, DOI 10.1159/000098142; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization, 2011, US MULT MICR POWD HO; World Health Organization, 1995, PHYS STAT US INT ANT; Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129	33	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151097	10.1371/journal.pone.0151097	http://dx.doi.org/10.1371/journal.pone.0151097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974146	gold, Green Submitted, Green Published			2022-12-27	WOS:000372570600048
J	Rehn, M; Uhnoo, I; Kuhlmann-Berenzon, S; Wallensten, A; Sparen, P; Netterlid, E				Rehn, Moa; Uhnoo, Ingrid; Kuhlmann-Berenzon, Sharon; Wallensten, Anders; Sparen, Par; Netterlid, Eva			Highest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; CERVICAL-CANCER; IMMUNIZATION; PROGRAM; COHORT	Background The Swedish school-based vaccination programme offers HPV vaccine to girls born >= 1999 in 5-6th grade. In 2012, all counties introduced free-of-charge catch-up vaccination campaigns targeting girls born 1993-1998. Varying vaccine uptake in the catch-up group by December 2012 suggested that some implementation strategies were more successful than others. In order to inform future vaccination campaigns, we assessed the impact of different implementation strategies on the county-level catch-up vaccine uptake. Methods We conducted an ecological study including all Swedish counties (n = 21), asking regional health offices about the information channels they used and where vaccination of the catch-up target group took place in their counties. The uptake of >= 1 dose by 30 September 2014 was estimated using data from the voluntary national vaccination register. We investigated associations between counties' catch-up vaccine uptake, information channels and vaccination settings by calculating incidence rate ratios (IRR) and 95% confidence intervals (CI), using negative binomial regression models. Results County level catch-up vaccine uptake varied between 49-84%. All counties offered vaccination through primary health care settings. Apart from this eight (34%) also offered the vaccine in some of their schools, four (19%) in all their schools, and two (10%) in other health care centres. The information channels most frequently used were: information at the national on-line health care consulting web-page (100%), letter/invitations (90%), and advertisement (81%). Counties offering vaccination to girls in all schools and counties offering vaccination in some of their schools, reached higher vaccine uptake compared to counties not offering vaccination in any of their schools (all schools adjusted IRR: 1.3, 95% CI: 1.1-1.5, some schools adjusted IRR: 1.2, 95% CI: 1.1-1.3). Conclusion Counties offering HPV vaccination to catch-up groups in schools reached the highest vaccine uptake. No information channel explained differences in county-level vaccine uptake. Our findings suggest that catch-up vaccination outside the national vaccination program can reach a high uptake at the population level if it is implemented primarily with an organized delivery (e.g. in schools).	[Rehn, Moa; Uhnoo, Ingrid; Kuhlmann-Berenzon, Sharon; Wallensten, Anders; Netterlid, Eva] Publ Hlth Agcy Sweden, Dept Monitoring & Evaluat, Solna, Sweden; [Rehn, Moa] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Wallensten, Anders] Uppsala Univ, Infect Dis Sect, Dept Med Sci, Uppsala, Sweden; [Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Solna, Sweden; [Netterlid, Eva] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Netterlid, Eva] Lund Univ, Skane Univ Hosp, Dept Occupat & Environm Dermatol, Malmo, Sweden	Public Health Agency of Sweden; European Centre for Disease Prevention & Control; Uppsala University; Karolinska Institutet; Lund University; Lund University; Skane University Hospital	Rehn, M (corresponding author), Publ Hlth Agcy Sweden, Dept Monitoring & Evaluat, Solna, Sweden.; Rehn, M (corresponding author), European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.	moa.rehn@folkhalsomyndigheten.se	Kühlmann-Berenzon, Sharon/J-1554-2019	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Sparen, Par/0000-0002-5184-8971				Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Brotherton JML, 2013, MED J AUSTRALIA, V199, P614, DOI 10.5694/mja13.10272; Dorell CG, 2012, VACCINE, V30, P503, DOI 10.1016/j.vaccine.2011.11.042; Fujiwara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084126; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Lim WT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1029; Lindley MC, 2008, PEDIATRICS, V121, pS46, DOI 10.1542/peds.2007-1115F; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; Marshall HS, 2013, VACCINE, V31, P3059, DOI 10.1016/j.vaccine.2013.04.064; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Paul P, 2014, VACCINE, V32, P320, DOI 10.1016/j.vaccine.2013.11.070; Potts A, 2013, EUROPEAN COMMUNICABL, V18; Public Health Agency of Sweden, 2014, HPV VACC STAT; Reeve C, 2008, COMMUN DIS INTELL, V32, P94; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Sinka K, 2013, J EPIDEMIOLOGY COMMU; Slattelid Schreiber SM, 2015, J ADOLESCENT HLTH OF; Statistic Sweden (SCB), 2014, POP SIZ MAR STAT AG; The national board of health and social welfare, 2015, ANT DOS VID HPV VACC; The national board of health and welfare, 2011, RECC HPV VACC; The national board of health and welfare, VACC HPV; The National Board of Health and Welfare (Socialstyrelsen), 2014, CANC INC SWED 2013; Vaccarella S, 2014, BRIT J CANCER, V111, P965, DOI 10.1038/bjc.2014.362; Widgren K, 2011, VACCINE, V29, P9663, DOI 10.1016/j.vaccine.2011.10.021; World Health Organization, 2009, HLTH SECT SECR LEAG, V84, P118	26	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149857	10.1371/journal.pone.0149857	http://dx.doi.org/10.1371/journal.pone.0149857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974977	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600014
J	Suparji, NS; Chan, G; Sapili, H; Arshad, NM; In, LLA; Awang, K; Nagoor, NH				Suparji, Noor Shahirah; Chan, Gomathi; Sapili, Hani; Arshad, Norhafiza M.; In, Lionel L. A.; Awang, Khalijah; Nagoor, Noor Hasima			Geranylated 4-Phenylcoumarins Exhibit Anticancer Effects against Human Prostate Cancer Cells through Caspase-Independent Mechanism	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; COUMARIN DERIVATIVES; NEURONAL DEATH; CYTOCHROME-C; APOPTOSIS; AUTOPHAGY; CALPAIN; LINES; AGENTS; SUBSTANCES	Geranylated 4-phenylcoumarins, DMDP-1 & -2 isolated from Mesua elegans were investigated for anticancer potential against human prostate cancer cells. Treatment with DMDP-1 & -2 resulted in cell death in a time and dose dependent manner in an MTT assay on all cancer cell lines tested with the exception of lung adenocarcinoma cells. DMDP-1 showed highest cytotoxic efficacy in PC-3 cells while DMDP-2 was most potent in DU 145 cells. Flow cytometry indicated that both coumarins were successful to induce programmed cell death after 24 h treatment. Elucidation on the mode-of-action via protein arrays and western blotting demonstrated death induced without any significant expressions of caspases, Bcl-2 family proteins and cleaved PARP, thus suggesting the involvement of caspase-independent pathways. In identifying autophagy, analysis of GFP-LC3 showed increased punctate in PC-3 cells pre-treated with CQ and treated with DMDP-1. In these cells decreased expression of autophagosome protein, p62 and cathepsin B further confirmed autophagy. In contrary, the DU 145 cells pre-treated with CQ and treated with DMDP-2 has reduced GFP-LC3 punctate although the number of cells with obvious GFP-LC3 puncta was significantly increased in the inhibitor-treated cells. The increase level of p62 suggested leakage of cathepsin B into the cytosol to trigger potential downstream death mediators. This correlated with increased expression of cathepsin B and reduced expression after treatment with its inhibitor, CA074. Also auto-degradation of calpain-2 upon treatment with DMDP-1 & -2 and its inhibitor alone, calpeptin compared with the combination treatment, further confirmed involvement of calpain-2 in PC-3 and DU 145 cells. Treatment with DMDP-1 & -2 also showed up-regulation of total and phosphorylated p53 levels in a time dependent manner. Hence, DMDP-1 & -2 showed ability to activate multiple death pathways involving autophagy, lysosomal and endoplasmic reticulum death proteins which could potentially be manipulated to develop anti-cancer therapy in apoptosis resistant cells.	[Suparji, Noor Shahirah; Sapili, Hani; Arshad, Norhafiza M.; In, Lionel L. A.; Nagoor, Noor Hasima] Univ Malaya, Fac Sci, Inst Biol Sci Genet & Mol Biol, Kuala Lumpur, Malaysia; [Chan, Gomathi; Awang, Khalijah] Univ Malaya, Fac Sci, Dept Chem, Ctr Nat Prod Res & Drug Discovery CENAR, Kuala Lumpur, Malaysia; [In, Lionel L. A.] UCSI Univ, Fac Sci Appl, Dept Biotechnol, Kuala Lumpur, Malaysia; [Arshad, Norhafiza M.; Nagoor, Noor Hasima] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; UCSI University; Universiti Malaya	Nagoor, NH (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci Genet & Mol Biol, Kuala Lumpur, Malaysia.; Nagoor, NH (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia.	hasima@um.edu.my	AWANG, KHALIJAH/B-8781-2010; IN, LIONEL/AAI-9847-2020; PITCHAI, NOOR HASIMA A K NAGOOR/B-9270-2010; In, Lionel/D-1338-2013; ARSHAD, NORHAFIZA MOHD/N-7615-2018	AWANG, KHALIJAH/0000-0001-5971-6570; IN, LIONEL/0000-0001-7182-112X; In, Lionel/0000-0001-7182-112X; ARSHAD, NORHAFIZA MOHD/0000-0003-1522-3373	University of Malaya Postgraduate Research Grant [PV043-2011A]; University Malaya Research Program [RP001-2012A]	University of Malaya Postgraduate Research Grant; University Malaya Research Program	This study was supported by the University of Malaya Postgraduate Research Grant (PV043-2011A) and University Malaya Research Program (RP001-2012A).	Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Aki T, 2012, CELL BIOL TOXICOL, V28, P125, DOI 10.1007/s10565-012-9212-3; Awaad AS, 2012, PHYTOTHER RES, V26, P452, DOI 10.1002/ptr.3690; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Chan G, 2012, EVID-BASED COMPL ALT, V2012, P18; Chen Y, 2012, EUR J MED CHEM, V49, P74, DOI 10.1016/j.ejmech.2011.12.025; Chi S, 1999, ONCOGENE, V18; Cromb Jones, 1987, J CHEM SOC PERK T, V1, P317; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawaii S, 2001, ANTICANCER RES, V21, P917; Khan KM, 2004, J ENZYM INHIB MED CH, V19, P373, DOI 10.1080/14756360409162453; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kostovo, 2005, CURR MED CHEM, V5, P29; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Linder S, 2005, DRUG RESIST UPDATE, V8, P199, DOI 10.1016/j.drup.2005.06.004; Lopez-Gonzalez JS, 2004, LUNG CANCER-J IASLC, V43, P275, DOI 10.1016/j.lungcan.2003.09.005; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakajima E, 2011, INVEST OPHTH VIS SCI, V52, P7059, DOI 10.1167/iovs.11-7497; Tung NH, 2013, BIOORG MED CHEM LETT, V23, P158, DOI 10.1016/j.bmcl.2012.10.127; OHKUMA S, 1981, J CELL BIOL, V90, P656, DOI 10.1083/jcb.90.3.656; Racoma IO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072882; Roberts Lewis R., 1999, Cell Biochemistry and Biophysics, V30, P71, DOI 10.1007/BF02737885; Rodriguez-Muela N, 2015, CELL DEATH DIFFER, V22, P476, DOI 10.1038/cdd.2014.203; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Verotta L, 2004, PHYTOCHEMISTRY, V65, P2867, DOI 10.1016/j.phytochem.2004.07.001; Wang L, 2006, RECENT PROGR CALOPHY, P325; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yang H, 2008, CURR PROTEIN PEPT SC, V9, P227, DOI 10.2174/138920308784533998; Yu DL, 2003, MED RES REV, V23, P322, DOI 10.1002/med.10034	43	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151472	10.1371/journal.pone.0151472	http://dx.doi.org/10.1371/journal.pone.0151472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974436	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600082
J	Wang, Z; Iida, A; Miyake, N; Nishiguchi, KM; Fujita, K; Nakazawa, T; Alswaid, A; Albalwi, MA; Kim, OH; Cho, TJ; Lim, GY; Isidor, B; David, A; Rustad, CF; Merckoll, E; Westvik, J; Stattin, EL; Grigelioniene, G; Kou, I; Nakajima, M; Ohashi, H; Smithson, S; Matsumoto, N; Nishimura, G; Ikegawa, S				Wang, Zheng; Iida, Aritoshi; Miyake, Noriko; Nishiguchi, Koji M.; Fujita, Kosuke; Nakazawa, Toru; Alswaid, Abdulrahman; Albalwi, Mohammed A.; Kim, Ok-Hwa; Cho, Tae-Joon; Lim, Gye-Yeon; Isidor, Bertrand; David, Albert; Rustad, Cecilie F.; Merckoll, Else; Westvik, Jostein; Stattin, Eva-Lena; Grigelioniene, Giedre; Kou, Ikuyo; Nakajima, Masahiro; Ohashi, Hirohumi; Smithson, Sarah; Matsumoto, Naomichi; Nishimura, Gen; Ikegawa, Shiro			Axial Spondylometaphyseal Dysplasia Is Caused by C21orf2 Mutations	PLOS ONE			English	Article							MESSENGER-RNA; CELL-LINE; I-TASSER; GENE; CLASSIFICATION; PREDICTION; FRAMEWORK; NOSOLOGY; SERVER; ATDC5	Axial spondylometaphyseal dysplasia (axial SMD) is an autosomal recessive disease characterized by dysplasia of axial skeleton and retinal dystrophy. We conducted whole exome sequencing and identified C21orf2 (chromosome 21 open reading frame 2) as a disease gene for axial SMD. C21orf2 mutations have been recently found to cause isolated retinal degeneration and Jeune syndrome. We found a total of five biallelic C21orf2 mutations in six families out of nine: three missense and two splicing mutations in patients with various ethnic backgrounds. The pathogenic effects of the splicing (splice-site and branch-point) mutations were confirmed on RNA level, which showed complex patterns of abnormal splicing. C21orf2 mutations presented with a wide range of skeletal phenotypes, including cupped and flared anterior ends of ribs, lacy ilia and metaphyseal dysplasia of proximal femora. Analysis of patients without C21orf2 mutation indicated genetic heterogeneity of axial SMD. Functional data in chondrocyte suggest C21orf2 is implicated in cartilage differentiation. C21orf2 protein was localized to the connecting cilium of the cone and rod photoreceptors, confirming its significance in retinal function. Our study indicates that axial SMD is a member of a unique group of ciliopathy affecting skeleton and retina.	[Wang, Zheng; Iida, Aritoshi; Kou, Ikuyo; Nakajima, Masahiro; Ikegawa, Shiro] RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Wang, Zheng] Chinese Acad Med Sci, Inst Basic Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China; [Wang, Zheng] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Wang, Zheng] Peking Union Med Coll, Beijing 100005, Peoples R China; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 9808574, Japan; [Fujita, Kosuke; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 9808574, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Opthalmol, Sendai, Miyagi 9808574, Japan; [Alswaid, Abdulrahman] King Abdulaziz Med City Natl Guard Hlth Affairs, Dept Pediat, Riyadh 22490, Saudi Arabia; [Albalwi, Mohammed A.] King Abdulaziz Med City Natl Guard Hlth Affairs, Dept Pathol & Lab Med, Riyadh 22490, Saudi Arabia; [Kim, Ok-Hwa] Woorisoa Childrens Hosp, Dept Radiol, Seoul 08291, South Korea; [Cho, Tae-Joon] Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Seoul 03080, South Korea; [Lim, Gye-Yeon] Catholic Univ, St Marys Hosp, Dept Radiol, Seoul 07345, South Korea; [Isidor, Bertrand; David, Albert] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Isidor, Bertrand; David, Albert] INSERM, UMR S 957, F-44093 Nantes, France; [Rustad, Cecilie F.] Oslo Univ Hosp, Clin Genet Sect, Dept Med Genet, N-0424 Oslo, Norway; [Merckoll, Else; Westvik, Jostein] Oslo Univ Hosp, Dept Radiol, N-0424 Oslo, Norway; [Stattin, Eva-Lena] Umea Univ, Dept Med Biosci Med & Clin Genet, S-90187 Umea, Sweden; [Grigelioniene, Giedre] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Grigelioniene, Giedre] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Ohashi, Hirohumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama 3398551, Japan; [Smithson, Sarah] St Michaels Hosp, Dept Clin Genet, Bristol BS2 8EG, Avon, England; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Fuchu, Tokyo 1838561, Japan	RIKEN; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Yokohama City University; Tohoku University; Tohoku University; Tohoku University; Seoul National University (SNU); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oslo; University of Oslo; Umea University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Saitama Children's Medical Center; Tokyo Metropolitan Children's Medical Center	Ikegawa, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Grigelioniene, Giedre/AAH-8408-2020; Grigelioniene, Giedre/N-6599-2013; Ikegawa, Shiro/N-6895-2015; Isidor, Bertrand/AAJ-3456-2021; Iida, Aritoshi/CAA-1373-2022	Grigelioniene, Giedre/0000-0001-9601-3137; Grigelioniene, Giedre/0000-0001-9601-3137; Ikegawa, Shiro/0000-0003-0316-2147; Isidor, Bertrand/0000-0001-6480-126X; Iida, Aritoshi/0000-0001-7538-1651; Rustad, Cecilie Fremstad/0000-0001-7903-9087; Al Balwi, Mohammed/0000-0003-2910-0390; Cho, Tae-Joon/0000-0001-8514-377X	Japan Agency For Medical Research and Development [M15319]; KAKENHI [26893018, 25293235]; Takeda Science Foundation; Japan Agency For Medical Research and Development (AMED) [M15319]	Japan Agency For Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Agency For Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was funded by No. M15319, Japan Agency For Medical Research and Development, http://www.amed.go.jp/en/, to SI; No. 26893018, KAKENHI Grants-in-Aid for Scientific Research, Research Activity Start-up, https://www.jsps.go.jp/english/e-grants, to KMN; No. 25293235, KAKENHI Grant-in-Aid for Scientific Research (B), https://www.jsps.go.jp/english/e-grants/grants01.html, to N. Miyake; Takeda Science Foundation, http://www.takeda-sci.or.jp/index.html, to ZW, N. Miyake, N. Matsumoto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank N. Atsumi for English revision. This study is supported and by KAKENHI Grants-in-Aid for Scientific Research, Research Activity Start-up (K. M. N., No. 26893018), KAKENHI Grant-in-Aid for Scientific Research (B) (N. Mi., No. 25293235), Takeda Science Foundation (Z. W., N. Mi., N. Ma.), and research grants from Japan Agency For Medical Research and Development (AMED) (S.I. N. Ma, No. M15319).	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ARIKAWA K, 1993, INVEST OPHTH VIS SCI, V34, P2145; Baujat G, 2013, J MED GENET, V50, P91, DOI 10.1136/jmedgenet-2012-101282; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Ehara S, 1997, EUR J PEDIATR, V156, P627, DOI 10.1007/s004310050679; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Isidor B, 2010, AM J MED GENET A, V152A, P1550, DOI 10.1002/ajmg.a.33397; Khan AO, 2015, C21ORF2 IS MUTATED R, P1725, DOI [10.1136/bjophthalmol-2015-307277, DOI 10.1136/BJOPHTHALMOL-2015-307277]; Krohn K, 1997, BIOCHEM BIOPH RES CO, V238, P806, DOI 10.1006/bbrc.1997.7352; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lyamichev Victor, 2003, Methods Mol Biol, V212, P229; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyake N, 2016, CLIN GENET, V89, P115, DOI 10.1111/cge.12586; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nakajima J, 2015, CLIN GENET, V87, P356, DOI 10.1111/cge.12394; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; Nishiguchi KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7006; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Scott HS, 1998, GENOMICS, V47, P64, DOI 10.1006/geno.1997.5066; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Suzuki S, 2011, AM J MED GENET A, V155A, P2521, DOI 10.1002/ajmg.a.34192; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Zhai ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064786; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150555	10.1371/journal.pone.0150555	http://dx.doi.org/10.1371/journal.pone.0150555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974433	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600026
J	Xue, H; Wu, Y; Wang, XY; Wang, YF				Xue, Hong; Wu, Yang; Wang, Xiaoyu; Wang, Youfa			Time Trends in Fast Food Consumption and Its Association with Obesity among Children in China	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION TRANSITION; URBAN CHINA; WEIGHT-GAIN; OVERWEIGHT; PREVALENCE; RISK; WORLDWIDE; HEALTH	Objective Study the trends in Western fast food consumption (FFC) among Chinese school-age children and the association between FFC and obesity using nationwide survey data. Design Cross-sectional and longitudinal analyses were conducted to study the trends in FFC and the associations between FFC and weight status (overweight, obesity and body mass index (BMI) z-score). Setting Longitudinal data from families were collected in the 2004 and 2009 China Health and Nutrition Survey (covering nine provinces throughout China). Subjects The analysis included 2656 Chinese children aged 6 to 18 years (1542 and 1114 children in the 2004 and 2009 survey, respectively). Results FFC (reported having consumed Western fast food in the past three months) has increased between 2004 and 2009, from 18.5% to 23.9% in those aged 6-18, and increased more rapidly among those aged 13-17, from 17.9% to 26.3%. The increase was significant in almost all groups by age, sex, family income, and residence. Our cross-sectional and longitudinal analyses did not detect a significant association between FFC and obesity/overweight or BMI z-score (e.g., for BMI z-score, boys: beta = 0.02, 95% CI: -0.71, 0.75; girls: beta = -0.14, 95% CI: -1.03, 0.75). Conclusions FFC has increased in Chinese school-age children, especially in older children, boys, and those from low- and medium-income families, rural areas, and East China, but decreased among those from high-income families during 2004-2009. The data did not show a significant association between FFC and obesity.	[Xue, Hong; Wang, Youfa] SUNY Buffalo, Dept Epidemiol & Environm Hlth, Syst Oriented Global Childhood Obes Intervent Pro, Buffalo, NY 14260 USA; [Wu, Yang; Wang, Youfa] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Wang, Xiaoyu] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wang, YF (corresponding author), SUNY Buffalo, Dept Epidemiol & Environm Hlth, Syst Oriented Global Childhood Obes Intervent Pro, Buffalo, NY 14260 USA.; Wang, YF (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA.	youfawan@buffalo.edu			Eunice Kennedy Shriver National Institute of Child Health & Human Development [U54HD070725]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD070725] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Grant U54HD070725 from Eunice Kennedy Shriver National Institute of Child Health & Human Development, received by YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2005, OBES RES, V13, P1281, DOI 10.1038/oby.2005.153; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2005, DIET REF INT EN CARB; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Du W, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2013-004528, DOI 10.1136/BMJOPEN-2013-004528]; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; Fraser LK, 2012, AM J PREV MED, V42, pE77, DOI 10.1016/j.amepre.2012.02.007; Houldcroft L, 2014, SOC DEV, V23, P19, DOI 10.1111/sode.12036; Hsu YW, 2011, AM J HEALTH BEHAV, V35, P496; KAMADA T, 1992, Frontiers of Medical and Biological Engineering, V4, P1; KFC, 2012, KFC IN CHIN; Ma HY, 2006, CAN J AGR ECON, V54, P101, DOI 10.1111/j.1744-7976.2006.00040.x; McDonald's, 2014, REST LIST; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Popkin BM, 2014, OBES REV, V15, P60, DOI 10.1111/obr.12120; Popkin BM, 2008, HEALTH AFFAIR, V27, P1064, DOI 10.1377/hlthaff.27.4.1064; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Ng SW, 2012, EMPIR ECON, V42, P413, DOI 10.1007/s00181-012-0547-7; Verstraeten R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087183; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wang Y., 2013, CHILDHOOD OBESITY PR; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Witkowski T.H., 2003, ASIA PACIFIC J MARKE, V15, P74, DOI DOI 10.1108/13555850310765088; Zhai FY, 2007, ASIA PAC J CLIN NUTR, V16, P374; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119; Zhang XY, 2012, PUBLIC HEALTH NUTR, V15, P88, DOI 10.1017/S1368980011002047; Zhou DS, 2002, J ADVERTISING RES, V42, P73, DOI 10.2501/JAR-42-3-73-81	32	31	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151141	10.1371/journal.pone.0151141	http://dx.doi.org/10.1371/journal.pone.0151141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26974536	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600051
J	Yang, SS; Fresnedo-Ramirez, J; Sun, Q; Manns, DC; Sacks, GL; Mansfield, AK; Luby, JJ; Londo, JP; Reisch, BI; Cadle-Davidson, LE; Fennell, AY				Yang, Shanshan; Fresnedo-Ramirez, Jonathan; Sun, Qi; Manns, David C.; Sacks, Gavin L.; Mansfield, Anna Katharine; Luby, James J.; Londo, Jason P.; Reisch, Bruce I.; Cadle-Davidson, Lance E.; Fennell, Anne Y.			Next Generation Mapping of Enological Traits in an F-2 Interspecific Grapevine Hybrid Family	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; DENSITY GENETIC-MAP; VITIS-VINIFERA; ENVIRONMENTAL COVARIABLES; AGRONOMIC TRAITS; MALIC-ACID; LOCI; WINE; CONSTRUCTION; SEGREGATION	In winegrapes (Vitis spp.), fruit quality traits such as berry color, total soluble solids content (SS), malic acid content (MA), and yeast assimilable nitrogen (YAN) affect fermentation or wine quality, and are important traits in selecting new hybrid winegrape cultivars. Given the high genetic diversity and heterozygosity of Vitis species and their tendency to exhibit inbreeding depression, linkage map construction and quantitative trait locus (QTL) mapping has relied on F-1 families with the use of simple sequence repeat (SSR) and other markers. This study presents the construction of a genetic map by single nucleotide polymorphisms identified through genotyping-by-sequencing (GBS) technology in an F-2 mapping family of 424 progeny derived from a cross between the wild species V. riparia Michx. and the interspecific hybrid winegrape cultivar, 'Seyval'. The resulting map has 1449 markers spanning 2424 cM in genetic length across 19 linkage groups, covering 95% of the genome with an average distance between markers of 1.67 cM. Compared to an SSR map previously developed for this F-2 family, these results represent an improved map covering a greater portion of the genome with higher marker density. The accuracy of the map was validated using the well-studied trait berry color. QTL affecting YAN, MA and SS related traits were detected. A joint MA and SS QTL spans a region with candidate genes involved in the malate metabolism pathway. We present an analytical pipeline for calling intercross GBS markers and a high-density linkage map for a large F-2 family of the highly heterozygous Vitis genus. This study serves as a model for further genetic investigations of the molecular basis of additional unique characters of North American hybrid wine cultivars and to enhance the breeding process by marker-assisted selection. The GBS protocols for identifying intercross markers developed in this study can be adapted for other heterozygous species.	[Yang, Shanshan; Reisch, Bruce I.] Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Geneva, NY USA; [Fresnedo-Ramirez, Jonathan; Sun, Qi] Cornell Univ, Inst Biotechnol, Bioinformat Facil, Rhodes Hall, Ithaca, NY USA; [Manns, David C.; Mansfield, Anna Katharine] Cornell Univ, Dept Food Sci, NYSAES, Geneva, NY USA; [Sacks, Gavin L.] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Luby, James J.] Univ Minnesota, Dept Hort Sci, St Paul, MN USA; [Londo, Jason P.; Cadle-Davidson, Lance E.] ARS, USDA, Grape Genet Res Unit, Geneva, NY USA; [Fennell, Anne Y.] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA; [Fennell, Anne Y.] BioSNTR, Brookings, SD USA	Cornell University; Cornell University; Cornell University; Cornell University; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); South Dakota State University	Fennell, AY (corresponding author), S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA.; Fennell, AY (corresponding author), BioSNTR, Brookings, SD USA.	Anne.Fennell@sdstate.edu	Sacks, Gavin L/B-2686-2009; Yang, Shanshan/G-9513-2018; Fresnedo-Ramírez, Jonathan/C-2811-2011	Fresnedo-Ramírez, Jonathan/0000-0003-1985-2513; Londo, Jason/0000-0003-0535-4820; Sacks, Gavin/0000-0002-1403-0505	United States Department of Agriculture, National Institute of Food and Agriculture Specialty Crops Research Initiative Award [2011-51181-30635]; ARS [ARS-0425016] Funding Source: Federal RePORTER	United States Department of Agriculture, National Institute of Food and Agriculture Specialty Crops Research Initiative Award; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the United States Department of Agriculture, National Institute of Food and Agriculture Specialty Crops Research Initiative Award No. 2011-51181-30635, BIR, LCD, AYF, GLS, JJL, AKM. This fund supported JFR and DCM. This work was also supported by the National Science Foundation Award No. IIA1355423, South Dakota Research Innovation Center and a gift from J. Lohr Vineyards & Wines to AYF. SY was supported by a grant from the National Grape and Wine Initiative to BIR. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the NSF, USDA or other funding entities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; [Anonymous], 2014, R LANG ENV STAT COMP; Azuma A, 2008, THEOR APPL GENET, V117, P1009, DOI 10.1007/s00122-008-0840-1; Banerjee S, 2008, GENETICS, V179, P2275, DOI 10.1534/genetics.108.088427; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Bell SJ, 2005, AUST J GRAPE WINE R, V11, P242, DOI 10.1111/j.1755-0238.2005.tb00028.x; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Boulton R. B., 1999, PRINCIPLES PRACTICES, P65; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brice C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-495; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cardoso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046021; Castellari M, 2000, J LIQ CHROMATOGR R T, V23, P2047, DOI 10.1081/JLC-100100472; Chen J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0428-2; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Di Gaspero G, 2010, AUST J GRAPE WINE R, V16, P122, DOI 10.1111/j.1755-0238.2009.00072.x; Doligez A, 2006, THEOR APPL GENET, V113, P369, DOI 10.1007/s00122-006-0295-1; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fennell A, 2005, ACTA HORTIC, P533, DOI 10.17660/ActaHortic.2005.689.66; Fennell AY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00834; Garris A, 2009, J AM SOC HORTIC SCI, V134, P261, DOI 10.21273/JASHS.134.2.261; Glaser A.I., 2014, GUIDE GENSTAT RELEAS; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GRATTAPAGLIA D, 1995, THEOR APPL GENET, V90, P933, DOI 10.1007/BF00222906; HUANG Z, 1989, AM J ENOL VITICULT, V40, P135; Jackson D., 2001, CLIMATE MONOGRAPHS C; Jackson R. S., 2014, WINE SCI PRINCIPLES; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; JIANG CJ, 1995, GENETICS, V140, P1111; Kanellis AK, 1993, BIOCH FRUIT RIPENING, P189, DOI DOI 10.1007/978-94-011-1584-1_6; Khan SA, 2013, TREE GENET GENOMES, V9, P475, DOI 10.1007/s11295-012-0571-y; KLIEWER W. M., 1967, AMER J ENOL VITICULT, V18, P87; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Lynch M., 1998, GENETICS ANAL QUANTI; Mahanil S, 2012, THEOR APPL GENET, V124, P23, DOI 10.1007/s00122-011-1684-7; Malosetti M, 2004, EUPHYTICA, V137, P139, DOI 10.1023/B:EUPH.0000040511.46388.ef; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Myles S, 2013, TRENDS GENET, V29, P190, DOI 10.1016/j.tig.2013.01.006; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Neto EC, 2013, QTLHOT INFERENCE QTL; Neto EC, 2013, GENETICS, V193, P1003, DOI 10.1534/genetics.112.147124; Nisbet MA, 2014, AM J ENOL VITICULT, V65, P325, DOI 10.5344/ajev.2014.13130; Plomion C, 1996, GENET SEL EVOL, V28, P223, DOI 10.1051/gse:19960302; Reisch BI, 2012, HANDB PLANT BREED, V8, P225, DOI 10.1007/978-1-4419-0763-9_7; Sacks GL, 2013, 15 AUSTR WIN IND TEC; Salmaso M, 2008, THEOR APPL GENET, V116, P1129, DOI 10.1007/s00122-008-0741-3; Sawler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080791; Song SR, 2014, EUPHYTICA, V195, P259, DOI 10.1007/s10681-013-0994-z; Sreekantan L, 2010, PLANT MOL BIOL, V73, P191, DOI 10.1007/s11103-010-9611-x; Staub JE, 1996, HORTSCIENCE, V31, P729, DOI 10.21273/HORTSCI.31.5.729; Stewart A. C., 2013, THESIS PURDUE U; Sun Q, 2011, J AGR FOOD CHEM, V59, P10657, DOI 10.1021/jf2026204; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Sweetman C, 2009, PHYTOCHEMISTRY, V70, P1329, DOI 10.1016/j.phytochem.2009.08.006; Ugliano M, 2011, J IND MICROBIOL BIOT, V38, P423, DOI 10.1007/s10295-010-0786-6; Ugliano Maurizio, 2009, P313, DOI 10.1007/978-0-387-74118-5_14; Van Ooijen J, 2006, JOINMAP 4 SOFTWARE C; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; VanOoijen JW, 2013, GENETIC MAPPING IN EXPERIMENTAL POPULATIONS, P1, DOI 10.1017/CBO9781139003889; Viana AP, 2013, GENET MOL RES, V12, P951, DOI 10.4238/2013.April.2.11; Volschenk H., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P123; VSN International, 2014, GENSTAT WIND; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wu RL, 2002, THEOR POPUL BIOL, V61, P349, DOI 10.1006/tpbi.2002.1577; Xu CW, 2005, GENETICS, V169, P1045, DOI 10.1534/genetics.103.019406; Yang RQ, 2008, GENETICA, V132, P323, DOI 10.1007/s10709-007-9175-0; Yang RQ, 2010, GENETICA, V138, P853, DOI 10.1007/s10709-010-9468-6; Young PR, 2010, WOODHEAD PUBL FOOD S, P316, DOI 10.1533/9781845699284.3.316; Zhu WS, 2009, J KOREAN STAT SOC, V38, P1, DOI 10.1016/j.jkss.2008.10.006	75	26	27	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149560	10.1371/journal.pone.0149560	http://dx.doi.org/10.1371/journal.pone.0149560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974672	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600012
J	Sherr, L; Yakubovich, AR; Skeen, S; Cluver, LD; Hensels, IS; Macedo, A; Tomlinson, M				Sherr, Lorraine; Yakubovich, Alexa R.; Skeen, Sarah; Cluver, Lucie D.; Hensels, Imca S.; Macedo, Ana; Tomlinson, Mark			How Effective Is Help on the Doorstep? A Longitudinal Evaluation of Community-Based Organisation Support	PLOS ONE			English	Article							VULNERABLE CHILDREN; HIV; HEALTH; CARE	Community-based responses have a lengthy history. The ravages of HIV on family functioning has included a widespread community response. Although much funding has been invested in front line community-based organisations (CBO), there was no equal investment in evaluations. This study was set up to compare children aged 9-13 years old, randomly sampled from two South African provinces, who had not received CBO support over time (YC) with a group of similarly aged children who were CBO attenders (CCC). YC baseline refusal rate was 2.5% and retention rate was 97%. CCC baseline refusal rate was 0.7% and retention rate was 86.5%. 1848 children were included-446 CBO attenders compared to 1402 9-13 year olds drawn from a random sample of high-HIV prevalence areas. Data were gathered at baseline and 12-15 months follow-up. Standardised measures recorded demographics, violence and abuse, mental health, social and educational factors. Multivariate regression analyses revealed that children attending CBOs had lower odds of experiencing weekly domestic conflict between adults in their home (OR 0.17; 95% CI 0.09, 0.32), domestic violence (OR 0.22; 95% CI 0.08, 0.62), or abuse (OR 0.11; 95% CI 0.05, 0.25) at follow-up compared to participants without CBO contact. CBO attenders had lower odds of suicidal ideation (OR 0.41; 95% CI 0.18, 0.91), fewer depressive symptoms (B = -0.40; 95% CI -0.62, -0.17), less perceived stigma (B = -0.37; 95% CI -0.57, -0.18), fewer peer problems (B = -1.08; 95% CI -1.29, -0.86) and fewer conduct problems (B = -0.77; 95% CI -0.95, -0.60) at follow-up. In addition, CBO contact was associated with more prosocial behaviours at follow-up (B = 1.40; 95% CI 1.13, 1.67). No associations were observed between CBO contact and parental praise or post-traumatic symptoms. These results suggest that CBO exposure is associated with behavioural and mental health benefits for children over time. More severe psychopathology was not affected by attendance and may need more specialised input.	[Sherr, Lorraine; Hensels, Imca S.; Macedo, Ana] UCL, Dept Infect & Populat Hlth, London, England; [Yakubovich, Alexa R.; Cluver, Lucie D.] Univ Oxford, Dept Social Policy & Social Intervent, Ctr Evidence Based Intervent, Oxford, England; [Skeen, Sarah; Cluver, Lucie D.] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, ZA-7600 Stellenbosch, South Africa	University of London; University College London; University of Oxford; University of Cape Town; Stellenbosch University	Sherr, L (corresponding author), UCL, Dept Infect & Populat Hlth, London, England.	sherr@ucl.ac.uk		Yakubovich, Alexa/0000-0003-4216-4305; Hensels, Imca/0000-0002-0729-9055; Cluver, Lucie/0000-0002-0418-835X; Sherr, Lorraine/0000-0002-5902-8011	Swedish SIDA-Norad; Coalition of Children Affected by AIDS; UNICEF; UK Economic and Social Research Council and South African National Research Foundation [RES-062-23-2068]; HEARD at the University of KwaZulu-Natal; South African National Department of Social Development; Claude Leon Foundation; John Fell Fund; Nuffield Foundation [CPF/41513]; European Research Council (ERC) under the European Union's Seventh Framework Program (FP7)/ERC grant [313421]; Philip Leverhulme Trust [PLP-2014095]; National Research Foundation, South Africa; Centre of Excellence in Human Development, University of Witwatersrand, South Africa; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA022919] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/H001743/1] Funding Source: researchfish; ESRC [ES/H001743/1] Funding Source: UKRI	Swedish SIDA-Norad; Coalition of Children Affected by AIDS; UNICEF; UK Economic and Social Research Council and South African National Research Foundation; HEARD at the University of KwaZulu-Natal; South African National Department of Social Development; Claude Leon Foundation; John Fell Fund; Nuffield Foundation; European Research Council (ERC) under the European Union's Seventh Framework Program (FP7)/ERC grant(European Research Council (ERC)); Philip Leverhulme Trust; National Research Foundation, South Africa(National Research Foundation - South Africa); Centre of Excellence in Human Development, University of Witwatersrand, South Africa; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	CCC was funded by a grant from Swedish SIDA-Norad through a nesting arrangement with HELPAge Kenya and supported by the Coalition of Children Affected by AIDS. Elements of the combined database were supported by UNICEF. YC was funded by the UK Economic and Social Research Council and South African National Research Foundation (RES-062-23-2068), HEARD at the University of KwaZulu-Natal, the South African National Department of Social Development, the Claude Leon Foundation, the John Fell Fund, and the Nuffield Foundation (CPF/41513). Support was provided to LC by European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no 313421 and the Philip Leverhulme Trust (PLP-2014095). Prof. Mark Tomlinson is supported by the National Research Foundation, South Africa, and is a lead investigator with the Centre of Excellence in Human Development, University of Witwatersrand, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya-Jackson L, 1995, CHILD PTSD CHECKLIST; Boyes ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046905; Briere J., 1996, TRAUMA SYMPTOM CHECK; Campbell DT, 1999, SOCIAL EXPT; Cluver L, 2014, LANCET GLOB HEALTH, V2, pE395, DOI 10.1016/S2214-109X(14)70267-0; Cluver LD, 2014, AIDS, V28, pS389, DOI 10.1097/QAD.0000000000000340; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Grandisson M, 2014, DISABIL REHABIL, V36, P265, DOI 10.3109/09638288.2013.785602; Joseph S., 2009, MANUAL MEASURES CARI; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; King E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006733.pub2; Kovacs M., 1992, CHILDRENS DEPRESSION; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; Moshabela M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083861; Richter LM, 2014, AIDS, V28, pS241, DOI 10.1097/QAD.0000000000000361; RICHTERS JE, 1993, PSYCHIATRY, V56, P7; Rossi PH, 2004, EVALUATION SYSTEMATI; Schenk KD, 2009, AIDS CARE, V21, P918, DOI 10.1080/09540120802537831; Sherr L, 2014, AIDS, V28, pS251, DOI 10.1097/QAD.0000000000000327; Sherr L, 2011, PEPFAR OVC EVALUATIO; Snider L., 2006, PSYCHOSOCIAL VULNERA; Statistics South Africa, 2001, CENS 2001; Thurman TR, 2014, AIDS CARE, V26, pS2, DOI 10.1080/09540121.2014.906555; UNAIDS UNICEF and USAID, 2004, CHILDR BRINK 2004 JO; UNICEF, 2013, AIDS FREE GEN CHILDR; van Pletzen E, 2014, HEALTH POLICY PLANN, V29, P742, DOI 10.1093/heapol/czt058; van Rensburg DJ, 2011, SOC SCI MED, V72, P1021, DOI 10.1016/j.socscimed.2011.01.026; Wouters E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-194; Yakubovich AR, 2016, CHILD YOUTH SERV REV, V62, P58, DOI 10.1016/j.childyouth.2016.01.016	29	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151305	10.1371/journal.pone.0151305	http://dx.doi.org/10.1371/journal.pone.0151305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967732	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200044
J	Hicks, KM; Onambele, GL; Winwood, K; Morse, CI				Hicks, K. M.; Onambele, G. L.; Winwood, K.; Morse, C. I.			Muscle Damage following Maximal Eccentric Knee Extensions in Males and Females	PLOS ONE			English	Article							CREATINE-KINASE RESPONSE; GENDER-DIFFERENCES; SEX-DIFFERENCES; IN-VIVO; EXERCISE; TENDON; FORCE; BEHAVIOR; CONTRACTIONS; FATIGUE	Aim To investigate whether there is a sex difference in exercise induced muscle damage. Materials and Method Vastus Lateralis and patella tendon properties were measured in males and females using ultrasonography. During maximal voluntary eccentric knee extensions (12 reps x 6 sets), Vastus Lateralis fascicle lengthening and maximal voluntary eccentric knee extensions torque were recorded every 10 degrees of knee joint angle (20-90 degrees). Isometric torque, Creatine Kinase and muscle soreness were measured pre, post, 48, 96 and 168 hours post damage as markers of exercise induced muscle damage. Results Patella tendon stiffness and Vastus Lateralis fascicle lengthening were significantly higher in males compared to females (p<0.05). There was no sex difference in isometric torque loss and muscle soreness post exercise induced muscle damage (p>0.05). Creatine Kinase levels post exercise induced muscle damage were higher in males compared to females (p<0.05), and remained higher when maximal voluntary eccentric knee extension torque, relative to estimated quadriceps anatomical cross sectional area, was taken as a covariate (p<0.05). Conclusion Based on isometric torque loss, there is no sex difference in exercise induced muscle damage. The higher Creatine Kinase in males could not be explained by differences in maximal voluntary eccentric knee extension torque, Vastus Lateralis fascicle lengthening and patella tendon stiffness. Further research is required to understand the significant sex differences in Creatine Kinase levels following exercise induced muscle damage.	[Hicks, K. M.] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Hicks, K. M.; Onambele, G. L.; Winwood, K.; Morse, C. I.] Manchester Metropolitan Univ Cheshire, Dept Exercise & Sport Sci, Inst Performance Res, Manchester, Lancs, England	Northumbria University; Manchester Metropolitan University	Hicks, KM (corresponding author), Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.; Hicks, KM (corresponding author), Manchester Metropolitan Univ Cheshire, Dept Exercise & Sport Sci, Inst Performance Res, Manchester, Lancs, England.	Kirsty.Hicks@northumbria.ac.uk	Onambélé-Pearson, Gladys Leopoldine/F-1679-2013; Morse, Christopher/AAE-7913-2022	Onambélé-Pearson, Gladys Leopoldine/0000-0002-1466-3265; Morse, Christopher/0000-0002-5261-2637; Winwood, Keith/0000-0002-8696-9976; Hicks, Kirsty/0000-0002-5057-9191	Institute for Performance Research at Manchester Metropolitan University Cheshire; Liverpool Football Club	Institute for Performance Research at Manchester Metropolitan University Cheshire; Liverpool Football Club	The funder (Liverpool Football Club) provided support in the form of salaries for authors (KMH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was also supported by the Institute for Performance Research at Manchester Metropolitan University Cheshire. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; Borsa PA, 2000, MED SCI SPORT EXER, V32, P891; BROWN JB, 1955, LANCET, V1, P320; Bryant AL, 2008, J APPL PHYSIOL, V105, P1035, DOI 10.1152/japplphysiol.01281.2007; CAROLAN B, 1992, J APPL PHYSIOL, V73, P911, DOI 10.1152/jappl.1992.73.3.911; Chapman D, 2006, INT J SPORTS MED, V27, P591, DOI 10.1055/s-2005-865920; Chapman DW, 2008, BRIT J SPORT MED, V42, P585, DOI 10.1136/bjsm.2007.037929; Chen TC, 2011, EUR J APPL PHYSIOL, V111, P211, DOI 10.1007/s00421-010-1648-7; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Dannecker EA, 2012, J PAIN, V13, P1242, DOI 10.1016/j.jpain.2012.09.014; Erskine RM, 2014, J BIOMECHANICS; Finni T, 2003, ACTA PHYSIOL SCAND, V177, P483, DOI 10.1046/j.1365-201X.2003.01069.x; Fredsted A, 2008, J STRENGTH COND RES, V22, P1136, DOI 10.1519/JSC.0b013e318173db9b; Friden J, 2001, SCAND J MED SCI SPOR, V11, P126, DOI 10.1034/j.1600-0838.2001.011002126.x; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Grosset JF, 2008, ANAT REC, V291, P1673, DOI 10.1002/ar.20759; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Heled Y, 2007, J APPL PHYSIOL, V103, P504, DOI 10.1152/japplphysiol.00081.2007; Hicks KM, 2013, ACTA PHYSIOL, V209, P235, DOI 10.1111/apha.12159; Hody S, 2013, SCAND J MED SCI SPOR, V23, P501, DOI 10.1111/j.1600-0838.2011.01413.x; Hoffman BW, 2014, J APPL PHYSIOL, V116, P1455, DOI 10.1152/japplphysiol.01431.2012; Jamurtas AZ, 2005, EUR J APPL PHYSIOL, V95, P179, DOI 10.1007/s00421-005-1345-0; Joyce S, 2014, EUROPEAN J APPL PHYS, P1; Komulainen J, 1999, ACTA PHYSIOL SCAND, V165, P57; Lichtwark GA, 2007, J BIOMECH, V40, P1768, DOI 10.1016/j.jbiomech.2006.07.025; LIEBER RL, 1993, J APPL PHYSIOL, V74, P520, DOI 10.1152/jappl.1993.74.2.520; LIPPOLD OCJ, 1952, J PHYSIOL-LONDON, V117, P492, DOI 10.1113/jphysiol.1952.sp004763; Machado M, 2012, RES Q EXERCISE SPORT, V83, P276, DOI 10.1080/02701367.2012.10599858; McHugh MP, 1999, AM J SPORT MED, V27, P594, DOI 10.1177/03635465990270050801; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; NEWHAM DJ, 1983, MUSCLE NERVE, V6, P380, DOI 10.1002/mus.880060507; Nosaka K, 1996, INT J SPORTS MED, V17, P120, DOI 10.1055/s-2007-972819; Onambele GNL, 2007, J ORTHOP RES, V25, P1635, DOI 10.1002/jor.20404; Reeves ND, 2004, EUR J APPL PHYSIOL, V91, P116, DOI 10.1007/s00421-003-0961-9; Reeves ND, 2003, J APPL PHYSIOL, V95, P1090, DOI 10.1152/japplphysiol.01046.2002; Rinard J, 2000, J SPORT SCI, V18, P229, DOI 10.1080/026404100364965; Roberts TJ, 2013, EXERC SPORT SCI REV, V41, P186, DOI 10.1097/JES.0b013e3182a4e6d5; Roberts TJ, 2010, J APPL PHYSIOL, V109, P396, DOI 10.1152/japplphysiol.01272.2009; Sayers SP, 2001, EUR J APPL PHYSIOL, V84, P122, DOI 10.1007/s004210000346; Sewright KA, 2008, MED SCI SPORT EXER, V40, P242, DOI 10.1249/mss.0b013e31815aedda; Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325; Tsakoniti AE, 2008, J APPL PHYSIOL, V105, P800, DOI 10.1152/japplphysiol.00961.2007; Walsh LD, 2004, J PHYSIOL-LONDON, V558, P705, DOI 10.1113/jphysiol.2004.062703; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; WARREN GL, 1993, J PHYSIOL-LONDON, V464, P457, DOI 10.1113/jphysiol.1993.sp019645; WISEMAN H, 1994, FREE RADICAL RES, V21, P187, DOI 10.3109/10715769409056569; Wolf MR, 2012, EUR J APPL PHYSIOL, V112, P3335, DOI 10.1007/s00421-012-2314-z	47	39	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150848	10.1371/journal.pone.0150848	http://dx.doi.org/10.1371/journal.pone.0150848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986066	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000372580300029
J	Alsop, RJ; Soomro, A; Zhang, YC; Pieterse, M; Fatona, A; Dej, K; Rheinstadter, MC				Alsop, Richard J.; Soomro, Asfia; Zhang, Yuchen; Pieterse, Marc; Fatona, Ayodele; Dej, Kimberly; Rheinstaedter, Maikel C.			Structural Abnormalities in the Hair of a Patient with a Novel Ribosomopathy	PLOS ONE			English	Article							ALPHA-KERATIN FIBERS; HELICAL COILED COILS; INTERMEDIATE FILAMENT; SEBACEOUS GLAND; PLASMA-MEMBRANE	We report the biophysical characterization of hair from a patient with a de novo ribosomopathy. The patient was diagnosed with a mutation on gene RPS23, which codes for a protein which comprises part of the 40S subunit of the ribosome. The patient presents with a number of phenotypes, including hypotonia, autism, extra teeth, elastic skin, and thin/brittle hair. We combined optical microscopy, tensile tests, and X-ray diffraction experiments on hair samples obtained from the scalp of the patient to a multi-scale characterization of the hair from macroscopic to molecular length scales and observe distinct differences in the biophysical properties in the patient's hair when compared to hair from other family members. While no differences were observed in the coiled-coil structure of the keratin proteins or the structure of the intermediate filaments, the patient's hair was 22% thinner, while the Young's modulus remained roughly constant. The X-ray diffraction results give evidence that the amount of lipids in the cell membrane complex is reduced by 20%, which well accounts for the other observations. The pathologies characterized by these techniques may be used to inform the diagnosis of similar de novo mutations in the future.	[Alsop, Richard J.; Soomro, Asfia; Zhang, Yuchen; Pieterse, Marc; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Fatona, Ayodele] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Dej, Kimberly] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Rheinstadter, MC (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009	Rheinstadter, Maikel C/0000-0002-0558-7475; Dej, Kim/0000-0002-4665-2392	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI); Ontario Ministry of Economic Development and Innovation; NSERC PGS-D; Early Researcher Award of the Province of Ontario	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Economic Development and Innovation; NSERC PGS-D(Natural Sciences and Engineering Research Council of Canada (NSERC)); Early Researcher Award of the Province of Ontario	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada (NRC), the Canada Foundation for Innovation (CFI) and the Ontario Ministry of Economic Development and Innovation. RJA is the recipient of an NSERC PGS-D. MCR is the recipient of an Early Researcher Award of the Province of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada (NRC), the Canada Foundation for Innovation (CFI) and the Ontario Ministry of Economic Development and Innovation. R.J.A. is the recipient of an NSERC PGS-D. M.C.R. is the recipient of an Early Researcher Award of the Province of Ontario.	Ahn HJ, 2002, INT J DERMATOL, V41, P88, DOI 10.1046/j.1365-4362.2002.01375.x; Astbury W.T., 1935, P ROY SOC LOND A MAT, V150, P533, DOI DOI 10.1098/RSPA.1935.0121; Chou CC, 2015, J MATER RES, V30, P26, DOI 10.1557/jmr.2014.267; COHEN C, 1994, SCIENCE, V263, P488, DOI 10.1126/science.8290957; Corino GL, 2009, BREAST CANCER-BASIC, V3, P83; COURTOIS M, 1995, BRIT J DERMATOL, V132, P86, DOI 10.1111/j.1365-2133.1995.tb08630.x; CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0; Feughelman M., 1959, TEXTIL RES J, V29, P223, DOI [DOI 10.1177/004051755902900305, 10.1177%2F004051755902900305]; Flagler M, 2012, EFFECTS AGING HAIR M, P1; FRASER RDB, 1962, NATURE, V193, P1052, DOI 10.1038/1931052a0; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; James V, 1999, NATURE, V398, P33, DOI 10.1038/17949; JONES AT, 1964, MAKROMOLEKUL CHEM, V71, P1; Jones LN, 1997, MICRON, V28, P469, DOI 10.1016/S0968-4328(97)00039-5; Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749; Kreplak L, 2002, BIOPHYS J, V82, P2265, DOI 10.1016/S0006-3495(02)75572-0; Kucerka N, 2005, BIOPHYS J, V88, P2626, DOI 10.1529/biophysj.104.056606; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lewis R, 2015, JAMA-J AM MED ASSOC, V313, P1301, DOI 10.1001/jama.2015.1389; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Neukirch S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038105; Ootsuka H., 1988, KOSHOKAISHI, V12, P192; PAULING L, 1951, P NATL ACAD SCI USA, V37, P261, DOI 10.1073/pnas.37.5.261; Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f; POCHI PE, 1979, J INVEST DERMATOL, V73, P108, DOI 10.1111/1523-1747.ep12532792; POCHI PE, 1974, J INVEST DERMATOL, V62, P191, DOI 10.1111/1523-1747.ep12676783; Poinapen D, 2013, SOFT MATTER, V9, P6804, DOI 10.1039/c3sm50355k; RANDALL VA, 1994, CLIN ENDOCRINOL, V40, P439, DOI 10.1111/j.1365-2265.1994.tb02483.x; Rheinstadter MC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108107; Robbins C.R, 2012, CHEM PHYS BEHAV HUMA, DOI 10.1007/978-3-642-25611-0_9; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Toppozini L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.228101; Tourlakis ME, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005288; WELTI R, 1981, J BIOL CHEM, V256, P7528; WORTMANN FJ, 1994, TEXT RES J, V64, P737, DOI 10.1177/004051759406401206; Yang FC, 2014, SOFT MATTER, V10, P5541, DOI 10.1039/c4sm00301b; Yang FC, 2014, PEERJ, V2, DOI 10.7717/peerj.619; Zhang YC, 2015, PEERJ, V3, DOI 10.7717/peerj.1296	39	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149619	10.1371/journal.pone.0149619	http://dx.doi.org/10.1371/journal.pone.0149619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982655	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900017
J	Chirebvu, E; Chimbari, MJ; Ngwenya, BN; Sartorius, B				Chirebvu, Elijah; Chimbari, Moses John; Ngwenya, Barbara Ntombi; Sartorius, Benn			Clinical Malaria Transmission Trends and Its Association with Climatic Variables in Tubu Village, Botswana: A Retrospective Analysis	PLOS ONE			English	Article							EXPLORING 30 YEARS; ANOPHELES-ARABIENSIS; USAMBARA MOUNTAINS; SOUTH-AFRICA; IMPACT; RAINFALL; TEMPERATURE; HIGHLANDS; EPIDEMIOLOGY; VARIABILITY	Good knowledge on the interactions between climatic variables and malaria can be very useful for predicting outbreaks and preparedness interventions. We investigated clinical malaria transmission patterns and its temporal relationship with climatic variables in Tubu village, Botswana. A 5-year retrospective time series data analysis was conducted to determine the transmission patterns of clinical malaria cases at Tubu Health Post and its relationship with rainfall, flood discharge, flood extent, mean minimum, maximum and average temperatures. Data was obtained from clinical records and respective institutions for the period July 2005 to June 2010, presented graphically and analysed using the Univariate ANOVA and Pearson cross-correlation coefficient tests. Peak malaria season occurred between October and May with the highest cumulative incidence of clinical malaria cases being recorded in February. Most of the cases were individuals aged > 5 years. Associations between the incidence of clinical malaria cases and several factors were strong at lag periods of 1 month; rainfall (r = 0.417), mean minimum temperature (r = 0.537), mean average temperature (r = 0.493); and at lag period of 6 months for flood extent (r = 0.467) and zero month for flood discharge (r = 0.497). The effect of mean maximum temperature was strongest at 2-month lag period (r = 0.328). Although malaria transmission patterns varied from year to year the trends were similar to those observed in sub-Saharan Africa. Age group > 5 years experienced the greatest burden of clinical malaria probably due to the effects of the national malaria elimination programme. Rainfall, flood discharge and extent, mean minimum and mean average temperatures showed some correlation with the incidence of clinical malaria cases.	[Chirebvu, Elijah; Ngwenya, Barbara Ntombi] Univ Botswana, Okavango Res Inst, Private Bag 285, Maun, Botswana; [Chimbari, Moses John] Univ KwaZulu Natal, Coll Hlth Sci, Howard Campus, ZA-4041 Durban, South Africa; [Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa	University of Botswana; University of Kwazulu Natal; University of Kwazulu Natal	Chimbari, MJ (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Howard Campus, ZA-4041 Durban, South Africa.	chimbari@ukzn.ac.za		, bennsartorius/0000-0001-6761-2325	International Development Centre, Canada [106024-001]	International Development Centre, Canada	This work was supported by International Development Centre, Canada. Grant Number: 106024-001 (MJC). The funder had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Alsop Z, 2007, LANCET, V370, P925, DOI 10.1016/S0140-6736(07)61428-7; [Anonymous], 2009, TRANSBOUNDARY DIAGNO; Bell D, 1991, LECT NOTES TROPICAL; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bonora S, 2001, TRENDS PARASITOL, V17, P572, DOI 10.1016/S1471-4922(01)02095-5; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111; Campanella N, 1998, PUBLIC HLTH REV, V27, P311; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Central Statistics Office, 2001, POP HOUS CENS PREL R; Chirebvu E, 1995, MALARIA INFECT DIS A, V2; Chirebvu E, 2015, J VECTOR ECOL, V40, P129, DOI 10.1111/jvec.12141; Craig MH, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-44; Craig MH, 2004, TROP MED INT HEALTH, V9, P1258, DOI 10.1111/j.1365-3156.2004.01341.x; Craig MH, 2004, TROP MED INT HEALTH, V9, P1247, DOI 10.1111/j.1365-3156.2004.01340.x; Devi N. Pemola, 2013, European Journal of Experimental Biology, V3, P28; Dominion, 2006, INT FLOOD RISK RED A; El Sayed BB, 2000, ACTA TROP, V75, P163, DOI 10.1016/S0001-706X(99)00098-4; Government of Botswana [GoB], 2001, BOTSW NAT ATL; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Kim YM, 2012, ENVIRON HEALTH PERSP, V120, P1314, DOI 10.1289/ehp.1104577; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Kondo Hisayoshi, 2002, Prehosp Disaster Med, V17, P126; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Mabaso MLH, 2005, TROP MED INT HEALTH, V10, P909, DOI 10.1111/j.1365-3156.2005.01462.x; MATOLA YG, 1987, J TROP MED HYG, V90, P127; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Midekisa A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0954-7; Ministry of Health, 2012, MAL SURV GUID; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Najera JA., 1998, MALARIA EPIDEMICS DE; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; RAMASAMY R, 1992, ANN TROP MED PARASIT, V86, P591, DOI 10.1080/00034983.1992.11812714; Ramberg L, 2006, AQUAT SCI, V68, P310, DOI 10.1007/s00027-006-0857-y; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Silal SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076640; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-44; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98; World Health Organization, 2011, MAL FACT SHEET; Worrall E, 2007, TROP MED INT HEALTH, V12, P75, DOI 10.1111/j.1365-3156.2006.01772.x; Yamana T, 2014, MALARIA J S1, V13, pP94; Zhang Y, 2010, ENVIRON INT, V36, P439, DOI 10.1016/j.envint.2010.03.005; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; Zinszer K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0758-4	56	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0139843	10.1371/journal.pone.0139843	http://dx.doi.org/10.1371/journal.pone.0139843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983035	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900010
J	Qiu, S; Wu, T; Wang, PF; Li, JL; Li, Q; Du, JC				Qiu, Shi; Wu, Tao; Wang, Peifu; Li, Jilai; Li, Qin; Du, Jichen			The Association between VEGFR Gene Polymorphisms and Stroke: A Meta-Analysis	PLOS ONE			English	Article							SILENT BRAIN INFARCTION; ISCHEMIC-STROKE; ANGIOGENESIS; RECEPTOR-2	Several published articles investigated the relationship between VEGF receptor gene polymorphisms and stroke, but they failed to reach the same conclusion. This meta-analysis was performed to identify the relationships between VEGF receptor gene and the risk of stroke. The PubMed, Embase, China National Knowledge Infrastructure (CNKI) database, Wanfang Chinese database, and VIP Chinese database were systemically searched. Data was extracted by two independent reviewers. The pooled odds ratio (OR) with 95% confidence interval (CI) were calculated. 5 case-control studies with a total of 2904 patients with stroke and 2824 control subjects were included, including 2904 cases and 2824 controls for -604T>C, 2733 cases and 2663 controls for +1192C>T, and 2733 cases and 2663 controls for +1719A>T. Under the dominant and recessive models, respectively, the overall ORs and 95% CIs of -604 C were 0.749, 0.493-1.138 (P = 0.176) and 0.819, 0.544-1.234 (P = 0.340); the overall ORs and 95% CIs of +1192 T were 1.148, 0.876-1.504 (P = 0.318) and 1.611, 1.004-2.586 (P = 0.048); the overall ORs and 95% CIs of +1719 T were 1.227, 0.932-1.615 (P = 0.146) and 1.139, 1.015-1.279 (P = 0.027). Our finding indicates that +1192C>T and +1719A>T may be associated with the risk of stroke, but not -604T>C.	[Qiu, Shi; Wu, Tao; Wang, Peifu; Li, Jilai; Li, Qin; Du, Jichen] Aerosp Ctr Hosp, Dept Neurol, Beijing, Peoples R China		Du, JC (corresponding author), Aerosp Ctr Hosp, Dept Neurol, Beijing, Peoples R China.	djc721@163.com						Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Dichgans M, 2005, STROKE, V36, P2027, DOI 10.1161/01.STR.0000177498.21594.9e; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fontanella M, 2013, ACTA NEUROCHIR, V155, P1511, DOI 10.1007/s00701-013-1779-9; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Han IB, 2012, J NEUROL SCI, V318, P85, DOI 10.1016/j.jns.2012.03.020; Kim OJ, 2011, STROKE, V42, P2393, DOI 10.1161/STROKEAHA.110.607739; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Li B, 2002, HYPERTENSION, V39, P1095, DOI 10.1161/01.HYP.0000018588.56950.7A; Liang XW, 2014, CURR MED CHEM, V21, P894, DOI 10.2174/09298673113206660264; Moulton KS, 2006, CURR OPIN LIPIDOL, V17, P548, DOI 10.1097/01.mol.0000245261.71129.f0; Oh SH, 2011, J NEUROL SCI, V308, P62, DOI 10.1016/j.jns.2011.06.012; Park YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047158; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shen X, 2014, VEGFR 2 GENE PROMOTE; Wang Y, 2007, J AM COLL CARDIOL, V50, P760, DOI 10.1016/j.jacc.2007.04.074; Wells G.A., NEWCASTLE OTTAWA SCA; Zhang H, 2014, CHINESE J TRAUMA DIS, P47, DOI 10.13214/j.cnki.cjotadm.2014.12.031; Zhang WL, 2009, STROKE, V40, P2720, DOI 10.1161/STROKEAHA.109.554394	23	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151371	10.1371/journal.pone.0151371	http://dx.doi.org/10.1371/journal.pone.0151371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981634	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900081
J	Richardson, M; Garner, P; Donegan, S				Richardson, Marty; Garner, Paul; Donegan, Sarah			Cluster Randomised Trials in Cochrane Reviews: Evaluation of Methodological and Reporting Practice	PLOS ONE			English	Review							METAANALYSES	Objective Systematic reviews can include cluster-randomised controlled trials (C-RCTs), which require different analysis compared with standard individual-randomised controlled trials. However, it is not known whether review authors follow the methodological and reporting guidance when including these trials. The aim of this study was to assess the methodological and reporting practice of Cochrane reviews that included C-RCTs against criteria developed from existing guidance. Methods Criteria were developed, based on methodological literature and personal experience supervising review production and quality. Criteria were grouped into four themes: identifying, reporting, assessing risk of bias, and analysing C-RCTs. The Cochrane Database of Systematic Reviews was searched (2nd December 2013), and the 50 most recent reviews that included C-RCTs were retrieved. Each review was then assessed using the criteria. Results The 50 reviews we identified were published by 26 Cochrane Review Groups between June 2013 and November 2013. For identifying C-RCTs, only 56% identified that C-RCTs were eligible for inclusion in the review in the eligibility criteria. For reporting C-RCTs, only eight (24%) of the 33 reviews reported the method of cluster adjustment for their included C-RCTs. For assessing risk of bias, only one review assessed all five C-RCT-specific risk-ofbias criteria. For analysing C-RCTs, of the 27 reviews that presented unadjusted data, only nine (33%) provided a warning that confidence intervals may be artificially narrow. Of the 34 reviews that reported data from unadjusted C-RCTs, only 13 (38%) excluded the unadjusted results from the meta-analyses. Conclusions The methodological and reporting practices in Cochrane reviews incorporating C-RCTs could be greatly improved, particularly with regard to analyses. Criteria developed as part of the current study could be used by review authors or editors to identify errors and improve the quality of published systematic reviews incorporating C-RCTs.	[Richardson, Marty; Garner, Paul] Univ Liverpool, Liverpool Sch Trop Med, Ctr Evidence Synth Global Hlth, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Donegan, Sarah] Univ Liverpool, Dept Biostat, Block F Waterhouse Bldg, Liverpool L69 3BX, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Richardson, M (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Evidence Synth Global Hlth, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	mhr@liverpool.ac.uk	Garner, Paul/HII-5856-2022; Garner, Paul/Y-8385-2019	Garner, Paul/0000-0002-0607-6941; Donegan, Sarah/0000-0003-1709-2290; Richardson, Marty/0000-0002-7097-8704	Effective Health Care Research Consortium - UKAid from the UK Government Department for International Development [PO 5242]; Medical Research Council [MR/K021435/1]; MRC [MR/K021435/1] Funding Source: UKRI; Department for International Development (DFID) [201400] Funding Source: researchfish	Effective Health Care Research Consortium - UKAid from the UK Government Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID)	MR, SD, and PG are supported by the Effective Health Care Research Consortium, which is funded by UKAid from the UK Government Department for International Development (Grant number, PO 5242; URL, https://www.gov.uk/government/organisations/department-forinternational-development). SD is also funded by the Medical Research Council (Grant number, MR/K021435/1; URL, http://www.mrc.ac.uk/).	Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007529.pub3; Bath-Hextall FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007281.pub2; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009853.pub2; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004150.pub4; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chamberlain Catherine, 2013, Cochrane Database Syst Rev, pCD001055, DOI 10.1002/14651858.CD001055.pub4; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Clement S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009453.pub2; Cramp F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008322.pub2; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3; Donegan S, 2009, 17 COCHR C 2009 11 1; Donner A, 2001, STAT METHODS MED RES, V10, P325, DOI 10.1191/096228001680678322; Donner A, 2002, STAT MED, V21, P2971, DOI 10.1002/sim.1301; Farrelly S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001711.pub2; Fellmeth GLT, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004534.pub3; Foster C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010395.pub2; Galappaththy GNL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004389.pub3; Gillaizeau F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002894.pub3; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Hajek P, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003999.pub3, 10.1002/14651858.CD003999.pub4]; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Holme O, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009259.pub2; Hu HK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005516.pub2; Hughes C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006354.pub4; Kahn SR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008201.pub2; Kinnersley P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009445.pub2; Kredo T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009987.pub2; Kruis AL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009437.pub2; Laopaiboon M, 2003, STAT METHODS MED RES, V12, P515, DOI 10.1191/0962280203sm347oa; Lavender T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009338.pub2; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Lopez LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010662.pub2; Lopez LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007249.pub4; Manser R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001991.pub3; Marinho VCC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002279.pub2; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moore ZEH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009362.pub2; Morag I, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006982.pub3; Omidvari Amir-Houshang, 2013, Cochrane Database Syst Rev, pCD005539, DOI 10.1002/14651858.CD005539.pub2; Paul M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003038.pub2; Rice VH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001188.pub4; Rosendal M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008142.pub2; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Schaafsma FG, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001822.pub3; Schoonees A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009000.pub2; Sharma SK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007545.pub2; Shinohara K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008696.pub2; Stanton A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003289.pub5; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Thomas RE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub4; Trestioreanu AZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004785.pub5; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; van der Meer RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006102.pub2; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Yonemoto N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009326.pub2	57	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151818	10.1371/journal.pone.0151818	http://dx.doi.org/10.1371/journal.pone.0151818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982697	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000372574900118
J	Ascensao, F; Mata, C; Malo, JE; Ruiz-Capillas, P; Silva, C; Silva, AP; Santos-Reis, M; Fernandes, C				Ascensao, Fernando; Mata, Cristina; Malo, Juan E.; Ruiz-Capillas, Pablo; Silva, Catarina; Silva, Andre P.; Santos-Reis, Margarida; Fernandes, Carlos			Disentangle the Causes of the Road Barrier Effect in Small Mammals through Genetic Patterns	PLOS ONE			English	Article							MOUSE APODEMUS-SYLVATICUS; EFFECTIVE POPULATION-SIZE; MICROSATELLITE NULL ALLELES; RED-BACKED SALAMANDERS; PER-GENERATION RULE; WOOD MICE; LINKAGE DISEQUILIBRIUM; GENOTYPING ERRORS; CLETHRIONOMYS-GLAREOLUS; SMALL RODENT	Road barrier effect is among the foremost negative impacts of roads on wildlife. Knowledge of the factors responsible for the road barrier effect is crucial to understand and predict species' responses to roads, and to improve mitigation measures in the context of management and conservation. We built a set of hypothesis aiming to infer the most probable cause of road barrier effect (traffic effect or road surface avoidance), while controlling for the potentially confounding effects road width, traffic volume and road age. The wood mouse Apodemus sylvaticus was used as a model species of small and forest-dwelling mammals, which are more likely to be affected by gaps in cover such as those resulting from road construction. We confront genetic patterns from opposite and same roadsides from samples of three highways and used computer simulations to infer migration rates between opposite roadsides. Genetic patterns from 302 samples (ca. 100 per highway) suggest that the highway barrier effect for wood mouse is due to road surface avoidance. However, from the simulations we estimated a migration rate of about 5% between opposite roadsides, indicating that some limited gene flow across highways does occur. To reduce highway impact on population genetic diversity and structure, possible mitigation measures could include retrofitting of culverts and underpasses to increase their attractiveness and facilitate their use by wood mice and other species, and setting aside roadside strips without vegetation removal to facilitate establishment and dispersal of small mammals.	[Ascensao, Fernando; Silva, Catarina; Silva, Andre P.; Santos-Reis, Margarida; Fernandes, Carlos] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, Ed C2-5 Piso, Lisbon, Portugal; [Mata, Cristina; Malo, Juan E.] Univ Autonoma Madrid, Dept Ecol, Terr Ecol Grp, Madrid, Spain; [Ruiz-Capillas, Pablo] Obrascon Huarte Lain SA, Direcc Innovac & Sostenibilidad, Madrid, Spain; [Ascensao, Fernando] Inst Super Agron, InBIO Rede Invest Biodiversidade & Biol Evolut, CIBIO Res Ctr Biodivers & Genet Resources, Infraestruturas Portugal Biodivers Chair, P-1349017 Lisbon, Portugal	Universidade de Lisboa; Autonomous University of Madrid; Universidade de Lisboa	Ascensao, F (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, Ed C2-5 Piso, Lisbon, Portugal.; Ascensao, F (corresponding author), Inst Super Agron, InBIO Rede Invest Biodiversidade & Biol Evolut, CIBIO Res Ctr Biodivers & Genet Resources, Infraestruturas Portugal Biodivers Chair, P-1349017 Lisbon, Portugal.	fernandoascensao@gmail.com	Afonso Silva, Ana Catarina/I-5462-2019; Fernandes, Carlos/J-3045-2013; Mata, Cristina/ABF-1169-2021; Fernandes, Carlos/AAB-5256-2019; Malo, Juan E/K-8305-2014; Ascensão, Fernando/G-1513-2014; Santos-Reis, Margarida/H-4064-2011; Silva, André P./J-1700-2012; Ascensão, Fernando/ABF-9787-2021; Arrazola, Juan Esteban Malo/Q-4819-2019	Afonso Silva, Ana Catarina/0000-0002-8808-1452; Fernandes, Carlos/0000-0002-1386-8103; Mata, Cristina/0000-0002-6206-1015; Fernandes, Carlos/0000-0002-1386-8103; Malo, Juan E/0000-0002-6033-5035; Ascensão, Fernando/0000-0003-1704-0212; Silva, André P./0000-0002-4722-8497; Ascensão, Fernando/0000-0003-1704-0212; Arrazola, Juan Esteban Malo/0000-0002-6033-5035; Santos-Reis, Margarida/0000-0002-0337-963X	Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal) [PTDC/BIA-BEC/101511/2008, SFRH/BD/38053/2007, C2007-UL-342-CBA1]; Centro para el Desarrollo Tecnologico e Industrial, CDTI, of the Spanish Ministry of Science and Innovation; Comunidad de Madrid; European Social Fund through the REMEDINAL-3 Research Network [S-2013/MAE-2719]	Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal)(Portuguese Foundation for Science and Technology); Centro para el Desarrollo Tecnologico e Industrial, CDTI, of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Comunidad de Madrid(Comunidad de Madrid); European Social Fund through the REMEDINAL-3 Research Network	The study was funded by Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal) through the project 'Effects of habitat fragmentation on the population structure and connectivity of forest-dwelling species: a comparative landscape genetics approach' (PTDC/BIA-BEC/101511/2008), a PhD grant (FA, SFRH/BD/38053/2007), and a Ciencia 2007 contract (CF, C2007-UL-342-CBA1). Obrascon Huarte Lain, S.A. provided support in the form of salaries for PRC. This study also forms part of the CENIT-OASIS project funded by a consortium of companies supported by the Centro para el Desarrollo Tecnologico e Industrial, CDTI, of the Spanish Ministry of Science and Innovation. The Comunidad de Madrid, together with the European Social Fund, supports the TEG research group through the REMEDINAL-3 Research Network (S-2013/MAE-2719). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Alexander SM, 2005, CAN GEOGR-GEOGR CAN, V49, P321, DOI 10.1111/j.0008-3658.2005.00099.x; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; [Anonymous], CORK OAK WOODLANDS E; [Anonymous], 1996, 5000 CNRS UMR; Ascensao F., 2006, P 2005 INT C ECOLOGY, P641; Ascensao F, 2015, HANDBOOK OF ROAD ECOLOGY, P325; Ascensao F, 2012, BIODIVERS CONSERV, V21, P3681, DOI 10.1007/s10531-012-0390-3; ASHBY KR, 1967, J ZOOL, V152, P389; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; BALLOUX F, 2001, J HERED, V92, P301; BENGTSON S A, 1976, Acta Theriologica, V21, P389; Berckmoes V, 2005, ENVIRON TOXICOL CHEM, V24, P2898, DOI 10.1897/04-483R.1; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Booth W, 2009, J ZOOL, V279, P219, DOI 10.1111/j.1469-7998.2009.00608.x; Borkovcova M, 2012, TRANSPORT RES D-TR E, V17, P66, DOI 10.1016/j.trd.2011.09.011; Brehme CS, 2013, CONSERV BIOL, V27, P710, DOI 10.1111/cobi.12081; Butet Alain, 1997, Arvicola, V9, P7; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chakraborty R, 1991, HDB STATISTICS, V8, P203; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Clark RW, 2010, CONSERV BIOL, V24, P1059, DOI 10.1111/j.1523-1739.2009.01439.x; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Corp N, 1997, OECOLOGIA, V109, P242, DOI 10.1007/s004420050079; CRAWLEY MC, 1969, OIKOS, V20, P310, DOI 10.2307/3543198; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DALLAS JF, 1992, MAMM GENOME, V3, P452, DOI 10.1007/BF00356155; De Meeus T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-443; Diaz M, 2010, ACTA THERIOL, V55, P251, DOI 10.4098/j.at.0001-7051.046.2009; DICKMAN CR, 1989, J ANIM ECOL, V58, P119, DOI 10.2307/4989; DIETRICH W, 1992, GENETICS, V131, P423; Dileo MF, 2013, MOL ECOL, V22, P4483, DOI 10.1111/mec.12411; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dolan L, 2006, P 2005 INT C EC TRAN, P608; Encarnacao JA, 2015, J NAT CONSERV, V27, P37, DOI 10.1016/j.jnc.2015.06.003; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Fedy BC, 2008, MOL ECOL, V17, P1905, DOI 10.1111/j.1365-294X.2008.03720.x; Finnegan LA, 2012, EUR J WILDLIFE RES, V58, P415, DOI 10.1007/s10344-011-0590-2; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; Gerlach G, 2000, CONSERV BIOL, V14, P1066, DOI 10.1046/j.1523-1739.2000.98519.x; Gibbs James P., 2005, Wetlands Ecology and Management, V13, P281, DOI 10.1007/s11273-004-7522-9; GIBSON DSC, 1984, J ZOOL, V203, P63; Goldberg CS, 2010, MOL ECOL RESOUR, V10, P304, DOI 10.1111/j.1755-0998.2009.02755.x; Gomez JM, 2008, OECOLOGIA, V155, P529, DOI 10.1007/s00442-007-0928-3; Goncalves P, 2012, AGROFOREST SYST, V85, P383, DOI 10.1007/s10457-011-9439-7; Goosem M, 2001, WILDLIFE RES, V28, P351, DOI 10.1071/WR99093; Goudet J, 1996, GENETICS, V144, P1933; GREEN R, 1979, J ZOOL, V188, P357; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Gu XD, 2009, CONSERV GENET, V10, P1961, DOI 10.1007/s10592-009-9868-2; Hacker H. P., 1951, Journal of the Linnean Society Zoology, V42, P1; HACKER HP, 1946, BIOMETRIKA, V33, P333, DOI 10.1093/biomet/33.4.333; HALLE S, 1993, OECOLOGIA, V94, P120, DOI 10.1007/BF00317312; Harr B, 2000, MOL ECOL, V9, P1664, DOI 10.1046/j.1365-294x.2000.01043-3.x; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; HOLM S, 1979, SCAND J STAT, V6, P65; Jaarsma CF, 2006, TRANSPORT RES D-TR E, V11, P264, DOI 10.1016/j.trd.2006.05.001; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Kalinowski ST, 2002, CONSERV BIOL, V16, P129, DOI 10.1046/j.1523-1739.2002.00134.x; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; KIKKAWA J, 1964, J ANIM ECOL, V33, P259, DOI 10.2307/2631; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KOZAKIEWICZ M, 1993, ACTA THERIOL, V38, P1; Lalis A, 2016, J ZOOL SYST EVOL RES, V54, P1, DOI 10.1111/jzs.12111; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Leng L, 2013, J SYST EVOL, V51, P44, DOI 10.1111/j.1759-6831.2012.00231.x; Leng L, 2011, MOL ECOL, V20, P2494, DOI 10.1111/j.1365-294X.2011.05108.x; Lode T, 2000, AMBIO, V29, P163, DOI 10.1579/0044-7447-29.3.163; Macdonald D., 1993, MAMMALS BRITAIN EURO; Macpherson D, 2011, APPL ECOL ENV RES, V9, P167, DOI 10.15666/aeer/0902_167180; Makova KD, 1998, MOL ECOL, V7, P247; Marsh DM, 2007, CAN J ZOOL, V85, P319, DOI 10.1139/Z07-008; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; Marsh DM, 2005, CONSERV BIOL, V19, P2004, DOI 10.1111/j.1523-1739.2005.00238.x; Mata C, 2005, BIOL CONSERV, V124, P397, DOI 10.1016/j.biocon.2005.01.044; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McDonald W, 2004, J APPL ECOL, V41, P82, DOI 10.1111/j.1365-2664.2004.00877.x; McDonald WR, 2004, OIKOS, V105, P397; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; McLaren AAD, 2011, CAN J ZOOL, V89, P1214, DOI 10.1139/Z11-100; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; MONTGOMERY WI, 1989, J ANIM ECOL, V58, P477, DOI 10.2307/4843; MORENO S, 1988, ACTA THERIOL, V33, P79, DOI 10.4098/AT.arch.88-7; Nagylaki T, 1998, GENETICS, V148, P1325; Orlowski G, 2006, POL J ECOL, V54, P283; OXLEY DJ, 1974, J APPL ECOL, V11, P51, DOI 10.2307/2402004; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pergams ORW, 2001, GENETICA, V112, P245, DOI 10.1023/A:1013343923155; Pinto-Correia T, 1999, LANDSCAPE URBAN PLAN, V46, P125, DOI 10.1016/S0169-2046(99)00036-5; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reed DH, 2007, ANIM CONSERV, V10, P275, DOI 10.1111/j.1469-1795.2007.00120.x; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Richardson JH, 1997, J ZOOL, V243, P840, DOI 10.1111/j.1469-7998.1997.tb01982.x; Rico A, 2009, ACTA THERIOL, V54, P297, DOI 10.4098/j.at.0001-7051.068.2008; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Roedenbeck IA, 2008, EUR J WILDLIFE RES, V54, P425, DOI 10.1007/s10344-007-0166-3; Rosalino LM, 2002, MAMMALIA, V66, P195, DOI 10.1515/mamm.2002.66.2.195; Rosalino LM, 2011, MAMM BIOL, V76, P268, DOI 10.1016/j.mambio.2010.08.004; Rosario IT, 2004, MAMMALIA, V68, P133, DOI 10.1515/mamm.2004.014; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruiz-Capillas P, 2015, ECOL RES, V30, P417, DOI 10.1007/s11284-014-1235-1; Ruiz-Capillas P, 2013, BIOL CONSERV, V158, P223, DOI 10.1016/j.biocon.2012.09.025; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SMAL CM, 1982, J ZOOL, V196, P1; Tallmon DA, 2002, MOL ECOL, V11, P699, DOI 10.1046/j.1365-294X.2002.01480.x; TELLERIA JL, 1991, J MAMMAL, V72, P183, DOI 10.2307/1381994; TEW TE, 1993, BIOL CONSERV, V65, P279, DOI 10.1016/0006-3207(93)90060-E; Thurfjell H, 2015, LANDSCAPE URBAN PLAN, V133, P98, DOI 10.1016/j.landurbplan.2014.09.015; Tkadlec E, 1998, EVOL ECOL, V12, P191, DOI 10.1023/A:1006583713042; Torre I., 2002, Galemys, V14, P1; Underhill JE, 2002, THESIS U BIRMINGHAM; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Wieren SE, 2001, NETH J ZOOL, V51, P97, DOI 10.1163/156854201750210869; VanderRee R, 2015, HANDBOOK OF ROAD ECOLOGY, P1, DOI 10.1002/9781118568170; Vucetich JA, 2000, ANIM CONSERV, V3, P261, DOI 10.1017/S1367943000000986; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2014, GENETICS, V197, P769, DOI 10.1534/genetics.114.164822; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; Waples RS, 2002, GENETICS, V161, P783; WATTS CHS, 1970, J ZOOL, V161, P247; WATTS CHS, 1969, J ANIM ECOL, V38, P285, DOI 10.2307/2772; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Wilson A, 2016, ECOGRAPHY, V39, P87, DOI 10.1111/ecog.01297; WOLTON RJ, 1985, J ZOOL, V206, P203; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1943, GENETICS, V28, P114; Wu H, 2008, CONSERV GENET, V9, P1691, DOI 10.1007/s10592-008-9535-z; YANES M, 1995, BIOL CONSERV, V71, P217, DOI 10.1016/0006-3207(94)00028-O; ZHANG ZB, 1991, ACTA THERIOL, V36, P239, DOI 10.4098/AT.arch.91-24	152	28	30	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151500	10.1371/journal.pone.0151500	http://dx.doi.org/10.1371/journal.pone.0151500			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978779	Green Published, gold			2022-12-27	WOS:000372572800079
J	Chipperfield, JG; Perry, RP; Pekrun, R; Barchfeld, P; Lang, FR; Hamm, JM				Chipperfield, Judith G.; Perry, Raymond P.; Pekrun, Reinhard; Barchfeld, Petra; Lang, Frieder R.; Hamm, Jeremy M.			The Paradoxical Role of Perceived Control in Late Life Health Behavior	PLOS ONE			English	Article							CONTROL STRATEGIES; RISK; OUTCOMES; LOCUS; MORTALITY; BELIEFS; SENSE; VULNERABILITY; INFORMATION; PERCEPTIONS	Research has established the health benefits of psychological factors, including the way individuals appraise outcomes. Although many studies confirm that appraising outcomes as controllable is adaptive for health, a paradoxical possibility is largely ignored: Perceived control may be detrimental under some conditions. Our premise was that appraising health as controllable but at the same time ascribing little value to it might signal a dysfunctional psychological mindset that fosters a mistaken sense of invincibility. During face-to-face interviews with a representative sample of older adults (age range = 72-99), we identified individuals with such a potentially maladaptive "invincible" mindset (high perceived control and low health value) and compared them to their counterparts on several outcomes. The findings were consistent with our hypotheses. The invincibles denied future risks, they lacked the activating emotion of fear, and they visited their physicians less often over a subsequent five-year period. Moreover, in contrast to their counterparts, the invincibles did not appear strategic in their approach to seeking care: Even poor health did not prompt them to seek the counsel of a physician. The recognition that psychological appraisals are modifiable highlights the promise of remedial methods to alter maladaptive mindsets, potentially improving quality of life.	[Chipperfield, Judith G.; Perry, Raymond P.; Hamm, Jeremy M.] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada; [Pekrun, Reinhard; Barchfeld, Petra] Univ Munich, Dept Psychol, Munich, Germany; [Lang, Frieder R.] Univ Erlangen Nurnberg, Inst Psychogerontol, Nurnberg, Germany	University of Manitoba; University of Munich; University of Erlangen Nuremberg	Chipperfield, JG (corresponding author), Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada.	Judith.Chipperfield@umanitoba.ca	Perry, Raymond/AAU-6160-2021; Lang, Frieder R./A-9846-2012; Pekrun, Reinhard/B-1208-2014; Chipperfield, Judith/AAC-9766-2020	Lang, Frieder R./0000-0002-2660-1619; Pekrun, Reinhard/0000-0003-4489-3827; Chipperfield, Judith/0000-0001-5047-9206	Manitoba Health Research Grant [201209RPA-297329-SDA-CDAA-49702]; Canadian Institutes of Health Research [MOP-130382]; Royal Society of Canada; Alexander von Humboldt Foundation; University of Munich; John G. Diefenbaker Award from the Canada Council of Arts; Social Sciences and Humanities Research Council Doctoral Canada Graduate Scholarship	Manitoba Health Research Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Royal Society of Canada; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); University of Munich; John G. Diefenbaker Award from the Canada Council of Arts; Social Sciences and Humanities Research Council Doctoral Canada Graduate Scholarship	This research was funded by a Manitoba Health Research Grant (201209RPA-297329-SDA-CDAA-49702) and Canadian Institutes of Health Research grants to (MOP-130382) to the first (JGC), second (RPP), and third (RP) authors; a Konrad Adenauer Award from the Royal Society of Canada and the Alexander von Humboldt Foundation to the second author (RPP); a Research Chair grant from the University of Munich and a John G. Diefenbaker Award from the Canada Council of Arts and the Alexander von Humboldt Foundation to the third (RP) author; and a Social Sciences and Humanities Research Council Doctoral Canada Graduate Scholarship to the sixth (JMH) author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2002, J SOC ISSUES, V58, P749, DOI 10.1111/1540-4560.00288; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Bailis DS, 2006, PSYCHOL AGING, V21, P291, DOI 10.1037/0882-7974.21.2.291; Bailis DS, 2010, J HEALTH PSYCHOL, V15, P326, DOI 10.1177/1359105309342296; Baltes P.B., 1990, SUCCESSFUL AGING PER, P1, DOI [10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; Bennett P, 1997, HEALTH PSYCHOL, V16, P179, DOI 10.1037/0278-6133.16.2.179; Bernoulli D., 1738, COMMENTARII ACAD SCI; Bollini AM, 2004, BIOL PSYCHOL, V67, P245, DOI 10.1016/j.biopsycho.2003.11.002; Bond L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-943; Branch L G, 1987, Clin Geriatr Med, V3, P29; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; BURTON LC, 1995, AM J PUBLIC HEALTH, V85, P387, DOI 10.2105/AJPH.85.3.387; Carstensen L.L., 1998, MOTIVATION SELF REGU, P341, DOI 10.1017/CBO9780511527869.015; Chipperfield J. G., 1993, J AGING HEALTH, V5, P123, DOI [DOI 10.1177/089826439300500106, DOI 10.1177/]; Chipperfield JG, 2006, HEALTH PSYCHOL, V25, P226, DOI 10.1037/0278-6133.25.2.226; Chipperfield JG, 2004, J AGING HEALTH, V16, P116, DOI 10.1177/0898264303260447; Chipperfield JG, 2003, J GERONTOL B-PSYCHOL, V58, pP23, DOI 10.1093/geronb/58.1.P23; Chipperfield JG, 1999, J GERONTOL B-PSYCHOL, V54, pP146, DOI 10.1093/geronb/54B.3.P146; Chipperfield JG, 1997, CAN J AGING, V16, P606, DOI 10.1017/S0714980800010990; Chipperfield JG, 2012, PERS SOC PSYCHOL B, V38, P1081, DOI 10.1177/0146167212444758; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Hoog N, 2007, REV GEN PSYCHOL, V11, P258, DOI 10.1037/1089-2680.11.3.258; DeCoster J, 2009, PSYCHOL METHODS, V14, P349, DOI 10.1037/a0016956; Dubayova T, 2010, INT J PUBLIC HEALTH, V55, P459, DOI 10.1007/s00038-010-0149-0; Earl A, 2007, HEALTH PSYCHOL, V26, P496, DOI 10.1037/0278-6133.26.4.496; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Franzini L, 2008, J AM GERIATR SOC, V56, P667, DOI 10.1111/j.1532-5415.2007.01629.x; FRIEDMAN HS, 1987, AM PSYCHOL, V42, P539, DOI 10.1037/0003-066X.42.6.539; Fry PS, 2006, INT J AGING HUM DEV, V62, P303, DOI 10.2190/3VAT-D77G-VCNQ-6T61; Galbreath AD, 2004, CIRCULATION, V110, P3518, DOI 10.1161/01.CIR.0000148957.62328.89; Goetz T, 2013, PSYCHOL SCI, V24, P2079, DOI 10.1177/0956797613486989; Goetz T, 2010, MOTIV EMOTION, V34, P49, DOI 10.1007/s11031-009-9152-2; Griffin MJ, 2006, PSYCHOSOM MED, V68, P493, DOI 10.1097/01.psy.0000221367.96439.da; Hamm JM, 2014, J GERONTOL B-PSYCHOL, V69, P533, DOI 10.1093/geronb/gbu048; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; HOOKER K, 1992, J GERONTOL, V47, pP85, DOI 10.1093/geronj/47.2.P85; Infurna FJ, 2014, HEALTH PSYCHOL, V33, P85, DOI 10.1037/a0030208; Infurna FJ, 2013, DEV PSYCHOL, V49, P1833, DOI 10.1037/a0031041; Infurna FJ, 2011, DEV PSYCHOL, V47, P9, DOI 10.1037/a0021022; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; Klein WMP, 2010, PSYCHOL HEALTH, V25, P1195, DOI 10.1080/08870440903261970; Krause N, 2000, PSYCHOL AGING, V15, P617, DOI 10.1037/0882-7974.15.4.617; Kunzmann U, 2002, J GERONTOL B-PSYCHOL, V57, pP484, DOI 10.1093/geronb/57.6.P484; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lachman ME, 1998, PSYCHOL AGING, V13, P553, DOI 10.1037/0882-7974.13.4.553; Lang FR, 2001, J PERS SOC PSYCHOL, V81, P509, DOI 10.1037//0022-3514.81.3.509; Lang FR, 2013, PSYCHOL AGING, V28, P249, DOI 10.1037/a0030797; LANGER EJ, 1976, J PERS SOC PSYCHOL, V34, P191, DOI 10.1037/0022-3514.34.2.191; LAU RR, 1986, HEALTH PSYCHOL, V5, P25, DOI 10.1037/0278-6133.5.1.25; Leotti LA, 2011, PSYCHOL SCI, V22, P1310, DOI 10.1177/0956797611417005; Mayne TJ, 2001, EMO SOC BEH, P361; Menec VH, 1999, J GERONTOL B-PSYCHOL, V54, pP85, DOI 10.1093/geronb/54B.2.P85; Menec VH, 1997, J GERONTOL B-PSYCHOL, V52, pP118, DOI 10.1093/geronb/52B.3.P118; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; National Center for Health Statistics (U.S.), 2014, HLTH US 2013 SPEC FE; Norman P, 1998, J Health Psychol, V3, P171, DOI 10.1177/135910539800300202; PEKRUN R, 1992, S HLTH PSYC, P23; Pekrun R, 2006, EDUC PSYCHOL REV, V18, P315, DOI 10.1007/s10648-006-9029-9; Pekrun R, 2010, J EDUC PSYCHOL, V102, P531, DOI 10.1037/a0019243; Perry RP, 2014, ADV MOTIV A, V18, P1, DOI 10.1108/S0749-742320140000018000; Perry RP, 2010, J SOC CLIN PSYCHOL, V29, P668, DOI 10.1521/jscp.2010.29.6.668; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; ROSENBERG SJ, 1987, INT J PSYCHIAT MED, V17, P85, DOI 10.2190/JWMW-8Q1U-71DJ-AN6E; Ruthig JC, 2008, J SOC PSYCHOL, V148, P667, DOI 10.3200/SOCP.148.6.667-688; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Sirois FM, 2015, J BEHAV MED, V38, P578, DOI 10.1007/s10865-015-9629-2; Tolman EC, 1938, PSYCHOL REV, V45, P1, DOI 10.1037/h0062733; TOLMAN EC, 1955, PSYCHOL REV, V62, P315, DOI 10.1037/h0049079; Waldrop D, 2001, J COUNS PSYCHOL, V48, P233, DOI 10.1037/0022-0167.48.2.233; WALLSTON KA, 1976, J RES PERS, V10, P215, DOI 10.1016/0092-6566(76)90074-X; Williams DA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2094; Wrosch C, 2008, PSYCHOL SCI, V19, P537, DOI 10.1111/j.1467-9280.2008.02120.x; WYLER AR, 1970, J PSYCHOSOM RES, V14, P59, DOI 10.1016/0022-3999(70)90070-X	74	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0148921	10.1371/journal.pone.0148921	http://dx.doi.org/10.1371/journal.pone.0148921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26974153	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600008
J	McIntosh, ACS; Macdonald, SE; Quideau, SA				McIntosh, Anne C. S.; Macdonald, S. Ellen; Quideau, Sylvie A.			Understory Plant Community Composition Is Associated with Fine-Scale Above- and Below-Ground Resource Heterogeneity in Mature Lodgepole Pine (Pinus contorta) Forests	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; BOREAL MIXEDWOOD; MYCORRHIZAL FUNGI; STAND COMPOSITION; SOIL; DIVERSITY; PATTERNS; VEGETATION; BIOMASS; CANOPY	Understory plant communities play critical ecological roles in forest ecosystems. Both above- and below-ground ecosystem properties and processes influence these communities but relatively little is known about such effects at fine (i.e., one to several meters within-stand) scales, particularly for forests in which the canopy is dominated by a single species. An improved understanding of these effects is critical for understanding how understory biodiversity is regulated in such forests and for anticipating impacts of changing disturbance regimes. Our primary objective was to examine the patterns of fine-scale variation in understory plant communities and their relationships to above-and below-ground resource and environmental heterogeneity within mature lodgepole pine forests. We assessed composition and diversity of understory vegetation in relation to heterogeneity of both the above ground (canopy tree density, canopy and tall shrub basal area and cover, downed wood biomass, litter cover) and below-ground (soil nutrient availability, decomposition, forest floor thickness, pH, and phospholipid fatty acids (PLFAs) and multiple carbon-source substrate-induced respiration (MSIR) of the forest floor microbial community) environment. There was notable variation in fine-scale plant community composition; cluster and indicator species analyses of the 24 most commonly occurring understory species distinguished four assemblages, one for which a pioneer forb species had the highest cover levels, and three others that were characterized by different bryophyte species having the highest cover. Constrained ordination (distance-based redundancy analysis) showed that two above-ground (mean tree diameter, litter cover) and eight below-ground (forest floor pH, plant available boron, microbial community composition and function as indicated by MSIR and PLFAs) properties were associated with variation in understory plant community composition. These results provide novel insights into the important ecological associations between understory plant community composition and heterogeneity in ecosystem properties and processes within forests dominated by a single canopy species.	[McIntosh, Anne C. S.; Macdonald, S. Ellen; Quideau, Sylvie A.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [McIntosh, Anne C. S.] Univ Alberta, Augustana Fac, Dept Sci, Camrose, AB, Canada	University of Alberta; University of Alberta	McIntosh, ACS (corresponding author), Univ Alberta, Augustana Fac, Dept Sci, Camrose, AB, Canada.	amcintos@ualberta.ca	Quideau, Sylvie A/C-9646-2015	Quideau, Sylvie A/0000-0002-2297-9024; McIntosh, Anne/0000-0002-7802-2205	Natural Sciences and Engineering Research Council of Canada - Canada Graduate Scholarship; Izaak Walton Killam Memorial Scholarship; Forest Resource Improvement Association of Alberta; Foothills Research Institute	Natural Sciences and Engineering Research Council of Canada - Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Izaak Walton Killam Memorial Scholarship; Forest Resource Improvement Association of Alberta; Foothills Research Institute	This project was supported by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) - Canada Graduate Scholarship and an Izaak Walton Killam Memorial Scholarship (http://killamlaureates.ca/) awarded to A.C.S.M. and funding from the Forest Resource Improvement Association of Alberta (http://www.friaa.ab.ca/) and Foothills Research Institute (http://foothillsri.ca/) awarded to S.E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M., 1977, Introduction to soil microbiology.; Anderson J. E., 1991, International Journal of Wildland Fire, V1, P119, DOI 10.1071/WF9910119; ANDERSON TH, 1985, SOIL BIOL BIOCHEM, V17, P197, DOI 10.1016/0038-0717(85)90115-4; BAATH E, 1992, APPL ENVIRON MICROB, V58, P4026; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Bartels SF, 2013, J VEG SCI, V24, P543, DOI 10.1111/j.1654-1103.2012.01479.x; Bartels SF, 2010, ECOLOGY, V91, P1931, DOI 10.1890/09-1376.1; Beckingham J. D., 1996, FIELD GUIDE ECOSITES; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennan PJ, 1988, MICROBIAL LIPIDS, V1, P203; Brown J. K., 1974, USDA Forest Service General Technical Report, Intermountain Forest and Range Experiment Station; Brown J. K., 1982, HDB INVENTORYING SUR; Cameron C. M., 2008, MICRORESP TECHNICAL; Campbell CD, 2003, APPL ENVIRON MICROB, V69, P3593, DOI 10.1128/AEM.69.6.3593-3599.2003; CAREY AB, 1995, ECOL APPL, V5, P336, DOI 10.2307/1942026; CARLETON TJ, 1981, CAN J BOT, V59, P1709, DOI 10.1139/b81-229; Chapman SJ, 2007, J SOIL SEDIMENT, V7, P406, DOI 10.1065/jss2007.10.259; Chavez V, 2010, FOREST ECOL MANAG, V259, P1067, DOI 10.1016/j.foreco.2009.12.013; Committee NR, 2006, GOVT ALB PUBL T; CROZIER CR, 1984, OECOLOGIA, V62, P337, DOI 10.1007/BF00384265; Degens BP, 2000, SOIL BIOL BIOCHEM, V32, P189, DOI 10.1016/S0038-0717(99)00141-8; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; FREGO KA, 1995, CAN J BOT, V73, P544, DOI 10.1139/b95-056; Frelich LE, 2003, J ECOL, V91, P283, DOI 10.1046/j.1365-2745.2003.00765.x; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gendreau-Berthiaume B, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00308.1; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; Goldberg S, 1997, PLANT SOIL, V193, P35, DOI 10.1023/A:1004203723343; Gundale MJ, 2006, ECOL APPL, V16, P479, DOI 10.1890/1051-0761(2006)016[0479:NSHIDF]2.0.CO;2; Hamman ST, 2007, SOIL BIOL BIOCHEM, V39, P1703, DOI 10.1016/j.soilbio.2007.01.018; Hannam KD, 2006, SOIL BIOL BIOCHEM, V38, P2565, DOI 10.1016/j.soilbio.2006.03.015; Hart SA, 2008, ECOL MONOGR, V78, P123, DOI 10.1890/06-2140.1; Hart SA, 2006, CRIT REV PLANT SCI, V25, P381, DOI 10.1080/07352680600819286; Hassett JE, 2005, SOIL SCI SOC AM J, V69, P227, DOI 10.2136/sssaj2005.0227; Hogberg MN, 2003, NEW PHYTOL, V160, P225, DOI 10.1046/j.1469-8137.2003.00867.x; Hu HN, 1997, PLANT SOIL, V193, P49, DOI 10.1023/A:1004255707413; HUE NV, 1986, SOIL SCI SOC AM J, V50, P28, DOI 10.2136/sssaj1986.03615995005000010006x; Kalra Y. P., 1991, Information Report - Northwest Region, Forestry Canada; Kroppenstedt RM, 1985, CHEM METHODS BACTERI, P173; Laliberte E, 2013, TRENDS ECOL EVOL, V28, P331, DOI 10.1016/j.tree.2013.02.008; Legare S, 2002, SILVA FENN, V36, P353, DOI 10.14214/sf.567; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leps J., 2003, MULTIVARIATE ANAL EC; LIEFFERS VI, 1993, CAN J FOREST RES, V23, P2070, DOI 10.1139/x93-258; MacKenzie MD, 2010, APPL SOIL ECOL, V44, P32, DOI 10.1016/j.apsoil.2009.09.002; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Marialigeti S, 2009, BIODIVERS CONSERV, V18, P2223, DOI 10.1007/s10531-009-9586-6; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; Matoh T, 1997, PLANT SOIL, V193, P59, DOI 10.1023/A:1004207824251; McCune B, 2002, ANAL ECOLOGICAL COMM; McIntosh ACS, 2012, ECOLOGY UNDERSTORY B; McIntosh ACS, 2013, SOIL BIOL BIOCHEM, V63, P61, DOI 10.1016/j.soilbio.2013.03.028; McIntosh ACS, 2013, FOREST ECOL MANAG, V295, P11, DOI 10.1016/j.foreco.2012.12.050; MILLIGAN GW, 1989, MULTIVAR BEHAV RES, V24, P163, DOI 10.1207/s15327906mbr2402_2; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Nalder IA, 1997, CAN J FOREST RES, V27, P1513, DOI 10.1139/cjfr-27-9-1513; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Olsson S, 2000, SOIL BIOL BIOCHEM, V32, P1443, DOI 10.1016/S0038-0717(00)00062-6; Pennanen T, 1999, MICROB ECOL, V38, P168, DOI 10.1007/s002489900161; Prescott CE, 2002, TREE PHYSIOL, V22, P1193, DOI 10.1093/treephys/22.15-16.1193; Reich PB, 2012, J ECOL, V100, P539, DOI 10.1111/j.1365-2745.2011.01922.x; Rhoades C, 2001, ECOSCIENCE, V8, P89, DOI 10.1080/11956860.2001.11682634; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Soil Classification Working Group, 1998, CAN SYST SOIL CLASS, V3rd; Stevenson BA, 2004, SOIL BIOL BIOCHEM, V36, P49, DOI 10.1016/j.soilbio.2003.08.018; STRONG WL, 1991, CAN J FOREST RES, V21, P1675, DOI 10.1139/x91-231; ter Braak CJF, 2009, CANOCO WINDOWS V 4 5; Urban D, 2002, ECOSCIENCE, V9, P200, DOI 10.1080/11956860.2002.11682706; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van Wagner CE, 1982, PRACTICAL ASPECTS LI; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; White David C., 1998, P255; Woodard P. M, 1988, 45 NO FOR CTR P M CA; Work TT, 2004, CAN J FOREST RES, V34, P417, DOI 10.1139/X03-238; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	80	13	14	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151436	10.1371/journal.pone.0151436	http://dx.doi.org/10.1371/journal.pone.0151436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975055	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600079
J	Zhou, JY; Xin, C; Mou, YP; Xu, XW; Zhang, MZ; Zhou, YC; Lu, C; Chen, RG				Zhou, Jia-Yu; Xin, Chang; Mou, Yi-Ping; Xu, Xiao-Wu; Zhang, Miao-Zun; Zhou, Yu-Cheng; Lu, Chao; Chen, Rong-Gao			Robotic versus Laparoscopic Distal Pancreatectomy: A Meta-Analysis of Short-Term Outcomes	PLOS ONE			English	Article							SURGERY	AIM To compare the safety and efficacy of robotic-assisted distal pancreatectomy (RADP) and laparoscopic distal pancreatectomy (LDP). METHODS A literature search of PubMed, EMBASE, and the Cochrane Library database up to June 30, 2015 was performed. The following key words were used: pancreas, distal pancreatectomy, pancreatic, laparoscopic, laparoscopy, robotic, and robotic-assisted. Fixed and random effects models were applied. Study quality was assessed using the Newcastle-Ottawa Scale. RESULTS Seven non-randomized controlled trials involving 568 patients met the inclusion criteria. Compared with LDP, RADP was associated with longer operating time, lower estimated blood loss, a higher spleen-preservation rate, and shorter hospital stay. There was no significant difference in transfusion, conversion to open surgery, R0 resection rate, lymph nodes harvested, overall complications, severe complications, pancreatic fistula, severe pancreatic fistula, ICU stay, total cost, and 30-day mortality between the two groups. CONCLUSION RADP is a safe and feasible alternative to LDP with regard to short-term outcomes. Further studies on the long-term outcomes of these surgical techniques are required. Core tip To date, there is no consensus on whether laparoscopic or robotic-assisted distal pancreatectomy is more beneficial to the patient. This is the first meta-analysis to compare laparoscopic and robotic-assisted distal pancreatectomy. We found that robotic-assisted distal pancreatectomy was associated with longer operating time, lower estimated blood loss, a higher spleen-preservation rate, and shorter hospital stay. There was no significant difference in transfusion, conversion to open surgery, overall complications, severe complications, pancreatic fistula, severe pancreatic fistula, ICU stay, total cost, and 30-day mortality between the two groups.	[Zhou, Jia-Yu; Zhang, Miao-Zun; Lu, Chao; Chen, Rong-Gao] Zhejiang Univ, Sch Med, Dept Gen Surg, Hangzhou 310016, Zhejiang, Peoples R China; [Xin, Chang] Ningbo Univ, Sch Med, Yinzhou Hosp, Dept Hepatobiliary Surg, Ningbo 315040, Zhejiang, Peoples R China; [Mou, Yi-Ping; Xu, Xiao-Wu; Zhou, Yu-Cheng] Zhejiang Prov People Hosp, Dept Gastroenterol & Pancreat Surg, Hangzhou 310016, Zhejiang, Peoples R China	Zhejiang University; Ningbo University; Zhejiang Provincial People's Hospital	Mou, YP (corresponding author), Zhejiang Prov People Hosp, Dept Gastroenterol & Pancreat Surg, Hangzhou 310016, Zhejiang, Peoples R China.	yipingmou@126.com						Allan C, 2016, UROL INT, V96, P373, DOI 10.1159/000435861; Altieri MS, 2016, SURG ENDOSC, V30, P925, DOI 10.1007/s00464-015-4327-2; Arms RG, 2015, GYNECOL ONCOL; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Berber E, 2015, J SURG ONCOL, V112, P239, DOI 10.1002/jso.23979; Bren L, 2000, FDA Consum, V34, P12; Brunaud L, 2011, J VISC SURG, V148, pE47, DOI 10.1016/j.jviscsurg.2011.05.006; Butturini G, 2015, SURG ENDOSC, V29, P3163, DOI 10.1007/s00464-014-4043-3; Chen S, 2015, SURG ENDOSC, V29, P3507, DOI 10.1007/s00464-015-4101-5; Conrad LB, 2015, INT J GYNECOL CANCER, V25, P1121, DOI 10.1097/IGC.0000000000000450; D'Ambrosio G, 2015, ANN ITAL CHIR, V86, P273; Daouadi M, 2013, ANN SURG, V257, P128, DOI 10.1097/SLA.0b013e31825fff08; de Rooij T, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/472906; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; DiNorcia J, 2010, J GASTROINTEST SURG, V14, P1804, DOI 10.1007/s11605-010-1264-1; Duran H, 2014, INT J MED ROBOT COMP, V10, P280, DOI 10.1002/rcs.1569; Elabbasy F, 2015, HEPATOB PANCREAT DIS, V14, P346, DOI 10.1016/S1499-3872(15)60399-X; Fedorov A V, 2010, Khirurgiia (Mosk), P16; Jaydeep P.H., 2009, J MINIM ACCESS SURG, V5, P1, DOI DOI 10.4103/0972-9941.51313; Kang CM, 2011, J HEPATO-BIL-PAN SCI, V18, P87, DOI 10.1007/s00534-010-0316-y; Kang CM, 2011, SURG ENDOSC, V25, P2004, DOI 10.1007/s00464-010-1504-1; Lee SY, 2015, J AM COLL SURGEONS, V220, P18, DOI 10.1016/j.jamcollsurg.2014.10.004; Napoli N, 2015, UPDATES SURG-ITALY, V67, P257, DOI 10.1007/s13304-015-0299-y; Novikova O. V., 2010, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P95; Rudmik L, 2015, J SURG ONCOL, V112, P155, DOI 10.1002/jso.23974; Rutz DR, 2014, HPB, V16, P907, DOI 10.1111/hpb.12288; Shakir M, 2015, HPB, V17, P580, DOI 10.1111/hpb.12412; Sound S, 2016, SURG ENDOSC, V30, P657, DOI 10.1007/s00464-015-4256-0; Stauffer JA, 2015, SEMIN ONCOL, V42, P123, DOI 10.1053/j.seminoncol.2014.12.011; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Waters JA, 2010, SURGERY, V148, P814, DOI 10.1016/j.surg.2010.07.027	31	42	44	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151189	10.1371/journal.pone.0151189	http://dx.doi.org/10.1371/journal.pone.0151189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974961	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600054
J	Petty, RD; McCarthy, NE; Le Dieu, R; Kerr, JR				Petty, Robert D.; McCarthy, Neil E.; Le Dieu, Rifca; Kerr, Jonathan R.			MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION PROFILE; PERIPHERAL-BLOOD; IMMUNOLOGICAL ABNORMALITIES; CANCER CELLS; IDENTIFICATION; PCR; EXPLORATION; ACTIVATION; MECHANISMS	Background Chronic Fatigue Syndrome (CFS/ME) is a complex multisystem disease of unknown aetiology which causes debilitating symptoms in up to 1% of the global population. Although a large cohort of genes have been shown to exhibit altered expression in CFS/ME patients, it is currently unknown whether microRNA (miRNA) molecules which regulate gene translation contribute to disease pathogenesis. We hypothesized that changes in microRNA expression in patient leukocytes contribute to CFS/ME pathology, and may therefore represent useful diagnostic biomarkers that can be detected in the peripheral blood of CFS/ME patients. Methods miRNA expression in peripheral blood mononuclear cells (PBMC) from CFS/ME patients and healthy controls was analysed using the Ambion Bioarray V1. miRNA demonstrating differential expression were validated by qRT-PCR and then replicated in fractionated blood leukocyte subsets from an independent patient cohort. The CFS/ME associated miRNA identified by these experiments were then transfected into primary NK cells and gene expression analyses conducted to identify their gene targets. Results Microarray analysis identified differential expression of 34 miRNA, all of which were up-regulated. Four of the 34 miRNA had confirmed expression changes by qRT-PCR. Fractionating PBMC samples by cell type from an independent patient cohort identified changes in miRNA expression in NK-cells, B-cells and monocytes with the most significant abnormalities occurring in NK cells. Transfecting primary NK cells with hsa-miR-99b or hsa-miR-330-3p, resulted in gene expression changes consistent with NK cell activation but diminished cytotoxicity, suggesting that defective NK cell function contributes to CFS/ME pathology. Conclusion This study demonstrates altered microRNA expression in the peripheral blood mononuclear cells of CFS/ME patients, which are potential diagnostic biomarkers. The greatest degree of miRNA deregulation was identified in NK cells with targets consistent with cellular activation and altered effector function.	[Petty, Robert D.; Kerr, Jonathan R.] St Georges Univ London, CFS Grp, Cranmer Terrace, London, England; [Petty, Robert D.; Le Dieu, Rifca] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England; [McCarthy, Neil E.] Queen Mary Univ London, Blizzard Inst, Ctr Immunobiol, London, England; [Kerr, Jonathan R.] Univ Rosario, Escuela Med & Ciencias Salud, Grp Salud Publ, Bogota 111221, Colombia	St Georges University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Universidad del Rosario	Petty, RD (corresponding author), St Georges Univ London, CFS Grp, Cranmer Terrace, London, England.; Petty, RD (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England.	r.d.petty@qmul.ac.uk	McCarthy, Neil E/B-6064-2008	McCarthy, Neil E/0000-0002-4330-4747	chronic fatigue syndrome research foundation (CFSRF); RDP; ME research UK; Joseph Hotung	chronic fatigue syndrome research foundation (CFSRF); RDP(Centre National de la Recherche Scientifique (CNRS)); ME research UK; Joseph Hotung	This work was partially funded by the chronic fatigue syndrome research foundation (CFSRF), who also funded the salary of RDP, and partially funded by ME research UK (http://www.meresearch.org.uk/). The salary of JRK was funded by Joseph Hotung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo J, 2014, NAT IMMUNOL, V15, P54, DOI 10.1038/ni.2767; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Bjersing JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078762; Braun M, 2011, J INNATE IMMUN, V3, P420, DOI 10.1159/000322720; Brenu EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102783; Brenu EW, 2012, J AFFECT DISORDERS, V141, P261, DOI 10.1016/j.jad.2012.03.037; Brenu EW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-88; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; Brenu EW, 2014, INT IMMUNOL, V26, P233, DOI 10.1093/intimm/dxt068; Broderick G, 2006, PHARMACOGENOMICS, V7, P407, DOI 10.2217/14622416.7.3.407; Carmel L, 2006, PHARMACOGENOMICS, V7, P375, DOI 10.2217/14622416.7.3.375; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Case AJ, 2011, FREE RADICAL BIO MED, V50, P448, DOI 10.1016/j.freeradbiomed.2010.11.025; Cerda-Olmedo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121903; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Fan HM, 2014, J PSYCHIATR RES, V59, P45, DOI 10.1016/j.jpsychires.2014.08.007; Fang H, 2006, PHARMACOGENOMICS, V7, P429, DOI 10.2217/14622416.7.3.429; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Fletcher MA, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-76; Fletcher MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010817; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Fostel J, 2006, PHARMACOGENOMICS, V7, P441, DOI 10.2217/14622416.7.3.441; Frampton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016872; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Grans H, 2005, J INTERN MED, V258, P388, DOI 10.1111/j.1365-2796.2005.01548.x; group Tcmosw, 2002, REP CFS ME WORK GROU; Hisaoka M, 2011, GENE CHROMOSOME CANC, V50, P137, DOI 10.1002/gcc.20837; Holgate ST, 2011, NAT REV NEUROSCI, V12, P539, DOI 10.1038/nrn3087; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kaminski MM, 2012, BBA-MOL CELL RES, V1823, P1041, DOI 10.1016/j.bbamcr.2012.03.003; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Kerr JR, 2008, J CLIN PATHOL, V61, P730, DOI 10.1136/jcp.2007.053553; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Kerr Jonathan R, 2008, Curr Rheumatol Rep, V10, P482; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Laytragoon-Lewin N, 2011, ANTICANCER RES, V31, P1527; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li YF, 2013, BIOCHEM BIOPH RES CO, V431, P560, DOI 10.1016/j.bbrc.2013.01.016; Light AR, 2009, J PAIN, V10, P1099, DOI 10.1016/j.jpain.2009.06.003; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu QQ, 2009, J VIROL, V83, P8705, DOI 10.1128/JVI.02666-08; Maher KJ, 2005, CLIN EXP IMMUNOL, V142, P505, DOI 10.1111/j.1365-2249.2005.02935.x; Mao YQ, 2013, ONCOL REP, V30, P327, DOI 10.3892/or.2013.2452; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Meade JL, 2006, BLOOD, V107, P3665, DOI 10.1182/blood-2005-03-1140; Melas PA, 2012, INT J NEUROPSYCHOPH, V15, P669, DOI 10.1017/S1461145711000940; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; Olsson J, 2011, NEPHROL DIAL TRANSPL, V26, P2195, DOI 10.1093/ndt/gfq673; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Papanicolaou DA, 2004, NEUROIMMUNOMODULAT, V11, P65, DOI 10.1159/000075315; Powell R, 2003, CLIN EXP ALLERGY, V33, P1450, DOI 10.1046/j.1365-2222.2003.01745.x; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Steinau M, 2004, J MOL MED, V82, P750, DOI 10.1007/s00109-004-0586-4; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Turchinovich A, 2012, RNA BIOL, V9, P1066, DOI 10.4161/rna.21083; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; Wan YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121975; Whistler T, 2006, PHARMACOGENOMICS, V7, P395, DOI 10.2217/14622416.7.3.395; Whistler Toni, 2005, BMC Physiol, V5, P5, DOI 10.1186/1472-6793-5-5; Whistler Toni, 2003, J Transl Med, V1, P10, DOI 10.1186/1479-5876-1-10; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Wurmbach E, 2003, METHODS, V31, P306, DOI 10.1016/S1046-2023(03)00161-0	84	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150904	10.1371/journal.pone.0150904	http://dx.doi.org/10.1371/journal.pone.0150904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967895	Green Published, gold			2022-12-27	WOS:000371989200018
J	Shire, KA; Hill, LJB; Snapp-Childs, W; Bingham, GP; Kountouriotis, GK; Barber, S; Mon-Williams, M				Shire, Katy A.; Hill, Liam J. B.; Snapp-Childs, Winona; Bingham, Geoffrey P.; Kountouriotis, Georgios K.; Barber, Sally; Mon-Williams, Mark			Robot Guided 'Pen Skill' Training in Children with Motor Difficulties	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; ASSISTED THERAPY; PERFORMANCE; STROKE; SCHOOL; TRIAL; TASK	Motor deficits are linked to a range of negative physical, social and academic consequences. Haptic robotic interventions, based on the principles of sensorimotor learning, have been shown previously to help children with motor problems learn new movements. We therefore examined whether the training benefits of a robotic system would generalise to a standardised test of 'pen-skills', assessed using objective kinematic measures [via the Clinical Kinematic Assessment Tool, CKAT]. A counterbalanced, cross-over design was used in a group of 51 children (37 male, aged 5-11 years) with manual control difficulties. Improved performance on a novel task using the robotic device could be attributed to the intervention but there was no evidence of generalisation to any of the CKAT tasks. The robotic system appears to have the potential to support motor learning, with the technology affording numerous advantages. However, the training regime may need to target particular manual skills (e.g. letter formation) in order to obtain clinically significant improvements in specific skills such as handwriting.	[Shire, Katy A.; Hill, Liam J. B.; Mon-Williams, Mark] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Shire, Katy A.; Barber, Sally] Bradford Teaching Hosp NHS Trust, Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Snapp-Childs, Winona; Bingham, Geoffrey P.] Indiana Univ, Dept Psychol & Brain Sci, Indiana, PA USA; [Kountouriotis, Georgios K.] Manchester Metropolitan Univ, Dept Psychol, Manchester M15 6BH, Lancs, England	University of Leeds; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Manchester Metropolitan University	Hill, LJB (corresponding author), Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England.	L.J.Hill@leeds.ac.uk		Shire, Katy/0000-0002-2093-181X; Mon-Williams, Mark/0000-0001-7595-8545; Barber, Sally/0000-0001-9872-6106; Snapp-Childs, Winona/0000-0003-4354-7092; Hill, Liam/0000-0002-4069-5121	Medical Research Council: Early Career Development award	Medical Research Council: Early Career Development award	This work was supported by Medical Research Council: Early Career Development award (http://www.mrc.ac.uk/skills-careers/fellowships/) to LJBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful to all the children, parents and teachers who made this research possible. Thanks also to Ella James-Brabham for her help in preparing the manuscript. The first, second, sixth and seventh authors of this paper are part of the Healthy Children, Healthy Families Theme of the NIHR CLAHRC Yorkshire and Humber. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. This research was supported by an MRC Early Career Development Award, awarded to the second author to fund their involvement in this research.	Blank R, 2012, DEV MED CHILD NEUROL, V54, P54, DOI 10.1111/j.1469-8749.2011.04171.x; Cameron CE, 2012, CHILD DEV, V83, P1229, DOI 10.1111/j.1467-8624.2012.01768.x; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Dinehart L, 2013, EARLY EDUC DEV, V24, P138, DOI 10.1080/10409289.2011.636729; Dinehart LH, 2015, J EARLY CHILD LIT, V15, P97, DOI 10.1177/1468798414522825; Flatters I, 2014, EXP BRAIN RES, V232, P1953, DOI 10.1007/s00221-014-3886-0; Flatters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088692; Grissmer D, 2010, DEV PSYCHOL, V46, P1008, DOI 10.1037/a0020104; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Holt R, 2013, J USABILITY STUD, V8, P111; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Medwell J, 2008, LANG EDUC-UK, V22, P34, DOI 10.2167/le722.0; Niemeijer AS, 2007, DEV MED CHILD NEUROL, V49, P406, DOI 10.1111/j.1469-8749.2007.00406.x; Nowak DA, 2013, NEUROSCI BIOBEHAV R, V37, P1578, DOI 10.1016/j.neubiorev.2013.06.003; Palsbo SE, 2012, AM J OCCUP THER, V66, P682, DOI 10.5014/ajot.2012.004556; Preston N, 2014, DISABIL REHABIL ASSI, P1, DOI [10.3109/17483107.2014. 932020., DOI 10.3109/17483107.2014.932020, 10.3109/17483107.2014.932020]; Reinkensmeyer DJ, 2009, EXERC SPORT SCI REV, V37, P43, DOI 10.1097/JES.0b013e3181912108; Roebers CM, 2014, HUM MOVEMENT SCI, V33, P284, DOI 10.1016/j.humov.2013.08.011; Sangster Claire A, 2005, Can J Occup Ther, V72, P67; Smits-Engelsman BCM, 2013, DEV MED CHILD NEUROL, V55, P229, DOI 10.1111/dmcn.12008; Snapp-Childs W, 2015, HUM MOVEMENT SCI, V43, P90, DOI 10.1016/j.humov.2015.07.006; Snapp-Childs W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092464; Snapp-Childs W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077609; Snapp-Childs W, 2013, J CHILD NEUROL, V28, P204, DOI 10.1177/0883073812461945; Williams CK, 2014, IEEE T HAPTICS, V7, P240, DOI 10.1109/TOH.2013.2297102; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Zwicker JG, 2012, EUR J PAEDIATR NEURO, V16, P573, DOI 10.1016/j.ejpn.2012.05.005	29	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151354	10.1371/journal.pone.0151354	http://dx.doi.org/10.1371/journal.pone.0151354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967993	Green Published, gold			2022-12-27	WOS:000371989200046
J	Lin, QY; Lin, ZG; Chiu, APY; He, DH				Lin, Qianying; Lin, Zhigui; Chiu, Alice P. Y.; He, Daihai			Seasonality of Influenza A(H7N9) Virus in China-Fitting Simple Epidemic Models to Human Cases	PLOS ONE			English	Article							LIVE-POULTRY MARKETS; A H7N9 VIRUS; TRANSMISSION; FERRETS; WATER; INFECTIVITY; INFERENCE; DYNAMICS	Background Three epidemic waves of influenza A(H7N9) (hereafter 'H7N9') human cases have occurred between March 2013 and July 2015 in China. However, the underlying transmission mechanism remains unclear. Our main objective is to use mathematical models to study how seasonality, secular changes and environmental transmission play a role in the spread of H7N9 in China. Methods Data on human cases and chicken cases of H7N9 infection were downloaded from the EMPRES-i Global Animal Disease Information System. We modelled on chicken-to-chicken transmission, assuming a constant ratio of 10(-6) human case per chicken case, and compared the model fit with the observed human cases. We developed three different modified Susceptible-Exposed-Infectious-Recovered-Susceptible models: (i) a non-periodic transmission rate model with an environmental class, (ii) a non-periodic transmission rate model without an environmental class, and (iii) a periodic transmission rate model with an environmental class. We then estimated the key epidemiological parameters and compared the model fit using Akaike Information Criterion and Bayesian Information Criterion. Results Our results showed that a non-periodic transmission rate model with an environmental class provided the best model fit to the observed human cases in China during the study period. The estimated parameter values were within biologically plausible ranges. Conclusions This study highlighted the importance of considering secular changes and environmental transmission in the modelling of human H7N9 cases. Secular changes were most likely due to control measures such as Live Poultry Markets closures that were implemented during the initial phase of the outbreaks in China. Our results suggested that environmental transmission via viral shedding of infected chickens had contributed to the spread of H7N9 human cases in China.	[Lin, Qianying; Chiu, Alice P. Y.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China; [Lin, Zhigui] Yangzhou Univ, Sch Math Sci, Yangzhou 225002, Jiangsu, Peoples R China	Hong Kong Polytechnic University; Yangzhou University	Chiu, APY (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.	alice.py.chiu@polyu.edu.hk	Lin, Qianying/ABD-8415-2021; He, Daihai/A-9347-2008; He, Daihai/AAT-8735-2021	He, Daihai/0000-0003-3253-654X	National Science Foundation of China [11371311]; RGC/ECS grant from Hong Kong Research Grant Council [PolyU 251001/14M]; Hong Kong Research Grants Council [PolyU 251001/14M]; National Natural Science Foundation of China [11371311]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); RGC/ECS grant from Hong Kong Research Grant Council; Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	ZL is supported by a research grant from the National Science Foundation of China (Grant No. 11371311). DH is supported by the RGC/ECS grant from Hong Kong Research Grant Council (PolyU 251001/14M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the reviewers for their comments that help improve the manuscript. D.H. was supported by the Early Career Scheme of the Hong Kong Research Grants Council (PolyU 251001/14M). Z.L. was supported by the National Natural Science Foundation of China (Grant No. 11371311).	Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Bulaga LL, 2003, AVIAN DIS, V47, P1169, DOI 10.1637/0005-2086-47.s3.1169; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camacho A, 2011, P ROY SOC B-BIOL SCI, V278, P3635, DOI 10.1098/rspb.2011.0300; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Fang CF, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5765; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Hai R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3854; He DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11013; He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Hsieh YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111834; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Ionides EL, 2011, ANN STAT, V39, P1776, DOI 10.1214/11-AOS886; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Kung NY, 2003, AVIAN DIS, V47, P1037, DOI 10.1637/0005-2086-47.s3.1037; Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348; Magalhaes RJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049712; Peng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093094; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shi JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077651; SIVANANDAN V, 1991, AVIAN DIS, V35, P974, DOI 10.2307/1591638; Tiwari A, 2006, AVIAN DIS, V50, P284, DOI 10.1637/7453-101205R.1; Wang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135718; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; WHO, AV INFL A H7N9 VIR; Xiao YN, 2014, J THEOR BIOL, V352, P1, DOI 10.1016/j.jtbi.2014.02.038; Xu R, 2013, SCIENCE, V342, P1230, DOI 10.1126/science.1243761; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhu GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093390; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	37	16	17	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151333	10.1371/journal.pone.0151333	http://dx.doi.org/10.1371/journal.pone.0151333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963937	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000138
J	Ting, K; Aitken, KJ; Penna, F; Samiei, AN; Sidler, M; Jiang, JX; Ibrahim, F; Tolg, C; Delgado-Olguin, P; Rosenblum, N; Bagli, DJ				Ting, Kenneth; Aitken, Karen J.; Penna, Frank; Samiei, Alaleh Najdi; Sidler, Martin; Jiang, Jia-Xin; Ibrahim, Fadi; Tolg, Cornelia; Delgado-Olguin, Paul; Rosenblum, Norman; Baegli, Darius J.			Uropathogenic E.coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2)	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ESCHERICHIA-COLI; EPIGENETIC REGULATION; PERSISTENCE; MECHANISMS; CELLS; HOST	Host-pathogen interactions can induce epigenetic changes in the host directly, as well as indirectly through secreted factors. Previously, uropathogenic Escherichia coli (UPEC) was shown to increase DNA methyltransferase activity and expression, which was associated with methylation-dependent alterations in the urothelial expression of CDKN2A. Here, we showed that paracrine factors from infected cells alter expression of another epigenetic writer, EZH2, coordinate with proliferation. Urothelial cells were inoculated with UPEC, UPEC derivatives, or vehicle (mock infection) at low moi, washed, then maintained in media with Gentamycin. Urothelial conditioned media (CM) and extracellular vesicles (EV) were isolated after the inoculations and used to treat naive urothelial cells. EZH2 increased with UPEC infection, inoculation-induced CM, and inoculation-induced EV vs. parallel stimulation derived from mock-inoculated urothelial cells. We found that infection also increased proliferation at one day post-infection, which was blocked by the EZH2 inhibitor UNC1999. Inhibition of demethylation at H3K27me3 had the opposite effect and augmented proliferation. CONCLUSION: Uropathogen-induced paracrine factors act epigenetically by altering expression of EZH2, which plays a key role in early host cell proliferative responses to infection.	[Ting, Kenneth; Baegli, Darius J.] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Ting, Kenneth; Sidler, Martin; Baegli, Darius J.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Aitken, Karen J.; Samiei, Alaleh Najdi; Sidler, Martin; Jiang, Jia-Xin; Ibrahim, Fadi; Tolg, Cornelia; Delgado-Olguin, Paul; Rosenblum, Norman; Baegli, Darius J.] Hosp Sick Children, Res Inst, Dev & Stem Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Aitken, Karen J.; Samiei, Alaleh Najdi; Sidler, Martin; Jiang, Jia-Xin; Ibrahim, Fadi; Tolg, Cornelia; Delgado-Olguin, Paul; Rosenblum, Norman; Baegli, Darius J.] Hosp Sick Children, Dept Surg, Div Urol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Delgado-Olguin, Paul] Hosp Sick Children, Res Inst, Physiol & Expt Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Rosenblum, Norman] Hosp Sick Children, Dept Surg, Div Nephrol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Aitken, KJ (corresponding author), Hosp Sick Children, Res Inst, Dev & Stem Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Aitken, KJ (corresponding author), Hosp Sick Children, Dept Surg, Div Urol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	kjaitken@sickkids.ca	Aitken, KJ/AAC-5383-2019; Olguin, Paul Delgado/H-9293-2019; Rosenblum, Norman D/H-4737-2015	Olguin, Paul Delgado/0000-0002-5355-247X; Rosenblum, Norman D/0000-0003-1767-6464	Canadian Institutes of Health Research Catalyst Grant; Victoria College Undergraduate Student award; Institute of Medical Sciences Summer Research Award; Training Program in Regenerative Medicine from Strategic program of CIHR	Canadian Institutes of Health Research Catalyst Grant(Canadian Institutes of Health Research (CIHR)); Victoria College Undergraduate Student award; Institute of Medical Sciences Summer Research Award; Training Program in Regenerative Medicine from Strategic program of CIHR(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research Catalyst Grant, Victoria College Undergraduate Student award, Institute of Medical Sciences Summer Research Award, Training Program in Regenerative Medicine from Strategic program of CIHR.	Aitken KJ, 2010, AM J PATHOL, V176, P304, DOI 10.2353/ajpath.2010.080834; [Anonymous], 2013, RETINOID SIGNALING P; Ashkar AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000233; Bardot ES, 2013, EMBO J, V32, P1990, DOI 10.1038/emboj.2013.110; Becknell B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077714; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; BOYER LA, 2006, NATURE; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bracken AP, 2006, GENES; Bracken AP, 2007, GENES; Brook P, 2015, EUROPEAN RESP J; Chen S, 2013, J IMMUNOL; Conti SL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003696; Ezhkova E, 2009, CELL; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Flynn RP, 2014, BLOOD; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Hamon MA, 2008, CELL HOST MICROBE; Hanna-Wakim RH, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00045; Hannan TJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006423; Hosseini HM, 2013, ALLERGY DRUG; Hu G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003261; Jandu N, 2006, INFECT IMMUN, V74, P1809, DOI 10.1128/IAI.74.3.1809-1818.2006; Jiang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069089; Johnstone RM, 2006, BLOOD CELLS; Jones NL, 2004, DIGESTIVE DIS; Kastelowitz N, 2014, CHEMBIOCHEM, V15, P923, DOI 10.1002/cbic.201400043; Klumpp DJ, 2006, UROPATHOGENIC ESCHER; Kruidenier L, 2012, NATURE; Ladomenou F, 2015, ACTA PAEDIATR, V104, pE324, DOI 10.1111/apa.12992; Lauss M, 2012, EPIGENETICS-US, V7, P858, DOI 10.4161/epi.20837; Lebreton A, 2012, VIRULENCE; Lin AE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004818; Mathivanan S, 2010, J PROTEOMICS; Maudet C, 2014, FEBS LETT, V588, P4140, DOI 10.1016/j.febslet.2014.08.002; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Ossa JC, 2013, CELL MICROBIOL, V15, P446, DOI 10.1111/cmi.12048; Pasini D, 2004, CELL CYCLE; Roy BC, 2015, ONCOGENE, V34, P4519, DOI 10.1038/onc.2014.386; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Schnitger AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027435; Schofield CJ, 1839, BIOCH BIOPHYS ACTA; Schroder A, 2013, J UROLOGY, V189, P2377, DOI 10.1016/j.juro.2012.12.110; Schulte LN, 2011, EMBO; Schwartz DJ, 2013, P NATL ACAD SCI USA, V110, P15530, DOI 10.1073/pnas.1315203110; Sesto N, 2014, FUTURE MICROBIOLOGY; Shipony Z., 2014, NATURE; Singh PP, 2015, TRAFFIC, V16, P555, DOI 10.1111/tra.12278; Tolg C, 2012, EPIGENOMICS-UK, V4, P229, DOI [10.2217/EPI.12.5, 10.2217/epi.12.5]; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658; Vlassov AV, 2012, BIOCH BIOPHYSICA; WINBERG J, 1975, KIDNEY INT, V8, pS101; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Zhang ZG, 2016, J INFECT DIS, V213, P1198, DOI 10.1093/infdis/jiv569; Zhou X, 2014, NATURE	59	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149118	10.1371/journal.pone.0149118	http://dx.doi.org/10.1371/journal.pone.0149118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964089	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000008
J	Cui, HW; Zhu, YJ; Jiang, DM				Cui, Hongwang; Zhu, Yongjun; Jiang, Dianming			The RIP1-RIP3 Complex Mediates Osteocyte Necroptosis after Ovariectomy in Rats	PLOS ONE			English	Article							PROTEIN-KINASE 1; BONE LOSS; CELL-DEATH; TNF-ALPHA; APOPTOSIS; OSTEOPOROSIS; MODEL; ESTROGEN; INJURY; MICE	Osteocyte apoptosis has been reported to play a central role in bone remodeling. In addition to apoptosis, other mechanisms may be involved in osteocyte loss. This study aimed to investigate the effect of necroptosis on osteocytes in ovariectomized (OVX) rats. Ninety-six female Sprague-Dawley rats were randomly divided into an OVX group and a sham group. At 0, 4, 8 and 12 weeks after surgery, specimens from each group (n = 12 each) were harvested. Bone mineral density (BMD) and body weight were measured. Transmission electron microscopy (TEM) and micro-CT were used to observe the changes in cellular morphology and bone microarchitecture induced by estrogen deficiency. Osteocyte apoptosis and necroptosis were evaluated via TUNEL and immunofluorescence staining for active caspase-3. At 8 weeks after ovariectomy, a greater number of osteocytes with typical necrotic morphological features were TUNEL positive but negative for active caspase-3. Western blotting, quantitative real-time PCR and immunofluorescence assessments demonstrated that the levels of receptor-interacting serine/threonine protein kinase 1 (RIP1) and RIP3 in osteocytes were significantly increased at 8 weeks after ovariectomy. These data are the first to suggest that necroptosis accelerates osteocyte loss under conditions of estrogen deficiency-induced osteoporosis in OVX rats. These findings provide evidence of a potential mechanism through which osteocyte necroptosis is associated with postmenopausal osteoporosis.	[Cui, Hongwang; Jiang, Dianming] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Chongqing, Peoples R China; [Zhu, Yongjun] Chongqing Med Univ, Affiliated Hosp 1, Dept Nephrol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Cui, HW; Jiang, DM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Chongqing, Peoples R China.	cqchw2013@sina.com; jdm571026@vip.163.com			National Science Foundation of China [81171685]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Science Foundation of China (81171685).	Abuohashish HM, 2015, ACTA PHARMACOL SIN, V36, P209, DOI 10.1038/aps.2014.111; Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Bjorkerud S, 1996, AM J PATHOL, V149, P367; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; Dunai Z, 2011, PATHOL ONCOL RES, V17, P791, DOI 10.1007/s12253-011-9433-4; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Feng M, 2014, J STEROID BIOCHEM, V144, P455, DOI 10.1016/j.jsbmb.2014.09.005; FROST HM, 1992, BONE MINER, V18, P227, DOI 10.1016/0169-6009(92)90809-R; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Heino TJ, 2004, EXP CELL RES, V294, P458, DOI 10.1016/j.yexcr.2003.11.016; Imai K, 2009, OSTEOPOROSIS INT, V20, P801, DOI 10.1007/s00198-008-0750-8; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; KENZORA JE, 1978, CLIN ORTHOP RELAT R, P8; KIMMEL DB, 1980, CALCIFIED TISSUE INT, V32, P113, DOI 10.1007/BF02408530; KIMMEL DB, 1990, CALCIFIED TISSUE INT, V46, P101, DOI 10.1007/BF02556093; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; McCreadie BR, 2004, J BIOMECH, V37, P563, DOI 10.1016/S0021-9290(03)00287-2; Notomi T, 2003, J BONE MINER RES, V18, P140, DOI 10.1359/jbmr.2003.18.1.140; Rudman KE, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-12; Santollo J, 2007, AM J PHYSIOL-REG I, V293, pR2194, DOI 10.1152/ajpregu.00385.2007; Singer FR, 2008, CLEV CLIN J MED, V75, P739, DOI 10.3949/ccjm.75.10.739; Sloop GD, 1999, ARCH PATHOL LAB MED, V123, P529; Smith SY, 2009, AM J PRIMATOL, V71, P752, DOI 10.1002/ajp.20715; Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; Tomkinson A, 1998, J BONE MINER RES, V13, P1243, DOI 10.1359/jbmr.1998.13.8.1243; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Waarsing JH, 2006, J ORTHOP RES, V24, P926, DOI 10.1002/jor.20063; Weinstein RS, 2000, AM J MED, V108, P153, DOI 10.1016/S0002-9343(99)00420-9; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhu YJ, 2015, BIOCHEM BIOPH RES CO, V461, P575, DOI 10.1016/j.bbrc.2015.03.164	40	14	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150805	10.1371/journal.pone.0150805	http://dx.doi.org/10.1371/journal.pone.0150805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985994	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300028
J	Djossou, F; Vesin, G; Bidaud, B; Mosnier, E; Simonnet, C; Matheus, S; Prince, C; Balcaen, J; Donutil, G; Egmann, G; Okandze, A; Malvy, D; Nacher, M				Djossou, Felix; Vesin, Guillaume; Bidaud, Bastien; Mosnier, Emilie; Simonnet, Christine; Matheus, Severine; Prince, Christelle; Balcaen, John; Donutil, Gerd; Egmann, GRald; Okandze, Antoine; Malvy, Denis; Nacher, Mathieu			Incidence and Predictive Factors of Central Nervous System Dysfunction in Patients Consulting for Dengue Fever in Cayenne Hospital, French Guiana	PLOS ONE			English	Article							NEUROLOGICAL MANIFESTATIONS; CASE CLASSIFICATION; CASE DEFINITIONS; IMMUNOPATHOGENESIS; INFECTION; NEED	Introduction The frequency, the clinical characteristics, and the prognosis of dengue is highly variable. Dengue fever is associated with a range of neurological manifestations. The objective of the present study was to determine the incidence of neurological signs and their predictive factors using data from cases of dengue seen and followed in Cayenne Hospital during the Dengue 2 epidemic in 2013. Methods In 2013, a longitudinal study using data from all cases of dengue seen in Cayenne hospital was collected. Medical records used a standardized form to collect demographic information, clinical signs and biological results and the date at which they were present. The analysis used Cox proportional modeling to obtain adjusted Hazard ratios. Results A total of 1574 patients were included 221 of whom developed central nervous system signs. These signs were spontaneously resolutive. There were 9298person days of follow-up and the overall incidence rate for central nervous system signs was 2.37 per 100 person-days. The variables independently associated with central nervous system anomalies were headache, Adjusted Hazard ratio (AHR) = 1.9(95% CI = 1.4-2.6), bleeding AHR = 2 ((95% CI = 1.3-3.1), P = 0.001, abdominal pain AHR = 1.9 ((95% CI = 1.4-2.6), P<0.001, aches AHR = 2.1 ((95% CI = 1.5-2.9), P<0.001, and fatigue AHR = 1.5 ((95% CI = 1.3-1.7), P<0.001. Discussion Overall, the present study suggests that neurological signs of dengue are not exceptional even in patients without the most severe features of dengue. These manifestations were spontaneously resolutive. Here it was not possible to distinguish between encephalitis or encephalopathy. Further studies would require more in depth exploration of the patients.	[Djossou, Felix; Vesin, Guillaume; Bidaud, Bastien; Mosnier, Emilie; Prince, Christelle] Ctr Hosp Cayenne, Dept Infect & Trop Dis, Cayenne, French Guiana; [Djossou, Felix; Nacher, Mathieu] Univ Guyane, Equipe Accueil Ecosyst Amazoniens & Pathol Trop E, Cayenne, French Guiana; [Simonnet, Christine; Okandze, Antoine] Ctr Hosp Cayenne, Lab, Cayenne, French Guiana; [Matheus, Severine] Inst Pasteur, Virol Lab, Cayenne, French Guiana; [Balcaen, John] Ctr Hosp Cayenne, Dept Pediat, Cayenne, French Guiana; [Donutil, Gerd; Egmann, GRald] Ctr Hosp Cayenne, Serv Aide Med Urgente, Serv Accueil Urgences, Cayenne, French Guiana; [Malvy, Denis] Ctr Hosp Univ Bordeaux, Unite Malad Trop & Voyageur, Bordeaux, France; [Nacher, Mathieu] Ctr Hosp Cayenne, INSERM 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana	CHU Bordeaux	Nacher, M (corresponding author), Univ Guyane, Equipe Accueil Ecosyst Amazoniens & Pathol Trop E, Cayenne, French Guiana.	mathieu.nacher@ch-cayenne.fr	MOSNIER, Emilie/GXV-4053-2022; nacher, mathieu/AAH-4796-2021; Djossou, Felix/AAM-8640-2020; MALVY, Denis/T-7930-2019	MOSNIER, Emilie/0000-0002-6004-3323; nacher, mathieu/0000-0001-9397-3204; Matheus, Severine/0000-0001-9171-1964	grant "Investissement d'Avenir" from the Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-0025]	grant "Investissement d'Avenir" from the Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	This study was supported by the grant "Investissement d'Avenir" from the Agence Nationale de la Recherche (CEBA reference no. ANR-10-LABX-0025) which provides yearly funding to the EA3593 laboratory.	Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bordignon J, 2007, J MED VIROL, V79, P1506, DOI 10.1002/jmv.20958; Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040; HENDARTO S K, 1992, Acta Paediatrica Japonica, V34, P350; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Malavige G N, 2007, Indian J Med Microbiol, V25, P143; Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341; Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068; Solbrig MV, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0550-4; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Soundravally R, 2007, HUM IMMUNOL, V68, P973, DOI 10.1016/j.humimm.2007.09.007; Thangaratham PS, 2007, LANCET INFECT DIS, V7, P81, DOI 10.1016/S1473-3099(07)70005-1; Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504; van de Weg CAM, 2012, AM J TROP MED HYG, V86, P166, DOI 10.4269/ajtmh.2012.11-0491; Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150828	10.1371/journal.pone.0150828	http://dx.doi.org/10.1371/journal.pone.0150828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981859	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900052
J	Dorso, L; Bigot-Corbel, E; Abadie, J; Diab, M; Gouard, S; Bruchertseifer, F; Morgenstern, A; Maurel, C; Cherel, M; Davodeau, F				Dorso, Laetitia; Bigot-Corbel, Edith; Abadie, Jerome; Diab, Maya; Gouard, Sebastien; Bruchertseifer, Frank; Morgenstern, Alfred; Maurel, Catherine; Cherel, Michel; Davodeau, Francois			Long-Term Toxicity of Bi-213-Labelled BSA in Mice	PLOS ONE			English	Article							TARGETED ALPHA-THERAPY; PARTICLE IMMUNOTHERAPY; MYELOID-LEUKEMIA; RENAL-FUNCTION; LOW-LET; BI-213; RADIOIMMUNOTHERAPY; RADIATION; ANTIBODY; MODEL	Background Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 (Bi-213). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation due to the circulating radiopharmaceutical in the blood. To assess this, an acute and chronic toxicity study was carried out in mice injected with Bi-213-labelled Bovine Serum Albumin (Bi-213-BSA) as an example of a long-term circulating vector. Method Biodistribution of Bi-213-BSA and 125I-BSA were compared in order to evaluate Bi-213 uptake by healthy organs. The doses to organs for injected Bi-213-BSA were calculated. Groups of nude mice were injected with 3.7, 7.4 and 11.1 MBq of Bi-213-BSA and monitored for 385 days. Plasma parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine, were measured and blood cell counts (white blood cells, platelets and red blood cells) were performed. Mouse organs were examined histologically at different time points. Results Haematological toxicity was transient and non-limiting for all evaluated injected activities. At the highest injected activity (11.1 MBq), mice died from liver and kidney failure (median survival of 189 days). This liver toxicity was identified by an increase in both ALT and AST and by histological examination. Mice injected with 7.4 MBq of Bi-213-BSA (median survival of 324 days) had an increase in plasma BUN and creatinine due to impaired kidney function, confirmed by histological examination. Injection of 3.7 MBq of Bi-213-BSA was safe, with no plasma enzyme modifications or histological abnormalities. Conclusion Haematological toxicity was not limiting in this study. Liver failure was observed at the highest injected activity (11.1 MBq), consistent with liver damage observed in human clinical trials. Intermediate injected activity (7.4 MBq) should be used with caution because of the risk of long-term toxicity to kidneys.	[Dorso, Laetitia; Bigot-Corbel, Edith; Diab, Maya; Gouard, Sebastien; Maurel, Catherine; Cherel, Michel; Davodeau, Francois] INSERM, Nantes Angers Canc Res Ctr CRCNA, UMR 892, Nucl Oncol, Nantes, France; [Dorso, Laetitia; Bigot-Corbel, Edith; Diab, Maya; Gouard, Sebastien; Maurel, Catherine; Cherel, Michel; Davodeau, Francois] Univ Nantes, Nantes, France; [Dorso, Laetitia; Bigot-Corbel, Edith; Diab, Maya; Gouard, Sebastien; Maurel, Catherine; Cherel, Michel; Davodeau, Francois] CNRS, UMR 6299, Nantes, France; [Bigot-Corbel, Edith] Laenneck Hosp, Dept Biochem, Nantes, France; [Dorso, Laetitia] LUNAM Univ, Oniris, AMaROC Unit, Nantes, France; [Bruchertseifer, Frank; Morgenstern, Alfred] Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany; [Cherel, Michel] Ctr Rene Gauducheau, ICO, Nucl Med, F-44035 Nantes, France; [Davodeau, Francois] Univ Hosp, Nucl Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; European Commission Joint Research Centre; EC JRC Institute for Transuranium Elements (ITU); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite; CHU de Nantes	Davodeau, F (corresponding author), INSERM, Nantes Angers Canc Res Ctr CRCNA, UMR 892, Nucl Oncol, Nantes, France.; Davodeau, F (corresponding author), Univ Nantes, Nantes, France.; Davodeau, F (corresponding author), CNRS, UMR 6299, Nantes, France.; Davodeau, F (corresponding author), Univ Hosp, Nucl Med, Nantes, France.	davodeau@nantes.inserm.fr	Chérel, Michel/F-8298-2013; Gouard, Sébastien/L-5465-2015; François, Davodeau/GLU-4061-2022; Abadie, Jérôme/ABF-5089-2020	Gouard, Sébastien/0000-0002-0973-5420; François, Davodeau/0000-0001-8181-0192; DORSO, Laetitia/0000-0001-7790-951X	Labex IRON project [ANR-11-LABX-0018-01]; ArronaxPlus Equipex project - "Investissements d'Avenir" French Government program [ANR-11-EQPX-0004]; region "Pays de la Loire": NUCSAN project [2010 10255]	Labex IRON project; ArronaxPlus Equipex project - "Investissements d'Avenir" French Government program(French National Research Agency (ANR)); region "Pays de la Loire": NUCSAN project(Region Pays de la Loire)	This work was supported by the Labex IRON project (no ANR-11-LABX-0018-01), and the ArronaxPlus Equipex project (no ANR-11-EQPX-0004) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR). This work was also supported by the region "Pays de la Loire": NUCSAN project (no 2010 10255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolidis C, 2005, ANAL CHEM, V77, P6288, DOI 10.1021/ac0580114; Back T, 2009, CANCER BIOTHER RADIO, V24, P649, DOI 10.1089/cbr.2009.0628; Behr TM, 1999, CANCER RES, V59, P2635; Bethge WA, 2003, BLOOD, V101, P5068, DOI 10.1182/blood-2002-12-3867; Cherel M, 2013, J NUCL MED, V54, P1597, DOI 10.2967/jnumed.112.111997; Essler M, 2012, EUR J NUCL MED MOL I, V39, P602, DOI 10.1007/s00259-011-2023-6; Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204; Fraker PJ, 1978, BIOCHEM BIOPH RES CO, P80; GREGUS Z, 1986, TOXICOL APPL PHARM, V85, P24, DOI 10.1016/0041-008X(86)90384-4; HACKBARTH H, 1982, J GERONTOL, V37, P540, DOI 10.1093/geronj/37.5.540; Jaggi JS, 2005, J AM SOC NEPHROL, V16, P2677, DOI 10.1681/ASN.2004110945; Jurcic JG, 2002, BLOOD, V100, P1233, DOI 10.1182/blood.V100.4.1233.h81602001233_1233_1239; Kennel SJ, 1999, BRIT J CANCER, V80, P175, DOI 10.1038/sj.bjc.6990337; Michel CC, 1996, CARDIOVASC RES, V32, P644, DOI 10.1016/0008-6363(96)00064-8; Milano MT, 2007, SEMIN RADIAT ONCOL, V17, P131, DOI 10.1016/j.semradonc.2006.11.009; Nakamae H, 2009, CANCER RES, V69, P2408, DOI 10.1158/0008-5472.CAN-08-4363; NIKULA TK, 1995, NUCL MED BIOL, V22, P387, DOI 10.1016/0969-8051(94)00126-5; Norenberg JP, 2006, CLIN CANCER RES, V12, P897, DOI 10.1158/1078-0432.CCR-05-1264; Pouget JP, 2001, EUR J NUCL MED, V28, P541, DOI 10.1007/s002590100484; Rosenblat TL, 2010, CLIN CANCER RES, V16, P5303, DOI 10.1158/1078-0432.CCR-10-0382; Sandmaier BM, 2002, BLOOD, V100, P318, DOI 10.1182/blood-2001-12-0322; Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14; Schmitt R, 2008, AM J PHYSIOL-RENAL, V294, pF1265, DOI 10.1152/ajprenal.00543.2007; Schwartz J, 2011, PHYS MED BIOL, V56, P721, DOI 10.1088/0031-9155/56/3/012; Sgouros G, 1999, J NUCL MED, V40, P1935; Song EY, 2007, CANCER BIOL THER, V6, P898, DOI 10.4161/cbt.6.6.4097; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Watchman CJ, 2007, J NUCL MED, V48, P645, DOI 10.2967/jnumed.106.035337; Wild D, 2011, CANCER RES, V71, P1009, DOI 10.1158/0008-5472.CAN-10-1186; Yao ZS, 2004, CLIN CANCER RES, V10, P3137, DOI 10.1158/1078-0432.CCR-03-0171	30	10	10	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151330	10.1371/journal.pone.0151330	http://dx.doi.org/10.1371/journal.pone.0151330			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982495	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900076
J	Gorski, MM; Lotta, LA; Pappalardo, E; de Haan, HG; Passamonti, SM; Vlieg, AV; Martinelli, I; Peyvandi, F				Gorski, Marcin M.; Lotta, Luca A.; Pappalardo, Emanuela; de Haan, Hugoline G.; Passamonti, Serena M.; Vlieg, Astrid van Hylckama; Martinelli, Ida; Peyvandi, Flora			Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis	PLOS ONE			English	Article							VENOUS THROMBOEMBOLIC DISEASE; WHOLE-GENOME ASSOCIATION; ISCHEMIC-STROKE; Z DEFICIENCY; RISK; MUTATIONS; POLYMORPHISMS; THROMBOPHILIA; COMMON; LOCI	Rare mutations in PROC, PROS1 or SERPINC1 as well as common variants in F5, F2, F11 and SERPINC1 have been identified as risk factors for deep vein thrombosis (DVT). To identify novel genetic risk factors for DVT, we have developed and applied next-generation DNA sequencing (NGS) of the coding area of hemostatic and proinflammatory genes. Using this strategy, we previously identified a single nucleotide variant (SNV) rs6050 in the FGA gene and novel, rare SNVs in the ADAMTS13 gene associated with DVT. To identify novel coding variants in the genetic predisposition to DVT, we applied NGS analysis of the coding area of 186 hemostatic and proinflammatory genes in 94 DVT cases and 98 controls and we identified 18 variants with putative role in DVT. A group of 585 Italian idiopathic DVT patients and 550 healthy controls was used to genotype all the 18 risk-associated variants identified by NGS. Replication study in the Italian population identified the rs2232710 variant in the protein Z-dependent protease inhibitor (ZPI) gene to be associated with an increased risk of DVT (OR 2.74; 95% CI 1.33-5.65; P = 0.0045; Bonferroni P = 0.081). However, the rs2232710 SNV showed no association with DVT in two Dutch replication cohorts the LETS study (454 patients and 451 controls) and the MEGA study (3799 patients and 4399 controls), indicating that the rs2232710 variant is not a risk factor for DVT.	[Gorski, Marcin M.; Pappalardo, Emanuela; Peyvandi, Flora] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Lotta, Luca A.; Passamonti, Serena M.; Martinelli, Ida; Peyvandi, Flora] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Lotta, Luca A.; Passamonti, Serena M.; Martinelli, Ida; Peyvandi, Flora] Fdn Luigi Villa, Milan, Italy; [de Haan, Hugoline G.; Vlieg, Astrid van Hylckama] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Peyvandi, F (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.; Peyvandi, F (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy.; Peyvandi, F (corresponding author), Fdn Luigi Villa, Milan, Italy.	flora.peyvandi@unimi.it	Peyvandi, Flora/AAK-7437-2020; Martinelli, ida/J-2287-2015; van Hylckama Vlieg, Astrid/A-3323-2017	Peyvandi, Flora/0000-0001-7423-9864; Martinelli, ida/0000-0001-9218-3622; de Haan, Hugoline/0000-0003-1126-4776; Lotta, Luca Andrea/0000-0002-2619-5956; Gorski, Marcin M./0000-0002-8276-3866; Passamonti, Serena Maria/0000-0003-2875-8860	Italian Ministry of Health [RF-2009-1530493]; Fondazione Cariplo [2011-0524]	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by the Italian Ministry of Health Grant No. RF-2009-1530493 and the Fondazione Cariplo Grant No. 2011-0524.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bezemer ID, 2009, ARCH INTERN MED, V169, P610, DOI 10.1001/archinternmed.2008.589; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Corral J, 2007, BRIT J HAEMATOL, V137, P99, DOI 10.1111/j.1365-2141.2007.06548.x; Corral J, 2006, BLOOD, V108, P177, DOI 10.1182/blood-2005-08-3249; Dahlback B, 2008, BLOOD, V112, P19, DOI 10.1182/blood-2008-01-077909; Fabbro D, 2007, J THROMB THROMBOLYS, V23, P77, DOI 10.1007/s11239-006-9003-x; Foo JN, 2012, NAT REV NEUROL, V8, P508, DOI 10.1038/nrneurol.2012.148; Germain M, 2015, AM J HUM GENET, V96, P532, DOI 10.1016/j.ajhg.2015.01.019; Gris JC, 2002, BLOOD, V99, P2606, DOI 10.1182/blood.V99.7.2606; Kobelt K, 2001, BRIT J HAEMATOL, V114, P169, DOI 10.1046/j.1365-2141.2001.02913.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lotta LA, 2013, J THROMB HAEMOST, V11, P1228, DOI 10.1111/jth.12291; Lotta LA, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-7; Martinelli I, 2014, NAT REV CARDIOL, V11, P140, DOI 10.1038/nrcardio.2013.211; McQuillan AM, 2003, STROKE, V34, P2415, DOI 10.1161/01.STR.0000092124.52084.4B; Morange PE, 2010, AM J HUM GENET, V86, P592, DOI 10.1016/j.ajhg.2010.02.011; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Razzari C, 2006, THROMB HAEMOSTASIS, V95, P909, DOI 10.1160/TH06-01-0060; Refaai MA, 2006, J THROMB HAEMOST, V4, P1628, DOI 10.1111/j.1538-7836.2006.02012.x; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Rosendaal FR, 2009, J THROMB HAEMOST, V7, P301, DOI 10.1111/j.1538-7836.2009.03394.x; Sherry ST, 1999, GENOME RES, V9, P677; Sofi F, 2009, J THROMB HAEMOST, V7, P731, DOI 10.1111/j.1538-7836.2009.03325.x; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Van de Water N, 2004, BRIT J HAEMATOL, V127, P190, DOI 10.1111/j.1365-2141.2004.05189.x; vanderMeer FJM, 1997, THROMB HAEMOSTASIS, V78, P631; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Young LK, 2012, THROMB HAEMOSTASIS, V107, P854, DOI 10.1160/TH11-10-0708; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151347	10.1371/journal.pone.0151347	http://dx.doi.org/10.1371/journal.pone.0151347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982741	Green Published, gold			2022-12-27	WOS:000372574900078
J	Groot, MP; Kooke, R; Knoben, N; Vergeer, P; Keurentjes, JJB; Ouborg, NJ; Verhoeven, KJF				Groot, Maartje P.; Kooke, Rik; Knoben, Nieke; Vergeer, Philippine; Keurentjes, Joost J. B.; Ouborg, N. Joop; Verhoeven, Koen J. F.			Effects of Multi-Generational Stress Exposure and Offspring Environment on the Expression and Persistence of Transgenerational Effects in Arabidopsis thaliana	PLOS ONE			English	Article							EPIGENETIC VARIATION; EVOLUTION; INHERITANCE; PLASTICITY; MEMORY; ADAPTATION; MECHANISMS; BEHAVIOR; PLANTS	Plant phenotypes can be affected by environments experienced by their parents. Parental environmental effects are reported for the first offspring generation and some studies showed persisting environmental effects in second and further offspring generations. However, the expression of these transgenerational effects proved context-dependent and their reproducibility can be low. Here we study the context-dependency of transgenerational effects by evaluating parental and transgenerational effects under a range of parental induction and offspring evaluation conditions. We systematically evaluated two factors that can influence the expression of transgenerational effects: single-versus multiple-generation exposure and offspring environment. For this purpose, we exposed a single homozygous Arabidopsis thaliana Col-0 line to salt stress for up to three generations and evaluated offspring performance under control and salt conditions in a climate chamber and in a natural environment. Parental as well as transgenerational effects were observed in almost all traits and all environments and traced back as far as great-grandparental environments. The length of exposure exerted strong effects; multiple-generation exposure often reduced the expression of the parental effect compared to single-generation exposure. Furthermore, the expression of transgenerational effects strongly depended on offspring environment for rosette diameter and flowering time, with opposite effects observed in field and greenhouse evaluation environments. Our results provide important new insights into the occurrence of transgenerational effects and contribute to a better understanding of the context-dependency of these effects.	[Groot, Maartje P.; Knoben, Nieke; Ouborg, N. Joop] Radboud Univ Nijmegen, Inst Water & Wetland Res, Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands; [Kooke, Rik] Wageningen Univ, Dept Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Vergeer, Philippine] Plant Ecol & Nat Conservat Grp, Wageningen, Netherlands; [Keurentjes, Joost J. B.] Wageningen Univ, Dept Genet, NL-6700 AP Wageningen, Netherlands; [Verhoeven, Koen J. F.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Kooke, Rik; Keurentjes, Joost J. B.] Ctr BioSyst Genom, Wageningen, Netherlands	Radboud University Nijmegen; Wageningen University & Research; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Centre for BioSystems Genomics	Groot, MP (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands.	m.groot@science.ru.nl	Verhoeven, Koen JF/C-9920-2010; Ouborg, Joop/C-1028-2011; KNAW, NIOO-KNAW/A-4320-2012	Verhoeven, Koen JF/0000-0003-3002-4102; Keurentjes, Joost/0000-0001-8918-0711; KNAW, NIOO-KNAW/0000-0002-3835-159X; Novoplansky, Ariel/0000-0003-0988-786X	European Science Foundation [EpiCOL]; Netherlands Organization for International Cooperation in Higher Education [864.10.008]; Centre of BioSystems Genomics [AA3-WU-PL]; Centre for BioSystems Genomics, Wageningen	European Science Foundation(European Science Foundation (ESF)European Commission); Netherlands Organization for International Cooperation in Higher Education; Centre of BioSystems Genomics; Centre for BioSystems Genomics, Wageningen	This work was supported by the following: Grant number: EpiCOL, URL: http://www.esf.org/home.html, Full name: European Science Foundation, author: MP; Grant number: 864.10.008, URL: http://www.nwo.nl/, full name: Netherlands Organization for International Cooperation in Higher Education, author: KV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Grant number: AA3-WU-PL, URL: http://www.narcis.nl/organisation/RecordID/ORG1242298, Full name: the Centre of BioSystems Genomics, author: RK. Centre for BioSystems Genomics, Wageningen, provided support in the form of salaries for authors RK and JJBK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2014, R LANG ENV STAT COMP; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bonduriansky R, 2012, EVOL APPL, V5, P192, DOI 10.1111/j.1752-4571.2011.00213.x; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Castro BM, 2013, J ECOL, V101, P1281, DOI 10.1111/1365-2745.12125; CLAUSS MJ, 1994, J ECOL, V82, P447, DOI 10.2307/2261254; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Furrow RE, 2014, EVOLUTION, V68, P673, DOI 10.1111/evo.12225; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Hafer N, 2011, BIOL LETTERS, V7, P755, DOI 10.1098/rsbl.2011.0139; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Holeski LM, 2012, TRENDS ECOL EVOL; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Jung SY, 2004, PLANT SCI, V166, P459, DOI 10.1016/j.plantsci.2003.10.012; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kim SG, 2007, PLANTA, V226, P647, DOI 10.1007/s00425-007-0513-3; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P734; Latzel V, 2014, OIKOS, V123, P41, DOI 10.1111/j.1600-0706.2013.00537.x; Latzel V, 2012, ANN BOT-LONDON, V110, P1423, DOI 10.1093/aob/mcs088; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Reboud X, 2004, Plant Adaptation: Molecular Genetics and Ecology, P135; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Sani E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r59; Sultan SE, 2009, ECOLOGY, V90, P1831, DOI 10.1890/08-1064.1; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080819; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060364; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Uller T, 2011, EVOLUTION, V65, P2075, DOI 10.1111/j.1558-5646.2011.01282.x; Verhoeven KJF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038605; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010	47	37	39	10	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151566	10.1371/journal.pone.0151566	http://dx.doi.org/10.1371/journal.pone.0151566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982489	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900096
J	Murgarella, M; Puiu, D; Novoa, B; Figueras, A; Posada, D; Canchaya, C				Murgarella, Maria; Puiu, Daniela; Novoa, Beatriz; Figueras, Antonio; Posada, David; Canchaya, Carlos			A First Insight into the Genome of the Filter-Feeder Mussel Mytilus galloprovincialis	PLOS ONE			English	Article							ELEVATED MUTATION-RATES; MITOCHONDRIAL-DNA; TRANSPOSABLE ELEMENTS; HYBRID DYSGENESIS; MULTIXENOBIOTIC RESISTANCE; DRAFT GENOME; SEQUENCE; BIVALVE; EDULIS; INHERITANCE	Mussels belong to the phylum Mollusca, one of the largest and most diverse taxa in the animal kingdom. Despite their importance in aquaculture and in biology in general, genomic resources from mussels are still scarce. To broaden and increase the genomic knowledge in this family, we carried out a whole-genome sequencing study of the cosmopolitan Mediterranean mussel (Mytilus galloprovincialis). We sequenced its genome (32X depth of coverage) on the Illumina platform using three pair-end libraries with different insert sizes. The large number of contigs obtained pointed out a highly complex genome of 1.6 Gb where repeated elements seem to be widespread (similar to 30% of the genome), a feature that is also shared with other marine molluscs. Notwithstanding the limitations of our genome sequencing, we were able to reconstruct two mitochondrial genomes and predict 10,891 putative genes. A comparative analysis with other molluscs revealed a gene enrichment of gene ontology categories related to multixenobiotic resistance, glutamate biosynthetic process, and the maintenance of ciliary structures.	[Murgarella, Maria; Posada, David; Canchaya, Carlos] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain; [Murgarella, Maria; Posada, David; Canchaya, Carlos] Univ Vigo, Unidad Asociada CSIC, Vigo 36310, Spain; [Puiu, Daniela] Johns Hopkins Univ, Sch Med, Inst Med Genet, Ctr Computat Biol McKusick Nathans, Baltimore, MD USA; [Novoa, Beatriz; Figueras, Antonio] CSIC, Inst Invest Marinas, Vigo, Spain	Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); Universidade de Vigo; Johns Hopkins University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Canchaya, C (corresponding author), Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain.; Canchaya, C (corresponding author), Univ Vigo, Unidad Asociada CSIC, Vigo 36310, Spain.	canchaya@uviga.es	Canchaya, Carlos/U-5752-2019; Novoa, Beatriz/K-3785-2014; Figueras, Antonio/AAB-8921-2019; Posada, David/C-4502-2008	Canchaya, Carlos/0000-0003-3463-7459; Figueras, Antonio/0000-0002-0617-0030; Posada, David/0000-0003-1407-3406; Murgarella, Maria/0000-0002-9905-4097; Novoa, Beatriz/0000-0003-4888-8419	spanish Axencia Galega de Innovacion para o desenvolvemento Project INCITE [10PXIB402096PR]; "Isidro Parga Pondal" spanish research fellowships from Xunta de Galicia; Axencia Galega de Innovacion para o Desenvolvemento (INCITE) (Spain) [10PXIB402096PR]; "Isidro Parga Pondal" research fellowship from Xunta de Galicia (Spain)	spanish Axencia Galega de Innovacion para o desenvolvemento Project INCITE; "Isidro Parga Pondal" spanish research fellowships from Xunta de Galicia; Axencia Galega de Innovacion para o Desenvolvemento (INCITE) (Spain); "Isidro Parga Pondal" research fellowship from Xunta de Galicia (Spain)	This work was supported by the spanish Axencia Galega de Innovacion para o desenvolvemento (http://gain.xunta.es) Project INCITE 10PXIB402096PR awarded to AF y CC. CC was funded by "Isidro Parga Pondal" spanish research fellowships from Xunta de Galicia (http://www.xunta.es).; Thanks to Steven Salzberg at Johns Hopkins University for providing technical advice and support on genome assembly. This work was supported by the Axencia Galega de Innovacion para o Desenvolvemento (Project INCITE 10PXIB402096PR) (Spain). CC was funded by an "Isidro Parga Pondal" research fellowship from Xunta de Galicia (Spain).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bassim S, 2015, REV AQUACULT, V7, P197, DOI 10.1111/raq.12064; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; Bierne N, 2002, EVOLUTION, V56, P292, DOI 10.1111/j.0014-3820.2002.tb01339.x; Bosnjak I, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2073-z; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Brahimi-Horn C, 2005, CRIT REV ONCOL HEMAT, V53, P115, DOI 10.1016/j.critrevonc.2004.09.003; Brannock PM, 2013, MAR ECOL PROG SER, V480, P131, DOI 10.3354/meps10228; Bray D., 2001, PLOS ONE, DOI [10.1371/journal.pone.0002648, DOI 10.1371/JOURNAL.PONE.0002648]; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Brusca RC, 2003, INVERTEBRATES; Cao LQ, 2004, GENETICS, V167, P835, DOI 10.1534/genetics.103.026187; Chen XS, 2014, P NATL ACAD SCI USA, V111, pE4062, DOI 10.1073/pnas.1412284111; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Ciocan CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022326; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Consuegra S, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0138-0; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Darling A., 2003, P CLUSTERWORLD; Diz AP, 2008, MAR BIOL, V154, P277, DOI 10.1007/s00227-008-0921-3; Ekblom R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-467; Elliott TA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0331; Elliott TA, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0339-8; Epel D, 2008, ENVIRON SCI TECHNOL, V42, P3914, DOI 10.1021/es087187v; Evgenev MB, 1997, P NATL ACAD SCI USA, V94, P196, DOI 10.1073/pnas.94.1.196; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Figueras A, 2007, BIOL CULTIVO MEJILLO; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Gestal C, 2008, REV FISH SCI, V16, P133, DOI 10.1080/10641260802325518; Gomez-Mendikute A, 2005, CELL TISSUE RES, V321, P131, DOI 10.1007/s00441-005-1093-9; GRANT WS, 1985, J EXP MAR BIOL ECOL, V90, P179, DOI 10.1016/0022-0981(85)90119-4; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Habu Y, 1998, PLANT J, V16, P371, DOI 10.1046/j.1365-313x.1998.00308.x; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ieyama Hiroshi, 1994, Venus the Japanese Journal of Malacology, V53, P327; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kenchington EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006976; KOEHN RK, 1984, MAR BIOL, V82, P1, DOI 10.1007/BF00392757; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; KURELEC B, 1992, CRIT REV TOXICOL, V22, P23, DOI 10.3109/10408449209145320; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lallias D, 2009, J SHELLFISH RES, V28, P547, DOI 10.2983/035.028.0317; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lea PJ, 2003, PLANT PHYSIOL BIOCH, V41, P555, DOI 10.1016/S0981-9428(03)00060-3; Leese F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049202; Lerat E, 2010, HEREDITY, V104, P520, DOI 10.1038/hdy.2009.165; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Letendre J, 2009, MAR ENVIRON RES, V67, P69, DOI 10.1016/j.marenvres.2008.11.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Liu B., 2013, ARXIV, V35, P62; LOZOVSKAYA ER, 1990, GENETICS, V126, P619; Luckenbach T, 2008, AM J PHYSIOL-REG I, V294, pR1919, DOI 10.1152/ajpregu.00563.2007; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Metcalfe CJ, 2014, MOB GENET ELEMENTS, V3; Mizi A, 2005, MOL BIOL EVOL, V22, P952, DOI 10.1093/molbev/msi079; Myrand B, 2000, MAR ECOL PROG SER, V197, P193, DOI 10.3354/meps197193; Park C, 2012, EMBO REP, V13, P1123, DOI 10.1038/embor.2012.165; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Rasmussen DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-382; Rawson PD, 1996, HEREDITY, V77, P599, DOI 10.1038/hdy.1996.187; Rawson PD, 1998, EVOLUTION, V52, P100, DOI 10.1111/j.1558-5646.1998.tb05142.x; Robert R, 2013, AQUACULTURE; Rodakis GC, 2007, J MOL EVOL, V65, P124, DOI 10.1007/s00239-005-0298-6; RodriguezJuiz AM, 1996, MAR BIOL, V126, P489, DOI 10.1007/BF00354631; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; Rosani U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026680; Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x; Simakov O, 2012, NATURE, V493, P1, DOI 10.1038/nature11696; SKIBINSKI DOF, 1994, GENETICS, V138, P801; SKIBINSKI DOF, 1980, BIOL J LINN SOC, V13, P65, DOI 10.1111/j.1095-8312.1980.tb00070.x; Smietanka B, 2014, HEREDITY, V113, P250, DOI 10.1038/hdy.2014.23; STANLEY SM, 1975, ANNU REV EARTH PL SC, V3, P361, DOI 10.1146/annurev.ea.03.050175.002045; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Suarez-Ulloa V, 2013, MAR DRUGS, V11, P830, DOI 10.3390/md11030830; Suzuki M, 2013, CAN J ZOOL, V91, P349, DOI 10.1139/cjz-2012-0333; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Teacher AGF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-248; THIRIOTQUIEVREUX C, 1982, MAR BIOL, V70, P165, DOI 10.1007/BF00397681; Venier P, 2003, GENE, V314, P29, DOI 10.1016/S0378-1119(03)00708-X; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Verhey KJ, 2011, BIOCHEM SOC T, V39, P1120, DOI 10.1042/BST0391120; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Watermann BT, 2008, J FISH DIS, V31, P621, DOI 10.1111/j.1365-2761.2008.00953.x; Wicker T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-518; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Woo S, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-15; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xunta de Galicia, 2013, AN AC; Yang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099120; YANNOPOULOS G, 1987, CELL, V49, P487, DOI 10.1016/0092-8674(87)90451-X; Yoshida M, 2011, GENE, V483, P63, DOI 10.1016/j.gene.2011.05.027; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zheng WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3673; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463; Zouros E, 2000, GENES GENET SYST, V75, P313, DOI 10.1266/ggs.75.313	111	81	83	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151561	10.1371/journal.pone.0151561	http://dx.doi.org/10.1371/journal.pone.0151561			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977809	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800089
J	Pesaro, AEP; Katz, M; Katz, JN; Barbas, CSV; Makdisse, MR; Correa, AG; Franken, M; Pereira, C; Serrano, CV; Lopes, RD				Pesaro, Antonio Eduardo P.; Katz, Marcelo; Katz, Jason N.; Valente Barbas, Carmen Silvia; Makdisse, Marcia R.; Correa, Alessandra G.; Franken, Marcelo; Pereira, Carolina; Serrano, Carlos V., Jr.; Lopes, Renato D.			Mechanical Ventilation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Observational Study	PLOS ONE			English	Article							CARDIOGENIC PULMONARY-EDEMA; POSITIVE AIRWAY PRESSURE; NONINVASIVE VENTILATION; EFFICACY; SAFETY	Purpose Patients with acute myocardial infarction (AMI) and respiratory impairment may be treated with either invasive or non-invasive mechanical ventilation (MV). However, there has been little testing of non-invasive MV in the setting of AMI. Our objective was to evaluate the incidence and associated clinical outcomes of patients with AMI who were treated with noninvasive or invasive MV. Methods This was a retrospective observational study in which consecutive patients with AMI (n = 1610) were enrolled. The association between exclusively non-invasive MV, invasive MV and outcomes was assessed by multivariable models. Results Mechanical ventilation was used in 293 patients (54% invasive and 46% exclusively noninvasive). In-hospital mortality rates for patients without MV, with exclusively non-invasive MV, and with invasive MV were 4.0%, 8.8%, and 39.5%, respectively (P<0.001). The median lengths of hospital stay were 6 (5.8-6.2), 13 (11.2-4.7), and 28 (18.0-37.9) days, respectively (P<0.001). Exclusively non-invasive MV was not associated with in-hospital death (adjusted HR = 0.90, 95% CI 0.40-1.99, P = 0.79). Invasive MV was strongly associated with a higher risk of in-hospital death (adjusted HR = 3.07, 95% CI 1.79-5.26, P<0.001). Conclusions In AMI setting, 18% of the patients required MV. Almost half of these patients were treated with exclusively non-invasive strategies with a favorable prognosis, while patients who needed to be treated invasively had a three-fold increase in the risk of death. Future prospective randomized trials are needed to compare the effectiveness of invasive and non-invasive MV for the initial approach of respiratory failure in AMI patients.	[Pesaro, Antonio Eduardo P.; Katz, Marcelo; Valente Barbas, Carmen Silvia; Makdisse, Marcia R.; Correa, Alessandra G.; Franken, Marcelo; Pereira, Carolina; Serrano, Carlos V., Jr.] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil; [Katz, Jason N.] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA; [Valente Barbas, Carmen Silvia] Univ Sao Paulo, Sch Med, Dept Pulm, Heart Inst INCOR, Sao Paulo, SP, Brazil; [Serrano, Carlos V., Jr.] Univ Sao Paulo, Sch Med, Heart Inst INCOR, Sao Paulo, Brazil; [Lopes, Renato D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Lopes, Renato D.] Univ Fed Sao Paulo, Paulista Sch Med, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein; University of North Carolina; University of North Carolina Chapel Hill; Universidade de Sao Paulo; Universidade de Sao Paulo; Duke University; Universidade Federal de Sao Paulo (UNIFESP)	Pesaro, AEP (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.	antonioepp@einstein.br	Serrano, Carlos Vicente/I-2729-2013; Barbas, Carmen Silvia Valente/H-1048-2013; Makdisse, Marcia/AAY-9814-2020	Barbas, Carmen Silvia Valente/0000-0002-3922-6256; Pesaro, Antonio/0000-0003-3133-4989; MAKDISSE, MARCIA/0000-0001-7522-9430				Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; Kouraki K, 2011, CLIN RES CARDIOL, V100, P235, DOI 10.1007/s00392-010-0235-6; Lazzeri C, 2013, CARDIOL J, V20, P612, DOI 10.5603/CJ.2013.0161; Lee MS, 2013, INFECT CONT HOSP EP, V34, P657, DOI 10.1086/670991; Lesage A, 2004, CRIT CARE MED, V32, P100, DOI 10.1097/01.CCM.0000098605.58349.76; LIN M, 1995, CHEST, V107, P1379, DOI 10.1378/chest.107.5.1379; Makdisse M, 2013, EINSTEIN-SAO PAULO, V11, P357, DOI 10.1590/S1679-45082013000300016; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Park M, 2004, CRIT CARE MED, V32, P2407, DOI 10.1097/01.CCM.0000147770.20400.10; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; Serra-Prat M, 2011, J AM GERIATR SOC, V59, P186, DOI 10.1111/j.1532-5415.2010.03227.x; Sevransky JE, 2003, CLIN GERIATR MED, V19, P205, DOI 10.1016/S0749-0690(02)00065-4; Takeda S, 1998, JPN CIRC J, V62, P553, DOI 10.1253/jcj.62.553; Tsai TH, 2011, CRIT CARE MED, V39, P436, DOI 10.1097/CCM.0b013e318206ccc3; Barbas CSV, 2013, CRIT CARE MED, V41, P2058, DOI 10.1097/CCM.0b013e31828c25f2; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; Vital FM, 2008, COCHRANE DB SYST REV, V16; Weng CL, 2010, ANN INTERN MED, V152, P590, DOI 10.7326/0003-4819-152-9-201005040-00009; Winck JC, 2006, CRIT CARE, V10, DOI 10.1186/cc4905; Yamamoto T, 2012, CIRC J, V76, P2586, DOI 10.1253/circj.CJ-12-0517	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151302	10.1371/journal.pone.0151302	http://dx.doi.org/10.1371/journal.pone.0151302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977804	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800057
J	Vaidya, H; Rumph, C; Katula, KS				Vaidya, Himani; Rumph, Candie; Katula, Karen S.			Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; CANCER; EXPRESSION; GENE; MIGRATION; ACTIVATION; INVASIVENESS; MALIGNANCIES; METASTASIS	WNT5A is a secreted ligand involved in Wnt pathway signaling and has a role in cell movement and differentiation. Altered WNT5A expression is associated with various cancers, although in most studies the focus has been on only one of the known WNT5A isoforms. In this study, we analyzed expression from two of the major WNT5A promoters, termed promoter A and promoter B, in normal human osteoblasts, SaOS-2 and U2OS osteosarcoma cell lines, and osteosarcoma tumor tissue. We found that both promoters A and B are active in normal osteoblasts with nearly 11-fold more promoter B than A transcripts. Promoter B but not promoter A transcripts are decreased or nearly undetectable in the SaOS-2 and U2OS cell lines and osteosarcoma tumor tissues. Transient transfection of promoter A and promoter B reporter constructs confirmed that SaOS-2 cells have the necessary factors to transcribe both promoters. Bisulfite sequencing analysis revealed that three CpG enriched regions upstream of the promoter B exon 1 beta are highly methylated in both SaOS-2 and U2OS cells. The CpG island sub-region R6 located in promoter B exon 1 beta was approximately 51% methylated in SaOS-2 and 25% methylated in U2OS. Region 3 was approximately 28% methylated in normal osteoblasts, whereas the others were unmethylated. Promoter B was re-activated by treatment of SaOS-2 cells with 1 mu M 5-azacytidine, which was associated with only a small insignificant change in methylation of sub-region R6. ChIP analysis of U2OS and SaOS-2 cells indicated that the promoter B region is less enriched in the active histone mark H3K4me3, in comparison to promoter A and that there is increased enrichment of the repressive mark H3K27me3 in association with the promoter B genomic region in the cell line SaOS-2. These findings show that epigenetic inactivation of the WNT5A promoter B involves both DNA methylation and histone modifications and suggest that differential expression of the WNT5A alternative promoters A and B is a characteristic of osteosarcomas.	[Vaidya, Himani] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA; [Rumph, Candie; Katula, Karen S.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of North Carolina; University of North Carolina Greensboro	Katula, KS (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	kskatula@uncg.edu			National Institutes of Health [R15 DK070581-01A1]; UNCG-Regular Faculty Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK070581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCG-Regular Faculty Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health R15 DK070581-01A1, 5/1/06 - 4/30/09 "Linking folate deficiency to changes in gene expression." KSK - PI www.nih.gov. Some of the data for this manuscript was derived from this grant, although not directly related. UNCG-Regular Faculty Grant, "Functional analysis of the WNT5A isoforms A and B." 1/2013-6/2014, KSK-PI, http://research.uncg.edu/internal-grants-and-awards/. Some of the data for this manuscript was derived from this grant.	Bauer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080526; Bo HJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-496; Davalos-Salas M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-232; Deng G, 2011, ONCOL REP, V25, P367, DOI 10.3892/or.2010.1108; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Estecio MRH, 2012, MOL CANCER RES, V10, P1332, DOI 10.1158/1541-7786.MCR-12-0351; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Fernandez-Cobo M, 2007, ONCOL REP, V17, P903; Gao F, 2014, GENOMICS, V103, P204, DOI 10.1016/j.ygeno.2013.12.006; Geng M, 2012, WORLD J GASTROENTERO, V18, P1328, DOI 10.3748/wjg.v18.i12.1328; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hibi K, 2012, HEPATO-GASTROENTEROL, V59, P2661, DOI 10.5754/hge09664; Hibi K, 2009, HEPATO-GASTROENTEROL, V56, P1007; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Kanzawa M, 2013, PATHOBIOLOGY, V80, P235, DOI 10.1159/000346843; Katula KS, 2012, DNA CELL BIOL, V31, P1585, DOI 10.1089/dna.2012.1698; Kemp CJ, 2014, CELL REP, V7, P1020, DOI 10.1016/j.celrep.2014.04.004; Khaja ASS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026539; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Lai C, 2011, J PATHOL, V223, P584, DOI 10.1002/path.2835; Li JS, 2010, CANCER BIOL THER, V10, P617, DOI 10.4161/cbt.10.6.12609; Li Q, 2012, EPIGENETICS-US, V7, P551, DOI 10.4161/epi.20050; Liu JJ, 2013, CELL SIGNAL, V25, P447, DOI 10.1016/j.cellsig.2012.10.012; Lu BJ, 2012, MOL MED REP, V5, P1033, DOI 10.3892/mmr.2012.772; Lu WL, 2014, INT J CLIN ONCOL, V19, P1011, DOI 10.1007/s10147-013-0648-0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Prasad CP, 2013, MOL ONCOL, V7, P870, DOI 10.1016/j.molonc.2013.04.005; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Wei W, 2014, HEPATOB PANCREAT DIS, V13, P529, DOI 10.1016/S1499-3872(14)60277-0; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Ying J, 2007, BLOOD, V110, P4130, DOI 10.1182/blood-2007-06-094870; Zhang AL, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-15; Zhu YC, 2013, CELL SIGNAL, V25, P1075, DOI 10.1016/j.cellsig.2013.01.015	46	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151392	10.1371/journal.pone.0151392	http://dx.doi.org/10.1371/journal.pone.0151392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978652	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800070
J	El-Bassel, N; Gilbert, L; Shaw, SA; Mergenova, G; Terlikbayeva, A; Primbetova, S; Ma, X; Chang, M; Ismayilova, L; Hunt, T; West, B; Wu, E; Beyrer, C				El-Bassel, Nabila; Gilbert, Louisa; Shaw, Stacey A.; Mergenova, Gaukhar; Terlikbayeva, Assel; Primbetova, Sholpan; Ma, Xin; Chang, Mingway; Ismayilova, Leyla; Hunt, Tim; West, Brooke; Wu, Elwin; Beyrer, Chris			The Silk Road Health Project: How Mobility and Migration Status Influence HIV Risks among Male Migrant Workers in Central Asia	PLOS ONE			English	Article							SEXUAL RISK; MEXICAN MIGRANTS; POTENTIAL ROLE; BEHAVIORS; DISEASE; CHINA; PREVENTION; INFECTION; MUMBAI; MEN	Objectives We examined whether mobility, migrant status, and risk environments are associated with sexually transmitted infections (STIs) and HIV risk behaviors (e.g. sex trading, multiple partners, and unprotected sex). Methods We used Respondent Driven Sampling (RDS) to recruit external male migrant market vendors from Kyrgyzstan, Uzbekistan, and Tajikistan as well internal migrant and non-migrant market vendors from Kazakhstan. We conducted multivariate logistic regressions to examine the effects of mobility combined with the interaction between mobility and migration status on STIs and sexual risk behaviors, when controlling for risk environment characteristics. Results Mobility was associated with increased risk for biologically-confirmed STIs, sex trading, and unprotected sex among non-migrants, but not among internal or external migrants. Condom use rates were low among all three groups, particularly external migrants. Risk environment factors of low-income status, debt, homelessness, and limited access to medical care were associated with unprotected sex among external migrants. Conclusion Study findings underscore the role mobility and risk environments play in shaping HIV/STI risks. They highlight the need to consider mobility in the context of migration status and other risk environment factors in developing effective prevention strategies for this population.	[El-Bassel, Nabila; Gilbert, Louisa; Shaw, Stacey A.; Ma, Xin; Chang, Mingway; Wu, Elwin] Columbia Univ, Sch Social Work, New York, NY USA; [Mergenova, Gaukhar; Terlikbayeva, Assel; Primbetova, Sholpan] Columbia Univ, Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan; [Ismayilova, Leyla] Univ Chicago, Sch Social Serv Adm, Chicago, IL 60637 USA; [West, Brooke] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Beyrer, Chris] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Epidemiol, Int Hlth, Baltimore, MD USA	Columbia University; University of Chicago; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	El-Bassel, N (corresponding author), Columbia Univ, Sch Social Work, New York, NY USA.	ne5@columbia.edu	Mergenova, Gaukhar/AAZ-1336-2020; Ma, Xin/I-7741-2019	Mergenova, Gaukhar/0000-0003-4702-1944; Ma, Xin/0000-0001-6631-9223; West, Brooke S./0000-0003-0496-5769; Ismayilova, Leyla/0000-0002-0027-4824; Terlikbayeva, Assel/0000-0002-4067-1998	National Institute of Health [NIMH R01 MH082684]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA041233, T32DA023356] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institute of Health, NIMH R01 MH082684 to Dr. Nabila El-Bassel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOB REP UNAIDS REP; Apostolopoulos Yorghos, 2006, J Immigr Minor Health, V8, P291, DOI 10.1007/s10903-006-9334-2; Beyrer C, 2007, CLIN INFECT DIS, V44, P981, DOI 10.1086/512371; Booth RE, 2004, JAIDS-J ACQ IMM DEF, V35, P82, DOI 10.1097/00126334-200401010-00012; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; El-Bassel N., 2015, J AIDS CLIN RES, V6, P1, DOI [10.4172/2155-6113.1000486, DOI 10.4172/2155-6113.1000486]; El-Bassel N, 2011, AM J PUBLIC HEALTH, V101, P1075, DOI 10.2105/AJPH.2010.300085; Godinho J., 2004, REVERSING TIDE PRIOR; Goldenberg SM, 2012, J IMMIGR MINOR HEALT, V14, P48, DOI 10.1007/s10903-011-9505-2; Gushulak BD, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-3; Heckathorn D. D., 2003, CHANGING BEAT STUDY, P48; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; International Organization for Migration, 2018, WORLD MIGRATION REPO, DOI DOI 10.1787/ECO_SURVEYS-USA-2018-EN; International Organization of Migration (iom), 2010, WORLD MIGRATION REPO; IOM, 2006, MIGR PERSP E EUR CEN; Keezhangatte JJ, 2006, TRANSNATIONAL MIGRAT; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Laruelle M., 2008, CENTRAL ASIA CAUCASU, V10; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Magis-Rodriguez C, 2009, JAIDS-J ACQ IMM DEF, V51, pS21, DOI 10.1097/QAI.0b013e3181a26433; Napper LE, 2010, AIDS BEHAV, V14, P152, DOI 10.1007/s10461-009-9575-5; NEEDLE R, 1995, PSYCHOL ADDICT BEHAV, V9, P242, DOI 10.1037/0893-164X.9.4.242; Organista KC, 2004, JAIDS-J ACQ IMM DEF, V37, pS227, DOI 10.1097/01.qai.0000141250.08475.91; Poudel KC, 2003, TROP MED INT HEALTH, V8, P933, DOI 10.1046/j.1365-3156.2003.01110.x; RAC, 2011, HIV SURV UPD KAZ OBL; RAC, 2013, SIT HIV AIDS REP KAZ; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2012, RETHINKING SOCIAL EPIDEMIOLOGY: TOWARDS A SCIENCE OF CHANGE, P205, DOI 10.1007/978-94-007-2138-8_10; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vaglio Joseph Jr, 2004, Health Qual Life Outcomes, V2, P24, DOI 10.1186/1477-7525-2-24; Volz E., 2012, RESPONDENT DRIVEN SA; Wang W, 2010, INT J STD AIDS, V21, P410, DOI 10.1258/ijsa.2009.008518; Weine S, 2013, J IMMIGR MINOR HEALT, V15, P700, DOI 10.1007/s10903-012-9718-z; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4; Wong DFK, 2008, INT J SOC PSYCHIATR, V54, P131, DOI 10.1177/0020764007083877; Yessenova S, 2005, RUSS REV, V64, P661, DOI 10.1111/j.1467-9434.2005.00380.x; Young H, 1998, J CLIN MICROBIOL, V36, P913, DOI 10.1128/JCM.36.4.913-917.1998	48	20	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151278	10.1371/journal.pone.0151278	http://dx.doi.org/10.1371/journal.pone.0151278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967159	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200040
J	Gonzalez, A; Bes, MT; Peleato, ML; Fillat, MF				Gonzalez, Andres; Teresa Bes, M.; Luisa Peleato, M.; Fillat, Maria F.			Expanding the Role of FurA as Essential Global Regulator in Cyanobacteria	PLOS ONE			English	Article							SP PCC 7120; SP-STRAIN PCC-7120; OXIDATIVE STRESS; GENE-EXPRESSION; PHYCOBILISOME DEGRADATION; DIFFERENTIAL EXPRESSION; POSITIVE REGULATION; ESCHERICHIA-COLI; IRON HOMEOSTASIS; ANABAENA	In the nitrogen-fixing heterocyst-forming cyanobacterium Anabaena sp. PCC 7120, the ferric uptake regulator FurA plays a global regulatory role. Failures to eliminate wild-type copies of furA gene from the polyploid genome suggest essential functions. In the present study, we developed a selectively regulated furA expression system by the replacement of furA promoter in the Anabaena sp. chromosomes with the Co2+/Zn2+ inducible coaT promoter from Synechocystis sp. PCC 6803. By removing Co2+ and Zn2+ from the medium and shutting off furA expression, we showed that FurA was absolutely required for cyanobacterial growth. RNA-seq based comparative transcriptome analyses of the furA-turning off strain and its parental wild-type in conjunction with subsequent electrophoretic mobility shift assays and semi-quantitative RT-PCR were carried out in order to identify direct transcriptional targets and unravel new biological roles of FurA. The results of such approaches led us to identify 15 novel direct iron-dependent transcriptional targets belonging to different functional categories including detoxification and defences against oxidative stress, phycobilisome degradation, chlorophyll catabolism and programmed cell death, light sensing and response, heterocyst differentiation, exopolysaccharide biosynthesis, among others. Our analyses evidence novel interactions in the complex regulatory network orchestrated by FurA in cyanobacteria.	[Gonzalez, Andres; Teresa Bes, M.; Luisa Peleato, M.; Fillat, Maria F.] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain	University of Zaragoza	Gonzalez, A; Fillat, MF (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain.	andresglezrod@gmail.com; fillat@unizar.es	González, Andrés/Y-3559-2019; Bes, M. Teresa/AAA-1035-2019; Fillat, María F/G-2609-2015	González, Andrés/0000-0002-0531-0943; /0000-0002-2742-3711; Fillat Castejon, Maria Francisca/0000-0001-8644-4574	Ministerio de Economia y Competitividad. Gobierno de Espana [BFU2012-31458]; Fondos FEDER; B18, Grupo Consolidado Biologia structural, Gobierno de Aragon	Ministerio de Economia y Competitividad. Gobierno de Espana; Fondos FEDER(European Commission); B18, Grupo Consolidado Biologia structural, Gobierno de Aragon	Support was provided by BFU2012-31458 Ministerio de Economia y Competitividad. Gobierno de Espana and Fondos FEDER [http://www.mineco.gob.es/portal/site/mineco/] to AG MTB MLP MFF; and B18, Grupo Consolidado Biologia structural, Gobierno de Aragon [http://www.aragon.es/] to AG MTB MLP MFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; Bender KS, 2007, APPL ENVIRON MICROB, V73, P5389, DOI 10.1128/AEM.00276-07; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; Bihani SC, 2013, ACTA CRYSTALLOGR F, V69, P1299, DOI 10.1107/S1744309113028017; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Boileau C, 2011, NEW PHYTOL, V191, P1108, DOI 10.1111/j.1469-8137.2011.03774.x; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; Cheng D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101743; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Craig SA, 2011, J BACTERIOL, V193, P6505, DOI 10.1128/JB.05681-11; Neto JFD, 2009, NUCLEIC ACIDS RES, V37, P4812, DOI 10.1093/nar/gkp509; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Dubrac S, 2000, J BACTERIOL, V182, P3802, DOI 10.1128/JB.182.13.3802-3808.2000; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fan YP, 2014, ENV MICROBIOL REP, V6, P468, DOI 10.1111/1758-2229.12157; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Ghassemian M, 1996, MICROBIOL-SGM, V142, P1469, DOI 10.1099/13500872-142-6-1469; Gilbreath JJ, 2012, J BACTERIOL, V194, P6490, DOI 10.1128/JB.01226-12; Gonzalez A, 2014, NUCLEIC ACIDS RES, V42, P4833, DOI 10.1093/nar/gku123; Gonzalez A, 2013, FEBS LETT, V587, P2682, DOI 10.1016/j.febslet.2013.07.007; Gonzalez A, 2012, ENVIRON MICROBIOL, V14, P3175, DOI 10.1111/j.1462-2920.2012.02897.x; Gonzalez A, 2011, J PROTEOMICS, V74, P660, DOI 10.1016/j.jprot.2011.02.001; Gonzalez A, 2010, PLANT CELL PHYSIOL, V51, P1900, DOI 10.1093/pcp/pcq148; Hernandez JA, 2006, BIOMETALS, V19, P259, DOI 10.1007/s10534-005-7750-3; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hernandez JA, 2002, BIOCHEM J, V366, P315, DOI 10.1042/BJ20020135; Hernandez JA, 2009, J PLANT PHYSL; Hernandez JA, 2007, FEBS LETT, V581, P1351, DOI 10.1016/j.febslet.2007.02.053; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Irieda H, 2012, J BIOL CHEM, V287, P32485, DOI 10.1074/jbc.M112.390864; Jittawuttipoka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055564; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latifi A, 2005, J BACTERIOL, V187, P6596, DOI 10.1128/JB.187.18.6596-6598.2005; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lopez-Gomollon S, 2007, MICROBIOL-SGM, V153, P42, DOI 10.1099/mic.0.2006/000091-0; Lopez-Gomollon S, 2007, J MOL BIOL, V374, P267, DOI 10.1016/j.jmb.2007.09.010; Lopez-Gomollon S, 2009, BIOCHEM J, V418, P201, DOI 10.1042/BJ20081066; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Montgomery BL, 2007, MOL MICROBIOL, V64, P16, DOI 10.1111/j.1365-2958.2007.05622.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolaisen K, 2008, J BACTERIOL, V190, P7500, DOI 10.1128/JB.01062-08; Okamoto S, 2004, PHOTOCHEM PHOTOBIOL, V80, P429, DOI 10.1562/0031-8655(2004)080&lt;0429:APPATT&gt;2.0.CO;2; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Peca L, 2008, FEMS MICROBIOL LETT, V289, P258, DOI 10.1111/j.1574-6968.2008.01393.x; Pellicer S, 2010, PROCESS BIOCHEM, V45, P292, DOI 10.1016/j.procbio.2009.09.019; Pelliciari S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00840; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Pinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034983; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Richaud C, 2001, J BACTERIOL, V183, P2989, DOI 10.1128/JB.183.10.2989-2994.2001; Richier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035571; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sambrook J., 2001, MOL CLONING LAB MANU; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; Sein-Echaluce VC, 2015, ENVIRON MICROBIOL, V17, P2006, DOI 10.1111/1462-2920.12628; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Singh AK, 2000, J BACTERIOL, V182, P3536, DOI 10.1128/JB.182.12.3536-3543.2000; Stevanovic M, 2013, BIOMETALS, V26, P549, DOI 10.1007/s10534-013-9644-0; Stevanovic M, 2012, ENVIRON MICROBIOL, V14, P1655, DOI 10.1111/j.1462-2920.2011.02619.x; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004; Whitton BA, 2000, ECOLOGY CYANOBACTERI, Vxvii; Yang YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S11; Yu CX, 2012, J BACTERIOL, V194, P6372, DOI 10.1128/JB.00262-12; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	84	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151384	10.1371/journal.pone.0151384	http://dx.doi.org/10.1371/journal.pone.0151384			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967347	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200050
J	Smith, BE; Johnston, MK; Lucking, R				Smith, B. Eugene; Johnston, Mark K.; Luecking, Robert			From GenBank to GBIF: Phylogeny-Based Predictive Niche Modeling Tests Accuracy of Taxonomic Identifications in Large Occurrence Data Repositories	PLOS ONE			English	Article							USNEA-LONGISSIMA; DNA BARCODE; SPECIES DISTRIBUTIONS; EPIPHYTIC LICHENS; ALIGNMENT; PERFORMANCE; BIAS; TOOL	Accuracy of taxonomic identifications is crucial to data quality in online repositories of species occurrence data, such as the Global Biodiversity Information Facility (GBIF), which have accumulated several hundred million records over the past 15 years. These data serve as basis for large scale analyses of macroecological and biogeographic patterns and to document environmental changes over time. However, taxonomic identifications are often unreliable, especially for non-vascular plants and fungi including lichens, which may lack critical revisions of voucher specimens. Due to the scale of the problem, restudy of millions of collections is unrealistic and other strategies are needed. Here we propose to use verified, georeferenced occurrence data of a given species to apply predictive niche modeling that can then be used to evaluate unverified occurrences of that species. Selecting the charismatic lichen fungus, Usnea longissima, as a case study, we used georeferenced occurrence records based on sequenced specimens to model its predicted niche. Our results suggest that the target species is largely restricted to a narrow range of boreal and temperate forest in the Northern Hemisphere and that occurrence records in GBIF from tropical regions and the Southern Hemisphere do not represent this taxon, a prediction tested by comparison with taxonomic revisions of Usnea for these regions. As a novel approach, we employed Principal Component Analysis on the environmental grid data used for predictive modeling to visualize potential ecogeographical barriers for the target species; we found that tropical regions conform a strong barrier, explaining why potential niches in the Southern Hemisphere were not colonized by Usnea longissima and instead by morphologically similar species. This approach is an example of how data from two of the most important biodiversity repositories, GenBank and GBIF, can be effectively combined to remotely address the problem of inaccuracy of taxonomic identifications in occurrence data repositories and to provide a filtering mechanism which can considerably reduce the number of voucher specimens that need critical revision, in this case from 4,672 to about 100.	[Smith, B. Eugene; Luecking, Robert] Field Museum, Integrat Res Ctr, Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA; [Smith, B. Eugene; Luecking, Robert] Field Museum, Gantz Family Collect Ctr, Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA; [Johnston, Mark K.] Field Museum, Sci Act Ctr, Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA; [Luecking, Robert] Bot Garden, Konigin Luise Str 6-8, D-14195 Berlin, Germany; [Luecking, Robert] Bot Museum, Konigin Luise Str 6-8, D-14195 Berlin, Germany	Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago)	Lucking, R (corresponding author), Field Museum, Gantz Family Collect Ctr, Sci & Educ, 1400 South Lake Shore Dr, Chicago, IL 60605 USA.; Lucking, R (corresponding author), Bot Garden, Konigin Luise Str 6-8, D-14195 Berlin, Germany.; Lucking, R (corresponding author), Bot Museum, Konigin Luise Str 6-8, D-14195 Berlin, Germany.	rlucking@fieldmuseum.org		Lucking, Robert/0000-0002-3431-4636; Johnston, Mark/0000-0002-2431-7083	National Science Foundation [NSF-EF 1115002, NSF-EF 1115116, NSF-EF 1115210]	National Science Foundation(National Science Foundation (NSF))	This study was conceived as part of a large digitization project of North American lichen and bryophyte collections funded by the National Science Foundation: Digitization TCN Collaborative Research: North American Lichens and Bryophytes: Sensitive Indicators of Environmental Quality and Change (NSF-EF 1115002 to The Field Museum; PI Robert Lucking, co-PI Matt von Konrat; coordinated by NSF-EF 1115116 to the University of Wisconsin-Madison; PI Corinna Gries, co-PI Thomas Nash) and Digitization HUB: A Collections Digitization Framework for the 21st Century (NSF-EF 1115210 to the University of Florida; PI Lawrence Page, co-PIs Bruce MacFadden, Jose Fortes, Pamela Soltis, Gregory Riccardi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097556; Articus K, 2004, TAXON, V53, P925, DOI 10.2307/4135560; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Beaman RS, 2012, ZOOKEYS, P7, DOI 10.3897/zookeys.209.3313; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berendsohn WG, 2010, J BIODIV INFORM, V7, P1; Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Braidwood D, 2012, BOTANY, V90, P1316, DOI 10.1139/b2012-103; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Brodo IM, 2001, LICHENS N AM; Costello MJ, 2013, TRENDS ECOL EVOL, V28, P454, DOI 10.1016/j.tree.2013.05.002; Crisci JV, 2006, SYST BOT, V31, P217, DOI 10.1600/036364406775971859; de Carvalho MR, 2007, EVOL BIOL, V34, P140, DOI 10.1007/s11692-007-9011-6; de Carvalho MR, 2005, SCIENCE, V307, P353; Derr C, 2003, SURVEY PROTOCOLS SUR; Doell J, 2004, B CALIF LICHEN SOC, V11, P37; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellis CJ, 2014, BIOL CONSERV, V180, P153, DOI 10.1016/j.biocon.2014.09.046; ESSEEN PA, 1981, LICHENOLOGIST, V13, P177, DOI 10.1017/S0024282981000224; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gaiji S., 2013, BIODIVERS INFORM, V8, P94; GAMS H., 1961, BERICHTE GEOBOT FORSCHUNGSINST RUBEL ZURICH/32, V32, P167; Garcia-Rosello E, 2015, GLOBAL ECOL BIOGEOGR, V24, P335, DOI 10.1111/geb.12260; Gilbert EE, SYMBIOTA PROMOTING B; Gries Corinna, 2014, Biodivers Data J, pe1114, DOI 10.3897/BDJ.2.e1114; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Halonen P, 1997, GRAPH SCR, V8, P51; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herrera-Campos MA, 1998, BRYOLOGIST, V101, P303; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jansson U, 2010, BIOFOKUS RAPPORT, V36, P1; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Josefsson T, 2005, LICHENOLOGIST, V37, P555, DOI 10.1017/S0024282905015355; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Keon DB, 2002, BRYOLOGIST, V105, P233, DOI 10.1639/0007-2745(2002)105[0233:GOULAA]2.0.CO;2; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kroken S, 2001, MYCOLOGIA, V93, P38, DOI 10.2307/3761604; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lucking R., 2013, DIGITIZATION TAXONOM; Lucking R, 2012, 7 IAL S LICH GEN EC; Lucking R, 2014, P NATL ACAD SCI USA, V111, P11091, DOI 10.1073/pnas.1403517111; Lucking R, 2008, ARCH SCI, V61, P75; McNeill J, 2012, REGNUM VEGETABILE; Moncada B, 2014, FUNGAL DIVERS, V64, P205, DOI 10.1007/s13225-013-0230-0; Nascimbene J, 2009, PLANT BIOSYST, V143, P14, DOI 10.1080/11263500802633188; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Ohmura Y, 2002, J HATTORI BOT LAB, P231; Ohmura Y, 2001, J HATTORI BOT LAB, P1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Rolstad Jorund, 2008, Blyttia, V66, P208; Rolstad J, 2013, BOTANY, V91, P69, DOI 10.1139/cjb-2012-0202; RUNDEL PW, 1978, LICHENOLOGIST, V10, P141, DOI 10.1017/S0024282978000262; Santos AMC, 2010, INSECT CONSERV DIVER, V3, P72, DOI 10.1111/j.1752-4598.2010.00079.x; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schoch CL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau061; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scotland Robert, 2003, Systematics and Biodiversity, V1, P139, DOI 10.1017/S1477200003001178; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Smith CW, 2009, LICHENS GREAT BRITAI, P1046; Smith VS, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.209.3699; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stevens G. N., 1999, BIBLIOTHECA LICHENOL, V72, P1; STEVENS GN, 2004, FLORA AUSTR A, V56, P78; Storaunet KO, 2014, SILVA FENN, V48, P685, DOI 10.14214/sf.949; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Truong C, 2013, LICHENOLOGIST, V45, P505, DOI 10.1017/S0024282913000133; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Vollmar A, 2010, BIODIVERSITY INFORM, V7, P93, DOI DOI 10.17161/BI.V7I2.3992; Walker ER, 1910, PLANT WORLD, V13, P173; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wheeler QD, 2008, SYST ASSOC SPEC VOL, V76, P211; Wirth V, 2013, FLECHTEN DTSCH 1 2	85	20	22	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151232	10.1371/journal.pone.0151232	http://dx.doi.org/10.1371/journal.pone.0151232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967999	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200037
J	Chen, XL; Zhou, B; Luo, YL; Huang, ZQ; Jia, G; Liu, GM; Zhao, H				Chen, Xiaoling; Zhou, Bo; Luo, Yanliu; Huang, Zhiqing; Jia, Gang; Liu, Guangmang; Zhao, Hua			Tissue Distribution of Porcine FTO and Its Effect on Porcine Intramuscular Preadipocytes Proliferation and Differentiation	PLOS ONE			English	Article							OBESITY-ASSOCIATED GENE; FAT-CONTENT; ADIPOSE-TISSUE; QUALITY TRAITS; EXPRESSION; MASS; POLYMORPHISM; ADIPOGENESIS; PURIFICATION; ASSOCIATION	The fat mass and obesity associated (FTO) gene plays an important role in adipogenesis. However, its function during porcine intramuscular preadipocyte proliferation and differentiation remains poorly understood. In this study, we prepared the antiserum against porcine FTO (pFTO), which was used to determine its subcellular localization and tissue distribution. Our data indicated that pFTO was localized predominantly in the nucleus. Real-time quantitative PCR and western blot analysis showed that pFTO was highly expressed in the lung and subcutaneous adipose tissue. Overexpression of pFTO in porcine intramuscular preadipocytes significantly promoted cell proliferation and lipid deposition. Furthermore, overexpression of pFTO in differentiating porcine intramuscular preadipocytes also significantly increased the mRNA levels of adipocyte differentiation transcription factors peroxisome proliferators-activated receptor. (PPAR.), CCAAT/enhancer binding protein a (C/EBPa), lipoprotein lipase (LPL) and fatty acid synthase (FAS). Our findings provide the first functional evidence to reveal a role of pFTO in porcine intramuscular preadipocyte proliferation and differentiation.	[Chen, Xiaoling; Zhou, Bo; Luo, Yanliu; Huang, Zhiqing; Jia, Gang; Liu, Guangmang; Zhao, Hua] Sichuan Agr Univ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University	Chen, XL; Huang, ZQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu 611130, Sichuan, Peoples R China.	xlchen@sicau.edu.cn; zqhuang@sicau.edu.cn			National Natural Science Foundation of China [31201811]; Specific Research Supporting Program for Discipline Construction at Sichuan Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Research Supporting Program for Discipline Construction at Sichuan Agricultural University	This work was supported by the National Natural Science Foundation of China (No. 31201811) (XC) and the Specific Research Supporting Program for Discipline Construction at Sichuan Agricultural University (ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Chen XiaoLing, 2014, Chinese Journal of Animal Nutrition, V26, P3349; Chen XL, 2013, BIOLOGIA, V68, P1010, DOI 10.2478/s11756-013-0240-0; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Du ZQ, 2009, OBESITY, V17, P323, DOI 10.1038/oby.2008.557; Dvorakova V, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-13; Fan B, 2009, ANIM BIOTECHNOL, V20, P58, DOI 10.1080/10495390902800792; Feng Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0592-2; Fernandez X, 1999, MEAT SCI, V53, P59, DOI 10.1016/S0309-1740(99)00037-6; Fontanesi L, 2009, ANIM GENET, V40, P90, DOI 10.1111/j.1365-2052.2008.01777.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu YF, 2013, ASIAN AUSTRAL J ANIM, V26, P1365, DOI 10.5713/ajas.2013.13055; [付言峰 Fu Yanfeng], 2013, [华北农学报, Acta Agriculturae Boreali-Sinica], V28, P128; Gan XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074235; Gardan D, 2006, AM J PHYSIOL-ENDOC M, V291, pE372, DOI 10.1152/ajpendo.00482.2005; Gerbens F, 2001, J ANIM SCI, V79, P347; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; Wang H, 2014, TURK J BIOL, V38, P523, DOI 10.3906/biy-1403-38; Janss LLG, 1997, GENETICS, V145, P395; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Liu XJ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/729197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Ovilo C, 2000, MAMM GENOME, V11, P344, DOI 10.1007/s003350010065; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Szydlowski M, 2012, LIVEST SCI, V150, P397, DOI 10.1016/j.livsci.2012.09.001; Tao X, 2013, CZECH J ANIM SCI, V58, P381, DOI 10.17221/6905-CJAS; van Wijk HJ, 2006, J ANIM SCI, V84, P789, DOI 10.2527/2006.844789x; Wang XX, 2015, BIOCHEM BIOPH RES CO, V459, P201, DOI 10.1016/j.bbrc.2015.02.048; Zhang LF, 2009, J ANIM VET ADV, V8, P2329; Zhang MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133788; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhou B, 2015, TURK J BIOL, V39, P217, DOI 10.3906/biy-1406-2	38	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151056	10.1371/journal.pone.0151056	http://dx.doi.org/10.1371/journal.pone.0151056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964098	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000096
J	Pallis, M; Harvey, T; Russell, N				Pallis, Monica; Harvey, Tamsin; Russell, Nigel			Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation	PLOS ONE			English	Article							MAMMALIAN TARGET; RAPAMYCIN MTOR; GROWTH; BLASTS; CD45; PROLIFERATION; INHIBITION; METABOLISM; 4E-BP1; ROLES	Mechanistic/mammalian target of rapamycin (mTOR) activity drives a number of key metabolic processes including growth and protein synthesis. Inhibition of the mTOR pathway promotes cellular dormancy. Since cells from patients with acute myeloid leukaemia (AML) can be phenotypically dormant (quiescent), we examined biomarkers of their mTOR pathway activity concurrently with Ki-67 and CD71 (indicators of cycling cells) by quantitative flow cytometry. Using antibodies to phosphorylated epitopes of mTOR (S2448) and its downstream targets ribosomal protein S6 (rpS6, S235/236) and 4E-BP1 (T36/45), we documented that these phosphorylations were negligible in lymphocytes, but evident in dormant as well as proliferating subsets of both mobilised normal stem cell harvest CD34+ cells and AML blasts. Although mTOR phosphorylation in AML blasts was lower than that of the normal CD34+ cells, p-4E-BP1 was 2.6-fold higher and p-rpS6 was 22-fold higher. Moreover, in contrast to 4E-BP1, rpS6 phosphorylation was higher in dormant than proliferating AML blasts, and was also higher in the immature CD34+ CD38-blast subset. Data from the Cancer Genome Atlas show that rpS6 expression is associated with that of respiratory chain enzymes in AML. We conclude that phenotypic quiescence markers do not necessarily predict metabolic dormancy and that elevated rpS6 ser235/236 phosphorylation is characteristic of AML.	[Pallis, Monica; Russell, Nigel] Univ Nottingham Hosp, Clin Haematol, Nottingham NG7 2UH, England; [Harvey, Tamsin; Russell, Nigel] Univ Nottingham, Dept Haematol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Pallis, M (corresponding author), Univ Nottingham Hosp, Clin Haematol, Nottingham NG7 2UH, England.	monica.pallis@nottingham.ac.uk			Nottinghamshire Leukaemia Appeal	Nottinghamshire Leukaemia Appeal	This study was supported by Nottinghamshire Leukaemia Appeal, http://www.nlaappeal.org/ (Chair and address, professor John Fletcher, Medical Research Centre, NUH City Hospital Campus, Nottingham NG5 1PB, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; BOROWITZ MJ, 1993, AM J CLIN PATHOL, V100, P534, DOI 10.1093/ajcp/100.5.534; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cargnello M, 2015, MUTAGENESIS, V30, P169, DOI 10.1093/mutage/geu045; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chow S, 2006, EXP HEMATOL, V34, P1183, DOI 10.1016/j.exphem.2006.05.002; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Dieterlen MT, 2012, CYTOM PART B-CLIN CY, V82B, P151, DOI 10.1002/cyto.b.21005; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gerdes J, 1984, Hematol Oncol, V2, P365; GERDES J, 1984, J IMMUNOL, V133, P1710; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guo FK, 2013, HAEMATOLOGICA, V98, P1353, DOI 10.3324/haematol.2012.080424; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hoshii T, 2014, J BIOCHEM, V156, P73, DOI 10.1093/jb/mvu037; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; Lacombe F, 1997, LEUKEMIA, V11, P1878, DOI 10.1038/sj.leu.2400847; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Mony U, 2008, LEUKEMIA, V22, P1395, DOI 10.1038/leu.2008.125; Pallis M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-32; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Perl AE, 2012, CLIN CANCER RES, V18, P1716, DOI 10.1158/1078-0432.CCR-11-2346; RAINER RO, 1995, CYTOMETRY, V22, P139, DOI 10.1002/cyto.990220210; Rosner M, 2011, AMINO ACIDS, V40, P595, DOI 10.1007/s00726-010-0684-2; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shults Keith, 2009, Cancer Manag Res, V1, P49; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063; TAFURI A, 1990, LEUKEMIA, V4, P826; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210	56	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151480	10.1371/journal.pone.0151480	http://dx.doi.org/10.1371/journal.pone.0151480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985829	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300075
J	Rammos, C; Zeus, T; Balzer, J; Kubatz, L; Hendgen-Cotta, UB; Veulemans, V; Hellhammer, K; Totzeck, M; Luedike, P; Kelm, M; Rassaf, T				Rammos, Christos; Zeus, Tobias; Balzer, Jan; Kubatz, Laura; Hendgen-Cotta, Ulrike B.; Veulemans, Verena; Hellhammer, Katharina; Totzeck, Matthias; Luedike, Peter; Kelm, Malte; Rassaf, Tienush			Percutaneous Mitral Valve Repair in Mitral Regurgitation Reduces Cell-Free Hemoglobin and Improves Endothelial Function	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; NITRIC-OXIDE BIOAVAILABILITY; CONTROLLED-TRIAL; MEDIATED VASODILATION; MITRACLIP(R) SYSTEM; VASCULAR FUNCTION; DISEASE; DYSFUNCTION; THERAPY; HEMODIALYSIS	Background and Objective Endothelial dysfunction is predictive for cardiovascular events and may be caused by decreased bioavailability of nitric oxide (NO). NO is scavenged by cell-free hemoglobin with reduction of bioavailable NO up to 70% subsequently deteriorating vascular function. While patients with mitral regurgitation (MR) suffer from an impaired prognosis, mechanisms relating to coexistent vascular dysfunctions have not been described yet. Therapy of MR using a percutaneous mitral valve repair (PMVR) approach has been shown to lead to significant clinical benefits. We here sought to investigate the role of endothelial function in MR and the potential impact of PMVR. Methods and Results Twenty-seven patients with moderate-to-severe MR treated with the MitraClip (R) device were enrolled in an open-label single-center observational study. Patients underwent clinical assessment, conventional echocardiography, and determination of endothelial function by measuring flow-mediated dilation (FMD) of the brachial artery using high-resolution ultrasound at baseline and at 3-month follow-up. Patients with MR demonstrated decompartmentalized hemoglobin and reduced endothelial function (cell-free plasma hemoglobin in heme 28.9 +/- 3.8 mu M, FMD 3.9 +/- 0.9%). Three months post-procedure, PMVR improved ejection fraction (from 41 +/- 3% to 46 +/- 3%, p = 0.03) and NYHA functional class (from 3.0 +/- 0.1 to 1.9 +/- 1.7, p < 0.001). PMVR was associated with a decrease in cell free plasma hemoglobin (22.3 +/- 2.4 mu M, p = 0.02) and improved endothelial functions (FMD 4.8 +/- 1.0%, p < 0.0001). Conclusion We demonstrate here that plasma from patients with MR contains significant amounts of cell-free hemoglobin, which is accompanied by endothelial dysfunction. PMVR therapy is associated with an improved hemoglobin decompartmentalization and vascular function.	[Rammos, Christos; Zeus, Tobias; Balzer, Jan; Kubatz, Laura; Hendgen-Cotta, Ulrike B.; Veulemans, Verena; Hellhammer, Katharina; Totzeck, Matthias; Luedike, Peter; Kelm, Malte; Rassaf, Tienush] Univ Hosp Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, Moorenstr 5, D-40225 Dusseldorf, Germany; [Rammos, Christos; Hendgen-Cotta, Ulrike B.; Totzeck, Matthias; Luedike, Peter; Rassaf, Tienush] Univ Hosp Essen, Fac Med, West German Heart & Vasc Ctr Essen, Dept Cardiol, Hufelandstr 55, D-45147 Essen, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Duisburg Essen	Rassaf, T (corresponding author), Univ Hosp Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, Moorenstr 5, D-40225 Dusseldorf, Germany.; Rassaf, T (corresponding author), Univ Hosp Essen, Fac Med, West German Heart & Vasc Ctr Essen, Dept Cardiol, Hufelandstr 55, D-45147 Essen, Germany.	Tienush.Rassaf@uk-essen.de	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	German Research Foundation (DFG) [RA969/7-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by grants from the German Research Foundation (DFG to TR (RA969/7-2).	Asgar AW, 2015, J AM COLL CARDIOL, V65, P1231, DOI 10.1016/j.jacc.2015.02.009; Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059; Ci HB, 2013, AM J PHYSIOL-ENDOC M, V304, pE695, DOI 10.1152/ajpendo.00016.2013; DREXLER H, 1992, AM J CARDIOL, V69, P1596, DOI 10.1016/0002-9149(92)90710-G; Feldman T, 2005, J AM COLL CARDIOL, V46, P2134, DOI 10.1016/j.jacc.2005.07.065; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Feldman T, 2009, J AM COLL CARDIOL, V54, P686, DOI 10.1016/j.jacc.2009.03.077; Fischer D, 2005, EUR HEART J, V26, P65, DOI 10.1093/eurheartj/ehi001; Franzen O, 2011, EUR J HEART FAIL, V13, P569, DOI 10.1093/eurjhf/hfr029; Giannini C, 2013, EUROPEAN HEART J CAR; Grayburn PA, 2013, CIRCULATION, V128, P1667, DOI 10.1161/CIRCULATIONAHA.112.001039; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Heiss C, 2012, FREE RADICAL BIO MED, V52, P1767, DOI 10.1016/j.freeradbiomed.2012.02.051; Heitzer T, 2005, ARTERIOSCL THROM VAS, V25, P1174, DOI 10.1161/01.ATV.0000166516.52477.81; Hellhammer K, 2015, INT J CARDIOL, V184, P399, DOI 10.1016/j.ijcard.2015.02.081; Hellhammer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111178; Katz SD, 1999, CIRCULATION, V99, P2113, DOI 10.1161/01.CIR.99.16.2113; KATZ SD, 1992, J AM COLL CARDIOL, V19, P918, DOI 10.1016/0735-1097(92)90271-N; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; Mauri L, 2013, J AM COLL CARDIOL, V62, P317, DOI 10.1016/j.jacc.2013.04.030; Meyer C, 2010, J AM COLL CARDIOL, V55, P454, DOI 10.1016/j.jacc.2009.07.068; Moesgaard SG, 2012, J VET INTERN MED, V26, P61, DOI 10.1111/j.1939-1676.2011.00846.x; ONTKEAN M, 1991, CIRC RES, V69, P1088, DOI 10.1161/01.RES.69.4.1088; Patel JB, 2004, J CARD FAIL, V10, P285, DOI 10.1016/j.cardfail.2003.12.006; Patel RP, 2004, FREE RADICAL BIO MED, V36, P399, DOI 10.1016/j.freeradbiomed.2003.11.019; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Rammos C, 2015, DEUT MED WOCHENSCHR, V140, P181, DOI 10.1055/s-0041-100102; Rammos C, 2014, J AM COLL CARDIOL, V63, P1584, DOI 10.1016/j.jacc.2013.08.691; Rammos C, 2013, INT J CARDIOL, V168, P5249, DOI 10.1016/j.ijcard.2013.08.021; Rassaf T, 2006, FREE RADICAL BIO MED, V41, P295, DOI 10.1016/j.freeradbiomed.2006.04.006; Rassaf T, 2016, CLIN J AM SOC NEPHRO, V11, P108, DOI 10.2215/CJN.05560515; Rassaf T, 2015, CATHETER CARDIO INTE, V85, P899, DOI 10.1002/ccd.25705; Rassaf T, 2014, CATHETER CARDIO INTE, V84, pE38, DOI 10.1002/ccd.25570; Rassaf T, 2010, J AM COLL CARDIOL, V55, P1502, DOI 10.1016/j.jacc.2009.10.064; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rossi A, 2011, HEART, V97, P1675, DOI 10.1136/hrt.2011.225789; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Taramasso M, 2012, EUR J CARDIO-THORAC, V42, P920, DOI 10.1093/ejcts/ezs294; Totzeck M, 2012, NITRIC OXIDE-BIOL CH, V27, P75, DOI 10.1016/j.niox.2012.05.003; Tousoulis D, 2005, INT J CARDIOL, V100, P347, DOI 10.1016/j.ijcard.2004.05.030; Vita JA, 2005, HEART, V91, P1278, DOI 10.1136/hrt.2005.061333; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151203	10.1371/journal.pone.0151203	http://dx.doi.org/10.1371/journal.pone.0151203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986059	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300053
J	Saynes-Vasquez, A; Vibrans, H; Vergara-Silva, F; Caballero, J				Saynes-Vasquez, Alfredo; Vibrans, Heike; Vergara-Silva, Francisco; Caballero, Javier			Intracultural Differences in Local Botanical Knowledge and Knowledge Loss among the Mexican Isthmus Zapotecs	PLOS ONE			English	Article							INDIGENOUS KNOWLEDGE; CULTURAL-CHANGE; ETHNOBOTANICAL KNOWLEDGE; NATURAL-RESOURCES; MEDICINAL-PLANTS; MAYA; SIERRA; COMMUNITIES; MANAGEMENT; DIVERSITY	This study reports on the socio-demographic and locality factors that influence ethnobiological knowledge in three communities of Zapotec indigenous people of the Isthmus of Tehuantepec, Mexico. It uses local botanical nomenclature as a proxy for general ethnobiological knowledge. In each of these communities (one urban and two rural), 100 adult men were interviewed aided with a field herbarium. Fifty had a background in farming, and 50 worked in the secondary or tertiary sector as their main economic activity, totaling 300 interviews. Using a field herbarium with samples of 30 common and rare wild regional species, we documented visual recognition, knowledge of the local life form, generic and specific names and uses (five knowledge levels measuring knowledge depth). The relationship between sociodemographic variables and knowledge was analyzed with simple correlations. Differences between the three communities and the five knowledge levels were then evaluated with a discriminant analysis. A general linear analysis identified factors and covariables that influenced the observed differences. Differences between the groups with different economic activities were estimated with a t-test for independent samples. Most of the relationships found between sociodemographic variables and plant knowledge were expected: age and rurality were positively related with knowledge and years of formal schooling was negatively related. However, the somewhat less rural site had more traditional knowledge due to local circumstances. The general linear model explained 70-77% of the variation, a high value. It showed that economic activity was by far the most important factor influencing knowledge, by a factor of five. The interaction of locality and economic activity followed. The discriminant analysis assigned interviewees correctly to their localities in 94% of the cases, strengthening the evidence for intracultural variation. Both sociodemographic and historic intracultural differences heavily influence local knowledge.	[Saynes-Vasquez, Alfredo; Vibrans, Heike] Colegio Postgrad, Postgrad Bot, Campus Montecillo, Montecillo, Texcoco, Mexico; [Vergara-Silva, Francisco; Caballero, Javier] Univ Nacl Autonoma Mexico, Inst Biol, Jardin Bot, Ciudad Univ, Mexico City 04510, DF, Mexico	Colegio de Postgraduados - Mexico; Universidad Nacional Autonoma de Mexico	Vibrans, H (corresponding author), Colegio Postgrad, Postgrad Bot, Campus Montecillo, Montecillo, Texcoco, Mexico.	heike@colpos.mx		Vergara-Silva, Francisco/0000-0001-5024-268X; Vibrans, Heike/0000-0002-1800-4320	Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencias y Tecnologia (CONACyT); National Council of Science and Technology (CONACyT), Mexico;  [172714]	Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencias y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council of Science and Technology (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	The study was financed by grants to the first author for his doctoral and postdoctoral studies from the Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (UNAM) and the Consejo Nacional de Ciencias y Tecnologia (CONACyT); this institution is the national science foundation of Mexico and is funded by the government. There was no other specific funding. The first author file number (which identifies the grants) is 172714. The website is http://www.conacyt.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Ovet Fuentes Trujillo (Juchitan), Andres Sanchez (Ejido Zapata), Victoriano Manuel Gomez, Rubicel Santiago Guerra and Roque Jimenez (Santa Maria Xadani), Octavio Morales and Rogelio de Sales (San Blas Atempa) and finally Juan Luis Sanchez (Ejido Alvaro Obregon) for their hospitality, willingness to share their knowledge, and collaboration with this research. The authors also thank the Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (UNAM) and the National Council of Science and Technology (CONACyT), Mexico, for academic and financial support for the Ph.D. and postdoc studies of the first author. Rafael Torres Colin and Veronica Juarez Jaimes of the MEXU herbarium helped to confirm some plant identifications. Polo Gomez kindly provided assistance with the statistical analysis. Arturo Nava, Kenia Velazco and Patricia Martinez gave valuable support in fieldwork. The Botany Department of the Colegio de Postgraduados, Texcoco, supported the final stages of the paper by hosting the first author for a postdoctoral stay. Finally, the suggestions of the anonymous reviewers improved the manuscript.	Arguello Suarez, 2013, CAMINO TEHUANTEPEC D; Atran S, 2002, CURR ANTHROPOL, V43, P421, DOI 10.1086/339528; Atran S, 1999, P NATL ACAD SCI USA, V96, P7598, DOI 10.1073/pnas.96.13.7598; Ayantunde A, 2008, HUM ECOL, V36, P881, DOI 10.1007/s10745-008-9200-7; Barnard Alan., 2000, HIST THEORY ANTHR; Beltran-Rodriguez L, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-14; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; Berlin B., 1972, LANG SOC, V1, P51, DOI [10.1017/S0047404500006540, DOI 10.1017/S0047404500006540]; BINFORD L, 1985, J LAT AM STUD, V17, P179, DOI 10.1017/S0022216X0000924X; Binford L., 1993, ZAPOTEC STRUGGLES HI; BOSTER JS, 1986, AM ANTHROPOL, V88, P428, DOI 10.1525/aa.1986.88.2.02a00100; Brown C.H., 1981, Journal of Anthropological Research, V37, P61; BURTON M, 1979, AM ANTHROPOL, V81, P841, DOI 10.1525/aa.1979.81.4.02a00050; Camou-Guerrero A, 2008, HUM ECOL, V36, P259, DOI 10.1007/s10745-007-9152-3; Campbell H, 1994, ZAPOTEC RENAISSANCE; Campbell HB, 1989, REV MEX SOCIOL, V51, P247, DOI 10.2307/3540686; Case RJ, 2005, ECON BOT, V59, P356, DOI 10.1663/0013-0001(2005)059[0356:FIMIKA]2.0.CO;2; Cortes-Gonzalez, 2007, THESIS U NACL AUTONO; Cruz S, 1992, ETNIAS DESARROLLO RE; Luna-Jose AD, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-24; Diamond J, 1999, FOLKBIOLOGY, P17; Fernandez MacGregor G., 1954, ISTMO TEHUANTEPEC ES; Frei B, 1998, J APPL BOT-ANGEW BOT, V72, P82; Frei B, 1998, PHYTOMEDICINE, V5, P177, DOI 10.1016/S0944-7113(98)80025-1; Frei B, 2000, ECON BOT, V54, P73, DOI 10.1007/BF02866601; Frei B, 1998, J ETHNOPHARMACOL, V62, P149, DOI 10.1016/S0378-8741(98)00051-8; GARRO LC, 1986, AM ANTHROPOL, V88, P351, DOI 10.1525/aa.1986.88.2.02a00040; Gimenez G., 2007, ESTUDIOS CULTURA IDE; Goodenough WH, 1957, REPORT 7TH ANN ROUND, P167; Hunn E.S., 2001, BIOCULTURAL DIVERSIT; Hunn ES, 2002, ETHNOBIOLOGY BIOCULT; Hunn Eugene, 2008, ZAPOTEC NATURAL HIST; Instituto Nacional de Estadistica y Geografia (INEGI), 2000, 12 CNES GEN POBL VIV; Kakudidi EK, 2004, AFR J ECOL, V42, P57, DOI 10.1111/j.1365-2028.2004.00462.x; Kottak CP, 2004, HUM ORGAN, V63, P501, DOI 10.17730/humo.63.4.g35k2c3t0tpyqgh3; Kuper A, 1999, CULTURE ANTHR ACCOUN; Lizarralde M., 2001, BIOCULTURAL DIVERSIT, P265; Luna-Jose A de L, 2006, THESIS COLEGIO POSTG; Machuca Gallegos L, 2013, REPRESENTADO PASADO; Maffi L, 2005, ANNU REV ANTHROPOL, V34, P599, DOI 10.1146/annurev.anthro.34.081804.120437; Maldonado-Almanza B, 2013, THESIS U NACL AUTONO; Manzo C, 2011, COMUNALIDAD RESISTEN; Marcus J, 2001, CUAD, V7, P5; Marcus Joyce, 1996, ZAPOTEC CIVILIZATION; Marino Flores A, 1963, DISTRIBUCION MUNICIP; Martin G.J., 1995, ETHNOBOTANY METHODS; Martinez-Balleste A, 2006, ECOL SOC, V11; Medin DL, 1999, FOLKBIOLOGY, P1; Messer E., 1978, ZAPOTEC PLANT KNOWLE; Nahmad Salomon., 2014, VISION ACTORES SOCIA; Nazarea V, 1998, HUM ORGAN, V57, P159, DOI 10.17730/humo.57.2.n8844vw5085w71x7; Nesheim I, 2006, HUM ECOL, V34, P99, DOI 10.1007/s10745-005-9004-y; Nguyen MLT, 2003, ECON BOT, V57, P472, DOI 10.1663/0013-0001(2003)057[0472:COFPKB]2.0.CO;2; Norton JB, 1998, J ARID ENVIRON, V39, P331, DOI 10.1006/jare.1998.0397; Ohmagari K, 1997, HUM ECOL, V25, P197, DOI 10.1023/A:1021922105740; Pelto P., 1975, AM ETHNOL, V2, P1, DOI DOI 10.1525/AE.1975.2.1.02A00010; Peterson Royce A, 1975, PRESTIGIO AFILIACION; Pickett V, 1967, HDB MIDDLE AM INDIAN; Pickett V. and collaborators, 1988, VOCABULARIO ZAPOTECO; Reko B., 1945, MITOBOTANICA ZAPOTEC; Ross N, 2002, HUM ORGAN, V61, P125, DOI 10.17730/humo.61.2.9bhqghxvpfh2qebc; Ross N, 2002, LACANDON MAYA INTERG, P585; Saynes-Vasquez A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-40; Saynes-Vazquez FE, 2002, THESIS U ARIZONA; Shenton J, 2011, ETHOS, V39, P349, DOI 10.1111/j.1548-1352.2011.01197.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Thompson RA, 1974, WINDS TOMORROW SOCIA; Toledo A, 1995, GEOPOLITICA DESARROL; Trejo I, 2002, BIODIVERS CONSERV, V11, P2063, DOI 10.1023/A:1020876316013; Turner NJ, 2000, ECOL APPL, V10, P1275, DOI 10.1890/1051-0761(2000)010[1275:TEKAWO]2.0.CO;2; Tylor E.B., 1871, PRIMITIVE CULTURE RE, V6th ed.; Valdes Luz Maria, 1995, INDIOS CENSOS POBLAC; Vandebroek I, 2004, SOC SCI MED, V59, P837, DOI 10.1016/j.socscimed.2003.11.030; Voeks RA, 2004, ECON BOT, V58, pS294, DOI 10.1663/0013-0001(2004)58[S294:FTFAMP]2.0.CO;2; VSSsquez Donato Acuca, 2001, CUADERNOS ANO, V7, P21; Weller S C, 1993, Med Anthropol, V15, P109; Wester Lyndon, 1995, Journal of Ethnobiology, V15, P71; Whitecotton J.W., 1977, ZAPOTECS PRINCES PRI; Yates S, 2004, ECON BOT, V58, P72, DOI 10.1663/0013-0001(2004)058[0072:EKOBAM]2.0.CO;2; Zarger RK, 2004, CURR ANTHROPOL, V45, P413, DOI 10.1086/420908; Zent S, 2001, BIOCULTURAL DIVERSIT, P90; Zent S., 1999, ETHNOECOLOGY KNOWLED, P90	82	17	17	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151693	10.1371/journal.pone.0151693	http://dx.doi.org/10.1371/journal.pone.0151693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26986077	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300113
J	Guerriero, EN; Smith, PM; Stergiou-Kita, M; Colantonio, A				Guerriero, E. Niki; Smith, Peter M.; Stergiou-Kita, Mary; Colantonio, Angela			Rehabilitation Utilization following a Work-Related Traumatic Brain Injury: A Sex-Based Examination of Workers' Compensation Claims in Victoria, Australia	PLOS ONE			English	Article							SERVICE UTILIZATION; HEALTH-CARE; GENDER-DIFFERENCES; MEDICAL-CARE; EPIDEMIOLOGY; DISABILITY; POPULATION; BEHAVIOR; OUTCOMES; TBI	Objectives To report on and examine differences in the use of four types of rehabilitation services (occupational therapy, physiotherapy, psychology, and speech therapy) by men and women following a work-related traumatic brain injury in Victoria, Australia; and to examine the importance of demographic, need, work-related and geographic factors in explaining these differences. Methods A retrospective cohort design was used to analyze 1786 work-related traumatic brain injury workers' compensation claims lodged between 2004 and 2012 in Victoria, Australia. ZINB regressions were conducted for each type of rehabilitation service to examine the relationship between sex and rehabilitation use. Covariates included demographic, need-related, work-related, and geographic factors. Results Out of all claims (63% male, 37% female), 13% used occupational therapy, 23% used physiotherapy, 9% used psychology, and 2% used speech therapy at least once during the first year of service utilization. After controlling for demographic, need-related, work-related, and geographic factors, women were more likely to use physiotherapy compared to men. Men and women were equally likely to use occupational therapy and psychology services. The number of visits in the first year for each type of service did not differ between male and female users. Conclusions Our findings support a sex-based approach to studying rehabilitation utilization in work-related populations. Future research is needed to examine other factors associated with rehabilitation utilization and to determine the implications of different rehabilitation utilization patterns on health and return-to-work outcomes.	[Guerriero, E. Niki; Stergiou-Kita, Mary; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Smith, Peter M.] Inst Work & Hlth, Toronto, ON, Canada; [Smith, Peter M.; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Smith, Peter M.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Stergiou-Kita, Mary; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Stergiou-Kita, Mary; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada	University of Toronto; Institute for Work & Health; University of Toronto; Monash University; University of Toronto; University of Toronto; University Health Network Toronto; Toronto Rehabilitation Institute	Guerriero, EN (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada.	eileennicolina@gmail.com	Smith, Peter/AAE-4293-2021	Smith, Peter/0000-0001-8286-4563; Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health Research [494372]; Research Chair in Gender, Work, & Health from the Canadian Institutes of Health Research [201210CGW]; Transport Accident Commission (TAC); WorkSafe Victoria (WSV); Monash University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Chair in Gender, Work, & Health from the Canadian Institutes of Health Research; Transport Accident Commission (TAC); WorkSafe Victoria (WSV); Monash University(Monash University)	This study, including support for ENG and AC, was funded by the Canadian Institutes of Health Research (#494372). PMS is supported by a Research Chair in Gender, Work, & Health from the Canadian Institutes of Health Research (#201210CGW). The Canadian Institutes of Health Research had no involvement in the study design; collection, analysis, and interpretation of the data; writing of the manuscript; and decision to submit the paper for publication. For more information about the Canadian Institutes of Health Research, go to http://www.cihr-irsc.gc.ca. Data for the analysis conducted uses unit record data from the Compensation Research Database (CRD), which was initiated and funded by the Transport Accident Commission (TAC), WorkSafe Victoria (WSV), and Monash University, and is managed by the Institute for Safety, Compensation, and Recovery Research (ISCRR). The findings and views reported in this paper, however, are those of the authors and should not be attributed to TAC, WSV, or ISCRR. For more information about ISCRR, go to http://www.iscrr.com.au.; The authors would like to thank the staff at the Institute for Safety, Compensation, and Recovery Research for data extraction, and Amber Bielecky for her assistance with SAS programming. Peter M. Smith and Angela Colantonio are both supported by a Research Chair in Gender, Work & Health from the Canadian Institutes of Health Research.	ABS (Australian Bureau of Statistics), 2006, AUSTR NZ STAND IND C; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Australian Bureau of Statistics, 2006, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA, V5; Australian Bureau of Statistics, 2005, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2011, SOCIO EC INDEXES ARE; Australian Safety and Compensation Council, 2008, TYP OCC CLASS SYST, VCanberra: 3rd ed, Revision 1 ed; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Borkhoff CM, 2008, CAN MED ASSOC J, V178, P681, DOI 10.1503/cmaj.071168; Brasure M., 2012, AHRQ PUBLICATION, V12-EHC101-EF; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Collie A, 2013, INJURY, V44, P1514, DOI 10.1016/j.injury.2013.03.006; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Foster M, 2000, BRAIN INJURY, V14, P1035; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Keene J, 2005, J PUBLIC HEALTH-UK, V27, P74, DOI 10.1093/pubmed/fdh208; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS295, DOI 10.1016/j.apmr.2013.08.296; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Menard MR, 1996, J OCCUP ENVIRON MED, V38, P1161, DOI 10.1097/00043764-199611000-00017; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Ruseckaite R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002396; Siqueira FV, 2005, REV SAUDE PUBL, V39, P663, DOI 10.1590/S0034-89102005000400022; The Victorian Neurotrauma Initiative, 2009, EC COST SPIN CORD IN; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327	34	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151462	10.1371/journal.pone.0151462	http://dx.doi.org/10.1371/journal.pone.0151462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982491	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900086
J	Pandey, S; Sharma, A; Tripathi, D; Kumar, A; Khubaib, M; Bhuwan, M; Chaudhuri, TK; Hasnain, SE; Ehtesham, NZ				Pandey, Saurabh; Sharma, Ashish; Tripathi, Deeksha; Kumar, Ashutosh; Khubaib, Mohd; Bhuwan, Manish; Chaudhuri, Tapan Kumar; Hasnain, Seyed Ehtesham; Ehtesham, Nasreen Zafar			Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Also Exhibit Chaperone like Activity In-Vitro and In-Vivo	PLOS ONE			English	Article							CIS-TRANS-ISOMERASES; HEAT-SHOCK-PROTEIN; HYDROPHOBIC SURFACES; ALPHA-CRYSTALLIN; HUMAN RESISTIN; CYCLOPHILIN-A; MACROPHAGES; CELLS; DISEASE; ROLES	Peptidyl-prolyl cis-trans isomerases (Ppiases), also known as cyclophilins, are ubiquitously expressed enzymes that assist in protein folding by isomerization of peptide bonds preceding prolyl residues. Mycobacterium tuberculosis (M.tb) is known to possess two Ppiases, PpiA and PpiB. However, our understanding about the biological significance of mycobacterial Ppiases with respect to their pleiotropic roles in responding to stress conditions inside the macrophages is restricted. This study describes chaperone-like activity of mycobacterial Ppiases. We show that recombinant rPpiA and rPpiB can bind to non-native proteins in vitro and can prevent their aggregation. Purified rPpiA and rPpiB exist in oligomeric form as evident from gel filtration chromatography. E. coli cells overexpressing PpiA and PpiB of M.tb could survive thermal stress as compared to plasmid vector control. HEK293T cells transiently expressing M.tb PpiA and PpiB proteins show increased survival as compared to control cells in response to oxidative stress and hypoxic conditions generated after treatment with H2O2 and CoCl2 thereby pointing to their likely role in adaption under host generated oxidative stress and conditions of hypoxia. The chaperone-like function of these M. tuberculosis cyclophilins may possibly function as a stress responder and consequently contribute to virulence.	[Pandey, Saurabh; Khubaib, Mohd; Bhuwan, Manish; Ehtesham, Nasreen Zafar] Natl Inst Pathol, Inflammat Biol & Cell Signaling Lab, New Delhi, India; [Pandey, Saurabh; Khubaib, Mohd; Hasnain, Seyed Ehtesham] Dr Reddys Inst Life Sci, Univ Hyderabad Campus,Prof CR Rao Rd, Hyderabad, Andhra Pradesh, India; [Sharma, Ashish; Tripathi, Deeksha; Kumar, Ashutosh; Hasnain, Seyed Ehtesham] Indian Inst Technol, Kusuma Sch Biol Sci, Mol Infect & Funct Biol Lab, New Delhi, India; [Chaudhuri, Tapan Kumar] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Ehtesham, NZ (corresponding author), Natl Inst Pathol, Inflammat Biol & Cell Signaling Lab, New Delhi, India.; Hasnain, SE (corresponding author), Dr Reddys Inst Life Sci, Univ Hyderabad Campus,Prof CR Rao Rd, Hyderabad, Andhra Pradesh, India.; Hasnain, SE (corresponding author), Indian Inst Technol, Kusuma Sch Biol Sci, Mol Infect & Funct Biol Lab, New Delhi, India.	seyedhasnain@gmail.com; nzehtesham@gmail.com	ALAM, ANWAR/AAI-3963-2020; EHTESHAM, NASREEN ZAFAR/AAI-3169-2020; Pandey, Saurabh/I-3460-2019; Kumar, Ashutosh/HDN-1519-2022	Kumar, Ashutosh/0000-0002-1699-2951; Pandey, Saurabh/0000-0002-5339-095X; Hasnain, Seyed/0000-0002-2967-0791; Tripathi, Deeksha/0000-0001-7059-5159	UGC/CSIR/ICMR, Government of India (GoI); Department of Biotechnology, GoI, India; Centre of Excellence Grant from the Department of Biotechnology, Ministry of Science and Technology, GoI [BT/PR12817/COE/34/23/2015]	UGC/CSIR/ICMR, Government of India (GoI); Department of Biotechnology, GoI, India; Centre of Excellence Grant from the Department of Biotechnology, Ministry of Science and Technology, GoI	SP, MK, AS and MB thank the UGC/CSIR/ICMR, Government of India (GoI) for the award of Research Fellowship. DT is a recipient of Research Associateship from Department of Biotechnology, GoI, India. This research was supported by Centre of Excellence Grant to SEH and NZE from the Department of Biotechnology, Ministry of Science and Technology, GoI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Ashok Kumar Patel for his help in protein oligomerization study. SP, MK, AS and MB thank the UGC/CSIR/ICMR, Government of India (GoI) for the award of Research Fellowship. DT is a recipient of Research Associateship from Department of Biotechnology, GoI, India. This research was supported by Centre of Excellence Grant (BT/PR12817/COE/34/23/2015) to SEH and NZE from the Department of Biotechnology, Ministry of Science and Technology, GoI.	[Anonymous], 2015, WHO TB REPORT GLOBAL; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banerjee S, 2004, P NATL ACAD SCI USA, V101, P12652, DOI 10.1073/pnas.0404347101; Banerjee S, 2007, J BACTERIOL, V189, P4046, DOI 10.1128/JB.00026-07; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Bhaduri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088090; Bhuwan M, 2016, MBIO IN PRESS; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127668; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Goyal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115877; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Henderson B, 2010, HEAT SHOCK PROTEINS, V4, P185, DOI 10.1007/978-90-481-2976-8_10; Henriksson LM, 2004, EUR J BIOCHEM, V271, P4107, DOI 10.1111/j.1432-1033.2004.04348.x; Huang DD, 2016, J MICROBIOL IMMUNOL, V49, P859, DOI 10.1016/j.jmii.2014.11.008; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Krishnan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085427; Kromina KA, 2008, BIOCHEM MOSC SUPPL S, V2, P195, DOI 10.1134/S199074780803001X; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P62, DOI 10.1038/nri3604; LILIE H, 1993, PROTEIN SCI, V2, P1490, DOI 10.1002/pro.5560020913; Lin CH, 2015, EXP BIOL MED, V240, P403, DOI 10.1177/1535370215570829; Liu TZ, 2014, BIOCHEM BIOPH RES CO, V452, P468, DOI 10.1016/j.bbrc.2014.08.089; Lu KP, 1996, NATURE, V380, P544; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Mark PJ, 2001, CELL STRESS CHAPERON, V6, P59, DOI 10.1379/1466-1268(2001)006<0059:HCIAHS>2.0.CO;2; Mukhopadhyay S, 2007, CURR SIGNAL TRANSD T, V2, P121, DOI 10.2174/157436207780619536; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, P1790, DOI 10.1093/nar/gkg263; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Ow WB, 2001, PROTEIN SCI, V10, P2346, DOI 10.1110/ps.23301; Paul S, 2008, J APPL MICROBIOL, V104, P35, DOI 10.1111/j.1365-2672.2007.03519.x; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Restelli M, 2014, HUM MOL GENET, V23, P3830, DOI 10.1093/hmg/ddu096; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shukla S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004471; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Stebbins CE, 2005, CELL MICROBIOL, V7, P1227, DOI 10.1111/j.1462-5822.2005.00564.x; Suragani M, 2013, P NATL ACAD SCI USA, V110, P20467, DOI 10.1073/pnas.1306145110; Sydenham M, 2000, INFECT IMMUN, V68, P1109, DOI 10.1128/IAI.68.3.1109-1115.2000; SYKES K, 1993, P NATL ACAD SCI USA, V90, P5853, DOI 10.1073/pnas.90.12.5853; Thapar R, 2015, BIOMOLECULES, V5, P974, DOI 10.3390/biom5020974; Triantafyllou A, 2006, FREE RADICAL RES, V40, P847, DOI 10.1080/10715760600730810; Tsurubuchi T, 2014, CHILD NERV SYST, V30, P1343, DOI 10.1007/s00381-014-2428-1; Tundup S, 2014, FEBS OPEN BIO, V4, P822, DOI 10.1016/j.fob.2014.09.001; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Wijeratne SSK, 2005, J AGR FOOD CHEM, V53, P8768, DOI 10.1021/jf0512003; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Yang HM, 1999, PROTEIN SCI, V8, P174; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; Yao QZ, 2005, WORLD J SURG, V29, P276, DOI 10.1007/s00268-004-7812-7; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	67	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150288	10.1371/journal.pone.0150288	http://dx.doi.org/10.1371/journal.pone.0150288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981873	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900032
J	Pilczynska, J; Cocito, S; Boavida, J; Serrao, E; Queiroga, H				Pilczynska, Joanna; Cocito, Silvia; Boavida, Joana; Serrao, Ester; Queiroga, Henrique			Genetic Diversity and Local Connectivity in the Mediterranean Red Gorgonian Coral after Mass Mortality Events	PLOS ONE			English	Article							PARAMURICEA-CLAVATA; LARVAL DISPERSAL; POPULATION-STRUCTURE; COMPUTER-PROGRAM; LIFE-HISTORY; LIGURIAN SEA; RECOVERY; SOFTWARE; RUBRUM; EVOLUTIONARY	Estimating the patterns of connectivity in marine taxa with planktonic dispersive stages is a challenging but crucial task because of its conservation implications. The red gorgonian Paramuricea clavata is a habitat forming species, characterized by short larval dispersal and high reproductive output, but low recruitment. In the recent past, the species was impacted by mass mortality events caused by increased water temperatures in summer. In the present study, we used 9 microsatellites to investigate the genetic structure and connectivity in the highly threatened populations from the Ligurian Sea (NW Mediterranean). No evidence for a recent bottleneck neither decreased genetic diversity in sites impacted by mass mortality events were found. Significant IBD pattern and high global F-ST confirmed low larval dispersal capability in the red gorgonian. The maximum dispersal distance was estimated at 20-60 km. Larval exchange between sites separated by hundreds of meters and between different depths was detected at each site, supporting the hypothesis that deeper subpopulations unaffected by surface warming peaks may provide larvae for shallower ones, enabling recovery after climatically induced mortality events.	[Pilczynska, Joanna; Queiroga, Henrique] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Pilczynska, Joanna; Queiroga, Henrique] Univ Aveiro, CESAM Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Pilczynska, Joanna] Univ Pavia, Dept Earth & Environm Sci, Via Palestro 3, I-27100 Pavia, Italy; [Cocito, Silvia] ENEA, Marine Environm Res Ctr, La Spezia, Italy; [Boavida, Joana; Serrao, Ester] Univ Algarve, CCMAR Ctr Ciencias Mar, Faro, Portugal	Universidade de Aveiro; Universidade de Aveiro; University of Pavia; Italian National Agency New Technical Energy & Sustainable Economics Development; Universidade do Algarve	Pilczynska, J (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.; Pilczynska, J (corresponding author), Univ Aveiro, CESAM Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal.; Pilczynska, J (corresponding author), Univ Pavia, Dept Earth & Environm Sci, Via Palestro 3, I-27100 Pavia, Italy.	jpilczynska@ua.pt	Queiroga, Henrique/C-5134-2008; Serrao, Ester A/C-6686-2012; boavida, joana/M-5744-2013	Queiroga, Henrique/0000-0002-2338-0013; Serrao, Ester A/0000-0003-1316-658X; boavida, joana/0000-0001-5265-2498	Erasmus Mundus Marine Ecosystem Health and Conservation (MARES) doctoral program; Fundacao para a Ciencia e Tecnologia (FCT) under the COMPETE program - European Regional Development Fund [PTDC/BIA-BIC/114526/2009]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BIC/114526/2009] Funding Source: FCT	Erasmus Mundus Marine Ecosystem Health and Conservation (MARES) doctoral program; Fundacao para a Ciencia e Tecnologia (FCT) under the COMPETE program - European Regional Development Fund; Fundação para a Ciência e a Tecnologia	JP was supported by a Ph.D. grant from the Erasmus Mundus Marine Ecosystem Health and Conservation (MARES) doctoral program; http://www.mares-eu.org/. This work is a part of the DiverseShores - Testing associations between genetic and community diversity in European rocky shore environments (PTDC/BIA-BIC/114526/2009) research project, funded by the Fundacao para a Ciencia e Tecnologia (FCT) under the COMPETE program supported by the European Regional Development Fund.	Agell G, 2009, CONSERV GENET, V10, P2025, DOI 10.1007/s10592-009-9885-1; Arizmendi-Mejia R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119585; Arnaud-Haond S, 2009, MAR ECOL PROG SER, V390, P129, DOI 10.3354/meps08183; ASTRALDI M, 1992, J GEOPHYS RES-OCEANS, V97, P9531, DOI 10.1029/92JC00114; Aurelle D, 2010, MOL ECOL RESOUR, V10, P751, DOI 10.1111/j.1755-0998.2010.02871.x; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Belkhir K, 2004, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2005, AQUAT CONSERV, V15, P147, DOI 10.1002/aqc.661; Cerrano C, 2008, CHEM ECOL, V24, P73, DOI 10.1080/02757540801979648; Cerrano C, 2009, ECOL STUD-ANAL SYNTH, V206, P295, DOI 10.1007/978-3-540-92704-4_21; Colson I, 2004, MOL ECOL, V13, P2223, DOI 10.1111/j.1365-294X.2004.02245.x; COMA R, 1995, MAR ECOL PROG SER, V117, P185, DOI 10.3354/meps117185; COMA R, 1995, MAR ECOL PROG SER, V117, P173, DOI 10.3354/meps117173; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Costantini F, 2007, MOL ECOL, V16, P5168, DOI 10.1111/j.1365-294X.2007.03579.x; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; Cupido R, 2008, AQUAT CONSERV, V18, P984, DOI 10.1002/aqc.904; Cupido R, 2012, MAR ECOL PROG SER, V469, P25, DOI 10.3354/meps09976; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gutierrez-Rodriguez C, 2004, MOL ECOL, V13, P2211, DOI 10.1111/j.1365-294X.2004.02247.x; Haza AC, 2010, OCEAN DYNAM, V60, P861, DOI 10.1007/s10236-010-0301-7; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Hughes JM, 2007, FRESHWATER BIOL, V52, P616, DOI 10.1111/j.1365-2427.2006.01722.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Ledoux JB, 2010, MOL ECOL, V19, P675, DOI 10.1111/j.1365-294X.2009.04516.x; Ledoux JB, 2014, 2 S MED CONS COR AUT; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2008, INVERTEBR BIOL, V127, P1, DOI 10.1111/j.1744-7410.2007.00109.x; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Magalon H, 2005, MOL ECOL, V14, P1861, DOI 10.1111/j.1365-294X.2005.02430.x; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Maier E, 2005, MAR BIOL, V147, P1109, DOI 10.1007/s00227-005-0013-6; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; Mokhtar-Jamai K, 2013, ECOL EVOL, V3, P1765, DOI 10.1002/ece3.588; NCSS LLC, 2015, POWER ANAL SAMPLE SI; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Neiva J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-78; OZTURK B, 2004, MARINE ED SERIES, V10; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palumbi SR, 2003, ECOL APPL, V13, pS146; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Peirano A, 2009, P 1 MED S COR OTH CA, P233; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Pujolar JM, 2011, CONSERV GENET, V12, P813, DOI 10.1007/s10592-011-0188-y; Pujolar JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023822; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Romano JC, 2000, CR ACAD SCI III-VIE, V323, P415, DOI 10.1016/S0764-4469(00)00141-4; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santangelo G, 2015, HYDROBIOLOGIA, P1; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	73	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150590	10.1371/journal.pone.0150590	http://dx.doi.org/10.1371/journal.pone.0150590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982334	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900045
J	Schmid, T; Blees, JS; Bajer, MM; Wild, J; Pescatori, L; Crucitti, GC; Scipione, L; Costi, R; Henrich, CJ; Brune, B; Colburn, NH; Di Santo, R				Schmid, Tobias; Blees, Johanna S.; Bajer, Magdalena M.; Wild, Janine; Pescatori, Luca; Crucitti, Giuliana Cuzzucoli; Scipione, Luigi; Costi, Roberta; Henrich, Curtis J.; Bruene, Bernhard; Colburn, Nancy H.; Di Santo, Roberto			Diaryl Disulfides as Novel Stabilizers of Tumor Suppressor Pdcd4	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TRANSLATION INHIBITOR; CELL-DEATH-4; DEGRADATION; EXPRESSION; PROTEIN; TRANSCRIPTION; INFLAMMATION; APOPTOSIS; OXIDATION	The translation inhibitor and tumor suppressor Pdcd4 was reported to be lost in various tumors and put forward as prognostic marker in tumorigenesis. Decreased Pdcd4 protein stability due to PI3K-mTOR-p70(S6K1) dependent phosphorylation of Pdcd4 followed by beta-TrCP1-mediated ubiquitination, and proteasomal destruction of the protein was characterized as a major mechanism contributing to the loss of Pdcd4 expression in tumors. In an attempt to identify stabilizers of Pdcd4, we used a luciferase-based high-throughput compatible cellular assay to monitor phosphorylation-dependent proteasomal degradation of Pdcd4 in response to mitogen stimulation. Following a screen of approximately 2000 compounds, we identified 1,2-bis(4-chlorophenyl)disulfide as a novel Pdcd4 stabilizer. To determine an initial structure-activity relationship, we used 3 additional compounds, synthesized according to previous reports, and 2 commercially available compounds for further testing, in which either the linker between the aryls was modified (compounds 2-4) or the chlorine residues were replaced by groups with different electronic properties (compounds 5 and 6). We observed that those compounds with alterations in the sulfide linker completely lost the Pdcd4 stabilizing potential. In contrast, modifications in the chlorine residues showed only minor effects on the Pdcd4 stabilizing activity. A reporter with a mutated phospho-degron verified the specificity of the compounds for stabilizing the Pdcd4 reporter. Interestingly, the active diaryl disulfides inhibited proliferation and viability at concentrations where they stabilized Pdcd4, suggesting that Pdcd4 stabilization might contribute to the anti-proliferative properties. Finally, computational modelling indicated that the flexibility of the disulfide linker might be necessary to exert the biological functions of the compounds, as the inactive compound appeared to be energetically more restricted.	[Schmid, Tobias; Blees, Johanna S.; Bajer, Magdalena M.; Wild, Janine; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60590 Frankfurt, Germany; [Pescatori, Luca; Crucitti, Giuliana Cuzzucoli; Scipione, Luigi; Costi, Roberta; Di Santo, Roberto] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, Ist Pasteur, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Henrich, Curtis J.] NCI, Mol Targets Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Henrich, Curtis J.] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Colburn, Nancy H.] NCI, Lab Canc Prevent, Ctr Canc Res, Frederick, MD 21702 USA	Goethe University Frankfurt; Fondazione Cenci Bolognetti; Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schmid, T (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60590 Frankfurt, Germany.	T.Schmid@biochem.uni-frankfurt.de	Pescatori, Luca/H-5917-2016; Scipione, Luigi/AAG-8097-2019	Pescatori, Luca/0000-0003-4734-7856; Scipione, Luigi/0000-0002-2006-7005; Di Santo, Roberto/0000-0002-4279-7666; Schmid, Tobias/0000-0002-1952-5259	DFG [GRK1172, SCHM2663/3]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Leidos Biomedical Research, Inc.	DFG(German Research Foundation (DFG)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health; Leidos Biomedical Research, Inc.	This work was supported by the DFG (GRK1172 (MMB) and SCHM2663/3 (TS)). This research was further supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project was also funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Furthermore, Leidos Biomedical Research, Inc., a contractor to the National Cancer Institute, provided support in the form of salaries for one author [CJH]. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Bajer MM, 2014, BIOCHEM PHARMACOL, V88, P313, DOI 10.1016/j.bcp.2014.01.034; Blees JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046567; Blees JS, 2010, J BIOMOL SCREEN, V15, P21, DOI 10.1177/1087057109351028; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Ruano JLG, 2008, GREEN CHEM, V10, P706, DOI 10.1039/b800705e; Gilbert AM, 2006, J MED CHEM, V49, P6027, DOI 10.1021/jm060499t; Grkovic T, 2011, J NAT PROD, V74, P1015, DOI 10.1021/np100918z; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Oba M, 2011, J ORG CHEM, V76, P4173, DOI 10.1021/jo200496r; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; van den Nieuwendijk AMCH, 2004, J MED CHEM, V47, P663, DOI 10.1021/jm030863d; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; White K, 2014, HYPERTENSION, V64, P185, DOI 10.1161/HYPERTENSIONAHA.113.03037; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhao LX, 2011, J NAT PROD, V74, P1990, DOI 10.1021/np200603g	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151643	10.1371/journal.pone.0151643	http://dx.doi.org/10.1371/journal.pone.0151643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982744	gold, Green Published			2022-12-27	WOS:000372574900108
J	Bender, AC; Luikart, BW; Lenck-Santini, PP				Bender, Alex C.; Luikart, Bryan W.; Lenck-Santini, Pierre-Pascal			Cognitive Deficits Associated with Na(v)1.1 Alterations: Involvement of Neuronal Firing Dynamics and Oscillations	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; HIPPOCAMPAL THETA-RHYTHM; REDUCED SODIUM CURRENT; SEPTUM-DIAGONAL BAND; MEDIAL SEPTUM; DRAVET-SYNDROME; MOUSE MODEL; SPATIAL MEMORY; SENSORIMOTOR INTEGRATION; REVERSIBLE INACTIVATION	Brain oscillations play a critical role in information processing and may, therefore, be essential to uncovering the mechanisms of cognitive impairment in neurological disease. In Dravet syndrome (DS), a mutation in SCN1A, coding for the voltage-gated sodium channel Na(v)1.1, is associated with severe cognitive impairment and seizures. While seizure frequency and severity do not correlate with the extent of impairment, the slowing of brain rhythms may be involved. Here we investigate the role of Na(v)1.1 on brain rhythms and cognition using RNA interference. We demonstrate that knockdown of Na(v)1.1 impairs fast-and burst-firing properties of neurons in the medial septum in vivo. The proportion of neurons that fired phase-locked to hippocampal theta oscillations was reduced, and medial septal regulation of theta rhythm was disrupted. During a working memory task, this deficit was characterized by a decrease in theta frequency and was negatively correlated with performance. These findings suggest a fundamental role for Na(v)1.1 in facilitating fast-firing properties in neurons, highlight the importance of precise temporal control of theta frequency for working memory, and imply that Na(v)1.1 deficits may disrupt information processing in DS via a dysregulation of brain rhythms.	[Bender, Alex C.] Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH USA; [Luikart, Bryan W.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA; [Lenck-Santini, Pierre-Pascal] Univ Vermont, Dept Neurol Sci, Burlington, VT USA; [Lenck-Santini, Pierre-Pascal] INSERM, Inst Neurobiol Mediterranee, F-13258 Marseille, France	Dartmouth College; Dartmouth College; University of Vermont; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lenck-Santini, PP (corresponding author), Univ Vermont, Dept Neurol Sci, Burlington, VT USA.; Lenck-Santini, PP (corresponding author), INSERM, Inst Neurobiol Mediterranee, F-13258 Marseille, France.	pierre-pascal.lenck-santini@inserm.fr	lenck-santini, pierre-pascal/N-3662-2016	lenck-santini, pierre-pascal/0000-0001-9925-9220; Luikart, Bryan/0000-0002-3181-6075	National Institutes of Health [F31NS077537, R01MH097949, R01NS076763]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077537, R01NS076763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health to ACB (F31NS077537), BWL (R01MH097949), and PPLS (R01NS076763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hangya B, 2009, J NEUROSCI, V29, P8094, DOI 10.1523/JNEUROSCI.5665-08.2009; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bender AC, 2013, NEUROBIOL DIS, V54, P297, DOI 10.1016/j.nbd.2012.12.021; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; BLAND BH, 1993, PROG NEUROBIOL, V41, P157, DOI 10.1016/0301-0082(93)90007-F; Bland BH, 1999, J NEUROSCI, V19, P3223; Buard I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00742; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Caplan JB, 2003, J NEUROSCI, V23, P4726; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Colom LV, 2005, SYNAPSE, V58, P151, DOI 10.1002/syn.20184; Doesburg SM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00785; Dravet C, 2006, ADV NEUROL, P89; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; Dwyer TA, 2007, J NEUROSCI, V27, P299, DOI 10.1523/JNEUROSCI.4189-06.2007; Fisher NI, 1995, STAT ANAL CIRCULAR D; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Genton P, 2011, EPILEPSIA, V52, P44, DOI 10.1111/j.1528-1167.2011.03001.x; GIVENS B, 1994, J NEUROSCI, V14, P3578; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Gupta AS, 2012, NAT NEUROSCI, V15, P1032, DOI 10.1038/nn.3138; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Harkin LA, 2007, BRAIN, V130, P843, DOI 10.1093/brain/awm002; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Holmes GL, 2012, BRAIN DEV-JPN, V34, P469, DOI 10.1016/j.braindev.2011.08.009; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kalume F, 2007, J NEUROSCI, V27, P11065, DOI 10.1523/JNEUROSCI.2162-07.2007; KELSEY JE, 1993, BEHAV NEUROSCI, V107, P565, DOI 10.1037/0735-7044.107.4.565; King C, 1998, EUR J NEUROSCI, V10, P464, DOI 10.1046/j.1460-9568.1998.00026.x; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Manseau F, 2005, J PHYSIOL-LONDON, V566, P865, DOI 10.1113/jphysiol.2005.089664; Marini C, 2011, EPILEPSIA, V52, P24, DOI 10.1111/j.1528-1167.2011.02997.x; MARKRAM H, 1990, BRAIN RES, V513, P171, DOI 10.1016/0006-8993(90)91106-Q; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Nabbout R, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-176; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331; Ohmori I, 2002, BIOCHEM BIOPH RES CO, V295, P17, DOI 10.1016/S0006-291X(02)00617-4; OHTSUKA Y, 1991, JPN J PSYCHIAT NEUR, V45, P416; Pang KCH, 2011, HIPPOCAMPUS, V21, P835, DOI 10.1002/hipo.20799; Papale LA, 2013, EPILEPSIA, V54, P625, DOI 10.1111/epi.12060; POUCET B, 1994, HIPPOCAMPUS, V4, P315, DOI 10.1002/hipo.450040315; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ragona F, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2011.03000.x; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Richard GR, 2013, HIPPOCAMPUS, V23, P1269, DOI 10.1002/hipo.22164; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Simon AP, 2006, J NEUROSCI, V26, P9038, DOI 10.1523/JNEUROSCI.1401-06.2006; SMYTHE JW, 1991, J NEUROSCI, V11, P2241; Sotty F, 2003, J PHYSIOL-LONDON, V551, P927, DOI 10.1113/jphysiol.2003.046847; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; VERTES RP, 1993, EXP BRAIN RES, V96, P419; Villette V, 2010, J NEUROSCI, V30, P10991, DOI 10.1523/JNEUROSCI.6284-09.2010; Vinogradova O S, 1998, Membr Cell Biol, V11, P715; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Walsh TJ, 1998, BEHAV NEUROSCI, V112, P1114, DOI 10.1037/0735-7044.112.5.1114; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wolff M, 2006, EPILEPSIA, V47, P45, DOI 10.1111/j.1528-1167.2006.00688.x; Womelsdorf T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00210; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	70	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151538	10.1371/journal.pone.0151538	http://dx.doi.org/10.1371/journal.pone.0151538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978272	gold, Green Published, Green Submitted			2022-12-27	WOS:000372572800084
J	Cremers, N; Neeb, A; Uhle, T; Dimmler, A; Rothley, M; Allgayer, H; Fodde, R; Sleeman, JP; Thiele, W				Cremers, Natascha; Neeb, Antje; Uhle, Tanja; Dimmler, Arno; Rothley, Melanie; Allgayer, Heike; Fodde, Riccardo; Sleeman, Jonathan Paul; Thiele, Wilko			CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC MARKER; COLORECTAL-CANCER; OVARIAN-CANCER; EXPRESSION; CELLS; IDENTIFICATION; CARCINOMA; MOLECULE; DISEASE; DIFFERENTIATION	CD24 is a small, heavily glycosylated, GPI-linked membrane protein, whose expression has been associated with the tumorigenesis and progression of several types of cancer. Here, we studied the expression of CD24 in tumors of MMTV-PyMT, Apc(1572/T+) and TRAMP genetic mouse models that spontaneously develop mammary or prostate carcinoma, respectively. We found that CD24 is expressed during tumor development in all three models. In MMTV-PyMT and Apc(1572T/+) breast tumors, CD24 was strongly but heterogeneously expressed during early tumorigenesis, but decreased in more advanced stages, and accordingly was increased in poorly differentiated lesions compared with well differentiated lesions. In prostate tumors developing in TRAMP mice, CD24 expression was strong within hyperplastic lesions in comparison with non-hyperplastic regions, and heterogeneous CD24 expression was maintained in advanced prostate carcinomas. To investigate whether CD24 plays a functional role in tumorigenesis in these models, we crossed CD24 deficient mice with MMTV-PyMT, Apc(1572T/+) and TRAMP mice, and assessed the influence of CD24 deficiency on tumor onset and tumor burden. We found that mice negative or positive for CD24 did not significantly differ in terms of tumor initiation and burden in the genetic tumor models tested, with the exception of Apc(1572T/+) mice, in which lack of CD24 reduced the mammary tumor burden slightly but significantly. Together, our data suggest that while CD24 is distinctively expressed during the early development of murine mammary and prostate tumors, it is not essential for the formation of tumors developing in MMTV-PyMT, Apc(1572T/+) and TRAMP mice.	[Cremers, Natascha; Uhle, Tanja; Rothley, Melanie; Allgayer, Heike; Sleeman, Jonathan Paul; Thiele, Wilko] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany; [Cremers, Natascha; Neeb, Antje; Uhle, Tanja; Rothley, Melanie; Sleeman, Jonathan Paul; Thiele, Wilko] Karlsruhe Inst Technol, Inst Toxikol & Genet, D-76021 Karlsruhe, Germany; [Dimmler, Arno] St Vincentiuskliniken Karlsruhe, Inst & Gemeinschaftspraxis Pathol, Karlsruhe, Germany; [Fodde, Riccardo] Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Thiele, W (corresponding author), Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany.; Thiele, W (corresponding author), Karlsruhe Inst Technol, Inst Toxikol & Genet, D-76021 Karlsruhe, Germany.	wilko.thiele@medma.uni-heidelberg.de	Fodde, Riccardo/AAW-9394-2021; Sleeman, Jonathan P/H-2515-2013; Thiele, Wilko/AAF-7856-2020	Fodde, Riccardo/0000-0001-9839-4324; Sleeman, Jonathan P/0000-0003-1718-7687; Thiele, Wilko/0000-0002-8978-4192; Neeb, Antje/0000-0002-6516-2938	BMBF NGFN2 CancerNet Programme [N1KR-S21T28]; European Union (FP7 collaborative project TuMIC) [HEALTH-F2-2008-201662]; Wilhelm Sander Foundation, Munich, Germany [2012.036.1]	BMBF NGFN2 CancerNet Programme(Federal Ministry of Education & Research (BMBF)); European Union (FP7 collaborative project TuMIC); Wilhelm Sander Foundation, Munich, Germany	Funding provided by BMBF NGFN2 CancerNet Programme N1KR-S21T28, http://www.bmbf.de/en/index.php; European Union (FP7 collaborative project TuMIC, contract no. HEALTH-F2-2008-201662), http://ec.europa.eu/research/fp7/index_en.cfm; Wilhelm Sander Foundation, Munich, Germany 2012.036.1, http://www.sanst.de/cms/front_content.php?idcat=1&lang=1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MAH, 2012, BREAST CANCER RES TR, V133, P979, DOI 10.1007/s10549-011-1865-8; Ahmed MAH, 2010, INFLAMM BOWEL DIS, V16, P795, DOI 10.1002/ibd.21134; Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Baumann P, 2012, CELL MOL LIFE SCI, V69, P435, DOI 10.1007/s00018-011-0756-9; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Bircan S, 2006, PATHOL RES PRACT, V202, P569, DOI 10.1016/j.prp.2006.05.004; Bretz N, 2012, CLIN EXP METASTAS, V29, P27, DOI 10.1007/s10585-011-9426-4; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Coombs GS, 2012, ONCOGENE, V31, P213, DOI 10.1038/onc.2011.228; Cremers N, 2010, CELL MOL LIFE SCI, V67, P2311, DOI 10.1007/s00018-010-0342-6; Duckworth CA, 2012, AM J PHYSIOL-GASTR L, V303, pG915, DOI 10.1152/ajpgi.00068.2012; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Ghazvini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073872; Gingrich JR, 1996, CANCER RES, V56, P4096; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hernandez-Campo PM, 2007, CYTOM PART B-CLIN CY, V72B, P34, DOI 10.1002/cyto.b.20143; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Israel E, 2005, CELL IMMUNOL, V236, P171, DOI 10.1016/j.cellimm.2005.08.026; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; KAY R, 1990, J IMMUNOL, V145, P1952; KAY R, 1991, J IMMUNOL, V147, P1412; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Kristiansen G, 2004, PROSTATE, V58, P183, DOI 10.1002/pros.10324; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Kristiansen G, 2010, LAB INVEST, V90, P1102, DOI 10.1038/labinvest.2010.70; Kuch V, 2013, INT J CANCER, V132, pE94, DOI 10.1002/ijc.27785; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li O, 2006, J EXP MED, V203, P1713, DOI 10.1084/jem.20052293; Lim SC, 2005, PATHOL RES PRACT, V201, P479, DOI 10.1016/j.prp.2005.05.004; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; Lu LW, 2000, EUR J IMMUNOL, V30, P2686, DOI 10.1002/1521-4141(200009)30:9<2686::AID-IMMU2686>3.0.CO;2-F; Ma J, 2012, TUMOR BIOL, V33, P1983, DOI 10.1007/s13277-012-0458-4; Monteiro J, 2014, CARCINOGENESIS, V35, P2, DOI 10.1093/carcin/bgt279; Muppala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059563; Nagy B, 2009, PATHOL ONCOL RES, V15, P279, DOI 10.1007/s12253-008-9077-1; Naumov I, 2014, INT J CANCER, V135, P1048, DOI 10.1002/ijc.28762; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Overdevest JB, 2012, P NATL ACAD SCI USA, V109, pE3588, DOI 10.1073/pnas.1113960109; Petkova N, 2013, PROSTATE, V73, P1576, DOI 10.1002/pros.22708; Poncet C, 1996, ACTA NEUROPATHOL, V91, P400, DOI 10.1007/s004010050442; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schostak M, 2006, BMC Urol, V6, P7, DOI 10.1186/1471-2490-6-7; Shewan D, 1996, J NEUROSCI, V16, P2624; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Sleeman JP, 2007, CLIN EXP METASTAS, V24, P707, DOI 10.1007/s10585-007-9122-6; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Surowiak P, 2006, BRIT J CANCER, V95, P339, DOI 10.1038/sj.bjc.6603254; Tani Y, 2005, VET PATHOL, V42, P306, DOI 10.1354/vp.42-3-306; Thaxton JE, 2014, J IMMUNOL, V192, P5679, DOI 10.4049/jimmunol.1302755; Toubai T, 2014, BLOOD, V123, P3512, DOI 10.1182/blood-2013-12-545335; Wang LZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6909; Weichert W, 2005, CLIN CANCER RES, V11, P6574, DOI 10.1158/1078-0432.CCR-05-0606; WENGER RH, 1991, EUR J IMMUNOL, V21, P1039, DOI 10.1002/eji.1830210427; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	66	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151468	10.1371/journal.pone.0151468	http://dx.doi.org/10.1371/journal.pone.0151468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978528	Green Submitted, gold, Green Published			2022-12-27	WOS:000372572800077
J	Kugler, P				Kuegler, Philipp			Early Afterdepolarizations with Growing Amplitudes via Delayed Subcritical Hopf Bifurcations and Unstable Manifolds of Saddle Foci in Cardiac Action Potential Dynamics	PLOS ONE			English	Article							GENESIS; MODEL; REPOLARIZATION; TRANSIENT; MYOCYTES	Early afterdepolarizations (EADs) are pathological oscillations in cardiac action potentials during the repolarization phase and may be caused by drug side effects, ion channel disease or oxidative stress. The most widely observed EAD pattern is characterized by oscillations with growing amplitudes. So far, its occurence has been explained in terms of a supercritical Hopf bifurcation in the fast subsystem of the action potential dynamics from which stable limit cycles with growing amplitudes emerge. The novel contribution of this article is the introduction of two alternative explanations of EAD genesis with growing amplitudes that do not involve stable limit cycles in fast subsystems. In particular, we demonstrate that EAD patterns with growing amplitudes may alternatively arise due to a delayed subcritical Hopf bifurcation or an unstable manifold of a saddle focus fixed point in the full fast-slow system modelling the action potential. Our work extends the list of possible dynamical EAD mechanisms and may contribute to a classification of drug effects in preclinical cardiotoxicity testing.	[Kuegler, Philipp] Univ Hohenheim, Inst Appl Math & Stat, Schloss 1, D-70599 Stuttgart, Germany; [Kuegler, Philipp] Radon Inst Computat & Appl Math, Res Grp Math Methods Mol & Syst Biol, Altenbergerstr 69, A-4040 Linz, Austria	University Hohenheim	Kugler, P (corresponding author), Univ Hohenheim, Inst Appl Math & Stat, Schloss 1, D-70599 Stuttgart, Germany.; Kugler, P (corresponding author), Radon Inst Computat & Appl Math, Res Grp Math Methods Mol & Syst Biol, Altenbergerstr 69, A-4040 Linz, Austria.	philipp.kuegler@uni-hohenheim.de						Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Engl HW, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123014; Fermini B, 2003, NAT REV DRUG DISCOV, V2, P439, DOI 10.1038/nrd1108; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Karagueuzian HS, 2013, AM J CARDIOVASC DIS, V3, P1; Krogh-Madsen T, 2012, ANNU REV BIOMED ENG, V14, P179, DOI [10.1146/annurev-bioeng-071811-150106, 10.1146/annurev.bioeng-071811-150106]; Kuegler P, 2012, SIAM J APPL MATH, V72, P982, DOI 10.1137/110834780; Kuehn C, 2015, MULTIPLE TIME SCALE, V191; Kuznetsov Y.A., 2013, ELEMENTS APPL BIFURC, V112; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Martin CA, 2012, HEART, V98, P536, DOI 10.1136/heartjnl-2011-300953; MATLAB, 2014, MATLAB VERS 8 3 0 53; NEISHTADT AI, 1987, DIFF EQUAT+, V23, P1385; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Paci M, 2013, ANN BIOMED ENG, V41, P2334, DOI 10.1007/s10439-013-0833-3; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Sato D, 2010, BIOPHYS J, V99, P765, DOI 10.1016/j.bpj.2010.05.019; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Shilnikov A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056214; Shilnikov L. P., 1968, MAT SB, V77, P461, DOI 10.1070/SM1968v006n03ABEH001069; Song Z, 2015, BIOPHYS J, V108, P1908, DOI 10.1016/j.bpj.2015.03.011; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; WANG XJ, 1993, PHYSICA D, V62, P263, DOI 10.1016/0167-2789(93)90286-A; Wisniowska B, 2014, EUROPACE, V16, P724, DOI 10.1093/europace/euu009; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; Xie YF, 2014, BIOPHYS J, V106, P1391, DOI 10.1016/j.bpj.2013.12.050	27	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151178	10.1371/journal.pone.0151178	http://dx.doi.org/10.1371/journal.pone.0151178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977805	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800049
J	Sakai, JT; Dalwani, MS; Mikulich-Gilbertson, SK; McWilliams, SK; Raymond, KM; Crowley, TJ				Sakai, Joseph T.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; McWilliams, Shannon K.; Raymond, Kristen M.; Crowley, Thomas J.			A Behavioral Measure of Costly Helping: Replicating and Extending the Association with Callous Unemotional Traits in Male Adolescents	PLOS ONE			English	Article							COMORBIDITY SURVEY REPLICATION; PROSOCIAL EMOTIONS SPECIFIER; CONDUCT DISORDER; ANTISOCIAL-BEHAVIOR; SEX-DIFFERENCES; SUBSTANCE USE; PSYCHOPATHIC TENDENCIES; DIAGNOSTIC INTERVIEW; CHARITABLE DONATIONS; MORAL ELEVATION	Background Some conduct-disordered youths have high levels of callous unemotional traits and meet the DSM-5's "with limited prosocial emotions" (LPE) specifier. These youths often do aggressive, self-benefitting acts that cost others. We previously developed a task, the AlAn's game, which asks participants to repeatedly decide whether to accept or reject offers in which they will receive money but a planned charity donation will be reduced. In our prior work, more "costly helping" (i.e., rejecting the offered money and protecting the donation) was associated with lower callous unemotional traits. Here we extend that prior work in a larger sample of adolescent male patients with serious conduct problems and controls, and test whether this association is mediated specifically by a Moral Elevation response (i.e., a positive emotional response to another's act of virtue). Methods The adolescent male participants were: 45 patients (23 with LPE) and 26 controls, who underwent an extensive phenotypic assessment including a measure of Moral Elevation. About 1 week later participants played the AlAn's game. Results All AlAn's game outcomes demonstrated significant group effects: (1) money taken for self (p = 0.02); (2) money left in the charitable donation (p = 0.03); and, (3) costly helping (p = 0.047). Controls took the least money and did the most costly helping, while patients with LPE took the most money and did the least costly helping. Groups also significantly differed in post-stimulus Moral Elevation scores (p = 0.005). Exploratory analyses supported that the relationship between callous unemotional traits and costly helping on the AlAn's game may be mediated in part by differences in Moral Elevation. Conclusions The AlAn's game provides a standardized behavioral measure associated with callous unemotional traits. Adolescents with high levels of callous unemotional traits engage in fewer costly helping behaviors, and those differences may be related to blunting of positive emotional responses.	[Sakai, Joseph T.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; McWilliams, Shannon K.; Raymond, Kristen M.; Crowley, Thomas J.] Univ Colorado, Sch Med, Dept Psychiat, Div Substance Dependence, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Sakai, JT (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Div Substance Dependence, Denver, CO 80262 USA.	Joseph.sakai@ucdenver.edu	Sakai, Joseph/AAH-5984-2020	Sakai, Joseph/0000-0003-1600-6100	National Institute of Drug Abuse (NIDA) [DA031761]; Kane Family Foundation; Hewit Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034604, R01DA031761] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Kane Family Foundation; Hewit Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Drug Abuse (NIDA) grant DA031761, the Kane Family Foundation and the Hewit Family Foundation. Dr. Mikulich-Gilbertson's time is also supported by DA034604.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Aharoni E, 2012, J ABNORM PSYCHOL, V121, P484, DOI 10.1037/a0024796; Algoe SB, 2009, J POSIT PSYCHOL, V4, P105, DOI 10.1080/17439760802650519; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Anderson Nathaniel E, 2014, Curr Top Behav Neurosci, V17, P369, DOI 10.1007/7854_2013_257; [Anonymous], 1991, MANUAL CHILD BEHAV C; Aquino K, 2011, J PERS SOC PSYCHOL, V100, P703, DOI 10.1037/a0022540; Armstrong TD, 2002, J CONSULT CLIN PSYCH, V70, P1224, DOI 10.1037/0022-006X.70.6.1224; Baum K, 2005, JUVENILE VICTIMIZATI; Black DW, 1996, PSYCHOSOMATICS, V37, P131, DOI 10.1016/S0033-3182(96)71579-7; Blair RJR, 2014, NEW ENGL J MED, V371, P2207, DOI 10.1056/NEJMra1315612; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Blair RJR, 2005, J CHILD PSYCHOL PSYC, V46, P327, DOI 10.1111/j.1469-7610.2004.00356.x; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; Blair RJR, 1997, PSYCHOPHYSIOLOGY, V34, P192; Carlo G, 2014, J ADOLESCENCE, V37, P359, DOI 10.1016/j.adolescence.2014.02.009; Cohen M, 2009, J QUANT CRIMINOL, V25, P25, DOI 10.1007/s10940-008-9057-3; Coker KL, 2014, J AM ACAD CHILD PSY, V53, P888, DOI 10.1016/j.jaac.2014.05.007; Colins OF, 2015, LAW HUMAN BEHAV, V39, P198, DOI 10.1037/lhb0000108; COTTLER LB, 1995, DRUG ALCOHOL DEPEN, V38, P59, DOI 10.1016/0376-8716(94)01091-X; Crowley TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132322; Crowley TJ, 2006, J AM ACAD CHILD PSY, V45, P175, DOI 10.1097/01.chi.0000188893.60551.31; Crowley TJ, 2001, J AM ACAD CHILD PSY, V40, P265, DOI 10.1097/00004583-200103000-00005; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Eckel CC, 1996, GAME ECON BEHAV, V16, P181, DOI 10.1006/game.1996.0081; EISENBERG N, 1995, CHILD DEV, V66, P1179, DOI 10.1111/j.1467-8624.1995.tb00930.x; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; EME RF, 1995, J CLIN CHILD PSYCHOL, V24, P406, DOI 10.1207/s15374424jccp2404_5; Eme RF, 2007, CLIN PSYCHOL REV, V27, P607, DOI 10.1016/j.cpr.2007.02.001; Englander ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039384; Essau CA, 2006, ASSESSMENT, V13, P454, DOI 10.1177/1073191106287354; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Freeman D, 2009, PERS SOC PSYCHOL B, V35, P72, DOI 10.1177/0146167208325415; Frick P.J., 2004, INVENTORY CALLOUS UN, DOI DOI 10.1037/T62639-000; Frick PJ, 2008, J CHILD PSYCHOL PSYC, V49, P359, DOI 10.1111/j.1469-7610.2007.01862.x; Frick PJ, 2003, J ABNORM CHILD PSYCH, V31, P457, DOI 10.1023/A:1023899703866; Frick PJ, 2010, PROPOSAL DSM 5 CHILD; Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204; Glenn AL, 2009, MOL PSYCHIATR, V14, P909, DOI 10.1038/mp.2009.76; Haidt J, 2003, FLOURISHING: POSITIVE PSYCHOLOGY AND THE LIFE WELL-LIVED, P275, DOI 10.1037/10594-012; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Hogstrom J, 2013, J FAM PSYCHOL, V27, P314, DOI 10.1037/a0031883; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Hopfer C, 2013, J AM ACAD CHILD PSY, V52, P511, DOI 10.1016/j.jaac.2013.02.014; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Kimonis ER, 2015, J CHILD PSYCHOL PSYC, V56, P1249, DOI 10.1111/jcpp.12357; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Konner M, 2015, NEW ENGL J MED, V372, P784, DOI 10.1056/NEJMc1415936; Lahey BB, 2014, PSYCHOL BULL, V140, P58, DOI 10.1037/a0033387; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Manders WA, 2013, J ABNORM CHILD PSYCH, V41, P1121, DOI 10.1007/s10802-013-9749-5; MARTIN RL, 1985, ARCH GEN PSYCHIAT, V42, P58; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; NEWMAN JP, 1987, J ABNORM PSYCHOL, V96, P145, DOI 10.1037/0021-843X.96.2.145; Nock MK, 2006, PSYCHOL MED, V36, P699, DOI 10.1017/S0033291706007082; OBrien BS, 1996, J ABNORM CHILD PSYCH, V24, P223, DOI 10.1007/BF01441486; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Przepiorka W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0247; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; RYDELIUS PA, 1988, ACTA PSYCHIAT SCAND, V77, P398, DOI 10.1111/j.1600-0447.1988.tb05141.x; Sakai JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036158; SAWYER J, 1966, AM J SOCIOL, V71, P407, DOI 10.1086/224129; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Steiner H, 1997, J AM ACAD CHILD PSY, V36, P1482, DOI 10.1097/00004583-199710000-00037; Tassy S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00229; Teplin LA, 2014, PEDIATRICS, V134, P63, DOI 10.1542/peds.2013-3966; Thurstone C, 2013, AM J ADDICTION, V22, P558, DOI 10.1111/j.1521-0391.2013.12064.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wasserman GA, 2002, J AM ACAD CHILD PSY, V41, P314, DOI 10.1097/00004583-200203000-00011; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wrangham D, 1996, DEMONIC MALES APES O; ZOCCOLILLO M, 1991, J AM ACAD CHILD PSY, V30, P973, DOI 10.1097/00004583-199111000-00016	77	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151678	10.1371/journal.pone.0151678	http://dx.doi.org/10.1371/journal.pone.0151678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977935	Green Published, gold			2022-12-27	WOS:000372572800098
J	Zhou, K; Motamed, S; Thouas, GA; Bernard, CC; Li, D; Parkington, HC; Coleman, HA; Finkelstein, DI; Forsythe, JS				Zhou, Kun; Motamed, Sepideh; Thouas, George A.; Bernard, Claude C.; Li, Dan; Parkington, Helena C.; Coleman, Harold A.; Finkelstein, David I.; Forsythe, John S.			Graphene Functionalized Scaffolds Reduce the Inflammatory Response and Supports Endogenous Neuroblast Migration when Implanted in the Adult Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; INJURED BRAIN; PEPTIDE; NEURONS; OXIDE; DIFFERENTIATION; CYTOTOXICITY; REGENERATION	Electroactive materials have been investigated as next-generation neuronal tissue engineering scaffolds to enhance neuronal regeneration and functional recovery after brain injury. Graphene, an emerging neuronal scaffold material with charge transfer properties, has shown promising results for neuronal cell survival and differentiation in vitro. In this in vivo work, electrospun microfiber scaffolds coated with self-assembled colloidal graphene, were implanted into the striatum or into the subventricular zone of adult rats. Microglia and astrocyte activation levels were suppressed with graphene functionalization. In addition, self-assembled graphene implants prevented glial scarring in the brain 7 weeks following implantation. Astrocyte guidance within the scaffold and redirection of neuroblasts from the subventricular zone along the implants was also demonstrated. These findings provide new functional evidence for the potential use of graphene scaffolds as a therapeutic platform to support central nervous system regeneration.	[Zhou, Kun; Motamed, Sepideh; Li, Dan; Forsythe, John S.] Monash Univ, Monash Inst Med Engn, Dept Mat Sci & Engn, Melbourne, Vic 3004, Australia; [Zhou, Kun; Bernard, Claude C.] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia; [Parkington, Helena C.; Coleman, Harold A.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Thouas, George A.] Monash Univ, Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Zhou, Kun; Finkelstein, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Monash University; Australian Regenerative Medicine Institute; Monash University; Monash University; Hudson Institute of Medical Research; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Forsythe, JS (corresponding author), Monash Univ, Monash Inst Med Engn, Dept Mat Sci & Engn, Melbourne, Vic 3004, Australia.	john.forsythe@monash.edu	Wang, Huanting/G-8399-2011; Finkelstein, David/B-9617-2009; Li, Dan/B-9316-2008	Wang, Huanting/0000-0002-9887-5555; Finkelstein, David/0000-0002-8167-4917; Li, Dan/0000-0003-3461-5751; Forsythe, John/0000-0003-2849-229X; Bernard, Claude Charles Andre/0000-0003-2816-5328	Australian Research Council [DP0985433, DP140100803]; National Health and Medical Research Council of Australia/CIRM [APP1053621]; Victoria/CIRM Joint Project [RMI-01739]; Department of Industry, Commonwealth of Australia [AISRF06680]; Australian Research Council's Future Fellowships [FT110100341]; Monash Micro Imaging; Monash University Centre for Electron Microscopy	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia/CIRM(National Health and Medical Research Council (NHMRC) of Australia); Victoria/CIRM Joint Project; Department of Industry, Commonwealth of Australia; Australian Research Council's Future Fellowships(Australian Research Council); Monash Micro Imaging; Monash University Centre for Electron Microscopy	This research was supported under Australian Research Council's Discovery Projects funding scheme (DP0985433 & DP140100803). Prof. Claude Bernard is supported by grants from the National Health and Medical Research Council of Australia/CIRM Joint Project (APP1053621), the Victoria/CIRM Joint Project (RMI-01739) and the Department of Industry, Commonwealth of Australia (AISRF06680). Prof. Dan Li was supported under Australian Research Council's Future Fellowships scheme (FT110100341).; The authors wish to thank Monash Micro Imaging and Monash University Centre for Electron Microscopy for providing imaging instrumentation and general support. The authors also like to thank Guizhi Sun for her kind advice in immunostaining and imaging.	Abidian MR, 2012, ADV HEALTHC MATER, V1, P762, DOI 10.1002/adhm.201200182; Baiguera S, 2014, BIOMATERIALS, V35, P1205, DOI 10.1016/j.biomaterials.2013.10.060; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bendali A, 2013, ADV HEALTHC MATER, V2, P929, DOI 10.1002/adhm.201200347; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Chowdhury SM, 2013, BIOMATERIALS, V34, P283, DOI 10.1016/j.biomaterials.2012.09.057; Fang Z, 2006, ACTA NEUROPATHOL, V111, P213, DOI 10.1007/s00401-005-0019-7; Feng ZQ, 2013, POLYMER, V54, P702, DOI 10.1016/j.polymer.2012.10.057; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fon D, 2014, ADV HEALTHC MATER, V3, P761, DOI 10.1002/adhm.201300287; Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; Gerardo-Nava J, 2009, NANOMEDICINE-UK, V4, P11, DOI 10.2217/17435889.4.1.11; Gold SM, 2009, IMMUNOL ALLERGY CLIN, V29, P309, DOI 10.1016/j.iac.2009.02.008; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Hosseinkhani H, 2013, ACS CHEM NEUROSCI, V4, P1229, DOI 10.1021/cn400075h; Hu SH, 2014, ADV FUNCT MATER, V24, P4144, DOI 10.1002/adfm.201400080; Kam NWS, 2009, NANO LETT, V9, P273, DOI 10.1021/nl802859a; Kim SY, 2011, ACS APPL MATER INTER, V3, P16, DOI 10.1021/am1008369; Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Li N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01604; Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707; Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v; Liu Q, 2013, NANO LETT, V13, P2436, DOI 10.1021/nl400368v; Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007; Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062; Mucksch C, 2011, LANGMUIR, V27, P12938, DOI 10.1021/la201972f; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ou LC, 2011, J PHYS CHEM B, V115, P9813, DOI 10.1021/jp201474m; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175; Rong PF, 2014, THERANOSTICS, V4, P229, DOI 10.7150/thno.8070; Shi SX, 2013, BIOMATERIALS, V34, P3002, DOI 10.1016/j.biomaterials.2013.01.047; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song Q, 2014, BIOMATERIALS, V35, P6930, DOI 10.1016/j.biomaterials.2014.05.002; Tang ML, 2013, BIOMATERIALS, V34, P6402, DOI 10.1016/j.biomaterials.2013.05.024; Thevenot P, 2008, CURR TOP MED CHEM, V8, P270; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Wang AX, 2013, J APPL TOXICOL, V33, P1156, DOI 10.1002/jat.2877; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang K, 2012, ADV MATER, V24, P1868, DOI 10.1002/adma.201104964; Zhou K, 2014, NANOMEDICINE-UK, V9, P1239, DOI [10.2217/nnm.13.112, 10.2217/NNM.13.112]; Zhou K, 2012, ACS APPL MATER INTER, V4, P4524, DOI 10.1021/am3007565; Zuidema J, 2015, EXTRACELLULAR MATRIX, P181	53	62	64	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151589	10.1371/journal.pone.0151589	http://dx.doi.org/10.1371/journal.pone.0151589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978268	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800092
J	Cooper, HLF; Linton, S; Kelley, ME; Ross, Z; Wolfe, ME; Chen, YT; Zlotorzynska, M; Hunter-Jones, J; Friedman, SR; Jarlais, DCD; Tempalski, B; DiNenno, E; Broz, D; Wejnert, C; Paz-Bailey, G				Cooper, Hannah L. F.; Linton, Sabriya; Kelley, Mary E.; Ross, Zev; Wolfe, Mary E.; Chen, Yen-Tyng; Zlotorzynska, Maria; Hunter-Jones, Josalin; Friedman, Samuel R.; Jarlais, Don C. Des; Tempalski, Barbara; DiNenno, Elizabeth; Broz, Dita; Wejnert, Cyprian; Paz-Bailey, Gabriela		National HIV Behav Surveillance	Risk Environments, Race/Ethnicity, and HIV Status in a Large Sample of People Who Inject Drugs in the United States	PLOS ONE			English	Article							SYRINGE EXCHANGE PROGRAMS; ALCOHOL OUTLET DENSITY; US METROPOLITAN-AREAS; NEW-YORK; BEHAVIORAL SURVEILLANCE; NEIGHBORHOOD POVERTY; DEPRESSIVE SYMPTOMS; RACIAL DISPARITIES; RESPONDENT-DRIVEN; SPATIAL ACCESS	Introduction We analyzed relationships between place characteristics and being HIV-negative among black, Latino, and white people who inject drugs (PWID) in the US. Methods Data on PWID (N = 9077) were from the Centers for Disease Control and Prevention's 2009 National HIV Behavioral Surveillance. Administrative data were analyzed to describe the 968 ZIP codes, 51 counties, and 19 metropolitan statistical areas (MSAs) where they lived. Multilevel multivariable models examined relationships between place characteristics and HIV status. Exploratory population attributable risk percents (e-PAR %s) were estimated. Results Black and Latino PWID were more likely to be HIV-negative if they lived in less economically disadvantaged counties, or in MSAs with less criminal-justice activity (i.e., lower drug-related arrest rates, lower policing/corrections expenditures). Latino PWID were more likely to be HIV-negative in MSAs with more Latino isolation, less black isolation, and less violent crime. E-PAR%s attributed 8-19% of HIV cases among black PWID and 1-15% of cases among Latino PWID to place characteristics. Discussion Evaluations of structural interventions to improve economic conditions and reduce drug-related criminal justice activity may show evidence that they protect black and Latino PWID from HIV infection.	[Cooper, Hannah L. F.; Linton, Sabriya; Kelley, Mary E.; Wolfe, Mary E.; Chen, Yen-Tyng; Zlotorzynska, Maria; Hunter-Jones, Josalin] Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA; [Ross, Zev] ZevRoss SpatialAnal, 120 N Aurora St,Suite 3A, Ithaca, NY 14850 USA; [Friedman, Samuel R.; Tempalski, Barbara] Natl Dev & Res Inst, Inst Infect Dis Res, 71 West 23rd St,4th Fl, New York, NY 10010 USA; [Jarlais, Don C. Des] Mt Sinai Beth Israel, Baron Edmond de Rothschild Chem Dependency Inst, 39 Broadway,5th Floor, New York, NY 10006 USA; [DiNenno, Elizabeth; Broz, Dita; Wejnert, Cyprian; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS-E46, Atlanta, GA 30333 USA	Emory University; Rollins School Public Health; National Development & Research Institutes, Inc; Centers for Disease Control & Prevention - USA	Cooper, HLF (corresponding author), Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	hcoope3@emory.edu		Al-Tayyib, Alia/0000-0002-5909-6719; Friedman, Sam/0000-0003-2083-1226; Raymond, Henry/0000-0001-8621-2749	NIH; National Institute on Drug Abuse [DA035101]; National Institutes of Health [P30 AI050409]; ZevRoss SpatialAnalysis; Centers and Disease Control and Prevention; National HIV Behavioral Surveillance Study Group: Atlanta, GA; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZevRoss SpatialAnalysis; Centers and Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National HIV Behavioral Surveillance Study Group: Atlanta, GA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by two NIH grants. One from the National Institute on Drug Abuse (http://www.drugabuse.gov/) entitled "Place Characteristics & Disparities in HIV in IDUS: A Multilevel Analysis of NHBS" (DA035101; Cooper, PI), and another from the National Institutes of Health (http://www.nih.gov/) funding the Emory Center for AIDS Research (P30 AI050409; Curran, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ZevRoss SpatialAnalysis provided support in the form of salaries for author ZR but did not have any additional role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This research was supported by the Centers and Disease Control and Prevention, and the National HIV Behavioral Surveillance Study Group: Atlanta, GA: Jennifer Taussig, Shacara Johnson, Jeff Todd; Baltimore, MD: Colin Flynn, Danielle German; Boston, MA: Debbie Isenberg, Maura Driscoll, Elizabeth Hurwitz; Chicago, IL: Nikhil Prachand, Nanette Benbow; Dallas, TX: Sharon Melville, Richard Yeager, Jim Dyer, Alicia Novoa; Denver, CO: Mark Thrun, Alia Al-Tayyib; Detroit, MI: Emily Higgins, Eve Mokotoff, Vivian Griffin; Houston, TX: Aaron Sayegh, Jan Risser, Hafeez Rehman; Los Angeles, CA: Trista Bingham, Ekow Kwa Sey; Miami, FL: Lisa Metsch, David Forrest, Dano Beck, Gabriel Cardenas; Nassau-Suffolk, NY: Chris Nemeth, Lou Smith, Carol-Ann Watson; New Orleans, LA: William T. Robinson, DeAnn Gruber, Narquis Barak; New York City, NY: Alan Neaigus, Samuel Jenness, Travis Wendel, Camila Gelpi-Acosta, Holly Hagan; Newark, NJ: Henry Godette, Barbara Bolden, Sally D'Errico; Philadelphia, PA: Kathleen A. Brady, Althea Kirkland, Mark Shpaner; San Diego, CA: Vanessa Miguelino-Keasling, Al Velasco; San Francisco, CA: H. Fisher Raymond; San Juan, PR: Sandra Miranda De Leo'n, Yadira Rolo'n-Colo'n; Seattle, WA: Maria Courogen, Hanne Thiede, Richard Burt; St Louis, MO: Michael Herbert, Yelena Friedberg, Dale Wrigley, Jacob Fisher; Washington, DC: Marie Sansone, Tiffany West-Ojo, Manya Magnus, Irene Kuo; Behavioral Surveillance Team. We would like to thank the NHBS participants for making this study possible. We also thank and acknowledge Mr. Scott Burris and Ms. Mona Bennett for their help documenting laws governing syringe access.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Alexander M., 2012, NEW JIM CROW MASS IN; Alvy LM, 2011, AIDS BEHAV, V15, P1171, DOI 10.1007/s10461-010-9678-z; [Anonymous], STRAT PLAN DIV HIV A; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Boardman JD, 2001, J HEALTH SOC BEHAV, V42, P151, DOI 10.2307/3090175; Bramson H, 2015, J PUBLIC HEALTH POL, V36, P212, DOI 10.1057/jphp.2014.54; Broz D, 2014, MMWR SURVEILL SUMM, V63, P1; Centers for Disease Control and Prevention, 2012, DIAGN HIV AD ADOL SE; Centers for Disease Control and Prevention, 2013, EXP TEST IN ATL; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P133; Cohen D, 2000, AM J PUBLIC HEALTH, V90, P230, DOI 10.2105/AJPH.90.2.230; Cohen DA, 2006, SOC SCI MED, V62, P3062, DOI 10.1016/j.socscimed.2005.11.060; Cooper H, 2005, SOC SCI MED, V61, P673, DOI 10.1016/j.socscimed.2004.12.030; Cooper HL, 2013, DRUG ALCOHOL DEPEN, V133, P37, DOI 10.1016/j.drugalcdep.2013.06.003; Cooper HLF, 2015, J URBAN HEALTH, V92, P527, DOI 10.1007/s11524-015-9941-8; Cooper HLF, 2014, J URBAN HEALTH, V91, P223, DOI 10.1007/s11524-013-9844-5; Cooper HLF, 2012, HEALTH PLACE, V18, P218, DOI 10.1016/j.healthplace.2011.09.005; Cooper HLF, 2011, AM J PUBLIC HEALTH, V101, P1118, DOI 10.2105/AJPH.2009.184580; Cooper HL, INT J DRUG POLICY; Cooper HL, AIDS BEHAV IN PRESS; Cooper HLF, 2005, INT J DRUG POLICY, V16, P150, DOI 10.1016/j.drugpo.2005.03.001; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; Curry A, 2008, SOC SCI MED, V67, P23, DOI 10.1016/j.socscimed.2008.03.007; Dauria E, SEXUALLY TR IN PRESS; DESJARLAIS DC, 1995, JAMA-J AM MED ASSOC, V274, P1226, DOI 10.1001/jama.274.15.1226; FIFE D, 1992, J ACQ IMMUN DEF SYND, V5, P1105; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Galea S, 2007, ANN EPIDEMIOL, V17, P171, DOI 10.1016/j.annepidem.2006.07.008; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; Genberg BL, 2011, ADDICTION, V106, P1966, DOI 10.1111/j.1360-0443.2011.03501.x; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hu D. J., 1994, AIDS and Public Policy Journal, V9, P20; Jarlais DCD, 2007, AIDS EDUC PREV, V19, P111, DOI 10.1521/aeap.2007.19.2.111; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Kim J, 1978, FACTOR ANAL STAT MET; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Kottiri BJ, 2002, J ACQ IMMUN DEF SYND, V30, P95, DOI 10.1097/00042560-200205010-00013; Kral AH, 2010, J URBAN HEALTH, V87, P839, DOI 10.1007/s11524-010-9486-9; Kramer MR, 2009, EPIDEMIOL REV, V31, P178, DOI 10.1093/epirev/mxp001; Laffoon B., 2011, Morbidity and Mortality Weekly Report, V60, P93; Lansky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097596; Latkin CA, 2005, HEALTH PSYCHOL, V24, P96, DOI 10.1037/0278-6133.24.1.96; Latkin CA, 2007, AM J PREV MED, V32, pS234, DOI 10.1016/j.amepre.2007.02.023; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lemstra M, 2011, CAN J PSYCHIAT, V56, P358, DOI 10.1177/070674371105600607; Linton S, AM J PUBLIC IN PRESS; Linton S, 2014, 142 M AM PUBL HLTH A; Logan JR, 2002, AM SOCIOL REV, V67, P299, DOI 10.2307/3088897; Massey D., 1993, AM APARTHEID SEGREGA; MASSEY DS, 1989, DEMOGRAPHY, V26, P373, DOI 10.2307/2061599; McKnight C. A., 2005, Morbidity and Mortality Weekly Report, V54, P673; Nakayama T, 1998, LANCET, V351, P1179, DOI 10.1016/S0140-6736(05)79123-6; Nakayama T, 2000, EPIDEMIOLOGY, V11, P366, DOI 10.1097/00001648-200005000-00032; Nandi A, 2010, AM J EPIDEMIOL, V171, P391, DOI 10.1093/aje/kwp416; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, PROT HUM SUBJ BELM R; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P1202, DOI 10.2105/AJPH.85.9.1202; Office of Applied Studies in the Substance Abuse and Mental Health Services Administration, 2010, NAT DIR DRUG ALC AB; Office of the Associate Director for Science, 2010, HUM RES PROT; Oster AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073779; Ostir GV, 2003, J EPIDEMIOL COMMUN H, V57, P987, DOI 10.1136/jech.57.12.987; Patel KV, 2003, ANN EPIDEMIOL, V13, P620, DOI 10.1016/S1047-2797(03)00060-7; Pouget ER, 2014, PUBLIC HEALTH REP, V129, P267, DOI 10.1177/003335491412900309; Putnam S, 2008, J PUBLIC HEALTH POL, V29, P275, DOI 10.1057/jphp.2008.15; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Robinson WT, 2006, J URBAN HEALTH, V83, pI29, DOI 10.1007/s11524-006-9100-3; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Schonlau M, 2008, GEOSPATIAL HEALTH, V3, P91, DOI 10.4081/gh.2008.235; Scribner RA, 2000, ALCOHOL CLIN EXP RES, V24, P188, DOI 10.1111/j.1530-0277.2000.tb04590.x; Scribner RA, 1998, SEX TRANSM DIS, V25, P544, DOI 10.1097/00007435-199811000-00009; Shrier LA, 2009, J ADOLESCENT HEALTH, V45, P63, DOI 10.1016/j.jadohealth.2008.11.016; Silver D, 2014, FACTTANK NEWS NUMBER; SIMON PA, 1995, AIDS, V9, P281, DOI 10.1097/00002030-199509030-00010; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; The White House Office of National AIDS Policy, 2010, NAT HIV AIDS STRAT; Theall KP, 2009, ALCOHOL ALCOHOLISM, V44, P491, DOI 10.1093/alcalc/agp042; Williams CT, 2010, AM J PUBLIC HEALTH, V100, P1068, DOI 10.2105/AJPH.2008.158337; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Yen IH, 1999, INT J EPIDEMIOL, V28, P90, DOI 10.1093/ije/28.1.90; Zierler S, 2000, AM J PUBLIC HEALTH, V90, P1064, DOI 10.2105/AJPH.90.7.1064	85	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150410	10.1371/journal.pone.0150410	http://dx.doi.org/10.1371/journal.pone.0150410			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26974165	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600024
J	Hsieh, MC; Tsai, CY; Liao, MC; Yang, JL; Su, CH; Chen, JH				Hsieh, Meng-Chi; Tsai, Ching-Yi; Liao, Min-Chiao; Yang, Jenq-Lin; Su, Chia-Hao; Chen, Jyh-Horng			Quantitative Susceptibility Mapping-Based Microscopy of Magnetic Resonance Venography (QSM-mMRV) for In Vivo Morphologically and Functionally Assessing Cerebromicrovasculature in Rat Stroke Model	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; PHASE-UNWRAPPING ALGORITHM; OXYGEN-SATURATION; BRAIN IMAGES; HIGH-FIELD; SIGNAL BEHAVIOR; ISCHEMIC-STROKE; CONTRAST AGENTS; MRI PHASE; ANGIOGRAPHY	Abnormal cerebral oxygenation and vessel structure is a crucial feature of stroke. An imaging method with structural and functional information is necessary for diagnosis of stroke. This study applies QSM-mMRV (quantitative susceptibility mapping-based microscopic magnetic resonance venography) for noninvasively detecting small cerebral venous vessels in rat stroke model. First, susceptibility mapping is optimized and calculated from magnetic resonance (MR) phase images of a rat brain. Subsequently, QSM-mMRV is used to simultaneously provide information on microvascular architecture and venous oxygen saturation (SvO(2)), both of which can be used to evaluate the physiological and functional characteristics of microvascular changes for longitudinally monitoring and therapeutically evaluating a disease model. Morphologically, the quantification of vessel sizes using QSM-mMRV was 30% smaller than that of susceptibility-weighted imaging (SWI), which eliminated the overestimation of conventional SWI. Functionally, QSM-mMRV estimated an average SvO(2) ranging from 73% to 85% for healthy rats. Finally, we also applied QSM to monitor the revascularization of post-stroke vessels from 3 to 10 days after reperfusion. QSM estimations of SvO(2) were comparable to those calculated using the pulse oximeter standard metric. We conclude that QSM-mMRV is useful for longitudinally monitoring blood oxygen and might become clinically useful for assessing cerebrovascular diseases.	[Hsieh, Meng-Chi; Chen, Jyh-Horng] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 106, Taiwan; [Hsieh, Meng-Chi; Chen, Jyh-Horng] Natl Taiwan Univ, Mol Imaging Ctr, Taipei 106, Taiwan; [Hsieh, Meng-Chi; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Taipei 106, Taiwan; [Tsai, Ching-Yi; Liao, Min-Chiao; Yang, Jenq-Lin; Su, Chia-Hao] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung 833, Taiwan; [Su, Chia-Hao] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University	Chen, JH (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 106, Taiwan.; Chen, JH (corresponding author), Natl Taiwan Univ, Mol Imaging Ctr, Taipei 106, Taiwan.; Chen, JH (corresponding author), Natl Taiwan Univ, Dept Elect Engn, Taipei 106, Taiwan.; Su, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung 833, Taiwan.; Su, CH (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	chiralsu@gmail.com; jhchen@ntu.edu.tw	Tsai, CY/AAV-9723-2021	Tsai, CY/0000-0002-9548-9851; Yang, Jenq-Lin/0000-0002-9897-8087	National Taiwan University under Excellent Research Projects [NTU-ERP-105R891602]; Ministry of Science and Technology [NSC-104-2321-B-002-040, MOST103-2320-B-182A-004MY3, MOST103-2633-B-182A-001-]; National Health Research Institute [NHRI-EX105-10424EI]; Chang Gung Medical Foundation, Taiwan [CMRPG8C1171, CMRPG8C1172, CMRPG8E1461]	National Taiwan University under Excellent Research Projects; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institute(National Health Research Institutes - Taiwan); Chang Gung Medical Foundation, Taiwan	This work was supported by grants from the National Taiwan University under Excellent Research Projects (NTU-ERP-105R891602), the Ministry of Science and Technology (NSC-104-2321-B-002-040 to JHC; MOST103-2320-B-182A-004MY3 and MOST103-2633-B-182A-001- to CHS), the National Health Research Institute (NHRI-EX105-10424EI), and Chang Gung Medical Foundation, Taiwan (CMRPG8C1171, CMRPG8C1172, and CMRPG8E1461 to CHS). The authors have declared that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Bilgic B, 2014, MAGN RESON MED, V72, P1444, DOI 10.1002/mrm.25029; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chen ZK, 2015, J NEUROSCI METH, V241, P85, DOI 10.1016/j.jneumeth.2014.12.014; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Driver ID, 2014, NEUROIMAGE, V101, P458, DOI 10.1016/j.neuroimage.2014.07.050; DUMOULIN CL, 1989, MAGN RESON MED, V9, P139, DOI 10.1002/mrm.1910090117; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fan AP, 2014, MAGN RESON MED, V72, P149, DOI 10.1002/mrm.24918; Fan AP, 2012, MAGN RESON MED, V67, P669, DOI 10.1002/mrm.23050; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; Gursoy Ozdemir Y, 2012, J NEUROCHEM, V123, P2, DOI [10.1111/j.1471-4159.2012.07938.x, DOI 10.1111/J.1471-4159.2012.07938.X]; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Haacke EM, 2011, SUSCEPTIBILITY WEIGH; Hammond KE, 2008, NEUROIMAGE, V39, P1682, DOI 10.1016/j.neuroimage.2007.10.037; HANSEN PC, 1992, SIAM REV, V34, P561, DOI 10.1137/1034115; Hsieh CY, 2015, MAGN RESON IMAGING, V33, P420, DOI 10.1016/j.mri.2015.01.004; Huang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078186; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jiang Q, 2008, SUSCEPTIBILITY WEIGH, P304; Kressler B, 2010, IEEE T MED IMAGING, V29, P273, DOI 10.1109/TMI.2009.2023787; Krishnamurthy LC, 2014, MAGN RESON MED, V71, P978, DOI 10.1002/mrm.24750; Langham MC, 2009, MAGN RESON MED, V62, P333, DOI 10.1002/mrm.21981; Lee J, 2010, NEUROIMAGE, V49, P193, DOI 10.1016/j.neuroimage.2009.07.017; Li DB, 1998, MAGNET RESON MED, V39, P685, DOI 10.1002/mrm.1910390503; Li W, 2014, NMR BIOMED, V27, P219, DOI 10.1002/nbm.3056; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Lin CY, 2009, NEUROIMAGE, V45, P824, DOI 10.1016/j.neuroimage.2008.12.030; Lin VL, 1999, J CEREBR BLOOD F MET, V19, P853, DOI 10.1097/00004647-199908000-00004; Lin WL, 1998, J CEREBR BLOOD F MET, V18, P1018, DOI 10.1097/00004647-199809000-00011; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Liu T, 2012, IEEE T MED IMAGING, V31, P816, DOI 10.1109/TMI.2011.2182523; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Marques JP, 2009, NEUROIMAGE, V46, P345, DOI 10.1016/j.neuroimage.2009.02.023; Miraux S, 2004, MAGN RESON MATER PHY, V17, P348, DOI 10.1007/s10334-004-0064-6; NAPEL S, 1992, RADIOLOGY, V185, P607, DOI 10.1148/radiology.185.2.1410382; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Park SH, 2008, MAGN RESON MED, V59, P855, DOI 10.1002/mrm.21573; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Reese T, 1999, NMR BIOMED, V12, P189, DOI 10.1002/(SICI)1099-1492(199906)12:4<189::AID-NBM557>3.0.CO;2-O; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; SAKAI F, 1985, J CEREBR BLOOD F MET, V5, P207, DOI 10.1038/jcbfm.1985.27; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; Schweser F, 2013, MAGN RESON MED, V69, P1581, DOI 10.1002/mrm.24405; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Sedlacik J, 2007, MAGN RESON MED, V58, P1035, DOI 10.1002/mrm.21283; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; Wang S, 2013, STROKE, V44, P2315, DOI 10.1161/STROKEAHA.113.001638; WEISSKOFF RM, 1992, MAGNET RESON MED, V24, P375, DOI 10.1002/mrm.1910240219; Wharton S, 2010, NEUROIMAGE, V53, P515, DOI 10.1016/j.neuroimage.2010.06.070; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000; Xia S, 2014, MAGN RESON IMAGING, V32, P1272, DOI 10.1016/j.mri.2014.08.012; Xu B, 2014, MAGN RESON MED, V72, P438, DOI 10.1002/mrm.24937; Zhang JW, 2015, MAGN RESON MED, V74, P945, DOI 10.1002/mrm.25463	72	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149602	10.1371/journal.pone.0149602	http://dx.doi.org/10.1371/journal.pone.0149602			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974842	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600013
J	Li, Y; Liu, HZ; Barta, CL; Judge, PD; Zhao, LD; Zhang, WPJ; Gong, SS; Beisel, KW; He, DZZ				Li, Yi; Liu, Huizhan; Barta, Cody L.; Judge, Paul D.; Zhao, Lidong; Zhang, Weiping J.; Gong, Shusheng; Beisel, Kirk W.; He, David Z. Z.			Transcription Factors Expressed in Mouse Cochlear Inner and Outer Hair Cells	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; GENE-EXPRESSION; GENOME-WIDE; IDENTIFICATION; PROTEIN; BCL-2	Regulation of gene expression is essential to determining the functional complexity and morphological diversity seen among different cells. Transcriptional regulation is a crucial step in gene expression regulation because the genetic information is directly read from DNA by sequence-specific transcription factors (TFs). Although several mouse TF data-bases created from genome sequences and transcriptomes are available, a cell type-specific TF database from any normal cell populations is still lacking. We identify cell type-specific TF genes expressed in cochlear inner hair cells (IHCs) and outer hair cells (OHCs) using hair cell-specific transcriptomes from adult mice. IHCs and OHCs are the two types of sensory receptor cells in the mammalian cochlea. We show that 1,563 and 1,616 TF genes are respectively expressed in IHCs and OHCs among 2,230 putative mouse TF genes. While 1,536 are commonly expressed in both populations, 73 genes are differentially expressed (with at least a twofold difference) in IHCs and 13 are differentially expressed in OHCs. Our datasets represent the first cell type-specific TF databases for two populations of sensory receptor cells and are key informational resources for understanding the molecular mechanism underlying the biological properties and phenotypical differences of these cells.	[Li, Yi] Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Li, Yi; Liu, Huizhan; Barta, Cody L.; Zhao, Lidong; Beisel, Kirk W.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Judge, Paul D.] Univ Nebraska Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Omaha, NE 68198 USA; [Zhao, Lidong] Chinese Peoples Liberat Army Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing 100853, Peoples R China; [Zhang, Weiping J.] Second Mil Med Univ, Dept Pathophysiol, Shanghai 200433, Peoples R China; [Gong, Shusheng] Beijing Friendship Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China	Capital Medical University; Creighton University; University of Nebraska System; University of Nebraska Medical Center; Chinese People's Liberation Army General Hospital; Naval Medical University; Capital Medical University	He, DZZ (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	hed@creighton.edu		He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Li (li yi), Yi/0000-0002-9986-6546; Zhao, Lidong/0000-0002-0810-0941	NIH from the NIDCD [R01 DC004696]; Major State Basic Research Development Program of China (973 Program) [2011CB504503]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	NIH from the NIDCD; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work has been supported by NIH grant R01 DC004696 to DZH from the NIDCD. YL and SSG are supported by the Major State Basic Research Development Program of China (973 Program) (no. 2011CB504503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bettuzzi S, 2009, ADV CANCER RES, V104, P59, DOI 10.1016/S0065-230X(09)04005-6; Briegel KJ, 2001, DEV BIOL, V233, P291, DOI 10.1006/dbio.2001.0225; Burns JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048704; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1992, J NEUROSCI, V12, P4575; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Felder E, 1995, HEARING RES, V91, P19, DOI 10.1016/0378-5955(95)00158-1; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gnedeva K, 2015, P NATL ACAD SCI USA, V112, P14066, DOI 10.1073/pnas.1517371112; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; Harding GW, 2004, J ACOUST SOC AM, V115, P2207, DOI 10.1121/1.1689961; He DZZ, 2000, HEARING RES, V145, P156, DOI 10.1016/S0378-5955(00)00084-8; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kopecky BJ, 2012, BRAIN RES, V1484, P1, DOI 10.1016/j.brainres.2012.09.027; Kurima K, NAT GENET, V30, P277; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Locker J., 2001, TRANSCRIPTION FACTOR; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; O'Shea JM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014258; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schimmang T, 2013, HEARING RES, V297, P84, DOI 10.1016/j.heares.2012.11.001; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yang Sienhung, 2012, Evid Based Complement Alternat Med, V2012, P521780, DOI 10.1155/2012/521780; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	58	15	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151291	10.1371/journal.pone.0151291	http://dx.doi.org/10.1371/journal.pone.0151291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974322	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600065
J	Malafoglia, V; Traversetti, L; Del Grosso, F; Scalici, M; Lauro, F; Russo, V; Persichini, T; Salvemini, D; Mollace, V; Fini, M; Raffaeli, W; Muscoli, C; Colasanti, M				Malafoglia, Valentina; Traversetti, Lorenzo; Del Grosso, Floriano; Scalici, Massimiliano; Lauro, Filomena; Russo, Valeria; Persichini, Tiziana; Salvemini, Daniela; Mollace, Vincenzo; Fini, Massimo; Raffaeli, William; Muscoli, Carolina; Colasanti, Marco			Transient Receptor Potential Melastatin-3 (TRPM3) Mediates Nociceptive-Like Responses in Hydra vulgaris	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NEUROPATHIC PAIN; OXIDATIVE STRESS; HEAT-STRESS; PATHWAY; CHANNEL; CLASSIFICATION; HYPERALGESIA; INVOLVEMENT; ACTIVATION	The ability of mammals to feel noxious stimuli lies in a heterogeneous group of primary somatosensory neurons termed nociceptors, which express specific membrane receptors, such as the Transient Receptor Potential (TRP) family. Here, we show that one of the most important nociceptive-like pathways is conserved in the freshwater coelenterate Hydra vulgaris, the most primitive organism possessing a nervous system. In particular, we found that H. vulgaris expresses TRPM3, a nociceptor calcium channel involved in the detection of noxious heat in mammals. Furthermore, we detected that both heat shock and TRPM3 specific agonist (i.e., pregnenolone sulfate) induce the modulation of the heat shock protein 70 (HSP70) and the nitric oxide synthase (NOS), two genes activated by TRP-mediated heat painful stimuli in mammals. As expected, these effects are inhibited by a TRPM3 antagonist (i.e., mefenamic acid). Interestingly, the TRPM3 agonist and heat shock also induce the expression of nuclear transcription erythroid 2-related factor (Nrf2) and superoxide dismutase (SOD), known markers of oxidative stress; noteworthy gene expression was also inhibited by the TRPM3 antagonist. As a whole, our results demonstrate the presence of conserved molecular oxidative/nociceptive-like pathways at the primordial level of the animal kingdom.	[Malafoglia, Valentina; Traversetti, Lorenzo; Del Grosso, Floriano; Scalici, Massimiliano; Russo, Valeria; Persichini, Tiziana; Colasanti, Marco] Univ Roma Tre, Dept Sci, Rome, Italy; [Malafoglia, Valentina; Raffaeli, William] ISAL Fdn, Inst Res Pain, Torre Pedrera, RN, Italy; [Malafoglia, Valentina; Lauro, Filomena; Fini, Massimo] IRCCS San Raffaele Pisana, Rome, Italy; [Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Mollace, Vincenzo; Muscoli, Carolina] Magna Graecia Univ Catanzaro, Dept Hlth Sci, IRC FSH, Catanzaro, Italy	Italfarmaco; Roma Tre University; IRCCS San Raffaele Pisana; Saint Louis University; Magna Graecia University of Catanzaro	Colasanti, M (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	marco.colasanti@uniroma3.it	Fini, Massimo/AAA-9948-2021; Malafoglia, Valentina/K-6495-2016; COLASANTI, MARCO/A-5616-2010	Malafoglia, Valentina/0000-0002-1533-704X; COLASANTI, MARCO/0000-0002-5752-4943; Raffaeli, William/0000-0003-0240-8993; SCALICI, Massimiliano/0000-0002-5677-8837; PERSICHINI, TIZIANA/0000-0001-8291-6706; Lauro, Filomena/0000-0001-8212-8603	University "ROMA TRE" contribution for the laboratory (CAL);  [PON03PE_00078_2]	University "ROMA TRE" contribution for the laboratory (CAL); 	This work was supported by University "ROMA TRE" contribution for the laboratory (CAL) to MC and by PON03PE_00078_2 to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone A, 2014, NANOMEDICINE-UK, V9, P1913, DOI [10.2217/NNM.14.100, 10.2217/nnm.14.100]; BOSCH TCG, 1988, P NATL ACAD SCI USA, V85, P7927, DOI 10.1073/pnas.85.21.7927; Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; Brennecke T, 1998, EUR J BIOCHEM, V255, P703, DOI 10.1046/j.1432-1327.1998.2550703.x; Bromberg Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057149; Campana G, 2010, INT IMMUNOPHARMACOL, V10, P1149, DOI 10.1016/j.intimp.2010.06.016; Cargnin S, 2013, J PAIN, V14, P1097, DOI 10.1016/j.jpain.2013.04.006; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; COLASANTI M, 1995, NATURE, V374, P505, DOI 10.1038/374505a0; Colasanti M, 1997, J NEUROSCI, V17, P493, DOI 10.1523/JNEUROSCI.17-01-00493.1997; Colasanti M, 2010, NITRIC OXIDE-BIOL CH, V23, P94, DOI 10.1016/j.niox.2010.05.286; Colasanti M, 2009, NITRIC OXIDE-BIOL CH, V21, P164, DOI 10.1016/j.niox.2009.07.003; Dash B, 2007, GENE, V387, P93, DOI 10.1016/j.gene.2006.08.020; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Doyle T, 2012, J NEUROSCI, V32, P6149, DOI 10.1523/JNEUROSCI.6343-11.2012; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; GELLNER K, 1992, EUR J BIOCHEM, V210, P683, DOI 10.1111/j.1432-1033.1992.tb17469.x; Gigliuto C, 2014, J PAIN RES, V7, P227, DOI 10.2147/JPR.S59161; Gracheva EO, 2015, CURR OPIN NEUROBIOL, V34, P67, DOI 10.1016/j.conb.2015.01.021; Harteneck C, 2013, MOLECULES, V18, P12012, DOI 10.3390/molecules181012012; Hawkins TD, 2013, FASEB J, V27, P4790, DOI 10.1096/fj.13-235051; Hervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014321; Keilhoff G, 2013, NEUROSCI RES, V77, P215, DOI 10.1016/j.neures.2013.08.008; Klose C, 2011, BRIT J PHARMACOL, V162, P1757, DOI 10.1111/j.1476-5381.2010.01186.x; Laing R. J., 2015, NEUROSCIENTIST; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Leonelli M, 2013, CELL MOL NEUROBIOL, V33, P379, DOI 10.1007/s10571-012-9904-5; Lesch A, 2014, BRIT J PHARMACOL, V171, P2645, DOI 10.1111/bph.12524; Li YS, 2014, ACTA HISTOCHEM, V116, P883, DOI 10.1016/j.acthis.2014.02.008; LOOMIS WF, 1953, SCIENCE, V117, P565, DOI 10.1126/science.117.3047.565; Malafoglia V, 2014, J CELL PHYSIOL, V229, P300, DOI 10.1002/jcp.24447; Malafoglia V, 2013, J CELL PHYSIOL, V228, P1956, DOI 10.1002/jcp.24379; Mickle AD, 2015, PROG MOL BIOL TRANSL, V131, P73, DOI 10.1016/bs.pmbts.2015.01.002; Miyake T, 2014, BIOCHEM BIOPH RES CO, V444, P212, DOI 10.1016/j.bbrc.2014.01.022; Muscoli C, 2004, PAIN, V111, P96, DOI 10.1016/j.pain.2004.06.004; Muscoli C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/950947; Nassini R, 2014, REV PHYSIOL BIOCH P, V167, P1, DOI 10.1007/112_2014_18; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Peng GD, 2015, MOL PHYLOGENET EVOL, V84, P145, DOI 10.1016/j.ympev.2014.06.016; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Raffaeli W, 2012, AM J HOSP PALLIAT ME, V29, P604, DOI 10.1177/1049909111435810; Rosa AO, 2008, PAIN, V137, P332, DOI 10.1016/j.pain.2007.09.015; Safavi-Hemami H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010379; Sung CS, 2004, BRAIN RES, V1015, P145, DOI 10.1016/j.brainres.2004.04.068; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Venturini G, 1999, NITRIC OXIDE-BIOL CH, V3, P375, DOI 10.1006/niox.1999.0250; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wenger Y, 2014, SEMIN IMMUNOL, V26, P277, DOI 10.1016/j.smim.2014.06.004; Woo S, 2012, COMP BIOCHEM PHYS C, V156, P37, DOI 10.1016/j.cbpc.2012.03.005	50	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151386	10.1371/journal.pone.0151386	http://dx.doi.org/10.1371/journal.pone.0151386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974325	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600073
J	Wultsch, C; Waits, LP; Kelly, MJ				Wultsch, Claudia; Waits, Lisette P.; Kelly, Marcella J.			A Comparative Analysis of Genetic Diversity and Structure in Jaguars (Panthera onca), Pumas (Puma concolor), and Ocelots (Leopardus pardalis) in Fragmented Landscapes of a Critical Mesoamerican Linkage Zone	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; POPULATION-STRUCTURE; MOUNTAIN LIONS; HABITAT USE; COMPUTER-PROGRAM; TEMPORAL INTERACTIONS; SYMPATRIC JAGUARS; FOREST RESERVE; DETECTION DOGS; CONSERVATION	With increasing anthropogenic impact and landscape change, terrestrial carnivore populations are becoming more fragmented. Thus, it is crucial to genetically monitor wild carnivores and quantify changes in genetic diversity and gene flow in response to these threats. This study combined the use of scat detector dogs and molecular scatology to conduct the first genetic study on wild populations of multiple Neotropical felids coexisting across a fragmented landscape in Belize, Central America. We analyzed data from 14 polymorphic microsatellite loci in 1053 scat samples collected from wild jaguars (Panthera onca), pumas (Puma concolor), and ocelots (Leopardus pardalis). We assessed levels of genetic diversity, defined potential genetic clusters, and examined gene flow for the three target species on a countrywide scale using a combination of individualand populationbased analyses. Wild felids in Belize showed moderate levels of genetic variation, with jaguars having the lowest diversity estimates (H-E = 0.57 +/- 0.02; A(R) = 3.36 +/- 0.09), followed by pumas (H-E = 0.57 +/- 0.08; A(R) = 4.20 +/- 0.16), and ocelots (H-E = 0.63 +/- 0.03; A(R) = 4.16 +/- 0.08). We observed low to moderate levels of genetic differentiation for all three target species, with jaguars showing the lowest degree of genetic subdivision across the country, followed by ocelots and pumas. Although levels of genetic diversity and gene flow were still fairly high, we detected evidence of finescale genetic subdivision, indicating that levels of genetic connectivity for wild felids in Belize are likely to decrease if habitat loss and fragmentation continue at the current rate. Our study demonstrates the value of understanding finescale patterns of gene flow in multiple cooccurring felid species of conservation concern, which is vital for wildlife movement corridor planning and prioritizing future conservation and management efforts within human-impacted landscapes.	[Wultsch, Claudia; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Wultsch, Claudia] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	Virginia Polytechnic Institute & State University; Idaho; University of Idaho; American Museum of Natural History (AMNH)	Wultsch, C (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	cwultsch@amnh.org	Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873; Waits, Lisette/0000-0002-1323-0812	Panthera; National Geographic/Waits Grant; Jaguar Conservation Fund; Oregon Zoo Conservation Fund; Woodland Park Zoo Jaguar Conservation Fund; Philadelphia Zoo; Explorers Club Exploration Fund; Acorn Alcinda Foundation; Department of Fish and Wildlife Conservation, Virginia Tech	Panthera; National Geographic/Waits Grant; Jaguar Conservation Fund; Oregon Zoo Conservation Fund; Woodland Park Zoo Jaguar Conservation Fund; Philadelphia Zoo; Explorers Club Exploration Fund; Acorn Alcinda Foundation; Department of Fish and Wildlife Conservation, Virginia Tech	This work was funded by the following institutions and/or grant programs: Panthera (http://www.panthera.org/; received by CW); National Geographic/Waits Grant (http://www.nationalgeographic.com/explorers/grants-programs/waitt-grants/; received by CW); Jaguar Conservation Fund (http://www.wcs.org/saving-wildlife/big-cats/jaguar.aspx; received by CW); Oregon Zoo Conservation Fund (http://www.oregonzoo.org/conserve/future-wildlife-program; received by CW); Woodland Park Zoo Jaguar Conservation Fund (https://www.zoo.org/conservation/jaguar; received by CW); Philadelphia Zoo (http://www.philadelphiazoo.org/; received by MJK); Explorers Club Exploration Fund (https://explorers.org/expeditions/funding/expedition_grants; received by CW); Acorn Alcinda Foundation (received by MJK); Department of Fish and Wildlife Conservation, Virginia Tech (http://www.fishwild.vt.edu/; received by CW and MJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; Amos JN, 2014, ECOLOGY, V95, P1556, DOI 10.1890/13-1328.1; Anderson CR, 2004, J MAMMAL, V85, P1207, DOI 10.1644/BEL-111.1; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; Baillie JEM, 2013, KEY TOPICS CONSERVAT, V2, P23, DOI DOI 10.1002/9781118520178.CH2; Balkenhol N, 2014, ECOGRAPHY, V37, P552, DOI 10.1111/j.1600-0587.2013.00462.x; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Biek R, 2006, BIOL LETT-UK, V2, P312, DOI 10.1098/rsbl.2005.0437; Bridgewater SGM, 2006, ECON BOT, V60, P265, DOI 10.1663/0013-0001(2006)60[265:CXITGM]2.0.CO;2; Briggs VS, 2013, HUM ECOL RISK ASSESS, V19, P317, DOI 10.1080/10807039.2012.685809; Carmichael LE, 2001, MOL ECOL, V10, P2787, DOI 10.1046/j.1365-294X.2001.t01-1-01408.x; Caso A., 2008, IUCN RED LIST THREAT; Castilho CS, 2012, GENET MOL BIOL, V35, P65, DOI 10.1590/S1415-47572011005000062; Castilho CS, 2011, MAMM BIOL, V76, P476, DOI 10.1016/j.mambio.2010.08.002; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chepko-Sade BD, 1987, MAMMALIAN DISPERSAL; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Dalerum F, 2009, BIOL LETTERS, V5, P35, DOI 10.1098/rsbl.2008.0520; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; DeClerck FAJ, 2010, BIOL CONSERV, V143, P2301, DOI 10.1016/j.biocon.2010.03.026; DeMatteo KE, 2014, INTEGR ZOOL, V9, P623, DOI 10.1111/1749-4877.12113; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Ek E., 2010, FOREST COVER DEFORES; Elbroch M, 2009, REV CHIL HIST NAT, V82, P459; Emch M, 2005, PROF GEOGR, V57, P256, DOI 10.1111/j.0033-0124.2005.476_1.x; Epperson BK, 1999, GENET RES, V73, P251, DOI 10.1017/S001667239900378X; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Ernest HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107985; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2020, GLOBAL FOREST RESOUR; Feer F, 1997, NEOTROPICAL RAINFORE; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frankham R., 2006, CONNECTIVITY CONSERV, P72; Frantz AC, 2012, MOL ECOL, V21, P3445, DOI 10.1111/j.1365-294X.2012.05623.x; Goldberg CS, 2010, MOL ECOL, V19, P3650, DOI 10.1111/j.1365-294X.2010.04673.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grisolia AB, 2007, GENET MOL RES, V6, P382; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Haag T, 2009, GENETICA, V136, P505, DOI 10.1007/s10709-008-9347-6; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Harveson PM, 2004, WILDLIFE SOC B, V32, P948, DOI 10.2193/0091-7648(2004)032[0948:HUBOIS]2.0.CO;2; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Holbrook JD, 2012, J MAMMAL, V93, P989, DOI 10.1644/11-MAMM-A-326.2; Hu YB, 2010, CONSERV GENET, V11, P2145, DOI 10.1007/s10592-010-0100-1; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IRIARTE JA, 1990, OECOLOGIA, V85, P185, DOI 10.1007/BF00319400; Jackson P., 1996, BIOL CONSERVATION; Jackson VL, 2005, J WILDLIFE MANAGE, V69, P733, DOI 10.2193/0022-541X(2005)069[0733:LMAWHU]2.0.CO;2; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janecka JE, 2011, ANIM CONSERV, V14, P608, DOI 10.1111/j.1469-1795.2011.00475.x; Janecka JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089384; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kay E., 2015, CENTRAL BELIZE CORRI; Kelly MJ, 2012, TECH ECOL CONSERVAT, P47; KITCHENER A., 1991, NATURAL HIST WILD CA; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Logan Kenneth A., 2010, P105; Loxterman JL, 2011, CONSERV GENET, V12, P1049, DOI 10.1007/s10592-011-0208-y; Macdonald David W., 2010, P471; Manier MK, 2006, P R SOC B, V273, P3001, DOI 10.1098/rspb.2006.3678; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Michalski F, 2011, MOL ECOL RESOUR, V11, P862, DOI 10.1111/j.1755-0998.2011.03031.x; Miotto RA, 2011, CONSERV GENET, V12, P1447, DOI 10.1007/s10592-011-0243-8; Napolitano C, 2015, J HERED, V106, P522, DOI 10.1093/jhered/esv025; Nicholson KL, 2011, EUR J WILDLIFE RES, V57, P1151, DOI 10.1007/s10344-011-0528-8; Nielsen C., 2015, IUCN RED LIST THREAT, V2015, pET18868A97216466, DOI 10.2305/IUCN.UK.2015-4.RLTS.T18868A50663436.en; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Paviolo A, 2015, IUCN RED LIST THREAT; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Petracca LS, 2014, J NAT CONSERV, V22, P436, DOI 10.1016/j.jnc.2014.04.002; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2016, R FDN STAT COMP; Rannala B, 1997, P NATL ACAD SCI US; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rousset F, 1996, GENETICS, V142, P1357; Ruell EW, 2012, AM MIDL NAT, V168, P265, DOI 10.1674/0003-0031-168.2.265; Ruiz-Garcia M, 2012, MOL POPULATION GENET; Ruiz-Garcia M, 2006, GENES GENET SYST, V81, P115, DOI 10.1266/ggs.81.115; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; SEYMOUR K L, 1989, Mammalian Species, P1, DOI 10.2307/3504096; Sotiropoulos K, 2013, CONSERV GENET, V14, P385, DOI 10.1007/s10592-013-0452-4; Soto Fournier S, 2014, DIVERSIDAD GENETICA; Spinozzi F, 2012, REND LINCEI-SCI FIS, V23, P365, DOI 10.1007/s12210-012-0184-2; Stoner DC, 2008, J WILDLIFE MANAGE, V72, P933, DOI 10.2193/2007-219; Sunquist ME, 2002, WILD CATS WORLD; SWANK W G, 1989, Oryx, V23, P14; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Thompson DJ, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00028.1; Urquiza-Haas T, 2009, BIOL CONSERV, V142, P134, DOI 10.1016/j.biocon.2008.10.007; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wultsch C, 2015, WILDLIFE SOC B, V39, P403, DOI 10.1002/wsb.540; Wultsch C, 2014, MOL ECOL RESOUR, V14, P1171, DOI 10.1111/1755-0998.12266; Young CA, 2008, TROP CONSERV SCI, V1, P18, DOI 10.1177/194008290800100102; ZELLER K., 2007, JAGUARS NEW MILLENNI	121	23	24	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151043	10.1371/journal.pone.0151043	http://dx.doi.org/10.1371/journal.pone.0151043			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974968	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600046
J	Qian, BY; Xue, LY; Huang, HL				Qian, Baoying; Xue, Liangyi; Huang, Hongli			Liver Transcriptome Analysis of the Large Yellow Croaker (Larimichthys crocea) during Fasting by Using RNA-Seq	PLOS ONE			English	Article							PROTEIN-METABOLISM; GENE-EXPRESSION; GROWTH; STARVATION; MUSCLE; BRAIN	The large yellow croaker (Larimichthys crocea) is an economically important fish species in Chinese mariculture industry. To understand the molecular basis underlying the response to fasting, Illumina HiSeq (TM) 2000 was used to analyze the liver transcriptome of fasting large yellow croakers. A total of 54,933,550 clean reads were obtained and assembled into 110,364 contigs. Annotation to the NCBI database identified a total of 38,728 unigenes, of which 19,654 were classified into Gene Ontology and 22,683 were found in Kyoto Encyclopedia of Genes and Genomes (KEGG). Comparative analysis of the expression profiles between fasting fish and normal-feeding fish identified a total of 7,623 differentially expressed genes (P < 0.05), including 2,500 upregulated genes and 5,123 downregulated genes. Dramatic differences were observed in the genes involved in metabolic pathways such as fat digestion and absorption, citrate cycle, and glycolysis/gluconeogenesis, and the similar results were also found in the transcriptome of skeletal muscle. Further qPCR analysis confirmed that the genes encoding the factors involved in those pathways significantly changed in terms of expression levels. The results of the present study provide insights into the molecular mechanisms underlying the metabolic response of the large yellow croaker to fasting as well as identified areas that require further investigation.	[Qian, Baoying; Xue, Liangyi; Huang, Hongli] Ningbo Univ, Coll Marine Sci, Ningbo 315211, Zhejiang, Peoples R China; [Qian, Baoying] Taizhou Univ, Sch Iife Sci, Taizhou, Zhejiang, Peoples R China; [Xue, Liangyi] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Taizhou University; Ningbo University	Xue, LY (corresponding author), Ningbo Univ, Coll Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.; Xue, LY (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo 315211, Zhejiang, Peoples R China.	xueliangyi@nbu.edu.cn			National Natural Science Foundation of China [31172398]; Science and Technology Department of Ningbo Municipality [2015C110005]; Zhejiang Provincial Natural Science Foundation of China [LY15C190005]; Zhejiang Provincial top key discipline of aquaculture in Ningbo University [xkzsc1410]; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Ningbo Municipality; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial top key discipline of aquaculture in Ningbo University; K. C. Wong Magna Fund in Ningbo University	The project was supported by National Natural Science Foundation of China (Grant No. 31172398), http://www.nsfc.gov.cn/publish/portal0/, LX: $. 96,660; Science and Technology Department of Ningbo Municipality (Grant No. 2015C110005), http://www.nbsti.gov.cn/gb/, LX: $. 84,577.5; The Project Supported by Zhejiang Provincial Natural Science Foundation of China (Grant No. LY15C190005), http://www.zjnsf.gov.cn/, LX: $. 14,449; The open fund of Zhejiang Provincial top key discipline of aquaculture in Ningbo University (Grant No. xkzsc1410), http://www.nbu.edu.cn/, BQ: $.12,888; K. C. Wong Magna Fund in Ningbo University, http://www.nbu.edu.cn/, LX: $.0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda A, 2001, PHYSIOL BEHAV, V73, P105, DOI 10.1016/S0031-9384(01)00464-4; Beckman BR, 2011, GEN COMP ENDOCR, V170, P233, DOI 10.1016/j.ygcen.2010.08.009; Caballero MJ, 1999, AQUACULTURE, V179, P277, DOI 10.1016/S0044-8486(99)00165-9; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Fox SE, 2014, MAR GENOM, V15, P13, DOI 10.1016/j.margen.2013.12.001; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Frick NT, 2008, COMP BIOCHEM PHYS A, V151, P85, DOI 10.1016/j.cbpa.2008.06.003; Gabillard JC, 2006, J ENDOCRINOL, V191, P15, DOI 10.1677/joe.1.06869; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Havel R J, 1975, Adv Exp Med Biol, V63, P37; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Johansen KA, 2006, COMP BIOCHEM PHYS B, V144, P119, DOI 10.1016/j.cbpb.2006.02.001; Liu RZ, 2003, EUR J BIOCHEM, V270, P3223, DOI 10.1046/j.1432-1033.2003.03705.x; Magnanou E, 2014, GENE, V544, P56, DOI 10.1016/j.gene.2014.04.032; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Meton I, 2003, AQUACULTURE, V225, P99, DOI 10.1016/S0044-8486(03)00281-3; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mommsen TP, 2004, COMP BIOCHEM PHYS B, V139, P383, DOI 10.1016/j.cbpc.2004.09.018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097471; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Picha ME, 2008, N AM J AQUACULT, V70, P196, DOI 10.1577/A07-038.1; Power DM, 2000, J FISH BIOL, V56, P374, DOI 10.1111/j.1095-8649.2000.tb02112.x; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Salem M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-328; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Takahashi LS, 2011, J ANIM PHYSIOL AN N, V95, P259, DOI 10.1111/j.1439-0396.2010.01050.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATANABE T, 1982, COMP BIOCHEM PHYS B, V73, P3, DOI 10.1016/0305-0491(82)90196-1; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Xiao SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124432; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319	36	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150240	10.1371/journal.pone.0150240	http://dx.doi.org/10.1371/journal.pone.0150240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967898	gold, Green Published, Green Submitted			2022-12-27	WOS:000371989200009
J	Bywater, RP				Bywater, Robert P.			Comparison of Algorithms for Prediction of Protein Structural Features from Evolutionary Data	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; CORRELATED MUTATIONS; RESIDUE CONTACTS; SUBSTITUTIONS; CONSTRAINTS; INFORMATION; FAMILIES	Proteins have many functions and predicting these is still one of the major challenges in theoretical biophysics and bioinformatics. Foremost amongst these functions is the need to fold correctly thereby allowing the other genetically dictated tasks that the protein has to carry out to proceed efficiently. In this work, some earlier algorithms for predicting protein domain folds are revisited and they are compared with more recently developed methods. In dealing with intractable problems such as fold prediction, when different algorithms show convergence onto the same result there is every reason to take all algorithms into account such that a consensus result can be arrived at. In this work it is shown that the application of different algorithms in protein structure prediction leads to results that do not converge as such but rather they collude in a striking and useful way that has never been considered before.	[Bywater, Robert P.] Francis Crick Inst, London NW7 1AA, England	Francis Crick Institute	Bywater, RP (corresponding author), Francis Crick Inst, London NW7 1AA, England.	robert.bywater@crick.ac.uk	Bywater, Robert Paul/AAY-1093-2020	Bywater, Robert Paul/0000-0002-3047-8123				ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Bywater RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119306; Bywater RP, 2013, J BIOMOL STRUCT DYN, V31, P351, DOI 10.1080/07391102.2012.703062; Bywater RP, 2016, TENSEGRITY IN PRESS; Crippen GM, 1988, DISTANCE GEOMETRY MO; de Moraes FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087107; Debe DA, 1999, J PHYS CHEM B, V103, P3001, DOI 10.1021/jp983429+; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Henikoff S, 1999, BIOINFORMATICS, V15, P471, DOI 10.1093/bioinformatics/15.6.471; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; KOLMOGOROV AN, 1968, INT J COMPUT MATH, V2, P157, DOI 10.1080/00207166808803030; Lund O, 1996, PROTEIN SCI, V5, P2217, DOI 10.1002/pro.5560051108; MACKAY AL, 1974, ACTA CRYSTALLOGR A, VA 30, P440, DOI 10.1107/S0567739474000945; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Oliveira L, 2003, PROTEINS, V52, P544, DOI 10.1002/prot.10490; Oliveira L, 2002, CHEMBIOCHEM, V3, P1010, DOI 10.1002/1439-7633(20021004)3:10<1010::AID-CBIC1010>3.0.CO;2-T; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Seddon GM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120087; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Singer MS, 2002, PROTEIN ENG, V15, P721, DOI 10.1093/protein/15.9.721; Talavera D, 2015, MOL BIOL EVOL, V32, P2456, DOI 10.1093/molbev/msv109; Taylor WR, 2013, CURR OPIN STRUC BIOL, V23, P473, DOI 10.1016/j.sbi.2013.04.001; Taylor WR, 2012, PROTEIN SCI, V21, P299, DOI 10.1002/pro.2002; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150769	10.1371/journal.pone.0150769	http://dx.doi.org/10.1371/journal.pone.0150769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963911	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000061
J	Chung, SD; Wang, KH; Tsai, MC; Lin, HC; Chen, CH				Chung, Shiu-Dong; Wang, Kuo-Hsien; Tsai, Ming-Chieh; Lin, Herng-Ching; Chen, Chao-Hung			Hyperlipidemia Is Associated with Chronic Urticaria: A Population-Based Study	PLOS ONE			English	Article							CHRONIC IDIOPATHIC URTICARIA; MAST-CELLS; METABOLIC SYNDROME; PLASMA-LEVELS; DISEASE; ATHEROSCLEROSIS; EPIDEMIOLOGY; EXPRESSION; CYTOKINES; MARKERS	The etiology of chronic urticaria (CU) is diverse, with chronic infections and inflammation being reported as considerable contributing factors. Although the prevalence of metabolic syndrome was found to be significantly elevated in patients with CU, no one has specifically estimated the effects on CU following hyperlipidemia. This study aimed to examine the association between hyperlipidemia and CU using a population-based dataset in Taiwan. This study included 9798 adults with CU as cases and 9798 sex-and age-matched controls. These patients were examined for whether they had received a prior diagnosis of hyperlipidemia. We used conditional logistic regression analyses to calculate the odds ratio (OR) and its corresponding 95% confidence interval (CI) for having been previously diagnosed with hyperlipidemia between cases and controls. In total, 7066 (36.1%) patients had received a prior diagnosis of hyperlipidemia, including 4287 (43.8%) among CU cases and 2779 (28.4%) among controls. The conditional logistic regression revealed that the OR of prior hyperlipidemia for cases was 1.97 (95% CI: 1.85 similar to 2.09) compared to the controls. Furthermore, compared to patients without CU, patients with CU independently experienced a 1.65-fold (95% CI = 1.55 similar to 1.76; p<0.001) increased risk of having a prior hyperlipidemia diagnosis, after adjustments were made. We concluded that CU was associated with having received a prior diagnosis of hyperlipidemia.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Taipei, Taiwan; [Chung, Shiu-Dong] Yuan Univ, Coll Informat, Grad Program Biomed Informat, Chungli, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Wang, Kuo-Hsien] Taipei Med Univ & Hosp, Dept Dermatol, Taipei, Taiwan; [Tsai, Ming-Chieh; Lin, Herng-Ching] Taipei Med Univ, Sch Healthcare Adm, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Hsinchu Branch, Dept Internal Med, Hsinchu, Taiwan; [Chen, Chao-Hung] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Chen, Chao-Hung] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chen, Chao-Hung] MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan	Far Eastern Memorial Hospital; Yuan Ze University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cathay General Hospital; National Yang Ming Chiao Tung University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital	Lin, HC (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.; Lin, HC (corresponding author), Taipei Med Univ, Sch Healthcare Adm, Taipei, Taiwan.	s448@eip.mkc.edu.tw	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Chow SKW, 2012, ASIA PAC ALLERGY, V2, P149, DOI 10.5415/apallergy.2012.2.2.149; Devaraj S, 2004, ENDOCRIN METAB CLIN, V33, P431, DOI 10.1016/j.ecl.2004.03.008; dos Santos JC, 2008, INT IMMUNOPHARMACOL, V8, P1433, DOI 10.1016/j.intimp.2008.05.016; Gaig P, 2004, J INVEST ALLERG CLIN, V14, P214; HARRIS A, 1983, ANN ALLERGY, V51, P161; Kaplan AP, 2009, CLIN EXP ALLERGY, V39, P777, DOI 10.1111/j.1365-2222.2009.03256.x; Kasperska-Zajac A, 2012, J EUR ACAD DERMATOL, V26, P665, DOI 10.1111/j.1468-3083.2011.04366.x; Kasperska-Zajac A, 2011, CLIN EXP ALLERGY, V41, P1386, DOI 10.1111/j.1365-2222.2011.03789.x; KOBAYASHI S, 1989, Journal of Dermatology (Tokyo), V16, P196; Kulthanan K, 2007, J DERMATOL, V34, P294, DOI 10.1111/j.1346-8138.2007.00276.x; Libby P, 1995, J CARDIOVASC PHARM, V25, pS9, DOI 10.1097/00005344-199500252-00003; Mathelier-Fusade P, 2006, CLIN REV ALLERG IMMU, V30, P19, DOI 10.1385/CRIAI:30:1:019; Metzler B, 1997, INT ARCH ALLERGY IMM, V114, P10, DOI 10.1159/000237636; Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959; Poon E, 1999, BRIT J DERMATOL, V140, P667; Prevete N, 2013, J BIOL REG HOMEOS AG, V27, P827; Sanchez-Borges M, 2012, WORLD ALLERGY ORGAN, V5, P125, DOI 10.1097/WOX.0b013e3182758d6c; Sheikh J, 2005, CURR OPIN ALLERGY CL, V5, P403, DOI 10.1097/01.all.0000182540.45348.bc; Siasos G, 2011, CURR PHARM DESIGN, V17, P4132, DOI 10.2174/138161211798764780; Spinas E, 2014, INT J IMMUNOPATH PH, V27, P517, DOI 10.1177/039463201402700407; Staubach P, 2006, BRIT J DERMATOL, V154, P294, DOI 10.1111/j.1365-2133.2005.06976.x; Takahagi S, 2010, ALLERGY, V65, P649, DOI 10.1111/j.1398-9995.2009.02222.x; Tedeschi A, 2010, CLIN EXP ALLERGY, V40, P875, DOI 10.1111/j.1365-2222.2010.03473.x; Tedeschi A, 2009, ALLERGY, V64, P1616, DOI 10.1111/j.1398-9995.2009.02069.x; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; Ye YM, 2013, ACTA DERM-VENEREOL, V93, P156, DOI 10.2340/00015555-1443; Zhong H, 2014, ALLERGY, V69, P359, DOI 10.1111/all.12338; Zuberbier T, 2006, ALLERGY, V61, P316, DOI 10.1111/j.1398-9995.2005.00964.x; Zuberbier T, 2010, CLIN EXP DERMATOL, V35, P869, DOI 10.1111/j.1365-2230.2010.03840.x	29	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150304	10.1371/journal.pone.0150304	http://dx.doi.org/10.1371/journal.pone.0150304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964045	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000029
J	Jonker, SJ; Menting, TP; Warle, MC; Ritskes-Hoitinga, M; Wever, KE				Jonker, Simone J.; Menting, Theo P.; Warle, Michiel C.; Ritskes-Hoitinga, Merel; Wever, Kimberley E.			Preclinical Evidence for the Efficacy of Ischemic Postconditioning against Renal Ischemia-Reperfusion Injury, a Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-INFARCTION; GRAFT FUNCTION; SEARCH FILTER; ANIMAL-MODELS; KIDNEY; REMOTE; PROTECTION; ATTENUATION; ACTIVATION	Background Renal ischemia-reperfusion injury (IRI) is a major cause of kidney damage after e.g. renal surgery and transplantation. Ischemic postconditioning (IPoC) is a promising treatment strategy for renal IRI, but early clinical trials have not yet replicated the promising results found in animal studies. Method We present a systematic review, quality assessment and meta-analysis of the preclinical evidence for renal IPoC, and identify factors which modify its efficacy. Results We identified 39 publications studying >250 control animals undergoing renal IRI only and >290 animals undergoing renal IRI and IPoC. Healthy, male rats undergoing warm ischemia were used in the vast majority of studies. Four studies applied remote IPoC, all others used local IPoC. Meta-analysis showed that both local and remote IPoC ameliorated renal damage after IRI for the outcome measures serum creatinine, blood urea nitrogen and renal histology. Subgroup analysis indicated that IPoC efficacy increased with the duration of index ischemia. Measures to reduce bias were insufficiently reported. Conclusion High efficacy of IPoC is observed in animal models, but factors pertaining to the internal and external validity of these studies may hamper the translation of IPoC to the clinical setting. The external validity of future animal studies should be increased by including females, comorbid animals, and transplantation models, in order to better inform clinical trial design. The severity of renal damage should be taken into account in the design and analysis of future clinical trials.	[Jonker, Simone J.; Ritskes-Hoitinga, Merel; Wever, Kimberley E.] Radboud Univ Nijmegen, Med Ctr, SYstemat Review Ctr Lab Anim Experimentat SYRCLE, NL-6525 ED Nijmegen, Netherlands; [Menting, Theo P.; Warle, Michiel C.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Wever, KE (corresponding author), Radboud Univ Nijmegen, Med Ctr, SYstemat Review Ctr Lab Anim Experimentat SYRCLE, NL-6525 ED Nijmegen, Netherlands.	kim.wever@radboudumc.nl	Warle, M.C./L-4743-2015; Ritskes-Hoitinga, J./H-8083-2014; Ritskes-Hoitinga, Merel/GLT-8517-2022; Wever, Kimberley E./D-9705-2016	Ritskes-Hoitinga, Merel/0000-0001-5315-284X; Wever, Kimberley E./0000-0003-3635-3660				Abdelnoor M, 2014, VASC HEALTH RISK MAN, V10, P477, DOI 10.2147/VHRM.S67154; Bice JS, 2015, BRIT J PHARMACOL, V172, P1933, DOI 10.1111/bph.12976; Chen HB, 2015, NEUROLOGY, V85, P481, DOI 10.1212/WNL.0000000000001813; Chen H, 2008, TRANSPL INT, V21, P364, DOI 10.1111/j.1432-2277.2007.00606.x; Chen H, 2014, RENAL FAILURE, V36, P1575, DOI 10.3109/0886022X.2014.949769; [陈莉娜 Chen Lina], 2011, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V32, P684; Currie GL, 2013, PAIN, V154, P917, DOI 10.1016/j.pain.2013.02.033; Dasta JF, 2008, NEPHROL DIAL TRANSPL, V23, P1970, DOI 10.1093/ndt/gfm908; de Vries RBM, 2014, LAB ANIM-UK, V48, P88, DOI 10.1177/0023677213494374; Eldaif SM, 2010, TRANSPL INT, V23, P217, DOI 10.1111/j.1432-2277.2009.00949.x; Fan ZL, 2009, J DALIAN MED U, V31, P524; Guo QM, 2014, MOL MED REP, V10, P2875, DOI 10.3892/mmr.2014.2641; HOLM S, 1979, SCAND J STAT, V6, P65; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Ji Xiang, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P511; Jiang B, 2012, TRANSPL P, V44, P1776, DOI 10.1016/j.transproceed.2012.05.040; Jiang BT, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.06.055; Jiang H, 2014, IR J MED SCI; Jonker SJ, 2015, SYSTEMATIC REV PROTO; Kadkhodaee M, 2014, INT J SURG, V12, P1162, DOI 10.1016/j.ijsu.2014.09.007; Kadkhodaee M, 2011, TRANSPLANTATION, V92, pE55, DOI 10.1097/TP.0b013e31823411f8; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; Khan AR, 2014, AM HEART J, V168, P512, DOI 10.1016/j.ahj.2014.06.021; Kim WH, 2014, TRANSPLANTATION, V98, P529, DOI 10.1097/TP.0000000000000098; Lemoine S, 2015, TRANSPLANTATION, V99, P717, DOI 10.1097/TP.0000000000000530; [李嫚 Li Man], 2012, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V33, P644; Li Yan, 2010, Yaoxue Xuebao, V45, P840; Liu XH, 2007, BIOCHEM BIOPH RES CO, V359, P628, DOI 10.1016/j.bbrc.2007.05.129; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Mahfoudh-Boussaid A, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-71; Mahmoudi A, 2014, ACTA PHYSL HUNG, P1; Mavridis D, 2014, EVID-BASED MENT HEAL, V17, P11, DOI 10.1136/eb-2013-101700; McCafferty K, 2014, DIS MODEL MECH, V7, P1321, DOI 10.1242/dmm.016741; Miklos Z, 2012, CLIN HEMORHEOL MICRO, V50, P167, DOI 10.3233/CH-2011-1414; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Przyklenk K, 2011, DRUG AGING, V28, P331, DOI 10.2165/11587190-000000000-00000; Robert R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-14; Roodnat JI, 2003, TRANSPLANTATION, V75, P799, DOI 10.1097/01.TP.0000056632.00848.8D; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Serviddio G, 2008, NEPHROL DIAL TRANSPL, V23, P1504, DOI 10.1093/ndt/gfm779; Shokeir AA, 2014, ACTA PHYSIOL, V210, P342, DOI 10.1111/apha.12164; Shokeir AA, 2012, ARAB J UROL, V10, P418, DOI 10.1016/j.aju.2012.08.003; Szwarc I, 2007, TRANSPL P, V39, P2554, DOI 10.1016/j.transproceed.2007.08.026; Tan XH, 2013, NEPHROL DIAL TRANSPL, V28, P2754, DOI 10.1093/ndt/gft278; [唐铁龙 TANG Tielong], 2008, [中国输血杂志, Chinese Journal of Blood Transfusion], V21, P502; [陶佳意 Tao Jiayi], 2012, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V16, P10015; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; van den Akker EK, 2014, TRANSPL INT, V27, P226, DOI 10.1111/tri.12242; van den Akker EK, 2013, TRANSPLANTATION, V95, P1299, DOI 10.1097/TP.0b013e318281b934; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Wang W, 2010, J UROLOGY, V183, P2424, DOI 10.1016/j.juro.2010.01.066; Weng X, 2012, UROLOGY, V80, P481, DOI DOI 10.1016/J.UR0L0GY.2012.02.054; Wever KE, 2012, TRANSPLANTATION, V94, pE1, DOI 10.1097/TP.0b013e318257ad76; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Xia AZ, 2014, INT UROL NEPHROL, V46, P1455, DOI 10.1007/s11255-014-0748-4; Yun Y, 2009, TRANSPL P, V41, P3597, DOI 10.1016/j.transproceed.2009.06.203; Yun Y, 2009, TRANSPL P, V41, P3585, DOI 10.1016/j.transproceed.2009.06.209; Zhang WL, 2011, CHINESE MED J-PEKING, V124, P2191, DOI 10.3760/cma.j.issn.0366-6999.2011.14.020; Zhao ZQ, 2010, CARDIOVASC DRUG THER, V24, P265, DOI 10.1007/s10557-010-6240-1; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zhu Yu-chun, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P921; Zhuang SL B., 2009, OPEN PATHOLOGY J, V3, P18, DOI DOI 10.1016/J.INTIMP.2014.11.011	67	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150863	10.1371/journal.pone.0150863	http://dx.doi.org/10.1371/journal.pone.0150863			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963819	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000071
J	Ngeve, MN; Van der Stocken, T; Menemenlis, D; Koedam, N; Triest, L				Ngeve, Magdalene N.; Van der Stocken, Tom; Menemenlis, Dimitris; Koedam, Nico; Triest, Ludwig			Contrasting Effects of Historical Sea Level Rise and Contemporary Ocean Currents on Regional Gene Flow of Rhizophora racemosa in Eastern Atlantic Mangroves	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; COLOMBIAN PACIFIC COAST; CLIMATE-CHANGE; AVICENNIA-GERMINANS; POPULATION-STRUCTURE; MOZAMBIQUE CHANNEL; EQUATORIAL-GUINEA; MUCRONATA LAM.; SEED DISPERSAL; CENTRAL-AFRICA	Mangroves are seafaring taxa through their hydrochorous propagules that have the potential to disperse over long distances. Therefore, investigating their patterns of gene flow provides insights on the processes involved in the spatial genetic structuring of populations. The coastline of Cameroon has a particular geomorphological history and coastal hydrology with complex contemporary patterns of ocean currents, which we hypothesize to have effects on the spatial configuration and composition of present-day mangroves within its spans. A total of 982 trees were sampled from 33 transects (11 sites) in 4 estuaries. Using 11 polymorphic SSR markers, we investigated genetic diversity and structure of Rhizophora racemosa, a widespread species in the region. Genetic diversity was low to moderate and genetic differentiation between nearly all population pairs was significant. Bayesian clustering analysis, PCoA, estimates of contemporary migration rates and identification of barriers to gene flow were used and complemented with estimated dispersal trajectories of hourly released virtual propagules, using high-resolution surface current from a mesoscale and tide-resolving ocean simulation. These indicate that the Cameroon Volcanic Line (CVL) is not a present-day barrier to gene flow. Rather, the Inter-Bioko-Cameroon (IBC) corridor, formed due to sea level rise, allows for connectivity between two mangrove areas that were isolated during glacial times by the CVL. Genetic data and numerical ocean simulations indicated that an oceanic convergence zone near the Cameroon Estuary complex (CEC) presents a strong barrier to gene flow, resulting in genetic discontinuities between the mangrove areas on either side. This convergence did not result in higher genetic diversity at the CEC as we had hypothesized. In conclusion, the genetic structure of Rhizophora racemosa is maintained by the contrasting effects of the contemporary oceanic convergence and historical climate change-induced sea level rise.	[Ngeve, Magdalene N.; Van der Stocken, Tom; Koedam, Nico; Triest, Ludwig] Vrije Univ Brussel, Lab Plant Biol & Nat Management APNA, Dept Biol, Pleinlaan 2, B-1050 Brussels, Belgium; [Menemenlis, Dimitris] CALTECH, Jet Prop Lab, Div Earth Sci, Pasadena, CA USA	Vrije Universiteit Brussel; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Ngeve, MN (corresponding author), Vrije Univ Brussel, Lab Plant Biol & Nat Management APNA, Dept Biol, Pleinlaan 2, B-1050 Brussels, Belgium.	ngevem@yahoo.com	Menemenlis, Dimitris/G-8091-2017	Ngeve, Magdalene/0000-0001-8201-514X; Triest, Ludwig/0000-0002-4946-9614; Van der Stocken, Tom/0000-0002-1820-9123	Vrije Universiteit Brussel-International Relations and Mobility Office (VUB-IRMO) Doctoral Scholarship; Doctoral School NSE of the VUB [NSE-TG-2013-82]; VUB; National Aeronautics and Space Administration (NASA)	Vrije Universiteit Brussel-International Relations and Mobility Office (VUB-IRMO) Doctoral Scholarship; Doctoral School NSE of the VUB; VUB; National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	This study was financed by the Vrije Universiteit Brussel-International Relations and Mobility Office (VUB-IRMO) Doctoral Scholarship awarded to M.N. Ngeve. The Doctoral School NSE of the VUB also awarded a travel grant (NSE-TG-2013-82) to M.N. Ngeve. The BAS 42 funding of the VUB also supported the laboratory analyses of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We extend sincere gratitude to Ma Christiana Nalova Ngenye, Mr. and Mrs. Ndoko Joseph (Ekondo-Titi), Pr. and Mrs. Oben Samuel (Bekumu), Mr. Peter Elive Ikome (Douala), Pr. Eban Daniel, Pr. Ntakim Clarence, Rev. Okala Dieudonne Bienvenue, Pr. and Mrs. Atiko Pierre (Kribi), Elder Atkin Egbe Obie (Kribi), Eugene N. Ngeve, and Ms Natalie Kana for logistical and field assistance. We are also grateful to Tim Sierens for technical and laboratory assistance. The numerical ocean modeling component of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration (NASA).	Adams AN, 2015, J GEOPHYS RES-SOL EA, V120, P1708, DOI 10.1002/2014JB011580; Alemagi Dieudonne, 2006, Environmentalist, V26, P41, DOI 10.1007/s10669-006-5357-z; Alleman LK, 2011, ESTUAR COAST, V34, P1068, DOI 10.1007/s12237-011-9404-8; ALLEN J. A., 2006, PAC SCI, V60, P657; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Alongi DM, 2015, CURR CLIM CHANGE REP, V1, P30, DOI 10.1007/s40641-015-0002-x; Arbelaez-Cortes E, 2007, HYDROBIOLOGIA, V583, P321, DOI 10.1007/s10750-007-0622-9; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Atheull AN, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-35; AYRE DJ, 1994, EVOLUTION, V48, P1183, DOI 10.1111/j.1558-5646.1994.tb05304.x; Balke T, 2011, MAR ECOL PROG SER, V440, P1, DOI 10.3354/meps09364; Briggs JC, 2013, J BIOGEOGR, V40, P1023, DOI 10.1111/jbi.12082; Britton J. C., 1989, SHORE ECOLOGY GULF M; Castillo-Cardenas MF, 2005, BIOTROPICA, V37, P266, DOI 10.1111/j.1744-7429.2005.00036.x; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Ceron-Souza I, 2005, BIOTROPICA, V37, P258, DOI 10.1111/j.1744-7429.2005.00035.x; Ceron-Souza I, 2015, ECOL EVOL, V5, P3486, DOI 10.1002/ece3.1569; Ceron-Souza I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-205; Clarke PJ, 2001, J ECOL, V89, P648, DOI 10.1046/j.0022-0477.2001.00584.x; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; Corcoran E., 2007, UNEP WCMC BIODIVERSI, V26; Cordon-Obras C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-31; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dahdouh-Guebas F, 2005, CURR BIOL, V15, pR443, DOI 10.1016/j.cub.2005.06.008; Dahdouh-Guebas F, 2001, HYDROBIOLOGIA, V458, P241, DOI 10.1023/A:1013126832741; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; De Ryck DJR, 2012, AQUAT BOT, V103, P66, DOI 10.1016/j.aquabot.2012.06.005; Di Nitto D, 2014, BIOGEOSCIENCES, V11, P857, DOI 10.5194/bg-11-857-2014; Diop S., 2014, LAND OCEAN INTERACTI; Dodd RS, 2002, MOL ECOL, V11, P1327, DOI 10.1046/j.1365-294X.2002.01525.x; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Drexler Judy Z., 2001, Pacific Science, V55, P17, DOI 10.1353/psc.2001.0004; Duke NC, 2002, TREES-STRUCT FUNCT, V16, P65, DOI 10.1007/s00468-001-0141-7; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1365-2699.1999.00126.x; Ellison Joanna C, 2012, Biology (Basel), V1, P617, DOI 10.3390/biology1030617; Elsheikh AA, 2014, J AFR EARTH SCI, V100, P96, DOI 10.1016/j.jafrearsci.2014.06.011; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Godoy MDP, 2015, AN ACAD BRAS CIENC, V87, P651, DOI 10.1590/0001-3765201520150055; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gunn CR., 1999, WORLD GUIDE TROPICAL; Hancke L, 2014, DEEP-SEA RES PT II, V100, P27, DOI 10.1016/j.dsr2.2013.10.014; Hill C, 2007, SCI PROGRAMMING-NETH, V15, P107, DOI 10.1155/2007/458463; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Lammi A, 1999, CONSERV BIOL, V13, P1069, DOI 10.1046/j.1523-1739.1999.98278.x; Lo EYY, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-83; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Menezes Moirah Paula Machado de, 2008, Acta Amaz., V38, P403, DOI 10.1590/S0044-59672008000300004; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; MENEMENLIS D, 2008, MERCATOR OCEAN Q NEW, V31, P13; Menezes MPM, 1997, ACTA HORTIC, V437, P431; Mitarai S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005166; Mori GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118710; Munji CA, 2014, ESTUAR COAST SHELF S, V140, P67, DOI 10.1016/j.ecss.2013.11.017; Nadia TL, 2014, AN ACAD BRAS CIENC, V86, P229, DOI 10.1590/0001-37652014101712; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; NEI M, 1978, GENETICS, V89, P583; Nettel A, 2007, EVOLUTION, V61, P958, DOI 10.1111/j.1558-5646.2007.00070.x; Nfotabong-Atheull A, 2013, ESTUAR COAST, V36, P1181, DOI 10.1007/s12237-013-9638-8; Nfotabong-Atheull A, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-41; Ng W, 2015, CONSERV GENET, V16, P137, DOI 10.1007/s10592-014-0647-3; Ngeve MN, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4574-7; Ngeve MN, 2016, AQUATIC BOT UNPUB; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pernetta John, 1993, MANGROVE FORESTS CLI; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; Peterson JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119128; Pil MW, 2011, AM J BOT, V98, P1031, DOI 10.3732/ajb.1000392; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Quisthoudt K, 2013, BIODIVERS CONSERV, V22, P1369, DOI 10.1007/s10531-013-0478-4; Quisthoudt K, 2012, TREES-STRUCT FUNCT, V26, P1919, DOI 10.1007/s00468-012-0760-1; Randin CF, 2013, GLOBAL ECOL BIOGEOGR, V22, P913, DOI 10.1111/geb.12040; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Sandoval-Castro E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093358; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Simpson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107610; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; Steele O, 2006, THESIS U HAWAII MANO, P93; Steinke TD, 2003, AFR J MAR SCI, V25, P169, DOI 10.2989/18142320309504007; Su GH, 2006, AQUAT BOT, V84, P341, DOI 10.1016/j.aquabot.2006.01.001; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Ternon JF, 2014, DEEP-SEA RES PT II, V100, P10, DOI 10.1016/j.dsr2.2013.10.013; Thomas L, 2015, P ROY SOC B-BIOL SCI, V282, P50, DOI 10.1098/rspb.2015.1217; Triest L, 2008, AQUAT BOT, V89, P138, DOI 10.1016/j.aquabot.2007.12.013; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wagner Philipp, 2014, Bonn Zoological Bulletin, V63, P1; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Wee AKS, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0331-3; Wee AKS, 2014, J BIOGEOGR, V41, P954, DOI 10.1111/jbi.12263; Wee K.S., 2013, THESIS NATL U SINGAP; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wilson GA, 2003, GENETICS, V163, P1177; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; Wronski T, 2014, J MOLLUS STUD, V80, P161, DOI 10.1093/mollus/eyu008	116	31	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150950	10.1371/journal.pone.0150950	http://dx.doi.org/10.1371/journal.pone.0150950			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964094	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000371993000085
J	Schimmer, RC; Urner, M; Voigtsberger, S; Booy, C; Z'Graggen, BR; Beck-Schimmer, B; Schlapfer, M				Schimmer, Ralph C.; Urner, Martin; Voigtsberger, Stefanie; Booy, Christa; Z'Graggen, Birgit Roth; Beck-Schimmer, Beatrice; Schlaepfer, Martin			Inflammatory Kidney and Liver Tissue Response to Different Hydroxyethylstarch (HES) Preparations in a Rat Model of Early Sepsis	PLOS ONE			English	Article							ORGAN FAILURE; INJURY; RESUSCITATION; SEVOFLURANE; DISEASE; PATHOPHYSIOLOGY; MECHANISMS; MORTALITY; SEVERITY; THERAPY	Background Tissue hypoperfusion and inflammation in sepsis can lead to organ failure including kidney and liver. In sepsis, mortality of acute kidney injury increases by more than 50%. Which type of volume replacement should be used is still an ongoing debate. We investigated the effect of different volume strategies on inflammatory mediators in kidney and liver in an early sepsis model. Material and Methods Adult male Wistar rats were subjected to sepsis by cecal ligation and puncture (CLP) and assigned to three fluid replenishment groups. Animals received 30mL/kg of Ringer's lactate (RL) for 2h, thereafter RL (75mL/kg), hydroxyethyl starch (HES) balanced (25mL/kg), containing malate and acetate, or HES saline (25mL/kg) for another 2h. Kidney and liver tissue was assessed for inflammation. In vitro rat endothelial cells were exposed to RL, HES balanced or HES saline for 2h, followed by stimulation with tumor necrosis factor-alpha (TNF-alpha) for another 4h. Alternatively, cells were exposed to malate, acetate or a mixture of malate and acetate, reflecting the according concentration of these substances in HES balanced. Pro-inflammatory cytokines were determined in cell supernatants. Results Cytokine mRNA in kidney and liver was increased in CLP animals treated with HES balanced compared to RL, but not after application of HES saline. MCP-1 was 3.5fold (95% CI: 1.3, 5.6) (p<0.01) and TNF-alpha 2.3fold (95% CI: 1.2, 3.3) (p<0.001) upregulated in the kidney. Corresponding results were seen in liver tissue. TNF-alpha-stimulated endothelial cells co-exposed to RL expressed 3529 +/- 1040pg/mL MCP-1 and 59 +/- 23pg/mL CINC-1 protein. These cytokines increased by 2358pg/mL (95% CI: 1511, 3204) (p<0.001) and 29pg/ml (95% CI: 14, 45) (p<0.01) respectively when exposed to HES balanced instead. However, no further upregulation was observed with HES saline. PBS supplemented with acetate increased MCP-1 by 1325pg/mL (95% CI: 741, 1909) (p<0.001) and CINC-1 by 24pg/mL (95% CI: 9, 38) (p<0.01) compared to RL. Malate as well as HES saline did not affect cytokine expression. Conclusion We identified HES balanced and specifically its component acetate as pro-inflammatory factor. How important this additional inflammatory burden on kidney and liver function is contributing to the sepsis-associated inflammatory burden in early sepsis needs further evaluation.	[Schimmer, Ralph C.] Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland; [Urner, Martin; Voigtsberger, Stefanie; Beck-Schimmer, Beatrice; Schlaepfer, Martin] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Urner, Martin; Booy, Christa; Z'Graggen, Birgit Roth; Beck-Schimmer, Beatrice; Schlaepfer, Martin] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Urner, Martin; Booy, Christa; Z'Graggen, Birgit Roth; Beck-Schimmer, Beatrice; Schlaepfer, Martin] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Beck-Schimmer, Beatrice] Univ Illinois, Dept Anesthesiol, Chicago, IL USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Schimmer, RC (corresponding author), Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland.	ralphchristian.schimmer@uzh.ch	Urner, Martin/AAK-5701-2020; Schlaepfer, Martin/B-9243-2017; Schlaepfer, Martin/AAA-3587-2021	Urner, Martin/0000-0003-1133-4885; Schlaepfer, Martin/0000-0003-4288-7124; Schlaepfer, Martin/0000-0003-4288-7124	Swiss National Science Foundation [3200B0-122305]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Institutional funding and the Swiss National Science Foundation, Grant number 3200B0-122305, www.snsf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2006, CURR OPIN CRIT CARE, V12, P527, DOI 10.1097/01.ccx.0000247446.09500.ac; Bayer O, 2011, CRIT CARE MED, V39, P1335, DOI 10.1097/CCM.0b013e318212096a; BINGEL M, 1987, LANCET, V1, P14; Bion J, 2014, INTENS CARE MED, V40, P256, DOI 10.1007/s00134-013-3167-6; Blumenthal S, 2006, ANESTHESIOLOGY, V104, P961, DOI 10.1097/00000542-200605000-00012; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Coriat P, 2014, BRIT J ANAESTH, V113, P194, DOI 10.1093/bja/aeu217; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; Gillies MA, 2014, BRIT J ANAESTH, V112, P25, DOI 10.1093/bja/aet303; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Hartog CS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5981; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Karimova A, 2001, INTENS CARE MED, V27, P19, DOI 10.1007/s001340000790; Kuznetsova A., 2013, LMERTEST TESTS RANDO, V2; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; MURPHY HS, 1992, AM J PHYSIOL, V263, pL51, DOI 10.1152/ajplung.1992.263.1.L51; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ronco C, 2008, CLIN J AM SOC NEPHRO, V3, P531, DOI 10.2215/CJN.03830907; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schlaepfer M, 2012, CLIN EXP IMMUNOL, V168, P125, DOI 10.1111/j.1365-2249.2012.04562.x; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Suter D, 2007, ANESTH ANALG, V104, P638, DOI 10.1213/01.ane.0000255046.06058.58; Thaha M, 2005, Acta Med Indones, V37, P145; Van Der Linden P, 2013, ANESTH ANALG, V116, P35, DOI 10.1213/ANE.0b013e31827175da; VEECH RL, 1988, ADV ENZYME REGUL, V27, P313, DOI 10.1016/0065-2571(88)90024-6; Vermont CL, 2006, CRIT CARE, V10, DOI 10.1186/cc4836; Voigtsberger S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093863; Voigtsberger S, 2009, ANESTHESIOLOGY, V111, P1238, DOI 10.1097/ALN.0b013e3181bdf857; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	35	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151903	10.1371/journal.pone.0151903	http://dx.doi.org/10.1371/journal.pone.0151903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985992	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000372580300148
J	Tytgat, HLP; van Teijlingen, NH; Sullan, RMA; Douillard, FP; Rasinkangas, P; Messing, M; Reunanen, J; Satokari, R; Vanderleyden, J; Dufrene, YF; Geijtenbeek, TBH; de Vos, WM; Lebeer, S				Tytgat, Hanne L. P.; van Teijlingen, Nienke H.; Sullan, Ruby May A.; Douillard, Francois P.; Rasinkangas, Pia; Messing, Marcel; Reunanen, Justus; Satokari, Reetta; Vanderleyden, Jos; Dufrene, Yves F.; Geijtenbeek, Teunis B. H.; de Vos, Willem M.; Lebeer, Sarah			Probiotic Gut Microbiota Isolate Interacts with Dendritic Cells via Glycosylated Heterotrimeric Pili	PLOS ONE			English	Article							LACTOBACILLUS-RHAMNOSUS GG; ATOMIC-FORCE MICROSCOPY; GRAM-POSITIVE BACTERIA; INTESTINAL EPITHELIAL-CELLS; LECTIN DC-SIGN; FUNCTIONAL-ANALYSIS; BIFIDOBACTERIUM-BIFIDUM; ISOPEPTIDE BONDS; ADHESION; IDENTIFICATION	Mapping of the microbial molecules underlying microbiota-host interactions is key to understand how microbiota preserve mucosal homeostasis. A pivotal family of such bacterial molecules are pili. Pili are proteinaceous cell wall appendages with a well-documented role in adhesion, whilst their role in immune interaction with the host is less established. Gram-positive pili are often posttranslationally modified by sortase-specific cleavage reactions and the formation of intramolecular peptide bonds. Here we report glycosylation as a new level of posttranslational modification of sortase-dependent pili of a beneficial microbiota species and its role in immune modulation. We focused on the SpaCBA pili of the model probiotic and beneficial human gut microbiota isolate Lactobacillus rhamnosus GG. A unique combination of molecular techniques, nanoscale mechanical and immunological approaches led to the identification of mannose and fucose residues on the SpaCBA pili. These glycans on the pili are recognized by human dendritic cells via the C-type lectin receptor DC-SIGN, a key carbohydrate-dependent immune tailoring pattern recognition receptor. This specific lectin-sugar interaction is moreover of functional importance and modulated the cytokine response of dendritic cells. This provides insight into the direct role bacterial glycoproteins can play in the immunomodulation of the host. Modification of the complex heterotrimeric pili of a model probiotic and microbiota isolate with mannose and fucose is of importance for the functional interaction with the host immune lectin receptor DC-SIGN on human dendritic cells. Our findings shed light on the yet underappreciated role of glycoconjugates in bacteria-host interactions.	[Tytgat, Hanne L. P.; Vanderleyden, Jos; Lebeer, Sarah] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium; [Tytgat, Hanne L. P.; Lebeer, Sarah] Univ Antwerp, Dept Biosci Engn Environm Ecol & Appl Microbiol, B-2020 Antwerp, Belgium; [Tytgat, Hanne L. P.; Dufrene, Yves F.; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [van Teijlingen, Nienke H.; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Sullan, Ruby May A.] Catholic Univ Louvain, Inst Life Sci, Louvain La Neuve, Belgium; [Douillard, Francois P.; Rasinkangas, Pia; Reunanen, Justus; Satokari, Reetta; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Messing, Marcel; de Vos, Willem M.] Univ Helsinki, Immunobiol Res Program, Helsinki, Finland; [Messing, Marcel; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Sullan, Ruby May A.] Max Planck Inst Colloids & Interfaces, Mechanobiochem Res Grp, Potsdam, Germany	KU Leuven; University of Antwerp; Wageningen University & Research; University of Amsterdam; Universite Catholique Louvain; University of Helsinki; University of Helsinki; University of Helsinki; Max Planck Society	Lebeer, S (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium.; Lebeer, S (corresponding author), Univ Antwerp, Dept Biosci Engn Environm Ecol & Appl Microbiol, B-2020 Antwerp, Belgium.	sarah.lebeer@uantwerpen.be	Lebeer, Sarah/D-5156-2014; Tytgat, Hanne L.P./B-4388-2013; Lebeer, Sarah/S-9951-2019; Sullan, Ruby May A./L-7511-2016	Lebeer, Sarah/0000-0002-9400-6918; Tytgat, Hanne L.P./0000-0001-6270-2110; Lebeer, Sarah/0000-0002-9400-6918; Sullan, Ruby May A./0000-0002-8927-2605; Satokari, Reetta/0000-0002-4258-3414; Dufrene, Yves/0000-0002-7289-4248	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen); University of Leuven [PF3M100234]; UAntwerp; AMC PhD Scholarship; NWO [VICI 918.10.619]; European Research Council grant MicrobesInside of WMdV [250172]; Academy of Finland [138902, 254439, 141140]; National Fund for Scientific Research (FNRS); UCLouvain (Fondation Louvain-Prix de Merre); Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme); Research Department of the Communaute francaise de Belgique (Concerted Research Action)	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); University of Leuven(KU Leuven); UAntwerp; AMC PhD Scholarship; NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council grant MicrobesInside of WMdV; Academy of Finland(Academy of Finland); National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); UCLouvain (Fondation Louvain-Prix de Merre); Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme); Research Department of the Communaute francaise de Belgique (Concerted Research Action)	HLPT acknowledges the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen) for her PhD scholarship. SL holds a 'Krediet aan Navorsers' (28960) from FWO-Vlaanderen. JV, SL and HLPT are grateful for the financial support of the University of Leuven via PF3M100234 and UAntwerp via BOF and IOF-SBO funding. NHvT is sponsored by the AMC PhD Scholarship. TBHG is sponsored by NWO; VICI 918.10.619. PR and FPD are funded by the European Research Council grant MicrobesInside (250172) of WMdV. JR, RS and WMdV want to acknowledge the financial support from the Academy of Finland (138902, 254439 and 141140). Work at UCLouvain was supported by the National Fund for Scientific Research (FNRS), the UCLouvain (Fondation Louvain-Prix de Merre), the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the Research Department of the Communaute francaise de Belgique (Concerted Research Action). YFD is a research Director of the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Brittan JL, 2015, MICROBES INFECT, V17, P360, DOI 10.1016/j.micinf.2014.12.013; Coyne MJ, 2013, MOL MICROBIOL, V88, P772, DOI 10.1111/mmi.12220; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Douillard FP, 2014, J BIOL CHEM, V289, P15764, DOI 10.1074/jbc.M113.542332; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Fletcher CM, 2011, J BIOL CHEM, V286, P3219, DOI 10.1074/jbc.M110.194506; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65; Garcia CEV, 2015, APPL ENVIRON MICROB, V81, P2050, DOI 10.1128/AEM.03949-14; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6074; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kainulainen V, 2013, APPL ENVIRON MICROB, V79, P6989, DOI 10.1128/AEM.01993-13; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Laakso K, 2011, MICROB BIOTECHNOL, V4, P746, DOI 10.1111/j.1751-7915.2011.00275.x; Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Morello E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138103; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rogers EA, 2011, ADV EXP MED BIOL, V715, P91, DOI 10.1007/978-94-007-0940-9_6; Segers ME, 2014, LACTOBACILLUS RHAMNO; Soriani M, 2010, FUTURE MICROBIOL, V5, P735, DOI [10.2217/fmb.10.37, 10.2217/FMB.10.37]; Sullan RMA, 2014, NANOSCALE, V6, P1134, DOI 10.1039/c3nr05462d; Thompson R, 2011, ANAL BIOCHEM, V413, P114, DOI 10.1016/j.ab.2011.02.013; Tillisch K, 2014, GUT MICROBES, V5, P404, DOI 10.4161/gmic.29232; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Tripathi P, 2012, LANGMUIR, V28, P2211, DOI 10.1021/la203834d; Turroni F, 2014, FEMS MICROBIOL LETT, V357, P23, DOI 10.1111/1574-6968.12509; Tytgat HLP, 2015, MICROB BIOTECHNOL, V8, P164, DOI 10.1111/1751-7915.12150; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Gisbergen KPJM, 2005, IMMUNOL LETT, V97, P199, DOI 10.1016/j.imlet.2004.11.008; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09	60	44	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151824	10.1371/journal.pone.0151824	http://dx.doi.org/10.1371/journal.pone.0151824			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985831	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300135
J	Antoci, A; Maccioni, AF; Russu, P				Antoci, Angelo; Maccioni, Alessandro Fiori; Russu, Paolo			The Ecology of Defensive Medicine and Malpractice Litigation	PLOS ONE			English	Article							HEALTH-CARE; PROVIDER COMPETITION; ANESTHESIA; ECONOMICS; LIABILITY; BEHAVIOR; RISK; REIMBURSEMENT; NEGLIGENCE; INSURANCE	Using an evolutionary game, we show that patients and physicians can interact with predator-prey relationships. Litigious patients who seek compensation are the 'predators' and physicians are their 'prey'. Physicians can adapt to the risk of being sued by performing defensive medicine. We find that improvements in clinical safety can increase the share of litigious patients and leave unchanged the share of physicians who perform defensive medicine. This paradoxical result is consistent with increasing trends in malpractice claims in spite of safety improvements, observed for example in empirical studies on anesthesiologists. Perfect cooperation with neither defensive nor litigious behaviors can be the Pareto-optimal solution when it is not a Nash equilibrium, so maximizing social welfare may require government intervention.	[Antoci, Angelo; Maccioni, Alessandro Fiori; Russu, Paolo] Univ Sassari, Dept Econ & Management, I-07100 Sassari, Italy	University of Sassari	Maccioni, AF (corresponding author), Univ Sassari, Dept Econ & Management, I-07100 Sassari, Italy.	alex.fiori.maccioni@gmail.com	Antoci, Angelo/AAG-2800-2021	Antoci, Angelo/0000-0003-3719-0437; Fiori Maccioni, Alessandro/0000-0002-2080-7405; russu, paolo/0000-0002-6999-7617	Regione Autonoma della Sardegna under the project 'Capitale sociale e divari economici regionali' [L.R. 7/2007]; P.O.R. FSE Sardegna under the project 'Risk Management System per aziende sanitarie' at the University of Sassari [2007/13]	Regione Autonoma della Sardegna under the project 'Capitale sociale e divari economici regionali'; P.O.R. FSE Sardegna under the project 'Risk Management System per aziende sanitarie' at the University of Sassari	The research of A. Antoci and P. Russu was financed by Regione Autonoma della Sardegna (L.R. 7/2007) under the project 'Capitale sociale e divari economici regionali'. The research of A. Fiori Maccioni was financed by P.O.R. FSE Sardegna 2007/13 under the project 'Risk Management System per aziende sanitarie', held at the University of Sassari with the logistical support of Prossima Isola. The authors declare that the funding sources had no involvment in the research and have no conflicts of interest.	Allard M, 2009, J ECON MANAGE STRAT, V18, P457, DOI 10.1111/j.1530-9134.2009.00220.x; [Anonymous], 1995, EVOLUTIONARY GAME TH; Antoci A., 2004, Journal of Bioeconomics, V6, P165, DOI 10.1023/B:JBIO.0000040371.20538.3f; ARROW KJ, 1963, AM ECON REV, V53, P941; Avraham R, 2010, AM LAW ECON REV, V12, P319, DOI 10.1093/aler/ahq003; Baker T., 2004, DEPAUL LAW REV, V54, P393; Black Bernard, 2005, J EMPIR LEGAL STUD, V2, P207, DOI DOI 10.1016/J.MRREV.2004.07.002; Branas-Garza P, 2007, J ECON PSYCHOL, V28, P477, DOI 10.1016/j.joep.2006.10.001; Branas-Garza P, 2006, J ECON BEHAV ORGAN, V60, P306, DOI 10.1016/j.jebo.2004.10.005; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Capraro V, 2015, SCI REP-UK, V5, DOI 10.1038/srep09916; Capraro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072427; Cheney FW, 2006, ANESTHESIOLOGY, V105, P1081, DOI 10.1097/00000542-200612000-00007; Crockett MJ, 2014, P NATL ACAD SCI USA, V111, P17320, DOI 10.1073/pnas.1408988111; Currie J, 2008, Q J ECON, V123, P795, DOI 10.1162/qjec.2008.123.2.795; DANZON PM, 1991, J ECON PERSPECT, V5, P51, DOI 10.1257/jep.5.3.51; Danzon PM, 2004, BROOKINGS WHARTON PA, V1, P55; DIONNE G, 1985, J HEALTH ECON, V4, P21, DOI 10.1016/0167-6296(85)90021-9; Dubay L, 2001, J HEALTH ECON, V20, P591, DOI 10.1016/S0167-6296(01)00082-0; Dubay L, 1999, J HEALTH ECON, V18, P491, DOI 10.1016/S0167-6296(99)00004-1; EICHHORN JH, 1989, ANESTHESIOLOGY, V70, P572, DOI 10.1097/00000542-198904000-00002; Ellis RP, 1998, J HEALTH ECON, V17, P537, DOI 10.1016/S0167-6296(97)00042-8; ELLIS RP, 1986, J HEALTH ECON, V5, P129, DOI 10.1016/0167-6296(86)90002-0; Feess E, 2012, EUR J HEALTH ECON, V13, P157, DOI 10.1007/s10198-010-0294-7; Gal-Or E, 1999, J REGUL ECON, V16, P237, DOI 10.1023/A:1008174905751; GOLDSCHMIDT W, 1993, MAN, V28, P341, DOI 10.2307/2803417; Hammer PJ, 2001, J HEALTH POLIT POLIC, V26, P835, DOI 10.1215/03616878-26-5-835; Hofbauer J., 1988, THEORY EVOLUTION DYN; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; KERR NL, 1983, J PERS SOC PSYCHOL, V45, P819, DOI 10.1037/0022-3514.45.4.819; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Koutsoupias E, 1999, LECT NOTES COMPUT SC, V1563, P404; Lewis David, 1969, CONVENTION PHILOS ST; Ma CTA, 1994, J ECON MANAGE STRAT, V3, P93, DOI 10.1111/j.1430-9134.1994.00093.x; Ma CTA, 1997, AM ECON REV, V87, P685; Madarasz K, 2012, REV ECON STUD, V79, P961, DOI 10.1093/restud/rdr044; Maynard Smith J., 1982, pi; McGuire TG, 2000, HANDB ECON, V17, P461; MECHANIC D, 1975, DUKE LAW J, P1179; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Mello MM, 2010, 1002 MEDPAC; Olbrich A, 2008, INT REV LAW ECON, V28, P78, DOI 10.1016/j.irle.2007.12.003; Papadimitriou C. H., 2001, PROC 33 S THEORY COM, P749, DOI DOI 10.1145/380752.380883; PAULY MV, 1968, AM ECON REV, V58, P531; Peng PWH, 2000, CAN J ANAESTH, V47, P105, DOI 10.1007/BF03018844; PriceWaterhouseCoopers, 2006, FACT FUEL RIS HEALTH; Quinn R, 1998, J RISK INSUR, V65, P467, DOI 10.2307/253660; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Rodwin MA, 2008, HEALTH AFFAIR, V27, P835, DOI 10.1377/hlthaff.27.3.835; Samuelson L., 1998, EVOLUTIONARY GAMES E; Sloan FA, 2009, J HEALTH ECON, V28, P481, DOI 10.1016/j.jhealeco.2008.12.006; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; TANCREDI LR, 1978, SCIENCE, V200, P879, DOI 10.1126/science.644329; Towse A, 1999, HEALTH ECON, V8, P93, DOI 10.1002/(SICI)1099-1050(199903)8:2<93::AID-HEC419>3.3.CO;2-7; U.S. General Accounting Office, 1986, GAOHRD8721; VINCENT C, 1994, LANCET, V343, P1609, DOI 10.1016/S0140-6736(94)93062-7; Weiler PC, 1993, MD L REV, V52, P908; ZECKHAUSER R, 1970, J ECON THEORY, V2, P10, DOI 10.1016/0022-0531(70)90010-4	60	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150523	10.1371/journal.pone.0150523	http://dx.doi.org/10.1371/journal.pone.0150523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982056	Green Published, gold			2022-12-27	WOS:000372574900043
J	Liu, SL; Xia, ZY; Liu, JH; Xu, J; Ren, H; Lu, T; Yang, XD				Liu, Shaoli; Xia, Zeyang; Liu, Jianhua; Xu, Jing; Ren, He; Lu, Tong; Yang, Xiangdong			Automatic Multiple-Needle Surgical Planning of Robotic-Assisted Microwave Coagulation in Large Liver Tumor Therapy	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; TRAJECTORIES; PLACEMENT; SYSTEM; EXPERIENCE; SURFACES; REGIONS	The "robotic-assisted liver tumor coagulation therapy" (RALTCT) system is a promising candidate for large liver tumor treatment in terms of accuracy and speed. A prerequisite for effective therapy is accurate surgical planning. However, it is difficult for the surgeon to perform surgical planning manually due to the difficulties associated with robot-assisted large liver tumor therapy. These main difficulties include the following aspects: (1) multiple needles are needed to destroy the entire tumor, (2) the insertion trajectories of the needles should avoid the ribs, blood vessels, and other tissues and organs in the abdominal cavity, (3) the placement of multiple needles should avoid interference with each other, (4) an inserted needle will cause some deformation of liver, which will result in changes in subsequently inserted needles' operating environment, and (5) the multiple needle-insertion trajectories should be consistent with the needle-driven robot's movement characteristics. Thus, an effective multiple-needle surgical planning procedure is needed. To overcome these problems, we present an automatic multiple-needle surgical planning of optimal insertion trajectories to the targets, based on a mathematical description of all relevant structure surfaces. The method determines the analytical expression of boundaries of every needle "collision-free reachable workspace" (CFRW), which are the feasible insertion zones based on several constraints. Then, the optimal needle insertion trajectory within the optimization criteria will be chosen in the needle CFRW automatically. Also, the results can be visualized with our navigation system. In the simulation experiment, three needle-insertion trajectories were obtained successfully. In the in vitro experiment, the robot successfully achieved insertion of multiple needles. The proposed automatic multiple-needle surgical planning can improve the efficiency and safety of robot-assisted large liver tumor therapy, significantly reduce the surgeon's workload, and is especially helpful for an inexperienced surgeon. The methodology should be easy to adapt in other body parts.	[Liu, Shaoli; Liu, Jianhua] Beijing Inst Technol, Sch Mech Engn, Beijing 100081, Peoples R China; [Xia, Zeyang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Xu, Jing; Yang, Xiangdong] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China; [Ren, He] Navy Gen Hosp PLA, Dept Ultrasound Med, Beijing, Peoples R China; [Lu, Tong] Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound, Beijing 100853, Peoples R China	Beijing Institute of Technology; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Tsinghua University; Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Liu, SL (corresponding author), Beijing Inst Technol, Sch Mech Engn, Beijing 100081, Peoples R China.	liushaoli@bit.edu.cn	xu, jing/GRR-8698-2022	w, yufan/0000-0003-2609-4706	National Natural Science Foundation of China (NSFC) [50675109]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Financial support is provided by National Natural Science Foundation of China (NSFC) under Grant No. 50675109, the URL is: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. Put the NO. and the year 2006, the information of the funding can be searched. Yang received the funding. The funder designed parts of the robot and agreed to publish the manuscript.	Abbott JJ, 2007, SPRINGER TRAC ADV RO, V28, P49; Azimian H, 2010, ROB AUT ICRA 2010 IE; Baegert C, 2007, STUD HEALTH TECHNOL, V125, P31; Baegert C, 2007, LECT NOTES COMPUT SC, V4792, P676; Boctor EM, 2008, INT J MED ROBOT COMP, V4, P180, DOI 10.1002/rcs.184; Boyd S., 2004, CONVEX OPTIMIZATION; Butnariu S, 2014, APPL MECH MATER, V332, P503, DOI 10.4028/www.scientific.net/AMM.332.503; Chakraborty N, 2008, IEEE T ROBOT, V24, P211, DOI 10.1109/TRO.2007.914851; Chen MH, 2004, RADIOLOGY, V232, P260, DOI 10.1148/radiol.2321030821; Davies BL, 1997, P I MECH ENG H, V211, P285, DOI 10.1243/0954411971534403; Dodd GD, 2001, AM J ROENTGENOL, V177, P777, DOI 10.2214/ajr.177.4.1770777; Gervais DA, 2011, AM J ROENTGENOL, V197, P789, DOI 10.2214/AJR.11.7656; Gettman MT, 2004, UROLOGY, V64, P914, DOI 10.1016/j.urology.2004.06.049; Hong JS, 2002, LECT NOTES COMPUT SC, V2488, P122; Inokuchi R, 2010, ONCOL REP, V24, P621, DOI 10.3892/or_00000900; Kapoor A, 2008, ROB AUT 2008 ICRA 20; Kapoor A, 2011, PROC SPIE, V7964, DOI 10.1117/12.876499; Khaianchee YS, 2004, SURG ENDOSC, V18, P696, DOI 10.1007/s00464-003-8180-3; Kosari K, 2002, J GASTROINTEST SURG, V6, P255, DOI 10.1016/S1091-255X(02)00002-1; LI SX, 1994, COMPUT AIDED DESIGN, V26, P165, DOI 10.1016/0010-4485(94)90040-X; Liang P, 2008, J UROLOGY, V180, P844, DOI 10.1016/j.juro.2008.05.012; liu S L, 2011, ROB BIOM ROBIO 2011; [刘少丽 Liu Shaoli], 2012, [高技术通讯, Chinese High Technology Letters], V22, P832; Livraghi T, 2000, RADIOLOGY, V214, P761, DOI 10.1148/radiology.214.3.r00mr02761; Lu MD, 2001, RADIOLOGY, V221, P167, DOI 10.1148/radiol.2211001783; Mundeleer L, 2009, INT J MED ROBOT COMP, V5, P458, DOI 10.1002/rcs.278; Park S., 2001, P 4 INT C MED IM COM, P1419, DOI DOI 10.1007/3-540-45468-3_; Ren HL, 2014, IEEE J BIOMED HEALTH, V18, P920, DOI 10.1109/JBHI.2013.2287202; Rheinboldt W.C., 1986, NUMERICAL ANAL PARAM; Rosenberg L.B., 1993, VIRT REAL ANN INT S; Schumann C, 2012, INT J COMPUT ASS RAD, V7, P191, DOI 10.1007/s11548-011-0624-y; Schumann C, 2010, PROC SPIE, V7625, DOI 10.1117/12.844186; Seitel A, 2011, MED PHYS, V38, P3246, DOI 10.1118/1.3590374; Shamir RR, 2010, LECT NOTES COMPUT SC, V6363, P457; Spencer A, 2008, ROB AUT 2008 ICRA 20; Suarez-Mejias Cristina, 2013, Clinical Image-Based Procedures. From Planning to Intervention. International Workshop, CLIP 2012 Held in Conjunction with MICCAI 2012. Revised Selected Papers, P83, DOI 10.1007/978-3-642-38079-2_11; TAUBIN G, 1994, IEEE T PATTERN ANAL, V16, P287, DOI 10.1109/34.276128; Taylor R, 1999, INT J ROBOT RES, V18, P1201, DOI 10.1177/02783649922067807; Villard C, 2005, LECT NOTES COMPUT SC, V3750, P49, DOI 10.1007/11566489_7; Villard Caroline, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P215, DOI 10.1080/10255840500289988; Wu J, 2011, FUZZ SYST KNOWL DISC; Xu J., 2007, THESIS TSINGHUA U BE; Xu J, 2010, INT J MED ROBOT COMP, V6, P256, DOI 10.1002/rcs.313; Yang LJ, 2010, IEEE-ASME T MECH, V15, P887, DOI 10.1109/TMECH.2010.2078827; Yang XD, 2010, MECH MACH THEORY, V45, P1024, DOI 10.1016/j.mechmachtheory.2010.02.002	45	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149482	10.1371/journal.pone.0149482	http://dx.doi.org/10.1371/journal.pone.0149482			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982341	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900015
J	Pajek, MB; Cuk, I; Leskosek, B; Mlinsek, G; Ponikvar, JB; Pajek, J				Pajek, Maja Bucar; Cuk, Ivan; Leskosek, Bojan; Mlinsek, Gregor; Ponikvar, Jadranka Buturovic; Pajek, Jernej			Six-Minute Walk Test in Renal Failure Patients: Representative Results, Performance Analysis and Perceived Dyspnea Predictors	PLOS ONE			English	Article							IRON-BINDING-CAPACITY; REFERENCE EQUATIONS; DIALYSIS PATIENTS; PHYSICAL PERFORMANCE; CLINICAL-OUTCOMES; HEMODIALYSIS; SURVIVAL; EXERCISE; ASSOCIATION; MORTALITY	Objectives Six-minute walk test in dialysis population hasn't been consistently evaluated for the isolated impact of renal failure and other predictive factors. We measured six-minute walk distance in patients representative for low level of comorbidity and searched for potentially modifiable predictive factors of performance and dyspnea. Methods This was a cross-sectional study with hemodialysis patients (N = 90) and control subjects (N = 140). Main outcome measures: six-minute walk test distance and dyspnea severity using the 10-item Borg scale. Results Median distance decreased from 600m below the 6th decade to 420m in the 8th decade of age. Dialysis dependence predicted 101.5m shorter distance in the adjusted model that explained 70% of variability in results. Adjusted for significant covariates of age, height and spontaneous gait speed, fat mass (but not lean body mass) and serum total iron binding capacity were significantly associated with distance (95% CI for B coefficients -4.6 to -1.4 m/kg and 0.1 to 5 m/mu mol/l, respectively). Serum total iron binding capacity as an explanatory variable was superior to C-reactive protein and albumin. Dialysis dependence, odds ratio (OR) 2.97 (1.11-7.94), spontaneous gait speed, OR 0.08 (0.02-0.41), rate-pressure product, OR 1.15 (1.08-1.23) and hemoglobin, OR 0.95 (0.92-0.98) predicted dyspnea in the adjusted model. Conclusions Renal failure without the confounding effect of comorbidity is a significant negative predictor of performance at six-minute walk test and perceived level of dyspnea. Body fat mass and serum total iron binding capacity are the main potentially modifiable predictors of performance, total iron binding capacity being superior to C-reactive protein and albumin. Although hemoglobin is not associated with test performance, it negatively predicts perceived shortness of breath.	[Pajek, Maja Bucar; Cuk, Ivan; Leskosek, Bojan] Univ Ljubljana, Fac Sport, Ljubljana, Slovenia; [Mlinsek, Gregor; Ponikvar, Jadranka Buturovic; Pajek, Jernej] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Pajek, J (corresponding author), Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia.	Jernej.pajek@mf.uni-lj.si	Pajek, Jernej/AAD-6776-2020	Pajek, Jernej/0000-0003-3265-8053; Cuk, Ivan/0000-0003-3300-5839; Buturovic-Ponikvar, Jadranka/0000-0001-7473-3731; Pajek, Maja/0000-0002-2706-7729	Slovenian Research Agency [P3-0323]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grant number P3-0323 from Slovenian Research Agency to JP and JBP (https://www.arrs.gov.si/en/novo.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Bossola M, 2014, BLOOD PURIFICAT, V38, P24, DOI 10.1159/000363599; Britto RR, 2013, BRAZ J PHYS THER, V17, P556, DOI 10.1590/S1413-35552012005000122; Bross R, 2009, AM J NEPHROL, V29, P571, DOI 10.1159/000191470; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Davies SJ, 2002, NEPHROL DIAL TRANSPL, V17, P1085, DOI 10.1093/ndt/17.6.1085; Delgado C, 2012, NEPHROL DIAL TRANSPL, V27, P1152, DOI 10.1093/ndt/gfr404; Eloot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076838; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Gambino R, 1997, CLIN CHEM, V43, P2408; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hamilton AL, 1996, CHEST, V110, P1255, DOI 10.1378/chest.110.5.1255; Kakiya R, 2006, KIDNEY INT, V70, P549, DOI 10.1038/sj.ki.5000331; Kalantar-Zadeh K, 1998, AM J KIDNEY DIS, V31, P263, DOI 10.1053/ajkd.1998.v31.pm9469497; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Keown PA, 2010, HEMODIAL INT, V14, P168, DOI 10.1111/j.1542-4758.2009.00422.x; Kohl LD, 2012, CLINICS, V67, P581, DOI 10.6061/clinics/2012(06)06; Kono K, 2014, THER APHER DIAL, V18, P623, DOI 10.1111/1744-9987.12177; Koufaki P, 2010, SPORTS MED, V40, P1055, DOI 10.2165/11536880-000000000-00000; MAK VHF, 1993, THORAX, V48, P33, DOI 10.1136/thx.48.1.33; Martinson M, 2014, CLIN J AM SOC NEPHRO, V9, P1082, DOI 10.2215/CJN.09200913; Matsuzawa R, 2012, CLIN J AM SOC NEPHRO, V7, P2010, DOI 10.2215/CJN.03660412; McDermott MM, 2008, J AM GERIATR SOC, V56, P724, DOI 10.1111/j.1532-5415.2008.01633.x; Pilutti LA, 2013, J NEUROL SCI, V334, P72, DOI 10.1016/j.jns.2013.07.2511; Pollentier Brittany, 2010, Cardiopulm Phys Ther J, V21, P13; Port FK, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341061; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Soper D.S., 2015, A PRIORI SAMPLE SIZE; Torino C, 2014, KIDNEY BLOOD PRESS R, V39, P205, DOI 10.1159/000355798; Tsirpanlis G, 2006, KIDNEY INT, V70, P1991, DOI 10.1038/sj.ki.5001848; Tveter AT, 2014, ARCH PHYS MED REHAB, V95, P1366, DOI 10.1016/j.apmr.2014.02.016; WIJKSTRA PJ, 1994, THORAX, V49, P468, DOI 10.1136/thx.49.5.468; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B	33	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150414	10.1371/journal.pone.0150414	http://dx.doi.org/10.1371/journal.pone.0150414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982967	gold, Green Published			2022-12-27	WOS:000372574900039
J	Baumann, A; Kerruth, S; Fitter, J; Buldt, G; Heberle, J; Schlesinger, R; Ataka, K				Baumann, Axel; Kerruth, Silke; Fitter, Joerg; Bueldt, Georg; Heberle, Joachim; Schlesinger, Ramona; Ataka, Kenichi			In-Situ Observation of Membrane Protein Folding during Cell-Free Expression	PLOS ONE			English	Article							INFRARED-ABSORPTION SPECTROSCOPY; CYTOCHROME-C-OXIDASE; GOLD ELECTRODE; 2-STAGE MODEL; ALPHA-HELIX; BACTERIORHODOPSIN; STABILITY; NANODISCS; SPECTRA; RECONSTITUTION	Proper insertion, folding and assembly of functional proteins in biological membranes are key processes to warrant activity of a living cell. Here, we present a novel approach to trace folding and insertion of a nascent membrane protein leaving the ribosome and penetrating the bilayer. Surface Enhanced IR Absorption Spectroscopy selectively monitored insertion and folding of membrane proteins during cell-free expression in a label-free and non-invasive manner. Protein synthesis was performed in an optical cell containing a prism covered with a thin gold film with nanodiscs on top, providing an artificial lipid bilayer for folding. In a pilot experiment, the folding pathway of bacteriorhodopsin via various secondary and tertiary structures was visualized. Thus, a methodology is established with which the folding reaction of other more complex membrane proteins can be observed during protein biosynthesis (in situ and in operando) at molecular resolution.	[Baumann, Axel; Fitter, Joerg; Bueldt, Georg] Forschungszentrum Julich, Inst Complex Syst, Mol Biophys ICS 5, D-52425 Julich, Germany; [Kerruth, Silke; Heberle, Joachim; Ataka, Kenichi] Free Univ Berlin, Dept Phys, Expt Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany; [Bueldt, Georg] Moscow Inst Phys & Technol, Lab Adv Studies Membrane Proteins, Dolgoprudnyi 141700, Russia; [Schlesinger, Ramona] Free Univ Berlin, Dept Phys, Genet Biophys, Arnimallee 14, D-14195 Berlin, Germany; [Fitter, Joerg] Rhein Westfal TH Aachen, Phys Inst IA, AG Biophys, Sommerfeldstr 14, D-52074 Aachen, Germany	Helmholtz Association; Research Center Julich; Free University of Berlin; Moscow Institute of Physics & Technology; Free University of Berlin; RWTH Aachen University	Ataka, K (corresponding author), Free Univ Berlin, Dept Phys, Expt Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany.; Schlesinger, R (corresponding author), Free Univ Berlin, Dept Phys, Genet Biophys, Arnimallee 14, D-14195 Berlin, Germany.	rschlesinger@zedat.fu-berlin.de; ataka@zedat.fu-berlin.de	Heberle, Joachim/D-8605-2016; Schlesinger, Ramona/W-2620-2018; Fitter, Joerg/J-3294-2013	Heberle, Joachim/0000-0001-6321-2615; Schlesinger, Ramona/0000-0002-7716-4439; Fitter, Joerg/0000-0002-4503-2079; Kerruth, Silke/0000-0003-4117-3189				Adato R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3154; Ataka K, 2006, J PHYS CHEM B, V110, P9339, DOI 10.1021/jp0534131; Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h; Ataka K, 2007, ANAL BIOANAL CHEM, V388, P47, DOI 10.1007/s00216-006-1071-4; Ataka K, 2013, BBA-BIOMEMBRANES, V1828, P2283, DOI 10.1016/j.bbamem.2013.04.026; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Booth PJ, 1997, FOLD DES, V2, pR85, DOI 10.1016/S1359-0278(97)00045-X; BOOTH PJ, 1995, NAT STRUCT BIOL, V2, P139, DOI 10.1038/nsb0295-139; Booth PJ, 1997, BIOCHEMISTRY-US, V36, P197, DOI 10.1021/bi962200m; Booth PJ, 2001, CRIT REV BIOCHEM MOL, V36, P501, DOI 10.1080/20014091074246; Booth PJ, 2000, BBA-BIOENERGETICS, V1460, P4, DOI 10.1016/S0005-2728(00)00125-0; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chalmers J.M., 2002, HDB VIBRATIONAL SPEC; Compton ELR, 2006, J MOL BIOL, V357, P325, DOI 10.1016/j.jmb.2005.12.042; Curnow P, 2010, J MOL BIOL, V403, P630, DOI 10.1016/j.jmb.2010.09.003; Dale H, 1999, J BIOL CHEM, V274, P22693, DOI 10.1074/jbc.274.32.22693; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; Grechko M, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764861; HUANG KS, 1981, J BIOL CHEM, V256, P3802; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Johnson PJM, 2014, PHYS CHEM CHEM PHYS, V16, P21310, DOI 10.1039/c4cp01826e; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P8829, DOI 10.1021/bi00152a020; Karjalainen EL, 2012, J PHYS CHEM B, V116, P4448, DOI 10.1021/jp300329k; Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023; Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065; Kiefer H, 2003, BBA-BIOMEMBRANES, V1610, P57, DOI 10.1016/S0005-2736(02)00717-4; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; LONDON E, 1982, J BIOL CHEM, V257, P7003; Nagy JK, 2001, BIOCHEMISTRY-US, V40, P8971, DOI 10.1021/bi010202n; NEVSKAYA NA, 1976, BIOPOLYMERS, V15, P637, DOI 10.1002/bip.1976.360150404; OSAWA M, 1993, APPL SPECTROSC, V47, P1497, DOI 10.1366/0003702934067478; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Riley ML, 1997, BIOCHEMISTRY-US, V36, P192, DOI 10.1021/bi962199r; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Swartz James R, 2004, Methods Mol Biol, V267, P169; Torres J, 1995, BIOCHEMISTRY-US, V34, P16320, DOI 10.1021/bi00050a012; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; Zaitseva E, 2010, BIOPHYS J, V99, P2327, DOI 10.1016/j.bpj.2010.06.054	47	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151051	10.1371/journal.pone.0151051	http://dx.doi.org/10.1371/journal.pone.0151051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978519	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000372572800045
J	Tran, J; Magenau, A; Rodriguez, M; Rentero, C; Royo, T; Enrich, C; Thomas, SR; Grewal, T; Gaus, K				Tran, Jason; Magenau, Astrid; Rodriguez, Macarena; Rentero, Carles; Royo, Teresa; Enrich, Carlos; Thomas, Shane R.; Grewal, Thomas; Gaus, Katharina			Activation of Endothelial Nitric Oxide (eNOS) Occurs through Different Membrane Domains in Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-2; LIPID RAFT STRUCTURE; PHOSPHOLIPID-MEMBRANES; 2-PHOTON MICROSCOPY; SIGNAL-TRANSDUCTION; ANCHORED PROTEINS; MODEL MEMBRANES; DUAL ACYLATION; SYNTHASE; CHOLESTEROL	Endothelial cells respond to a large range of stimuli including circulating lipoproteins, growth factors and changes in haemodynamic mechanical forces to regulate the activity of endothelial nitric oxide synthase (eNOS) and maintain blood pressure. While many signalling pathways have been mapped, the identities of membrane domains through which these signals are transmitted are less well characterized. Here, we manipulated bovine aortic endothelial cells (BAEC) with cholesterol and the oxysterol 7-ketocholesterol (7KC). Using a range of microscopy techniques including confocal, 2-photon, super-resolution and electron microscopy, we found that sterol enrichment had differential effects on eNOS and caveolin-1 (Cav1) colocalisation, membrane order of the plasma membrane, caveolae numbers and Cav1 clustering. We found a correlation between cholesterol-induced condensation of the plasma membrane and enhanced high density lipoprotein (HDL)-induced eNOS activity and phosphorylation suggesting that cholesterol domains, but not individual caveolae, mediate HDL stimulation of eNOS. Vascular endothelial growth factor (VEGF)-induced and shear stress-induced eNOS activity was relatively independent of membrane order and may be predominantly controlled by the number of caveolae on the cell surface. Taken together, our data suggest that signals that activate and phosphorylate eNOS are transmitted through distinct membrane domains in endothelial cells.	[Tran, Jason; Magenau, Astrid; Rodriguez, Macarena; Gaus, Katharina] Univ New S Wales, EMBL Australia Node Single Mol Sci, Sch Med Sci, Sydney, NSW, Australia; [Tran, Jason; Magenau, Astrid; Rodriguez, Macarena; Gaus, Katharina] Univ New S Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia; [Rentero, Carles; Royo, Teresa; Enrich, Carlos] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Barcelona 08036, Spain; [Royo, Teresa; Enrich, Carlos] Ctr Recerca Biomed CELLEX, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain; [Thomas, Shane R.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Grewal, Thomas] Univ Sydney, Fac Pharm A15, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of New South Wales Sydney; University of Sydney	Gaus, K (corresponding author), Univ New S Wales, EMBL Australia Node Single Mol Sci, Sch Med Sci, Sydney, NSW, Australia.; Gaus, K (corresponding author), Univ New S Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia.	k.gaus@unsw.edu.au	Royo, Teresa/AAB-5331-2019; Rentero Alfonso, Carles/L-4430-2017	Royo, Teresa/0000-0002-7502-9583; Rentero Alfonso, Carles/0000-0003-4684-0278; Enrich, Carlos/0000-0003-0382-2993; Gaus, Katharina/0000-0002-8009-9658; Grewal, Thomas/0000-0002-7937-8887	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) of Australia [1037320]; University of Sydney, Australia [U1758, U7007]; Ministerio de Economia y Competitividad (MINECO) [BFU2012-36272, CSD2009-00016]; Fundacio Marato TV3 (Spain) [PI042182]; CONSOLIDER-INGENIO (MINECO) research program [CSD2009-00016]; Fundacio Marato TV3	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney, Australia(University of Sydney); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fundacio Marato TV3 (Spain); CONSOLIDER-INGENIO (MINECO) research program; Fundacio Marato TV3	This work was supported by the Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC) of Australia (Program grant 1037320). TG received support from The University of Sydney, Australia (U1758, U7007). CE received support from the Ministerio de Economia y Competitividad (MINECO; BFU2012-36272, CSD2009-00016) and Fundacio Marato TV3 (PI042182) (Spain). CR received a post-doctoral fellowship (CSD2009-00016) from CONSOLIDER-INGENIO (MINECO) research program and support from Fundacio Marato TV3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Berthier A, 2004, CELL DEATH DIFFER, V11, P897, DOI 10.1038/sj.cdd.4401434; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Boyd NL, 2003, AM J PHYSIOL-HEART C, V285, pH1113, DOI 10.1152/ajpheart.00302.2003; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; Feng YY, 1999, INVEST OPHTH VIS SCI, V40, P157; Feron O, 1998, BIOCHEMISTRY-US, V37, P193, DOI 10.1021/bi972307p; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Han B, 2015, TRAFFIC, V16, P417, DOI 10.1111/tra.12254; HECKER M, 1994, BIOCHEM J, V299, P247, DOI 10.1042/bj2990247; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; Massey JB, 2005, BIOCHEMISTRY-US, V44, P14376, DOI 10.1021/bi051169y; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mineo C, 2003, TRENDS CARDIOVAS MED, V13, P226, DOI 10.1016/S1050-1738(03)00098-7; Mulay V, 2012, CURR PHARM BIOTECHNO, V13, P352, DOI 10.2174/138920112799095356; Owen DM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00503; Owen DM, 2012, BIOESSAYS, V34, P739, DOI 10.1002/bies.201200044; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Park H, 2000, AM J PHYSIOL-HEART C, V278, pH1285, DOI 10.1152/ajpheart.2000.278.4.H1285; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724; ROBINSON LJ, 1995, P NATL ACAD SCI USA, V92, P11776, DOI 10.1073/pnas.92.25.11776; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Saddar S, 2010, ARTERIOSCL THROM VAS, V30, P144, DOI 10.1161/ATVBAHA.109.196170; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; SESSA WC, 1990, P NATL ACAD SCI USA, V87, P8607, DOI 10.1073/pnas.87.21.8607; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Sowa G, 2001, P NATL ACAD SCI USA, V98, P14072, DOI 10.1073/pnas.241409998; Sun RJ, 2003, BIORHEOLOGY, V40, P31; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Wunderlich C, 2006, BIOCHEM BIOPH RES CO, V340, P702, DOI 10.1016/j.bbrc.2005.12.058; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100	63	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151556	10.1371/journal.pone.0151556	http://dx.doi.org/10.1371/journal.pone.0151556			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977592	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800088
J	Davis, JS; Gupta, V; Gagea, M; Wu, XW				Davis, Jennifer S.; Gupta, Vineet; Gagea, Mihai; Wu, Xiangwei			An Advanced Histologic Method for Evaluation of Intestinal Adenomas in Mice Using Digital Slides	PLOS ONE			English	Article							NEOPLASIA; MUTATION	Background and Methods Mice are used for modelling the biology of many human diseases, including colorectal cancer (CRC). Mouse models recapitulate many aspects of human disease and are invaluable tools for studying the biology, treatment and prevention of CRC. Unlike humans, many mouse models develop lesions primarily in the small intestine, which necessitates removal and examination of this organ in order to evaluate treatment efficacy. Commonly, the small intestine is visually examined for gross lesions and then selectively embedded in paraffin blocks for further microscopic analysis. Unfortunately, this method suffers from inherent bias toward counting large lesions and simultaneously missing smaller lesions. Even more, this method leaves no permanent record of diagnosed and measured lesions. We evaluated inter-observer variability in a mouse model of CRC using visual examination, and directly compared the visual, gross examination with a histologic analytic method using digital slides of hematoxylin and eosin stained tissue sections. Results Using visual examination, there was a high degree of inter-observer variability. As this method does not provide a permanent record of measurements, there is no capability to arbitrate between differing observations. In contrast, histologic analysis allowed for the creation of a permanent record of lesion measurements taken. When compared directly, histologic analysis of annotated digital images has significantly improved accuracy. Using this method we were able to distinguish mutant mice from wild type littermates even at a very young age. With gross visual examination, this distinction was not possible. Conclusion Histologic analysis of digital images of murine intestinal tissue provides a vital improvement over the commonly used visual, gross examination method. Unlike visual gross examination, histologic analysis is not biased by the size of intestinal adenoma, misdiagnosis of another lesion type, or presence of a Peyer's patch. It also provides accountability in the form of a permanent record of lesions counted. Histologic analysis using digital slides represents a critical improvement over the current, widely used method of visual gross examination and should be considered for future studies using mouse models of CRC.	[Davis, Jennifer S.; Gupta, Vineet; Wu, Xiangwei] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Unit 1013, Houston, TX 77030 USA; [Gagea, Mihai] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Unit 0063, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, XW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Unit 1013, Houston, TX 77030 USA.	xwwu@mdanderson.org		Davis, Jennifer/0000-0001-9456-1682	Janice Davis Gordon Memorial Postdoctoral Fellowship in Colorectal Cancer Prevention Research; CPRIT [RP120280]	Janice Davis Gordon Memorial Postdoctoral Fellowship in Colorectal Cancer Prevention Research; CPRIT	JS Davis is supported by the Janice Davis Gordon Memorial Postdoctoral Fellowship in Colorectal Cancer Prevention Research. Research is supported by CPRIT grant RP120280 to X Wu.	FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Spahn TW, 2004, GUT, V53, P456, DOI 10.1136/gut.2003.023671; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534	6	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151463	10.1371/journal.pone.0151463	http://dx.doi.org/10.1371/journal.pone.0151463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974326	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600081
J	Fares, EJ; Charriere, N; Montani, JP; Schutz, Y; Dulloo, AG; Miles-Chan, JL				Fares, Elie-Jacques; Charriere, Nathalie; Montani, Jean-Pierre; Schutz, Yves; Dulloo, Abdul G.; Miles-Chan, Jennifer L.			Energy Expenditure and Substrate Oxidation in Response to Side-Alternating Whole Body Vibration across Three Commonly-Used Vibration Frequencies	PLOS ONE			English	Article							ENDOCRINE SYSTEM; MUSCLE-ACTIVITY; EXTERNAL LOAD; OXYGEN-UPTAKE; OBESE WOMEN; HEALTHY-MEN; EXERCISE; ACCELERATION; MOVEMENT; STRENGTH	Background and Aim There is increasing recognition about the importance of enhancing energy expenditure (EE) for weight control through increases in low-intensity physical activities comparable with daily life (1.5-4 METS). Whole-body vibration (WBV) increases EE modestly and could present both a useful adjuvant for obesity management and tool for metabolic phenotyping. However, it is unclear whether a "dose-response" exists between commonly-used vibration frequencies (VF) and EE, nor if WBV influences respiratory quotient (RQ), and hence substrate oxidation. We aimed to investigate the EE-VF and RQ-VF relationships across three different frequencies (30, 40, and 50Hz). Methods EE and RQ were measured in 8 healthy young adults by indirect calorimetry at rest, and subsequently during side-alternating WBV at one of 3 VFs (30, 40, and 50 Hz). Each frequency was assessed over 5 cycles of intermittent WBV (30s vibration/30s rest), separated by 5 min seated rest. During the WBV participants stood on the platform with knees flexed sufficiently to maintain comfort, prevent transmission of vibration to the upper body, and minimise voluntary physical exertion. Repeatability was assessed across 3 separate days in a subset of 4 individuals. In order to assess any sequence/habituation effect, an additional group of 6 men underwent 5 cycles of intermittent WBV (30s vibration/30s rest) at 40 Hz, separated by 5 min seated rest. Results Side-alternating WBV increased EE relative to standing, non-vibration levels (+36%, p<0.001). However, no differences in EE were observed across VFs. Similarly, no effect of VF on RQ was found, nor did WBV alter RQ relative to standing without vibration. Conclusion No relationship could be demonstrated between EE and VF in the range of 30-50Hz, and substrate oxidation did not change in response to WBV. Furthermore, the thermogenic effect of intermittent WBV, whilst robust, was quantitatively small (<2 METS).	[Fares, Elie-Jacques; Charriere, Nathalie; Montani, Jean-Pierre; Schutz, Yves; Dulloo, Abdul G.; Miles-Chan, Jennifer L.] Univ Fribourg, Dept Med, Div Physiol, Lab Integrat Cardiovasc & Metab Physiol, CH-1700 Fribourg, Switzerland	University of Fribourg	Miles-Chan, JL (corresponding author), Univ Fribourg, Dept Med, Div Physiol, Lab Integrat Cardiovasc & Metab Physiol, CH-1700 Fribourg, Switzerland.	jenniferlynn.miles@unifr.ch	Miles-Chan, Jennifer/Q-2464-2019	Miles-Chan, Jennifer/0000-0003-0313-7048; DULLOO, Abdul/0000-0003-3877-6149; Fares, Elie Jacques/0000-0001-6506-9867	Department of Medicine (University of Fribourg)	Department of Medicine (University of Fribourg)	This study was in part supported by the Department of Medicine (University of Fribourg) internal funding scheme.	Adams JB, 2009, J STRENGTH COND RES, V23, P237, DOI 10.1519/JSC.0b013e3181876830; Cardinale M, 2003, J STRENGTH COND RES, V17, P621; Cardinale M, 2010, BRIT J SPORT MED, V44, P284, DOI 10.1136/bjsm.2007.043232; Cardinale M, 2006, CLIN PHYSIOL FUNCT I, V26, P380, DOI 10.1111/j.1475-097X.2006.00706.x; Charriere N, 2016, J NUTR SCI IN PRESS; Cochrane DJ, 2012, SCAND J MED SCI SPOR, V22, P705, DOI 10.1111/j.1600-0838.2011.01411.x; Cochrane DJ, 2011, INT J SPORTS MED, V32, P75, DOI 10.1055/s-0030-1268010; Cristi-Montero C, 2013, NUTR HOSP, V28, P1365, DOI 10.3305/nh.2013.28.5.6656; Da Silva ME, 2007, J STRENGTH COND RES, V21, P470, DOI 10.1519/R-19025.1; Dempsey PC, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0522-0; Di Giminiani R, 2015, J ELECTROMYOGR KINES, V25, P853, DOI 10.1016/j.jelekin.2015.09.004; Di Giminiani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111521; Di Loreto C, 2004, J ENDOCRINOL INVEST, V27, P323, DOI 10.1007/BF03351056; Fjeldstad C, 2009, MATURITAS, V63, P79, DOI 10.1016/j.maturitas.2009.03.013; Fratini A, 2009, MED ENG PHYS, V31, P1166, DOI 10.1016/j.medengphy.2009.07.014; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Games KE, 2015, J ATHL TRAINING, V50, P542, DOI 10.4085/1062-6050-50.2.09; Garatachea N, 2007, J STRENGTH COND RES, V21, P594, DOI 10.1519/R-20566.1; Giunta M, 2012, OBESITY FACTS, V5, P567, DOI 10.1159/000342066; Gojanovic B, 2014, PHYSIOL RES, V63, P779, DOI 10.33549/physiolres.932628; Gojanovic B, 2012, J SPORT SCI, V30, P1397, DOI 10.1080/02640414.2012.710756; Goto K, 2005, JPN J PHYSIOL, V55, P279, DOI 10.2170/jjphysiol.RP000305; Kiiski J, 2008, J BONE MINER RES, V23, P1318, DOI [10.1359/jbmr.080315, 10.1359/JBMR.080315]; Levine JA, 2000, AM J CLIN NUTR, V72, P1451; Lienhard K, 2015, J STRENGTH COND RES, V29, P2844, DOI 10.1519/JSC.0000000000000927; Lienhard K, 2014, EUR J APPL PHYSIOL, V114, P1493, DOI 10.1007/s00421-014-2874-1; Maddalozzo GF, 2008, INT J OBESITY, V32, P1348, DOI 10.1038/ijo.2008.111; Miles-Chan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065827; Nigg B M, 2001, Exerc Sport Sci Rev, V29, P37, DOI 10.1097/00003677-200101000-00008; Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739; Rittweger J, 2001, EUR J APPL PHYSIOL, V86, P169, DOI 10.1007/s004210100511; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Ritzmann R, 2013, EUR J APPL PHYSIOL, V113, P1, DOI 10.1007/s00421-012-2402-0; Roelants M, 2004, INT J SPORTS MED, V25, P1, DOI 10.1055/s-2003-45238; Sarafian D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00155; Tapp LR, 2014, CLIN INTERV AGING, V9, P63, DOI 10.2147/CIA.S30048; Vissers D, 2009, PHYSICIAN SPORTSMED, V37, P88, DOI 10.3810/psm.2009.10.1733; Vissers D, 2010, OBESITY FACTS, V3, P93, DOI 10.1159/000301785; von Stengel S, 2012, SCAND J MED SCI SPOR, V22, P119, DOI 10.1111/j.1600-0838.2010.01126.x; Wakeling JM, 2001, J APPL PHYSIOL, V90, P412, DOI 10.1152/jappl.2001.90.2.412; Wang Y, 2002, J APPL PHYSIOL, V92, P2409, DOI 10.1152/japplphysiol.00376.2001; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wilms B, 2012, INT J SPORTS MED, V33, P740, DOI 10.1055/s-0032-1306284; Zaidell LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085247; Zange J, 2009, EUR J APPL PHYSIOL, V105, P265, DOI 10.1007/s00421-008-0898-0	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151552	10.1371/journal.pone.0151552	http://dx.doi.org/10.1371/journal.pone.0151552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974147	Green Published, gold			2022-12-27	WOS:000372570600088
J	Fernandez-Gil, A; Naves, J; Ordiz, A; Quevedo, M; Revilla, E; Delibes, M				Fernandez-Gil, Alberto; Naves, Javier; Ordiz, Andres; Quevedo, Mario; Revilla, Eloy; Delibes, Miguel			Conflict Misleads Large Carnivore Management and Conservation: Brown Bears and Wolves in Spain	PLOS ONE			English	Article							WOLF CANIS-LUPUS; URSUS-ARCTOS; HUMAN ATTITUDES; RISK; DEPREDATION; LIVESTOCK; PREY; ECOLOGY; PERCEPTION; PREDATORS	Large carnivores inhabiting human-dominated landscapes often interact with people and their properties, leading to conflict scenarios that can mislead carnivore management and, ultimately, jeopardize conservation. In northwest Spain, brown bears Ursus arctos are strictly protected, whereas sympatric wolves Canis lupus are subject to lethal control. We explored ecological, economic and societal components of conflict scenarios involving large carnivores and damages to human properties. We analyzed the relation between complaints of depredations by bears and wolves on beehives and livestock, respectively, and bear and wolf abundance, livestock heads, number of culled wolves, amount of paid compensations, and media coverage. We also evaluated the efficiency of wolf culling to reduce depredations on livestock. Bear damages to beehives correlated positively to the number of female bears with cubs of the year. Complaints of wolf predation on livestock were unrelated to livestock numbers; instead, they correlated positively to the number of wild ungulates harvested during the previous season, the number of wolf packs, and to wolves culled during the previous season. Compensations for wolf complaints were fivefold higher than for bears, but media coverage of wolf damages was thirty-fold higher. Media coverage of wolf damages was unrelated to the actual costs of wolf damages, but the amount of news correlated positively to wolf culling. However, wolf culling was followed by an increase in compensated damages. Our results show that culling of the wolf population failed in its goal of reducing damages, and suggest that management decisions are at least partly mediated by press coverage. We suggest that our results provide insight to similar scenarios, where several species of large carnivores share the landscape with humans, and management may be reactive to perceived conflicts.	[Fernandez-Gil, Alberto; Naves, Javier; Revilla, Eloy; Delibes, Miguel] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Ordiz, Andres] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Quevedo, Mario] Univ Oviedo, UMIB, Dept Biol Organismos & Sistemas, Oviedo, Spain; [Ordiz, Andres] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Norwegian University of Life Sciences; University of Oviedo; Swedish University of Agricultural Sciences	Fernandez-Gil, A (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	albertofg@ebd.csic.es	Revilla, Eloy/B-5100-2008; Delibes, Miguel/K-2744-2014	Revilla, Eloy/0000-0001-5534-5581; Delibes, Miguel/0000-0002-3569-567X; Naves, Javier/0000-0003-3773-0288; Ordiz, Andres/0000-0002-6141-8457	Consejeria de Medio Ambiente, Ordenacion del Territorio e Infraestracturas, Principado de Asturias [2008-2010 EBD-CSIC]; HARMONIA project [2013/08/M/NZ9/00469]; Spanish Ministerio de Ciencia e Innovacion [CGL2009-07301, CGL2012-35931]; FEDER	Consejeria de Medio Ambiente, Ordenacion del Territorio e Infraestracturas, Principado de Asturias; HARMONIA project; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission)	This work was partially funded by Consejeria de Medio Ambiente, Ordenacion del Territorio e Infraestracturas, Principado de Asturias (Brown Bear Project 2008-2010 EBD-CSIC) and by cooperation within HARMONIA project 2013/08/M/NZ9/00469 (Polish National Science Centre). ER was supported by projects CGL2009-07301 and CGL2012-35931 from the Spanish Ministerio de Ciencia e Innovacion, co-funded with FEDER funds.	Alvares F, 2005, C FRONT WOLF REC SW, P76; [Anonymous], 2014, R LANG ENV STAT COMP; BLANCO JC, 1992, BIOL CONSERV, V60, P73, DOI 10.1016/0006-3207(92)91157-N; Borg BL, 2015, J ANIM ECOL, V84, P177, DOI 10.1111/1365-2656.12256; Bruskotter J. T., 2010, Human Dimensions of Wildlife, V15, P311, DOI 10.1080/10871209.2010.508068; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; CLEVENGER AP, 1994, ACTA THERIOL, V39, P267, DOI 10.4098/AT.arch.94-30; CUESTA L, 1991, MAMMALIA, V55, P239, DOI 10.1515/mamm.1991.55.2.239; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Dressel S, 2015, CONSERV BIOL, V29, P565, DOI 10.1111/cobi.12420; European Commission (EC), 2015, COMM AGR POL 2013; Fernandez-Gil A, 2013, THESIS U OVIEDO; Frank LG, 2005, CONSERV BIOL SER, V9, P286; Gore ML, 2009, J WILDLIFE MANAGE, V73, P1407, DOI 10.2193/2008-343; Gore ML, 2005, WILDLIFE SOC B, V33, P507, DOI 10.2193/0091-7648(2005)33[507:EORPOM]2.0.CO;2; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Haber GC, 1996, CONSERV BIOL, V10, P1068, DOI 10.1046/j.1523-1739.1996.10041068.x; Harper EK, 2008, J WILDLIFE MANAGE, V72, P778, DOI 10.2193/2007-273; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Jacobs MH, 2014, EUR J WILDLIFE RES, V60, P589, DOI 10.1007/s10344-014-0823-2; Kaczensky Petra, 1999, Ursus, V11, P59; Karlsson J, 2007, BIOL CONSERV, V137, P610, DOI 10.1016/j.biocon.2007.03.023; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Naves J, 2006, J MAMMAL, V87, P899, DOI 10.1644/05-MAMM-A-318R2.1; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Ordiz A, 2013, BIOL CONSERV, V168, P128, DOI 10.1016/j.biocon.2013.09.024; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Perez T, 2014, WILDLIFE BIOL, V20, P300, DOI 10.2981/wlb.00069; Peterson RO, 1984, WILDLIFE MONOGR, P3; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Pooley SP, 2014, CONSERV BIOL, V28, P22, DOI 10.1111/cobi.12183; Principado de Asturias, 2002, PLAN GESTION LOBO PR; Principado de Asturias, 2002, PLAN RECUPERACION OS; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith JA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2711; Sociedad Asturiana de Estudios Economicos e Industriales (SADEI), 2015, CAB GAN; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; THURBER JM, 1993, J MAMMAL, V74, P879, DOI 10.2307/1382426; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Treves A, 2010, URSUS, V21, P30, DOI 10.2192/09GR012.1; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Treves A, 2009, BIODIVERS CONSERV, V18, P4003, DOI 10.1007/s10531-009-9695-2; Vucetich JA, 2014, OXFORD HDB ANIMAL ST, DOI [10.1093/oxfordhb/9780199927142.013.007, DOI 10.1093/OXFORDHB/9780199927142.013.007]; Vucetich JA, 2012, BEHAV ECOL SOCIOBIOL, V66, P295, DOI 10.1007/s00265-011-1277-0; Wallach A.D., 2015, OIKOS; Weber W, 1996, CONSERV BIOL, V10, P1046, DOI 10.1046/j.1523-1739.1996.10041046.x; White Lynsey A., 2009, Human Dimensions of Wildlife, V14, P419; White RM, 2009, LAND USE POLICY, V26, P242, DOI 10.1016/j.landusepol.2008.03.005; Wiegand T, 1998, ECOL MONOGR, V68, P539, DOI 10.1890/0012-9615(1998)068[0539:ATROEF]2.0.CO;2; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R., 2005, CONSERV BIOL	61	66	67	10	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151541	10.1371/journal.pone.0151541	http://dx.doi.org/10.1371/journal.pone.0151541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974962	gold, Green Published, Green Accepted			2022-12-27	WOS:000372570600086
J	Liu, J; Tian, ZY; Xiao, YC; Wang, XL; Jin, ML; Shi, DS				Liu, Jin; Tian, Zhong-Yuan; Xiao, Yun-Cai; Wang, Xi-Liang; Jin, Mei-Lin; Shi, De-Shi			The Role of Porcine Monocyte Derived Dendritic Cells (MoDC) in the Inflammation Storm Caused by Streptococcus suis Serotype 2 Infection	PLOS ONE			English	Article							PATHOGENESIS; MENINGITIS; RECEPTORS; PIGS	Background Streptococcus suis is an important swine pathogen and zoonotic agent. Infection with this highly pathogenic strain can cause streptococcal toxic shock-like syndrome (STSLS), characterized by a Th-1 inflammatory cytokine storm, and a high mortality rate. Monocyte derived dendritic cells (MoDCs) are known to stimulate Th-1 cell differentiation, but the role of MoDCs in STSLS remains to be elucidated. Methodology and Findings Porcine CD14-positive monocytes, purified from peripheral blood mononuclear cells (PBMCs), were used to generate MoDCs using granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). Highly pure MoDCs were generated, as proved by their morphology, phenotype analysis, phagocytic ability, and induction of T cells proliferation. The MoDCs were further stimulated by the virulent S. suis serotype 2 (SS2) SC19 strain which triggered a strong release of several pro-inflammatory cytokines, including IL-1 beta, IL-8, TNF-alpha, IFN-gamma, and IL-12. Furthermore, the stimulated MoDCs induced CD4(+) T cell differentiation towards Th-1 cells in vitro. Conclusions The results of this study indicated that the porcine MoDCs stimulated by SS2 could release high levels of Th-1 inflammatory cytokines and induce CD4(+) T cell differentiation towards Th-1 cells. Hence, it is likely that porcine MoDCs play an important role in the STSLS caused by SS2.	[Liu, Jin; Tian, Zhong-Yuan; Xiao, Yun-Cai; Wang, Xi-Liang; Jin, Mei-Lin; Shi, De-Shi] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Liu, Jin; Tian, Zhong-Yuan; Xiao, Yun-Cai; Wang, Xi-Liang; Jin, Mei-Lin; Shi, De-Shi] Huazhong Agr Univ, Coll Vet Med, Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Shi, DS (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.; Shi, DS (corresponding author), Huazhong Agr Univ, Coll Vet Med, Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan 430070, Hubei, Peoples R China.	rock@mail.hzau.edu.cn			China National Natural Science Foundation of China [31372484]; Natural Science Foundation of Hubei Province of China [2012FFB02906]; Fundamental Research Funds for the Central Universities [2015PY117]	China National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by: De-Shi Shi: China National Natural Science Foundation of China (31372484); De-Shi Shi: the Natural Science Foundation of Hubei Province of China (2012FFB02906); De-Shi Shi: the Fundamental Research Funds for the Central Universities (2015PY117).	Araki H, 2001, BRIT J HAEMATOL, V114, P681, DOI 10.1046/j.1365-2141.2001.02973.x; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bi YH, 2014, VET MICROBIOL, V173, P299, DOI 10.1016/j.vetmic.2014.08.010; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Cecere TE, 2012, VET MICROBIOL, V160, P233, DOI 10.1016/j.vetmic.2012.04.040; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Ezquerra A, 2009, DEV COMP IMMUNOL, V33, P284, DOI 10.1016/j.dci.2008.06.002; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Higgins R, 1996, CAN VET J, V37, P242; Ip M, 2007, DIAGN MICR INFEC DIS, V57, P15, DOI 10.1016/j.diagmicrobio.2006.05.011; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; Knosp CA, 2012, IMMUNOLOGY, V135, P101, DOI 10.1111/j.1365-2567.2011.03520.x; Lecours MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044746; LEVIN D, 1993, J IMMUNOL, V151, P6742; Liu ML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-253; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Silva-Campa E, 2009, VIROLOGY, V387, P373, DOI 10.1016/j.virol.2009.02.033; Smith HE, 1999, INFECT IMMUN, V67, P1750; Speyer CL, 2011, J INVEST SURG, V24, P18, DOI 10.3109/08941939.2010.521232; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Yao Y, 2009, CLIN PEDIATR, V24, P789; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang QF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01180; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	33	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151256	10.1371/journal.pone.0151256	http://dx.doi.org/10.1371/journal.pone.0151256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974437	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600058
J	Rise, MB; Steinsbekk, A				Rise, Marit By; Steinsbekk, Aslak			Long Term Effect on Professionals' Knowledge, Practice and Attitudes towards User Involvement Four Years after Implementing an Organisational Development Plan: A Controlled Study	PLOS ONE			English	Article							MENTAL-HEALTH-SERVICES; NORMALIZATION PROCESS THEORY; CROSS-SECTIONAL SURVEY; PATIENT INVOLVEMENT; CONSUMER PARTICIPATION; COMPLEX INTERVENTIONS; QUALITY IMPROVEMENT; DECISION-MAKING; PRIMARY-CARE; CHALLENGES	Background Health service organisations are increasingly implementing user involvement initiatives according to requirements from governments, such as user representation in administrational boards, better information to users, and more involvement of the users during treatment. Professionals are vital in all initiatives to enhance user involvement, and initiatives to increase involvement should influence the professionals' practice and attitudes. The implementation of a development plan intending to enhance user involvement in a mental health hospital in Central Norway had no effect on the professionals after 16 months. The objective was therefore to investigate the long term effect on the professionals' knowledge, practice and attitudes towards user involvement after four years. Methods This was a non-randomized controlled study including professionals from three mental health hospitals in Central Norway. A development plan intended to enhance user participation was implemented in one of the hospitals, including establishing a patient education centre and a user office, purchasing of user expertise, appointing contact professionals for next of kin, and improving of the centre's information and the professional culture. The professionals at two other hospitals constituted the control group. All professionals were invited to answer the Consumer Participation Questionnaire (CPQ) and additional questions, at a four year interval. Results A total of 399 professionals participated (43% response rate). Comparing the changes in the intervention group with the changes in the control group, the results showed that the plan had improved some aspects of the professionals' knowledge about the user involvement taking place in the hospital. In addition, some parts of the professionals' practice of providing information to the service users was improved, and the development plan might have raised their awareness about insufficient involvement of next of kin. Conclusions This is the first controlled study on the long term effect on professionals from implementing a development plan to enhance user participation in a mental health hospital. Since there was more effect after four years than after 16 months, this study indicates that it takes time before the effect of complex interventions to enhance patient participation in organisations can be detected among the professionals. More long-term studies are thus warranted.	[Rise, Marit By; Steinsbekk, Aslak] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Rise, MB (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	marit.b.rise@ntnu.no	Steinsbekk, Aslak/E-9223-2012	Steinsbekk, Aslak/0000-0001-9090-0739	Research Council of Norway	Research Council of Norway(Research Council of Norway)	The Research Council of Norway funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Armstrong N, 2013, HEALTH EXPECT, V16, pE36, DOI 10.1111/hex.12039; Arnold J., 2005, UNDERSTANDING HUMAN; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Bamford C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0549-6; Boivin A, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-24; CHARLES C, 1993, J HEALTH POLIT POLIC, V18, P881, DOI 10.1215/03616878-18-4-881; Contandriopoulos D, 2004, SOC SCI MED, V58, P321, DOI 10.1016/S0277-9536(03)00164-3; Coulter A, 2006, PATIENT FOCUSED INTE; Coulter A., 2011, ENGAGING PATIENTS HL; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Crawford MJ, 2003, ACTA PSYCHIAT SCAND, V107, P410, DOI 10.1034/j.1600-0447.2003.00049.x; Crawford MJ, 2002, BRIT MED J, V325, P1263, DOI 10.1136/bmj.325.7375.1263; Daykin N, 2002, J Interprof Care, V16, P405; Dixon-Woods M, 2012, BMJ QUAL SAF, V21, P876, DOI 10.1136/bmjqs-2011-000760; European Commission, 2001, WHIT PAP EUR GOV; Forster DA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S5-S8; Fudge N, 2008, BMJ-BRIT MED J, V336, P313, DOI 10.1136/bmj.39456.552257.BE; Gagliardi AR, 2008, PATIENT EDUC COUNS, V70, P234, DOI 10.1016/j.pec.2007.09.009; Grant J, 2007, INT J SOC PSYCHIATR, V53, P148, DOI 10.1177/0020764006074557; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Kent H, 1998, INT J SOC PSYCHIATR, V44, P295, DOI 10.1177/002076409804400406; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; May CR, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-42; McCann TV, 2008, NURS HEALTH SCI, V10, P78, DOI 10.1111/j.1442-2018.2008.00388.x; Murray E, 2003, IVEY BUSINESS J  MAR; Muusmann research and consulting, 2008, MAPP COMM MENT HLTH; Nathan Sally, 2006, J Health Organ Manag, V20, P551, DOI 10.1108/14777260610702299; Nathan S, 2011, HEALTH EXPECT, V14, P272, DOI 10.1111/j.1369-7625.2010.00628.x; Nilsen E, 2010, COCHRANE DATABASE SY; Norwegian directorate for health and social affairs, 2005, NAT STRAT QUAL IMPR; Omeni E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0491-7; Phillips RL, 2015, HEALTH EXPECT, V18, P2616, DOI 10.1111/hex.12234; Richter J, 2009, ADM POLICY MENT HLTH, V36, P265, DOI 10.1007/s10488-009-0219-x; Rise MB, 2015, HEALTH EXPECT, V18, P809, DOI 10.1111/hex.12105; Rise MB, 2014, INT J SOC PSYCHIATR, V60, P387, DOI 10.1177/0020764013491739; Rise MB, 2013, HEALTH EXPECT, V16, P266, DOI 10.1111/j.1369-7625.2011.00713.x; Rise MB, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-296; Rose D., 2003, J MENTAL HLTH, V12, P59; Sibitz I, 2008, PSYCHIAT PRAX, V35, P128, DOI 10.1055/s-2007-986231; Soffe J., 2004, J MENTAL HLTH, V13, P583, DOI [10.1080/09638230400017020, DOI 10.1080/09638230400017020]; Storm M, 2011, PSYCHOSIS, V3, P29, DOI 10.1080/17522439.2010.501521; Storm M, 2010, PSYCHIAT QUART, V81, P111, DOI 10.1007/s11126-009-9122-6; Tempfer CB, 2011, WIEN KLIN WOCHENSCHR, V123, P408, DOI 10.1007/s00508-011-0008-x; Thompson AGH, 2007, SOC SCI MED, V64, P1297, DOI 10.1016/j.socscimed.2006.11.002; Tritter JQ, 2009, HEALTH EXPECT, V12, P275, DOI 10.1111/j.1369-7625.2009.00564.x; Walker HJ, 2007, J ORGAN CHANGE MANAG, V20, P761, DOI 10.1108/09534810710831000; Wiig S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-206; World Health Organization (WHO), 1978, INT C PRIM HLTH CAR; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	51	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150742	10.1371/journal.pone.0150742	http://dx.doi.org/10.1371/journal.pone.0150742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26974971	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600030
J	Gossmann, J; Stolte, M; Lohoff, M; Yu, P; Moll, R; Finkernagel, F; Garn, H; Brendel, C; Bittner, A; Neubauer, A; Huynh, MQ				Gossmann, Jennifer; Stolte, Manfred; Lohoff, Michael; Yu, Philipp; Moll, Roland; Finkernagel, Florian; Garn, Holger; Brendel, Cornelia; Bittner, Alwina; Neubauer, Andreas; Huynh, Minh Q.			A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma	PLOS ONE			English	Article							REGULATORY T-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PYLORI-ASSOCIATED GASTRITIS; FOXP3(+) TREG CELLS; SEE VOL. 79; B-CELLS; TISSUE LYMPHOMA; PHOSPHOLIPASE C-GAMMA-2; RHEUMATOID-ARTHRITIS; IMMUNE SUPPRESSION	Gastric mucosa-associated lymphoid tissue (MALT) lymphomas develop from a chronic Helicobacter infection. Phospholipase C gamma 2 (PLCG2) is important for B-cell survival and proliferation. We used BALB/c mice with a gain-of-function mutation in the Plcg2 gene (Ali5) to analyze its role in the development of gastric MALT lymphoma. Heterozygous BALB/c Plcg2(Ali5/+) and wildtype (WT) mice were infected with Helicobacter felis (H. felis) and observed up to 16 months for development of gastric MALT lymphomas. In contrast to our initial hypothesis, Plcg2(Ali5/+) mice developed MALT lymphomas less frequently than their WT littermates after long-term infection of 16 months. Infected Plcg2(Ali5/+) mice showed downregulation of proinflammatory cytokines and decreased H. felis-specific IgG1 and IgG2a antibody responses. These results suggested a blunted immune response of Plcg2(Ali5/+) mice towards H. felis infection. Intriguingly, Plcg2(Ali5/+) mice harboured higher numbers of CD73 expressing regulatory T cells (Tregs), possibly responsible for impaired immune response towards Helicobacter infection. We suggest that Plcg2(Ali5/+) mice may be protected from developing gastric MALT lymphomas as a result of elevated Treg numbers, reduced response to H. felis and decrease of proinflammatory cytokines.	[Gossmann, Jennifer; Brendel, Cornelia; Bittner, Alwina; Neubauer, Andreas; Huynh, Minh Q.] Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany; [Gossmann, Jennifer; Brendel, Cornelia; Bittner, Alwina; Neubauer, Andreas; Huynh, Minh Q.] Univ Hosp Giessen & Marburg, Marburg, Germany; [Stolte, Manfred] Kulmbach Hosp, Inst Pathol, Kulmbach, Germany; [Lohoff, Michael] Univ Marburg, Inst Med Microbiol, Marburg, Germany; [Yu, Philipp] Univ Marburg, Inst Immunol, Marburg, Germany; [Moll, Roland] Univ Marburg, Inst Pathol, Marburg, Germany; [Finkernagel, Florian] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany; [Garn, Holger] Univ Marburg, Inst Lab Med & Pathobiochem Mol Diagnost, Marburg, Germany; [Neubauer, Andreas] Univ Marburg, Inst Pharmacol & Clin Pharm, Marburg, Germany; [Huynh, Minh Q.] Landeskrankenhaus Bregenz, Bregenz, Austria	Philipps University Marburg; University Hospital of Giessen & Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Neubauer, A (corresponding author), Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany.; Neubauer, A (corresponding author), Univ Hosp Giessen & Marburg, Marburg, Germany.	neubauer@staff.uni-marburg.de	Brendel, Cornelia/U-5901-2019	Brendel, Cornelia/0000-0003-1612-9557; Garn, Holger/0000-0002-5178-4023	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) grant "Tumor and Inflammation"; University Hospital Giessen and Marburg (UKGM) [11/2013 MR]; Deutsche Forschungsgemeinschaft [KFO 210, NE 310/14-2, SFB TR22, 491.000]; Jose Carreras Leukamie-Stiftung [AH06-01]; Behring-Rontgen-Stiftung [TP3, 51-0057, 600.000]	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) grant "Tumor and Inflammation"; University Hospital Giessen and Marburg (UKGM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jose Carreras Leukamie-Stiftung; Behring-Rontgen-Stiftung	This work was supported by Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) grant "Tumor and Inflammation" (http://www.imt.uni-marburg.de/loewe/, project A1, to AN); research grant of the University Hospital Giessen and Marburg (UKGM, 11/2013 MR, to JG and MQH); Deutsche Forschungsgemeinschaft (KFO 210, NE 310/14-2, to AN and SFB TR22, 491.000., to ML; http://www.dfg.de); Jose Carreras Leukamie-Stiftung (https://www.carreras-stiftung.de, AH06-01, to AN); Behring-Rontgen-Stiftung (TP3, 51-0057, to AN and fellowship, 600.000., to ML; http://www.br-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2009, J INFECT DIS, V199, P494, DOI 10.1086/596205; Alvarado-Sanchez B, 2006, J AUTOIMMUN, V27, P110, DOI 10.1016/j.jaut.2006.06.005; BAYERDORFFER E, 1995, LANCET, V345, P1591, DOI 10.1016/S0140-6736(95)90113-2; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Bell SE, 2004, EUR J IMMUNOL, V34, P2237, DOI 10.1002/eji.200425054; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Cheng TY, 2006, J CLIN ONCOL, V24, P3483, DOI 10.1200/JCO.2005.05.5434; Chiu BCH, 2005, BRIT J HAEMATOL, V128, P610, DOI 10.1111/j.1365-2141.2004.05358.x; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; D'Elios MM, 2007, FEMS IMMUNOL MED MIC, V50, P157, DOI 10.1111/j.1574-695X.2007.00258.x; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Flores-Borja F, 2008, P NATL ACAD SCI USA, V105, P19396, DOI 10.1073/pnas.0806855105; Hellmig S, 2004, BLOOD, V104, P2994, DOI 10.1182/blood-2004-05-1792; Herz U, 1998, CLIN EXP ALLERGY, V28, P625; Huynh MQ, 2015, LEUKEMIA LYMPHOMA, V56, P1088, DOI 10.3109/10428194.2014.941832; Huynh MQ, 2008, LEUKEMIA LYMPHOMA, V49, P974, DOI 10.1080/10428190802007734; ISAACSON P, 1983, CANCER, V51, P80, DOI 10.1002/1097-0142(19830101)51:1<80::AID-CNCR2820510118>3.0.CO;2-0; Kaparakis M, 2006, INFECT IMMUN, V74, P3519, DOI 10.1128/IAI.01314-05; Kudo T, 2005, INFECT IMMUN, V73, P7602, DOI 10.1128/IAi.73.11.7602-7612.2005; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lindholm C, 2001, SCAND J GASTROENTERO, V36, P1022, DOI 10.1080/003655201750422602; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Lyssuk EY, 2007, ADV EXP MED BIOL, V601, P113; MANDLER R, 1993, J IMMUNOL, V150, P407; Mori N, 2003, INFECT IMMUN, V71, P3748, DOI 10.1128/IAI.71.7.3748-3756.2003; Neubauer A, 1997, JNCI-J NATL CANCER I, V89, P1350, DOI 10.1093/jnci/89.18.1350; Nielsen CH, 2005, TRANSFUS MED HEMOTH, V32, P339, DOI 10.1159/000089121; Nishi T, 2003, INFECT IMMUN, V71, P2153, DOI 10.1128/IAI.71.4.2153-2162.2003; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Petro JB, 2001, J BIOL CHEM, V276, P1715, DOI 10.1074/jbc.M009137200; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Rollinson S, 2003, BLOOD, V102, P1007, DOI 10.1182/blood-2002-12-3803; Sagaert X, 2010, NAT REV GASTRO HEPAT, V7, P336, DOI 10.1038/nrgastro.2010.58; Sarigul M, 2010, LUPUS, V19, P138, DOI 10.1177/0961203309348234; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; SNAPPER CM, 1988, J IMMUNOL, V141, P489; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; STOLTE M, 1992, LANCET, V339, P745, DOI 10.1016/0140-6736(92)90645-J; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Tomimori K, 2007, INFECT IMMUN, V75, P5223, DOI 10.1128/IAI.00731-07; Valencia X, 2007, NAT CLIN PRACT RHEUM, V3, P619, DOI 10.1038/ncprheum0624; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Wundisch T, 2006, LEUKEMIA LYMPHOMA, V47, P2110, DOI 10.1080/10428190600783536; Wundisch T, 2012, GASTROENTEROLOGY, V143, P936, DOI 10.1053/j.gastro.2012.06.035; Wundisch T, 2005, J CLIN ONCOL, V23, P8018, DOI 10.1200/JCO.2005.02.3903; Yamaoka Y, 1998, GUT, V42, P609, DOI 10.1136/gut.42.5.609; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Yoshida A, 2009, CLIN IMMUNOL, V130, P290, DOI 10.1016/j.clim.2008.09.016; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	54	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150411	10.1371/journal.pone.0150411	http://dx.doi.org/10.1371/journal.pone.0150411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966907	Green Submitted, gold, Green Published			2022-12-27	WOS:000371989200012
J	Liu, CC; Janke, LJ; Kawedia, JD; Ramsey, LB; Cai, XJ; Mattano, LA; Boyd, KL; Funk, AJ; Relling, MV				Liu, Chengcheng; Janke, Laura J.; Kawedia, Jitesh D.; Ramsey, Laura B.; Cai, Xiangjun; Mattano, Leonard A., Jr.; Boyd, Kelli L.; Funk, Amy J.; Relling, Mary V.			Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse Model	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; AVASCULAR NECROSIS; FEMORAL-HEAD; CHILDREN; THERAPY; DEXAMETHASONE; RISK; PHARMACOKINETICS; ARTERIOPATHY; COMPLICATION	Osteonecrosis is a common dose-limiting toxicity of glucocorticoids. Data from clinical trials suggest that other medications can increase the risk of glucocorticoid-induced osteonecrosis. Here we utilized a mouse model to study the effect of asparaginase treatment on dexamethasone-induced osteonecrosis. Mice receiving asparaginase along with dexamethasone had a higher rate of osteonecrosis than those receiving only dexamethasone after 6 weeks of treatment (44% vs. 10%, P = 0.006). Similarly, epiphyseal arteriopathy, which we have shown to be an initiating event for osteonecrosis, was observed in 58% of mice receiving asparaginase and dexamethasone compared to 17% of mice receiving dexamethasone only (P = 0.007). As in the clinic, greater exposure to asparaginase was associated with greater plasma exposure to dexamethasone (P = 0.0001). This model also recapitulated other clinical risk factors for osteonecrosis, including age at start of treatment, and association with the systemic exposure to dexamethasone (P = 0.027) and asparaginase (P = 0.036). We conclude that asparaginase can potentiate the osteonecrotic effect of glucocorticoids.	[Liu, Chengcheng; Cai, Xiangjun; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Janke, Laura J.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kawedia, Jitesh D.] Univ Texas MD Anderson Canc Ctr, Dept Pharm Res, Houston, TX 77030 USA; [Ramsey, Laura B.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Mattano, Leonard A., Jr.] HARP Pharma Consulting, Mystic, CT USA; [Boyd, Kelli L.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Funk, Amy J.] St Jude Childrens Res Hosp, Anim Resource Ctr Vet Serv, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Texas System; UTMD Anderson Cancer Center; Cincinnati Children's Hospital Medical Center; Vanderbilt University; St Jude Children's Research Hospital	Relling, MV (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	mary.relling@stjude.org	Ramsey, Laura/ABD-6113-2020; Janke, Laura/N-8121-2018; Relling, Mary/N-5032-2018	Ramsey, Laura/0000-0001-6417-3961; Janke, Laura/0000-0002-9871-6239; Kawedia, Jitesh/0000-0001-9685-9378	NIH; HARP Pharma Consulting; NATIONAL CANCER INSTITUTE [R01CA142665, P30CA021765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HARP Pharma Consulting; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grants provided by the NIH to MVR. HARP Pharma Consulting provided support in the form of salary for author LAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Appel IM, 2008, THROMB HAEMOSTASIS, V100, P330, DOI 10.1160/TH07-10-0620; Arico M, 2003, HAEMATOLOGICA, V88, P747; Athale UH, 2003, THROMB RES, V111, P199, DOI 10.1016/j.thromres.2003.10.007; Bhat V, 2015, AM J HEMATOL, V90, P1027, DOI 10.1002/ajh.24133; Bhojwani D, 2014, EUR J CANCER, V50, P2685, DOI 10.1016/j.ejca.2014.06.023; Bielinski SJ, 2014, MAYO CLIN PROC, V89, P25, DOI 10.1016/j.mayocp.2013.10.021; Burckart GJ, 2006, THER DRUG MONIT, V28, P23, DOI 10.1097/01.ftd.0000194502.85763.bc; Burger B, 2005, PEDIATR BLOOD CANCER, V44, P220, DOI 10.1002/pbc.20244; Chalothorn D, 2010, PHYSIOL GENOMICS, V42, P469, DOI 10.1152/physiolgenomics.00070.2010; Fernandez CA, 2013, INT J CLIN EXP MED, V6, P478; Halton JM, 1998, CANCER, V83, P379, DOI 10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P; HANADA T, 1989, EUR J PEDIATR, V149, P162, DOI 10.1007/BF01958270; Hawkins DS, 2004, CLIN CANCER RES, V10, P5335, DOI 10.1158/1078-0432.CCR-04-0222; Janke LJ, 2013, AM J PATHOL, V183, P19, DOI 10.1016/j.ajpath.2013.03.004; Kawedia JD, 2012, COMPARATIVE MED, V62, P466; Kawedia JD, 2012, BLOOD, V119, P1658, DOI 10.1182/blood-2011-09-381731; Kawedia JD, 2011, BLOOD, V117, P2340, DOI 10.1182/blood-2010-10-311969; Kerachian MA, 2009, J STEROID BIOCHEM, V114, P121, DOI 10.1016/j.jsbmb.2009.02.007; Liu C, 2012, LEUKEMIA, V26, P2303, DOI 10.1038/leu.2012.102; Mattano Jr LA, 2014, BLOOD; Mattano LA, 2000, J CLIN ONCOL, V18, P3262, DOI 10.1200/JCO.2000.18.18.3262; Mattano LAJ, 2012, BLOOD; Mitchell LG, 2003, CANCER, V97, P508, DOI 10.1002/cncr.11042; Muller HJ, 2000, BRIT J HAEMATOL, V110, P379, DOI 10.1046/j.1365-2141.2000.02187.x; Muller HJ, 2002, CANCER CHEMOTH PHARM, V49, P149, DOI 10.1007/s00280-001-0391-5; Murata M, 2007, J ORTHOP SCI, V12, P289, DOI 10.1007/s00776-007-1129-y; Niinimaki RA, 2007, J CLIN ONCOL, V25, P1498, DOI 10.1200/JCO.2006.06.2539; Parsons SK, 1997, BLOOD, V89, P1886, DOI 10.1182/blood.V89.6.1886; Patel B, 2008, LEUKEMIA, V22, P308, DOI 10.1038/sj.leu.2405032; Ramsey LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135134; Relling MV, 2004, J CLIN ONCOL, V22, P3930, DOI 10.1200/JCO.2004.11.020; Ribeiro RC, 2001, LEUKEMIA, V15, P891, DOI 10.1038/sj.leu.2402139; SAITO S, 1992, CLIN ORTHOP RELAT R, P98; Szymanska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033894; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Winkel MLT, 2008, HAEMATOL-HEMATOL J, V93, P1570, DOI 10.3324/haematol.12956; Winkel MLT, 2011, J CLIN ONCOL, V29, P4143, DOI 10.1200/JCO.2011.37.3217; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; Yang L, 2009, J ORTHOP RES, V27, P169, DOI 10.1002/jor.20733	39	34	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151433	10.1371/journal.pone.0151433	http://dx.doi.org/10.1371/journal.pone.0151433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967741	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200053
J	Kluge, R; Chavdarova, L; Hoffmann, M; Kobe, C; Malkowski, B; Montravers, F; Kurch, L; Georgi, T; Dietlein, M; Wallace, WH; Karlen, J; Fernandez-Teijeiro, A; Cepelova, M; Wilson, L; Bergstraesser, E; Sabri, O; Mauz-Korholz, C; Korholz, D; Hasenclever, D				Kluge, Regine; Chavdarova, Lidia; Hoffmann, Martha; Kobe, Carsten; Malkowski, Bogdan; Montravers, Francoise; Kurch, Lars; Georgi, Thomas; Dietlein, Markus; Wallace, W. Hamish; Karlen, Jonas; Fernandez-Teijeiro, Ana; Cepelova, Michaela; Wilson, Lorrain; Bergstraesser, Eva; Sabri, Osama; Mauz-Koerholz, Christine; Koerholz, Dieter; Hasenclever, Dirk			Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INTERNATIONAL WORKSHOP; MULTICENTER TRIALS; CRITERIA; CONCORDANCE; GUIDELINES; ONCOLOGY; THERAPY; NETWORK; FRANCE	Purpose The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination between score D1,2,3 and score D4,5. Inter-reader reliability of the whole scale is not well characterised. Methods Five international expert readers scored 100 interim PET/CT scans from paediatric HL patients. Scans were acquired in 51 European hospitals after two courses of OEPA chemotherapy (according to the EuroNet-PHL-C1 study). Images were interpreted in direct comparison with staging PET/CTs. Results The probability that two random readers concord on the five point D score of a random case is only 42% (global kappa = 0.24). Aggregating to a three point scale D1,2 vs. D3 vs. D4,5 improves concordance to 60% (kappa = 0.34). Concordance if one of two readers assigns a given score is 70% for score D1,2 only 36% for score D3 and 64% for D4,5. Concordance for the binary decisions D1,2 vs. D3,4,5 is 67% and 86% for D1,2,3 vs D4,5 (kappa = 0.36 resp. 0.56). If one reader assigns D1,2,3 concordance probability is 92%, but only 64% if D4,5 is called. Discrepancies occur mainly in mediastinum, neck and skeleton. Conclusion Inter-reader reliability of the five point D-scale is poor in this interobserver analysis of paediatric patients who underwent OEPA. Inter-reader variability is maximal in cases assigned to D2 or D3. The binary distinction D1,2,3 versus D4,5 is the most reliable criterion for clinical decision making.	[Kluge, Regine; Kurch, Lars; Georgi, Thomas; Sabri, Osama] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany; [Chavdarova, Lidia] Natl Hosp Act Treatment Oncol, Clin Nucl Med, Sofia, Bulgaria; [Hoffmann, Martha] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Kobe, Carsten; Dietlein, Markus] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany; [Malkowski, Bogdan] Nicholas Copernicus Univ, Dept PET & Mol Imaging, Coll Med Bydgoszcz, Torun, Poland; [Montravers, Francoise] Hop Tenon, AP HP, Fac Med Pierre & Marie Curie, Dept Nucl Med, F-75970 Paris, France; [Wallace, W. Hamish] Univ Edinburgh, Royal Hosp Sick Children, Dept Paediat Oncol, Edinburgh, Midlothian, Scotland; [Karlen, Jonas] Astrid Lindgrens Childrens Hosp, Karolinska Univ Hosp, Stockholm, Sweden; [Fernandez-Teijeiro, Ana] Hosp Univ Virgen Macarena, Pediat Oncol Unit, Seville, Spain; [Fernandez-Teijeiro, Ana] Hosp Univ Virgen Rocio, Seville, Spain; [Cepelova, Michaela] Charles Univ Prague, Univ Hosp Motol, Dept Pediat Hematol & Oncol, Prague, Czech Republic; [Cepelova, Michaela] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Wilson, Lorrain] Blackrock Clin, Dept Nucl Med, Dublin, Ireland; [Bergstraesser, Eva] Univ Childrens Hosp Zurich, Dept Paediat Oncol, Zurich, Switzerland; [Mauz-Koerholz, Christine; Koerholz, Dieter] Univ Halle, Dept Pediat Oncol, Halle, Germany; [Hasenclever, Dirk] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany	Leipzig University; Medical University of Vienna; University of Cologne; Nicolaus Copernicus University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Edinburgh; Karolinska Institutet; Karolinska University Hospital; Hospital Universitario Virgen Macarena; Virgen del Rocio University Hospital; Charles University Prague; Motol University Hospital; Charles University Prague; University Children's Hospital Zurich; Martin Luther University Halle Wittenberg; Leipzig University	Kluge, R (corresponding author), Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany.	Regine.Kluge@medizin.uni-leipzig.de	Cepelova, Michaela/AAM-7116-2021; Körholz, Dieter/AAX-4347-2020; Mauz-Koerholz, Christine/AAX-4349-2020; Fernandez-Teijeiro, Ana/ABF-5086-2021	Fernandez-Teijeiro, Ana/0000-0002-2359-9330; Bergstrasser, Eva/0000-0002-0340-1868; Malkowski, Bogdan/0000-0003-1421-4694; Sabri, Osama/0000-0002-6425-3504				Barrington SF, 2011, ANN ONCOL, V22, P739, DOI 10.1093/annonc/mdq428; Barrington SF, 2010, EUR J NUCL MED MOL I, V37, P1824, DOI 10.1007/s00259-010-1490-5; Biggi A, 2013, J NUCL MED, V54, P683, DOI 10.2967/jnumed.112.110890; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Duhrsen U, 2009, LEUKEMIA LYMPHOMA, V50, P1757, DOI 10.3109/10428190903308031; Furth C, 2013, NUKLEARMED-NUCL MED, V52, P148, DOI 10.3413/Nukmed-0546-12-12; Furth C, 2011, ANN ONCOL, V22, P1198, DOI 10.1093/annonc/mdq557; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Hasenclever D, 2014, EUR J NUCL MED MOL I, V41, P1301, DOI 10.1007/s00259-014-2715-9; Horning SJ, 2010, BLOOD, V115, P775, DOI 10.1182/blood-2009-08-234351; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Kluge R, 2011, KLIN PADIATR, V223, P315, DOI 10.1055/s-0031-1287834; Kurch L, 2013, KLIN PADIATR, V225, P357, DOI 10.1055/s-0033-1354416; Meignan M, 2014, LEUKEMIA LYMPHOMA, V55, P31, DOI 10.3109/10428194.2013.802784; Meignan M, 2010, LEUKEMIA LYMPHOMA, V51, P2171, DOI 10.3109/10428194.2010.529208; Meignan M, 2009, LEUKEMIA LYMPHOMA, V50, P1257, DOI 10.1080/10428190903040048; Oki Y, 2014, BRIT J HAEMATOL, V165, P112, DOI 10.1111/bjh.12715; Press OW, 2013, HEMATOL ONCOL S1, V31; Stauss J, 2008, EUR J NUCL MED MOL I, V35, P1581, DOI 10.1007/s00259-008-0826-x; UEBERSAX JS, 1983, J PSYCHIAT RES, V17, P335, DOI 10.1016/0022-3956(82)90039-5; Vach W, 2005, J CLIN EPIDEMIOL, V58, P655, DOI 10.1016/j.jclinepi.2004.02.021; von Eye A, 2008, EUR PSYCHOL, V13, P305, DOI 10.1027/1016-9040.13.4.305; Ware C., 2012, INFORM VISUALIZATION	23	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149072	10.1371/journal.pone.0149072	http://dx.doi.org/10.1371/journal.pone.0149072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963909	Green Published, gold			2022-12-27	WOS:000371993000006
J	Wassmer, T; Refinetti, R				Wassmer, Thomas; Refinetti, Roberto			Daily Activity and Nest Occupation Patterns of Fox Squirrels (Sciurus niger) throughout the Year	PLOS ONE			English	Article							FIELD METABOLIC-RATES; BODY-TEMPERATURE; CIRCADIAN ENTRAINMENT; BEHAVIOR; RHYTHMS; WINTER; PHOTOPERIODS; PERIODOGRAM; HIBERNATION; PREDATION	The authors investigated the general activity and nest occupation patterns of fox squirrels in a natural setting using temperature-sensitive data loggers that measure activity as changes in the microenvironment of the animal. Data were obtained from 25 distinct preparations, upon 14 unique squirrels, totaling 1385 recording days. The animals were clearly diurnal, with a predominantly unimodal activity pattern, although individual squirrels occasionally exhibited bimodal patterns, particularly in the spring and summer. Even during the short days of winter (9 hours of light), the squirrels typically left the nest after dawn and returned before dusk, spending only about 7 hours out of the nest each day. Although the duration of the daily active phase did not change with the seasons, the squirrels exited the nest earlier in the day when the days became longer in the summer and exited the nest later in the day when the days became shorter in the winter, thus tracking dawn along the seasons. During the few hours spent outside the nest each day, fox squirrels seemed to spend most of the time sitting or lying. These findings suggest that fox squirrels may have adopted a slow life history strategy that involves long periods of rest on trees and short periods of ground activity each day.	[Wassmer, Thomas] Siena Hts Univ, Dept Biol, Adrian, MI USA; [Refinetti, Roberto] Boise State Univ, Dept Psychol, Boise, ID 83725 USA	Idaho; Boise State University	Wassmer, T (corresponding author), Siena Hts Univ, Dept Biol, Adrian, MI USA.	twassmer@sienaheights.edu	Refinetti, Roberto/B-1535-2009; Wassmer, Thomas/D-7727-2011	Refinetti, Roberto/0000-0003-2875-2389; Wassmer, Thomas/0000-0002-1456-3475	Biology Department of Siena Heights University; Siena Heights University	Biology Department of Siena Heights University; Siena Heights University	This research was funded by the Biology Department of Siena Heights University and the Siena Heights University Faculty Development Grant.	ADAMS CE, 1984, TEX J SCI, V36, P197; Beersma DGM, 1999, J BIOL RHYTHM, V14, P320, DOI 10.1177/074873099129000740; Berger A, 2003, BEHAV RES METH INS C, V35, P458, DOI 10.3758/BF03195524; Campi KL, 2010, J COMP NEUROL, V518, P4491, DOI 10.1002/cne.22466; CHAPPELL MA, 1981, PHYSIOL ZOOL, V54, P215, DOI 10.1086/physzool.54.2.30155822; Dall SRX, 2002, EVOL ECOL RES, V4, P883; DECOURSEY PJ, 1986, J COMP PHYSIOL A, V159, P161, DOI 10.1007/BF00612299; DECOURSEY PJ, 1973, J INTERDISCIPL CYCLE, V4, P67, DOI 10.1080/09291017309359368; Ditgen RS, 2007, AM MIDL NAT, V158, P403, DOI 10.1674/0003-0031(2007)158[403:BCFSSN]2.0.CO;2; Dobson FS, 2007, P NATL ACAD SCI USA, V104, P17565, DOI 10.1073/pnas.0708868104; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Everts LG, 2004, CHRONOBIOL INT, V21, P57, DOI 10.1081/CBI-120027982; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; Florant GL, 2000, LIFE IN THE COLD, P223; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; Higginson AD, 2012, AM NAT, V179, P338, DOI 10.1086/664457; HUGGINS JG, 1995, WILDLIFE SOC B, V23, P204; Hut RA, 1999, J BIOL RHYTHM, V14, P290, DOI 10.1177/074873099129000704; JODICE PGR, 1992, J WILDLIFE MANAGE, V56, P685, DOI 10.2307/3809461; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kanda LL, 2005, WILDLIFE SOC B, V33, P1425, DOI 10.2193/0091-7648(2005)33[1425:TSEOOW]2.0.CO;2; Koprowski JL, 2005, J MAMMAL, V86, P947, DOI 10.1644/1545-1542(2005)86[947:TBAPAB]2.0.CO;2; Koprowski John L., 1994, Mammalian Species, V479, P1; Koukkari WL., 2006, INTRO BIOL RHYTHMS P; KRAMM KR, 1980, INT J BIOMETEOROL, V24, P65, DOI 10.1007/BF02245543; Larivee ML, 2010, FUNCT ECOL, V24, P597, DOI 10.1111/j.1365-2435.2009.01680.x; LAYNE JN, 1954, ECOL MONOGR, V24, P227, DOI 10.2307/1948465; LaZerte SE, 2011, WILDLIFE SOC B, V35, P481, DOI 10.1002/wsb.74; Lee JE, 2010, WEST N AM NATURALIST, V70, P189, DOI 10.3398/064.070.0205; Lincoln G, 2002, P NATL ACAD SCI USA, V99, P13890, DOI 10.1073/pnas.212517599; Long RA, 2005, J MAMMAL, V86, P314, DOI 10.1644/BRG-224.1; Monecke S, 2005, J COMP PHYSIOL B, V175, P167, DOI 10.1007/s00360-005-0472-6; Moore D.S., 2013, BASIC PRACTICE STAT, V6th ed.; Murray IW, 2012, CAN J ZOOL, V90, P1171, DOI 10.1139/Z2012-084; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Refinetti R, 2006, J COMP PHYSIOL A, V192, P701, DOI 10.1007/s00359-006-0093-x; REFINETTI R, 1995, J COMP PHYSIOL A, V177, P701; Refinetti R, 1998, PHYSIOL BEHAV, V63, P517, DOI 10.1016/S0031-9384(97)00485-X; Refinetti R., 2016, CIRCADIAN PHYSL; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Reighard Steven L., 2004, Proceedings of the South Dakota Academy of Science, V83, P47; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; Schilling A, 1999, CR ACAD SCI III-VIE, V322, P759, DOI 10.1016/S0764-4469(00)80034-7; Schroeder Michael A., 2005, P303; Sikes RS, 2012, BIOSCIENCE, V62, P830, DOI 10.1525/bio.2012.62.9.9; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Speakman JR, 2000, ADV ECOL RES, V30, P177; Stearns S.C., 1992, pi; Steele M. A., 2001, N AM TREE SQUIRRELS; Steppan SJ, 2004, MOL PHYLOGENET EVOL, V30, P703, DOI 10.1016/S1055-7903(03)00204-5; SULZMAN FM, 1982, PHYSIOL BEHAV, V29, P637, DOI 10.1016/0031-9384(82)90232-3; Sweitzer RA, 1996, J MAMMAL, V77, P1068, DOI 10.2307/1382787; Szafranska PA, 2005, INTEGR COMP BIOL, V45, P1080; Tester JR, 1978, 4 INT S BIOT; Thorington R.W., 2012, SQUIRRELS WORLD; Wassmer T, 2004, J ZOOL, V262, P281, DOI 10.1017/S0952836903004643; WAUTERS L, 1992, J ZOOL, V227, P71, DOI 10.1111/j.1469-7998.1992.tb04345.x; Zervanos SM, 2009, J COMP PHYSIOL B, V179, P411, DOI 10.1007/s00360-008-0327-z; Zhao ZJ, 2013, J EXP BIOL, V216, P2349, DOI 10.1242/jeb.078436	61	5	5	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151249	10.1371/journal.pone.0151249	http://dx.doi.org/10.1371/journal.pone.0151249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963918	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000127
J	Dave, JA; Levitt, NS; Ross, IL; Lacerda, M; Maartens, G; Blom, D				Dave, Joel A.; Levitt, Naomi S.; Ross, Ian L.; Lacerda, Miguel; Maartens, Gary; Blom, Dirk			Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; INSULIN SENSITIVITY; CARDIOVASCULAR RISK; LIPID-LEVELS; ABNORMALITIES; LIPODYSTROPHY; CHOLESTEROL; HYPERTRIGLYCERIDEMIA; PLASMA	Purpose Data on the prevalence of dyslipidaemia and associated risk factors in HIV-infected patients from sub-Saharan Africa is sparse. We performed a cross-sectional analysis in a cohort of HIV-infected South African adults. Methods We studied HIV-infected patients who were either antiretroviral therapy (ART)-naive or receiving non-nucleoside reverse transcriptase inhibitor (NNRTI)-based or protease inhibitor (PI)-based ART. Evaluation included fasting lipograms, oral glucose tolerance tests and clinical anthropometry. Dyslipidemia was defined using the NCEP ATPIII guidelines. Results The median age of the participants was 34 years (range 19-68 years) and 78% were women. The prevalence of dyslipidemia in 406 ART-naive and 551 participants on ART was 90.0% and 85%, respectively. Low HDL-cholesterol (HDLC) was the most common abnormality [290/406 (71%) ART-naive and 237/551 (43%) ART-participants]. Participants on ART had higher triglycerides (TG), total cholesterol (TC), LDL-cholesterol (LDLC) and HDLC than the ART-naive group. Severe dyslipidaemia, (LDLC > 4.9 mmol/L or TG > 5.0 mmol/L) was present in <5% of participants. In multivariate analyses there were complex associations between age, gender, type and duration of ART and body composition and LDLC, HDLC and TG, which differed between ART-naive and ART-participants. Conclusion Participants on ART had higher TG, TC, LDLC and HDLC than those who were ART-naive but severe lipid abnormalities requiring evaluation and treatment were uncommon.	[Dave, Joel A.; Levitt, Naomi S.; Ross, Ian L.] Univ Cape Town, Dept Med, Div Diabet Med, ZA-7925 Cape Town, South Africa; [Dave, Joel A.; Levitt, Naomi S.; Ross, Ian L.] Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa; [Lacerda, Miguel] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Blom, Dirk] Univ Cape Town, Dept Med, Div Lipidol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Dave, JA (corresponding author), Univ Cape Town, Dept Med, Div Diabet Med, ZA-7925 Cape Town, South Africa.; Dave, JA (corresponding author), Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa.	joel.dave@uct.ac.za	Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019; Ross, Ian Louis/N-7420-2017	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Levitt, Naomi/0000-0001-6480-8066; Dave, joel/0000-0003-3084-7408; Ross, Ian Louis/0000-0002-5308-7563	World Diabetes Foundation; South African Department of Health; National Research Foundation of South Africa	World Diabetes Foundation; South African Department of Health; National Research Foundation of South Africa(National Research Foundation - South Africa)	JD and NL received grants from the World Diabetes Foundation and the South African Department of Health. GM acknowledges partial support by the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams Z, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-26; Ali MK, 2014, JAIDS-J ACQ IMM DEF, V67, pS27, DOI 10.1097/QAI.0000000000000256; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Anastos K, 2007, JAIDS-J ACQ IMM DEF, V45, P34, DOI 10.1097/QAI.0b013e318042d5fe; Asiki G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126166; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Bekolo CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-236; Carey RAB, 2013, J POSTGRAD MED, V59, P258, DOI 10.4103/0022-3859.123145; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dave JA, 2011, JAIDS-J ACQ IMM DEF, V57, P284, DOI 10.1097/QAI.0b013e318221863f; De Requena DG, 2003, AIDS PATIENT CARE ST, V17, P443, DOI 10.1089/108729103322395465; de Waal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063623; Dube MP, 2001, J ACQ IMMUN DEF SYND, V27, P506; Ekali LG, 2013, DIABETES METAB, V39, P71, DOI 10.1016/j.diabet.2012.08.012; Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Friis-Moller N, 2008, CURR OPIN HIV AIDS, V3, P220, DOI 10.1097/COH.0b013e3282fb7bcf; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; GRUNFELD C, 1989, AM J MED, V86, P27, DOI 10.1016/0002-9343(89)90225-8; GRUNFELD C, 1991, AM J MED, V90, P154, DOI 10.1016/0002-9343(91)80154-E; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; Hammond R, 2008, INT J STD AIDS, V19, P291, DOI 10.1258/ijsa.2007.007248; Hurley E, 2011, SAMJ S AFR MED J, V101, P645; Janiszewski PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025032; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; Krentz AJ, 2003, DIABETES OBES METAB, V5, pS19, DOI 10.1046/j.1462-8902.2003.0310.x; Kuti Modupe Akinrele, 2015, J Int Assoc Provid AIDS Care, V14, P355, DOI 10.1177/2325957414555227; Liu E, 2013, CLIN INFECT DIS, V56, P1820, DOI 10.1093/cid/cit120; Martinez E, 2004, CLIN INFECT DIS, V38, P1017, DOI 10.1086/382531; Menezes CN, 2014, HIV MED, V15, P3, DOI 10.1111/hiv.12074; Muhammad S, 2013, ANN AFR MED, V12, P24, DOI 10.4103/1596-3519.108246; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; Norman R, 2007, S AFR MED J 2, V97, P708; Oka F, 2012, J INFECT CHEMOTHER, V18, P17, DOI 10.1007/s10156-011-0275-5; Schwartz SL, 2006, DIABETES OBES METAB, V8, P355, DOI 10.1111/j.1463-1326.2005.00516.x; SEEDAT YK, 1992, S AFR MED J, V82, P251; Stein JH, 2008, J CLIN LIPIDOL, V2, P464, DOI 10.1016/j.jacl.2008.08.442; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; van der Voort PHJ, 2003, INTENS CARE MED, V29, P2199, DOI 10.1007/s00134-003-2021-7; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	44	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151911	10.1371/journal.pone.0151911	http://dx.doi.org/10.1371/journal.pone.0151911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986065	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300149
J	Garces-Rimon, M; Gonzalez, C; Uranga, JA; Lopez-Miranda, V; Lopez-Fandino, R; Miguel, M				Garces-Rimon, M.; Gonzalez, C.; Uranga, J. A.; Lopez-Miranda, V.; Lopez-Fandino, R.; Miguel, M.			Pepsin Egg White Hydrolysate Ameliorates Obesity-Related Oxidative Stress, Inflammation and Steatosis in Zucker Fatty Rats	PLOS ONE			English	Article							LONG-TERM INTAKE; ARTERIAL-BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ANTIOXIDANT ACTIVITY; ADIPOSE-TISSUE; PEPTIDES; PLASMA; MODEL; ADIPONECTIN; PROTEINS	The aim of this work was to evaluate the effect of the administration of egg white hydrolysates on obesity-related disorders, with a focus on lipid metabolism, inflammation and oxidative stress, in Zucker fatty rats. Obese Zucker rats received water, pepsin egg white hydrolysate (750 mg/kg/day) or Rhizopus aminopeptidase egg white hydrolysate (750 mg/kg/day) for 12 weeks. Lean Zucker rats received water. Body weight, solid and liquid intakes were weekly measured. At the end of the study, urine, faeces, different organs and blood samples were collected. The consumption of egg white hydrolysed with pepsin significantly decreased the epididymal adipose tissue, improved hepatic steatosis, and lowered plasmatic concentration of free fatty acids in the obese animals. It also decreased plasma levels of tumor necrosis factor-alpha and reduced oxidative stress. Pepsin egg white hydrolysate could be used as a tool to improve obesity-related complications.	[Garces-Rimon, M.; Lopez-Fandino, R.; Miguel, M.] UAM, CSIC, CIAL, Inst Invest Ciencias Alimentac, Madrid, Spain; [Gonzalez, C.; Uranga, J. A.; Lopez-Miranda, V.] Univ Rey Juan Carlos, Fac Ciencias Salud, Dept Ciencias Basicas Salud, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); Universidad Rey Juan Carlos	Garces-Rimon, M (corresponding author), UAM, CSIC, CIAL, Inst Invest Ciencias Alimentac, Madrid, Spain.	m.garces.rimon@gmail.com	Garces-Rimon, Marta/AAD-3050-2021; MIGUEL, MARTA/F-6112-2011; López-Fandiño, Rosina/H-4132-2012; Uranga, Jose A/M-4343-2018; Lopez-Miranda, Visitacion/E-1116-2012	Garces-Rimon, Marta/0000-0002-3888-4150; MIGUEL, MARTA/0000-0002-5525-1056; López-Fandiño, Rosina/0000-0002-6979-9258; Uranga, Jose A/0000-0003-4656-8569; Lopez-Miranda, Visitacion/0000-0003-1378-0387	Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2012-32387, SAF2012-40075-C02-01]	Spanish Ministry of Economy and Competitiveness (MINECO)	This study has received financial support from the project AGL2012-32387 and SAF2012-40075-C02-01 from the Spanish Ministry of Economy and Competitiveness (MINECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1990, OFFICIAL METHODS ANA, VII; ARGILES JM, 1989, BIOCHEM J, V259, P673, DOI 10.1042/bj2590673; Bauer S, 2010, ARCH MED RES, V41, P75, DOI 10.1016/j.arcmed.2010.02.010; Beaulieu J, 2010, J MED FOOD, V13, P509, DOI 10.1089/jmf.2009.0083; Bjorndal B, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-143; Chentouf M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022954; Davalos A, 2004, J FOOD PROTECT, V67, P1939, DOI 10.4315/0362-028X-67.9.1939; DeMarco VG, 2010, CURR HYPERTENS REP, V12, P93, DOI 10.1007/s11906-010-0095-5; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Galisteo M, 2005, J NUTR, V135, P2399, DOI 10.1093/jn/135.10.2399; Galisteo M, 2010, CLIN NUTR, V29, P261, DOI 10.1016/j.clnu.2009.08.011; Garces-Rimon M, 2016, EUR FOOD RES TECHNOL, V242, P61, DOI 10.1007/s00217-015-2518-7; Gomez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; KASISKE BL, 1992, HYPERTENSION, V19, pI110, DOI 10.1161/01.HYP.19.1_Suppl.I110; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Lassoued I, 2014, FOOD FUNCT, V5, P1224, DOI 10.1039/c3fo60705d; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Manso MA, 2008, FOOD CHEM, V109, P361, DOI 10.1016/j.foodchem.2007.12.049; Matsunami T, 2011, METABOLISM, V60, P805, DOI 10.1016/j.metabol.2010.07.032; Matsunami T, 2010, INT J CLIN EXP PATHO, V3, P472; Miguel M, 2005, BRIT J NUTR, V94, P731, DOI 10.1079/BJN20051570; Miguel M, 2004, J FOOD PROTECT, V67, P1914, DOI 10.4315/0362-028X-67.9.1914; Miguel M, 2007, J AGR FOOD CHEM, V55, P10615, DOI 10.1021/jf072307o; Miguel M, 2007, MOL NUTR FOOD RES, V51, P555, DOI 10.1002/mnfr.200700012; Miguel M, 2006, LIFE SCI, V78, P2960, DOI 10.1016/j.lfs.2005.11.025; Miguel M, 2010, MOL NUTR FOOD RES, V54, P1422, DOI 10.1002/mnfr.200900448; Moran-Ramos S, 2012, J NUTR, V142, P1956, DOI 10.3945/jn.112.165563; Moughan PJ, 2014, NUTR RES REV, V27, P16, DOI 10.1017/S0954422413000206; Oana F, 2005, METABOLISM, V54, P995, DOI 10.1016/j.metabol.2005.02.016; Otani H, 2011, ANTIOXID REDOX SIGN, V15, P1911, DOI 10.1089/ars.2010.3739; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Picchi A, 2006, CIRC RES, V99, P69, DOI 10.1161/01.RES.0000229685.37402.80; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Ratliff J, 2010, NUTR RES, V30, P96, DOI 10.1016/j.nutres.2010.01.002; Richards RJ, 2001, KIDNEY INT, V59, P37, DOI 10.1046/j.1523-1755.2001.00463.x; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Sanchez D, 2011, PHARMACOL RES, V64, P31, DOI 10.1016/j.phrs.2011.02.005; Tovar AR, 2005, J LIPID RES, V46, P1823, DOI 10.1194/jlr.M500067-JLR200; VASSELLI JR, 1980, PHYSIOL BEHAV, V25, P565, DOI 10.1016/0031-9384(80)90123-7; Vaughn N, 2008, PLANT FOOD HUM NUTR, V63, P41, DOI 10.1007/s11130-007-0067-3; Vendrame S, 2013, J NUTR BIOCHEM, V24, P1508, DOI 10.1016/j.jnutbio.2012.12.010; Wang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046781; Wergedahl H, 2004, J NUTR, V134, P1320, DOI 10.1093/jn/134.6.1320; ZUCKER TF, 1962, P SOC EXP BIOL MED, V110, P165, DOI 10.3181/00379727-110-27455	48	54	57	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151193	10.1371/journal.pone.0151193	http://dx.doi.org/10.1371/journal.pone.0151193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985993	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300052
J	Mendoza, MLZ; Lundberg, J; Ivarsson, M; Campos, P; Nylander, JAA; Sallstedt, T; Dalen, L				Mendoza, Marie Lisandra Zepeda; Lundberg, Johannes; Ivarsson, Magnus; Campos, Paula; Nylander, Johan A. A.; Sallstedt, Therese; Dalen, Love			Metagenomic Analysis from the Interior of a Speleothem in Tjuv-Ante's Cave, Northern Sweden	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; RNA GENE DATABASE; ANCIENT DNA; CARBONATE; ADSORPTION; GROWTH; STONE; EXOPOLYSACCHARIDES; EUSTIGMATOPHYCEAE; CONTAMINATION	Speleothems are secondary mineral deposits normally formed by water supersaturated with calcium carbonate percolating into underground caves, and are often associated with low-nutrient and mostly non-phototrophic conditions. Tjuv-Ante's cave is a shallow-depth cave formed by the action of waves, with granite and dolerite as major components, and opal-A and calcite as part of the speleothems, making it a rare kind of cave. We generated two DNA shotgun sequencing metagenomic datasets from the interior of a speleothem from Tjuv-Ante's cave representing areas of old and relatively recent speleothem formation. We used these datasets to perform i) an evaluation of the use of these speleothems as past biodiversity archives, ii) functional and taxonomic profiling of the speleothem's different formation periods, and iii) taxonomic comparison of the metagenomic results to previous microscopic analyses from a nearby speleothem of the same cave. Our analyses confirm the abundance of Actinobacteria and fungi as previously reported by microscopic analyses on this cave, however we also discovered a larger biodiversity. Interestingly, we identified photosynthetic genes, as well as genes related to iron and sulphur metabolism, suggesting the presence of chemoautotrophs. Furthermore, we identified taxa and functions related to biomineralization. However, we could not confidently establish the use of this type of speleothems as biological paleoarchives due to the potential leaching from the outside of the cave and the DNA damage that we propose has been caused by the fungal chemical etching.	[Mendoza, Marie Lisandra Zepeda; Campos, Paula] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Lundberg, Johannes] Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden; [Ivarsson, Magnus; Sallstedt, Therese] Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden; [Ivarsson, Magnus; Sallstedt, Therese] Swedish Museum Nat Hist, NordCEE, S-10405 Stockholm, Sweden; [Nylander, Johan A. A.; Dalen, Love] Swedish Museum Nat Hist, Dept Bioinformat & Genet, S-10405 Stockholm, Sweden	University of Copenhagen; Swedish Museum of Natural History; Swedish Museum of Natural History; Swedish Museum of Natural History; Swedish Museum of Natural History	Mendoza, MLZ (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	lisandracady@gmail.com	Dalén, Love/A-6686-2008; Campos, Paula F/B-1634-2010; Campos, Paula/ABF-9898-2021; Mendoza, Marie Lisandra Zepeda/C-2001-2015; Lundberg, Johannes/E-5844-2011	Dalén, Love/0000-0001-8270-7613; Campos, Paula F/0000-0003-1285-4671; Mendoza, Marie Lisandra Zepeda/0000-0002-1126-8219; Lundberg, Johannes/0000-0003-4316-9183	Danish Council for Independent Research grant [10-081390]; Lundbeck Foundation grant [R52-A5062]; Swedish Research Council [2012-4364, 2010-3929]; Danish National Research Foundation [DNRF53]; Tjuv-Ante's cave [521-6864-2010]	Danish Council for Independent Research grant; Lundbeck Foundation grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Tjuv-Ante's cave	MLZM acknowledges funding from the Danish Council for Independent Research grant 10-081390 and Lundbeck Foundation grant R52-A5062. MI acknowledges funding from the Swedish Research Council (Contracts 2012-4364 and 2010-3929) and the Danish National Research Foundation (DNRF53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very thankful to the Lansstyrelsen Vasterbotten, which granted us sampling permit for Tjuv-Ante's cave (case number 521-6864-2010). We are also grateful to M. Thomas P. Gilbert for mentoring and support. We are also grateful to Thomas Sicheritz-Ponten for providing access to the server at the Center for Biological Sequence Analysis (CBS) in The Technical University of Denmark (DTU) and for useful insights on the identified bacteria. We are also thankful to Rabbe Sjoberg and Juan Ramon Vidal Romani for initiating the studies of Tjuv-Ante's speleothems. We also acknowledge the Danish National High-Throughput DNA Sequencing Centre for performing the sequencing of the samples.	Abdullahi AS, 2006, J PHYCOL, V42, P363, DOI 10.1111/j.1529-8817.2006.00193.x; Abraham WR, 1999, INT J SYST BACTERIOL, V49, P1053, DOI 10.1099/00207713-49-3-1053; Andersen RA, 1998, PROTIST, V149, P61, DOI 10.1016/S1434-4610(98)70010-0; Arnstein HRV, 1988, FEBS LETT, V234, P506; ASHWORTH JM, 1975, BIOL SLIME MOULDS; Baranasic D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00581-13; BEZANILLA M, 1995, LANGMUIR, V11, P655, DOI 10.1021/la00002a050; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Brace S, 2012, P NATL ACAD SCI USA, V109, P20532, DOI 10.1073/pnas.1213322109; Braissant O, 2003, J SEDIMENT RES, V73, P485, DOI 10.1306/111302730485; Braissant O, 2012, J CAVE KARST STUD, V74, P116, DOI 10.4311/2011JCKS0213; Bricelj VM, 1997, LIMNOL OCEANOGR, V42, P1023, DOI 10.4319/lo.1997.42.5_part_2.1023; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chouaia B, 2012, J BACTERIOL, V194, P2752, DOI 10.1128/JB.00320-12; Cleaves HJ, 2011, CHEMOSPHERE, V83, P1560, DOI 10.1016/j.chemosphere.2011.01.023; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; de Boer W, 2004, INT J SYST EVOL MICR, V54, P857, DOI 10.1099/ijs.0.02920-0; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhami NK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00314; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fawley KP, 2007, PROTIST, V158, P325, DOI 10.1016/j.protis.2007.03.003; GarciaValles M, 1997, APPL GEOCHEM, V12, P255, DOI 10.1016/S0883-2927(96)00057-1; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Gonzalez JM, 2005, INT MICROBIOL, V8, P189; GORING CAI, 1952, SOIL SCI, V74, P149, DOI 10.1097/00010694-195208000-00005; Groth I, 1999, GEOMICROBIOL J, V16, P1, DOI 10.1080/014904599270703; Hammes Frederik, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P3, DOI 10.1023/A:1015135629155; Hasman H, 2014, J CLIN MICROBIOL, V52, P3136, DOI 10.1128/JCM.01369-14; Hill C., 1997, CAVE MINERALS WORLD; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HOLO H, 1986, ARCH MICROBIOL, V145, P173, DOI 10.1007/BF00446776; Holtzel A, 1998, J ANTIBIOT, V51, P699; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ivanova N, 2010, STAND GENOMIC SCI, V2, P158, DOI 10.4056/sigs.711311; Jones B, 2001, GEOMICROBIOL J, V18, P345, DOI 10.1080/01490450152467831; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kamennaya NA, 2012, MINERALS-BASEL, V2, P338, DOI 10.3390/min2040338; Klatt CG, 2013, ISME J, V7, P1775, DOI 10.1038/ismej.2013.52; Kouduka M, 2012, FEMS MICROBIOL LETT, V326, P47, DOI 10.1111/j.1574-6968.2011.02437.x; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Lauritzen SE, 1999, HOLOCENE, V9, P643, DOI 10.1191/095968399666229065; Le Metayer-Levrel G, 1999, SEDIMENT GEOL, V126, P25, DOI 10.1016/S0037-0738(99)00029-9; Liu N, 2005, FUEL PROCESS TECHNOL, V86, P1615, DOI 10.1016/j.fuproc.2005.01.008; Lundberg JEK, 2013, INT C SPEL P, P461; Luttge A, 2004, APPL ENVIRON MICROB, V70, P1627, DOI 10.1128/AEM.70.3.1627-1632.2004; MADIGAN MT, 1979, J BACTERIOL, V137, P524, DOI 10.1128/JB.137.1.524-530.1979; Maechler M., 2014, DIPTEST HARTIGANS DI; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Misiak K, 2011, WATER RES, V45, P3512, DOI 10.1016/j.watres.2011.04.020; OLTMANNS RH, 1989, APPL ENVIRON MICROB, V55, P2499, DOI 10.1128/AEM.55.10.2499-2504.1989; Oostergetel GT, 2010, PHOTOSYNTH RES, V104, P245, DOI 10.1007/s11120-010-9533-0; Ortiz M, 2014, ISME J, V8, P478, DOI 10.1038/ismej.2013.159; Ortiz M, 2013, MICROB ECOL, V65, P371, DOI 10.1007/s00248-012-0143-6; Persoons A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00450; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rodriguez-Navarro C, 2003, APPL ENVIRON MICROB, V69, P2182, DOI 10.1128/AEM.69.4.2182-2193.2003; Rosenbaum L., 2006, WALL STREET J, pD6; Sallstedt T, 2014, INT J SPELEOL, V43, P305, DOI 10.5038/1827-806X.43.3.7; Schleheck D, 2011, STAND GENOMIC SCI, V5, P298, DOI 10.4056/sigs.2215005; Sjooberg R, 1982, TUNNEL CAVES SO VAAS; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; Spear JR, 2007, APPL ENVIRON MICROB, V73, P6172, DOI 10.1128/AEM.00393-07; Stamm I, 2005, MOL MICROBIOL, V56, P1386, DOI 10.1111/j.1365-2958.2005.04640.x; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Stocks-Fischer S, 1999, SOIL BIOL BIOCHEM, V31, P1563, DOI 10.1016/S0038-0717(99)00082-6; Sutherland IW, 2001, WATER SCI TECHNOL, V43, P77, DOI 10.2166/wst.2001.0345; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; UFFEN RL, 1970, J BACTERIOL, V104, P462, DOI 10.1128/JB.104.1.462-472.1970; Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013; Webster A, 2006, TRENDS BIOTECHNOL, V24, P255, DOI 10.1016/j.tibtech.2006.04.005; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004; Yucel S, 2010, PAK J PHARM SCI, V23, P1	83	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151577	10.1371/journal.pone.0151577	http://dx.doi.org/10.1371/journal.pone.0151577			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985997	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300088
J	Yen, YF; Jen, I; Chen, M; Chuang, PH; Liu, YL; Sharp, GB; Chen, YMA				Yen, Yung-Feng; Jen, Ian; Chen, Marcelo; Chuang, Pei-Hung; Liu, Yen-Ling; Sharp, Gerald B.; Chen, Yi-Ming Arthur			Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SMOOTH-MUSCLE-CELLS; RISK; TAIWAN; VIRUS; EXPRESSION; INFARCTION; EVENTS; BURDEN	Objectives Cytomegalovirus (CMV) infection might increase the risk of cardiovascular event. However, data on the link between incident stroke and co-infections of CMV and human immunodeficiency virus (HIV) are limited and inconsistent. This nationwide population-based cohort study analyzed the association of CMV end-organ disease and stroke among people living with HIV/AIDS (PLWHA). Methods From January 1, 1998, this study identified adult HIV individuals with and without CMV endorgan disease in the Taiwan National Health Insurance Research Database. All patients were observed for incident stroke and were followed until December 31, 2012. Time-dependent analysis was used to evaluate associations of CMV end-organ disease with stroke. Results Of the 22,581 PLWHA identified (439 with CMV end-organ disease and 22,142 without CMV end-organ disease), 228 (1.01%) had all-cause stroke during a mean follow-up period of 4.85 years, including 169 (0.75%) with ischemic stroke and 59 (0.26%) with hemorrhagic stroke. After adjusting for age, sex, comorbidities, opportunistic infections after HIV diagnosis, and antiretroviral treatment, CMV end-organ disease was found to be an independent risk factor for incident all-cause stroke (adjusted hazard ratio [AHR], 3.07; 95% confidence interval [CI], 1.70 to 5.55). When stroke type was considered, CMV end-organ disease was significantly positively associated with the risk of ischemic stroke (AHR, 3.14; 95% CI, 1.49 to 6.62) but not hemorrhagic stroke (AHR, 2.52; 95% CI, 0.64 to 9.91). Conclusions This study suggested that CMV end-organ disease was an independent predictor of ischemic stroke among PLWHA.	[Yen, Yung-Feng] Taipei City Hosp, Taipei City Govt, Infect Dis Sect, Taipei, Taiwan; [Yen, Yung-Feng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yen, Yung-Feng; Jen, Ian; Chuang, Pei-Hung; Liu, Yen-Ling; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Jen, Ian] Natl Yang Ming Univ, Dept & Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Marcelo] Mackay Mem Hosp, Dept Urol, Taipei, Taiwan; [Chen, Marcelo] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chuang, Pei-Hung] Taipei Vet Gen Hosp, Ctr Prevent & Treatment Occupat Injury & Dis, Taipei, Taiwan; [Chuang, Pei-Hung] Taipei Vet Gen Hosp, Dept Med, Div Clin Toxicol & Occupat Med, Taipei, Taiwan; [Sharp, Gerald B.] NIAID, Epidemiol Branch, Basic Sci Program, Div AIDS,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Dept Microbiol, Kaohsiung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Inst Med Res, Kaohsiung, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kaohsiung Medical University; Kaohsiung Medical University	Chen, YMA (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.; Chen, YMA (corresponding author), Kaohsiung Med Univ, Dept Microbiol, Kaohsiung, Taiwan.; Chen, YMA (corresponding author), Kaohsiung Med Univ, Inst Med Res, Kaohsiung, Taiwan.	arthur@kmu.edu.tw			amfAR (The Foundation for AIDS Research); U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute, International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01AI069907]; Kaohsiung Medical University "Aim for the Top Universities Grant" grant [KMU-TP103E01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	amfAR (The Foundation for AIDS Research); U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute, International Epidemiologic Databases to Evaluate AIDS (IeDEA); Kaohsiung Medical University "Aim for the Top Universities Grant" grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from amfAR (The Foundation for AIDS Research), with support from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Cancer Institute, as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA; U01AI069907). This study was also supported by Kaohsiung Medical University "Aim for the Top Universities Grant" grant No. KMU-TP103E01. The interpretation and conclusions contained herein are solely the responsibility of the authors and do not represent any of the above-mentioned institutions.	Anderson AM, 2010, J NEUROVIROL, V16, P179, DOI 10.3109/13550281003735717; Bolovan-Fritts CA, 2008, BLOOD, V111, P175, DOI 10.1182/blood-2007-08-107730; Chen M, 2015, J ACQUIR IMMUNE DEFI; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Collett, 2003, MODELLING SURVIVAL D; Ford N, 2013, CLIN INFECT DIS, V57, P1351, DOI 10.1093/cid/cit494; Huang ZR, 2012, CNS NEUROSCI THER, V18, P457, DOI 10.1111/j.1755-5949.2012.00326.x; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Juang HT, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0345-x; KOWALIK TF, 1993, P NATL ACAD SCI USA, V90, P1107, DOI 10.1073/pnas.90.3.1107; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Muller BT, 2005, VASA-J VASCULAR DIS, V34, P163, DOI 10.1024/0301-1526.34.3.163; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nagel M. A., 2010, Infectious Disorders - Drug Targets, V10, P105; Qiu H, 2008, J EXP MED, V205, P19, DOI 10.1084/jem.20070201; Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Shen YH, 2006, CARDIOVASC RES, V69, P502, DOI 10.1016/j.cardiores.2005.10.007; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Speir E, 1998, CIRC RES, V83, P210, DOI 10.1161/01.RES.83.2.210; Streblow DN, 2008, CURR TOP MICROBIOL, V325, P397; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yen YF, 2015, J CLIN PSYCHIAT, V76, pE505, DOI 10.4088/JCP.14m09403; Zhang XH, 2011, CNS NEUROSCI THER, V17, P590, DOI 10.1111/j.1755-5949.2011.00271.x	27	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151684	10.1371/journal.pone.0151684	http://dx.doi.org/10.1371/journal.pone.0151684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986005	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300112
J	Brekelmans, MP; Fens, N; Brinkman, P; Bos, LD; Sterk, PJ; Tak, PP; Gerlag, DM				Brekelmans, Marjolein P.; Fens, Niki; Brinkman, Paul; Bos, Lieuwe D.; Sterk, Peter J.; Tak, Paul P.; Gerlag, Danielle M.			Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study	PLOS ONE			English	Article							PSORIATIC-ARTHRITIS; BREATH ANALYSIS; EXHALED BREATH; RHEUMATOID-ARTHRITIS; CLINICAL-APPLICATION; LUNG; DISCRIMINATION; CANCER	Objective To investigate whether exhaled breath analysis using an electronic nose can identify differences between inflammatory joint diseases and healthy controls. Methods In a cross-sectional study, the exhaled breath of 21 rheumatoid arthritis (RA) and 18 psoriatic arthritis (PsA) patients with active disease was compared to 21 healthy controls using an electronic nose (Cyranose 320; Smiths Detection, Pasadena, CA, USA). Breathprints were analyzed with principal component analysis, discriminant analysis, and area under curve (AUC) of receiver operating characteristics (ROC) curves. Volatile organic compounds (VOCs) were identified by gas chromatography and mass spectrometry (GC-MS), and relationships between breathprints and markers of disease activity were explored. Results Breathprints of RA patients could be distinguished from controls with an accuracy of 71% (AUC 0.75, 95% CI 0.60-0.90, sensitivity 76%, specificity 67%). Breathprints from PsA patients were separated from controls with 69% accuracy (AUC 0.77, 95% CI 0.61-0.92, sensitivity 72%, specificity 71%). Distinction between exhaled breath of RA and PsA patients exhibited an accuracy of 69% (AUC 0.72, 95% CI 0.55-0.89, sensitivity 71%, specificity 72%). There was a positive correlation in RA patients of exhaled breathprints with disease activity score (DAS28) and number of painful joints. GC-MS identified seven key VOCs that significantly differed between the groups. Conclusions Exhaled breath analysis by an electronic nose may play a role in differential diagnosis of inflammatory joint diseases. Data from this study warrant external validation.	[Brekelmans, Marjolein P.; Tak, Paul P.; Gerlag, Danielle M.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Fens, Niki; Brinkman, Paul; Bos, Lieuwe D.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Bos, Lieuwe D.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Tak, Paul P.] Univ Cambridge, Cambridge, England; [Tak, Paul P.] Univ Ghent, B-9000 Ghent, Belgium; [Tak, Paul P.] GlaxoSmithKline, Stevenage, Herts, England; [Gerlag, Danielle M.] GlaxoSmithKline, Cambridge, England	University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Cambridge; Ghent University; GlaxoSmithKline; GlaxoSmithKline	Brekelmans, MP; Tak, PP (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Tak, PP (corresponding author), Univ Cambridge, Cambridge, England.; Tak, PP (corresponding author), Univ Ghent, B-9000 Ghent, Belgium.; Tak, PP (corresponding author), GlaxoSmithKline, Stevenage, Herts, England.	m.p.brekelmans@amc.nl; p.p.tak@amc.nl	Bos, Lieuwe/H-2578-2018; Sterk, P.J./AAK-8175-2020; Brinkman, Paul/AAV-5110-2021	Bos, Lieuwe/0000-0003-2911-4549; Brinkman, Paul/0000-0003-4546-8478				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Boots AW, 2015, TRENDS MOL MED, V21, P633, DOI 10.1016/j.molmed.2015.08.001; Buszewski B, 2007, BIOMED CHROMATOGR, V21, P553, DOI 10.1002/bmc.835; de Hair MJH, 2013, ANN RHEUM DIS, V72, P1654, DOI 10.1136/annrheumdis-2012-202254; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Fend R, 2006, J CLIN MICROBIOL, V44, P2039, DOI 10.1128/JCM.01591-05; Fens N, 2013, CLIN EXP ALLERGY, V43, P705, DOI 10.1111/cea.12052; Fens N, 2011, EUR RESPIR J, V38, P1301, DOI 10.1183/09031936.00032911; Fens N, 2011, CLIN EXP ALLERGY, V41, P1371, DOI 10.1111/j.1365-2222.2011.03800.x; Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Firestein GS, 2013, KELLEYS TXB RHEUMATO, V9th; Gladman DD, 2006, ANN RHEUM DIS, V65, P22, DOI 10.1136/ard.2006.058453; Greiter MB, 2010, DIABETES TECHNOL THE, V12, P455, DOI 10.1089/dia.2009.0181; Haick H, 2014, CHEM SOC REV, V43, P1423, DOI 10.1039/c3cs60329f; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Leopold JH, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/4/046002; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Mandl P, 2014, RHEUMATOLOGY, V53, P2136, DOI 10.1093/rheumatology/keu211; Mease PJ, 2011, ANN RHEUM DIS, V70, pI77, DOI 10.1136/ard.2010.140582; Mikuls TR, 2006, ANN RHEUM DIS, V65, P1252, DOI 10.1136/ard.2005.050641; Moser B, 2005, RESP PHYSIOL NEUROBI, V145, P295, DOI 10.1016/j.resp.2004.02.002; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Pereira J, 2015, METABOLITES, V5, P3, DOI 10.3390/metabo5010003; Phillips M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090226; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sethi S, 2013, CLIN MICROBIOL REV, V26, P462, DOI 10.1128/CMR.00020-13; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van de Sande MGH, 2012, RHEUMATOLOGY, V51, P1240, DOI 10.1093/rheumatology/kes011; van der Schee MP, 2015, CHEST, V147, P224, DOI 10.1378/chest.14-0781; Wilson AD, 2015, METABOLITES, V5, P140, DOI 10.3390/metabo5010140	41	18	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151715	10.1371/journal.pone.0151715	http://dx.doi.org/10.1371/journal.pone.0151715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982569	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900117
J	Hsieh, RL; Lee, WC; Lin, JH				Hsieh, Ru-Lan; Lee, Wen-Chung; Lin, Jui-Hsiang			The Impact of Short-Term Video Games on Performance among Children with Developmental Delays: A Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; COMPUTER GAMES; HEALTH; SLEEP; PEDSQL(TM)-4.0; RELIABILITY; RESPONSES; DOPAMINE	This prospective, randomized controlled study investigated the effects of short-term interactive video game playing among children with developmental delays participating in traditional rehabilitation treatment at a rehabilitation clinic. One hundred and one boys and 46 girls with a mean age of 5.8 years (range: 3 to 12 years) were enrolled in this study. All patients were confirmed to suffer from developmental delays, and were participating in traditional rehabilitation treatment. Children participated in two periods of 4 weeks each, group A being offered intervention of eight 30-minute sessions of interactive video games in the first period, and group B in the second, in addition to the traditional rehabilitation treatment. The physical, psychosocial, and total health of the children was periodically assessed using the parent-reported Pediatric Quality of Life Inventory-Generic Core Scales (PedsQL); and the children's upper extremity and physical function, transfer and basic mobility, sports and physical functioning, and global functioning were assessed using the Pediatric Outcomes Data Collection Instrument. Parental impact was evaluated using the PedsQL-Family Impact Module for family function, PedsQL-Health Satisfaction questionnaire for parents' satisfaction with their children's care and World Health Organization-Quality of Life-Brief Version for quality of life. Compared with the baseline, significant improvements of physical function were observed in both groups (5.6 +/- 19.5, p = 0.013; 4.7 +/- 13.8, p = 0.009) during the intervention periods. No significant improvement of psychosocial health, functional performance, or family impact was observed in children with developmental delays. Short-term interactive video game play in conjunction with traditional rehabilitation treatment improved the physical health of children with developmental delays.	[Hsieh, Ru-Lan] Shin Kong Wu Ho Su Mem Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hsieh, Ru-Lan] Taipei Med Univ, Dept Phys Med & Rehabil, Sch Med, Coll Med, Taipei, Taiwan; [Lee, Wen-Chung; Lin, Jui-Hsiang] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; National Taiwan University	Hsieh, RL (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Hsieh, RL (corresponding author), Taipei Med Univ, Dept Phys Med & Rehabil, Sch Med, Coll Med, Taipei, Taiwan.	M001052@ms.skh.org.tw		Lee, Wen-Chung/0000-0003-3171-7672; LIN, JUI-HSIANG/0000-0002-1303-2736	Supreme Investment Co., Ltd., Taiwan; Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-103-DR-36, SKH-8302-104-DR-29, SKH-8602-105-DR-24, SKHNSC 02-2628-B-002-036-MY3, NSC 102-2314-B-341-001, MOST-103-2314-B-341-002, MOST-104-2314-B-341-001]; Ministry of Science and Technology, Taiwan	Supreme Investment Co., Ltd., Taiwan; Shin Kong Wu Ho-Su Memorial Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was partially supported by a grant from Supreme Investment Co., Ltd., Taiwan and research grants (SKH-8302-103-DR-36, SKH-8302-104-DR-29; SKH-8602-105-DR-24, SKHNSC 02-2628-B-002-036-MY3; NSC 102-2314-B-341-001; MOST-103-2314-B-341-002; MOST-104-2314-B-341-001) from Shin Kong Wu Ho-Su Memorial Hospital and Ministry of Science and Technology, Taiwan.	Berg P, 2012, PEDIATR PHYS THER, V24, P78, DOI 10.1097/PEP.0b013e31823e05e6; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Carson V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-539; Chan LFP, 2005, INT J REHABIL RES, V28, P219, DOI 10.1097/00004356-200509000-00004; Chang A, STATSTODO SAMPLE SIZ; Christison A, 2012, CLIN PEDIATR, V51, P382, DOI 10.1177/0009922811429480; Daley AJ, 2009, PEDIATRICS, V124, P763, DOI 10.1542/peds.2008-2357; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; Ganesan Samyukta, EFFECTIVENESS REHABI; Graf DL, 2009, PEDIATRICS, V124, P534, DOI 10.1542/peds.2008-2851; Griffiths MD, 1998, PSYCHOL REP, V82, P475, DOI 10.2466/PR0.82.2.475-480; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Haynes RJ, 2001, J PEDIATR ORTHOPED, V21, P619, DOI 10.1097/00004694-200109000-00013; Hsieh RL, 2009, CORRELATION PEDIAT O; Hsieh RL, 2011, INT J PERS CENT MED, V1, P1; Hsieh RL, 2014, DEV NEUROREHABIL, V17, P176, DOI 10.3109/17518423.2012.747569; Hwang HF, 2003, AGE AGEING, V32, P593, DOI 10.1093/ageing/afg102; Ilg W, 2012, NEUROLOGY, V79, P2056, DOI 10.1212/WNL.0b013e3182749e67; James WB, 2009, P 2009 C GAM VIRT WO; Kevitiyagala D, 2011, ARCH DIS CHILD, V96, P894, DOI 10.1136/archdischild-2011-300409; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Krotoski A, 2010, NATURE, V466, P695, DOI 10.1038/466695a; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Lieu JEC, 2014, CURR OPIN OTOLARYNGO, V22, P506, DOI 10.1097/MOO.0000000000000105; Maddison R, 2011, AM J CLIN NUTR, V94, P156, DOI 10.3945/ajcn.110.009142; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Mellecker RR, 2008, ARCH PEDIAT ADOL MED, V162, P886, DOI 10.1001/archpedi.162.9.886; Paez S, 2009, PEDIATR PHYS THER, V21, P245, DOI 10.1097/PEP.0b013e3181b13a82; Przybylski AK, 2014, PEDIATRICS, V134, pE716, DOI 10.1542/peds.2013-4021; Rhodes RE, 2009, PSYCHOL HEALTH MED, V14, P631, DOI 10.1080/13548500903281088; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Salem Y, 2012, PHYSIOTHERAPY, V98, P189, DOI 10.1016/j.physio.2012.06.003; Sharif I, 2006, PEDIATRICS, V118, pE1061, DOI 10.1542/peds.2005-2854; Smallwood SR, 2012, ARCH PEDIAT ADOL MED, V166, P1005, DOI 10.1001/archpediatrics.2012.1271; Strasburger VC, 2014, CLIN PEDIATR, V53, P721, DOI 10.1177/0009922813500340; Szturm T, 2011, PHYS THER, V91, P1449, DOI 10.2522/ptj.20090205; Tseng WC, 2013, CHINESE MED J-PEKING, V126, P2313, DOI 10.3760/cmaj.issn.0366-6999.20123272; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Witherspoon L, 2012, AM J PLAY, V4, P464; You SH, 2005, DEV MED CHILD NEUROL, V47, P628, DOI 10.1017/S0012162205001234; Zoccolillo L, 2015, EUR J PHYS REHAB MED, V51, P669	43	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149714	10.1371/journal.pone.0149714	http://dx.doi.org/10.1371/journal.pone.0149714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983099	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900020
J	Kim, SH; Park, WS; Kim, SH; Park, B; Joo, J; Lee, GK; Joung, JY; Seo, HK; Chung, J; Lee, KH				Kim, Sung Han; Park, Weon Seo; Kim, Sun Ho; Park, Boram; Joo, Jungnam; Lee, Geon Kook; Joung, Jae Young; Seo, Ho Kyung; Chung, Jinsoo; Lee, Kang Hyun			Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy	PLOS ONE			English	Article							SEMINAL-VESICLE INVASION; ANDROGEN DEPRIVATION THERAPY; POSITIVE SURGICAL MARGINS; CARCINOMA; ADENOCARCINOMA; RADIATION; SURGERY; BENIGN	We aimed to identify tissue biomarkers that predict early biochemical recurrence (BCR) in patients with high-risk prostate cancer (PC), toward the goal of increasing the benefits of neoadjuvant hormonal therapy (NHT). In 2005-2012, prostatectomy specimens were collected from 134 PC patients who had received NHT and radical prostatectomy. The expression of 13 tissue biomarkers was assessed in the specimens via immunohistochemistry. Time to BCR and factors predictive of BCR were determined by using the Cox proportional hazards model. During the follow-up period (median, 57.5 months), 67 (50.0%) patients experienced BCR. Four (3.0%) patients were tumor-free in the final pathology assessment, and 101 (75.4%) had negative resection margins. Prostate stem cell antigen (PSCA) was the only significant prognostic tissue biomarker of BCR [hazard ratio (HR), 2.58; 95% confidence interval (CI), 1.06-6.27; p = 0.037] in a multivariable analysis adjusted by the clinicopathological variables that also significantly predicted BCR; these were seminal vesicle invasion (HR, 2.39; 95% CI, 1.32-4.34), initial prostate serum antigen level (HR 1.01; 95% CI, 1.001-1.020), prostate size (HR, 0.93; 95% CI, 0.90-0.97), and the Gleason score of preoperative biopsies (HR, 1.34; 95% CI, 1.01-1.79). We suggest that PSCA is a useful tissue marker for predicting BCR in patients with high risk PC receiving NHT and radical prostatectomy.	[Kim, Sung Han; Park, Weon Seo; Joung, Jae Young; Seo, Ho Kyung; Chung, Jinsoo; Lee, Kang Hyun] Natl Canc Ctr, Res Inst & Hosp, Dept Urol, Ctr Prostate Canc, Goyang, South Korea; [Park, Weon Seo; Lee, Geon Kook] Natl Canc Ctr, Res Inst & Hosp, Dept Pathol, Ctr Prostate Canc, Goyang, South Korea; [Kim, Sun Ho] Natl Canc Ctr, Res Inst & Hosp, Dept Radiol, Ctr Prostate Canc, Goyang, South Korea; [Park, Boram; Joo, Jungnam] Natl Canc Ctr, Res Inst & Hosp, Biometr Res Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Lee, KH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Dept Urol, Ctr Prostate Canc, Goyang, South Korea.	uroonco@ncc.re.kr		KIM, Sung Han/0000-0002-1689-5203; Park, Boram/0000-0003-2683-8795	Korean National Cancer Center Grants [1510170]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [20110010731]	Korean National Cancer Center Grants; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by the Korean National Cancer Center Grants (nos. 1510170). This treatise was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110010731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 2004, J UROLOGY, V171, P2221, DOI 10.1097/01.ju.0000124381.93689.b4; Bastide C, 2012, BJU INT, V109, P525, DOI 10.1111/j.1464-410X.2011.10332.x; Bazinet M, 1997, UROLOGY, V49, P721, DOI 10.1016/S0090-4295(97)00062-9; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Cho IC, 2011, J KOREAN MED SCI, V26, P807, DOI 10.3346/jkms.2011.26.6.807; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; DiPaola RS, 1999, SEMIN ONCOL, V26, P112; Epstein J. I., 2004, ACINAR ADENOCARCINOM; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Gleave ME, 2001, J UROLOGY, V166, P500, DOI 10.1016/S0022-5347(05)65971-X; Hamada R, 2016, INT J CLIN ONCOL, V21, P595, DOI 10.1007/s10147-015-0923-3; Han KR, 2004, J UROLOGY, V171, P1117, DOI 10.1097/01.ju.0000109982.60619.93; Joung JY, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0079-5; Kim SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/292454; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122498; Kristiansen A, 2013, HISTOPATHOLOGY, V62, P1049, DOI 10.1111/his.12104; Kusumi T, 2008, PATHOL INT, V58, P687, DOI 10.1111/j.1440-1827.2008.02294.x; Lam JS, 2005, CLIN CANCER RES, V11, P2591, DOI 10.1158/1078-0432.CCR-04-1842; Lou DY, 2014, UROLOGIC ONCOLOGY, DOI 10.1016/j.urolonc.2013.12.001; Mckay RR, 2013, DRUGS, V73, P1417, DOI 10.1007/s40265-013-0107-2; Petraki CD, 2007, HISTOL HISTOPATHOL, V22, P107, DOI 10.14670/HH-22.107; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Reuter VE, 1997, UROLOGY, V49, P16, DOI 10.1016/S0090-4295(97)00164-7; Richard V, 2014, PROG UROL, V24, P595, DOI 10.1016/j.purol.2014.02.005; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Shelley MD, 2009, CANCER TREAT REV, V35, P9, DOI 10.1016/j.ctrv.2008.08.002; Stamey TA, 2000, J UROLOGY, V163, P1155, DOI 10.1016/S0022-5347(05)67713-0; Szende B, 2001, PROSTATE, V49, P93, DOI 10.1002/pros.1122; TETU B, 1991, AM J SURG PATHOL, V15, P111, DOI 10.1097/00000478-199102000-00002; Vaillancourt L, 1996, AM J SURG PATHOL, V20, P86, DOI 10.1097/00000478-199601000-00010; Vogel UF, 2006, AM J CLIN PATHOL, V126, P342, DOI 10.1309/F2Q38DXN1V1V4GQM; Yossepowitch O, 2014, EUR UROL, V65, P303, DOI 10.1016/j.eururo.2013.07.039; Zhao ZG, 2005, PROSTATE, V65, P299, DOI 10.1002/pros.20290; Zhao ZG, 2007, PROSTATE, V67, P653, DOI 10.1002/pros.20536; Zhigang Zhao, 2006, Jpn J Clin Oncol, V36, P121, DOI 10.1093/jjco/hyi253	35	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151646	10.1371/journal.pone.0151646	http://dx.doi.org/10.1371/journal.pone.0151646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982980	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900109
J	DiNofia, AM; Salazar, E; Seif, AE; Li, YM; Huang, YSV; Bagatell, R; Fisher, BT; Aplenc, R				DiNofia, Amanda M.; Salazar, Elizabeth; Seif, Alix E.; Li, Yimei; Huang, Yuan-Shung Vera; Bagatell, Rochelle; Fisher, Brian T.; Aplenc, Richard			Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States	PLOS ONE			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; ACUTE LYMPHOBLASTIC-LEUKEMIA; ANTIBODY-MEDIATED REJECTION; ONCOLOGY GROUP; PEDIATRIC-PATIENTS; PHASE-I; THERAPEUTIC ADVANCES; CHILDHOOD LEUKEMIA; SOLID TUMORS; TRANSPLANT	This study is a pharmacoepidemiologic description of pediatric bortezomib use. Exposure was identified through billing codes in patients admitted to US children's hospitals that participated with the Pediatric Health Information System between 2004 and 2013. Associated information on underlying diseases, demographics, institutional use, mortality, and physician type was collected. Exposure to bortezomib was identified in 314 patients. Hematologist/Oncologists prescribed half of the bortezomib used. Use increased during the study period. Inpatient volume was positively correlated with bortezomib utilization. Bortezomib use in pediatrics is increasing for a variety of diseases. Variation in use exists across institutions. Further studies are needed to characterize bortezomib's efficacy in pediatric diseases.	[DiNofia, Amanda M.; Salazar, Elizabeth; Seif, Alix E.; Li, Yimei; Bagatell, Rochelle; Aplenc, Richard] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Seif, Alix E.; Bagatell, Rochelle; Fisher, Brian T.; Aplenc, Richard] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Yimei; Fisher, Brian T.; Aplenc, Richard] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Huang, Yuan-Shung Vera; Fisher, Brian T.; Aplenc, Richard] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Fisher, Brian T.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	DiNofia, AM (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA.	dinofiaa@email.chop.edu	; Seif, Alix/B-9918-2013	Fisher, Brian/0000-0002-8224-4281; Seif, Alix/0000-0002-1799-2582	National Cancer Institute [R01CA165277, 5T32CA009679-24]; National Institute of Child Health and Human Development [5T32HD064567-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD064567] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009679, P30CA016520, R01CA165277] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RA's work on this project was supported by the National Cancer Institute grant: R01CA165277 (http://www.cancer.gov). AD's work on this project was supported by the National Institute of Child Health and Human Development grant: 5T32HD064567-05 (https://www.nichd.nih.gov) and the National Cancer Institute grant: 5T32CA009679-24 (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaney SM, 2004, J CLIN ONCOL, V22, P4804, DOI 10.1200/JCO.2004.12.185; Claes DJ, 2014, PEDIATR TRANSPLANT, V18, pE100, DOI 10.1111/petr.12256; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Horton TM, 2015, BRIT J HAEMATOL, V170, P118, DOI 10.1111/bjh.13388; Horton TM, 2014, PEDIATR BLOOD CANCER, V61, P1754, DOI 10.1002/pbc.25117; Kavcic M, 2013, J PEDIATR-US, V162, P1252, DOI 10.1016/j.jpeds.2012.11.038; Khandelwal P, 2014, BIOL BLOOD MARROW TR, V20, pS174, DOI 10.1016/j.bbmt.2014.06.032; May LJ, 2014, PEDIATR TRANSPLANT, V18, pE280, DOI 10.1111/petr.12347; Mehta B, 2014, PEDIATR BLOOD CANCER, V61, P2324, DOI 10.1002/pbc.25172; Messinger Y, 2010, PEDIATR BLOOD CANCER, V55, P254, DOI 10.1002/pbc.22456; Messinger YH, 2012, BLOOD, V120, P285, DOI 10.1182/blood-2012-04-418640; Morrow WR, 2012, TRANSPLANTATION, V93, P319, DOI 10.1097/TP.0b013e31823f7eea; Muscal JA, 2013, PEDIATR BLOOD CANCER, V60, P390, DOI 10.1002/pbc.24271; Richardson PG, 2004, ANN MED, V36, P304, DOI 10.1080/07853890410030877; United Stated Census Bureau, 2015, STAT COUNT QUICK FAC; van Balen T, 2014, EUR J HAEMATOL, V92, P80, DOI 10.1111/ejh.12206; Zinn MD, 2014, PEDIATR TRANSPLANT, V18, P469, DOI 10.1111/petr.12300	18	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151362	10.1371/journal.pone.0151362	http://dx.doi.org/10.1371/journal.pone.0151362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978062	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800067
J	Knapp, M				Knapp, Michal			Relative Importance of Sex, Pre-Starvation Body Mass and Structural Body Size in the Determination of Exceptional Starvation Resistance of Anchomenus dorsalis (Coleoptera: Carabidae)	PLOS ONE			English	Article							ENERGY RESERVES; DROSOPHILA-MELANOGASTER; FOOD LIMITATION; BEETLE; FIELD; INSECTS; AVAILABILITY; POPULATION; DIMORPHISM; PHYSIOLOGY	In nature, almost all animals have to cope with periods of food shortage during their lifetimes. Starvation risks are especially high for carnivorous predatory species, which often experience long intervals between stochastic prey capturing events. A laboratory experiment using the common predatory carabid beetle Anchomenus dorsalis revealed an exceptional level of starvation resistance in this species: males survived up to 137 days and females up to 218 days without food at 20 degrees C. Individual starvation resistance was strongly positively affected by pre-starvation body mass but only slightly by beetle structural body size per se. Females outperformed males even when the effect of gender was corrected for the effects of structural body size and pre-starvation body mass. The better performance of females compared to males and of beetles with higher relative pre-starvation body mass could be linked to higher fat content and lean dry mass before starvation, followed by a greater decrease in both during starvation. There was also a difference between the sexes in the extent of body mass changes both during ad libitum feeding and following starvation; the body masses of females fluctuated more compared to males. This study stresses the need to distinguish between body mass and structural body size when investigating the ecological and evolutionary consequences of body size. Investigation of the net effects of body size and sex is necessary to disentangle the causes of differences in individual performances in studies of species with significant sexual size dimorphism.	[Knapp, Michal] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Kamycka 129, CZ-16521 Prague 6, Suchdol, Czech Republic	Czech University of Life Sciences Prague	Knapp, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Kamycka 129, CZ-16521 Prague 6, Suchdol, Czech Republic.	knapp@fzp.czu.cz	Knapp, Michal/AAF-4864-2020	Knapp, Michal/0000-0003-4487-7317	Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences in Prague (IGA) [42900/1312/3166, 42110/1312/3123]	Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences in Prague (IGA)	The work was supported by Internal Grant Agency of Faculty of Environmental Sciences, Czech University of Life Sciences in Prague (IGA); http://ga.czu.cz/; grant no. 42900/1312/3166 and 42110/1312/3123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal DD, 2014, J EXP BIOL, V217, P1849, DOI 10.1242/jeb.096792; [Anonymous], 2014, LANG ENV STAT COMP; [Anonymous], 1996, CARABIDAE CZECH SLOV; Baranovska E, 2014, EUR J ENTOMOL, V111, P608, DOI 10.14411/eje.2014.085; Baranovska E, 2014, CENT EUR J BIOL, V9, P476, DOI 10.2478/s11535-013-0282-x; Bilde T, 1998, OECOLOGIA, V115, P54, DOI 10.1007/s004420050490; BILDE T, 1994, ENTOMOL EXP APPL, V73, P151, DOI 10.1007/BF02383421; Blanckenhorn WU, 2007, PHYSIOL ENTOMOL, V32, P372, DOI 10.1111/j.1365-3032.2007.00589.x; Bommarco R, 1998, ENVIRON ENTOMOL, V27, P863, DOI 10.1093/ee/27.4.863; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Chaabane K, 1996, ANN ZOOL FENN, V33, P97; Chen H, 2011, B ENTOMOL RES, V101, P53, DOI 10.1017/S0007485310000209; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Gergs A, 2014, J ANIM ECOL, V83, P758, DOI 10.1111/1365-2656.12195; Goenaga J, 2013, EVOL BIOL, V40, P601, DOI 10.1007/s11692-013-9235-6; Hering D, 1997, OECOLOGIA, V111, P261, DOI 10.1007/s004420050234; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; Knapp M, 2013, J INSECT SCI, P13; Knapp M, 2014, J INSECT SCI, P14; Knapp M, 2012, ENTOMOL EXP APPL, V143, P185, DOI 10.1111/j.1570-7458.2012.01247.x; Krasnov BR, 2002, J VECTOR ECOL, V27, P70; Lang A, 2003, OECOLOGIA, V134, P144, DOI 10.1007/s00442-002-1091-5; Laparie M, 2012, COMP BIOCHEM PHYS A, V161, P122, DOI 10.1016/j.cbpa.2011.09.011; Lease HM, 2011, PHYSIOL ENTOMOL, V36, P29, DOI 10.1111/j.1365-3032.2010.00767.x; Lease HM, 2010, J MORPHOL, V271, P759, DOI 10.1002/jmor.10835; Lee KP, 2014, FUNCT ECOL, V28, P1144, DOI 10.1111/1365-2435.12247; Leps J, 2014, MULTIVARIATE ANAL EC; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; McCue M.D., 2012, COMP PHYSL FASTING S; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; McKemey AR, 2003, B ENTOMOL RES, V93, P227, DOI 10.1079/BER2003240; NEDVED O, 1994, EUR J ENTOMOL, V91, P307; Osawa N, 2005, EUR J ENTOMOL, V102, P503, DOI 10.14411/eje.2005.072; Ostman O, 2005, ECOL ENTOMOL, V30, P63, DOI 10.1111/j.0307-6946.2005.00661.x; Pijpe J, 2007, EVOL ECOL, V21, P589, DOI 10.1007/s10682-006-9137-5; Reim C, 2006, EVOL ECOL RES, V8, P1215; Resh VH., 2009, ENCY INSECTS; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; Saastamoinen M, 2009, P ROY SOC B-BIOL SCI, V276, P1313, DOI 10.1098/rspb.2008.1464; Stahlschmidt ZR, 2013, FUNCT ECOL, V27, P800, DOI 10.1111/1365-2435.12071; Stern DL, 1999, DEVELOPMENT, V126, P1091; Teder T, 2014, FUNCT ECOL, V28, P479, DOI 10.1111/1365-2435.12172; Tejeda MT, 2014, J INSECT PHYSIOL, V70, P73, DOI 10.1016/j.jinsphys.2014.08.011; van Uitregt VO, 2012, J ANIM ECOL, V81, P108, DOI 10.1111/j.1365-2656.2011.01880.x; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Young OP, 2008, ANN ENTOMOL SOC AM, V101, P104, DOI 10.1603/0013-8746(2008)101[104:BWASOC]2.0.CO;2	46	16	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151459	10.1371/journal.pone.0151459	http://dx.doi.org/10.1371/journal.pone.0151459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978071	gold, Green Published			2022-12-27	WOS:000372572800075
J	Luo, Y; Iyengar, G; Venkatasubramanian, V				Luo, Yu; Iyengar, Garud; Venkatasubramanian, Venkat			Soft Regulation with Crowd Recommendation: Coordinating Self-Interested Agents in Sociotechnical Systems under Imperfect Information	PLOS ONE			English	Article								Regulating emerging industries is challenging, even controversial at times. Under-regulation can result in safety threats to plant personnel, surrounding communities, and the environment. Over-regulation may hinder innovation, progress, and economic growth. Since one typically has limited understanding of, and experience with, the novel technology in practice, it is difficult to accomplish a properly balanced regulation. In this work, we propose a control and coordination policy called soft regulation that attempts to strike the right balance and create a collective learning environment. In soft regulation mechanism, individual agents can accept, reject, or partially accept the regulator's recommendation. This non-intrusive coordination does not interrupt normal operations. The extent to which an agent accepts the recommendation is mediated by a confidence level (from 0 to 100%). Among all possible recommendation methods, we investigate two in particular: the best recommendation wherein the regulator is completely informed and the crowd recommendation wherein the regulator collects the crowd's average and recommends that value. We show by analysis and simulations that soft regulation with crowd recommendation performs well. It converges to optimum, and is as good as the best recommendation for a wide range of confidence levels. This work sheds a new theoretical perspective on the concept of the wisdom of crowds.	[Luo, Yu; Venkatasubramanian, Venkat] Columbia Univ, Dept Chem Engn, New York, NY USA; [Iyengar, Garud; Venkatasubramanian, Venkat] Columbia Univ, Dept Ind Engn & Operat Res, New York, NY 10027 USA	Columbia University; Columbia University	Venkatasubramanian, V (corresponding author), Columbia Univ, Dept Chem Engn, New York, NY USA.; Venkatasubramanian, V (corresponding author), Columbia Univ, Dept Ind Engn & Operat Res, New York, NY 10027 USA.	venkat@columbia.edu		Luo, Yu/0000-0002-1379-6373	Columbia University	Columbia University	This work is supported by Columbia University.	Abbe EA, 2012, AM ECON REV, V102, P65, DOI 10.1257/aer.102.3.65; Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; CARVER CS, 1982, PSYCHOL BULL, V92, P111, DOI 10.1037/0033-2909.92.1.111; De Condorcet N., 2014, ESSAI APPL ANAL PROB; Gold Russell, 2014, BOOM FRACKING IGNITE; Jing Han, 2006, Journal of Systems Science and Complexity, V19, P54, DOI 10.1007/s11424-006-0054-z; KANDEL E, 1992, J POLIT ECON, V100, P801, DOI 10.1086/261840; Kennedy J., 2010, ENCY MACHINE LEARNIN, P760, DOI DOI 10.1007/978-0-387-30164-8_630; KIEFER J, 1952, ANN MATH STAT, V23, P462, DOI 10.1214/aoms/1177729392; Krishnamurthy V, 2014, IEEE TRANS COMPUT SO, V1, P3, DOI 10.1109/TCSS.2014.2307452; Leveson NG, 2011, ENG SYST, P1; Mani A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01735; POWERS WT, 1973, SCIENCE, V179, P351, DOI 10.1126/science.179.4071.351; Rai Arti K, 1999, WAKE FOREST L REV, V34, P827; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Shmueli E, 2014, IEEE TRANS COMPUT SO, V1, P22, DOI 10.1109/TCSS.2014.2307438; Sunstein CR., 2014, WISER GETTING GROUPT; Surowiecki J., 2005, WISDOM CROWDS; Teel AR, 2004, LECT NOTES CONTR INF, V301, P3; Thaler R.H., 2021, NUDGE FINAL EDITION; Thaler RH, 2003, AM ECON REV, V93, P175, DOI 10.1257/000282803321947001; Trochim WM, 2006, AM J PUBLIC HEALTH, V96, P538, DOI 10.2105/AJPH.2005.066001; Zhang H., 2008, PROC AAAI C ARTIF IN, P208	23	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150343	10.1371/journal.pone.0150343	http://dx.doi.org/10.1371/journal.pone.0150343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977699	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800024
J	Demeyer, H; Gimeno-Santos, E; Rabinovich, RA; Hornikx, M; Louvaris, Z; de Boer, WI; Karlsson, N; de Jong, C; Van der Molen, T; Vogiatzis, I; Janssens, W; Garcia-Aymerich, J; Troosters, T; Polkey, MI				Demeyer, Heleen; Gimeno-Santos, Elena; Rabinovich, Roberto A.; Hornikx, Miek; Louvaris, Zafeiris; de Boer, Willem I.; Karlsson, Niklas; de Jong, Corina; Van der Molen, Thys; Vogiatzis, Ioannis; Janssens, Wim; Garcia-Aymerich, Judith; Troosters, Thierry; Polkey, Michael I.		PROactive Consortium	Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DAILY-LIFE; COPD; PREDICTION; INACTIVITY; MORTALITY; VALIDITY; OUTCOMES; DYSPNEA; GRADES	Background The GOLD multidimensional classification of COPD severity combines the exacerbation risk with the symptom experience, for which 3 different questionnaires are permitted. This study investigated differences in physical activity (PA) in the different GOLD quadrants and patient's distribution in relation to the questionnaire used. Methods 136 COPD patients (58+/- 21% FEV1 predicted, 34F/102M) completed COPD assessment test (CAT), clinical COPD questionnaire (CCQ) and modified Medical Research Council (mMRC) questionnaire. Exacerbation history, spirometry and 6MWD were collected. PA was objectively measured for 2 periods of 1 week, 6 months apart, in 5 European centres; to minimise seasonal and clinical variation the average of these two periods was used for analysis. Results GOLD quadrants C+D had reduced PA compared with A+B (3824 [2976] vs. 5508 [4671] steps. d-1, p<0.0001). The choice of questionnaire yielded different patient distributions agreement mMRC-CAT kappa = 0.57; CCQ-mMRC kappa = 0.71; CCQ-CAT kappa = 0.72) with different clinical characteristics. PA was notably lower in patients with an mMRC score >= 2 (3430 [2537] vs. 5443 [3776] steps. d(-1), p < 0.001) in both the low and high risk quadrants. Conclusions Using different questionnaires changes the patient distribution and results in different clinical characteristics. Therefore, standardization of the questionnaire used for classification is critical to allow comparison of different studies using this as an entry criterion.	[Demeyer, Heleen; Hornikx, Miek; Troosters, Thierry] Katholieke Univ Leuven, Dept Rehabil Sci, B-3000 Leuven, Belgium; [Demeyer, Heleen; Hornikx, Miek; Janssens, Wim; Troosters, Thierry] Univ Hosp Leuven, Dept Resp Dis, B-3000 Leuven, Belgium; [Gimeno-Santos, Elena; Garcia-Aymerich, Judith] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Gimeno-Santos, Elena; Garcia-Aymerich, Judith] CIBERESP, Barcelona, Spain; [Gimeno-Santos, Elena; Garcia-Aymerich, Judith] UPF, Barcelona, Spain; [Rabinovich, Roberto A.] Univ Edinburgh, UoE MRC Ctr Inflammat Res, ELEGI Colt Lab, Edinburgh, Midlothian, Scotland; [Louvaris, Zafeiris; Vogiatzis, Ioannis] Univ Athens, Thorax Fdn, M Simou & GP Livanos Labs, Dept Crit Care Med,Pulm Rehabil Ctr,Evangelismos, Athens 11528, Greece; [de Boer, Willem I.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Karlsson, Niklas] Astra Zeneca, Molndal, Sweden; [de Jong, Corina] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Van der Molen, Thys] Univ Groningen, Univ Med Ctr Groningen, Dept Primary Care, Groningen, Netherlands; [Polkey, Michael I.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Polkey, Michael I.] Univ London Imperial Coll Sci Technol & Med, London, England	KU Leuven; KU Leuven; University Hospital Leuven; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; University of Edinburgh; National & Kapodistrian University of Athens; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; AstraZeneca; University of Groningen; University of Groningen; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London	Troosters, T (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, B-3000 Leuven, Belgium.; Troosters, T (corresponding author), Univ Hosp Leuven, Dept Resp Dis, B-3000 Leuven, Belgium.	thierry.troosters@med.kuleuven.be	J, Garcia-Aymerich/G-6867-2014; Hornikx, Miek/ABI-5441-2020	J, Garcia-Aymerich/0000-0002-7097-4586; VOGIATZIS, IOANNIS/0000-0003-4830-7207; Louvaris, Zafeiris/0000-0001-8661-8546; Janssens, Wim/0000-0003-1830-2982; Demeyer, Heleen/0000-0001-8925-0564	Innovative Medicines Initiative Joint Undertaking (IMU JU) [115011]; AZ; ERS/SEPAR; Flemish Research Foundation [G.0871.13]; NIHR Biomedical Research Unit; MRC [G0901697] Funding Source: UKRI; Medical Research Council [G0901697] Funding Source: researchfish	Innovative Medicines Initiative Joint Undertaking (IMU JU); AZ; ERS/SEPAR; Flemish Research Foundation(FWO); NIHR Biomedical Research Unit(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PROactive project is funded by the Innovative Medicines Initiative Joint Undertaking (IMU JU) #115011. NK receives personal fees from AstraZeneca, outside the submitted work. AZ provided support in the form of salaries for the author as part of the in-kind contribution to the IMI-JU PROactive project. The specific role of this author is articulated in the author contributions' section. HD is the recipient of a joint ERS/SEPAR Fellowship (LTRF 2015); WJ is a post-doctoral research fellow of the FWO Flanders. This work was supported by the Flemish Research Foundation (grant # G.0871.13) and was undertaken in part at the NIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; MIP's salary is partly funded by the NIHR Biomedical Research Unit. The views expressed in this publication are those of the authors and not necessarily those of the NHS, The National Institute for Health Research nor the Department of Health.	Agusti A, 2013, EUR RESPIR J, V42, P1391, DOI 10.1183/09031936.00036513; Agusti A, 2013, EUR RESPIR J, V42, P636, DOI 10.1183/09031936.00195212; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Boland MRS, 2014, PRIM CARE RESP J, V23, P30, DOI 10.4104/pcrj.2014.00002; Casanova C, 2015, CHEST, V148, P154; Demeyer H, 2014, CHEST, V146, P318, DOI 10.1378/chest.13-1968; Depew ZS, 2012, RESPIROLOGY, V17, P1026, DOI 10.1111/j.1440-1843.2012.02207.x; Durheim MT, 2015, ANN AM THORAC SOC, V12, P349, DOI DOI 10.1513/ANNALSATS.201408-3650C; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garfield BE, 2012, EUR RESPIR J, V40, P356, DOI 10.1183/09031936.00113611; Gimeno-Santos E, 2015, EUR RESPIR J, V46, P988, DOI 10.1183/09031936.00183014; Gimeno-Santos E, 2014, THORAX, V69, P731, DOI 10.1136/thoraxjnl-2013-204763; GOLD, 2011, GLOB STRAT DIAGN MAN; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Jones PW, 2013, EUR RESPIR J, V42, P647, DOI 10.1183/09031936.00125612; Kim S, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-35; Kon S, 2014, AM J RESP CRITICAL C, V189; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moreira GL, 2015, CHRON RESP DIS, V12, P102, DOI 10.1177/1479972315573528; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Park SK, 2013, HEART LUNG, V42, P465, DOI 10.1016/j.hrtlng.2013.08.008; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Shrikrishna D, 2012, EUR RESPIR J, V40, P1115, DOI 10.1183/09031936.00170111; Singh SJ, 2014, EUR RESPIR J, V44, P1447, DOI 10.1183/09031936.00150414; Soriano JB, 2015, LANCET RESP MED, V3, P443, DOI 10.1016/S2213-2600(15)00157-5; Soriano JB, 2013, THORAX, V68, P902, DOI 10.1136/thoraxjnl-2013-203595; Soriano JB, 2013, CHEST, V143, P694, DOI 10.1378/chest.12-1053; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; Van Remoortel H, 2014, AM J RESP CRIT CARE, V189, P30, DOI 10.1164/rccm.201307-1240OC; Van Remoortel H, 2013, THORAX, V68, P962, DOI 10.1136/thoraxjnl-2013-203534; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Viera AJ, 2005, FAM MED, V37, P360; Vorrink SNW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-33; Waschki B, 2012, RESP MED, V106, P522, DOI 10.1016/j.rmed.2011.10.022; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151255	10.1371/journal.pone.0151255	http://dx.doi.org/10.1371/journal.pone.0151255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974332	Green Published, gold, Green Accepted			2022-12-27	WOS:000372570600057
J	Langlois, A; Mura, C; Bietiger, W; Seyfritz, E; Dollinger, C; Peronet, C; Maillard, E; Pinget, M; Jeandidier, N; Sigrist, S				Langlois, Allan; Mura, Carole; Bietiger, William; Seyfritz, Elodie; Dollinger, Camille; Peronet, Claude; Maillard, Elisa; Pinget, Michel; Jeandidier, Nathalie; Sigrist, Severine			In Vitro and In Vivo Investigation of the Angiogenic Effects of Liraglutide during Islet Transplantation	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ENDOTHELIAL GROWTH-FACTOR; BETA-CELLS; PANCREATIC-ISLETS; SURVIVAL; ANALOG; VEGF; VIABILITY; APOPTOSIS; PATHWAY	Introduction This study investigated the angiogenic properties of liraglutide in vitro and in vivo and the mechanisms involved, with a focus on Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) and mammalian target of rapamycin (mTOR). Materials and Methods Rat pancreatic islets were incubated in vitro with 10 mu mol/L of liraglutide (Lira) for 12, 24 and 48 h. Islet viability was studied by fluorescein diacetate/propidium iodide staining and their function was assessed by glucose stimulation. The angiogenic effect of liraglutide was determined in vitro by the measure of vascular endothelial growth factor (VEGF) secretion using enzyme-linked immunosorbent assay and by the evaluation of VEGF and platelet-derived growth factor-a (PDGF alpha) expression with quantitative polymerase chain reaction technic. Then, in vitro and in vivo, angiogenic property of Lira was evaluated using immunofluorescence staining targeting the cluster of differentiation 31 (CD31). To understand angiogenic mechanisms involved by Lira, HIF-1a and mTOR activation were studied using western blotting. In vivo, islets (1000/kg body-weight) were transplanted into diabetic (streptozotocin) Lewis rats. Metabolic control was assessed for 1 month by measuring body-weight gain and fasting blood glucose. Results Islet viability and function were respectively preserved and enhanced (p<0.05) with Lira, versus control. Lira increased CD31-positive cells, expression of VEGF and PDGFa (p<0.05) after 24 h in culture. Increased VEGF secretion versus control was also observed at 48 h (p<0.05). Moreover, Lira activated mTOR (p<0.05) signalling pathway. In vivo, Lira improved vascular density (p<0.01), body-weight gain (p<0.01) and reduced fasting blood glucose in transplanted rats (p<0.001). Conclusion The beneficial effects of liraglutide on islets appeared to be linked to its angiogenic properties. These findings indicated that glucagon-like peptide-1 analogues could be used to improve transplanted islet revascularisation.	[Langlois, Allan; Mura, Carole; Bietiger, William; Seyfritz, Elodie; Dollinger, Camille; Peronet, Claude; Maillard, Elisa; Pinget, Michel; Jeandidier, Nathalie; Sigrist, Severine] Univ Strasbourg, Ctr Europeen Etude Diabete, UMR DIATHEC, EA 7294,FMTS, Bld Rene Leriche, F-67200 Strasbourg, France; [Pinget, Michel; Jeandidier, Nathalie] Hop Univ Strasbourg, Pole NUDE, Serv Endocrinol, Diabete,Malad Metabol, F-67000 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sigrist, S (corresponding author), Univ Strasbourg, Ctr Europeen Etude Diabete, UMR DIATHEC, EA 7294,FMTS, Bld Rene Leriche, F-67200 Strasbourg, France.	s.sigrist@ceed-diabete.org			Novo Nordisk; ASDIA; Vaincre le diabete	Novo Nordisk(Novo Nordisk); ASDIA; Vaincre le diabete	This work was funded by Novo Nordisk, ASDIA and Vaincre le diabete. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Bloch K, 2012, HISTOCHEM CELL BIOL, V137, P801, DOI 10.1007/s00418-012-0925-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Carmeliet P, 2004, J INTERN MED, V255, P538, DOI 10.1111/j.1365-2796.2003.01297.x; Coppens V, 2013, DIABETOLOGIA, V56, P382, DOI 10.1007/s00125-012-2754-3; Cornu M, 2009, ISLETS, V1, P280, DOI 10.4161/isl.1.3.9932; Cross SE, 2007, DIABETOLOGIA, V50, P1423, DOI 10.1007/s00125-007-0670-8; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254; Emamaullee JA, 2009, ENDOCRINOLOGY, V150, P2145, DOI 10.1210/en.2008-1116; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Kang HM, 2013, BIOCHEM BIOPH RES CO, V434, P150, DOI 10.1016/j.bbrc.2013.03.053; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Langlois A, 2011, CELL TRANSPLANT, V20, P1333, DOI 10.3727/096368910X557182; Langlois A, 2009, J DRUG TARGET, V17, P415, DOI 10.1080/10611860902929832; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merani S, 2008, ENDOCRINOLOGY, V149, P4322, DOI 10.1210/en.2008-0501; Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x; Narang AS, 2006, PHARM RES, V23, P1970, DOI 10.1007/s11095-006-9065-7; Nishimura R, 2013, TRANSPL P, V45, P1892, DOI 10.1016/j.transproceed.2013.01.047; Padmasekar M, 2013, ENDOCRINOLOGY, V154, P1424, DOI 10.1210/en.2012-1983; Pepper AR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/352315; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Samikannu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082639; Sato K, 2013, INT J MOL SCI, V14, P21513, DOI 10.3390/ijms141121513; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sigrist S, 2003, CELL TRANSPLANT, V12, P627, DOI 10.3727/000000003108747109; Stokes RA, 2013, CELL TRANSPLANT, V22, P253, DOI 10.3727/096368912X647180; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Toso C, 2010, TRANSPL INT, V23, P259, DOI 10.1111/j.1432-2277.2009.00984.x; Wittig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069975; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963	39	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0147068	10.1371/journal.pone.0147068	http://dx.doi.org/10.1371/journal.pone.0147068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974949	Green Published, gold			2022-12-27	WOS:000372570600007
J	Loibner, M; Buzina, W; Viertler, C; Groelz, D; Hausleitner, A; Siaulyte, G; Kufferath, I; Kolli, B; Zatloukal, K				Loibner, Martina; Buzina, Walter; Viertler, Christian; Groelz, Daniel; Hausleitner, Anja; Siaulyte, Gintare; Kufferath, Iris; Koelli, Bettina; Zatloukal, Kurt			Pathogen Inactivating Properties and Increased Sensitivity in Molecular Diagnostics by PAXgene, a Novel Non-Crosslinking Tissue Fixative	PLOS ONE			English	Article							STERILIZATION; FORMALIN; TRANSPLANTS; MORPHOLOGY; VIRUS	Background Requirements on tissue fixatives are getting more demanding as molecular analysis becomes increasingly relevant for routine diagnostics. Buffered formaldehyde in pathology laboratories for tissue fixation is known to cause chemical modifications of biomolecules which affect molecular testing. A novel non-crosslinking tissue preservation technology, PAXgene Tissue (PAXgene), was developed to preserve the integrity of nucleic acids in a comparable way to cryopreservation and also to preserve morphological features comparable to those of formalin fixed samples. Methods Because of the excellent preservation of biomolecules by PAXgene we investigated its pathogen inactivation ability and biosafety in comparison to formalin by in-vitro testing of bacteria, human relevant fungi and human cytomegalovirus (CMV). Guidelines for testing disinfectants served as reference for inactivation assays. Furthermore, we tested the properties of PAXgene for detection of pathogens by PCR based assays. Results All microorganisms tested were similarly inactivated by PAXgene and formalin except Clostridium sporogenes, which remained viable in seven out of ten assays after PAXgene treatment and in three out of ten assays after formalin fixation. The findings suggest that similar biosafety measures can be applied for PAXgene and formalin fixed samples. Detection of pathogens in PCR-based diagnostics using two CMV assays resulted in a reduction of four to ten quantification cycles of PAXgene treated samples which is a remarkable increase of sensitivity. Conclusion PAXgene fixation might be superior to formalin fixation when molecular diagnostics and highly sensitive detection of pathogens is required in parallel to morphology assessment.	[Loibner, Martina; Hausleitner, Anja; Siaulyte, Gintare; Kufferath, Iris; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Christian Doppler Lab Biospecimen Res & Biobankin, Graz, Austria; [Loibner, Martina; Viertler, Christian; Siaulyte, Gintare; Kufferath, Iris; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Buzina, Walter; Koelli, Bettina] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria; [Groelz, Daniel] Qiagen GmbH, Res & Dev, Hilden, Germany; [Hausleitner, Anja] LKH Hosp Weiz, Dept Lab Med, Weiz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; QIAGEN GmbH	Zatloukal, K (corresponding author), Med Univ Graz, Inst Pathol, Christian Doppler Lab Biospecimen Res & Biobankin, Graz, Austria.; Zatloukal, K (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	kurt.zatloukal@medunigraz.at			Christian Doppler Research Fund for Biospecimen Research and Biobanking Technologies; Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; Hygiene-Funds of the Medical University of Graz; Christian Doppler Laboratory for Biospecimen Research and Biobanking Technologies	Christian Doppler Research Fund for Biospecimen Research and Biobanking Technologies; Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; Hygiene-Funds of the Medical University of Graz; Christian Doppler Laboratory for Biospecimen Research and Biobanking Technologies	This work was supported by the Christian Doppler Research Fund for Biospecimen Research and Biobanking Technologies, the Austrian Federal Ministry of Science, Research and Economy, the National Foundation for Research, Technology and Development and the Hygiene-Funds of the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to Dr. Ralf Wyrich (Qiagen GmbH) for critical reading and scientific discussions, Dr. Penelope Kungl (Medical University of Graz) for critical reading and reviewing for verbal skills, Dr. Clemes Kittinger and Rita Baumert for their excellent support with Mycobacteria experiments. The work was supported by the Christian Doppler Laboratory for Biospecimen Research and Biobanking Technologies.	[Anonymous], 2008, HEALTHCARE INFECT CO; Blum F, 1983, Z WISS MIKROSK, V10, P314; BROWN F, 1993, DEV BIOL STAND, V81, P103; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; DellIsola G., 1895, BOLL ACAD MED GENOVA, V10, P84; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Ergin B, 2010, J PROTEOME RES, V9, P5188, DOI 10.1021/pr100664e; Gebel J, 2007, GMS KRANKENHAUSHYGIE, V2, pDoc17; Gebel J., 2002, STANDARDMETHODEN DGH; Grizzle WE, 2001, BIOTECH HISTOCHEM, V76, P183, DOI 10.1080/714028143; Groelz D, 2013, EXP MOL PATHOL, V94, P188, DOI 10.1016/j.yexmp.2012.07.002; Gundisch S, 2014, VIRCHOWS ARCH, V465, P509, DOI 10.1007/s00428-014-1624-4; Gundisch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060638; Gullett JC, 2015, CLIN CHEM, V61, P72, DOI 10.1373/clinchem.2014.223289; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Kap M, 2013, BIOPRESERV BIOBANK, V11, P229, DOI 10.1089/bio.2013.0010; Kap M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027704; Kashofer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070714; Nadji M, 2005, APPL IMMUNOHISTO M M, V13, P277, DOI 10.1097/01.pai.0000146544.51771.79; Nietner T, 2012, VIRCHOWS ARCH, V461, P259, DOI 10.1007/s00428-012-1248-5; Olert J, 2001, PATHOL RES PRACT, V197, P823, DOI 10.1078/0344-0338-00166; Pruss A, 2001, BIOLOGICALS, V29, P59, DOI 10.1006/biol.2001.0286; Pruss A, 1999, BIOLOGICALS, V27, P195, DOI 10.1006/biol.1999.0177; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P107, DOI 10.1086/650197; Sagripanti JL, 1997, AM J INFECT CONTROL, V25, P335, DOI 10.1016/S0196-6553(97)90026-2; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Staff S, 2013, J CLIN PATHOL, V66, P807, DOI 10.1136/jclinpath-2012-201283; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Thatcher SA, 2015, CLIN CHEM, V61, P89, DOI 10.1373/clinchem.2014.221374; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Viertler C, 2012, J MOL DIAGN, V14, P458, DOI 10.1016/j.jmoldx.2012.05.002	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151383	10.1371/journal.pone.0151383	http://dx.doi.org/10.1371/journal.pone.0151383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974150	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600072
J	Loiola, CM; Azevedo, AON; Diniz, LEC; Aragao, WM; Azevedo, CDD; Santos, PHAD; Ramos, HCC; Pereira, MG; Ramos, SRR				Loiola, Carina Mendes; Nunes Azevedo, Alinne Oliveira; Diniz, Leandro E. C.; Aragao, Wilson Menezes; Azevedo, Carlos Diego de O.; Santos, Pedro Henrique A. D.; Ramos, Helaine Christine C.; Pereira, Messias Gonzaga; Ramalho Ramos, Semiramis R.			Genetic Relationships among Tall Coconut Palm (Cocos nucifera L.) Accessions of the International Coconut Genebank for Latin America and the Caribbean (ICG-LAC), Evaluated Using Microsatellite Markers (SSRs)	PLOS ONE			English	Article							DIVERSITY; POPULATIONS	The diversity and genetic relationships among two accessions of tall coconut palms collected in Brazil and seven accessions introduced from different geographic regions of the world were analyzed using 25 microsatellite primers, 19 of which were polymorphic and detected between 4 and 10 alleles per locus, with an average of 6.57. The observed and expected heterozygosity ranged from 0.25 and 0.40 in the Rennell Islands Tall (RIT) accession to 0.54 and 0.62 in the Polynesian Tall (PYT) accession. The analysis of genetic structure resulted in the formation of five distinct groups. The first group was formed by the accessions Brazilian Tall-Praia do Forte (BRTPF), Brazilian Tall-Merepe (BRTMe) and West African Tall (WAT); the second group consisted of Malaysian Tall (MLT); the third group of RIT; the fourth group of Vanuatu Tall (VTT); and the fifth group of Rotuman Tall (RTMT), Tonga Tall (TONT) and PYT. The dendrogram based on the nearest-neighbor method detected the formation of two main groups and five subgroups, indicating that the genetic relationships of the accessions are based on their geographic regions of origin. The analyses revealed genetic relationships between the accessions collected in Brazil and the accession from Africa, and among palms from South East Asia and the South Pacific, confirming the common origin of these accessions. The information obtained in this study can guide decisions on germplasm conservation activities and the efficient selection of genetically divergent parents for use in coconut breeding programs in Brazil, which are attempting to select for disease resistance, mainly to lethal yellowing, among other characteristics.	[Loiola, Carina Mendes] Fed Rural Univ Semiarido, Embrapa Coastal Tablelands, Aracaju, Sergipe, Brazil; [Nunes Azevedo, Alinne Oliveira; Azevedo, Carlos Diego de O.; Santos, Pedro Henrique A. D.; Ramos, Helaine Christine C.; Pereira, Messias Gonzaga] North Fluminense State Univ UENF, Campos Goytacazes, Rio De Janeiro, Brazil; [Diniz, Leandro E. C.; Aragao, Wilson Menezes; Ramalho Ramos, Semiramis R.] Embrapa Coastal Tablelands, Aracaju, Sergipe, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Ramos, SRR (corresponding author), Embrapa Coastal Tablelands, Aracaju, Sergipe, Brazil.	semiramis.ramos@embrapa.br	Pereira, Messias G/G-4782-2015; Santos, Pedro/W-2641-2019; Pereira, Messias/AAS-4261-2020	Pereira, Messias/0000-0002-3463-3768; Ramos, Semiramis/0000-0003-1289-1341; Cancela Ramos, Helaine Christine/0000-0002-0098-1027; Diniz, Leandro E C/0000-0003-1980-9945; Santos, PedroHenrique Araujo Diniz/0000-0002-7781-215X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Projeto Nacional de Acoes Integradas Publico-Privadas para Biodiversidade (PROBIO II); National Project for Public-Private Integrated Actions for Biodiversity-PROBIO II	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Projeto Nacional de Acoes Integradas Publico-Privadas para Biodiversidade (PROBIO II); National Project for Public-Private Integrated Actions for Biodiversity-PROBIO II	CML was supported by 'Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior' (CAPES) with a Scholarship during her PhD. 'Projeto Nacional de Acoes Integradas Publico-Privadas para Biodiversidade (PROBIO II)' gave financial support for developing all steps of this work.; We are very thankful to the National Project for Public-Private Integrated Actions for Biodiversity-PROBIO II for supporting this work and Dr. Clara Goedert for providing research facilities.	Abreu FAP, 2002, COCO COLHEITA, P29; Aragao WM, 2003, COCO PRODUCAO ASPECT, P21; Baudouin, 2005, COCONUT GENETIC RESO, P225; Baudouin L, 2009, APO08007 LOA, P1; Baudouin L, 2014, ANN BOT-LONDON, V113, P1, DOI 10.1093/aob/mct244; Baudouin L, 2009, OCL OILS FAT CROP LI, V16, P127, DOI 10.1051/ocl.2009.0244; Clement CR, 2013, BOT REV, V79, P342, DOI 10.1007/s12229-013-9121-z; Daher R. F., 2002, Crop Breeding and Applied Biotechnology, V2, P431; Dias BC, 1980, SUBSIDIOS AO GRUPO T, P1; Dollet M, 2009, OCL OILS FAT CROP LI, V16, P97, DOI 10.1051/ocl.2009.0246; Doyle J. J., 1987, PHYTOCHEM B, P11; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gunn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021143; HARRIES H C, 1992, Principes, V36, P155; HARRIES HC, 1977, TURRIALBA, V27, P227; HARRIES HC, 1978, BOT REV, V44, P265, DOI 10.1007/BF02957852; HOLCOMB J, 1977, EUPHYTICA, V26, P441, DOI 10.1007/BF00027006; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lebrun P, 1998, EUPHYTICA, V101, P103, DOI 10.1023/A:1018323721803; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Manjula C., 2014, J PLANT CROPS, V42, P301; Martinez RT, 2010, TREE GENET GENOMES, V6, P73, DOI 10.1007/s11295-009-0229-6; Martins CR, 2011, EVOLUCAO PRODUCAO CO, P30; Myrie WA, 2006, PLANT DIS, V90, P834, DOI 10.1094/PD-90-0834A; Okwuagwu C.O., 2005, COCONUT GENETIC RESO, P667; Peakall R, 2009, GENAIEX TUTORIALS 1; Pearson K, 1900, PHILOS MAG, V50, P1; Perera L, 2000, GENOME, V43, P15, DOI 10.1139/gen-43-1-15; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2006, LANG ENV STAT COMP; Rajesh MK, 2014, J PLANT CROPS, V42, P277; Ribeiro FE, 1999, PESQUI AGROPECU BRAS, V34, P1615, DOI 10.1590/S0100-204X1999000900012; Ribeiro FE, 2011, CARACTERIZACAO POPUL, P16; Ribeiro FE, 2010, GENET MOL BIOL, V33, P696, DOI 10.1590/S1415-47572010005000077; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Romney DH, 1979, SESSION FAO TECHNICA, V5, P4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer J, 1971, MAN SEA, P309; Teulat B, 2000, THEOR APPL GENET, V100, P764, DOI 10.1007/s001220051350; ZizumboVillarreal D, 1996, GENET RESOUR CROP EV, V43, P505, DOI 10.1007/BF00138827	40	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151309	10.1371/journal.pone.0151309	http://dx.doi.org/10.1371/journal.pone.0151309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974540	gold, Green Submitted, Green Published			2022-12-27	WOS:000372570600067
J	Luo, Z; Nan, F; Miao, J; Chen, ZH; Li, M; Liang, MZ				Luo, Zhu; Nan, Feng; Miao, Jia; Chen, Zhihui; Li, Mei; Liang, Maozhi			Pharmacokinetics and Bioequivalence of Two Formulations of Febuxostat 40-Mg and 80-Mg Tablets: A Randomized, Open-Label, 4-Way Crossover Study in Healthy Chinese Male Volunteers	PLOS ONE			English	Article							NONPURINE SELECTIVE INHIBITOR; XANTHINE-OXIDASE; PHARMACODYNAMICS; HYPERURICEMIA; SAFETY; GOUT; MANAGEMENT; ADULTS	The present study aimed to investigate the pharmacokinetic properties of febuxostat in healthy Chinese male volunteers and evaluate whether the two formulations of febuxostat 40-mg and 80-mg tablets are bioequivalent. A randomized, open-label, 4-way crossover study was conducted in healthy Chinese male volunteers under fasting conditions. 24 eligible subjects were randomized in a 1: 1: 1: 1 ratio to receive a single dose of test or reference formulation of febuxostat 40-mg or 80-mg tablet. The washout period between each administration was 1 week. Plasma febuxostat was quantified by a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Tolerability was evaluated by monitoring adverse events, physical examinations, 12-lead ECG and laboratory tests. After single-dosing of 1 tablet of 40-mg febuxostat, the pharmacokinetic parameters of test and reference formulations were: T-max 1.22 +/- 0.87 and 1.85 +/- 1.03 h, C-max 1689.16 +/- 461.31 and 1613.80 +/- 608.43 ng.mL(-1), AUC(0-t) 5139.87 +/- 1349.28 and 5517.91 +/- 2024.26 ng.mL(-1).h, AUC(0-infinity) 5263.06 +/- 1339.16 and 5640.48 +/- 2040.22 ng.mL(-1).h, t(1/2) 4.82 +/- 2.61 and 4.85 +/- 1.78 h, respectively. After single-dosing of 1 tablet of 80-mg febuxostat, the pharmacokinetic parameters of test and reference formulations were: T-max 1.71 +/- 1.21 and 2.23 +/- 1.55 h, C-max 2744.47 +/- 1157.44 and 2998.17 +/- 1200.13 ng.mL(-1), AUC(0-t) 9634.03 +/- 2768.25 and 10467.95 +/- 3501.65 ng.mL(-1).h, AUC(0-infinity) 9834.32 +/- 2730.51 and 10626.63 +/- 3504.08 ng.mL(-1).h, t(1/2) 6.25 +/- 2.44 and 5.46 +/- 1.65 h, respectively. For single-dosing of 1 tablet of 40-mg febuxostat, 90% CIs for the test/reference ratio of AUC(0-t), AUC(0-infinity) and Cmax were 89.79 to 102.55, 90.14 to 102.56 and 93.99 to 129.63, respectively. For single-dosing of 1 tablet of 80-mg febuxostat, 90% CIs for the test/reference ratio of AUC(0-t), AUC(0-infinity) and Cmax were 86.67 to 100.00, 87.50 to 100.51 and 79.48 to 105.99, respectively. This single dose study revealed similar pharmacokinetic properties in healthy Chinese male volunteers as those found in Caucasic population. The test and reference febuxostat tablets formulations met the regulatory criteria for bioequivalence at 40-mg and 80-mg strengths in fasting healthy Chinese male volunteers.	[Luo, Zhu; Nan, Feng; Miao, Jia; Chen, Zhihui; Li, Mei; Liang, Maozhi] Sichuan Univ, Inst Drug Clin Trials, West China Hosp, Chengdu 610041, Peoples R China	Sichuan University	Liang, MZ (corresponding author), Sichuan Univ, Inst Drug Clin Trials, West China Hosp, Chengdu 610041, Peoples R China.	wchscu@sohu.com			Beijing Furuikangzheng Pharmaceuticals Co. Ltd.(Beijing, People's Republic of China)	Beijing Furuikangzheng Pharmaceuticals Co. Ltd.(Beijing, People's Republic of China)	This study was funded by Beijing Furuikangzheng Pharmaceuticals Co. Ltd.(Beijing, People's Republic of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FEB FULL PRESCR INF; Ernst ME, 2009, CLIN THER, V31, P2503, DOI 10.1016/j.clinthera.2009.11.033; Frampton JE, 2015, DRUGS, V75, P427, DOI 10.1007/s40265-015-0360-7; Grabowski BA, 2011, J CLIN PHARMACOL, V51, P189, DOI 10.1177/0091270010365549; Grewal HK, 2014, EXPERT OPIN DRUG MET, V10, P747, DOI 10.1517/17425255.2014.904285; Khosravan R, 2006, J CLIN PHARMACOL, V46, P88, DOI 10.1177/0091270005282634; Khosravan R, 2008, J CLIN PHARMACOL, V48, P1014, DOI 10.1177/0091270008322035; Khosravan R, 2008, BRIT J CLIN PHARMACO, V65, P355, DOI 10.1111/j.1365-2125.2007.03016.x; Khosravan R, 2006, CLIN PHARMACOKINET, V45, P821, DOI 10.2165/00003088-200645080-00005; Liu B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-832; Liu XX, 2012, ARZNEIMITTELFORSCH, V62, P463, DOI 10.1055/s-0032-1321847; Luo Z, 2015, CURR THER RES CLIN E, V77, P52, DOI 10.1016/j.curtheres.2015.02.001; Richette P, 2015, EUR REV MED PHARMACO, V19, P630; Roddy E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5648; State Food and Drug Administration Peoples' Republic of China, GUID TECHN INV DRUG; Takeda Pharmaceuticals America Inc, 2013, ULORIC FEB TABL OR U; Vaka VRR, 2013, BIOMED CHROMATOGR, V27, P1406, DOI 10.1002/bmc.2936; Wallace KL, 2004, J RHEUMATOL, V31, P1582; Wang HD, 2013, BIOMED CHROMATOGR, V27, P34, DOI 10.1002/bmc.2744; Wertheimer Albert, 2013, Curr Ther Res Clin Exp, V75, P1, DOI 10.1016/j.curtheres.2013.04.003; Ye P, 2013, CLIN THER, V35, P180, DOI 10.1016/j.clinthera.2012.12.011	21	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150661	10.1371/journal.pone.0150661	http://dx.doi.org/10.1371/journal.pone.0150661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974539	Green Submitted, gold, Green Published			2022-12-27	WOS:000372570600027
J	Turner, ML; Cronin, JG; Noleto, PG; Sheldon, IM				Turner, Matthew L.; Cronin, James G.; Noleto, Pablo G.; Sheldon, I. Martin			Glucose Availability and AMP-Activated Protein Kinase Link Energy Metabolism and Innate Immunity in the Bovine Endometrium	PLOS ONE			English	Article							DAIRY-COWS; ESCHERICHIA-COLI; UTERINE DISEASE; STROMAL CELLS; IN-VITRO; EXPRESSION; BALANCE; SYSTEM; GROWTH; INFLAMMATION	Defences against the bacteria that usually infect the endometrium of postpartum cattle are impaired when there is metabolic energy stress, leading to endometritis and infertility. The endometrial response to bacteria depends on innate immunity, with recognition of pathogen-associated molecular patterns stimulating inflammation, characterised by secretion of interleukin (IL)-1 beta, IL-6 and IL-8. How metabolic stress impacts tissue responses to pathogens is unclear, but integration of energy metabolism and innate immunity means that stressing one system might affect the other. Here we tested the hypothesis that homeostatic pathways integrate energy metabolism and innate immunity in bovine endometrial tissue. Glucose deprivation reduced the secretion of IL-1 beta, IL-6 and IL-8 from ex vivo organ cultures of bovine endometrium challenged with the pathogen-associated molecular patterns lipopolysaccharide and bacterial lipopeptide. Endometrial inflammatory responses to lipopolysaccharide were also reduced by small molecules that activate or inhibit the intracellular sensor of energy, AMP-activated protein kinase (AMPK). However, inhibition of mammalian target of rapamycin, which is a more global metabolic sensor than AMPK, had little effect on inflammation. Similarly, endometrial inflammatory responses to lipopolysaccharide were not affected by insulin-like growth factor-1, which is an endocrine regulator of metabolism. Interestingly, the inflammatory responses to lipopolysaccharide increased endometrial glucose consumption and induced the Warburg effect, which could exacerbate deficits in glucose availability in the tissue. In conclusion, metabolic energy stress perturbed inflammatory responses to pathogen-associated molecular patterns in bovine endometrial tissue, and the most fundamental regulators of cellular energy, glucose availability and AMPK, had the greatest impact on innate immunity.	[Turner, Matthew L.; Cronin, James G.; Noleto, Pablo G.; Sheldon, I. Martin] Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales; [Noleto, Pablo G.] Univ Fed Uberlandia, Fac Vet Med, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil	Swansea University; Universidade Federal de Uberlandia	Sheldon, IM (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales.	i.m.sheldon@swansea.ac.uk	Sheldon, I Martin/E-1567-2013	Sheldon, I Martin/0000-0001-7902-5558; Cronin, James/0000-0002-0590-9462; Turner, Matthew/0000-0002-1369-4051; NOLETO, PABLO/0000-0003-1787-951X	Biotechnology and Biological Sciences Research Council [BB/F017596/1, BB/I017240/1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [99999.010219/2014-05]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [486143/2013-9]; BBSRC [BB/I017240/1, BB/F005121/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005121/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Doctoral training for MLT was funded by the Biotechnology and Biological Sciences Research Council (BB/F017596/1), and the work was supported in part by a project grant to IMS funded by the Biotechnology and Biological Sciences Research Council (BB/I017240/1). PGN was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (99999.010219/2014-05) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (486143/2013-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos MR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115972; ARCHBALD LF, 1972, J REPROD FERTIL, V29, P133, DOI 10.1530/jrf.0.0290133; Badinga L, 2002, J DAIRY SCI, V85, P537, DOI 10.3168/jds.S0022-0302(02)74106-4; Borges AM, 2012, AM J REPROD IMMUNOL, V67, P526, DOI 10.1111/j.1600-0897.2012.01106.x; Chagas LM, 2007, J DAIRY SCI, V90, P4022, DOI 10.3168/jds.2006-852; Chamberlain A., 1996, FEEDING DAIRY COW, P28; CHASE CC, 1992, J ANIM SCI, V70, P1496, DOI 10.2527/1992.7051496x; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Esposito G, 2014, ANIM REPROD SCI, V144, P60, DOI 10.1016/j.anireprosci.2013.11.007; Franca MR, 2015, DOMEST ANIM ENDOCRIN, V50, P83, DOI 10.1016/j.domaniend.2014.09.005; Frolova AI, 2011, REPRODUCTION, V142, P211, DOI 10.1530/REP-11-0114; Gabler C, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-152; Giuliodori MJ, 2013, J DAIRY SCI, V96, P3621, DOI 10.3168/jds.2012-5922; Gutierrez CG, 1997, BIOL REPROD, V56, P608, DOI 10.1095/biolreprod56.3.608; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Healey GD, 2016, J IMMUNOL, V196, P823, DOI 10.4049/jimmunol.1501080; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hou XY, 2010, ENDOCRINOLOGY, V151, P2846, DOI 10.1210/en.2009-1032; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Llewellyn S, 2008, DOMEST ANIM ENDOCRIN, V34, P391, DOI 10.1016/j.domaniend.2007.11.003; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Moyes KM, 2009, J DAIRY SCI, V92, P4301, DOI 10.3168/jds.2009-2170; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Rinaldi M, 2008, VET IMMUNOL IMMUNOP, V126, P199, DOI 10.1016/j.vetimm.2008.07.001; Saut JPE, 2014, REPRODUCTION, V148, P593, DOI 10.1530/REP-14-0230; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Turner ML, 2014, ENDOCRINOLOGY, V155, P1453, DOI 10.1210/en.2013-1822; Wathes DC, 2011, REPRODUCTION, V141, P269, DOI 10.1530/REP-10-0177; Wathes DC, 2009, PHYSIOL GENOMICS, V39, P1, DOI 10.1152/physiolgenomics.00064.2009; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	50	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151416	10.1371/journal.pone.0151416	http://dx.doi.org/10.1371/journal.pone.0151416			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974839	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600077
J	Daume, S; Galaz, V				Daume, Stefan; Galaz, Victor			"Anyone Know What Species This Is?" - Twitter Conversations as Embryonic Citizen Science Communities	PLOS ONE			English	Article							SOCIAL MEDIA	Social media like blogs, micro-blogs or social networks are increasingly being investigated and employed to detect and predict trends for not only social and physical phenomena, but also to capture environmental information. Here we argue that opportunistic biodiversity observations published through Twitter represent one promising and until now unexplored example of such data mining. As we elaborate, it can contribute to real-time information to traditional ecological monitoring programmes including those sourced via citizen science activities. Using Twitter data collected for a generic assessment of social media data in ecological monitoring we investigated a sample of what we denote biodiversity observations with species determination requests (N = 191). These entail images posted as messages on the micro-blog service Twitter. As we show, these frequently trigger conversations leading to taxonomic determinations of those observations. All analysed Tweets were posted with species determination requests, which generated replies for 64% of Tweets, 86% of those contained at least one suggested determination, of which 76% were assessed as correct. All posted observations included or linked to images with the overall image quality categorised as satisfactory or better for 81% of the sample and leading to taxonomic determinations at the species level in 71% of provided determinations. We claim that the original message authors and conversation participants can be viewed as implicit or embryonic citizen science communities which have to offer valuable contributions both as an opportunistic data source in ecological monitoring as well as potential active contributors to citizen science programmes.	[Daume, Stefan] Univ Gottingen, Fac Forest Sci & Forest Ecol, Busgenweg 5, D-37077 Gottingen, Germany; [Daume, Stefan; Galaz, Victor] Stockholm Univ, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden; [Daume, Stefan] Swedish Museum Nat Hist, Dept Biodivers Informat, Box 50007, S-10405 Stockholm, Sweden	University of Gottingen; Stockholm University; Swedish Museum of Natural History	Daume, S (corresponding author), Univ Gottingen, Fac Forest Sci & Forest Ecol, Busgenweg 5, D-37077 Gottingen, Germany.; Daume, S (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden.; Daume, S (corresponding author), Swedish Museum Nat Hist, Dept Biodivers Informat, Box 50007, S-10405 Stockholm, Sweden.	stefan.daume@ecoveillance.org		Galaz, Victor/0000-0002-7303-8849	Futura Foundation; Foundation for Strategic Environmental Research (Mistra) through the Stockholm Resilience Centre (Stockholm University); Stockholm Resilience Centre (SRC)	Futura Foundation; Foundation for Strategic Environmental Research (Mistra) through the Stockholm Resilience Centre (Stockholm University); Stockholm Resilience Centre (SRC)	Stefan Daume has no support or funding to report. Victor Galaz's work has been supported by the Futura Foundation, and the Foundation for Strategic Environmental Research (Mistra) through the Stockholm Resilience Centre (Stockholm University).; The idea for this contribution was developed while the first author was staying as a guest researcher at the Stockholm Resilience Centre (SRC), which has generously supported the author with access to an excellent research infrastructure. Victor Galaz's work has been supported by the Futura Foundation and the Foundation for Strategic Environmental Research (Mistra) through the Stockholm Resilience Centre (Stockholm University).	[Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Butt N, 2013, ECOL APPL, V23, P936, DOI 10.1890/11-2059.1; Cha Y, 2015, ENVIRON POLLUT, V198, P97, DOI 10.1016/j.envpol.2014.12.027; Cooper CB, 2007, ECOL SOC, V12; Crall AW, 2011, CONSERV LETT, V4, P433, DOI 10.1111/j.1755-263X.2011.00196.x; Croitoru A., 2014, BIG DATA TECHNIQUES, P207; Crooks A, 2015, INT J GEOGR INF SCI, V29, P720, DOI 10.1080/13658816.2014.977905; Crooks A, 2013, T GIS, V17, P124, DOI 10.1111/j.1467-9671.2012.01359.x; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Darling ES, 2013, IDEAS ECOL EVOL, V6, DOI 10.4033/iee.2013.6.6.f; DAUME S., 2012, ECOVEILLANCE SOCIAL; Daume S, 2014, FOREST ECOL MANAG, V316, P9, DOI 10.1016/j.foreco.2013.09.004; Davies L, 2011, ENVIRON POLLUT, V159, P2203, DOI 10.1016/j.envpol.2011.02.053; De Longueville Bertrand, 2009, P 2009 INT WORKSH LO, P73, DOI [DOI 10.1145/1629890.1629907, 10.1145/1629890.1629907]; Galaz V, 2010, FRONT ECOL ENVIRON, V8, P99, DOI 10.1890/070204; Gardenfors U, 2014, HUM COMPUT, V1, DOI 10.15346/hc.v1i2.6; Gomide J., 2011, P 3 INT WEB SCI C, V3, DOI DOI 10.1145/2527031.2527049; Hill A, 2012, ZOOKEYS, P219, DOI 10.3897/zookeys.209.3472; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Hu H, 2014, IEEE ACCESS, V2, P652, DOI 10.1109/ACCESS.2014.2332453; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kuper Lindsey, 2014, SAW THIS BEAUTIFUL I; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Malcevschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042128; Mykhalovskiy E, 2006, CAN J PUBLIC HEALTH, V97, P42, DOI 10.1007/BF03405213; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Otegui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055144; Qu Y., 2011, P ACM 2011 C COMP SU, P25, DOI DOI 10.1145/1958824.1958830; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; See L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069958; Sheppard S, 2014, P 17 ACM C COMP SUPP, P1234, DOI DOI 10.1145/2531602.2531689; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Smith A, 2012, PEW RES CTR INTERNET; Smith AM, 2011, MON NOT R ASTRON SOC, V412, P1309, DOI 10.1111/j.1365-2966.2010.17994.x; Sobkowicz P, 2012, GOV INFORM Q, V29, P470, DOI 10.1016/j.giq.2012.06.005; Stafford R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014381; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; Vieweg S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1079, DOI 10.1145/1753326.1753486; Wiggins A., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P3426, DOI 10.1109/HICSS.2012.295; Wiggins A., 2011, Proceedings of the 2011 IEEE Seventh International Conference on e-Science Workshops (eScienceW 2011), P14, DOI 10.1109/eScienceW.2011.27; Wood C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001220; Xu KQ, 2012, EXPERT SYST APPL, V39, P13009, DOI 10.1016/j.eswa.2012.05.098	46	28	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151387	10.1371/journal.pone.0151387	http://dx.doi.org/10.1371/journal.pone.0151387			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967526	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200051
J	Seip, KL; Gron, O				Seip, Knut Lehre; Gron, Oyvind			Leading the Game, Losing the Competition: Identifying Leaders and Followers in a Repeated Game	PLOS ONE			English	Article							TRUST; REPUTATION	We explore a new method for identifying leaders and followers, LF, in repeated games by analyzing an experimental, repeated (50 rounds) game where Row player shifts the payoff between small and large values-a type of "investor" and Column player determines who gets the payoff-a type of "manager". We found that i) the Investor (Row) most often is a leading player and the manager (Column) a follower. The longer the Investor leads the game, the higher is both player's payoff. Surprisingly however, it is always the Manager that achieves the largest payoff. ii) The game has an efficient cooperative strategy where the players alternate in receiving a high payoff, but the players never identify, or accept, that strategy. iii) Under the assumption that the information used by the players is closely associated with the leader-follower sequence, and that information is available before the player's decisions are made, the players switched LF-strategy primarily as a function of information on the Investor's investment and moves and secondly as a function of the Manager's payoff.	[Seip, Knut Lehre; Gron, Oyvind] Oslo & Akershus Univ, Fac Technol Art & Design, Coll Appl Sci, Oslo, Norway	Oslo Metropolitan University (OsloMet)	Seip, KL (corresponding author), Oslo & Akershus Univ, Fac Technol Art & Design, Coll Appl Sci, Oslo, Norway.	Knut.lehre.seip@hioa.no			Oslo and Akershus University College for Applied Sciences; ERASMUS grant	Oslo and Akershus University College for Applied Sciences; ERASMUS grant	Oslo and Akershus University College for Applied Sciences provided funding for this research, and an ERASMUS grant provided travel funds for KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Marc Willinger for allowing us to use the data in the study "Mixed strategies in an unprofitable game: an experiment." The study was conducted by Charles N. Noussair, and Marc Willinger. We also thank Marc Willinger for letting one of us (KLS) borrow his office and for introducing KLS to the faculty at Faculte des Sciences Economiques. Universite de Montpellier. While KLS visited the the university, Marc Willinger was unfortunately giving a seminar at another institution, so assistance for the present study had to be through e-mail. The visit was made possible by an ERASMUS grant to Knut L. Seip.	Au WT, 2002, J BEHAV DECIS MAKING, V15, P343, DOI 10.1002/bdm.419; Connelly BL, 2014, J MANAGE, V40, P16, DOI 10.1177/0149206313498902; Dreber A, 2014, J ECON BEHAV ORGAN, V98, P41, DOI 10.1016/j.jebo.2013.12.007; Engle-Warnick J, 2004, J ECON BEHAV ORGAN, V55, P553, DOI 10.1016/j.jebo.2003.11.008; Fudenberg D., 1998, GAME THEORY; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Hermalin BE, 2007, J ECON BEHAV ORGAN, V62, P1, DOI 10.1016/j.jebo.2005.05.005; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lunawat R, 2013, J ECON BEHAV ORGAN, V94, P130, DOI 10.1016/j.jebo.2013.07.018; Martin JM, 2014, J BEHAV DECIS MAKING, V27, P349, DOI 10.1002/bdm.1810; Nie PY, 2011, COMPUT MATH APPL, V61, P2039, DOI 10.1016/j.camwa.2010.08.063; Nie PY, 2007, NONLINEAR ANAL-HYBRI, V1, P548, DOI 10.1016/j.nahs.2006.02.001; Nocera Joe, 2015, NY TIMES; Noussair C, 2012, MIXED STRATEGIES UNP; Seip KL, 2015, THEORETICAL APPL CLI; Seip KL, 2015, HYDROBIOLOGIA, V744, P127, DOI 10.1007/s10750-014-2068-1; Seip KL, 2015, J POLICY MODEL, V37, P281, DOI 10.1016/j.jpolmod.2015.01.012; Shachat J, 2012, MUNICH PERSONAL REPE, P26; Woodford M, 2003, REV ECON STUD, V70, P861, DOI 10.1111/1467-937X.00270	21	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150398	10.1371/journal.pone.0150398	http://dx.doi.org/10.1371/journal.pone.0150398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26968032	gold, Green Published, Green Submitted			2022-12-27	WOS:000371989200011
J	Denion, E; Lux, AL; Mouriaux, F; Beraud, G				Denion, Eric; Lux, Anne-Laure; Mouriaux, Frederic; Beraud, Guillaume			The Sclerotic Scatter Limbal Arc Is More Easily Elicited under Mesopic Rather Than Photopic Conditions	PLOS ONE			English	Article							CONTRAST SENSITIVITY; LIGHT; GLARE; EYE	Introduction We aimed to determine the limbal lighting illuminance thresholds (LLITs) required to trigger perception of sclerotic scatter at the opposite non-illuminated limbus (i.e. perception of a light limbal scleral arc) under different levels of ambient lighting illuminance (ALI). Material and Methods Twenty healthy volunteers were enrolled. The iris shade (light or dark) was graded by retrieving the median value of the pixels of a pre-determined zone of a gray-level iris photograph. Mean keratometry and central corneal pachymetry were recorded. Each subject was asked to lie down, and the ALI at eye level was set to mesopic values (10, 20, 40 lux), then photopic values (60, 80, 100, 150, 200 lux). For each ALI level, a light beam of gradually increasing illuminance was applied to the right temporal limbus until the LLIT was reached, i.e. the level required to produce the faint light arc that is characteristic of sclerotic scatter at the nasal limbus. Results After log-log transformation, a linear relationship between the logarithm of ALI and the logarithm of the LLIT was found (p<0.001), a 10% increase in ALI being associated with an average increase in the LLIT of 28.9%. Higher keratometry values were associated with higher LLIT values (p = 0.008) under low ALI levels, but the coefficient of the interaction was very small, representing a very limited effect. Iris shade and central corneal thickness values were not significantly associated with the LLIT. We also developed a censored linear model for ALI values <= 40 lux, showing a linear relationship between ALI and the LLIT, in which the LLIT value was 34.4 times greater than the ALI value. Conclusion Sclerotic scatter is more easily elicited under mesopic conditions than under photopic conditions and requires the LLIT value to be much higher than the ALI value, i.e. it requires extreme contrast.	[Denion, Eric; Lux, Anne-Laure] CHU Caen, Dept Ophthalmol, F-14000 Caen 9, France; [Denion, Eric] INSERM, COMETE U1075, Caen 9, France; [Denion, Eric; Lux, Anne-Laure] Unicaen, Sch Med, Pole Format & Rech Sante, Caen, France; [Mouriaux, Frederic] CHU Rennes, Serv Ophtalmol, Rennes, France; [Mouriaux, Frederic] Univ Rennes 1, Fac Med, Rennes, France; [Beraud, Guillaume] CHU Poitiers, Med Interne & Malad Infect, Poitiers, France; [Beraud, Guillaume] Univ Droit & Sante Lille 2, EA2694, Lille, France; [Beraud, Guillaume] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium	CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Universite de Franche-Comte; CHU Rennes; Universite de Rennes; CHU Poitiers; Universite de Poitiers; Universite de Lille - ISITE; Universite de Lille; Hasselt University	Denion, E (corresponding author), CHU Caen, Dept Ophthalmol, F-14000 Caen 9, France.; Denion, E (corresponding author), INSERM, COMETE U1075, Caen 9, France.; Denion, E (corresponding author), Unicaen, Sch Med, Pole Format & Rech Sante, Caen, France.	edenion@wanadoo.fr	Mouriaux, Frederic/T-1440-2019; Béraud, Guillaume/O-6062-2017	Béraud, Guillaume/0000-0002-4705-0916				ABRAHAMSSON M, 1986, INVEST OPHTH VIS SCI, V27, P1131; Agarwal A, 2002, TXB OPHTHALMOLOGY BA, P186; Alward WLM, 2001, COLOR ATLAS GONIOSCO; AYOUB MI, 1973, BRIT J OPHTHALMOL, V57, P722, DOI 10.1136/bjo.57.10.722; BARRAQUER JI, 1967, AM J OPHTHALMOL, V63, P90, DOI 10.1016/0002-9394(67)90581-8; Bennett TJ, 2009, CLIN EXP OPHTHALMOL, V37, P2, DOI 10.1111/j.1442-9071.2008.01812.x; Colladon J, 1842, CR HEBD ACAD SCI, V15, P800; CORONEO MT, 1990, OPHTHALMIC SURG LAS, V21, P60; Dahan E, 2011, FREE MED TXB OPHTHAL, P1577; Flynn H, 2003, BASIC CLIN SCI COURS; Gabbard JL, 2006, PRESENCE-TELEOP VIRT, V15, P16, DOI 10.1162/pres.2006.15.1.16; Gatinel D, 2011, CORNEA, V30, P508, DOI 10.1097/ICO.0b013e3181fb4fa7; Graves B, 1924, Br J Ophthalmol, V8, P502, DOI 10.1136/bjo.8.11.502; Graves B, 1936, EYE ITS DIS, P443; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hayashi H, 2003, AM J OPHTHALMOL, V135, P559, DOI 10.1016/S0002-9394(02)01981-5; HEDBLOM EE, 1961, ARCH ENVIRON HEALTH, V2, P685, DOI 10.1080/00039896.1961.10662927; Kanski J., 2007, CLIN OPHTHALMOLOGY S, P1; MALOOF AJ, 1994, INVEST OPHTH VIS SCI, V35, P2592; Martonyi C., 2005, CORNEA, P191; Miller K. M., 2003, BASIC CLIN SCI COURS; Munoz G, 2009, J GLAUCOMA, V18, P262, DOI 10.1097/IJG.0b013e3181812812; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; PAULSSON LE, 1980, INVEST OPHTH VIS SCI, V19, P401; R Core Team, 2021, R LANGUAGE ENV STAT; Rosen ES, 2002, J CATARACT REFR SURG, V28, P203, DOI 10.1016/S0886-3350(01)01326-8; Rosen ES, 2002, J CATARACT REFR SURG, V28, P1433, DOI 10.1016/S0886-3350(01)01350-5; Schwartz G., 2006, EYE EXAM COMPLETE GU, P109; Sliney D, 2000, PTERYGIUM, P29; Sutphin J, 2003, BASIC CLIN SCI COURS; Walland MJ, 1998, OPHTHALMIC SURG LAS, V29, P852	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150314	10.1371/journal.pone.0150314	http://dx.doi.org/10.1371/journal.pone.0150314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964096	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000030
J	Gao, LZ; Gao, CW				Gao, Li-Zhi; Gao, Cheng-Wen			Lowered Diversity and Increased Inbreeding Depression within Peripheral Populations of Wild Rice Oryza rufipogon	PLOS ONE			English	Article							GENETIC-STRUCTURE; ALLOZYME VARIATION; CULTIVATED RICE; SATIVA L.; CONSERVATION; RANGE; POLYMORPHISM; DNA; DIFFERENTIATION; MARKERS	Background The distribution of genetic variability from the interior towards the periphery of a species' range is of great interest to evolutionary biologists. Although it has been long presumed that population genetic variation should decrease as a species' range is approached, results of empirical investigations still remain ambiguous. Knowledge regarding patterns of genetic variability as well as affected factors is particularly not conclusive in plants. Methodology/Principal Findings To determine genetic divergence in peripheral populations of the wild rice Oryza rufipogon Griff. from China, genetic diversity and population structure were studied in five northern & northeastern peripheral and 16 central populations using six microsatellite loci. We found that populations resided at peripheries of the species possessed markedly decreased microsatellite diversity than those located in its center. Population size was observed to be positively correlated with microsatellite diversity. Moreover, there are significantly positive correlations between levels of microsatellite diversity and distances from the northern and northeastern periphery of this species. To investigate genetic structure and heterozygosity variation between generations of O. rufipogon, a total of 2382 progeny seeds from 186 maternal families were further assayed from three peripheral and central populations, respectively. Peripheral populations exhibited significantly lower levels of heterozygosities than central populations for both seed and maternal generations. In comparisons with maternal samples, significantly low observed heterozygosity (HO) and high heterozygote deficit within populations (FIS) values were detected in seed samples from both peripheral and central populations. Significantly lower observed heterozygosity (HO) and higher FIS values were further observed in peripheral populations than those in central populations for seed samples. The results indicate an excess of homozygotes and thus high inbreeding depression in peripheral populations. Conclusions/Significance Our results together suggest that historical contraction of geographical range, demographic changes, and environmental conditions near the northern and northeastern margins of O. rufipogon favor inbreeding and possibly selfing, leading to the rapidly decreased effective population size. Genetic drift, reduced gene flow, and possible local selection, consequently lead to lowered gene diversity, accelerated genetic divergence and increased inbreeding depression found in peripheral populations of O. rufipogon. Given these characteristics observed, northern and northeastern peripheral populations deserve relatively different conservation strategies for either germplasm sampling of ex situ conservation or setting in situ reserves for the adaptation to possible environmental changes and the future germplasm utilization of wild rice.	[Gao, Li-Zhi] Chinese Acad Sci, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species Southwest China, Kunming Inst Bot, Kunming 650204, Peoples R China; [Gao, Cheng-Wen] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650504, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Kunming University of Science & Technology	Gao, LZ (corresponding author), Chinese Acad Sci, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species Southwest China, Kunming Inst Bot, Kunming 650204, Peoples R China.	Lgao@mail.kib.ac.cn			International Foundation for Sciences (IFS) [2378/1, 2378/2]; Project of Innovation Team of Yunnan Province, Talents Program of Yunnan Province [20080A009]; Hundreds Oversea Talents Program of Yunnan Province; Hundreds Talents Program of the Chinese Academy of Sciences (CAS)	International Foundation for Sciences (IFS)(International Foundation for Science); Project of Innovation Team of Yunnan Province, Talents Program of Yunnan Province; Hundreds Oversea Talents Program of Yunnan Province; Hundreds Talents Program of the Chinese Academy of Sciences (CAS)	Support of the research was from International Foundation for Sciences (IFS) (2378/1, 2), Project of Innovation Team of Yunnan Province, Talents Program of Yunnan Province (20080A009), Hundreds Oversea Talents Program of Yunnan Province, and the Hundreds Talents Program of the Chinese Academy of Sciences (CAS) to L.-Z. Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi H, 1996, THEOR APPL GENET, V93, P1071, DOI 10.1007/BF00230127; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; BROWN AHD, 1979, THEOR POPUL BIOL, V15, P1, DOI 10.1016/0040-5809(79)90025-X; Brown James H., 1996, V27, P597; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BRUSSARD PF, 1984, ANNU REV ECOL SYST, V15, P25, DOI 10.1146/annurev.es.15.110184.000325; CARSON HL, 1959, COLD SPRING HARB SYM, V24, P87, DOI 10.1101/SQB.1959.024.01.010; Carter R, 1981, EPIDEMIC MODELS USED; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Eckstein RL, 2006, MOL ECOL, V15, P2367, DOI 10.1111/j.1365-294X.2006.02944.x; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; EXCOFFIER L, 1992, GENETICS, V131, P479; Fazekas AJ, 2001, GENOME, V44, P13, DOI 10.1139/gen-44-1-13; Frankel OH, 1981, CONSERVATION EVOLUTI; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Gao L., 1996, CHINA BIODIVERS, V48, P160; Gao L., 2000, ACTA AGRON SIN, V26, P210; Gao LZ, 2003, GENET RESOUR CROP EV, V50, P17, DOI 10.1023/A:1022933230689; Gao LZ, 2000, HEREDITAS, V133, P47, DOI 10.1111/j.1601-5223.2000.00047.x; Gao LZ, 2000, THEOR APPL GENET, V101, P494, DOI 10.1007/s001220051508; Gapare WJ, 2005, MOL ECOL, V14, P2659, DOI 10.1111/j.1365-294X.2005.02633.x; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Gilpin M.E., 1986, P19; Goudet J, 1996, GENETICS, V144, P1933; Goudet J, 2001, FSTAT PROGRAM WINDOW; Hamrick J. L., 1996, P281; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hoffman EA, 2004, MOL ECOL, V13, P271, DOI 10.1046/j.1365-294X.2003.02057.x; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; HOFFMANN AA, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P165; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; LAGERCRANTZ U, 1990, EVOLUTION, V44, P38, DOI 10.1111/j.1558-5646.1990.tb04278.x; Lammi A, 1999, CONSERV BIOL, V13, P1069, DOI 10.1046/j.1523-1739.1999.98278.x; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; LESICA P, 1992, CONSERV BIOL, V6, P135, DOI 10.1046/j.1523-1739.1992.610135.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Liu FX, 2003, CHINESE SCI BULL, V48, P2068, DOI 10.1360/03wc0287; MANTEL N, 1967, CANCER RES, V27, P209; Maurer B. A, 1994, GEOGRAPHICAL POPULAT; Mayr E, 1970, POPULATIONS SPECIES; McCauley RA, 2002, J TORREY BOT SOC, V129, P311, DOI 10.2307/3088702; Muir G, 2004, ANN BOT-LONDON, V93, P691, DOI 10.1093/aob/mch096; *NAT EXPL GROUP WI, 1984, ACTA AGR SINICA, V6, P1; Pamilo P, 1999, HEREDITAS, V130, P229, DOI 10.1111/j.1601-5223.1999.00229.x; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Pedersen AA, 2001, MOL ECOL, V10, P1133, DOI 10.1046/j.1365-294X.2001.01266.x; Persson H, 2004, PLANT SYST EVOL, V244, P157, DOI 10.1007/s00606-003-0073-3; Podolsky RH, 2001, CONSERV BIOL, V15, P412, DOI 10.1046/j.1523-1739.2001.015002412.x; Rajora OP, 1998, CAN J BOT, V76, P500, DOI 10.1139/cjb-76-3-500; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rowe G, 2003, EVOLUTION, V57, P177; SCHOEN DJ, 1991, EVOLUTION, V45, P1651, DOI [10.1111/j.1558-5646.1991.tb02670.x, 10.2307/2409786]; Schwartz MK, 2003, MOL ECOL, V12, P1807, DOI 10.1046/j.1365-294X.2003.01878.x; Sun CQ, 2001, THEOR APPL GENET, V102, P157, DOI 10.1007/s001220051631; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; TIGERSTEDT PM, 1973, HEREDITAS, V75, P47; TREMBLAY M, 1989, CAN J FOREST RES, V19, P1371, DOI 10.1139/x89-211; Vaughan D. A., 1989, GENUS ORYZA L CURREN; Vaughan D.A., 1994, GENETIC HDB; Volis S, 1998, BIODIVERS CONSERV, V7, P799, DOI 10.1023/A:1008844504010; Vrijenhoek R. C., 1994, V68, P37; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS, 1990, GENETIC DATA ANAL; WU KS, 1993, MOL GEN GENET, V241, P225, DOI 10.1007/BF00280220; YOU X, 1995, HIST RICE CULTIVATIO; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	74	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150468	10.1371/journal.pone.0150468	http://dx.doi.org/10.1371/journal.pone.0150468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963913	gold, Green Published			2022-12-27	WOS:000371993000039
J	Bethke, K; Andrei, V; Rademann, K				Bethke, Kevin; Andrei, Virgil; Rademann, Klaus			Decreasing the Effective Thermal Conductivity in Glass Supported Thermoelectric Layers	PLOS ONE			English	Article							DIFFUSIVE HEAT-CONDUCTION; THIN-FILMS; ORGANIC COMPOSITES; PERFORMANCE; POWER; TRANSPORT; GENERATOR; BULK; OXYTELLURIDE; SIMULATIONS	As thermoelectric devices begin to make their way into commercial applications, the emphasis is put on decreasing the thermal conductivity. In this purely theoretical study, finite element analysis is used to determine the effect of a supporting material on the thermal conductivity of a thermoelectric module. The simulations illustrate the heat transfer along a sample, consisting from Cu, Cu2O and PbTe thermoelectric layers on a 1 mm thick Pyrex glass substrate. The influence of two different types of heating, at a constant temperature and at a constant heat flux, is also investigated. It is revealed that the presence of a supporting material plays an important role on lowering the effective thermal conductivity of the layer-substrate ensemble. By using thinner thermoelectric layers the effective thermal conductivity is further reduced, almost down to the value of the glass substrate. As a result, the temperature gradient becomes steeper for a fixed heating temperature, which allows the production of devices with improved performance under certain conditions. Based on the simulation results, we also propose a model for a robust thin film thermoelectric device. With this suggestion, we invite the thermoelectric community to prove the applicability of the presented concept for practical purposes.	[Bethke, Kevin; Andrei, Virgil; Rademann, Klaus] Humboldt Univ, Dept Chem, D-10099 Berlin, Germany	Humboldt University of Berlin	Rademann, K (corresponding author), Humboldt Univ, Dept Chem, D-10099 Berlin, Germany.	klaus.rademann@chemie.hu-berlin.de		Andrei, Virgil/0000-0002-6914-4841; Bethke, Kevin/0000-0002-0528-8635	International Max-Planck Research School at the Fritz Haber Institute; Gesellschaft Deutscher Chemiker; German Federal Government; Bayer Foundations	International Max-Planck Research School at the Fritz Haber Institute; Gesellschaft Deutscher Chemiker; German Federal Government; Bayer Foundations	K.B. is most grateful for the scholarship from the International Max-Planck Research School at the Fritz Haber Institute. V.A. is most grateful to the Gesellschaft Deutscher Chemiker for the August-Wilhelm-von-Hofmann-Scholarship and to the German Federal Government and the Bayer Foundations for the "Deutschlandstipendium" scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Melanie Nossler (COMSOL) for support and helpful discussions. K.B. is most grateful for the scholarship from the International Max-Planck Research School at the Fritz Haber Institute. V.A. is most grateful to the Gesellschaft Deutscher Chemiker for the August-Wilhelm-von-Hofmann-Scholarship and to the German Federal Government and the Bayer Foundations for the "Deutschlandstipendium" scholarship.	Agrawal N, 2007, ANGEW CHEM INT EDIT, V46, P4316, DOI 10.1002/anie.200700306; Amasia M, 2012, SENSOR ACTUAT B-CHEM, V161, P1191, DOI 10.1016/j.snb.2011.11.080; Andrei V, 2016, PHYS CHEM CHEM PHYS, V18, P10700, DOI 10.1039/c5cp06828b; Andrei V, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4903832; Apertet Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4897350; Baranowski LL, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807314; Belytschko T, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/4/043001; Bentley RE, 1998, HD TEMPERATURE MEASU, V3; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Bosbach WA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143011; Boukai AI, 2008, NATURE, V451, P168, DOI 10.1038/nature06458; Cahill DG, 2003, J APPL PHYS, V93, P793, DOI 10.1063/1.1524305; Cahill DG, 2004, REV SCI INSTRUM, V75, P5119, DOI 10.1063/1.1819431; Chani MTS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095287; Chen G, 1998, PHYS REV B, V57, P14958, DOI 10.1103/PhysRevB.57.14958; Christensen M, 2008, NAT MATER, V7, P811, DOI 10.1038/nmat2273; CUSACK N, 1958, P PHYS SOC LOND, V72, P898, DOI 10.1088/0370-1328/72/5/429; De Bellis L, 2000, J THERMOPHYS HEAT TR, V14, P144; Dong Y, 2015, PHYSICA E, V66, P1, DOI 10.1016/j.physe.2014.09.011; Dong Y, 2014, PHYSICA E, V56, P256, DOI 10.1016/j.physe.2013.10.006; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Endrodi B, 2014, RSC ADV, V4, P55328, DOI 10.1039/c4ra09037c; Endrodi B, 2015, J POLYM SCI POL PHYS, V53, P1507, DOI 10.1002/polb.23782; Endrodi B, 2015, J PHYS CHEM C, V119, P8472, DOI 10.1021/acs.jpcc.5b00135; Fleurial JP, 2009, JOM-US, V61, P79, DOI 10.1007/s11837-009-0057-z; Freeman DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047822; Hartung D, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4923031; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; Hogblom O, 2014, J ELECTRON MATER, V43, P2247, DOI 10.1007/s11664-014-3020-x; Holgate TC, 2014, J ALLOY COMPD, V582, P827, DOI 10.1016/j.jallcom.2013.08.096; Hu XK, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4916545; Hua YC, 2016, INT J THERM SCI, V101, P126, DOI 10.1016/j.ijthermalsci.2015.10.037; Hua YC, 2014, INT J HEAT MASS TRAN, V78, P755, DOI 10.1016/j.ijheatmasstransfer.2014.07.037; Huber TE, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816621; Jood P, 2014, RSC ADV, V4, P6363, DOI 10.1039/c3ra46813e; Kim SJ, 2014, ENERG ENVIRON SCI, V7, P1959, DOI 10.1039/c4ee00242c; Komine T, 2010, J ELECTRON MATER, V39, P1606, DOI 10.1007/s11664-010-1266-5; Kraemer D, 2011, NAT MATER, V10, P532, DOI [10.1038/NMAT3013, 10.1038/nmat3013]; Kuhn R, 2015, MATER TODAY-PROC, V2, P761, DOI 10.1016/j.matpr.2015.05.096; Kurosaki K, 2013, PHYS STATUS SOLIDI A, V210, P82, DOI 10.1002/pssa.201228680; LaLonde AD, 2011, MATER TODAY, V14, P526, DOI 10.1016/S1369-7021(11)70278-4; Lan JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07783; Landry ES, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165304; Lee Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4640; Liebl H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116907; LIEBL J., 2009, MTZ MOTORTECHNISCHE, V70, P272, DOI DOI 10.1007/BF03225479; Losego MD, 2012, NAT MATER, V11, P502, DOI [10.1038/NMAT3303, 10.1038/nmat3303]; Loureiro J, 2014, J MATER CHEM A, V2, P6649, DOI 10.1039/c3ta15052f; Loureiro J, 2014, J MATER CHEM A, V2, P6456, DOI 10.1039/c3ta15168a; Luu SDN, 2015, J SOLID STATE CHEM, V226, P219, DOI 10.1016/j.jssc.2015.02.026; Matoso RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111192; Meng XN, 2015, J ELECTRON MATER, V44, P1469, DOI 10.1007/s11664-014-3418-5; Mitdank R, 2012, J APPL PHYS, V111, DOI 10.1063/1.4721896; Music D, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864078; Pei YZ, 2012, ADV MATER, V24, P6125, DOI 10.1002/adma.201202919; POLLACK GL, 1969, REV MOD PHYS, V41, P48, DOI 10.1103/RevModPhys.41.48; Prasher RS, 2001, J HEAT TRANS-T ASME, V123, P105, DOI 10.1115/1.1338138; Qiu B, 2012, COMP MATER SCI, V53, P278, DOI 10.1016/j.commatsci.2011.08.016; Reddy P, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2133890; Rodriguez-Barreiro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056358; Rowe DM, 1995, CRC HDB THERMOELECTR; Sharma R., 2015, Journal of the Institution of Engineers (India): Series C (Mechanical, Production, Aerospace and Marine Engineering), V96, P73, DOI 10.1007/s40032-014-0125-1; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Sondergaard M, 2013, ACTA MATER, V61, P3314, DOI 10.1016/j.actamat.2013.02.021; Sootsman JR, 2009, ANGEW CHEM INT EDIT, V48, P8616, DOI 10.1002/anie.200900598; SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605; Takahashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01501; Thiel P, 2013, J APPL PHYS, V114, DOI 10.1063/1.4854475; Vaqueiro P, 2013, J MATER CHEM A, V1, P520, DOI 10.1039/c2ta00878e; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Vogel-Schauble N, 2012, THIN SOLID FILMS, V520, P6869, DOI 10.1016/j.tsf.2012.07.046; Vogt W., 1930, ANN PHYS, V399, P183, DOI [10.1002/andp.19303990204, DOI 10.1002/ANDP.19303990204]; Walia S, 2013, PROG MATER SCI, V58, P1443, DOI 10.1016/j.pmatsci.2013.06.003; Wan CL, 2015, NAT MATER, V14, P622, DOI [10.1038/nmat4251, 10.1038/NMAT4251]; Wang Z, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/12/125707; Weidemann S, 2015, J NANOMATER, V2015, DOI 10.1155/2015/672305; Wilson RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6075; Xu B, 2014, J APPL PHYS, V115, DOI 10.1063/1.4881781; Yu C, 2011, ACS NANO, V5, P7885, DOI 10.1021/nn202868a; Yuan GD, 2012, J PHYS CHEM C, V116, P13767, DOI 10.1021/jp212427g; Zhang JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140567; Zhang K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03448; Zhang Q, 2014, ADV MATER, V26, P6829, DOI 10.1002/adma.201305371; Zhao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07671; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184; Zhao WY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7197; Zhou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08099; Zhou WX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07150	88	11	11	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151708	10.1371/journal.pone.0151708	http://dx.doi.org/10.1371/journal.pone.0151708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982458	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900116
J	Hillary, CJ; Roman, S; Bullock, AJ; Green, NH; Chapple, CR; MacNeil, S				Hillary, Christopher J.; Roman, Sabiniano; Bullock, Anthony J.; Green, Nicola H.; Chapple, Christopher R.; MacNeil, Sheila			Developing Repair Materials for Stress Urinary Incontinence to Withstand Dynamic Distension	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; BIOMECHANICAL PROPERTIES; TISSUE; COMPLICATIONS; SCAFFOLDS; FASCIA; WOMEN; MESH	Background Polypropylene mesh used as a mid-urethral sling is associated with severe clinical complications in a significant minority of patients. Current in vitro mechanical testing shows that polypropylene responds inadequately to mechanical distension and is also poor at supporting cell proliferation. Aims and Objectives Our objective therefore is to produce materials with more appropriate mechanical properties for use as a sling material but which can also support cell integration. Methods Scaffolds of two polyurethanes (PU), poly-L-lactic acid (PLA) and co-polymers of the two were produced by electrospinning. Mechanical properties of materials were assessed and compared to polypropylene. The interaction of adipose derived stem cells (ADSC) with the scaffolds was also assessed. Uniaxial tensiometry of scaffolds was performed before and after seven days of cyclical distension. Cell penetration (using DAPI and a fluorescent red cell tracker dye), viability (AlamarBlue assay) and total collagen production (Sirius red assay) were measured for ADSC cultured on scaffolds. Results Polypropylene was stronger than polyurethanes and PLA. However, polypropylene mesh deformed plastically after 7 days of sustained cyclical distention, while polyurethanes maintained their elasticity. Scaffolds of PU containing PLA were weaker and stiffer than PU or polypropylene but were significantly better than PU scaffolds alone at supporting ADSC. Conclusions Therefore, prolonged mechanical distension in vitro causes polypropylene to fail. Materials with more appropriate mechanical properties for use as sling materials can be produced using PU. Combining PLA with PU greatly improves interaction of cells with this material.	[Hillary, Christopher J.; Roman, Sabiniano; Bullock, Anthony J.; Green, Nicola H.; MacNeil, Sheila] Univ Sheffield, Kroto Res Inst, Broad Lane, Sheffield, S Yorkshire, England; [Hillary, Christopher J.; Chapple, Christopher R.] Royal Hallamshire Hosp, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield	MacNeil, S (corresponding author), Univ Sheffield, Kroto Res Inst, Broad Lane, Sheffield, S Yorkshire, England.	s.macneil@sheffield.ac.uk	Green, Nicola/K-4674-2019; Bullock, Anthony/AAC-2773-2021	Green, Nicola/0000-0001-5413-0642; Bullock, Anthony/0000-0003-0579-3997; Roman Regueros, Sabiniano/0000-0002-2368-7955; Chapple, Christopher/0000-0002-2960-9931	TRUST European Marie Curie Network; Urology Foundation Scholarship; Robert Luff Foundation; Rosetrees Trust [M293-F1] Funding Source: researchfish	TRUST European Marie Curie Network; Urology Foundation Scholarship; Robert Luff Foundation; Rosetrees Trust(Rosetrees Trust)	This work was supported by a grant from the TRUST European Marie Curie Network, The Urology Foundation Scholarship 2015 (CH) and the Robert Luff Foundation (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the TRUST European Marie Curie Network, The Urology Foundation and the Robert Luff Foundation.	Abdel-fattah M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000206; Abed H, 2011, INT UROGYNECOL J, V22, P789, DOI 10.1007/s00192-011-1384-5; Aboushwareb T, 2011, NEUROUROL URODYNAM, V30, P775, DOI 10.1002/nau.21101; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Bergmeister H, 2015, ACTA BIOMATER, V11, P104, DOI 10.1016/j.actbio.2014.09.003; Boennelycke M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.020; Brubaker L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.011; Bye FJ, 2013, BIOMATER SCI-UK, V1, P942, DOI 10.1039/c3bm60074b; Claerhout F, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.032; Gigliobianco G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/968087; Guerrero KL, 2010, BJOG-INT J OBSTET GY, V117, P1493, DOI 10.1111/j.1471-0528.2010.02696.x; Hung MJ, 2010, INT UROGYNECOL J, V21, P1085, DOI 10.1007/s00192-010-1168-3; Jackson WM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt111; Jones R, 2010, NEUROUROL URODYNAM, V29, P40, DOI 10.1002/nau.20851; Kruger JA, 2015, NEUROUROL URODYNAM, V34, P133, DOI 10.1002/nau.22537; Lei LL, 2007, INT UROGYNECOL J, V18, P603, DOI 10.1007/s00192-006-0214-7; Li XX, 2014, J MECH BEHAV BIOMED, V37, P48, DOI 10.1016/j.jmbbm.2014.05.005; Mangera A, 2013, BJU INT, V112, P674, DOI 10.1111/bju.12186; Mangera A, 2012, NEUROUROL URODYNAM, V31, P13, DOI 10.1002/nau.21156; Manodoro S, 2013, BJOG-INT J OBSTET GY, V120, P244, DOI 10.1111/1471-0528.12081; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; McBride AW, 2005, AM J OBSTET GYNECOL, V192, P1677, DOI 10.1016/j.ajog.2005.01.078; McGuire E J, 1981, Prog Clin Biol Res, V78, P351; Petros PEP, 1990, ACTA OBSTET GYN SCAN, V69, P7, DOI 10.1111/j.1600-0412.1990.tb08027.x; Petros PEP, 1990, ACTA OBSTET GYN SCAN, V69, P53, DOI 10.1111/j.1600-0412.1990.tb08032.x; Regueros SR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/853610; Roman S, 2014, NEUROUROL URODYNAM, V33, P531, DOI 10.1002/nau.22443; Takanari K, 2016, J TISSUE ENG REGEN M, V10, P748, DOI 10.1002/term.1834; Woodruff AJ, 2008, UROLOGY, V72, P85, DOI 10.1016/j.urology.2008.03.012	29	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149971	10.1371/journal.pone.0149971	http://dx.doi.org/10.1371/journal.pone.0149971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981860	Green Published, Green Accepted, gold			2022-12-27	WOS:000372574900022
J	Ibanez, C; Criscioni, P; Arriaga, H; Merino, P; Espinos, FJ; Fernandez, C				Ibanez, Carla; Criscioni, Patricia; Arriaga, Haritz; Merino, Pilar; Juan Espinos, Francisco; Fernandez, Carlos			Murciano-Granadina Goat Performance and Methane Emission after Replacing Barley Grain with Fibrous By-Products	PLOS ONE			English	Article							MANURE-DERIVED METHANE; CHAIN FATTY-ACIDS; DAIRY-COWS; MILK; ENERGY; LACTATION; NITROGEN; METABOLISM; BIOMARKERS; OXIDATION	The aim of this experiment was to study the effects of substituting dietary barley grain with orange pulp or soybean hulls on energy, nitrogen and carbon balance, methane emission and milk performance in dairy goats. Twelve Murciano-Granadina dairy goats in midlactation were selected and divided into three groups based on similar body weight (42.1 +/- 1.2 kg) and milk yield (2.16 +/- 0.060 kg/goat/day). The experiment was conducted in an incomplete crossover design where one group of four goats was fed a mixed ration of barley grain (BRL), another group of four goats replaced barley grain with orange pulp (OP) and the last group of four goats with soybean hulls (SH). After adaptation to diets, the goats were allocated to individual metabolism cages and intake, faeces, urine and milk were recorded and analysed. Then, gas exchange measurements were recorded by a mobile open-circuit indirect calorimetry system using a head box. Dry matter intake was similar for all three groups (2.03 kg/d, on average). No influence of the diet was observed for energy balance and the efficiency of use of metabolizable energy for milk production was 0.61. The OP and SH diets showed greater (P < 0.05) fat mobilization (-42.8 kJ/kg of BW0.75, on average) than BRL (19.2 kJ/kg of BW0.75). Pentadecanoic acid (15: 0) and heptadecanoic acid (17: 0) were potential biomarkers of rumen function because the higher contents found in the milk of OP and SH goats than BRL suggest a negative impact of these diets on rumen bacterial metabolism; probably linked to the lower nitrogen supply of diet OP to synthesize microbial protein and greater content of fat in diet SH. Replacement of cereal grain with fibrous by-products did not increased enteric methane emissions (54.7 L/goat per day, on average). Therefore, lactating goats could utilize dry orange pulp and soybean hulls diets with no detrimental effect on milk performance.	[Ibanez, Carla] Univ Catolica Valencia, Dept Prod Anim & Salud Publ, Fac Vet & Ciencias Expt, Valencia 46001, Spain; [Criscioni, Patricia; Juan Espinos, Francisco; Fernandez, Carlos] Univ Politecn Valencia, Dept Anim Sci, Res Ctr ACUMA, Valencia 46022, Spain; [Arriaga, Haritz; Merino, Pilar] NEIKER Tecnalia, Environm Qual Dept, Bizkaia Technol Pk,P 812, Derio 48160, Bizkaia, Spain	Universidad Catolica de Valencia San Vicente Martir; Universitat Politecnica de Valencia	Fernandez, C (corresponding author), Univ Politecn Valencia, Dept Anim Sci, Res Ctr ACUMA, Valencia 46022, Spain.	cjfernandez@dca.upv.es	Fernández, Carlos Javier/I-4027-2015; Merino, Pilar/K-4555-2014	Fernández, Carlos Javier/0000-0002-0368-0158; Merino, Pilar/0000-0002-5242-5479; IBANEZ SANCHIS, CARLA/0000-0001-5280-2740; Arriaga, Haritz/0000-0002-7552-0735	Spanish National Institute for Agronomic Research [RTA2011-00107-C02]; European Regional Development Fund (ERDF)	Spanish National Institute for Agronomic Research; European Regional Development Fund (ERDF)(European Commission)	This study was supported by the Spanish National Institute for Agronomic Research (RTA2011-00107-C02) and the European Regional Development Fund (ERDF).	AFRC, 1993, ENERGY PROTEIN REQUI; AGUILERA JF, 1990, BRIT J NUTR, V63, P165, DOI 10.1079/BJN19900104; AGUILERA JF, 1986, ARCH TIERERNAHR, V36, P1009, DOI 10.1080/17450398609429522; Angelidaki Irini, 2004, Reviews in Environmental Science and Bio/Technology, V3, P117, DOI 10.1007/s11157-004-2502-3; [Anonymous], 2006, IPCC GUIDELINES NATL; [Anonymous], 2001, US GUID VERS 8 02; AOAC, 2000, OFFICIAL METHODS ANA, V17th; BATEY IL, 1982, STARKE, V34, P125, DOI 10.1002/star.19820340407; Bava L, 2001, J DAIRY SCI, V84, P2450, DOI 10.3168/jds.S0022-0302(01)74695-4; BROCKWAY JM, 1971, J APPL PHYSIOL, V31, P296, DOI 10.1152/jappl.1971.31.2.296; Brouwer E., 1958, EAAP PUBLICATION, P182; Brouwer E., 1965, EAAP PUB, V11, P441, DOI DOI 10.4236/NS.2011.312129; Casper DP, 1999, J DAIRY SCI, V82, P1779, DOI 10.3168/jds.S0022-0302(99)75408-1; Chilliard Y, 2003, J DAIRY SCI, V86, P1751, DOI 10.3168/jds.S0022-0302(03)73761-8; Chwalibog A, 1997, Z ERNAHRUNGSWISS, V36, P313, DOI 10.1007/BF01617806; de Bias C, 2010, TABL FEDNA COMP VAL; Fahey G. C., 1988, RUMINANT ANIMAL DIGE, P269; Fernandez C, 2015, J AGR SCI-CAMBRIDGE, V153, P1302, DOI 10.1017/S0021859615000416; Fernandez C, 2012, ANIM FEED SCI TECH, V172, P242, DOI 10.1016/j.anifeedsci.2012.01.006; Fievez V, 2012, ANIM FEED SCI TECH, V172, P51, DOI 10.1016/j.anifeedsci.2011.12.008; Godbout S, 2010, ENVIRON TECHNOL, V31, P1371, DOI 10.1080/09593331003743096; Gonzalez-Avalos E, 2001, BIORESOURCE TECHNOL, V80, P63, DOI 10.1016/S0960-8524(01)00052-9; GRASSER LA, 1995, J DAIRY SCI, V78, P962, DOI 10.3168/jds.S0022-0302(95)76711-X; Hellwing ALF, 2014, LIVEST SCI, V165, P189, DOI 10.1016/j.livsci.2014.04.011; Jarret G, 2011, LIVEST SCI, V140, P275, DOI 10.1016/j.livsci.2011.04.006; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Jorjong S, 2015, J DAIRY SCI, V98, P5211, DOI 10.3168/jds.2014-8728; Jouany J. P., 1982, SCI ALIMENTS, V2, P131; Kebreab E, 2010, PUBL EAAP, P417; Klevenhusen F, 2011, ANIMAL, V5, P450, DOI 10.1017/S1751731110001795; Knapp JR, 2014, J DAIRY SCI, V97, P3231, DOI 10.3168/jds.2013-7234; Lopez MC, 2013, J DAIRY SCI, V96, P4542, DOI 10.3168/jds.2012-6473; McLean JA, 1990, ANIMAL HUMAN CALORIM; Mertens DR, 2002, J AOAC INT, V85, P1217; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; PALMQUIST DL, 1980, J DAIRY SCI, V63, P1, DOI 10.3168/jds.S0022-0302(80)82881-5; Robertson J.B., 1981, ANAL DIETARY FIBER F, V123, DOI DOI 10.1016/S0031-9384(00)00286-9; Spek JW, 2013, J AGR SCI-CAMBRIDGE, V151, P407, DOI 10.1017/S0021859612000561; Tovar-Luna I, 2010, J DAIRY SCI, V93, P4818, DOI 10.3168/jds.2010-3315; Triolo JM, 2011, BIORESOURCE TECHNOL, V102, P9395, DOI 10.1016/j.biortech.2011.07.026; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; van Knegsel ATM, 2007, J DAIRY SCI, V90, P1467, DOI 10.3168/jds.S0022-0302(07)71632-6; Vasta V, 2008, ANIM FEED SCI TECH, V147, P223, DOI 10.1016/j.anifeedsci.2007.09.020; Vedrenne F, 2008, BIORESOURCE TECHNOL, V99, P146, DOI 10.1016/j.biortech.2006.11.043; Velthof GL, 2005, J ENVIRON QUAL, V34, P698, DOI 10.2134/jeq2005.0698; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Vlaeminck B, 2015, J DAIRY SCI, V98, P4829, DOI 10.3168/jds.2014-9207	48	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151215	10.1371/journal.pone.0151215	http://dx.doi.org/10.1371/journal.pone.0151215			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983120	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900070
J	Zhou, SJ; Tanaka, K; O'Keeffe, M; Qi, M; El-Assaad, F; Weaver, JC; Chen, G; Weatherall, C; Wang, Y; Giannakopoulos, B; Chen, LM; Yu, D; Hamilton, MJ; Wensing, LA; Stevens, RL; Krilis, SA				Zhou, Saijun; Tanaka, Kumiko; O'Keeffe, Meredith; Qi, Miao; El-Assaad, Fatima; Weaver, James C.; Chen, Gang; Weatherall, Christopher; Wang, Ying; Giannakopoulos, Bill; Chen, Liming; Yu, DeMint; Hamilton, Matthew J.; Wensing, Lislaine A.; Stevens, Richard L.; Krilis, Steven A.			CD117(+) Dendritic and Mast Cells Are Dependent on RasGRP4 to Function as Accessory Cells for Optimal Natural Killer Cell-Mediated Responses to Lipopolysaccharide	PLOS ONE			English	Article							NUCLEOTIDE-RELEASING PROTEIN-4; SULFATE-E-PROTEOGLYCAN; C-KIT; MOLECULAR-CLONING; NK CELL; SIGNALING PROTEIN; SERINE-PROTEASE; TYROSINE KINASE; MOUSE; RECEPTOR	Ras guanine nucleotide-releasing protein-4 (RasGRP4) is an evolutionarily conserved calcium-regulated, guanine nucleotide exchange factor and diacylglycerol/phorbol ester receptor. While an important intracellular signaling protein for CD117(+) mast cells (MCs), its roles in other immune cells is less clear. In this study, we identified a subset of in vivo-differentiated splenic CD117(+) dendritic cells (DCs) in wild-type (WT) C57BL/6 mice that unexpectedly contained RasGRP4 mRNA and protein. In regard to the biologic significance of these data to innate immunity, LPS-treated splenic CD117(+) DCs from WT mice induced natural killer (NK) cells to produce much more interferon-gamma (IFN-gamma) than comparable DCs from RasGRP4-null mice. The ability of LPS-responsive MCs to cause NK cells to increase their expression of IFN-gamma was also dependent on this intracellular signaling protein. The discovery that RasGRP4 is required for CD117(+) MCs and DCs to optimally induce acute NK cell-dependent immune responses to LPS helps explain why this signaling protein has been conserved in evolution.	[Zhou, Saijun; Tanaka, Kumiko; Qi, Miao; El-Assaad, Fatima; Weaver, James C.; Chen, Gang; Weatherall, Christopher; Wang, Ying; Giannakopoulos, Bill; Stevens, Richard L.; Krilis, Steven A.] Univ New S Wales, St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia; [Zhou, Saijun; Tanaka, Kumiko; Qi, Miao; El-Assaad, Fatima; Weaver, James C.; Chen, Gang; Weatherall, Christopher; Wang, Ying; Giannakopoulos, Bill; Stevens, Richard L.; Krilis, Steven A.] Univ New S Wales, Fac Med, St George & Sutherland Clin Sch, Sydney, NSW, Australia; [Zhou, Saijun; Chen, Liming; Yu, DeMint] Tianjin Med Univ, Lab Hormones & Dev, Metab Hosp, Minist Hlth, Tianjin, TJ, Peoples R China; [Zhou, Saijun; Chen, Liming; Yu, DeMint] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, TJ, Peoples R China; [O'Keeffe, Meredith] Burnet Inst, Dendrit Cell Res Lab, Immun Vaccines & Immunisat, Prahran, Vic, Australia; [Weaver, James C.] St George Hosp, Dept Cardiol, Sydney, NSW, Australia; [Hamilton, Matthew J.; Stevens, Richard L.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Hamilton, Matthew J.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Wensing, Lislaine A.] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil	St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Tianjin Medical University; Tianjin Medical University; Burnet Institute; St George Hospital; University of Newcastle; Harvard University; Brigham & Women's Hospital; Universidade de Sao Paulo	Krilis, SA (corresponding author), Univ New S Wales, St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia.; Krilis, SA (corresponding author), Univ New S Wales, Fac Med, St George & Sutherland Clin Sch, Sydney, NSW, Australia.	s.krilis@unsw.edu.au	O'Keeffe, Meredith/U-9347-2017	O'Keeffe, Meredith/0000-0002-0779-4654	National Health and Medical Research Council of Australia [630402]; USA National Institutes of Health [DK09497]; Mastocytosis Society of the United States; St George and Sutherland Medical Research Foundation; University of New South Wales; Fundacao de Amparo a Pesquisa do Estado de Sao-FAPESP [2015/11868-7]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK094971] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mastocytosis Society of the United States; St George and Sutherland Medical Research Foundation; University of New South Wales; Fundacao de Amparo a Pesquisa do Estado de Sao-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/), #630402: SK; USA National Institutes of Health (http://www.nih.gov/), DK09497, and the Mastocytosis Society of the United States (http://www.tmsforacure.org/welcome.php): RLS; and St George and Sutherland Medical Research Foundation (http://www.stgeorgemrf.com.au/): RLS. FE-A obtained a Vice Chancellors Fellowship grant from the University of New South Wales (https://www.unsw.edu.au/). LAW obtained a Fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao-FAPESP, (http://www.fapesp.br/en/), 2015/11868-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Fogel-Petrovic M, 2004, IMMUNOL CELL BIOL, V82, P47, DOI 10.1111/j.1440-1711.2004.01213.x; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; GHILDYAL N, 1992, J IMMUNOL, V149, P2123; Hansbro PM, 2014, J BIOL CHEM, V289, P18214, DOI 10.1074/jbc.M114.548594; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; Katsoulotos GP, 2008, J BIOL CHEM, V283, P1610, DOI 10.1074/jbc.M707042200; Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835; Kono M, 2015, ARTHRITIS RHEUMATOL, V67, P396, DOI 10.1002/art.38924; Li LX, 2003, J IMMUNOL, V171, P390, DOI 10.4049/jimmunol.171.1.390; Li LX, 2003, J BIOL CHEM, V278, P4725, DOI 10.1074/jbc.C200635200; Li LX, 2002, MOL IMMUNOL, V38, P1283, DOI 10.1016/S0161-5890(02)00076-7; Marcenaro E, 2012, ADV EXP MED BIOL, V946, P295, DOI 10.1007/978-1-4614-0106-3_17; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; METZGER H, 1982, FED PROC, V41, P8; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Pulendran B, 1997, J IMMUNOL, V159, P2222; Ray P, 2010, ANN NY ACAD SCI, V1183, P104, DOI 10.1111/j.1749-6632.2009.05122.x; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; RAZIN E, 1984, J IMMUNOL, V132, P1479; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907; Stevens Richard L, 2005, Novartis Found Symp, V271, P54; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Tang SQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5657; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Trong H Le, 1989, BIOCHEMISTRY-US, V28, P391, DOI 10.1021/BI00427A054; Varma TK, 2002, CLIN DIAGN LAB IMMUN, V9, P530, DOI 10.1128/CDLI.9.3.530-543.2002; Vosskuhl K, 2010, J IMMUNOL, V185, P119, DOI 10.4049/jimmunol.0902406; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580	53	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151638	10.1371/journal.pone.0151638	http://dx.doi.org/10.1371/journal.pone.0151638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982501	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900106
J	Chen, QF; Chen, HJ; Liu, J; Sun, T; Shen, QT				Chen, Qiu-Feng; Chen, Hua-Jun; Liu, Jun; Sun, Tao; Shen, Qun-Tai			Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL GLUCOSE-METABOLISM; ANTERIOR CINGULATE CORTEX; HBV-RELATED CIRRHOSIS; NEURAL MECHANISM; DIAGNOSIS; ABNORMALITIES; SPECTROSCOPY; IMPAIRMENT; PREDICTION	Machine learning-based approaches play an important role in examining functional magnetic resonance imaging (fMRI) data in a multivariate manner and extracting features predictive of group membership. This study was performed to assess the potential for measuring brain intrinsic activity to identify minimal hepatic encephalopathy (MHE) in cirrhotic patients, using the support vector machine (SVM) method. Resting-state fMRI data were acquired in 16 cirrhotic patients with MHE and 19 cirrhotic patients without MHE. The regional homogeneity (ReHo) method was used to investigate the local synchrony of intrinsic brain activity. Psychometric Hepatic Encephalopathy Score (PHES) was used to define MHE condition. SVM-classifier was then applied using leave-one-out cross-validation, to determine the discriminative ReHo-map for MHE. The discrimination map highlights a set of regions, including the prefrontal cortex, anterior cingulate cortex, anterior insular cortex, inferior parietal lobule, precentral and postcentral gyri, superior and medial temporal cortices, and middle and inferior occipital gyri. The optimized discriminative model showed total accuracy of 82.9% and sensitivity of 81.3%. Our results suggested that a combination of the SVM approach and brain intrinsic activity measurement could be helpful for detection of MHE in cirrhotic patients.	[Chen, Qiu-Feng; Shen, Qun-Tai] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Chen, Hua-Jun; Liu, Jun; Sun, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing 210029, Jiangsu, Peoples R China	Central South University; Nanjing Medical University	Chen, QF (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China.; Chen, HJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing 210029, Jiangsu, Peoples R China.	chenqiufeng0204@126.com; chj0075@126.com			Priority Academic Program Development of Jiangsu Higher Education Institutions [JX 10231801]; National Natural Science Foundation of China [81501450]; China Postdoctoral Science Foundation	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX 10231801), a grant from the National Natural Science Foundation of China (No. 81501450), and the Project Funded by China Postdoctoral Science Foundation.	Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen HJ, 2015, AM J NEURORADIOL, V36, P481, DOI 10.3174/ajnr.A4146; Chen HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089684; Chen HJ, 2013, RADIOLOGY, V266, P261, DOI 10.1148/radiol.12120026; Chen HJ, 2012, J NEUROL SCI, V318, P140, DOI 10.1016/j.jns.2012.02.019; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; Dhiman RK, 2010, DIGEST DIS SCI, V55, P2381, DOI 10.1007/s10620-010-1249-7; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Kato A, 2000, HEPATOL RES, V17, P237, DOI 10.1016/S1386-6346(99)00080-7; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Li SW, 2013, WORLD J GASTROENTERO, V19, P8745, DOI 10.3748/wjg.v19.i46.8745; Lockwood AH, 2002, METAB BRAIN DIS, V17, P431, DOI 10.1023/A:1021978422783; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Lv XF, 2013, METAB BRAIN DIS, V28, P485, DOI 10.1007/s11011-013-9420-4; Lv XF, 2013, LIVER INT, V33, P375, DOI 10.1111/liv.12096; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Montagnese S, 2007, J HEPATOL, V46, P447, DOI 10.1016/j.jhep.2006.10.015; Nakanishi H, 2014, HEPATOL RES, V44, P319, DOI 10.1111/hepr.12127; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Saxena N, 2002, LIVER, V22, P190, DOI 10.1034/j.1600-0676.2002.01431.x; Seo YS, 2012, J GASTROEN HEPATOL, V27, P1695, DOI 10.1111/j.1440-1746.2012.07217.x; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053206; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x	42	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151263	10.1371/journal.pone.0151263	http://dx.doi.org/10.1371/journal.pone.0151263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978777	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800055
J	Dou, FG; Soriano, J; Tabien, RE; Chen, K				Dou, Fugen; Soriano, Junel; Tabien, Rodante E.; Chen, Kun			Soil Texture and Cultivar Effects on Rice (Oryza sativa, L.) Grain Yield, Yield Components and Water Productivity in Three Water Regimes	PLOS ONE			English	Article							ORGANIC-MATTER; MANAGEMENT; INCREASE; QTL	The objective of this study was to determine the effects of water regime/soil condition (continuous flooding, saturated, and aerobic), cultivar ('Cocodrie' and 'Rondo'), and soil texture (clay and sandy loam) on rice grain yield, yield components and water productivity using a greenhouse trial. Rice grain yield was significantly affected by soil texture and the interaction between water regime and cultivar. Significantly higher yield was obtained in continuous flooding than in aerobic and saturated soil conditions but the latter treatments were comparable to each other. For Rondo, its grain yield has decreased with soil water regimes in the order of continuous flooding, saturated and aerobic treatments. The rice grain yield in clay soil was 46% higher than in sandy loam soil averaged across cultivar and water regime. Compared to aerobic condition, saturated and continuous flooding treatments had greater panicle numbers. In addition, panicle number in clay soil was 25% higher than in sandy loam soil. The spikelet number of Cocodrie was 29% greater than that of Rondo, indicating that rice cultivar had greater effect on spikelet number than soil type and water management. Water productivity was significantly affected by the interaction of water regime and cultivar. Compared to sandy loam soil, clay soil was 25% higher in water productivity. Our results indicated that cultivar selection and soil texture are important factors in deciding what water management option to practice.	[Dou, Fugen; Tabien, Rodante E.] Texas A&M AgriLife Res Ctr Beaumont, 1509 Aggie Dr, Beaumont, TX 77713 USA; [Soriano, Junel] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Telangana, India; [Chen, Kun] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Connecticut	Dou, FG (corresponding author), Texas A&M AgriLife Res Ctr Beaumont, 1509 Aggie Dr, Beaumont, TX 77713 USA.	f-dou@aesrg.tamu.edu	Chen, Kun/C-2975-2015	Chen, Kun/0000-0003-3579-5467; Tabien, Rodante/0000-0001-8573-4123	Fulbright-Philippine Agriculture Scholarship Program under the Philippine-American Educational Foundation; Bureau of Agricultural Research of the Department of Agriculture in the Philippines; Bulacan Agricultural State College; International Rice Research Institute	Fulbright-Philippine Agriculture Scholarship Program under the Philippine-American Educational Foundation; Bureau of Agricultural Research of the Department of Agriculture in the Philippines; Bulacan Agricultural State College; International Rice Research Institute(CGIAR)	This research was partially funded by the Fulbright-Philippine Agriculture Scholarship Program under the Philippine-American Educational Foundation, Bureau of Agricultural Research of the Department of Agriculture in the Philippines, Bulacan Agricultural State College and International Rice Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, METHODS SOIL ANAL 1; Bond JA, 2008, AGRON J, V100, P393, DOI 10.2134/agronj2007.0107; Bouman BAM, 2006, FIELD CROP RES, V97, P53, DOI 10.1016/j.fcr.2005.08.015; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; Brodersen CR, 2008, PLANT CELL ENVIRON, V31, P159, DOI 10.1111/j.1365-3040.2007.01751.x; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Kachurina OM, 2000, COMMUN SOIL SCI PLAN, V31, P893, DOI 10.1080/00103620009370485; Kato Y, 2009, FIELD CROP RES, V113, P328, DOI 10.1016/j.fcr.2009.06.010; Kreye C, 2009, FIELD CROP RES, V111, P197, DOI 10.1016/j.fcr.2008.12.007; Linscombe SD, 2000, CROP SCI, V40, P294, DOI 10.2135/cropsci2000.0007rcv; Liu MJ, 2013, FIELD CROP RES, V150, P19, DOI 10.1016/j.fcr.2013.06.005; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; MISHRA HS, 1990, AGR WATER MANAGE, V18, P231, DOI 10.1016/0378-3774(90)90045-Z; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Peng SB, 2006, FIELD CROP RES, V96, P252, DOI 10.1016/j.fcr.2005.07.007; Powers RF, 2005, FOREST ECOL MANAG, V220, P31, DOI 10.1016/j.foreco.2005.08.003; Ramamasy S, 2007, CLIMATE VARIABILITY; Rao PR, 2013, J PLANT NUTR, V36, P390, DOI 10.1080/01904167.2012.744420; Schofield R. K, 1955, SOIL SCI SOC AM J, V19, P164, DOI DOI 10.2136/SSSAJ1955.03615995001900020013X; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Tsubo M, 2007, PLANT PROD SCI, V10, P232, DOI 10.1626/pps.10.232; Tuong T. P., 1999, Journal of Crop Production, V2, P241; Wang H, 2002, WATER WISE RICE PROD, P143; Wight JP, 2012, BIOMASS BIOENERG, V46, P593, DOI 10.1016/j.biombioe.2012.06.036; Wilson CE, 2008, ARKANSAS RICE PERFOR; Wu GW, 1998, AGRON J, V90, P317, DOI 10.2134/agronj1998.00021962009000030001x; Yan J, 2010, FIELD CROP RES, V116, P252, DOI 10.1016/j.fcr.2010.01.002; Ye Quanbao, 2007, Frontiers of Agriculture in China, V1, P30, DOI 10.1007/s11703-007-0005-z; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Yoshida S, 1981, FUNDAMENTALS RICE CR; Zhang XiaoCui, 2012, Acta Agronomica Sinica, V38, P1494, DOI 10.3724/SP.J.1006.2012.01494; Zhang YS, 2009, THEOR APPL GENET, V118, P1035, DOI 10.1007/s00122-008-0960-7; Zhao DL, 2010, CROP SCI, V50, P2268, DOI 10.2135/cropsci2010.10.0028; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	35	47	49	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150549	10.1371/journal.pone.0150549	http://dx.doi.org/10.1371/journal.pone.0150549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978525	Green Published, gold			2022-12-27	WOS:000372572800029
J	Fuehner, T; Fuge, J; Jungen, M; Buck, A; Suhling, H; Welte, T; Gottlieb, J; Greer, M				Fuehner, Thomas; Fuge, Jan; Jungen, Meike; Buck, Anna; Suhling, Hendrik; Welte, Tobias; Gottlieb, Jens; Greer, Mark			Topical Nasal Anesthesia in Flexible Bronchoscopy - A Cross-Over Comparison between Two Devices	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; FIBEROPTIC BRONCHOSCOPY; DOUBLE-BLIND; LIGNOCAINE; MIDAZOLAM; LIDOCAINE; SEDATION	Introduction Topical airway anesthesia is known to improve tolerance and patient satisfaction during flexible bronchoscopy (FB). Lidocaine is commonly used, delivered as an atomized spray. The current study assesses safety and patient satisfaction for nasal anesthesia of a new atomization device during outpatient bronchoscopy in lung transplant recipients. Methods Using a prospective, non-blinded, cross-over design, patients enrolled between 01-10-2014 and 24-11-2014 received 2% lidocaine using the standard reusable nasal atomizer (CRNA). Those enrolled between 25-11-2014 and 30-01-2015, received a disposable intranasalmucosal atomization device (DIMAD). After each procedure, the treating physician, their assistant and the patient independently rated side-effects and satisfaction, basing their responses on visual analogue scales (VAS). At their next scheduled bronchoscopy during the study period, patients then received the alternative atomizer. Written consent was obtained prior to the first bronchoscopy, and the study approved by the institutional ethics committee. Results Of the 252 patients enrolled between 01-10-2014 and 30-01-2015, 80 (32%) received both atomizers. Physicians reported better efficacy (p = 0.001) and fewer side effects (p < = 0.001) for DIMAD in patients exposed to both procedures. Among patients with one visit, physicians and their assistants reported improved efficacy (p = 0.018, p = 0.002) and fewer side effects (p < = 0.001, p = 0.029) for the disposable atomizer, whereas patients reported no difference in efficacy or side effects (p = 0.72 and p = 0.20). No severe adverse events were noted. The cost of the reusable device was 4.08(sic) per procedure, compared to 3.70(sic) for the disposable device. Discussion Topical nasal anesthesia via a disposable intranasal mucosal atomization device (DIMAD) offers comparable safety and patient comfort, compared to conventional reusable nasal atomizers (CRNA) in lung transplant recipients. Procedural costs were reduced by 0.34(sic) per procedure.	[Fuehner, Thomas; Fuge, Jan; Jungen, Meike; Buck, Anna; Suhling, Hendrik; Welte, Tobias; Gottlieb, Jens; Greer, Mark] Biomed Res Endstage & Obstruct Lung Dis Hannover, Dept Internal Med, Hannover Med Sch, Hannover, Germany	Hannover Medical School	Fuehner, T (corresponding author), Biomed Res Endstage & Obstruct Lung Dis Hannover, Dept Internal Med, Hannover Med Sch, Hannover, Germany.	fuehner.thomas@mh-hannover.de		Gottlieb, Prof. Jens/0000-0002-9540-9022; Fuge, Jan/0000-0003-2926-3608				ACKART RS, 1983, ARCH INTERN MED, V143, P30, DOI 10.1001/archinte.143.1.30; Casal RF, 2013, CLIN CHEST MED, V34, P341, DOI 10.1016/j.ccm.2013.03.001; Charalampidou S, 2006, Ir Med J, V99, P8; Cox B, 2003, Best Pract Res Clin Anaesthesiol, V17, P111, DOI 10.1053/bean.2003.0275; DELEON CM, 1986, SCHWEIZ MED WSCHR, V116, P1267; DONLAN CJ, 1978, ARCH INTERN MED, V138, P698, DOI 10.1001/archinte.138.5.698; Du Rand IA, 2013, THORAX, V68, P1, DOI 10.1136/thoraxjnl-2013-203618; FOSTER WM, 1992, AM REV RESPIR DIS, V146, P520, DOI 10.1164/ajrccm/146.2.520; FRY WA, 1978, CHEST, V73, P694, DOI 10.1378/chest.73.5.694; FULKERSON WJ, 1984, NEW ENGL J MED, V311, P511, DOI 10.1056/NEJM198408233110806; GRAHAM DR, 1992, CHEST, V102, P704, DOI 10.1378/chest.102.3.704; Hadzri Hm, 2010, JRSM Short Rep, V1, P35, DOI 10.1258/shorts.2010.010044; Kaur H, 2015, CHEST, V148, P739, DOI 10.1378/chest.15-0022; KEANE D, 1992, EUR RESPIR J, V5, P1123; MIDDLETON RM, 1991, CHEST, V99, P1093, DOI 10.1378/chest.99.5.1093; Pani N, 2009, INDIAN J ANAESTH, V53, P641; PERRY LB, 1978, CHEST, V73, P691, DOI 10.1378/chest.73.5.691; Rademacher J, 2014, TRANSPLANT RES, V3, DOI 10.1186/2047-1440-3-11; RANDELL T, 1992, BRIT J ANAESTH, V68, P164, DOI 10.1093/bja/68.2.164; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Stolz D, 2005, CHEST, V128, P1756, DOI 10.1378/chest.128.3.1756; Stolz D, 2004, THORAX, V59, P773, DOI 10.1136/thx.2003.019836; Wahidi MM, 2011, CHEST, V140, P1342, DOI 10.1378/chest.10-3361; WEBB AR, 1989, THORAX, V44, P674, DOI 10.1136/thx.44.8.674; Zainudin B. M. Z., 1993, Singapore Medical Journal, V34, P148	25	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150905	10.1371/journal.pone.0150905	http://dx.doi.org/10.1371/journal.pone.0150905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978775	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800039
J	Schartel, TE; Schauber, EM				Schartel, Tyler E.; Schauber, Eric M.			Relative Preference and Localized Food Affect Predator Space Use and Consumption of Incidental Prey	PLOS ONE			English	Article							GYPSY-MOTH LEPIDOPTERA; WHITE-FOOTED MOUSE; PEROMYSCUS-LEUCOPUS; FORAGING BEHAVIOR; APPARENT COMPETITION; GENERALIST HERBIVORE; SPATIAL SCALE; AVAILABILITY; POPULATIONS; HABITAT	Abundant, localized foods can concentrate predators and their foraging efforts, thus altering both the spatial distribution of predation risk and predator preferences for prey that are encountered incidentally. However, few investigations have quantified the spatial scale over which localized foods affect predator foraging behavior and consumption of incidental prey. In spring 2010, we experimentally tested how point-source foods altered how generalist predators (white-footed mice, Peromyscus leucopus) utilized space and depredated two incidental prey items: almonds (Prunus dulcis; highly profitable) and maple seeds (Acer saccharum; less profitable). We estimated mouse population densities with trapping webs, quantified mouse consumption rates of these incidental prey items, and measured local mouse activity with track plates. We predicted that 1) mouse activity would be elevated near full feeders, but depressed at intermediate distances from the feeder, 2) consumption of both incidental prey would be high near feeders providing less-preferred food and, 3) consumption of incidental prey would be contingent on predator preference for prey relative to feeders providing more-preferred food. Mouse densities increased significantly from pre- to post-experiment. Mean mouse activity was unexpectedly greatest in control treatments, particularly <15 m from the control (empty) feeder. Feeders with highly preferred food (sunflower seeds) created localized refuges for incidental prey at intermediate distances (15 to 25 m) from the feeder. Feeders with less-preferred food (corn) generated localized high risk for highly preferred almonds <10 m of the feeder. Our findings highlight the contingent but predictable effects of locally abundant food on risk experienced by incidental prey, which can be positive or negative depending on both spatial proximity and relative preference.	[Schartel, Tyler E.; Schauber, Eric M.] So Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA; [Schartel, Tyler E.] So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA; [Schauber, Eric M.] So Illinois Univ, Ctr Ecol, Carbondale, IL 62901 USA; [Schartel, Tyler E.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Mississippi State University	Schartel, TE (corresponding author), So Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA.; Schartel, TE (corresponding author), So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA.; Schartel, TE (corresponding author), Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA.	tes164@msstate.edu	Schauber, Eric/K-4043-2019	Schauber, Eric/0000-0002-0667-2604	National Science Foundation [0743759]	National Science Foundation(National Science Foundation (NSF))	The research described in this manuscript was supported by the National Science Foundation (http://www.nsf.gov/) under Grant No. 0743759. This grant was authored by and awarded to EMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, ECOLOGY, V77, P610, DOI 10.2307/2265634; Ackerman JT, 2002, OIKOS, V99, P469, DOI 10.1034/j.1600-0706.2002.11802.x; ANDERSON R C, 1975, Castanea, V40, P345; Barraquand F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028924; BESS HA, 1947, HARVARD FOR B, V22, P56; BROWN JS, 1995, OIKOS, V74, P122, DOI 10.2307/3545681; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CAMPBELL RW, 1977, ENVIRON ENTOMOL, V6, P323, DOI 10.1093/ee/6.2.323; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Connors MJ, 2005, J MAMMAL, V86, P991, DOI 10.1644/1545-1542(2005)86[991:UOTPTQ]2.0.CO;2; Cooper SM, 2000, WILDLIFE SOC B, V28, P660; COURTNEY PA, 1976, J APPL ECOL, V13, P413, DOI 10.2307/2401790; CRABTREE RL, 1988, WILDLIFE SOC B, V16, P163; Cramer MJ, 2014, CAN J ZOOL, V92, P771, DOI 10.1139/cjz-2014-0090; Davis GT, 1987, THESIS SO ILLINOIS U; DIXON AFG, 1959, J ANIM ECOL, V28, P259, DOI 10.2307/2082; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Greenwood RJ, 1998, WILDLIFE SOC B, V26, P219; GRIFFITHS D, 1975, ECOLOGY, V56, P1209, DOI 10.2307/1936161; Hamilton AM, 2002, AM MIDL NAT, V147, P123, DOI 10.1674/0003-0031(2002)147[0123:EODFHA]2.0.CO;2; HANSEN L, 1978, CAN J ZOOL, V56, P2530, DOI 10.1139/z78-341; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; JEDRZEJEWSKI W, 1992, ECOGRAPHY, V15, P212, DOI 10.1111/j.1600-0587.1992.tb00027.x; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Lacher TE, 1996, J MAMMAL, V77, P833, DOI 10.2307/1382689; LACKEY J A, 1985, Mammalian Species, P1, DOI 10.2307/3503904; LEIMGRUBER P, 1994, J WILDLIFE MANAGE, V58, P254, DOI 10.2307/3809388; Lewis CE, 2001, CAN J ZOOL, V79, P562, DOI 10.1139/cjz-79-4-562; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Manson RH, 2000, OIKOS, V91, P162, DOI 10.1034/j.1600-0706.2000.910116.x; Martinson TJ, 2003, WILDLIFE SOC B, V31, P510; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; Morgan RA, 1997, ECOLOGY, V78, P1087, DOI 10.1890/0012-9658(1997)078[1087:TEOSSO]2.0.CO;2; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Musser FR, 2003, ENVIRON ENTOMOL, V32, P1131, DOI 10.1603/0046-225X-32.5.1131; Orros ME, 2012, BASIC APPL ECOL, V13, P286, DOI 10.1016/j.baae.2012.03.001; Ostfeld RS, 1997, ECOLOGY, V78, P1531, DOI 10.1890/0012-9658(1997)078[1531:EOROSO]2.0.CO;2; Parmenter RR, 2003, ECOL MONOGR, V73, P1, DOI 10.1890/0012-9615(2003)073[0001:SMDEAF]2.0.CO;2; Pusenius J, 2002, OIKOS, V98, P251, DOI 10.1034/j.1600-0706.2002.980207.x; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Sacks BN, 2007, J WILDLIFE MANAGE, V71, P2404, DOI 10.2193/2006-564; Sacks BN, 2002, ECOL APPL, V12, P299, DOI 10.1890/1051-0761(2002)012[0299:FSOAGP]2.0.CO;2; *SAS I INC, 2003, SAS STAT US GUID REL; Schauber EM, 2006, ENVIRON ENTOMOL, V35, P293, DOI 10.1603/0046-225X-35.2.293; Schauber EM, 2009, ECOLOGY, V90, P240, DOI 10.1890/07-0980.1; SCHEEL D, 1993, BEHAV ECOL, V4, P90, DOI 10.1093/beheco/4.1.90; Schmidt KA, 2004, OIKOS, V106, P335, DOI 10.1111/j.0030-1299.2004.13093.x; Schmidt KA, 2003, ECOLOGY, V84, P406, DOI 10.1890/0012-9658(2003)084[0406:SPIFEP]2.0.CO;2; Schmidt KA, 2001, ECOLOGY, V82, P2937, DOI 10.1890/0012-9658(2001)082[2937:INPISB]2.0.CO;2; Schmidt KA, 2008, J ANIM ECOL, V77, P830, DOI 10.1111/j.1365-2656.2008.01378.x; SCHMITT RJ, 1987, ECOLOGY, V68, P1887, DOI 10.2307/1939880; Schnurr JL, 2004, ECOLOGY, V85, P741, DOI 10.1890/02-0644; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Smith HR, 1981, USDA TECHNICAL B; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; SPEISER B, 1991, OIKOS, V62, P306, DOI 10.2307/3545495; Stephens D.W., 1986, pi; Sulok M, 2004, J MAMMAL, V85, P1102, DOI 10.1644/BEH-112.1; THOMPSON ID, 1990, OECOLOGIA, V83, P443, DOI 10.1007/BF00317193; VANNI MJ, 1987, ECOL MONOGR, V57, P61, DOI 10.2307/1942639; VIVAS HJ, 1987, J ANIM ECOL, V56, P509, DOI 10.2307/5064; WOLFF JO, 1985, CAN J ZOOL, V63, P2657, DOI 10.1139/z85-397; Yates ED, 2004, FOREST ECOL MANAG, V190, P119, DOI 10.1016/j.foreco.2003.11.008; Young HS, 2013, OECOLOGIA, V172, P857, DOI 10.1007/s00442-012-2542-2	68	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151483	10.1371/journal.pone.0151483	http://dx.doi.org/10.1371/journal.pone.0151483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978659	gold, Green Published, Green Submitted			2022-12-27	WOS:000372572800078
J	Csagola, A; Zadori, Z; Meszaros, I; Tuboly, T				Csagola, Attila; Zadori, Zoltan; Meszaros, Istvan; Tuboly, Tamas			Detection of Porcine Parvovirus 2 (Ungulate Tetraparvovirus 3) Specific Antibodies and Examination of the Serological Profile of an Infected Swine Herd	PLOS ONE			English	Article							PIG FARMS; IDENTIFICATION; SAMPLES; PPV2	Porcine parvovirus 2 (PPV2) is a member of a recently discovered group of swine parvoviruses occurring worldwide. It is frequently detected in lung samples suggesting some pathological role of the virus in diseases. To study this possibility an indirect ELISA was developed to detect PPV2 specific antibodies and to examine the serological profile of an infected swine herd where 185 serum samples collected from different age groups including sows were analyzed. According to the results maternal antibody levels decreased until 14 days of age and PPV2 specific antibodies started to rise between 28 to 43 days of age when respiratory signs were also observed in the examined swine herd. At 57 days of age the clinical signs disappeared and a rapid increase of PPV2 specific antibody levels could be measured simultaneously, peaking at 57 days of age. The viraemic status of different age groups was determined by qPCR using serum samples. At least a low level of viraemia was measured in every age group, but higher copy number of PPV2 was only detected at 57 days of age and the level decreased in older age groups. The changes in virus load and antibody levels together with the onset and decrease of clinical signs suggested that PPV2 had a role in the development of respiratory signs.	[Csagola, Attila; Tuboly, Tamas] Szent Istvan Univ, Fac Vet Sci, Dept Microbiol & Infect Dis, Budapest, Hungary; [Zadori, Zoltan; Meszaros, Istvan] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Csagola, A (corresponding author), Szent Istvan Univ, Fac Vet Sci, Dept Microbiol & Infect Dis, Budapest, Hungary.	Csagola.Attila@aotk.szie.hu			OTKA of the Hungarian Government [PD 100405]; KK-UK of the Hungarian Government; KTIA-AIK of the Hungarian Government; Hungarian Government [9877-3/2015/FEKUT]	OTKA of the Hungarian Government(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); KK-UK of the Hungarian Government; KTIA-AIK of the Hungarian Government; Hungarian Government	Research was funded by OTKA PD 100405, KK-UK 2014, KTIA-AIK and 9877-3/2015/FEKUT grants of the Hungarian Government.	Agbandje-McKenna M., 2006, PARVOVIRUSES, P125; Cadar D, 2013, J GEN VIROL, V94, P2330, DOI 10.1099/vir.0.055129-0; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Csagola A, 2012, ARCH VIROL, V157, P1003, DOI 10.1007/s00705-012-1257-3; Hijikata M, 2001, JPN J INFECT DIS, V54, P244; Kaufmann B, 2004, P NATL ACAD SCI USA, V101, P11628, DOI 10.1073/pnas.0402992101; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Opriessnig T, 2014, VET MICROBIOL, V173, P9, DOI 10.1016/j.vetmic.2014.06.024; Opriessnig T, 2013, VET MICROBIOL, V163, P177, DOI 10.1016/j.vetmic.2012.12.019; Saekhow P, 2014, MICROBIOL IMMUNOL, V58, P382, DOI 10.1111/1348-0421.12159; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simpson AA, 2002, J MOL BIOL, V315, P1189, DOI 10.1006/jmbi.2001.5319; Wang F, 2010, VIRUS GENES, V41, P305, DOI 10.1007/s11262-010-0506-3; Xiao CT, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00021-12; Xiao CT, 2013, INFECT GENET EVOL, V16, P369, DOI 10.1016/j.meegid.2013.03.017; Xiao CT, 2013, VET MICROBIOL, V161, P325, DOI 10.1016/j.vetmic.2012.07.038; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4	19	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151036	10.1371/journal.pone.0151036	http://dx.doi.org/10.1371/journal.pone.0151036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974825	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600045
J	Li, X; Zhao, J; Liu, JX; Li, G; Zhao, Y; Zeng, X				Li, Xiong; Zhao, Jin; Liu, Jianxing; Li, Geng; Zhao, Ya; Zeng, Xing			Systematic Analysis of Absorbed Anti-Inflammatory Constituents and Metabolites of Sarcandra glabra in Rat Plasma Using Ultra-High-Pressure Liquid Chromatography Coupled with Linear Trap Quadrupole Orbitrap Mass Spectrometry	PLOS ONE			English	Article							NF-KAPPA-B; ROSMARINIC ACID; CAFFEIC ACID; BIOACTIVE CONSTITUENTS; CHLOROGENIC ACID; ABSORPTION; ASTILBIN	Ultra-high-pressure liquid chromatography (UHPLC) was coupled with linear ion trap quad-rupole Orbitrap mass spectrometry (LTQ-Orbitrap) and was used for the first time to systematically analyze the absorbed components and metabolites in rat plasma after oral administration of the water extract of Sarcandra glabra. This extract is a well-known Chinese herbal medicine for the treatment of inflammation and immunity related diseases. The anti-inflammatory activities of the absorbed components were evaluated by measuring nitric oxide (NO) production and proinflammatory genes expression in lipopolysaccharide (LPS)stimulated murine RAW 264.7 macrophages. As a result, 54 components in Sarcandra glabra were detected in dosed rat plasma, and 36 of them were positively identified. Moreover, 23 metabolites were characterized and their originations were traced. Furthermore, 20 of the 24 studied components showed anti-inflammatory activities. These results provide evidence that this method efficiency detected constituents in plasma based on the anti-inflammatory mechanism of multiple components and would be a useful technique for screening multiple targets for natural medicine research.	[Li, Xiong; Zhao, Ya; Zeng, Xing] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Zhao, Jin] Zhongshan City Peoples Hosp, Zhongshan, Peoples R China; [Liu, Jianxing; Li, Geng] Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Zhao, Ya] Guangzhou Univ Chinese Med, Postdoctoral Res Stn, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Zhao, Y; Zeng, X (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China.; Zhao, Y (corresponding author), Guangzhou Univ Chinese Med, Postdoctoral Res Stn, Guangzhou, Guangdong, Peoples R China.	22355795@qq.com; zengxing-china@163.com			National Natural Science Foundation of China [81202888]; Natural Science Foundation of Guangdong Province [S2013030011515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by a National Natural Science Foundation of China ( No. 81202888) and partly supported by Natural Science Foundation of Guangdong Province ( No. S2013030011515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PHARM PEOPL REP CHIN, p[223, 409, 861, 1102]; Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q; Baba S, 2005, EUR J NUTR, V44, P1, DOI 10.1007/s00394-004-0482-2; Baba S, 2004, LIFE SCI, V75, P165, DOI 10.1016/j.lfs.2003.11.028; Bufalo MC, 2013, J ETHNOPHARMACOL, V149, P84, DOI 10.1016/j.jep.2013.06.004; Fan DS, 2011, FITOTERAPIA, V82, P805, DOI 10.1016/j.fitote.2011.04.007; Huang HQ, 2011, J AGR FOOD CHEM, V59, P4562, DOI 10.1021/jf2002969; Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4; Jiang WL, 2009, SHOCK, V32, P608, DOI 10.1097/SHK.0b013e3181a48e86; Lee DS, 2014, ARCH PHARM RES, V37, P947, DOI 10.1007/s12272-013-0243-y; Li X, 2014, ANAL METHODS-UK, V6, P7989, DOI 10.1039/c4ay01259c; [黎雄 Li Xiong], 2012, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V23, P295; Li X, 2012, HELV CHIM ACTA, V95, P998, DOI 10.1002/hlca.201100352; Li Xiong, 2011, Yaoxue Xuebao, V46, P1349; Li X, 2011, RAPID COMMUN MASS SP, V25, P2439, DOI 10.1002/rcm.5123; Liu Shumin, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1840; Min SW, 2010, INT IMMUNOPHARMACOL, V10, P959, DOI 10.1016/j.intimp.2010.05.009; Nakazawa T, 1998, J NAT PROD, V61, P993, DOI 10.1021/np980072s; Niu XF, 2012, INT IMMUNOPHARMACOL, V14, P164, DOI 10.1016/j.intimp.2012.06.022; Pei LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057414; Pragasam SJ, 2013, INFLAMMATION, V36, P169, DOI 10.1007/s10753-012-9532-8; Wang M., 2015, NANOTOXICOLOGY, V1, P1; [王文艳 Wang Wenyan], 2011, [质谱学报, Journal of Chinese Mass Spectrometry Society], V32, P36; Wu HF, 2013, J PHARMACEUT BIOMED, V72, P267, DOI 10.1016/j.jpba.2012.09.004; Xie Cen, 2011, Yaoxue Xuebao, V46, P88; Zhang QF, 2013, J AGR FOOD CHEM, V61, P12085, DOI 10.1021/jf404420s	26	10	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150063	10.1371/journal.pone.0150063	http://dx.doi.org/10.1371/journal.pone.0150063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974321	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600017
J	Motzek, A; Knezevic, J; Switzeny, OJ; Cooper, A; Baric, I; Beluzic, R; Strauss, KA; Puffenberger, EG; Mudd, SH; Vugrek, O; Zechner, U				Motzek, Antje; Knezevic, Jelena; Switzeny, Olivier J.; Cooper, Alexis; Baric, Ivo; Beluzic, Robert; Strauss, Kevin A.; Puffenberger, Erik G.; Mudd, S. Harvey; Vugrek, Oliver; Zechner, Ulrich			Abnormal Hypermethylation at Imprinting Control Regions in Patients with S-Adenosylhomocysteine Hydrolase (AHCY) Deficiency	PLOS ONE			English	Article							GLOBAL DNA HYPOMETHYLATION; GENE-EXPRESSION; METHYLATION; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; MUTATIONS; IDENTIFICATION; EXPOSURE; INCREASE; ELEMENTS	S-adenosylhomocysteine hydrolase (AHCY) deficiency is a rare autosomal recessive disorder in methionine metabolism caused by mutations in the AHCY gene. Main characteristics are psychomotor delay including delayed myelination and myopathy (hypotonia, absent tendon reflexes etc.) from birth, mostly associated with hypermethioninaemia, elevated serum creatine kinase levels and increased genome wide DNA methylation. The prime function of AHCY is to hydrolyse and efficiently remove S-adenosylhomocysteine, the by-product of transmethylation reactions and one of the most potent methyltransferase inhibitors. In this study, we set out to more specifically characterize DNA methylation changes in blood samples from patients with AHCY deficiency. Global DNA methylation was increased in two of three analysed patients. In addition, we analysed the DNA methylation levels at differentially methylated regions (DMRs) of six imprinted genes (MEST, SNRPN, LIT1, H19, GTL2 and PEG3) as well as Alu and LINE1 repetitive elements in seven patients. Three patients showed a hypermethylation in up to five imprinted gene DMRs. Abnormal methylation in Alu and LINE1 repetitive elements was not observed. We conclude that DNA hypermethylation seems to be a frequent but not a constant feature associated with AHCY deficiency that affects different genomic regions to different degrees. Thus AHCY deficiency may represent an ideal model disease for studying the molecular origins and biological consequences of DNA hypermethylation due to impaired cellular methylation status.	[Motzek, Antje; Cooper, Alexis; Zechner, Ulrich] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, D-55122 Mainz, Germany; [Knezevic, Jelena; Beluzic, Robert; Vugrek, Oliver] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Switzeny, Olivier J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Toxicol, D-55122 Mainz, Germany; [Baric, Ivo] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb, Croatia; [Baric, Ivo] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Strauss, Kevin A.; Puffenberger, Erik G.] Clin Special Children, Strasburg, PA USA; [Strauss, Kevin A.; Puffenberger, Erik G.] Franklin & Marshall Coll, Lancaster, PA 17604 USA; [Mudd, S. Harvey] NIMH, Mol Biol Lab, Bethesda, MD 20892 USA	Johannes Gutenberg University of Mainz; Rudjer Boskovic Institute; Johannes Gutenberg University of Mainz; University of Zagreb; University of Zagreb; Franklin & Marshall College; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zechner, U (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, D-55122 Mainz, Germany.; Vugrek, O (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	ovugrek@irb.hr; ulrich.zechner@unimedizin-mainz.de		Switzeny, Olivier/0000-0001-6279-2558; Cooper, Alexis/0000-0002-2182-0046; Puffenberger, Erik/0000-0002-6388-9148; Knezevic, Jelena/0000-0002-3152-3563	European Union [316289 - InnoMol, FP7-REGPOT-2012-2013-1]; German Academic Exchange Service; Ministry of Science, Education and Sport of the Republic of Croatia [54392779]	European Union(European Commission); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	Our work was supported by funds received from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No 316289 - InnoMol, FP7-REGPOT-2012-2013-1, as well as from the German Academic Exchange Service and the Ministry of Science, Education and Sport of the Republic of Croatia (project reference number 54392779).	Baric I, 2005, J INHERIT METAB DIS, V28, P885, DOI 10.1007/s10545-005-0192-9; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Baric I, 2009, J INHERIT METAB DIS, V32, P459, DOI 10.1007/s10545-009-1146-4; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Beluzic R., 2010, RAD MED SCI, V35, P77; Bhargava S, 2014, MOL CELL BIOCHEM, V387, P55, DOI 10.1007/s11010-013-1869-2; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Brun ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019464; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Cuk M., 2007, CLIN CHEM LAB MED, V45, pA43; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; El Hajj N, 2013, DIABETES, V62, P1320, DOI 10.2337/db12-0289; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Grubbs R, 2010, J INHERIT METAB DIS, V33, P705, DOI 10.1007/s10545-010-9171-x; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Heyn H, 2013, EPIGENETICS-US, V8, P28, DOI 10.4161/epi.23366; HOFFMAN DR, 1980, J BIOL CHEM, V255, P822; Honzik T, 2012, MOL GENET METAB, V107, P611, DOI 10.1016/j.ymgme.2012.08.014; Jamaluddin MS, 2007, BLOOD, V110, P3648, DOI 10.1182/blood-2007-06-096701; Jiang YD, 2007, ACTA BIOCH BIOPH SIN, V39, P657, DOI 10.1111/j.1745-7270.2007.00327.x; Jiang YD, 2012, ACTA BIOCH BIOPH SIN, V44, P866, DOI 10.1093/abbs/gms075; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; MEEHAN R, 1992, J CELL SCI, P9; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; Monnier P, 2013, P NATL ACAD SCI USA, V110, P20693, DOI 10.1073/pnas.1310201110; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pogribny IP, 2006, MUTAT RES-FUND MOL M, V593, P80, DOI 10.1016/j.mrfmmm.2005.06.028; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Stender S, 2015, MOL GENET METAB, V116, P269, DOI 10.1016/j.ymgme.2015.10.009; Strauss KA, 2015, MOL GENET METAB, V116, P44, DOI 10.1016/j.ymgme.2015.06.005; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Tsai JC, 1996, J CLIN INVEST, V97, P146, DOI 10.1172/JCI118383; Ulrich CM, 2012, EPIGENETICS-US, V7, P1020, DOI 10.4161/epi.21464; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vugrek O, 2009, HUM MUTAT, V30, pE555, DOI 10.1002/humu.20985; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	59	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151261	10.1371/journal.pone.0151261	http://dx.doi.org/10.1371/journal.pone.0151261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974671	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000372570600060
J	Xu, WT; Chen, L; Guo, S; Wu, LX; Zhang, JH				Xu, Wanting; Chen, Ling; Guo, Sheng; Wu, Liangxia; Zhang, Jianhua			Intranasal Administration of Recombinant Mycobacterium smegmatis Inducing IL-17A Autoantibody Attenuates Airway Inflammation in a Murine Model of Allergic Asthma	PLOS ONE			English	Article							T-CELL; MOUSE MODEL; HYPERRESPONSIVENESS; INTERLEUKIN-13; PATHOGENESIS; CYTOKINES; IMMUNITY; TUBERCULOSIS; EOSINOPHILS; VACCINATION	Asthma is a chronic inflammatory disorder, previous studies have shown that IL-17A contributes to the development of asthma, and there is a positive correlation between the level of IL-17A and the severity of disease. Here, we constructed recombinant Mycobacterium smegmatis expressing fusion protein Ag85A-IL-17A (rMS-Ag85a-IL-17a) and evaluated whether it could attenuate allergic airway inflammation, and further investigated the underlying mechanism. In this work, the murine model of asthma was established with ovalbumin, and mice were intranasally vaccinated with rMS-Ag85a-IL-17a. Autoantibody of IL-17A in sera was detected, and the airway inflammatory cells infiltration, the local cytokines and chemokines production and the histopathological changes of lung tissue were investigated. We found that the administration of rMS-Ag85a-IL-17a induced the autoantibody of IL-17A in sera. The vaccination of rMS-Ag85a-IL-17a remarkably reduced the infiltration of inflammatory cells and the secretion of mucus in lung tissue and significantly decreased the numbers of the total cells, eosinophils and neutrophils in BALF. Th1 cells count in spleen, Th1 cytokine levels in BALF and supernatant of splenocytes and mediastinal lymph nodes, and T-bet mRNA in lung tissue were significantly increased with rMS-Ag85a-IL-17a administration. Meanwhile, rMS-Ag85a-IL-17a vaccination markedly decreased Th2 cells count, Th2 cytokine and Th17 cytokine levels in BALF and supernatant of splenocytes and mediastinal lymph nodes, and chemokines mRNA expression in lung tissue. These data confirmed that recombinant Mycobacterium smegmatis in vivo could induce autoantibody of IL-17A, which attenuated asthmatic airway inflammation.	[Xu, Wanting; Chen, Ling; Wu, Liangxia; Zhang, Jianhua] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Paediat, Shanghai 200030, Peoples R China; [Guo, Sheng] Shanghai Jiao Tong Univ, Affiliated Childrens Hosp, Dept Endocrinol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, JH (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Paediat, Shanghai 200030, Peoples R China.	zhangjh12195@aliyun.com		Chen, Ling/0000-0001-8604-6808	National Natural Science Foundation of China [81172887]; Science and Technology Commission of Shanghai Municipality [14JC1492000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China, No. 81172887, http://www.nsfc.gov.cn, to Jianhua Zhang; and Science and Technology Commission of Shanghai Municipality, No. 14JC1492000, http://www.stcsm.gov.cn, to Jianhua Zhang.	Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Bergquist M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-110; Boyce JA, 2012, J ALLERGY CLIN IMMUN, V129, P335, DOI 10.1016/j.jaci.2011.12.968; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chen L, 2015, APPL BIOCHEM BIOTECH, V176, P2018, DOI 10.1007/s12010-015-1697-9; Chiarella SE, 2015, J ALLERGY CLIN IMMUN, V135, P290, DOI 10.1016/j.jaci.2014.09.037; Davoine F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00570; Delavallee L, 2008, ANN MED, V40, P343, DOI 10.1080/07853890801995298; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Elamin AA, 2011, MOL MICROBIOL, V81, P1577, DOI 10.1111/j.1365-2958.2011.07792.x; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Huang W., 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/910520; Ildiko F, 2011, ACTA MICROBIOL IMM H, V58, P13, DOI 10.1556/AMicr.58.2011.1.2; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Kumar RK, 2002, CLIN EXP ALLERGY, V32, P1104, DOI 10.1046/j.1365-2222.2002.01420.x; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Li J, 2014, ANN ALLERG ASTHMA IM, V113, P173, DOI 10.1016/j.anai.2014.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu L, 2011, CLIN VACCINE IMMUNOL, V18, P1957, DOI 10.1128/CVI.05306-11; Manni ML, 2014, EXPERT REV RESP MED, V8, P25, DOI 10.1586/17476348.2014.854167; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; O'Byrne PM, 2001, J ALLERGY CLIN IMMUN, V108, P503, DOI 10.1067/mai.2001.119149; Olin JT, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5517; Ota K, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/602846; Robinson DS, 2015, EXPERT OPIN BIOL TH, V15, P909, DOI 10.1517/14712598.2015.1041911; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spencer AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033555; Sterk PJ, 2014, J ALLERGY CLIN IMMUN, V133, P395, DOI 10.1016/j.jaci.2013.10.008; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tomita K, 2002, CLIN IMMUNOL, V102, P258, DOI 10.1006/clim.2001.5176; Tournoy KG, 2001, J IMMUNOL, V166, P6982, DOI 10.4049/jimmunol.166.11.6982; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Zietkowski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-110; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	48	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151581	10.1371/journal.pone.0151581	http://dx.doi.org/10.1371/journal.pone.0151581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974537	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600091
J	Wang, ZQ; Wu, WZ; Liu, YK; Wang, TY; Chen, X; Zhang, JH; Zhou, GX; Chen, R				Wang, Zhongqiu; Wu, Wenzhong; Liu, Yongkang; Wang, Tianyao; Chen, Xiao; Zhang, Jianhua; Zhou, Guoxing; Chen, Rong			Altered Cerebellar White Matter Integrity in Patients with Mild Traumatic Brain Injury in the Acute Stage	PLOS ONE			English	Article							AXONAL INJURY; DEFICITS	Background and Purpose Imaging studies of traumatic brain injury demonstrate that the cerebellum is often affected. We aim to examine fractional anisotropy alteration in acute-phase mild traumatic brain injury patients in cerebellum-related white matter tracts. Materials and Methods This prospective study included 47 mild traumatic brain injury patients in the acute stage and 37 controls. MR imaging and neurocognitive tests were performed in patients within 7 days of injury. White matter integrity was examined by using diffusion tensor imaging. We used three approaches, tract-based spatial statistics, graphical-model-based multivariate analysis, and region-of-interest analysis, to detect altered cerebellar white matter integrity in mild traumatic brain injury patients. Results Results from three analysis methods were in accordance with each other, and suggested fractional anisotropy in the middle cerebellar peduncle and the pontine crossing tract was changed in the acute-phase mild traumatic brain injury patients, relative to controls (adjusted p-value < 0.05). Higher fractional anisotropy in the middle cerebellar peduncle was associated with worse performance in the fluid cognition composite (r = -0.289, p-value = 0.037). Conclusion Altered cerebellar fractional anisotropy in acute-phase mild traumatic brain injury patients is localized in specific regions and statistically associated with cognitive deficits detectable on neurocognitive testing.	[Wang, Zhongqiu; Liu, Yongkang; Chen, Xiao] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wu, Wenzhong] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Acupuncture & Rehabil, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Tianyao] Fudan Univ, Peoples Hosp Shanghai 5, Dept Radiol, Shanghai 200240, Peoples R China; [Zhang, Jianhua; Zhou, Guoxing] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Radiol, Shanghai 200120, Peoples R China; [Chen, Rong] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Fudan University; Tongji University; University System of Maryland; University of Maryland Baltimore	Wang, ZQ (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.; Chen, R (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA.	Zhq2001us@163.com; rchen@umm.edu						Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Chen R, 2005, IEEE T MED IMAGING, V24, P1237, DOI 10.1109/TMI.2005.854305; Chen R, 2007, NEUROIMAGE, V35, P635, DOI 10.1016/j.neuroimage.2006.11.040; Chen R, 2012, NEUROINFORMATICS, V10, P119, DOI 10.1007/s12021-011-9129-7; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellison-Wright I, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-99; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Lupi A, 2007, CLIN NUCL MED, V32, P445, DOI 10.1097/RLU.0b013e3180537621; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mendoza J., 2007, CLIN NEUROANATOMY NE; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7	34	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151489	10.1371/journal.pone.0151489	http://dx.doi.org/10.1371/journal.pone.0151489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967320	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200059
J	Yamasaki, S; Ando, S; Shimodera, S; Endo, K; Okazaki, Y; Asukai, N; Usami, S; Nishida, A; Sasaki, T				Yamasaki, Syudo; Ando, Shuntaro; Shimodera, Shinji; Endo, Kaori; Okazaki, Yuji; Asukai, Nozomu; Usami, Satoshi; Nishida, Atsushi; Sasaki, Tsukasa			The Recognition of Mental Illness, Schizophrenia Identification, and Help-Seeking from Friends in Late Adolescence	PLOS ONE			English	Article							YOUNG-PEOPLE; HEALTH; DISORDERS; ATTITUDES; BELIEFS; STIGMA	Objective The recognition of mental illness without anticipating stigma might encourage adolescents' help-seeking behavior. We aimed to identify the relationship between mental illness identification and adolescents' intention to seek help if faced with mental illness. Method We examined the relationships between help-seeking intentions and recognition of mental illness (RMI) without correctly identifying the disease name, as well as correct labelling of schizophrenia (LSC) using a vignette about a person with schizophrenia in a cross-sectional survey of 9,484 Japanese high-school students aged 15-18 years. Results When compared with adolescents who were unable to recognize the mental illness (UMI) in the vignette, those in the RMI group reported they were significantly more likely to seek help from friends (odds ratio [OR] = 1.29; 95% confidence interval [CI] = 1.17-1.41; P < 0.001) and expressed an increased likelihood to seek help from professionals (all P < .05). Those in the LSC group reported they were significantly less likely to exhibit help-seeking behavior (OR = 0.77, 95% CI = 0.65-0.92, P = 0.003) and expressed an increased likelihood of help-seeking from health professionals than the UMI group (all P < .05). Conclusion The ability to recognize mental illness without identifying the disease may increase help-seeking from friends, while the ability to identify the disease as schizophrenia might decrease late adolescents' help-seeking. To promote help-seeking behavior among adolescents, improving their ability to recognize mental illness generally is recommended.	[Yamasaki, Syudo; Ando, Shuntaro; Endo, Kaori; Asukai, Nozomu; Nishida, Atsushi] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo 113, Japan; [Ando, Shuntaro; Endo, Kaori] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Shimodera, Shinji] Kochi Univ, Dept Neuropsychiat, Kochi Med Sch, Kochi 780, Japan; [Okazaki, Yuji] Kouseikai Michinoo Hosp, Nagasaki, Japan; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Tokyo, Japan; [Asukai, Nozomu] Aoyamakai Aoki Hosp, Tokyo, Japan; [Usami, Satoshi] Univ Tsukuba, Dept Psychol, Ibaraki, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Dept Phys & Hlth Educ, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Kochi University; University of Tsukuba; University of Tokyo	Shimodera, S (corresponding author), Kochi Univ, Dept Neuropsychiat, Kochi Med Sch, Kochi 780, Japan.	shimodes@kochi-u.ac.jp	Andoh, Akira/AAB-9303-2022	Endo, Kaori/0000-0003-0854-5120	Japan Scientific Research Grant from the Ministry of Health, Labour and Welfare [H19-kokoro-ippan-012]; Japan Scientific Research Grant on an Innovative Area (MEXT) from the Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 23118002, 23118004]; Japanese Society for the Promotion of Science Scientific Research Grant; Tokyo Metropolitan Institute of Medical Science Project Grant [Kokoronokenko H21-H26]; International Early Psychosis Association; Grants-in-Aid for Scientific Research [24530855] Funding Source: KAKEN	Japan Scientific Research Grant from the Ministry of Health, Labour and Welfare; Japan Scientific Research Grant on an Innovative Area (MEXT) from the Ministry of Education, Culture, Sports, Science and Technology; Japanese Society for the Promotion of Science Scientific Research Grant; Tokyo Metropolitan Institute of Medical Science Project Grant; International Early Psychosis Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Japan Scientific Research Grant (#H19-kokoro-ippan-012) from the Ministry of Health, Labour and Welfare; a Japan Scientific Research Grant on an Innovative Area (MEXT KAKENHI 23118002, 23118004; Adolescent Mind & Self-Regulation) from the Ministry of Education, Culture, Sports, Science and Technology; a Japanese Society for the Promotion of Science Scientific Research Grant (Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation); a Tokyo Metropolitan Institute of Medical Science Project Grant (Kokoronokenko H21-H26); and an International Early Psychosis Association 2014 poster award (to S.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2003, ACTA PSYCHIAT SCAND, V108, P304, DOI 10.1034/j.1600-0447.2003.00150.x; CHOQUET M, 1990, ACTA PSYCHIAT SCAND, V81, P170, DOI 10.1111/j.1600-0447.1990.tb06474.x; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Jorm AF, 2007, MED J AUSTRALIA, V187, P556, DOI 10.5694/j.1326-5377.2007.tb01415.x; Jorm AF, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-12; Jorm AF, 2013, LANCET, V381, P10, DOI 10.1016/S0140-6736(12)61457-3; McGorry PD, 2014, LANCET PSYCHIAT, V1, P559, DOI 10.1016/S2215-0366(14)00082-0; Read J, 2006, ACTA PSYCHIAT SCAND, V114, P303, DOI 10.1111/j.1600-0447.2006.00824.x; Rickwood D, 2005, ADV MENT HEALTH, V4, P218, DOI 10.5172/jamh.4.3.218; Rickwood DJ, 2007, MED J AUSTRALIA, V187, pS35, DOI 10.5694/j.1326-5377.2007.tb01334.x; RICKWOOD DJ, 1994, SOC SCI MED, V39, P563, DOI 10.1016/0277-9536(94)90099-X; Ross AM, 2012, EARLY INTERV PSYCHIA, V6, P229, DOI 10.1111/j.1751-7893.2011.00331.x; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wright A, 2007, SOC PSYCH PSYCH EPID, V42, P244, DOI 10.1007/s00127-006-0156-x; Wright A, 2012, SOC PSYCH PSYCH EPID, V47, P917, DOI 10.1007/s00127-011-0399-z	16	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151298	10.1371/journal.pone.0151298	http://dx.doi.org/10.1371/journal.pone.0151298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967510	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200042
J	Cho, SS; Kim, Y; Yoon, J; Seo, M; Shin, SK; Kwon, EY; Kim, SE; Bae, YJ; Lee, S; Sung, MK; Choi, MS; Park, T				Cho, Samuel Sunghwan; Kim, Yongkang; Yoon, Joon; Seo, Minseok; Shin, Su-kyung; Kwon, Eun-Young; Kim, Sung-Eun; Bae, Yun-Jung; Lee, Seungyeoun; Sung, Mi-Kyung; Choi, Myung-Sook; Park, Taesung			A Model-Based Joint Identification of Differentially Expressed Genes and Phenotype-Associated Genes	PLOS ONE			English	Article							MICROARRAY TECHNOLOGY; STATISTICAL-METHODS; DNA MICROARRAYS; BREAST-CANCER; LEPTIN; ADIPONECTIN	Over the last decade, many analytical methods and tools have been developed for microarray data. The detection of differentially expressed genes (DEGs) among different treatment groups is often a primary purpose of microarray data analysis. In addition, association studies investigating the relationship between genes and a phenotype of interest such as survival time are also popular in microarray data analysis. Phenotype association analysis provides a list of phenotype-associated genes (PAGs). However, it is sometimes necessary to identify genes that are both DEGs and PAGs. We consider the joint identification of DEGs and PAGs in microarray data analyses. The first approach we used was a naive approach that detects DEGs and PAGs separately and then identifies the genes in an intersection of the list of PAGs and DEGs. The second approach we considered was a hierarchical approach that detects DEGs first and then chooses PAGs from among the DEGs or vice versa. In this study, we propose a new model-based approach for the joint identification of DEGs and PAGs. Unlike the previous two-step approaches, the proposed method identifies genes simultaneously that are DEGs and PAGs. This method uses standard regression models but adopts different null hypothesis from ordinary regression models, which allows us to perform joint identification in one-step. The proposed model-based methods were evaluated using experimental data and simulation studies. The proposed methods were used to analyze a microarray experiment in which the main interest lies in detecting genes that are both DEGs and PAGs, where DEGs are identified between two diet groups and PAGs are associated with four phenotypes reflecting the expression of leptin, adiponectin, insulin-like growth factor 1, and insulin. Model-based approaches provided a larger number of genes, which are both DEGs and PAGs, than other methods. Simulation studies showed that they have more power than other methods. Through analysis of data from experimental microarrays and simulation studies, the proposed model-based approach was shown to provide a more powerful result than the naive approach and the hierarchical approach. Since our approach is model-based, it is very flexible and can easily handle different types of covariates.	[Cho, Samuel Sunghwan; Yoon, Joon; Seo, Minseok; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Kwan Ak St 599, Seoul, South Korea; [Kim, Yongkang; Park, Taesung] Seoul Natl Univ, Dept Stat, Kwan Ak St 599, Seoul, South Korea; [Shin, Su-kyung; Kwon, Eun-Young; Choi, Myung-Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, Ctr Food & Nutr Genom Res, Daegu, South Korea; [Kim, Sung-Eun; Sung, Mi-Kyung] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Bae, Yun-Jung] Shinhan Univ, Div Food Sci & Culinary Arts, Gyeonggi, South Korea; [Lee, Seungyeoun] Sejong Univ, Dept Math & Stat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Sookmyung Women's University; Sejong University	Park, T (corresponding author), Seoul Natl Univ, Interdisciplinary Program Bioinformat, Kwan Ak St 599, Seoul, South Korea.; Park, T (corresponding author), Seoul Natl Univ, Dept Stat, Kwan Ak St 599, Seoul, South Korea.	tspark@stats.snu.ac.kr	Kim, Yongkang/AAC-7436-2020	Kim, Yongkang/0000-0002-8837-2620; BAE, YUN JUNG/0000-0003-1185-3095	National Research Foundation of Korea (NRF) grants - Korean government (MSIP) [2012R1A3A2026438, 2008-0062618]	National Research Foundation of Korea (NRF) grants - Korean government (MSIP)	This work is supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIP) GRANT numbers: 2012R1A3A2026438 and 2008-0062618. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475; Dudoit S, 2002, STAT SINICA, V12, P111; Esapa CT, 2007, HUM MOL GENET, V16, P327, DOI 10.1093/hmg/ddl472; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Gershon D, 2002, NATURE, V416, P885, DOI 10.1038/416885a; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iacobellis G, 2005, CLIN ENDOCRINOL, V62, P487, DOI 10.1111/j.1365-2265.2005.02247.x; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Karanth S, 2008, FEBS J, V275, P3031, DOI 10.1111/j.1742-4658.2008.06455.x; Klebanov L, 2006, COMPUT STAT DATA AN, V50, P3619, DOI 10.1016/j.csda.2005.08.005; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; NEWLAND RC, 1994, CANCER, V73, P2076, DOI 10.1002/1097-0142(19940415)73:8<2076::AID-CNCR2820730811>3.0.CO;2-6; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Osuna JA, 2006, ARCH ANDROLOGY, V52, P355, DOI 10.1080/01485010600692017; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Park T, 2006, BIOINFORMATICS, V22, P1682, DOI 10.1093/bioinformatics/btl183; Reiner-Benaim A, 2007, BIOINFORMATICS, V23, P2239, DOI 10.1093/bioinformatics/btm300; Schulze A, 2001, NAT CELL BIOL, V3, pE190, DOI 10.1038/35087138; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Hal NLW, 2000, J BIOTECHNOL, V78, P271, DOI 10.1016/S0168-1656(00)00204-2; WEI LJ, 1992, STAT MED, V11, P1871, DOI 10.1002/sim.4780111409; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zoico E, 2008, J ENDOCRINOL INVEST, V31, P297, DOI 10.1007/BF03346361	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149086	10.1371/journal.pone.0149086	http://dx.doi.org/10.1371/journal.pone.0149086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964035	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000007
J	Zhang, K; Shen, YG; Zhang, X; Ma, L; Wang, HY; An, NY; Guo, AT; Ye, HY				Zhang, Kun; Shen, Yanguang; Zhang, Xu; Ma, Lu; Wang, Haiyi; An, Ningyu; Guo, Aitao; Ye, Huiyi			Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker	PLOS ONE			English	Article							CANCER; MRI; ANTIGEN; ABDOMEN	Background Routine screening of prostate specific antigen (PSA) is no longer recommended because of a high rate of over-diagnosis of prostate cancer (PCa). Objective To evaluate the efficacy of diffusion-weighted magnetic resonance imaging (DW-MRI) for PCa detection, and to explore the clinical utility of ultrahigh b-value DW-MRI in predicting prostate biopsy outcomes. Methodology 73 male patients were selected for the study. They underwent 3T MRI using T2WI conventional DW-MRI with b-value 1000 s/mm(2), and ultrahigh b-value DW-MRI with b-values of 2000 s/mm(2) and 3000 s/mm(2). Two radiologists evaluated individual prostate gland images on a 5-point rating scale using PI-RADS, for the purpose of region-specific comparisons among modalities. Sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV) and likelihood ratios (LR) were investigated for each MRI modality. The area under the receiver operating characteristic (ROC) curve (AUC) was also calculated. Results Results showed the improved diagnostic value of ultrahigh b-value DWI-MRI for detection of PCa when compared to other b values and conventional MRI protocols. Sensitivity values for 3000 s/mm(2) in both peripheral zone (PZ) and transition zone (TZ) were significantly higher than those observed with conventional DW-MRI-Specificity values for 3000 s/mm(2) in the TZ were significantly higher than other b-value images, whereas specificity values using 3000 s/mm(2) in the PZ were not significantly higher than 2000 s/mm(2) images. PPV and NPV between 3000 s/mm(2) and the other three modalities were significantly higher for both PZ and TZ images. The PLRs and NLRs of b-value 3000 s/mm(2) DW-MRI in the PZ and TZ were also recorded. ROC analysis showed greater AUCs for the b value 3000 s/ mm(2) DWI than for the other three modalities. Conclusions DW-MRI with a b-value of 3000 s/mm(2) was found to be the most accurate and reliable MRI modality for PCa tumor detection and localization, particularly for TZ lesion discrimination. It may be stated that the b-value of 3000 s/mm(2) is a novel, improved diagnostic biomarker with greater predictive accuracy for PCa prior to biopsy.	[Zhang, Kun; Shen, Yanguang; Ma, Lu; Wang, Haiyi; An, Ningyu; Ye, Huiyi] Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Zhang, Kun] Navy Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Zhang, Xu] Peoples Liberat Army Gen Hosp, Dept Urol, Beijing, Peoples R China; [Guo, Aitao] Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Ye, HY (corresponding author), Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China.	hyi_ye@163.com		Wang, Haiyi/0000-0002-0717-1748	Health Care Special Project, General Logistics Department of PLA [14BJZ02]	Health Care Special Project, General Logistics Department of PLA	The Health Care Special Project (14BJZ02)" is The General Logistics Department of PLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Bozkurt M, 2011, EUR J RADIOL, V80, P224, DOI 10.1016/j.ejrad.2010.06.004; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Gibbs P, 2009, INVEST RADIOL, V44, P572, DOI 10.1097/RLI.0b013e3181b4c10e; Hambrock T, 2011, RADIOLOGY, V259, P453, DOI 10.1148/radiol.11091409; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Junker D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/252939; Katahira K, 2011, EUR RADIOL, V21, P188, DOI 10.1007/s00330-010-1883-7; Kim CK, 2010, AM J ROENTGENOL, V194, pW33, DOI 10.2214/AJR.09.3004; Le JD, 2015, EUR UROL, V67, P569, DOI 10.1016/j.eururo.2014.08.079; LeFevre M, 2013, J FAM PRACTICE, V62, P617; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; Mistry K, 2003, J AM BOARD FAM PRACT, V16, P95, DOI 10.3122/jabfm.16.2.95; Moore WA, 2014, AM J ROENTGENOL, V202, P995, DOI 10.2214/AJR.12.9563; Ohgiya Y, 2012, CLIN IMAG, V36, P526, DOI 10.1016/j.clinimag.2011.11.016; Oto A, 2010, RADIOLOGY, V257, P715, DOI 10.1148/radiol.10100021; Qayyum A, 2009, RADIOGRAPHICS, V29, P1797, DOI 10.1148/rg.296095521; Rosenkrantz AB, 2015, AM J ROENTGENOL, V204, pW266, DOI 10.2214/AJR.14.12955; Schimmoller L, 2013, EUR RADIOL, V23, P3185, DOI 10.1007/s00330-013-2922-y; Shah ZK, 2015, ACAD RADIOL, V22, P467, DOI 10.1016/j.acra.2014.11.007; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smeenge M, 2012, CURR OPIN UROL, V22, P297, DOI 10.1097/MOU.0b013e3283548154; Ueno Y, 2013, J MAGN RESON IMAGING, V38, P154, DOI 10.1002/jmri.23953; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052	26	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151176	10.1371/journal.pone.0151176	http://dx.doi.org/10.1371/journal.pone.0151176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963936	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000116
J	Gao, LF; Jia, JZ; Kong, XY				Gao, LiFeng; Jia, JiZeng; Kong, XiuYing			A SNP-Based Molecular Barcode for Characterization of Common Wheat	PLOS ONE			English	Article							POLYMORPHISM; DIVERSITY; TRAITS; MARKER; ARRAY; MAP	Wheat is grown as a staple crop worldwide. It is important to develop an effective genotyping tool for this cereal grain both to identify germplasm diversity and to protect the rights of breeders. Single-nucleotide polymorphism (SNP) genotyping provides a means for developing a practical, rapid, inexpensive and high-throughput assay. Here, we investigated SNPs as robust markers of genetic variation for typing wheat cultivars. We identified SNPs from an array of 9000 across a collection of 429 well-known wheat cultivars grown in China, of which 43 SNP markers with high minor allele frequency and variations discriminated the selected wheat varieties and their wild ancestors. This SNP-based barcode will allow for the rapid and precise identification of wheat germplasm resources and newly released varieties and will further assist in the wheat breeding program.	[Gao, LiFeng; Jia, JiZeng; Kong, XiuYing] CAAS, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,MOA, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Kong, XY (corresponding author), CAAS, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,MOA, Beijing 100081, Peoples R China.	kongxiuying@caas.cn			State Hi-Tech Research and Development Program (863 Program) [2012AA021602]; National Natural Science Foundation of China [31271292]; National 948 Project [2011-G9]	State Hi-Tech Research and Development Program (863 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 948 Project	This study was supported by the State Hi-Tech Research and Development Program (863 Program, no. 2012AA021602); the National Natural Science Foundation of China (no. 31271292); and the National 948 Project (2011-G9).	Baniecki ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003539; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BRUNEL D, 1994, PLANT MOL BIOL, V24, P397, DOI 10.1007/BF00020177; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; Chen XH, 1986, JIANGSU AGR SCI, DOI [10.1589/j.issn.1002-1302, DOI 10.1589/J.ISSN.1002-1302]; Cheng BaoShan, 2011, Acta Agriculturae Zhejiangensis, V23, P20; Coissac E, 2016, MOL ECOL, DOI 10.1111/mec.13549; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Faris JD, 2014, THEOR APPL GENET, V127, P2333, DOI 10.1007/s00122-014-2380-1; Frey JE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-106; Grover A, 2016, CRIT REV BIOTECHNOL, V36, P290, DOI 10.3109/07388551.2014.959891; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hao ChenYang, 2005, Acta Agronomica Sinica, V31, P144; Hulse-Kemp AM, 2015, G3-GENES GENOM GENET, V5, P1187, DOI 10.1534/g3.115.018416; Lee YG, 2015, PLANT J, V81, P625, DOI 10.1111/tpj.12755; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Roder MS, 1998, GENETICS, V149, P2007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; [王忠华 Wang Zhonghua], 2006, [分子植物育种, Molecular Plant Breeding], V4, P425; WU KS, 1993, MOL GEN GENET, V241, P225, DOI 10.1007/BF00280220; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; [张金波 Zhang Jinbo], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P29	27	32	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150947	10.1371/journal.pone.0150947	http://dx.doi.org/10.1371/journal.pone.0150947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985664	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300038
J	Agardh, A; Ross, M; Ostergren, PO; Larsson, M; Tumwine, G; Mansson, SA; Simpson, JA; Patton, G				Agardh, Anette; Ross, Michael; Ostergren, Per-Olof; Larsson, Markus; Tumwine, Gilbert; Mansson, Sven-Axel; Simpson, Julie A.; Patton, George			Health Risks in Same-Sex Attracted Ugandan University Students: Evidence from Two Cross-Sectional Studies	PLOS ONE			English	Article							HIV-RISK; BISEXUAL MEN; BEHAVIOR; GAY; POPULATION; VALIDITY; KAMPALA	Widespread discrimination across much of sub-Saharan Africa against persons with same-sex sexuality, including recent attempts in Uganda to extend criminal sanctions against same-sex behavior, are likely to have profound effects on this group's health, health care access, and well-being. Yet knowledge of the prevalence of same-sex sexuality in this region is scarce. This study aimed to systematically examine prevalence of same-sex sexuality and related health risks in young Ugandan adults. We conducted two cross-sectional survey studies in south-western Uganda targeting student samples (n = 980, n = 1954) representing 80% and 72% of the entire undergraduate classes attending a university in 2005 and 2010, respectively. A questionnaire assessed items concerning same-sex sexuality (same-sex attraction/fantasies, same-sex sexual relations), mental health, substance use, experience of violence, risky sexual behavior, and sexual health counseling needs. Our findings showed that same-sex sexual attraction/fantasies and behavior were common among male and female students, with 10-25% reporting having sexual attraction/fantasies regarding persons of the same-sex, and 6-16% reporting same-sex sexual relations. Experiences of same-sex sexuality were associated with health risks, e.g. poor mental health (2010, AOR = 1.5; 95% CI: 1.0-2.3), sexual coercion (2010, AOR 2.9; CI: 1.9-4.6), and unmet sexual health counseling needs (2010, AOR 2.2; CI: 1.4-3.3). This first study of young adults in Uganda with same-sex sexuality found high levels of health needs but poor access to health care. Effective response is likely to require major shifts in current policy, efforts to reduce stigmatization, and reorientation of health services to better meet the needs of this vulnerable group of young people.	[Agardh, Anette; Ostergren, Per-Olof; Larsson, Markus] Lund Univ, Dept Clin Sci, Social Med & Global Hlth, Malmo, Sweden; [Ross, Michael] Univ Minnesota, Sch Med, Dept Family Med & Community Hlth, Minneapolis, MN 55455 USA; [Tumwine, Gilbert] St Francis Hosp, Dept Obstet & Gynaecol, Nsambya, Uganda; [Mansson, Sven-Axel] Malmo Univ, Ctr Sexol & Sexual Studies, Malmo, Sweden; [Simpson, Julie A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Patton, George] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Adolescent Hlth,Dept Paediat, Melbourne, Vic, Australia	Lund University; University of Minnesota System; University of Minnesota Twin Cities; Malmo University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Agardh, A (corresponding author), Lund Univ, Dept Clin Sci, Social Med & Global Hlth, Malmo, Sweden.	anette.agardh@med.lu.se	Ribeiro, Ana Cristina/HHN-7466-2022; Patton, George C/B-5246-2013	Ribeiro, Ana Cristina/0000-0002-0493-8376; Patton, George C/0000-0001-5039-8326; Ross, Michael/0000-0002-5718-9989	Swedish International Cooperation Agency (SIDA) [SWE-2004-200A, 2005-147]	Swedish International Cooperation Agency (SIDA)	This study was supported by grants from the Swedish International Cooperation Agency (SIDA), project grant number SWE-2004-200A and PhD grant number 2005-147 (URL: www.sida.se - author: AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-527; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Brown R., 2012, ANN SURVEY INT COMP, V18, P45; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Chapleau KM, 2014, J TRAUMA DISSOCIATIO, V15, P204, DOI 10.1080/15299732.2014.867573; Dingeta T, 2012, PAN AFR MED J, V12; Dunkle KL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001472; Faulkner AH, 1998, AM J PUBLIC HEALTH, V88, P262, DOI 10.2105/AJPH.88.2.262; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; Hayes J, 2012, ARCH SEX BEHAV, V41, P631, DOI 10.1007/s10508-011-9856-8; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; Kinyanda E, 2011, SOC PSYCH PSYCH EPID, V46, P35, DOI 10.1007/s00127-009-0164-8; LEWIN B, 2000, SEX SWEDEN SWEDISH S; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Nala R, 2015, AIDS BEHAV, V19, P393, DOI 10.1007/s10461-014-0895-8; Nyanzi S, 2013, CULT HEALTH SEX, V15, P952, DOI 10.1080/13691058.2013.798684; Olukya G, 2010, HUFFING POST; Peltzer K, 2014, J PSYCHOL AFR, V24, P241, DOI 10.1080/14330237.2014.906083; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; Ross MW, 2013, INT J STD AIDS, V24, P409, DOI 10.1177/0956462412472793; SELL RL, 1995, ARCH SEX BEHAV, V24, P235, DOI 10.1007/BF01541598; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Statistics UBos, 2006, 2002 UG POP HOUS CEN; Windle M, 1996, J STUD ALCOHOL, V57, P627, DOI 10.15288/jsa.1996.57.627	27	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150627	10.1371/journal.pone.0150627	http://dx.doi.org/10.1371/journal.pone.0150627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982494	Green Published, gold			2022-12-27	WOS:000372574900046
J	Lafferriere, NAR; Antelo, R; Alda, F; Martensson, D; Hailer, F; Castroviejo-Fisher, S; Ayarzaguena, J; Ginsberg, JR; Castroviejo, J; Doadrio, I; Vila, C; Amato, G				Lafferriere, Natalia A. Rossi; Antelo, Rafael; Alda, Fernando; Martensson, Dick; Hailer, Frank; Castroviejo-Fisher, Santiago; Ayarzagueena, Jose; Ginsberg, Joshua R.; Castroviejo, Javier; Doadrio, Ignacio; Vila, Carles; Amato, George			Multiple Paternity in a Reintroduced Population of the Orinoco Crocodile (Crocodylus intermedius) at the El Frio Biological Station, Venezuela	PLOS ONE			English	Article							GENETIC DIVERSITY; SPERM STORAGE; AMERICAN ALLIGATOR; PARENTAGE ANALYSIS; MATING SYSTEMS; MATE CHOICE; REPRODUCTIVE SUCCESS; NATURAL-POPULATIONS; MICROSATELLITE DATA; GENOTYPING ERRORS	The success of a reintroduction program is determined by the ability of individuals to reproduce and thrive. Hence, an understanding of the mating system and breeding strategies of reintroduced species can be critical to the success, evaluation and effective management of reintroduction programs. As one of the most threatened crocodile species in the world, the Orinoco crocodile (Crocodylus intermedius) has been reduced to only a few wild populations in the Llanos of Venezuela and Colombia. One of these populations was founded by reintroduction at Cano Macanillal and La Ramera lagoon within the El Frio Biological Station, Venezuela. Twenty egg clutches of C. intermedius were collected at the El Frio Biological Station for incubation in the lab and release of juveniles after one year. Analyzing 17 polymorphic microsatellite loci from 335 hatchlings we found multiple paternity in C. intermedius, with half of the 20 clutches fathered by two or three males. Sixteen mothers and 14 fathers were inferred by reconstruction of multilocus parental genotypes. Our findings showed skewed paternal contributions to multiple-sired clutches in four of the clutches (40%), leading to an overall unequal contribution of offspring among fathers with six of the 14 inferred males fathering 90% of the total offspring, and three of those six males fathering more than 70% of the total offspring. Our results provide the first evidence of multiple paternity occurring in the Orinoco crocodile and confirm the success of reintroduction efforts of this critically endangered species in the El Frio Biological Station, Venezuela.	[Lafferriere, Natalia A. Rossi; Ginsberg, Joshua R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Lafferriere, Natalia A. Rossi; Amato, George] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Antelo, Rafael] Fdn Palmarito Casanare, Bogota, Colombia; [Antelo, Rafael; Alda, Fernando; Doadrio, Ignacio] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolutiva, E-28006 Madrid, Spain; [Antelo, Rafael; Ayarzagueena, Jose; Castroviejo, Javier] Estn Biol Frio, Apure, Venezuela; [Alda, Fernando] Louisiana State Univ, Dept Biol Sci, LSU Museum Nat Sci, Baton Rouge, LA 70803 USA; [Martensson, Dick] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden; [Hailer, Frank] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hailer, Frank] Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Castroviejo-Fisher, Santiago] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Sistemat Vertebrados, Porto Alegre, RS, Brazil; [Ginsberg, Joshua R.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Castroviejo, Javier] Asociac Amigos Donana, Seville, Spain; [Vila, Carles] CSIC, EBD, Conservat & Evolutionary Genet Grp, E-41080 Seville, Spain	Columbia University; American Museum of Natural History (AMNH); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Louisiana State University System; Louisiana State University; Uppsala University; Cardiff University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Pontificia Universidade Catolica Do Rio Grande Do Sul; Cary Institute of Ecosystem Studies; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lafferriere, NAR (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA.; Lafferriere, NAR (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	nar2118@columbia.edu	Doadrio, Ignacio/F-8448-2016; Hailer, Frank/C-9114-2012; Castroviejo-Fisher, Santiago/G-9007-2013; Hailer, Frank/Y-3595-2019; Vila, Carles/H-4893-2013; Alda, Fernando/C-5646-2011	Doadrio, Ignacio/0000-0003-4863-9711; Hailer, Frank/0000-0002-2340-1726; Castroviejo-Fisher, Santiago/0000-0002-1048-2168; Hailer, Frank/0000-0002-2340-1726; Vila, Carles/0000-0002-4206-5246; Alda, Fernando/0000-0002-6858-9566	Department of Evolutionary biology, Uppsala University, Uppsala, Sweden; Dpto. Biodiversidad y Biologia Evolutiva, Museo Nacional de Ciencias Naturales, CSIC, Madrid, Spain; Sackler Institute of Comparative Genomics at the American Museum of Natural History (NARL)	Department of Evolutionary biology, Uppsala University, Uppsala, Sweden; Dpto. Biodiversidad y Biologia Evolutiva, Museo Nacional de Ciencias Naturales, CSIC, Madrid, Spain; Sackler Institute of Comparative Genomics at the American Museum of Natural History (NARL)	Funders included the Department of Evolutionary biology, Uppsala University, Uppsala, Sweden (DM), to support fieldwork and laboratory work; Dpto. Biodiversidad y Biologia Evolutiva, Museo Nacional de Ciencias Naturales, CSIC, Madrid, Spain (RA FA SCF ID), to support fieldwork and laboratory work; Sackler Institute of Comparative Genomics at the American Museum of Natural History (NARL), to support data analysis and preparation of manuscript.	Adams EM, 2005, MOL ECOL, V14, P1803, DOI 10.1111/j.1365-294X.2005.02539.x; Alonso-Tabet M, 2009, COMPORTAMIENTO COCOD; Amavet P, 2008, J EXP ZOOL PART A, V309A, P637, DOI 10.1002/jez.496; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; [Anonymous], 2010, R LANG ENV STAT COMP; Antelo R, 2008, THESIS U AUTONOMA MA; Antelo R, 2010, HERPETOL J, V20, P51; Bach L, 2012, AQUAT TOXICOL, V114, P58, DOI 10.1016/j.aquatox.2012.02.003; Ballouard JM, 2010, AQUAT CONSERV, V20, P756, DOI 10.1002/aqc.1151; Barros Tito, 2010, Conservation Evidence, V7, P111; Birkhead TR, 2000, EVOLUTION, V54, P1057; Boomer JJ, 2013, J HERED, V104, P371, DOI 10.1093/jhered/est010; Brante A, 2011, J EXP MAR BIOL ECOL, V396, P83, DOI 10.1016/j.jembe.2010.10.001; Budd KM, 2015, S AM J HERPETOL, V10, P4, DOI 10.2994/SAJH-D-14-00022.1; Calsbeek R, 2007, EVOL ECOL RES, V9, P495; Canal D, 2012, BEHAV ECOL SOCIOBIOL, V66, P67, DOI 10.1007/s00265-011-1253-8; Castro Casal Antonio, 2013, Biota Colombiana, V14, P65; Chave C., 2002, VIDA SILVESTRE NEOTR, V11, P23; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Daltry Jennifer C., 2010, P118; Davenport Michael, 1995, Herpetological Review, V26, P14; Dever JA, 2002, COPEIA, P1078; Dever JA, 2001, J HERPETOL, V35, P541, DOI 10.2307/1565981; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; Elsey RM, 2008, SOUTHEAST NAT, V7, P737, DOI 10.1656/1528-7092-7.4.737; Espinosa-Blanco AS, 2013, INTERCIENCIA, V38, P358; Farias IP, 2004, ANIM CONSERV, V7, P265, DOI 10.1017/S136794300400143X; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; FitzSimmons N, 2001, MICROSATELLITE MARKE, P51; GARRICK LD, 1977, AM ZOOL, V17, P225; Gist DH, 2008, J EXP ZOOL PART A, V309A, P581, DOI 10.1002/jez.434; Grigg G, 2015, BIOLOGY AND EVOLUTION OF CROCODYLIANS, P1; Gumilla J, 1745, HIST NATURAL; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; Hernandez O, 2014, VENEZUELA B ACAD CIE, V2, P53; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hu Y, 2010, AMPHIBIA-REPTILIA, V31, P419, DOI 10.1163/156853810791769446; Jamieson IG, 2012, REINTRODUCTION BIOL, V12, P441; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones B, 2007, GENETICS, V176, P2427, DOI 10.1534/genetics.106.067066; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KOFRON CP, 1990, J ZOOL, V221, P477, DOI 10.1111/j.1469-7998.1990.tb04014.x; LANCE VA, 1989, AM ZOOL, V29, P999; Lewis JL, 2013, J HERPETOL, V47, P24, DOI 10.1670/10-303; Liu JX, 2011, MAR BIOL, V158, P893, DOI 10.1007/s00227-010-1616-0; Martinez JL, 2000, MOL ECOL, V9, P293, DOI 10.1046/j.1365-294x.2000.00857.x; McVay JD, 2008, J EXP ZOOL PART A, V309A, P643, DOI 10.1002/jez.500; Medem F., 1981, CROCODYLIA AM; Miles LG, 2009, CONSERV GENET, V10, P963, DOI 10.1007/s10592-008-9600-7; Milian-Garcia Y, 2011, J EXP ZOOL PART A, V315A, P358, DOI 10.1002/jez.683; Moller AP, 2000, BEHAV ECOL, V11, P161, DOI 10.1093/beheco/11.2.161; Moorhouse TP, 2009, BIOL CONSERV, V142, P53, DOI 10.1016/j.biocon.2008.09.023; Muniz FL, 2011, AMPHIBIA-REPTILIA, V32, P428, DOI 10.1163/017353711X587741; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; Neuman W, 2013, NY TIMES, pA4; Nonacs P, 2003, ANIM BEHAV, V65, P615, DOI 10.1006/anbe.2003.2096; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Oliveira DP, 2014, J HERED, V105, P485, DOI 10.1093/jhered/esu020; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Perez I, 2012, FRONT ECOL ENVIRON, V10, P494, DOI 10.1890/110175; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Rafajlovic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075587; RAMO C, 1992, BIOL CONSERV, V60, P101, DOI 10.1016/0006-3207(92)91160-T; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reynolds John D., 1996, Trends in Ecology and Evolution, V11, P68, DOI 10.1016/0169-5347(96)81045-7; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Rodriguez-Soberon R., 1996, CROCODILE SPECIALIST, V15, P10; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rubenstein DR, 2007, P R SOC B, V274, P1895, DOI 10.1098/rspb.2007.0424; Schmidt F., 2015, International Zoo Yearbook, V49, P125, DOI 10.1111/izy.12082; Sefc KM, 2009, J HERED, V100, P197, DOI 10.1093/jhered/esn095; SUGG DW, 1994, GENETICS, V137, P1147; Taylor ML, 2014, TRENDS ECOL EVOL, V29, P376, DOI 10.1016/j.tree.2014.04.005; Thorbjarnarson J. B., 1989, CROCODILES THEIR ECO, P228; THORBJARNARSON JB, 1992, BIOL CONSERV, V62, P179, DOI 10.1016/0006-3207(92)91046-U; Thorbjarnarson JB, 1993, J HERPETOL, P363; Thorbjarnarson JB, 1993, J HERPETOL, P371; Thorbjarnarson JB, 1996, HERPETOLOGICA, P8; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Weerd M, 2010, ORYX, V44, P13; Vliet KA, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P383; Wang, 2012, MICRODROP PROGRAM ES; Wang CL, 2012, GENETICS, V192, P651, DOI 10.1534/genetics.112.139519; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang ZH, 2011, CHINESE SCI BULL, V56, P2586, DOI 10.1007/s11434-011-4615-8; Willoughby JR, 2015, MOL ECOL, V24, P98, DOI 10.1111/mec.13020; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	94	14	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150245	10.1371/journal.pone.0150245	http://dx.doi.org/10.1371/journal.pone.0150245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982578	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900027
J	Li, X; Niu, X; Wang, B; Gao, P; Liu, Y				Li, Xiao; Niu, Xiang; Wang, Bing; Gao, Peng; Liu, Yu			Driving Forces of Dynamic Changes in Soil Erosion in the Dahei Mountain Ecological Restoration Area of Northern China Based on GIS and RS	PLOS ONE			English	Article							COVER CHANGE; LAND-USE; RISK; VEGETATION; IMPACT; BASIN	Dynamic change in soil erosion is an important focus of regional ecological restoration research. Here, the dynamic changes of soil erosion and its driving forces in the Dahei Mountain ecological restoration area of northern China were analyzed by LANDSAT TM remote sensing captured via geographic information system (GIS) technologies during three typical periods in 2004, 2008 and 2013. The results showed the following: (1) a decrease in intensive erosion and moderate erosion areas, as well as an increase in light erosion areas, was observed during two periods: one from 2004 to 2008 and the other from 2008 to 2013. (2) Between 2004 and 2008, the variation in the range of slight erosion was the largest (24.28%), followed by light erosion and intensive erosion; between 2008 and 2013, the variation in the range of intensive erosion area was the largest (9.89%), followed by slight erosion and moderate erosion. (3) Socioeconomic impact, accompanied by natural environmental factors, was the main driving force underlying the change in soil erosion within the ecological restoration area. In particular, the socioeconomic factors of per capita forest area and land reclamation rate, as well as the natural environmental factor of terrain slope, significantly influenced soil erosion changes within the ecological restoration area.	[Li, Xiao; Gao, Peng; Liu, Yu] Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Tai An 271018, Shandong, Peoples R China; [Niu, Xiang; Wang, Bing] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing 100091, Peoples R China	Shandong Agricultural University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Gao, P (corresponding author), Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Tai An 271018, Shandong, Peoples R China.; Niu, X (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing 100091, Peoples R China.	niuxiang0603@163.com; gaopengy@163.com			Special Fund for Forestry Scientific Research in the Public Interest [201204101, 201404303]; CFERN Award Fund; GENE Award Fund	Special Fund for Forestry Scientific Research in the Public Interest; CFERN Award Fund; GENE Award Fund	The study was supported by the Special Fund for Forestry Scientific Research in the Public Interest (No.201204101; No.201404303). In addition, this paper was supported by CFERN & GENE Award Funds for Ecological Papers.	Alkharabsheh MM, 2013, PROCEDIA ENVIRON SCI, V19, P912, DOI 10.1016/j.proenv.2013.06.101; Andrade RFS, 2006, EUR PHYS J B, V50, P33, DOI 10.1140/epjb/e2006-00114-1; Arekhi S, 2012, ARAB J GEOSCI, V5, P285, DOI 10.1007/s12517-010-0220-4; Bahadur KCK, 2009, ENVIRON GEOL, V57, P695, DOI 10.1007/s00254-008-1348-3; Bhandari KP, 2015, NAT HAZARDS, V75, P321, DOI 10.1007/s11069-014-1321-2; Dotterweich M, 2013, GEOMORPHOLOGY, V201, P1, DOI 10.1016/j.geomorph.2013.07.021; Duan WX, 2011, SCI SOIL WATER CONSE, P38; Fan JR, 2001, J SOIL WATER CONSERV, V15, P25; Nacinovic MGG, 2014, SOIL TILL RES, V144, P164, DOI 10.1016/j.still.2014.07.002; Hu SW, 2006, YUNNAN GEOGRAPHIC EN, V18, P40; Jain SK, 2001, WATER RESOUR MANAG, V15, P41, DOI 10.1023/A:1012246029263; Jellinek S, 2014, BIOL CONSERV, V169, P60, DOI 10.1016/j.biocon.2013.10.023; Jin JS, 2011, ECOL COMPLEX, V8, P161, DOI 10.1016/j.ecocom.2011.01.005; Kachouri S, 2015, ARAB J GEOSCI, V8, P4257, DOI 10.1007/s12517-014-1464-1; Lin WH, 2007, YELLOW RIVER, V29, P71; Liu X, 2008, SPORTS ETHICS, V6, P27; [吕航 LV Hang], 2007, [遥感技术与应用, Remote Sensing Technology and Application], V22, P715; Lv XZ, 2012, J FOOD AGRIC ENVIRON, V10, P1045; [孟国才 MENG Guocai], 2007, [干旱区地理, Arid Land Geography], V30, P759; Mosbahi M, 2013, ARAB J GEOSCI, V6, P4011, DOI 10.1007/s12517-012-0658-7; Na B., 2008, GRASSLAND TURF, P13; Naqvi HR, 2013, ARAB J GEOSCI, V6, P4045, DOI 10.1007/s12517-012-0661-z; Niu RQ, 2014, ENVIRON EARTH SCI, V72, P2741, DOI 10.1007/s12665-014-3179-8; Pijanowski B. C., 2002, Computers, Environment and Urban Systems, V26, P553, DOI 10.1016/S0198-9715(01)00015-1; Pradhan B, 2012, ENVIRON MONIT ASSESS, V184, P715, DOI 10.1007/s10661-011-1996-8; Ren ZP, 2009, EVALUATION REGIONAL; Rozos D, 2013, ENVIRON EARTH SCI, V70, P3255, DOI 10.1007/s12665-013-2390-3; Uchida S, 2015, PROCEDIA ENVIRON SCI, V24, P29, DOI 10.1016/j.proenv.2015.03.005; WANG B., 2011, OBSERVATION METHODOL, P133; Wang SJ, 2009, SOIL BIOL BIOCHEM, V41, P891, DOI 10.1016/j.soilbio.2008.12.016; Wijitkosum S, 2012, SOIL WATER RES, V7, P10, DOI 10.17221/32/2011-SWR; Wu YongHong, 2004, Ganhanqu Yanjiu (Arid Zone Research), V21, P259; YANG H.L., 2009, SCI SOIL WATER CONSE, V7, P52; Yang QY, 2014, ENVIRON EARTH SCI, V71, P287, DOI 10.1007/s12665-013-2432-x; Yoo K, 2015, SCI TOTAL ENVIRON, V521, P326, DOI 10.1016/j.scitotenv.2015.03.084; Yu X. X., 2004, SCI SOIL WATER CONSE, V2, P4; Zang S., 2007, J BEIJING FOR UNIV, V29, P216; [张喜旺 Zhang Xiwang], 2010, [土壤通报, Journal of Soil Science], V41, P1010; Zhao XN, 2014, NAT HAZARDS, V70, P957, DOI 10.1007/s11069-013-0849-x; [郑云龙 Zheng Yunlong], 2014, [山地学报, Mountain Research], V32, P691; Zhuang D., 1997, J NAT RESOUR, V12, P105, DOI DOI 10.11849/ZRZYXB.1997.02.002	41	7	8	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0142331	10.1371/journal.pone.0142331	http://dx.doi.org/10.1371/journal.pone.0142331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981637	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900011
J	Ma, TT; Chen, LK; Wu, LH; Zhang, HB; Luo, YM				Ma, Tingting; Chen, Li'ke; Wu, Longhua; Zhang, Haibo; Luo, Yongming			Oxidative Stress, Cytotoxicity and Genotoxicity in Earthworm Eisenia fetida at Different Di-n-Butyl Phthalate Exposure Levels	PLOS ONE			English	Article							NEUTRAL RED RETENTION; DNA-DAMAGE; COMET ASSAY; FOETIDA; ESTERS; SOIL; CELOMOCYTES; BIOMARKER; CELLS; EXPRESSION	Recognized as ubiquitous contaminants in soil, the environmental risk of phthalic acid esters (PAEs) is of great concern recently. Effects of di-n-butyl phthalate (DnBP), an extensively used PAE compound to Eisenia fetida have been investigated in spiked natural brown yellow soil (Alfisol) for soil contact test. The toxicity of DnBP to E. fetida on the activity of superoxide dismutase (SOD) activity, peroxidase (POD), reactive oxygen species (ROS) content, and the apoptosis of coelomocytes and DNA damage at the 7th, 14th, 21st and 28th day of the incubation have been paid close attention to. In general, SOD activity and ROS content were significantly induced, opposite to total protein content and POD activity, during the toxicity test of 28 days especially under concentrations higher than 2.5 mg kg(-1). The reduction in neutral red retention (NRR) time along with the increase of dead coelomocytes as the increasing of DnBP concentrations, indicating severe damage to cell viability under varying pollutant stress during cultivation, which could also be proved by comet assay results for exerting evident DNA damage in coelomocytes. DnBP in spiked natural soil could indeed cause damage to tissues, coelomocytes and the nucleus of E. fetida. The key point of the apparent change in different indices presented around 2.5 mg DnBP kg(-1) soil, which could be recommended as the threshold of DnBP soil contamination, so that further investigation on threshold values to other soil animals or microorganisms could be discussed.	[Ma, Tingting] Hubei Univ Arts & Sci, Inst Hanjiang, Xiangyang, Peoples R China; [Ma, Tingting; Chen, Li'ke; Wu, Longhua; Zhang, Haibo; Luo, Yongming] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China; [Chen, Li'ke] Shanghai Res Inst Chem Ind, Shanghai, Peoples R China; [Zhang, Haibo; Luo, Yongming] Chinese Acad Sci, Yantai Inst Costal Zone Res, Key Lab Coastal Zone Environm Proc, Yantai, Peoples R China	Hubei University of Arts & Science; Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Luo, YM (corresponding author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China.; Luo, YM (corresponding author), Chinese Acad Sci, Yantai Inst Costal Zone Res, Key Lab Coastal Zone Environm Proc, Yantai, Peoples R China.	ymluo@yic.ac.cn		WU, Longhua/0000-0002-0287-8963	National Natural Science Foundation of China [41401581, 41271326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this work was provided by National Natural Science Foundation of China (41401581 & 41271326).; This research was supported by the National Natural Science Foundation of China (41401581 & 41271326). We thank Hui Zhao who worked in Life Science Experiment Teaching Center of Nanjing Normal University for the help in the Instrument use of FACScan Flow Cytometer and data analysis of apoptosis experiment.	BATE CM, 1976, EXPERIENTIA, V32, P451, DOI 10.1007/BF01920789; Bigorgne E, 2011, ENVIRON POLLUT, V159, P2698, DOI 10.1016/j.envpol.2011.05.024; BILEJ M, 1990, CELL BIOL INT REP, V14, P831, DOI 10.1016/0309-1651(90)90010-V; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Ding JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119216; Duan XC, 2015, ENVIRON TOXICOL CHEM, V34, P283, DOI 10.1002/etc.2785; EYAMBE GS, 1991, LAB ANIM, V25, P61, DOI 10.1258/002367791780808095; Garcia-Gomez C, 2014, ARCH ENV CONTAM TOXI, V67, P1; Gichner T, 2004, MUTAT RES-GEN TOX EN, V559, P49, DOI 10.1016/j.mrgentox.2003.12.008; Hu CW, 2014, SOIL BIOL BIOCHEM, V70, P123, DOI 10.1016/j.soilbio.2013.12.018; Il Kwak J, 2014, ENVIRON RES, V134, P118, DOI 10.1016/j.envres.2014.07.014; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; KONO Y, 1982, J BIOL CHEM, V257, P5751; Liu S, 2011, CHEMOSPHERE, V83, P1080, DOI 10.1016/j.chemosphere.2011.01.046; Loeb MJ, 2000, ARCH INSECT BIOCHEM, V45, P12, DOI 10.1002/1520-6327(200009)45:1&lt;12::AID-ARCH2&gt;3.0.CO;2-P; Ma TT, 2013, FRONT ENV SCI ENG, V7, P31, DOI 10.1007/s11783-012-0463-2; Pant N, 2014, ENVIRON SCI POLLUT R, V21, P11066, DOI 10.1007/s11356-014-2986-5; Plytycz B, 2007, EUR J SOIL BIOL, V43, pS116, DOI 10.1016/j.ejsobi.2007.08.050; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; Rieder SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061215; ROBERTS R, 2000, APOPTOSIS TOXICOLOGY; Sabatini SE, 2009, ECOTOX ENVIRON SAFE, V72, P1200, DOI 10.1016/j.ecoenv.2009.01.003; Scott-Fordsmand JJ, 2000, REV ENVIRON CONTAM T, V165, P117; Song Y, 2009, SOIL BIOL BIOCHEM, V41, P905, DOI 10.1016/j.soilbio.2008.09.009; Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Svendsen C, 2004, ECOTOX ENVIRON SAFE, V57, P20, DOI 10.1016/j.ecoenv.2003.08.009; TAN GH, 1995, B ENVIRON CONTAM TOX, V54, P171, DOI 10.1007/BF00197427; Teil MJ, 2006, SCI TOTAL ENVIRON, V354, P212, DOI 10.1016/j.scitotenv.2004.12.083; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang J, 2013, ENVIRON POLLUT, V180, P265, DOI 10.1016/j.envpol.2013.05.036; Weeks JM, 1996, ENVIRON TOXICOL CHEM, V15, P1801, DOI [10.1002/etc.5620151022, 10.1897/1551-5028(1996)015&lt;1801:NRRBLF&gt;2.3.CO;2]; Xue YG, 2009, ECOTOXICOLOGY, V18, P693, DOI 10.1007/s10646-009-0333-2; Yin R, 2003, CHEMOSPHERE, V50, P801, DOI 10.1016/S0045-6535(02)00222-9; Zhang W, 2015, ECOTOX ENVIRON SAFE, V113, P45, DOI 10.1016/j.ecoenv.2014.11.014	35	32	33	11	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151128	10.1371/journal.pone.0151128	http://dx.doi.org/10.1371/journal.pone.0151128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982081	gold, Green Published			2022-12-27	WOS:000372574900063
J	Tachet, R; Santi, P; Sobolevsky, S; Reyes-Castro, LI; Frazzoli, E; Helbing, D; Ratti, C				Tachet, Remi; Santi, Paolo; Sobolevsky, Stanislav; Reyes-Castro, Luis Ignacio; Frazzoli, Emilio; Helbing, Dirk; Ratti, Carlo			Revisiting Street Intersections Using Slot-Based Systems	PLOS ONE			English	Article							MODEL; QUEUE; DELAY	Since their appearance at the end of the 19th century, traffic lights have been the primary mode of granting access to road intersections. Today, this centuries-old technology is challenged by advances in intelligent transportation, which are opening the way to new solutions built upon slot-based systems similar to those commonly used in aerial traffic: what we call Slot-based Intersections (SIs). Despite simulation-based evidence of the potential benefits of SIs, a comprehensive, analytical framework to compare their relative performance with traffic lights is still lacking. Here, we develop such a framework. We approach the problem in a novel way, by generalizing classical queuing theory. Having defined safety conditions, we characterize capacity and delay of SIs. In the 2-road crossing configuration, we provide a capacity-optimal SI management system. For arbitrary intersection configurations, near-optimal solutions are developed. Results theoretically show that transitioning from a traffic light system to SI has the potential of doubling capacity and significantly reducing delays. This suggests a reduction of non-linear dynamics induced by intersection bottlenecks, with positive impact on the road network. Such findings can provide transportation engineers and planners with crucial insights as they prepare to manage the transition towards a more intelligent transportation infrastructure in cities.	[Tachet, Remi; Santi, Paolo; Sobolevsky, Stanislav; Ratti, Carlo] MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Santi, Paolo] CNR, Ist Informat & Telemat, I-56100 Pisa, Italy; [Reyes-Castro, Luis Ignacio; Frazzoli, Emilio] MIT, Lab Informat & Decis Syst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Helbing, Dirk] ETH, Computat Social Sci, Clausiusstr 50, CH-8092 Zurich, Switzerland	Massachusetts Institute of Technology (MIT); Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR); Massachusetts Institute of Technology (MIT); Swiss Federal Institutes of Technology Domain; ETH Zurich	Santi, P (corresponding author), MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Santi, P (corresponding author), CNR, Ist Informat & Telemat, I-56100 Pisa, Italy.	psanti@mit.edu	Sobolevsky, Stanislav/ABH-7108-2020	Sobolevsky, Stanislav/0000-0001-6281-0656; /0000-0002-0505-1400	Volkswagen Electronics Research Lab; ENEL Foundation; Accenture China; American Air Liquide; Emirates Integrated Telecommunications Company (du); Ericsson; Kuwait-MIT Center for Natural Resources and the Environment; Liberty Mutual Institute; Singapore-MIT Alliance for Research and Technology (SMART); Regional Municipality of Wood Buffalo	Volkswagen Electronics Research Lab; ENEL Foundation; Accenture China; American Air Liquide; Emirates Integrated Telecommunications Company (du); Ericsson(Ericsson); Kuwait-MIT Center for Natural Resources and the Environment; Liberty Mutual Institute; Singapore-MIT Alliance for Research and Technology (SMART)(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Regional Municipality of Wood Buffalo	R.T., P.S., S.S., and C.R. thank Volkswagen Electronics Research Lab, ENEL Foundation, Accenture China, American Air Liquide, Emirates Integrated Telecommunications Company (du), Ericsson, Kuwait-MIT Center for Natural Resources and the Environment, Liberty Mutual Institute, Singapore-MIT Alliance for Research and Technology (SMART), Regional Municipality of Wood Buffalo, and all the members of the MIT Senseable City Lab Consortium for supporting this research. E.F. thanks the Future Urban Mobility program at the Singapore-MIT Alliance for Research and Technology (SMART).	Banerjee A, 2014, COMPUT IND ENG, V75, P121, DOI 10.1016/j.cie.2014.06.009; Claeys D, 2013, COMPUT OPER RES, V40, P1497, DOI 10.1016/j.cor.2012.10.009; Claeys D, 2010, MATH METHOD OPER RES, V72, P1, DOI 10.1007/s00186-009-0297-2; Cohen J., 1969, SINGLE SERVER QUEUE; Courtois P. J., 1974, OPER RES, V19, P424, DOI [10.1287/opre.19.2.424, DOI 10.1287/OPRE.19.2.424]; Dresner K, 2008, J ARTIF INTELL RES, V31, P591, DOI 10.1613/jair.2502; Eichler D, 2013, NETW SPAT ECON, V13, P229, DOI 10.1007/s11067-012-9179-x; Gazis D. C., 2002, TRAFFIC THEORY; Giridhar A, 2006, IEEE T VEH TECHNOL, V55, P1467, DOI 10.1109/TVT.2006.877472; Gupta UC, 1998, OR SPEKTRUM, V20, P83; HARRIS CM, 1967, OPER RES, V15, P117, DOI 10.1287/opre.15.1.117; Hausknecht M, 2011, IEEE INT C INT ROBOT, P4581, DOI 10.1109/IROS.2011.6048565; Heidemann D, 2001, TRANSPORT SCI, V35, P405, DOI 10.1287/trsc.35.4.405.10430; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D., 1992, Complex Systems, V6, P391; Helbing D, 2009, EUR PHYS J B, V70, P229, DOI 10.1140/epjb/e2009-00093-7; Helbing D., 2006, ECONOPHYSICS SOCIOPH, P535; Kleinrock L, 1975, QUEUING SYSTEMS, V1; Kowshik H, 2011, IEEE T VEH TECHNOL, V60, P804, DOI 10.1109/TVT.2011.2107584; Lammer S, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/04/P04019; Lee J, 2012, IEEE T INTELL TRANSP, V13, P81, DOI 10.1109/TITS.2011.2178836; Roess R.P., 2010, TRAFFIC ENG; Tang TQ, 2010, INT J MOD PHYS C, V21, P159, DOI 10.1142/S0129183110015038; Tang TQ, 2012, NONLINEAR DYNAM, V67, P2255, DOI 10.1007/s11071-011-0143-y; van Leeuwaarden JSH, 2006, TRANSPORT SCI, V40, P189, DOI 10.1287/trsc.1050.0125; Van Woensel T, 2007, ASIA PAC J OPER RES, V24, P435, DOI 10.1142/S0217595907001383; World Bank, 2009, WORLD DEV IND	27	117	122	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149607	10.1371/journal.pone.0149607	http://dx.doi.org/10.1371/journal.pone.0149607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982532	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900016
J	Krukowski, RA; Bursac, Z; Little, MA; Klesges, RC				Krukowski, Rebecca A.; Bursac, Zoran; Little, Melissa A.; Klesges, Robert C.			The Relationship between Body Mass Index and Post-Cessation Weight Gain in the Year after Quitting Smoking: A Cross-Sectional Study	PLOS ONE			English	Article							MORTALITY; HEIGHT	Introduction There is wide variability in the amount of weight gained when quitting smoking, but little is known about key predictors of weight gain. We examined the impact of body mass index (BMI) category and sociodemographic variables on post-cessation weight gain. Materials and Methods We utilized National Health and Nutrition Examination Survey data from five consecutive cycles of data collection from 2003-2004 to 2011-2012 to estimate post-cessation weight gain by BMI category among recent quitters (n = 654). We analyzed data on their "current weight" and their "past year weight". We also compared the recent quitters with current smokers, in order to estimate the amount of weight that could be attributed to quitting smoking. Results Recent quitters gained 1.4 kg (95% CI: 0.8 to 2.0), while current smokers had a non-significant weight change (-0.01 kg (95% CI: -0.3 to 0.2). Weight gain was significant for those in the normal weight (3.1 kg, 95% CI: 2.3 to 3.9) and overweight BMI categories (2.2 kg, 95% CI: 1.1 to 3.2). Conclusions BMI category is a key factor in the extent of post-cessation weight gain, with normal and overweight recent quitters gaining significant amounts of weight.	[Krukowski, Rebecca A.; Bursac, Zoran; Little, Melissa A.; Klesges, Robert C.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Ctr Populat Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Krukowski, RA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Ctr Populat Sci, Memphis, TN 38163 USA.	rkrukows@uthsc.edu	Krukowski, Becca/GVU-7068-2022; Krukowski, Rebecca/AAS-4304-2020; Bursac, Zoran/AAH-9152-2021; Krukowski, Becca/GQI-3653-2022	Krukowski, Becca/0000-0001-9193-2783; Krukowski, Rebecca/0000-0001-9193-2783; Krukowski, Becca/0000-0001-9193-2783; Bursac, Zoran/0000-0001-9306-0907				Aubin Henri-Jean, 2012, BMJ, V345, pe4439, DOI 10.1136/bmj.e4439; BROWMAN GP, 1993, NEW ENGL J MED, V328, P159, DOI 10.1056/NEJM199301213280302; Bush TM, 2014, ANN BEHAV MED, V47, P208, DOI 10.1007/s12160-013-9537-z; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; Flegal KM, 2012, PREV MED, V54, P193, DOI 10.1016/j.ypmed.2012.01.015; Godtfredsen NS, 2008, EUR RESPIR J, V32, P844, DOI 10.1183/09031936.00160007; Janzon E, 2004, J INTERN MED, V255, P266, DOI 10.1046/j.1365-2796.2003.01293.x; Kasteridis P, 2012, HEALTH SERV RES, V47, P1580, DOI 10.1111/j.1475-6773.2012.01380.x; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; KLESGES RC, 1989, PSYCHOL BULL, V106, P204, DOI 10.1037/0033-2909.106.2.204; KLESGES RC, 1988, HEALTH PSYCHOL, V7, P575, DOI 10.1037/0278-6133.7.6.575; KLESGES RC, 1992, HEALTH PSYCHOL, V11, P1, DOI 10.1037/h0090339; Komiyama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072010; Lycett D, 2011, ADDICTION, V106, P188, DOI 10.1111/j.1360-0443.2010.03136.x; Merrill RM, 2009, PREV CHRONIC DIS, V6; MUST A, 1993, AM J EPIDEMIOL, V138, P56, DOI 10.1093/oxfordjournals.aje.a116777; Nilsson P, 1996, J INTERN MED, V240, P189, DOI 10.1046/j.1365-2796.1996.16844000.x; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Siahpush M, 2013, IT IS BETTER BE FAT; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Travier N, 2012, PREV MED, V54, P183, DOI 10.1016/j.ypmed.2011.09.003; Veldheer S, 2015, INT J OBESITY, V39, P1727, DOI 10.1038/ijo.2015.127; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106	26	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151290	10.1371/journal.pone.0151290	http://dx.doi.org/10.1371/journal.pone.0151290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977598	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800056
J	Morrill, HJ; Caffrey, AR; Gaitanis, MM; LaPlante, KL				Morrill, Haley J.; Caffrey, Aisling R.; Gaitanis, Melissa M.; LaPlante, Kerry L.			Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program at a Veterans Affairs Medical Center: A Six-Point Assessment	PLOS ONE			English	Article							INTERRUPTED TIME-SERIES; CLOSTRIDIUM-DIFFICILE INFECTION; RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE EPIDEMIOLOGY; DISEASES SOCIETY; ANTIBIOTIC USE; PRESCRIPTION; OUTCOMES; GUIDELINES; REDUCTION	Background Prospective audit and feedback is a core antimicrobial stewardship program (ASP) strategy; however its impact is difficult to measure. Methods Our quasi-experimental study measured the effect of an ASP on clinical outcomes, antimicrobial use, resistance, costs, patient safety (adverse drug events [ADE] and Clostridium difficile infection [CDI]), and process metrics pre-(9/10-10/11) and post-ASP (9/12-10/13) using propensity adjusted and matched Cox proportional-hazards regression models and interrupted time series (ITS) methods. Results Among our 2,696 patients, median length of stay was 1 day shorter post-ASP (5, interquartile range [IQR] 3-8 vs. 4, IQR 2-7 days, p < 0.001). Mortality was similar in both periods. Mean broad-spectrum (-11.3%), fluoroquinolone (-27.0%), and anti-pseudomonal (-15.6%) use decreased significantly (p < 0.05). ITS analyses demonstrated a significant increase in monthly carbapenem use post-ASP (trend: + 1.5 days of therapy/1,000 patient days [1000PD] per month; 95% CI 0.1-3.0). Total antimicrobial costs decreased 14%. Resistance rates did not change in the one-year post-ASP period. Mean CDI rates/10,000PD were low pre-and post-ASP (14.2 +/- 10.4 vs. 13.8 +/- 10.0, p = 0.94). Fewer patients experienced ADEs post-ASP (6.0% vs. 4.4%, p = 0.06). Conclusions Prospective audit and feedback has the potential to improve antimicrobial use and outcomes, and contain bacterial resistance. Our program demonstrated a trend towards decreased length of stay, broad-spectrum antimicrobial use, antimicrobial costs, and adverse events.	[Morrill, Haley J.; Caffrey, Aisling R.; Gaitanis, Melissa M.; LaPlante, Kerry L.] Vet Affairs Med Ctr, Infect Dis Res Program, Providence, RI USA; [Morrill, Haley J.; Caffrey, Aisling R.; LaPlante, Kerry L.] Univ Rhode Isl, Coll Pharm, Dept Pharm Practice, Kingston, RI 02881 USA; [Morrill, Haley J.; Caffrey, Aisling R.; LaPlante, Kerry L.] Vet Affairs Med Ctr, Ctr Ctr Innovat Long Term Serv & Supports, Providence, RI USA; [Gaitanis, Melissa M.; LaPlante, Kerry L.] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; University of Rhode Island; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	LaPlante, KL (corresponding author), Vet Affairs Med Ctr, Infect Dis Res Program, Providence, RI USA.; LaPlante, KL (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Pharm Practice, Kingston, RI 02881 USA.; LaPlante, KL (corresponding author), Vet Affairs Med Ctr, Ctr Ctr Innovat Long Term Serv & Supports, Providence, RI USA.; LaPlante, KL (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA.	KerryLaPlante@uri.edu		LaPlante, Kerry/0000-0002-9650-4275	Office of Research and Development, Department of Veterans Affairs	Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs)	These authors have no support or funding to report. This material is based upon work supported, in part, by the Office of Research and Development, Department of Veterans Affairs.	Ashley ESD, 2014, CLIN INFECT DIS, V59, pS112, DOI 10.1093/cid/ciu546; Bauer KA, 2014, CLIN INFECT DIS, V59, pS134, DOI 10.1093/cid/ciu547; Bornard L, 2011, MED MALADIES INFECT, V41, P480, DOI 10.1016/j.medmal.2010.12.022; Brown SH, 2003, INT J MED INFORM, V69, P135, DOI 10.1016/S1386-5056(02)00131-4; Caffrey AR, 2015, ADV PHARMACOEPIDEMIO, V4, P176, DOI DOI 10.4172/2167-1052.1000176; Camins BC, 2009, INFECT CONT HOSP EP, V30, P931, DOI 10.1086/605924; Centers for Disease Control and Prevention, 2014, ANT US RES AUR MOD; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Centers for Medicare and Medicaid Services, HOSP COMP DAT ARCH; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cook PP, 2004, J ANTIMICROB CHEMOTH, V53, P853, DOI 10.1093/jac/dkh163; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; Dickey DA, STATIONARITY ISSUES; Dunn K, 2011, INT J CLIN PHARM-NET, V33, P208, DOI 10.1007/s11096-010-9475-9; Elligsen M, 2012, INFECT CONT HOSP EP, V33, P354, DOI 10.1086/664757; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Fridkin SK, 2014, CLIN INFECT DIS, V58, P401, DOI 10.1093/cid/cit710; GILLINGS D, 1981, AM J PUBLIC HEALTH, V71, P38, DOI 10.2105/AJPH.71.1.38; Huttner B, 2013, J ANTIMICROB CHEMOTH, V68, P2393, DOI 10.1093/jac/dkt171; Huttner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036649; Lautenbach E, 2006, INFECT CONT HOSP EP, V27, P893, DOI 10.1086/507274; Lesprit P, 2013, CLIN MICROBIOL INFEC, V19, pE91, DOI 10.1111/1469-0691.12062; Manuel O, 2010, J HOSP INFECT, V74, P326, DOI 10.1016/j.jhin.2009.07.011; Masia M, 2008, EUR J CLIN MICROBIOL, V27, P597, DOI 10.1007/s10096-008-0482-x; Maynard C, 2004, DIABETES CARE, V27, pB22, DOI 10.2337/diacare.27.suppl_2.B22; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Rhee SM, 2014, INFECT DIS CLIN N AM, V28, P237, DOI 10.1016/j.idc.2014.01.001; Rhode Island Department of Health Division of Infectious Disease & Epidemiology, INFL EP SUMM REP RHO; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Septimus E, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0433-x; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Standiford HC, 2012, INFECT CONT HOSP EP, V33, P338, DOI 10.1086/664909; Teo J, 2012, EUR J CLIN MICROBIOL, V31, P947, DOI 10.1007/s10096-011-1391-y; The White House, 2015, NAT ACT PLAN COMB AN; VA Inpatient Evaluation Center (IPEC), 2014, CLOSTR DIFF DAT REP; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Weiss CH, 2011, AM J RESP CRIT CARE, V184, P680, DOI 10.1164/rccm.201101-0037OC	40	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150795	10.1371/journal.pone.0150795	http://dx.doi.org/10.1371/journal.pone.0150795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978263	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800036
J	Yang, ZN; Zhou, K; Liu, H; Wu, AD; Mei, L; Liu, QZ				Yang, Zhouning; Zhou, Ke; Liu, Hao; Wu, Andong; Mei, Long; Liu, Qingzhen			SfDredd, a Novel Initiator Caspase Possessing Activity on Effector Caspase Substrates in Spodoptera frugiperda	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DROSOPHILA CASPASE; IN-VIVO; INSECT CELLS; APOPTOSIS; P35; ACTIVATION; INHIBITOR; PROTEASE; IDENTIFICATION	Sf9, a cell line derived from Spodoptera frugiperda, is an ideal model organism for studying insect apoptosis. The first notable study that attempted to identify the apoptotic pathway in Sf9 was performed in 1997 and included the discovery of Sf-caspase-1, an effector caspase of Sf9. However, it was not until 2013 that the first initiator caspase in Sf9, SfDronc, was discovered, and the apoptotic pathway in Sf9 became clearer. In this study, we report another caspase of Sf9, SfDredd. SfDredd is highly similar to insect initiator caspase Dredd homologs. Experimentally, recombinant SfDredd underwent autocleavage and exhibited different efficiencies in cleavage of synthetic caspase substrates. This was attributed to its caspase activity for the predicted active site mutation blocked the above autocleavage and synthetic caspase substrates cleavage activity. SfDredd was capable of not only cleaving Sf-caspase-1 in vitro but also cleaving Sf-caspase-1 and inducing apoptosis when it was co-expressed with Sf-caspase-1 in Sf9 cells. The protein level of SfDredd was increased when Sf9 cells were treated by Actinomycin D, whereas silencing of SfDredd reduced apoptosis and Sf-caspase-1 cleavage induced by Actinomycin D treatment. These results clearly indicate that SfDredd functioned as an apoptotic initiator caspase. Apoptosis induced in Sf9 cells by overexpression of SfDredd alone was not as obvious as that induced by SfDronc alone, and the cleavage sites of Sf-caspase-1 for SfDredd and SfDronc are different. In addition, despite sharing a sequence homology with initiator caspases and possessing weak activity on initiator caspase substrates, SfDredd showed strong activity on effector caspase substrates, making it the only insect caspase reported so far functioning similar to human caspase-2 in this aspect. We believe that the discovery of SfDredd, and its different properties from SfDronc, will improve the understanding of apoptosis pathway in Sf9 cells.	[Liu, Qingzhen] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Liu, QZ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	qzhliu@whu.edu.cn			National Natural Science Foundation of China [31070686]; Chinese 111 project from The Department of Science & Technology, Ministry of Education [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project from The Department of Science & Technology, Ministry of Education	This project was supported by the grant from National Natural Science Foundation of China (#31070686; recipient: QL; http://www.nsfc.gov.cn/publish/portal1/) and was partially supported by the Chinese 111 project from The Department of Science & Technology, Ministry of Education (#B06018; http://www.dost.moe.edu.cn/dostmoe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1997, J BIOL CHEM, V272, P1421, DOI 10.1074/jbc.272.3.1421; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; CARTIER JL, 1994, J VIROL, V68, P7728, DOI 10.1128/JVI.68.12.7728-7737.1994; Chen P, 1998, DEV BIOL, V201, P202, DOI 10.1006/dbio.1998.9000; Clem RJ, 2007, CURR DRUG TARGETS, V8, P1069, DOI 10.2174/138945007782151405; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cooper DM, 2007, INSECT BIOCHEM MOLEC, V37, P559, DOI 10.1016/j.ibmb.2007.03.005; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; Courtiade J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-357; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Dorstyn L, 1999, J BIOL CHEM, V274, P30778, DOI 10.1074/jbc.274.43.30778; Doumanis J, 2001, CELL DEATH DIFFER, V8, P387, DOI 10.1038/sj.cdd.4400864; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fraser AG, 1997, EMBO J, V16, P2805, DOI 10.1093/emboj/16.10.2805; Harvey NL, 2001, J BIOL CHEM, V276, P25342, DOI 10.1074/jbc.M009444200; Huang N, 2013, INSECT BIOCHEM MOLEC, V43, P444, DOI 10.1016/j.ibmb.2013.02.005; Kitevska T, 2014, BIOSCIENCE REP, V34, P127, DOI 10.1042/BSR20140025; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; LaCount DJ, 2000, J BIOL CHEM, V275, P15657, DOI 10.1074/jbc.M000791200; LaCount DJ, 1997, J VIROL, V71, P1530, DOI 10.1128/JVI.71.2.1530-1537.1997; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu Q, 2006, APOPTOSIS, V11, P487, DOI 10.1007/s10495-006-5059-5; Manji GA, 1997, J VIROL, V71, P4509, DOI 10.1128/JVI.71.6.4509-4516.1997; Manji GA, 2001, J BIOL CHEM, V276, P16704, DOI 10.1074/jbc.M010179200; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Pop C, 2008, METHOD ENZYMOL, V446, P351, DOI 10.1016/S0076-6879(08)01621-2; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Troy CM, 2003, CELL DEATH DIFFER, V10, P101, DOI 10.1038/sj.cdd.4401175; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Ying ZF, 2013, ARCH INSECT BIOCHEM, V83, P195, DOI 10.1002/arch.21106; Zoog SJ, 2002, EMBO J, V21, P5130	38	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151016	10.1371/journal.pone.0151016	http://dx.doi.org/10.1371/journal.pone.0151016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977926	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800042
J	de Menezes, RRPPB; Mello, CP; Lima, DB; Tessarolo, LD; Sampaio, TL; Paes, LCF; Alves, NTQ; Assis, EM; Lima, RCP; Toyama, MH; Martins, AMC				de Menezes, Ramon R. P. P. B.; Mello, Clarissa P.; Lima, Danya B.; Tessarolo, Louise D.; Sampaio, Tiago Lima; Paes, Livia C. F.; Alves, Natacha T. Q.; Assis Junior, Eudmar M.; Lima Junior, Roberto C. P.; Toyama, Marcos H.; Martins, Alice M. C.			Involvement of Nitric Oxide on Bothropoides insularis Venom Biological Effects on Murine Macrophages In Vitro	PLOS ONE			English	Article							ASPER SNAKE-VENOM; ACID OXIDASE; INFLAMMATORY MEDIATORS; PHOSPHOLIPASE A(2); METALLOPROTEINASE; PURIFICATION; EXPRESSION; TOXINS; CELLS; MOUSE	Viperidae venom has several local and systemic effects, such as pain, edema, inflammation, kidney failure and coagulopathy. Additionally, bothropic venom and its isolated components directly interfere on cellular metabolism, causing alterations such as cell death and proliferation. Inflammatory cells are particularly involved in pathological envenomation mechanisms due to their capacity of releasing many mediators, such as nitric oxide (NO). NO has many effects on cell viability and it is associated to the development of inflammation and tissue damage caused by Bothrops and Bothropoides venom. Bothropoides insularis is a snake found only in Queimada Grande Island, which has markedly toxic venom. Thus, the aim of this work was to evaluate the biological effects of Bothropoides insularis venom (BiV) on RAW 264.7 cells and assess NO involvement. The venom was submitted to colorimetric assays to identify the presence of some enzymatic components. We observed that BiV induced H2O2 production and showed proteolytic and phospholipasic activities. RAW 264.7 murine macrophages were incubated with different concentrations of BiV and then cell viability was assessed by MTT reduction assay after 2, 6, 12 and 24 hours of incubation. A time-and concentration-dependent effect was observed, with a tendency to cell proliferation at lower BiV concentrations and cell death at higher concentrations. The cytotoxic effect was confirmed after lactate dehydrogenase (LDH) measurement in the supernatant from the experimental groups. Flow cytometry analyses revealed that necrosis is the main cell death pathway caused by BiV. Also, BiV induced NO release. The inhibition of both proliferative and cytotoxic effects with L-NAME were demonstrated, indicating that NO is important for these effects. Finally, BiV induced an increase in iNOS expression. Altogether, these results demonstrate that B. insularis venom have proliferative and cytotoxic effects on macrophages, with necrosis participation. We also suggest that BiV acts by inducing iNOS expression and causing NO release.	[de Menezes, Ramon R. P. P. B.; Sampaio, Tiago Lima; Paes, Livia C. F.; Alves, Natacha T. Q.; Lima Junior, Roberto C. P.] Univ Fed Ceara, Sch Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Mello, Clarissa P.; Lima, Danya B.; Tessarolo, Louise D.; Martins, Alice M. C.] Univ Fed Ceara, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil; [Assis Junior, Eudmar M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Toyama, Marcos H.] Sao Paulo State Univ UNESP, Sao Vicente Unit, Paulista Coastal Campus, Sao Paulo, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; University of Bristol; Universidade Estadual Paulista	de Menezes, RRPPB (corresponding author), Univ Fed Ceara, Sch Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil.	ramonppessoa@gmail.com	Martins, Alice Maria Costa/AAX-3093-2020; Lima, Danya Bandeira/ABG-1565-2020; Menezes, Ramon/ABA-1109-2021; Lima-Júnior, Roberto CP/W-5095-2019; Toyama, Marcos H/P-4673-2017; Assis-Junior, Eudmar/F-7102-2012	Menezes, Ramon/0000-0003-3109-9683; Lima-Júnior, Roberto CP/0000-0002-7033-655X; Toyama, Marcos H/0000-0001-6836-3084; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) and "Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES).	Ash D, 2015, AM J CANCER RES, V5, P481; Baldo C, 2008, TOXICON, V51, P54, DOI 10.1016/j.toxicon.2007.08.005; Bonfim VL, 2009, CELL BIOL TOXICOL, V25, P523, DOI 10.1007/s10565-008-9106-6; Brenes O, 2010, EXP MOL PATHOL, V88, P424, DOI 10.1016/j.yexmp.2010.02.002; Bustillo S, 2012, TOXICON, V59, P338, DOI 10.1016/j.toxicon.2011.11.007; Chae HS, 2015, INT IMMUNOPHARMACOL, V29, P966, DOI 10.1016/j.intimp.2015.09.008; Chaves F, 2006, INFLAMM RES, V55, P245, DOI 10.1007/s00011-006-0078-9; COGO JC, 1993, TOXICON, V31, P1237, DOI 10.1016/0041-0101(93)90397-2; Cogo JC, 2006, BIOCHIMIE, V88, P1947, DOI 10.1016/j.biochi.2006.10.006; Torres AFC, 2010, TOXICON, V55, P795, DOI 10.1016/j.toxicon.2009.11.013; Cotrim CA, 2011, CHEM-BIOL INTERACT, V189, P9, DOI 10.1016/j.cbi.2010.10.016; Menezes RRPPB, 2012, NAT PROD COMMUN, V7, P71; de Souza Carlos At, 2012, J Venom Res, V3, P28; Furtado JL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/683123; Giannotti KC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/807982; Gomes MSR, 2015, J BIOCHEM, V157, P137, DOI 10.1093/jb/mvu058; Gomes MSR, 2011, COMP BIOCHEM PHYS C, V153, P290, DOI 10.1016/j.cbpc.2010.11.008; Goncalves LR, 2016, J MAR BIOL ASSOC UK, V96, P943, DOI 10.1017/S0025315415001812; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Grishin EV, 1996, ADV EXPT MED BIOL, P231; Grzegorz B, 1996, ACTA BIOCHIM POL, P645; Gutierrez JM, 2006, MICROVASC RES, V71, P55, DOI 10.1016/j.mvr.2005.10.007; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Izidoro LFM, 2006, BIOORGAN MED CHEM, V14, P7034, DOI 10.1016/j.bmc.2006.06.025; Jorge Roberta J B, 2011, J Exp Ther Oncol, V9, P249; Jorge RJB, 2015, J PROTEOMICS, V114, P93, DOI 10.1016/j.jprot.2014.11.011; Khan MW, 2015, HUM EXP TOXICOL, P1; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; Li W, 2015, INT J CLIN EXP PATHO, V8, P2274; Lira MS, 2007, TOXICON, V49, P982, DOI 10.1016/j.toxicon.2007.01.009; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; LOMONTE B, 1993, INFLAMMATION, V17, P93, DOI 10.1007/BF00916097; Lopes DS, 2012, TOXICON, V60, P1072, DOI 10.1016/j.toxicon.2012.07.004; Braga MDM, 2008, TOXICON, V51, P199, DOI 10.1016/j.toxicon.2007.09.003; Marangoni FA, 2013, UNMASKING SNAKE VENO, V2013; Marcussi S, 2013, TOXICON, V65, P9, DOI 10.1016/j.toxicon.2012.12.020; Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X; Mello CP, 2014, TOXICON, V88, P107, DOI 10.1016/j.toxicon.2014.05.009; Monteiro-Machado M, 2015, TOXICON, V98, P20, DOI 10.1016/j.toxicon.2015.02.010; Moreira V, 2011, TOXICON, V57, P288, DOI 10.1016/j.toxicon.2010.12.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moura-Da-Silva AM, 2007, CURR PHARM DESIGN, V13, P2893, DOI 10.2174/138161207782023711; Naumann GB, 2011, BBA-GEN SUBJECTS, V1810, P683, DOI 10.1016/j.bbagen.2011.04.003; de Souza DLN, 2012, COMP BIOCHEM PHYS B, V161, P102, DOI 10.1016/j.cbpb.2011.10.002; Nunes ES, 2012, TOXICON, V59, P667, DOI 10.1016/j.toxicon.2012.03.002; de Morais ICO, 2013, TOXICON, V61, P38, DOI 10.1016/j.toxicon.2012.10.005; Oliveira-Carvalho AL, 2008, TOXICON, V51, P659, DOI 10.1016/j.toxicon.2007.11.026; de Paula FFP, 2014, COMP BIOCHEM PHYS D, V12, P74, DOI 10.1016/j.cbd.2014.09.001; Rajendra W, 2004, TOXICON, V44, P1, DOI 10.1016/j.toxicon.2004.04.014; Ramos OHP, 2007, ARCH BIOCHEM BIOPHYS, V461, P1, DOI 10.1016/j.abb.2007.02.021; Rucavado A, 2008, TOXICON, V52, P754, DOI 10.1016/j.toxicon.2008.08.009; Rueda AQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/789689; Saturnino-Oliveira J., 2014, BIOMED RES INT, V2014, P1; Setubal SD, 2013, TOXICON, V76, P143, DOI 10.1016/j.toxicon.2013.09.019; Souza JM, 2012, MACROPHAGE ACTIVATIO, V417, P223; Sucasaca-monzon G, 2015, BP 13 PLA 2 PURIFICA, V2015; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Ullah A, 2012, ACTA CRYSTALLOGR F, V68, P1222, DOI 10.1107/S1744309112036603; Valente RH, 2009, J PROTEOMICS, V72, P241, DOI 10.1016/j.jprot.2009.01.001; Wanderley CWS, 2014, TOXICON, V90, P134, DOI 10.1016/j.toxicon.2014.08.001; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Yang CA, 2012, J AGR FOOD CHEM, V60, P2464, DOI 10.1021/jf203883u; Zhang WY, 2015, MOL CELL BIOCHEM, V405, P281, DOI 10.1007/s11010-015-2418-y	63	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151029	10.1371/journal.pone.0151029	http://dx.doi.org/10.1371/journal.pone.0151029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974665	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600044
J	Kim, G; Lee, YH; Han, MH; Lee, EK; Kim, CH; Kwon, HS; Jeong, IK; Kang, ES; Kim, DJ				Kim, Gyuri; Lee, Yong-ho; Han, Mi Hye; Lee, Eui-Kyung; Kim, Chong Hwa; Kwon, Hyuk Sang; Jeong, In Kyung; Kang, Eun Seok; Kim, Dae Jung			Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea	PLOS ONE			English	Article							RISK; COMPLICATIONS; COSTS	Background Hypoglycemia is a very serious complication in patients with type 2 diabetes mellitus (T2DM) and affects the economic burden of treatment. This study aims to create models of the cost of treating hypoglycemia in patients with T2DM based upon physician estimates of medical resource usage. Methods Using a literature review and personal advice from endocrinologists and emergency physicians, we developed several models for managing patients with hypoglycemia. The final model was approved by the consulting experts. We also developed 3 unique surveys to allow endocrinologists, emergency room (ER) physicians, and primary care physicians to evaluate the resource usage of patients with hypoglycemia. Medical costs were calculated by multiplying the estimated medical resource usage by the corresponding health insurance medical care costs reported in 2014. Results In total, 40 endocrinologists, 20 ER physicians, and 30 primary care physicians completed the survey. We identified 12 types of standard medical models for secondary or tertiary hospitals and 4 for primary care clinics based on the use of ER, general ward, or intensive care unit (ICU) and patients' status of consciousness and self-respiration. Estimated medical costs per person per hypoglycemic event ranged from $17.28 to $1,857.09 for secondary and tertiary hospitals. These costs were higher for patients who were unconscious and for those requiring ICU admission. Conclusion Hypoglycemia has a substantial impact on the medical costs and its prevention will result in economic benefits for T2DM patients and society.	[Kim, Gyuri; Lee, Yong-ho; Kang, Eun Seok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Gyuri] Yonsei Univ, Coll Med, Grad Sch, Seoul, South Korea; [Han, Mi Hye] Merck Sharp & Dohme Ltd, Market Access, Seoul, South Korea; [Han, Mi Hye; Lee, Eui-Kyung] Sungkyunkwan Univ, Sch Pharm, Pharmaceut Policy & Outcomes Res, Seoul, South Korea; [Kim, Chong Hwa] Sejong Gen Hosp, Dept Internal Med, Bucheon, South Korea; [Kwon, Hyuk Sang] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Jeong, In Kyung] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Kim, Dae Jung] Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon 441749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Sejong General Hospital; Catholic University of Korea; Kyung Hee University; Ajou University	Kang, ES (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, DJ (corresponding author), Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon 441749, South Korea.	edgo@yuhs.ac; djkim@ajou.ac.kr	Jeong, In-Kyung/AAI-6488-2020; Kim, Gyuri/E-8992-2018; Lee, Yong-ho/AAT-4106-2020	Jeong, In-Kyung/0000-0001-7857-546X; Kim, Gyuri/0000-0002-2242-2816; Lee, Yong-ho/0000-0002-6219-4942; Kang, Eun Seok/0000-0002-0364-4675; Kim, Dae Jung/0000-0003-1025-2044	MSD Korea LTD, Merck & Co., Inc., Kenilworth, NJ, USA	MSD Korea LTD, Merck & Co., Inc., Kenilworth, NJ, USA	Funding for this study was provided by MSD Korea LTD, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. The sponsor participated in part of study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. GK, Y-hL, E-KL, CHK, HSK, IKJ, ESK, DJK have no financial disclosures. MHH is employee of MSD Korea.	Brandle M, 2003, DIABETES CARE, V26, P2300, DOI 10.2337/diacare.26.8.2300; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; Brown JB, 1999, ARCH INTERN MED, V159, P1873, DOI 10.1001/archinte.159.16.1873; Chan Siew-Pheng, 2010, Diabetes Res Clin Pract, V89, pe30, DOI 10.1016/j.diabres.2010.05.008; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giorda CB, 2015, ACTA DIABETOL, V52, P845, DOI 10.1007/s00592-015-0713-4; Ha WC, 2012, DIABETES METAB J, V36, P280, DOI 10.4093/dmj.2012.36.4.280; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Henriksson F, 2000, J INTERN MED, V248, P387, DOI 10.1046/j.1365-2796.2000.00749.x; Ho KM, 2009, J CRIT CARE, V24, P101, DOI 10.1016/j.jcrc.2007.11.015; Hoste EAJ, 2003, J AM SOC NEPHROL, V14, P1022, DOI 10.1097/01.ASN.0000059863.48590.E9; Liu SQ, 2012, EXPERT REV PHARM OUT, V12, P47, DOI [10.1586/ERP.11.87, 10.1586/erp.11.87]; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Unger J, 2012, DIABETES METAB SYNDR, V5, P57, DOI 10.2147/DMSO.S29367; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	18	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151282	10.1371/journal.pone.0151282	http://dx.doi.org/10.1371/journal.pone.0151282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975054	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600063
J	Papalexakis, E; Hooi, B; Pelechrinis, K; Faloutsos, C				Papalexakis, Evangelos; Hooi, Bryan; Pelechrinis, Konstantinos; Faloutsos, Christos			Power-Hop: A Pervasive Observation for Real Complex Networks	PLOS ONE			English	Article							SCALE-FREE NETWORKS; PERCOLATION; DYNAMICS; GROWTH	Complex networks have been shown to exhibit universal properties, with one of the most consistent patterns being the scale-free degree distribution, but are there regularities obeyed by the r-hop neighborhood in real networks? We answer this question by identifying another power-law pattern that describes the relationship between the fractions of node pairs C(r) within r hops and the hop count r. This scale-free distribution is pervasive and describes a large variety of networks, ranging from social and urban to technological and biological networks. In particular, inspired by the definition of the fractal correlation dimension D-2 on a point-set, we consider the hop-count r to be the underlying distance metric between two vertices of the network, and we examine the scaling of C(r) with r. We find that this relationship follows a power-law in real networks within the range 2 <= r <= d, where d is the effective diameter of the network, that is, the 90-th percentile distance. We term this relationship as power-hop and the corresponding power-law exponent as power-hop exponent h. We provide theoretical justification for this pattern under successful existing network models, while we analyze a large set of real and synthetic network datasets and we show the pervasiveness of the power-hop.	[Papalexakis, Evangelos; Faloutsos, Christos] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Hooi, Bryan] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA; [Pelechrinis, Konstantinos] Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pelechrinis, K (corresponding author), Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA USA.	kpele@pitt.edu	Hooi, Bryan/AAU-5707-2020; Pelechrinis, Konstantinos/ACX-4835-2022	Hooi, Bryan/0000-0002-5645-1754; Pelechrinis, Konstantinos/0000-0002-6443-3935; Papalexakis, Evangelos/0000-0002-3411-8483	National Science Foundation [IIS-1217559, IIS-1247489, CNS-1314632, IIS-1408924]; National Institute of Health NIH [1R01GM108339-1]; Defense Advanced Research Projects Agency [W911NF-09-2-0053]; Army Research Office Young Investigator Award [W911NF-15-1-0599 (67192-NS-YIP)]; Direct For Computer & Info Scie & Enginr [1314632] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office Young Investigator Award; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation IIS-1217559, http://www.nsf.gov/awardsearch/showAward?AWD_ID=1217559 (CF); National Science Foundation IIS-1247489, http://www.nsf.gov/awardsearch/showAward?AWD_ID=1247489 (also National Institute of Health NIH 1R01GM108339-1) (CF); National Science Foundation CNS-1314632, http://www.nsf.gov/awardsearch/showAward?AWD_ID=1314632 (CF); National Science Foundation IIS-1408924, http://www.nsf.gov/awardsearch/showAward?AWD_ID=1408287 (CF); and Defense Advanced Research Projects Agency Contract no. W911NF-09-2-0053 (ARL: CTA-INARC), http://www.ns-cta.org (CF). Konstantinos Pelechrinis' work was partially supported by the Army Research Office Young Investigator Award #W911NF-15-1-0599 (67192-NS-YIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batty M., 1994, FRACTAL CITIES; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Chakrabarti D, 2004, SIAM PROC S, P442; Cho E., 2011, ACM SIGKDD 2011; Decker EH, 2000, ANNU REV ENERG ENV, V25, P685, DOI 10.1146/annurev.energy.25.1.685; Eguiluz VM, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.055102; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Girardet H., 1996, GAIA ATLAS CITIES NE; Goh KI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018701; Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604; Lacasa L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168703; Leskovec J, 2005, LECT NOTES ARTIF INT, V3721, P133; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Miller JG, 1978, LIVING SYSTEMS; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Rozenfeld AF, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.218701; Serrano MA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078701; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Svirejeva-Hopkins A, 2004, ECOL MODEL, V173, P295, DOI 10.1016/j.ecolmodel.2003.09.022; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046111; Viswanath B., 2009, WOSN; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xiao Fan Wang, 2003, IEEE Circuits and Systems Magazine, V3, P6, DOI 10.1109/MCAS.2003.1228503	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151027	10.1371/journal.pone.0151027	http://dx.doi.org/10.1371/journal.pone.0151027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974560	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000372570600043
J	Zhang, XN; Wang, YY; Han, SS; Xiang, HY; Peng, Y; Wu, YH; Pan, SW; Zhang, Y; Ruan, JL				Zhang, Xuenong; Wang, Yanyan; Han, Shishi; Xiang, Huiyao; Peng, Yan; Wu, Yinghua; Pan, Songwei; Zhang, Ye; Ruan, Jinlan			RY10-4 Inhibits the Proliferation of Human Hepatocellular Cancer HepG2 Cells by Inducing Apoptosis In Vitro and In Vivo	PLOS ONE			English	Article							HUMAN TUMOR XENOGRAFTS; ANTITUMOR COMPOUND; PROTOAPIGENONE; STRESS; GROWTH; STAT3; STRATEGIES; AUTOPHAGY; INVASION; PATHWAY	This study aimed to investigate the anti-tumor activity of RY10-4, a small molecular that was designed and synthesized based on the structure of protoapigenone. A previous screening study showed that RY10-4 possessed anti-proliferative effects against HepG2 human hepatocellular carcinoma cells. However, the full range of RY10-4 anti-cancer effects on liver tumors and the underlying mechanisms have not been identified. Herein, employing flow cytometry, and Western blot analysis, we demonstrate that RY10-4 can induce cell cycle arrest, intracellular reactive oxygen species (ROS) production and apoptosis in HepG2 cells. In HepG2 cell xenograft tumor model, RY10-4 significantly inhibited the growth of tumors and induced apoptosis in tumor cells, with little side effects. Moreover, RY10-4 caused the suppression of STAT3 activation, which may be involved the apoptosis induction. In addition, RY10-4 inhibited the proliferation of Hep3B and HuH-7 human hepatocellular carcinoma cells in a concentration-dependent manner. Taken together, our results suggest that RY10-4 has a great potential to develop as chemotherapeutic agent for liver cancer.	[Zhang, Xuenong; Wang, Yanyan; Han, Shishi; Peng, Yan; Wu, Yinghua; Pan, Songwei; Zhang, Ye] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Pharm, Yichang 443003, Peoples R China; [Zhang, Xuenong; Wang, Yanyan; Han, Shishi; Xiang, Huiyao; Peng, Yan; Wu, Yinghua; Pan, Songwei; Zhang, Ye] Yichang Cent Peoples Hosp, Yichang 443003, Peoples R China; [Zhang, Xuenong; Han, Shishi; Ruan, Jinlan] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan 430030, Peoples R China; [Xiang, Huiyao] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Clin Lab, Yichang 443003, Peoples R China	China Three Gorges University; Huazhong University of Science & Technology; China Three Gorges University	Zhang, XN; Wang, YY (corresponding author), China Three Gorges Univ, Coll Clin Med Sci 1, Dept Pharm, Yichang 443003, Peoples R China.; Zhang, XN; Wang, YY (corresponding author), Yichang Cent Peoples Hosp, Yichang 443003, Peoples R China.; Zhang, XN (corresponding author), Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan 430030, Peoples R China.	13986258801@163.com; wangyy1001@163.com	wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022		National Natural Science Foundation of China [31270390]; Natural Science Foundation of Hubei Province [2015CFC852]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (No. 31270390, to YYW) and the Natural Science Foundation of Hubei Province (No. 2015CFC852, to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486; Badr CE, 2013, JNCI-J NATL CANCER I, V105, P643, DOI 10.1093/jnci/djt037; Chan SL, 2004, CLIN EXP PHARMACOL P, V31, P119, DOI 10.1111/j.1440-1681.2004.03975.x; Chang HL, 2008, CANCER LETT, V267, P85, DOI 10.1016/j.canlet.2008.03.007; Chaveli-Lopez Begonya, 2014, J Clin Exp Dent, V6, pe81, DOI 10.4317/jced.51337; Chen HM, 2011, FREE RADICAL BIO MED, V50, P1151, DOI 10.1016/j.freeradbiomed.2011.01.015; Chen YJ, 2013, BASIC CLIN PHARMACOL, V113, P8, DOI 10.1111/bcpt.12057; Chiu CC, 2009, DNA CELL BIOL, V28, P501, DOI 10.1089/dna.2009.0852; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hao WH, 2014, PEERJ, V2, DOI 10.7717/peerj.555; Hather G, 2014, CANCER INFORM, V13, P65, DOI 10.4137/CIN.S13974; Hong B, 2014, CURR DRUG TARGETS, V15, P80, DOI 10.2174/1389450114666140106101412; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Liu ZW, 2012, CANCER CHEMOTH PHARM, V69, P1633, DOI 10.1007/s00280-012-1873-3; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pflaumf J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00285; Poor M, 2013, J PHOTOCH PHOTOBIO B, V124, P20, DOI 10.1016/j.jphotobiol.2013.04.002; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Tomasetti M, 2015, CURR MED CHEM, V22, P552, DOI 10.2174/0929867321666140915142219; Tomek M, 2012, J PHARM PHARMACOL, V64, P1695, DOI 10.1111/j.2042-7158.2012.01526.x; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Xue PP, 2014, CHEM-BIOL INTERACT, V209, P25, DOI 10.1016/j.cbi.2013.11.014; Yuan QY, 2012, CANCER LETT, V324, P210, DOI 10.1016/j.canlet.2012.05.025; Yuan QY, 2011, BIOORG MED CHEM LETT, V21, P3427, DOI 10.1016/j.bmcl.2011.03.108; Zhang XN, 2013, TOXICOL APPL PHARM, V270, P122, DOI 10.1016/j.taap.2013.04.011; Zips D, 2005, IN VIVO, V19, P1	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151679	10.1371/journal.pone.0151679	http://dx.doi.org/10.1371/journal.pone.0151679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974964	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600094
J	Hoenigl, M; Chaillon, A; Kessler, HH; Haas, B; Stelzl, E; Weninger, K; Little, SJ; Mehta, SR				Hoenigl, Martin; Chaillon, Antoine; Kessler, Harald H.; Haas, Bernhard; Stelzl, Evelyn; Weninger, Karin; Little, Susan J.; Mehta, Sanjay R.			Characterization of HIV Transmission in South-East Austria	PLOS ONE			English	Article							INFECTION; RISK; EVOLUTION; HISTORY; COHORT; VIRUS; MEN; SEX	To gain deeper insight into the epidemiology of HIV-1 transmission in South-East Austria we performed a retrospective analysis of 259 HIV-1 partial pol sequences obtained from unique individuals newly diagnosed with HIV infection in South-East Austria from 2008 through 2014. After quality filtering, putative transmission linkages were inferred when two sequences were <= 1.5% genetically different. Multiple linkages were resolved into putative transmission clusters. Further phylogenetic analyses were performed using BEAST v1.8.1. Finally, we investigated putative links between the 259 sequences from South-East Austria and all publicly available HIV polymerase sequences in the Los Alamos National Laboratory HIV sequence database. We found that 45.6% (118/259) of the sampled sequences were genetically linked with at least one other sequence from South-East Austria forming putative transmission clusters. Clustering individuals were more likely to be men who have sex with men (MSM; p<0.001), infected with subtype B (p<0.001) or subtype F (p = 0.02). Among clustered males who reported only heterosexual (HSX) sex as an HIV risk, 47% clustered closely with MSM (either as pairs or within larger MSM clusters). One hundred and seven of the 259 sequences (41.3%) from South-East Austria had at least one putative inferred linkage with sequences from a total of 69 other countries. In conclusion, analysis of HIV-1 sequences from newly diagnosed individuals residing in South-East Austria revealed a high degree of national and international clustering mainly within MSM. Interestingly, we found that a high number of heterosexual males clustered within MSM networks, suggesting either linkage between risk groups or misrepresentation of sexual risk behaviors by subjects.	[Hoenigl, Martin; Chaillon, Antoine; Little, Susan J.; Mehta, Sanjay R.] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA; [Hoenigl, Martin] Med Univ Graz, Dept Internal Med, Sect Infect Dis & Trop Med, Graz, Austria; [Hoenigl, Martin] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Kessler, Harald H.; Stelzl, Evelyn; Weninger, Karin] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria; [Haas, Bernhard] Landeskrankenhaus Graz West, Dept Infect Dis, Graz, Austria; [Mehta, Sanjay R.] Vet Affairs Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; Medical University of Graz; Medical University of Graz; Medical University of Graz	Kessler, HH (corresponding author), Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria.	harald.kessler@medunigraz.at	Hoenigl, Martin/E-8802-2010; Little, Susan/AAA-6116-2019; chaillon, antoine/GNH-1623-2022; Chaillon, Antoine/GNH-6121-2022	Hoenigl, Martin/0000-0002-1653-2824; 	Max Kade Foundation, New York (Max Kade Postdoctoral Research grant); Interdisciplicinary Research Fellowship in NeuroAIDS [R25-MH081482]; Bettencourt-Schueller Foundation; California HIV/AIDS Research Program (CHRP) [F13SD321]; National Institutes of Health: NIH [AI106039, AI43638, AI074621, AI108351, MH100974, AI036214, AI093163, AI100665, DA034978]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074621, K23AI093163, R24AI106039, R21AI108351, K24AI100665, P30AI036214, U01AI043638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100974, R25MH081482] Funding Source: NIH RePORTER	Max Kade Foundation, New York (Max Kade Postdoctoral Research grant); Interdisciplicinary Research Fellowship in NeuroAIDS; Bettencourt-Schueller Foundation; California HIV/AIDS Research Program (CHRP); National Institutes of Health: NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funds from the following: the Max Kade Foundation, New York (Max Kade Postdoctoral Research grant), Interdisciplicinary Research Fellowship in NeuroAIDS (R25-MH081482), the Bettencourt-Schueller Foundation, the California HIV/AIDS Research Program (CHRP) Grant F13SD321, and grants from the National Institutes of Health: NIH Grants including AI106039, AI43638, AI074621, AI108351, MH100974, AI036214, AI093163, AI100665, DA034978, and AI036214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52; Chaillon A, 2016, C RETR OPP INF CROI; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; European Union Agency for Fundamental Rights, 2014, EUR UN LES GAY BIS T; Gisinger M, 2014, 26 REPORT AUSTRIAN H, P26; Hightower GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068188; Hoenigl M, 2016, EMERG INFECT DIS, V22, P532, DOI 10.3201/eid2203.151607; Hoenigl M, 2016, CLIN INFECT DIS, V62, P501, DOI 10.1093/cid/civ912; Hoenigl M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0458-5; Hoenigl M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001242; Hoenigl M, 2015, CLIN INFECT DIS, V61, P468, DOI 10.1093/cid/civ335; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098443; Mehta SR, 2011, INFECT GENET EVOL, V11, P975, DOI 10.1016/j.meegid.2011.03.009; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Salzer HJF, 2011, INT J HYG ENVIR HEAL, V214, P407, DOI 10.1016/j.ijheh.2011.05.002; Stamatakis A, 2015, CURR PROTOC BIOINFOR, V51, DOI DOI 10.1002/0471250953.BI0614S51; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; UNAIDS, 2012, AUSTR COUNTR PROGR R	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151478	10.1371/journal.pone.0151478	http://dx.doi.org/10.1371/journal.pone.0151478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967154	Green Published, gold			2022-12-27	WOS:000371989200058
J	Chou, A; Morganti, JM; Rosi, S				Chou, Austin; Morganti, Josh M.; Rosi, Susanna			Frontal Lobe Contusion in Mice Chronically Impairs Prefrontal-Dependent Behavior	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CARD SORTING TEST; SOCIAL COGNITION; ORBITOFRONTAL CORTEX; HEAD-INJURY; LESIONS; ANXIETY; DYSFUNCTION; PERFORMANCE; REVERSAL	Traumatic brain injury (TBI) is a major cause of chronic disability in the world. Moderate to severe TBI often results in damage to the frontal lobe region and leads to cognitive, emotional, and social behavioral sequelae that negatively affect quality of life. More specifically, TBI patients often develop persistent deficits in social behavior, anxiety, and executive functions such as attention, mental flexibility, and task switching. These deficits are intrinsically associated with prefrontal cortex (PFC) functionality. Currently, there is a lack of analogous, behaviorally characterized TBI models for investigating frontal lobe injuries despite the prevalence of focal contusions to the frontal lobe in TBI patients. We used the controlled cortical impact (CCI) model in mice to generate a frontal lobe contusion and studied behavioral changes associated with PFC function. We found that unilateral frontal lobe contusion in mice produced long-term impairments to social recognition and reversal learning while having only a minor effect on anxiety and completely sparing rule shifting and hippocampal-dependent behavior.	[Chou, Austin; Morganti, Josh M.; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Chou, Austin; Rosi, Susanna] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Chou, Austin; Morganti, Josh M.; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA.	rosis@ptrehab.ucsf.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049; Chou, Austin/0000-0003-4328-5811	National Institute Of Neurological Disorders And Stroke; National Institute on Aging of the National Institutes of Health [R21NS087458, R21AG042016]; Alzheimer's Association [IIRG-11-202064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042016] Funding Source: NIH RePORTER	National Institute Of Neurological Disorders And Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute Of Neurological Disorders And Stroke and National Institute on Aging of the National Institutes of Health under award numbers R21NS087458 (S.R.); R21AG042016 (S.R.); Alzheimer's Association IIRG-11-202064 (S.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsop SA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00241; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Brooks JM, 2012, NEUROPSYCHOPHARMACOL, V37, P2476, DOI 10.1038/npp.2012.106; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fox MT, 2003, J NEUROSCI, V23, P676, DOI 10.1523/JNEUROSCI.23-02-00676.2003; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Placek K, 2013, BEHAV BRAIN RES, V256, P405, DOI 10.1016/j.bbr.2013.08.034; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Rudebeck PH, 2014, NEURON, V84, P1143, DOI 10.1016/j.neuron.2014.10.049; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Sobota R, 2015, BEHAV NEUROSCI, V129, P389, DOI 10.1037/bne0000074; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; Wood Jacqueline N, 2003, Behav Cogn Neurosci Rev, V2, P97; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Young JW, 2010, COGN AFFECT BEHAV NE, V10, P243, DOI 10.3758/CABN.10.2.243	51	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151418	10.1371/journal.pone.0151418	http://dx.doi.org/10.1371/journal.pone.0151418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964036	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000150
J	Qiu, LF; Wang, K; Long, WL; Wang, K; Hu, W; Amable, GS				Qiu, Lefeng; Wang, Kai; Long, Wenli; Wang, Ke; Hu, Wei; Amable, Gabriel S.			A Comparative Assessment of the Influences of Human Impacts on Soil Cd Concentrations Based on Stepwise Linear Regression, Classification and Regression Tree, and Random Forest Models	PLOS ONE			English	Article							HEAVY-METAL SOURCES; SPATIAL-DISTRIBUTION; ANTHROPOGENIC ACTIVITIES; AGRICULTURAL SOILS; FUYANG COUNTY; PB; IDENTIFICATION; CONTAMINATION; ZN; BIOAVAILABILITY	Soil cadmium (Cd) contamination has attracted a great deal of attention because of its detrimental effects on animals and humans. This study aimed to develop and compare the performances of stepwise linear regression (SLR), classification and regression tree (CART) and random forest (RF) models in the prediction and mapping of the spatial distribution of soil Cd and to identify likely sources of Cd accumulation in Fuyang County, eastern China. Soil Cd data from 276 topsoil (0-20 cm) samples were collected and randomly divided into calibration (222 samples) and validation datasets (54 samples). Auxiliary data, including detailed land use information, soil organic matter, soil pH, and topographic data, were incorporated into the models to simulate the soil Cd concentrations and further identify the main factors influencing soil Cd variation. The predictive models for soil Cd concentration exhibited acceptable overall accuracies (72.22% for SLR, 70.37% for CART, and 75.93% for RF). The SLR model exhibited the largest predicted deviation, with a mean error (ME) of 0.074 mg/kg, a mean absolute error (MAE) of 0.160 mg/kg, and a root mean squared error (RMSE) of 0.274 mg/kg, and the RF model produced the results closest to the observed values, with an ME of 0.002 mg/kg, an MAE of 0.132 mg/kg, and an RMSE of 0.198 mg/kg. The RF model also exhibited the greatest R-2 value (0.772). The CART model predictions closely followed, with ME, MAE, RMSE, and R-2 values of 0.013 mg/kg, 0.154 mg/kg, 0.230 mg/kg and 0.644, respectively. The three prediction maps generally exhibited similar and realistic spatial patterns of soil Cd contamination. The heavily Cd-affected areas were primarily located in the alluvial valley plain of the Fuchun River and its tributaries because of the dramatic industrialization and urbanization processes that have occurred there. The most important variable for explaining high levels of soil Cd accumulation was the presence of metal smelting industries. The good performance of the RF model was attributable to its ability to handle the non-linear and hierarchical relationships between soil Cd and environmental variables. These results confirm that the RF approach is promising for the prediction and spatial distribution mapping of soil Cd at the regional scale.	[Qiu, Lefeng; Hu, Wei] Zhejiang Acad Agr Sci, Inst Rural Dev, Hangzhou, Zhejiang, Peoples R China; [Wang, Kai] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China; [Long, Wenli] Zhejiang Acad Agr Sci, Inst Digital Agr, Hangzhou, Zhejiang, Peoples R China; [Wang, Ke] Zhejiang Univ, Inst Remote Sensing & Informat Syst Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Amable, Gabriel S.] Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England	Zhejiang Academy of Agricultural Sciences; Ningbo University; Zhejiang Academy of Agricultural Sciences; Zhejiang University; University of Cambridge	Hu, W (corresponding author), Zhejiang Acad Agr Sci, Inst Rural Dev, Hangzhou, Zhejiang, Peoples R China.; Amable, GS (corresponding author), Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England.	huwei@mail.zaas.ac.cn; gabriel.amable@geog.cam.ac.uk	Qiu, Lefeng/AAA-4999-2021; Wang, Kai/AFS-2080-2022	Wang, Kai/0000-0001-9596-1274	National Natural Science Foundation of China [41401595]; National Science and Technology Support Program [2015BAL02B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program	This study was financially supported by National Natural Science Foundation of China (no. 41401595) and National Science and Technology Support Program (no. 2015BAL02B03).	Alloway BJ, 1995, HEAVY METALS SOILS; Bacon JR, 2005, ENVIRON POLLUT, V134, P247, DOI 10.1016/j.envpol.2004.07.030; Barcan V, 2002, ENVIRON INT, V28, P451, DOI 10.1016/S0160-4120(02)00064-8; Bi XY, 2006, ENVIRON INT, V32, P883, DOI 10.1016/j.envint.2006.05.010; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2013, BREIMAN CUTLERS RAND; Breiman L., 2017, CLASSIFICATION REGRE; Cai LM, 2015, J GEOCHEM EXPLOR, V148, P189, DOI 10.1016/j.gexplo.2014.09.010; Chen HY, 2015, SCI TOTAL ENVIRON, V512, P143, DOI 10.1016/j.scitotenv.2015.01.025; Chen T, 2009, ENVIRON POLLUT, V157, P1003, DOI 10.1016/j.envpol.2008.10.011; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Ettler V, 2016, APPL GEOCHEM, V64, P56, DOI 10.1016/j.apgeochem.2015.09.020; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Guo PT, 2015, GEODERMA, V237, P49, DOI 10.1016/j.geoderma.2014.08.009; Hayes AW., 2007, PRINCIPLES METHODS T, V5th, DOI DOI 10.1093/nar/gkw124; Houben D, 2013, J SOIL SEDIMENT, V13, P543, DOI 10.1007/s11368-012-0546-5; Kelly J, 1996, APPL GEOCHEM, V11, P363, DOI 10.1016/0883-2927(95)00084-4; Kheir RB, 2014, J GEOCHEM EXPLOR, V147, P250, DOI 10.1016/j.gexplo.2014.05.015; Kheir RB, 2010, ENVIRON POLLUT, V158, P520, DOI 10.1016/j.envpol.2009.08.009; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Li ZW, 2005, PLANT SOIL, V271, P165, DOI 10.1007/s11104-004-2296-7; Lienard A, 2014, J GEOCHEM EXPLOR, V147, P107, DOI 10.1016/j.gexplo.2014.07.014; Martinez RE, 2013, ENVIRON SCI POLLUT R, V20, P7686, DOI 10.1007/s11356-013-2030-1; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McLennan SM, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000gc000109; Mico C, 2006, CHEMOSPHERE, V65, P863, DOI 10.1016/j.chemosphere.2006.03.016; Montgomery D.C., 2012, INTRO LINEAR REGRESS; Nriagu JO, 1996, SCIENCE, V272, P223, DOI 10.1126/science.272.5259.223; Pourret O, 2016, APPL GEOCHEM, V64, P43, DOI 10.1016/j.apgeochem.2015.07.012; Pouyat R, 2007, THE IGBP SERIES; Qishlaqi A, 2009, J HAZARD MATER, V172, P374, DOI 10.1016/j.jhazmat.2009.07.024; Qiu LF, 2012, FRESEN ENVIRON BULL, V21, P1390; Quenea K, 2009, GEODERMA, V149, P217, DOI 10.1016/j.geoderma.2008.11.037; Schwarz K, 2012, ENVIRON POLLUT, V163, P32, DOI 10.1016/j.envpol.2011.12.003; Schwarz K, 2013, ENVIRON GEOCHEM HLTH, V35, P495, DOI 10.1007/s10653-013-9510-6; Sterckeman T, 2000, ENVIRON POLLUT, V107, P377, DOI 10.1016/S0269-7491(99)00165-7; Therneau T, 2014, RECURSIVE PARTITIONI; Thompson JA, 2006, GEODERMA, V133, P57, DOI 10.1016/j.geoderma.2006.03.037; Wang K, 2012, J SOIL SEDIMENT, V12, P556, DOI 10.1007/s11368-012-0471-7; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Wei CY, 2009, J ENVIRON SCI-CHINA, V21, P1230, DOI 10.1016/S1001-0742(08)62409-2; Were K, 2015, ECOL INDIC, V52, P394, DOI 10.1016/j.ecolind.2014.12.028; Xia XH, 2011, J HAZARD MATER, V186, P2043, DOI 10.1016/j.jhazmat.2010.12.104; Zhang XY, 2009, ENVIRON MONIT ASSESS, V154, P439, DOI 10.1007/s10661-008-0410-7; Zhang XY, 2009, ENVIRON MONIT ASSESS, V155, P205, DOI 10.1007/s10661-008-0429-9; Zhang XY, 2008, ENVIRON POLLUT, V156, P1260, DOI 10.1016/j.envpol.2008.03.009; Zhao Y, 2010, GEODERMA, V156, P216, DOI 10.1016/j.geoderma.2010.02.020	49	26	29	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151131	10.1371/journal.pone.0151131	http://dx.doi.org/10.1371/journal.pone.0151131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964095	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000107
J	Strom, SP; Clark, MJ; Martinez, A; Garcia, S; Abelazeem, AA; Matynia, A; Parikh, S; Sullivan, LS; Bowne, SJ; Daiger, SP; Gorin, MB				Strom, Samuel P.; Clark, Michael J.; Martinez, Ariadna; Garcia, Sarah; Abelazeem, Amira A.; Matynia, Anna; Parikh, Sachin; Sullivan, Lori S.; Bowne, Sara J.; Daiger, Stephen P.; Gorin, Michael B.			De Novo Occurrence of a Variant in ARL3 and Apparent Autosomal Dominant Transmission of Retinitis Pigmentosa	PLOS ONE			English	Article							MUTATIONS; GENE; PROTEIN; PREVALENCE; DIAGNOSIS; FAMILIES; SPECTRUM; PROBANDS	Background Retinitis pigmentosa is a phenotype with diverse genetic causes. Due to this genetic heterogeneity, genome-wide identification and analysis of protein-altering DNA variants by exome sequencing is a powerful tool for novel variant and disease gene discovery. In this study, exome sequencing analysis was used to search for potentially causal DNA variants in a two-generation pedigree with apparent dominant retinitis pigmentosa. Methods Variant identification and analysis of three affected members (mother and two affected offspring) was performed via exome sequencing. Parental samples of the index case were used to establish inheritance. Follow-up testing of 94 additional retinitis pigmentosa pedigrees was performed via retrospective analysis or Sanger sequencing. Results and Conclusions A total of 136 high quality coding variants in 123 genes were identified which are consistent with autosomal dominant disease. Of these, one of the strongest genetic and functional candidates is a c.269A>G (p.Tyr90Cys) variant in ARL3. Follow-up testing established that this variant occurred de novo in the index case. No additional putative causal variants in ARL3 were identified in the follow-up cohort, suggesting that if ARL3 variants can cause adRP it is an extremely rare phenomenon.	[Strom, Samuel P.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Clark, Michael J.; Garcia, Sarah] Personalis Inc, Menlo Pk, CA USA; [Martinez, Ariadna] Cedars Sinai Med Ctr, Dept Cardiol, Los Angeles, CA 90048 USA; [Abelazeem, Amira A.] Res Inst Ophthalmol, Cairo, Egypt; [Matynia, Anna; Parikh, Sachin; Gorin, Michael B.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Matynia, Anna; Parikh, Sachin; Gorin, Michael B.] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; [Sullivan, Lori S.; Bowne, Sara J.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA	University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Research Institute of Ophthalmology (RIO); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Texas System; University of Texas Health Science Center Houston	Strom, SP (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA.	sstrom@mednet.ucla.edu			Harold and Pauline Price Foundation; Foundation Fighting Blindness; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007142, P30EY000331] Funding Source: NIH RePORTER	Harold and Pauline Price Foundation; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by the Harold and Pauline Price Foundation, Foundation Fighting Blindness, and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors MJC and GS are employees of Personalis Inc. Personalis Inc. did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; [Anonymous], 1993, GENEREVIEWS; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Bowne SJ, 2013, MOL VIS, V19, P2407; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Davidson AE, 2013, HUM MUTAT, V34, P506, DOI 10.1002/humu.22264; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Haim Marianne, 2002, Acta Ophthalmol Scand Suppl, P1; Hillig RC, 2000, STRUCTURE, V8, P1239, DOI 10.1016/S0969-2126(00)00531-1; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kawamura T, 2010, HUM MUTAT, V31, P667, DOI 10.1002/humu.21240; Keen TJ, 1996, HUM MUTAT, V8, P297; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Levenson D, 2014, AM J MED GENET A, V164, pIX, DOI [10.1002/ajmg.a.36385, 10.1002/ajmg.a.36460]; Mears AJ, 1999, AM J HUM GENET, V64, P897, DOI 10.1086/302298; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ortube MC, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-11; Patwardhan A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0197-4; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Schwarz N, 2012, VISION RES, V75, P2, DOI 10.1016/j.visres.2012.07.016; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Sikkema-Raddatz B, 2013, HUM MUTAT, V34, P1035, DOI 10.1002/humu.22332; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Strom Samuel P, 2013, Mol Vis, V19, P980; Strom SP, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-67; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Sullivan LS, 2014, INVEST OPHTH VIS SCI, V55, P7147, DOI 10.1167/iovs.14-15419; Sullivan LS, 2013, INVEST OPHTH VIS SCI, V54, P6255, DOI 10.1167/iovs.13-12605; Sullivan LS, RETINAL INFORM NETWO; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; van Zelst-Stams WA, 2014, GENOME MED, V6, DOI 10.1186/gm521; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Watzlich D, 2013, EMBO REP, V14, P465, DOI 10.1038/embor.2013.37; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915	44	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150944	10.1371/journal.pone.0150944	http://dx.doi.org/10.1371/journal.pone.0150944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964041	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000084
J	Hansen, JF; Brorson, MM; Boas, M; Frederiksen, H; Nielsen, CH; Lindstrom, ES; Hofman-Bang, J; Hartoft-Nielsen, ML; Frisch, T; Main, KM; Bendtzen, K; Rasmussen, AK; Feldt-Rasmussen, U				Hansen, Juliana Frohnert; Brorson, Marianne Moller; Boas, Malene; Frederiksen, Hanne; Nielsen, Claus Henrik; Lindstrom, Emma Sofie; Hofman-Bang, Jacob; Hartoft-Nielsen, Marie-Louise; Frisch, Thomas; Main, Katharina M.; Bendtzen, Klaus; Rasmussen, Ase Krogh; Feldt-Rasmussen, Ulla			Phthalates Are Metabolised by Primary Thyroid Cell Cultures but Have Limited Influence on Selected Thyroid Cell Functions In Vitro	PLOS ONE			English	Article							ENDOCRINE DISRUPTING CHEMICALS; DI(2-ETHYL HEXYL) PHTHALATE; EPITHELIAL-CELLS; HORMONE LEVELS; ENVIRONMENTAL CHEMICALS; URINARY PHTHALATE; MALE RATS; EXPOSURE; SERUM; THYROGLOBULIN	Phthalates are plasticisers added to a wide variety of products, resulting in measurable exposure of humans. They are suspected to disrupt the thyroid axis as epidemiological studies suggest an influence on the peripheral thyroid hormone concentration. The mechanism is still unknown as only few in vitro studies within this area exist. The aim of the present study was to investigate the influence of three phthalate diesters (di-ethyl phthalate, di-n-butyl phthalate (DnBP), di-(2-ethylhexyl) phthalate (DEHP)) and two monoesters (mono-n-butyl phthalate and mono-(2-ethylhexyl) phthalate (MEHP)) on the differentiated function of primary human thyroid cell cultures. Also, the kinetics of phthalate metabolism were investigated. DEHP and its monoester, MEHP, both had an inhibitory influence on 3'-5'-cyclic adenosine monophosphate secretion from the cells, and MEHP also on thyroglobulin (Tg) secretion from the cells. Results of the lactate dehydrogenase-measurements indicated that the MEHP-mediated influence was caused by cell death. No influence on gene expression of thyroid specific genes (Tg, thyroid peroxidase, sodium iodine symporter and thyroid stimulating hormone receptor) by any of the investigated diesters could be demonstrated. All phthalate diesters were metabolised to the respective monoester, however with a fall in efficiency for high concentrations of the larger diesters DnBP and DEHP. In conclusion, human thyroid cells were able to metabolise phthalates but this phthalate-exposure did not appear to substantially influence selected functions of these cells.	[Hansen, Juliana Frohnert; Brorson, Marianne Moller; Lindstrom, Emma Sofie; Hofman-Bang, Jacob; Hartoft-Nielsen, Marie-Louise; Rasmussen, Ase Krogh; Feldt-Rasmussen, Ulla] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, PE 2132, DK-2100 Copenhagen, Denmark; [Boas, Malene; Frederiksen, Hanne; Main, Katharina M.] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Nielsen, Claus Henrik; Bendtzen, Klaus] Univ Copenhagen, Rigshosp, Inst Inflammat Res, Sect 7521, DK-2100 Copenhagen, Denmark; [Frisch, Thomas] Univ Copenhagen, Rigshosp, Dept ENT Head & Neck Surg, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Feldt-Rasmussen, U (corresponding author), Univ Copenhagen, Rigshosp, Dept Med Endocrinol, PE 2132, DK-2100 Copenhagen, Denmark.	ufeldt@rh.dk	Frederiksen, Hanne/N-8632-2013; Feldt-Rasmussen, Ulla/AAB-9218-2021	Frederiksen, Hanne/0000-0002-3180-9879; Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Nielsen, Claus Henrik/0000-0001-7543-9016; Main, Katharina Maria/0000-0001-7259-1039	Arvid Nilsson's Fund; Novo Nordisk Foundation; Capital Region of Denmark; Danish Council for Independent Research [11-107874]; Musikforlaeggerne Agnes og Knut Morks Fond; Rigshospitalets Forskningspuljer; Novo Nordisk A/S Denmark; Novo Nordisk Fonden [NNF15OC0014622] Funding Source: researchfish	Arvid Nilsson's Fund; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Capital Region of Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Musikforlaeggerne Agnes og Knut Morks Fond; Rigshospitalets Forskningspuljer; Novo Nordisk A/S Denmark(Novo Nordisk); Novo Nordisk Fonden(Novo Nordisk Foundation)	Ulla Feldt-Rasmussen has received funding for her research salary by Arvid Nilsson's Fund and Novo Nordisk Foundation. JFH received salary from three Danish public funds and one private fund: The Capital Region of Denmark, Rigshospitalets Forskningspuljer, the Danish Council for Independent Research (grant number: 11-107874) and Musikforlaeggerne Agnes og Knut Morks Fond. Equipment and materials were also sponsored by the three public funds as well as by the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novo Nordisk A/S Denmark funder provided support in the form of salaries for authors [MLHN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALBRO PW, 1989, TOXICOL APPL PHARM, V100, P193, DOI 10.1016/0041-008X(89)90305-0; Bernal CA, 2002, FOOD ADDIT CONTAM, V19, P1091, DOI 10.1080/02652030210157709; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009; Brucker-Davis F, 2011, THYROID, V21, P1133, DOI 10.1089/thy.2010.0459; de Cock M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-106; Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069; Dhanya C. R., 2004, Indian Journal of Experimental Biology, V42, P871; DIAMANT M, 1991, AUTOIMMUNITY, V11, P21, DOI 10.3109/08916939108994704; Elcombe CR, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110363; FELDTRASMUSSEN U, 1978, J IMMUNOL METHODS, V21, P295, DOI 10.1016/0022-1759(78)90156-4; Frederiksen H, 2014, ENV HLTH PERSPECT; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Frederiksen H, 2014, REPRODUCTION, V147, P555, DOI 10.1530/REP-13-0522; Frederiksen H, 2010, J ANAL TOXICOL, V34, P400, DOI 10.1093/jat/34.7.400; Gayathri NS, 2004, INDIAN J MED RES, V119, P139; Ghisari M, 2009, TOXICOL LETT, V189, P67, DOI 10.1016/j.toxlet.2009.05.004; Hansen J, SCANDINAVIAN J CLIN; HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356; Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205; Ishihara A, 2003, MOL CELL ENDOCRINOL, V199, P105, DOI 10.1016/S0303-7207(02)00302-7; Ishihara A, 2003, GEN COMP ENDOCR, V134, P36, DOI 10.1016/S0016-6480(03)00197-7; Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755; Kay VR, 2014, CRIT REV TOXICOL, V44, P467, DOI 10.3109/10408444.2013.875983; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635; Lhuguenot J-C, 1985, TOXICOLOGY APPL PHAR, V80, P1985; Liu C, 2015, ENV SCI POLLUT RES I; MADSEN SN, 1976, ACTA ENDOCRINOL-COP, V81, P208, DOI 10.1530/acta.0.0810208; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Muczynski V, 2012, TOXICOL APPL PHARM, V261, P97, DOI 10.1016/j.taap.2012.03.016; O'Connor JC, 2002, TOXICOL SCI, V69, P92, DOI 10.1093/toxsci/69.1.92; Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901; Rajoria S, 2012, BIOMED PHARMACOTHER, V66, P151, DOI 10.1016/j.biopha.2011.11.010; RASMUSSEN AK, 1994, J ENDOCRINOL, V143, P359, DOI 10.1677/joe.0.1430359; RASMUSSEN AK, 1990, ACTA ENDOCRINOL-COP, V122, P520, DOI 10.1530/acta.0.1220520; RASMUSSEN AK, 1988, ALLERGY, V43, P435, DOI 10.1111/j.1398-9995.1988.tb00915.x; Rasmussen AK, 2000, EXP CLIN ENDOCR DIAB, V108, P67, DOI 10.1055/s-2000-5797; Rasmussen AK, 1997, ENDOCRINOLOGY, V138, P2043, DOI 10.1210/en.138.5.2043; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P173, DOI 10.1016/0303-7207(95)03712-8; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P165, DOI 10.1016/0303-7207(95)03711-X; SANDERMANN H, 1984, ECOTOX ENVIRON SAFE, V8, P167, DOI 10.1016/0147-6513(84)90059-9; Santini F, 2003, J ENDOCRINOL INVEST, V26, P950, DOI 10.1007/BF03348190; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Song M, 2011, ENVIRON SCI TECHNOL, V45, P7906, DOI 10.1021/es200475k; Spitzweg C, 2002, CLIN ENDOCRINOL, V57, P559, DOI 10.1046/j.1365-2265.2002.01640.x; Tonk ECM, 2012, TOXICOL APPL PHARM, V260, P48, DOI 10.1016/j.taap.2012.01.018; Wang Q, 2011, ENVIRON SCI POLLUT R, V18, P987, DOI 10.1007/s11356-010-0420-1; Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008	55	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151192	10.1371/journal.pone.0151192	http://dx.doi.org/10.1371/journal.pone.0151192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985823	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300051
J	Krishna, YC; Kumar, A; Isvaran, K				Krishna, Yarlagadda Chaitanya; Kumar, Ajith; Isvaran, Kavita			Wild Ungulate Decision-Making and the Role of Tiny Refuges in Human-Dominated Landscapes	PLOS ONE			English	Article							PREDATION RISK; HABITAT SELECTION; BLACKBUCK ANTELOPE; FORAGE QUALITY; STRATEGIES; HERBIVORES; ECOLOGY; CATTLE; FEAR; DEER	Wildlife conservation in human-dominated landscapes requires that we understand how animals, when making habitat-use decisions, obtain diverse and dynamically occurring resources while avoiding risks, induced by both natural predators and anthropogenic threats. Little is known about the underlying processes that enable wild animals to persist in densely populated human-dominated landscapes, particularly in developing countries. In a complex, semi-arid, fragmented, human-dominated agricultural landscape, we analyzed the habitat-use of blackbuck, a large herbivore endemic to the Indian sub-continent. We hypothesized that blackbuck would show flexible habitat-use behaviour and be risk averse when resource quality in the landscape is high, and less sensitive to risk otherwise. Overall, blackbuck appeared to be strongly influenced by human activity and they offset risks by using small protected patches (similar to 3 km(2)) when they could afford to do so. Blackbuck habitat use varied dynamically corresponding with seasonally-changing levels of resources and risks, with protected habitats registering maximum use. The findings show that human activities can strongly influence and perhaps limit ungulate habitat-use and behaviour, but spatial heterogeneity in risk, particularly the presence of refuges, can allow ungulates to persist in landscapes with high human and livestock densities.	[Krishna, Yarlagadda Chaitanya; Isvaran, Kavita] Indian Inst Sci, Ctr Ecol Sci, Bengaluru, Karnataka, India; [Krishna, Yarlagadda Chaitanya] Manipal Univ, Manipal, Karnataka, India; [Krishna, Yarlagadda Chaitanya; Kumar, Ajith] Wildlife Conservat Soc, India Program, Ctr Wildlife Studies, Bengaluru, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Manipal Academy of Higher Education (MAHE)	Krishna, YC (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bengaluru, Karnataka, India.; Krishna, YC (corresponding author), Manipal Univ, Manipal, Karnataka, India.; Krishna, YC (corresponding author), Wildlife Conservat Soc, India Program, Ctr Wildlife Studies, Bengaluru, Karnataka, India.	chethikrishna@yahoo.com			Royal Norwegian Embassy, New Delhi; Ministry of Environment, Forest and Climate Change, Government of India	Royal Norwegian Embassy, New Delhi; Ministry of Environment, Forest and Climate Change, Government of India	This study was funded by grants from the Royal Norwegian Embassy, New Delhi (http://www.norwayemb.org.in/) and the Ministry of Environment, Forest and Climate Change, Government of India (http://www.moef.nic.in/) to KI.	Barton K., 2013, MUMIN MULTIMODEL INF; Beecham JA, 1998, ECOL MODEL, V113, P141, DOI 10.1016/S0304-3800(98)00139-2; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Brashares JS, 2002, J ANIM ECOL, V71, P626, DOI 10.1046/j.1365-2656.2002.00633.x; DEUTSCH JC, 1994, J ANIM ECOL, V63, P101, DOI 10.2307/5587; Frid A, 2002, CONSERV ECOL, V6; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; GORDON IJ, 1988, J APPL ECOL, V25, P1, DOI 10.2307/2403605; Isvaran K, 2007, OECOLOGIA, V154, P435, DOI 10.1007/s00442-007-0840-x; Jhala YV, 1997, J APPL ECOL, V34, P1348, DOI 10.2307/2405252; Johst K, 2001, ECOL APPL, V11, P60, DOI 10.1890/1051-0761(2001)011[0060:FIAPAD]2.0.CO;2; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Kotler BP, 1995, OIKOS, V74, P251, DOI 10.2307/3545654; KUDO G, 1992, ECOL RES, V7, P297, DOI 10.1007/BF02347098; Kumar S, 2008, INT J ECOL ENV SCI, V34, P9; LARTER NC, 1991, CAN J ZOOL, V69, P2677, DOI 10.1139/z91-376; LOFT ER, 1991, J WILDLIFE MANAGE, V55, P16, DOI 10.2307/3809236; Namgail T, 2007, ECOL RES, V22, P25, DOI 10.1007/s11284-006-0015-y; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; R Core Team, 2012, R LANG ENV STAT COMP; Rahmani A.R., 1991, Journal of the Bombay Natural History Society, V88, P35; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Skaug H., 2013, GEN LINEAR MIXED MOD; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; WallisDeVries MF, 1999, OECOLOGIA, V121, P355, DOI 10.1007/s004420050939; WILMSHURST JF, 1995, BEHAV ECOL, V6, P209, DOI 10.1093/beheco/6.2.209; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x	34	10	12	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151748	10.1371/journal.pone.0151748	http://dx.doi.org/10.1371/journal.pone.0151748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985668	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000372580300122
J	Li, GY; Zhang, DG				Li, Guangye; Zhang, Dingguo			Brain-Computer Interface Controlled Cyborg: Establishing a Functional Information Transfer Pathway from Human Brain to Cockroach Brain	PLOS ONE			English	Article							EEG; STIMULATION; BEHAVIOR; FATIGUE; SYSTEM; BCI	An all-chain-wireless brain-to-brain system (BTBS), which enabled motion control of a cyborg cockroach via human brain, was developed in this work. Steady-state visual evoked potential (SSVEP) based brain-computer interface (BCI) was used in this system for recognizing human motion intention and an optimization algorithm was proposed in SSVEP to improve online performance of the BCI. The cyborg cockroach was developed by surgically integrating a portable microstimulator that could generate invasive electrical nerve stimulation. Through Bluetooth communication, specific electrical pulse trains could be triggered from the microstimulator by BCI commands and were sent through the antenna nerve to stimulate the brain of cockroach. Serial experiments were designed and conducted to test overall performance of the BTBS with six human subjects and three cockroaches. The experimental results showed that the online classification accuracy of three-mode BCI increased from 72.86% to 78.56% by 5.70% using the optimization algorithm and the mean response accuracy of the cyborgs using this system reached 89.5%. Moreover, the results also showed that the cyborg could be navigated by the human brain to complete walking along an S-shape track with the success rate of about 20%, suggesting the proposed BTBS established a feasible functional information transfer pathway from the human brain to the cockroach brain.	[Li, Guangye; Zhang, Dingguo] Shanghai Jiao Tong Univ, Inst Robot, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, DG (corresponding author), Shanghai Jiao Tong Univ, Inst Robot, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China.	dgzhang@sjtu.edu.cn		Zhang, Dingguo/0000-0003-4803-7489	National Natural Science Foundation of China [41751475292]; National Basic Research Program (973 program) of China [2011CB013305]; National High Technology Research and Development Program (863 Program) of 419 China [2015AA020501]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020501] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 program) of China(National Basic Research Program of China); National High Technology Research and Development Program (863 Program) of 419 China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Natural Science Foundation of China (No. 41751475292), the National Basic Research Program (973 program) of China (2011CB013305), and the National High Technology Research and Development Program (863 Program) of 419 China (2015AA020501).; This work was supported by the National Natural Science Foundation of China (No. 51475292), the National Basic Research Program (973 program) of China (2011CB013305), the National High Technology Research and Development Program (863 Program) of China (2015AA020501). The authors would like to thank all the subjects for their participation in the experiments.	Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Bobrov P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020674; Burdohan JA, 1996, J NEUROSCI, V16, P5830; Cao T, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-28; Chang MH, 2014, CLIN NEUROPHYSIOL, V125, P1380, DOI 10.1016/j.clinph.2013.11.016; Comer C, 2011, PHILOS T R SOC B, V366, P3006, DOI 10.1098/rstb.2011.0149; Comer CM, 2003, J COMP PHYSIOL A, V189, P97, DOI 10.1007/s00359-002-0384-9; Craig A, 2012, PSYCHOPHYSIOLOGY, V49, P574, DOI 10.1111/j.1469-8986.2011.01329.x; Debener S, 2012, PSYCHOPHYSIOLOGY, V49, P1617, DOI 10.1111/j.1469-8986.2012.01471.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Graimann B, 2010, FRONT COLLECT, P1, DOI 10.1007/978-3-642-02091-9_1; Krames ES, 2009, NEUROMODULATION, VOLS 1 AND 2, P3, DOI 10.1016/B978-0-12-374248-3.00002-1; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Latif T, 2012, IEEE ENG MED BIO, P972, DOI 10.1109/EMBC.2012.6346095; Louwerse M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00385; Mika S., 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P41, DOI 10.1109/NNSP.1999.788121; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Pais-Vieira M, 2012, SCI REPORTS, V3, P1319; Pinheiro CG, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-31; Rao RPN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111332; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Shih JJ, 2012, BRAIN COMPUTER INTER, P268; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Volosyak I, 2011, IEEE T NEUR SYS REH, V19, P232, DOI 10.1109/TNSRE.2011.2121919; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu SH, 2004, J NEUROSCI METH, V133, P57, DOI 10.1016/j.jneumeth.2003.09.012; Ye SP, 1996, J NEUROSCI, V16, P5844; Yoo SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060410	35	27	28	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150667	10.1371/journal.pone.0150667	http://dx.doi.org/10.1371/journal.pone.0150667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982717	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900048
J	Tian, RBD; Niamke, S; Tissot-Dupont, H; Drancourt, M				Tian, Roger Bi Diangone; Niamke, Sebastian; Tissot-Dupont, Herve; Drancourt, Michel			Detection of Mycobacterium ulcerans DNA in the Environment, Ivory Coast	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; REAL-TIME PCR; BURULI ULCER; COTE-DIVOIRE; TRANSMISSION; ECOLOGY; MYCOLACTONE; MACROLIDE; DISEASE; SAMPLES	Background Ivory Coast is a West African country with the highest reported cases of Buruli ulcer, a disabling subcutaneous infection due to Mycobacterium ulcerans. However, the prevalence of environmental M. ulcerans is poorly known in this country. Methods We collected 496 environmental specimens consisting of soil (n = 100), stagnant water (n = 200), plants (n = 100) and animal feces (n = 96) in Ivory Coast over five months in the dry and wet seasons in regions which are free of Buruli ulcer (control group A; 250 specimens) and in regions where the Buruli ulcer is endemic (group B; 246 specimens). After appropriate total DNA extraction incorporating an internal control, the M. ulcerans IS2404 and KR-B gene were amplified by real-time PCR in samples. In parallel, a calibration curve was done for M. ulcerans Agy99 IS2404 and KR-B gene. Results Of 460 samples free of PCR inhibition, a positive real-time PCR detection of insertion sequence IS2404 and KR-B gene was observed in 1/230 specimens in control group A versus 9/230 specimens in group B (P = 0.02; Fisher exact test). Positive specimens comprised seven stagnant water specimens, two feces specimens confirmed to be of Thryonomys swinderianus (agouti) origin by real-time PCR of the cytb gene; and one soil specimen. Extrapolation from the calibration curves indicated low inoculums ranging from 1 to 102 mycobacteria/mL. Conclusion This study confirms the presence of M. ulcerans in the watery environment surrounding patients with Buruli ulcer in Ivory Coast. It suggests that the agouti, which is in close contacts with populations, could play a role in the environmental cycle of M. ulcerans, as previously suggested for the closely related possums in Australia.	[Tian, Roger Bi Diangone; Tissot-Dupont, Herve; Drancourt, Michel] Aix Marseille Univ, INSERM 1095, URMITE, UMR,CNRS 7278,IRD 198,Fac Med, Marseille, France; [Tian, Roger Bi Diangone; Niamke, Sebastian] Univ Felix Houphouet Boigny, UFR Biosci, Lab Biotechnol, Abidjan, Cote Ivoire	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Drancourt, M (corresponding author), Aix Marseille Univ, INSERM 1095, URMITE, UMR,CNRS 7278,IRD 198,Fac Med, Marseille, France.	Michel.Drancourt@univ-amu.fr	TISSOT-DUPONT, Hervé/P-5808-2016					Addo P, 2006, INTERNET J TROP MED, V2; Brou T, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000271; Doannio J M C, 2011, Med Trop (Mars), V71, P53; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; Garchitorena A, 2015, ELIFE, V4, DOI 10.7554/eLife.07616; Gryseels S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001764; Konan KL, 2015, MED SANTE TROP, V25, P44, DOI 10.1684/mst.2014.0363; Landier J, 2015, EMERG INFECT DIS, V21, P1414, DOI 10.3201/eid2108.141336; Marion E, 2011, Med Trop (Mars), V71, P169; Marion E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000731; Marsollier L, 2003, PATHOL BIOL, V51, P490, DOI 10.1016/S0369-8114(03)00151-2; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Morris A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002660; Mve-Obiang A, 2005, INFECT IMMUN, V73, P3307, DOI 10.1128/IAI.73.6.3307-3312.2005; Narh CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003437; Ngazoa-Kakou ES, 2011, AFR J MICROBIOL RES, V5, P2211; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Ranger BS, 2006, INFECT IMMUN, V74, P6037, DOI 10.1128/IAI.00970-06; Robert B, 1997, J CLIN MICROBIOL, V35, P2709, DOI 10.1128/JCM.35.10.2709-2711.1997; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tian RDB, 2015, AM J TROP MED HYG; Tobias NJ, 2013, J BACTERIOL, V195, P556, DOI 10.1128/JB.02132-12; WHO, WHO GLOBAL HLTH OBSE; Williamson HR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000205; Williamson HR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001506	28	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151567	10.1371/journal.pone.0151567	http://dx.doi.org/10.1371/journal.pone.0151567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982581	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900097
J	Zhu, XX; Li, QY; Shen, CC; Duan, ZB; Yu, DY; Niu, JS; Ni, YJ; Jiang, YM				Zhu, Xin-Xin; Li, Qiao-Yun; Shen, Chun-Cai; Duan, Zong-Biao; Yu, Dong-Yan; Niu, Ji-Shan; Ni, Yong-Jing; Jiang, Yu-Mei			Transcriptome Analysis for Abnormal Spike Development of the Wheat Mutant dms	PLOS ONE			English	Article							MADS-BOX GENES; PISTIL-LIKE STRUCTURES; FLORAL ORGAN IDENTITY; TRITICUM-AESTIVUM L.; RICE ORYZA-SATIVA; HOMEOTIC TRANSFORMATION; ARABIDOPSIS-THALIANA; FLOWER DEVELOPMENT; ALLOPLASMIC WHEAT; COMMON WHEAT	Background Wheat (Triticum aestivum L.) spike development is the foundation for grain yield. We obtained a novel wheat mutant, dms, characterized as dwarf, multi-pistil and sterility. Although the genetic changes are not clear, the heredity of traits suggests that a recessive gene locus controls the two traits of multi-pistil and sterility in self-pollinating populations of the medium plants (M), such that the dwarf genotype (D) and tall genotype (T) in the progeny of the mutant are ideal lines for studies regarding wheat spike development. The objective of this study was to explore the molecular basis for spike abnormalities of dwarf genotype. Results Four unigene libraries were assembled by sequencing the mRNAs of the super-bulked differentiating spikes and stem tips of the D and T plants. Using integrative analysis, we identified 419 genes highly expressed in spikes, including nine typical homeotic genes of the MADS-box family and the genes TaAP2, TaFL and TaDL. We also identified 143 genes that were significantly different between young spikes of T and D, and 26 genes that were putatively involved in spike differentiation. The result showed that the expression levels of TaAP1-2, TaAP2, and other genes involved in the majority of biological processes such as transcription, translation, cell division, photosynthesis, carbohydrate transport and metabolism, and energy production and conversion were significantly lower in D than in T. Conclusions We identified a set of genes related to wheat floral organ differentiation, including typical homeotic genes. Our results showed that the major causal factors resulting in the spike abnormalities of dms were the lower expression homeotic genes, hormonal imbalance, repressed biological processes, and deficiency of construction materials and energy. We performed a series of studies on the homeotic genes, however the other three causal factors for spike abnormal phenotype of dms need further study.	[Zhu, Xin-Xin; Li, Qiao-Yun; Shen, Chun-Cai; Duan, Zong-Biao; Yu, Dong-Yan; Niu, Ji-Shan; Ni, Yong-Jing; Jiang, Yu-Mei] Henan Agr Univ, Natl Ctr Engn & Technol Res Wheat, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Henan, Peoples R China; [Ni, Yong-Jing] Shangqiu Acad Agr & Forestry Sci, Shangqiu, Henan, Peoples R China	Henan Agricultural University	Niu, JS (corresponding author), Henan Agr Univ, Natl Ctr Engn & Technol Res Wheat, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Henan, Peoples R China.	jsniu@263.net			National High-tech R&D Program (863 Program) [2012AA101105]; National Natural Science Fundation of China [31571646]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a National High-tech R&D Program (863 Program) (program.most.gov.cn) grant (2012AA101105) to JSN and National Natural Science Fundation of China (www.nsfc.gov.cn) grant (31571646) to JSN.	BEFFA RS, 1993, P NATL ACAD SCI USA, V90, P8792, DOI 10.1073/pnas.90.19.8792; BHATIA CR, 1963, GENETICA, V34, P58, DOI 10.1007/BF01664179; Brock MT, 2012, NEW PHYTOL, V195, P58, DOI 10.1111/j.1469-8137.2012.04145.x; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Chen J S, 1983, ACTA AGRONOMICA SINI, V9, P67; Chen LY, 2013, MOL PLANT, V6, P1388, DOI 10.1093/mp/sst005; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Chujo A, 2003, PLANT CELL PHYSIOL, V44, P1311, DOI 10.1093/pcp/pcg155; Ciaffi M, 2011, SEX PLANT REPROD, V24, P247, DOI 10.1007/s00497-011-0175-y; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Dai XY, 2007, PLANT GROWTH REGUL, V52, P229, DOI 10.1007/s10725-007-9194-y; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Duan ZB, 2015, J INTEGR AGR, V14, P1706, DOI 10.1016/S2095-3119(14)60936-9; Fambrini M, 2011, PLANT MOL BIOL, V75, P431, DOI 10.1007/s11103-011-9740-x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hama E, 2004, PLANTA, V218, P712, DOI 10.1007/s00425-003-1157-6; Hames C, 2008, EMBO J, V27, P2628, DOI 10.1038/emboj.2008.184; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Jang S, 2004, PLANT MOL BIOL, V56, P133, DOI 10.1007/s11103-004-2648-y; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kinjo H, 2012, MOL GENET GENOMICS, V287, P283, DOI 10.1007/s00438-012-0679-7; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Laudencia-Chingcuanco DL, 2007, PLANT MOL BIOL, V63, P651, DOI 10.1007/s11103-006-9114-y; Li QY, 2014, J PLANT DIS PROTECT, V121, P79, DOI 10.1007/BF03356495; Liu T, 2011, AFR J BIOTECHNOL, V10, P3978; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Ma H, 2013, NAT GENET, V45, P472, DOI 10.1038/ng.2618; Ma ShouCai, 2006, Journal of Triticeae Crops, V26, P35; Mathews S, 2012, NEW PHYTOL, V194, P910, DOI 10.1111/j.1469-8137.2012.04091.x; Matsumura Y, 2009, PLANT J, V58, P525, DOI 10.1111/j.1365-313X.2009.03797.x; Meiyalaghan S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-2; Mizumoto K, 2009, DEV GENES EVOL, V219, P175, DOI 10.1007/s00427-009-0275-y; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murai K, 2002, PLANT J, V29, P169, DOI 10.1046/j.0960-7412.2001.01203.x; Murai Koji, 2013, Plants-Basel, V2, P379, DOI 10.3390/plants2030379; Nagasawa N, 2003, DEVELOPMENT, V130, P705, DOI 10.1242/dev.00294; O'Maoileidigh DS, 2014, NEW PHYTOL, V201, P16, DOI 10.1111/nph.12444; Ohmori S, 2009, PLANT CELL, V21, P3008, DOI 10.1105/tpc.109.068742; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Paolacci AR, 2008, P 11 INT WHEAT GEN S, P1; Paollacci AR, 2007, MOL GENET GENOMICS, V278, P689, DOI 10.1007/s00438-007-0285-2; Pearce S, 2013, PLANT PHYSIOL, V163, P1433, DOI 10.1104/pp.113.225854; Peng ZS, 2008, J APPL GENET, V49, P135, DOI 10.1007/BF03195606; Peng ZhengSong, 2013, Australian Journal of Crop Science, V7, P159; Peng ZS, 2004, HEREDITAS, V141, P15, DOI 10.1111/j.1601-5223.2004.01787.x; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rijpkema AS, 2010, SEMIN CELL DEV BIOL, V21, P100, DOI 10.1016/j.semcdb.2009.11.002; Robert HS, 2009, PLANT J, V58, P109, DOI 10.1111/j.1365-313X.2008.03764.x; Rubinovich L, 2014, MOL PLANT, V7, P244, DOI 10.1093/mp/sst141; Saraike T, 2007, PLANTA, V227, P211, DOI 10.1007/s00425-007-0608-x; Shen Guanghua, 1992, Acta Genetica Sinica, V19, P513; Shi LF, 1998, PLANT MOL BIOL, V38, P1053, DOI 10.1023/A:1006007315718; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Theissen G, 1999, DEV GENET, V25, P181, DOI 10.1002/(SICI)1520-6408(1999)25:3<181::AID-DVG1>3.0.CO;2-F; Tong Y Z, 1984, J SHANGHAI NORMAL U, V2, P48; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Vahamidis P, 2014, ANN APPL BIOL, V164, P220, DOI 10.1111/aab.12097; Wang H, 2013, PLANT J, V74, P511, DOI 10.1111/tpj.12146; Wang X L, 2000, ACTA BOT BOREALI-OCC, V20, P949; Wang Y., 1990, J LANZHOU U NAT SCI, V26, P80; WANG Y-Z, 1991, Acta Botanica Sinica, V33, P176; Wang Y-Z., 1989, ACTA BOT BOREALI-OCC, V9, P131; Wang ZG, 2009, CAN J PLANT SCI, V89, P845, DOI 10.4141/CJPS09022; Wei SH, 2011, GENET MOL BIOL, V34, P606, DOI 10.1590/S1415-47572011000400013; Winfield MO, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-55; Wu J, 2000, J NW AGR U, V28, P58; Xu GX, 2007, J INTEGR PLANT BIOL, V49, P927, DOI 10.1111/j.1744-7909.2007.00502.x; Xu P, 2008, J EXP BOT, V59, P1375, DOI 10.1093/jxb/ern068; Yamada K, 2009, PLANT MOL BIOL, V71, P1, DOI 10.1007/s11103-009-9504-z; Yamaguchi T, 2004, PLANT CELL, V16, P500, DOI 10.1105/tpc.018044; Yamamoto M, 2013, PLANTA, V237, P1001, DOI 10.1007/s00425-012-1812-x; Yoshida K, 2006, PLANT CELL PHYSIOL, V47, P1555, DOI 10.1093/pcp/pcl021; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x; Zhang LongYu, 2011, Acta Agronomica Sinica, V37, P620; Zhao ZG, 2013, DEV CELL, V27, P113, DOI 10.1016/j.devcel.2013.09.005; Zheng YS, 2013, J INTEGR AGR, V12, P398, DOI [10.1016/S2095-3119(13)60239-7, 10.1016/s2095-3119(13)60239-7]; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149; Zhu Y, 2008, PLANT CELL PHYSIOL, V49, P1723, DOI 10.1093/pcp/pcn143	79	6	7	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149287	10.1371/journal.pone.0149287	http://dx.doi.org/10.1371/journal.pone.0149287			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982202	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900014
J	Ates, D; Sever, T; Aldemir, S; Yagmur, B; Temel, HY; Kaya, HB; Alsaleh, A; Kahraman, A; Ozkan, H; Vandenberg, A; Tanyolac, B				Ates, Duygu; Sever, Tugce; Aldemir, Secil; Yagmur, Bulent; Temel, Hulya Yilmaz; Kaya, Hilal Betul; Alsaleh, Ahmad; Kahraman, Abdullah; Ozkan, Hakan; Vandenberg, Albert; Tanyolac, Bahattin			Identification QTLs Controlling Genes for Se Uptake in Lentil Seeds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; SERUM SELENIUM LEVELS; MINERAL CONCENTRATIONS; LINKAGE MAP; ZINC; BIOFORTIFICATION; IRON; SELENOPROTEINS; PREVENTION; NUTRIENTS	Lentil (Lens culinaris Medik.) is an excellent source of protein and carbohydrates and is also rich in essential trace elements for the human diet. Selenium (Se) is an essential micronutrient for human health and nutrition, providing protection against several diseases and regulating important biological systems. Dietary intake of 55 mu g of Se per day is recommended for adults, with inadequate Se intake causing significant health problems. The objective of this study was to identify and map quantitative trait loci (QTL) of genes controlling Se accumulation in lentil seeds using a population of 96 recombinant inbred lines (RILs) developed from the cross "PI 320937" x "Eston" grown in three different environments for two years (2012 and 2013). Se concentration in seed varied between 119 and 883 mu g/kg. A linkage map consisting of 1,784 markers (4 SSRs, and 1,780 SNPs) was developed. The map spanned a total length of 4,060.6 cM, consisting of 7 linkage groups (LGs) with an average distance of 2.3 cM between adjacent markers. Four QTL regions and 36 putative QTL markers, with LOD scores ranging from 3.00 to 4.97, distributed across two linkage groups (LG2 and LG5) were associated with seed Se concentration, explaining 6.3-16.9% of the phenotypic variation.	[Ates, Duygu; Sever, Tugce; Aldemir, Secil; Yagmur, Bulent; Temel, Hulya Yilmaz; Kaya, Hilal Betul; Tanyolac, Bahattin] Ege Univ, Fac Engn, Dept Bioengn, Izmir, Turkey; [Kahraman, Abdullah] Harran Univ, Fac Agr, Dept Field Crops, Sanli Urfa, Turkey; [Alsaleh, Ahmad; Ozkan, Hakan] Cukurova Univ, Dept Field Crops, Fac Agr, Adana, Turkey; [Vandenberg, Albert] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK S7N 0W0, Canada	Ege University; Harran University; Cukurova University; University of Saskatchewan	Tanyolac, B (corresponding author), Ege Univ, Fac Engn, Dept Bioengn, Izmir, Turkey.	bahattin.tanyolac@ege.edu.tr	Kahraman, Abdullah/AAB-1400-2020; Aldemir, Seçil/AAZ-4351-2020; ÖZKAN, Hakan/C-8510-2011; Aldemir, Secil/AAE-6246-2019; ALSALEH, Ahmad/AAB-6508-2021; Tanyolac, Bahattin/AAD-3762-2019; ALSALEH, Ahmad/CAA-2655-2022; Kahraman, Abdullah/W-1029-2017	ÖZKAN, Hakan/0000-0003-3530-2626; Aldemir, Secil/0000-0003-1025-4875; ALSALEH, Ahmad/0000-0001-7078-3221; ALSALEH, Ahmad/0000-0001-7078-3221; Kaya, Hilal Betul/0000-0002-2543-7212; Yilmaz Temel, Hulya/0000-0003-1842-0145; Kahraman, Abdullah/0000-0002-8829-3797; Vandenberg, Albert/0000-0001-6177-1392	Scientific and Technological Research Foundation of Turkey [TUBITAK-COST-114O446]	Scientific and Technological Research Foundation of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The Study was funded by Scientific and Technological Research Foundation of Turkey, with grant number TUBITAK-COST-114O446.	Acikgoz N, 2004, COMPUTER EVALUATIONS; Adams ML, 2002, J SCI FOOD AGR, V82, P1160, DOI 10.1002/jsfa.1167; Anoma A., 2014, African Journal of Food, Agriculture, Nutrition and Development, V14, P9529; [Anonymous], 1972, CHEM ANAL PLANT SOIL; BINGHAM FRANK T., 1949, CALIFORNIA AGRIC, V3, P11; Bjelakovic G, 2008, ALIMENT PHARM THER, V28, P689, DOI 10.1111/j.1365-2036.2008.03785.x; Black C.A., 1965, METHODS SOIL ANAL 2, P1372; Blair M, 2009, MOL BREEDING, V23, P197, DOI 10.1007/s11032-008-9225-z; Bleys J, 2008, ARCH INTERN MED, V168, P404, DOI 10.1001/archinternmed.2007.74; Bordoni A, 2008, BRIT J NUTR, V99, P191, DOI 10.1017/S0007114507793911; Bouyoucos G.J., 1955, AGRON J, V4, P434, DOI DOI 10.2134/AGRONJ1951.00021962004300090005X; Broadley MR, 2006, P NUTR SOC, V65, P169, DOI 10.1079/PNS2006490; Broome CS, 2004, AM J CLIN NUTR, V80, P154; Cakir O, 2012, ADVANCES IN SELECTED PLANT PHYSIOLOGY ASPECTS, P209; CHURCHILL GA, 1994, GENETICS, V138, P963; Coppinger RJ, 2001, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, P219; Della Rovere F, 2006, ANTICANCER RES, V26, P2937; Duran Y, 2004, THEOR APPL GENET, V108, P1265, DOI 10.1007/s00122-003-1542-3; Ellis DR, 2003, CURR OPIN PLANT BIOL, V6, P273, DOI 10.1016/S1369-5266(03)00030-X; Farnham MW, 2007, PLANT BREEDING, V126, P195, DOI 10.1111/j.1439-0523.2007.01294.x; Fleet JC, 1997, NUTR REV, V55, P277, DOI 10.1111/j.1753-4887.1997.tb01617.x; Flores-Mateo G, 2006, AM J CLIN NUTR, V84, P762, DOI 10.1093/ajcn/84.4.762; Gore F, 2010, J WATER HEALTH; Gupta M, 2012, J GENET, V91, P279, DOI 10.1007/s12041-012-0180-4; Gupta UC, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P171; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Karunasinghe N, 2004, CANCER EPIDEM BIOMAR, V13, P391; Kellen E, 2006, INT J UROL, V13, P1180, DOI 10.1111/j.1442-2042.2006.01526.x; KIEN CL, 1983, AM J CLIN NUTR, V37, P319, DOI 10.1093/ajcn/37.2.319; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; Navarro-Alarcon M, 2000, SCI TOTAL ENVIRON, V249, P347, DOI 10.1016/S0048-9697(99)00526-4; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; Peters U, 2008, MOL NUTR FOOD RES, V52, P1261, DOI 10.1002/mnfr.200800103; PILLEN K, 1992, THEOR APPL GENET, V84, P129, DOI 10.1007/BF00223992; Pitts MW, 2014, BIOL TRACE ELEM RES, V161, P231, DOI 10.1007/s12011-014-0060-2; Pratt PE., 1965, METHOD SOIL ANAL 2, P1022, DOI DOI 10.2134/AGRONMONOGR9.2.C20; Pu ZE, 2013, J INTEGR AGR, P2095; Rahman WMM, 2013, FOOD RES INT, V54, P1596; Ramamurthy RK, 2014, MOL BREEDING, V34, P431, DOI 10.1007/s11032-014-0045-z; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Rayman MP, 2004, BRIT J NUTR, V92, P557, DOI 10.1079/BJN20041251; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; Rubeena, 2003, THEOR APPL GENET, V107, P910, DOI 10.1007/s00122-003-1326-9; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; Schlicting E, 1966, BODENKUNDLICHES PRAC, P94; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Shi RL, 2008, PLANT SOIL, V306, P95, DOI 10.1007/s11104-007-9483-2; SLOCUM MK, 1990, THEOR APPL GENET, V80, P57, DOI 10.1007/BF00224016; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Tezuka K, 2010, THEOR APPL GENET, V120, P1175, DOI 10.1007/s00122-009-1244-6; Thavarajah D, 2008, J AGR FOOD CHEM, V56, P10747, DOI 10.1021/jf802307h; Thavarajah D, 2011, EUPHYTICA, V180, P123, DOI 10.1007/s10681-011-0365-6; Tiwari VK, 2009, J HERED, V100, P771, DOI 10.1093/jhered/esp030; United States Department of Agriculture ARS [USDA] USDA Nutrient Data Laboratory., 2008, USDA NAT NUTR DAT ST; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2004, JOINMAP 4 0 SOFTWARE; WAGNER H, 1992, PLANT BREEDING, V108, P89, DOI 10.1111/j.1439-0523.1992.tb00106.x; Wang N, 2006, FOOD CHEM, V95, P493, DOI 10.1016/j.foodchem.2005.02.001; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Zhang S, 2010, MECH AGEING DEV, V131, P253, DOI 10.1016/j.mad.2010.02.006; [张现伟 Zhang Xianwei], 2010, [植物遗传资源学报, Journal of Plant Genetic Resources], V11, P445	67	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149210	10.1371/journal.pone.0149210	http://dx.doi.org/10.1371/journal.pone.0149210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978666	gold, Green Published			2022-12-27	WOS:000372572800014
J	Morgan, TJ; Turn, SQ; Sun, N; George, A				Morgan, Trevor James; Turn, Scott Q.; Sun, Ning; George, Anthe			Fast Pyrolysis of Tropical Biomass Species and Influence of Water Pretreatment on Product Distributions	PLOS ONE			English	Article							FLUIDIZED-BED PYROLYSIS; BIO-OIL; FLASH PYROLYSIS; ELEPHANT GRASS; SECONDARY REACTIONS; EUCALYPTUS-GRANDIS; REACTOR; LIGNIN; CONVERSION; BANAGRASS	The fast pyrolysis behaviour of pretreated banagrass was examined at four temperatures (between 400 and 600 C) and four residence times (between similar to 1.2 and 12 s). The pretreatment used water washing/leaching to reduce the inorganic content of the banagrass. Yields of bio-oil, permanent gases and char were determined at each reaction condition and compared to previously published results from untreated banagrass. Comparing the bio-oil yields from the untreated and pretreated banagrass shows that the yields were greater from the pretreated banagrass by 4 to 11 wt%(absolute) at all reaction conditions. The effect of pretreatment (i.e. reducing the amount of ash, and alkali and alkali earth metals) on pyrolysis products is: 1) to increase the dry bio-oil yield, 2) to decrease the amount of undetected material, 3) to produce a slight increase in CO yield or no change, 4) to slightly decrease CO2 yield or no change, and 5) to produce a more stable bio-oil (less aging). Char yield and total gas yield were unaffected by feedstock pretreatment. Four other tropical biomass species were also pyrolyzed under one condition (450 degrees C and 1.4 s residence time) for comparison to the banagrass results. The samples include two hardwoods: leucaena and eucalyptus, and two grasses: sugarcane bagasse and energy-cane. A sample of pretreated energy-cane was also pyrolyzed. Of the materials tested, the best feedstocks for fast pyrolysis were sugarcane bagasse, pretreated energy cane and eucalyptus based on the yields of 'dry bio-oil', CO and CO2. On the same basis, the least productive feedstocks are untreated banagrass followed by pretreated banagrass and leucaena.	[Morgan, Trevor James; Turn, Scott Q.] Univ Hawaii Manoa, Hawaii Nat Energy Inst, Honolulu, HI 96822 USA; [Sun, Ning] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [George, Anthe] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94550 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories	Morgan, TJ (corresponding author), Univ Hawaii Manoa, Hawaii Nat Energy Inst, Honolulu, HI 96822 USA.	morgatr@gmail.com			U.S. Department of Energy [DE-EE0003507]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was conducted under the Hawai'i Energy Sustainability Program with funding from the U.S. Department of Energy (Cooperative Agreement #DE-EE0003507). The funding was provided to the Hawaii Natural Energy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LK, 2013, ENERG FUEL, V27, P7439, DOI 10.1021/ef4015394; Boateng AA, 2007, IND ENG CHEM RES, V46, P1891, DOI 10.1021/ie0614529; Braga RM, 2014, J THERM ANAL CALORIM, V117, P1341, DOI 10.1007/s10973-014-3884-2; Cetinkol OP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052820; Cui H, FUEL PROCESSING TECH; Eom IY, 2013, BIORESOURCE TECHNOL, V128, P664, DOI 10.1016/j.biortech.2012.09.082; Fahmi R, 2008, FUEL, V87, P1230, DOI 10.1016/j.fuel.2007.07.026; Fahmi R, 2007, J ANAL APPL PYROL, V80, P16, DOI 10.1016/j.jaap.2006.12.018; FRAGA AR, 1991, FUEL, V70, P803, DOI 10.1016/0016-2361(91)90186-E; George A, 2014, ENERG FUEL, V28, P6918, DOI 10.1021/ef501459c; Greenhalf CE, 2013, FUEL, V108, P216, DOI 10.1016/j.fuel.2013.01.075; Heidari A, 2014, J IND ENG CHEM, V20, P2594, DOI 10.1016/j.jiec.2013.10.046; Islam MR, 2010, J THERM SCI TECH-JPN, V5, P11, DOI 10.1299/jtst.5.11; Joubert JE, 2015, FUEL PROCESS TECHNOL, V131, P389, DOI 10.1016/j.fuproc.2014.12.012; Keffer VI, 2009, BIOMASS BIOENERG, V33, P247, DOI 10.1016/j.biombioe.2008.05.018; Kim KH, 2013, RENEW ENERG, V50, P188, DOI 10.1016/j.renene.2012.06.030; Lee MK, 2010, J ANAL APPL PYROL, V88, P110, DOI 10.1016/j.jaap.2010.03.003; LIDEN AG, 1988, CHEM ENG COMMUN, V65, P207, DOI 10.1080/00986448808940254; Mesa-Perez JM, 2014, APPL THERM ENG, V65, P322, DOI 10.1016/j.applthermaleng.2013.12.072; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Montoya JI, 2015, J ANAL APPL PYROL, V112, P379, DOI 10.1016/j.jaap.2014.11.007; Morgan TJ, 2015, ENERG FUEL, V29, P1669, DOI 10.1021/ef502380x; Morgan TJ, 2014, CHEM REV, V114, P1547, DOI 10.1021/cr400194p; Morgan TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136511; Mourant D, 2011, FUEL, V90, P2915, DOI 10.1016/j.fuel.2011.04.033; Mythili R, 2013, BIORESOURCE TECHNOL, V138, P71, DOI 10.1016/j.biortech.2013.03.161; Oasmaa A, 2010, ENERG FUEL, V24, P1380, DOI 10.1021/ef901107f; Ogoshi R., 2008, CROP ASSESSMEN UNPUB; Phan BMQ, 2014, BIOMASS BIOENERG, V62, P74, DOI 10.1016/j.biombioe.2014.01.012; Samolada MC, 1993, EFFECT EXPT CONDITIO; Shafizedeh F, 1985, FUNDAMENTALS THERMOC, P183, DOI DOI 10.1007/978-94-009-4932-4_11; Sluiter A, 2008, NRELTP51042618; Steele P. H, 2013, US Patent, Patent No. [US 8,603,199 B2, 8603199, 8,603,199B2]; STILES HN, 1989, FUEL, V68, P275, DOI 10.1016/0016-2361(89)90087-2; Strezov V, 2008, BIORESOURCE TECHNOL, V99, P8394, DOI 10.1016/j.biortech.2008.02.039; Tran N, 2011, BIOMASS BIOENERG, V35, P1756, DOI 10.1016/j.biombioe.2011.01.012; Turn SQ, 1998, FUEL, V77, P135, DOI 10.1016/S0016-2361(97)00190-7; TYLER RJ, 1979, FUEL, V58, P680, DOI 10.1016/0016-2361(79)90223-0; Vassilev SV, 2012, FUEL, V94, P1, DOI 10.1016/j.fuel.2011.09.030; Xu R, 2011, J ANAL APPL PYROL, V91, P263, DOI 10.1016/j.jaap.2011.03.001; Yoshida T, 2008, IND ENG CHEM RES, V47, P9882, DOI 10.1021/ie801123a	41	18	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151368	10.1371/journal.pone.0151368	http://dx.doi.org/10.1371/journal.pone.0151368			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978265	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800068
J	Rinalduzzi, S; Serafini, M; Capozza, M; Accornero, N; Missori, P; Trompetto, C; Fattapposta, F; Curra, A				Rinalduzzi, Steno; Serafini, Marco; Capozza, Marco; Accornero, Neri; Missori, Paolo; Trompetto, Carlo; Fattapposta, Francesco; Curra, Antonio			Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy	PLOS ONE			English	Article							DIABETIC SENSORY NEUROPATHY; PERIPHERAL NEUROPATHY; PROPRIOCEPTIVE CONTROL; INVERTED PENDULUM; MUSCLE-ACTIVITY; BALANCE CONTROL; POLYNEUROPATHY; ANKLE; MOVEMENTS; FALLS	Introduction Polyneuropathy leads to postural instability and an increased risk of falling. We investigated how impaired motor impairment and proprioceptive input due to neuropathy influences postural strategies. Methods Platformless bisegmental posturography data were recorded in healthy subjects and patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Each subject stood on the floor, wore a head and a hip electromagnetic tracker. Sway amplitude and velocity were recorded and the mean direction difference (MDD) in the velocity vector between trackers was calculated as a flexibility index. Results Head and hip postural sway increased more in patients with CIDP than in healthy controls. MDD values reflecting hip strategies also increased more in patients than in controls. In the eyes closed condition MDD values in healthy subjects decreased but in patients remained unchanged. Discussion Sensori-motor impairment changes the balance between postural strategies that patients adopt to maintain upright quiet stance. Motor impairment leads to hip postural strategy overweight (eyes open), and prevents strategy re-balancing when the sensory context predominantly relies on proprioceptive input (eyes closed).	[Rinalduzzi, Steno; Serafini, Marco] Sandro Pertini Hosp, Neurol & Neurophysiopathol Unit, Rome, Italy; [Capozza, Marco; Accornero, Neri; Fattapposta, Francesco] Univ Roma La Sapienza, Dept Neurol & Psychiat, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Missori, Paolo] Univ Roma La Sapienza, Neurosurg Unit, Policlin Umberto 1, Dept Neurol & Psychiat, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Trompetto, Carlo] Univ Genoa, Inst Neurol, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; [Curra, Antonio] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, A Fiorini Hosp, Acad Neurol Unit, Terracina, LT, Italy	Ospedale Sandro Pertini; Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; University of Genoa; Sapienza University Rome	Rinalduzzi, S (corresponding author), Sandro Pertini Hosp, Neurol & Neurophysiopathol Unit, Rome, Italy.	r.steno@libero.it	Trompetto, Carlo/AAC-3550-2022	Trompetto, Carlo/0000-0003-3419-0669; Curra, Antonio/0000-0002-7945-8342				Accornero N, 1997, ELECTROMYOGR MOTOR C, V105, P213, DOI 10.1016/S0924-980X(97)96567-X; Allet L, 2012, MUSCLE NERVE, V45, P578, DOI 10.1002/mus.22325; Allum JHJ, 1998, GAIT POSTURE, V8, P214, DOI 10.1016/S0966-6362(98)00027-7; Andersen H, 1997, EUR NEUROL, V37, P239, DOI 10.1159/000117450; Andersen H, 1997, DIABETIC MED, V14, P221, DOI 10.1002/(SICI)1096-9136(199703)14:3<221::AID-DIA338>3.0.CO;2-K; Banks RW, 2009, J ANAT, V214, P859, DOI 10.1111/j.1469-7580.2009.01072.x; Bloem BR, 2002, EXP BRAIN RES, V142, P91, DOI 10.1007/s00221-001-0926-3; Butler AA, 2008, BRAIN RES, V1242, P244, DOI 10.1016/j.brainres.2008.03.094; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; Corriveau H, 2000, DIABETES CARE, V23, P1187, DOI 10.2337/diacare.23.8.1187; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; DeMott TK, 2007, AM J PHYS MED REHAB, V86, P125, DOI 10.1097/PHM.0b013e31802ee1d1; DYCK PJ, 1980, ANN NEUROL, V8, P590, DOI 10.1002/ana.410080608; Finley JM, 2009, IEEE ENG MED BIO, P7265, DOI 10.1109/IEMBS.2009.5334730; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; Frohman EM, 1996, ANN NEUROL, V39, P529, DOI 10.1002/ana.410390415; Gorson KC, 2012, THER ADV NEUROL DISO, V5, P359, DOI 10.1177/1756285612457215; Gorson KC, 2010, J PERIPHER NERV SYST, V15, P326, DOI 10.1111/j.1529-8027.2010.00284.x; Gutierrez EM, 2001, CLIN BIOMECH, V16, P522, DOI 10.1016/S0268-0033(01)00034-1; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1990, EXP BRAIN RES, V82, P167; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Horlings CGC, 2008, CLIN NEUROPHYSIOL, V119, P2338, DOI 10.1016/j.clinph.2008.07.221; Koski CL, 2009, J NEUROL SCI, V277, P1, DOI 10.1016/j.jns.2008.11.015; KUO AD, 1993, PROG BRAIN RES, V97, P349; Lafond D, 2004, DIABETES CARE, V27, P173, DOI 10.2337/diacare.27.1.173; Ledin T, 1990, J Vestib Res, V1, P123; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Loram ID, 2009, J NEUROPHYSIOL, V102, P460, DOI 10.1152/jn.00007.2009; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; MacGilchrist C, 2010, DIABETIC MED, V27, P162, DOI 10.1111/j.1464-5491.2009.02914.x; MANCHESTER D, 1989, J GERONTOL MED SCI, V44, P118; MERGNER T, 1991, EXP BRAIN RES, V85, P389; Nardone A, 2007, CLIN NEUROPHYSIOL, V118, P538, DOI 10.1016/j.clinph.2006.11.012; Oppenheim U, 1999, DIABETES CARE, V22, P328, DOI 10.2337/diacare.22.2.328; PEARSON MB, 1985, AGE AGEING, V14, P49, DOI 10.1093/ageing/14.1.49; PEDOTTI A, 1989, EXP BRAIN RES, V74, P3; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Rinalduzzi S, 2011, ACTA NEUROL SCAND, V123, P111, DOI 10.1111/j.1600-0404.2010.01349.x; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; SIMONEAU GG, 1994, DIABETES CARE, V17, P1411, DOI 10.2337/diacare.17.12.1411; Son J, 2009, MUSCLE NERVE, V39, P150, DOI 10.1002/mus.21194; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Turcot K, 2012, DIABETES TECHNOL THE, V14, P403, DOI 10.1089/dia.2011.0181; UCCIOLI L, 1995, DIABETES CARE, V18, P339, DOI 10.2337/diacare.18.3.339; van der Linden MH, 2010, GAIT POSTURE, V31, P483, DOI 10.1016/j.gaitpost.2010.02.005; VANDERVOORT AA, 1989, EUR J APPL PHYSIOL O, V58, P389, DOI 10.1007/BF00643514; Yamamoto R, 2001, DIABETES RES CLIN PR, V52, P213, DOI 10.1016/S0168-8227(01)00236-4	50	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151629	10.1371/journal.pone.0151629	http://dx.doi.org/10.1371/journal.pone.0151629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977594	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800096
J	Scheider, L; Waller, BM; Ona, L; Burrows, AM; Liebal, K				Scheider, Linda; Waller, Bridget M.; Ona, Leonardo; Burrows, Anne M.; Liebal, Katja			Social Use of Facial Expressions in Hylobatids	PLOS ONE			English	Article							COMMUNICATION; VOCALIZATIONS; DISPLAYS; BEHAVIOR; JACCHUS; CONTEXT	Non-human primates use various communicative means in interactions with others. While primate gestures are commonly considered to be intentionally and flexibly used signals, facial expressions are often referred to as inflexible, automatic expressions of affective internal states. To explore whether and how non-human primates use facial expressions in specific communicative interactions, we studied five species of small apes (gibbons) by employing a newly established Facial Action Coding System for hylobatid species (Gibbon-FACS). We found that, despite individuals often being in close proximity to each other, in social (as opposed to non-social contexts) the duration of facial expressions was significantly longer when gibbons were facing another individual compared to non-facing situations. Social contexts included grooming, agonistic interactions and play, whereas non-social contexts included resting and self-grooming. Additionally, gibbons used facial expressions while facing another individual more often in social contexts than non-social contexts where facial expressions were produced regardless of the attentional state of the partner. Also, facial expressions were more likely 'responded to' by the partner's facial expressions when facing another individual than non-facing. Taken together, our results indicate that gibbons use their facial expressions differentially depending on the social context and are able to use them in a directed way in communicative interactions with other conspecifics.	[Scheider, Linda; Liebal, Katja] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Waller, Bridget M.] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Ona, Leonardo] Univ Groningen, Dept Nat Sci & Math, Groningen, Netherlands; [Burrows, Anne M.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Burrows, Anne M.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA	Free University of Berlin; University of Portsmouth; University of Groningen; Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Scheider, L (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.	scheider@zedat.fu-berlin.de	Burrows, Anne M/AAP-3577-2021; Liebal, Katja/AAQ-7910-2020; aubertin, rebeckah/O-9624-2015	Burrows, Anne M/0000-0002-9952-8125; Waller, Bridget/0000-0001-6303-7458; aubertin, rebeckah/0000-0002-0558-7571; Liebal, Katja/0000-0003-2447-8327; Ona, Leonardo/0000-0002-0883-7134	Deutsche Forschungsgemeinschaft (DFG)/Excellence Cluster "Languages of Emotion" [EXC 302]; Deutsche Forschungsgemeinschaft (DFG) within Excellence initiative Languages of Emotion "Comparing emotional expression across species-Gibbon-FACS"; European Research Council [309555]	Deutsche Forschungsgemeinschaft (DFG)/Excellence Cluster "Languages of Emotion"(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) within Excellence initiative Languages of Emotion "Comparing emotional expression across species-Gibbon-FACS"(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This project was supported by Deutsche Forschungsgemeinschaft (DFG)/Excellence Cluster "Languages of Emotion" (EXC 302).; This project was funded by Deutsche Forschungsgemeinschaft (DFG) within the Excellence initiative Languages of Emotion "Comparing emotional expression across species-Gibbon-FACS." We thank Robert Zingg and Zoo Zurich (Switzerland), Jennifer Spalton and Twycross Zoo (UK), Neil Spooner and Howletts Wild Animal Park (UK), and Corinne Di Trani, Mulhouse Zoo (France) and Johann Achim and NaturZoo Rheine (Germany) for allowing us to collect footage of their animals. We also thank Manuela Lembeck, Wiebke Hoffman and Paul Kuchenbuch for support in collecting the video footage. We thank Manuela Lembeck and Laura Asperud Thomsen for reliability coding. Thanks to Roger Mundry and Bodo Winter who helped with the statistical analyses. LO was financially supported by the European Research Council (Starting Independent Researcher Grant #309555 to G.S. van Doorn).	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2012, LME4 LINEAR MIXED EF; Burrows AM, 2011, ANAT REC, V294, P645, DOI 10.1002/ar.21355; Chevalier-Skolnikoff S., 1940, DARWIN FACIAL EXPRES, V16; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davila-Ross M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127337; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dobson SD, 2009, AM J PHYS ANTHROPOL, V139, P413, DOI 10.1002/ajpa.21007; Ekman P, 2002, FACIAL CTION CODING; Epple G, 1967, PROGR PRIMATOLOGY, P247; Field A, 2013, DISCOVERING STAT USI; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Fox J., 2019, R COMPANION APPL REG, V.; Ghazanfar AA, 2012, CURR BIOL, V22, P1176, DOI 10.1016/j.cub.2012.04.055; Gulledge JP, 2015, PSYCHOL REC, V65, P203, DOI 10.1007/s40732-014-0069-0; HINDE R. A., 1962, PROC ZOOL SOC LONDON, V138, P1; Hook-Costigan MA, 1998, NEUROPSYCHOLOGIA, V36, P1265, DOI 10.1016/S0028-3932(98)00037-2; Hopkins WD, 2011, DO CHIMPANZEES HAVE; Kemp C, 2013, ANIM COGN, V16, P773, DOI 10.1007/s10071-013-0611-5; Liebal K, 2004, PRIMATES, V45, P41, DOI 10.1007/s10329-003-0063-7; Liebal K., 2014, PRIMATE COMMUNICATIO; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Maple TL, 1980, ORANG UTAN BEHAV; McCullagh P., 1996, GEN LINEAR MODELS; Parr L.A., 2002, INFANT CHIMPANZEE HU, P411; Parr LA, 2005, INT J PRIMATOL, V26, P73, DOI 10.1007/s10764-005-0724-z; Parr LA, 2006, SOC COGN AFFECT NEUR, V1, P221, DOI 10.1093/scan/nsl031; Partan SR, 2002, BEHAVIOUR, V139, P993, DOI 10.1163/15685390260337877; R Core Team, 2012, R LANG ENV STAT COMP; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Scheider L, 2014, AM J PRIMATOL, V76, P618, DOI 10.1002/ajp.22255; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; STEVENSON MF, 1976, ANIM BEHAV, V24, P428, DOI 10.1016/S0003-3472(76)80053-X; VAN HOOF J. A. R. A. M., 1967, P7; Vick SJ, 2010, AM J PRIMATOL, V72, P262, DOI 10.1002/ajp.20781; Waller BM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0974; Waller BM, 2015, PEERJ, V3, DOI 10.7717/peerj.827; Waller BM, 2013, EMOT REV, V5, P54, DOI 10.1177/1754073912451503; Waller BM, 2012, INT J PRIMATOL, V33, P809, DOI 10.1007/s10764-012-9611-6; Waller BM, 2012, AM J PRIMATOL, V74, P157, DOI 10.1002/ajp.21018	44	26	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151733	10.1371/journal.pone.0151733	http://dx.doi.org/10.1371/journal.pone.0151733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978660	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000372572800102
J	Kuchta, SR; Brown, AD; Converse, PE; Highton, R				Kuchta, Shawn R.; Brown, Ashley D.; Converse, Paul E.; Highton, Richard			Multilocus Phylogeography and Species Delimitation in the Cumberland Plateau Salamander, Plethodon kentucki: Incongruence among Data Sets and Methods	PLOS ONE			English	Article							NORTH-AMERICAN SALAMANDERS; ANCESTRAL POPULATION SIZES; GENE TREES; PHYLOGENETIC ANALYSIS; DIVERGENCE TIME; DNA-SEQUENCES; MULTISPECIES COALESCENT; ENSATINA-ESCHSCHOLTZII; BAYES ESTIMATION; SPECIATION	Species are a fundamental unit of biodiversity, yet can be challenging to delimit objectively. This is particularly true of species complexes characterized by high levels of population genetic structure, hybridization between genetic groups, isolation by distance, and limited phenotypic variation. Previous work on the Cumberland Plateau Salamander, Plethodon kentucki, suggested that it might constitute a species complex despite occupying a relatively small geographic range. To examine this hypothesis, we sampled 135 individuals from 43 populations, and used four mitochondrial loci and five nuclear loci (5693 base pairs) to quantify phylogeographic structure and probe for cryptic species diversity. Rates of evolution for each locus were inferred using the multidistribute package, and time calibrated gene trees and species trees were inferred using BEAST 2 and *BEAST 2, respectively. Because the parameter space relevant for species delimitation is large and complex, and all methods make simplifying assumptions that may lead them to fail, we conducted an array of analyses. Our assumption was that strongly supported species would be congruent across methods. Putative species were first delimited using a Bayesian implementation of the GMYC model (bGMYC), Geneland, and Brownie. We then validated these species using the genealogical sorting index and BPP. We found substantial phylogeographic diversity using mtDNA, including four divergent clades and an inferred common ancestor at 14.9 myr (95% HPD: 10.8-19.7 myr). By contrast, this diversity was not corroborated by nuclear sequence data, which exhibited low levels of variation and weak phylogeographic structure. Species trees estimated a far younger root than did the mtDNA data, closer to 1.0 myr old. Mutually exclusive putative species were identified by the different approaches. Possible causes of data set discordance, and the problem of species delimitation in complexes with high levels of population structure and introgressive hybridization, are discussed.	[Kuchta, Shawn R.; Brown, Ashley D.; Converse, Paul E.] Ohio Univ, Dept Biol Sci, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Highton, Richard] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Ohio University; University System of Maryland; University of Maryland College Park	Kuchta, SR (corresponding author), Ohio Univ, Dept Biol Sci, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA.	kuchta@ohio.edu			Ohio University	Ohio University	Funding was provided to SRK by Ohio University.	Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blair C, 2015, MOL PHYLOGENET EVOL, V84, P254, DOI 10.1016/j.ympev.2015.01.003; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Camargo A, 2013, SPECIES PROBLEM ONGO, P225; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chatfield MWH, 2009, EVOLUTIONARY DYNAMIC, P1; Chung YJ, 2011, SYST BIOL, V60, P261, DOI 10.1093/sysbio/syr003; CLAY WILLIAM M., 1955, TRANS KENTUCKY ACAD SCI, V16, P57; Coyne J.A., 2004, SPECIATION; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; Dellicour S, 2015, SYST BIOL, V64, P900, DOI 10.1093/sysbio/syu130; Drummond A. J., 2015, BAYESIAN EVOLUTIONAR, DOI [10.1017/CBO9781139095112, DOI 10.1017/CBO9781139095112]; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Fisher-Reid MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-300; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Flot JF, 2006, MOL ECOL NOTES, V6, P627, DOI 10.1111/j.1471-8286.2006.01355.x; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Good D.A., 1992, U CALIFORNIA PUBLICA, V126, P1; Gottscho AD, 2014, ECOL EVOL, V4, P2546, DOI 10.1002/ece3.1111; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guillot G, 2012, SYST BIOL, V61, P897, DOI 10.1093/sysbio/sys038; Guillot G, 2009, MOL ECOL RESOUR, V9, P1112, DOI 10.1111/j.1755-0998.2008.02496.x; Heibl C, LAGOPUS BAYESIAN REL; Heled J, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-44, 10.1186/1471-2148-13-221]; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HIGHTON R, 1995, ANNU REV ECOL SYST, V26, P579, DOI 10.1146/annurev.es.26.110195.003051; HIGHTON R, 1990, HERPETOLOGICA, V46, P114; HIGHTON R, 1983, HERPETOLOGICA, V39, P189; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P215; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P31; Highton R, 1998, HERPETOLOGICA, V54, P254; Highton R., 1989, ILLINOIS BIOL MONGRA, P1; Highton R, 2014, MOL PHYLOGENET EVOL, V71, P127, DOI 10.1016/j.ympev.2013.11.002; Highton R, 2012, MOL PHYLOGENET EVOL, V63, P278, DOI 10.1016/j.ympev.2011.12.018; HIGHTON RICHARD, 1962, BULL FLORIDA STATE MUS, V6, P235; Holman JA, 2006, FOSSIL SALAMANDERS N; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; JACKMAN TR, 1994, EVOLUTION, V48, P876, DOI 10.1111/j.1558-5646.1994.tb01369.x; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; KLEEBERGER SR, 1982, COPEIA, P409, DOI 10.2307/1444622; Knowles LL, 2010, ESTIMATING SPECIES T; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Kuchta S, 2016, COPEIA IN PRESS; Kuchta SR, 2007, HERPETOLOGICA, V63, P332, DOI 10.1655/0018-0831(2007)63[332:CZASLH]2.0.CO;2; Kuchta SR, 2009, MOL PHYLOGENET EVOL, V50, P240, DOI 10.1016/j.ympev.2008.10.019; Kuchta SR, 2005, MOL ECOL, V14, P225, DOI 10.1111/j.1365-294X.2004.02388.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2014, SYST BIOL, V63, P534, DOI 10.1093/sysbio/syu018; Leache AD, 2014, SYST BIOL, V63, P17, DOI 10.1093/sysbio/syt049; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MADISON DM, 1969, ANIM BEHAV, V17, P25, DOI 10.1016/0003-3472(69)90109-2; Martinez-Solano I, 2007, MOL ECOL, V16, P4335, DOI 10.1111/j.1365-294X.2007.03527.x; Marvin GA, 2009, COPEIA, P227, DOI 10.1643/CH-08-116; Mayr E., 1942, P1; Mead LS, 2001, EVOLUTION, V55, P2287; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MITTLEMAN M. B., 1951, HERPETOLOGICA, V7, P105; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Myers EA, 2013, MOL ECOL, V22, P5418, DOI 10.1111/mec.12478; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M., 1987, MOL EVOLUTIONARY GEN; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Pelletier TA, 2015, SYST BIOL, V64, P909, DOI 10.1093/sysbio/syu090; Polihronakis M, 2010, EVOLUTION, V64, P1048, DOI 10.1111/j.1558-5646.2009.00884.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rannala B, 2003, GENETICS, V164, P1645; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Reid NM, 2014, SYST BIOL, V63, P322, DOI 10.1093/sysbio/syt057; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Reilly SB, 2015, J BIOGEOGR, V42, P280, DOI 10.1111/jbi.12413; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ruane S, 2014, SYST BIOL, V63, P231, DOI 10.1093/sysbio/syt099; Rundell RJ, 2009, TRENDS ECOL EVOL, V24, P394, DOI 10.1016/j.tree.2009.02.007; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Sequeira F, 2006, AMPHIBIA-REPTILIA, V27, P409, DOI 10.1163/156853806778190114; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; SLATKIN M, 1989, GENETICS, V123, P603; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tilley SG, 2013, ECOL EVOL, V3, P2547, DOI 10.1002/ece3.636; Tilley Stephen G., 1996, Herpetological Monographs, V10, P1, DOI 10.2307/1466979; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vieites DR, 2011, MOL PHYLOGENET EVOL, V59, P623, DOI 10.1016/j.ympev.2011.03.012; Wake DB, 2009, ANNU REV ECOL EVOL S, V40, P333, DOI 10.1146/annurev.ecolsys.39.110707.173552; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; WAKE DB, 1983, J THEOR BIOL, V101, P211, DOI 10.1016/0022-5193(83)90335-1; Wake DB, 1998, HERPETOLOGICA, V54, P279; Wakeley J, 1999, GENETICS, V153, P1863; Weisrock DW, 2012, MOL BIOL EVOL, V29, P1615, DOI 10.1093/molbev/mss008; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Wiens JJ, 2006, EVOLUTION, V60, P2585; Yang ZH, 2002, GENETICS, V162, P1811; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	126	17	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150022	10.1371/journal.pone.0150022	http://dx.doi.org/10.1371/journal.pone.0150022			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974148	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600016
J	McDonald, AT; Campbell, CE; Thomas, B				McDonald, Andrew T.; Campbell, Carl E.; Thomas, Brian			A New Specimen of the Controversial Chasmosaurine Torosaurus latus (Dinosauria: Ceratopsidae) from the Upper Cretaceous Hell Creek Formation of Montana	PLOS ONE			English	Article							CRANIOFACIAL ONTOGENY; ORNITHISCHIA; TRICERATOPS; ALBERTA; CANADA	Torosaurus latus is an uncommon and contentious taxon of chasmosaurine ceratopsid known from several upper Maastrichtian units in western North America. We describe a partial parietal of To. latus from the Hell Creek Formation of Montana. Although the specimen's ontogenetic maturity means that it cannot inform the ongoing debate over whether To. latus is the old adult form of the contemporary Triceratops, the specimen is one of the best-preserved To. latus parietals and supplements previous descriptions.	[McDonald, Andrew T.; Thomas, Brian] St Louis Sci Ctr, Earth Sci, St Louis, MO USA; [Campbell, Carl E.] St Louis Community Coll Meramec, Geol, St Louis, MO USA	Saint Louis University	McDonald, AT (corresponding author), St Louis Sci Ctr, Earth Sci, St Louis, MO USA.	atmcdonald28@gmail.com						Brown CM, 2015, CURR BIOL, V25, P1641, DOI 10.1016/j.cub.2015.04.041; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; COLBERT EDWIN H., 1947, PROC ACAD NAT SCI PHILADELPHIA, V99, P93; Farke Andrew A., 2007, P235; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; Forster CA, 1996, J VERTEBR PALEONTOL, V16, P259, DOI 10.1080/02724634.1996.10011313; Frederickson JA, 2014, PEERJ, V2, DOI 10.7717/peerj.252; GILMORE CW, 1946, US GEOLOGICAL SURV C, V210, P29; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Longrich NR, 2014, CRETACEOUS RES, V51, P292, DOI 10.1016/j.cretres.2014.06.011; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Maiorino L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081608; Mallon JC, 2014, CAN J EARTH SCI, V51, P618, DOI 10.1139/cjes-2014-0028; MARSH OC, 1891, AM J SCI 3, V42, P265, DOI DOI 10.2475/AJS.S3-42.249.265; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2014, P NATL ACAD SCI USA, V111, P10245, DOI 10.1073/pnas.1313334111; Scannella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028705; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Sullivan RM, 2005, J PALEONTOL, V79, P564, DOI 10.1666/0022-3360(2005)079<0564:ROTCDT>2.0.CO;2; Sullivan Robert M., 2010, P169; Tumarkin-Deratzian Allison R., 2010, P251; Wu XC, 2007, CAN J EARTH SCI, V44, P1243, DOI 10.1139/e07-011	25	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151453	10.1371/journal.pone.0151453	http://dx.doi.org/10.1371/journal.pone.0151453			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974149	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600080
J	Zhang, TH; Casanova, R; Resnick, SM; Manson, JE; Baker, LD; Padual, CB; Kuller, LH; Bryan, RN; Espeland, MA; Davatzikos, C				Zhang, Tianhao; Casanova, Ramon; Resnick, Susan M.; Manson, Joann E.; Baker, Laura D.; Padual, Claudia B.; Kuller, Lewis H.; Bryan, R. Nick; Espeland, Mark A.; Davatzikos, Christos			Effects of Hormone Therapy on Brain Volumes Changes of Postmenopausal Women Revealed by Optimally-Discriminative Voxel-Based Morphometry	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; HEALTH INITIATIVE MEMORY; SUBCLINICAL CEREBROVASCULAR-DISEASE; CONJUGATED EQUINE ESTROGENS; MILD COGNITIVE IMPAIRMENT; WHIMS-MRI; MAGNETIC-RESONANCE; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX	Backgrounds The Women's Health Initiative Memory Study Magnetic Resonance Imaging (WHIMS-MRI) provides an opportunity to evaluate how menopausal hormone therapy (HT) affects the structure of older women's brains. Our earlier work based on region of interest (ROI) analysis demonstrated potential structural changes underlying adverse effects of HT on cognition. However, the ROI-based analysis is limited in statistical power and precision, and cannot provide fine-grained mapping of whole-brain changes. Methods We aimed to identify local structural differences between HT and placebo groups from WHIMS-MRI in a whole-brain refined level, by using a novel method, named Optimally-Discriminative Voxel-Based Analysis (ODVBA). ODVBA is a recently proposed imaging pattern analysis approach for group comparisons utilizing a spatially adaptive analysis scheme to accurately locate areas of group differences, thereby providing superior sensitivity and specificity to detect the structural brain changes over conventional methods. Results Women assigned to HT treatments had significant Gray Matter (GM) losses compared to the placebo groups in the anterior cingulate and the adjacent medial frontal gyrus, and the orbitofrontal cortex, which persisted after multiple comparison corrections. There were no regions where HT was significantly associated with larger volumes compared to placebo, although a trend of marginal significance was found in the posterior cingulate cortical area. The CEE-Alone and CEE+MPA groups, although compared with different placebo controls, demonstrated similar effects according to the spatial patterns of structural changes. Conclusions HT had adverse effects on GM volumes and risk for cognitive impairment and dementia in older women. These findings advanced our understanding of the neurobiological underpinnings of HT effects.	[Zhang, Tianhao; Bryan, R. Nick; Davatzikos, Christos] Univ Penn, Dept Radiol, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA; [Casanova, Ramon; Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Resnick, Susan M.] NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA; [Manson, Joann E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Manson, Joann E.] Harvard Univ, Sch Med, Boston, MA USA; [Manson, Joann E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Baker, Laura D.] Wake Forest Sch Med, Dept Internal Med & Epidemiol, Winston Salem, NC USA; [Padual, Claudia B.] VA Palo Alto Hlth Care Syst, Sierra Pacific Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Padual, Claudia B.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Kuller, Lewis H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of Pennsylvania; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Wake Forest University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, TH (corresponding author), Univ Penn, Dept Radiol, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA.	tianhao.zhang@uphs.upenn.edu	Davatzikos, Christos/ABE-2057-2021	Davatzikos, Christos/0000-0002-1025-8561	National Heart, Lung, and Blood Institute; National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NIH [R01AG14971]; NATIONAL INSTITUTE ON AGING [ZIAAG000190, R01AG014971] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The WHI program is funded by the National Heart, Lung, and Blood Institute (http://www.nhlbi.nih.gov/), National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. TZ and CD were supported by NIH grant R01AG14971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, PHANT TEST GUID ACR; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Berent-Spillson A, 2010, MENOPAUSE, V17, P692, DOI 10.1097/gme.0b013e3181cc49e9; Boccardi M, 2005, NEUROBIOL AGING, V26, P37, DOI 10.1016/j.neurobiolaging.2004.02.019; Boccardi M, 2006, MENOPAUSE, V13, P584, DOI 10.1097/01.gme.0000196811.88505.10; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Casanova R, 2011, MAGN RESON IMAGING, V29, P546, DOI 10.1016/j.mri.2010.12.001; Chaim TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110199; Coker LH, 2009, NEUROLOGY, V72, P125, DOI 10.1212/01.wnl.0000339036.88842.9e; Coker LH, 2014, NEUROLOGY, V82, P427, DOI 10.1212/WNL.0000000000000079; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Erickson KI, 2005, NEUROBIOL AGING, V26, P1205, DOI 10.1016/j.neurobiolaging.2004.11.009; Erus G, 2015, DIABETES CARE, V38, P97, DOI 10.2337/dc14-1196; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Espeland MA, 2010, J AM GERIATR SOC, V58, P1263, DOI 10.1111/j.1532-5415.2010.02953.x; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goveas JS, 2011, J AFFECT DISORDERS, V132, P275, DOI 10.1016/j.jad.2011.01.020; Grady D, 2002, AM J MED, V113, P543, DOI 10.1016/S0002-9343(02)01270-6; Hakamata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075526; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Ihara M, 2010, ACTA NEUROPATHOL, V119, P579, DOI 10.1007/s00401-009-0635-8; Jaramillo SA, 2007, ACAD RADIOL, V14, P603, DOI 10.1016/j.acra.2007.02.001; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Kabani N. J., 1998, 4 INT C FUNCT MAPP H; Kamitani Y, 2010, NEUROIMAGE, V49, P1949, DOI 10.1016/j.neuroimage.2009.06.040; Kiebel S., 2003, GEN LINEAR MODEL; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Lord C, 2010, MENOPAUSE, V17, P846, DOI 10.1097/gme.0b013e3181e06b83; Lundstrom BN, 2003, NEUROIMAGE, V20, P1934, DOI 10.1016/j.neuroimage.2003.07.017; Maki PM, 2013, MENOPAUSE, V20, P695, DOI [10.1097/gme.0b013e3182960cf8, 10.1097/GME.0b013e3182960cf8]; Natrella M, 2010, NIST SEMATECH HDB ST; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pham DL, 1999, IEEE T MED IMAGING, V18, P737, DOI 10.1109/42.802752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Rasgon NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089095; Resnick SM, 2009, NEUROLOGY, V72, P135, DOI 10.1212/01.wnl.0000339037.76336.cf; Resnick SM, 2002, JAMA-J AM MED ASSOC, V288, P2170, DOI 10.1001/jama.288.17.2170; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Saltelli A, 2002, RISK ANAL, V22, P579, DOI 10.1111/0272-4332.00040; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 1998, CONTROL CLIN TRIALS, V19, P604, DOI 10.1016/S0197-2456(98)00038-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stelzer J, 2013, NEUROIMAGE, V65, P69, DOI 10.1016/j.neuroimage.2012.09.063; Swartz RH, 2008, STROKE, V39, P822, DOI 10.1161/STROKEAHA.107.491936; Talairach J., 1988, COPLANAR STEREOTAXIC; Tekin S, 2001, ANN NEUROL, V49, P355, DOI 10.1002/ana.72; Thomas J, 2014, PSYCHONEUROENDOCRINO, V50, P167, DOI 10.1016/j.psyneuen.2014.08.012; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Whitmer RA, 2011, ANN NEUROL, V69, P163, DOI 10.1002/ana.22239; Zhang TH, 2015, SCHIZOPHRENIA BULL, V41, P74, DOI 10.1093/schbul/sbu136; Zhang TH, 2013, NEUROIMAGE, V79, P94, DOI 10.1016/j.neuroimage.2013.04.063; Zhang TH, 2011, IEEE T MED IMAGING, V30, P1441, DOI 10.1109/TMI.2011.2114362; Zhang Y, 2008, NEUROIMAGE, V42, P218, DOI 10.1016/j.neuroimage.2008.04.181	68	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150834	10.1371/journal.pone.0150834	http://dx.doi.org/10.1371/journal.pone.0150834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974440	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000372570600034
J	Stebler, N; Schuepbach-Regula, G; Braam, P; Falzon, LC				Stebler, Nadine; Schuepbach-Regula, Gertraud; Braam, Peter; Falzon, Laura Cristina			Weighting of Criteria for Disease Prioritization Using Conjoint Analysis and Based on Health Professional and Student Opinion	PLOS ONE			English	Article							SETTING PRIORITIES; ANIMAL DISEASES; RISKS; LAY	Disease prioritization exercises have been used by several organizations to inform surveillance and control measures. Though most methodologies for disease prioritization are based on expert opinion, it is becoming more common to include different stakeholders in the prioritization exercise. This study was performed to compare the weighting of disease criteria, and the consequent prioritization of zoonoses, by both health professionals and students in Switzerland using a Conjoint Analysis questionnaire. The health professionals comprised public health and food safety experts, cantonal physicians and cantonal veterinarians, while the student group comprised first-year veterinary and agronomy students. Eight criteria were selected for this prioritization based on expert elicitation and literature review. These criteria, described on a 3-tiered scale, were evaluated through a choice-based Conjoint Analysis questionnaire with 25 choice tasks. Questionnaire results were analyzed to obtain importance scores (for each criterion) and mean utility values (for each criterion level), and the latter were then used to rank 16 zoonoses. While the most important criterion for both groups was "Severity of the disease in humans", the second ranked criteria by the health professionals and students were "Economy" and "Treatment in humans", respectively. Regarding the criterion "Control and Prevention", health professionals tended to prioritize a disease when the control and preventive measures were described to be 95% effective, while students prioritized a disease if there were almost no control and preventive measures available. Bovine Spongiform Encephalopathy was the top-ranked disease by both groups. Health professionals and students agreed on the weighting of certain criteria such as "Severity" and "Treatment of disease in humans", but disagreed on others such as "Economy" or "Control and Prevention". Nonetheless, the overall disease ranking lists were similar, and these may be taken into consideration when making future decisions regarding resource allocation for disease control and prevention in Switzerland.	[Stebler, Nadine; Schuepbach-Regula, Gertraud; Falzon, Laura Cristina] Univ Bern, Vet Publ Hlth Inst, Liebefeld, Switzerland; [Braam, Peter] Fed Food Safety & Vet Off, Liebefeld, Switzerland	University of Bern	Falzon, LC (corresponding author), Univ Bern, Vet Publ Hlth Inst, Liebefeld, Switzerland.	laura.falzon@vetsuisse.unibe.ch	Schüpbach-Regula, Gertraud/S-1971-2017	Schüpbach-Regula, Gertraud/0000-0002-2310-7105; Falzon, Laura Cristina/0000-0002-4043-1644	Federal Food Safety and Veterinary Office, Liebefeld, Switzerland [1.14.10]	Federal Food Safety and Veterinary Office, Liebefeld, Switzerland	This research was supported by a grant from the Federal Food Safety and Veterinary Office, Liebefeld, Switzerland (Project Number: 1.14.10). Funding was received by GS-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Ridder B, 2015, VET REC, V177, P148, DOI 10.1136/vr.h4196; [Anonymous], 2002, EMERG INFECT DIS; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Cediel N, 2013, REV PANAM SALUD PUBL, V33, P316, DOI 10.1590/S1020-49892013000500002; Cohen NE, 2007, AGR HUM VALUES, V24, P499, DOI 10.1007/s10460-007-9086-9; Council of the European Union, 2008, NONP PRIOR AN REL TH; Cox R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068338; Cox R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041590; European Food Safety Authority, 2013, ZOON MON SWITZ TREND; Federal Food Safety and Veterinary Office, 2013, OV ZOON; Federal Office of Public Health, 2013, INFECT DIS; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hansen J, 2003, APPETITE, V41, P111, DOI 10.1016/S0195-6663(03)00079-5; Hansen J., 2014, EUR COLL VET PUBL HL; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Horby P, 2001, Commun Dis Public Health, V4, P8; Horst HS, 1998, LIVEST PROD SCI, V53, P253, DOI 10.1016/S0301-6226(97)00098-5; Jensen KK, 2005, INT J FOOD MICROBIOL, V99, P245, DOI 10.1016/j.ijfoodmicro.2004.09.004; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lomas J, 2003, MILBANK Q, V81, P363, DOI 10.1111/1468-0009.t01-1-00060; LUCE RD, 1964, J MATH PSYCHOL, V1, P1, DOI 10.1016/0022-2496(64)90015-X; Morgan D, 2009, EPIDEMIOL INFECT, V137, P1521, DOI 10.1017/S0950268809990227; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048519; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029752; O'Brien D, 2012, PRIORITISING RES CON; Palmer SR, 2013, OXFORD TXB ZOONOSES; Parker G, 1985, PREHISTORIC FARMING; Sawtooth Software Inc, 2013, AN TIN SAMPL SIZ; Stebler N, 2015, PREV VET MED, V121, P165, DOI 10.1016/j.prevetmed.2015.05.006; Swiss Federal Statistical Office, 2010, LANDW KENNZ INT VERG; Swiss Food Safety and Veterinary Office, 2012, AN HLTH STRAT 2010; Vilas VJD, 2013, PREV VET MED, V108, P94, DOI 10.1016/j.prevetmed.2012.08.007; Voelk V, 2014, J DAIRY SCI, V97, P4184, DOI 10.3168/jds.2013-7291; Wauters E., 2014, Society for Veterinary Epidemiology and Preventive Medicine, Proceedings of a meeting held in Dublin, Irish Republic, 26-28 March 2014, P133; WHO, 2006, SETT PRIOR COMM DIS; World Health Organisation, RAT INV GLOB EL DOG; World Health Organization, 2003, WHO M BUCH ROM 21 23	39	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151394	10.1371/journal.pone.0151394	http://dx.doi.org/10.1371/journal.pone.0151394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967655	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200052
J	Sundarrajan, S; Arumugam, M				Sundarrajan, Sudharsana; Arumugam, Mohanapriya			Comorbidities of Psoriasis - Exploring the Links by Network Approach	PLOS ONE			English	Article							GENE-EXPRESSION; INNATE IMMUNITY; DISEASE; INFLAMMATION; PATHOGENESIS; METAANALYSIS; DATABASE; RISK	Increasing epidemiological studies in patients with psoriasis report the frequent occurrence of one or more associated disorders. Psoriasis is associated with multiple comorbidities including autoimmune disease, neurological disorders, cardiometabolic diseases and inflammatory-bowel disease. An integrated system biology approach is utilized to decipher the molecular alliance of psoriasis with its comorbidities. An unbiased integrative network medicine methodology is adopted for the investigation of diseasome, biological process and pathways of five most common psoriasis associated comorbidities. A significant overlap was observed between genes acting in similar direction in psoriasis and its comorbidities proving the mandatory occurrence of either one of its comorbidities. The biological processes involved in inflammatory response and cell signaling formed a common basis between psoriasis and its associated comorbidities. The pathway analysis revealed the presence of few common pathways such as angiogenesis and few uncommon pathways which includes CCKR signaling map and gonadotrophin-realising hormone receptor pathway overlapping in all the comorbidities. The work shed light on few common genes and pathways that were previously overlooked. These fruitful targetsmay serve as a starting point for diagnosis and/or treatment of psoriasis comorbidities. The current research provides an evidence for the existence of shared component hypothesis between psoriasis and its comorbidities.	[Sundarrajan, Sudharsana; Arumugam, Mohanapriya] Vellore Inst Technol Univ, Sch Biosci & Technol, Div Bioinformat, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Arumugam, M (corresponding author), Vellore Inst Technol Univ, Sch Biosci & Technol, Div Bioinformat, Vellore, Tamil Nadu, India.	mohanapriyaa@vit.ac.in	Arumugam, Mohanapriya/AAV-8106-2020; Arumugam, Mohanapriya/AAA-6232-2019	Arumugam, Mohanapriya/0000-0002-1647-3182; Sundarrajan, Sudharsana/0000-0002-2828-0310				Al Harthi F, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/239645; Aurangabadkar SJ, 2013, INDIAN J DERMATOL VE, V79, pS10, DOI 10.4103/0378-6323.115506; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bechtel Mark, 2009, J Clin Aesthet Dermatol, V2, P27; Christophers E, 2007, CLIN DERMATOL, V25, P529, DOI 10.1016/j.clindermatol.2007.08.006; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Frers RAK, 2015, IJC METAB ENDOCR, V6, P43, DOI 10.1016/j.ijcme.2015.01.005; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gottlieb AB, 2008, J DERMATOL TREAT, V19, P5, DOI 10.1080/09546630701364768; GRIBBLE MD, 1955, ANN RHEUM DIS, V14, P198, DOI 10.1136/ard.14.2.198; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jeong SH, 2014, EXP DERMATOL, V23, P890, DOI 10.1111/exd.12554; Karpouzis Anthony, 2014, ISRN Dermatol, V2014, P845272, DOI 10.1155/2014/845272; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; KOCH AE, 1994, J CLIN INVEST, V93, P921, DOI 10.1172/JCI117097; Liu Y, 2007, GENES IMMUN, V8, P1, DOI 10.1038/sj.gene.6364351; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; McGowan JW, 2005, ARCH DERMATOL, V141, P1601, DOI 10.1001/archderm.141.12.1601; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Melamed RD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8033; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Nalls MA, 2014, HUM MOL GENET, V23, P831, DOI 10.1093/hmg/ddt465; Nazir N, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0103-8; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Sitras V, 2015, PLACENTA, V36, P170, DOI 10.1016/j.placenta.2014.11.017; Sticherling M., 2005, DRUG DISCOV TODAY DI, V2, P275, DOI DOI 10.1016/J.DDMEC.2005.05.019; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Wolf N, 2008, J MED GENET, V45, P114, DOI 10.1136/jmg.2007.053595	41	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149175	10.1371/journal.pone.0149175	http://dx.doi.org/10.1371/journal.pone.0149175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966903	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200003
J	Chen, JT; Zhou, AG; Xie, SL; Wang, C; Lv, ZJ; Zou, JX				Chen, Jintao; Zhou, Aiguo; Xie, Shaolin; Wang, Chao; Lv, Zijun; Zou, Jixing			Comparative Proteomic Identification of Mature and Immature Sperm in the Catfish Cranoglanis bouderius	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; GLYCOGEN-SYNTHASE KINASE; ACTIVATED PROTEIN-KINASE; C-JUN; REQUIRES PHOSPHORYLATION; ACROSOME REACTION; MOTILITY; CAPACITATION; METABOLISM; SPERMATOGENESIS	To understand the molecular responses of mature and immature sperm in the catfish Cranoglanis bouderius, we used the iTRAQ proteomics approach to perform proteomic profiling of spermatogenesis in C. bouderius. As a result, 1,941 proteins were identified, including 361 differentially expressed proteins, 157 upregulated proteins and 204 downregulated proteins in mature sperm relative to immature sperm. All of the identified proteins were categorized into seven types of subcellular localizations and three molecular functions and were found to be involved in nine biological processes. All of the differential proteins were involved in 235 different pathways. Moreover, we found that the tricarboxylic acid (TCA) pathway played an important role in the energy metabolism of sperm and that the EABB pathway was involved in the mechanism of spermatogenesis. Our study is the first to use the iTRAQ-based proteomic approach to analyze the catfish sperm proteome, and the results we obtained using this approach are valuable for understanding the molecular mechanisms of fish spermatogenesis.	[Chen, Jintao; Zhou, Aiguo; Xie, Shaolin; Wang, Chao; Lv, Zijun; Zou, Jixing] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Lv, Zijun] Qingyuan North River Fishery Sci Inst, Qingyuan, Guangdong, Peoples R China	South China Agricultural University	Zou, JX (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	zoujixing@163.com	Zhou, Aiguo/AAN-2012-2020	Zhou, Aiguo/0000-0002-7209-1234	Ocean Fishery Science and Technology and Industry Development of Guangdong Province [A201501A02, A201301F03]; Science and Technology Planning Project of Guangdong Province [2015A020209126]; Innovation Fund for Technology based Firms of MOST [14C26214402655]	Ocean Fishery Science and Technology and Industry Development of Guangdong Province; Science and Technology Planning Project of Guangdong Province; Innovation Fund for Technology based Firms of MOST	This work received the support of the Ocean Fishery Science and Technology and Industry Development of Guangdong Province (A201501A02, A201301F03), the Science and Technology Planning Project of Guangdong Province (2015A020209126), and the Innovation Fund for Technology based Firms of MOST (14C26214402655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog T, 2010, MOL CELL ENDOCRINOL, V314, P239, DOI 10.1016/j.mce.2009.05.009; Amaral A, 2014, HUM REPROD UPDATE, V20, P40, DOI 10.1093/humupd/dmt046; Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Ashizawa K, 1997, BIOCHEM BIOPH RES CO, V240, P116, DOI 10.1006/bbrc.1997.7626; Aslam MKM, 2015, THERIOGENOLOGY, V84, P624, DOI 10.1016/j.theriogenology.2015.04.020; Barratt CLR, 2008, HUM REPROD, V23, P1240, DOI 10.1093/humrep/den019; Berndt Nikolaus, 2012, Int J Cell Biol, V2012, P757594, DOI 10.1155/2012/757594; Bhattacharjee R, 2015, FASEB J, V29; Bhattacharjee R, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124495; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Breitbart H, 2003, CELL MOL BIOL, V49, P321; Brewis IA, 2010, MOL HUM REPROD, V16, P68, DOI 10.1093/molehr/gap077; Butch ER, 1996, J BIOL CHEM, V271, P4230; CHRISTEN R, 1983, J BIOL CHEM, V258, P5392; CLAPPER DL, 1985, J BIOL CHEM, V260, P3947; Conner S J, 2007, Soc Reprod Fertil Suppl, V63, P237; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Finkelstein M, 2010, J BIOL CHEM, V285, P39702, DOI 10.1074/jbc.M110.170951; Forne I, 2011, PROTEOMICS, V11, P2195, DOI 10.1002/pmic.201000296; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Lardy HA, 1941, AM J PHYSIOL, V133, P0602, DOI 10.1152/ajplegacy.1941.133.3.602; Leclerc P, 1997, FREE RADICAL BIO MED, V22, P643, DOI 10.1016/S0891-5849(96)00379-6; Lefievre Linda, 2003, Reprod Biomed Online, V7, P419; Lu Q, 1999, ARCH ANDROLOGY, V43, P55, DOI 10.1080/014850199262733; Garcia BM, 2011, J ANDROL, V33, P105, DOI 10.2164/jandrol.110.011957; Muscolo A, 2003, PLANT SCI, V164, P1103, DOI 10.1016/S0168-9452(03)00119-5; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NUCCITELLI R, 1991, CURR TOP DEV BIOL, V25, P1; O'Toole CMB, 1996, MOL HUM REPROD, V2, P317, DOI 10.1093/molehr/2.5.317; Przybyla-Zawislak B, 1999, GENETICS, V152, P153; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Rickard JP, 2015, J PROTEOMICS, V126, P303, DOI 10.1016/j.jprot.2015.05.017; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; ROGERS BJ, 1975, BIOL REPROD, V13, P568, DOI 10.1095/biolreprod13.5.568; ROTEM R, 1990, P NATL ACAD SCI USA, V87, P7305, DOI 10.1073/pnas.87.18.7305; Schneider LV, 2005, DRUG DISCOV TODAY, V10, P353, DOI 10.1016/S1359-6446(05)03381-7; Schoettger RA, 1967, MS 222 ANESTHETIC CH; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Sheng QH, 2012, J PROTEOME RES, V11, P1494, DOI 10.1021/pr200194p; Shetty J, 2008, J REPROD IMMUNOL, V77, P23, DOI 10.1016/j.jri.2007.04.006; Shi QL, 2008, BBA-MOL BASIS DIS, V1782, P229, DOI 10.1016/j.bbadis.2007.12.008; SIFFERT W, 1988, J BIOL CHEM, V263, P4223; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Spungin B, 1996, J CELL SCI, V109, P1947; SZABO P, 1994, GENOMICS, V20, P324, DOI 10.1006/geno.1994.1178; Tanaka H, 2004, INT J ANDROL, V27, P172, DOI 10.1111/j.1365-2605.2004.00471.x; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Whittington E, 2015, INSECT BIOCHEM MOLEC, V62, P183, DOI 10.1016/j.ibmb.2015.02.011; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xu WJ, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111245; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	60	7	7	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151254	10.1371/journal.pone.0151254	http://dx.doi.org/10.1371/journal.pone.0151254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964044	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000128
J	Gao, X; Liu, M; Qu, AJ; Chen, Z; Jia, YM; Yang, N; Feng, XM; Liu, J; Xu, Y; Yang, XC; Wang, G				Gao, Xia; Liu, Min; Qu, Aijuan; Chen, Zhe; Jia, Yumei; Yang, Ning; Feng, Xiaomeng; Liu, Jia; Xu, Yuan; Yang, Xinchun; Wang, Guang			Native Magnetic Resonance T1-Mapping Identifies Diffuse Myocardial Injury in Hypothyroidism	PLOS ONE			English	Article							HEART-FAILURE; SUBCLINICAL HYPOTHYROIDISM; INVERSION-RECOVERY; THYROID-HORMONE; CARDIOVASCULAR-SYSTEM; FIBROSIS; DISEASE; INFARCTION; SURVIVAL; DYSFUNCTION	Background and Aim Hypothyroidism (HT) is characterized by thyroid hormone deficiencies, which can lead to diffuse myocardial interstitium lesions in patients with HT. Myocardial longitudinal relaxation time (T1) mapping is a potential diagnostic tool for quantifying diffuse myocardial injury. This study aimed to assess the usefulness of T1 mapping in identifying myocardial involvement in HT, and determine the relationship between T1 values and myocardial function. Methods A cross-sectional study was conducted with 30 untreated HT patients alongside 23 age-and sex-matched healthy controls. All subjects underwent cardiac magnetic resonance (CMR) with non-contrast (native) T1 mapping using a modified Look-Locker inversion-recovery (MOLLI) sequence to assess the native T1 values of myocardium and cardiac function. Results Native myocardial T1 values were significantly increased in HT patients, especially those with pericardial effusion (p < 0.05), compared with healthy controls. In addition, significantly reduced peak filling rate (PFR) and prolonged peak filling time (PFT) were obtained (p < 0.05) in HT patients compared with controls. Furthermore, stroke volume (SV) and cardiac index (CI) were significantly lower in HT patients than controls (all p < 0.05). Interestingly, native T1 values were negatively correlated with free triiodothyronine (FT3), PFR, SV and CI (all p < 0.05). Conclusion Diffuse myocardial injuries are common in HT patients, and increased T1 values are correlated with FT3 and cardiac function impairment. These findings indicate that T1 mapping might be useful in evaluating myocardial injuries in HT patients.	[Gao, Xia; Chen, Zhe; Jia, Yumei; Yang, Ning; Feng, Xiaomeng; Liu, Jia; Xu, Yuan; Wang, Guang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Endocrinol, Beijing, Peoples R China; [Liu, Min] Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiol, Beijing, Peoples R China; [Qu, Aijuan] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Yang, Xinchun] Capital Med Univ, Beijing Chaoyang Hosp, Ctr Heart, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Wang, G (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Endocrinol, Beijing, Peoples R China.; Yang, XC (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Ctr Heart, Beijing, Peoples R China.	yxc6229@sina.com; drwg6688@126.com			Major National Basic Research Program of China [2011CB503904]; Beijing Natural Science Foundation [7142060]; Chinese National Natural Science Foundation [81270369, 81070244]; Beijing Young Resident Researching Foundation [2014-3-26]; Capital Medical University Research Foundation [15JL03]; National Scientific Research Foundation [30900364]	Major National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Young Resident Researching Foundation; Capital Medical University Research Foundation; National Scientific Research Foundation	This work was supported by grants from the Major National Basic Research Program of China (No. 2011CB503904), the Beijing Natural Science Foundation (No.7142060) and the Chinese National Natural Science Foundation (No. 81270369, 81070244) to Guang Wang; and from Beijing Young Resident Researching Foundation (2014-3-26), Capital Medical University Research Foundation (15JL03) and National Scientific Research Foundation (30900364) to Min Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2007, THYROID, V17, P1211, DOI 10.1089/thy.2006.0235; Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60; Bull S, 2013, HEART, V99, P932, DOI 10.1136/heartjnl-2012-303052; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Christ-Crain M, 2003, ATHEROSCLEROSIS, V166, P379, DOI 10.1016/S0021-9150(02)00372-6; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; Di Carli MF, 2012, CIRCULATION, V126, P1179, DOI 10.1161/CIRCULATIONAHA.112.126466; Di Paola Roberto, 2004, Ital Heart J, V5, P857; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Ferreira VM, 2014, J THORAC IMAG, V29, P147, DOI 10.1097/RTI.0000000000000077; Ferreira VM, 2013, JACC-CARDIOVASC IMAG, V6, P1048, DOI 10.1016/j.jcmg.2013.03.008; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Gunduz H, 2006, INT J CARDIOVAS IMAG, V22, P141, DOI 10.1007/s10554-005-9011-5; Hajje G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109753; Hekimsoy Z, 2005, ENDOCR RES, V31, P171, DOI 10.1080/07435800500371706; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kellman P, 2002, MAGNET RESON MED, V47, P372, DOI 10.1002/mrm.10051; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Kwon DH, 2009, EUR J HEART FAIL, V11, P937, DOI 10.1093/eurjhf/hfp118; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Messroghli DR, 2007, MAGN RESON MED, V58, P34, DOI 10.1002/mrm.21272; Messroghli DR, 2006, RADIOLOGY, V238, P1004, DOI 10.1148/radiol.2382041903; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Nassenstein K, 2014, ROFO-FORTSCHR RONTG, V186, P166, DOI 10.1055/s-0033-1350516; Nepomnyashchikh LM, 2013, B EXP BIOL MED+, V155, P692, DOI 10.1007/s10517-013-2228-8; Nicolini G, 2013, J THROID RES, V2013, DOI 10.1155/2013/264387; Okabe M, 1990, Kokyu To Junkan, V38, P1159; Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69; Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019; Quirante FAP, 2015, INT J CARDIOL, V182, P281, DOI 10.1016/j.ijcard.2014.12.156; Rhee CM, 2013, J CLIN ENDOCR METAB, V98, P2326, DOI 10.1210/jc.2013-1039; Ripoli A, 2005, J AM COLL CARDIOL, V45, P439, DOI 10.1016/j.jacc.2004.10.044; Satoh H, 2014, WORLD J CARDIOL, V6, P585, DOI 10.4330/wjc.v6.i7.585; Scherer T, 2014, J CLIN ENDOCR METAB, V99, pE2341, DOI 10.1210/jc.2014-2112; Shuvya M, 2009, CARDIOVASC PATHOL, V18, P183, DOI 10.1016/j.carpath.2007.12.015; Sugihara N, 1988, J Cardiol, V18, P353; Toussaint M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001868; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vargas-Uricoechea H, 2014, CLIN INVEST ARTERIOS, V26, P296, DOI 10.1016/j.arteri.2014.07.003; Von Knorring J, 1970, Ann Med Exp Biol Fenn, V48, P8; Wiig H, 2000, AM J PHYSIOL-HEART C, V278, pH1627, DOI 10.1152/ajpheart.2000.278.5.H1627; Won S, 2013, CURR OPIN CARDIOL, V28, P282, DOI 10.1097/HCO.0b013e32835f5a2b; YOUNG AA, 1994, CIRCULATION, V89, P740, DOI 10.1161/01.CIR.89.2.740	46	14	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151266	10.1371/journal.pone.0151266	http://dx.doi.org/10.1371/journal.pone.0151266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964099	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000129
J	Leung, CM; Yim, CL; Yan, CTY; Chan, CC; Xiang, YT; Mak, ADP; Fok, MLY; Ungvari, GS				Leung, Chi Ming; Yim, Chi Lap; Yan, Connie T. Y.; Chan, Cheuk Chi; Xiang, Yu-Tao; Mak, Arthur D. P.; Fok, Marcella Lei-Yee; Ungvari, Gabor S.			The Bipolar II Depression Questionnaire: A Self-Report Tool for Detecting Bipolar II Depression	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; MENTAL-HEALTH SURVEY; SPECTRUM DISORDER; MOOD DISORDER; DIAGNOSTIC CONVERSION; UNIPOLAR DEPRESSION; CLINICAL-FEATURES; RATING-SCALE; VALIDATION; PREVALENCE	Bipolar II (BP-II) depression is often misdiagnosed as unipolar (UP) depression, resulting in suboptimal treatment. Tools for differentiating between these two types of depression are lacking. This study aimed to develop a simple, self-report screening instrument to help distinguish BP-II depression from UP depressive disorder. A prototype BP-II depression questionnaire (BPIIDQ-P) was constructed following a literature review, panel discussions and a field trial. Consecutively assessed patients with a diagnosis of depressive disorder or BP with depressive episodes completed the BPIIDQ-P at a psychiatric outpatient clinic in Hong Kong between October and December 2013. Data were analyzed using discriminant analysis and logistic regression. Of the 298 subjects recruited, 65 (21.8%) were males and 233 (78.2%) females. There were 112 (37.6%) subjects with BP depression [BP-I = 42 (14.1%), BP-II = 70 (23.5%)] and 182 (62.4%) with UP depression. Based on family history, age at onset, postpartum depression, episodic course, attacks of anxiety, hypersomnia, social phobia and agoraphobia, the 8-item BPIIDQ-8 was constructed. The BPIIDQ-8 differentiated subjects with BP-II from those with UP depression with a sensitivity/specificity of 0.75/0.63 for the whole sample and 0.77/0.72 for a female subgroup with a history of childbirth. The BPIIDQ-8 can differentiate BP-II from UP depression at the secondary care level with satisfactory to good reliability and validity. It has good potential as a screening tool for BP-II depression in primary care settings. Recall bias, the relatively small sample size, and the high proportion of females in the BP-II sample limit the generalization of the results.	[Leung, Chi Ming; Yim, Chi Lap; Yan, Connie T. Y.; Chan, Cheuk Chi] Shatin Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Xiang, Yu-Tao] Univ Macau, Unit Psychiat, Fac Hlth Sci, Macau, Macao Sar, Peoples R China; [Mak, Arthur D. P.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Fok, Marcella Lei-Yee] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, Kings Hlth Partners, London, England; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia	University of Macau; Chinese University of Hong Kong; University of London; King's College London; University of Western Australia; University of Notre Dame Australia	Leung, CM (corresponding author), Shatin Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.; Xiang, YT (corresponding author), Univ Macau, Unit Psychiat, Fac Hlth Sci, Macau, Macao Sar, Peoples R China.	cmleung@ha.org.hk; xyutly@gmail.com	Mak, Arthur Dun Ping/V-6345-2017; Yan, Connie/AAJ-8510-2021	Mak, Arthur Dun Ping/0000-0003-1627-6434; Yan, Connie/0000-0002-0278-2259; Leung, CM/0000-0001-9341-8032				Akiskal HS, 2005, J AFFECT DISORDERS, V84, P209, DOI 10.1016/j.jad.2004.05.004; Angst J, 2005, J AFFECT DISORDERS, V84, P149, DOI 10.1016/S0165-0327(03)00195-2; Angst J, 2013, EUR ARCH PSY CLIN N, V263, P663, DOI 10.1007/s00406-013-0393-4; Angst J, 1966, ATIOLOGIE NOSOLOGIE; Antypa N, 2014, J AFFECT DISORDERS, V156, P178, DOI 10.1016/j.jad.2013.12.013; Awad A George, 2007, Prim Care Companion J Clin Psychiatry, V9, P195; Bega S, 2012, J AFFECT DISORDERS, V138, P46, DOI 10.1016/j.jad.2011.12.032; Benazzi F, 2000, EUR ARCH PSY CLIN N, V250, P53, DOI 10.1007/s004060050010; Benazzi F, 2008, J AFFECT DISORDERS, V107, P77, DOI 10.1016/j.jad.2007.07.032; Benazzi F, 2007, LANCET, V369, P935, DOI 10.1016/S0140-6736(07)60453-X; Berk M, 2007, BIPOLAR DISORD, V9, P571, DOI 10.1111/j.1399-5618.2007.00536.x; Biederman J, 2009, J AFFECT DISORDERS, V119, P16, DOI 10.1016/j.jad.2009.02.024; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Birnbaum HG, 2003, J CLIN PSYCHIAT, V64, P1201, DOI 10.4088/JCP.v64n1010; Boschloo L, 2013, J AFFECT DISORDERS, V151, P203, DOI 10.1016/j.jad.2013.05.078; Bowden Charles L, 2010, J Clin Psychiatry, V71, pe01, DOI 10.4088/JCP.8125cc5c; Brugue E, 2008, PSYCHOPATHOLOGY, V41, P111, DOI 10.1159/000112026; CHEN CN, 1993, ARCH GEN PSYCHIAT, V50, P125; Correa R, 2010, J AFFECT DISORDERS, V127, P10, DOI 10.1016/j.jad.2010.06.036; Das Chandan, 2012, Ann Clin Psychiatry, V24, P225; de Almeida JRC, 2013, BIOL PSYCHIAT, V73, P111, DOI 10.1016/j.biopsych.2012.06.010; Dilsaver SC, 2011, J AFFECT DISORDERS, V129, P79, DOI 10.1016/j.jad.2010.08.030; Everaert J, 2014, EMOTION, V14, P331, DOI 10.1037/a0035250; First MB, 2002, STRUCTURED CLIN INTE; Ghaemi N, 2000, CONTROVERSIES DIAGNO, V1, P65, DOI DOI 10.3109/15622970009150569; Ghaemi SN, 2005, J AFFECT DISORDERS, V84, P273, DOI 10.1016/S0165-0327(03)00196-4; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Goodwin GM, 2008, EUR NEUROPSYCHOPHARM, V18, P535, DOI 10.1016/j.euroneuro.2008.03.003; Green EK, 2013, MOL PSYCHIATR, V18, P614, DOI 10.1038/mp.2012.48; Grotegerd D, 2013, EUR ARCH PSY CLIN N, V263, P119, DOI 10.1007/s00406-012-0329-4; Gunderson JG, 2006, AM J PSYCHIAT, V163, P1173, DOI 10.1176/appi.ajp.163.7.1173; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Kapella MC, 2011, INT J CHRONIC OBSTR, V6, P625, DOI 10.2147/COPD.S24858; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kokkevi A, 2012, J CHILD PSYCHOL PSYC, V53, P381, DOI 10.1111/j.1469-7610.2011.02457.x; Lee DTS, 1998, BRIT J PSYCHIAT, V172, P433, DOI 10.1192/bjp.172.5.433; Leung CM, 1999, ACTA PSYCHIAT SCAND, V100, P456, DOI 10.1111/j.1600-0447.1999.tb10897.x; Lu YA, 2012, J CLIN PSYCHIAT, V73, P339, DOI 10.4088/JCP.10m06330; McCombs JS, 2007, J AFFECT DISORDERS, V97, P171, DOI 10.1016/j.jad.2006.06.018; Merikangas KR, 2014, MOL PSYCHIATR, V19, P214, DOI 10.1038/mp.2013.116; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Meyer F, 2009, J AFFECT DISORDERS, V112, P174, DOI 10.1016/j.jad.2008.04.022; Mitchell PB, 2008, BIPOLAR DISORD, V10, P144, DOI 10.1111/j.1399-5618.2007.00559.x; Moreno C, 2012, BIPOLAR DISORD, V14, P271, DOI 10.1111/j.1399-5618.2012.01009.x; Nurnberger JI, 2014, JAMA PSYCHIAT, V71, P657, DOI 10.1001/jamapsychiatry.2014.176; OCarroll PW, 1996, SUICIDE LIFE-THREAT, V26, P237; Parker G, 2014, J AFFECT DISORDERS, V152, P57, DOI 10.1016/j.jad.2013.10.006; Parker G, 2013, J AFFECT DISORDERS, V148, P202, DOI 10.1016/j.jad.2012.11.061; Perlis RH, 2006, AM J PSYCHIAT, V163, P225, DOI 10.1176/appi.ajp.163.2.225; Perlis RH, 2005, AM J MANAG CARE, V11, pS271; Perlis RH, 2011, ARCH GEN PSYCHIAT, V68, P351, DOI 10.1001/archgenpsychiatry.2010.179; Rastelli CPB, 2013, J AFFECT DISORDERS, V150, P1120, DOI 10.1016/j.jad.2013.05.003; Reinares M, 2011, MEDICOGRAPHIA, V33, P145; RIHMER Z, 1980, PSYCHIAT RES, V3, P247, DOI 10.1016/0165-1781(80)90054-2; Rosa AR, 2010, VALUE HEALTH, V13, P984, DOI 10.1111/j.1524-4733.2010.00768.x; Rouillon F, 2011, J AFFECT DISORDERS, V130, P492, DOI 10.1016/j.jad.2010.10.037; Sani G, 2014, PSYCHOTHER PSYCHOSOM, V83, P213, DOI 10.1159/000358808; Selbaek G, 2008, AM J GERIAT PSYCHIAT, V16, P528, DOI 10.1097/JGP.0b013e318167ae76; Sharma V, 2014, BIPOLAR DISORD, V16, P16, DOI 10.1111/bdi.12140; So E., 2003, HK J PSYCHIAT, V13, P7; Tondo L, 2007, ACTA PSYCHIAT SCAND, V116, P419, DOI 10.1111/j.1600-0447.2007.01066.x; Undurraga J, 2012, J CLIN PSYCHIAT, V73, P778, DOI 10.4088/JCP.11m07041; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; Winokur G., 1969, MANIC DEPRESSIVE ILL; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmerman M, 2010, J CLIN PSYCHIAT, V71, P1212, DOI 10.4088/JCP.09m05161yel	67	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149752	10.1371/journal.pone.0149752	http://dx.doi.org/10.1371/journal.pone.0149752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963908	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000017
J	Rosenbaum, C; Schick, MA; Wollborn, J; Heider, A; Scholz, CJ; Cecil, A; Niesler, B; Hirrlinger, J; Walles, H; Metzger, M				Rosenbaum, Corinna; Schick, Martin Alexander; Wollborn, Jakob; Heider, Andreas; Scholz, Claus-Juergen; Cecil, Alexander; Niesler, Beate; Hirrlinger, Johannes; Walles, Heike; Metzger, Marco			Activation of Myenteric Glia during Acute Inflammation In Vitro and In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; ENTERIC NERVOUS-SYSTEM; PHOSPHODIESTERASE-4 INHIBITION; GENE-EXPRESSION; S100B PROTEIN; CELLS; ASTROCYTES; TOOL; GUT; CYTOKINES	Background Enteric glial cells (EGCs) are the main constituent of the enteric nervous system and share similarities with astrocytes from the central nervous system including their reactivity to an inflammatory microenvironment. Previous studies on EGC pathophysiology have specifically focused on mucosal glia activation and its contribution to mucosal inflammatory processes observed in the gut of inflammatory bowel disease (IBD) patients. In contrast knowledge is scarce on intestinal inflammation not locally restricted to the mucosa but systemically affecting the intestine and its effect on the overall EGC network. Methods and Results In this study, we analyzed the biological effects of a systemic LPS-induced hyperinflammatory insult on overall EGCs in a rat model in vivo, mimicking the clinical situation of systemic inflammation response syndrome (SIRS). Tissues from small and large intestine were removed 4 hours after systemic LPS-injection and analyzed on transcript and protein level. Laser capture microdissection was performed to study plexus-specific gene expression alterations. Upon systemic LPS-injection in vivo we observed a rapid and dramatic activation of Glial Fibrillary Acidic Protein (GFAP)-expressing glia on mRNA level, locally restricted to the myenteric plexus. To study the specific role of the GFAP subpopulation, we established flow cytometry-purified primary glial cell cultures from GFAP promotor-driven EGFP reporter mice. After LPS stimulation, we analyzed cytokine secretion and global gene expression profiles, which were finally implemented in a bioinformatic comparative transcriptome analysis. Enriched GFAP+ glial cells cultured as gliospheres secreted increased levels of prominent inflammatory cytokines upon LPS stimulation. Additionally, a shift in myenteric glial gene expression profile was induced that predominantly affected genes associated with immune response. Conclusion and Significance Our findings identify the myenteric GFAP-expressing glial subpopulation as particularly susceptible and responsive to acute systemic inflammation of the gut wall and complement knowledge on glial involvement in mucosal inflammation of the intestine.	[Rosenbaum, Corinna; Walles, Heike; Metzger, Marco] Univ Hosp Wuerzburg, Dept Tissue Engn & Regenerat Med TERM, Wurzburg, Germany; [Schick, Martin Alexander; Wollborn, Jakob] Univ Wurzburg, Dept Anaesthesia & Crit Care, D-97070 Wurzburg, Germany; [Wollborn, Jakob] Univ Med Ctr Freiburg, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Heider, Andreas] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Scholz, Claus-Juergen] Univ Hosp Wuerzburg, Interdisciplinary Ctr Clin Res IZKF, Wurzburg, Germany; [Cecil, Alexander] Univ Wurzburg, Dept Bioinformat, D-97070 Wurzburg, Germany; [Niesler, Beate] Heidelberg Univ, Inst Human Genet, Dept Human Mol Genet, Heidelberg, Germany; [Niesler, Beate] Heidelberg Univ, nCounter Core Facil, Inst Human Genet, Heidelberg, Germany; [Hirrlinger, Johannes] Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany; [Hirrlinger, Johannes] Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany; [Walles, Heike; Metzger, Marco] Branch Fraunhofer Inst Interfacial Engn & Biotech, Translat Ctr Regenerat Therapies Oncol & Musculos, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Freiburg; Leipzig University; University of Wurzburg; University of Wurzburg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Leipzig University; Max Planck Society; Fraunhofer Gesellschaft	Metzger, M (corresponding author), Univ Hosp Wuerzburg, Dept Tissue Engn & Regenerat Med TERM, Wurzburg, Germany.; Metzger, M (corresponding author), Branch Fraunhofer Inst Interfacial Engn & Biotech, Translat Ctr Regenerat Therapies Oncol & Musculos, Wurzburg, Germany.	marco.metzger@uni-wuerzburg.de	Schick, Martin/ABH-6971-2020; Scholz, Claus Jürgen/H-3202-2019; Metzger, Marco/F-9706-2019	Scholz, Claus Jürgen/0000-0002-6406-7859; Walles, Heike/0000-0002-1512-7448	German Federal Ministry of Education and Research (BMBF) [0313909]; Free State of Bavaria, BayernFIT program; Interdisciplinary Center for Clinical Research, University of Wuerzburg [D-241]; University of Wuerzburg	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Free State of Bavaria, BayernFIT program; Interdisciplinary Center for Clinical Research, University of Wuerzburg; University of Wuerzburg	This work was supported by the German Federal Ministry of Education and Research (BMBF), grant number 0313909, https://www.bmbf.de/; Free State of Bavaria, BayernFIT program; Interdisciplinary Center for Clinical Research, University of Wuerzburg, grant number D-241, http://www.izkf.ukw.de/en/izkf.html. This publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066873; Bernhardt J, 2009, 2009 6TH INTERNATIONAL SYMPOSIUM ON VORONOI DIAGRAMS (ISVD 2009), P233, DOI 10.1109/ISVD.2009.33; Bhowmick S, 2007, NEUROSCI LETT, V414, P45, DOI 10.1016/j.neulet.2006.11.070; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Boesmans W, 2015, GLIA, V63, P229, DOI 10.1002/glia.22746; Bohorquez DV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089881; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cirillo C, 2011, NEUROGASTROENT MOTIL, V23, pE372, DOI 10.1111/j.1365-2982.2011.01748.x; Cirillo C, 2009, NEUROGASTROENT MOTIL, V21, P1209, DOI 10.1111/j.1365-2982.2009.01346.x; Cirillo C, 2011, WORLD J GASTROENTERO, V17, P1261, DOI 10.3748/wjg.v17.i10.1261; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; Cuadrado E, 2013, BRAIN, V136, P245, DOI 10.1093/brain/aws321; De Winter BY, 2010, WORLD J GASTROENTERO, V16, P5523, DOI 10.3748/wjg.v16.i44.5523; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esposito G, 2007, GASTROENTEROLOGY, V133, P918, DOI 10.1053/j.gastro.2007.06.009; FERRI GL, 1982, NATURE, V297, P409, DOI 10.1038/297409a0; Flemming S, 2014, SHOCK, V41, P537, DOI 10.1097/SHK.0000000000000152; GABELLA G, 1981, NEUROSCIENCE, V6, P425, DOI 10.1016/0306-4522(81)90135-4; GEBOES K, 1992, GASTROENTEROLOGY, V103, P439, DOI 10.1016/0016-5085(92)90832-J; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gulbransen BD, 2014, ENTERIC GLIA; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HANANI M, 1994, CELL TISSUE RES, V278, P153; Hegewald C, 2011, NEUROGASTROENT MOTIL, V23, pE412, DOI 10.1111/j.1365-2982.2011.01761.x; Heider A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-75; Hoff S, 2008, J COMP NEUROL, V509, P356, DOI 10.1002/cne.21769; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JESSEN KR, 1983, J NEUROSCI, V3, P2206; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Liu YA, 2013, NEUROGASTROENT MOTIL, V25, pe324, DOI 10.1111/nmo.12115; Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Murakami M, 2009, J NEUROSCI RES, V87, P2095, DOI 10.1002/jnr.22036; Neunlist M, 2007, AM J PHYSIOL-GASTR L, V292, pG231, DOI 10.1152/ajpgi.00276.2005; Nolte C, 2001, GLIA, V33, P72; Parpura V, 2014, PATHOLOGICAL POTENTI; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rao M, 2015, GLIA; Ruhl A, 2005, NEUROGASTROENT MOTIL, V17, P777, DOI 10.1111/j.1365-2982.2005.00687.x; Ruhl A, 2001, AM J PHYSIOL-GASTR L, V280, pG1163, DOI 10.1152/ajpgi.2001.280.6.G1163; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schick MA, 2012, J PHYSIOL-LONDON, V590, P2693, DOI 10.1113/jphysiol.2012.232116; Schick MA, 2010, INTENS CARE MED, V36, P541, DOI 10.1007/s00134-009-1704-0; Stoffels B, 2014, GASTROENTEROLOGY, V146, P176, DOI 10.1053/j.gastro.2013.09.030; The FO, 2011, BRIT J PHARMACOL, V163, P1007, DOI 10.1111/j.1476-5381.2011.01296.x; Turner R, 2015, DELDIR DELAUNAY TRIA; Van Landeghem L, 2011, AM J PHYSIOL-GASTR L, V300, pG976, DOI 10.1152/ajpgi.00427.2010; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; von Boyen GBT, 2004, GUT, V53, P222, DOI 10.1136/gut.2003.012625; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; Wollborn J, 2015, J PHARMACOL PHARMACO, V6, P13, DOI 10.4103/0976-500X.149138; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; [No title captured]; [No title captured]	63	44	45	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151335	10.1371/journal.pone.0151335	http://dx.doi.org/10.1371/journal.pone.0151335			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964064	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000139
J	Sandberg, TE; Long, CP; Gonzalez, JE; Feist, AM; Antoniewicz, MR; Palsson, BO				Sandberg, Troy E.; Long, Christopher P.; Gonzalez, Jacqueline E.; Feist, Adam M.; Antoniewicz, Maciek R.; Palsson, Bernhard O.			Evolution of E. coli on [U-C-13] Glucose Reveals a Negligible Isotopic Influence on Metabolism and Physiology	PLOS ONE			English	Article							ADAPTIVE LABORATORY EVOLUTION; PARALLEL LABELING EXPERIMENTS; ESCHERICHIA-COLI; FLUX ANALYSIS; EXPRESSION; MUTATIONS; GROWTH; MG1655	C-13-Metabolic flux analysis (C-13-MFA) traditionally assumes that kinetic isotope effects from isotopically labeled compounds do not appreciably alter cellular growth or metabolism, despite indications that some biochemical reactions can be non-negligibly impacted. Here, populations of Escherichia coli were adaptively evolved for similar to 1000 generations on uniformly labeled C-13-glucose, a commonly used isotope for C-13-MFA. Phenotypic characterization of these evolved strains revealed similar to 40% increases in growth rate, with no significant difference in fitness when grown on either labeled (C-13) or unlabeled (C-12) glucose. The evolved strains displayed decreased biomass yields, increased glucose and oxygen uptake, and increased acetate production, mimicking what is observed after adaptive evolution on unlabeled glucose. Furthermore, full genome re-sequencing revealed that the key genetic changes underlying these phenotypic alterations were essentially the same as those acquired during adaptive evolution on unlabeled glucose. Additionally, glucose competition experiments demonstrated that the wild-type exhibits no isotopic preference for unlabeled glucose, and the evolved strains have no preference for labeled glucose. Overall, the results of this study indicate that there are no significant differences between C-12 and C-13-glucose as a carbon source for E. coli growth.	[Sandberg, Troy E.; Feist, Adam M.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Long, Christopher P.; Gonzalez, Jacqueline E.; Antoniewicz, Maciek R.] Univ Delaware, Metab Engn & Syst Biol Lab, Dept Biomol & Chem Engn, Newark, DE 19716 USA; [Feist, Adam M.; Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark	University of California System; University of California San Diego; University of Delaware; Technical University of Denmark	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Palsson, BO (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark.	palsson@ucsd.edu		Long, Christopher/0000-0003-1007-417X; Sandberg, Troy/0000-0003-3240-3659; Antoniewicz, Maciek/0000-0002-0087-2875	Novo Nordisk Foundation Center for Biosustainability [2011-3780]; National Science Foundation Graduate Research Fellowship [DGE1144086]; NSF CAREER Award [CBET-1054120]; University of Delaware; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Ale Technology & Software Developme, Network Reconstruction] Funding Source: researchfish	Novo Nordisk Foundation Center for Biosustainability; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); University of Delaware; Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	This work was funded by the Novo Nordisk Foundation Center for Biosustainability (grant 2011-3780). TES is supported through the National Science Foundation Graduate Research Fellowship (grant DGE1144086). MRA and CPL are supported by NSF CAREER Award (CBET-1054120). CPL is also supported by the University of Delaware Graduate Fellows Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewicz MR, 2007, METAB ENG, V9, P277, DOI 10.1016/j.ymben.2007.01.003; Antoniewicz MR, 2015, J IND MICROBIOL BIOT, V42, P317, DOI 10.1007/s10295-015-1585-x; Antoniewicz MR, 2013, CURR OPIN BIOTECH, V24, P973, DOI 10.1016/j.copbio.2013.03.018; Antoniewicz MR, 2011, ANAL CHEM, V83, P3211, DOI 10.1021/ac200012p; Au J, 2014, METAB ENG, V26, P23, DOI 10.1016/j.ymben.2014.08.002; Boghigian BA, 2010, METAB ENG, V12, P81, DOI 10.1016/j.ymben.2009.10.004; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Crown SB, 2015, METAB ENG, V28, P151, DOI 10.1016/j.ymben.2015.01.001; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Dragosits M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.76; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; He L, 2014, BIOTECHNOL BIOENG, V111, P575, DOI 10.1002/bit.25124; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Klein S, 2012, WIRES SYST BIOL MED, V4, P261, DOI 10.1002/wsbm.1167; LaCroix RA, 2015, APPL ENVIRON MICROB, V81, P17, DOI 10.1128/AEM.02246-14; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026172; Long CP, 2014, ANAL CHEM, V86, P9423, DOI 10.1021/ac502734e; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Millard P, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0213-8; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Sandberg TE, 2014, MOL BIOL EVOL, V31, P2647, DOI 10.1093/molbev/msu209; Shachrai I, 2010, MOL CELL, V38, P758, DOI 10.1016/j.molcel.2010.04.015; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Torres-Cruz J, 2003, J BACTERIOL, V185, P6990, DOI 10.1128/JB.185.23.6990-6994.2003; Wasylenko TM, 2013, BIOTECHNOL J, V8, P1080, DOI 10.1002/biot.201200276; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	31	37	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151130	10.1371/journal.pone.0151130	http://dx.doi.org/10.1371/journal.pone.0151130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964043	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000106
J	Wen, CH; Zhang, J; Rebelo, A; Cheng, FY				Wen, Cuihong; Zhang, Jing; Rebelo, Ana; Cheng, Fanyong			A Directed Acyclic Graph-Large Margin Distribution Machine Model for Music Symbol Classification	PLOS ONE			English	Article							ALGORITHMS; NETWORKS; SCORES	Optical Music Recognition (OMR) has received increasing attention in recent years. In this paper, we propose a classifier based on a new method named Directed Acyclic Graph-Large margin Distribution Machine (DAG-LDM). The DAG-LDM is an improvement of the Large margin Distribution Machine (LDM), which is a binary classifier that optimizes the margin distribution by maximizing the margin mean and minimizing the margin variance simultaneously. We modify the LDM to the DAG-LDM to solve the multi-class music symbol classification problem. Tests are conducted on more than 10000 music symbol images, obtained from handwritten and printed images of music scores. The proposed method provides superior classification capability and achieves much higher classification accuracy than the state-of-the-art algorithms such as Support Vector Machines (SVMs) and Neural Networks (NNs).	[Wen, Cuihong; Zhang, Jing; Cheng, Fanyong] Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China; [Rebelo, Ana] Univ Porto, INESC Porto, Rua Campo Alegre 823, P-4100 Oporto, Portugal	Hunan University; INESC TEC; Universidade do Porto	Wen, CH (corresponding author), Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China.	cuihong_wen@hnu.edu.cn	Rebelo, Ana/I-1121-2015	Rebelo, Ana/0000-0003-4776-6057	Fund of Doctoral Program of the Ministry of Education [20110161110035]; China National Natural Science Foundation [61174140, 61573299]	Fund of Doctoral Program of the Ministry of Education; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work is financed by Fund of Doctoral Program of the Ministry of Education (Approval No. 20110161110035) and China National Natural Science Foundation (Approval No. 61174140 and 61573299) (http://www.nsfc.gov.cn/).	[Anonymous], 1998, NEURAL NETWORKS COMP; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cotter A, 2013, P INT C MACH LEARN, P266; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dalitz C, 2008, IEEE T PATTERN ANAL, V30, P753, DOI [10.1109/TPAMI.2007.70749, 10.1109/TPAM1.2007.70749]; Hui M, 2010, PATTERN RECOGN, V31, P100; Jiu MY, 2014, PATTERN RECOGN LETT, V50, P122, DOI 10.1016/j.patrec.2013.09.021; Miyao H, 1996, IEICE T INF SYST, VE79D, P548; Ng KC, 1996, IMAGE VISION COMPUT, V14, P39, DOI 10.1016/0262-8856(95)01038-6; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Platt JC, 2000, ADV NEUR IN, V12, P547; Pugin L, 2006, OPTICAL MUSIC RECOGN, P53; Rebelo A, 2010, INT J DOC ANAL RECOG, V13, P19, DOI 10.1007/s10032-009-0100-1; Rebelo A, 2011, 10 INT C MACH LEARN, P18; Vapnik V., 1999, NATURE STAT LEARNING; Wen CH, 2015, PATTERN RECOGN LETT, V58, P1, DOI 10.1016/j.patrec.2015.02.002; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Zhang T., 2014, P 20 ACM SIGKDD INT, P313, DOI [10.1145/2623330.2623710, DOI 10.1145/2623330.2623710]; ZHOU Z, 2014, MEM ASSOC AUSTRALAS, P1, DOI DOI 10.1007/S11042-014-2162-4	19	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0149688	10.1371/journal.pone.0149688	http://dx.doi.org/10.1371/journal.pone.0149688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985826	Green Published, gold			2022-12-27	WOS:000372580300015
J	Liu, SY; Schad, DJ; Kuschpel, MS; Rapp, MA; Heinz, A				Liu, Shuyan; Schad, Daniel J.; Kuschpel, Maxim S.; Rapp, Michael A.; Heinz, Andreas			Music and Video Gaming during Breaks: Influence on Habitual versus Goal-Directed Decision Making	PLOS ONE			English	Article							MODEL; SYSTEMS; MEMORY; CHOICE; REST	Different systems for habitual versus goal-directed control are thought to underlie human decision-making. Working memory is known to shape these decision-making systems and their interplay, and is known to support goal-directed decision making even under stress. Here, we investigated if and how decision systems are differentially influenced by breaks filled with diverse everyday life activities known to modulate working memory performance. We used a within-subject design where young adults listened to music and played a video game during breaks interleaved with trials of a sequential two-step Markov decision task, designed to assess habitual as well as goal-directed decision making. Based on a neuro-computational model of task performance, we observed that for individuals with a rather limited working memory capacity video gaming as compared to music reduced reliance on the goal-directed decision-making system, while a rather large working memory capacity prevented such a decline. Our findings suggest differential effects of everyday activities on key decision-making processes.	[Liu, Shuyan; Schad, Daniel J.; Kuschpel, Maxim S.; Rapp, Michael A.; Heinz, Andreas] Charite, Dept Psychiat & Psychotherapy, Charite Campus Mitte, D-13353 Berlin, Germany; [Rapp, Michael A.] Univ Potsdam, Social & Prevent Med, Potsdam, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Potsdam	Rapp, MA (corresponding author), Charite, Dept Psychiat & Psychotherapy, Charite Campus Mitte, D-13353 Berlin, Germany.; Rapp, MA (corresponding author), Univ Potsdam, Social & Prevent Med, Potsdam, Germany.	michael.rapp@uni-potsdam.de	Rapp, Michael/ABB-7573-2020; Heinz, Andreas/ABB-7736-2020	Rapp, Michael/0000-0003-0106-966X; Heinz, Andreas/0000-0001-5405-9065; Schad, Daniel/0000-0003-2586-6823; Kuschpel, Maxim/0000-0002-9314-9888	China Scholarship Council (CSC) [201208080013]; German Research Foundation (DFG grant) [FOR 1617, RA1047/2-2, SCHA 1971/1-2]; German Federal Ministry of Education and Research (BMBF grant) [01EE1406A, 01EE1406I]	China Scholarship Council (CSC)(China Scholarship Council); German Research Foundation (DFG grant)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF grant)	This research was supported by the China Scholarship Council (CSC, grant 201208080013 to SL) (http://en.csc.edu.cn/), the German Research Foundation (http://www.dfg.de/en/) (DFG grant FOR 1617), "Learning and habitization as predictors of the development and maintenance of alcoholism" to AH and Subproject 3, Model of learning, RA1047/2-2 to MAR, SCHA 1971/1-2 to DJS), and the German Federal Ministry of Education and Research (BMBF grant 01EE1406A "Addiction: Early Recognition and Intervention Across the Lifespan (AERIAL)" to AH and grant 01EE1406I to MAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bates D, IME4 LINEAR MIXED EF; Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Cassidy G, 2009, MUSIC SCI, V13, P357, DOI 10.1177/102986490901300207; Craig M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093915; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dege F, 2011, EUR J DEV PSYCHOL, V8, P608, DOI 10.1080/17405629.2011.590668; Dewar M, 2012, PSYCHOL SCI, V23, P955, DOI 10.1177/0956797612441220; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Ferreira LA, 2013, P INT JOINT C ART IN; Friedel E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00587; Hebert S, 2005, LIFE SCI, V76, P2371, DOI 10.1016/j.lfs.2004.11.011; Helton WS, 2015, COGNITION, V134, P165, DOI 10.1016/j.cognition.2014.10.001; Huys QJM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002410; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Jakobson LS, 2008, MUSIC PERCEPT, V26, P41, DOI 10.1525/MP.2008.26.1.41; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Kuhn S, 2014, MOL PSYCHIATR, V19, P842, DOI 10.1038/mp.2013.100; Kuschpel MS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01683; Kyoung-nam Kim, 2013, Advances in Information Sciences and Service Sciences, V5, P314; Lehrl S., 2005, MANUAL ZUM MWT B MEH; Lipscomb Scott D, 2004, J Physiol Anthropol Appl Human Sci, V23, P337, DOI 10.2114/jpa.23.337; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Mercer T, 2015, MEMORY, V23, P127, DOI 10.1080/09658211.2013.872279; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Otto AR, 2015, J COGNITIVE NEUROSCI, V27, P319, DOI 10.1162/jocn_a_00709; Otto AR, 2013, P NATL ACAD SCI USA, V110, P20941, DOI 10.1073/pnas.1312011110; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; Radenbach C, 2015, PSYCHONEUROENDOCRINO, V53, P268, DOI 10.1016/j.psyneuen.2014.12.017; Rauscher F.H., 2002, IMPROVING ACAD ACHIE, P267, DOI [10.1016/B978-012064455-1/50016-6, DOI 10.1016/B978-012064455-1/50016-6]; Rummery G.A., 1994, CITESEER; Schad DJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01450; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Smittenaar P, 2013, NEURON, V80, P914, DOI 10.1016/j.neuron.2013.08.009; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tang Y, 2013, POSTLEARNING ACTIVIT; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345; US Army Individual Test Battery, 1944, MAN DIR SCOR; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	46	6	6	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150165	10.1371/journal.pone.0150165	http://dx.doi.org/10.1371/journal.pone.0150165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982326	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900025
J	ten Have, R; Reubsaet, K; van Herpen, P; Kersten, G; Amorij, JP				ten Have, R.; Reubsaet, K.; van Herpen, P.; Kersten, G.; Amorij, J. -P.			Demonstrating Functional Equivalence of Pilot and Production Scale Freeze-Drying of BCG	PLOS ONE			English	Article							VACCINE POWDER; DESIGN; FORMULATIONS; CHALLENGES; PRINCIPLES; FROZEN	Process analytical technology (PAT)-tools were used to monitor freeze-drying of Bacille Calmette-Guerin (BCG) at pilot and production scale. Among the evaluated PAT-tools, there is the novel use of the vacuum valve open/close frequency for determining the end-point of primary drying at production scale. The duration of primary drying, the BCG survival rate, and the residual moisture content (RMC) were evaluated using two different freeze-drying protocols and were found to be independent of the freeze-dryer scale evidencing functional equivalence. The absence of an effect of the freeze-dryer scale on the process underlines the feasibility of the pilot scale freeze-dryer for further BCG freeze-drying process optimization which may be carried out using a medium without BCG.	[ten Have, R.; Reubsaet, K.; van Herpen, P.; Kersten, G.; Amorij, J. -P.] Intravacc, POB 450, NL-3720 AL Bilthoven, Netherlands; [Kersten, G.] Leiden Acad Ctr Drug Res, Drug Delivery Technol, POB 9502, NL-2300 RA Leiden, Netherlands; [Reubsaet, K.] Sanquin, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands; [Amorij, J. -P.] Virtuvax BV, Odijk, Netherlands		ten Have, R (corresponding author), Intravacc, POB 450, NL-3720 AL Bilthoven, Netherlands.	Rimko.ten.Have@intravacc.nl						Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; Amorij JP, 2012, J CONTROL RELEASE, V161, P363, DOI 10.1016/j.jconrel.2011.12.039; Barresi AA, 2011, PHARM TECHNOLOGY EUR, V23, P29; Barresi AA, 2009, CHEM ENG PROCESS, V48, P408, DOI 10.1016/j.cep.2008.05.004; Christensen D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015043; Debruyne F M, 1988, Prog Clin Biol Res, V269, P511; Fissore D, 2008, DRY TECHNOL, V26, P685, DOI 10.1080/07373930802046161; Franks F, 1998, EUR J PHARM BIOPHARM, V45, P221, DOI 10.1016/S0939-6411(98)00004-6; Vazquez-Lavista LG, 2007, REV INVEST CLIN, V59, P146; Gheorghiu M, 1996, DEV BIOL STAND, V87, P251; Hirschberg HJHB, 2008, VACCINE, V26, P2389, DOI 10.1016/j.vaccine.2008.02.067; Hirschberg HJHB, 2010, J CONTROL RELEASE, V147, P211, DOI 10.1016/j.jconrel.2010.06.028; Jennings TA, 2002, AM PHARM REV, V5, P34; Kraan H, 2014, J CONTROL RELEASE, V190, P580, DOI 10.1016/j.jconrel.2014.05.060; Kramer T, 2009, J PHARM SCI-US, V98, P307, DOI 10.1002/jps.21430; Kuu WY, 2005, INT J PHARMACEUT, V302, P56, DOI 10.1016/j.ijpharm.2005.06.022; Liu JS, 2006, PHARM DEV TECHNOL, V11, P3, DOI 10.1080/10837450500463729; Patel SM, 2010, J PHARM SCI-US, V99, P4363, DOI 10.1002/jps.22132; Patel SM, 2010, AAPS PHARMSCITECH, V11, P73, DOI 10.1208/s12249-009-9362-7; Patel SM, 2011, AAPS PHARMSCITECH, V12, P372, DOI 10.1208/s12249-011-9599-9; Pisano R, 2013, AAPS PHARMSCITECH, V14, P1137, DOI 10.1208/s12249-013-0003-9; Rahmat JN, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2012.01.017; Rambhatla Shailaja, 2003, AAPS PharmSciTech, V4, pE14; ROY ML, 1989, J PARENT SCI TECHN, V43, P60; Saluja V, 2010, J CONTROL RELEASE, V144, P127, DOI 10.1016/j.jconrel.2010.02.025; Sane SU, 2007, AM PHARM REV, V41, P132; Searles JA, 2001, J PHARM SCI, V90, P860, DOI 10.1002/jps.1039; Soema PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092806; Tang XL, 2005, PHARM RES-DORDR, V22, P685, DOI 10.1007/s11095-005-2501-2; Tang XL, 2004, PHARM RES-DORDR, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75; Tsinontides SC, 2004, INT J PHARM, V280, P1, DOI 10.1016/j.ijpharm.2004.04.018; van Hemert P, 1974, Prog Ind Microbiol, V13, P151	32	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151239	10.1371/journal.pone.0151239	http://dx.doi.org/10.1371/journal.pone.0151239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981867	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900072
J	Zhuo, L; Tao, H; Wei, H; Wu, CZ				Zhuo, Lin; Tao, Hong; Wei, Hong; Wu Chengzhen			Compatible Models of Carbon Content of Individual Trees on a Cunninghamia lanceolata Plantation in Fujian Province, China	PLOS ONE			English	Article							ALLOMETRIC EQUATIONS; ABOVEGROUND BIOMASS; FOREST BIOMASS; STOCKS; BALANCE; HEIGHT; POOLS; NORTH	We tried to establish compatible carbon content models of individual trees for a Chinese fir (Cunninghamia lanceolata (Lamb.) Hook.) plantation from Fujian province in southeast China. In general, compatibility requires that the sum of components equal the whole tree, meaning that the sum of percentages calculated from component equations should equal 100%. Thus, we used multiple approaches to simulate carbon content in boles, branches, foliage leaves, roots and the whole individual trees. The approaches included (i) single optimal fitting (SOF), (ii) nonlinear adjustment in proportion (NAP) and (iii) nonlinear seemingly unrelated regression (NSUR). These approaches were used in combination with variables relating diameter at breast height (D) and tree height (H), such as D, (DH)-H-2, DH and D&H (where D&H means two separate variables in bivariate model). Power, exponential and polynomial functions were tested as well as a new general function model was proposed by this study. Weighted least squares regression models were employed to eliminate heteroscedasticity. Model performances were evaluated by using mean residuals, residual variance, mean square error and the determination coefficient. The results indicated that models with two dimensional variables (DH, (DH)-H-2 and D&H) were always superior to those with a single variable (D). The D&H variable combination was found to be the most useful predictor. Of all the approaches, SOF could establish a single optimal model separately, but there were deviations in estimating results due to existing incompatibilities, while NAP and NSUR could ensure predictions compatibility. Simultaneously, we found that the new general model had better accuracy than others. In conclusion, we recommend that the new general model be used to estimate carbon content for Chinese fir and considered for other vegetation types as well.	[Zhuo, Lin; Tao, Hong; Wei, Hong; Wu Chengzhen] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian Province, Peoples R China; [Wu Chengzhen] Wuyi Univ, Wuyishan City, Fujian Province, Peoples R China	Fujian Agriculture & Forestry University; Wuyi University, Fujian	Wu, CZ (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian Province, Peoples R China.; Wu, CZ (corresponding author), Wuyi Univ, Wuyishan City, Fujian Province, Peoples R China.	fafuwcz@163.com			Science and Technology Major Project of the Hall of Science and Technology of Fujian Fujian provincial department of science and technology [2012NZ0001]; Project of National Natural Science Fund of China, National Natural Science foundation of China [30671664]	Science and Technology Major Project of the Hall of Science and Technology of Fujian Fujian provincial department of science and technology; Project of National Natural Science Fund of China, National Natural Science foundation of China	The Science and Technology Major Project of the Hall of Science and Technology of Fujian (No. 2012NZ0001) Fujian provincial department of science and technology http://www.fjkjt.gov.cn/ WCZ. The Project of National Natural Science Fund of China (No. 30671664), National Natural Science foundation of China http://www.nsfc.gov.cn/ WCZ.	Alvarez E, 2012, FOREST ECOL MANAG, V267, P297, DOI 10.1016/j.foreco.2011.12.013; Amichev BY, 2008, FOREST ECOL MANAG, V256, P1949, DOI 10.1016/j.foreco.2008.07.020; Asante P, 2011, J FOREST ECON, V17, P3, DOI 10.1016/j.jfe.2010.07.001; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; BOX GEP, 1957, ANN MATH STAT, V28, P195, DOI 10.1214/aoms/1177707047; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chojnacky DC, 2014, FORESTRY, V87, P129, DOI 10.1093/forestry/cpt053; DETWILER RP, 1988, SCIENCE, V239, P42, DOI 10.1126/science.239.4835.42; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Djomo AN, 2010, FOREST ECOL MANAG, V260, P1873, DOI 10.1016/j.foreco.2010.08.034; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fayolle A, 2013, FOREST ECOL MANAG, V305, P29, DOI 10.1016/j.foreco.2013.05.036; Fu LiYong, 2014, Scientia Silvae Sinicae, V50, P42; Han FXX, 2007, CLIMATIC CHANGE, V84, P191, DOI 10.1007/s10584-007-9244-5; Henry M, 2011, SILVA FENN, V45, P477, DOI 10.14214/sf.38; Holst J, 2008, AGR FOREST METEOROL, V148, P1815, DOI 10.1016/j.agrformet.2008.06.008; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; [黄贤松 Huang Xiansong], 2013, [自然资源学报, Journal of Natural Resources], V28, P349; Kangas AS, 1997, FOREST ECOL MANAG, V96, P207, DOI 10.1016/S0378-1127(97)00056-X; Kenzo T, 2009, J FOREST RES-JPN, V14, P365, DOI 10.1007/s10310-009-0149-1; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Kittredge Joseph, 1944, JOUR FOREST, V42, P905; Li GZ, 1987, J HENAN U SCI TECHNO, V2; Lin CQ, 1996, J FUJIAN FORESTRY SC, V3, P21; Lin JQ, 2004, SCI TECHNOLOGY QINGH, V4, P29; Lin KM, 1996, SCI SILVAE SINICAE, V5, p[386, 389]; [刘雯雯 Liu Wenwen], 2010, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V30, P7; Mate R, 2014, FORESTS, V5, P535, DOI 10.3390/f5030535; Meng SX, 2009, FOREST SCI, V55, P238; Moore JR, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010042; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Lima AJN, 2012, FOREST ECOL MANAG, V277, P163, DOI 10.1016/j.foreco.2012.04.028; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parresol BR, 2001, CAN J FOREST RES, V31, P865, DOI 10.1139/cjfr-31-5-865; Qiu GY, 1999, J FUJIAN FORESTRY SC, V3, P21; Rutishauser E, 2013, FOREST ECOL MANAG, V307, P219, DOI 10.1016/j.foreco.2013.07.013; Shvidenko A, 2002, CLIMATIC CHANGE, V55, P5, DOI 10.1023/A:1020243304744; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; Singh V, 2011, FOREST ECOL MANAG, V261, P1945, DOI 10.1016/j.foreco.2011.02.019; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Tang ShouZheng, 2000, Scientia Silvae Sinicae, V36, P19; Vedrova EF, 2002, J VEG SCI, V13, P341, DOI 10.1111/j.1654-1103.2002.tb02058.x; Viana H, 2012, ECOL MODEL, V226, P22, DOI 10.1016/j.ecolmodel.2011.11.027; Weng X, 2011, ANHUI FORESTRY SCI T, V3, P18; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Williamson GB, 2010, AM J BOT, V97, P519, DOI 10.3732/ajb.0900243; WOODWELL GM, 1978, SCIENCE, V199, P141, DOI 10.1126/science.199.4325.141; Wu CZ, 1999, CHINESE J APPL ECOLO, V10, P395; Wu CZ, 1998, J INNER MONGOLIA FOR, V2, P21; Wu Z. X., 1991, J FUJIAN FORESTRY S, V11, P19; Wulder MA, 2010, ENVIRON MONIT ASSESS, V166, P543, DOI 10.1007/s10661-009-1022-6; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Yang YuSheng, 1999, Journal of Northeast Forestry University, V27, P9; Ye JZ, 1984, J NANJING FOR U, V4, P1; Yu XT, 1982, CHINESE FIR CUNNINGH; Zeng Wei-sheng, 2010, Forest Research, V23, P797; Zhou HS, 1999, J FUJIAN COLL FOREST, V2, P51; Zianis D, 2011, EUR J FOREST RES, V130, P145, DOI 10.1007/s10342-010-0417-9	58	2	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151527	10.1371/journal.pone.0151527	http://dx.doi.org/10.1371/journal.pone.0151527			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982054	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900093
J	Eldridge, SM; Lancaster, GA; Campbell, MJ; Thabane, L; Hopewell, S; Coleman, CL; Bond, CM				Eldridge, Sandra M.; Lancaster, Gillian A.; Campbell, Michael J.; Thabane, Lehana; Hopewell, Sally; Coleman, Claire L.; Bond, Christine M.			Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework	PLOS ONE			English	Article							DISEASE; INTERVENTION; PAIN; RECOMMENDATIONS; PHYSIOTHERAPY; INJECTION; DIAGNOSIS; PROTOCOL; LIFE; CARE	We describe a framework for defining pilot and feasibility studies focusing on studies conducted in preparation for a randomised controlled trial. To develop the framework, we undertook a Delphi survey; ran an open meeting at a trial methodology conference; conducted a review of definitions outside the health research context; consulted experts at an international consensus meeting; and reviewed 27 empirical pilot or feasibility studies. We initially adopted mutually exclusive definitions of pilot and feasibility studies. However, some Delphi survey respondents and the majority of open meeting attendees disagreed with the idea of mutually exclusive definitions. Their viewpoint was supported by definitions outside the health research context, the use of the terms 'pilot' and 'feasibility' in the literature, and participants at the international consensus meeting. In our framework, pilot studies are a subset of feasibility studies, rather than the two being mutually exclusive. A feasibility study asks whether something can be done, should we proceed with it, and if so, how. A pilot study asks the same questions but also has a specific design feature: in a pilot study a future study, or part of a future study, is conducted on a smaller scale. We suggest that to facilitate their identification, these studies should be clearly identified using the terms 'feasibility' or 'pilot' as appropriate. This should include feasibility studies that are largely qualitative; we found these difficult to identify in electronic searches because researchers rarely used the term 'feasibility' in the title or abstract of such studies. Investigators should also report appropriate objectives and methods related to feasibility; and give clear confirmation that their study is in preparation for a future randomised controlled trial designed to assess the effect of an intervention.	[Eldridge, Sandra M.; Coleman, Claire L.] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [Lancaster, Gillian A.] Univ Lancaster, Dept Math & Stat, Lancaster, Lancs, England; [Campbell, Michael J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Thabane, Lehana] McMaster Univ, Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Hopewell, Sally] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, Oxon, England; [Bond, Christine M.] Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland	University of London; Queen Mary University London; Lancaster University; University of Sheffield; McMaster University; University of Oxford; University of Aberdeen	Eldridge, SM (corresponding author), Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England.	s.eldridge@qmul.ac.uk	Campbell, Michael J/I-4253-2014	Campbell, Michael J/0000-0003-3529-2739; Eldridge, Sandra/0000-0001-5638-2317; Hopewell, Sally/0000-0002-6881-6984	Queen Mary University of London; University of Sheffield; NIHR RDS London; NIHR RDS South East; Chief Scientist Office Scotland; National Institute for Health Research (NIHR) Research Methods Fellowship; NIHR; National Institute for Health Research [NIHR-RMFI-2013-04-012-101] Funding Source: researchfish	Queen Mary University of London; University of Sheffield; NIHR RDS London; NIHR RDS South East; Chief Scientist Office Scotland; National Institute for Health Research (NIHR) Research Methods Fellowship; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors received small grants from Queen Mary University of London (7495) pound, University of Sheffield (8000) pound, NIHR RDS London (2000) pound, NIHR RDS South East (2400) pound, Chief Scientist Office Scotland (1000) pound. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alicia O'Cathain and Pat Hoddinot for discussions about the reporting of qualitative studies, and consensus participants for their views on our developing framework. Claire Coleman was funded by a National Institute for Health Research (NIHR) Research Methods Fellowship. This article presents independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Alers NO, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004141; Allen J, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-138; Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Boogerd EA, 2014, PEDIATR DIABETES, V15, P394, DOI 10.1111/pedi.12103; Brooks D, 2009, PHYSIOTH CAN, V61, P66, DOI 10.3138/physio.61.2.66; Bugge C, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-353; Buse GL, 2014, CAN MED ASSOC J, V186, pE52, DOI 10.1503/cmaj.130901; Carlesso LC, 2013, PHYSIOTHER CAN, V65, P255, DOI 10.3138/ptc.2012-28; Clark WF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003666; Collado A, 2014, BEHAV THER, V45, P102, DOI 10.1016/j.beth.2013.10.001; Colon HM, 2009, AIDS BEHAV, V13, P523, DOI 10.1007/s10461-009-9540-3; Conference Ltd, 2013, 2 CLIN TRIALS METH C; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Crawley E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-415; Galantino ML, 2013, ALTERN THER HEALTH M, V19, P38; Garcia MK, 2014, INTEGR CANCER THER, V13, P133, DOI 10.1177/1534735413510558; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Goodall M, 2014, J PUBLIC HEALTH-UK, V36, P635, DOI 10.1093/pubmed/fdt112; Heazell AEP, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-95; Higgins J, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/539146; Holt TA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-425; Hu XY, 2016, CHIN J INTEGR MED, V22, P88, DOI 10.1007/s11655-013-1557-9; Hurt CN, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-405; Lakes KD, 2013, MENT HEALTH PHYS ACT, V6, P181, DOI 10.1016/j.mhpa.2013.07.002; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Lancaster Gillian A, 2015, Pilot Feasibility Stud, V1, P1, DOI 10.1186/2055-5784-1-1; Le Reste JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115796; Lee EC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-41; Lee TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079419; McKenna S, 2015, INT J STROKE, V10, P697, DOI 10.1111/ijs.12195; Misumi Y, 2014, JPN J CLIN ONCOL, V44, P116, DOI 10.1093/jjco/hyt195; Moore CG, 2011, CTS-CLIN TRANSL SCI, V4, P332, DOI 10.1111/j.1752-8062.2011.00347.x; National Institute for Health Research, 2015, NIHR EV TRIALS STUD; Palmer AJR, 2013, BONE JOINT RES, V2, P33, DOI 10.1302/2046-3758.22.2000137; PARNELL RW, 1947, LANCET, V253, P939; Penn L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003585; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Pompeu JE, 2014, PHYSIOTHERAPY, V100, P162, DOI 10.1016/j.physio.2013.10.003; Post Marcel W M, 2014, Top Spinal Cord Inj Rehabil, V20, P167, DOI 10.1310/sci2003-167; Powell JE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003726; Saez C, 2014, COMPUT BIOL MED, V45, P26, DOI 10.1016/j.compbiomed.2013.11.009; Safdar N, 2015, INT J TUBERC LUNG D, V19, P237, DOI 10.5588/ijtld.14.0615; San L, 2015, INT J PSYCHIAT CLIN, V19, P90, DOI 10.3109/13651501.2014.1002501; Schoultz M, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-431; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Shanyinde M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-117; Siriwardhana C, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-423; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Vanderver A, 2015, MOL GENET METAB, V114, P494, DOI 10.1016/j.ymgme.2015.01.006; Wolf KH, 2013, Z GERONTOL GERIATR, V46, P727, DOI 10.1007/s00391-013-0560-2	50	470	472	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150205	10.1371/journal.pone.0150205	http://dx.doi.org/10.1371/journal.pone.0150205			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978655	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800022
J	Jung, JY; Lee, HJ; Chun, BH; Jeon, CO				Jung, Ji Young; Lee, Hyo Jung; Chun, Byung Hee; Jeon, Che Ok			Effects of Temperature on Bacterial Communities and Metabolites during Fermentation of Myeolchi-Aekjeot, a Traditional Korean Fermented Anchovy Sauce	PLOS ONE			English	Article							FISH SAUCE; TETRAGENOCOCCUS-HALOPHILUS; MICROBIAL SUCCESSION; HISTAMINE FORMATION; GENOME SEQUENCE; ORGANIC-ACIDS; RICE BRAN; PRODUCTS; GENE; CHROMOHALOBACTER	Myeolchi-aekjeot (MA) in Korea is produced outdoors without temperature controls, which is a major obstacle to produce commercial MA products with uniform quality. To investigate the effects of temperature on MA fermentation, pH, bacterial abundance and community, and metabolites were monitored during fermentation at 15 degrees C, 20 degrees C, 25 degrees C, and 30 degrees C. Initial pH values were approximately 6.0, and pH values increased after approximately 42 days, with faster increases at higher temperatures. Bacterial abundances increased rapidly in all MA samples after quick initial decreases during early fermentation and then they again steadily decreased after reaching their maxima, which were significantly greater at higher temperatures. Bacterial community analysis revealed that Proteobacteria and Tenericutes were predominant in all initial MA samples, but they were rapidly displaced by Firmicutes as fermentation progressed. Photobacterium and Mycoplasma belonging to Proteobacteria and Tenericutes, respectively, which may include potentially pathogenic strains, were dominant in initial MA, but decreased with the growth of Chromohalobacter, which occurred faster at higher temperatures--they were dominant until 273 and 100 days at 15 degrees C and 20 degrees C, respectively, but not detected after 30 days at 25 degrees C and 30 degrees C. Chromohalobacter also decreased with the appearance of subsequent genera belonging to Firmicutes in all MA samples. Tetragenococcus, halophilic lactic acid bacteria, appeared predominantly at 20 degrees C, 25 degrees C, and 30 degrees C; they were most abundant at 30 degrees C, but not detected at 15 degrees C. Alkalibacillus and Lentibacillus appeared as dominant genera with the decrease of Tetragenococcus at 25 degrees C and 30 degrees C, but only Lentibacillus was dominant at 15 degrees C and 20 degrees C. Metabolite analysis showed that amino acids related to tastes were major metabolites and their concentrations were relatively higher at high temperatures. This study suggests that high temperatures (approximately 30 degrees C) may be appropriate in MA fermentation, in the light of faster disappearance of potentially pathogenic genera, higher amino acids, growth of Tetragenococcus, and faster fermentation.	[Jung, Ji Young; Lee, Hyo Jung; Chun, Byung Hee; Jeon, Che Ok] Chung Ang Univ, Dept Life Sci, Seoul 06974, South Korea	Chung Ang University	Jeon, CO (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 06974, South Korea.	cojeon@cau.ac.kr	Lee, Hyo Jung/AAE-9943-2020	Jung, Ji Young/0000-0002-6703-3072	Cooperative Research Program for Agriculture Science & Technology Development, RDA [PJ00999302]; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs (as part of the (multi-ministerial) Genome Technology to Business Translation Program, Republic of Korea)	Cooperative Research Program for Agriculture Science & Technology Development, RDA; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs (as part of the (multi-ministerial) Genome Technology to Business Translation Program, Republic of Korea)	This work was supported by the Cooperative Research Program for Agriculture Science & Technology Development (project no. PJ00999302), RDA and the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs (as part of the (multi-ministerial) Genome Technology to Business Translation Program, Republic of Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2000, OFFICIAL METHODS ANA; Aubourg SP, 2001, FOOD SCI TECHNOL INT, V7, P199, DOI 10.1106/4H8U-9GAD-VMG0-3GLR; BARRETT EL, 1985, ANNU REV MICROBIOL, V39, P131, DOI 10.1146/annurev.mi.39.100185.001023; Beutling DM, 2009, EUR FOOD RES TECHNOL, V229, P725, DOI 10.1007/s00217-009-1106-0; Cho Young Je, 1999, Journal of the Korean Fisheries Society, V32, P385; Chuon MR, 2014, J SCI FOOD AGR, V94, P1124, DOI 10.1002/jsfa.6379; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Copeland A, 2011, STAND GENOMIC SCI, V5, P379, DOI 10.4056/sigs.2285059; Ercolini D, 2011, APPL ENVIRON MICROB, V77, P7372, DOI 10.1128/AEM.05521-11; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Figueiredo IM, 2006, J AGR FOOD CHEM, V54, P4102, DOI 10.1021/jf0525176; Fukui Y, 2012, J GEN APPL MICROBIOL, V58, P273; Guan L, 2011, FOOD MICROBIOL, V28, P101, DOI 10.1016/j.fm.2010.09.001; HALASZ A, 1994, TRENDS FOOD SCI TECH, V5, P42, DOI 10.1016/0924-2244(94)90070-1; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; IMHOFF JF, 1984, J BACTERIOL, V160, P478, DOI 10.1128/JB.160.1.478-479.1984; Jung JY, 2015, J FOOD SCI, V80, pM2853, DOI 10.1111/1750-3841.13114; Jung JY, 2013, FOOD MICROBIOL, V34, P360, DOI 10.1016/j.fm.2013.01.009; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Jung MJ, 2011, J BACTERIOL, V193, P6414, DOI 10.1128/JB.06139-11; Kim MS, 2014, J FOOD SCI, V79, pM927, DOI 10.1111/1750-3841.12431; Kimura B, 2001, INT J FOOD MICROBIOL, V70, P71, DOI 10.1016/S0168-1605(01)00514-1; Kiyohara M, 2012, BIOSCI BIOTECH BIOCH, V76, P48, DOI 10.1271/bbb.110424; Kobayashi T, 2004, J APPL MICROBIOL, V96, P1215, DOI 10.1111/j.1365-2672.2004.02267.x; Kosaka Y, 2012, FISHERIES SCI, V78, P463, DOI 10.1007/s12562-011-0457-1; Kuda T, 2012, FOOD CHEM, V130, P569, DOI 10.1016/j.foodchem.2011.07.074; Lee C. H., 1993, FISH FERMENTATION TE; Lee HJ, 2012, APPL ENVIRON MICROB, V78, P5983, DOI 10.1128/AEM.00104-12; Lee SH, 2015, INT J FOOD MICROBIOL, V203, P15, DOI 10.1016/j.ijfoodmicro.2015.02.031; Lee SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090115; Lee SH, 2014, FOOD MICROBIOL, V38, P16, DOI 10.1016/j.fm.2013.08.004; Lopetcharat K, 2001, FOOD REV INT, V17, P65, DOI 10.1081/FRI-100000515; Lopez JR, 2012, AQUACULTURE, V324, P33, DOI 10.1016/j.aquaculture.2011.10.043; MIZUTANI T, 1992, Journal of Food Composition and Analysis, V5, P152, DOI 10.1016/0889-1575(92)90031-E; Osako K, 2005, FISHERIES SCI, V71, P1347, DOI 10.1111/j.1444-2906.2005.01101.x; Rawal CM, 2012, J BACTERIOL, V194, P4775, DOI 10.1128/JB.01031-12; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Saisithi P., 1994, FISHERIES PROCESSING, P111, DOI [10.1007/978-1-4615-5303-8_5, DOI 10.1007/978-1-4615-5303-8_5]; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Satomi M, 2014, FISHERIES SCI, V80, P849, DOI 10.1007/s12562-014-0756-4; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sitdhipol J, 2013, ANN MICROBIOL, V63, P745, DOI 10.1007/s13213-012-0529-1; Taira W, 2007, FISHERIES SCI, V73, P913, DOI 10.1111/j.1444-2906.2007.01414.x; Tungkawachara S, 2003, J FOOD SCI, V68, P855, DOI 10.1111/j.1365-2621.2003.tb08255.x; Udomsil N, 2011, J AGR FOOD CHEM, V59, P8401, DOI 10.1021/jf201953v; Udomsil N, 2010, INT J FOOD MICROBIOL, V141, P186, DOI 10.1016/j.ijfoodmicro.2010.05.016; VENTOSA A, 2005, BERGEYS MANUAL SYSTE, V2, P316; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xiao YZ, 2014, FOOD ANAL METHOD, V7, P1634, DOI 10.1007/s12161-014-9799-5; Yongsawatdigul J, 2007, J FOOD SCI, V72, pM382, DOI 10.1111/j.1750-3841.2007.00532.x; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	53	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151351	10.1371/journal.pone.0151351	http://dx.doi.org/10.1371/journal.pone.0151351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977596	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800064
J	Nagata, N; Niikura, R; Yamada, A; Sakurai, T; Shimbo, T; Kobayashi, Y; Okamoto, M; Mitsuno, Y; Ogura, K; Hirata, Y; Fujimoto, K; Akiyama, J; Uemura, N; Koike, K				Nagata, Naoyoshi; Niikura, Ryota; Yamada, Atsuo; Sakurai, Toshiyuki; Shimbo, Takuro; Kobayashi, Yuka; Okamoto, Makoto; Mitsuno, Yuzo; Ogura, Keiji; Hirata, Yoshihiro; Fujimoto, Kazuma; Akiyama, Junichi; Uemura, Naomi; Koike, Kazuhiko			Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SMALL-INTESTINAL INJURY; LOW-DOSE ASPIRIN; SMALL-BOWEL; MUCOSAL INJURY; CAPSULE; ENDOSCOPY; LESIONS; AGENTS	Background Middle gastrointestinal bleeding (MGIB) risk has not been fully investigated due to its extremely rare occurrence and the need for multiple endoscopies to exclude upper and lower gastrointestinal bleeding. This study investigated whether MGIB is associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), low-dose aspirin (LDA), thienopyridines, anticoagulants, and proton-pump inhibitors (PPIs), and whether PPI use affects the interactions between MGIB and antithrombotic drugs. Methods In this multicenter, hospital-based, case-control study, 400 patients underwent upper and lower endoscopy, 80 had acute overt MGIB and 320 had no bleeding and were matched for age and sex as controls (1: 4). MGIB was additionally evaluated by capsule and/or double-balloon endoscopy, after excluding upper and lower GI bleeding. Adjusted odds ratios (AOR) for MGIB risk were calculated using conditional logistic regression. To estimate the propensity score, we employed a logistic regression model for PPI use. Results In patients with MGIB, mean hemoglobin level was 9.4 g/dL, and 28 patients (35%) received blood transfusions. Factors significantly associated with MGIB were chronic kidney disease (p<0.001), liver cirrhosis (p = 0.034), NSAIDs (p<0.001), thienopyridines (p<0.001), anticoagulants (p = 0.002), and PPIs (p<0.001). After adjusting for these factors, NSAIDs (AOR, 2.5; p = 0.018), thienopyridines (AOR, 3.2; p = 0.015), anticoagulants (AOR, 4.3; p = 0.028), and PPIs (AOR; 2.0; p = 0.021) were independently associated with MGIB. After adjusting for propensity score, the use of PPIs remained an independent risk factors for MGIB (AOR, 1.94; p = 0.034). No significant interactions were observed between PPIs and NSAIDs (AOR, 0.7; p = 0.637), LDA (AOR, 0.3; p = 0.112), thienopyridine (AOR, 0.7, p = 0.671), or anticoagulants (AOR, 0.5; p = 0.545). Conclusions One-third of patients with acute small intestinal bleeding required blood transfusion. NSAIDs, thienopyridines, anticoagulants, and PPIs increased the risk of acute small intestinal bleeding. However, there were no significant interactions found between antithrombotic drugs and PPI use for bleeding risk.	[Nagata, Naoyoshi; Sakurai, Toshiyuki; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan; [Nagata, Naoyoshi; Sakurai, Toshiyuki; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Hepatol, Tokyo, Japan; [Niikura, Ryota; Yamada, Atsuo; Kobayashi, Yuka; Hirata, Yoshihiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Fukushima, Japan; [Okamoto, Makoto] JR Tokyo Gen Hosp, Dept Gastroenterol, Tokyo, Japan; [Mitsuno, Yuzo] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan; [Ogura, Keiji] Tokyo Metropolitan Police Hosp, Dept Gastroenterol, Tokyo, Japan; [Fujimoto, Kazuma] Saga Med Sch, Dept Internal Med & Gastrointestinal Endoscopy, Saga, Japan; [Uemura, Naomi] Tokyo Metropolitan Police Hosp, Dept Gastroenterol, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; University of Tokyo; Japanese Red Cross Medical Center; University of Tokyo; Saga University	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan.; Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported by Grants-in-Aid for Research from the National Center for Global Health and Medicine (26A-201). No funding existed other than this. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2004, GASTROINTEST ENDOSC, V59, P487, DOI 10.1016/S0016-5107(04)00003-3; Bollinger E, 2012, WORLD J GASTROENTERO, V18, P6235, DOI 10.3748/wjg.v18.i43.6235; Crooks CJ, 2013, GASTROENTEROLOGY, V144, P1384, DOI 10.1053/j.gastro.2013.02.040; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Endo H, 2014, GASTROINTEST ENDOSC; Fujimori S, 2010, DIGESTION, V82, P167, DOI 10.1159/000308361; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Hagiwara Mari, 2004, Journal of Medical Investigation, V51, P43, DOI 10.2152/jmi.51.43; Kuramoto T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-85; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Lanas Angel, 2010, Rheumatology (Oxford), V49 Suppl 2, pii3, DOI 10.1093/rheumatology/keq058; Lin CC, 2013, ALIMENT PHARM THER, V38, P1119, DOI 10.1111/apt.12483; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Maiden L, 2007, CLIN GASTROENTEROL H, V5, P1040, DOI 10.1016/j.cgh.2007.04.031; Nagata N, 2014, J GASTROENTEROL HEPA; Nagata N, 2014, GASTROINTEST ENDOSC; Nagata N, 2015, J GASTROENTEROL; Nagata N, 2015, J GASTROEN HEPATOL, V30, P292, DOI 10.1111/jgh.12805; Okazaki H, 2009, J GASTROENTEROL, V44, P550, DOI 10.1007/s00535-009-0039-5; Pasha SF, 2014, GASTROINTEST ENDOSC, V79, P875, DOI 10.1016/j.gie.2013.10.039; Sakai E, 2013, DIGEST ENDOSC, V25, P412, DOI 10.1111/den.12002; Saurin JC, 2003, ENDOSCOPY, V35, P576; Shiotani A, 2011, SCAND J GASTROENTERO, V46, P281, DOI 10.3109/00365521.2010.533381; Smecuol E, 2009, CLIN GASTROENTEROL H, V7, P524, DOI 10.1016/j.cgh.2008.12.019; Sturmer T, 2000, J Epidemiol Biostat, V5, P125; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Watanabe T, 2013, DIGEST LIVER DIS, V45, P390, DOI 10.1016/j.dld.2012.12.005; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; Watari I, 2014, DIGESTION, V89, P225, DOI 10.1159/000358287	30	22	25	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151332	10.1371/journal.pone.0151332	http://dx.doi.org/10.1371/journal.pone.0151332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978517	gold, Green Published, Green Submitted			2022-12-27	WOS:000372572800061
J	Cabezon, O; Cerda-Cuellar, M; Morera, V; Garcia-Bocanegra, I; Gonzalez-Solis, J; Napp, S; Ribas, MP; Blanch-Lazaro, B; Fernandez-Aguilar, X; Antilles, N; Lopez-Soria, S; Lorca-Oro, C; Dubey, JP; Almeria, S				Cabezon, Oscar; Cerda-Cuellar, Marta; Morera, Virginia; Garcia-Bocanegra, Ignacio; Gonzalez-Solis, Jacob; Napp, Sebastian; Ribas, Maria P.; Blanch-Lazaro, Berta; Fernandez-Aguilar, Xavier; Antilles, Noelia; Lopez-Soria, Sergio; Lorca-Oro, Cristina; Dubey, Jitender P.; Almeria, Sonia			Toxoplasma gondii Infection in Seagull Chicks Is Related to the Consumption of Freshwater Food Resources	PLOS ONE			English	Article							NEOSPORA-CANINUM; ARCTIC FOXES; WILD; SEROPREVALENCE; PREVALENCE; OOCYSTS; TRANSMISSION; ANTIBODIES; SURVIVAL; PARASITE	Understanding the spread of Toxoplasma gondii (T. gondii) in wild birds, particularly in those with opportunistic feeding behavior, is of interest for elucidating the epidemiological involvement of these birds in the maintenance and dissemination of the parasite. Overall, from 2009 to 2011, we collected sera from 525 seagull chicks (Yellow-legged gull (Larus michahellis) and Audouin's gull (L. audouinii)) from 6 breeding colonies in Spain and tested them using the modified agglutination test (MAT) for the presence of antibodies against T. gondii. Chick age was estimated from bill length. Main food source of seagull chicks was evaluated using stable isotope analyses from growing scapular feathers. Overall T. gondii seroprevalence was 21.0% (IC95% 17.5-24.4). A generalized linear mixed-effects model indicated that year (2009) and food source (freshwater) were risk factors associated to the individual risk of infection by T. gondii, while age (days) was close to significance. Freshwater food origin was related to the highest seroprevalence levels, followed by marine origin, supporting freshwater and sewages as important routes of dispersion of T. gondii. Year differences could indicate fluctuating rates of exposure of seagull chicks to T. gondii. Age ranged from 4 to 30 days and seropositivity tended to increase with age (P = 0.07), supporting that seropositivity is related to T. gondii infection rather than to maternal transfer of antibodies, which in gulls is known to sharply decrease with chick age. This study is the first to report T. gondii antibodies in Yellow-legged and Audouin's gulls, thereby extending the range of intermediate hosts for this parasite and underscoring the complexity of its epidemiology.	[Cabezon, Oscar; Ribas, Maria P.; Blanch-Lazaro, Berta; Fernandez-Aguilar, Xavier] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Spain; [Cabezon, Oscar; Cerda-Cuellar, Marta; Napp, Sebastian; Fernandez-Aguilar, Xavier; Antilles, Noelia; Lopez-Soria, Sergio; Lorca-Oro, Cristina; Almeria, Sonia] Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Morera, Virginia; Gonzalez-Solis, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Morera, Virginia; Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Garcia-Bocanegra, Ignacio] UCO, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Dubey, Jitender P.] ARS, Anim Parasit Dis Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA; [Almeria, Sonia] Univ Autonoma Barcelona, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; University of Barcelona; University of Barcelona; Universidad de Cordoba; United States Department of Agriculture (USDA); Autonomous University of Barcelona	Cabezon, O (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Spain.; Cabezon, O (corresponding author), Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona, Spain.	ocabezon@yahoo.com	González-Solís, Jacob/AAB-1161-2019; Cabezón, Oscar/AAV-7876-2020; Fernandez Aguilar, Xavier/P-9919-2017; Gonzalez-Solis, Jacob/C-3942-2008; Bocanegra, Ignacio Garcia/G-1443-2016; Cerda, Marta/U-4534-2018; Napp, Sebastian/F-3331-2016; Lopez-Soria, Sergio/F-9858-2012; Morera-Pujol, Virginia/AAE-6412-2020; Gonzalez-Solis, Jacob/AAZ-5338-2021; Lorca-Oró, Cristina/ABE-7268-2021; Cabezon, Oscar/L-3812-2014	Fernandez Aguilar, Xavier/0000-0002-4939-6048; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Cerda, Marta/0000-0001-6842-1299; Napp, Sebastian/0000-0001-5813-7286; Lopez-Soria, Sergio/0000-0001-7134-2014; Morera-Pujol, Virginia/0000-0001-6500-5548; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Lorca-Oró, Cristina/0000-0001-5351-4169; Cabezon, Oscar/0000-0001-7543-8371; Antilles, Noelia/0000-0002-3762-3135; Puig Ribas, Maria/0000-0003-3242-0758	Spanish MINECO grant [AGL2012-39830-C02, CGL2009-11278/BOS]; INIA grant [FAU2008-00012-C02-01]; Fondos FEDER funds; FEDER funds	Spanish MINECO grant(Spanish Government); INIA grant; Fondos FEDER funds; FEDER funds(European Commission)	This study was partially supported by Spanish MINECO grant AGL2012-39830-C02, Spanish MINECO grant CGL2009-11278/BOS, INIA grant FAU2008-00012-C02-01 and Fondos FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks for the legal permissions to develop this work to the Dept. de Medi Ambient i Habitatge de la Generalitat de Catalunya; Conselleria de Medi Ambient i Mobilitat del Govern de les Illes Balears; Conselleria de Medi Ambient de la Generalitat Valenciana; Consejeria de Medio Ambiente de la Junta de Andalucia; Conselleria do Medio Rural de la Xunta de Galicia; Parc Natural del Delta de l'Ebre, Parc Natural del Montgri, les Illes Medes i el Baix Ter; Parc Natural illes Columbrets; Parc Natural de sa Dragonera; Parque Nacional Maritimo-Terrestre de las Islas Atlanticas; and to Mariano Paracuellos, Juan Carlos Nevado, Jose Antonio Fernandez Bouzas, Joan Mayol, Jose Vicente Escobar and the guarderia de Columbrets, for their help in logistics and sampling. The authors would also like to thank our many colleagues at University of Barcelona and the staff of CReSA for their help in the field. This study was partially supported by the Spanish MINECO grant AGL2012-39830-C02, CGL2009-11278/BOS and INIA grant FAU2008-00012-C02-01 and FEDER funds.	Afonso E, 2010, EPIDEMIOL INFECT, V138, P1105, DOI 10.1017/S0950268809991270; Arnal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089601; Cabezon O, 2004, J PARASITOL, V90, P643, DOI 10.1645/GE-257R; Cabezon O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029549; Chadwick EA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-75; Darwich L, 2012, VET PARASITOL, V183, P377, DOI 10.1016/j.vetpar.2011.07.024; Dubey JP, 2010, ZOONOSES PUBLIC HLTH, V57, P60, DOI 10.1111/j.1863-2378.2009.01274.x; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Fernandez-Aguilar X, 2013, VET PARASITOL, V196, P194, DOI 10.1016/j.vetpar.2013.01.061; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Garnier R, 2014, INTEGR COMP BIOL, V54, P363, DOI 10.1093/icb/icu022; Gotteland C, 2014, VECTOR-BORNE ZOONOT, V14, P403, DOI 10.1089/vbz.2013.1304; Jensen SK, 2010, POLAR BIOL, V33, P599, DOI 10.1007/s00300-009-0735-x; KAPPERUD G, 1978, J WILDLIFE DIS, V14, P157, DOI 10.7589/0090-3558-14.2.157; Ladeiro MP, 2013, ENVIRON SCI POLLUT R, V20, P778, DOI 10.1007/s11356-012-1189-1; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Lindsay DS, 2004, J PARASITOL, V90, P1054, DOI 10.1645/GE-296R; Lopes AP, 2011, PARASITOL RES, V108, P1163, DOI 10.1007/s00436-010-2158-6; Mancianti F, 2013, J PARASITOL, V99, P561, DOI 10.1645/12-34.1; Massie GN, 2010, VET PARASITOL, V169, P296, DOI 10.1016/j.vetpar.2010.01.002; Miao Q, 2014, J WILDLIFE DIS, V50, P717, DOI 10.7589/2014-01-016; Miller MA, 2002, INT J PARASITOL, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; Molina-Lopez R, 2012, RES VET SCI, V93, P300, DOI 10.1016/j.rvsc.2011.05.011; Moreno R, 2010, MAR BIOL, V157, P545, DOI 10.1007/s00227-009-1340-9; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Prestrud KW, 2007, VET PARASITOL, V150, P6, DOI 10.1016/j.vetpar.2007.09.006; Ramos R, 2009, J ORNITHOL, V150, P265, DOI 10.1007/s10336-008-0346-2; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Resendes AR, 2002, J PARASITOL, V88, P1029, DOI 10.1645/0022-3395(2002)088[1029:DTIAMP]2.0.CO;2; ROSE ME, 1981, DEV COMP IMMUNOL, V5, P15, DOI 10.1016/S0145-305X(81)80003-1; Sandstrom CAM, 2013, VET PARASITOL, V194, P9, DOI 10.1016/j.vetpar.2012.12.027; Shapiro K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1287; Sorensen KK, 2005, RES VET SCI, V78, P161, DOI 10.1016/j.rvsc.2004.07.010; Staszewski V, 2007, J ANIM ECOL, V76, P1215, DOI 10.1111/j.1365-2656.2007.01293.x; Steigerwald EC, 2015, IBIS, V157, P439, DOI 10.1111/ibi.12252; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Yu L, 2013, PARASITOL RES, V112, P1333, DOI 10.1007/s00436-012-3187-0; Zoller B, 2013, PARASITOL RES, V112, P1841, DOI 10.1007/s00436-013-3337-z; Zuur Alain F., 2009, P1	40	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150249	10.1371/journal.pone.0150249	http://dx.doi.org/10.1371/journal.pone.0150249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974667	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600020
J	Hirooka, K; Misaki, K; Nitta, E; Ukegawa, K; Sato, S; Tsujikawa, A				Hirooka, Kazuyuki; Misaki, Kana; Nitta, Eri; Ukegawa, Kaori; Sato, Shino; Tsujikawa, Akitaka			Comparison of Macular Integrity Assessment (MAIA (TM)), MP-3, and the Humphrey Field Analyzer in the Evaluation of the Relationship between the Structure and Function of the Macula	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; VISUAL-FIELD; GANGLION-CELL; HUMAN RETINA; GLAUCOMA; MICROPERIMETRY; SENSITIVITY; DEFECTS; SEGMENTATION	Purpose This study was conducted in order to compare relationships between the macular visual field (VF) mean sensitivity measured by MAIATM (Macular Integrity Assessment), MP-3, or Humphry field analyzer (HFA) and the ganglion cell and inner plexiform layer (GCA) thicknesses. Methods This cross-sectional study examined 73 glaucoma patients and 19 normal subjects. All subjects underwent measurements for GCA thickness by Cirrus HD-OCT and static threshold perimetry using MAIA (TM), MP-3, or HFA. VF and OCT in the retinal view were used to examine both the global relationship between the VF sensitivity and GCA thickness, and the superior hemiretina and inferior hemiretina. The relationship between the GCA thickness and macular sensitivity was examined by Spearman correlation analysis. Results For each instrument, statistically significant macular VF sensitivity (dB) and GCA thickness relationships were observed using the decibel scale (R = 0.547-0.687, all P < 0.001). The highest correlation for the global (R = 0.682) and the superior hemiretina (R = 0.594) GCA thickness-VF mean sensitivity was observed by the HFA. The highest correlation for the inferior hemiretina (R = 0.687) GCA thickness-VF mean sensitivity was observed by the MP-3. Among the three VF measurement instruments, however, no significant differences were found for the structure-function relationships. Conclusions All three VF measurement instruments found similar structure-function relationships in the central VF.	[Hirooka, Kazuyuki; Misaki, Kana; Nitta, Eri; Ukegawa, Kaori; Sato, Shino; Tsujikawa, Akitaka] Kagawa Univ, Dept Ophthalmol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan	Kagawa University	Hirooka, K (corresponding author), Kagawa Univ, Dept Ophthalmol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kazuyk@med.kagawa-u.ac.jp		Tsujikawa, Akitaka/0000-0003-0779-7799	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26462689]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (26462689).	Acton JH, 2011, OPTOMETRY VISION SCI, V88, P1288, DOI 10.1097/OPX.0b013e31822b3746; ANCTIL JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P363; Anderson RS, 2006, PROG RETIN EYE RES, V25, P79, DOI 10.1016/j.preteyeres.2005.06.001; Coeckelbergh TRM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1509, DOI 10.1001/archopht.120.11.1509; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Curcio CA, 2011, INVEST OPHTH VIS SCI, V52, P3943, DOI 10.1167/iovs.10-6377; Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; Fujita Kyoko, 2006, Nippon Ganka Gakkai Zasshi, V110, P914; Hodapp E., 1993, CLIN DECISIONS GLAUC, P52; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P940, DOI 10.1167/iovs.10-5803; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Jung KI, 2012, INVEST OPHTH VIS SCI, V53, P4813, DOI 10.1167/iovs.12-9908; Kim KE, 2014, ACTA OPHTHALMOL, V92, pe650, DOI 10.1111/aos.12438; Kok PHB, 2013, ACTA OPHTHALMOL, V91, P418, DOI 10.1111/j.1755-3768.2012.02514.x; Leung CKS, 2005, INVEST OPHTH VIS SCI, V46, P3702, DOI 10.1167/iovs.05-0490; Lima VC, 2010, BRIT J OPHTHALMOL, V94, P64, DOI 10.1136/bjo.2009.159772; Maddess T, 2014, GRAEF ARCH CLIN EXP, V252, P1611, DOI 10.1007/s00417-014-2751-y; Mishra A, 2009, OPT EXPRESS, V17, P23719, DOI 10.1364/OE.17.023719; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nakamura Y, 2010, EYE, V24, P784, DOI 10.1038/eye.2009.207; Ozturk F, 2008, J GLAUCOMA, V17, P118, DOI 10.1097/IJG.0b013e31814b97fd; Ooka E, 2011, AM J OPHTHALMOL, V152, P283, DOI 10.1016/j.ajo.2011.02.001; Orzalesi N, 1998, VISION RES, V38, P763, DOI 10.1016/S0042-6989(97)00171-5; Ozdemir H, 2012, ACTA OPHTHALMOL, V90, P71, DOI 10.1111/j.1755-3768.2009.01838.x; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; Raza AS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1529, DOI 10.1001/archophthalmol.2011.352; Sato S, 2008, ACTA OPHTHALMOL, V86, P609, DOI 10.1111/j.1600-0420.2007.01108.x; Sato S, 2013, INVEST OPHTH VIS SCI, V54, P3046, DOI 10.1167/iovs.12-11173; STEWART WC, 1993, SURV OPHTHALMOL, V37, P353, DOI 10.1016/0039-6257(93)90065-F; Wang M, 2009, ARCH OPHTHALMOL-CHIC, V127, P875, DOI 10.1001/archophthalmol.2009.145; Weingessel B, 2009, EYE, V23, P1052, DOI 10.1038/eye.2008.237	33	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151000	10.1371/journal.pone.0151000	http://dx.doi.org/10.1371/journal.pone.0151000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974468	gold, Green Submitted, Green Published			2022-12-27	WOS:000372570600042
J	Jin, Z; Li, RC; Zhou, CX; Shi, LY; Zhang, XL; Yang, ZX; Zhang, D				Jin, Zhen; Li, Ruichao; Zhou, Chunxiang; Shi, Liya; Zhang, Xiaolan; Yang, Zhixia; Zhang, Dong			Efficient Gene Knockdown in Mouse Oocytes through Peptide Nanoparticle-Mediated SiRNA Transfection	PLOS ONE			English	Article							DELIVERY; CELLS	The use of mouse oocytes as a model for studying female meiosis is very important in reproductive medicine. Gene knockdown by specific small interfering RNA (siRNA) is usually the first step in the study of the function of a target gene in mouse oocytes during in vitro maturation. Traditionally, the only way to introduce siRNA into mouse oocytes is through microinjection, which is certainly less efficient and strenuous than siRNA transfection in somatic cells. Recently, in research using somatic cells, peptide nanoparticle-mediated siRNA transfection has been gaining popularity over liposome nanoparticle-mediated methods because of its high efficiency, low toxicity, good stability, and strong serum compatibility. However, no researchers have yet tried transfecting siRNA into mouse oocytes because of the existence of the protective zona pellucida surrounding the oocyte membrane (vitelline membrane). We therefore tested whether peptide nanoparticles can introduce siRNA into mouse oocytes. In the present study, we showed for the first time that our optimized program can efficiently knock down a target gene with high specificity. Furthermore, we achieved the expected meiotic phenotypes after we knocked down a test unknown target gene TRIM75. We propose that peptide nanoparticles may be superior for preliminary functional studies of unknown genes in mouse oocytes.	[Jin, Zhen; Li, Ruichao; Zhou, Chunxiang; Shi, Liya; Zhang, Xiaolan; Yang, Zhixia; Zhang, Dong] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, ZX; Zhang, D (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	yang_zhixia@sina.com; dong.ray.zhang@njmu.edu.cn	shi, liya/HDM-6854-2022; Zhang, Dong/AAM-8146-2021		National Basic Research Program of China (973 Program) [2013CB945504]; National Natural Science Foundation of China [31271441, 31471406]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program; Grant No: 2013CB945504, http://program.most.gov.cn/); General Program of the National Natural Science Foundation of China (Grant No: 31271441 and 31471406; http://isis.nsfc.gov.cn).	Baumann C, 2015, JOVE-J VIS EXP, DOI 10.3791/53586; Carballada R, 2000, MOL REPROD DEV, V56, P360, DOI 10.1002/1098-2795(200007)56:3&lt;360::AID-MRD5&gt;3.0.CO;2-8; Crombez L, 2011, METHODS MOL BIOL, V683, P349, DOI [10.1007/978-1-60751-919-2_25, 10.1007/978-1-60761-919-2_25]; Farkhani SM, 2014, PEPTIDES, V57, P78, DOI 10.1016/j.peptides.2014.04.015; Gallardo TD, 2007, GENETICS, V177, P179, DOI 10.1534/genetics.107.074823; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Huang CJ, 2012, MOL CELL BIOCHEM, V360, P121, DOI 10.1007/s11010-011-1050-8; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Lambeth Luke S, 2013, Methods Mol Biol, V942, P205, DOI 10.1007/978-1-62703-119-6_12; Miyajima N, 2009, BIOCHEM BIOPH RES CO, V381, P383, DOI 10.1016/j.bbrc.2009.02.059; Petersson J, 2010, EXP CELL RES, V316, P568, DOI 10.1016/j.yexcr.2009.12.007; Pfender S, 2015, NATURE, V524, P239, DOI 10.1038/nature14568; Presente A, 2013, CURR PHARM DESIGN, V19, P2943; Safinya CR, 2014, NEW J CHEM, V38, P5164, DOI 10.1039/c4nj01314j; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Stein Paula, 2013, Methods Mol Biol, V957, P135, DOI 10.1007/978-1-62703-191-2_9	16	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150462	10.1371/journal.pone.0150462	http://dx.doi.org/10.1371/journal.pone.0150462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974323	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600025
J	Malenfant, RM; Davis, CS; Cullingham, CI; Coltman, DW				Malenfant, Rene M.; Davis, Corey S.; Cullingham, Catherine I.; Coltman, David W.			Circumpolar Genetic Structure and Recent Gene Flow of Polar Bears: A Reanalysis	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; URSUS-MARITIMUS; POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; PHYLOGENETIC TREES; COMPUTER-PROGRAM; HUDSON-BAY; R-PACKAGE; ICE; SOFTWARE	Recently, an extensive study of 2,748 polar bears (Ursus maritimus) from across their circumpolar range was published in PLOS ONE, which used microsatellites and mitochondrial haplotypes to apparently show altered population structure and a dramatic change in directional gene flow towards the Canadian Archipelago-an area believed to be a future refugium for polar bears as their southernmost habitats decline under climate change. Although this study represents a major international collaborative effort and promised to be a baseline for future genetics work, methodological shortcomings and errors of interpretation undermine some of the study's main conclusions. Here, we present a reanalysis of this data in which we address some of these issues, including: (1) highly unbalanced sample sizes and large amounts of systematically missing data; (2) incorrect calculation of FST and of significance levels; (3) misleading estimates of recent gene flow resulting from non-convergence of the program BAYESASS. In contrast to the original findings, in our reanalysis we find six genetic clusters of polar bears worldwide: the Hudson Bay Complex, the Western and Eastern Canadian Arctic Archipelago, the Western and Eastern Polar Basin, and-importantly-we reconfirm the presence of a unique and possibly endangered cluster of bears in Norwegian Bay near Canada's expected last sea-ice refugium. Although polar bears' abundance, distribution, and population structure will certainly be negatively affected by ongoing-and increasingly rapid-loss of Arctic sea ice, these genetic data provide no evidence of strong directional gene flow in response to recent climate change.	[Malenfant, Rene M.; Davis, Corey S.; Cullingham, Catherine I.; Coltman, David W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Malenfant, RM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	rene.malenfant@ualberta.ca	Davis, Corey/I-4058-2014; Cullingham, Catherine/AAE-9591-2020; Malenfant, René Michael/A-2916-2010; Coltman, David W/A-4453-2012	Davis, Corey/0000-0003-4362-0659; Cullingham, Catherine/0000-0002-6715-0674; Malenfant, René Michael/0000-0003-1505-3669; Coltman, David W/0000-0002-1268-2307	Alberta Innovates Technology Futures; University of Alberta; Province of Alberta; Natural Sciences and Engineering Research Council of Canada [312207-2011]	Alberta Innovates Technology Futures; University of Alberta(University of Alberta); Province of Alberta; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	RMM has been funded by scholarships from Alberta Innovates Technology Futures, the University of Alberta, and the Province of Alberta. Part of this work was funded by a Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/ ( Grant ID 312207-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup SC, 2005, ARCTIC, V58, P247; Amstrup SC, 2001, CAN J ZOOL, V79, P2147, DOI 10.1139/cjz-79-12-2147; AMSTRUP SC, 1994, J WILDLIFE MANAGE, V58, P1, DOI 10.2307/3809542; Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Beerli Peter, 2009, V17, P42; Bethke R, 1996, ECOL APPL, V6, P311, DOI 10.2307/2269574; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bohling JH, 2013, MOL ECOL, V22, P74, DOI 10.1111/mec.12109; Campagna L, 2013, ECOL EVOL, V3, P3152, DOI 10.1002/ece3.662; Cheng L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-302; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Chesser RK, 1996, GENETICS, V144, P1225; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2006, FISH B-NOAA, V104, P550; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crompton AE, 2008, BIOL CONSERV, V141, P2528, DOI 10.1016/j.biocon.2008.07.018; Cronin MA, 2012, J HERED, V103, P873, DOI 10.1093/jhered/ess090; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Drummond CS, 2007, MOL ECOL, V16, P753, DOI 10.1111/j.1365-294X.2006.03186.x; Durner GM, 1995, ARCTIC, V48, P338; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Ferguson SH, 1999, ECOL LETT, V2, P311, DOI 10.1046/j.1461-0248.1999.00090.x; Fetterer F., 2010, MULTISENSOR ANAL SEA; Fung T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085925; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hamilton SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113746; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; HOLM S, 1979, SCAND J STAT, V6, P65; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; IUCN/SSC Polar Bear Specialist Group, 2014, 2014 POL BEAR STAT T; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2009, HEREDITY, V102, P506, DOI 10.1038/hdy.2008.136; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Laidre KL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2371; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Lone K, 2013, POLAR BIOL, V36, P27, DOI 10.1007/s00300-012-1235-y; Malenfant RM, 2015, MOL ECOL RESOUR, V15, P587, DOI 10.1111/1755-0998.12327; Mauritzen M, 2003, ANIM BEHAV, V66, P107, DOI 10.1006/anbe.2003.2171; Mauritzen M, 2001, CAN J ZOOL, V79, P1704, DOI 10.1139/z01-126; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Meirmans PG, 2014, MOL ECOL RESOUR, V14, P726, DOI 10.1111/1755-0998.12216; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Michalakis Y, 1996, GENETICS, V142, P1061; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1978, GENETICS, V89, P583; Nei M., 1987, MOL EVOLUTIONARY GEN; Obbard ME, 2012, URSUS, V23, P134, DOI 10.2192/URSUS-D-11-00030.1; Obbard ME, 2010, POLAR BEARS; Oksanen J, 2015, COMMUNITY ECOLOGY PA; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Peacock E, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P93, DOI 10.1007/978-90-481-9121-5_5; Peacock E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136126; Peacock E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112021; Peacock E, 2013, J WILDLIFE MANAGE, V77, P463, DOI 10.1002/jwmg.489; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Pop M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0668-z; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; R Core Team, 2013, R LANG ENV STAT COMP; RAMSAY MA, 1986, CAN J ZOOL, V64, P2142, DOI 10.1139/z86-329; Rode KD, 2015, FRONT ECOL ENVIRON, V13, P138, DOI 10.1890/140202; Rodriguez-Ramilo ST, 2012, MOL ECOL RESOUR, V12, P873, DOI 10.1111/j.1755-0998.2012.03156.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sahanatien V, 2010, FOXE BASIN POLAR B 1, P29; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; SLATKIN M, 1995, GENETICS, V139, P457; Smith BJ, 2007, J STAT SOFTW, V21, P1; Takezaki N, 1996, GENETICS, V144, P389; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TAYLOR M, 1995, ARCTIC, V48, P147; Taylor MK, 2008, ARCTIC, V61, P143; Taylor MK, 2001, CAN J ZOOL, V79, P690, DOI 10.1139/cjz-79-4-690; Thiemann GW, 2008, ORYX, V42, P504, DOI 10.1017/S0030605308001877; Viengkone M, 2015, THESIS U ALBERTA EDM; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang J, 2015, MOL ECOL, V24, P3546, DOI 10.1111/mec.13204; Waples RS, 2015, J HERED, V106, P1, DOI 10.1093/jhered/esu062; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wilson GW, 2005, DOCUMENTATION BAYESA; Zeyl E, 2009, MOL ECOL, V18, P735, DOI 10.1111/j.1365-294X.2008.04049.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	108	15	17	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0148967	10.1371/journal.pone.0148967	http://dx.doi.org/10.1371/journal.pone.0148967			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974333	Green Submitted, gold, Green Published			2022-12-27	WOS:000372570600009
J	Tong, YX; Chen, Q; Nichols, TE; Rasetti, R; Callicott, JH; Berman, KF; Weinberger, DR; Mattay, VS				Tong, Yunxia; Chen, Qiang; Nichols, Thomas E.; Rasetti, Roberta; Callicott, Joseph H.; Berman, Karen F.; Weinberger, Daniel R.; Mattay, Venkata S.			Seeking Optimal Region-Of-Interest (ROI) Single-Value Summary Measures for fMRI Studies in Imaging Genetics	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DORSOLATERAL PREFRONTAL CORTEX; QUANTITATIVE TRAIT; DYSFUNCTION; ACTIVATION; PHENOTYPES; SIGNAL; GENES	A data-driven hypothesis-free genome-wide association (GWA) approach in imaging genetics studies allows screening the entire genome to discover novel genes that modulate brain structure, chemistry, and function. However, a whole brain voxel-wise analysis approach in such genome-wide based imaging genetic studies can be computationally intense and also likely has low statistical power since a stringent multiple comparisons correction is needed for searching over the entire genome and brain. In imaging genetics with functional magnetic resonance imaging (fMRI) phenotypes, since many experimental paradigms activate focal regions that can be pre-specified based on a priori knowledge, reducing the voxel-wise search to single-value summary measures within a priori ROIs could prove efficient and promising. The goal of this investigation is to evaluate the sensitivity and reliability of different single-value ROI summary measures and provide guidance in future work. Four different fMRI databases were tested and comparisons across different groups (patients with schizophrenia, their siblings, vs. normal control subjects; across genotype groups) were conducted. Our results show that four of these measures, particularly those that represent values from the top most-activated voxels within an ROI are more powerful at reliably detecting group differences and generating greater effect sizes than the others.	[Tong, Yunxia; Callicott, Joseph H.; Berman, Karen F.] NIMH, Clin & Translat Neurosci Branch, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA; [Chen, Qiang; Weinberger, Daniel R.; Mattay, Venkata S.] Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD USA; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Warwick, England; [Rasetti, Roberta] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Weinberger, Daniel R.; Mattay, Venkata S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Mattay, Venkata S.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins Medicine; University of Warwick; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Tong, YX (corresponding author), NIMH, Clin & Translat Neurosci Branch, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA.	yunxia@mail.nih.gov	Nichols, Thomas E./N-9902-2017; Callicott, Joseph H/AAE-7243-2022; chen, qiang/GWZ-7308-2022; chen, qiang/HGU-5418-2022; Callicott, Joseph/C-9102-2009	Nichols, Thomas E./0000-0002-4516-5103; Callicott, Joseph/0000-0003-1298-3334	National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America [NCT: 00001486, 95-M-0150]; National Institute of Mental Health, NIH, Bethesda, MD, USA [NCT: 00001486, 95-M-0150]; Medical Research Council [G0900908] Funding Source: researchfish; Wellcome Trust [100309/A/12/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002863, ZIAMH002652, ZIAMH002717, ZIAMH002942] Funding Source: NIH RePORTER; MRC [G0900908] Funding Source: UKRI	National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America; National Institute of Mental Health, NIH, Bethesda, MD, USA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Intramural Research Program (NCT: 00001486; Protocol ID: 95-M-0150) of the National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, United States of America.; This research was supported by the Intramural Research Program (NCT: 00001486; Protocol ID: 95-M-0150) of the National Institute of Mental Health, NIH, Bethesda, MD 20892, USA.	Bigos KL, 2010, NEUROIMAGE, V53, P804, DOI 10.1016/j.neuroimage.2010.01.035; Blasi G, 2006, EUR J NEUROSCI, V23, P1658, DOI 10.1111/j.1460-9568.2006.04680.x; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Buck R, 2008, NEUROIMAGE, V40, P1157, DOI 10.1016/j.neuroimage.2008.01.001; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Cohen J.E., 1988, STAT POWER ANAL BEHA; Constable RT, 1998, MAGN RESON IMAGING, V16, P289, DOI 10.1016/S0730-725X(97)00278-6; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Ge T, 2013, QUANTITATIVE BIOL, V1, P227, DOI DOI 10.1007/S40484-013-0023-1; Hariri AR, 2003, BRIT MED BULL, V65, P259, DOI 10.1093/bmb/65.1.259; Kirk RE, 1996, EDUC PSYCHOL MEAS, V56, P746, DOI 10.1177/0013164496056005002; Kotrlik J. W., 2003, Information Technology, Learning, and Performance Journal, V21, P1; Marrelec G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014788; Mattay VS, 2006, METHODS MIND, P263; Medland SE, 2014, NAT NEUROSCI, V17, P791, DOI 10.1038/nn.3718; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Mitsis GD, 2008, NEUROIMAGE, V40, P121, DOI 10.1016/j.neuroimage.2007.11.026; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nieto-Castanon A, 2003, NEUROIMAGE, V19, P1303, DOI 10.1016/S1053-8119(03)00188-5; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Potkin Steven G, 2009, Cogn Neuropsychiatry, V14, P391, DOI 10.1080/13546800903059829; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Rasetti R, 2011, CURR OPIN GENET DEV, V21, P340, DOI 10.1016/j.gde.2011.02.003; Sambataro F, 2013, NEUROPSYCHOPHARMACOL, V38, P846, DOI 10.1038/npp.2012.250; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Stein JL, 2011, MOL PSYCHIATR, V16, P927, DOI 10.1038/mp.2011.32; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; Thompson PM, 2013, NEUROIMAGE, V80, P475, DOI 10.1016/j.neuroimage.2013.05.013; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	38	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151391	10.1371/journal.pone.0151391	http://dx.doi.org/10.1371/journal.pone.0151391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974435	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600074
J	Xu, SX; Shi, XZ; Wang, MY; Zhao, YC				Xu, Shengxiang; Shi, Xuezheng; Wang, Meiyan; Zhao, Yongcun			Effects of Subsetting by Parent Materials on Prediction of Soil Organic Matter Content in a Hilly Area Using Vis-NIR Spectroscopy	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; LEAST-SQUARE REGRESSION; CHEMICAL-PROPERTIES; CARBON FRACTIONS; FIELD-SCALE; QUALITY; CALIBRATION; PERFORMANCE; COMPONENTS; LIBRARY	Assessment and monitoring of soil organic matter (SOM) quality are important for understanding SOM dynamics and developing management practices that will enhance and maintain the productivity of agricultural soils. Visible and near-infrared (Vis-NIR) diffuse reflectance spectroscopy (350-2500 nm) has received increasing attention over the recent decades as a promising technique for SOM analysis. While heterogeneity of sample sets is one critical factor that complicates the prediction of soil properties from Vis-NIR spectra, a spectral library representing the local soil diversity needs to be constructed. The study area, covering a surface of 927 km(2) and located in Yujiang County of Jiangsu Province, is characterized by a hilly area with different soil parent materials (e.g., red sandstone, shale, Quaternary red clay, and river alluvium). In total, 232 topsoil (0-20 cm) samples were collected for SOM analysis and scanned with a Vis-NIR spectrometer in the laboratory. Reflectance data were related to surface SOM content by means of a partial least square regression (PLSR) method and several data pre-processing techniques, such as first and second derivatives with a smoothing filter. The performance of the PLSR model was tested under different combinations of calibration/validation sets (global and local calibrations stratified according to parent materials). The results showed that the models based on the global calibrations can only make approximate predictions for SOM content (RMSE (root mean squared error) = 4.23-4.69 g kg(-1); R-2 (coefficient of determination) = 0.80-0.84; RPD (ratio of standard deviation to RMSE) = 2.19-2.44; RPIQ (ratio of performance to inter-quartile distance) = 2.88-3.08). Under the local calibrations, the individual PLSR models for each parent material improved SOM predictions (RMSE = 2.55-3.49 g kg(-1); R-2 = 0.87-0.93; RPD = 2.67-3.12; RPIQ = 3.15-4.02). Among the four different parent materials, the largest R-2 and the smallest RMSE were observed for the shale soils, which had the lowest coefficient of variation (CV) values for clay (18.95%), free iron oxides (15.93%), and pH (1.04%). This demonstrates the importance of a practical subsetting strategy for the continued improvement of SOM prediction with Vis-NIR spectroscopy.	[Xu, Shengxiang; Shi, Xuezheng; Wang, Meiyan; Zhao, Yongcun] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Xu, Shengxiang; Shi, Xuezheng; Wang, Meiyan; Zhao, Yongcun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, XZ (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.; Shi, XZ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	xzshi@issas.ac.cn			National Natural Science Foundation of China [41301242]; National Key Technology Research and Development Program of China [2013BAD11B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (41301242) and the National Key Technology Research and Development Program of China (2013BAD11B00).	Araujo SR, 2014, EUR J SOIL SCI, V65, P718, DOI 10.1111/ejss.12165; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; Ben-Dor E., 1999, MANUAL REMOTE SENSIN, V3, P111; Bilgili AV, 2010, J ARID ENVIRON, V74, P229, DOI 10.1016/j.jaridenv.2009.08.011; Brown DJ, 2006, GEODERMA, V132, P273, DOI 10.1016/j.geoderma.2005.04.025; Brown DJ, 2005, GEODERMA, V129, P251, DOI 10.1016/j.geoderma.2005.01.001; Brunet D, 2008, BIOSYST ENG, V100, P448, DOI 10.1016/j.biosystemseng.2008.04.008; Cecillon L, 2009, EUR J SOIL SCI, V60, P770, DOI 10.1111/j.1365-2389.2009.01178.x; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; Couteaux MM, 2003, SOIL BIOL BIOCHEM, V35, P1587, DOI 10.1016/j.soilbio.2003.08.003; DALAL RC, 1986, SOIL SCI SOC AM J, V50, P120, DOI 10.2136/sssaj1986.03615995005000010023x; Dardenne P, 2000, J NEAR INFRARED SPEC, V8, P229, DOI 10.1255/jnirs.283; Dematte JAM, 1999, SOIL SCI SOC AM J, V63, P327, DOI 10.2136/sssaj1999.03615995006300020010x; Dunn BW, 2002, AUST J EXP AGR, V42, P607, DOI 10.1071/EA01172; Fystro G, 2002, PLANT SOIL, V246, P139, DOI 10.1023/A:1020612319014; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; HENDERSON TL, 1992, SOIL SCI SOC AM J, V56, P865, DOI 10.2136/sssaj1992.03615995005600030031x; Hunt G. R., 1982, HDB PHYS PROPERTIES, P295; Jenny H., 1941, FACTORS SOIL FORMATI; Kuang B, 2011, EUR J SOIL SCI, V62, P629, DOI 10.1111/j.1365-2389.2011.01358.x; Ladoni M, 2010, PRECIS AGRIC, V11, P82, DOI 10.1007/s11119-009-9123-3; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; LEE KS, 2007, ASABE ANN INT M ST J; Lu R.K., 2000, SOIL AGR CHEM ANAL; Madari BE, 2005, SPECTROSC LETT, V38, P721, DOI 10.1080/00387010500315876; Martens H., 1992, MULTIVARIATE CALIBRA; McDowell M.L., 2012, APPL ENVIRON SOIL SC, DOI [10.1155/2012/294121, DOI 10.1155/2012/294121]; MEHRA O. P., 1960, Proceedings 7th nat. Conf. Clays, V5, P317; Mouazen AM, 2007, SOIL TILL RES, V93, P13, DOI 10.1016/j.still.2006.03.009; Nelson D.W., 1982, AGRONOMY SERIES, V9, P570; Nocita M, 2014, SOIL BIOL BIOCHEM, V68, P337, DOI 10.1016/j.soilbio.2013.10.022; O'Rourke SM, 2012, SOIL SCI SOC AM J, V76, P586, DOI 10.2136/sssaj2011.0053; Peng Y, 2013, J NEAR INFRARED SPEC, V21, P213, DOI 10.1255/jnirs.1053; Rawlins BG, 2011, GEODERMA, V166, P84, DOI 10.1016/j.geoderma.2011.07.015; Reeves J, 2002, ENVIRON POLLUT, V116, pS277, DOI 10.1016/S0269-7491(01)00259-7; Rinnan R, 2007, SOIL BIOL BIOCHEM, V39, P1664, DOI 10.1016/j.soilbio.2007.01.022; Rossel RAV, 2008, AUST J SOIL RES, V46, P1, DOI 10.1071/SR07099; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Rossel RAV, 2009, GEODERMA, V150, P253, DOI 10.1016/j.geoderma.2009.01.025; Rossel RAV, 2009, EUR J SOIL SCI, V60, P453, DOI 10.1111/j.1365-2389.2009.01121.x; Sankey JB, 2008, GEODERMA, V148, P149, DOI 10.1016/j.geoderma.2008.09.019; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Savvides A, 2010, GEODERMA, V154, P353, DOI 10.1016/j.geoderma.2009.11.007; [沙晋明 Sha Jinming], 2003, [水土保持研究, Research of Soil and Water Conservation], V10, P21; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Shi Z, 2015, EUR J SOIL SCI, V66, P679, DOI 10.1111/ejss.12272; Shi Z, 2014, SCI CHINA EARTH SCI, V57, P1671, DOI 10.1007/s11430-013-4808-x; Soil Survey Office of Yujiang County, 1986, SOIL SPEC YUJ COUNT, P23; St Luce M, 2014, GEODERMA, V232, P449, DOI 10.1016/j.geoderma.2014.05.023; Stevens A, 2010, GEODERMA, V158, P32, DOI 10.1016/j.geoderma.2009.11.032; STONER ER, 1981, SOIL SCI SOC AM J, V45, P1161, DOI 10.2136/sssaj1981.03615995004500060031x; Tian YC, 2013, GEODERMA, V202, P161, DOI 10.1016/j.geoderma.2013.03.018; Udelhoven T, 2003, PLANT SOIL, V251, P319, DOI 10.1023/A:1023008322682; Van Waes C, 2005, J AGR SCI, V143, P487, DOI 10.1017/S0021859605005630; Vasques GM, 2010, J ENVIRON QUAL, V39, P923, DOI 10.2134/jeq2009.0314; Vasques GM, 2009, SOIL SCI SOC AM J, V73, P176, DOI 10.2136/sssaj2008.0015; Waiser TH, 2007, SOIL SCI SOC AM J, V71, P389, DOI 10.2136/sssaj2006.0211; Wetterlind J, 2010, GEODERMA, V156, P152, DOI 10.1016/j.geoderma.2010.02.012; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zornoza R, 2008, SOIL BIOL BIOCHEM, V40, P1923, DOI 10.1016/j.soilbio.2008.04.003	63	12	14	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151536	10.1371/journal.pone.0151536	http://dx.doi.org/10.1371/journal.pone.0151536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974821	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600085
J	Prieto-Torres, DA; Rojas-Soto, OR				Prieto-Torres, David A.; Rojas-Soto, Octavio R.			Reconstructing the Mexican Tropical Dry Forests via an Autoecological Niche Approach: Reconsidering the Ecosystem Boundaries	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; GEOGRAPHICAL DISTRIBUTIONS; SELECTING THRESHOLDS; CLOUD FOREST; PREDICTION; BIODIVERSITY; REGIONALIZATION; PERFORMANCE; VEGETATION	We used Ecological Niche Modeling (ENM) of individual species of two taxonomic groups (plants and birds) in order to reconstruct the climatic distribution of Tropical Dry Forests (TDFs) in Mexico and to analyze their boundaries with other terrestrial ecosystems. The reconstruction for TDFs' distribution was analyzed considering the prediction and omission errors based upon the combination of species, obtained from the overlap of individual models (only plants, only birds, and all species combined). Two verifications were used: a primary vegetation map and 100 independent TDFs localities. We performed a Principal Component (PCA) and Discriminant Analysis (DA) to evaluate the variation in the environmental variables and ecological overlap among ecosystems. The modeling strategies showed differences in the ecological patterns and prediction areas, where the "all species combined" model (with a threshold of >= 10 species) was the best strategy to use in the TDFs reconstruction. We observed a concordance of 78% with the primary vegetation map and a prediction of 98% of independent locality records. Although PCA and DA tests explained 75.78% and 97.9% of variance observed, respectively, we observed an important overlap among the TDFs with other adjacent ecosystems, confirming the existence of transition zones among them. We successfully modeled the distribution of Mexican TDFs using a number of bioclimatic variables and co-distributed species. This autoecological niche approach suggests the necessity of rethinking the delimitations of ecosystems based on the recognition of transition zones among them in order to understand the real nature of communities and association patterns of species.	[Prieto-Torres, David A.; Rojas-Soto, Octavio R.] Inst Ecol AC, Lab Bioclimatol, Red Biol Evolut, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Rojas-Soto, OR (corresponding author), Inst Ecol AC, Lab Bioclimatol, Red Biol Evolut, Xalapa, Veracruz, Mexico.	octavio.rojas@inecol.mx	Rojas-Soto, Octavio/Q-6252-2018; Prieto-Torres, David A./N-1157-2017	Rojas-Soto, Octavio/0000-0002-0201-1454; Prieto-Torres, David A./0000-0002-0493-5941	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico); Smithsonian-Mason School of Conservation [MCCS 0500]; Rufford Foundation [16017-1]; Idea Wild;  [CONACyT 152060]	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Smithsonian-Mason School of Conservation; Rufford Foundation; Idea Wild; 	The first author offers thanks to Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) for a doctoral scholarship, and the Smithsonian-Mason School of Conservation for the scholarship during the course "Spatial Ecology, Geospatial Analysis and Remote Sensing for Conservation (MCCS 0500)" that provided the tools and skills necessary for the spatial analysis in this study. The Rufford Foundation (D. Prieto-Torres 16017-1), Idea Wild (D. Prieto-Torres), and the project CONACyT 152060 (O. Rojas-Soto) provided financial and logistical support.; The first author offers thanks to Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) for a doctoral scholarship, and the Smithsonian-Mason School of Conservation for the scholarship during the course "Spatial Ecology, Geospatial Analysis and Remote Sensing for Conservation (MCCS 0500)" that provided the tools and skills necessary for the spatial analysis in this study. The Rufford Foundation (D. Prieto-Torres 16017-1), Idea Wild (D. Prieto-Torres), and the project CONACyT 152060 (O. Rojas-Soto) provided financial and logistical support. Rosario Landgrave, H. Mauricio Ortega-Navarro and Claudio Mota-Vargas helped with the statistical analyses. Pablo C. Hernandez and Mayitza Ramirez kindly providing data for DTFs locality records. Alejandro Gordillo coordinated the geocoding of bird localities in the Atlas database. This manuscript was improved by comments from Diego Santiago, Elisa A. Bonaccorso, Adolfo G. Navarro-Siguenza Luis A. Sanchez-Gonzalez, and Cesar A. Rios-Munoz. Allison M. Jermain and Cristina Vallejo kindly reviewed the English translation.	Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; AUSTIN MP, 1989, VEGETATIO, V83, P35, DOI 10.1007/BF00031679; Bailey RG, 2014, ECOREGIONS ECOSYSTEM, V2nd; BARVE N, 2008, TOOL PARTIAL ROC VER; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Berger YG, 2007, BIOMETRIKA, V94, P953, DOI 10.1093/biomet/asm072; Challenger A, 2008, CAPITAL NATURAL MEXI, VI, DOI DOI 10.32800/ABC.2019.42.0187; Collevatti R. G., 2013, American Journal of Plant Sciences, V4, P792, DOI 10.4236/ajps.2013.44098; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dupin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020957; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2010, ARCMAP 10 0; Feria TP, 2002, DIVERS DISTRIB, V8, P49, DOI 10.1046/j.1472-4642.2002.00127.x; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2309, DOI 10.1023/A:1021374009951; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Gentry Alwyn H., 1995, P146, DOI 10.1017/CBO9780511753398.007; Giraldo J. P., 2011, Seasonally dry tropical forests: ecology and conservation, P129; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2000, PHYTOCOENOLOGIA, V30, P353; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUNTLEY B, 1991, ANN BOT-LONDON, V67, P15, DOI 10.1093/oxfordjournals.aob.a088205; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Krebs C., 1985, ECOLOGA ESTUDIO DIST; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Leibold MA, 1998, EVOL ECOL, V12, P95, DOI 10.1023/A:1006511124428; Linares-Palomino R., 2011, Seasonally dry tropical forests: ecology and conservation, P3; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Ortega-Andrade HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121137; Mayer AL, 2004, BIOSCIENCE, V54, P1013, DOI 10.1641/0006-3568(2004)054[1013:TDRCFE]2.0.CO;2; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; MCINTOSH RP, 1967, BOT REV, V33, P130, DOI 10.1007/BF02858667; Meloun M, 2002, ANALYST, V127, P433, DOI 10.1039/b110779h; MIRANDA F., 1963, BOL SOC BOT MEXICO, V28, P29; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Morrone JJ, 2014, CLADISTICS, V30, P202, DOI 10.1111/cla.12039; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Navarro S. Adolfo G., 2003, Bulletin of the British Ornithologists' Club, V123A, P207; Nie N. H., 1975, SPSS STAT PACKAGE SO, V227; Nood?n L.D., 1988, SENESCENCE AGING PLA, P329, DOI DOI 10.1016/B978-0-12-520920-5.50007-9.; Olden JD, 2003, CONSERV BIOL, V17, P854, DOI 10.1046/j.1523-1739.2003.01280.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Perez-Garcia EA, 2012, ACTA BOT MEX, V100, P149; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ponce-Reyes R, 2012, NAT CLIM CHANGE, V2, P448, DOI 10.1038/NCLIMATE1453; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Pottier J, 2013, GLOBAL ECOL BIOGEOGR, V22, P52, DOI 10.1111/j.1466-8238.2012.00790.x; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Prieto-Torres DA, 2016, GLOBAL CHANGE BIOL, V22, P364, DOI 10.1111/gcb.13090; Rios-Munoz CA, 2012, STUD NEOTROP FAUNA E, V47, P171, DOI 10.1080/01650521.2012.734175; RITCHIE JC, 1986, VEGETATIO, V67, P65, DOI 10.1007/BF00037358; Rojas-Soto OR, 2012, BIODIVERS CONSERV, V21, P2671, DOI 10.1007/s10531-012-0327-x; Rojas-Soto OR, 2003, J BIOGEOGR, V30, P449, DOI 10.1046/j.1365-2699.2003.00836.x; Rzedowski J., 1978, VEGETACION MEXICO; Rzedowski J, 1979, TOPICOS ECOLOGIA CON, P37; Sanchez-Azofeifa GA, 2005, BIOTROPICA, V37, P477, DOI 10.1111/j.1744-7429.2005.00066.x; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stoner K. E., 2004, BIODIVERS CONSERV, P8; Stoner Kathryn E., 2011, P85; Thompson J. N., 2005, INTERSPEC INTERACT; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; TREJO I, 1998, DISTRIBUCION DIVERSI; Trejo Vazquez I, 1999, INVESTIGACIONES GEOG, P40, DOI DOI 10.14350/RIG.59082; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142	84	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150932	10.1371/journal.pone.0150932	http://dx.doi.org/10.1371/journal.pone.0150932			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968031	Green Submitted, gold, Green Published			2022-12-27	WOS:000371989200020
J	Baglaenko, Y; Manion, KP; Chang, NH; Gracey, E; Loh, C; Wither, JE				Baglaenko, Yuriy; Manion, Kieran P.; Chang, Nan-Hua; Gracey, Eric; Loh, Christina; Wither, Joan E.			IL-10 Production Is Critical for Sustaining the Expansion of CD5(+) B and NKT Cells and Restraining Autoantibody Production in Congenic Lupus-Prone Mice	PLOS ONE			English	Article							SYSTEMIC AUTOIMMUNITY; DENDRITIC CELLS; B-1A CELLS; B10 CELLS; T-CELLS; SUSCEPTIBILITY; SUPPRESSION; DISEASE; ERYTHEMATOSUS; ACCUMULATION	The development and progression of systemic lupus erythematosus is mediated by the complex interaction of genetic and environmental factors. To decipher the genetics that contribute to pathogenesis and the production of pathogenic autoantibodies, our lab has focused on the generation of congenic lupus-prone mice derived from the New Zealand Black (NZB) strain. Previous work has shown that an NZB-derived chromosome 4 interval spanning 32 to 151 Mb led to expansion of CD5(+) B and Natural Killer T (NKT) cells, and could suppress autoimmunity when crossed with a lupus-prone mouse strain. Subsequently, it was shown that CD5(+) B cells but not NKT cells derived from these mice could suppress the development of pro-inflammatory T cells. In this paper, we aimed to further resolve the genetics that leads to expansion of these two innate-like populations through the creation of additional sub-congenic mice and to characterize the role of IL-10 in the suppression of autoimmunity through the generation of IL-10 knockout mice. We show that expansion of CD5(+) B cells and NKT cells localizes to a chromosome 4 interval spanning 91 to 123 Mb, which is distinct from the region that mediates the majority of the suppressive phenotype. We also demonstrate that IL-10 is critical to restraining autoantibody production and surprisingly plays a vital role in supporting the expansion of innate-like populations.	[Baglaenko, Yuriy; Manion, Kieran P.; Chang, Nan-Hua; Gracey, Eric; Loh, Christina; Wither, Joan E.] Univ Hlth Network, Dept Genet & Dev, Krembil Res Inst, Toronto, ON, Canada; [Baglaenko, Yuriy; Manion, Kieran P.; Gracey, Eric; Loh, Christina; Wither, Joan E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Wither, Joan E.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Loh, Christina] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Stanford University	Wither, JE (corresponding author), Univ Hlth Network, Dept Genet & Dev, Krembil Res Inst, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca	Gracey, Eric/AAD-7560-2020	Manion, Kieran/0000-0001-8945-9384; Baglaenko, Yuriy/0000-0002-9020-6824; Wither, Joan/0000-0001-5961-9228; Gracey, Eric/0000-0003-0984-435X	Canadian Institutes of Health Research awarded; Arthritis Centre of Excellence; Arthritis Research Foundation of the University Health Network; Canadian Institutes of Health Research Doctoral Research Award; Ontario Graduate Scholarship; Vanier Canadian Graduate Scholarship	Canadian Institutes of Health Research awarded; Arthritis Centre of Excellence; Arthritis Research Foundation of the University Health Network; Canadian Institutes of Health Research Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Vanier Canadian Graduate Scholarship	This work was supported by a research grant from the Canadian Institutes of Health Research awarded to JW. JW receives salary support from The Arthritis Centre of Excellence and the Arthritis Research Foundation of the University Health Network. YB is the recipient of a Canadian Institutes of Health Research Doctoral Research Award. KM is the recipient of an Ontario Graduate Scholarship. EG is the recipient of the Vanier Canadian Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baev DV, 2008, J IMMUNOL, V181, P869, DOI 10.4049/jimmunol.181.2.869; Baglaenko Y, 2015, GENES IMMUN, V16, P311, DOI 10.1038/gene.2015.17; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Cho YN, 2011, RHEUMATOLOGY, V50, P1054, DOI 10.1093/rheumatology/keq457; Chong SY, 2001, GENES IMMUN, V2, P239, DOI 10.1038/sj.gene.6363773; Czarneski J, 2004, LEUKEMIA, V18, P597, DOI 10.1038/sj.leu.2403244; de Masson A, 2015, BLOOD, V125, P1830, DOI 10.1182/blood-2014-09-599159; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fletcher CA, 2006, EUR J IMMUNOL, V36, P2504, DOI 10.1002/eji.200636270; Gao N, 2014, ARTHRITIS RHEUMATOL, V66, P2849, DOI 10.1002/art.38742; Gordy LE, 2011, J IMMUNOL, V187, P6335, DOI 10.4049/jimmunol.1003965; Guerrier T, 2012, J AUTOIMMUN, V39, P173, DOI 10.1016/j.jaut.2012.05.012; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Lantow M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4208; Liu Y, 2007, J IMMUNOL, V179, P1340, DOI 10.4049/jimmunol.179.2.1340; Loh C, 2007, J IMMUNOL, V178, P1608, DOI 10.4049/jimmunol.178.3.1608; Loh C, 2011, J IMMUNOL, V186, P5845, DOI 10.4049/jimmunol.1003426; Maricic I, 2014, J IMMUNOL, V193, P1035, DOI 10.4049/jimmunol.1302898; Maseda D, 2013, J IMMUNOL, V191, P2780, DOI 10.4049/jimmunol.1300649; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mohan C, 1998, ARTHRITIS RHEUM-US, V41, P1652, DOI 10.1002/1529-0131(199809)41:9<1652::AID-ART17>3.0.CO;2-W; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pathak S, 2016, J IMMUNOL, V196, P1507, DOI 10.4049/jimmunol.1500291; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Potula HHSK, 2012, J IMMUNOL, V189, P2931, DOI 10.4049/jimmunol.1200556; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Rogner UC, 2003, NAT REV IMMUNOL, V3, P243, DOI 10.1038/nri1031; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Scapini P, 2011, P NATL ACAD SCI USA, V108, pE823, DOI 10.1073/pnas.1107913108; Stacey MA, 2011, J IMMUNOL, V187, P2944, DOI 10.4049/jimmunol.1101021; Stolp J, 2013, J IMMUNOL, V191, P97, DOI 10.4049/jimmunol.1203252; Talaei N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075166; Teichmann LL, 2012, J IMMUNOL, V188, P678, DOI 10.4049/jimmunol.1102456; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Xu ZW, 2011, J IMMUNOL, V186, P6673, DOI 10.4049/jimmunol.1002544; Xu ZW, 2011, J IMMUNOL, V186, P4130, DOI 10.4049/jimmunol.1003512; Xu ZW, 2004, J IMMUNOL, V173, P6050, DOI 10.4049/jimmunol.173.10.6050; Yang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075588; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	53	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150515	10.1371/journal.pone.0150515	http://dx.doi.org/10.1371/journal.pone.0150515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964093	Green Submitted, gold, Green Published			2022-12-27	WOS:000371993000041
J	Korostil, IA; Regan, DG				Korostil, Igor A.; Regan, David G.			Varicella-Zoster Virus in Perth, Western Australia: Seasonality and Reactivation	PLOS ONE			English	Article							HERPES-ZOSTER; EPIDEMIOLOGY; VACCINATION; HYPOTHESIS	Background Identification of the factors affecting reactivation of varicella-zoster virus (VZV) largely remains an open question. Exposure to solar ultra violet (UV) radiation is speculated to facilitate reactivation. Should the role of UV in reactivation be significant, VZV reactivation patterns would generally be expected to be synchronous with seasonal UV profiles in temperate climates. Methods We analysed age and gender specific VZV notification time series data from Perth, Western Australia (WA). This city has more daily sunshine hours than any other major Australian city. Using the cosinor and generalized linear models, we tested these data for seasonality and correlation with UV and temperature. Results We established significant seasonality of varicella notifications and showed that while herpes-zoster (HZ) was not seasonal it had a more stable seasonal component in males over 60 than in any other subpopulation tested. We also detected significant association between HZ notifications and UV for the entire Perth population as well as for females and males separately. In most cases, temperature proved to be a significant factor as well. Conclusions Our findings suggest that UV radiation may be important for VZV reactivation, under the assumption that notification data represent an acceptably accurate qualitative measure of true VZV incidence.	[Korostil, Igor A.; Regan, David G.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Korostil, IA (corresponding author), Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia.	eeghor@gmail.com		Regan, David/0000-0002-2893-0969	Capital Markets Co-operative Research Centre; Australian Government Department of Health and Ageing	Capital Markets Co-operative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This research was funded by the Capital Markets Co-operative Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Gary Dowse and Paul Saunders from Communicable Disease Control Directorate, Department of Health, Government of Western Australia for their valuable help with varicella-zoster notification data. The Kirby Institute receives funding from the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 3218 0 REG POP GROWT; Australian Bureau of Statistics, 2006, 4153 0 AUSTR US THEI; Australian Bureau of Statistics, 2011, 4177 0 PART SPORT PH; Australian Government, NAT NOT DES SURV SYS; Australian Government, CLIM DAT ONL DAIL MA; Australian Government, MONTHL UV IND SUMM P; Australian Government, UV IND; Australian Government. Bureau of Meteorology, AV ANN MONTHL SUNSH; Barnett, 2010, ANAL SEASONAL HLTH D; Barnett AG, 2014, SEASON ANAL SEASONAL; BROOKNER ELI, 1998, TRACKING KALMAN FILT; Donahue J. G., 2010, American Journal of Public Health, V100, P1116, DOI 10.2105/AJPH.2009.160002; Gidding HF, 2005, AUST NZ J PUBL HEAL, V29, P544, DOI 10.1111/j.1467-842X.2005.tb00248.x; Guzzetta G, 2013, AM J EPIDEMIOL, V177, P1134, DOI 10.1093/aje/kws370; Hanneman KK, 2006, DERMATOL CLIN, V24, P19, DOI 10.1016/j.det.2005.08.003; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099762; Jardine A, 2011, EPIDEMIOL INFECT, V139, P658, DOI 10.1017/S0950268810001949; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Miller ER, 2008, J INFECTION, V56, P360, DOI 10.1016/j.jinf.2008.01.050; Miller Megge, 2004, Commun Dis Intell Q Rep, V28, P311; National Centre for Immunization Research and Surveillance, 2014, CHILDH IMM COV EST; Nelson MR, 2010, MED J AUSTRALIA, V193, P110, DOI 10.5694/j.1326-5377.2010.tb03818.x; Perez-Farinos N, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-59; Rice PS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-189; Robert CP., 2010, MONTE CARLO STAT MET, V2nd ed.; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Toyama N, 2009, J MED VIROL, V81, P2053, DOI 10.1002/jmv.21599; Vaughan G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-370; Vergara-Castaneda A, 2012, J CLIN VIROL, V55, P51, DOI 10.1016/j.jcv.2012.06.004; Wu PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077709; Zak-Prelich M, 2002, EPIDEMIOL INFECT, V129, P593, DOI 10.1017/S0950268802007793	34	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151319	10.1371/journal.pone.0151319	http://dx.doi.org/10.1371/journal.pone.0151319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963841	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000137
J	Urbaniak, M; Tygielska, A; Krauze, K; Mankiewicz-Boczek, J				Urbaniak, Magdalena; Tygielska, Adrianna; Krauze, Kinga; Mankiewicz-Boczek, Joanna			Effects of Stormwater and Snowmelt Runoff on ELISA-EQ Concentrations of PCDD/PCDF and Triclosan in an Urban River	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; WATER TREATMENT-PLANT; DIBENZO-P-DIOXINS; WASTE-WATER; POLYCHLORINATED-BIPHENYLS; SURFACE WATERS; SPATIAL-DISTRIBUTION; 1ST FLUSH; SEDIMENTS; POLLUTANTS	The aim of the study was to determine the effects of stormwater and snowmelt runoff on the ELISA EQ PCDD/PCDF and triclosan concentrations in the small urban Sokolowka River (Central Poland). The obtained results demonstrate the decisive influence of hydrological conditions occurring in the river itself and its catchment on the quoted PCDD/PCDF ELISA EQ concentrations. The lowest PCDD/PCDF values of 87, 60 and 67 ng EQ L-1 in stormwater, the river and its reservoirs, respectively, were associated with the highest river flow of 0.02 m(3) s(-1) and high precipitation (11.2 mm) occurred five days before sampling. In turn, the highest values of 353, 567 and 343 ng EQ L-1 in stormwater, the river and its reservoirs, respectively, were observed during periods of intensive snow melting (stormwater samples) and spring rainfall preceded by a rainless phase (river and reservoir samples) followed by low and moderate river flows of 0.01 and 0.005 m3 s(-1). An analogous situation was observed for triclosan, with higher ELISA EQ concentrations (444 to 499 ng EQ L-1) noted during moderate river flow and precipitation, and the lowest (232 to 288 ng EQ L-1) observed during high river flow and high precipitation preceded by violent storms. Stormwater was also found to influence PCDD/PCDF EQ concentrations of the river and reservoirs, however only during high and moderate flow, and no such effect was observed for triclosan. The study clearly demonstrates that to mitigate the high peaks of the studied pollutants associated with river hydrology, the increased in-site stormwater infiltration and purification, the development of buffering zones along river course and the systematic maintenance of reservoirs to avoid the accumulation of the studied micropollutants and their subsequent release after heavy rainfall are required.	[Urbaniak, Magdalena; Krauze, Kinga; Mankiewicz-Boczek, Joanna] Polish Acad Sci, European Reg Ctr Ecohydrol, Tylna 3, PL-90364 Lodz, Poland; [Urbaniak, Magdalena; Tygielska, Adrianna; Mankiewicz-Boczek, Joanna] Univ Lodz, Fac Biol & Environm Protect, Dept Appl Ecol, Banacha 12-16, PL-90237 Lodz, Poland	Polish Academy of Sciences; European Regional Centre for Ecohydrology of the Polish Academy of Sciences; University of Lodz	Urbaniak, M (corresponding author), Polish Acad Sci, European Reg Ctr Ecohydrol, Tylna 3, PL-90364 Lodz, Poland.; Urbaniak, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Appl Ecol, Banacha 12-16, PL-90237 Lodz, Poland.	m.urbaniak@unesco.lodz.pl	Mankiewicz-Boczek, Joanna/J-2427-2018	Mankiewicz-Boczek, Joanna/0000-0001-7358-0673; Krauze, Kinga/0000-0002-8767-0183; Urbaniak, Magdalena/0000-0001-5118-4530	Life+ EnvEurope [LIFE08 ENV/IT/0003999]	Life+ EnvEurope	This work was funded by the Life+ EnvEurope project No LIFE08 ENV/IT/0003999 (www.enveurope.eu).; The sampling and analyses have been conducted as a contribution to Life+ EnvEurope project No LIFE08 ENV/IT/0003999 (www.enveurope.eu).	Aguera A, 2003, ANAL CHIM ACTA, V480, P193, DOI 10.1016/S0003-2670(03)00040-0; Aranami K, 2007, CHEMOSPHERE, V66, P1052, DOI 10.1016/j.chemosphere.2006.07.010; Bartnik A, 2008, PROBLEMY EKOLOGII KR, VXXII, P39; Brausch JM, 2011, CHEMOSPHERE, V82, P1518, DOI 10.1016/j.chemosphere.2010.11.018; Chalew TEA, 2009, J AM WATER RESOUR AS, V45, P4, DOI 10.1111/j.1752-1688.2008.00284.x; Engelhard C, 2007, SCI TOTAL ENVIRON, V382, P286, DOI 10.1016/j.scitotenv.2007.04.008; Gilbreath AN, 2015, SCI TOTAL ENVIRON, V526, P251, DOI 10.1016/j.scitotenv.2015.04.052; Gobel P, 2007, J CONTAM HYDROL, V91, P26, DOI 10.1016/j.jconhyd.2006.08.008; GREGOR DJ, 1995, SCI TOTAL ENVIRON, V160-61, P117, DOI 10.1016/0048-9697(95)04349-6; Gromaire-Mertz MC, 1999, WATER SCI TECHNOL, V39, P1, DOI 10.1016/S0273-1223(99)00002-5; Hathaway JM, 2012, WATER AIR SOIL POLL, V223, P5903, DOI 10.1007/s11270-012-1327-x; Hathaway JM, 2011, WATER AIR SOIL POLL, V217, P135, DOI 10.1007/s11270-010-0574-y; Herbert BMJ, 2006, ECOTOX ENVIRON SAFE, V63, P3, DOI 10.1016/j.ecoenv.2005.05.012; HORSTMANN M, 1995, CHEMOSPHERE, V31, P2887, DOI 10.1016/0045-6535(95)00156-3; Hua WY, 2005, ENVIRON INT, V31, P621, DOI 10.1016/j.envint.2004.10.019; Jartun M, 2008, SCI TOTAL ENVIRON, V396, P147, DOI 10.1016/j.scitotenv.2008.02.002; Kanda R, 2003, J ENVIRON MONITOR, V5, P823, DOI 10.1039/b306355k; Kantiani L, 2008, J HYDROL, V361, P1, DOI 10.1016/j.jhydrol.2008.07.016; Katz DR, 2013, SCI TOTAL ENVIRON, V443, P123, DOI 10.1016/j.scitotenv.2012.10.052; KAWAMURA K, 1986, ATMOS ENVIRON, V20, P527, DOI 10.1016/0004-6981(86)90093-4; Kayhanian M, 2003, J ENVIRON ENG-ASCE, V129, P975, DOI 10.1061/(ASCE)0733-9372(2003)129:11(975); Kim SW, 2014, ENVIRON EARTH SCI, V71, P483, DOI 10.1007/s12665-013-2933-7; Kishida M, 2013, J ENVIRON SCI-CHINA, V25, P441, DOI 10.1016/S1001-0742(12)60091-6; Kundzewicz ZW, 2009, NATURE, V459, P31, DOI 10.1038/459031a; Latch DE, 2005, ENVIRON TOXICOL CHEM, V24, P517, DOI 10.1897/04-243R.1; Latch DE, 2003, J PHOTOCH PHOTOBIO A, V158, P63, DOI 10.1016/S1010-6030(03)00103-5; Lei YD, 2004, ATMOS ENVIRON, V38, P3557, DOI 10.1016/j.atmosenv.2004.03.039; Levy W, 2014, TOXICOL IN VITRO, V28, P1036, DOI 10.1016/j.tiv.2014.04.009; Li W, 2012, FRONT ENV SCI ENG, V6, P692, DOI 10.1007/s11783-012-0444-5; Lindstrom A, 2002, ENVIRON SCI TECHNOL, V36, P2322, DOI 10.1021/es0114254; Lohmann R, 1998, SCI TOTAL ENVIRON, V219, P53, DOI 10.1016/S0048-9697(98)00237-X; Marsalek J, 2006, TECHNICAL DOCUMENTS; McAvoy DC, 2002, ENVIRON TOXICOL CHEM, V21, P1323, DOI 10.1897/1551-5028(2002)021<1323:MOTIWT>2.0.CO;2; McLachlan MS, 1996, SCI TOTAL ENVIRON, V185, P109, DOI 10.1016/0048-9697(96)05046-2; Meharg AA, 2003, SCI TOTAL ENVIRON, V314, P439, DOI 10.1016/S0048-9697(03)00067-6; Mezcua M, 2004, ANAL CHIM ACTA, V524, P241, DOI 10.1016/j.aca.2004.05.050; Montagner CC, 2014, ENVIRON SCI POLLUT R, V21, P1850, DOI 10.1007/s11356-013-2063-5; NAF C, 1990, CHEMOSPHERE, V20, P1503, DOI 10.1016/0045-6535(90)90304-C; Negussie Yohannes Zerihun, 2012, Ecohydrology & Hydrobiology, V12, P271, DOI 10.2478/v10104-012-0028-9; Nichkova M, 2004, TALANTA, V63, P1213, DOI 10.1016/j.talanta.2004.05.030; Rossi L, 2004, SCI TOTAL ENVIRON, V322, P179, DOI 10.1016/S0048-9697(03)00361-9; Rule KL, 2005, ENVIRON SCI TECHNOL, V39, P3176, DOI 10.1021/es048943+; Sabaliunas D, 2003, WATER RES, V37, P3145, DOI 10.1016/S0043-1354(03)00164-7; Sanchez-Prado L, 2006, CHEMOSPHERE, V65, P1338, DOI 10.1016/j.chemosphere.2006.04.025; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Sriyaraj K, 2002, ENVIRON INT, V26, P433; Stolarska M, 2011, RAINWATER EXTREME EV, P215; Sugawara Y, 2002, CHEMOSPHERE, V46, P1471, DOI 10.1016/S0045-6535(01)00267-3; Szklarek S, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4252-1; Urbaniak M, 2008, POL J ENVIRON STUD, V17, P941; Urbaniak M, 2015, INT J ENVIRON RES, V9, P745; Urbaniak M, 2013, HYDROL RES, V44, P614, DOI 10.2166/nh.2012.236; Urbaniak M, 2012, CHEMOSPHERE, V88, P1358, DOI 10.1016/j.chemosphere.2012.05.040; Urbaniak M, 2010, FRESEN ENVIRON BULL, V19, P2710; Urbaniak M, 2010, POL J ENVIRON STUD, V19, P201; Urbaniak M, 2009, ENVIRON PROT ENG, V35, P93; Van Emon JM, 2008, CHEMOSPHERE, V72, P95, DOI 10.1016/j.chemosphere.2008.01.012; von der Ohe PC, 2012, ENVIRON SCI POLLUT R, V19, P585, DOI 10.1007/s11356-011-0580-7; Wagner Iwona, 2013, Ecohydrology & Hydrobiology, V13, P113, DOI 10.1016/j.ecohyd.2013.06.002; Waltman EL, 2006, ENVIRON TOXICOL CHEM, V25, P367, DOI 10.1897/05-112R.1; Wilson B, 2009, MAR POLLUT BULL, V59, P207, DOI 10.1016/j.marpolbul.2009.03.026; Zgheib S, 2012, WATER RES, V46, P6683, DOI 10.1016/j.watres.2011.12.012; Zhao JL, 2013, WATER RES, V47, P395, DOI 10.1016/j.watres.2012.10.022	64	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151756	10.1371/journal.pone.0151756	http://dx.doi.org/10.1371/journal.pone.0151756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985830	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300123
J	Cobos-Trigueros, N; Sole, M; Castro, P; Torres, JL; Rinaudo, M; De Lazzari, E; Morata, L; Hernandez, C; Fernandez, S; Soriano, A; Nicolas, JM; Mensa, J; Vila, J; Martinez, JA				Cobos-Trigueros, Nazaret; Sole, Mar; Castro, Pedro; Luis Torres, Jorge; Rinaudo, Mariano; De lazzari, Elisa; Morata, Laura; Hernandez, Cristina; Fernandez, Sara; Soriano, Alex; Maria Nicolas, Jose; Mensa, Josep; Vila, Jordi; Antonio Martinez, Jose			Evaluation of a Mixing versus a Cycling Strategy of Antibiotic Use in Critically-Ill Medical Patients: Impact on Acquisition of Resistant Microorganisms and Clinical Outcomes	PLOS ONE			English	Article							REDUCE ANTIMICROBIAL RESISTANCE; VENTILATOR-ASSOCIATED PNEUMONIA; INFECTIOUS-DISEASES SOCIETY; GRAM-NEGATIVE BACTERIA; ROTATION; UNIT; EPIDEMIOLOGY; GUIDELINES; EXPERIENCE; HOSPITALS	Objective To compare the effect of two strategies of antibiotic use (mixing vs. cycling) on the acquisition of resistant microorganisms, infections and other clinical outcomes. Methods Prospective cohort study in an 8-bed intensive care unit during 35- months in which a mixing-cycling policy of antipseudomonal beta-lactams (meropenem, ceftazidime/piperacillin-tazobactam) and fluoroquinolones was operative. Nasopharyngeal and rectal swabs and respiratory secretions were obtained within 48h of admission and thrice weekly thereafter. Target microorganisms included methicillin-resistant S. aureus, vancomycin-resistant enterococci, third-generation cephalosporin-resistant Enterobacteriaceae and non-fermenters. Results A total of 409 (42%) patients were included in mixing and 560 (58%) in cycling. Exposure to ceftazidime/piperacillin-tazobactam and fluoroquinolones was significantly higher in mixing while exposure to meropenem was higher in cycling, although overall use of antipseudomonals was not significantly different (37.5/100 patient-days vs. 38.1/100 patient-days). There was a barely higher acquisition rate of microorganisms during mixing, but this difference lost its significance when the cases due to an exogenous Burkholderia cepacia outbreak were excluded (19.3% vs. 15.4%, OR 0.8, CI 0.5-1.1). Acquisition of Pseudomonas aeruginosa resistant to the intervention antibiotics or with multiple-drug resistance was similar. There were no significant differences between mixing and cycling in the proportion of patients acquiring any infection (16.6% vs. 14.5%, OR 0.9, CI 0.6-1.2), any infection due to target microorganisms (5.9% vs. 5.2%, OR 0.9, CI 0.5-1.5), length of stay (median 5 d for both groups) or mortality (13.9 vs. 14.3%, OR 1.03, CI 0.7-1.3). Conclusions A cycling strategy of antibiotic use with a 6-week cycle duration is similar to mixing in terms of acquisition of resistant microorganisms, infections, length of stay and mortality.	[Cobos-Trigueros, Nazaret; Luis Torres, Jorge; Morata, Laura; Soriano, Alex; Mensa, Josep; Antonio Martinez, Jose] Univ Barcelona, Dept Infect Dis, Hosp Clin, IDIBAPS, Barcelona, Spain; [Sole, Mar; Vila, Jordi] Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain; [Castro, Pedro; Rinaudo, Mariano; Hernandez, Cristina; Fernandez, Sara; Maria Nicolas, Jose] Univ Barcelona, Med Intens Care Unit, IDIBAPS, Hosp Clin, Barcelona, Spain; [De lazzari, Elisa] Univ Barcelona, Hlth Biostat, IDIBAPS, Hosp Clin, Barcelona, Spain; [Vila, Jordi] Univ Barcelona, Dept Clin Microbiol, Sch Med, Hosp Clin, Barcelona, Spain; [Luis Torres, Jorge] Univ Hosp Salamanca, Dept Internal Med, Inst Biomed Res Salamanca IBSAL, Salamanca, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Salamanca	Cobos-Trigueros, N (corresponding author), Univ Barcelona, Dept Infect Dis, Hosp Clin, IDIBAPS, Barcelona, Spain.	fncobos@clinic.ub.es	Rebollo, Pedro Castro/AAF-4792-2021; Soriano, Alex/I-1210-2017; Vila, Jordi/P-3613-2016; Fernandez, Sara/AGZ-0326-2022; Morata, Laura/B-1817-2019; Castro, Pedro/AAG-2513-2021; Triana, Jorge Luis Torres/AAA-7819-2019	Rebollo, Pedro Castro/0000-0002-6118-8970; Soriano, Alex/0000-0002-9374-0811; Vila, Jordi/0000-0002-8025-3926; Morata, Laura/0000-0001-5795-0814; Triana, Jorge Luis Torres/0000-0001-6853-9115; De Lazzari, Elisa/0000-0003-2614-6545	Fondo de Investigaciones Sanitarias, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Ciencia e Innovacion, Gobierno de Espana [PI050167]	Fondo de Investigaciones Sanitarias, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Ciencia e Innovacion, Gobierno de Espana	This study was supported by a grant from the Fondo de Investigaciones Sanitarias, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Ciencia e Innovacion, Gobierno de Espana (PI050167 to JAM).	Allegranzi B, 2002, J HOSP INFECT, V52, P136, DOI 10.1053/jhin.2002.1277; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Bal AM, 2010, ANN NY ACAD SCI, V1213, P81, DOI 10.1111/j.1749-6632.2010.05867.x; Bennett KM, 2007, J TRAUMA, V63, P307, DOI 10.1097/TA.0b013e318120595e; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Cadena J, 2007, BONE MARROW TRANSPL, V40, P151, DOI 10.1038/sj.bmt.1705704; Chong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054190; Chow Karen, 2011, Journal of Biological Dynamics, V5, P27, DOI 10.1080/17513758.2010.488300; CLSI, 2009, M100S19 CLSI S; Damas P, 2006, INTENS CARE MED, V32, P67, DOI 10.1007/s00134-005-2805-z; Evans Heather L, 2005, Surg Infect (Larchmt), V6, P223, DOI 10.1089/sur.2005.6.223; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; GERDING DN, 1991, ANTIMICROB AGENTS CH, V35, P1284, DOI 10.1128/AAC.35.7.1284; Gruson D, 2003, CRIT CARE MED, V31, P1908, DOI 10.1097/01.CCM.0000069729.06687.DE; Gruson D, 2000, AM J RESP CRIT CARE, V162, P837, DOI 10.1164/ajrccm.162.3.9905050; Hedrick TL, 2008, SURG INFECT, V9, P139, DOI 10.1089/sur.2006.102; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Magee JT, 2005, J ANTIMICROB CHEMOTH, V56, P427, DOI 10.1093/jac/dki229; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Martinez JA, 2006, CRIT CARE MED, V34, P329, DOI 10.1097/01.CCM.0000195010.63855.45; MCGOWAN JE, 1983, REV INFECT DIS, V5, P1033; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Moss WJ, 2002, CRIT CARE MED, V30, P1877, DOI 10.1097/00003246-200208000-00034; Nijssen S, 2010, INTENS CARE MED, V36, P512, DOI 10.1007/s00134-009-1714-y; Raymond DP, 2001, CRIT CARE MED, V29, P1101, DOI 10.1097/00003246-200106000-00001; Ruiz M, 2000, AM J RESP CRIT CARE, V162, P119, DOI 10.1164/ajrccm.162.1.9907090; Sandiumenge A, 2006, J ANTIMICROB CHEMOTH, V57, P1197, DOI 10.1093/jac/dkl097; Sarraf-Yazdi S, 2012, J SURG RES, V176, pE73, DOI 10.1016/j.jss.2011.12.014; Shlaes DM, 1997, CLIN INFECT DIS, V25, P584, DOI 10.1086/513766; Smith RL, 2008, SURG INFECT, V9, P423, DOI 10.1089/sur.2007.024; Takesue Y, 2010, J HOSP INFECT, V75, P28, DOI 10.1016/j.jhin.2009.11.022; Toltzis P, 2002, PEDIATRICS, V110, P707, DOI 10.1542/peds.110.4.707; van Duijn PJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-277; van Loon HJ, 2005, AM J RESP CRIT CARE, V171, P480, DOI 10.1164/rccm.200401-070OC; Warren DK, 2004, CRIT CARE MED, V32, P2450, DOI 10.1097/01.CCM.0000147685.79487.28; zur Wiesch PA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004225	39	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150274	10.1371/journal.pone.0150274	http://dx.doi.org/10.1371/journal.pone.0150274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982807	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900029
J	Farran, LK; Lee, CC; Yoo, H; Oller, DK				Farran, Lama K.; Lee, Chia-Cheng; Yoo, Hyunjoo; Oller, D. Kimbrough			Cross-Cultural Register Differences in Infant-Directed Speech: An Initial Study	PLOS ONE			English	Article							MOTHERS SPEECH; VOCABULARY GROWTH; MATERNAL SPEECH; LANGUAGE; CHILDREN; PITCH; AGE; SPECIFICITY; ADJUSTMENTS; BEHAVIORS	Infant-directed speech (IDS) provides an environment that appears to play a significant role in the origins of language in the human infant. Differences have been reported in the use of IDS across cultures, suggesting different styles of infant language-learning. Importantly, both cross-cultural and intra-cultural research suggest there may be a positive relationship between the use of IDS and rates of language development, underscoring the need to investigate cultural differences more deeply. The majority of studies, however, have conceptualized IDS monolithically, granting little attention to a potentially key distinction in how IDS manifests across cultures during the first two years. This study examines and quantifies for the first time differences within IDS in the use of baby register (IDS/BR), an acoustically identifiable type of IDS that includes features such as high pitch, long duration, and smooth intonation (the register that is usually assumed to occur in IDS), and adult register (IDS/AR), the type of IDS that does not include such features and thus sounds as if it could have been addressed to an adult. We studied IDS across 19 American and 19 Lebanese mother-infant dyads, with particular focus on the differential use of registers within IDS as mothers interacted with their infants ages 0-24 months. Our results showed considerable usage of IDS/AR (>30% of utterances) and a tendency for Lebanese mothers to use more IDS than American mothers. Implications for future research on IDS and its role in elucidating how language evolves across cultures are explored.	[Farran, Lama K.] Univ West Georgia, Commun Sci & Disorders, Carrollton, GA USA; [Lee, Chia-Cheng; Yoo, Hyunjoo; Oller, D. Kimbrough] Univ Memphis, Commun Sci & Disorders, Memphis, TN 38152 USA; [Oller, D. Kimbrough] Konrad Lorenz Inst Evolut & Cognit Res, Klosterneuburg, Austria	University System of Georgia; University of West Georgia; University of Memphis	Farran, LK (corresponding author), Univ West Georgia, Commun Sci & Disorders, Carrollton, GA USA.	lfarran@westga.edu	Lee, Chia-Cheng/J-3439-2019; Oller, D. Kimbrough/G-1804-2010; Lee, Chia-Cheng/I-7459-2016	Lee, Chia-Cheng/0000-0002-9324-6645; Lee, Chia-Cheng/0000-0002-9324-6645	National Institute on Deafness and Other Communication Disorders [R01 DC006099, DC011027]; Plough Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011027, R01DC006099] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Plough Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported in part by grants R01 DC006099 and DC011027 to DKO from the National Institute on Deafness and Other Communication Disorders and by the Plough Foundation, which supports DKO's Chair of Excellence at the University of Memphis (http://www.nidcd.nih.gov/Pages/default.aspx) (http://plough.org/grantinformation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin DD, 1996, INFANT BEHAV DEV, V19, P401, DOI 10.1016/S0163-6383(96)90002-8; Bates E., 1976, LANGUAGE CONTEXT ACQ; Boersma P., 2014, PRAAT DOING PHONETIC; Bornstein M, 1992, DEV INFANCY INTRO; Bornstein MH, 2012, J CROSS CULT PSYCHOL, V43, P171, DOI 10.1177/0022022110388563; Bornstein MH, 2000, J CHILD LANG, V27, P407, DOI 10.1017/S0305000900004165; BORNSTEIN MH, 1992, DEV PSYCHOL, V28, P593, DOI 10.1037/0012-1649.28.4.593; Bryant GA, 2007, PSYCHOL SCI, V18, P746, DOI 10.1111/j.1467-9280.2007.01970.x; CARROLL SB, 2005, ENDLESS FORMS MOST B; COHN JF, 1988, DEV PSYCHOL, V24, P386, DOI 10.1037/0012-1649.24.3.386; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; Deacon T., 1997, SYMBOLIC SPECIES COE; Deacon TW, 2010, P NATL ACAD SCI USA, V107, P9000, DOI 10.1073/pnas.0914624107; Estes KG, 2013, INFANCY, V18, P797, DOI 10.1111/infa.12006; FERGUSON CA, 1964, AM ANTHROPOL, V66, P103, DOI 10.1525/aa.1964.66.suppl_3.02a00060; FERGUSON CA, 1959, WORD, V15, P325, DOI 10.1080/00437956.1959.11659702; FERNALD A, 1989, J CHILD LANG, V16, P477, DOI 10.1017/S0305000900010679; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; Fernald A, 1991, ANN CHILD DEV; Fernald A., 1992, ADAPTED MIND EVOLUTI; Golinkoff RM, 2015, CURR DIR PSYCHOL SCI, V24, P339, DOI 10.1177/0963721415595345; Hart B., 1995, MEANINGFUL DIFFERENC; Heath S, 1983, WAYS WORDS ETHNOGRAP; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Hoff E, 2002, CHILD DEV, V73, P418, DOI 10.1111/1467-8624.00415; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; Huttenlocher J, 2010, COGNITIVE PSYCHOL, V61, P343, DOI 10.1016/j.cogpsych.2010.08.002; Jaffe J, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00137; KAPLAN PS, 1995, DEV PSYCHOBIOL, V28, P45, DOI 10.1002/dev.420280105; Keller H, 2007, INT J BEHAV DEV, V31, P210, DOI 10.1177/0165025407074633; Kitamura C, 2003, INFANCY, V4, P85, DOI 10.1207/S15327078IN0401_5; Kitamura C, 2002, INFANT BEHAV DEV, V24, P372; KLEIN RP, 1979, PSYCHOL REP, V44, P1059, DOI 10.2466/pr0.1979.44.3c.1059; Liu HM, 2009, J CHILD LANG, V36, P909, DOI 10.1017/S030500090800929X; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; LYNCH MP, 1995, DEV PSYCHOBIOL, V28, P3, DOI 10.1002/dev.420280103; Ma WY, 2011, LANG LEARN DEV, V7, P185, DOI 10.1080/15475441.2011.579839; Milenkovic P, 2001, TF32 U WISC MAD; Monnot M, 1999, HUM NATURE-INT BIOS, V10, P415, DOI 10.1007/s12110-999-1010-0; Newport E., 1977, TALKING CHILDREN LAN; Newport E, 1977, COGNITIVE THEORY; OCHS E, 1982, LANG SOC, V11, P77, DOI 10.1017/S0047404500009040; Odling-Smee F.J., 1988, P73; Oller D.K, 2000, EMERGENCE SPEECH CAP, DOI [10.4324/9781410602565, DOI 10.4324/9781410602565]; PAPOUSEK M, 1991, INFANT BEHAV DEV, V14, P415, DOI 10.1016/0163-6383(91)90031-M; PAPOUSEK M, 1987, J PSYCHOLINGUIST RES, V16, P491, DOI 10.1007/BF01073274; Papousek M., 1985, SOCIAL PERCEPTION IN, P269; RATNER NB, 1984, J CHILD LANG, V11, P515, DOI 10.1017/S0305000900005924; Saiegh-Haddad E., 2014, HDB ARABIC LITERACY, P3; Saint-Georges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078103; Shneidman LA, 2013, J CHILD LANG, V40, P672, DOI 10.1017/S0305000912000141; Shneidman LA, 2012, DEVELOPMENTAL SCI, V15, P659, DOI 10.1111/j.1467-7687.2012.01168.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SNOW CE, 1972, CHILD DEV, V43, P549, DOI 10.1111/j.1467-8624.1972.tb01123.x; Thiemann-Bourque KS, 2014, AM J SPEECH-LANG PAT, V23, P474, DOI 10.1044/2014_AJSLP-12-0010; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; TRONICK ED, 1977, J COMMUN, V27, P74, DOI 10.1111/j.1460-2466.1977.tb01829.x; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; West M.J., 1988, Handbook of Behavioral Neurobiology, V9, P41	61	29	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151518	10.1371/journal.pone.0151518	http://dx.doi.org/10.1371/journal.pone.0151518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26981626	gold, Green Submitted, Green Published			2022-12-27	WOS:000372574900091
J	Herlihy, MV; Talamas, EJ; Weber, DC				Herlihy, Megan V.; Talamas, Elijah J.; Weber, Donald C.			Attack and Success of Native and Exotic Parasitoids on Eggs of Halyomorpha halys in Three Maryland Habitats	PLOS ONE			English	Article							PODISUS-MACULIVENTRIS HEMIPTERA; MARMORATED STINK BUG; ASHMEAD HYMENOPTERA; NATURAL ENEMIES; PENTATOMIDAE; HETEROPTERA; SCELIONIDAE; ATTRACTION; MORTALITY	Egg parasitoids of the exotic invasive brown marmorated stink bug, Halyomorpha halys (Stal), were investigated using lab-reared fresh (live) and frozen (killed) lab-reared sentinel egg masses deployed for 72h on foliage in three habitats-woods, orchard, and soybean field-in Maryland, USA, in summer 2014. Four native hymenopteran species, Telenomus podisi Ashmead (Scelionidae), Trissolcus euschisti (Ashmead) and Tr. brochymenae Ashmead (Scelionidae), and Anastatus reduvii (Howard) (Eupelmidae), developed and emerged from H. halys eggs. One exotic parasitoid, Trissolcus japonicus (Ashmead), emerged, providing the first known occurrence of this species in North America. Native parasitoids emerged from frozen eggs significantly more often than from fresh eggs (89.3% of egg masses and 98.1% of individual eggs), whereas the exotic Tr. japonicus did not show a similar difference, strongly suggesting adaptation to H. halys as a host by Tr. japonicus but not by the native species. Parasitoids were habitat-specific: all three Trissolcus species were significantly more likely to occur in the woods habitat, whereas Te. podisi was found exclusively in the soybean field. Further investigations are required to elucidate evolving host-parasitoid relationships, habitat specificity, and non-target effects of Tr. japonicus over the expanded range of H. halys in North America.	[Herlihy, Megan V.; Weber, Donald C.] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD USA; [Talamas, Elijah J.] ARS, Systemat Entomol Lab, USDA, Washington, DC USA; [Talamas, Elijah J.] Smithsonian Inst, Washington, DC 20560 USA	United States Department of Agriculture (USDA); Smithsonian Institution; United States Department of Agriculture (USDA); Smithsonian Institution	Weber, DC (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville, MD USA.	Don.Weber@ars.usda.gov		Talamas, Elijah/0000-0002-1048-6345	Systematic Entomology Laboratory; Invasive Insect Biocontrol and Behavior Laboratory, USDA ARS	Systematic Entomology Laboratory; Invasive Insect Biocontrol and Behavior Laboratory, USDA ARS	This work was made possible by funding from the Systematic Entomology Laboratory and the Invasive Insect Biocontrol and Behavior Laboratory, USDA ARS. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA; USDA is an equal opportunity provider and employer.	Abram PK, 2014, BIOL INVASIONS, V16, P1387, DOI 10.1007/s10530-013-0576-y; BURKS B. D., 1967, TRANS AMER ENTOMOL SOC, V93, P423; ELKINTON JS, 1992, RES POPUL ECOL, V34, P29, DOI 10.1007/BF02513520; Gariepy TD, 2014, MOL ECOL, V23, P3912, DOI 10.1111/mec.12515; Haye T, 2015, J PEST SCI, V88, P693, DOI 10.1007/s10340-015-0671-1; Haye T, 2015, J PEST SCI, V88, P665, DOI 10.1007/s10340-015-0670-2; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hoffmann M. P., 1993, NATURAL ENEMIES VEGE; Johnson NF., 1984, BULL OHIO BIOL SURV, V6, P1; Jones AL, 2014, BIOL CONTROL, V78, P61, DOI 10.1016/j.biocontrol.2014.07.011; JONES WA, 1981, ENVIRON ENTOMOL, V10, P409, DOI 10.1093/ee/10.3.409; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey TC, 2015, ENVIRON ENTOMOL, V44, P746, DOI 10.1093/ee/nvv049; Lowry R., 2015, VASSARSTATS WEBSITE; MCPHERSON JE, 1980, GREAT LAKES ENTOMOL, V13, P17; Montemayor CO, 2011, ENVIRON ENTOMOL, V40, P948, DOI 10.1603/EN10275; Northeastern IPM Center, 2014, WHER IS BMSB; Northeastern IPM Center, 2014, HOST PLANTS BROWN MA; Okuda MS, 1998, ENVIRON ENTOMOL, V17, P795; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; Talamas EJ, 2015, J HYMENOPT RES, V43, P45, DOI 10.3897/JHR.43.8560; Talamas EJ, 2015, J HYMENOPT RES, V43, P119, DOI 10.3897/JHR.43.4661; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Weber DC, 2014, J ECON ENTOMOL, V107, P1061, DOI 10.1603/EC13502; Wiedenmann Robert N., 1996, P94	25	82	83	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150275	10.1371/journal.pone.0150275	http://dx.doi.org/10.1371/journal.pone.0150275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983012	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900030
J	Hunter, DW; Hibbard, PB				Hunter, David W.; Hibbard, Paul B.			Ideal Binocular Disparity Detectors Learned Using Independent Subspace Analysis on Binocular Natural Image Pairs	PLOS ONE			English	Article							RECEPTIVE-FIELD ORGANIZATION; SLOW FEATURE ANALYSIS; CAT STRIATE CORTEX; COMPLEX CELLS; VISUAL-CORTEX; HORIZONTAL DISPARITY; NEURAL MECHANISMS; SPATIAL STRUCTURE; ENERGY MODELS; NEURONS	An influential theory of mammalian vision, known as the efficient coding hypothesis, holds that early stages in the visual cortex attempts to form an efficient coding of ecologically valid stimuli. Although numerous authors have successfully modelled some aspects of early vision mathematically, closer inspection has found substantial discrepancies between the predictions of some of these models and observations of neurons in the visual cortex. In particular analysis of linear-non-linear models of simple-cells using Independent Component Analysis has found a strong bias towards features on the horoptor. In order to investigate the link between the information content of binocular images, mathematical models of complex cells and physiological recordings, we applied Independent Subspace Analysis to binocular image patches in order to learn a set of complex-cell-like models. We found that these complex-cell-like models exhibited a wide range of binocular disparity-discriminability, although only a minority exhibited high binocular discrimination scores. However, in common with the linear-non-linear model case we found that feature detection was limited to the horoptor suggesting that current mathematical models are limited in their ability to explain the functionality of the visual cortex.	[Hunter, David W.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Hibbard, Paul B.] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England	University of St Andrews; University of Essex	Hunter, DW (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	dwh5@st-andrews.ac.uk	Hibbard, Paul/AAD-4044-2020	Hibbard, Paul/0000-0001-6133-6729	Biotechnology and Biological Sciences Research Council (BBSRC) grant [BB/K018973/1]; BBSRC [BB/K018973/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K018973/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) grant [BB/K018973/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anzai A, 1997, P NATL ACAD SCI USA, V94, P5438, DOI 10.1073/pnas.94.10.5438; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Banks MS, 2004, J NEUROSCI, V24, P2077, DOI 10.1523/JNEUROSCI.3852-02.2004; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; Blaschke T, 2006, NEURAL COMPUT, V18, P2495, DOI 10.1162/neco.2006.18.10.2495; Bouguet J.Y, 2004, CAMERA CALIBRATION T; Burge J, 2014, J VISION, V14, DOI 10.1167/14.2.1; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Durand JB, 2007, CEREB CORTEX, V17, P1260, DOI 10.1093/cercor/bhl050; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Fournier J, 2014, J NEUROSCI, V34, P5515, DOI 10.1523/JNEUROSCI.0474-13.2014; Gutmann MU, 2013, J PHYSIOL-PARIS, V107, P369, DOI 10.1016/j.jphysparis.2013.01.001; Haefner RM, 2008, NEURON, V57, P147, DOI 10.1016/j.neuron.2007.10.042; Hansard M, 2011, NEURAL COMPUT, V23, P2324, DOI 10.1162/NECO_a_00163; HEGGELUND P, 1981, EXP BRAIN RES, V42, P89; Hibbard PB, 2008, VISION RES, V48, P1427, DOI 10.1016/j.visres.2008.03.013; Hong G, 2001, STUDY DIGITAL CAMERA; Hoyer PO, 2000, NETWORK-COMP NEURAL, V11, P191, DOI 10.1088/0954-898X/11/3/302; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hunter DW, 2015, J VISION, V15, DOI 10.1167/15.13.6; Hyvarinen A, 2000, NEURAL COMPUT, V12, P1705, DOI 10.1162/089976600300015312; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, ADV NEUR IN, V12, P827; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Jarrett K., 2009, P IEEE INT C COMP VI; Kayser C, 2001, LECT NOTES COMPUT SC, V2130, P1075; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LI ZP, 1994, NETWORK-COMP NEURAL, V5, P157, DOI 10.1088/0954-898X/5/2/003; Lies JP, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003468; Liu Y, 2008, J VISION, V8, DOI 10.1167/8.11.19; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Okajima K, 2004, NEURAL NETWORKS, V17, P953, DOI 10.1016/j.neunet.2004.02.004; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Olshausen BA, 2009, SPIE OPTICAL ENG APP; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P391; Pillow JW, 2006, J VISION, V6, P414, DOI 10.1167/6.4.9; POGGIO GF, 1988, J NEUROSCI, V8, P4531; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Qian N, 1997, VISION RES, V37, P1811, DOI 10.1016/S0042-6989(96)00331-8; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Read JCA, 2007, NAT NEUROSCI, V10, P1322, DOI 10.1038/nn1951; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sasaki KS, 2010, J NEUROSCI, V30, P13826, DOI 10.1523/JNEUROSCI.1135-10.2010; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; TYLER CW, 1995, PERCEPTION, V24, P127, DOI 10.1068/p240127; Watanabe O, 2009, J VISION, V9, DOI 10.1167/9.12.24; Weng J, 1992, NEUR NETW 1992 IJCNN; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938	68	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150117	10.1371/journal.pone.0150117	http://dx.doi.org/10.1371/journal.pone.0150117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982184	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000372574900024
J	Zhang, C; Li, XM; Liu, Y; Qiao, S; Zhang, LY; Zhou, YJ; Tang, ZZ; Shen, ZY; Chen, Y				Zhang, Chen; Li, Xiaoming; Liu, Yu; Qiao, Shan; Zhang, Liying; Zhou, Yuejiao; Tang, Zhenzhu; Shen, Zhiyong; Chen, Yi			Stigma against People Living with HIV/AIDS in China: Does the Route of Infection Matter?	PLOS ONE			English	Article							HIV-RELATED STIGMA; INJECTION-DRUG USERS; FEMALE SEX WORKERS; QUALITY-OF-LIFE; SOCIAL SUPPORT; REDUCTION INTERVENTION; DISCRIMINATION; HEALTH; DISCLOSURE; ATTITUDES	In the current study, we tested the hypothesis that people who contracted HIV from "blameless" routes (e.g., blood transfusion, sex with stable partners) are less stigmatized compared to people who contracted HIV from "blamable" routes (e.g., injection drug use, sex with sex workers). A cross-sectional study was conducted among 2,987 participants in Guangxi province, China, between 2012 and 2013. We employed both explanatory and predictive modeling strategy by using multivariate linear regression models. In the explanatory models, we assessed the association between routes of infection and three types of stigma (perceived, internalized, and enacted). From identified routes of infection that significantly contributed to higher stigma, we employed predictive modeling to explore predictors for the specific type of stigma. Multiple-imputation was employed for sensitivity analyses. Of the total sample, 63% were male and the average age was 42.9 years (ranged between 18 and 88). Multivariate regression models revealed that contraction from commercial sex increased the perceived (beta = 0.46, 95% CI = 0.02, 0.90) and internalized stigma (beta = 0.60, 95% CI = 0.09, 1.10), while injecting drug use increased the perceived (beta = 0.65, 95% CI = 0.07, 1.22) and enacted stigma (beta = 0.09, 95% CI = 0.02, 0.16) after controlling for confounders. Among PLWHA who were infected via commercial sex partners, social support was negatively associated with perceived (beta = -0.47, 95% CI = -0.79, -0.14) and internalized stigma (beta = -0.80, 95% CI = -1.24, -0.35). Among PLWHA who were infected via injecting drugs, no adherence to antiretroviral treatment (beta = 0.41, 95% CI = 0.01, 0.82) was positively associated with perceived stigma, and disclosure of serostatus to others was negatively associated with enacted stigma (beta = -0.20, 95% CI = -0.34, -0.05). Knowledge of the association between routes of infection and stigma can guide health professionals and policy makers to develop tailored intervention strategies to mitigate the effects of stigma and enhance HIV care utilization among PLWHA in China.	[Zhang, Chen; Liu, Yu] Vanderbilt Univ, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Li, Xiaoming; Qiao, Shan] Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Zhang, Liying] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Zhou, Yuejiao; Tang, Zhenzhu; Shen, Zhiyong; Chen, Yi] Guangxi CDC, Dept HIV STD Prevent, Nanning, Guangxi, Peoples R China	Vanderbilt University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Wayne State University	Zhang, C (corresponding author), Vanderbilt Univ, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	chen.zhang.1@vanderbilt.edu	Li, Xiaoming/AAF-1362-2019	Li, Xiaoming/0000-0002-5555-9034; Zhang, Chen/0000-0002-8771-561X	National Institute of Child and Human Development Grant [R01HD074221]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074221] Funding Source: NIH RePORTER	National Institute of Child and Human Development Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by the National Institute of Child and Human Development Grant (#R01HD074221) (URL: https://www.nichd.nih.gov/Pages/index.aspx). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Child and Human Development.	Akena D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048671; Alemu T, 2013, SAHARA J-J SOC ASP H, V10, P1, DOI 10.1080/17290376.2013.806645; [Anonymous], 2008, HLTH BEHAV HLTH ED T; AVERT, 2014, HIV AIDS STIGM DISCR; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Cao HJ, 2010, AIDS EDUC PREV, V22, P445, DOI 10.1521/aeap.2010.22.5.445; Cao Xiao-bin, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1022; Cao XB, 2006, AIDS EDUC PREV, V18, P518, DOI 10.1521/aeap.2006.18.6.518; Chen JJ, 2005, AIDS EDUC PREV, V17, P1, DOI 10.1521/aeap.17.1.1.58689; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Gaskins Susan, 2011, Issues Ment Health Nurs, V32, P367, DOI 10.3109/01612840.2011.571807; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Greene MC, 2013, AIDS BEHAV, V17, P1775, DOI 10.1007/s10461-012-0396-6; Hong Y, 2008, AIDS PATIENT CARE ST, V22, P823, DOI 10.1089/apc.2008.0001; Hong Y, 2010, J TRANSCULT NURS, V21, P29, DOI 10.1177/1043659609349063; King EJ, 2013, AIDS BEHAV, V17, P2597, DOI 10.1007/s10461-013-0447-7; Knowlton A, 2004, AIDS BEHAV, V8, P357, DOI 10.1007/s10461-004-7320-7; Knowlton AR, 2005, AIDS CARE, V17, P479, DOI 10.1080/0954012051233131314349; Lee SJ, 2007, AIDS PATIENT CARE ST, V21, P409, DOI 10.1089/apc.2006.0066; Li L, 2007, AIDS PATIENT CARE ST, V21, P753, DOI 10.1089/apc.2006.0219; Li L, 2014, SOC PSYCH PSYCH EPID, V49, P991, DOI 10.1007/s00127-013-0808-6; Li L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18710; Li Li, 2008, Fam Syst Health, V26, P431; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Li MJ, 2014, AIDS EDUC PREV, V26, P471, DOI 10.1521/aeap.2014.26.5.471; Li XH, 2012, J ASSOC NURSE AIDS C, V23, DOI 10.1016/j.jana.2011.07.002; Li XH, 2011, AIDS PATIENT CARE ST, V25, P665, DOI 10.1089/apc.2011.0174; Li XH, 2009, J ASSOC NURSE AIDS C, V20, P22, DOI 10.1016/j.jana.2008.09.007; Liao MZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/143738; Lindberg MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114867; Liu HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056815, 10.1371/journal.pone.0055680]; Liu Yan, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P658, DOI 10.11817/j.issn.1672-7347.2014.07.002; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parsons JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127392; Peretti-Watel P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000411; Phillips Kenneth D, 2011, Issues Ment Health Nurs, V32, P359, DOI 10.3109/01612840.2011.575533; Qian HZ, 2007, AIDS CARE, V19, P1283, DOI 10.1080/09540120701402814; Qiao S, 2015, AIDS CARE, V27, P28, DOI 10.1080/09540121.2015.1034648; Qiao Shan, 2015, AIDS, V29 Suppl 1, pS25, DOI 10.1097/QAD.0000000000000670; Rao D, 2008, SOC SCI MED, V67, P1541, DOI 10.1016/j.socscimed.2008.07.024; Rezvan Panteha Hayati, 2015, BMC Med Res Methodol, V15, P83, DOI 10.1186/s12874-015-0074-2; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Steward Wayne T, 2013, J Int Assoc Provid AIDS Care, V12, P103, DOI 10.1177/1545109711432315; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Sullivan SG, 2010, AIDS CARE, V22, P104, DOI 10.1080/09540120903012528; Tang YL, 2007, ADDICTION, V102, P1057, DOI 10.1111/j.1360-0443.2007.01849.x; Thi MDA, 2008, AIDS BEHAV, V12, pS63, DOI 10.1007/s10461-008-9374-4; UNAIDS, 2015, 2015 CHIN AIDS RESP; Valdiserri RO, 2002, AM J PUBLIC HEALTH, V92, P341, DOI 10.2105/AJPH.92.3.341; Wang JW, 2010, HEALTH PROMOT INT, V25, P394, DOI 10.1093/heapro/daq039; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; Wong LP, 2011, SE ASIAN J TROP MED, V42, P1119; Wong WCW, 2011, SOCIOL HEALTH ILL, V33, P50, DOI 10.1111/j.1467-9566.2010.01276.x; Wu F, 2015, GLOB PUBLIC HEALTH, V10, P1032, DOI 10.1080/17441692.2014.1003572; Wu LY, 2013, HEALTH PSYCHOL BEHAV, V1, P31, DOI 10.1080/21642850.2013.822798; Yang Y, 2004, BIOMED ENVIRON SCI, V17, P410; Zhang C, 2016, AIDS CARE, V28, P124, DOI 10.1080/09540121.2016.1146206; Zhang YJ, 2015, INT J NURS PRACT, V21, P221, DOI 10.1111/ijn.12254; Zukoski AP, 2009, AIDS PATIENT CARE ST, V23, P267, DOI 10.1089/apc.2008.0168	64	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151078	10.1371/journal.pone.0151078	http://dx.doi.org/10.1371/journal.pone.0151078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26981636	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900061
J	Yu, WQ; Eom, YS; Shin, JA; Nair, D; Grzywacz, SXZ; Grzywacz, NM; Craft, CM; Lee, EJ				Yu, Wan-Qing; Eom, Yun Sung; Shin, Jung-A; Nair, Divya; Grzywacz, Sara X. Z.; Grzywacz, Norberto M.; Craft, Cheryl Mae; Lee, Eun-Jin			Reshaping the Cone-Mosaic in a Rat Model of Retinitis Pigmentosa: Modulatory Role of ZO-1 Expression in DL-Alpha-Aminoadipic Acid Reshaping	PLOS ONE			English	Article							PHOTORECEPTOR DEGENERATION; TIGHT JUNCTION; MULLER CELLS; TARGETED DISRUPTION; ADAPTIVE OPTICS; PROTEINS; REARRANGEMENT; ORGANIZATION; INTEGRATION; ADHESION	In S334ter-line-3 rat model of Retinitis Pigmentosa (RP), rod cell death induces the rearrangement of cones into mosaics of rings while the fibrotic processes of Muller cells remodel to fill the center of the rings. In contrast, previous work established that DL-alpha-aminoadipic-acid (AAA), a compound that transiently blocks Muller cell metabolism, abolishes these highly structured cone rings. Simultaneously, adherens-junction associated protein, Zonula occludens-1 (ZO-1) expression forms in a network between the photoreceptor segments and Muller cells processes. Thus, we hypothesized that AAA treatment alters the cone mosaic rings by disrupting the distal sealing formed by these fibrotic processes, either directly or indirectly, by down regulating the expression of ZO-1. Therefore, we examined these processes and ZO-1 expression at the outer retina after intravitreal injection of AAA and observed that AAA treatment transiently disrupts the distal glial sealing in RP retina, plus induces cones in rings to become more homogeneous. Moreover, ZO-1 expression is actively suppressed after 3 days of AAA treatment, which coincided with cone ring disruption. Similar modifications of glial sealing and cone distribution were observed after injection of siRNA to inhibit ZO-1 expression. These findings support our hypothesis and provide additional information about the critical role played by ZO-1 in glial sealing and shaping the ring mosaic in RP retina. These studies represent important advancements in the understanding of retinal degeneration's etiology and pathophysiology.	[Yu, Wan-Qing; Grzywacz, Norberto M.] Univ So Calif, Neurosci Grad Program, Los Angeles, CA USA; [Grzywacz, Sara X. Z.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Los Angeles, CA USA; [Eom, Yun Sung; Shin, Jung-A; Craft, Cheryl Mae; Lee, Eun-Jin] Univ So Calif, USC Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA USA; [Nair, Divya; Grzywacz, Norberto M.; Lee, Eun-Jin] Univ So Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA; [Craft, Cheryl Mae; Lee, Eun-Jin] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Craft, Cheryl Mae] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Shin, Jung-A] Ewha Womans Univ, Sch Med, Dept Anat, Seoul, South Korea; [Grzywacz, Norberto M.] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Grzywacz, Norberto M.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Yu, Wan-Qing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Ewha Womans University; Georgetown University; Georgetown University; University of Washington; University of Washington Seattle	Lee, EJ (corresponding author), Univ So Calif, USC Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA USA.; Lee, EJ (corresponding author), Univ So Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA.; Lee, EJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA.	eunjinl@usc.edu		Yu, Wan-Qing/0000-0002-9275-391X	VSoE Research Innovation Fund; National Science Foundation [0310723]; National Eye Institute [EY016093, EY11170, EY015851, EY03040]; Research to Prevent Blindness; Mary D. Allen Foundation; NATIONAL EYE INSTITUTE [R01EY011170, R01EY016093, R01EY015851, P30EY003040] Funding Source: NIH RePORTER	VSoE Research Innovation Fund; National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Mary D. Allen Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by a VSoE Research Innovation Fund to EJL, and by National Science Foundation Grant 0310723 and National Eye Institute Grants EY016093 and EY11170 to NMG, EY015851 to CMC, EY03040 (Core, Doheny Eye Institute), Research to Prevent Blindness (USC Ophthalmology) and the Mary D. Allen Foundation (CMC).	Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; BIGNAMI A, 1979, EXP EYE RES, V28, P63; BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; Bringmann A, 2001, FRONT BIOSCI-LANDMRK, V6, pE77, DOI 10.2741/Bringman; Campbell M, 2006, EXP EYE RES, V83, P484, DOI 10.1016/j.exer.2006.01.032; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997; Daniele LL, 2007, J COMP NEUROL, V505, P166, DOI 10.1002/cne.21489; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; EISENFELD AJ, 1984, INVEST OPHTH VIS SCI, V25, P1321; Fredriksson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117074; Garcia-Ayuso D, 2013, INVEST OPHTH VIS SCI, V54, P5888, DOI 10.1167/iovs.13-12643; Hombrebueno JR, 2010, BRAIN RES, V1321, P60, DOI 10.1016/j.brainres.2010.01.051; Jablonski MM, 2000, GLIA, V32, P192, DOI 10.1002/1098-1136(200011)32:2<192::AID-GLIA80>3.0.CO;2-6; Ji Y, 2015, INVEST OPHTH VIS SCI, V56, P352, DOI 10.1167/iovs.14-15398; Ji Y, 2012, J COMP NEUROL, V520, P874, DOI 10.1002/cne.22800; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; KARLSEN RL, 1982, EXP EYE RES, V35, P305; Lee EJ, 2011, GLIA, V59, P1107, DOI 10.1002/glia.21183; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; LEWIS GP, 1989, EXP EYE RES, V49, P93, DOI 10.1016/0014-4835(89)90079-1; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; LINSER PJ, 1981, DEV BRAIN RES, V1, P103, DOI 10.1016/0165-3806(81)90097-3; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; Marc RE, 2003, MOL NEUROBIOL, V28, P139, DOI 10.1385/MN:28:2:139; Milam AH, 1996, INVEST OPHTH VIS SCI, V37, P753; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; PEDERSEN OO, 1979, EXP EYE RES, V28, P569, DOI 10.1016/0014-4835(79)90044-7; Puller C, 2009, J NEUROSCI, V29, P6266, DOI 10.1523/JNEUROSCI.5867-08.2009; Ray A, 2010, CELL TISSUE RES, V339, P481, DOI 10.1007/s00441-009-0916-5; Reichelt W, 1997, NEUROSCIENCE, V77, P1213, DOI 10.1016/S0306-4522(96)00509-X; Rossi EA, 2011, EYE, V25, P301, DOI 10.1038/eye.2010.221; Shin JA, 2015, EXP EYE RES, V140, P41, DOI 10.1016/j.exer.2015.08.005; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Tserentsoodol N, 1998, HISTOCHEM CELL BIOL, V110, P543, DOI 10.1007/s004180050316; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Zhu CL, 2013, CELL TISSUE RES, V351, P29, DOI 10.1007/s00441-012-1522-5; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	44	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151668	10.1371/journal.pone.0151668	http://dx.doi.org/10.1371/journal.pone.0151668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977812	Green Published, gold			2022-12-27	WOS:000372572800097
J	Hubel, N; Ullah, G				Huebel, Niklas; Ullah, Ghanim			Anions Govern Cell Volume: A Case Study of Relative Astrocytic and Neuronal Swelling in Spreading Depolarization	PLOS ONE			English	Article							DEPRESSION SD; HUMAN BRAIN; SEIZURES; MIGRAINE; DYNAMICS; CHANNELS; INJURY; TISSUE; ISCHEMIA; RELEASE	Cell volume changes are ubiquitous in normal and pathological activity of the brain. Nevertheless, we know little about the dynamics of cell and tissue swelling, and the differential changes in the volumes of neurons and glia during pathological states such as spreading depolarizations (SD) under ischemic and non-ischemic conditions, and epileptic seizures. By combining the Hodgkin-Huxley type spiking dynamics, dynamic ion concentrations, and simultaneous neuronal and astroglial volume changes into a comprehensive model, we elucidate why glial cells swell more than neurons in SD and the special case of anoxic depolarization (AD), and explore the relative contributions of the two cell types to tissue swelling. Our results demonstrate that anion channels, particularly Cl-, are intrinsically connected to cell swelling and blocking these currents prevents changes in cell volume. The model is based on a simple and physiologically realistic description. We introduce model extensions that are either derived purely from first physical principles of electroneutrality, osmosis, and conservation of particles, or by a phenomenological combination of these principles and known physiological facts. This work provides insights into numerous studies related to neuronal and glial volume changes in SD that otherwise seem contradictory, and is broadly applicable to swelling in other cell types and conditions.	[Huebel, Niklas; Ullah, Ghanim] Univ S Florida, Dept Phys, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Hubel, N (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	niklas.huebel@gmail.com			College of Arts and Sciences, University of South Florida	College of Arts and Sciences, University of South Florida	This work was funded by a startup grant from College of Arts and Sciences, University of South Florida to G Ullah.	Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Barreto E, 2011, J BIOL PHYS, V37, P361, DOI 10.1007/s10867-010-9212-6; Basarsky TA, 1999, J NEUROSCI, V19, P6439; Brisson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079589; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; Chang JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070469; Cressman JR, 2011, J COMPUT NEUROSCI, V30, P781, DOI 10.1007/s10827-011-0333-0; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; CZEH G, 1993, BRAIN RES, V632, P195, DOI 10.1016/0006-8993(93)91154-K; Dahlem MA, 2014, PEERJ, V2, DOI 10.7717/peerj.379; Dahlem MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005007; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2013, NEUROSCIENTIST, V19, P25, DOI 10.1177/1073858412453340; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Endresen LP, 2000, EUR BIOPHYS J BIOPHY, V29, P90, DOI 10.1007/s002490050254; Ermentrout B., 2002, SIMULATING ANAL ANIM, DOI DOI 10.1137/1.9780898718195; Ermentrout B, 2012, XPPAUT 7 0; Gutkin BS, 2001, J COMPUT NEUROSCI, V11, P121, DOI 10.1023/A:1012837415096; HAGLUND MM, 1990, J NEUROPHYSIOL, V63, P225, DOI 10.1152/jn.1990.63.2.225; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hubel N, 2015, LARGE EXTRA IN PRESS; Hubel N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003941; Hubel N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003551; Ingram J, 2014, J NEUROPHYSIOL, V112, P205, DOI 10.1152/jn.00540.2013; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; JAKOBSSON E, 1980, AM J PHYSIOL, V238, pC196, DOI 10.1152/ajpcell.1980.238.5.C196; JING J, 1994, J NEUROPHYSIOL, V71, P2548, DOI 10.1152/jn.1994.71.6.2548; Kager H, 2007, J COMPUT NEUROSCI, V22, P105, DOI 10.1007/s10827-006-0001-y; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kimelberg HK, 2000, NEUROSCIENTIST, V6, P14, DOI 10.1177/107385840000600110; Kofuji Paulo, 2009, P151, DOI 10.1007/978-0-387-79492-1_6; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Lascola CD, 1998, J NEUROSCI, V18, P1679; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lee J, 2010, NEUROIMAGE, V51, P713, DOI 10.1016/j.neuroimage.2010.02.076; Mazel T, 1998, NEUROREPORT, V9, P1299; MCBAIN CJ, 1990, SCIENCE, V249, P674, DOI 10.1126/science.2382142; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Ostby I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000272; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rogawski M. A., 2012, JASPERS BASIC MECH E; Rogawski MA, 2010, EPILEPSIA, V51, P80, DOI 10.1111/j.1528-1167.2010.02866.x; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shandilya SG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013004; Shapiro BE, 2001, J COMPUT NEUROSCI, V10, P99, DOI 10.1023/A:1008924227961; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Ullah G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004414; Volman V, 2012, FRONT COMPUT NEUROSC, V6, P1; WALZ W, 1985, BRAIN RES, V343, P44, DOI 10.1016/0006-8993(85)91156-4; WALZ W, 1991, ANN NY ACAD SCI, V633, P589; Walz W, 2002, GLIA, V40, P1, DOI 10.1002/glia.10125; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Wei YN, 2014, J NEUROPHYSIOL, V112, P213, DOI 10.1152/jn.00541.2013; Witthoft A, 2013, BIOPHYS J, V105, P2046, DOI 10.1016/j.bpj.2013.09.012; Yao CG, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061129; Zandt BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022127; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	72	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0147060	10.1371/journal.pone.0147060	http://dx.doi.org/10.1371/journal.pone.0147060			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974767	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600006
J	Kotzybik, K; Graf, V; Kugler, L; Stoll, DA; Greiner, R; Geisen, R; Schmidt-Heydt, M				Kotzybik, Kathrin; Graef, Volker; Kugler, Lena; Stoll, Dominic A.; Greiner, Ralf; Geisen, Rolf; Schmidt-Heydt, Markus			Influence of Different Nanomaterials on Growth and Mycotoxin Production of Penicillium verrucosum	PLOS ONE			English	Article							OXIDATIVE STRESS; SILVER NANOPARTICLES; WATER ACTIVITY; CANDIDA-ALBICANS; IN-VITRO; BIOSYNTHESIS; TEMPERATURE; OCHRATOXIN; FUNGI; ACQUISITION	Nanoparticles are ubiquitous in the environment. They originate from anthropogenic or natural sources or they are intentionally produced for different purposes. There exist manifold applications of nanoparticles in modern life leading unavoidably to a confrontation and interaction between nanomaterial and living organisms. Based on their wide distribution tending to increase steadily, the influence of particles based on silica and silver, exhibiting nominal sizes between 0.65 nm and 200 nm, on the physiology of the mycotoxigenic filamentous fungus Penicillium verrucosum was analyzed. The applied concentration and time-point, the size and the chemical composition of the particles was shown to have a strong influence on growth and mycotoxin biosynthesis. On microscopic scale it could be shown that silver nanoparticles attach to the mycelial surface. Moreover, silver nanoparticles with 0.65 nm and 5 nm in size were shown to internalize within the cell, form agglomerates in the cytoplasm and associate to cell organelles.	[Kotzybik, Kathrin; Kugler, Lena; Stoll, Dominic A.; Geisen, Rolf; Schmidt-Heydt, Markus] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Safety & Qual Fruits & Vegetables, Karlsruhe, Germany; [Graef, Volker; Greiner, Ralf] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Food Technol & Bioproc Engn, Karlsruhe, Germany		Schmidt-Heydt, M (corresponding author), Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Safety & Qual Fruits & Vegetables, Karlsruhe, Germany.	Markus.Schmidt-Heydt@mri.bund.de	Schmidt-Heydt, Markus/AAC-3278-2022	Schmidt-Heydt, Markus/0000-0003-2844-9873; Stoll, Dominic/0000-0003-2982-6458				Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; [Anonymous], 800041 ISOTS; Astoreca AL, 2010, WORLD MYCOTOXIN J, V3, P175, DOI 10.3920/WMJ2009.1164; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bundschuh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048956; Cox PW, 1998, MICROBIOL-SGM, V144, P817, DOI 10.1099/00221287-144-4-817; Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6; FAO, 2001, FAO FOOD NUTR PAP, P73; Feng YZ, 2013, ENVIRON SCI TECHNOL, V47, P9496, DOI 10.1021/es402109n; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; Gaikwad S, 2013, INT J NANOMED, V8, P4303, DOI 10.2147/IJN.S50070; Gibbs PA, 2000, CRIT REV BIOTECHNOL, V20, P17, DOI 10.1080/07388550091144177; Gonzalez-Parraga P, 2003, YEAST, V20, P1161, DOI 10.1002/yea.1029; Hassan A. A., 2013, STUDIES CHEM PROCESS, V1, P66; Heider EM, 2006, TETRAHEDRON, V62, P1199, DOI 10.1016/j.tet.2005.10.066; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Kim SW, 2009, J MICROBIOL BIOTECHN, V19, P760, DOI 10.4014/jmb.0812.649; Lamsal Kabir, 2011, Mycobiology, V39, P194, DOI 10.5941/MYCO.2011.39.3.194; Magan N, 2011, PLANT PATHOL, V60, P150, DOI 10.1111/j.1365-3059.2010.02412.x; Mittal A, 2015, NANOMED-NANOTECHNOL, V11, P147, DOI 10.1016/j.nano.2014.08.009; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Pardo E, 2005, J SCI FOOD AGR, V85, P1681, DOI 10.1002/jsfa.2171; Paul G C, 1998, Adv Biochem Eng Biotechnol, V60, P1; Ponts N, 2006, FEMS MICROBIOL LETT, V258, P102, DOI 10.1111/j.1574-6968.2006.00200.x; Ren HX, 2011, J BIOMED NANOTECHNOL, V7, P677, DOI 10.1166/jbn.2011.1338; Romero SM, 2007, INT J FOOD MICROBIOL, V115, P140, DOI 10.1016/j.ijfoodmicro.2006.10.014; Schmidt-Heydt M, 2008, FEMS MICROBIOL LETT, V284, P142, DOI 10.1111/j.1574-6968.2008.01182.x; Schmidt-Heydt M, 2015, INT J FOOD MICROBIOL, V192, P1, DOI 10.1016/j.ijfoodmicro.2014.09.008; Schmidt-Heydt M, 2012, FOOD MICROBIOL, V29, P233, DOI 10.1016/j.fm.2011.08.003; Simonelli F, 2015, J PHYS CHEM LETT, V6, P3175, DOI 10.1021/acs.jpclett.5b01469; Stoll DA, 2014, INT J FOOD MICROBIOL, V175, P20, DOI 10.1016/j.ijfoodmicro.2014.01.010; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Van de Perre E, 2015, FOOD RES INT, V68, P41, DOI 10.1016/j.foodres.2014.10.014; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zhang SL, 2015, ACS NANO, V9, P8655, DOI 10.1021/acsnano.5b03184	38	18	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150855	10.1371/journal.pone.0150855	http://dx.doi.org/10.1371/journal.pone.0150855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974550	Green Published, gold			2022-12-27	WOS:000372570600035
J	van den Boom, J; Trusch, F; Hoppstock, L; Beuck, C; Bayer, P				van den Boom, Johannes; Trusch, Franziska; Hoppstock, Lukas; Beuck, Christine; Bayer, Peter			Structural Characterization of the Loop at the Alpha-Subunit C-Terminus of the Mixed Lineage Leukemia Protein Activating Protease Taspase1	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; CHEMICAL-SHIFTS; FORCE-FIELD; MLL; ASPARTYLGLUCOSAMINIDASE; MECHANISM; SUBSTRATE; N-15	Type 2 asparaginases, a subfamily of N- terminal nucleophile (Ntn) hydrolases, are activated by limited proteolysis. This activation yields a heterodimer and a loop region at the Cterminus of the alpha-subunit is released. Since this region is unresolved in all type 2 asparaginase crystal structures but is close to the active site residues, we explored this loop region in six members of the type 2 asparaginase family using homology modeling. As the loop model for the childhood cancer-relevant protease Taspase1 differed from the other members, Taspase1 activation as well as the conformation and dynamics of the 56 amino acids loop were investigated by CD and NMR spectroscopy. We propose a helix-turn-helix motif, which can be exploited as novel anticancer target to inhibit Taspase1 proteolytic activity.	[van den Boom, Johannes; Hoppstock, Lukas; Beuck, Christine; Bayer, Peter] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Dept Struct & Med Biochem, Essen, Germany; [Trusch, Franziska] Univ Aberdeen, Inst Med Sci, Aberdeen Oomycetes Lab, Aberdeen, Scotland	University of Duisburg Essen; University of Aberdeen	Bayer, P (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Dept Struct & Med Biochem, Essen, Germany.	peter.bayer@uni-due.de	Bayer, Peter/B-8803-2009; Beuck, Christine/E-1242-2015	Bayer, Peter/0000-0003-0435-7202; Beuck, Christine/0000-0001-7513-7384	Fonds of Chemical Industry, Chemiefonds grant; DFG [CRC 1093]	Fonds of Chemical Industry, Chemiefonds grant; DFG(German Research Foundation (DFG))	The authors acknowledge the Fonds of Chemical Industry for funding JvdB by their Chemiefonds grant and the DFG for funding PB and CB (CRC 1093).	Bier C, 2011, TRAFFIC, V12, P703, DOI 10.1111/j.1600-0854.2011.01191.x; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Bush LA, 2002, MOL REPROD DEV, V62, P233, DOI 10.1002/mrd.10092; Chen DY, 2012, CANCER RES, V72, P736, DOI 10.1158/0008-5472.CAN-11-2584; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dong Y. M., 2014, ACTA CHROMATOGR, V1, P1, DOI DOI 10.1007/S13277-014-2631-4; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Grum D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065346; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Harris RK, 2008, MAGN RESON CHEM, V46, P582, DOI 10.1002/mrc.2225; Hayouka Z, 2010, BIOCHEM BIOPH RES CO, V394, P260, DOI 10.1016/j.bbrc.2010.02.100; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018253; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Levin A, 2011, BBA-MOL CELL RES, V1813, P1646, DOI 10.1016/j.bbamcr.2010.07.010; Michalska K, 2008, J BIOL CHEM, V283, P13388, DOI 10.1074/jbc.M800746200; NERI D, 1992, P NATL ACAD SCI USA, V89, P4397, DOI 10.1073/pnas.89.10.4397; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nomme J, 2012, BIOCHEMISTRY-US, V51, P6816, DOI 10.1021/bi300870g; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Qi GF, 2005, J IMMUNOL METHODS, V299, P9, DOI 10.1016/j.jim.2004.11.018; Saarela J, 1998, J BIOL CHEM, V273, P25320, DOI 10.1074/jbc.273.39.25320; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; Stauber RH, 2016, FASEB J, V30, P1012, DOI 10.1096/fj.15-270611; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vranken WF, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-20; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wunsch D, 2016, ONCOGENE, V35, P3351, DOI 10.1038/onc.2015.436; Xuan JC, 1998, PROTEIN SCI, V7, P774, DOI 10.1002/pro.5560070327; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	40	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151431	10.1371/journal.pone.0151431	http://dx.doi.org/10.1371/journal.pone.0151431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974973	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600078
J	Wang, SL; Yu, LJ; Yang, H; Li, CS; Hui, Z; Xu, Y; Zhu, XL				Wang, Sulei; Yu, Linjie; Yang, Hui; Li, Chaosheng; Hui, Zhen; Xu, Yun; Zhu, Xiaolei			Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an A beta(1-42)-Induced Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA OLIGOMER; AMYLOID-BETA; OXIDATIVE STRESS; BDNF; PLASTICITY; BRAIN; SYNAPTOSOMES; IMPAIRMENT; CORTEX; MICE	Synaptic loss induced by beta-amyloid (A beta) plays a critical role in the pathophysiology of Alzheimer's disease (AD), but the mechanisms underlying this process remain unknown. In this study, we found that oridonin (Ori) rescued synaptic loss induced by A beta(1-42) in vivo and in vitro and attenuated the alterations in dendritic structure and spine density observed in the hippocampus of AD mice. In addition, Ori increased the expression of PSD-95 and synaptophysin and promoted mitochondrial activity in the synaptosomes of AD mice. Ori also activated the BDNF/TrkB/CREB signaling pathway in the hippocampus of AD mice. Furthermore, in the Morris water maze test, Ori reduced latency and searching distance and increased the number of platform crosses in AD mice. These data suggest that Ori might prevent synaptic loss and improve behavioral symptoms in A beta(1-42)-induced AD mice.	[Wang, Sulei; Yang, Hui; Li, Chaosheng; Hui, Zhen; Xu, Yun] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Yu, Linjie; Xu, Yun; Zhu, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Yun] Jiangsu Stroke Res Collaborat Grp, Nanjing, Jiangsu, Peoples R China; [Xu, Yun] Jiangsu Prov Stroke Ctr Diag & Therapy, Nanjing, Jiangsu, Peoples R China; [Xu, Yun] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University; Nanjing University	Xu, Y (corresponding author), Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China.; Xu, Y; Zhu, XL (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China.; Xu, Y (corresponding author), Jiangsu Stroke Res Collaborat Grp, Nanjing, Jiangsu, Peoples R China.; Xu, Y (corresponding author), Jiangsu Prov Stroke Ctr Diag & Therapy, Nanjing, Jiangsu, Peoples R China.; Xu, Y (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; zhuquelee@126.com			National Nature Science Foundation of China [81200839, 81230026, 81171085]; Nanjing Medical Technology Development Project [YKK13086]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical Technology Development Project	This work was supported by National Nature Science Foundation of China (No. 81200839, No. 81230026, and No. 81171085) and Nanjing Medical Technology Development Project (No. YKK13086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Bayrakdar ET, 2014, CELL BIOCHEM FUNCT, V32, P557, DOI 10.1002/cbf.3049; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Chen K, 2007, MOL CELL NEUROSCI, V36, P108, DOI 10.1016/j.mcn.2007.06.004; Chen YT, 2012, CLIN EXP PHARMACOL P, V39, P751, DOI 10.1111/j.1440-1681.2012.05729.x; Ciaramella A, 2013, BRAIN BEHAV IMMUN, V32, P29, DOI 10.1016/j.bbi.2013.04.001; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Evans Gareth J O, 2015, Cold Spring Harb Protoc, V2015, P421, DOI 10.1101/pdb.top074450; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Francis BM, 2012, NEUROBIOL AGING, V33, P555, DOI 10.1016/j.neurobiolaging.2010.04.003; Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Jin JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10224; Kim BK, 2014, J EXERC REHABIL, V10, P2, DOI 10.12965/jer.140086; Kim J, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00044; Kirkwood CM, 2013, J NEUROPATH EXP NEUR, V72, P791, DOI 10.1097/NEN.0b013e31829ecc89; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Liu X, 2015, J ALZHEIMERS DIS, V44, P251, DOI 10.3233/JAD-141062; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; MASLIAH E, 1991, AM J PATHOL, V138, P235; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Middei S, 2013, HIPPOCAMPUS, V23, P488, DOI 10.1002/hipo.22108; Mo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116802; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Postupna NO, 2014, LAB INVEST, V94, P1161, DOI 10.1038/labinvest.2014.103; Pozueta J, 2013, NEUROSCIENCE, V251, P51, DOI 10.1016/j.neuroscience.2012.05.050; Price KA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-41; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Rodriguez-Tornos FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053848; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shao CY, 2011, ACTA NEUROPATHOL, V122, P285, DOI 10.1007/s00401-011-0843-x; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Sokolow S, 2015, J NEUROCHEM, V133, P368, DOI 10.1111/jnc.12991; Sokolow S, 2012, CYTOM PART A, V81A, P248, DOI 10.1002/cyto.a.22009; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Wang SB, 2014, CANC CELL RES, V1, P1, DOI DOI 10.1093/EJCTS/EZU215; Wei L, 2015, FITOTERAPIA, V101, P208, DOI 10.1016/j.fitote.2015.01.017; Wilcox KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125263; Xu SJ, 2014, J ALZHEIMERS DIS, V39, P239, DOI 10.3233/JAD-130680; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yu LJ, 2015, LIFE SCI, V121, P104, DOI 10.1016/j.lfs.2014.11.021; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130; Zeng YQ, 2015, J NEUROCHEM, V133, P38, DOI 10.1111/jnc.13056; Zhang F, 2012, J CLIN NEUROSCI, V19, P946, DOI 10.1016/j.jocn.2011.12.022; Zhao H, 2013, CNS NEUROSCI THER, V19, P117, DOI 10.1111/cns.12043; Zhu XL, 2014, INT J NEUROPSYCHOPH, V17, P1511, DOI 10.1017/S1461145714000315; Zhu XL, 2013, AGING CELL, V12, P85, DOI 10.1111/acel.12022	54	38	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151397	10.1371/journal.pone.0151397	http://dx.doi.org/10.1371/journal.pone.0151397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974541	Green Published, gold			2022-12-27	WOS:000372570600075
J	Beaumont, E; Roch, E; Chopin, L; Roingeard, P				Beaumont, Elodie; Roch, Emmanuelle; Chopin, Lucie; Roingeard, Philippe			Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties	PLOS ONE			English	Article							CELL-CULTURE SYSTEMS; GLYCOPROTEIN COMPLEX; VACCINE; CLEARANCE; INFECTION; CHIMPANZEES; RESPONSES; LOCALIZATION; TOLERABILITY; IMMUNIZATION	Various strategies involving the use of hepatitis C virus (HCV) E1 and E2 envelope glycoproteins as immunogens have been developed for prophylactic vaccination against HCV. However, the ideal mode of processing and presenting these immunogens for effective vaccination has yet to be determined. We used our recently described vaccine candidate based on full-length HCV E1 or E2 glycoproteins fused to the heterologous hepatitis B virus S envelope protein to compare the use of the E1 and E2 proteins as separate immunogens with their use as the E1E2 heterodimer, in terms of immunogenetic potential and the capacity to induce neutralizing antibodies. The specific anti-E1 and anti-E2 antibody responses induced in animals immunized with vaccine particles harboring the heterodimer were profoundly impaired with respect to those in animals immunized with particles harboring E1 and E2 separately. Moreover, the anti-E1 and anti-E2 antibodies had additive neutralizing properties that increase the cross-neutralization of heterologous strains of various HCV genotypes, highlighting the importance of including both E1 and E2 in the vaccine for an effective vaccination strategy. Our study has important implications for the optimization of HCV vaccination strategies based on HCV envelope proteins, regardless of the platform used to present these proteins to the immune system.	[Roingeard, Philippe] Univ Tours, INSERM U966, Tours, France; CHRU Tours, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Roingeard, P (corresponding author), Univ Tours, INSERM U966, Tours, France.	roingeard@med.univ-tours.fr			Agence Nationale pour la Recherche (ANR, France) [ANR-11-EMMA-026]; Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS, France) [2014-1]; Ligue contre le Cancer (Comites de l'Indre et Loire, du Maine et Loire, de la Sarthe, France); Academie Nationale de Medecine, France	Agence Nationale pour la Recherche (ANR, France)(French National Research Agency (ANR)); Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS, France)(French National Research Agency (ANR)); Ligue contre le Cancer (Comites de l'Indre et Loire, du Maine et Loire, de la Sarthe, France); Academie Nationale de Medecine, France	This study was supported by the "Hepatibivax" grant from the "Emergence" program of the Agence Nationale pour la Recherche (ANR, France, grant ANR-11-EMMA-026), the Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS, France, grant 2014-1), the Ligue contre le Cancer (Comites de l'Indre et Loire, du Maine et Loire, de la Sarthe, France), and the Academie Nationale de Medecine, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2014, LIVER INT, V34, P60, DOI 10.1111/liv.12424; Ball JK, 2014, ANTIVIR RES, V105, P100, DOI 10.1016/j.antiviral.2014.02.013; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Baumert TF, 2014, J HEPATOL, V61, pS34, DOI 10.1016/j.jhep.2014.09.009; Beaumont E, 2015, VACCINE, V33, P973, DOI 10.1016/j.vaccine.2015.01.007; Beaumont E, 2013, HEPATOLOGY, V57, P1303, DOI 10.1002/hep.26132; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Dahari H, 2010, GASTROENTEROLOGY, V139, P965, DOI 10.1053/j.gastro.2010.05.077; Duvet S, 1998, J BIOL CHEM, V273, P32088, DOI 10.1074/jbc.273.48.32088; Edwards VC, 2012, J GEN VIROL, V93, P1, DOI 10.1099/vir.0.035956-0; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Garrone P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002330; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hagan LM, 2013, TRENDS MICROBIOL, V21, P625, DOI 10.1016/j.tim.2013.09.008; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2004, J VIROL, V78, P7257, DOI 10.1128/JVI.78.13.7257-7263.2004; Leroux-Roels G, 2004, VACCINE, V22, P3080, DOI 10.1016/j.vaccine.2004.02.002; Leroux-Roels G, 2005, HUM VACCINES, V1, P61, DOI 10.4161/hv.1.2.1554; LerouxRoels G, 1996, HEPATOLOGY, V23, P8, DOI 10.1002/hep.510230102; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Meunier JC, 2011, J INFECT DIS, V204, P1186, DOI 10.1093/infdis/jir511; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Netter HJ, 2001, J VIROL, V75, P2130, DOI 10.1128/JVI.75.5.2130-2141.2001; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Pape GR, 1999, J VIRAL HEPATITIS, V6, P36, DOI 10.1046/j.1365-2893.1999.00006.x; Patient R, 2009, NEW BIOTECHNOL, V25, P226, DOI 10.1016/j.nbt.2009.01.001; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Raghuraman S, 2012, J INFECT DIS, V205, P763, DOI 10.1093/infdis/jir835; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Reyes-del Valle J, 2012, J VIROL, V86, P11558, DOI 10.1128/JVI.01776-12; Ruwona TB, 2014, J VIROL, V88, P10459, DOI 10.1128/JVI.01584-14; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Sominskaya I, 2006, MOL IMMUNOL, V43, P1941, DOI 10.1016/j.molimm.2005.11.018; SPAETE RR, 1992, VIROLOGY, V188, P819, DOI 10.1016/0042-6822(92)90537-Y; Stamataki Z, 2007, VACCINE, V25, P7773, DOI 10.1016/j.vaccine.2007.08.053; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Verstrepen BE, 2011, J INFECT DIS, V204, P837, DOI 10.1093/infdis/jir423; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Ward John W, 2013, Top Antivir Med, V21, P15	48	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151626	10.1371/journal.pone.0151626	http://dx.doi.org/10.1371/journal.pone.0151626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966906	gold, Green Published, Green Submitted			2022-12-27	WOS:000371989200066
J	Frerichs, W; Hahlweg, P; Muller, E; Adis, C; Scholl, I				Frerichs, Wiebke; Hahlweg, Pola; Mueller, Evamaria; Adis, Christine; Scholl, Isabelle			Shared Decision-Making in Oncology - A Qualitative Analysis of Healthcare Providers' Views on Current Practice	PLOS ONE			English	Article							PATIENT PARTICIPATION; PATIENTS PREFERENCES; INVOLVEMENT; CANCER; BARRIERS; FACILITATORS; IMPLEMENTATION; PHYSICIANS; KNOWLEDGE; TYPOLOGY	Background Despite an increased awareness of shared decision-making (SDM) and its prominent position on the health policy agenda, its implementation in routine care remains a challenge in Germany. In order to overcome this challenge, it is important to understand healthcare providers' views regarding SDM and to take their perspectives and opinions into account in the development of an implementation program. The present study aimed at exploring a) the attitudes of different healthcare providers regarding SDM in oncology and b) their experiences with treatment decisions in daily practice. Material and Methods A qualitative study was conducted using focus groups and individual interviews with different healthcare providers at the University Cancer Center Hamburg, Germany. Focus groups and interviews were audio-recorded, transcribed and analyzed using conventional content analysis and descriptive statistics. Results N = 4 focus groups with a total of N = 25 participants and N = 17 individual interviews were conducted. Attitudes regarding SDM varied greatly between the different participants, especially concerning the definition of SDM, the attitude towards the degree of patient involvement in decision-making and assumptions about when SDM should take place. Experiences on how treatment decisions are currently made varied. Negative experiences included time and structural constraints, and a lack of (multidisciplinary) communication. Positive experiences comprised informed patients, involvement of relatives and a good physician-patient relationship. Conclusion The results show that German healthcare providers in oncology have a range of attitudes that currently function as barriers towards the implementation of SDM. Also, their experiences on how decision-making is currently done reveal difficulties in actively involving patients in decision-making processes. It will be crucial to take these attitudes and experiences seriously and to subsequently disentangle existing misconceptions in future implementation programs.	[Frerichs, Wiebke; Hahlweg, Pola; Mueller, Evamaria; Scholl, Isabelle] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Adis, Christine] Hamburg Univ Appl Sci, Dept Hlth Sci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hochschule Angewandte Wissenschaft Hamburg	Scholl, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	i.scholl@uke.de	Scholl, Isabelle/AAN-9450-2020; Frerichs, Wiebke/AAA-5857-2022; Hahlweg, Pola/AAQ-2945-2020	Scholl, Isabelle/0000-0002-7639-0880; Hahlweg, Pola/0000-0002-8768-8594	German Research Foundation (Deutsche Forschungsgemeinschaft) [SCHO 155/1-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft), grant number: SCHO 155/1-1, www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barr PJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3085; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bergelt C., 2005, BEST PRACT ONKOL, V5, P49, DOI [10.1007/BF03359893, DOI 10.1007/BF03359893]; Berger S, 2012, PATIENT EDUC COUNS, V88, P129, DOI 10.1016/j.pec.2012.01.003; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Clark Noreen M, 2009, Open Nurs J, V3, P65, DOI 10.2174/1874434600903010065; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dresing T., 2013, PRAXISBUCH INTERVIEW, V5; Edwards A, 2006, HEALTH EXPECT, V9, P307, DOI 10.1111/j.1369-7625.2006.00401.x; Elkin EB, 2007, J CLIN ONCOL, V25, P5275, DOI 10.1200/JCO.2007.11.1922; Elwyn G, 2012, PART ROUTINE CASE ST, P23; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Elwyn G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-57; Entwistle VA, 2004, PATIENT EDUC COUNS, V55, P105, DOI 10.1016/j.pec.2003.08.005; Entwistle VA, 2001, SOC SCI MED, V53, P721, DOI 10.1016/S0277-9536(00)00382-8; Entwistle VA, 2006, PATIENT EDUC COUNS, V63, P268, DOI 10.1016/j.pec.2006.05.002; Ernst J, 2013, EUR J CANCER CARE, V22, P684, DOI 10.1111/ecc.12077; Ernst J, 2011, PSYCHO-ONCOLOGY, V20, P186, DOI 10.1002/pon.1723; Flynn KE, 2006, SOC SCI MED, V63, P1158, DOI 10.1016/j.socscimed.2006.03.030; Goss Claudia, 2007, Z Arztl Fortbild Qualitatssich, V101, P236, DOI 10.1016/j.zgesun.2007.02.041; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Hack TF, 2006, PSYCHO-ONCOL, V15, P9, DOI 10.1002/pon.907; Harter M, 2011, Z EVIDENZ FORTBILD Q, V105, P263, DOI 10.1016/j.zefq.2011.04.002; Harter Martin, 2004, Z Arztl Fortbild Qualitatssich, V98, P89; Hoffmann TC, 2014, MED J AUSTRALIA, V201, P35, DOI 10.5694/mja14.00002; Hofstede SN, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-95; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hurtado M.P., 2001, ENVISIONING NATL HLT; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Janus K, 2008, J HEALTH POLIT POLIC, V33, P1133, DOI 10.1215/03616878-2008-035; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Kane HL, 2014, CA-CANCER J CLIN, V64, P377, DOI 10.3322/caac.21245; Karnieli-Miller O, 2009, SOC SCI MED, V69, P1, DOI 10.1016/j.socscimed.2009.04.030; Kehl KL, 2015, JAMA ONCOL, V1, P50, DOI 10.1001/jamaoncol.2014.112; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kunneman M, 2014, BRIT J CANCER, V111, P674, DOI 10.1038/bjc.2014.322; Legare F, 2014, PATIENT EDUC COUNS, V96, P281, DOI 10.1016/j.pec.2014.06.014; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Legare F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub2; Legare F, 2011, PRENATAL DIAG, V31, P319, DOI 10.1002/pd.2624; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Longtin Y, 2010, MAYO CLIN PROC, V85, P53, DOI 10.4065/mcp.2009.0248; Medicine Io, 2013, DELIVERING HIGH QUAL; Pak R, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1220; Scheibler F, 2003, SOZ PRAVENTIV MED, V48, P11, DOI 10.1007/s000380300002; Scholl I, 2014, PATIENT PREFER ADHER, V8, P1153, DOI 10.2147/PPA.S64051; Shepherd HL, 2007, BRIT J CANCER, V97, P6, DOI 10.1038/sj.bjc.6603841; Stalmeier PFM, 2007, J CLIN ONCOL, V25, P3096, DOI 10.1200/JCO.2006.07.4955; Tesch R., 1990, QUALITATIVE RES ANAL; Thompson AGH, 2007, SOC SCI MED, V64, P1297, DOI 10.1016/j.socscimed.2006.11.002; Trump Benjamin D, 2015, Evid Based Med, V20, P193, DOI 10.1136/ebmed-2015-110274; Whitney SN, 2008, MED DECIS MAKING, V28, P699, DOI 10.1177/0272989X08318465; Wright K B, 1997, Gastroenterol Nurs, V20, P74, DOI 10.1097/00001610-199705000-00002	57	19	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149789	10.1371/journal.pone.0149789	http://dx.doi.org/10.1371/journal.pone.0149789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967325	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200005
J	Deuchler, S; Wagner, C; Singh, P; Muller, M; Al-Dwairi, R; Benjilali, R; Schill, M; Ackermann, H; Bon, D; Kohnen, T; Schoene, B; Koss, M; Koch, F				Deuchler, Svenja; Wagner, Clemens; Singh, Pankaj; Mueller, Michael; Al-Dwairi, Rami; Benjilali, Rachid; Schill, Markus; Ackermann, Hanns; Bon, Dimitra; Kohnen, Thomas; Schoene, Benjamin; Koss, Michael; Koch, Frank			Clinical Efficacy of Simulated Vitreoretinal Surgery to Prepare Surgeons for the Upcoming Intervention in the Operating Room	PLOS ONE			English	Article							VIRTUAL-REALITY; SURGICAL SIMULATOR; CONSTRUCT-VALIDITY; CAPSULORHEXIS; PERFORMANCE; CURRICULUM; PROGRAM	Purpose To evaluate the efficacy of the virtual reality training simulator Eyesi to prepare surgeons for performing pars plana vitrectomies and its potential to predict the surgeons' performance. Methods In a preparation phase, four participating vitreoretinal surgeons performed repeated simulator training with predefined tasks. If a surgeon was assigned to perform a vitrectomy for the management of complex retinal detachment after a surgical break of at least 60 hours it was randomly decided whether a warmup training on the simulator was required (n = 9) or not (n = 12). Performance at the simulator was measured using the built-in scoring metrics. The surgical performance was determined by two blinded observers who analyzed the videorecorded interventions. One of them repeated the analysis to check for intra-observer consistency. The surgical performance of the interventions with and without simulator training was compared. In addition, for the surgeries with simulator training, the simulator performance was compared to the performance in the operating room. Results Comparing each surgeon's performance with and without warmup trainingshowed a significant effect of warmup training onto the final outcome in the operating room. For the surgeries that were preceeded by the warmup procedure, the performance at the simulator was compared with the operating room performance. We found that there is a significant relation. The governing factor of low scores in the simulator were iatrogenic retinal holes, bleedings and lens damage. Surgeons who caused minor damage in the simulation also performed well in the operating room. Conclusions Despite the large variation of conditions, the effect of a warmup training as well as a relation between the performance at the simulator and in the operating room was found with statistical significance. Simulator training is able to serve as a warmup to increase the average performance.	[Deuchler, Svenja; Singh, Pankaj; Mueller, Michael; Al-Dwairi, Rami; Benjilali, Rachid; Koss, Michael; Koch, Frank] Univ Eye Hosp, Vitreoretinal Unit, Frankfurt, Hessen, Germany; [Wagner, Clemens; Schoene, Benjamin] VRmagic, Mannheim, Baden Wurttembe, Germany; [Ackermann, Hanns; Bon, Dimitra] Univ Hosp, Inst Biostat & Math Modelling, Frankfurt, Hessen, Germany; [Kohnen, Thomas] Univ Eye Hosp, Frankfurt, Hessen, Germany; [Al-Dwairi, Rami] King Abdullah Univ Hosp, Irbid, Jordan; [Koss, Michael] Univ Eye Hosp, Heidelberg, Baden Wurttembe, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Jordan University of Science & Technology; King Abdullah University Hospital; Ruprecht Karls University Heidelberg	Deuchler, S (corresponding author), Univ Eye Hosp, Vitreoretinal Unit, Frankfurt, Hessen, Germany.	s.deuchler@icloud.com	Kohnen, Thomas/AAA-2172-2020	Kohnen, Thomas/0000-0002-6933-9585; Deuchler, Svenja/0000-0002-2758-4910	Adolf Messer Stiftung; Gemeinnutzige Hertie-Stiftung; Hessisches Ministerium fur Wissenschaft und Kunst	Adolf Messer Stiftung; Gemeinnutzige Hertie-Stiftung; Hessisches Ministerium fur Wissenschaft und Kunst	This work was supported by Adolf Messer Stiftung, http://www.adolf-messer-stiftung.de/, to FK; Gemeinnutzige Hertie-Stiftung, http://www.ghst.de/, to FK; and Hessisches Ministerium fur Wissenschaft und Kunst, http://www.lehrpreis-hessen.de/, to FK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No grant numbers are available. VRmagic provided support in the form of salaries for authors [Markus Schill, Clemens Wagner, and Benjamin Schoene], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ACKERMANN H, 1991, COMPUT STAT DATA AN, V11, P223, DOI 10.1016/0167-9473(91)90073-B; Baxter JM, 2013, EYE, V27, P742, DOI 10.1038/eye.2013.54; Belyea DA, 2011, J CATARACT REFR SURG, V37, P1756, DOI 10.1016/j.jcrs.2011.04.032; Bergqvist J, 2014, ACTA OPHTHALMOL, V92, P629, DOI 10.1111/aos.12383; Cremers SL, 2005, OPHTHALMOLOGY, V112, P1655, DOI 10.1016/j.ophtha.2005.05.010; Deuchler SK, ARVO 2011 ANN M FORT; Ericsson KA, 2014, ACAD MED, V89, P17, DOI 10.1097/ACM.0000000000000049; Erie EA, 2011, CAN J OPHTHALMOL, V46, P61, DOI 10.3129/i10-112; Feudner EM, 2009, GRAEF ARCH CLIN EXP, V247, P955, DOI 10.1007/s00417-008-1029-7; Gill HS, 2009, OPEN MED, V3, P3; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Jonas JB, 2003, ACTA OPHTHALMOL SCAN, V81, P600, DOI 10.1046/j.1395-3907.2003.0078.x; Khalifa YM, 2006, SURV OPHTHALMOL, V51, P259, DOI 10.1016/j.survophthal.2006.02.005; Le TDB, 2011, CAN J OPHTHALMOL, V46, P56, DOI 10.3129/i10-051; Lillie EO, 2011, PERS MED, V8, P161, DOI 10.2217/PME.11.7; Mahr MA, 2008, J CATARACT REFR SURG, V34, P980, DOI 10.1016/j.jcrs.2008.02.015; McCannel CA, 2013, OPHTHALMOLOGY, V120, P2456, DOI 10.1016/j.ophtha.2013.05.003; Pointdujour R, 2011, OPHTHALMOLOGY, V118, P1893, DOI 10.1016/j.ophtha.2011.04.019; Privett B, 2010, J CATARACT REFR SURG, V36, P1835, DOI 10.1016/j.jcrs.2010.05.020; Rogers GM, 2009, J CATARACT REFR SURG, V35, P1956, DOI 10.1016/j.jcrs.2009.05.046; Rossi JV, 2004, RETINA-J RET VIT DIS, V24, P231, DOI 10.1097/00006982-200404000-00007; Saleh GM, 2013, BRIT J OPHTHALMOL, V97, P789, DOI 10.1136/bjophthalmol-2012-302764; Selvander M, 2013, ACTA OPHTHALMOL, V91, P469, DOI 10.1111/j.1755-3768.2012.02440.x; Selvander M, 2012, ACTA OPHTHALMOL, V90, P412, DOI 10.1111/j.1755-3768.2010.02028.x; Spiteri A, 2010, BRIT J OPHTHALMOL, V94, P536, DOI 10.1136/bjo.2009.159715; Stowell S., 2014, USING R STAT; Waqar S, 2011, GRAEF ARCH CLIN EXP, V249, P77, DOI 10.1007/s00417-010-1531-6	27	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150690	10.1371/journal.pone.0150690	http://dx.doi.org/10.1371/journal.pone.0150690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964040	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000051
J	Barbuti, R; Chessa, S; Micheli, A; Pucci, R				Barbuti, Roberto; Chessa, Stefano; Micheli, Alessio; Pucci, Rita			Localizing Tortoise Nests by Neural Networks	PLOS ONE			English	Article							TIME; BEHAVIOR; SYSTEM; TOOLS; EGGS	The goal of this research is to recognize the nest digging activity of tortoises using a device mounted atop the tortoise carapace. The device classifies tortoise movements in order to discriminate between nest digging, and non-digging activity (specifically walking and eating). Accelerometer data was collected from devices attached to the carapace of a number of tortoises during their two-month nesting period. Our system uses an accelerometer and an activity recognition system (ARS) which is modularly structured using an artificial neural network and an output filter. For the purpose of experiment and comparison, and with the aim of minimizing the computational cost, the artificial neural network has been modelled according to three different architectures based on the input delay neural network (IDNN). We show that the ARS can achieve very high accuracy on segments of data sequences, with an extremely small neural network that can be embedded in programmable low power devices. Given that digging is typically a long activity (up to two hours), the application of ARS on data segments can be repeated over time to set up a reliable and efficient system, called Tortoise@, for digging activity recognition.	[Barbuti, Roberto; Chessa, Stefano; Micheli, Alessio; Pucci, Rita] Univ Pisa, Dept Comp Sci, Pisa, Italy	University of Pisa	Pucci, R (corresponding author), Univ Pisa, Dept Comp Sci, Pisa, Italy.	pucci@di.unipi.it	Pucci, Rita/U-4201-2018; Pucci, Rita/AAX-2555-2020	Pucci, Rita/0000-0002-2970-1180; Pucci, Rita/0000-0002-2970-1180; Chessa, Stefano/0000-0002-1248-9478; MICHELI, ALESSIO/0000-0001-5764-5238				Aguilera WT, 2013, GIANT TORTOISES HATC; [Anonymous], 2013, PROJECT REPORT PLOUG; Barbuti R, 2014, 50 ANN CONV AISB; Barbuti Roberto, 2012, Atti della Societa Toscana di Scienze Naturali Residente in Pisa Memorie Serie B, V119, P89; Baronti P, 2007, COMPUT COMMUN, V30, P1655, DOI 10.1016/j.comcom.2006.12.020; Bettini C, 2010, PERVASIVE MOB COMPUT, V6, P161, DOI 10.1016/j.pmcj.2009.06.002; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Colbourne R, 2005, DEV OPERATION NEST E; Gaill F., 2012, SENSORS ECOLOGY INTE, P17; Gao LL, 2013, ECOL INFORM, V13, P47, DOI 10.1016/j.ecoinf.2012.09.003; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Haykin S., 2009, NEURAL NETWORKS COMP; Kays R, 2011, ACTA OECOL, V37, P625, DOI 10.1016/j.actao.2011.06.007; Kooyman Gerald L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P15; Kuehler C, 2000, ZOO BIOL, V19, P263, DOI 10.1002/1098-2361(2000)19:4<263::AID-ZOO4>3.0.CO;2-G; Ladha C, 2013, UBICOMP'13: PROCEEDINGS OF THE 2013 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P415, DOI 10.1145/2493432.2493519; LANG KJ, 1990, NEURAL NETWORKS, V3, P23, DOI 10.1016/0893-6080(90)90044-L; Lara OD, 2013, IEEE COMMUN SURV TUT, V15, P1192, DOI 10.1109/SURV.2012.110112.00192; LeCun Y., 1995, Neural Networks: The Statistical Mechanics Perspective. Proceedings of the CTP-PBSRI. Joint Workshop on Theoretical Physics, P261; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; LeCun Y, 2010, IEEE INT SYMP CIRC S, P253, DOI 10.1109/ISCAS.2010.5537907; Levasseur K, 2011, MONITORING ERETMOCHE; Lopez-Risueno G, 2002, LECT NOTES COMPUT SC, V2415, P1150; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; Milligan H, 2014, FREEMAN R PROTECTING; Mitrus S, 2005, AMPHIBIA-REPTILIA, V26, P333, DOI 10.1163/156853805774408504; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Oczak M, 2014, BIOSYST ENG, V119, P89, DOI 10.1016/j.biosystemseng.2014.01.005; Rogoza V, 2014, ADV SYSTEMS SCI; Ropert-Coudert Yan, 2010, Endangered Species Research, V10, P21, DOI 10.3354/esr00188; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sejnowski T. J., 1987, Complex Systems, V1, P145; Sermanet P, 2012, INT C PATT RECOG, P3288; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Smith SW, 1997, SCI ENG GUIDE DIGITA; Soltis Joseph, 2012, Endangered Species Research, V18, P255, DOI 10.3354/esr00452; Technology C, 2007, TECHN C MICAZ WIR ME; Thornton I., 1971, DARWINS ISLANDS NATU; Waibel A, 1989, NEURAL COMPUT, V1, P39, DOI 10.1162/neco.1989.1.1.39; Zylstra ER, 2013, OECOLOGIA, V173, P107, DOI 10.1007/s00442-012-2464-z	46	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151168	10.1371/journal.pone.0151168	http://dx.doi.org/10.1371/journal.pone.0151168			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985660	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300050
J	Lopez-Campos, JL; Arranz, MA; Calero-Acuna, C; Romero-Valero, F; Ayerbe-Garcia, R; Hidalgo-Molina, A; Aguilar-Perez-Grovas, RI; Garcia-Gil, F; Casas-Maldonado, F; Caballero-Ballesteros, L; Sanchez-Palop, M; Perez-Tejero, D; Segado, A; Calvo-Bonachera, J; Hernandez-Sierra, B; Domenech, A; Arroyo-Varela, M; Gonzalez-Vargas, F; Cruz-Rueda, JJ				Lopez-Campos, Jose L.; Abad Arranz, Maria; Calero-Acuna, Carmen; Romero-Valero, Fernando; Ayerbe-Garcia, Ruth; Hidalgo-Molina, Antonio; Aguilar-Perez-Grovas, Ricardo I.; Garcia-Gil, Francisco; Casas-Maldonado, Francisco; Caballero-Ballesteros, Laura; Sanchez-Palop, Maria; Perez-Tejero, Dolores; Segado, Alejandro; Calvo-Bonachera, Jose; Hernandez-Sierra, Barbara; Domenech, Adolfo; Arroyo-Varela, Macarena; Gonzalez-Vargas, Francisco; Cruz-Rueda, Juan J.			Guideline Adherence in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Results from a Clinical Audit	PLOS ONE			English	Article							COPD PATIENTS; INHALED CORTICOSTEROIDS; BODE INDEX; APPROPRIATENESS; EXACERBATIONS; MANAGEMENT; RISK; LIFE; CARE; POPULATION	Objectives Previous clinical audits of COPD have provided relevant information about medical intervention in exacerbation admissions. The present study aims to evaluate adherence to current guidelines in COPD through a clinical audit. Methods This is a pilot clinical audit performed in hospital outpatient respiratory clinics in Andalusia, Spain (eight provinces with more than 8 million inhabitants), including 9 centers (20% of the public centers in the area) between 2013 and 2014. Cases with an established diagnosis of COPD based on risk factors, clinical symptoms, and a post-bronchodilator FEV1/FVC ratio of less than 0.70 were deemed eligible. The performance of the outpatient clinics was benchmarked against three guidance documents available at the time of the audit. The appropriateness of the performance was categorized as excellent (>80%), good (60-80%), adequate (40-59%), inadequate (20-39%), and highly inadequate (<20%). Results During the audit, 621 clinical records were audited. Adherence to the different guidelines presented a considerable variability among the different participating hospitals, with an excellent or good adherence for symptom recording, MRC or CAT use, smoking status evaluation, spirometry, or bronchodilation therapy. The most outstanding areas for improvement were the use of the BODE index, the monitoring of treatments, the determination of alpha1-antitrypsin, the performance of exercise testing, and vaccination recommendations. Conclusions The present study reflects the situation of clinical care for COPD patients in specialized secondary care outpatient clinics. Adherence to clinical guidelines shows considerable variability in outpatient clinics managing COPD patients, and some aspects of the clinical care can clearly be improved.	[Lopez-Campos, Jose L.; Abad Arranz, Maria; Calero-Acuna, Carmen] Univ Seville, Unidad Med Quirurg Enfermedades Resp, Inst Biomed Sevilla IBiS, Hosp Univ Virgen del Rocio, Seville, Spain; [Lopez-Campos, Jose L.; Calero-Acuna, Carmen] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Romero-Valero, Fernando; Hidalgo-Molina, Antonio] Hosp Puerta del Mar, Cadiz, Spain; [Ayerbe-Garcia, Ruth; Aguilar-Perez-Grovas, Ricardo I.] Hosp Juan Ramon Jimenez, Huelva, Spain; [Garcia-Gil, Francisco; Caballero-Ballesteros, Laura] Hosp Univ Reina Sofia, Cordoba, Spain; [Casas-Maldonado, Francisco; Sanchez-Palop, Maria] Hosp Univ San Cecilio, Granada, Spain; [Perez-Tejero, Dolores; Segado, Alejandro] Hosp Infanta Margarita, Cordoba, Spain; [Calvo-Bonachera, Jose; Hernandez-Sierra, Barbara] Hosp Torrecardenas, Almeria, Spain; [Domenech, Adolfo; Arroyo-Varela, Macarena] Hosp Reg Univ Malaga, Malaga, Spain; [Gonzalez-Vargas, Francisco; Cruz-Rueda, Juan J.] Hosp Univ Virgen de las Nieves, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital Juan Ramon Jimenez; Hospital Universitario Reina Sofia - Cordoba; Hospital Universitario San Cecilio; Hospital Torrecardenas; Hospital Universitario Virgen de las Nieves	Lopez-Campos, JL (corresponding author), Univ Seville, Unidad Med Quirurg Enfermedades Resp, Inst Biomed Sevilla IBiS, Hosp Univ Virgen del Rocio, Seville, Spain.; Lopez-Campos, JL (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain.	lcampos@separ.es	Bodineau, José Luis López-Campos/AAG-5203-2019	Bodineau, José Luis López-Campos/0000-0003-1703-1367; Domenech del Rio, Adolfo/0000-0002-3127-9150; Arroyo Varela, Macarena/0000-0003-4939-9174; Casas, Francisco/0000-0002-8007-9323	Laboratorios Menarini, SA (Barcelona, Spain)	Laboratorios Menarini, SA (Barcelona, Spain)	This study was financially supported by an unrestricted grant from Laboratorios Menarini, SA (Barcelona, Spain).	Agabiti N, 2010, EUR RESPIR J, V35, P1031, DOI 10.1183/09031936.00056209; Navarrete BA, 2015, ARCH BRONCONEUMOL, V51, P193, DOI 10.1016/j.arbres.2014.11.001; Asche CV, 2012, INT J CHRONIC OBSTR, V7, P201, DOI 10.2147/COPD.S25805; Sorroche PB, 2015, ARCH BRONCONEUMOL, V51, P539, DOI 10.1016/j.arbres.2015.01.008; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Casas F, 2015, ARCH BRONCONEUMOL, V51, P185, DOI 10.1016/j.arbres.2014.05.008; Chorostowska-Wynimko J, 2015, EUR RESPIR REV, V24, P40, DOI 10.1183/09059180.00010614; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Flottorp SA, 2010, USING AUDIT FEEDBACK; Ivers NM, 2014, J GEN INTERN MED, V29, P1534, DOI 10.1007/s11606-014-2913-y; Soler-Cataluna JJ, 2009, ARCH BRONCONEUMOL, V45, P196, DOI 10.1016/j.arbres.2008.05.008; Soler-Cataluna JJ, 2009, RESP MED, V103, P692, DOI 10.1016/j.rmed.2008.12.005; Liaaen ED, 2010, RESP MED, V104, P1304, DOI 10.1016/j.rmed.2010.03.007; Lopez-Campos JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141856; Lopez-Campos JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110394; Lopez-Campos JL, 2014, EUR RESPIR J, V43, P754, DOI 10.1183/09031936.00074413; Lopez-Campos JL, 2013, EUR RESPIR J, V41, P270, DOI 10.1183/09031936.00021812; Marcos PJ, 2015, ARCH BRONCONEUMOL, V51, P360, DOI 10.1016/j.arbres.2014.05.007; Miravitlles M, 2016, ARCH BRONCONEUMOL, V52, P1, DOI 10.1016/j.arbres.2015.04.001; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P155, DOI 10.1016/j.arbres.2013.09.001; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; de Oca MM, 2015, ARCH BRONCONEUMOL, V51, P403, DOI 10.1016/j.arbres.2014.11.017; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nardini S, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-40; Nonato NL, 2015, ARCH BRONCONEUMOL, V51, P315, DOI 10.1016/j.arbres.2014.02.017; Perez-Rubio G, 2015, ARCH BRONCONEUMOL, V51, P80, DOI 10.1016/j.arbres.2014.09.010; Pozo-Rodriguez F, 2015, INT J CLIN PRACT, V69, P938, DOI 10.1111/ijcp.12601; Pozo-Rodriguez F, 2010, ARCH BRONCONEUMOL, V46, P349, DOI 10.1016/j.arbres.2010.04.004; Pretto JJ, 2012, INTERN MED J, V42, P380, DOI 10.1111/j.1445-5994.2011.02475.x; Price D, 2014, INT J CHRONIC OBSTR, V9, P889, DOI 10.2147/COPD.S62750; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Roberts CM, 2001, EUR RESPIR J, V17, P343, DOI 10.1183/09031936.01.17303430; Roisin RR, 2015, ARCH BRONCONEUMOL, V51, P57, DOI 10.1016/j.arbres.2014.11.003; Rossi A, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-77; Sanchez-Salcedo P, 2015, ARCH BRONCONEUMOL, V51, P169, DOI 10.1016/j.arbres.2014.09.019; Sanchez-Salcedo P, 2015, ARCH BRONCONEUMOL, V51, P311, DOI 10.1016/j.arbres.2015.03.003; Stephenson M, 2016, INT J QUAL HEALTH C, V28, P92, DOI 10.1093/intqhc/mzv113; Teckman J, 2014, J PEDIATR GASTR NUTR, V58, P199, DOI 10.1097/MPG.0000000000000196; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914	41	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151896	10.1371/journal.pone.0151896	http://dx.doi.org/10.1371/journal.pone.0151896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985822	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300147
J	Chien, CH; Lee, MJ; Liou, HC; Liou, HH; Fu, WM				Chien, Chia-Hung; Lee, Ming-Jen; Liou, Houng-Chi; Liou, Horng-Huei; Fu, Wen-Mei			Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice	PLOS ONE			English	Article							NITRIC-OXIDE; PARKINSONS-DISEASE; INTERFERON-GAMMA; DJ-1-DEFICIENT MICE; GLIAL RESPONSES; CELLS; ACTIVATION; LIPOPOLYSACCHARIDE; EXPRESSION; MODEL	Mutation of DJ-1 (PARK7) has been linked to the development of early-onset Parkinson's disease (PD). However, the underlying molecular mechanism is still unclear. This study is aimed to compare the sensitivity of nigrostriatal dopaminergic neurons to lipopolysaccharide (LPS) challenge between DJ-1 knockout (KO) and wild-type (WT) mice, and explore the underlying cellular and molecular mechanisms. Our results found that the basal levels of interferon (IFN)-gamma (the hub cytokine) and interferon-inducible T-cell alpha chemoattractant (I-TAC) (a downstream mediator) were elevated in the substantia nigra of DJ-1 KO mice and in microglia cells with DJ-1 deficiency, and the release of cytokine/chemokine was greatly enhanced following LPS administration in the DJ-1 deficient conditions. In addition, direct intranigral LPS challenge caused a greater loss of nigrostriatal dopaminergic neurons and striatal dopamine content in DJ-1 KO mice than in WT mice. Furthermore, the sensitization of microglia cells to LPS challenge to release IFN-gamma and I-TAC was via the enhancement of NF-kappa B signaling, which was antagonized by NF-kappa B inhibitors. LPS-induced increase in neuronal death in the neuron-glia co-culture was enhanced by DJ-1 deficiency in microglia, which was antagonized by the neutralizing antibodies against IFN-gamma or I-TAC. These results indicate that DJ-1 deficiency sensitizes microglia cells to release IFN-gamma and I-TAC and causes inflammatory damage to dopaminergic neurons. The interaction between the genetic defect (i.e. DJ-1) and inflammatory factors (e.g. LPS) may contribute to the development of PD.	[Chien, Chia-Hung; Fu, Wen-Mei] Natl Taiwan Univ, Dept Life Sci, Coll Life Sci, Taipei 10764, Taiwan; [Lee, Ming-Jen; Liou, Horng-Huei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chien, Chia-Hung; Liou, Houng-Chi; Liou, Horng-Huei; Fu, Wen-Mei] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Chien, Chia-Hung; Fu, Wen-Mei] Natl Taiwan Univ, Coll Med, Drug Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Fu, WM (corresponding author), Natl Taiwan Univ, Dept Life Sci, Coll Life Sci, Taipei 10764, Taiwan.; Fu, WM (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.; Fu, WM (corresponding author), Natl Taiwan Univ, Coll Med, Drug Res Ctr, Taipei, Taiwan.	wenmei@ntu.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C. [MOST 102-2321-B-002-016]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	The study was financially supported by the grant MOST 102-2321-B-002-016 from the Ministry of Science and Technology, Taiwan, R.O.C. to H.H.L. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Arai H, 2004, J BIOL CHEM, V279, P51647, DOI 10.1074/jbc.M407328200; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bifsha P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004863; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chung KKK, 2003, J NEUROL, V250, P15, DOI 10.1007/s00415-003-1304-9; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Delgado M, 2003, J BIOL CHEM, V278, P27620, DOI 10.1074/jbc.M303199200; Domanskyi A, 2011, FASEB J, V25, P2898, DOI 10.1096/fj.11-181958; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; GALEA E, 1992, P NATL ACAD SCI USA, V89, P10945, DOI 10.1073/pnas.89.22.10945; Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006; Guadagno J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.59; Hayley S, 2004, J NEUROSCI, V24, P2045, DOI 10.1523/JNEUROSCI.4564-03.2004; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Huang Y, 2004, BRAIN RES REV, V46, P44, DOI 10.1016/j.brainresrev.2004.04.007; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jung SH, 2014, ATHEROSCLEROSIS, V235, P503, DOI 10.1016/j.atherosclerosis.2014.05.955; Kim JH, 2013, NEUROBIOL DIS, V60, P1, DOI 10.1016/j.nbd.2013.08.007; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Lin YC, 2007, J PHARMACOL EXP THER, V323, P877, DOI 10.1124/jpet.107.125955; Long-Smith CM, 2010, J NEUROIMMUNOL, V226, P20, DOI 10.1016/j.jneuroim.2010.05.030; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mclaughlin P, 2006, GLIA, V53, P567, DOI 10.1002/glia.20294; Mcnally RS, 2011, J BIOL CHEM, V286, P4098, DOI 10.1074/jbc.M110.147371; Molina-Holgado F, 2001, GLIA, V33, P97, DOI 10.1002/1098-1136(200102)33:2<97::AID-GLIA1009>3.0.CO;2-N; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Nguyen TA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-50; Ock J, 2010, BRIT J PHARMACOL, V159, P1646, DOI 10.1111/j.1476-5381.2010.00659.x; Pham TT, 2010, GENES BRAIN BEHAV, V9, P305, DOI 10.1111/j.1601-183X.2009.00559.x; Platten M, 2001, BRIT J PHARMACOL, V134, P1279, DOI 10.1038/sj.bjp.0704373; Rock RB, 2005, GENES IMMUN, V6, P712, DOI 10.1038/sj.gene.6364246; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tanaka S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-143; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Thomas KJ, 2009, INT J BIOCHEM CELL B, V41, P2025, DOI 10.1016/j.biocel.2009.02.018; Trudler D, 2014, J NEUROCHEM, V129, P434, DOI 10.1111/jnc.12633; Waak J, 2009, FASEB J, V23, P2478, DOI 10.1096/fj.08-125153; Weinstein JR, 2008, GLIA, V56, P16, DOI 10.1002/glia.20585; Xie Z, 2003, EXP NEUROL, V182, P135, DOI 10.1016/S0014-4886(03)00057-8; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056	53	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151569	10.1371/journal.pone.0151569	http://dx.doi.org/10.1371/journal.pone.0151569			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982707	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900098
J	Lehtinen, L; Vesterkvist, P; Roering, P; Korpela, T; Hattara, L; Kaipio, K; Mpindi, JP; Hynninen, J; Auranen, A; Davidson, B; Haglund, C; Iljin, K; Grenman, S; Siitari, H; Carpen, O				Lehtinen, Laura; Vesterkvist, Pia; Roering, Pia; Korpela, Taina; Hattara, Liisa; Kaipio, Katja; Mpindi, John-Patrick; Hynninen, Johanna; Auranen, Annika; Davidson, Ben; Haglund, Caj; Iljin, Kristiina; Grenman, Seija; Siitari, Harri; Carpen, Olli			REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker	PLOS ONE			English	Article							IV; CARCINOMA; INVASION; PATTERN; TUMORS	Preoperative diagnostics of ovarian neoplasms rely on ultrasound imaging and the serum biomarkers CA125 and HE4. However, these markers may be elevated in non-neoplastic conditions and may fail to identify most non-serous epithelial cancer subtypes. The objective of this study was to identify histotype-specific serum biomarkers for mucinous ovarian cancer. The candidate genes with mucinous histotype specific expression profile were identified from publicly available gene-expression databases and further in silico data mining was performed utilizing the MediSapiens database. Candidate biomarker validation was done using qRT-PCR, western blotting and immunohistochemical staining of tumor tissue microarrays. The expression level of the candidate gene in serum was compared to the serum CA125 and HE4 levels in a patient cohort of prospectively collected advanced ovarian cancer. Database searches identified REG4 as a potential biomarker with specificity for the mucinous ovarian cancer subtype. The specific expression within epithelial ovarian tumors was further confirmed by mRNA analysis. Immunohistochemical staining of ovarian tumor tissue arrays showed distinctive cytoplasmic expression pattern only in mucinous carcinomas and suggested differential expression between benign and malignant mucinous neoplasms. Finally, an ELISA based serum biomarker assay demonstrated increased expression only in patients with mucinous ovarian cancer. This study identifies REG4 as a potential serum biomarker for histotype-specific detection of mucinous ovarian cancer and suggests serum REG4 measurement as a non-invasive diagnostic tool for postoperative follow-up of patients with mucinous ovarian cancer.	[Lehtinen, Laura; Roering, Pia; Korpela, Taina; Kaipio, Katja; Carpen, Olli] Univ Turku, Dept Pathol, Turku, Finland; [Lehtinen, Laura; Roering, Pia; Korpela, Taina; Kaipio, Katja; Carpen, Olli] Turku Univ Hosp, FIN-20520 Turku, Finland; [Vesterkvist, Pia; Hattara, Liisa; Iljin, Kristiina; Siitari, Harri] VTT Tech Res Ctr Finland, Espoo, Finland; [Vesterkvist, Pia; Hattara, Liisa; Iljin, Kristiina; Siitari, Harri] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Mpindi, John-Patrick] Univ Helsinki, Inst Mol Med Finland, FIMM, Helsinki, Finland; [Hynninen, Johanna; Auranen, Annika; Grenman, Seija] Univ Turku, Turku Univ Hosp, Dept Obstet & Gynecol, Turku, Finland; [Davidson, Ben] Norwegian Radium Hosp, Dept Pathol, Oslo Univ Hosp, Oslo, Norway; [Davidson, Ben] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Haglund, Caj] Univ Helsinki, Translat Canc Biol, Res Programs Unit, Helsinki, Finland	University of Turku; University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki; University of Turku; University of Oslo; University of Oslo; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Lehtinen, L (corresponding author), Univ Turku, Dept Pathol, Turku, Finland.; Lehtinen, L (corresponding author), Turku Univ Hosp, FIN-20520 Turku, Finland.	lauleh@utu.fi	Haglund, Caj/N-1240-2019; Hynninen, Johanna/AAX-5424-2021; Hynninen, Johanna/AAY-5269-2020	Hynninen, Johanna/0000-0002-0854-7225; Hynninen, Johanna/0000-0002-0854-7225; Iljin, Kristiina/0000-0002-5161-0584; Auranen, Annika/0000-0002-9678-4684; Roering, Pia/0000-0003-1650-0918	Sigrid Juselius Foundation; Finnish Cancer Society; Turku University Hospital Research Fund; European Regional Development Fund [A31859]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; Turku University Hospital Research Fund; European Regional Development Fund(European Commission)	This study was supported by Sigrid Juselius Foundation, http://www.sigridjuselius.fi/foundation, to LL, TK, KK; Finnish Cancer Society, https://www.cancersociety.fi/grants/, to LL, PR, TK, KK; Turku University Hospital Research Fund, http://www.vsshp.fi/en/toimipaikat/tyks/Pages/default.aspx, to LL, PR, KK; European Regional Development Fund (A31859), http://ec.europa.eu/regional_policy/EN/funding/erdf/, to LL, PR, KK, PV, LH, KI, HS, OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1435-2; Coward JIG, 2015, INT J WOMENS HEALTH, V7, P189, DOI 10.2147/IJWH.S52379; HALILA H, 1988, BRIT J CANCER, V57, P304, DOI 10.1038/bjc.1988.67; Hayashi T, 2009, ONCOL REP, V21, P95, DOI 10.3892/or_00000194; Heiskala K, 2006, VIRCHOWS ARCH, V448, P295, DOI 10.1007/s00428-005-0105-1; Hellstrom I, 2003, CANCER RES, V63, P3695; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; Holcomb K, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.017; Kaprio T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109600; Kelly PJ, 2010, J CLIN PATHOL, V63, P169, DOI 10.1136/jcp.2009.072355; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Ludwick C, 2005, INT J GYNECOL PATHOL, V24, P205, DOI 10.1097/01.pgp.0000159935.38913.57; Miller K, 2011, AM J SURG PATHOL, V35, P1331, DOI 10.1097/PAS.0b013e3182233fce; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Mpindi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017259; Myohanen TT, 2012, J HISTOCHEM CYTOCHEM, V60, P706, DOI 10.1369/0022155412453051; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; Pectasides D, 2005, GYNECOL ONCOL, V97, P436, DOI 10.1016/j.ygyno.2004.12.056; Prat Jaime, 2009, Eur J Cancer, V45 Suppl 1, P427, DOI 10.1016/S0959-8049(09)70076-0; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Tabrizi AD, 2010, INT J GYNECOL PATHOL, V29, P99, DOI 10.1097/PGP.0b013e3181bbbcc1; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635	25	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151590	10.1371/journal.pone.0151590	http://dx.doi.org/10.1371/journal.pone.0151590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981633	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900101
J	Turco, M; Bedia, J; Di Liberto, F; Fiorucci, P; von Hardenberg, J; Koutsias, N; Llasat, MC; Xystrakis, F; Provenzale, A				Turco, Marco; Bedia, Joaquin; Di Liberto, Fabrizio; Fiorucci, Paolo; von Hardenberg, Jost; Koutsias, Nikos; Llasat, Maria-Carmen; Xystrakis, Fotios; Provenzale, Antonello			Decreasing Fires in Mediterranean Europe	PLOS ONE			English	Article							CLIMATE; MANAGEMENT; LANDSCAPE; REGIME; SPAIN; AREA; ABANDONMENT; EMISSIONS; WILDFIRES; PATTERNS	Forest fires are a serious environmental hazard in southern Europe. Quantitative assessment of recent trends in fire statistics is important for assessing the possible shifts induced by climate and other environmental/socioeconomic changes in this area. Here we analyse recent fire trends in Portugal, Spain, southern France, Italy and Greece, building on a homogenized fire database integrating official fire statistics provided by several national/EU agencies. During the period 1985-2011, the total annual burned area (BA) displayed a general decreasing trend, with the exception of Portugal, where a heterogeneous signal was found. Considering all countries globally, we found that BA decreased by about 3020 km(2) over the 27-year-long study period (i.e. about -66% of the mean historical value). These results are consistent with those obtained on longer time scales when data were available, also yielding predominantly negative trends in Spain and France (1974-2011) and a mixed trend in Portugal (1980-2011). Similar overall results were found for the annual number of fires (NF), which globally decreased by about 12600 in the study period (about -59%), except for Spain where, excluding the provinces along the Mediterranean coast, an upward trend was found for the longer period. We argue that the negative trends can be explained, at least in part, by an increased effort in fire management and prevention after the big fires of the 1980's, while positive trends may be related to recent socioeconomic transformations leading to more hazardous landscape configurations, as well as to the observed warming of recent decades. We stress the importance of fire data homogenization prior to analysis, in order to alleviate spurious effects associated with non-stationarities in the data due to temporal variations in fire detection efforts.	[Turco, Marco; von Hardenberg, Jost] Natl Res Council CNR, Inst Atmospher Sci & Climate ISAC, Corso Fiume 4, I-10133 Turin, Italy; [Bedia, Joaquin] Univ Cantabria, CSIC, Inst Phys Cantabria, Meteorol Grp, Avda Los Castros S-N, E-39005 Santander, Spain; [Di Liberto, Fabrizio] State Forestry Corps, Viale Antonio Ciamarra 139, I-00173 Rome, Italy; [Fiorucci, Paolo] CIMA Res Fdn, Via Armando Magliotto 2, I-17100 Savona, Italy; [Koutsias, Nikos; Xystrakis, Fotios] Univ Patras, Dept Environm & Nat Resources Management, Seferi 2, Agrinion 30100, Greece; [Llasat, Maria-Carmen] Univ Barcelona, Dept Astron & Meteorol, Ave Diagonal 647, E-08028 Barcelona, Spain; [Provenzale, Antonello] Natl Res Council CNR, Inst Geosci & Earth Resources IGG, Via Moruzzi 1, I-56124 Pisa, Italy; [Turco, Marco] CNS, BSC, Jordi Girona 29, Barcelona 08034, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA); University of Patras; University of Barcelona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS)	Turco, M (corresponding author), Natl Res Council CNR, Inst Atmospher Sci & Climate ISAC, Corso Fiume 4, I-10133 Turin, Italy.; Turco, M (corresponding author), CNS, BSC, Jordi Girona 29, Barcelona 08034, Spain.	turco.mrc@gmail.com	Bedia, Joaquin/Q-2148-2015; Llasat, Maria Carmen/AAB-7873-2020; Turco, Marco/B-5814-2011; Xystrakis, Fotios/AAD-2076-2019	Bedia, Joaquin/0000-0001-6219-4312; Llasat, Maria Carmen/0000-0001-8720-4193; Turco, Marco/0000-0001-8589-7459; Xystrakis, Fotios/0000-0002-3318-2686; Koutsias, Nikos/0000-0001-8898-9957	PRIN, Project of Interest "NextData" of the Italian Ministry for Education, University and Research [20108 TZKHC]; 321 EU H2020 Project "ECOPOTENTIAL: Improving Future Ecosystem Benefits 322 through Earth Observations" [641762]	PRIN, Project of Interest "NextData" of the Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); 321 EU H2020 Project "ECOPOTENTIAL: Improving Future Ecosystem Benefits 322 through Earth Observations"	This work was partially funded by the PRIN 2010-11 project 20108 TZKHC, the Project of Interest "NextData" of the Italian Ministry for Education, University and Research and by the 321 EU H2020 Project 641762 "ECOPOTENTIAL: Improving Future Ecosystem Benefits 322 through Earth Observations". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the data provider listed in Table 1 for providing access to fire series. EFFIS Data were provided by the European Forest Fire Information System-EFFIS (http://effis.jrc.ec.europa.eu) of the European Commission Joint Research Centre. Our thanks to Raul Marcos and Guido Biondi for their collaboration and Sixto Herrera for his insightful comments in an early analysis of the results. This work was partially funded by the PRIN 2010-11 project 20108 TZKHC, the Project of Interest "NextData" of the Italian Ministry for Education, University and Research and by the EU H2020 Project 641762 "ECOPOTENTIAL: Improving Future Ecosystem Benefits through Earth Observations".	Amatulli G, 2013, SCI TOTAL ENVIRON, V450, P209, DOI 10.1016/j.scitotenv.2013.02.014; Arca B, 2014, FOREST FIRES CLIMATE, P24; Batllori E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1118, DOI 10.1111/geb.12065; Bedia J, 2014, NAT HAZARD EARTH SYS, V14, P53, DOI 10.5194/nhess-14-53-2014; Bedia J, 2013, CLIMATIC CHANGE, V120, P229, DOI 10.1007/s10584-013-0787-3; Bedia J, 2015, AGR FOREST METEOROL, V214, P369, DOI 10.1016/j.agrformet.2015.09.002; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Brotons L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062392; Camia A., 2013, EARTH SCI ENG, V3, P497, DOI DOI 10.17265/2159-581X/2013.07.006; Collins RD, 2013, J ENVIRON MANAGE, V130, P1, DOI 10.1016/j.jenvman.2013.08.033; Cumming SG, 2001, ECOL APPL, V11, P97, DOI 10.1890/1051-0761(2001)011[0097:FTAWIT]2.0.CO;2; Duguy B, 2012, ENVIRON MANAGE, V50, P1012, DOI 10.1007/s00267-012-9933-3; Duguy Beatriz, 2013, ADV GLOBAL CHANGE, V51, P101, DOI DOI 10.1007/978-94-007-5772-1_; Edenhofer O., 2014, CONTRIBUTION WORKING; Fernandes PM, 2013, FRONT ECOL ENVIRON, V11, pE4, DOI 10.1890/120298; Frejaville T, 2015, CLIMATIC CHANGE, V129, P239, DOI 10.1007/s10584-015-1332-3; Gouveia CM, 2016, AGR FOREST METEOROL, V218, P135, DOI 10.1016/j.agrformet.2015.11.023; Harrison SP, 2010, FIRE EARTH SYSTEM; Kiktev D, 2003, J CLIMATE, V16, P3560, DOI 10.1175/1520-0442(2003)016<3560:COMAOT>2.0.CO;2; Koutsias N, 2013, INT J WILDLAND FIRE, V22, P493, DOI 10.1071/WF12003; Koutsias N, 2012, AGR FOREST METEOROL, V156, P41, DOI 10.1016/j.agrformet.2011.12.006; Koutsias N, 2010, GISCI REMOTE SENS, V47, P221, DOI 10.2747/1548-1603.47.2.221; Krawchuk MA, 2011, ECOLOGY, V92, P121, DOI 10.1890/09-1843.1; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Martinez-Fernandez J, 2013, NAT HAZARD EARTH SYS, V13, P311, DOI 10.5194/nhess-13-311-2013; Mavsar R, 2013, FOREST POLICY ECON, V29, P45, DOI 10.1016/j.forpol.2012.11.009; Migliavacca M, 2013, J GEOPHYS RES-BIOGEO, V118, P1732, DOI 10.1002/2013JG002444; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moreno MV, 2014, ENVIRON SCI POLICY, V37, P11, DOI 10.1016/j.envsci.2013.08.005; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; Park S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099699, 10.1371/journal.pone.0085264]; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JG, 2014, ECOSYSTEMS, V17, P1109, DOI 10.1007/s10021-014-9773-5; Pereira MG, 2011, NAT HAZARD EARTH SYS, V11, P3343, DOI 10.5194/nhess-11-3343-2011; Raul M, 2015, INT J WILDLAND FIRE; Ricotta C, 2012, NAT HAZARD EARTH SYS, V12, P1333, DOI 10.5194/nhess-12-1333-2012; Ruffault J, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00182.1; San-Miguel-Ayanz J, 2012, APPROACHES TO MANAGING DISASTER - ASSESSING HAZARDS, EMERGENCIES AND DISASTER IMPACTS, P87; San-Miguel-Ayanz J, 2013, FOREST ECOL MANAG, V294, P11, DOI 10.1016/j.foreco.2012.10.050; San-Miguel-Ayanz J, 2013, FOREST POLICY ECON, V29, P19, DOI 10.1016/j.forpol.2011.08.012; San-Miguel-Ayanz J, 2012, MANAG FOR ECOSYST, V24, P21, DOI 10.1007/978-94-007-2208-8_2; Schelhaas MJ, 2003, GLOBAL CHANGE BIOL, V9, P1620, DOI 10.1046/j.1365-2486.2003.00684.x; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sousa PM, 2015, AGR FOREST METEOROL, V202, P11, DOI 10.1016/j.agrformet.2014.11.018; Spano D, 2014, FOREST FIRES CLIMATE, P6; Thonicke K, 2010, BIOGEOSCIENCES, V7, P1991, DOI 10.5194/bg-7-1991-2010; Turco M, 2013, NAT HAZARD EARTH SYS, V13, P649, DOI 10.5194/nhess-13-649-2013; Turco M, 2011, NAT HAZARD EARTH SYS, V11, P3213, DOI 10.5194/nhess-11-3213-2011; Turco M, 2015, GEOPHYS RES LETT; Turco M, 2014, CLIMATIC CHANGE, V125, P369, DOI 10.1007/s10584-014-1183-3; Turco M, 2013, CLIMATIC CHANGE, V116, P665, DOI 10.1007/s10584-012-0505-6; Urbieta IR, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/114013; Viedma O, 2008, LANDSCAPE ECOL, V23, P657, DOI 10.1007/s10980-008-9228-5; Viedma O, 2015, AGR ECOSYST ENVIRON, V207, P126, DOI 10.1016/j.agee.2015.04.011	55	122	126	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150663	10.1371/journal.pone.0150663	http://dx.doi.org/10.1371/journal.pone.0150663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982584	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900047
J	Zaatreh, S; Wegner, K; Strauss, M; Pasold, J; Mittelmeier, W; Podbielski, A; Kreikemeyer, B; Bader, R				Zaatreh, Sarah; Wegner, Katharina; Strauss, Madlen; Pasold, Juliane; Mittelmeier, Wolfram; Podbielski, Andreas; Kreikemeyer, Bernd; Bader, Rainer			Co-Culture of S. epidermidis and Human Osteoblasts on Implant Surfaces: An Advanced In Vitro Model for Implant-Associated Infections	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; GROWTH; ARTHROPLASTY; ADHESION	Objectives Total joint arthroplasty is one of the most frequent and effective surgeries today. However, despite improved surgical techniques, a significant number of implant-associated infections still occur. Suitable in vitro models are needed to test potential approaches to prevent infection. In the present study, we aimed to establish an in vitro co-culture setup of human primary osteoblasts and S. epidermidis to model the onset of implant-associated infections, and to analyze antimicrobial implant surfaces and coatings. Materials and Methods For initial surface adhesion, human primary osteoblasts (hOB) were grown for 24 hours on test sample discs made of polystyrene, titanium alloy Ti6Al4V, bone cement PALACOS R (R), and PALACOS R (R) loaded with antibiotics. Co-cultures were performed as a single-species infection on the osteoblasts with S. epidermidis (multiplicity of infection of 0.04), and were incubated for 2 and 7 days under aerobic conditions. Planktonic S. epidermidis was quantified by centrifugation and determination of colony-forming units (CFU). The quantification of biofilm-bound S. epidermidis on the test samples was performed by sonication and CFU counting. Quantification of adherent and vital primary osteoblasts on the test samples was performed by trypan-blue staining and counting. Scanning electron microscopy was used for evaluation of topography and composition of the species on the sample surfaces. Results After 2 days, we observed approximately 10(4) CFU/ml biofilm-bound S. epidermidis (10(3) CFU/ml initial population) on the antibiotics-loaded bone cement samples in the presence of hOB, while no bacteria were detected without hOB. No biofilm-bound bacteria were detectable after 7 days in either case. Similar levels of planktonic bacteria were observed on day 2 with and without hOB. After 7 days, about 10(5) CFU/ml planktonic bacteria were present, but only in the absence of hOB. Further, no bacteria were observed within the biofilm, while the number of hOB was decreased to 10% of its initial value compared to 150% in the mono-culture of hOB. Conclusion We developed a co-culture setup that serves as a more comprehensive in vitro model for the onset of implant-associated infections and provides a test method for antimicrobial implant materials and coatings. We demonstrate that observations can be made that are unavailable from mono-culture experiments.	[Zaatreh, Sarah; Wegner, Katharina; Strauss, Madlen; Pasold, Juliane; Mittelmeier, Wolfram; Bader, Rainer] Univ Med Rostock, Biomech & Implant Technol Res Lab, Dept Orthoped, Rostock, Mecklenburg Wes, Germany; [Podbielski, Andreas; Kreikemeyer, Bernd] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Mecklenburg Wes, Germany	University of Rostock; University of Rostock	Zaatreh, S (corresponding author), Univ Med Rostock, Biomech & Implant Technol Res Lab, Dept Orthoped, Rostock, Mecklenburg Wes, Germany.	sarah.zaatreh@med.uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098; Ekat, Katharina/0000-0003-2423-201X				Borens O, 2012, HIP INT, V22, pS9, DOI 10.5301/HIP.2012.9565; Borghetti P, 2005, VET RES COMMUN, V29, P221, DOI 10.1007/s11259-005-0047-8; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1; GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205; Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010; Jonitz A, 2011, J MATER SCI-MATER M, V22, P2089, DOI 10.1007/s10856-011-4384-6; Lee HS, 2014, J BONE JOINT SURG AM, V96A, P1468, DOI 10.2106/JBJS.M.01280; Lee JH, 2008, BIOMED MICRODEVICES, V10, P489, DOI 10.1007/s10544-007-9157-0; Lee JH, 2011, TISSUE ENG PART C-ME, V17, P39, DOI [10.1089/ten.tec.2010.0285, 10.1089/ten.TEC.2010.0285]; Lee JH, 2010, ACTA BIOMATER, V6, P4422, DOI 10.1016/j.actbio.2010.05.021; Leunig M, 1998, INT ORTHOP, V22, P209, DOI 10.1007/s002640050244; Maduka-Ezeh AN, 2012, DIAGN MICR INFEC DIS, V74, P224, DOI 10.1016/j.diagmicrobio.2012.06.029; Salvati Eduardo A, 2003, Instr Course Lect, V52, P223; Sendi P, 2012, INT J ARTIF ORGANS, V35, P913, DOI 10.5301/ijao.5000150; Shaikh AA, 2014, CLIN ORTHOP RELAT R, V472, P2201, DOI 10.1007/s11999-014-3545-6; Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648; Smith SL, 2001, P I MECH ENG H, V215, P161, DOI 10.1243/0954411011533724; Stormer M, 2008, TRANSFUSION, V48, P836, DOI 10.1111/j.1537-2995.2008.01644.x; Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827; Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0; Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011; Uchiyama K, 2013, SCI WORLD J, DOI 10.1155/2013/147248; Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]; Vaudaux P, 2006, INJURY, V37, P15, DOI 10.1016/j.injury.2006.04.004; Weber WP, 2008, ANN SURG, V247, P918, DOI 10.1097/SLA.0b013e31816c3fec; Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003; Zmistowski B, 2011, J ARTHROPLASTY, V26, P104, DOI 10.1016/j.arth.2011.03.044	28	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151534	10.1371/journal.pone.0151534	http://dx.doi.org/10.1371/journal.pone.0151534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982194	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900094
J	Moges, AD; Admassu, B; Belew, D; Yesuf, M; Njuguna, J; Kyalo, M; Ghimire, SR				Moges, Asmare D.; Admassu, Belayneh; Belew, Derbew; Yesuf, Mohammed; Njuguna, Joyce; Kyalo, Martina; Ghimire, Sita R.			Development of Microsatellite Markers and Analysis of Genetic Diversity and Population Structure of Colletotrichum gloeosporioides from Ethiopia	PLOS ONE			English	Article							SEQUENCE REPEAT MARKERS; PATHOGENIC RUST FUNGUS; LINKAGE MAP; CAUSAL AGENT; DNA; ANTHRACNOSE; SPP.; VARIABILITY; SOFTWARE; DISEASE	Twenty three polymorphic microsatellite markers were developed for citrus plant pathogenic fungus, Colletotrichum gloeosporioides, and were used to analyze genetic diversity and population structure of 163 isolates from four different geographical regions of Ethiopia. These loci produced a total of 118 alleles with an average of 5.13 alleles per microsatellite marker. The polymorphic information content values ranged from 0.104 to 0.597 with an average of 0.371. The average observed heterozygosity across all loci varied from 0.046 to 0.058. The gene diversity among the loci ranged from 0.106 to 0.664. Unweighted Neighbor-joining and population structure analysis grouped these 163 isolates into three major groups. The clusters were not according to the geographic origin of the isolates. Analysis of molecular variance showed 85% of the total variation within populations and only 5% among populations. There was low genetic differentiation in the total populations (FST = 0.049) as evidenced by high level of gene flow estimate (N-m = 4.8 per generation) among populations. The results show that Ethiopian C. gloeosporioides populations are generally characterized by a low level of genetic diversity. The newly developed microsatellite markers were useful in analyzing the genetic diversity and population structure of the C. gloeosporioides populations. Information obtained from this study could be useful as a base to design strategies for better management of leaf and fruit spot disease of citrus in Ethiopia.	[Moges, Asmare D.; Yesuf, Mohammed] Ethiopian Inst Agr Res, Dept Hort, Adama, Ethiopia; [Admassu, Belayneh] Ethiopian Inst Agr Res, Dept Agr Biotechnol, Holetta, Ethiopia; [Moges, Asmare D.; Belew, Derbew] Jimma Univ, Dept Hort & Plant Sci, Coll Agr & Vet Med, Jimma, Ethiopia; [Moges, Asmare D.; Njuguna, Joyce; Kyalo, Martina; Ghimire, Sita R.] Int Livestock Res Inst, Biosci Eastern & Cent Africa Hub, Nairobi, Kenya; [Admassu, Belayneh] USDA ARS, Aberdeen, MD USA	Ethiopian Institute of Agricultural Research (EIAR); Ethiopian Institute of Agricultural Research (EIAR); Jimma University; CGIAR; International Livestock Research Institute (ILRI); United States Department of Agriculture (USDA)	Ghimire, SR (corresponding author), Int Livestock Res Inst, Biosci Eastern & Cent Africa Hub, Nairobi, Kenya.	S.ghimire@cgiar.org		Njuguna, Joyce/0000-0003-2008-3387	BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; Syngenta Foundation for Sustainable Agriculture (SFSA); Bill & Melinda Gates Foundation (BMGF); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida)	BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership(Australian Government); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida)	This project was supported by the BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program. The ABCF Program is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and; the Swedish International Development Cooperation Agency (Sida), recipient: ADM. The funder had no role in preparation of the manuscript and the decision to publish.	Abang Mathew M., 2003, African Journal of Biotechnology, V2, P486; Abang MM, 2006, J PHYTOPATHOL, V154, P51, DOI 10.1111/j.1439-0434.2005.01060.x; Adaskaveg JE, 2000, COLLETOTRICHUM, P317; Admassu B, 2010, J PHYTOPATHOL, V158, P806, DOI 10.1111/j.1439-0434.2010.01702.x; Afanador-Kafuri L, 2003, PHYTOPATHOLOGY, V93, P579, DOI 10.1094/PHYTO.2003.93.5.579; Aiello D, 2015, J PHYTOPATHOL, V163, P168, DOI 10.1111/jph.12299; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Babu TK, 2013, PHYSIOL MOL PLANT P, V84, P10, DOI 10.1016/j.pmpp.2013.06.001; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bayraktar H, 2007, J PLANT PATHOL, V89, P341; Benali S., 2011, EUR J SCI RES, V50, P110; Bennett RS, 2005, PHYTOPATHOLOGY, V95, P300, DOI 10.1094/PHYTO-95-0300; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brouwer DJ, 1999, THEOR APPL GENET, V99, P1194, DOI 10.1007/s001220051324; Buddie AG, 1999, MYCOL RES, V103, P385, DOI 10.1017/S0953756298007254; Burdon JJ, 1997, PHYTOPATHOLOGY, V87, P664, DOI 10.1094/PHYTO.1997.87.7.664; Cai ZY, 2013, MICROBIOL RES, V168, P340, DOI 10.1016/j.micres.2013.01.005; Cannon PF, 2008, MYCOTAXON, V104, P189; Cannon PF, 2000, COLLETOTRICHUM, P1; Capote N., 2012, PLANT PATHOL, P151, DOI DOI 10.5772/38011; Carvalho Flavia M. S., 2000, Fitopatologia Brasileira, V25, P72; Ciampi MB, 2011, CONSERV GENET RESOUR, V3, P651, DOI 10.1007/s12686-011-9425-4; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; Derso E., 1999, Fruits (Paris), V54, P225; Dessalegn Y., 2002, AgriTopia, V17, P12; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Farr DF, 2006, MYCOL RES, V110, P1395, DOI 10.1016/j.mycres.2006.09.001; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freeman S, 2013, ACTA HORTIC, V975, P209; Freeman S, 2000, COLLETOTRICHUM, P131; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Gebre-Mariam Seifu., 2003, STATUS COMMERCIAL FR; Ghimire SR, 2011, FUNGAL DIVERS, V47, P19, DOI 10.1007/s13225-010-0085-6; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hancock JM, 1995, J MOL EVOL, V41, P1038; Heip Carlo H. R., 1998, Oceanis, V24, P61; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Jana T, 2005, MYCOL RES, V109, P81, DOI 10.1017/S0953756204001364; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; JIN L, 1994, MOL BIOL EVOL, V11, P120; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KISTLER HC, 1992, ANNU REV PHYTOPATHOL, V30, P131, DOI 10.1146/annurev.py.30.090192.001023; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LITT M, 1989, AM J HUM GENET, V44, P397; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Mahmodi F, 2014, PLANT PATHOLOGY J, V30, P10, DOI 10.5423/PPJ.OA.05.2013.0054; Martin MP, 1999, EUR J PLANT PATHOL, V105, P733, DOI 10.1023/A:1008785703330; Marulanda ML, 2014, GENET MOL RES, V13, P7673, DOI 10.4238/2014.September.26.5; Matsuoka Y, 2002, THEOR APPL GENET, V104, P436, DOI 10.1007/s001220100694; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; McDonald BA, 1997, PHYTOPATHOLOGY, V87, P448, DOI 10.1094/PHYTO.1997.87.4.448; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Mekbib SB, 2007, THESIS U PRETORIA; Milgroom MG, 2003, PLANT DIS, V87, P608, DOI 10.1094/PDIS.2003.87.6.608; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peixoto RF, 2014, GENET MOL RES, V13, P7852, DOI 10.4238/2014.September.26.23; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Pritchard JK, 2000, GENETICS, V155, P945; Ramos A. P., 2006, Bulletin OILB/SROP, V29, P317; Rampersad SN, 2013, PHYTOPATHOLOGY, V103, P182, DOI 10.1094/PHYTO-07-12-0160-R; Ranathunge NP, 2009, MOL ECOL RESOUR, V9, P1175, DOI 10.1111/j.1755-0998.2009.02608.x; Rizatto S, 2010, CONSERV GENET RESOUR, V2, P55, DOI 10.1007/s12686-009-9144-2; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sharopova N, 2008, GENOME, V51, P79, DOI [10.1139/G07-110, 10.1139/g07-110]; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SMITH BJ, 1990, PLANT DIS, V74, P69, DOI 10.1094/PD-74-0069; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sreenivasaprasad S, 2005, MOL PLANT PATHOL, V6, P361, DOI 10.1111/J.1364-3703.2005.00291.X; SUTTON B, 1992, CL LIB APPL, P1; Szabo LJ, 2007, MOL ECOL NOTES, V7, P92, DOI 10.1111/j.1471-8286.2006.01540.x; Szabo LJ, 2007, MOL ECOL NOTES, V7, P708, DOI 10.1111/j.1471-8286.2007.01686.x; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Timmer LW, 2000, COLLETOTRICHUM, P300; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Urena-Padilla AR, 2002, PHYTOPATHOLOGY, V92, P1245, DOI 10.1094/PHYTO.2002.92.11.1245; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weeds PL, 2003, PHYTOPATHOLOGY, V93, P176, DOI 10.1094/PHYTO.2003.93.2.176; Weir BS, 1996, SINAUER ASS SUNDERL; WEISING K, 1995, PCR METH APPL, V4, P249; Winton LM, 2007, MOL ECOL NOTES, V7, P1077, DOI 10.1111/j.1471-8286.2007.01782.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xie L, 2010, J ZHEJIANG UNIV-SC B, V11, P61, DOI 10.1631/jzus.B0900174; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Yesuf Mohammed, 2007, Fruits, V62, P99, DOI 10.1051/fruits:2007003; Yimenu J, 1993, PRELIMINARY SURVEY R; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	121	33	33	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151257	10.1371/journal.pone.0151257	http://dx.doi.org/10.1371/journal.pone.0151257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978654	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800054
J	Ha, HR; Oh, DY; Kim, TY; Lee, K; Kim, K; Lee, KH; Han, SW; Chie, EK; Jang, JY; Im, SA; Kim, TY; Kim, SW; Bang, YJ				Ha, Hye Rim; Oh, Do-Youn; Kim, Tae-Yong; Lee, KyoungBun; Kim, Kyubo; Lee, Kyung-Hun; Han, Sae-Won; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Bang, Yung-Jue			Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; INFLAMMATION; THERAPY; TUMOR	Background Ampulla of Vater cancer (AoV Ca) is a rare tumor, and its adjuvant treatment has not been established. The purpose of this study was to find out prognostic factors including host immunity and role of adjuvant treatment in AoV Ca. Methods and Findings We reviewed 227 AoV Ca patients with curative resection. Clinical characteristics, adjuvant treatment, disease-free survival (DFS) and overall survival (OS) were analyzed. Among all patients, 63.9, 36.1 and 33.9% had T1/T2, T3/T4 stage and lymph node-positive disease (LN+), respectively. OS of all patients was 90.9months (95% CI: 52.9-129.0). OS was different according to neutrophil-to-lymphocyte ratio (HR 1.651, 95% CI: 1.11-2.47), platelet-tolymphocyte ratio (HR 1.488, 95% CI: 1.00-2.21) and systemic inflammatory index (HR 1.669, 95% CI: 1.13-2.47). In multivariate analysis, adverse prognostic factors for OS included vascular invasion (HR 2.571, 95% CI: 1.20-5.53) and elevated CA 19-9 (HR 1.794, 95% CI: 1.07-3.05). A total of 104 patients (46.3%) received adjuvant treatment (25 out of 111of T1/T2 & LN (-), 79 out of 116 of T3/T4 or LN (+)). In T3/T4 or LN (+) stage, adjuvant CCRT with maintenance chemotherapy provided the longest OS (5-year OS rate: 47.0 vs. 41.4%). Conclusions Vascular invasion and elevated CA 19-9 were adverse prognostic factors in resected AoV Ca. In T3/T4 or LN (+) stage, adjuvant CCRT with maintenance chemotherapy provided the best survival outcome. Adjuvant treatment should be further defined in AoV Ca, especially with poor prognostic factors.	[Ha, Hye Rim; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, KyoungBun] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Kim, Kyubo; Chie, Eui Kyu] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul 110744, South Korea; [Jang, Jin-Young; Kim, Sun-Whe] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Oh, DY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.; Oh, DY (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	ohdoyoun@snu.ac.kr	Bang, Yung Jue/J-2759-2012; Kim, Sun/GSN-4867-2022; Kim, Kyubo/R-8061-2019; Lee, Kyoungbun/J-2571-2016	Bang, Yung Jue/0000-0001-6000-4597; Chie, Eui Kyu/0000-0003-2027-7472; Lee, Kyoungbun/0000-0001-8427-3003	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1320090]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (Grant No. 1320090).	Beger HG, 1999, ARCH SURG-CHICAGO, V134, P526, DOI 10.1001/archsurg.134.5.526; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Haddad LBD, 2010, J GASTROINTEST SURG, V14, P719, DOI 10.1007/s11605-010-1156-4; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horgan AM, 2012, J CLIN ONCOL, V30, P1934, DOI 10.1200/JCO.2011.40.5381; Howe JR, 1998, ANN SURG, V228, P87, DOI 10.1097/00000658-199807000-00013; Hu B, 2014, CLIN CANCER RES, V20, P6212, DOI 10.1158/1078-0432.CCR-14-0442; Jang JY, 2005, ANN SURG, V241, P77, DOI 10.1097/01.sla.0000150166.94732.88; Jarnagin WR, 2012, NAT REV GASTRO HEPAT, V9, P622, DOI 10.1038/nrgastro.2012.186; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Kim K, 2009, INT J RADIAT ONCOL, V75, P436, DOI 10.1016/j.ijrobp.2008.11.067; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Krishnan S, 2008, INT J RADIAT ONCOL, V70, P735, DOI 10.1016/j.ijrobp.2007.07.2327; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Narang AK, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-126; Perez DR, 2013, ANN SURG ONCOL, V20, P593, DOI 10.1245/s10434-012-2682-y; Randi G, 2009, ANN ONCOL, V20, P146, DOI 10.1093/annonc/mdn533; Riall TS, 2006, SURGERY, V140, P764, DOI 10.1016/j.surg.2006.04.006; Sikora SS, 2005, EJSO-EUR J SURG ONC, V31, P158, DOI 10.1016/j.ejso.2004.08.013; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Valsangkar NP, 2015, SURGERY, V157, P260, DOI 10.1016/j.surg.2014.08.092; Woo SM, 2007, ANN SURG ONCOL, V14, P3195, DOI 10.1245/s10434-007-9537-y; Zhang YJ, 2012, INT J HYPERTHER, V28, P132, DOI 10.3109/02656736.2011.654374; Zhou J, 2009, RADIOTHER ONCOL, V92, P244, DOI 10.1016/j.radonc.2009.05.006	30	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151406	10.1371/journal.pone.0151406	http://dx.doi.org/10.1371/journal.pone.0151406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974670	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600076
J	Javidpour, P; Deutsch, S; Mutalik, VK; Hillson, NJ; Petzold, CJ; Keasling, JD; Beller, HR				Javidpour, Pouya; Deutsch, Samuel; Mutalik, Vivek K.; Hillson, Nathan J.; Petzold, Christopher J.; Keasling, Jay D.; Beller, Harry R.			Investigation of Proposed Ladderane Biosynthetic Genes from Anammox Bacteria by Heterologous Expression in E-coli	PLOS ONE			English	Article							ACID-DERIVED FUELS; MICROBIAL-PRODUCTION; BIOLOGY; PROTEIN; TRANSCRIPTION; POLYMERASE; CHEMICALS; PRODUCTS; PATHWAY; COMPLEX	Ladderanes are hydrocarbon chains with three or five linearly concatenated cyclobutane rings that are uniquely produced as membrane lipid components by anammox (anaerobic ammonia-oxidizing) bacteria. By virtue of their angle and torsional strain, ladderanes are unusually energetic compounds, and if produced biochemically by engineered microbes, could serve as renewable, high-energy-density jet fuel components. The biochemistry and genetics underlying the ladderane biosynthetic pathway are unknown, however, previous studies have identified a pool of 34 candidate genes from the anammox bacterium, Kuenenia stuttgartiensis, some or all of which may be involved with ladderane fatty acid biosynthesis. The goal of the present study was to establish a systematic means of testing the candidate genes from K. stuttgartiensis for involvement in ladderane biosynthesis through heterologous expression in E. coli under anaerobic conditions. This study describes an efficient means of assembly of synthesized, codon-optimized candidate ladderane biosynthesis genes in synthetic operons that allows for changes to regulatory element sequences, as well as modular assembly of multiple operons for simultaneous heterologous expression in E. coli (or potentially other microbial hosts). We also describe in vivo functional tests of putative anammox homologs of the phytoene desaturase CrtI, which plays an important role in the hypothesized ladderane pathway, and a method for soluble purification of one of these enzymes. This study is, to our knowledge, the first experimental effort focusing on the role of specific anammox genes in the production of ladderanes, and lays the foundation for future efforts toward determination of the ladderane biosynthetic pathway. Our substantial, but far from comprehensive, efforts at elucidating the ladderane biosynthetic pathway were not successful. We invite the scientific community to take advantage of the considerable synthetic biology resources and experimental results developed in this study to elucidate the biosynthetic pathway that produces unique and intriguing ladderane lipids.	[Javidpour, Pouya; Hillson, Nathan J.; Petzold, Christopher J.; Keasling, Jay D.; Beller, Harry R.] Joint BioEnergy Inst, 5885 Hollis Ave, Emeryville, CA USA; [Javidpour, Pouya; Hillson, Nathan J.; Petzold, Christopher J.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Syst & Engn, Berkeley, CA 94720 USA; [Deutsch, Samuel; Hillson, Nathan J.] Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA USA; [Mutalik, Vivek K.] LBNL, Environm Genom & Syst Biol, Berkeley, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Beller, Harry R.] LBNL, Earth & Environm Sci, Berkeley, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Beller, HR (corresponding author), Joint BioEnergy Inst, 5885 Hollis Ave, Emeryville, CA USA.; Beller, HR (corresponding author), LBNL, Earth & Environm Sci, Berkeley, CA USA.	HRBeller@lbl.gov	Beller, Harry R/H-6973-2014; Mutalik, Vivek/AAB-6827-2021; Keasling, Jay D/J-9162-2012	Beller, Harry R/0000-0001-9637-3650; Mutalik, Vivek/0000-0001-7934-0400; Keasling, Jay D/0000-0003-4170-6088; Petzold, Christopher/0000-0002-8270-5228	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Synthetic Biology Tools for Yeast] Funding Source: researchfish	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U. S. Department of Energy (http://www.energy.gov/), Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy. Work conducted by the Joint Genome Institute was supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batth Tanveer S, 2012, Methods Mol Biol, V944, P237, DOI 10.1007/978-1-62703-122-6_17; Beller HR, 2015, NAT PROD REP, V32, P1508, DOI 10.1039/c5np00068h; Cambray G, 2013, NUCLEIC ACIDS RES, V41, P5139, DOI 10.1093/nar/gkt163; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chen J, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-1; Chou HH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3595; Damste JSS, 2005, FEBS J, V272, P4270, DOI 10.1111/j.1742-4658.2005.04842.x; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fernandez-Nino SMG, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00044; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goh EB, 2014, METAB ENG, V26, P67, DOI 10.1016/j.ymben.2014.09.003; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; Grawert T, 2004, J AM CHEM SOC, V126, P12847, DOI 10.1021/ja0471727; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Ham TS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks531; Heins RA, 2014, ACS CHEM BIOL, V9, P2082, DOI 10.1021/cb500244v; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Jetten MSM, 2009, CRIT REV BIOCHEM MOL, V44, P65, DOI 10.1080/10409230902722783; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kartal B, 2012, ADV MICROB PHYSIOL, V60, P211, DOI 10.1016/B978-0-12-398264-3.00003-6; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kumar S, 2012, METAB ENG, V14, P19, DOI 10.1016/j.ymben.2011.11.005; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lennen RM, 2013, CURR OPIN BIOTECH, V24, P1044, DOI 10.1016/j.copbio.2013.02.028; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mascitti V, 2006, J AM CHEM SOC, V128, P3118, DOI 10.1021/ja058370g; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Nouri DH, 2006, CURR ORG CHEM, V10, P2055, DOI 10.2174/138527206778742678; Nouri DH, 2012, ORG BIOMOL CHEM, V10, P5514, DOI 10.1039/c2ob25717c; Novak I, 2008, J PHYS CHEM A, V112, P10059, DOI 10.1021/jp805377c; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Rattray JE, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-8; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; van Niftrik L, 2012, MICROBIOL MOL BIOL R, V76, P585, DOI 10.1128/MMBR.05025-11; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18	42	16	17	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151087	10.1371/journal.pone.0151087	http://dx.doi.org/10.1371/journal.pone.0151087			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975050	Green Published, gold			2022-12-27	WOS:000372570600047
J	Bernhard, FP; Heinzel, S; Binder, G; Weber, K; Apel, A; Roeben, B; Deuschle, C; Maechtel, M; Heger, T; Nussbaum, S; Gasser, T; Maetzler, W; Berg, D				Bernhard, Felix P.; Heinzel, Sebastian; Binder, Gerhard; Weber, Karin; Apel, Anja; Roeben, Benjamin; Deuschle, Christian; Maechtel, Mirjam; Heger, Tanja; Nussbaum, Susanne; Gasser, Thomas; Maetzler, Walter; Berg, Daniela			Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; FACTOR-I; SERUM-LEVELS; ADULTS; RISK; AGE; DEPRESSION; BIOMARKERS; NEURONS; SYSTEM	Introduction Biomarkers indicating trait, progression and prediction of pathology and symptoms in Parkinson's disease (PD) often lack specificity or reliability. Investigating biomarker variance between individuals and over time and the effect of confounding factors is essential for the evaluation of biomarkers in PD, such as insulin-like growth factor 1 (IGF-1). Materials and Methods IGF-1 serum levels were investigated in up to 8 biannual visits in 37 PD patients and 22 healthy controls (HC) in the longitudinal MODEP study. IGF-1 baseline levels and annual changes in IGF-1 were compared between PD patients and HC while accounting for baseline disease duration (19 early stage: <= 3.5 years; 18 moderate stage: >4 years), age, sex, body mass index (BMI) and common medical factors putatively modulating IGF-1. In addition, associations of baseline IGF-1 with annual changes of motor, cognitive and depressive symptoms and medication dose were investigated. Results PD patients in moderate (130 +/- 26 ng/mL; p = .004), but not early stages (115 +/- 19, p>.1), showed significantly increased baseline IGF-1 levels compared with HC (106 +/- 24 ng/mL; p = .017). Age had a significant negative correlation with IGF-1 levels in HC (r = -.47, p = .028) and no correlation in PD patients (r = -.06, p>.1). BMI was negatively correlated in the overall group (r = -.28, p = .034). The annual changes in IGF-1 did not differ significantly between groups and were not correlated with disease duration. Baseline IGF-1 levels were not associated with annual changes of clinical parameters. Discussion Elevated IGF-1 in serum might differentiate between patients in moderate PD stages and HC. However, the value of serum IGF-1 as a trait-, progression- and prediction marker in PD is limited as IGF-1 showed large inter- and intraindividual variability and may be modulated by several confounders.	[Bernhard, Felix P.; Heinzel, Sebastian; Apel, Anja; Roeben, Benjamin; Deuschle, Christian; Maechtel, Mirjam; Heger, Tanja; Nussbaum, Susanne; Gasser, Thomas; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany; [Roeben, Benjamin; Gasser, Thomas; Maetzler, Walter; Berg, Daniela] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Binder, Gerhard; Weber, Karin] Univ Childrens Hosp Tuebingen, Dept Pediat Endocrinol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Bernhard, FP (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany.	felix.bernhard@med.uni-tuebingen.de	Maetzler, Walter/A-6796-2011; Heinzel, Sebastian/AFK-4188-2022; Berg, Daniela/A-8728-2019; Maetzler, Walter/AAE-5831-2020; Gasser, Thomas/GNH-5293-2022	Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Gasser, Thomas/0000-0002-1069-1146; Heinzel, Sebastian/0000-0003-4516-0529	Solvay Pharmaceuticals; Teva Pharmaceutical Industries Ltd.; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University; Bundesministerium fur Bildung und Forschung (BMBF) Neuroallianz D13B project	Solvay Pharmaceuticals(Solvay SA); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University; Bundesministerium fur Bildung und Forschung (BMBF) Neuroallianz D13B project(Federal Ministry of Education & Research (BMBF))	The MODEP study was initially supported by Solvay Pharmaceuticals and recently received financial support by Teva Pharmaceutical Industries Ltd. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. Moreover, the authors acknowledge support of the Bundesministerium fur Bildung und Forschung (BMBF) Neuroallianz D13B project. These funders were not involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Aimaretti G, 2008, J ENDOCRINOL INVEST, V31, P445, DOI 10.1007/BF03346389; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Benarroch EE, 2012, NEUROLOGY, V79, P2148, DOI 10.1212/WNL.0b013e3182752eef; Blum W.F., 1994, GROWTH REGUL S1, V4, P11; Chahine Lama M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS99, DOI 10.1016/S1353-8020(13)70025-7; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Erro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070244; Faupel-Badger JM, 2009, ANN EPIDEMIOL, V19, P841, DOI 10.1016/j.annepidem.2009.08.005; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Gerlach M, 2012, J NEURAL TRANSM, V119, P39, DOI 10.1007/s00702-011-0682-x; Godau J, 2011, ARCH NEUROL-CHICAGO, V68, P925, DOI 10.1001/archneurol.2011.129; Godau J, 2010, J NEUROL NEUROSUR PS, V81, P536, DOI 10.1136/jnnp.2009.175752; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Heinzel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114566; Iglesias P, 2001, THYROID, V11, P1043, DOI 10.1089/105072501753271734; JUUL A, 1994, CLIN ENDOCRINOL, V41, P85, DOI 10.1111/j.1365-2265.1994.tb03788.x; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Kang J-H, 2012, JAMA NEUROL, V127, P358; Katsanos KH, 2001, GROWTH HORM IGF RES, V11, P364, DOI 10.1054/ghir.2001.0248; Kopczak A, 2015, EUR NEUROPSYCHOPHARM, V25, P864, DOI 10.1016/j.euroneuro.2014.12.013; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Lin CM, 2009, YONSEI MED J, V50, P407, DOI 10.3349/ymj.2009.50.3.407; Ma JF, 2015, DEMENT GERIATR COGN, V39, P251, DOI 10.1159/000371510; Maetzler W, 2015, TIME FREQUENCY DOMAI, P419, DOI [10.1007/s00702-014-1276-1, DOI 10.1007/S00702-014-1276-1]; Maetzler W, 2011, MOVEMENT DISORD, V26, P176, DOI 10.1002/mds.23358; Mashayekhi F, 2010, J CLIN NEUROSCI, V17, P623, DOI 10.1016/j.jocn.2009.08.013; Melkersson KI, 1999, J CLIN PSYCHIAT, V60, P783, DOI 10.4088/JCP.v60n1112; Mielke MM, 2014, BIOMARK MED, V8, P225, DOI 10.2217/bmm.13.139; Numao A, 2014, PARKINSONISM RELAT D, V20, P212, DOI 10.1016/j.parkreldis.2013.11.005; Offen D, 2001, NEUROSCI LETT, V316, P129, DOI 10.1016/S0304-3940(01)02344-8; Pellecchia MT, 2014, EUR J NEUROL, V21, P802, DOI 10.1111/ene.12137; Perlmutter JS, 2014, ANN NEUROL, V76, P769, DOI 10.1002/ana.24291; Picillo M, 2013, J NEUROL, V260, P2849, DOI [10.1007/s00415-013-7085-x, 10.1007/s00415-013-6851-0]; Rabinovsky ED, 2004, NEUROL RES, V26, P204, DOI 10.1179/016164104225013851; Rajpathak SN, 2009, INSULIN LIKE GROWTH, V18, P166; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Schaefer S, 2008, J NEUROENDOCRINOL, V20, P104, DOI 10.1111/j.1365-2826.2007.01622.x; Strasburger CJ, 2001, HORM RES, V55, P100, DOI 10.1159/000063484; Teppala S, 2010, DIABETES CARE, V33, P2257, DOI 10.2337/dc10-0770; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trejo JL, 2004, J MOL MED, V82, P156, DOI 10.1007/s00109-003-0499-7; Tuncel D, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/132464; van Varsseveld NC, 2015, PSYCHONEUROENDOCRINO, V54, P31, DOI 10.1016/j.psyneuen.2015.01.014; Vestergaard PF, 2014, EUR J ENDOCRINOL, V170, P229, DOI 10.1530/EJE-13-0661; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382; Zawada WM, 1996, EXP NEUROL, V140, P60, DOI 10.1006/exnr.1996.0115	51	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150552	10.1371/journal.pone.0150552	http://dx.doi.org/10.1371/journal.pone.0150552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967642	Green Submitted, gold, Green Published			2022-12-27	WOS:000371989200016
J	Kim, J; Lee, KJ; Kim, JS; Rho, JG; Shin, JJ; Song, WK; Lee, EK; Egan, JM; Kim, W				Kim, Jihye; Lee, Kyung Jin; Kim, Jung Seok; Rho, Jun Gi; Shin, Jung Jae; Song, Woo Keun; Lee, Eun Kyung; Egan, Josephine M.; Kim, Wook			Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic beta Cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; PROSTATE-CANCER; DEATH; RECEPTOR; PHOSPHORYLATION; SURVIVAL; P27(KIP1); KNOCKOUT; BINDING; MICE	Recent reports have shown that cannabinoid 1 receptors (CB1Rs) are expressed in pancreatic beta cells, where they induce cell death and cell cycle arrest by directly inhibiting insulin receptor activation. Here, we report that CB1Rs regulate the expression of the anti-apoptotic protein Bcl-2 and cell cycle regulator cyclin D2 in pancreatic beta cells. Treatment of MIN6 and beta TC6 cells with a synthetic CB1R agonist, WIN55,212-2, led to a decrease in the expression of Bcl-2 and cyclin D2, in turn inducing cell cycle arrest in G0/G1 phase and caspase-3-dependent apoptosis. Additionally, genetic deletion and pharmacological blockade of CB1Rs after injury in mice led to increased levels of Bcl-2 and cyclin D2 in pancreatic beta cells. These findings provide evidence for the involvement of Bcl-2 and cyclin D2 mediated by CB1Rs in the regulation of beta-cell survival and growth, and will serve as a basis for developing new therapeutic interventions to enhance beta-cell function and growth in diabetes.	[Kim, Jihye; Kim, Jung Seok; Rho, Jun Gi; Shin, Jung Jae; Kim, Wook] Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea; [Lee, Kyung Jin] Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Convergence Med,Asan Med Ctr, Seoul 05505, South Korea; [Song, Woo Keun] Gwangju Inst Sci & Technol, Dept Life Sci, Bio Imaging & Cell Dynam Res Ctr, Kwangju 61005, South Korea; [Lee, Eun Kyung] Catholic Univ Korea, Dept Biochem, Coll Med, Seoul 06591, South Korea; [Egan, Josephine M.] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA	Ajou University; University of Ulsan; Gwangju Institute of Science & Technology (GIST); Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kim, W (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea.; Egan, JM (corresponding author), NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA.	eganj@grc.nia.nih.gov; wookkim21@ajou.ac.kr			Ministry of Education [NRF-2015R1A2A1A15054227, NRF-2009-0093826, NRF-2014R1A2A1A11053431]; Intramural Research Program of the NIH/NIA; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future; NATIONAL INSTITUTE ON AGING [ZIAAG000905, ZIAAG000960] Funding Source: NIH RePORTER	Ministry of Education; Intramural Research Program of the NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future and the Ministry of Education (NRF-2015R1A2A1A15054227 and NRF-2009-0093826 for WK and NRF-2014R1A2A1A11053431 for EKL). JME was supported by the Intramural Research Program of the NIH/NIA.	Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Georgia S, 2010, DIABETES, V59, P987, DOI 10.2337/db09-0838; Gonzalez-Mariscal I, 2016, MOL CELL ENDOCRINOL, V423, P1, DOI 10.1016/j.mce.2015.12.015; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Iwahashi H, 1996, DIABETOLOGIA, V39, P530, DOI 10.1007/s001250050475; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rabinovitch A, 1999, DIABETES, V48, P1223, DOI 10.2337/diabetes.48.6.1223; Sarfaraz S, 2005, CANCER RES, V65, P1635, DOI 10.1158/0008-5472.CAN-04-3410; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; SHIN I, NAT MED, V8, P1145; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	26	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150981	10.1371/journal.pone.0150981	http://dx.doi.org/10.1371/journal.pone.0150981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967640	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200025
J	Loftus, JC; Smith, ML; Seeley, TD				Loftus, J. Carter; Smith, Michael L.; Seeley, Thomas D.			How Honey Bee Colonies Survive in the Wild: Testing the Importance of Small Nests and Frequent Swarming	PLOS ONE			English	Article							VARROA-JACOBSONI OUD; APIS-MELLIFERA; DRONE BROOD; POPULATION; DESTRUCTOR; INFECTIONS; WINTER	The ectoparasitic mite, Varroa destructor, and the viruses that it transmits, kill the colonies of European honey bees (Apis mellifera) kept by beekeepers unless the bees are treated with miticides. Nevertheless, there exist populations of wild colonies of European honey bees that are persisting without being treated with miticides. We hypothesized that the persistence of these wild colonies is due in part to their habits of nesting in small cavities and swarming frequently. We tested this hypothesis by establishing two groups of colonies living either in small hives (42 L) without swarm-control treatments or in large hives (up to 168 L) with swarm-control treatments. We followed the colonies for two years and compared the two groups with respect to swarming frequency, Varroa infesttion rate, disease incidence, and colony survival. Colonies in small hives swarmed more often, had lower Varroa infestation rates, had less disease, and had higher survival compared to colonies in large hives. These results indicate that the smaller nest cavities and more frequent swarming of wild colonies contribute to their persistence without mite treatments.	[Loftus, J. Carter; Smith, Michael L.; Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Seeley, TD (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	tds5@cornell.edu		Smith, Michael/0000-0002-3454-962X	Eastern Apiculture Society of North America; National Institute of Food and Agriculture [NYC-191400]; National Science Foundation Graduate Research Fellowship [DGE-1144153]	Eastern Apiculture Society of North America; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This study was supported by the Eastern Apiculture Society of North America, the National Institute of Food and Agriculture (Project No. NYC-191400), and a National Science Foundation Graduate Research Fellowship (DGE-1144153) to MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, HONEY BEE PESTS PRED; Cervo R, 2014, J EXP BIOL, V217, P2998, DOI 10.1242/jeb.099978; Chauzat MP, 2010, J APICULT RES, V49, P40, DOI 10.3896/IBRA.1.49.1.06; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DeJong D, 1997, AM BEE J, V137, P742; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Feldman S, 2011, AM BEE J, V151, P579; Fries I, 2001, APIDOLOGIE, V38, P525; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; FUCHS S, 1990, APIDOLOGIE, V21, P193, DOI 10.1051/apido:19900304; GREATTI M, 1992, EXP APPL ACAROL, V16, P279, DOI 10.1007/BF01218569; Hansen H, 1987, HONEY BEE BROOD DIS; KORPELA S, 1992, J APICULT RES, V31, P157, DOI 10.1080/00218839.1992.11101278; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; MARTIN SJ, 1995, EXP APPL ACAROL, V19, P199, DOI 10.1007/BF00130823; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mikheyev AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8991; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rangel J, 2012, INSECT SOC, V59, P453, DOI 10.1007/s00040-012-0239-5; Rinderer TE, 2001, APIDOLOGIE, V32, P381, DOI 10.1051/apido:2001138; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Seeley TD, 2015, APIDOLOGIE, V46, P716, DOI 10.1007/s13592-015-0361-2; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Simpson J., 1963, Journal of Apicultural Research London, V2, P50; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; WINSTON ML, 1980, INSECT SOC, V27, P391, DOI 10.1007/BF02223731	32	42	43	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150362	10.1371/journal.pone.0150362	http://dx.doi.org/10.1371/journal.pone.0150362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968000	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200010
J	van der Valk, JPM; van Wijk, RG; Dubois, AEJ; de Groot, H; Reitsma, M; Vlieg-Boerstra, B; Savelkoul, HFJ; Wichers, HJ; de Jong, NW				van der Valk, Johanna P. M.; van Wijk, Roy Gerth; Dubois, Anthony E. J.; de Groot, Hans; Reitsma, Marit; Vlieg-Boerstra, Berber; Savelkoul, Huub F. J.; Wichers, Harry J.; de Jong, Nicolette W.			Multicentre Double-Blind Placebo-Controlled Food Challenge Study in Children Sensitised to Cashew Nut	PLOS ONE			English	Article							PEANUT ALLERGY; NATURAL-HISTORY; CLINICAL IMMUNOLOGY; CROSS-REACTIVITY; EUROPEAN ACADEMY; PISTACHIO; ANAPHYLAXIS; RESOLUTION	Background Few studies with a limited number of patients have provided indications that cashew-allergic patients may experience severe allergic reactions to minimal amounts of cashew nut. The objectives of this multicentre study were to assess the clinical relevance of cashew nut sensitisation, to study the clinical reaction patterns in double-blind placebo-controlled food challenge tests and to establish the amount of cashew nuts that can elicit an allergic reaction. Methods and Findings A total of 179 children were included (median age 9.0 years; range 2-17 years) with cashew nut sensitisation and a clinical history of reactions to cashew nuts or unknown exposure. Sensitised children who could tolerate cashew nuts were excluded. The study included three clinical visits and a telephone consultation. During the first visit, the medical history was evaluated, physical examinations were conducted, blood samples were drawn and skin prick tests were performed. The children underwent a double-blind placebo-controlled food challenge test with cashew nut during the second and third visits. The study showed that 137 (76.5%) of the sensitised children suspected of allergy to cashew nut had a positive double-blind placebo-controlled food challenge test, with 46% (63) manifesting subjective symptoms to the lowest dose of 1 mg cashew nut protein and 11% (15) developing objective symptoms to the lowest dose. Children most frequently had gastro-intestinal symptoms, followed by oral allergy and skin symptoms. A total of 36% (49/137) of the children experienced an anaphylactic reaction and 6% (8/137) of the children were treated with epinephrine. Conclusion This prospective study demonstrated a strikingly high percentage of clinical reactions to cashew nut in this third line population. Severe allergic reactions, including anaphylaxis requiring epinephrine, were observed. These reactions were to minimal amounts of cashew nut, demonstrated the high potency of this allergens.	[van der Valk, Johanna P. M.; van Wijk, Roy Gerth; de Jong, Nicolette W.] Erasmus MC, Dept Internal Med, Allergol, Rotterdam, Netherlands; [Dubois, Anthony E. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, GRIAC Res Inst, Groningen, Netherlands; [de Groot, Hans] RdGG, Diaconessenhuis Voorburg, Dept Pediat Allergol, Delft, Netherlands; [Reitsma, Marit; Wichers, Harry J.] Univ Wageningen & Res Ctr, Food & Biobased Res, Wageningen, Netherlands; [Vlieg-Boerstra, Berber] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Pediat Resp Med & Allergy, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Savelkoul, Huub F. J.] Univ Wageningen & Res Ctr, Lab Cell Biol & Immunol, Wageningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen; Wageningen University & Research; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Wageningen University & Research	van der Valk, JPM (corresponding author), Erasmus MC, Dept Internal Med, Allergol, Rotterdam, Netherlands.	j.p.m.vandervalk@erasmusmc.nl	Savelkoul, Huub FJ/F-6026-2012; Vlieg-Boerstra, Berber/O-1922-2019	Vlieg-Boerstra, Berber/0000-0001-7962-5406; Wichers, HJ/0000-0002-8030-7090	Technology Foundation STW [11868]; Food Allergy Foundation; Siemens Healthcare Diagnostics; HAL Allergy; Intersnack the Netherlands B.V.; ALK-Abello B.V.; Netherlands Anaphylaxis Network	Technology Foundation STW(Technologiestichting STW); Food Allergy Foundation; Siemens Healthcare Diagnostics; HAL Allergy(HAL Allergy Group); Intersnack the Netherlands B.V.; ALK-Abello B.V.(Bioceros B.V.); Netherlands Anaphylaxis Network	This project was funded by Technology Foundation STW, Food Allergy Foundation, Siemens Healthcare Diagnostics, HAL Allergy, Intersnack the Netherlands B.V., ALK-Abello B.V., and The Netherlands Anaphylaxis Network. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. All agreed with this publication. (STW number 11868).; Technology Foundation STW (STW number 11868), Food Allergy Foundation, Siemens Healthcare Diagnostics, HAL Allergy, Intersnack the Netherlands B.V., ALK-Abello B. V., and the Netherlands Anaphylaxis Network funded this project.	Blom WM, 2013, J ALLERGY CLIN IMMUN, V131, P172, DOI 10.1016/j.jaci.2012.10.034; Davoren M, 2005, ARCH DIS CHILD, V90, P1084, DOI 10.1136/adc.2005.073817; de Jong NW, 2010, CLIN EXP ALLERGY, V40, P1571, DOI 10.1111/j.1365-2222.2010.03496.x; Fleischer DM, 2007, CURR ALLERGY ASTHM R, V7, P175, DOI 10.1007/s11882-007-0018-y; Flinterman AE, 2006, J ALLERGY CLIN IMMUN, V118, P1186, DOI 10.1016/j.jaci.2006.08.017; Hasegawa Miki, 2009, Allergology International, V58, P209, DOI 10.2332/allergolint.08-OA-0010; Hourihane JO, 2005, ALLERGY, V60, P536, DOI 10.1111/j.1398-9995.2005.00752.x; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; Niggemann B, 2007, J PEDIATR GASTR NUTR, V45, P399, DOI 10.1097/MPG.0b013e318054b0c3; Noorbakhsh Reihaneh, 2011, Allergology International, V60, P425, DOI 10.2332/allergolint.10-OA-0222; PARRA FM, 1993, CLIN EXP ALLERGY, V23, P996, DOI 10.1111/j.1365-2222.1993.tb00290.x; Peters RL, 2015, J ALLERGY CLIN IMMUN, V135, P1257, DOI 10.1016/j.jaci.2015.01.002; Rance F, 2003, ALLERGY, V58, P1311, DOI 10.1046/j.1398-9995.2003.00342.x; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Skolnick HS, 2001, J ALLERGY CLIN IMMUN, V107, P367, DOI 10.1067/mai.2001.112129; van der Valk JPM, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0092-0; van der Valk JPM, 2014, ALLERGY, V69, P692, DOI 10.1111/all.12401; Vlieg-Boerstra BJ, 2008, ALLERGY, V63, P903, DOI 10.1111/j.1398-9995.2008.01634.x; Vlieg-Boerstra BJ, 2011, ALLERGY, V66, P948, DOI 10.1111/j.1398-9995.2010.02539.x; Wainstein BK, 2015, ASIA PAC ALLERGY, V5, P170, DOI 10.5415/apallergy.2015.5.3.170; Willison LN, 2008, CLIN EXP ALLERGY, V38, P1229, DOI 10.1111/j.1365-2222.2008.02998.x; Zhu JM, 2015, FOOD CHEM TOXICOL, V80, P92, DOI 10.1016/j.fct.2015.02.023	22	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151055	10.1371/journal.pone.0151055	http://dx.doi.org/10.1371/journal.pone.0151055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967158	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200031
J	Brown, TL; Petrovski, S; Dyson, ZA; Seviour, R; Tucci, J				Brown, Teagan L.; Petrovski, Steve; Dyson, Zoe A.; Seviour, Robert; Tucci, Joseph			The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SUSTAINED-RELEASE; GENOME SEQUENCE; COMPLEX; SKIN; OTITIS	Aims To isolate and characterise phage which could lyse P. acnes and to formulate the phage into a delivery form for potential application in topical treatment of acne infection. Methods and Results Using standard phage isolation techniques, ten phage capable of lysing P. acnes were isolated from human skin microflora. Their genomes showed high homology to previously reported P. acnes phage. These phage were formulated into cetomacrogol cream aqueous at a concentration of 2.5x10(8) PFU per gram, and shown to lyse underlying P. acnes cells grown as lawn cultures. These phage formulations remained active for at least 90 days when stored at four degrees Celsius in a light protected container. Conclusions P. acnes phage formulated into cetomacrogol cream aqueous will lyse surrounding and underlying P. acnes bacteria, and are effective for at least 90 days if stored appropriately. Significance and Impact of the Study There are few reports of phage formulation into semi solid preparations for application as phage therapy. The formulation method described here could potentially be applied topically to treat human acne infections. The potential exists for this model to be extended to other phage applied to treat other bacterial skin infections.	[Brown, Teagan L.; Dyson, Zoe A.; Tucci, Joseph] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Petrovski, Steve; Seviour, Robert] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia	La Trobe University; La Trobe University	Tucci, J (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia.	J.Tucci@latrobe.edu.au	Brown, Teagan L./AAL-8749-2020; Dyson, Zoe Anne/AAW-4294-2021	Dyson, Zoe Anne/0000-0002-8887-3492; Petrovski, Steve/0000-0002-6304-6853; seviour, robert/0000-0002-1366-0484; Brown, Teagan L./0000-0001-8885-5668				Alfadhel M, 2011, INT J PHARMACEUT, V416, P280, DOI 10.1016/j.ijpharm.2011.07.006; [Anonymous], REMINGTON INTRO PHAR; Brayfield A., 2014, MARTINDALE COMPLETE; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Chen LK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-154; CHENG XD, 1994, P NATL ACAD SCI USA, V91, P4034, DOI 10.1073/pnas.91.9.4034; Coates P, 2002, BRIT J DERMATOL, V146, P840, DOI 10.1046/j.1365-2133.2002.04690.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; Eady EA, 2003, DERMATOLOGY, V206, P54, DOI 10.1159/000067822; Farrar MD, 2007, J BACTERIOL, V189, P4161, DOI 10.1128/JB.00106-07; Fukuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047742; GEHSE M, 1983, ARCH DERMATOL RES, V275, P100, DOI 10.1007/BF00412883; Golshahi L, 2011, J APPL MICROBIOL, V110, P106, DOI 10.1111/j.1365-2672.2010.04863.x; Hawkins C, 2010, VET MICROBIOL, V146, P309, DOI 10.1016/j.vetmic.2010.05.014; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Jikia D, 2005, CLIN EXP DERMATOL, V30, P23, DOI 10.1111/j.1365-2230.2004.01600.x; Kasimatis G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/918320; Krautheim A, 2004, CLIN DERMATOL, V22, P398, DOI 10.1016/j.clindermatol.2004.03.009; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEYDEN JJ, 1975, J INVEST DERMATOL, V65, P382, DOI 10.1111/1523-1747.ep12607634; Liu J, 2015, ISME J, V9, P2078, DOI 10.1038/ismej.2015.47; Loc-Carrillo Catherine, 2011, Bacteriophage, V1, P111; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Lood R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-198; Marinelli LJ, 2012, MBIO, V3, DOI 10.1128/mBio.00279-12; Markoishvili K, 2002, INT J DERMATOL, V41, P453, DOI 10.1046/j.1365-4362.2002.01451.x; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; McDowell A, 2011, MICROBIOL-SGM, V157, P1990, DOI 10.1099/mic.0.049676-0; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; National Institutes of Health (NIH), 2014, NIAIDS ANT RES PROGR; Oprica C, 2004, ANAEROBE, V10, P155, DOI 10.1016/j.anaerobe.2004.02.002; Petrovski S, 2011, WATER RES, V45, P2146, DOI 10.1016/j.watres.2010.12.026; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P1389, DOI 10.1128/AEM.01938-10; Rhoads D D, 2009, J Wound Care, V18, P237; Ross JI, 2003, BRIT J DERMATOL, V148, P467, DOI 10.1046/j.1365-2133.2003.05067.x; Ross JI, 2001, BRIT J DERMATOL, V144, P339, DOI 10.1046/j.1365-2133.2001.03956.x; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scholz CFP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104199; SOOTHILL JS, 1994, BURNS, V20, P209, DOI 10.1016/0305-4179(94)90184-8; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; Tzellos T, 2011, EXPERT OPIN PHARMACO, V12, P1233, DOI 10.1517/14656566.2011.553192; Webster GF, 2002, BMJ-BRIT MED J, V325, P475, DOI 10.1136/bmj.325.7362.475; Wei HP, 2015, VIROL SIN, V30, P1, DOI 10.1007/s12250-014-3562-y; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Wu J, 2015, J DRUGS DERMATOL, V14, P176	52	40	43	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151184	10.1371/journal.pone.0151184	http://dx.doi.org/10.1371/journal.pone.0151184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964063	Green Published, gold			2022-12-27	WOS:000371993000117
J	Singh, KD; Roschitzki, B; Snoek, LB; Grossmann, J; Zheng, X; Elvin, M; Kamkina, P; Schrimpf, SP; Poulin, GB; Kammenga, JE; Hengartner, MO				Singh, Kapil Dev; Roschitzki, Bernd; Snoek, L. Basten; Grossmann, Jonas; Zheng, Xue; Elvin, Mark; Kamkina, Polina; Schrimpf, Sabine P.; Poulin, Gino B.; Kammenga, Jan E.; Hengartner, Michael O.			Natural Genetic Variation Influences Protein Abundances in C. elegans Developmental Signalling Pathways	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PHOSPHATIDYLSERINE RECEPTOR; TRANSGRESSIVE SEGREGATION; EXPRESSION; HERITABILITY; PROTEOMICS; APOPTOSIS; DATABASE; COMMON	Complex traits, including common disease-related traits, are affected by many different genes that function in multiple pathways and networks. The apoptosis, MAPK, Notch, and Wnt signalling pathways play important roles in development and disease progression. At the moment we have a poor understanding of how allelic variation affects gene expression in these pathways at the level of translation. Here we report the effect of natural genetic variation on transcript and protein abundance involved in developmental signalling pathways in Caenorhabditis elegans. We used selected reaction monitoring to analyse proteins from the abovementioned four pathways in a set of recombinant inbred lines (RILs) generated from the wild-type strains N2 (Bristol) and CB4856 (Hawaii) to enable quantitative trait locus (QTL) mapping. About half of the cases from the 44 genes tested showed a statistically significant change in protein abundance between various strains, most of these were however very weak (below 1.3-fold change). We detected a distant QTL on the left arm of chromosome II that affected protein abundance of the phosphatidylserine receptor protein PSR-1, and two separate QTLs that influenced embryonic and ionizing radiation-induced apoptosis on chromosome IV. Our results demonstrate that natural variation in C. elegans is sufficient to cause significant changes in signalling pathways both at the gene expression (transcript and protein abundance) and phenotypic levels.	[Singh, Kapil Dev; Zheng, Xue; Kamkina, Polina; Schrimpf, Sabine P.; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Roschitzki, Bernd; Grossmann, Jonas] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Roschitzki, Bernd; Grossmann, Jonas] Swiss Fed Inst Technol, Zurich, Switzerland; [Snoek, L. Basten; Kammenga, Jan E.] Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands; [Elvin, Mark; Poulin, Gino B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; University of Manchester	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@uzh.ch	Snoek, Basten L/E-4713-2014	Snoek, Basten L/0000-0001-5321-2996; Singh, Kapil Dev/0000-0002-5682-0708; Poulin, Gino/0000-0003-1016-348X; Hengartner, Michael/0000-0002-7584-596X	Swiss National Science Foundation [31003A_143932]; European Community's Health Seventh Framework Programme under project PANACEA [222936]; Netherlands Organisation for Scientific Research [823.01.001]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Health Seventh Framework Programme under project PANACEA; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Swiss National Science Foundation (grant No. 31003A_143932; http://www.snf.ch) to MOH and the European Community's Health Seventh Framework Programme under project PANACEA (project No. 222936; http://www.panaceaproject.eu) to JEK. LBS was funded by the Netherlands Organisation for Scientific Research (project No. 823.01.001; http://www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRENNER S, 1974, GENETICS, V77, P71; Chang CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014662; Choi M., 2014, MSSTATS PROTEIN SIGN; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Conradt Barbara, 2005, WormBook, P1; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Elvin M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-510; Escher C, 2012, PROTEOMICS, V12, P1111, DOI 10.1002/pmic.201100463; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Gallien S, 2011, J MASS SPECTROM, V46, P298, DOI 10.1002/jms.1895; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Green Iain, 2005, P1; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hodgkin J, 1997, GENETICS, V146, P149; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kamkina P, 2015, MOL CELL PR IN PRESS; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kristensen VN, 2006, P NATL ACAD SCI USA, V103, P7735, DOI 10.1073/pnas.0601893103; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Li Y, 2010, GENETICS, V186, P405, DOI 10.1534/genetics.110.119677; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; NICHOLAS WL, 1959, ANN NY ACAD SCI, V77, P218, DOI 10.1111/j.1749-6632.1959.tb36902.x; Page BD, 2007, DEVELOPMENT, V134, P2303, DOI 10.1242/dev.02855; Parts L, 2014, GENOME RES, V24, P1363, DOI 10.1101/gr.170506.113; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; R Core Team, R LANG ENV STAT COMP; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Rieseberg LH, 2003, PHILOS T R SOC B, V358, P1141, DOI 10.1098/rstb.2003.1283; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Rodriguez M, 2012, EXP GERONTOL, V47, P581, DOI 10.1016/j.exger.2012.05.005; Saito RM, 2002, CANCER INVEST, V20, P264, DOI 10.1081/CNV-120001153; Salido EC, 2006, P NATL ACAD SCI USA, V103, P18249, DOI 10.1073/pnas.0607218103; Schmid T, 2015, CURR OPIN GENET DEV, V32, P1, DOI 10.1016/j.gde.2015.01.006; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Seitz S, 2006, GENE CHROMOSOME CANC, V45, P612, DOI 10.1002/gcc.20325; Sendoel A, 2014, NAT CELL BIOL, V16, P812, DOI 10.1038/ncb3010; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Snoek LB, 2014, G3-GENES GENOM GENET, V4, P1813, DOI 10.1534/g3.114.013151; Snoek L Basten, 2014, Worm, V3, pe28357, DOI 10.4161/worm.28357; Snoek LB, 2014, SCI REP-UK, V4, DOI 10.1038/srep03912; Snoek LB, 2013, NUCLEIC ACIDS RES, V41, pD738, DOI 10.1093/nar/gks1124; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Sundaram Meera V, 2006, WormBook, P1; Thompson DA, 2005, HUM MOL GENET, V14, P3865, DOI 10.1093/hmg/ddi411; Thompson OA, 2015, GENETICS, V200, P975, DOI 10.1534/genetics.115.175950; Tsuchiya N, 2006, J HUM GENET, V51, P741, DOI 10.1007/s10038-006-0030-4; van der Velde KJ, 2014, NUCLEIC ACIDS RES, V42, pD794, DOI 10.1093/nar/gkt1044; Vinuela A, 2012, G3-GENES GENOM GENET, V2, P597, DOI 10.1534/g3.112.002212; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Yang HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6717	69	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0149418	10.1371/journal.pone.0149418	http://dx.doi.org/10.1371/journal.pone.0149418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985669	Green Published, gold, Green Accepted			2022-12-27	WOS:000372580300014
J	Kagy, V; Wong, M; Vandenbroucke, H; Jenny, C; Dubois, C; Ollivier, A; Cardi, C; Mournet, P; Tuia, V; Roux, N; Dolezel, J; Perrier, X				Kagy, Valerie; Wong, Maurice; Vandenbroucke, Henri; Jenny, Christophe; Dubois, Cecile; Ollivier, Anthony; Cardi, Celine; Mournet, Pierre; Tuia, Valerie; Roux, Nicolas; Dolezel, Jaroslav; Perrier, Xavier			Traditional Banana Diversity in Oceania: An Endangered Heritage	PLOS ONE			English	Article							MUSA; ASIA; SSR; DNA	This study aims to understand the genetic diversity of traditional Oceanian starchy bananas in order to propose an efficient conservation strategy for these endangered varieties. SSR and DArT molecular markers are used to characterize a large sample of Pacific accessions, from New Guinea to Tahiti and Hawaii. All Pacific starchy bananas are shown of New Guinea origin, by interspecific hybridization between Musa acuminata (AA genome), more precisely its local subspeciesM. acuminata ssp. banksii, and M. balbisiana (BB genome) generating triploid AAB Pacific starchy bananas. These AAB genotypes do not form a subgroup sensu stricto and genetic markers differentiate two subgroups across the three morphotypes usually identified: Iholena versus Popoulu and Maoli. The Popoulu/Maoli accessions, even if morphologically diverse throughout the Pacific, cluster in the same genetic subgroup. However, the subgroup is not strictly monophyletic and several close, but different genotypes are linked to the dominant genotype. One of the related genotypes is specific to New Caledonia (NC), with morphotypes close to Maoli, but with some primitive characters. It is concluded that the diffusion of Pacific starchy AAB bananas results from a series of introductions of triploids originating in New Guinea area from several sexual recombination events implying different genotypes of M. acuminata ssp. banksii. This scheme of multiple waves from the New Guinea zone is consistent with the archaeological data for peopling of the Pacific. The present geographic distribution suggests that a greater diversity must have existed in the past. Its erosion finds parallels with the erosion of cultural traditions, inexorably declining in most of the Polynesian or Melanesian Islands. Symmetrically, diversity hot spots appear linked to the local persistence of traditions: Maoli in New Caledonian Kanak traditions or Iholena in a few Polynesian islands. These results will contribute to optimizing the conservation strategy for the ex-situ Pacific Banana Collection supported collectively by the Pacific countries.	[Kagy, Valerie; Ollivier, Anthony] Inst Agron Neo Caledonien, Connaissance & Ameliorat Agrosyst, BP 32, La Foa 98880, New Caledonia; [Wong, Maurice] SDR, Dept Rech Agron, BP 100, F-98713 Papeete, France; [Vandenbroucke, Henri; Jenny, Christophe; Dubois, Cecile; Cardi, Celine; Mournet, Pierre; Perrier, Xavier] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Ave Agropolis, F-34398 Montpellier 5, France; [Tuia, Valerie] Ctr Pacific Crops & Trees CePaCT, Land Resources Div, Pacific Community, Suva, Fiji; [Roux, Nicolas] Biovers Int, Parc Sci Agropolis 2, F-34397 Montpellier 5, France; [Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Slechtitelu 31, CZ-78371 Olomouc, Czech Republic	CIRAD; Alliance; Bioversity International; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Kagy, V (corresponding author), Inst Agron Neo Caledonien, Connaissance & Ameliorat Agrosyst, BP 32, La Foa 98880, New Caledonia.	kagy@iac.nc	Dolezel, Jaroslav/B-7716-2008; Roux, Nicolas/ABG-4156-2020	Dolezel, Jaroslav/0000-0002-6263-0492; PERRIER, Xavier/0000-0002-0092-003X; Mournet, Pierre/0000-0001-8011-8647; Jenny, Christophe/0000-0001-6165-6888	South Pacific Integrated Observatory For Environment and Terrestrial and Marine Biodiversity (GOPS); French National Research Agency (ANR); National Program of Sustainability [LO 2014]	South Pacific Integrated Observatory For Environment and Terrestrial and Marine Biodiversity (GOPS); French National Research Agency (ANR)(French National Research Agency (ANR)); National Program of Sustainability	The authors acknowledge the South Pacific Integrated Observatory For Environment and Terrestrial and Marine Biodiversity (GOPS), which funded this project associating the following: the 'Institut Agronomique neo Caledonien' (IAC), New Caledonia; the 'Regional Pacific Plantain Collection' at the 'Centre for Pacific Crops and Trees' (CePaCT), Secretariat of the Pacific Community (SPC); 'Bioversity International'; 'Service de Developpement Rural de la Polynesie Francaise'; and UMR AGAP Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD). The project Leader was Valerie Kagy (IAC, New Caledonia). The authors thank also the French National Research Agency (ANR), program SYSTERRA, which funded the 'Vegeculture' project associating CIRAD-AGAP, IRD, University of Montpellier 2 (France), Jean Monnet University of Saint Etienne (France), CNRS-CREDO, Geo-Consult, and CTRAV (Technical Centre for Agricultural Research in the Vanuatu). The 'Vegeculture' project coordinator was Vincent Lebot (CIRAD-AGAP, Vanuatu). Jaroslav Dolezel has been supported by the National Program of Sustainability (award no. LO 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Angela Kepler for help to obtain samples of leaf tissues of some Hawaian Musa accessions, and who together with Edmond de Langhe contributed to the improvement of the manuscript. We thank also Severine Bouard and Melissa Nayral for advice on Oceanian culture and traditions, and Anne Vezina and Julie Sardos for advice on agricultural systems in Oceania, and Elodie Cinquin, Ines Van Den Houwe, Amit Sukal and Eva Hribova for valuable technical assistance. We acknowledge the South Pacific Integrated Observatory For Environment and Terrestrial and Marine Biodiversity (GOPS), which funded this project associating:r the 'Institut Agronomique neo Caledonien' (IAC), New Caledoniar the 'Regional Pacific Plantain Collection' at the 'Centre for Pacific Crops and Trees' (CePaCT), Secretariat of the Pacific Community (SPC)r 'Bioversity International'r 'Service de Developpement Rural de la Polynesie Francaise'r UMR AGAP Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD).r We thank also the French National Research Agency (ANR), program SYSTERRA, which funded the 'Vegeculture' project associating CIRAD- AGAP, IRD, University of Montpellier 2 (France), Jean Monnet University of Saint Etienne (France), CNRS- CREDO, Geo-Consult, CTRAV (Technical Centre for Agricultural Research in the Vanuatu). The 'Vegeculture' project coordinator was Vincent Lebot (CIRAD-AGAP, Vanuatu).r Jaroslav Dolezel has been supported by the National Program of Sustainability (award no. LO 2014).	Barrau J, 1956, JSO, V12, P181; Barrau J, 1957, THESIS; Barrau J., 1954, ETUDES MELANESIENNES, V6, P61; Bonnemaison J, 1997, GENS LIEUX HIST GEOS; Carreel F, 2002, GENOME, V45, P679, DOI [10.1139/g02-033, 10.1139/G02-033]; CARREEL F, 1994, GENET SEL EVOL, V26, pS125, DOI 10.1051/gse:19940709; Christelova P, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr024; Daniells J., 1990, MUSARAMA, V1, P6; Daniells J., 1995, ILLUSTRATED GUIDE ID; Denham T, 2004, ANTIQUITY, V78, P839, DOI 10.1017/S0003598X00113481; Donohue M., 2009, ETHNOBOTANY RES APPL, V7, P293, DOI [DOI 10.17348/ERA.7.0.293-332, 10.17348/era.7.0.293-332]; Englberger L, 2010, J FOOD COMPOS ANAL, V23, P624, DOI 10.1016/j.jfca.2010.03.002; Galipaud J-C, 2011, LAPITA NOMADES PACIF; Haudricourt G. A., 1964, LHOMME, V4, P93, DOI [10.3406/HOM.1964.366613, 10.3406/hom.1964.366613, DOI 10.3406/HOM.1964.366613]; Hermanto C, 2012, TRIANGLE BANANA EXPL, P18; Higgins JE, 1904, THE BANANA IN HAWAII; Hippolyte I, 2012, ANN BOT-LONDON, V109, P937, DOI 10.1093/aob/mcs010; Hippolyte I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-65; Horrocks M, 2009, J ARCHAEOL SCI, V36, P2048, DOI 10.1016/j.jas.2009.05.024; Horrocks M, 2009, J ARCHAEOL SCI, V36, P1115, DOI 10.1016/j.jas.2008.12.014; Horry J-P, 1989, FRUITS, V44, P573; Jeanneney A., 1894, NOUVELLE CALEDONIE A; Jenny Christophe, 2003, P99; Kagy V., 2004, ETHNOBOT RES APPL, V2, P29; Kagy V, 2012, B CHAMB AGR PECHE LA, P12; Kagy V, 1998, IMPORTANCE CULTURELL, P40; Kennedy J, 2009, ETHNOBOT J APPL, V7, P179, DOI [10.17348/era.7.0.179-197, DOI 10.17348/ERA.7.0.179-197, DOI 10.17348/era.7.0.179-197]; KENNEDY J, 2008, ASIAN PERSPECT, V47, P75, DOI DOI 10.1353/ASI.2008.0004; Kepler A.K., 2011, WORLD BANANAS HAWAII; Kirch P.V, 1997, LAPITA PEOPLEANCES; Lagoda PJL, 1998, MOL ECOL, V7, P659; Langhe E. de, 2015, Ethnobotany Research and Applications, V14, P299, DOI 10.17348/era.14.0.299-312; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; LEBOT V, 1993, EUPHYTICA, V67, P163, DOI 10.1007/BF00040618; Lebot Vincent, 1994, Pacific Science, V48, P16; Li R, 2008, J VIROL METHODS, V154, P48, DOI 10.1016/j.jviromet.2008.09.008; MacDaniels L.H., 1947, STUDY FEI BANANA ITS; Merrill ED., 1954, CHRON BOT, V14, P161; Noyer JL, 2005, GENETICA, V124, P61, DOI 10.1007/s10709-004-7319-z; Pawley A, 2010, LAPITA OCEANIC ANCES, P76; Perrier X., 2006, DARWIN SOFTWARE; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Ploetz RC., 2007, BANANA PLANTAIN OVER; Pope WT., 1926, BANANA CULTURE HAWAI; Risterucci AM, 2009, THEOR APPL GENET, V119, P1093, DOI 10.1007/s00122-009-1111-5; Sacher-Smith G, 2011, SOLOMON ISLANDS BANA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sand C., 1989, MIGRATIONS IDENTITES, P39; Santos JRU, 2010, BIOCHEM SYST ECOL, V38, P1010, DOI 10.1016/j.bse.2010.10.001; Sharrock S, 2001, INIBAP ANN REPORT 20, P14; Sheppard P.J., 2010, LAPITA ANCETRES OCEA, P105; SIMMONDS N, 1959, BANANAS; SIMONDS N. W., 1956, Tropical Agriculture, V33, P251; SIMMONDS N. W., 1954, PACIFIC SCI, V8, P226; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stover RH, 1987, BANANAS, P486; Tezenas du Montcel H, 1990, IDENTIFICATION GENET, P211; Viellard E, 1863, ESSAIS NOUVELLE CALE; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Yen D. E., 1991, MAN HALF ESSAYS PACI, P558; YEN DE, 1993, ECON BOT, V47, P3, DOI 10.1007/BF02862202	64	8	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151208	10.1371/journal.pone.0151208	http://dx.doi.org/10.1371/journal.pone.0151208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982801	gold, Green Published			2022-12-27	WOS:000372574900068
J	Kozowyk, PRB; Langejans, GHJ; Poulis, JA				Kozowyk, P. R. B.; Langejans, G. H. J.; Poulis, J. A.			Lap Shear and Impact Testing of Ochre and Beeswax in Experimental Middle Stone Age Compound Adhesives	PLOS ONE			English	Article							MODERN HUMAN-BEHAVIOR; SOUTH-AFRICA; COMPLEX COGNITION; EXPERIMENTAL ARCHAEOLOGY; HOWIESONS POORT; ACACIA-SEYAL; EVOLUTION; TOOLS; IDENTIFICATION; TECHNOLOGY	The production of compound adhesives using disparate ingredients is seen as some of the best evidence of advanced cognition outside of the use of symbolism. Previous field and laboratory testing of adhesives has shown the complexities involved in creating an effective Middle Stone Age glue using Acacia gum. However, it is currently unclear how efficient different adhesive recipes are, how much specific ingredients influence their performance, and how difficult it may have been for those ingredients to be combined to maximum effect. We conducted a series of laboratory-based lap shear and impact tests, following modern adhesion testing standards, to determine the efficacy of compound adhesives, with particular regard to the ingredient ratios. We tested rosin (colophony) and gum adhesives, containing additives of beeswax and ochre in varying ratios. During both lap shear and impact tests compound rosin adhesives performed better than single component rosin adhesives, and pure acacia gum was the strongest. The large difference in performance between each base adhesive and the significant changes in performance that occur due to relatively small changes in ingredient ratios lend further support to the notion that high levels of skill and knowledge were required to consistently produce the most effective adhesives.	[Kozowyk, P. R. B.; Langejans, G. H. J.] Leiden Univ, Fac Archaeol, Leiden, Netherlands; [Langejans, G. H. J.] Univ Johannesburg, Dept Anthropol & Dev Studies, Johannesburg, South Africa; [Poulis, J. A.] Delft Univ Technol, Adhes Inst, Delft, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Johannesburg; Delft University of Technology	Kozowyk, PRB (corresponding author), Leiden Univ, Fac Archaeol, Leiden, Netherlands.	p.r.b.kozowyk@arch.leidenuniv.nl		Langejans, Geeske/0000-0003-3640-9054	Netherlands Organization for Scientific Research Veni grant [275-60-007]; Archon National Research School of Archaeology the Netherlands	Netherlands Organization for Scientific Research Veni grant; Archon National Research School of Archaeology the Netherlands	This work was supported by the Netherlands Organization for Scientific Research Veni grant (file number 275-60-007), http://www.nwo.nl/ GHJL; and the Archon National Research School of Archaeology the Netherlands, PhD grant (file number N/A). http://www.archonline.nl/ PRBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN J, 1986, ANTHROPOLOGIE, V90, P713; Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Ambrose SH, 2010, CURR ANTHROPOL, V51, pS135, DOI 10.1086/650296; ASTM, 2011, D95003 ASTM INT; ASTM-International, 2010, D100210 ASTM INT, V15.06, DOI [10.1520/D1002-99, DOI 10.1520/D1002-99]; Barham L, 2013, HAND HANDLE 1 IND RE, DOI DOI 10.1073/pnas.1221285110; BARTON RNE, 1982, WORLD ARCHAEOL, V14, P237, DOI 10.1080/00438243.1982.9979864; Boeda E, 2008, ANTIQUITY, V82, P853, DOI 10.1017/S0003598X00097623; Brockmann W., 2009, ADHESIVE BONDING MAT, VVolume 1; Broughton B, 2001, MEASUREMENT GOOD PRA; Callister William D., 2021, MAT SCI ENG INTRO; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; Clark JD., 1977, PALEORIENT, V3, P127, DOI [10.3406/paleo.1975.4193, DOI 10.3406/PALEO.1975.4193]; Coles J. M, 1979, EXPT ARCHAEOLOGY; Cunningham ML., 2011, FOOD PRODUCT DESIGNS, V21, P1; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; Flindt C, 2005, FOOD HYDROCOLLOID, V19, P687, DOI 10.1016/j.foodhyd.2004.09.006; Gaillard Y, 2016, ARCHAEOMETRY, V58, P465, DOI 10.1111/arcm.12175; Gaillard Y, 2011, THERMOCHIM ACTA, V521, P90, DOI 10.1016/j.tca.2011.04.010; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Girard M, 2014, MECH MATER, V69, P185, DOI 10.1016/j.mechmat.2013.10.005; Haidle MN, 2015, J ANTHROPOL SCI, V93, P43, DOI [10.4436/jass.93011, 10.4436/JASS.93011]; Hassan EA, 2005, FOOD HYDROCOLLOID, V19, P669, DOI 10.1016/j.foodhyd.2004.09.004; Helwig K, 2014, J ARCHAEOL SCI, V41, P655, DOI 10.1016/j.jas.2013.09.010; Imam SH, 2013, J ADHES SCI TECHNOL, V27, P1972, DOI 10.1080/01694243.2012.696892; Iovita R, 2014, J ARCHAEOL SCI, V48, P73, DOI 10.1016/j.jas.2013.01.031; Kennedy JF, 2011, GUM ARABIC ROYAL SOC; Koller J., 2001, EUR J ARCHAEOL, V4, P385, DOI DOI 10.3346/jkms.2014.29.12.1597; Lombard M, 2004, S AFR ARCHAEOL BULL, V59, P37, DOI 10.2307/3889241; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P27; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P57; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Marsh EJ, 2010, DESIGNING EXPERIMENTAL RESEARCH IN ARCHAEOLOGY: EXAMINING TECHNOLOGY THROUGH PRODUCTION AND USE, P1; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mhinzi GS, 2008, FOOD CHEM, V107, P1407, DOI 10.1016/j.foodchem.2007.09.069; Moss EH., 1982, TAILLER POURQUOI FAI, P289; Norlin L-H, 2005, TALL OIL ULLMANNS EN; Outram AK, 2008, WORLD ARCHAEOL, V40, P1, DOI 10.1080/00438240801889456; Pawlik AF, 2011, J ARCHAEOL SCI, V38, P1699, DOI 10.1016/j.jas.2011.03.001; Petillon JM, 2011, J ARCHAEOL SCI, V38, P1266, DOI 10.1016/j.jas.2011.01.002; Pope Saxton T., 1918, U CALIFORNIA PUBLICA, V13, P103; Regert M, 2004, J SEP SCI, V27, P244, DOI 10.1002/jssc.200301608; Rots V, 2006, J ARCHAEOL SCI, V33, P360, DOI 10.1016/j.jas.2005.08.002; Rots V, 2011, J HUM EVOL, V60, P637, DOI 10.1016/j.jhevol.2011.01.001; Rots Veerle, 2008, Anthropozoologica, V43, P43; Sato C., 2005, ADHESIVE BONDING SCI, P164; Shea JJ., 2002, EXPT ARCHAEOLOGY REP, P55; Villa P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131273; Wadley L, 2005, J HUM EVOL, V49, P587, DOI 10.1016/j.jhevol.2005.06.007; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L., 2004, WORLD ARCHAEOL, V26, P19; Wadley L, 2013, CAMB ARCHAEOL J, V23, P163, DOI 10.1017/S0959774313000309; Wadley L, 2010, CURR ANTHROPOL, V51, pS111, DOI 10.1086/649836; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wragg Sykes RM, 2015, SETTLEMENT SOC COGNI; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106; Zipkin AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112560	60	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150436	10.1371/journal.pone.0150436	http://dx.doi.org/10.1371/journal.pone.0150436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DH1WF	26983080	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900040
J	Kuhn, R; Rothman, DS; Turner, S; Solorzano, J; Hughes, B				Kuhn, Randall; Rothman, Dale S.; Turner, Sara; Solorzano, Jose; Hughes, Barry			Beyond Attributable Burden: Estimating the Avoidable Burden of Disease Associated with Household Air Pollution	PLOS ONE			English	Article							SOLID-FUEL USE; PARTICULATE MATTER; RISK; COMBUSTION; PNEUMONIA; EXPOSURE; COOKING	Background The Global Burden of Disease (GBD) studies have transformed global understanding of health risks by producing comprehensive estimates of attributable disease burden, or the current disease that would be eliminated if a risk factor did not exist. Yet many have noted the greater policy significance of avoidable burden, or the future disease that could actually be eliminated if a risk factor were eliminated today. Avoidable risk may be considerably lower than attributable risk if baseline levels of exposure or disease are declining, or if a risk factor carries lagged effects on disease. As global efforts to deliver clean cookstoves accelerate, a temporal estimation of avoidable risk due to household air pollution (HAP) becomes increasingly important, particularly in light of the rapid uptake of modern stoves and ongoing epidemiologic transitions in regions like South and Southeast Asia. Methods and Findings We estimate the avoidable burden associated with HAP using International Futures (IFs), an integrated forecasting system that has been used to model future global disease burdens and risk factors. Building on GBD and other estimates, we integrated a detailed HAP exposure estimation and exposure-response model into IFs. We then conducted a counterfactual experiment in which HAP exposure is reduced to theoretical minimum levels in 2015. We evaluated avoidable mortality and DALY reductions for the years 2015 to 2024 relative to a Base Case scenario in which only endogenous changes occurred. We present results by cause and region, looking at impacts on acute lower respiratory infection (ALRI) and four noncommunicable diseases (NCDs). We found that just 2.6% of global DALYs would be averted between 2015 and 2024, compared to 4.5% of global DALYs attributed to HAP in the 2010 GBD study, due in large part to the endogenous tendency towards declining traditional stove usage in the IFs base case forecast. The extent of diminished impact was comparable for ALRI and affected NCDs, though for different reasons. ALRI impacts diminish due to the declining burden of ALRI in the base case forecast, particularly apparent in South Asia and Southeast Asia. Although NCD burdens are rising in regions affected by HAP, the avoidable risk of NCD nonetheless diminishes due to lagged effects. Because the stove transition and the decline of ALRI are proceeding more slowly in Sub-Saharan Africa, avoidable impacts would also be more persistent (3.9% of total DALY due to HAP) compared to South Asia (3.6%) or Southeast Asia (2.5%). Conclusions Our results illustrate how a temporal dynamic calculation of avoidable risk may yield different estimates, compared to a static attributable risk estimate, of the global and regional burden of disease. Our results suggest a window of rising and falling opportunity for HAP interventions that may have already closed in Southeast Asia and may be closing quickly in South Asia, but may remain open longer in Sub-Saharan Africa. A proper accounting of global health priorities should apply an avoidable risk framework that considers the role of ongoing social, economic and health transitions in constantly altering the disease and risk factor landscape.	[Kuhn, Randall] Univ Denver, Josef Korbel Sch Int Studies, Global Hlth Affairs Program, Denver, CO USA; [Rothman, Dale S.; Turner, Sara; Solorzano, Jose; Hughes, Barry] Univ Denver, Frederick S Pardee Ctr Int Futures, Josef Korbel Sch Int Studies, Denver, CO USA	University of Denver; University of Denver	Kuhn, R (corresponding author), Univ Denver, Josef Korbel Sch Int Studies, Global Hlth Affairs Program, Denver, CO USA.	rkuhn@du.edu		Kuhn, Randall/0000-0001-5664-6933	Population Services International (PSI)	Population Services International (PSI)	This study was funded in part by Population Services International (PSI) through the grant "New impact models for global health service delivery: Tobacco-related disease and cook stoves" to the University of Denver. Other support came from the University of Denver and the Frederick S. Pardee Center for International Futures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, EXPLORING SHAPING IN; Balakrishnan K, 2002, ENVIRON HEALTH PERSP, V110, P1069, DOI 10.1289/ehp.021101069; Balakrishnan K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-77; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Chafe ZA, 2014, ENVIRON HEALTH PERSP, V122, P1314, DOI 10.1289/ehp.1206340; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Global Burden of Disease, 2012, GLOB BURD DIS STUD 2; Hanna R, 2012, 18033 NAT BUR EC RES, P1; Hughes B.B., 2011, IMPROVING GLOBAL HLT; Hughes BB, 2011, B WORLD HEALTH ORGAN, V89, P478, DOI 10.2471/BLT.10.083766; Hughes BB, 2009, FORECASTING LONG TER, V2009; Kim KH, 2011, J HAZARD MATER, V192, P425, DOI 10.1016/j.jhazmat.2011.05.087; Lee MS, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-18; Lim SS, 2013, LANCET, P1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mishra V K, 1999, Int J Infect Dis, V3, P119, DOI 10.1016/S1201-9712(99)90032-2; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Pillarisetti A, 2016, BROKEN PUMPS AND PROMISES: INCENTIVIZING IMPACT IN ENVIRONMENTAL HEALTH, P147, DOI 10.1007/978-3-319-28643-3_10; Pope CA, 2011, AIR QUAL ATMOS HLTH, V4, P5, DOI 10.1007/s11869-010-0082-7; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rajagopalan S, 2012, GLOB HEART, V7, P207, DOI 10.1016/j.gheart.2012.06.009; Rothman DS, 2014, BUILDING GLOBAL INFR; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424; Smith KR, 1995, ASSESSING MANAGING H, P3; UNSTATS, 2013, POP US SOL FUELS PER; WHO, 2013, HOUS FUEL DAT; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X	34	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149669	10.1371/journal.pone.0149669	http://dx.doi.org/10.1371/journal.pone.0149669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982804	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900018
J	Klimecki, OM; Vuilleumier, P; Sander, D				Klimecki, Olga M.; Vuilleumier, Patrik; Sander, David			The Impact of Emotions and Empathy-Related Traits on Punishment Behavior: Introduction and Validation of the Inequality Game	PLOS ONE			English	Article							TORONTO-ALEXITHYMIA-SCALE; PERSPECTIVE-TAKING; POSITIVE AFFECT; SEX-DIFFERENCES; NEURAL BASIS; AGGRESSION; ANGER; RESPONSES; CATHARSIS; ACTIVATION	In the prevention and resolution of conflicts in social contexts, an important step is to understand how different emotions and empathic traits are linked to punishment behaviors. Unfortunately, few paradigms exist to study these phenomena. Here, we developed the Inequality Game (IG) as an economic and verbal interaction paradigm in which participants are faced with an "unfair other" as opposed to a "fair other" and subsequently have the opportunity to engage in a range of social behaviors. These social behaviors include cooperative or competitive economic choices and nice or derogatory verbal behavior toward the unfair and fair other. Participants could thus engage in punishment or forgiveness behavior toward the unfair other as well as in cooperative or aggressive behavior toward the fair other. We validated the IG through multimodal measures comprising the assessment of personality traits, emotions (by means of facial expressions and self-reports), arousal (by means of skin conductance responses), physical effort (force exertion), and behavioral reactions. Second, we examined the influence of emotions and empathy-related traits on punishment behavior. With regard to emotions, we observed a positive relation between malicious joy and punishment behavior. This result highlights the role of reward-related mechanisms in favoring punishment behavior. In addition, different empathic traits had opposing effects on antisocial behavior. Whereas personal distress predicted aggressive verbal behavior, perspective taking and empathic concern predicted a reduction in punishment behavior. Empathic traits also modulated emotional experience and person evaluations, such that perspective taking was related to more positive affect (less frowning and more smiling) and a more favorable evaluation of the unfair other. The current data validate the IG, reveal that malicious joy is positively related to punishment behavior, and show that different types of empathic traits can have opposing effects on antisocial behavior as well as on related emotions and person evaluations.	[Klimecki, Olga M.; Vuilleumier, Patrik; Sander, David] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Klimecki, Olga M.; Sander, David] Univ Geneva, Dept Psychol, Lab Study Emot Elicitat & Express, Geneva, Switzerland; [Vuilleumier, Patrik] Univ Geneva, Sch Med, Dept Neurosci, Lab Behav Neurol & Imaging Cognit, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Klimecki, OM (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.; Klimecki, OM (corresponding author), Univ Geneva, Dept Psychol, Lab Study Emot Elicitat & Express, Geneva, Switzerland.	olga.klimecki@unige.ch	Vuilleumier, Patrik/AAJ-1839-2021; Klimecki, Olga M/L-5034-2016	Vuilleumier, Patrik/0000-0002-8198-9214; Klimecki, Olga M/0000-0003-0757-7761; Sander, David/0000-0003-1266-9361	Marie Curie fellowship; European Union [267171]; National Center of Competence in Research (NCCR) for the Affective Sciences; Swiss National Science Foundation [51NF40-104897]	Marie Curie fellowship(European Commission); European Union(European Commission); National Center of Competence in Research (NCCR) for the Affective Sciences; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a Marie Curie fellowship to Olga M. Klimecki and it received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 267171. The research was also supported by the National Center of Competence in Research (NCCR) for the Affective Sciences, financed by a grant from the Swiss National Science Foundation (51NF40-104897), hosted by the University of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, HDB EMOTIONS, DOI DOI 10.1017/CB09780511609978.013; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; AVERILL JR, 1983, AM PSYCHOL, V38, P1145, DOI 10.1037/0003-066X.38.11.1145; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; BATSON CD, 1983, J PERS SOC PSYCHOL, V45, P706, DOI 10.1037//0022-3514.45.3.706; Beck AT, 1996, PSYCHOL ASSESS; BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037/0033-2909.106.1.59; BERKOWITZ L, 1990, AM PSYCHOL, V45, P494, DOI 10.1037/0003-066X.45.4.494; Berkowitz L., 1993, AGGRESSION ITS CAUSE, DOI 3.0.CO;2-9; BJORKQVIST K, 1994, SEX ROLES, V30, P177, DOI 10.1007/BF01420988; Borteyrou X, 2008, ENCEPHALE, V34, P249, DOI 10.1016/j.encep.2007.06.001; Bouchard J., 2007, VALIDATION VERSION F; Bushman BJ, 2002, PERS SOC PSYCHOL B, V28, P724, DOI 10.1177/0146167202289002; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Caci H, 2007, PERS INDIV DIFFER, V42, P987, DOI 10.1016/j.paid.2006.09.008; CARNEVALE PJD, 1986, ORGAN BEHAV HUM DEC, V37, P1, DOI 10.1016/0749-5978(86)90041-5; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CHEREK DR, 1993, PSYCHOPHARMACOLOGY, V111, P163, DOI 10.1007/BF02245518; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Dreu CKW, 2000, J PERS SOC PSYCHOL, V78, P889, DOI 10.1037/0022-3514.78.5.889; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Denson TF, 2009, J COGNITIVE NEUROSCI, V21, P734, DOI 10.1162/jocn.2009.21051; DEUTSCH M, 1960, HUM RELAT, V13, P123, DOI 10.1177/001872676001300202; DODGE KA, 1987, J PERS SOC PSYCHOL, V53, P1146, DOI 10.1037/0022-3514.53.6.1146; DOOB AN, 1972, J PERS SOC PSYCHOL, V22, P156, DOI 10.1037/h0032598; DOOB AN, 1970, J EXP RES PERS, V4, P291; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; Ekman P., 1979, HUMAN ETHOLOGY, P169, DOI DOI 10.1007/978-1-4020-2783-33; Ekman P., 2002, MANUAL INVESTIGATORS; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Galinsky AD, 2004, PERS SOC PSYCHOL B, V30, P594, DOI 10.1177/0146167203262802; Gilet AL, 2013, CAN J BEHAV SCI, V45, P42, DOI 10.1037/a0030425; Greenwald M. K., 1989, J PSYCHOPHYSIOL, V3, P51; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Hegtvedt KA, 1999, SOC FORCES, V78, P269, DOI 10.2307/3005797; Kassinove H, 2002, AGGRESSIVE BEHAV, V28, P117, DOI 10.1002/ab.90013; Keltner D., 2007, ENCY SOCIAL PSYCHOL, P159; Klimecki O, 2013, CAMBRIDGE HDB HUMAN, P533; Klimecki OM, 2015, SOC NEUROSCI-UK, V10, P466, DOI 10.1080/17470919.2015.1087427; Klimecki OM, 2014, SOC COGN AFFECT NEUR, V9, P873, DOI 10.1093/scan/nst060; KOMORITA SS, 1995, ANNU REV PSYCHOL, V46, P183, DOI 10.1146/annurev.ps.46.020195.001151; Leiberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017798; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Lieberman JD, 1999, AGGRESSIVE BEHAV, V25, P331, DOI 10.1002/(SICI)1098-2337(1999)25:5<331::AID-AB2>3.0.CO;2-1; Littlewort G., 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P298, DOI 10.1109/FG.2011.5771414; Loas G, 1996, PSYCHOPATHOLOGY, V29, P139, DOI 10.1159/000284983; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Mikula G, 1998, PERS SOC PSYCHOL B, V24, P769, DOI 10.1177/0146167298247009; MILLER PA, 1988, PSYCHOL BULL, V103, P324, DOI 10.1037/0033-2909.103.3.324; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Savard C, 2005, ANN M CAN PSYCH ASS; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smits DJM, 2005, PERS INDIV DIFFER, V39, P783, DOI 10.1016/j.paid.2005.02.023; Spielberger C., 1988, MANUAL STATE TRAIT A; Talmi D, 2008, J NEUROSCI, V28, P360, DOI 10.1523/JNEUROSCI.4028-07.2008; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; UNDERWOOD B, 1982, PSYCHOL BULL, V91, P143, DOI 10.1037/0033-2909.91.1.143; Van Kleef GA, 2013, ELGAR ORIG REF, P103; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337	64	14	15	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151028	10.1371/journal.pone.0151028	http://dx.doi.org/10.1371/journal.pone.0151028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978065	gold, Green Published			2022-12-27	WOS:000372572800043
J	Maruo, N; Sakagami, R; Yoshinaga, Y; Okamura, K; Sawa, Y				Maruo, Naoki; Sakagami, Ryuji; Yoshinaga, Yasunori; Okamura, Kazuhiko; Sawa, Yoshihiko			Differentiation of Apical Bud Cells in a Newly Developed Apical Bud Transplantation Model Using GFP Transgenic Mice as Donor	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; EPITHELIAL ROOT SHEATH; STEM-CELLS; IN-VIVO; IMMUNOHISTOCHEMICAL EXAMINATION; TOOTH DEVELOPMENT; REGENERATION; PODOPLANIN; CEMENTOGENESIS; EXPRESSION	Rodent mandibular incisors have a unique anatomical structure that allows teeth to grow throughout the lifetime of the rodent. This report presents a novel transplantation technique for studying the apical bud differentiation of rodent mandibular incisors. Incisal apical end tissue with green fluorescent protein from transgenic mouse was transplanted to wild type mice, and the development of the transplanted cells were immunohistologically observed for 12 weeks after the transplantation. Results indicate that the green fluorescent apical end tissue replaced the original tissue, and cells from the apical bud differentiated and extended toward the incisal edge direction. The immunostaining with podoplanin also showed that the characteristics of the green fluorescent tissue were identical to those of the original. The green fluorescent cells were only found in the labial side of the incisor up to 4 weeks. After 12 weeks, however, they were also found in the lingual side. Here the green fluorescent cementocyte-like cells were only present in the cementum close to the dentin surface. This study suggests that some of the cells that form the cellular cementum come from the apical tissue including the apical bud in rodent incisors.	[Maruo, Naoki; Sakagami, Ryuji; Yoshinaga, Yasunori] Fukuoka Dent Coll, Dept Odontol, Sect Periodontol, Fukuoka, Japan; [Okamura, Kazuhiko] Fukuoka Dent Coll, Sect Pathol, Dept Morphol Biol, Fukuoka, Japan; [Sawa, Yoshihiko] Fukuoka Dent Coll, Sect Funct Struct, Dept Morphol Biol, Fukuoka, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Sakagami, R (corresponding author), Fukuoka Dent Coll, Dept Odontol, Sect Periodontol, Fukuoka, Japan.	sakagami@college.fdcnet.ac.jp		Sakagami, Ryuji/0000-0002-5720-6929	ministry of Japanese education, science, sports and culture, Japan	ministry of Japanese education, science, sports and culture, Japan	This work was supported by Project for control of aging, industry to support private universities building up their foundations of strategic research 2012, the ministry of Japanese education, science, sports and culture, Japan.	Bosshardt DD, 2005, J DENT RES, V84, P390, DOI 10.1177/154405910508400501; Brazelton TR, 2005, STEM CELLS, V23, P1251, DOI 10.1634/stemcells.2005-0149; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2004, ARCH HISTOL CYTOL, V67, P1, DOI 10.1679/aohc.67.1; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; IKAWA M, 1995, DEV GROWTH DIFFER, V37, P455, DOI 10.1046/j.1440-169X.1995.t01-2-00012.x; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Imaizumi Y, 2010, ACTA HISTOCHEM CYTOC, V43, P115, DOI 10.1267/ahc.10023; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Masaoka T, 2009, J PERIODONTAL RES, V44, P489, DOI 10.1111/j.1600-0765.2008.01142.x; Morotomi T, 2005, ARCH ORAL BIOL, V50, P695, DOI 10.1016/j.archoralbio.2004.12.006; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Noda Y, 2010, ACTA HISTOCHEM CYTOC, V43, P61, DOI 10.1267/ahc.10008; Ohshima H, 2005, ARCH ORAL BIOL, V50, P153, DOI 10.1016/j.archoralbio.2004.09.008; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Sawa Y, 2008, ACTA HISTOCHEM CYTOC, V41, P121, DOI 10.1267/ahc.08019; Slavkin H C, 1974, Oral Sci Rev, V4, P7; THOMAS HF, 1995, INT J DEV BIOL, V39, P231; Xu XY, 2010, MOL THER, V18, P835, DOI 10.1038/mt.2010.3; Yamamoto T, 2015, ACTA HISTOCHEM CYTOC, V48, P95, DOI 10.1267/ahc.15006; Yamamoto T, 2009, ANN ANAT, V191, P547, DOI 10.1016/j.aanat.2009.07.004; Yang Z, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-55; Zeichner-David M, 2006, PERIODONTOL 2000, V41, P196, DOI 10.1111/j.1600-0757.2006.00162.x; Zhang L, 2012, GENE EXPR PATTERNS, V12, P273, DOI 10.1016/j.gep.2012.07.001	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150766	10.1371/journal.pone.0150766	http://dx.doi.org/10.1371/journal.pone.0150766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978064	gold, Green Published, Green Submitted			2022-12-27	WOS:000372572800035
J	Schlieve, CR; Mojica, SG; Holoyda, KA; Hou, XG; Fowler, KL; Grikscheit, TC				Schlieve, Christopher R.; Mojica, Salvador Garcia; Holoyda, Kathleen A.; Hou, Xiaogang; Fowler, Kathryn L.; Grikscheit, Tracy C.			Vascular Endothelial Growth Factor (VEGF) Bioavailability Regulates Angiogenesis and Intestinal Stem and Progenitor Cell Proliferation during Postnatal Small Intestinal Development	PLOS ONE			English	Article							ENGINEERED SMALL-INTESTINE; CRE-MEDIATED RECOMBINATION; MOUSE INTESTINE; NEONATAL MICE; SELF-RENEWAL; IN-VITRO; RECEPTOR; EXPRESSION; EPITHELIUM; NOTCH	Background Vascular endothelial growth factor (VEGF) is a highly conserved, master regulatory molecule required for endothelial cell proliferation, organization, migration and branching morphogenesis. Podocoryne carnea and drosophila, which lack endothelial cells and a vascular system, express VEGF homologs, indicating potential roles beyond angiogenesis and vasculogenesis. The role of VEGF in the development and homeostasis of the postnatal small intestine is unknown. We hypothesized regulating VEGF bioavailability in the postnatal small intestine would exhibit effects beyond the vasculature and influence epithelial cell stem/progenitor populations. Methods VEGF mutant mice were created that overexpressed VEGF in the brush border of epithelium via the villin promotor following doxycycline treatment. To decrease VEGF bioavailability, sFlt-1 mutant mice were generated that overexpressed the soluble VEGF receptor sFlt-1 upon doxycycline administration in the intestinal epithelium. Mice were analyzed after 21 days of doxycycline administration. Results Increased VEGF expression was confirmed by RT-qPCR and ELISA in the intestine of the VEGF mutants compared to littermates. The VEGF mutant duodenum demonstrated increased angiogenesis and vascular leak as compared to littermate controls. The VEGF mutant duodenum revealed taller villi and increased Ki-67-positive cells in the transit-amplifying zone with reduced Lgr5 expression. The duodenum of sFlt-1 mutants revealed shorter villi and longer crypts with reduced proliferation in the transit-amplifying zone, reduced expression of Dll1, Bmp4 and VE-cadherin, and increased expression of Sox9 and EphB2. Conclusions Manipulating VEGF bioavailability leads to profound effects on not only the intestinal vasculature, but epithelial stem and progenitor cells in the intestinal crypt. Elucidation of the crosstalk between VEGF signaling in the vasculature, mesenchyme and epithelial stem/progenitor cell populations may direct future cell therapies for intestinal dysfunction or disease.	[Schlieve, Christopher R.; Mojica, Salvador Garcia; Holoyda, Kathleen A.; Hou, Xiaogang; Fowler, Kathryn L.; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Schlieve, Christopher R.; Holoyda, Kathleen A.; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Dept Surg, Div Pediat Surg, Los Angeles, CA 90027 USA; [Mojica, Salvador Garcia] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; California State University System; California State University San Bernardino	Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.; Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Dept Surg, Div Pediat Surg, Los Angeles, CA 90027 USA.	tgrikscheit@chla.usc.edu	Schlieve, Christopher/I-6167-2019	Schlieve, Christopher/0000-0002-8355-4046; Fowler, Kathryn/0000-0003-1252-8905	California Institute for Regenerative Medicine [RN2-00946-1, RN3-06425]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute for Regenerative Medicine (https://www.cirm.ca.gov/); RN2-00946-1 and RN3-06425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres SF, 2013, J CELL SCI, V126, P5645, DOI 10.1242/jcs.132985; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Berendsen AD, 2014, J HISTOCHEM CYTOCHEM, V62, P103, DOI 10.1369/0022155413516347; Bond D, 2012, J BIOL CHEM, V287, P27359, DOI 10.1074/jbc.M112.378018; Boquoi A, 2009, GASTROENTEROLOGY, V136, P596, DOI 10.1053/j.gastro.2008.10.028; BREIER G, 1992, DEVELOPMENT, V114, P521; CALVERT R, 1990, ANAT REC, V227, P199, DOI 10.1002/ar.1092270208; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carulli AJ, 2015, DEV BIOL, V402, P98, DOI 10.1016/j.ydbio.2015.03.012; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Delcombel R, 2013, ANGIOGENESIS, V16, P353, DOI 10.1007/s10456-012-9320-y; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Goel HL, 2012, CANCER DISCOV, V2, P906, DOI 10.1158/2159-8290.CD-12-0085; Grikscheit TC, 2004, ANN SURG, V240, P748, DOI 10.1097/01.sla.0000143246.07277.73; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4024, DOI 10.3748/wjg.v11.i26.4024; Haigh J. J, 2008, ORGANOGENESIS, V4, P247, DOI DOI 10.4161/0RG.4.4.7415; Han J, 2015, CELL REP, V10, P1158, DOI 10.1016/j.celrep.2015.01.049; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Holmes K, 2008, PEDIATR RES, V63, P143, DOI 10.1203/PDR.0b013e31815f00e0; Karlsson L, 2000, DEVELOPMENT, V127, P3457; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Landeghem LV, 2012, AM J PHYSIOL-GASTR L, V302, pG1111; Levin DE, 2013, J PEDIATR SURG, V48, P129, DOI 10.1016/j.jpedsurg.2012.10.029; Lopez-Arribillaga E, 2015, DEVELOPMENT, V142, P41, DOI 10.1242/dev.107714; Matthews JA, 2012, J SURG RES, V172, P40, DOI 10.1016/j.jss.2011.04.043; May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105; Nankervis CA, 2001, MICROCIRCULATION, V8, P377; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Sabnis A, 2015, NEONATOLOGY, V107, P191, DOI 10.1159/000368879; Sala FG, 2011, TISSUE ENG PT A, V17, P1841, DOI [10.1089/ten.TEA.2010.0564, 10.1089/ten.tea.2010.0564]; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seipel K, 2004, DEV DYNAM, V231, P303, DOI 10.1002/dvdy.20139; Shi ZC, 2013, AM J PHYSIOL-GASTR L, V305, pG74, DOI 10.1152/ajpgi.00086.2013; Shimizu H, 2014, PEERJ, V2, DOI 10.7717/peerj.370; Siafakas CG, 1999, PEDIATR RES, V45, P652, DOI 10.1203/00006450-199905010-00007; Simmen AF, 2007, AM J PHYSL GASTROINT, V292, pG1757; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Landeghem L, 2015, FASEB J, V29, P2828, DOI 10.1096/fj.14-264010; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vuorela P, 2000, AM J CLIN NUTR, V72, P1196; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	58	19	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151396	10.1371/journal.pone.0151396	http://dx.doi.org/10.1371/journal.pone.0151396			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978773	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800071
J	Zappia, KJ; Garrison, SR; Palygin, O; Weyer, AD; Barabas, ME; Lawlor, MW; Staruschenko, A; Stucky, CL				Zappia, Katherine J.; Garrison, Sheldon R.; Palygin, Oleg; Weyer, Andy D.; Barabas, Marie E.; Lawlor, Michael W.; Staruschenko, Alexander; Stucky, Cheryl L.			Mechanosensory and ATP Release Deficits following Keratin14-Cre-Mediated TRPA1 Deletion Despite Absence of TRPA1 in Murine Keratinocytes	PLOS ONE			English	Article							SENSORY NEURONS; MECHANICAL STIMULATION; CONTRIBUTES; IDENTIFICATION; NOCICEPTION; EXPRESSION; RESPONSES; IMMUNE; NERVE; MODEL	Keratinocytes are the first cells that come into direct contact with external tactile stimuli; however, their role in touch transduction in vivo is not clear. The ion channel Transient Receptor Potential Ankyrin 1 (TRPA1) is essential for some mechanically-gated currents in sensory neurons, amplifies mechanical responses after inflammation, and has been reported to be expressed in human and mouse skin. Other reports have not detected Trpa1 mRNA transcripts in human or mouse epidermis. Therefore, we set out to determine whether selective deletion of Trpa1 from keratinocytes would impact mechanosensation. We generated K14Cre-Trpa1(fl/fl) mice lacking TRPA1 in K14-expressing cells, including keratinocytes. Surprisingly, Trpa1 transcripts were very poorly detected in epidermis of these mice or in controls, and detection was minimal enough to preclude observation of Trpa1 mRNA knockdown in the K14Cre-Trpa1(fl/fl) mice. Unexpectedly, these K14Cre-Trpa1(fl/fl) mice nonetheless exhibited a pronounced deficit in mechanosensitivity at the behavioral and primary afferent levels, and decreased mechanically-evoked ATP release from skin. Overall, while these data suggest that the intended targeted deletion of Trpa1 from keratin 14-expressing cells of the epidermis induces functional deficits in mechanotransduction and ATP release, these deficits are in fact likely due to factors other than reduction of Trpa1 expression in adult mouse keratinocytes because they express very little, if any, Trpa1.	[Zappia, Katherine J.; Garrison, Sheldon R.; Weyer, Andy D.; Barabas, Marie E.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Palygin, Oleg; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Lawlor, Michael W.] Med Coll Wisconsin, Dept Pathol, Div Pediat Pathol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Zappia, KJ; Stucky, CL (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	kzappia@mcw.edu; cstucky@mcw.edu	Palygin, Oleg/AAT-3047-2020; Garrison, Sheldon/AAA-2740-2021; Barabas, Marie-Elizabeth/AAG-8822-2021	Palygin, Oleg/0000-0002-3680-5527; Garrison, Sheldon/0000-0003-0745-629X; Barabas, Marie-Elizabeth/0000-0002-4240-6979; Zappia, Katherine/0000-0002-4419-4834; Staruschenko, Alexander/0000-0002-5190-8356; Weyer, Andy/0000-0003-4485-9530	National Institute of Neurological Disorders and Stroke [NS040538, NS070711, NS087716]; National Heart, Lung, and Blood Institute [HL108880]; Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; National Institute of General Medical Sciences [GM080202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070711, F31NS087716, R01NS040538] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Projects were supported by funding from the National Institute of Neurological Disorders and Stroke, grants NS040538 and NS070711 to C.L.S., Research Supplement to NS070711 to S.R.G., and grant NS087716 to K.J.Z. Funding was also obtained through the National Heart, Lung, and Blood Institute, grant HL108880 to A.S. Partial support provided by the Research and Education Component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin. Further, K.J.Z is a member of the MCW-MSTP which is partially supported by a T32 grant from the National Institute of General Medical Sciences, GM080202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Azorin N, 2011, EXP DERMATOL, V20, P401, DOI 10.1111/j.1600-0625.2010.01219.x; Barabas ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047988; Barr TP, 2014, PAIN, V155, P1091, DOI 10.1016/j.pain.2014.02.014; Barr TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056744; Baumbauer KM, 2015, ELIFE, V4, DOI 10.7554/eLife.09674; Birklein F, 2014, J PAIN, V15, P485, DOI 10.1016/j.jpain.2014.01.490; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen LH, 2013, PROSTAG OTH LIPID M, V104, P58, DOI 10.1016/j.prostaglandins.2012.08.006; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Denda M, 2010, J INVEST DERMATOL, V130, P1942, DOI 10.1038/jid.2010.32; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Garrison SR, 2012, J NEUROPHYSIOL, V107, P913, DOI 10.1152/jn.00658.2011; Gil MP, 2012, BLOOD, V120, P3718, DOI 10.1182/blood-2012-05-428672; Gilchrist LS, 2005, BRAIN RES, V1044, P197, DOI 10.1016/j.brainres.2005.02.081; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Hudecova I, 2015, CLIN BIOCHEM, P30; Inoue K, 2013, J INVEST DERMATOL, P1; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klusch A, 2013, J INVEST DERMATOL, V133, P1387, DOI 10.1038/jid.2012.471; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Levy H, 2012, GENES IMMUN, V13, P593, DOI 10.1038/gene.2012.41; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Manjavachi MN, 2010, PAIN, V151, P345, DOI 10.1016/j.pain.2010.07.018; McGrath JA, 2004, ROOKS TXB DERMATOLOG, V7th; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Pang ZX, 2015, PAIN, V156, P656, DOI 10.1097/j.pain.0000000000000092; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Shi XY, 2011, ANESTH ANALG, V113, P175, DOI 10.1213/ANE.0b013e31821a0258; Sieber-Blum M, 2004, PROG BRAIN RES, V146, P63, DOI 10.1016/S0079-6123(03)46004-4; Soya M, 2014, CELL CALCIUM, V55, P208, DOI 10.1016/j.ceca.2014.02.015; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Wacnik PW, 2001, J NEUROSCI, V21, P9355, DOI 10.1523/JNEUROSCI.21-23-09355.2001; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Woo SH, 2010, DEVELOPMENT, V137, P3965, DOI 10.1242/dev.055970; Wright MC, 2015, J CELL BIOL, V208, P367, DOI 10.1083/jcb.201407101; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhou YM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3399; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	59	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151602	10.1371/journal.pone.0151602	http://dx.doi.org/10.1371/journal.pone.0151602			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978657	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800094
J	Chilengi, R; Simuyandi, M; Beach, L; Mwila, K; Becker-Dreps, S; Emperador, DM; Velasquez, DE; Bosomprah, S; Jiang, BM				Chilengi, Roma; Simuyandi, Michelo; Beach, Lauren; Mwila, Katayi; Becker-Dreps, Sylvia; Emperador, Devy M.; Velasquez, Daniel E.; Bosomprah, Samuel; Jiang, Baoming			Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants	PLOS ONE			English	Article							1ST 2 YEARS; SERUM ANTIBODY; DOUBLE-BLIND; BREAST-MILK; DIARRHEA; LIVE; EFFICACY; CHILDREN; RESPONSES; SAFETY	Introduction Live attenuated oral vaccines against rotavirus (RV) have been shown to be less efficacious in children from developing countries. Reasons for this disparity are not fully understood. We assessed the role of maternal factors including breast milk RV-specific IgA, transplacentally acquired infant serum RV-specific IgG and maternal HIV status in seroconversion among Zambian infants routinely immunized with Rotarix (TM) (RV1). Methods 420 mother-child pairs were recruited at infant age 6-12 weeks in Lusaka. Clinical information and samples were collected at baseline and at one month following the second dose of RV1. Determination of breast milk RV-specific IgA and serum RV-specific IgA and IgG was done using standardized ELISA. Seroconversion was defined as a >= 4 fold rise in serum IgA titre from baseline to one-month post RV1 dose 2, while seropositivity of IgA was defined as serum titre >= 40 and antibody variables were modelled on log-base 2. Logistic regression was used to identify predictors of the odds of seroconversion. Results Baseline infant seropositivity was 25.5%(91/357). The seroconversion frequency was 60.2% (130/216). Infants who were IgA seropositive at baseline were less likely to seroconvert compared to their seronegative counterparts (P = 0.04). There was no evidence of an association between maternal HIV status and seroconversion (P = 0.25). Higher titres of breast milk rotavirus-specific IgA were associated with a lower frequency of seroconverson (Nonparametric test for trend Z = -2.84; P<0.01): a two-fold increase in breast milk RV-specific IgA titres was associated with a 22% lower odds of seroconversion (OR = 0.80; 95% CI = 0.68-0.94; P = 0.01). There was seasonal variation in baseline breast milk rotavirus-specific IgA titres, with significantly higher GMTs during the cold dry months (P = 0.01). Conclusion Low immunogenicity of RV1 vaccine could be explained in part by exposure to high antibody titres in breast milk and early exposure to wild-type rotavirus infections. Potential interference of anti-RV specific IgA in breast milk and pre-vaccination serum RV specific-IgA and IgG titres with RV1 seroconversion and effectiveness requires further research.	[Chilengi, Roma; Simuyandi, Michelo; Beach, Lauren; Mwila, Katayi; Bosomprah, Samuel] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Chilengi, Roma; Becker-Dreps, Sylvia] Univ N Carolina, Chapel Hill, NC USA; [Emperador, Devy M.; Velasquez, Daniel E.; Jiang, Baoming] Ctr Dis Control & Prevent, Atlanta, GA USA	University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Chilengi, R (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.; Chilengi, R (corresponding author), Univ N Carolina, Chapel Hill, NC USA.	Roma.Chilengi@cidrz.org	Simuyandi, Michelo/I-5598-2018	Simuyandi, Michelo/0000-0002-7348-2835; Beach, Lauren/0000-0003-3302-5047; Mwila Kazimbaya, Katayi/0000-0002-8482-4693; Bosomprah, PhD, Prof. Samuel/0000-0002-2826-3887; Emperador, Devy/0000-0002-8228-1824	National Institutes for Health (NIH), USA [1R01AI099601]; NIH [1R56A1108515-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099601] Funding Source: NIH RePORTER	National Institutes for Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is funded by the National Institutes for Health (NIH), USA, through an R01 grant 1R01AI099601. Co-author SD was supported by 1R56A1108515-01 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127622; Appaiahgari MB, 2014, VACCINE, V32, P651, DOI 10.1016/j.vaccine.2013.12.017; Becker-Dreps S, 2015, PEDIATR INFECT DIS J, V34, P115, DOI 10.1097/INF.0000000000000481; Campbel DI, 2003, PAEDIAT RES, V54; Chan J, 2011, VACCINE, V29, P1242, DOI 10.1016/j.vaccine.2010.11.087; CLEMENS JD, 1992, J INFECT DIS, V165, P161, DOI 10.1093/infdis/165.1.161; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Dennehy PH, 1996, PEDIATR INFECT DIS J, V15, P1012, DOI 10.1097/00006454-199611000-00016; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; GLASS RI, 1989, ACTA PAEDIATR SCAND, P131; GlaxoSmithKline, ROTARIX PRESCR INF; Groome MJ, 2014, B WORLD HEALTH ORGAN, V92, P238, DOI 10.2471/BLT.13.128066; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Jiang BM, 2002, CLIN INFECT DIS, V34, P1351, DOI 10.1086/340103; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kvistgaard AS, 2004, J DAIRY SCI, V87, P4088, DOI 10.3168/jds.S0022-0302(04)73551-1; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Maier EA, 2013, VACCINE, V32, P48, DOI 10.1016/j.vaccine.2013.10.072; Moon SS, 2016, CLIN INFECT DIS, V62, P157, DOI 10.1093/cid/civ828; Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; MPABALWANI M, 1995, ANN TROP PAEDIATR, V15, P39, DOI 10.1080/02724936.1995.11747747; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; ORYAN ML, 1994, J INFECT DIS, V169, P504, DOI 10.1093/infdis/169.3.504; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Ray PG, 2004, J MED VIROL, V72, P416, DOI 10.1002/jmv.20020; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Rongsen-Chandola T, 2014, VACCINE, V32, pA134, DOI 10.1016/j.vaccine.2014.04.078; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Waggie Z, 2010, J INFECT DIS, V202, pS23, DOI 10.1086/653554; WHO Strategic Advisory Group of Experts (SAGE) on Immunisation, 2009, WEEKLY EPIDEMIOLOGIC, P213; WHO. World Health Organization, 2009, INTR ROT VACC NAT IM; Wood D, 2005, VACCINE, V23, P5478, DOI 10.1016/j.vaccine.2005.07.035; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; World Health Organization, 2008, Weekly Epidemiological Record, V83, P421; Xu J, 2005, CLIN DIAGN LAB IMMUN, V12, P273, DOI 10.1128/CDLI.12.2.273-279.2005	43	43	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150100	10.1371/journal.pone.0150100	http://dx.doi.org/10.1371/journal.pone.0150100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974432	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600018
J	Maheshwari, N; Kantipudi, S; Maheshwari, A; Arora, K; Kwatra, VN; Sahni, G				Maheshwari, Neeraj; Kantipudi, Satish; Maheshwari, Anand; Arora, Kashika; Kwatra, Vandana Neha; Sahni, Girish			Amino-Terminal Fusion of Epidermal Growth Factor 4,5,6 Domains of Human Thrombomodulin on Streptokinase Confers Anti-Reocclusion Characteristics along with Plasmin-Mediated Clot Specificity	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; FIBRIN DEGRADATION-PRODUCTS; ACUTE MYOCARDIAL-INFARCTION; HEPARIN-ANTITHROMBIN; INTRACRANIAL HEMORRHAGE; INDEPENDENT INHIBITORS; FIBRINOPEPTIDE-A; HOMOLOGY DOMAIN; BINDING-SITE; THROMBIN	Streptokinase (SK) is a potent clot dissolver but lacks fibrin clot specificity as it activates human plasminogen (HPG) into human plasmin (HPN) throughout the system leading to increased risk of bleeding. Another major drawback associated with all thrombolytics, including tissue plasminogen activator, is the generation of transient thrombin and release of clot-bound thrombin that promotes reformation of clots. In order to obtain anti-thrombotic as well as clot-specificity properties in SK, cDNAs encoding the EGF 4,5,6 domains of human thrombomodulin were fused with that of streptokinase, either at its N- or C-termini, and expressed these in Pichia pastoris followed by purification and structural-functional characterization, including plasminogen activation, thrombin inhibition, and Protein C activation characteristics. Interestingly, the N-terminal EGF fusion construct (EGF-SK) showed plasmin-mediated plasminogen activation, whereas the C-terminal (SK-EGF) fusion construct exhibited 'spontaneous' plasminogen activation which is quite similar to SK i.e. direct activation of systemic HPG in absence of free HPN. Since HPN is normally absent in free circulation due to rapid serpin-based inactivation (such as alpha-2-antiplasmin and alpha-2-Macroglobin), but selectively present in clots, a plasmin-dependent mode of HPG activation is expected to lead to a desirable fibrin clot-specific response by the thrombolytic. Both the N- and C-terminal fusion constructs showed strong thrombin inhibition and Protein C activation properties as well, and significantly prevented re-occlusion in a specially designed assay. The EGF-SK construct exhibited fibrin clot dissolution properties with much-lowered levels of fibrinogenolysis, suggesting unmistakable promise in clot dissolver therapy with reduced hemorrhage and re-occlusion risks.	[Maheshwari, Neeraj; Kantipudi, Satish; Maheshwari, Anand; Arora, Kashika; Kwatra, Vandana Neha; Sahni, Girish] CSIR Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sahni, G (corresponding author), CSIR Inst Microbial Technol, Chandigarh, India.	sahni@imtech.res.in		arora, kashika/0000-0002-1354-4811	Council of Scientific and Industrial Research (C.S.I.R.), government of India	Council of Scientific and Industrial Research (C.S.I.R.), government of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from the Council of Scientific and Industrial Research (C.S.I.R.), government of India.	Aneja R, 2009, J BIOL CHEM, V284, P32642, DOI 10.1074/jbc.M109.046573; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; Buerke M, 2000, EXS, V89, P193; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; CHRISTENSEN U, 1977, BIOCHEM J, V163, P389, DOI 10.1042/bj1630389; COLLEN D, 1990, BIOCHEM PHARMACOL, V40, P177, DOI 10.1016/0006-2952(90)90676-C; DAVEY MG, 1967, NATURE, V216, P857, DOI 10.1038/216857a0; DEJAEGERE PP, 1992, J AM COLL CARDIOL, V19, P289, DOI 10.1016/0735-1097(92)90480-B; EISENBERG PR, 1986, J AM COLL CARDIOL, V7, P1255, DOI 10.1016/S0735-1097(86)80144-9; EISENBERG PR, 1987, J AM COLL CARDIOL, V10, P527, DOI 10.1016/S0735-1097(87)80194-8; FAY PJ, 1988, BIOCHIM BIOPHYS ACTA, V952, P181, DOI 10.1016/0167-4838(88)90114-8; FRANCIS CW, 1991, PROG CARDIOVASC DIS, V34, P193, DOI 10.1016/0033-0620(91)90013-C; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Goldstein J, 1996, THROMB HAEMOSTASIS, V76, P429; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; Johnston SC, 2010, STROKE, V41, pS59, DOI 10.1161/STROKEAHA.110.597351; KASE CS, 1990, ANN INTERN MED, V112, P17, DOI 10.7326/0003-4819-112-1-17; Keramati Malihe, 2013, Cardiovascular & Hematological Agents in Medicinal Chemistry, V11, P218, DOI 10.2174/187152571103140120103816; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LANDI G, 1990, STROKE, V21, P424, DOI 10.1161/01.STR.21.3.424; Lijnen H R, 1983, Behring Inst Mitt, P43; LIJNEN HR, 1988, BLUT, V57, P147, DOI 10.1007/BF00319543; LORAND L, 1964, ARCH BIOCHEM BIOPHYS, V105, P58, DOI 10.1016/0003-9861(64)90235-8; LOUGHEED JC, 1995, PROTEIN SCI, V4, P773; LUESCHER EF, 1961, VOX SANG, V6, P116, DOI 10.1111/j.1423-0410.1961.tb03141.x; Maheshwari N, 2013, GOOGLE PATENTS; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; MERLINI PA, 1995, J AM COLL CARDIOL, V25, P203, DOI 10.1016/0735-1097(94)00360-3; MOSESSON M W, 1992, Seminars in Hematology, V29, P177; Nihalani D, 1998, PROTEIN SCI, V7, P637, DOI 10.1002/pro.5560070313; OHMAN EM, 1990, CIRCULATION, V82, P781, DOI 10.1161/01.CIR.82.3.781; Parrado J, 1996, PROTEIN SCI, V5, P693; RAMPLING MW, 1976, CLIN CHIM ACTA, V67, P43, DOI 10.1016/0009-8981(76)90215-1; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Reed GL, 1999, P NATL ACAD SCI USA, V96, P8879, DOI 10.1073/pnas.96.16.8879; SAKHAROV DV, 1995, CIRCULATION, V92, P1883, DOI 10.1161/01.CIR.92.7.1883; Sakharov DV, 1996, J BIOL CHEM, V271, P2133, DOI 10.1074/jbc.271.4.2133; Sazonova IY, 2009, J THROMB HAEMOST, V7, P1321, DOI 10.1111/j.1538-7836.2009.03491.x; SCHUMACHER WA, 1989, J CARDIOVASC PHARM, V13, P853, DOI 10.1097/00005344-198906000-00007; SHI GY, 1994, BIOCHEM J, V304, P235, DOI 10.1042/bj3040235; STEARNS DJ, 1989, J BIOL CHEM, V264, P3352; STENFLO J, 1988, J BIOL CHEM, V263, P21; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; VALI Z, 1988, BIOCHEMISTRY-US, V27, P1956, DOI 10.1021/bi00406a023; Wang H, 1999, J CONTROL RELEASE, V59, P119, DOI 10.1016/S0168-3659(99)00019-X; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang XD, 2009, THROMB HAEMOSTASIS, V102, P1194, DOI 10.1160/TH09-04-0235; WEITZ JI, 1991, J CLIN INVEST, V87, P1082, DOI 10.1172/JCI115069; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Weitz JI, 1998, CIRCULATION, V97, P544; White CE, 1995, PROTEIN ENG, V8, P1177, DOI 10.1093/protein/8.11.1177; WOHL RC, 1980, J BIOL CHEM, V255, P2005; ZUSHI M, 1991, J BIOL CHEM, V266, P19886	59	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150315	10.1371/journal.pone.0150315	http://dx.doi.org/10.1371/journal.pone.0150315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974970	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600022
J	Watanabe, J; Takiyama, Y; Honjyo, J; Makino, Y; Fujita, Y; Tateno, M; Haneda, M				Watanabe, Jun; Takiyama, Yumi; Honjyo, Jun; Makino, Yuichi; Fujita, Yukihiro; Tateno, Masatoshi; Haneda, Masakazu			Role of IGFBP7 in Diabetic Nephropathy: TGF-beta 1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACUTE KIDNEY INJURY; TGF-BETA; CYCLE ARREST; MESENCHYMAL TRANSITION; IDENTIFICATION; EXPRESSION; BIOMARKERS; MATRIPTASE; DISEASE	Tubular injury is one of the important determinants of progressive renal failure in diabetic nephropathy (DN), and TGF-beta 1 has been implicated in the pathogenesis of tubulointerstitial disease that characterizes proteinuric renal disease. The aim of this study was to identify novel therapeutic target molecules that play a role in the tubule damage of DN. We used an LC-MS/MS-based proteomic technique and human renal proximal epithelial cells (HRPTECs). Urine samples from Japanese patients with type 2 diabetes (n = 46) were used to quantify the candidate protein. Several proteins in HRPTECs in cultured media were observed to be driven by TGF-beta 1, one of which was 33-kDa IGFBP7, which is a member of IGFBP family. TGF-beta 1 up-regulated the expressions of IGFBP7 mRNA and protein in a dose-and time-dependent fashion via Smad2 and 4, but not MAPK pathways in HRPTECs. In addition, the knockdown of IGFBP7 restored the TGF-beta 1-induced epithelial to mesenchymal transition (EMT). In the immunohistochemical analysis, IGFBP7 was localized to the cytoplasm of tubular cells but not that of glomerular cells in diabetic kidney. Urinary IGFBP7 levels were significantly higher in the patients with macroalbuminuria and were correlated with age (r = 0.308, p = 0.037), eGFR (r = -0.376, p = 0.01), urinary beta(2)-microglobulin (r = 0.385, p = 0.008), and urinary N-acetyl-beta-D-glucosaminidase (NAG) (r = 0.502, p = 0.000). A multivariate regression analysis identified urinary NAG and age as determinants associated with urinary IGFBP7 levels. In conclusion, our data suggest that TGF-beta 1 enhances IGFBP7 via Smad2/4 pathways, and that IGFBP7 might be involved in the TGF-beta 1-induced tubular injury in DN.	[Watanabe, Jun; Takiyama, Yumi; Honjyo, Jun; Makino, Yuichi; Fujita, Yukihiro; Haneda, Masakazu] Asahikawa Med Univ, Dept Med, Div Metab & Biosyst Sci, Asahikawa, Hokkaido, Japan; [Tateno, Masatoshi] Asahikawa Med Univ, Dept Pathol, Asahikawa, Hokkaido, Japan	Asahikawa Medical College; Asahikawa Medical College	Takiyama, Y (corresponding author), Asahikawa Med Univ, Dept Med, Div Metab & Biosyst Sci, Asahikawa, Hokkaido, Japan.	taka0716@asahikawa-med.ac.jp						Ahmed S, 2006, FEBS J, V273, P615, DOI 10.1111/j.1742-4658.2005.05094.x; Ahmed S, 2003, BIOCHEM BIOPH RES CO, V310, P612, DOI 10.1016/j.bbrc.2003.09.058; Akaogi K, 1996, P NATL ACAD SCI USA, V93, P8384, DOI 10.1073/pnas.93.16.8384; Andersen S, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-29; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Brocco E, 1997, KIDNEY INT, pS40; Cefalu WT, 2002, DIABETES CARE, V25, P2123, DOI 10.2337/diacare.25.12.2123; Choi ME, 2000, KIDNEY INT, V58, pS53, DOI 10.1046/j.1523-1755.2000.07709.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dewitte A, 2015, CLIN J AM SOC NEPHRO, V10, P1900, DOI 10.2215/CJN.12651214; Fioretto P, 1996, DIABETOLOGIA, V39, P1569, DOI 10.1007/s001250050616; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Grant PJ, 1996, DIABETES CARE, V19, P64, DOI 10.2337/diacare.19.1.64; Guo BL, 2005, KIDNEY INT, V68, P972, DOI 10.1111/j.1523-1755.2005.00491.x; Hagiwara K, 2008, PROTEOMICS, V8, P1871, DOI 10.1002/pmic.200701051; Hata Y, 2000, J CLIN INVEST, V106, P541, DOI 10.1172/JCI8338; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kellum JA, 2016, NEPHROL DIAL TRANSPL, V31, P16, DOI 10.1093/ndt/gfv130; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; Koyner JL, 2015, J AM SOC NEPHROL, V26, P1747, DOI 10.1681/ASN.2014060556; Liu LX, 2009, WORLD J GASTROENTERO, V15, P3246, DOI 10.3748/wjg.15.3246; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Loftheim H, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-9; Lopez-Bermejo A, 2007, DIABETES CARE, V30, P1615, DOI 10.2337/dc06-1905; Lopez-Bermejo A, 2006, DIABETES, V55, P2333, DOI 10.2337/db05-1627; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093460; Miyauchi K, 2009, DIABETES RES CLIN PR, V83, P190, DOI 10.1016/j.diabres.2008.11.018; MURPHY M, 1993, CELL GROWTH DIFFER, V4, P715; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Pan CC, 2004, HISTOPATHOLOGY, V45, P452, DOI 10.1111/j.1365-2559.2004.01962.x; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Reeves WB, 2000, P NATL ACAD SCI USA, V97, P7667, DOI 10.1073/pnas.97.14.7667; Russo LM, 2007, DIABETES, V56, P380, DOI 10.2337/db06-1018; Sato J, 1999, J CELL BIOCHEM, V75, P187, DOI 10.1002/(SICI)1097-4644(19991101)75:2<187::AID-JCB1>3.0.CO;2-R; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Sharma K, 1997, DIABETES, V46, P854, DOI 10.2337/diabetes.46.5.854; TAFT JL, 1994, DIABETES, V43, P1046, DOI 10.2337/diabetes.43.8.1046; Takiyama Y, 2011, DIABETES, V60, P981, DOI 10.2337/db10-0655; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Vallon V, 2014, NEPHRON CLIN PRACT, V127, P133, DOI 10.1159/000363554; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; Yamauchi T, 1996, BIOCHEM J, V303, P591; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	53	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150897	10.1371/journal.pone.0150897	http://dx.doi.org/10.1371/journal.pone.0150897			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974954	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600038
J	Chao, Z; Cui, Q; Tian, EW; Zeng, WP; Cai, X; Li, XL; Tanaka, H; Shoyama, Y; Wu, YS				Chao, Zhi; Cui, Qian; Tian, Enwei; Zeng, Weiping; Cai, Xuan; Li, Xiaolei; Tanaka, Hiroyuki; Shoyama, Yukihiro; Wu, Yingsong			Ultrasensitive Time-Resolved Fluoroimmunoassay for Saikosaponin a in Chaihu (Bupleuri Radix)	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; ASSAY; DERIVATIVES; ACTIVATION; COMPONENTS; INDUCTION; CELLS; ELISA	The aim of this study is to establish a time-resolved fluoroimmunoassay (TRFIA) system for quantitative analysis of saikosaponin a (SSa) in the crude drug of Chaihu (Bupleuri Radix). A 96-well microplate coated with rabbit anti-mouse IgG was incubated with the methanol extracts of Chaihu samples and a mouse anti-SSa monoclonal antibody, and a Eu3+-labeled SSa-human serum albumin conjugate was used as the tracer. The established competitive TRFIA showed a good fourth order polynomial fitting from 0.01 to 10.0 mu g/mL for standard SSa sample with a detection limit of 0.006 mu g/mL. The intra-and inter-assay coefficients of variation of the assay were 7.3% and 8.9%, respectively, and the average SSa recovery was 119.2%. For samples of Chaihu extract, the results of this assay showed a good correlation with those by enzyme-linked immunosorbent assay established previously. This TRFIA system is ultrasensitive for detecting SSa with a wide detection range and a good stability and represents the first attempt of using TRFIA for quality evaluation of the crude drug of Chaihu.	[Chao, Zhi; Cui, Qian; Tian, Enwei; Zeng, Weiping; Cai, Xuan; Li, Xiaolei] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China; [Tanaka, Hiroyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Shoyama, Yukihiro] Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo 8593298, Japan; [Wu, Yingsong] Southern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Kyushu University; Nagasaki International University; Southern Medical University - China	Chao, Z (corresponding author), Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China.; Wu, YS (corresponding author), Southern Med Univ, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China.	chaozhi@smu.edu.cn; wg@smu.edu.cn		Chao, Zhi/0000-0002-3583-9848	NSFC [81373905, 30873387]; GDNSF [2014A030313321]	NSFC(National Natural Science Foundation of China (NSFC)); GDNSF	The work was supported by the following: NSFC no. 81373905 and no. 30873387, http://www.nsfc.gov.cn/, ZC; NSFC no. 81373905 and no. 30873387, http://www.nsfc.gov.cn/; GDNSF no. 2014A030313321, http://pro.gdstc.gov.cn/egrantweb/; ZC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YW, 2004, ANAL CHEM, V76, P4208, DOI 10.1021/ac0499423; Chao Z, 2014, PHYTOMEDICINE, V21, P1767, DOI 10.1016/j.phymed.2014.09.001; Chao Z, 2013, J NAT MED-TOKYO, V67, P512, DOI 10.1007/s11418-012-0708-1; Chen JC, 2003, AM J CHINESE MED, V31, P363, DOI 10.1142/S0192415X03001065; Chen Y, 2011, MOLECULES, V16, P9600, DOI 10.3390/molecules16119600; Crowther J. R., 2001, ELISA GUIDEBOOK; Fang JH, 2009, J CHIN U METROL, V20, P211; Fujii S, 2014, J NAT MED-TOKYO, V68, P717, DOI 10.1007/s11418-014-0847-7; [郭智 Guo Zhi], 2014, [天然产物研究与开发, Natural Product Research and Development], V26, P716; HATTORI T, 1991, FOLIA PHARMACOL JPN, V97, P13, DOI 10.1254/fpj.97.1_13; Jung DW, 1998, CHEM PHARM BULL, V46, P1140, DOI 10.1248/cpb.46.1140; Kim BM, 2011, APOPTOSIS, V16, P184, DOI 10.1007/s10495-010-0557-x; Li XQ, 2005, BIOL PHARM BULL, V28, P1736, DOI 10.1248/bpb.28.1736; Liang QN, 2015, LUMINESCENCE, V30, P649, DOI 10.1002/bio.2800; Lin XL, 2005, ANAL BIOANAL CHEM, V382, P1610, DOI 10.1007/s00216-005-3371-5; Liu ZJ, 2013, ANAL METHODS-UK, V5, P3572, DOI 10.1039/c3ay00033h; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Ma Li-ling, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1006; Morinaga O, 2009, FITOTERAPIA, V80, P28, DOI 10.1016/j.fitote.2008.09.004; MOTOO Y, 1994, CANCER LETT, V86, P91, DOI 10.1016/0304-3835(94)90184-8; National Pharmacopoeia Committee, 2010, PHARMACOPOEIA PEOPLE; NOSE M, 1989, CHEM PHARM BULL, V37, P2736, DOI 10.1248/cpb.37.2736; Park IS, 2000, J CHROMATOGR SCI, V38, P229, DOI 10.1093/chromsci/38.6.229; Paudel MK, 2011, ANAL CHIM ACTA, V701, P189, DOI 10.1016/j.aca.2011.05.054; Peng K, 2014, MABS-AUSTIN, V6, P1500, DOI 10.4161/mabs.36208; Secundo F, 2012, J FOOD COMPOS ANAL, V25, P221, DOI 10.1016/j.jfca.2011.09.003; Sheng YJ, 2014, BIOMED ENVIRON SCI, V27, P126, DOI 10.3967/bes2014.027; Sritularak B, 2009, J NAT MED-TOKYO, V63, P360, DOI 10.1007/s11418-009-0332-x; Sun Y, 2009, INT IMMUNOPHARMACOL, V9, P978, DOI 10.1016/j.intimp.2009.04.006; [汤芳玲 TANG Fangling], 2011, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V31, P1654; Tsai YJ, 2002, PHYTOTHER RES, V16, P117, DOI 10.1002/ptr.752; [卫吴 Wei Hao], 2013, [中成药, Chinese Traditional Patent Medicine], V35, P342; Wu SJ, 2008, J MED FOOD, V11, P224, DOI 10.1089/jmf.2007.555; Wu WS, 2003, ONCOGENE, V22, P955, DOI 10.1038/sj.onc.1206237; Xu WW, 2010, J MOL THER, V2, P140; YEN MH, 1991, J ETHNOPHARMACOL, V34, P155, DOI 10.1016/0378-8741(91)90033-A; YEN MH, 1995, PHYTOTHER RES, V9, P351, DOI 10.1002/ptr.2650090509; Yu T, 2013, J IMMUNOASS IMMUNOCH, V34, P365, DOI 10.1080/15321819.2012.744999; Zhang GuoSong, 2014, Chinese Journal of Information on Traditional Chinese Medicine, V21, P74; [张宏娜 ZHANG Hongna], 2007, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V27, P1150; [周琼 Zhou Qiong], 2012, [天然产物研究与开发, Natural Product R & D], V24, P644; Zhu SH, 2004, BIOL PHARM BULL, V27, P66, DOI 10.1248/bpb.27.66	42	11	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151032	10.1371/journal.pone.0151032	http://dx.doi.org/10.1371/journal.pone.0151032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968034	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200029
J	Eger, C; Siebert, N; Seidel, D; Zumpe, M; Juttner, M; Brandt, S; Muller, HP; Lode, HN				Eger, Christin; Siebert, Nikolai; Seidel, Diana; Zumpe, Maxi; Juettner, Madlen; Brandt, Sven; Mueller, Hans-Peter; Lode, Holger N.			Generation and Characterization of a Human/Mouse Chimeric GD(2)-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma	PLOS ONE			English	Article							TUMOR-CELLS; GD2; THERAPY; GANGLIOSIDE; METASTASES; INDUCTION; IMMUNITY; GROWTH; CANCER; TRIAL	Vaccination with proteins mimicking GD(2) that is highly expressed on neuroblastoma (NB) cells is a promising strategy in treatment of NB, a pediatric malignancy with poor prognosis. We previously showed efficacy of ganglidiomab in vivo, a murine anti-idiotype (anti-Id) IgG1. In order to tailor immune responses to variable regions, we generated a new human/mouse chimeric anti-Id antibody (Ab) ganglidiximab by replacing murine constant fragments with corresponding human IgG1 regions. DNA sequences encoding for variable regions of heavy (VH) and light chains (VL) were synthesized by RT-PCR from total RNA of ganglidiomab-producing hybridoma cells and further ligated into mammalian expression plasmids with coding sequences for constant regions of human IgG1 heavy and light chains, respectively. We established a stable production cell line using Chinese hamster ovarian (CHO) cells co-transfected with two expression plasmids driving the expression of either ganglidiximab heavy or light chain. After purification from supernatants, anti-idiotypic characteristics of ganglidiximab were demonstrated. Binding of ganglidiximab to anti-GD(2) Abs of the 14.18 family as well as to NK-92tr cells expressing a GD(2)-specific chimeric antigen receptor (scFv(ch14.18)-zeta) was shown using standard ELISA and flow cytometry analysis, respectively. Ganglidiximab binding affinities to anti-GD(2) Abs were further determined by surface plasmon resonance technique. Moreover, binding of anti-GD(2) Abs to the nominal antigen GD(2) as well as GD(2)-specific Ab-mediated cytotoxicity (ADCC, CDC) was competitively inhibited by ganglidiximab. Finally, ganglidiximab was successfully used as a protein vaccine in vivo to induce a GD(2)-specific humoral immune response. In summary, we report generation and characterization of a new human/mouse chimeric anti-Id Ab ganglidiximab for active immunotherapy against NB. This Ab may be useful to tailor immune responses to the paratope regions mimicking GD(2) overexpressed in NB.	[Eger, Christin; Siebert, Nikolai; Seidel, Diana; Zumpe, Maxi; Juettner, Madlen; Lode, Holger N.] Univ Med Greifswald, Dept Pediat Oncol & Hematol, D-17475 Greifswald, Germany; [Brandt, Sven; Mueller, Hans-Peter] Ernst Moritz Arndt Univ Greifswald, Ctr Innovat Competence Humoral Immune React Cardi, ZIK HIKE, Greifswald, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald	Siebert, N (corresponding author), Univ Med Greifswald, Dept Pediat Oncol & Hematol, D-17475 Greifswald, Germany.	nikolai.siebert@uni-greifswald.de		Lode, Holger/0000-0002-1201-208X	University Medicine Greifswald, Germany [97237000]; H.W. & J. Hector Stiftung, Germany [M57]; Deutsche Kinderkrebsstiftung, Germany [DKS 2014.05 A/B]; APEIRON Biologics AG, Austria [APN]	University Medicine Greifswald, Germany; H.W. & J. Hector Stiftung, Germany; Deutsche Kinderkrebsstiftung, Germany; APEIRON Biologics AG, Austria	This work was funded by University Medicine Greifswald, Germany (grant number 97237000; http://www2.medizin.uni-greifswald.de/; recipient: HL); H.W. & J. Hector Stiftung, Germany (grant number M57; http://www.hector-stiftung.de/; recipient: HL); Deutsche Kinderkrebsstiftung, Germany (grant number: DKS 2014.05 A/B; http://www.kinderkrebsstiftung.de/; recipient: HL); and APEIRON Biologics AG, Austria (grant number: APN; http://www.apeiron-biologics.com/; recipient: HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice L.Yu., PROGR TREATMENT HIGH; Basak S, 2003, CANCER IMMUNOL IMMUN, V52, P145, DOI 10.1007/s00262-002-0340-0; Becker R, 2002, BRIT J NEUROSURG, V16, P269, DOI 10.1080/02688690220148860; Bhattacharya-Chatterjee M, 2002, EXPERT OPIN BIOL TH, V2, P869, DOI 10.1517/14712598.2.8.869; CHEUNG NKV, 1987, J NUCL MED, V28, P1577; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; DeNardo GL, 2003, CANCER IMMUNOL IMMUN, V52, P309, DOI 10.1007/s00262-002-0350-y; Esser R, 2012, J CELL MOL MED, V16, P569, DOI 10.1111/j.1582-4934.2011.01343.x; Fest S, 2006, CANCER RES, V66, P10567, DOI 10.1158/0008-5472.CAN-06-1158; GILLIES SD, 1992, P NATL ACAD SCI USA, V89, P1428, DOI 10.1073/pnas.89.4.1428; GILLIES SD, 1989, J IMMUNOL METHODS, V125, P191, DOI 10.1016/0022-1759(89)90093-8; Herlyn D, 1996, CANCER IMMUNOL IMMUN, V43, P65, DOI 10.1007/s002620050305; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Khan KH, 2013, ADV PHARM BULL, V3, P257, DOI 10.5681/apb.2013.042; Ladenstein R, 2013, MABS-AUSTIN, V5, P801, DOI 10.4161/mabs.25215; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Lode HN, 2015, IMMUNE ACTIVATION CL; Lode HN, 2013, CANCER IMMUNOL IMMUN, V62, P999, DOI 10.1007/s00262-013-1413-y; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MUELLER BM, 1990, P NATL ACAD SCI USA, V87, P5702, DOI 10.1073/pnas.87.15.5702; MUJOO K, 1989, CANCER RES, V49, P2857; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; SCHULZ G, 1984, CANCER RES, V44, P5914; SEEGER RC, 1977, CANCER RES, V37, P1364; Seidel D, 2015, CANCER IMMUNOL IMMUN, V64, P621, DOI 10.1007/s00262-015-1669-5; Sen G, 1998, J IMMUNOTHER, V21, P75, DOI 10.1097/00002371-199801000-00010; Siebert N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107692; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; SVENNERHOLM L, 1994, BBA-LIPID LIPID MET, V1214, P115, DOI 10.1016/0005-2760(94)90034-5; Yang RK, 2010, DRUG FUTURE, V35, P665, DOI 10.1358/dof.2010.035.08.1513490	33	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150479	10.1371/journal.pone.0150479	http://dx.doi.org/10.1371/journal.pone.0150479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967324	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200014
J	Nantasanti, S; Toussaint, MJM; Youssef, SA; Tooten, PCJ; de Bruin, A				Nantasanti, Sathidpak; Toussaint, Mathilda J. M.; Youssef, Sameh A.; Tooten, Peter C. J.; de Bruin, Alain			Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MOUSE-LIVER; CANCER; CRE; DISEASE; CELLS; POLYPLOIDIZATION; CARCINOGENESIS; PLOIDY; STEM	The tumor suppressors Retinoblastoma (Rb) and p53 are frequently inactivated in liver diseases, such as hepatocellular carcinomas (HCC) or infections with Hepatitis B or C viruses. Here, we discovered a novel role for Rb and p53 in xenobiotic metabolism, which represent a key function of the liver for metabolizing therapeutic drugs or toxins. We demonstrate that Rb and p53 cooperate to metabolize the xenobiotic 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). DDC is metabolized mainly by cytochrome P450 (Cyp)3a enzymes resulting in inhibition of heme synthesis and accumulation of protoporphyrin, an intermediate of heme pathway. Protoporphyrin accumulation causes bile injury and ductular reaction. We show that loss of Rb and p53 resulted in reduced Cyp3a expression decreased accumulation of protoporphyrin and consequently less ductular reaction in livers of mice fed with DDC for 3 weeks. These findings provide strong evidence that synergistic functions of Rb and p53 are essential for metabolism of DDC. Because Rb and p53 functions are frequently disabled in liver diseases, our results suggest that liver patients might have altered ability to remove toxins or properly metabolize therapeutic drugs. Strikingly the reduced biliary injury towards the oxidative stress inducer DCC was accompanied by enhanced hepatocellular injury and formation of HCCs in Rb and p53 deficient livers. The increase in hepatocellular injury might be related to reduce protoporphyrin accumulation, because protoporphrin is well known for its anti-oxidative activity. Furthermore our results indicate that Rb and p53 not only function as tumor suppressors in response to carcinogenic injury, but also in response to non-carcinogenic injury such as DDC.	[Nantasanti, Sathidpak; Toussaint, Mathilda J. M.; Youssef, Sameh A.; Tooten, Peter C. J.; de Bruin, Alain] Univ Utrecht, Dept Pathobiol, Fac Vet Med, NL-3584 CL Utrecht, Netherlands; [de Bruin, Alain] Univ Groningen, Univ Med Ctr Groningen, Div Mol Genet, Dept Pediat, NL-9713 AV Groningen, Netherlands	Utrecht University; University of Groningen	de Bruin, A (corresponding author), Univ Utrecht, Dept Pathobiol, Fac Vet Med, NL-3584 CL Utrecht, Netherlands.; de Bruin, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Mol Genet, Dept Pediat, NL-9713 AV Groningen, Netherlands.	a.debruin@uu.nl	de Bruin, Alain/AAL-9195-2020	de Bruin, Alain/0000-0001-8579-2649	Netherlands Organization for Scientific Research [NWO-ALW-IN/11-28, 834.11.002]; Dutch Cancer Society [KWF UU 2013-5777]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Netherlands Organization for Scientific Research (A. d.B., NWO-ALW-IN/11-28; 834.11.002.) and the Dutch Cancer Society (A.d.B. KWF UU 2013-5777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgo RJ, 2011, MOL BIOL CELL, V22, P931, DOI 10.1091/mbc.E10-11-0895; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Gentric G, 2015, J CLIN INVEST, V125, P981, DOI 10.1172/JCI73957; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hutcheson J, 2014, HEPATOLOGY, V60, P1231, DOI 10.1002/hep.27217; Casanova-Gonzalez MJ, 2010, WORLD J GASTROENTERO, V16, P4526, DOI 10.3748/wjg.v16.i36.4526; Koike H, 2012, J HEPATO-BIL-PAN SCI, V19, P587, DOI 10.1007/s00534-012-0544-4; Kurinna S, 2013, HEPATOLOGY, V57, P2004, DOI 10.1002/hep.26233; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; McClendon AK, 2011, GASTROENTEROLOGY, V141, P1439, DOI 10.1053/j.gastro.2011.06.046; McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202; Meeks RG., 1991, HEPATOTOXICOLOGY; Nassar AF, 2009, DRUG METABOLISM HDB; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Oh-McGinnis R, 2010, BRIEF FUNCT GENOMICS, V9, P281, DOI 10.1093/bfgp/elq017; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Pflaumf J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00285; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Reed C, 2014, AM J PATHOL, V184, P1853, DOI 10.1016/j.ajpath.2014.02.025; Robles MTS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026019; Sancho-Bru P, 2009, GUT, V58, P594, DOI 10.1136/gut.2008.171116; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Thompson MD, 2010, AM J PATHOL, V177, P1812, DOI 10.2353/ajpath.2010.100173; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Weinberg R. A., 2013, BIOL CANC; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790	38	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150064	10.1371/journal.pone.0150064	http://dx.doi.org/10.1371/journal.pone.0150064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967735	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200008
J	Wang, QQ; Qian, LL; Jiang, SW; Cai, CB; Ma, DZ; Gao, PF; Li, HG; Jiang, K; Tang, MX; Hou, J; Liu, J; Cui, WT				Wang, Qingqing; Qian, Lili; Jiang, Shengwang; Cai, Chunbo; Ma, Dezun; Gao, Pengfei; Li, Hegang; Jiang, Ke; Tang, Maoxue; Hou, Jian; Liu, Jie; Cui, Wentao			Safety Evaluation of Neo Transgenic Pigs by Studying Changes in Gut Microbiota Using High-Throughput Sequencing Technology	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GENES; INTEGRONS; EXPRESSION; RESISTANCE; DIVERSITY; EVOLUTION; PROMOTER	The neo (neomycin phosphotransferase) gene is widely used as a selection marker in the production of genetically engineered animals and plants. Recent attention has been focused on safety concerns regarding neo transgene expression. In this study, neo transgenic and non-transgenic piglets were randomly assigned into Group A and Group B to evaluate effects of neo transgene by studying changes in gut microbiota using high-throughput sequencing. Group A pigs were fed a standard diet supplemented with antibiotic neomycin; Group B pigs were fed a standard diet. We examined horizontal transfer of exogenous neo gene using multiplex PCR; and investigated if the presence of secreted NPT II (neo expression product) in the intestine could lead to some protection against neomycin in transgenic pigs by monitoring different patterns of changes in gut microbiota in Group A animals. The unintended effects of neo transgene on gut microbiota were studied in Group B animals. Horizontal gene transfer was not detected in gut microbiota of any transgenic pigs. In Group A, a significant difference was observed between transgenic pigs and non-transgenic pigs in pattern of changes in Proteobacteria populations in fecal samples during and post neomycin feeding. In Group B, there were significant differences in the relative abundance of phyla Firmicutes, Bacteroidetes and Proteobacteria, and genera Lactobacillus and Escherichia-Shigella-Hafnia between transgenic pigs and non-transgenic pigs. We speculate that the secretion of NPT II from transgenic tissues/cells into gut microbiota results in the inhibition of neomycin activity and the different patterns of changes in bacterial populations. Furthermore, the neo gene also leads to unintended effects on gut microbiota in transgenic pigs that were fed with basic diet (not supplemented with neomycin). Thus, our data in this study caution that wide use of the neo transgene in genetically engineered animals should be carefully considered and fully assessed.	[Wang, Qingqing; Qian, Lili; Jiang, Shengwang; Cai, Chunbo; Ma, Dezun; Gao, Pengfei; Tang, Maoxue; Cui, Wentao] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Qian, Lili; Cai, Chunbo; Hou, Jian] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Li, Hegang; Jiang, Ke] Inst Anim Sci, Qingdao 266100, Peoples R China; [Gao, Pengfei; Liu, Jie] Qingdao Univ Sci & Technol, Dept Bioengn & Biotechnol, Coll Chem Engn, Qingdao 266042, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University; Qingdao University of Science & Technology	Cui, WT (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	cuiwentao@caas.cn	钱, 钱丽丽/GWV-8162-2022		National Transgenic Project of China from Ministry of Agriculture of china [2011ZX08011-004]; Agricultural Science and Technology Innovation Program (ASTIP-IAS) from Chinese Academy of Agricultural Sciences; Safety Evaluation Project of Transgenic Animals and Feeding Materials [2011-G11]	National Transgenic Project of China from Ministry of Agriculture of china; Agricultural Science and Technology Innovation Program (ASTIP-IAS) from Chinese Academy of Agricultural Sciences; Safety Evaluation Project of Transgenic Animals and Feeding Materials	This work was supported by the National Transgenic Project of China (2011ZX08011-004) from Ministry of Agriculture of china (www.moa.gov.cn), the Agricultural Science and Technology Innovation Program (ASTIP-IAS05) from Chinese Academy of Agricultural Sciences (www.caas.net.cn) and Safety Evaluation Project of Transgenic Animals and Feeding Materials (2011-G11). WTC received above fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank BGI ARK Biotechnology Co. LTD. (Shenzhen, China) for providing the transgenic pigs as a good model. This work was supported by the National Transgenic Project of China (2011ZX08011-004) from Ministry of Agriculture of china (www.moa.gov.cn), the Agricultural Science and Technology Innovation Program (ASTIP-IAS05) from Chinese Academy of Agricultural Sciences(www.caas.net.cn) and Safety Evaluation Project of Transgenic Animals and Feeding Materials (2011-G11). W.T.C received above fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow RS, 2004, ANTIMICROB AGENTS CH, V48, P838, DOI 10.1128/AAC.48.3.838-842.2004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen LP, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000051; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; Isaacson Richard, 2012, Animal Health Research Reviews, V13, P100, DOI 10.1017/S1466252312000084; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; Ladics GS, 2015, TRANSGENIC RES, V24, P587, DOI 10.1007/s11248-015-9867-7; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Laparra JM, 2010, PHARMACOL RES, V61, P219, DOI 10.1016/j.phrs.2009.11.001; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Liu Y, 2008, CLONING STEM CELLS, V10, P421, DOI 10.1089/clo.2008.0015; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Freijo P, 1998, J ANTIMICROB CHEMOTH, V42, P689, DOI 10.1093/jac/42.6.689; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; PENG JY, 1995, PLANT MOL BIOL, V27, P91, DOI 10.1007/BF00019181; Ploy MC, 2000, CLIN CHEM LAB MED, V38, P483, DOI 10.1515/CCLM.2000.070; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Ruth MR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-27; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tang MX, 2011, TRANSGENIC RES, V20, P749, DOI 10.1007/s11248-010-9457-7; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; VELTEN J, 1984, EMBO J, V3, P2723, DOI 10.1002/j.1460-2075.1984.tb02202.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; YENOFSKY RL, 1990, P NATL ACAD SCI USA, V87, P3435, DOI 10.1073/pnas.87.9.3435	34	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150937	10.1371/journal.pone.0150937	http://dx.doi.org/10.1371/journal.pone.0150937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966911	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200021
J	Weberruss, H; Pirzer, R; Dalla Pozza, R; Netz, H; Oberhoffer, R				Weberruss, Heidi; Pirzer, Raphael; Dalla Pozza, Robert; Netz, Heinrich; Oberhoffer, Renate			Intima-Media Thickness Does Not Differ between Two Common Carotid Artery Segments in Children	PLOS ONE			English	Article							CARDIOVASCULAR RISK; FAMILIAL HYPERCHOLESTEROLEMIA; ENDOTHELIAL DYSFUNCTION; OBESE CHILDREN; DISEASE RISK; YOUNG-ADULTS; ADOLESCENTS; WALL; ATHEROSCLEROSIS; ULTRASOUND	Carotid intima-media thickness (cIMT) is a surrogate marker of early atherosclerotic changes in children. cIMT-studies are hard to compare, due to variations in ultrasound protocols, especially regarding the common carotid artery (CCA) segment measured in relation to the bulb. This study's purpose was therefore to compare two distinct CCA segments in children, to see if cIMT values differ substantially according to the site of measurement. cIMT was assessed after power calculation in 30 children (15 girls) aged 8-17, using B-Mode ultrasound (5-13 MHz) at two CCA locations. The first measurement was performed over a distance of 1 cm immediately after the bulb (A), the second 1 cm proximal the bulb (B) over the same distance of 1cm length. Means of end-diastolic far wall cIMT were compared between measurement A and B. cIMT in 30 participants was 0.51 +/- 0.06 mm for measurement A and 0.51 +/- 0.05 mm for measurement B. Results did not differ significantly (p = .947) over a distance of 2 cm after the bulb. According to our results, studies measuring CCA IMT within the first 2 cm, either close to the bulb or further proximal, can be compared. This will improve interpretation of data and application of reference values.	[Weberruss, Heidi; Oberhoffer, Renate] Tech Univ Munich, Inst Prevent Pediat, D-80290 Munich, Germany; [Pirzer, Raphael; Dalla Pozza, Robert; Netz, Heinrich] Univ Munich, Dept Pediat Cardiol, Munich, Germany	Technical University of Munich; University of Munich	Weberruss, H (corresponding author), Tech Univ Munich, Inst Prevent Pediat, D-80290 Munich, Germany.	heidi.weberruss@tum.de	Pozza, Robert Dalla/E-8711-2018		Sternstunden e.V.; district office Berchtesgadener Land, Germany	Sternstunden e.V.; district office Berchtesgadener Land, Germany	The study was funded by Sternstunden e.V. (non-profit organization) and district office Berchtesgadener Land, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by Sternstunden e.V. (non-profit organization) and district office Berchtesgadener Land, Germany.	Aggoun Y, 2000, ARTERIOSCL THROM VAS, V20, P2070; Bohma B, 2009, ATHEROSCLEROSIS, V206, P458, DOI 10.1016/j.atherosclerosis.2009.03.016; Dalla Pozza R, 2015, ATHEROSCLEROSIS, V238, P380, DOI 10.1016/j.atherosclerosis.2014.12.029; Dawson JD, 2009, J AM COLL CARDIOL, V53, P2273, DOI 10.1016/j.jacc.2009.03.026; de Groot E, 2008, NAT CLIN PRACT CARD, V5, P280, DOI 10.1038/ncpcardio1163; Doyon A, 2013, HYPERTENSION, V62, P550, DOI 10.1161/HYPERTENSIONAHA.113.01297; Engelen L, 2013, EUR HEART J, V34, P2368, DOI 10.1093/eurheartj/ehs380; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gariepy J, 1998, ARTERIOSCL THROM VAS, V18, P584, DOI 10.1161/01.ATV.18.4.584; Iannuzzi A, 2006, AM J CARDIOL, V97, P528, DOI 10.1016/j.amjcard.2005.08.072; Ishizu T, 2004, HEART VESSELS, V19, P189, DOI 10.1007/s00380-004-0766-8; Jarvisalo MJ, 2004, CIRCULATION, V109, P1750, DOI 10.1161/01.CIR.0000124725.46165.2C; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Jourdan C, 2005, J HYPERTENS, V23, P1707, DOI 10.1097/01.hjh.0000178834.26353.d5; Kornet L, 1998, ARTERIOSCL THROM VAS, V18, P1877, DOI 10.1161/01.ATV.18.12.1877; Krantz JS, 2004, J PEDIATR-US, V145, P452, DOI 10.1016/j.jpeds.2004.06.042; Krebs A, 2009, PEDIATR CARDIOL, V30, P1131, DOI 10.1007/s00246-009-9510-6; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lande MB, 2006, HYPERTENSION, V48, P40, DOI 10.1161/01.HYP.0000227029.10536.e8; Lavrencic A, 1996, HEART, V76, P321, DOI 10.1136/hrt.76.4.321; Litwin M, 2004, PEDIATR NEPHROL, V19, P767, DOI 10.1007/s00467-004-1480-6; Litwin M, 2009, PEDIATR NEPHROL, V24, P707, DOI 10.1007/s00467-008-0962-3; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Luo X, 2011, CLIN RADIOL, V66, P393, DOI 10.1016/j.crad.2010.12.002; Menees S, 2010, J AM SOC ECHOCARDIOG, V23, P58, DOI 10.1016/j.echo.2009.10.016; Meyer AA, 2006, PEDIATRICS, V117, P1560, DOI 10.1542/peds.2005-2140; Mittelman SD, 2010, J PEDIATR-US, V156, P592, DOI 10.1016/j.jpeds.2009.10.014; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; PAUCIULLO P, 1994, ARTERIOSCLER THROMB, V14, P1075, DOI 10.1161/01.ATV.14.7.1075; Pena AS, 2016, PEDIATR DIABETES, V17, P199, DOI 10.1111/pedi.12265; Peters SAE, 2011, EUR J CARDIOV PREV R, V18, P167, DOI 10.1177/1741826710389400; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Reinehr T, 2006, METABOLISM, V55, P113, DOI 10.1016/j.metabol.2005.07.016; Sass C, 1998, J HYPERTENS, V16, P1593, DOI 10.1097/00004872-199816110-00005; Schmidt C, 1999, CLIN PHYSIOL, V19, P45; Singh TP, 2003, J AM COLL CARDIOL, V41, P661, DOI 10.1016/S0735-1097(02)02894-2; Sorof JM, 2003, PEDIATRICS, V111, P61, DOI 10.1542/peds.111.1.61; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Urbina EM, 2009, HYPERTENSION, V54, P919, DOI 10.1161/HYPERTENSIONAHA.109.192639; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Virkola K, 1997, ACTA PAEDIATR, V86, P1203, DOI 10.1111/j.1651-2227.1997.tb14847.x; Weberruss H, 2015, ATHEROSCLEROSIS, V242, P48, DOI 10.1016/j.atherosclerosis.2015.06.045; WONG ML, 1993, ARTERIOSCLER THROMB, V13, P482, DOI 10.1161/01.ATV.13.4.482; Woo KS, 2004, INT J OBESITY, V28, P852, DOI 10.1038/sj.ijo.0802539	46	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149057	10.1371/journal.pone.0149057	http://dx.doi.org/10.1371/journal.pone.0149057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968038	Green Published, gold			2022-12-27	WOS:000371989200002
J	April, KT; Stinson, J; Boon, H; Duffy, CM; Huber, AM; Gibbon, M; Descarreaux, M; Spiegel, L; Vohra, S; Tugwell, P				April, Karine Toupin; Stinson, Jennifer; Boon, Heather; Duffy, Ciaran M.; Huber, Adam M.; Gibbon, Michele; Descarreaux, Martin; Spiegel, Lynn; Vohra, Sunita; Tugwell, Peter			Development and Preliminary Face and Content Validation of the "Which Health Approaches and Treatments Are You Using?" (WHAT) Questionnaires Assessing Complementary and Alternative Medicine Use in Pediatric Rheumatology	PLOS ONE			English	Article							STATUS MEASUREMENT INSTRUMENTS; METHODOLOGICAL QUALITY; COSMIN CHECKLIST; ARTHRITIS; CONSENSUS; CRITERIA; CHILDREN; DEFINITIONS	Objective Complementary and alternative medicine (CAM) is commonly used by children with juvenile idiopathic arthritis (JIA), yet no validated questionnaires assess that use. The objective of this study was to develop child self- and parent proxy-report questionnaires assessing CAM use and to determine the face and content validity of the "Which Health Approaches and Treatments are you using?" (WHAT) questionnaires in pediatric rheumatology. Methods A sequential phased mixed methods approach was used to develop the questionnaires. A Delphi Survey of 126 experts followed by an interdisciplinary consensus conference of 14 stakeholders in CAM, general pediatrics and pediatric rheumatology was held to develop consensus on the content of the questionnaires using a nominal group technique. To determine face and content validity of the questionnaires, two groups, including (a) a purposive sample of 22 children with JIA 8 to 18 years and their parents from the Children's Hospital of Eastern Ontario and the Hospital for Sick Children, and (b) 21 Canadian pediatric rheumatology experts, participated in interviews. Participants were independently asked about the goal, understandability and comprehensiveness of the WHAT questionnaires, as well as the relevance of items. Results Consensus was reached on 17 items of the WHAT questionnaires. The domains found to be relevant were child's CAM use, factors associated with CAM use, perceived impact of CAM use, and communication about CAM. A total of 15 items in the parent proxy-report questionnaire and 13 items in the child report questionnaire showed adequate content validity. Conclusions Consensus was reached by experts on the content of a pediatric CAM questionnaire. Face and content validity testing and modifications made to the WHAT questionnaires have helped ensure adequate preliminary validity for use in pediatric rheumatology. This constitutes the basis for further testing of these questionnaires in pediatric rheumatology and for adaptation to other chronic diseases.	[April, Karine Toupin; Gibbon, Michele] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [April, Karine Toupin; Duffy, Ciaran M.] Univ Ottawa, Fac Med, Dept Pediat, Ottawa, ON, Canada; [April, Karine Toupin; Tugwell, Peter] Univ Ottawa, Inst Populat Hlth, Ctr Global Hlth, Ottawa, ON, Canada; [Stinson, Jennifer] Hosp Sick Children, Child Hlth Evaluat Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Stinson, Jennifer] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Boon, Heather] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Duffy, Ciaran M.] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Huber, Adam M.] IWK Hlth Ctr, Halifax, NS, Canada; [Huber, Adam M.] Dalhousie Univ, Fac Med, Dept Pediat, Halifax, NS B3H 3J5, Canada; [Descarreaux, Martin] Univ Quebec Trois Rivieres, Dept Sci Act Phys, Trois Rivieres, PQ GA9 5H7, Canada; [Spiegel, Lynn] Hosp Sick Children, Dept Rheumatol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Spiegel, Lynn] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Vohra, Sunita] Univ Alberta, Dept Pediat, CARE Program, Fac Med & Dent, Edmonton, AB, Canada; [Vohra, Sunita] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Vohra, Sunita] Univ Alberta, Integrat Hlth Inst, Edmonton, AB, Canada; [Tugwell, Peter] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Tugwell, Peter] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Tugwell, Peter] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario; Dalhousie University; Dalhousie University; University of Quebec; University of Quebec Trois Rivieres; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Alberta; University of Alberta; University of Alberta; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	April, KT (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.; April, KT (corresponding author), Univ Ottawa, Fac Med, Dept Pediat, Ottawa, ON, Canada.; April, KT (corresponding author), Univ Ottawa, Inst Populat Hlth, Ctr Global Hlth, Ottawa, ON, Canada.	ktoupin@cheo.on.ca	Tugwell, Peter/AFD-8076-2022	Tugwell, Peter/0000-0001-5062-0556; Descarreaux, Martin/0000-0002-3545-5860; Huber, Adam/0000-0002-6616-1689	Canadian Arthritis Network, one of the Networks of Centres of Excellence of the Canadian Institutes of Health Research in Canada; Canadian Arthritis Network; Arthritis Society; Canadian Institutes of Health Research; Alberta Innovates-Health Solutions as a Health Scholar	Canadian Arthritis Network, one of the Networks of Centres of Excellence of the Canadian Institutes of Health Research in Canada(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network; Arthritis Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions as a Health Scholar	Phases 1 to 3 were funded by the Canadian Arthritis Network, one of the Networks of Centres of Excellence of the Canadian Institutes of Health Research in Canada [Grant number: Not applicable. URL: Not applicable (CAN does not exist anymore)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Toupin April was funded by the Canadian Arthritis Network [Grant number: Not applicable. URL: Not applicable (CAN does not exist anymore)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Toupin April was also funded by the Arthritis Society [Grant number: Not applicable. URL: (http://www.arthritis.ca/page.aspx?pid=1068)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Toupin April was funded by the Canadian Institutes of Health Research [Grant number: Not applicable. URL: (http://www.cihr-irsc.gc.ca/e/37788.html)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Sunita Vohra received salary support from Alberta Innovates-Health Solutions as a Health Scholar [Grant number: Not applicable. URL: (http://www.aihealthsolutions.ca/)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April K. T., 2012, PLoS ONE, V7, pe39611, DOI 10.1371/journal.pone.0039611; April KT, 2009, COMPLEMENT THER MED, V17, P208, DOI 10.1016/j.ctim.2009.03.003; Bot SDM, 2004, ANN RHEUM DIS, V63, P335, DOI 10.1136/ard.2003.007724; Brunner HI, 2010, ARTHRIT CARE RES, V62, P811, DOI 10.1002/acr.20126; Cockayne NL, 2005, BRIT J CLIN PHARMACO, V59, P254, DOI 10.1111/j.1365-2125.2004.02328.x; Fearon Julia, 2005, Complement Ther Clin Pract, V11, P32, DOI 10.1016/j.ctcp.2004.11.001; Feldman DE, 2004, ARTHRIT RHEUM-ARTHR, V51, P527, DOI 10.1002/art.20536; Fennell D, 2009, COMPLEMENT THER MED, V17, P71, DOI 10.1016/j.ctim.2008.09.002; Hagen LEM, 2003, ARTHRIT RHEUM-ARTHR, V49, P3, DOI 10.1002/art.10931; Huber AM, 2012, ARTHRIT CARE RES, V64, P546, DOI 10.1002/acr.20695; Kemper KJ, 2008, PEDIATRICS, V122, P1374, DOI 10.1542/peds.2008-2173; Kristoffersen AE, 2008, J ALTERN COMPLEM MED, V14, P911, DOI 10.1089/acm.2008.0127; Kroll T, 1999, SCAND J RHEUMATOL, V28, P10; Lovell DJ, 2011, ARTHRIT CARE RES, V63, P10, DOI 10.1002/acr.20348; Martel D, 2005, PEDIATR BLOOD CANCER, V44, P660, DOI 10.1002/pbc.20205; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-82; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; RAPOFF MA, 1984, ARCH PHYS MED REHAB, V65, P267; Rosenberg AM, 1996, J RHEUMATOL, V23, P1652; Rouster-Stevens K, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-25; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; Ruperto Nicolino, 2008, Curr Rheumatol Rep, V10, P142, DOI 10.1007/s11926-008-0025-6; Sibinga EMS, 2004, CLIN PEDIATR, V43, P367, DOI 10.1177/000992280404300408; SOUTHWOOD TR, 1990, PEDIATRICS, V85, P150; Stinson JN, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-7; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Zebracki K, 2007, J PEDIATR PSYCHOL, V32, P1006, DOI 10.1093/jpepsy/jsm033	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149809	10.1371/journal.pone.0149809	http://dx.doi.org/10.1371/journal.pone.0149809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964088	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000019
J	Koszalka, P; Golunska, M; Urban, A; Stasilojc, G; Stanislawowski, M; Majewski, M; Skladanowski, AC; Bigda, J				Koszalka, Patrycja; Golunska, Monika; Urban, Aleksandra; Stasilojc, Grzegorz; Stanislawowski, Marcin; Majewski, Marceli; Skladanowski, Andrzej C.; Bigda, Jacek			Specific Activation of A(3), A(2A) and A(1) Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; HL-60 CELLS; EXPRESSION; BREAST; STIMULATION; CARCINOMA; HYPOXIA; CANCER	CD73 (ecto-5'-nucleotidase), a cell surface enzyme hydrolyzing AMP to adenosine, was lately demonstrated to play a direct role in tumor progression including regulation of tumor vascularization. It was also shown to stimulate tumor macrophage infiltration. Interstitial adenosine, accumulating in solid tumors due to CD73 enzymatic activity, is recognized as a main mediator regulating the production of pro-and anti-angiogenic factors, but the engagement of specific adenosine receptors in tumor progression in vivo is still poorly researched. We have analyzed the role of high affinity adenosine receptors A(1), A(2A), and A(3) in B16F10 melanoma progression using specific agonists (CCPA, CGS-21680 and IB-MECA, respectively). We limited endogenous extracellular adenosine background using CD73 knockout mice treated with CD73 chemical inhibitor, AOPCP (adenosine alpha,beta-methylene 5'-diphosphate). Activation of any adenosine receptor significantly inhibited B16F10 melanoma growth but only at its early stage. At 14th day of growth, the decrease in tumor neovascularization and MAPK pathway activation induced by CD73 depletion was reversed by all agonists. Activation of A(1)AR primarily increased angiogenic activation measured by expression of VEGF-R2 on tumor blood vessels. However, mainly A(3)AR activation increased both the microvessel density and expression of pro-angiogenic factors. All agonists induced significant increase in macrophage tumor infiltration, with IB-MECA being most effective. This effect was accompanied by substantial changes in cytokines regulating macrophage polarization between pro-inflammatory and pro-angiogenic phenotype. Our results demonstrate an evidence that each of the analyzed receptors has a specific role in the stimulation of tumor angiogenesis and confirm significantly more multifaceted role of adenosine in its regulation than was already observed. They also reveal previously unexplored consequences to extracellular adenosine signaling depletion in recently proposed anti-CD73 cancer therapy.	[Koszalka, Patrycja; Golunska, Monika; Urban, Aleksandra; Stasilojc, Grzegorz; Majewski, Marceli; Bigda, Jacek] Med Univ Gdansk, Intercollegiate Fac Biotechnol UG MUG, Dept Med Biotechnol, Cell Biol Lab, Gdansk, Poland; [Stanislawowski, Marcin] Med Univ Gdansk, Dept Histol, Fac Med, Gdansk, Poland; [Skladanowski, Andrzej C.] Med Univ Gdansk, Intercollegiate Fac Biotechnol UG MUG, Dept Med Biotechnol, Lab Mol Enzymol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Koszalka, P (corresponding author), Med Univ Gdansk, Intercollegiate Fac Biotechnol UG MUG, Dept Med Biotechnol, Cell Biol Lab, Gdansk, Poland.	pkosz@gumed.edu.pl	Skladanowski, Andrzej C. C/B-4687-2010; Koszałka, Patrycja/L-5954-2014	Skladanowski, Andrzej C. C/0000-0003-3408-1147; Stasilojc, Grzegorz/0000-0002-4158-1935; Koszalka, Patrycja/0000-0002-1224-5860; Stanislawowski, Marcin/0000-0001-7176-0937	National Science Centre [N N401 006938]; (METENDOPHA) [STRATEGMED1/233226/11/NCBR/2015]; European Social Fund [POKL.04.01.01-00-017/10-00]	National Science Centre(National Science Centre, Poland); (METENDOPHA); European Social Fund(European Social Fund (ESF))	This work was supported by grant N N401 006938 from National Science Centre (https://www.ncn.gov.pl/) (PK); grant STRATEGMED1/233226/11/NCBR/2015 strategic programmes "Prevention practices and treatment of civilization" - STRATEGMED: "Prostacyclin, nitric oxide and carbon monoxide - based pharmacotherapy of endothelial dysfunction and platelet activation - a novel strategy to inhibit cancer metastasis" (METENDOPHA) (http://www.ncbir.pl/) (PK); European Social Fund POKL.04.01.01-00-017/10-00 "We educate the best - a comprehensive program of development of graduate students, young doctors and academic teaching staff of the University of Gdansk" (http://ec.europa.eu/esf/home.jsp) (MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Allard B, 2014, INT J CANCER, V134, P1466, DOI 10.1002/ijc.28456; Auchampach JA, 2007, CIRC RES, V101, P1075, DOI 10.1161/CIRCRESAHA.107.165761; Barr MP, 2008, INT J ONCOL, V32, P41; BRENNAN JK, 1991, J CELL PHYSIOL, V146, P425, DOI 10.1002/jcp.1041460313; Burghoff S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-898; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010; Choi SB, 2011, INT J MOL MED, V28, P449, DOI 10.3892/ijmm.2011.719; Clark AN, 2007, CIRC RES, V101, P1130, DOI 10.1161/CIRCRESAHA.107.150110; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Deng R, 2014, J BREAST CANCER, V17, P25, DOI 10.4048/jbc.2014.17.1.25; Desai A, 2005, MOL PHARMACOL, V67, P1406, DOI 10.1124/mol.104.007807; Dewhirst MW, 2004, HEMATOL ONCOL CLIN N, V18, P973, DOI 10.1016/j.hoc.2004.06.006; Eljaszewicz A., 2013, MEDIAT INFLAMM, V2013, P1; Eter N, 2002, BRIT J OPHTHALMOL, V86, P1303, DOI 10.1136/bjo.86.11.1303; Feoktistov I, 2003, CIRC RES, V92, P485, DOI 10.1161/01.RES.0000061572.10929.2D; Fishman P, 2009, Handb Exp Pharmacol, P399, DOI 10.1007/978-3-540-89615-9_14; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Gacche RN, 2013, PROG BIOPHYS MOL BIO, V113, P333, DOI 10.1016/j.pbiomolbio.2013.10.001; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Headrick JP, 2013, PHARMACOL THERAPEUT, V140, P92, DOI 10.1016/j.pharmthera.2013.06.002; Kelava T, 2011, PERIOD BIOL, V113, P311; Klinger M, 2002, CELL SIGNAL, V14, P99, DOI 10.1016/S0898-6568(01)00235-2; Koizumi K, 2003, BIOL PHARM BULL, V26, P1295; Koo N, 2009, ARCH PHARM RES, V32, P1637, DOI 10.1007/s12272-009-2118-9; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Koszalka P, 2015, INT J BIOCHEM CELL B, V69, P1, DOI 10.1016/j.biocel.2015.10.003; Koszalka P, 2014, ONCOL REP, V31, P819, DOI 10.3892/or.2013.2883; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Lyons J, 2013, P NATL ACAD SCI USA, V110, P13845, DOI 10.1073/pnas.1201917110; Mabley J, 2003, EUR J PHARMACOL, V466, P323, DOI 10.1016/S0014-2999(03)01570-X; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Merighi S, 2002, J INVEST DERMATOL, V119, P923, DOI 10.1046/j.1523-1747.2002.00111.x; Nardin C, 2014, OA DERMATOLOGY, V2, P5; Persson P, 2015, ACTA PHYSIOL, V214, P311, DOI 10.1111/apha.12511; Rumjahn SM, 2009, BRIT J CANCER, V100, P1465, DOI 10.1038/sj.bjc.6604998; Ryzhov S, 2008, NEOPLASIA, V10, P987, DOI 10.1593/neo.08478; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Stagg J, 2012, ONCOIMMUNOLOGY, V1, P217, DOI 10.4161/onci.1.2.18101; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Takagi H, 1996, INVEST OPHTH VIS SCI, V37, P1311; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Wang L, 2013, CLIN EXP METASTAS, V30, P671, DOI 10.1007/s10585-013-9571-z; Yegutkin GG, 2011, EUR J IMMUNOL, V41, P1231, DOI 10.1002/eji.201041292; Yu HN, 2008, INT J HEMATOL, V87, P189, DOI 10.1007/s12185-008-0037-z; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	52	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151420	10.1371/journal.pone.0151420	http://dx.doi.org/10.1371/journal.pone.0151420			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964090	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000151
J	Chan, YH; Wu, LS; Chang, SH; Lee, HF; Liu, JR; See, LC; Yeh, YH; Kuo, CT				Chan, Yi-Hsin; Wu, Lung-Sheng; Chang, Shang-Hung; Lee, Hsin-Fu; Liu, Jia-Rou; See, Lai-Chu; Yeh, Yung-Hsin; Kuo, Chi-Tai			Young Male Patients with Atrial Fibrillation and CHA(2)DS(2)-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study	PLOS ONE			English	Article							ISCHEMIC-STROKE; RISK STRATIFICATION; PREDICTING STROKE; WARFARIN; VALIDATION; THROMBOEMBOLISM; DYSFUNCTION; DIAGNOSIS; CHADS(2); SCHEMES	Background It is unclear whether oral anticoagulants are beneficial for atrial fibrillation (AF) patients with low CHA(2)DS(2)-VASc score. Age could be important in determining the risk of thromboembolism in low risk AF patients (CHA(2)DS(2)-VASc score of 1 for male or 2 for female). Methods The Taiwan National Health Insurance Research Database (NHIRD) was used and 27,521 AF patients with CHA(2)DS(2)-VASc score of 1 (male) or 2 (female) not receiving anticoagulants were acquired as the study cohort, which were classified into three age groups: 20-49, 50-64, and 65-74 years. The clinical endpoint was the occurrence of ischemic thromboembolism within one year of follow up. Results During the follow-up of 0.94 +/- 0.19 years, 385 (2.19%) male patients experienced ischemic thromboembolism, with annual rate of 2.32%. The annual risk ranged from 1.29%, 2.43% to 2.77% for male patients aged 20-49, 50-64 and 65-74 years respectively. Of the female patients, 218 (2.20%) experienced clinical event with annual rate of 2.32%. The annual risk increased from 1.87%, 2.28% to 2.64% for female patients aged 20-49, 50-64 and 65-74 years respectively. There was no difference in risk between the male patients aged 20-49 years with CHA(2)DS(2)-VASc score of 1 and overall male patients with CHA(2)DS(2)-VASc score of 0. (P = 0.631) The female patients aged 20-49 years with CHA(2)DS(2)-VASc score of 2 was associated with a higher risk of thromboembolic events than overall female patients with CHA(2)DS(2)-VASc score of 1 (HR = 1.93; P = 0.008). Conclusions Age is important in determining the risk of thromboembolism in AF patients with single risk factor. In male patients <50 years old with CHA(2)DS(2)-VASc score of 1, the risk of ischemic thromboembolism was low. Considering the benefits and the risk of bleeding, oral anticoagulation therapy may not be favorable in these patients.	[Chan, Yi-Hsin; Wu, Lung-Sheng; Chang, Shang-Hung; Lee, Hsin-Fu; Yeh, Yung-Hsin; Kuo, Chi-Tai] Chang Gung Mem Hosp, Cardiovasc Dept, Taoyuan, Taiwan; [Chan, Yi-Hsin; Wu, Lung-Sheng; Chang, Shang-Hung; Lee, Hsin-Fu; Yeh, Yung-Hsin; Kuo, Chi-Tai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Liu, Jia-Rou; See, Lai-Chu] Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan; [See, Lai-Chu] Chang Gung Univ, Mol Med Res Ctr, Biostat Core Lab, Taoyuan, Taiwan; [See, Lai-Chu] Chang Gung Mem Hosp, Dept Internal Med, Div Rheumat & Allergy & Immunol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Yeh, YH; Kuo, CT (corresponding author), Chang Gung Mem Hosp, Cardiovasc Dept, Taoyuan, Taiwan.; Yeh, YH; Kuo, CT (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	yeongshinn@cgmh.org.tw; chitai@cgmh.org.tw	Chan, Yi-Hsin/ABA-5023-2021; Yeh, Yung-Hsin/ABD-9351-2021; Lee, Hsin-Fu/AAC-1560-2019	See, Lai-Chu/0000-0002-1379-8969; Chang, Shang-hung/0000-0003-0462-2344; Chan, Yi-Hsin/0000-0002-1406-8503	 [CMRPG3B0991];  [CMRPG3E0291]	; 	This study was supported by CMRPG3B0991 and CMRPG3E0291. https://www.cgmh.org.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum Arnon, 2012, J Vasc Interv Neurol, V5, P33; Camm AJ, 2012, EUR HEART J, V33; Chang CH, 2014, ATHEROSCLEROSIS, V232, P224, DOI 10.1016/j.atherosclerosis.2013.11.036; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Chao TF, 2011, J AM COLL CARDIOL, V58, P2380, DOI 10.1016/j.jacc.2011.08.045; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2008, STROKE, V39, P1901, DOI 10.1161/STROKEAHA.107.501825; Hart RG, 2007, NEUROLOGY, V69, P546; Higashi Y, 2012, HYPERTENS RES, V35, P1039, DOI 10.1038/hr.2012.138; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Jones C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3655; Jung BC, 2015, KOREAN CIRC J, V45, P9, DOI 10.4070/kcj.2015.45.1.9; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lin LJ, 2008, CLIN THER, V30, P1726, DOI 10.1016/j.clinthera.2008.09.010; Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Maaijwee NAMM, 2014, NAT REV NEUROL, V10, P315, DOI 10.1038/nrneurol.2014.72; Mayhan WG, 2008, MICROCIRCULATION, V15, P225, DOI 10.1080/10739680701641421; Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pena-Silva RA, 2012, STROKE, V43, P3358, DOI 10.1161/STROKEAHA.112.667063; Sohrabji F, 2013, NEUROCHEM INT, V63, P291, DOI 10.1016/j.neuint.2013.06.013; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551	32	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151485	10.1371/journal.pone.0151485	http://dx.doi.org/10.1371/journal.pone.0151485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986069	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300077
J	Weiser, AA; Thons, C; Filter, M; Falenski, A; Appel, B; Kasbohrer, A				Weiser, Armin A.; Thoens, Christian; Filter, Matthias; Falenski, Alexander; Appel, Bernd; Kaesbohrer, Annemarie			FoodChain-Lab: A Trace-Back and Trace-Forward Tool Developed and Applied during Food-Borne Disease Outbreak Investigations in Germany and Europe	PLOS ONE			English	Article							TRACEABILITY	FoodChain-Lab is modular open-source software for trace-back and trace-forward analysis in food-borne disease outbreak investigations. Development of FoodChain-Lab has been driven by a need for appropriate software in several food-related outbreaks in Germany since 2011. The software allows integrated data management, data linkage, enrichment and visualization as well as interactive supply chain analyses. Identification of possible outbreak sources or vehicles is facilitated by calculation of tracing scores for food-handling stations (companies or persons) and food products under investigation. The software also supports consideration of station-specific cross-contamination, analysis of geographical relationships, and topological clustering of the tracing network structure. FoodChain-Lab has been applied successfully in previous outbreak investigations, for example during the 2011 EHEC outbreak and the 2013/14 European hepatitis A outbreak. The software is most useful in complex, multi-area outbreak investigations where epidemiological evidence may be insufficient to discriminate between multiple implicated food products. The automated analysis and visualization components would be of greater value if trading information on food ingredients and compound products was more easily available.	[Weiser, Armin A.; Thoens, Christian; Filter, Matthias; Falenski, Alexander; Appel, Bernd; Kaesbohrer, Annemarie] BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany	Federal Institute for Risk Assessment	Weiser, AA (corresponding author), BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany.	armin.weiser@bfr.bund.de		Filter, Matthias/0000-0001-9347-021X	Federal Ministry of Education and Research [13N11202]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work is part of the German national research project SiLeBAT and is funded by the Federal Ministry of Education and Research, research grant 13N11202.	Abe K, 2002, J FOOD PROTECT, V65, P66, DOI 10.4315/0362-028X-65.1.66; [Anonymous], 2013, BERICHTE LEBENSMITTE; [Anonymous], 2012, EPIDEMIOL B, V41, P414; [Anonymous], 2010, EC COST FOODBORNE DI; Berthold M., 2009, ACM SIGKDD EXPLOR NE, V11, P26, DOI [10.1145/1656274.1656280, DOI 10.1145/1656274.1656280]; Donnelly Kathryn Anne-Marie, 2008, International Journal of Metadata, Semantics and Ontologies, V3, P283, DOI 10.1504/IJMSO.2008.023575; Dupuy C., 2002, IEEE INT C SYST MAN, P494; DWYER DM, 1994, EPIDEMIOL REV, V16, P109, DOI 10.1093/oxfordjournals.epirev.a036137; EFSA, 2013, REQ EFSA SCI ASS MUL; ESRI, 1998, ESRI SHAP TECHN DESC; Ester M., 1996, P 2 INT C KNOWL DISC, V1996, P226, DOI DOI 10.1023/A:1009745219419; European Food Safety Authority, 2014, TRAC FOOD IT CONN MU, V12, P1; Filter M., 2013, 5 INT WORKSH COLD CH; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Kaufman J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003692; Kaufman JH, 2014, SPATIO TEMPORAL EPID; LeBlanc DI, 2015, J FOOD ENG, V147, P24, DOI 10.1016/j.jfoodeng.2014.09.026; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; O'Madadhain J, 2005, J STAT SOFTW, VVV, P1; Regattieri A, 2007, J FOOD ENG, V81, P347, DOI 10.1016/j.jfoodeng.2006.10.032; Riden CP, 2007, BIOSYST ENG, V98, P401, DOI 10.1016/j.biosystemseng.2007.07.004; SIMONE B, 2014, INVESTIGATING OUTBRE, V19, P16; Weiser AA, 2014, FOODPROCESS LAB; Weiser AA, 2013, FOODBORNE PATHOG DIS, V10, P263, DOI 10.1089/fpd.2012.1296	26	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151977	10.1371/journal.pone.0151977	http://dx.doi.org/10.1371/journal.pone.0151977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985673	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300158
J	Liou, LB; Huang, CC				Liou, Lieh-bang; Huang, Che-ching			Sialyltransferase and Neuraminidase Levels/Ratios and Sialic Acid Levels in Peripheral Blood B Cells Correlate with Measures of Disease Activity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Pilot Study	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITY; T-LYMPHOCYTES; BIOMARKERS; EXPRESSION; MACROPHAGES; VALIDATION; ACTIVATION; CANCER; SCORE; FC	Objective We attempted to determine whether the level of enzymes sialyltransferase (ST) and neuraminidase (Neu) and sialic acid (SIA) in patients with systemic lupus erythematosus (SLE) correlates with the SLE Disease Activity Index (SLEDAI) and in patients with rheumatoid arthritis (RA) correlates with the Disease Activity Score28 (DAS28). Methods We examined cell-surface levels of ST6Gal-1, Neu1, ST3Gal-1, Neu3, alpha-2,6-SIA, and alpha-2,3-SIA by using fluorescent anti-enzyme antibodies, fluorescent-conjugated Sambucus nigra lectin, and fluorescent-conjugated Maackia amurensis lectin on blood cells in SLE and RA patients and assessed correlations of these levels with SLEDAI and with DAS28. Areas under the curve (AUC) were calculated for different variables against SLEDAI. Results The B-cell ST3Gal-1/Neu3 ratio positively correlated with SLEDAI scores (rho = 0.409 and P = 0.002, statistically significant after Bonferroni' correction for multiple analyses.). It was supported by the inverse correlation of B-cell Neu3 levels with SLEDAI scores (rho = -0.264, P = 0.048). The B-cell ST3Gal-1/Neu3 ratio against SLEDAI yielded an AUC of 0.689, which was comparable to that of anti-dsDNA levels at 0.635. In contrast, both ST3Gal-1 and Neu3 levels of RA B cells (r = 0.376, P = 0.013; r = 0.425, P = 0.005, respectively) correlated positively with high disease-activity DAS28 scores. Conclusion B-cell ST3Gal-1/Neu3 ratios in SLE and B-cell ST3Gal-1 and Neu3 levels in RA with high disease-activity DAS28 scores correlated with disease activity measures and may be useful in monitoring disease activities.	[Liou, Lieh-bang; Huang, Che-ching] Chang Gung Mem Hosp Lin Kou, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Liou, Lieh-bang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Liou, LB (corresponding author), Chang Gung Mem Hosp Lin Kou, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan.; Liou, LB (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	b890121@cgmh.org.tw; lblhome.f260127@msa.hinet.net			Chang Gung Medical Foundation, Taiwan; Ministry of Science and Technology, Taiwan, ROC [CMRPG3B0171, NSC 102-2314-B-182A-093]	Chang Gung Medical Foundation, Taiwan; Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Medical Foundation, Taiwan and Ministry of Science and Technology, Taiwan, ROC (CMRPG3B0171 and NSC 102-2314-B-182A-093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand D, 2014, CLIN EXP IMMUNOL, V176, P327, DOI 10.1111/cei.12274; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Bakker MF, 2012, ANN RHEUM DIS, V71, P1692, DOI 10.1136/annrheumdis-2011-200963; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Bauer JW, 2009, ARTHRITIS RHEUM-US, V60, P3098, DOI 10.1002/art.24803; Castro-Villegas C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0555-z; Cerezo LA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/740357; Chen XP, 1997, J IMMUNOL, V158, P3070; Costa-Nogueira C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-431; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Crowson CS, 2010, J INTERN MED, V268, P552, DOI 10.1111/j.1365-2796.2010.02296.x; Cutis JR, 2012, ARTHRIT CARE RES, V64, P1794; Fabrizio C, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/328078; Fuushima K, 1993, BIOCHEM BIOPH RES CO, V192, P333; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; GORCZYCA W, 1989, FEBS LETT, V259, P99, DOI 10.1016/0014-5793(89)81504-2; Greisen SR, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0434-z; Ha YJ, 2014, J KOREAN MED SCI, V29, P1199, DOI 10.3346/jkms.2014.29.9.1199; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Illei GG, 2004, ARTHRITIS RHEUM-US, V50, P1709, DOI 10.1002/art.20344; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Jones MB, 2012, J BIOL CHEM, V287, P15365, DOI 10.1074/jbc.M112.345710; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kao AH, 2010, ARTHRITIS RHEUM-US, V62, P837, DOI 10.1002/art.27267; Kidder D, 2013, J IMMUNOL, V190, P2593, DOI 10.4049/jimmunol.1201172; Klime E, 2014, MEDIAT INFLAMM, P1; Lateef A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3919; Lehoux S, 2010, GLYCOCONJUGATE J, V27, P99, DOI 10.1007/s10719-009-9260-y; Lepers AH, 2001, BIOCHIMIE, V83, P727; Liou LB, 2003, CLIN EXP RHEUMATOL, V21, P437; Liou LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055346; Liu CC, 2009, BEST PRACT RES CL RH, V23, P507, DOI 10.1016/j.berh.2009.01.008; Mondal S, 2010, LEUKEMIA RES, V34, P463, DOI 10.1016/j.leukres.2009.07.042; NARAPARAJU VR, 1994, IMMUNOL LETT, V43, P143, DOI 10.1016/0165-2478(94)90214-3; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Pincus T, 2005, CLIN EXP RHEUMATOL, V23, pS109; Podolska MJ, 2015, J INFLAMM RES, V8, P161, DOI 10.2147/JIR.S70325; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rajasekhar L, 2004, CLIN EXP RHEUMATOL, V22, P597; Riboldi P, 2005, AUTOIMMUNITY, V38, P39, DOI 10.1080/08916930400022616; Seyrantepe V, 2010, J BIOL CHEM, V285, P206, DOI 10.1074/jbc.M109.055475; Smith MF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2834; Stypinska B, 2015, INT J MOL SCI, V16, P24194, DOI 10.3390/ijms161024194; Urata Y, 2012, ANN RHEUM DIS, V71, P534, DOI 10.1136/annrheumdis-2011-200108; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151669	10.1371/journal.pone.0151669	http://dx.doi.org/10.1371/journal.pone.0151669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981635	gold, Green Published			2022-12-27	WOS:000372574900111
J	Zhou, HY; Gao, M; Skolnick, J				Zhou, Hongyi; Gao, Mu; Skolnick, Jeffrey			ENTPRISE: An Algorithm for Predicting Human Disease-Associated Amino Acid Substitutions from Sequence Entropy and Predicted Protein Structures	PLOS ONE			English	Article							BENCHMARK DATABASE; SOMATIC MUTATIONS; DATA-BANK; CANCER; VARIANTS; SEARCH; IMPACT; SCORE; SNVS	The advance of next-generation sequencing technologies has made exome sequencing rapid and relatively inexpensive. A major application of exome sequencing is the identification of genetic variations likely to cause Mendelian diseases. This requires processing large amounts of sequence information and therefore computational approaches that can accurately and efficiently identify the subset of disease-associated variations are needed. The accuracy and high false positive rates of existing computational tools leave much room for improvement. Here, we develop a boosted tree regression machine-learning approach to predict human disease-associated amino acid variations by utilizing a comprehensive combination of protein sequence and structure features. On comparing our method, ENTPRISE, to the state-of-the-art methods SIFT, PolyPhen-2, MUTATIONASSESSOR, MUTATIONTASTER, FATHMM, ENTPRISE exhibits significant improvement. In particular, on a testing dataset consisting of only proteins with balanced disease-associated and neutral variations defined as having the ratio of neutral/disease-associated variations between 0.3 and 3, the Mathews Correlation Coefficient by ENTPRISE is 0.493 as compared to 0.432 by PPH2-HumVar, 0.406 by SIFT, 0.403 by MUTATIONASSESSOR, 0.402 by PPH2-HumDiv, 0.305 by MUTATIONTASTER, and 0.181 by FATHMM. ENTPRISE is then applied to nucleic acid binding proteins in the human proteome. Disease-associated predictions are shown to be highly correlated with the number of protein-protein interactions. Both these predictions and the ENTPRISE server are freely available for academic users as a web service at http://cssb.biology.gatech.edu/entprise/.	[Zhou, Hongyi; Gao, Mu; Skolnick, Jeffrey] Georgia Inst Technol, Sch Biol, Ctr Study Syst Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Skolnick, J (corresponding author), Georgia Inst Technol, Sch Biol, Ctr Study Syst Biol, Atlanta, GA 30332 USA.	skolnick@gatech.edu	Gao, Mu/I-2826-2013	Gao, Mu/0000-0002-0378-3704	National Institutes of Health [GM-37408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118039, R01GM037408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant No GM-37408.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Byron P., 2006, STAT PROBLEMS PARTIC, V40, P139; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Dudley J, 2014, EXPLORING PERSONAL G; Finn R, 2009, NUCLEIC ACIDS RES, V36, pD281; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gao M, 2015, STRUCTURE IN PRESS; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenberg RA, 2006, CANCER BIOL THER, V5, P1103, DOI 10.4161/cbt.5.9.3370; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li MR, 2013, ELECTRON J DIFFER EQ; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nair PS, 2013, HUM MUTAT, V34, P42, DOI 10.1002/humu.22204; Ogutu Joseph O, 2011, BMC Proc, V5 Suppl 3, pS11, DOI 10.1186/1753-6561-5-S3-S11; Reardon S, 2013, NATURE, V503, P449, DOI 10.1038/503449a; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schaafsma GCP, 2015, HUM MUTAT, V36, P161, DOI 10.1002/humu.22727; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Skolnick J, 2004, PROTEINS, V56, P502, DOI 10.1002/prot.20106; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Weiss GM, 2003, J ARTIF INTELL RES, V19, P315, DOI 10.1613/jair.1199; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yates CM, 2014, J MOL BIOL, V426, P2692, DOI 10.1016/j.jmb.2014.04.026; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhou HY, 2007, PROTEINS, V69, P90, DOI 10.1002/prot.21649; Zhou HY, 2013, J CHEM INF MODEL, V53, P230, DOI 10.1021/ci300510n; Zhou HY, 2012, MOL PHARMACEUT, V9, P1775, DOI 10.1021/mp3000716; Zhou HY, 2012, PROTEINS, V80, P352, DOI 10.1002/prot.23183	59	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150965	10.1371/journal.pone.0150965	http://dx.doi.org/10.1371/journal.pone.0150965			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982818	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900059
J	Gil-Prieto, R; Pascual-Garcia, R; San-Roman-Montero, J; Martinez-Martin, P; Castrodeza-Sanz, J; Gil-de-Miguel, A				Gil-Prieto, Ruth; Pascual-Garcia, Raquel; San-Roman-Montero, Jesus; Martinez-Martin, Pablo; Castrodeza-Sanz, Javier; Gil-de-Miguel, Angel			Measuring the Burden of Hospitalization in Patients with Parkinson's Disease in Spain	PLOS ONE			English	Article							IMPACT; COMORBIDITIES; EPIDEMIOLOGY; ADMISSIONS; MORTALITY; LIFE	Introduction This epidemiological survey estimates the hospitalization burden related to Parkinson's Disease in Spain. Methods This observational retrospective survey was performed by reviewing data from the National Surveillance System for Hospital Data, which includes more than 98% of Spanish hospitals. All hospitalizations of patients with Parkinson's disease that were reported from 1997-2012 were analyzed. Codes were selected using the 9th International Classification of Diseases: ICD-9-CM: 332.0. Results A total of 438,513 hospital discharges of patients with Parkinson's Disease were reported during the study period. The annual hospitalization rate was 64.2 cases per 100,000. The average length of hospital stay was 10 days. The trend for the annual hospitalization rate differed significantly depending on whether Parkinson's disease was the main cause of hospitalization (n = 23,086, 1.14% annual increase) or was not the main cause of hospitalization (n = 415,427, 15.37% annual increase). The overall case-fatality rate among hospitalized patients was 10%. The case fatality rate among patient's hospitalized with Parkinson's disease as the main cause of hospitalization was 2.5%. The hospitalization rate and case-fatality rate significantly increased with age. The primary causes of hospitalization when Parkinson's disease was not coded as the main cause of hospitalization were as follows: respiratory system diseases (24%), circulatory system diseases (19%), injuries and poisoning, including fractures (12%), diseases of the digestive system (10%) and neoplasms (5%). The annual average cost for National Health Care System was (sic) 120 M, with a mean hospitalization cost of (sic)4,378. Conclusions Parkinson's disease poses a significant health threat in Spain, particularly in the elderly. While hospitalizations due to Parkinson's Disease are relatively stable over time, the number of patients presenting with Parkinson's disease as an important comorbidity has increased dramatically. Medical staff must be specifically trained to treat the particular needs of hospitalized patients suffering from Parkinson's disease as an important comorbidity.	[Gil-Prieto, Ruth; Pascual-Garcia, Raquel; Gil-de-Miguel, Angel] Rey Juan Carlos Univ, Area Prevent Med Publ Hlth, Madrid, Spain; [Gil-Prieto, Ruth; Gil-de-Miguel, Angel] Rey Juan Carlos Univ, Catedra Evaluac Resultados Salud, Madrid, Spain; [San-Roman-Montero, Jesus] Rey Juan Carlos Univ, Area Med, Madrid, Spain; [Martinez-Martin, Pablo] Natl Ctr Epidemiol, Madrid, Spain; [Martinez-Martin, Pablo] CIBERNED, Carlos III Inst Hlth, Madrid, Spain; [Castrodeza-Sanz, Javier] Univ Valladolid, Dept Prevent Med Publ Hlth, Valladolid, Spain	Universidad Rey Juan Carlos; Universidad Rey Juan Carlos; Universidad Rey Juan Carlos; CIBERNED; Instituto de Salud Carlos III; Universidad de Valladolid	Gil-Prieto, R (corresponding author), Rey Juan Carlos Univ, Area Prevent Med Publ Hlth, Madrid, Spain.; Gil-Prieto, R (corresponding author), Rey Juan Carlos Univ, Catedra Evaluac Resultados Salud, Madrid, Spain.	ruth.gil@urjc.es	Martinez-Martin, Pablo/N-9909-2019	Martinez-Martin, Pablo/0000-0003-0837-5280; GIL DE MIGUEL, ANGEL/0000-0003-1295-7101	cathedra "Evaluacion de Resultados en Salud; Abbvie	cathedra "Evaluacion de Resultados en Salud; Abbvie(AbbVie)	Funding sources for study: The cathedra "Evaluacion de Resultados en Salud. Rey Juan Carlos University" is sponsored by Abbvie.	Alvaro-Meca A, 2013, CANCER EPIDEMIOL, V37, P91, DOI 10.1016/j.canep.2012.09.001; Aminoff MJ, 2011, PARKINSONISM RELAT D, V17, P139, DOI 10.1016/j.parkreldis.2010.11.009; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Benito-Leon J, 2006, NEUROLOGY, V62, P734; Braga M, 2014, PARKINSONISM RELAT D, V20, P488, DOI 10.1016/j.parkreldis.2014.01.022; Chou KL, 2011, PARKINSONISM RELAT D, V17, P440, DOI 10.1016/j.parkreldis.2011.03.002; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Diem-Zangerl A, 2009, MOVEMENT DISORD, V24, P819, DOI 10.1002/mds.22414; Dodel RC, 1998, PHARMACOECONOMICS, V14, P299, DOI 10.2165/00019053-199814030-00006; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Gerlach OHH, 2013, PARKINSONISM RELAT D, V19, P737, DOI 10.1016/j.parkreldis.2013.04.017; Gil-Prieto R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000831; Guttman M, 2003, MOVEMENT DISORD, V18, P313, DOI 10.1002/mds.10333; Hassan A, 2013, PARKINSONISM RELAT D, V19, P949, DOI 10.1016/j.parkreldis.2013.06.006; Ishihara LS, 2007, J NEUROL NEUROSUR PS, V78, P1304, DOI 10.1136/jnnp.2006.100107; Leibson CL, 2006, MOVEMENT DISORD, V21, P446, DOI 10.1002/mds.20685; Lindgren P, 2005, EUR J NEUROL, V12, P68, DOI 10.1111/j.1468-1331.2005.01197.x; Low V, 2015, PARKINSONISM RELAT D, V21, P449, DOI 10.1016/j.parkreldis.2015.01.017; Lubomski M, 2015, J NEUROL NEUROSUR PS, V86, P324, DOI 10.1136/jnnp-2014-307822; Romero JP, 2012, TREMOR OTHER HYPERK, V2; Peiro S, 1999, REV NEUROLOGIA, V29, P651, DOI 10.33588/rn.2907.99330; Phillips AR, 2011, AGE AGEING, V40, P294, DOI 10.1093/ageing/afr022; RAJPUT AH, 1984, ANN NEUROL, V16, P278, DOI 10.1002/ana.410160303; Riedel O, 2014, PARKINSONISM RELAT D, V20, P1365, DOI 10.1016/j.parkreldis.2014.09.025; Rivero Cuadrado A., ANALISIS DESARROLLO; Schreyogg Jonas, 2006, Health Care Manag Sci, V9, P215, DOI 10.1007/s10729-006-9040-1; Tejedor-Alonso MA, 2015, ALLERGY, V70, P880, DOI 10.1111/all.12613; Willis AW, 2012, NEUROLOGY, V79, P1774, DOI 10.1212/WNL.0b013e3182703f92; Woodford H, 2005, MOVEMENT DISORD, V20, P1104, DOI 10.1002/mds.20485	29	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151563	10.1371/journal.pone.0151563	http://dx.doi.org/10.1371/journal.pone.0151563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977930	gold, Green Published, Green Submitted			2022-12-27	WOS:000372572800090
J	Mhlongo, MI; Piater, LA; Madala, NE; Steenkamp, PA; Dubery, IA				Mhlongo, Msizi I.; Piater, Lizelle A.; Madala, Ntakadzeni E.; Steenkamp, Paul A.; Dubery, Ian A.			Phenylpropanoid Defences in Nicotiana tabacum Cells: Overlapping Metabolomes Indicate Common Aspects to Priming Responses Induced by Lipopolysaccharides, Chitosan and Flagellin-22	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; LC-MSN IDENTIFICATION; DISEASE-RESISTANCE; CHLOROGENIC ACID; ABSCISIC-ACID; ARABIDOPSIS; METABOLITES; EXPRESSION; HORMONES; PATHOGEN	Plants have evolved both constitutive and inducible defence strategies to cope with different biotic stimuli and stresses. Exposure of a plant to a challenging stress can lead to a primed state that allows it to launch a more rapid and stronger defence. Here we applied a metabolomic approach to study and compare the responses induced in Nicotiana tabacum cells by microbe-associated molecular pattern (MAMP) molecules, namely lipopolysaccharides (LPS), chitosan (CHT) and flagellin-22 (FLG22). Early response metabolites, extracted with methanol, were analysed by UHPLC-MS/MS. Using multivariate statistical tools the metabolic profiles induced by these elicitors were analysed. In the metabolic fingerprint of these agents a total of 19 cinnamic acid derivatives conjugated to quinic acids (chlorogenic acids), shikimic acid, tyramine, polyamines or glucose were found as discriminant biomarkers. In addition, treatment with the phytohormones salicylic acid (SA), methyljasmonic acid (MJ) and abscisic acid (ABA) resulted in differentially-induced phenylpropanoid pathway metabolites. The results indicate that the phenylpropanoid pathway is activated by these elicitors while hydroxycinnamic acid derivatives are commonly associated with the metabolic response to the MAMPs, and that the activated responses are modulated by both SA and MJ, with ABA not playing a role.	[Mhlongo, Msizi I.; Piater, Lizelle A.; Madala, Ntakadzeni E.; Steenkamp, Paul A.; Dubery, Ian A.] Univ Johannesburg, Dept Biochem, Auckland Pk, Johannesburg, South Africa; [Steenkamp, Paul A.] CSIR Biosci, Nat Prod & Agroproc Grp, Pretoria, South Africa	University of Johannesburg; Council for Scientific & Industrial Research (CSIR) - South Africa	Dubery, IA (corresponding author), Univ Johannesburg, Dept Biochem, Auckland Pk, Johannesburg, South Africa.	idubery@uj.ac.za	Madala, Ntakadzeni/AAR-3437-2021; Dubery, Ian/A-6346-2013	Dubery, Ian/0000-0002-9079-4769; Mhlongo, Msizi/0000-0002-6418-6620; Piater, Lizelle/0000-0002-9526-0109	South African National Research Foundation (ZA) [95818]; NRF; University of Johannesburg; South African National Research Foundation (NRF) [95818]	South African National Research Foundation (ZA); NRF; University of Johannesburg; South African National Research Foundation (NRF)(National Research Foundation - South Africa)	The South African National Research Foundation (ZA) funded the research through a grant (95818) to IAD. The NRF and the University of Johannesburg are thanked for fellowship support to MIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The South African National Research Foundation (NRF) is thanked for grant support (number 95818) to IAD. The NRF and the University of Johannesburg are thanked for fellowship support to MIM.	Alon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076619; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Balmer A, 2015, TRENDS PLANT SCI, V20, P443, DOI 10.1016/j.tplants.2015.04.002; Balmerl D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00082; Bautista-Banos S, 2006, CROP PROT, V25, P108, DOI 10.1016/j.cropro.2005.03.010; Benton HP, 2008, ANAL CHEM, V80, P6382, DOI 10.1021/ac800795f; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Bostock RM, 1999, PHYSIOL MOL PLANT P, V54, P37, DOI 10.1006/pmpp.1998.0189; Chakraborty M, 2009, J PLANT PHYSIOL, V166, P63, DOI 10.1016/j.jplph.2008.02.004; Clifford MN, 2008, FOOD CHEM, V106, P379, DOI 10.1016/j.foodchem.2007.05.081; Clifford MN, 2005, J AGR FOOD CHEM, V53, P3821, DOI 10.1021/jf050046h; Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; De Vleesschauwer D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00611; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dempsey DA, 2012, TRENDS PLANT SCI, V17, P538, DOI 10.1016/j.tplants.2012.05.011; Denance N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00155; Desaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051953; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Faoro F, 2008, BIOCONTROL, V53, P387, DOI 10.1007/s10526-007-9091-3; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gamir J, 2014, PLANT J, V78, P227, DOI 10.1111/tpj.12465; Gao XQ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003127; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; Gust AA, 2010, CURR OPIN BIOTECH, V21, P204, DOI 10.1016/j.copbio.2010.02.004; Hammerschmidt R, 2014, PHYSIOL MOL PLANT P, V88, pIII, DOI 10.1016/j.pmpp.2014.11.002; Hao GX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0211-9; Homayoun S.B., 2011, SCI RES ESSAYS, V6, P4369, DOI [10.5897/SRE10.1147, DOI 10.5897/SRE10.1147]; Hossain MB, 2010, J AGR FOOD CHEM, V58, P10576, DOI 10.1021/jf102042g; Huang P, 2012, PLANT CELL PHYSIOL, V53, P193, DOI 10.1093/pcp/pcr162; Ibrahim MH, 2013, MOLECULES, V18, P7957, DOI 10.3390/molecules18077957; Iriti M, 2007, MYCOPATHOLOGIA, V164, P57, DOI 10.1007/s11046-007-9026-7; Iriti M, 2010, BIOL CONTROL, V54, P241, DOI 10.1016/j.biocontrol.2010.05.012; Iriti M, 2009, PLANT SIGNAL BEHAV, V4, P66, DOI 10.4161/psb.4.1.7408; Jaiswal R, 2014, J AGR FOOD CHEM, V62, P9252, DOI 10.1021/jf501210s; Jansen JJ, 2009, METABOLOMICS, V5, P150, DOI 10.1007/s11306-008-0124-4; Joet T, 2010, PLANT CELL ENVIRON, V33, P1220, DOI 10.1111/j.1365-3040.2010.02141.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Keyu G, 2002, TRENDS PLANT SCI, V7, P196, DOI [10.1016/S1360-1385(02)02264-1, DOI 10.1016/S1360-1385(02)02264-1]; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kovacik J, 2009, PLANT CELL REP, V28, P135, DOI 10.1007/s00299-008-0627-5; Lee MH, 2007, PHYTOPATHOLOGY, V97, P269, DOI 10.1094/PHYTO-97-3-0269; Leiss KA, 2011, PHYTOCHEM REV, V10, P205, DOI 10.1007/s11101-010-9175-z; Li Y, 2013, PHYSIOL MOL PLANT P, V83, P51, DOI 10.1016/j.pmpp.2013.05.001; Liang YS, 2006, J CHROMATOGR A, V1112, P148, DOI 10.1016/j.chroma.2005.11.114; Madala NE, 2014, J ANAL METHODS CHEM, V2014, DOI 10.1155/2014/650879; Madala NE, 2012, INNATE IMMUN-LONDON, V18, P140, DOI 10.1177/1753425910392609; Martinez-Medina A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00206; MATHEIS G, 1984, J FOOD BIOCHEM, V8, P137, DOI 10.1111/j.1745-4514.1984.tb00322.x; Mhlongo MI, 2014, PHYSIOL MOL PLANT P, V88, P61, DOI 10.1016/j.pmpp.2014.09.002; Mikulic-Petkovsek M, 2011, PHYSIOL MOL PLANT P, V76, P159, DOI 10.1016/j.pmpp.2011.09.006; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Ncube EN, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0066-z; New SA, 2015, BIOL PLANTARUM, V59, P18, DOI 10.1007/s10535-014-0478-6; Newman MA, 2002, PLANT J, V29, P487, DOI 10.1046/j.0960-7412.2001.00233.x; Ni Y, 2008, FEBS LETT, V582, P2627, DOI 10.1016/j.febslet.2008.06.040; O'Donnell PJ, 2003, PLANT PHYSIOL, V133, P1181, DOI 10.1104/pp.103.030379; Pastor V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00295; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Peng B, 2015, PROTEIN CELL, V6, P628, DOI 10.1007/s13238-015-0185-x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; Ramabulana T, 2016, J PHOTOCH PHOTOBIO B, V156, P79, DOI 10.1016/j.jphotobiol.2016.01.013; RANJEVA R, 1987, ANNU REV PLANT PHYS, V38, P73, DOI 10.1146/annurev.pp.38.060187.000445; Sanabria NM, 2006, BIOCHEM BIOPH RES CO, V344, P1001, DOI 10.1016/j.bbrc.2006.03.216; Sanabria NM, 2009, SELF NONSELF IMMUNE, V1, P1, DOI [10.4161/self.1.1.10442, DOI 10.4161/SELF.1.1.10442]; Song WW, 2011, PLANT PHYSIOL BIOCH, V49, P693, DOI 10.1016/j.plaphy.2011.03.018; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sun XiaoJuan, 2008, Agricultural Sciences in China, V7, P615, DOI 10.1016/S1671-2927(08)60060-7; Tugizimana F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087846; Tugizimana F, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20120005; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Villarino M, 2011, J AGR FOOD CHEM, V59, P3205, DOI 10.1021/jf104251z; Walters D, 2002, J EXP BOT, V53, P747, DOI 10.1093/jexbot/53.369.747; Wei CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041056; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wojciechowska E, 2014, EUR J PLANT PATHOL, V139, P735, DOI 10.1007/s10658-014-0428-3	83	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151350	10.1371/journal.pone.0151350	http://dx.doi.org/10.1371/journal.pone.0151350			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978774	Green Published, gold			2022-12-27	WOS:000372572800063
J	Moharana, TR; Byreddy, AR; Puri, M; Barrow, C; Rao, NM				Moharana, Tushar Ranjan; Byreddy, Avinesh R.; Puri, Munish; Barrow, Colin; Rao, Nalam Madhusudhana			Selective Enrichment of Omega-3 Fatty Acids in Oils by Phospholipase A1	PLOS ONE			English	Article							STAPHYLOCOCCUS-HYICUS LIPASE; POLYUNSATURATED FATTY-ACIDS; FISH-OIL; DOCOSAHEXAENOIC ACID; SOYBEAN OIL; EICOSAPENTAENOIC ACID; LECITASE(R) ULTRA; STRUCTURAL BASIS; TUNA OIL; HYDROLYSIS	Omega fatty acids are recognized as key nutrients for healthier ageing. Lipases are used to release omega-3 fatty acids from oils for preparing enriched omega-3 fatty acid supplements. However, use of lipases in enrichment of omega-3 fatty acids is limited due to their insufficient specificity for omega-3 fatty acids. In this study use of phospholipase A1 (PLA1), which possesses both sn-1 specific activity on phospholipids and lipase activity, was explored for hydrolysis of omega-3 fatty acids from anchovy oil. Substrate specificity of PLA1 from Thermomyces lenuginosus was initially tested with synthetic p-nitrophenyl esters along with a lipase from Bacillus subtilis (BSL), as a lipase control. Gas chromatographic characterization of the hydrolysate obtained upon treatment of anchovy oil with these enzymes indicated a selective retention of omega-3 fatty acids in the triglyceride fraction by PLA1 and not by BSL. C-13 NMR spectroscopy based position analysis of fatty acids in enzyme treated and untreated samples indicated that PLA1 preferably retained omega-3 fatty acids in oil, while saturated fatty acids were hydrolysed irrespective of their position. Hydrolysis of structured triglyceride, 1,3-dioleoyl-2-palmitoylglycerol, suggested that both the enzymes hydrolyse the fatty acids at both the positions. The observed discrimination against omega-3 fatty acids by PLA1 appears to be due to its fatty acid selectivity rather than positional specificity. These studies suggest that PLA1 could be used as a potential enzyme for selective concentration of omega-3 fatty acids.	[Moharana, Tushar Ranjan; Rao, Nalam Madhusudhana] Ctr Cellular & Mol Biol, CSIR, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Byreddy, Avinesh R.; Puri, Munish; Barrow, Colin] Deakin Univ, Ctr Chem & Biotechnol, 75 Pigdons Rd, Waurn Ponds, Vic 3220, Australia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Deakin University	Rao, NM (corresponding author), Ctr Cellular & Mol Biol, CSIR, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.; Barrow, C (corresponding author), Deakin Univ, Ctr Chem & Biotechnol, 75 Pigdons Rd, Waurn Ponds, Vic 3220, Australia.	colin.barrow@deakin.edu.au; madhu@ccmb.res.in	Puri, Munish/C-2398-2013; Puri, Munish/M-5577-2019	Puri, Munish/0000-0003-2469-3326; Barrow, Colin/0000-0002-2153-7267	Indo-Australian Biotechnology Fund [GAP373]; CSIR	Indo-Australian Biotechnology Fund; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Indo-Australian Biotechnology Fund (http://www.science.gov.au/international/CollaborativeOpportunities/AISRF/Pages/default.aspx) GAP373. TRM acknowledges the fellowship received from CSIR.	Ackman RG, 2002, ANAL CHIM ACTA, V465, P175, DOI 10.1016/S0003-2670(02)00098-3; Akanbi TO, 2014, FOOD CHEM, V160, P61, DOI 10.1016/j.foodchem.2014.03.092; Akanbi TO, 2013, FOOD CHEM, V138, P615, DOI 10.1016/j.foodchem.2012.11.007; Aloulou A, 2014, BBA-MOL CELL BIOL L, V1841, P581, DOI 10.1016/j.bbalip.2013.12.009; Aoki J, 2007, BIOCHIMIE, V89, P197, DOI 10.1016/j.biochi.2006.09.021; Carriere F, 1998, BBA-REV BIOMEMBRANES, V1376, P417, DOI 10.1016/S0304-4157(98)00016-1; Casas-Godoy L, 2014, J BIOTECHNOL, V180, P30, DOI 10.1016/j.jbiotec.2014.03.018; Christie W. W., 2010, LIPID ANAL ISOLATION, V4; DARTOIS V, 1992, BIOCHIM BIOPHYS ACTA, V1131, P253, DOI 10.1016/0167-4781(92)90023-S; Fernandez-Lorente G, 2008, J MOL CATAL B-ENZYM, V51, P110, DOI 10.1016/j.molcatb.2007.11.017; Gamez-Meza N, 2003, FOOD RES INT, V36, P721, DOI 10.1016/S0963-9969(03)00052-8; Halldorsson A, 2004, EUR J LIPID SCI TECH, V106, P79, DOI 10.1002/ejlt.200300867; Kamal MZ, 2015, FOOD CHEM, V173, P1030, DOI 10.1016/j.foodchem.2014.10.124; Klinkesorn U, 2004, FOOD CHEM, V87, P415, DOI 10.1016/j.foodchem.2003.12.021; KOSUGI Y, 1994, J AM OIL CHEM SOC, V71, P1397, DOI 10.1007/BF02541362; Kralovec JA, 2012, FOOD CHEM, V131, P639, DOI 10.1016/j.foodchem.2011.08.085; Kralovec JA, 2010, AUST J CHEM, V63, P922, DOI 10.1071/CH10087; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Liu N, 2012, FOOD CHEM, V134, P301, DOI 10.1016/j.foodchem.2012.02.145; Lyberg AM, 2008, BBA-PROTEINS PROTEOM, V1784, P343, DOI 10.1016/j.bbapap.2007.11.003; Miller MR, 2008, NUTR RES REV, V21, P85, DOI 10.1017/S0954422408102414; Mishra MK, 2009, TETRAHEDRON-ASYMMETR, V20, P2854, DOI 10.1016/j.tetasy.2009.11.012; Molfino A, 2014, NUTRIENTS, V6, P4058, DOI 10.3390/nu6104058; Nalder TD, 2014, J FUNCT FOODS, V6, P259, DOI 10.1016/j.jff.2013.10.015; NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221; Okada T, 2007, FOOD CHEM, V103, P1411, DOI 10.1016/j.foodchem.2006.10.057; Richmond GS, 2011, INT J MOL SCI, V12, P588, DOI 10.3390/ijms12010588; Shahidi F, 1998, TRENDS FOOD SCI TECH, V9, P230, DOI 10.1016/S0924-2244(98)00044-2; Sheelu G, 2008, J AM OIL CHEM SOC, V85, P739, DOI 10.1007/s11746-008-1261-7; Shimada Y, 1998, J AM OIL CHEM SOC, V75, P1565, DOI 10.1007/s11746-998-0095-7; Shimada Y, 1997, J AM OIL CHEM SOC, V74, P1441, DOI 10.1007/s11746-997-0251-5; Suarez ER, 2010, J AM OIL CHEM SOC, V87, P1425, DOI 10.1007/s11746-010-1638-2; Tiesinga JJW, 2007, J MOL BIOL, V371, P447, DOI 10.1016/j.jmb.2007.05.041; van Kampen MD, 1998, CHEM PHYS LIPIDS, V93, P39, DOI 10.1016/S0009-3084(98)00027-9; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Wang Y, 2010, FOOD CHEM, V121, P1066, DOI 10.1016/j.foodchem.2010.01.051; Yang B, 2008, J AM OIL CHEM SOC, V85, P421, DOI 10.1007/s11746-008-1225-y; Yang JG, 2006, FOOD TECHNOL BIOTECH, V44, P101	38	24	25	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151370	10.1371/journal.pone.0151370	http://dx.doi.org/10.1371/journal.pone.0151370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978518	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800069
J	Nicolas, G; Robinson, TP; Wint, GRW; Conchedda, G; Cinardi, G; Gilbert, M				Nicolas, Galle; Robinson, Timothy P.; Wint, G. R. William; Conchedda, Giulia; Cinardi, Giuseppina; Gilbert, Marius			Using Random Forest to Improve the Downscaling of Global Livestock Census Data	PLOS ONE			English	Article							DUCKS	Large scale, high-resolution global data on farm animal distributions are essential for spatially explicit assessments of the epidemiological, environmental and socio-economic impacts of the livestock sector. This has been the major motivation behind the development of the Gridded Livestock of the World (GLW) database, which has been extensively used since its first publication in 2007. The database relies on a downscaling methodology whereby census counts of animals in sub-national administrative units are redistributed at the level of grid cells as a function of a series of spatial covariates. The recent upgrade of GLW1 to GLW2 involved automating the processing, improvement of input data, and downscaling at a spatial resolution of 1 km per cell (5 km per cell in the earlier version). The underlying statistical methodology, however, remained unchanged. In this paper, we evaluate new methods to downscale census data with a higher accuracy and increased processing efficiency. Two main factors were evaluated, based on sample census datasets of cattle in Africa and chickens in Asia. First, we implemented and evaluated Random Forest models (RF) instead of stratified regressions. Second, we investigated whether models that predicted the number of animals per rural person (per capita) could provide better downscaled estimates than the previous approach that predicted absolute densities (animals per km(2)). RF models consistently provided better predictions than the stratified regressions for both continents and species. The benefit of per capita over absolute density models varied according to the species and continent. In addition, different technical options were evaluated to reduce the processing time while maintaining their predictive power. Future GLW runs (GLW 3.0) will apply the new RF methodology with optimized modelling options. The potential benefit of per capita models will need to be further investigated with a better distinction between rural and agricultural populations.	[Nicolas, Galle; Gilbert, Marius] Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium; [Nicolas, Galle; Gilbert, Marius] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Robinson, Timothy P.] ILRI, LSE, Nairobi, Kenya; [Wint, G. R. William] Univ Oxford, Dept Zool, ERGO, S Parks Rd, Oxford, England; [Conchedda, Giulia; Cinardi, Giuseppina] United Nations FAO, Anim Prod & Hlth Div AGA, FAO, Rome, Italy	Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; CGIAR; International Livestock Research Institute (ILRI); University of Oxford; Food & Agriculture Organization of the United Nations (FAO)	Nicolas, G (corresponding author), Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium.; Nicolas, G (corresponding author), Fonds Natl Rech Sci, B-1050 Brussels, Belgium.	gaelle.nicolas6@gmail.com		Wint, William/0000-0003-0916-0847; Nicolas, Gaelle/0000-0002-7116-2811	FNRS [PDR T.0073.13]; CGIAR	FNRS(Fonds de la Recherche Scientifique - FNRS); CGIAR(CGIAR)	GN and MG were funded by the FNRS project "Mapping people and livestock" (PDR T.0073.13). TPR is funded by the CGIAR Research Programmes on the Humid tropics; Climate Change, Agriculture and Food Security (CCAFS) and Agriculture for Nutrition and Health (A4NH).	Anderson W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100037; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davy RJ, 2010, BOUND-LAY METEOROL, V135, P161, DOI 10.1007/s10546-009-9462-7; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FAO, 2007, GRIDD LIV WORLD 2007; Fritz S., 2013, T AM GEOPHYS UNION, V94, P31, DOI DOI 10.1002/2013E0030006; Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882; GILBERT M, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0133381; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Grace D., 2012, MAPPING POVERTY LIKE; Griguolo S, 1996, SDGCPINT578NET FAO; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Havlik P, 2014, P NATL ACAD SCI USA, V111, P3709, DOI 10.1073/pnas.1308044111; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Jones PG, 2009, ENVIRON SCI POLICY, V12, P427, DOI 10.1016/j.envsci.2008.08.006; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Linard C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-7; Mottet, 2013, TACKLING CLIMATE CHA; Nelson A., 2008, TRAVEL TIME MAJOR CI; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Prosser DJ, 2011, AGR ECOSYST ENVIRON, V141, P381, DOI 10.1016/j.agee.2011.04.002; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson T., 2011, Global livestock production systems; Robinson Timothy P, 2014, PLoS One, V9, pe96084, DOI 10.1371/journal.pone.0096084; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Tatem AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-8; Vaca RA, 2011, APPL VEG SCI, V14, P388, DOI 10.1111/j.1654-109X.2011.01132.x; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; Van Boeckel TP, 2011, AGR ECOSYST ENVIRON, V141, P373, DOI 10.1016/j.agee.2011.04.013; Wint W., 2007, GRIDDED LIVESTOCK WO; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9	39	36	38	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150424	10.1371/journal.pone.0150424	http://dx.doi.org/10.1371/journal.pone.0150424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977807	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800025
J	Verma, SK; Willetts, JL; Corns, HL; Marucci-Wellman, HR; Lombardi, DA; Courtney, TK				Verma, Santosh K.; Willetts, Joanna L.; Corns, Helen L.; Marucci-Wellman, Helen R.; Lombardi, David A.; Courtney, Theodore K.			Falls and Fall-Related Injuries among Community-Dwelling Adults in the United States	PLOS ONE			English	Article							OLDER-ADULTS; POSTURAL STABILITY; PHYSICAL-ACTIVITY; IMPACT FORCES; RISK-FACTORS; POPULATION; WOMEN; HOME; PREVENTION; YOUNG	Introduction Falls are the leading cause of unintentional injuries in the U.S.; however, national estimates for all community-dwelling adults are lacking. This study estimated the national incidence of falls and fall-related injuries among community-dwelling U.S. adults by age and gender and the trends in fall-related injuries across the adult life span. Methods Nationally representative data from the National Health Interview Survey (NHIS) 2008 Balance and Dizziness supplement was used to develop national estimates of falls, and pooled data from the NHIS was used to calculate estimates of fall-related injuries in the U.S. and related trends from 2004-2013. Costs of unintentional fall-related injuries were extracted from the CDC's Web-based Injury Statistics Query and Reporting System. Results Twelve percent of community-dwelling U.S. adults reported falling in the previous year for a total estimate of 80 million falls at a rate of 37.2 falls per 100 person-years. On average, 9.9 million fall-related injuries occurred each year with a rate of 4.38 fall-related injuries per 100 person-years. In the previous three months, 2.0% of older adults (65+), 1.1% of middle-aged adults (45-64) and 0.7% of young adults (18-44) reported a fall-related injury. Of all fall-related injuries among community-dwelling adults, 32.3% occurred among older adults, 35.3% among middle-aged adults and 32.3% among younger adults. The age-adjusted rate of fall-related injuries increased 4% per year among older women (95% CI 1%-7%) from 2004 to 2013. Among U.S. adults, the total lifetime cost of annual unintentional fall-related injuries that resulted in a fatality, hospitalization or treatment in an emergency department was 111 billion U.S. dollars in 2010. Conclusions Falls and fall-related injuries represent a significant health and safety problem for adults of all ages. The findings suggest that adult fall prevention efforts should consider the entire adult lifespan to ensure a greater public health benefit.	[Verma, Santosh K.; Willetts, Joanna L.; Corns, Helen L.; Marucci-Wellman, Helen R.; Lombardi, David A.; Courtney, Theodore K.] Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA USA; [Verma, Santosh K.] Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA; [Lombardi, David A.; Courtney, Theodore K.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA	Liberty Mutual Research Institute for Safety; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard T.H. Chan School of Public Health	Verma, SK (corresponding author), Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA USA.; Verma, SK (corresponding author), Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA.	Santosh.Verma@LibertyMutual.com	Courtney, Theodore K./P-4829-2019; Courtney, Theodore/J-8902-2013	Courtney, Theodore K./0000-0001-8139-1565; Courtney, Theodore/0000-0001-8139-1565; Verma, Santosh/0000-0001-9285-0325; Lombardi, David/0000-0001-6151-2024				Adams PE, 2010, VITAL HLTH STAT, V10, P1; Adams PE, 2012, VITAL HLTH STAT, V10, P2013; Andresen EM, 2006, GERONTOLOGIST, V46, P249, DOI 10.1093/geront/46.2.249; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Barrett-Connor E, 2009, OSTEOPOROSIS INT, V20, P715, DOI 10.1007/s00198-008-0748-2; Brault M., 2012, US CENSUS BUREAU CUR, V5; Brown MJ, 2011, PUBLIC HEALTH REP, V126, P131, DOI 10.1177/00333549111260S117; Caban-Martinez AJ, 2015, AM J PREV MED, V49, P888, DOI 10.1016/j.amepre.2015.05.022; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Carande-Kulis V, 2015, J SAFETY RES, V52, P65, DOI 10.1016/j.jsr.2014.12.007; Centers for Disease Control and Prevention, 2012, DAT STAT WISQARS COS; Centers for Disease Control and Prevention, 2014, FALLS OLD AD 2014; Centers for Disease Control and Prevention, 2010, 10 LEAD CAUS INJ DEA; Centers for Disease Control and Prevention National Center for Health Statistics, 2014, NAT HLTH INT SURV 20; Choy NL, 2003, J GERONTOL A-BIOL, V58, P525; Cigolle CT, 2015, JAMA INTERN MED, V175, P443, DOI 10.1001/jamainternmed.2014.7533; Cohen HH, 2016, APPL ERGON, V52, P112, DOI 10.1016/j.apergo.2015.07.002; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P57, DOI 10.4103/2229-5151.79283; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Gillespie L.D., 2012, COCHRANE DATABASE SY; Gorina Y, 2005, TRENDS CAUSES DEATH; Groen BE, 2007, J BIOMECH, V40, P458, DOI 10.1016/j.jbiomech.2005.12.014; Gustavsson J, 2015, INJURY PREV, V21, P320, DOI 10.1136/injuryprev-2014-041468; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hoidrup S, 2003, SCAND J PUBLIC HEALT, V31, P24, DOI 10.1080/14034940210134185; Howe TE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000333, 10.1002/14651858.CD000333.pub2]; Hu GQ, 2009, AM J PREV MED, V37, P188, DOI 10.1016/j.amepre.2009.04.023; Hu GQ, 2012, PUBLIC HEALTH REP, V127, P275, DOI 10.1177/003335491212700307; Institute for Health Metrics and Evaluation (IHME), 2013, GBD PROF US SEATTL; Isles RC, 2004, J AM GERIATR SOC, V52, P1367, DOI 10.1111/j.1532-5415.2004.52370.x; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kool B, 2012, INJURY PREV, V18, P200, DOI 10.1136/injuryprev-2011-040202; Kool B, 2010, NEW ZEAL MED J, V123, P75; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Liu Jian, 2015, Biomed Sci Instrum, V51, P189; Lombardi DA, 2010, CHRONOBIOL INT, V27, P1013, DOI 10.3109/07420528.2010.489466; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; Mertz KJ, 2010, AM J PREV MED, V39, P15, DOI 10.1016/j.amepre.2010.03.013; Murphy SL, 2013, NATL VITAL STAT REP, P61; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nemire K, 2016, APPL ERGON, V52, P309, DOI 10.1016/j.apergo.2015.07.021; Nitz JC, 2003, CLIN REHABIL, V17, P765, DOI 10.1191/0269215503cr675oa; Orces CH, 2014, INJURY PREV, V20, P421, DOI 10.1136/injuryprev-2014-041268; Orces Carlos H, 2008, Tex Med, V104, P55; Pai YC, 2007, PHYS THER, V87, P1478, DOI 10.2522/ptj.20060326; Parijat P, 2015, ANN BIOMED ENG, V43, P958, DOI 10.1007/s10439-014-1128-z; Porell FW, 2012, J AM GERIATR SOC, V60, P1498, DOI 10.1111/j.1532-5415.2012.04053.x; Santesso N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub5; Sihvonen S, 2004, AGING CLIN EXP RES, V16, P139; Smith GS, 2005, AM J PUBLIC HEALTH, V95, P1213, DOI 10.2105/AJPH.2004.049338; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Warner M, 2005, INJURY PREV, V11, P282, DOI 10.1136/ip.2004.006965; Warner M, 2000, Vital Health Stat 10, P1; Weerdesteyn V, 2008, J ELECTROMYOGR KINES, V18, P235, DOI 10.1016/j.jelekin.2007.06.010; Wells G., 2008, COCHRANE DATABASE SY, V1	60	146	151	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150939	10.1371/journal.pone.0150939	http://dx.doi.org/10.1371/journal.pone.0150939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977599	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800040
J	Wang, ZY; Zhou, QJ; Duan, HY; Wang, Y; Dong, MC; Shi, WY				Wang, Zhenyu; Zhou, Qingjun; Duan, Haoyun; Wang, Yao; Dong, Muchen; Shi, Weiyun			Immunological Properties of Corneal Epithelial-Like Cells Derived from Human Embryonic Stem Cells	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; NATURAL-KILLER-CELLS; OCULAR SURFACE; IN-VITRO; HLA-G; AMNIOTIC MEMBRANE; TRANSPLANTATION; DIFFERENTIATION; IMMUNE; RECONSTRUCTION	Transplantation of ex vivo expanded corneal limbal stem cells (LSCs) has been the main treatment for limbal stem cell deficiency, although the shortage of donor corneal tissues remains a major concern for its wide application. Due to the development of tissue engineering, embryonic stem cells (ESCs)-derived corneal epithelial-like cells (ESC-CECs) become a new direction for this issue. However, the immunogenicity of ESC-CECs is a critical matter to be solved. In the present study, we explored the immunological properties of ESC-CECs, which were differentiated from ESCs. The results showed that ESC-CECs had a similar character and function with LSCs both in vitro and in vivo. In ESC-CECs, a large number of genes related with immune response were down-regulated. The expressions of MHC-I, MHC-II, and co-stimulatory molecules were low, but the expression of HLA-G was high. The ESC-CECs were less responsible for T cell proliferation and NK cell lysis in vitro, and there was less immune cell infiltration after transplantation in vivo compared with LSCs. Moreover, the immunological properties were not affected by interferon-gamma All these results indicated a low immunogenicity of ESC-CECs, and they can be promising in clinical use.	[Wang, Zhenyu] Qingdao Univ, Qingdao 266071, Shandong, Peoples R China; [Wang, Zhenyu; Zhou, Qingjun; Duan, Haoyun; Wang, Yao; Dong, Muchen; Shi, Weiyun] Shandong Acad Med Sci, Shandong Prov Key Lab Ophthalmol, Shandong Eye Inst, Qingdao, Shandong, Peoples R China	Qingdao University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Shi, WY (corresponding author), Shandong Acad Med Sci, Shandong Prov Key Lab Ophthalmol, Shandong Eye Inst, Qingdao, Shandong, Peoples R China.	weiyunshi@163.com			State Basic Research Development Program of China (973 Program) [2013CB967004]	State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	The study was supported by the State Basic Research Development Program of China (973 Program, 2013CB967004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2007, STEM CELLS, V25, P1145, DOI 10.1634/stemcells.2006-0516; Apps R, 2008, TRENDS IMMUNOL, V29, P313, DOI 10.1016/j.it.2008.02.012; Boyd AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010965; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Brzeszczynska J, 2014, INT J MOL MED, V33, P1597, DOI 10.3892/ijmm.2014.1714; Buja LM, 2010, J AM COLL CARDIOL, V56, P1693, DOI 10.1016/j.jacc.2010.06.041; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Daniels JT, 2001, WOUND REPAIR REGEN, V9, P483, DOI 10.1046/j.1524-475x.2001.00483.x; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Grinnemo KH, 2006, REPROD BIOMED ONLINE, V13, P712, DOI 10.1016/S1472-6483(10)60663-3; Hanson C, 2013, ACTA OPHTHALMOL, V91, P127, DOI 10.1111/j.1755-3768.2011.02358.x; Hayashi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045435; Horuzsko A, 2001, INT IMMUNOL, V13, P385, DOI 10.1093/intimm/13.3.385; Ideguchi M, 2008, J NEUROSCI RES, V86, P1936, DOI 10.1002/jnr.21652; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Kanayama S, 2009, BRIT J OPHTHALMOL, V93, P263, DOI 10.1136/bjo.2008.141580; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Koch CA, 2008, STEM CELLS, V26, P89, DOI 10.1634/stemcells.2007-0151; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Li De-Quan, 2014, J Stem Cells, V9, P79; Ma DHK, 2006, PROG RETIN EYE RES, V25, P563, DOI 10.1016/j.preteyeres.2006.09.001; Mikhailova A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14684; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Opelz G, 2005, LANCET, V365, P1570, DOI 10.1016/S0140-6736(05)66458-6; Pan ZQ, 2002, CHINESE MED J-PEKING, V115, P767; Pauklin M, 2009, OPHTHALMOLOGY, V116, P1048, DOI 10.1016/j.ophtha.2009.01.005; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2014, STEM CELLS, V32, P26, DOI 10.1002/stem.1517; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Qi XL, 2014, AM J OPHTHALMOL, V158, P1192, DOI 10.1016/j.ajo.2014.08.019; Qi XL, 2013, OPHTHALMOLOGY, V120, P931, DOI 10.1016/j.ophtha.2012.11.001; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Roopenian D, 2002, IMMUNOL REV, V190, P86, DOI 10.1034/j.1600-065X.2002.19007.x; Tanaka K, 2001, INVEST OPHTH VIS SCI, V42, P2878; Tang C, 2011, SEMIN IMMUNOPATHOL, V33, P563, DOI 10.1007/s00281-011-0269-5; Toivonen S, 2013, STEM CELL TRANSL MED, V2, P83, DOI 10.5966/sctm.2012-0047; Tseng HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011590; Tseng SCG, 1996, MOL BIOL REP, V23, P47, DOI 10.1007/BF00357072; Wen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101841; Wylegala E, 2008, EUR J OPHTHALMOL, V18, P886, DOI 10.1177/112067210801800605; Yokoyama WM, 2008, NAT IMMUNOL, V9, P481, DOI 10.1038/ni1583; Zhou PY, 2015, J CELL SCI, V128, P2169, DOI 10.1242/jcs.169086; Zhu J, 2013, TISSUE ENG PT A, V19, P2412, DOI [10.1089/ten.tea.2013.0097, 10.1089/ten.TEA.2013.0097]	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150731	10.1371/journal.pone.0150731	http://dx.doi.org/10.1371/journal.pone.0150731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977925	Green Submitted, gold, Green Published			2022-12-27	WOS:000372572800034
J	Redlberger-Fritz, M; Kundi, M; Popow-Kraupp, T				Redlberger-Fritz, Monika; Kundi, Michael; Popow-Kraupp, Theresia			Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network	PLOS ONE			English	Article							HEMAGGLUTININ; INFECTION; EFFICACY; A(H3N2); CANADA	Background Influenza vaccine effectiveness (VE) is influenced by the antigenic similarity between vaccine-and circulating strains. Material and Methods This paper presents data obtained by the Austrian sentinel surveillance system on the evolution of influenza viruses during the season 2014/15 and its impact on influenza vaccine effectiveness in primary care in Austria as estimated by a test-negative case control design. VE estimates were performed for each influenza virus type/subtype, stratified by underlying diseases and adjusted for age, sex and calendar week of infection. Results Detailed genetic and antigenic analyses showed that circulating A(H3N2) viruses were genetically distinct from the 2014/15 A(H3N2) vaccine component indicating a profound vaccine mismatch. The Influenza A(H1N1)pdm09 viruses were antigenically conserved and matched the respective vaccine component. Influenza B viruses were lineage-matched B/Yamagata viruses with a clade-level variation. Consistent with substantial vaccine mismatch for the A(H3N2) viruses a crude overall VE of only 47% was estimated, whereas the VE estimates for A(H1N1)pdm09 were 84% and for influenza B viruses 70%. Increased VE estimates were obtained after stratification by underlying diseases and adjustment for the covariates sex and age, whereby the adjustment for the calendar week of infection was the covariate exerting the highest influence on adjusted VE estimates. Conclusion In summary, VE data obtained in this study underscore the importance to perform VE estimates in the context of detailed characterization of the contributing viruses and also demonstrate that the calendar week of influenza virus infection is the most important confounder of VE estimates.	[Redlberger-Fritz, Monika; Popow-Kraupp, Theresia] Med Univ Vienna, Dept Virol, Vienna, Austria; [Kundi, Michael] Med Univ Vienna, Inst Environm Hlth, Ctr Publ Hlth, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Popow-Kraupp, T (corresponding author), Med Univ Vienna, Dept Virol, Vienna, Austria.	theresia.popow-kraupp@meduniwien.ac.at		Redlberger-Fritz, Monika/0000-0001-6265-557X	Roche Austria AG	Roche Austria AG	The authors received no specific funding for this work. The Austrian Sentinel Physician Surveillance Network was supported by Roche Austria AG (www.roche.at). The supporter had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Serres G, 2013, Euro Surveill, V18; (ECDC) ECfDPaC, 2015, SURV REP; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Gilca R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132195; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heikkinen T, 2011, VACCINE, V29, P7529, DOI 10.1016/j.vaccine.2011.08.011; Jackson ML, 2015, VACCINE, V33, P1313, DOI 10.1016/j.vaccine.2015.01.069; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Janjua NZ, 2012, J INFECT DIS, V205, P1858, DOI 10.1093/infdis/jis283; Kissling E, 2013, EUROSURVEILLANCE, V18, P33; Kissling E, 2014, EUROSURVEILLANCE, V19, P22, DOI 10.2807/1560-7917.ES2014.19.6.20701; Kissling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027622; Kunze U, 2013, VACCINE, V31, P5099, DOI 10.1016/j.vaccine.2013.08.050; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Morokutti A, 2013, J CLIN VIROL, V56, P323, DOI 10.1016/j.jcv.2012.12.002; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pebody R, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.36.30013; Pebody RG, 2015, EUROSURVEILLANCE, V20, P6, DOI [10.2807/1560-7917.ES2015.20.5.21025, 10.2807/1560-7917.ES.2015.20.36.30013]; Petrie JG, 2015, J INFECT DIS, V212, P1914, DOI 10.1093/infdis/jiv313; Redlberger M, 2007, VACCINE, V25, P6061, DOI 10.1016/j.vaccine.2007.05.045; Savage RD, 2015, EUROSURVEILLANCE, V20; Skowronski D. M., 2005, Canada Communicable Disease Report, V31, P181; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.4.21022; Skowronski DM, 2015, J INFECT DIS, V212, P726, DOI 10.1093/infdis/jiv177; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Stucker KM, 2015, EUROSURVEILLANCE, V20, P20, DOI 10.2807/1560-7917.ES2015.20.18.21122; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; Valenciano M, 2015, VACCINE, V33, P2813, DOI 10.1016/j.vaccine.2015.04.012; Valenciano M, 2010, VACCINE, V28, P7381, DOI 10.1016/j.vaccine.2010.09.010	34	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149916	10.1371/journal.pone.0149916	http://dx.doi.org/10.1371/journal.pone.0149916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975056	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600015
J	Shih, TY; Wu, J; Shih, CT; Lee, YT; Wu, SH; Yao, CH; Hsieh, BT				Shih, Tian-Yu; Wu, Jay; Shih, Cheng-Ting; Lee, Yao-Ting; Wu, Shin-Hua; Yao, Chun-Hsu; Hsieh, Bor-Tsung			Small-Field Measurements of 3D Polymer Gel Dosimeters through Optical Computed Tomography	PLOS ONE			English	Article							RADIATION-DOSE DISTRIBUTIONS; NMR	With advances in therapeutic instruments and techniques, three-dimensional dose delivery has been widely used in radiotherapy. The verification of dose distribution in a small field becomes critical because of the obvious dose gradient within the field. The study investigates the dose distributions of various field sizes by using NIPAM polymer gel dosimeter. The dosimeter consists of 5% gelatin, 5% monomers, 3% cross linkers, and 5 mM THPC. After irradiation, a 24 to 96 hour delay was applied, and the gel dosimeters were read by a cone beam optical computed tomography (optical CT) scanner. The dose distributions measured by the NIPAM gel dosimeter were compared to the outputs of the treatment planning system using gamma evaluation. For the criteria of 3%/3 mm, the pass rates for 5 x 5, 3 x 3, 2 x 2, 1 x 1, and 0.5 x 0.5 cm(2) were as high as 91.7%, 90.7%, 88.2%, 74.8%, and 37.3%, respectively. For the criteria of 5%/5 mm, the gamma pass rates of the 5 x 5, 3 x 3, and 2 x 2 cm2 fields were over 99%. The NIPAM gel dosimeter provides high chemical stability. With cone-beam optical CT readouts, the NIPAM polymer gel dosimeter has potential for clinical dose verification of small-field irradiation.	[Shih, Tian-Yu; Yao, Chun-Hsu] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Shih, Tian-Yu; Lee, Yao-Ting; Hsieh, Bor-Tsung] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Shih, Tian-Yu; Wu, Shin-Hua] Cheng Ching Hosp Chung Kang, Dept Radiol, Taichung, Taiwan; [Wu, Jay] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Shih, Cheng-Ting] China Med Univ Hosp, Printing Med Res Ctr 3D, Taichung, Taiwan; [Yao, Chun-Hsu] China Med Univ, Coll Hlth Care, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Yao, Chun-Hsu] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; Central Taiwan University Science & Technology; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Yao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Hsieh, BT (corresponding author), Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.; Yao, CH (corresponding author), China Med Univ, Coll Hlth Care, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.; Yao, CH (corresponding author), Asia Univ, Dept Biomed Informat, Taichung, Taiwan.	chyao@mail.cmu.edu.tw; bthsieh@ctust.edu.tw	Shih, Cheng-Ting/Q-2842-2019	Shih, Cheng-Ting/0000-0002-8554-9136	Cheng Ching Hospital [CTU103-CCGH-001]; Central Taiwan University of Science and Technology [CTU103-CCGH-001]	Cheng Ching Hospital; Central Taiwan University of Science and Technology	The research fund comes from the collaborated project between Cheng Ching Hospital and Central Taiwan University of Science and Technology; Project No.: CTU103-CCGH-001.	Baxter P, 2007, MED PHYS, V34, P1934, DOI 10.1118/1.2732032; Chang KY, 2011, NUCL INSTRUM METH A, V652, P775, DOI 10.1016/j.nima.2010.09.099; Chang YJ, 2014, RADIAT PHYS CHEM, V104, P180, DOI 10.1016/j.radphyschem.2013.11.031; Chang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044905; Chang YJ, 2011, NUCL INSTRUM METH A, V652, P783, DOI 10.1016/j.nima.2010.09.097; Chiang CM, 2013, J RADIOANAL NUCL CH, V298, P1435, DOI 10.1007/s10967-013-2564-1; GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002; Gore JC, 1996, PHYS MED BIOL, V41, P2695, DOI 10.1088/0031-9155/41/12/009; Hassani H, 2014, MED DOSIM, V39, P102, DOI 10.1016/j.meddos.2013.10.007; Hsieh LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031836; Jirasek A, 2010, PHYS MED BIOL, V55, P5269, DOI 10.1088/0031-9155/55/18/002; Karlsson A, 2007, PHYS MED BIOL, V52, P4697, DOI 10.1088/0031-9155/52/15/021; Mesbahi A, 2012, REP PRACT ONCOL RADI, V17, P146, DOI 10.1016/j.rpor.2012.03.009; Olding T, 2011, J MED PHYS, V36, P3, DOI 10.4103/0971-6203.75466; Senden RJ, 2006, PHYS MED BIOL, V51, P3301, DOI 10.1088/0031-9155/51/14/001; Shih CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067281; Shih CT, 2013, IEEE T NUCL SCI, V60, P2155, DOI 10.1109/TNS.2013.2258038	17	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151300	10.1371/journal.pone.0151300	http://dx.doi.org/10.1371/journal.pone.0151300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974434	Green Published, gold			2022-12-27	WOS:000372570600066
J	Choi, YY; An, JY; Katai, H; Seto, Y; Fukagawa, T; Okumura, Y; Kim, DW; Kim, HI; Cheong, JH; Hyung, WJ; Noh, SH				Choi, Yoon Young; An, Ji Yeong; Katai, Hitoshi; Seto, Yasuyuki; Fukagawa, Takeo; Okumura, Yasuhiro; Kim, Dong Wook; Kim, Hyoung-Il; Cheong, Jae-Ho; Hyung, Woo Jin; Noh, Sung Hoon			A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; AMERICAN JOINT COMMITTEE; TNM CLASSIFICATION; 7TH EDITION; N RATIO; METASTASIS; JAPANESE; SURVIVAL	Although changing a lymph node staging system from an anatomically based system to a numerically based system in gastric cancer offers better prognostic performance, several problems can arise: it does not offer information on the anatomical extent of disease and cannot represent the extent of lymph node dissection. The purpose of this study was to discover an alternative lymph node staging system for gastric cancer. Data from 6025 patients who underwent gastrectomy for primary gastric cancer between January 2000 and December 2010 were reviewed. The lymph node groups were reclassified into lesser-curvature, greater-curvature, and extra-perigastric groups. Presence of any metastatic lymph node in one group was considered positive. Lymph node groups were further stratified into four (new N0-new N3) according to the number of positive lymph node groups. Survival outcomes with this new N staging were compared with those of the current TNM system. For validation, two centers in Japan (large center, n = 3443; medium center, n = 560) were invited. Even among the same pN stages, the more advanced new N stage showed worse prognosis, indicating that the anatomical extent of metastatic lymph nodes is important. The prognostic performance of the new staging system was as good as that of the current TNM system for overall advanced gastric cancer as well as lymph node-positive gastric cancer (Harrell C-index was 0.799, 0.726, and 0.703 in current TNM and 0.799, 0.727, and 0.703 in new TNM stage). Validation sets supported these outcomes. The new N staging system demonstrated prognostic performance equal to that of the current TNM system and could thus be used as an alternative.	[Choi, Yoon Young; An, Ji Yeong; Kim, Hyoung-Il; Cheong, Jae-Ho; Hyung, Woo Jin; Noh, Sung Hoon] Yonsei Univ, Coll Med, Dept Surg, Yonsei Univ Hlth Syst, Seoul, South Korea; [Noh, Sung Hoon] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Yonsei Univ Hlth Syst, Seoul, South Korea; [Kim, Dong Wook] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Yonsei Univ Hlth Syst, Seoul, South Korea; [Katai, Hitoshi; Fukagawa, Takeo] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan; [Seto, Yasuyuki; Okumura, Yasuhiro] Univ Tokyo, Dept Gastrointestinal Surg, Tokyo, Japan; [An, Ji Yeong] Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 06351, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Cancer Center - Japan; University of Tokyo; Sungkyunkwan University (SKKU); Samsung Medical Center	Noh, SH (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Yonsei Univ Hlth Syst, Seoul, South Korea.; Noh, SH (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Yonsei Univ Hlth Syst, Seoul, South Korea.	sunghoonn@yuhs.ac	Kim, Hyoungil/M-7288-2019	Kim, Hyoungil/0000-0002-6134-4523; Choi, Yoon Young/0000-0002-2179-7851; Noh, Sung Hoon/0000-0003-4386-6886; Cheong, Jae-Ho/0000-0002-1703-1781; Hyung, Woo Jin/0000-0002-8593-9214				Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Alatengbaolide, 2013, AM J CLIN ONCOL-CANC, V36, P325, DOI 10.1097/COC.0b013e318246b4e9; [Anonymous], 2010, AJCC CANC STAGING MA; [Anonymous], 1997, J CLIN PATHOL; Biondi A, 2011, J CLIN ONCOL, V29, P4338, DOI 10.1200/JCO.2011.36.9900; Cheong JH, 2006, ANN SURG ONCOL, V13, P377, DOI 10.1245/ASO.2006.04.018; Coburn NG, 2006, CANCER-AM CANCER SOC, V107, P2143, DOI 10.1002/cncr.22229; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujii K, 1999, BRIT J SURG, V86, P685, DOI 10.1046/j.1365-2168.1999.01115.x; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hayashi H, 2000, SURGERY, V127, P129, DOI 10.1067/msy.2000.102171; Ichikura T, 1999, CANCER-AM CANCER SOC, V86, P553, DOI 10.1002/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO;2-D; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; Jung KW, 2015, CANCER RES TREAT, V47, P142, DOI 10.4143/crt.2015.066; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim CY, 2009, ANN SURG ONCOL, V16, P1868, DOI 10.1245/s10434-009-0430-8; Kwee RM, 2009, GASTRIC CANCER, V12, P6, DOI 10.1007/s10120-008-0492-5; Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1; Memon MA, 2011, ANN SURG, V253, P900, DOI 10.1097/SLA.0b013e318212bff6; Nakagawa M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1940-3; Naylor GM, 2006, GUT, V55, P1545, DOI 10.1136/gut.2005.080358; Okines A, 2010, ANN ONCOL, V21, pv50, DOI 10.1093/annonc/mdq164; Reim D, 2013, J CLIN ONCOL, V31, P263, DOI 10.1200/JCO.2012.44.4315; ROBERTSON CS, 1994, ANN SURG, V220, P176, DOI 10.1097/00000658-199408000-00009; Sayegh Mazin E, 2004, Gastric Cancer, V7, P140; Seevaratnam R, 2012, GASTRIC CANCER, V15, pS3, DOI 10.1007/s10120-011-0069-6; Seevaratnam R, 2012, GASTRIC CANCER, V15, pS60, DOI 10.1007/s10120-011-0110-9; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Theuer CP, 2002, ARCH SURG-CHICAGO, V137, P960, DOI 10.1001/archsurg.137.8.960; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wittekind C, 2010, TNM CLASSIFICATION M; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yoon HM, 2012, J AM COLL SURGEONS, V214, P88, DOI 10.1016/j.jamcollsurg.2011.09.018; Yu W, 1997, BRIT J SURG, V84, P1305; Zhang JZ, 2013, ANN SURG, V257, P81, DOI 10.1097/SLA.0b013e31825eff3f	40	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149555	10.1371/journal.pone.0149555	http://dx.doi.org/10.1371/journal.pone.0149555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967161	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200004
J	Li, CX; Li, P; Tan, YM; Lam, SH; Chan, ECY; Gong, ZY				Li, Caixia; Li, Ping; Tan, Yee Min; Lam, Siew Hong; Chan, Eric C. Y.; Gong, Zhiyuan			Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; OXIDATIVE STRESS; METAL INTERACTIONS; DANIO-RERIO; EXPOSURE; DISEASE; CELLS; APOPTOSIS; BIOMARKER; RESPONSES	Arsenic is one of the most common metalloid contaminants in groundwater and it has both acute and chronic toxicity affecting multiple organs. Details of the mechanism of arsenic toxicity are still lacking and profile studies at metabolic level are very limited. Using gas chromatography coupled with mass spectroscopy (GC/MS), we first generated metabolomic profiles from the livers of arsenic-treated zebrafish and identified 34 significantly altered metabolite peaks as potential markers, including four prominent ones: cholic acid, glycylglycine, glycine and hypotaurine. Combined results from GC/MS, histological examination and pathway analyses suggested a series of alterations, including apoptosis, glycogenolysis, changes in amino acid metabolism and fatty acid composition, accumulation of bile acids and fats, and disturbance in glycolysis related energy metabolism. The alterations in glycolysis partially resemble Warburg effect commonly observed in many cancer cells. However, cellular damages were not reflected in two conventional liver function tests performed, Bilirubin assay and alanine aminotransferase (ALT) assay, probably because the short arsenate exposure was insufficient to induce detectable damage. This study demonstrated that metabolic changes could reflect mild liver impairments induced by arsenic exposure, which underscored their potential in reporting early liver injury.	[Li, Caixia; Li, Ping; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore; [Tan, Yee Min; Chan, Eric C. Y.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.; Gong, ZY (corresponding author), Natl Univ Singapore, NUS Environm Res Inst, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Chan, Eric Chun Yong/E-7101-2013; Gong, Zhiyuan/H-8794-2012; Lam, Siew Hong/H-8483-2012	Gong, Zhiyuan/0000-0002-9660-5260; Chan, Eric Chun Yong/0000-0001-6107-9072; Li, Caixia/0000-0003-2190-655X	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment & Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme; Environment & Water Industry Programme Office (EWI) of the PUB	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2000, LEUKEMIA LYMPHOMA, V37, P53, DOI 10.3109/10428190009057628; Allen T, 2004, BIOL TRACE ELEM RES, V98, P63, DOI 10.1385/BTER:98:1:63; Garcia-Sevillano MA, 2014, J PROTEOMICS, V104, P66, DOI 10.1016/j.jprot.2014.02.011; Aoki M, 2011, RAPID COMMUN MASS SP, V25, P1847, DOI 10.1002/rcm.5072; Banerjee N, 2008, TOXICOLOGY, V246, P101, DOI 10.1016/j.tox.2007.12.029; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166; Bears H, 2006, AQUAT TOXICOL, V77, P257, DOI 10.1016/j.aquatox.2005.12.008; Bolt HM, 2012, ARCH TOXICOL, V86, P825, DOI 10.1007/s00204-012-0866-7; Carlson P, 2014, AQUAT TOXICOL, V153, P66, DOI 10.1016/j.aquatox.2013.10.006; Chakraborti D., 2011, ENCY ENV HLTH, P165; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Correia Nuno, 2009, Cases J, V2, P7768, DOI 10.4076/1757-1626-2-7768; Das N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-639; de Wit NJW, 2012, J HEPATOL, V57, P1370, DOI 10.1016/j.jhep.2012.07.003; Dudka I, 2014, ENVIRON INT, V68, P71, DOI 10.1016/j.envint.2014.03.015; Garcia-Sevillano MA, 2013, METALLOMICS, V5, P1644, DOI 10.1039/c3mt00186e; Garcia-Sevillano MA, 2013, BIOMETALS, V26, P651, DOI 10.1007/s10534-013-9642-2; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Guha Mazumder D N, 2001, J Indian Med Assoc, V99, P314; Guha Mazumder DN., 2001, J INDIAN MED ASSOC, V99, P8; Guha Mazumder DN., 2001, J INDIAN MED ASSOC, V99, P4; Hamdi M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-104; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Islam K, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-64; Kharroubi W, 2014, ENVIRON SCI POLLUT R, V21, P1648, DOI 10.1007/s11356-013-2057-3; Kim JH, 2015, ENVIRON TOXICOL PHAR, V39, P668, DOI 10.1016/j.etap.2015.01.012; Koppenol WH, 2011, NAT REV CANCER, V11, P618, DOI 10.1038/nrc3108; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Lage CR, 2006, INTEGR COMP BIOL, V46, P1040, DOI 10.1093/icb/icl048; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lee JJ, 2004, J KOREAN MED SCI, V19, P127, DOI 10.3346/jkms.2004.19.1.127; Lee J, 2012, ANAL SCI, V28, P801, DOI 10.2116/analsci.28.801; Lefkowitch JH, 2006, ZAKIM BOYERS HEPATOL, P205; Levitt DG, 2014, CLIN EXP GASTROENTER, V7, P307, DOI 10.2147/CEG.S64283; Li D, 2009, AQUAT TOXICOL, V91, P229, DOI 10.1016/j.aquatox.2008.11.007; Li YY, 2013, BIOCHEM PHARMACOL, V86, P1517, DOI 10.1016/j.bcp.2013.08.015; Li Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132319; Liu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083954; Liu ZT, 2014, INT J MED SCI, V11, P925, DOI 10.7150/ijms.8951; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; Ma Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16093; Marchiset-Ferlay N, 2012, ENVIRON INT, V39, P150, DOI 10.1016/j.envint.2011.07.015; Mattingly CJ, 2009, ENVIRON HEALTH PERSP, V117, P981, DOI 10.1289/ehp.0900555; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; McCollum CW, 2014, AQUAT TOXICOL, V152, P152, DOI 10.1016/j.aquatox.2014.04.006; McIntyre D. O., 2011, FISH PHYSIOL, V31, P297; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Mikawa T, 2015, CELL MOL LIFE SCI, V72, P1881, DOI 10.1007/s00018-015-1840-3; Moore LE, 2013, ENVIRON MOL MUTAGEN, V54, P589, DOI 10.1002/em.21792; Nagato EG, 2013, CHEMOSPHERE, V93, P331, DOI 10.1016/j.chemosphere.2013.04.085; Nain S, 2012, ENVIRON TOXICOL, V27, P244, DOI 10.1002/tox.20635; Nayak AS, 2007, TOXICOL SCI, V98, P118, DOI 10.1093/toxsci/kfm072; Nemeti B, 2007, TOXICOL SCI, V100, P36, DOI 10.1093/toxsci/kfm211; PATEL DK, 1990, HUM EXP TOXICOL, V9, P389, DOI 10.1177/096032719000900606; Patel HV, 2013, J ENVIRON BIOL, V34, P231; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; REICHL FX, 1988, ARCH TOXICOL, V62, P473, DOI 10.1007/BF00288353; Shi X, 2014, J PROTEOME RES, V13, P547, DOI 10.1021/pr400719u; Sjovall J, 2010, STEROID ANALYSIS: SECOND EDITION, P837, DOI 10.1023/b135931_10; Stegeman JJ, 2010, FISH PHYSIOL, V29, P367, DOI 10.1016/S1546-5098(10)02910-9; Torres DM, 2010, GI LIVER SECRETS, P201; Vaitheesvaran B, 2015, METABOLOMICS, V11, P787, DOI 10.1007/s11306-014-0760-9; Vutukuru Sesha Srinivas, 2007, Int J Environ Res Public Health, V4, P224, DOI 10.3390/ijerph2007030005; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wang Y, 2011, EXP THER MED, V2, P481, DOI 10.3892/etm.2011.224; Wang YM, 2014, MOL PHARMACOL, V86, P62, DOI 10.1124/mol.113.091462; Watanabe T, 2013, ARCH TOXICOL, V87, P969, DOI 10.1007/s00204-012-0904-5; Wei L, 2009, TOXICOL APPL PHARM, V234, P314, DOI 10.1016/j.taap.2008.11.010; Woo SH, 2002, INT J ONCOL, V21, P57; Wu HF, 2013, AQUAT TOXICOL, V136, P91, DOI 10.1016/j.aquatox.2013.03.020; Xu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068737; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Yoshimura Y, 2011, J OCCUP HEALTH, V53, P45, DOI 10.1539/joh.L10108; Zhao F, 2013, TOXICOL APPL PHARM, V271, P72, DOI 10.1016/j.taap.2013.04.020	76	32	36	9	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151225	10.1371/journal.pone.0151225	http://dx.doi.org/10.1371/journal.pone.0151225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967897	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200036
J	Sabet, JA; Park, LK; Iyer, LK; Tai, AK; Koh, GY; Pfalzer, AC; Parnell, LD; Mason, JB; Liu, ZH; Byun, AJ; Crott, JW				Sabet, Julia A.; Park, Lara K.; Iyer, Lakshmanan K.; Tai, Albert K.; Koh, Gar Yee; Pfalzer, Anna C.; Parnell, Laurence D.; Mason, Joel B.; Liu, Zhenhua; Byun, Alexander J.; Crott, Jimmy W.			Paternal B Vitamin Intake Is a Determinant of Growth, Hepatic Lipid Metabolism and Intestinal Tumor Volume in Female Apc(1638N) Mouse Offspring	PLOS ONE			English	Article							MATERNAL METHYL SUPPLEMENTS; HIGH-FAT DIET; DNA METHYLATION; GENE-EXPRESSION; FOLIC-ACID; RNA; FOLATE; EPIGENETICS; PREGNANCY; OBESITY	Background The importance of maternal nutrition to offspring health and risk of disease is well established. Emerging evidence suggests paternal diet may affect offspring health as well. Objective In the current study we sought to determine whether modulating pre-conception paternal B vitamin intake alters intestinal tumor formation in offspring. Additionally, we sought to identify potential mechanisms for the observed weight differential among offspring by profiling hepatic gene expression and lipid content. Methods Male Apc(1638N) mice (prone to intestinal tumor formation) were fed diets containing replete (control, CTRL), mildly deficient (DEF), or supplemental (SUPP) quantities of vitamins B-2, B-6, B-12, and folate for 8 weeks before mating with control-fed wild type females. Wild type offspring were euthanized at weaning and hepatic gene expression profiled. Apc(1638N) offspring were fed a replete diet and euthanized at 28 weeks of age to assess tumor burden. Results No differences in intestinal tumor incidence or burden were found between male Apc(1638N) offspring of different paternal diet groups. Although in female Apc(1638N) offspring there were no differences in tumor incidence or multiplicity, a stepwise increase in tumor volume with increasing paternal B vitamin intake was observed. Interestingly, female offspring of SUPP and DEF fathers had a significantly lower body weight than those of CTRL fed fathers. Moreover, hepatic trigylcerides and cholesterol were elevated 3-fold in adult female offspring of SUPP fathers. Weanling offspring of the same fathers displayed altered expression of several key lipid-metabolism genes. Hundreds of differentially methylated regions were identified in the paternal sperm in response to DEF and SUPP diets. Aside from a few genes including Igf2, there was a striking lack of overlap between these genes differentially methylated in sperm and differentially expressed in offspring. Conclusions In this animal model, modulation of paternal B vitamin intake prior to mating alters offspring weight gain, lipid metabolism and tumor growth in a sex-specific fashion. These results highlight the need to better define how paternal nutrition affects the health of offspring.	[Sabet, Julia A.; Park, Lara K.; Koh, Gar Yee; Pfalzer, Anna C.; Parnell, Laurence D.; Mason, Joel B.; Liu, Zhenhua; Byun, Alexander J.; Crott, Jimmy W.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Sabet, Julia A.; Park, Lara K.; Pfalzer, Anna C.; Mason, Joel B.; Crott, Jimmy W.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Iyer, Lakshmanan K.] Tufts Univ, Sch Med, Tufts Ctr Neurosci Res, Neurosci Dept, Boston, MA 02111 USA; [Iyer, Lakshmanan K.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Tai, Albert K.] Tufts Univ, Sch Med, Tufts Univ Core Facil, Boston, MA 02111 USA; [Liu, Zhenhua] UMass Amherst, Sch Publ Hlth & Hlth Sci, Amherst, MA USA	Tufts University; United States Department of Agriculture (USDA); Tufts University; Tufts University; Tufts Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Crott, JW (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.; Crott, JW (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	jimmy.crott@tufts.edu	Sabet, Julia/AAE-1225-2021	Koh, Gar Yee/0000-0002-2783-1723	NCI (National Cancer Institute) [1 R03CA162505-1]; USDA-ARS [58-1950-0-014, 58-1950-4-003]; NATIONAL CANCER INSTITUTE [R03CA162505] Funding Source: NIH RePORTER	NCI (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by NCI (National Cancer Institute) 1 R03CA162505-1 and USDA-ARS #58-1950-0-014 and ##58-1950-4-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RJ, 1998, DIGEST DIS SCI, V43, P2652, DOI 10.1023/A:1026699126899; Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Bailey RL, 2010, AM J CLIN NUTR, V91, P231, DOI 10.3945/ajcn.2009.28427; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; CAMP VM, 1983, CLIN CHEM, V29, P642; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cerrato F, 2003, HUM MOL GENET, V12, P3123, DOI 10.1093/hmg/ddg338; Ciappio ED, 2011, GUT, V60, P1695, DOI 10.1136/gut.2011.240291; Cooney CA, 2002, J NUTR, V132, p2393S; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dolinoy DC, 2007, PEDIATR RES, V61, p30R, DOI 10.1203/pdr.0b013e31804575f7; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Ehara T, 2012, DIABETES, V61, P2442, DOI 10.2337/db11-1834; [范林峰 Fan Linfeng], 2012, [地理与地理信息科学, Geography and Geo-information Science], V28, P28; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gong Y, 2014, EUR REV MED PHARMACO, V18, P2808; Haggarty P, 2013, AM J CLIN NUTR, V97, P94, DOI 10.3945/ajcn.112.042572; Huffman DM, 2013, CANCER PREV RES, V6, P177, DOI 10.1158/1940-6207.CAPR-12-0414; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kim HW, 2013, MOL NUTR FOOD RES, V57, P671, DOI 10.1002/mnfr.201200558; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Levene AP, 2012, HISTOPATHOLOGY, V60, P971, DOI 10.1111/j.1365-2559.2012.04193.x; Levin BE, 2009, INT J OBESITY, V33, pS53, DOI 10.1038/ijo.2009.18; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu L, 2009, J AM ASSOC LAB ANIM, V48, P39; Liu ZH, 2007, J NUTR, V137, P2701, DOI 10.1093/jn/137.12.2701; Liu ZH, 2011, FASEB J, V25, P3136, DOI 10.1096/fj.11-184143; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Metayer C, 2014, EPIDEMIOLOGY, V25, P811, DOI 10.1097/EDE.0000000000000141; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; NICHOALDS GE, 1974, CLIN CHEM, V20, P624; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Rand E, 2003, J CELL BIOCHEM, V88, P400, DOI 10.1002/jcb.10352; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Sable PS, 2012, NEUROSCIENCE, V217, P46, DOI 10.1016/j.neuroscience.2012.05.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi LJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-59; Sie K, 2008, AM ASS CANC RES ANN; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Targher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949	57	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151579	10.1371/journal.pone.0151579	http://dx.doi.org/10.1371/journal.pone.0151579			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968002	Green Submitted, gold, Green Published			2022-12-27	WOS:000371989200064
J	Vila-Casadesus, M; Gironella, M; Lozano, JJ				Vila-Casadesus, Maria; Gironella, Meritxell; Jose Lozano, Juan			MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers	PLOS ONE			English	Article							MICRORNA TARGETS; PREDICTION; IDENTIFICATION; BIOCONDUCTOR; DISEASE; GENES; TOOLS	MicroRNAs (miRNAs) are small RNAs that regulate the expression of target mRNAs by specific binding on the mRNA 3'UTR and promoting mRNA degradation in the majority of cases. It is often of interest to know the specific targets of a miRNA in order to study them in a particular disease context. In that sense, some databases have been designed to predict potential miRNA-mRNA interactions based on hybridization sequences. However, one of the main limitations is that these databases have too many false positives and do not take into account disease-specific interactions. We have developed an R package (miRComb) able to combine miRNA and mRNA expression data with hybridization information, in order to find potential miRNA-mRNA targets that are more reliable to occur in a specific physiological or disease context. This article summarizes the pipeline and the main outputs of this package by using as example TCGA data from five gastrointestinal cancers (colon cancer, rectal cancer, liver cancer, stomach cancer and esophageal cancer). The obtained results can be used to develop a huge number of testable hypotheses by other authors. Globally, we show that the miRComb package is a useful tool to deal with miRNA and mRNA expression data, that helps to filter the high amount of miRNA-mRNA interactions obtained from the pre-existing miRNA target prediction databases and it presents the results in a standardised way (pdf report). Moreover, an integrative analysis of the miRComb miRNA-mRNA interactions from the five digestive cancers is presented. Therefore, miRComb is a very useful tool to start understanding miRNA gene regulation in a specific context. The package can be downloaded in http://mircomb.sourceforge.net.	[Vila-Casadesus, Maria; Jose Lozano, Juan] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Bioinformat Platform, Barcelona, Catalonia, Spain; [Vila-Casadesus, Maria; Gironella, Meritxell; Jose Lozano, Juan] Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer IDIBAP, Gastrointestinal & Pancreat Oncol Grp, Barcelona, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Lozano, JJ (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Bioinformat Platform, Barcelona, Catalonia, Spain.; Gironella, M; Lozano, JJ (corresponding author), Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer IDIBAP, Gastrointestinal & Pancreat Oncol Grp, Barcelona, Catalonia, Spain.	meritxell.gironella@ciberehd.org; juanjo.lozano@ciberehd.org	Vila Casadesús, Maria/J-8207-2016	Vila Casadesús, Maria/0000-0001-6597-7953; Gironella, Meritxell/0000-0003-4437-5181; Lozano, Juan Jose/0000-0001-7613-3908	Instituto de Salud Carlos III (FEDER-European Union) [PI13/02192]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer [GCB13131592CAST]; Instituto de Salud Carlos III; Ministerio de Educacion Cultura y Deporte [FPU12/05138]	Instituto de Salud Carlos III (FEDER-European Union); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Educacion Cultura y Deporte(Spanish Government)	The present work was supported by grants from Instituto de Salud Carlos III (PI13/02192; co-funded by FEDER-European Union) and from Fundacion Cientifica de la Asociacion Espanola contra el Cancer (GCB13131592CAST) to MG. CIBEREHD is funded by the Instituto de Salud Carlos III. MVC is funded by Ministerio de Educacion Cultura y Deporte (FPU12/05138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gade S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-488; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023; R Core Team, 2013, R LANG ENV STAT COMP; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ru YB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku631; Schroder MS, 2013, BIOINFORMATICS, V29, P666, DOI 10.1093/bioinformatics/bts708; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303	23	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151127	10.1371/journal.pone.0151127	http://dx.doi.org/10.1371/journal.pone.0151127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967326	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200032
J	Weeks, RJ; Ludgate, JL; LeMee, G; Morison, IM				Weeks, Robert J.; Ludgate, Jackie L.; LeMee, Gwenn; Morison, Ian M.			TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DOWN-REGULATION; LIM-DOMAIN; PROMOTER METHYLATION; EXTENSIVE ANALYSIS; GENE-EXPRESSION; SQUAMOUS-CELL; HYPERMETHYLATION; HETEROZYGOSITY; REGION	Background Childhood acute lymphoblastic leukaemia (ALL) is the most common malignancy in children. Despite high cure rates, side effects and late consequences of the intensive treatments are common. Unquestionably, the identification of new therapeutic targets will lead to safer, more effective treatments. We identified TES promoter methylation and transcriptional silencing as a very common molecular abnormality in childhood ALL, irrespective of molecular subtype. The aims of the present study were to demonstrate that TES promoter methylation is aberrant, to determine the effects of TES re-expression in ALL, and to determine if those effects are mediated via TP53 activity. Methods Normal fetal and adult tissue DNA was isolated and TES promoter methylation determined by Sequenom MassARRAY. Quantitative RT-PCR and immunoblot were used to confirm re-expression of TES in ALL cell lines after 5'-aza-2'-deoxycytidine (decitabine) exposure or transfection with TES expression plasmids. The effects of TES re-expression on ALL cells were investigated using standard cell proliferation, cell death and cell cycle assays. Results In this study, we confirm that the TES promoter is unmethylated in normal adult and fetal tissues. We report that decitabine treatment of ALL cell lines results in demethylation of the TES promoter and attendant expression of TES mRNA. Re-expression of TESTIN protein in ALL cells using expression plasmid transfection results in rapid cell death or cell cycle arrest independent of TP53 activity. Conclusions These results suggest that TES is aberrantly methylated in ALL and that re-expression of TESTIN has anti-leukaemia effects which point to novel therapeutic opportunities for childhood ALL.	[Weeks, Robert J.; Ludgate, Jackie L.; LeMee, Gwenn; Morison, Ian M.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand	University of Otago	Weeks, RJ (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand.	rob.weeks@otago.ac.nz	Weeks, Robert J/A-6876-2012; Morison, Ian M/A-1236-2008	Weeks, Robert J/0000-0003-0474-9089; Morison, Ian M/0000-0003-3616-0025	Cancer Society of New Zealand Inc.; CureKids NZ; Genesis Oncology Trust; Lottery Health Research	Cancer Society of New Zealand Inc.; CureKids NZ; Genesis Oncology Trust; Lottery Health Research	This work was funded in part by grants awarded by Cancer Society of New Zealand Inc. (www.cancernz.org.nz; IMM & RJW), CureKids NZ (http://www.curekids.org.nz; IMM & RJW), Genesis Oncology Trust (http://www.genesisoncology.org.nz; IMM & RJW) and Lottery Health Research (http://www.communitymatters.govt.nz/Funding-and-grants; IMM & RJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Arumemi F, 2013, ADV BIOSCIENCE BIOTE, V4; Bai Y, 2014, EUR J MED RES, V19, DOI 10.1186/s40001-014-0066-4; BIERNAUX C, 1995, BLOOD, V86, P3118; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Boeda B, 2011, J BIOL CHEM, V286, P11543, DOI 10.1074/jbc.M110.171264; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Chene L, 2004, INT J CANCER, V111, P798, DOI 10.1002/ijc.20337; Cigognini D, 2007, LEUKEMIA RES, V31, P477, DOI 10.1016/j.leukres.2006.09.007; Crone J, 2011, CANCER RES, V71, P2350, DOI 10.1158/0008-5472.CAN-10-3486; Dockerty JD, 2009, BLOOD CELL MOL DIS, V42, P113, DOI 10.1016/j.bcmd.2008.10.008; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fujiwara T, 2010, P NATL ACAD SCI USA, V107, P20429, DOI 10.1073/pnas.1007804107; Garvalov BK, 2003, J CELL BIOL, V161, P33, DOI 10.1083/jcb.200211015; Greaves Mel, 2003, Rev Clin Exp Hematol, V7, P233; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Griffith E, 2004, CELL MOTIL CYTOSKEL, V57, P133, DOI 10.1002/cm.10162; Gu ZP, 2014, MED SCI MONITOR, V20, P980, DOI 10.12659/MSM.890544; Gunduz E, 2009, ARCH OTOLARYNGOL, V135, P254, DOI 10.1001/archoto.2008.560; Hussain FTN, 2012, AM J HEMATOL, V87, P684, DOI 10.1002/ajh.23230; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; Krawchuk D, 2008, DEV DYNAM, V237, P1183, DOI 10.1002/dvdy.21514; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; Ma HQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-190; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; Mirebeau D, 2006, HAEMATOL-HEMATOL J, V91, P881; Mody R, 2008, BLOOD, V111, P5515, DOI 10.1182/blood-2007-10-117150; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Mullighan CG, 2012, J CLIN INVEST, V122, P3407, DOI 10.1172/JCI61203; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; PROKOCIMER M, 1986, BLOOD, V68, P113; Pui CH, 2014, LEUKEMIA, V28, P2336, DOI 10.1038/leu.2014.142; Qiu HF, 2010, CANCER SCI, V101, P1255, DOI 10.1111/j.1349-7006.2010.01497.x; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Sarti M, 2005, CLIN CANCER RES, V11, P806; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Skiriute D, 2013, J NEURO-ONCOL, V113, P441, DOI 10.1007/s11060-013-1133-3; Sproul D, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R84, 10.1186/gb-2012-13-10-r84]; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Tatarelli C, 2000, GENOMICS, V68, P1, DOI 10.1006/geno.2000.6272; Weeks RJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-163; Wiederschain D, 2003, MOL CELL BIOL, V23, P4230, DOI 10.1128/MCB.23.12.4230-4246.2003; Xia JC, 2006, CANCER GENET CYTOGEN, V166, P166, DOI 10.1016/j.cancergencyto.2005.11.005; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zhong YL, 2009, MOL CELL BIOCHEM, V320, P85, DOI 10.1007/s11010-008-9901-7; Zhu J, 2012, CANCER SCI, V103, P2092, DOI 10.1111/cas.12020	50	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151341	10.1371/journal.pone.0151341	http://dx.doi.org/10.1371/journal.pone.0151341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985820	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300063
J	Calabrese, G; Giuffrida, R; Fabbi, C; Figallo, E; Lo Furno, D; Gulino, R; Colarossi, C; Fullone, F; Giuffrida, R; Parenti, R; Memeo, L; Forte, S				Calabrese, Giovanna; Giuffrida, Raffaella; Fabbi, Claudia; Figallo, Elisa; Lo Furno, Debora; Gulino, Rosario; Colarossi, Cristina; Fullone, Francesco; Giuffrida, Rosario; Parenti, Rosalba; Memeo, Lorenzo; Forte, Stefano			Collagen-Hydroxyapatite Scaffolds Induce Human Adipose Derived Stem Cells Osteogenic Differentiation In Vitro	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; TRANSPLANTATION; MINERALIZATION; PHOSPHATASE; THERAPY; INSULIN; DESIGN	Mesenchymal stem cells (MSCs) play a crucial role in regulating normal skeletal homeostasis and, in case of injury, in bone healing and reestablishment of skeletal integrity. Recent scientific literature is focused on the development of bone regeneration models where MSCs are combined with biomimetic three-dimensional scaffolds able to direct MSC osteogenesis. In this work the osteogenic potential of human MSCs isolated from adipose tissue (hADSCs) has been evaluated in vitro in combination with collagen/Mg doped hydroxyapatite scaffolds. Results demonstrate the high osteogenic potential of hADSCs when cultured in specific differentiation induction medium, as revealed by the Alizarin Red S staining and gene expression profile analysis. In combination with collagen/hydroxyapatite scaffold, hADSCs differentiate into mature osteoblasts even in the absence of specific inducing factors; nevertheless, the supplement of the factors markedly accelerates the osteogenic process, as confirmed by the expression of specific markers of pre-osteoblast and mature osteoblast stages, such as osterix, osteopontin (also known as bone sialoprotein I), osteocalcin and specific markers of extracellular matrix maturation and mineralization stages, such as ALPL and osteonectin. Hence, the present work demonstrates that the scaffold per se is able to induce hADSCs differentiation, while the addition of osteo-inductive factors produces a significant acceleration of the osteogenic process. This observation makes the use of our model potentially interesting in the field of regenerative medicine for the treatment of bone defects.	[Calabrese, Giovanna; Giuffrida, Raffaella; Gulino, Rosario; Memeo, Lorenzo; Forte, Stefano] IOM Ric, Viagrande, Italy; [Fabbi, Claudia; Figallo, Elisa] Finceramica, Faenza, Italy; [Lo Furno, Debora; Gulino, Rosario; Giuffrida, Rosario; Parenti, Rosalba] Univ Catania, Dept Biomed & Biotechnol Sci, Physiol Sect, Catania, Italy; [Colarossi, Cristina; Fullone, Francesco; Memeo, Lorenzo] Mediterranean Inst Oncol, Dept Expt Oncol, Viagrande, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Catania; Mediterranean Institute of Oncology	Forte, S (corresponding author), IOM Ric, Viagrande, Italy.	stefano.forte@grupposamed.com	Furno, Debora Lo/P-1667-2019; Parenti, Rosalba/AAS-5489-2020; Giuffrida, Rosario/AFP-2975-2022; Parenti, Rosalba/ABC-5780-2020; Forte, Stefano/D-3645-2013	Furno, Debora Lo/0000-0002-1971-8990; Giuffrida, Rosario/0000-0001-7494-3675; Parenti, Rosalba/0000-0002-1614-4696; Forte, Stefano/0000-0001-5746-7451; Calabrese, Giovanna/0000-0003-1937-5403; Colarossi, Cristina/0000-0001-5395-8608; Memeo, Lorenzo/0000-0003-4251-7203	Italian "PON Ricerca e Competitivita" [ASSE I 829]; Finceramica	Italian "PON Ricerca e Competitivita"; Finceramica	The present research was funded by the Italian "PON Ricerca e Competitivita 2007-2013, ASSE I 829" grant programme entitled "Piattaforme tecnologiche innovative per l'ingegneria tissutale". Finceramica provided support in the form of salaries for authors CF and EF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. There was no additional external funding received for this study.; The present research was funded by the Italian "PON Ricerca e Competitivita 2007-2013, ASSE I 829" grant programme entitled "Piattaforme tecnologiche innovative per l'ingegneria tissutale". There was no additional external funding received for this study. The authors gratefully acknowledge Gabriele Anastasi for technical assistance.	Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Arinzeh Treena Livingston, 2005, Foot Ankle Clin, V10, P651, DOI 10.1016/j.fcl.2005.06.004; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Calabrese G, 2015, INT J MOL SCI, V16, P15609, DOI 10.3390/ijms160715609; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chim H, 2006, INT J ORAL MAX SURG, V35, P928, DOI 10.1016/j.ijom.2006.03.024; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]; Grigolo B, 2011, J Biol Regul Homeost Agents, V25, pS3; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; Karsenty G, 2000, MATRIX BIOL, V19, P85, DOI 10.1016/S0945-053X(00)00053-6; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014; Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Manferdini C, 2016, J TISSUE ENG REGEN M, V10, P374, DOI 10.1002/term.1723; Meyer U., 2009, FUNDAMENTALS TISSUE; Minuto F, 2005, J ENDOCRINOL INVEST, V28, P1; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nicoletti A, 2013, J MATER SCI-MATER M, V24, P17, DOI 10.1007/s10856-012-4782-4; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Pasqui D, 2014, J BIOMED MATER RES A, V102, P1568, DOI 10.1002/jbm.a.34810; Pham L, 2011, J CELL BIOCHEM, V112, P793, DOI 10.1002/jcb.23003; Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Sugawara Y, 2002, JPN J PHARMACOL, V88, P262, DOI 10.1254/jjp.88.262; Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008; Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Vicari L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5282185; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032364; Yu G, 2011, METHODS MOL BIOL, V702, P17, DOI 10.1007/978-1-61737-960-4_2; Zanetti AS, 2013, J BIOMED MATER RES B, V101B, P187, DOI 10.1002/jbm.b.32817; Zhu FC, 2012, J CELL PHYSIOL, V227, P2677, DOI 10.1002/jcp.23010; Zhu XS, 2012, CELL TISSUE RES, V350, P277, DOI 10.1007/s00441-012-1453-1; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	54	77	79	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151181	10.1371/journal.pone.0151181	http://dx.doi.org/10.1371/journal.pone.0151181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982592	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900067
J	Zeng, XZ; Wang, HL; Xing, XC; Wang, Q; Li, WZ				Zeng, Xianzhang; Wang, Honglei; Xing, Xichun; Wang, Qi; Li, Wenzhi			Dexmedetomidine Protects against Transient Global Cerebral Ischemia/Reperfusion Induced Oxidative Stress and Inflammation in Diabetic Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NADPH OXIDASE; BRAIN-INJURY; ALPHA(2)-AGONIST DEXMEDETOMIDINE; GLUCOSE DEPRIVATION; RISK-FACTORS; CELL-DEATH; DAMAGE; RECEPTORS; STROKE	Background Transient global cerebral ischemia/reperfusion (I/R) is a major perioperative complication, and diabetes increases the response of oxidative stress and inflammation induced by I/R. The objective of this study was to determine the protective effect of dexmedetomidine against transient global cerebral ischemia/reperfusion induced oxidative stress and inflammation in diabetic rats. Methods Sixty-four rats were assigned into four experimental groups: normoglycemia, normoglycemia + dexmedetomidine, hyperglycemia, and hyperglycemia + dexmedetomidine and all subsequent neurological examinations were evaluated by a blinded observer. Damage to the brain was histologically assessed using the TUNEL staining method while western blotting was used to investigate changes in the expression levels of apoptosis-related proteins as well as the microglia marker, ionized calcium-binding adapter molecule 1 (Iba1). Water content in the brain was also analyzed. In addition, hippocampal concentrations of malondialdehyde (MDA) and Nox2 (a member of the Nox family of NADPH oxidases), and the activity of superoxide dismutase and catalase were analyzed. Finally, changes in serum concentrations of tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 were detected. Results Results showed that diabetes increased brain water content, the number of apoptotic neurons, early neurological deficit scores, oxidative stress (MDA and Nox2) and inflammation (pro-inflammatory cytokines including TNF-alpha and IL-6) levels following transient global I/R injury, but that these symptoms were attenuated following administration of dexmedetomidine. Conclusions These findings suggest that dexmedetomidine can significantly alleviate damage resulting from I/R, and this mechanism may be related to a reduction in both oxidative stress and inflammation which is normally associated with I/R.	[Zeng, Xianzhang; Wang, Honglei; Xing, Xichun; Wang, Qi; Li, Wenzhi] Harbin Med Univ, Dept Anaesthesiol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Li, WZ (corresponding author), Harbin Med Univ, Dept Anaesthesiol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China.	wenzhili9@126.com			National Natural Science Foundation of China [81171076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by the National Natural Science Foundation of China (NO. 81171076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Arslan M, 2014, BRATISL MED J, V115, P494, DOI 10.4149/BLL_2014_096; Bitar MS, 1997, PHARMACOL BIOCHEM BE, V56, P15, DOI 10.1016/S0091-3057(96)00129-3; Bosca L, 1999, CELL SIGNAL, V11, P239, DOI 10.1016/S0898-6568(98)00064-3; Brambrink AM, 2006, ANESTHESIOLOGY, V104, P1208, DOI 10.1097/00000542-200606000-00016; Brambrink AM, 2000, J CEREBR BLOOD F MET, V20, P1425, DOI 10.1097/00004647-200010000-00004; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dahmani S, 2005, ANESTHESIOLOGY, V103, P969, DOI 10.1097/00000542-200511000-00011; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Dahmani S, 2010, ANESTHESIOLOGY, V112, P373, DOI 10.1097/ALN.0b013e3181ca6982; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Engelhard K, 2002, ANESTHESIOLOGY, V96, P450, DOI 10.1097/00000542-200202000-00034; Engelhard K, 2003, ANESTH ANALG, V96, P524, DOI 10.1097/00000539-200302000-00041; Eser O, 2008, BRAIN RES, V1218, P250, DOI 10.1016/j.brainres.2008.04.045; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; Figiel I, 2007, BRAIN RES, V1131, P17, DOI 10.1016/j.brainres.2006.10.095; Flaherty JH, 2007, J AM GERIATR SOC, V55, P1295, DOI 10.1111/j.1532-5415.2007.01273.x; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; GUO TZ, 1991, PHARMACOL BIOCHEM BE, V39, P383; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Han Z, 2009, NEUROL RES, V31, P390, DOI 10.1179/174313209X444116; Hanci V, 2010, UROL INT, V84, P105, DOI 10.1159/000273476; HOFFMAN WE, 1991, ANESTHESIOLOGY, V75, P328, DOI 10.1097/00000542-199108000-00022; Huang R, 2000, J CEREBR BLOOD F MET, V20, P895, DOI 10.1097/00004647-200006000-00001; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kip G, 2015, LIBYAN J MED, V10, DOI 10.3402/ljm.v10.27828; Kocoglu H, 2009, RENAL FAILURE, V31, P70, DOI 10.1080/08860220802546487; Kosenko E, 1999, FREE RADICAL BIO MED, V26, P1369, DOI 10.1016/S0891-5849(98)00339-6; Kowluru A, 2014, BIOCHEM PHARMACOL, V88, P275, DOI 10.1016/j.bcp.2014.01.017; Li LX, 2011, BRAIN RES BULL, V86, P390, DOI 10.1016/j.brainresbull.2011.09.005; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LI PA, 1995, NEUROBIOL DIS, V2, P97, DOI 10.1006/nbdi.1995.0010; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MAIER C, 1993, ANESTHESIOLOGY, V79, P306, DOI 10.1097/00000542-199308000-00016; MCCALL AL, 1992, DIABETES, V41, P557, DOI 10.2337/diabetes.41.5.557; Milhaud D, 2000, NEUROPHARMACOLOGY, V39, P2244, DOI 10.1016/S0028-3908(00)00085-X; MOORADIAN AD, 1988, ENDOCR REV, V9, P346, DOI 10.1210/edrv-9-3-346; Moreira PI, 2004, J NEUROENDOCRINOL, V16, P32, DOI 10.1111/j.1365-2826.2004.01107.x; Muranyi M, 2006, DIABETES, V55, P349, DOI 10.2337/diabetes.55.02.06.db05-0654; Muranyi M, 2003, DIABETES, V52, P481, DOI 10.2337/diabetes.52.2.481; Okada H, 2007, RESUSCITATION, V74, P538, DOI 10.1016/j.resuscitation.2007.01.032; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; RYAN CM, 1988, DIABETES CARE, V11, P86, DOI 10.2337/diacare.11.1.86; Shi HL, 2007, FRONT BIOSCI-LANDMRK, V12, P1318, DOI 10.2741/2150; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Straub RH, 1997, J NEUROCHEM, V68, P1633; Suzuki T, 2008, J SURG RES, V149, P69, DOI 10.1016/j.jss.2008.01.020; Tsuruta R, 2010, BRAIN RES, V1309, P155, DOI 10.1016/j.brainres.2009.10.065; Wong CHY, 2008, CURR MED CHEM, V15, P1; Xiang FL, 2010, DIABETES, V59, P2603, DOI 10.2337/db09-1562; Zhang FJ, 2012, J PHARM PHARMACOL, V64, P120, DOI 10.1111/j.2042-7158.2011.01382.x; ZHANG PL, 1991, DIABETES, V40, P338, DOI 10.2337/diabetes.40.3.338; Zhang XY, 2012, ANESTHESIOLOGY, V116, P1035, DOI 10.1097/ALN.0b013e3182503964; Zhu YY, 2006, NEUROSCI LETT, V393, P122, DOI 10.1016/j.neulet.2005.08.072	59	71	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151620	10.1371/journal.pone.0151620	http://dx.doi.org/10.1371/journal.pone.0151620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982373	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900105
J	Zhang, BZ; Zhang, L; Cui, RK; Zeng, XN; Gao, XW				Zhang, Baizhong; Zhang, Lei; Cui, Rukun; Zeng, Xinnian; Gao, Xiwu			Cloning and Expression of Multiple Cytochrome P450 Genes: Induction by Fipronil in Workers of the Red Imported Fire Ant (Solenopsis invicta Buren)	PLOS ONE			English	Article							CHIRONOMUS-TENTANS DIPTERA; DROSOPHILA-MELANOGASTER; HOUSE-FLY; INSECTICIDE RESISTANCE; MUSCA-DOMESTICA; APIS-MELLIFERA; P450 GENES; STRAIN; HYMENOPTERA; FORMICIDAE	Both exogenous and endogenous compounds can induce the expression of cytochrome P450 genes. The insect cytochrome P450 genes related to insecticide resistance are likely to be expressed as the "first line of defense" when challenged with insecticides. In this study, four cytochrome P450 genes, SinvCYP6B1, SinvCYP6A1, SinvCYP4C1, and SinvCYP4G15, were firstly isolated from workers of the red imported fire ant (Solenopsis invicta) through rapid amplification of cDNA ends (RACE) and sequenced. The fipronil induction profiles of the four cytochrome P450 genes and the two previously isolated CYP4AB1 and CYP4AB2 were characterized in workers. The results revealed that the expression of SinvCYP6B1, SinvCYP6A1, CYP4AB2, and SinvCYP4G15, increased 1.4-fold and 1.3-fold more than those of acetone control, respectively, after 24 h exposure to fipronil at concentrations of 0.25 mu g mL(-1) (median lethal dose) and 0.56 mu g mL(-1) (90% lethal dose), while no significant induction of the expression of CYP4AB1 and SinvCYP4C1 was detected. Among these genes, SinvCYP6B1 was the most significantly induced, and its maximum expression was 3.6-fold higher than that in acetone control. These results might suggest that multiple cytochrome P450 genes are co-up-regulated in workers of the fire ant through induction mechanism when challenged with fipronil. These findings indicated that cytochrome P450 genes play an important role in the detoxification of insecticides and provide a theoretical basis for the mechanisms of insecticide metabolism in the fire ant.	[Zhang, Baizhong; Cui, Rukun; Zeng, Xinnian] South China Agr Univ, Minist Educ, Key Lab Nat Pesticide & Chem Biol, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Lei; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China; [Zhang, Baizhong] Henan Inst Sci & Technol, Coll Nat Resources & Environm, Xinxiang 453003, Peoples R China	South China Agricultural University; China Agricultural University; Henan Institute of Science & Technology	Zeng, XN (corresponding author), South China Agr Univ, Minist Educ, Key Lab Nat Pesticide & Chem Biol, Guangzhou 510642, Guangdong, Peoples R China.; Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China.	zengxn@scau.edu.cn; gaoxiwu@263.net.cn			National Science Foundation of China [31071712]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are highly obliged to the National Science Foundation of China (31071712) for the financial support given to the present research work.; The authors are highly grateful to the National Science Foundation of China (31071712) for the financial support provided for the present research.	Abbas N, 2014, PARASITOL RES, V113, P1343, DOI 10.1007/s00436-014-3773-4; Ay R, 2010, J PEST SCI, V83, P85, DOI 10.1007/s10340-009-0274-9; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Cornette R, 2006, INSECT MOL BIOL, V15, P235, DOI 10.1111/j.1365-2583.2006.00632.x; Drummond AJ, 2012, GENEIOUSV 4 8; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Feyereisen R, 2005, COMPREHENSIVE MOL IN, V4, P1; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Gondhalekar AD, 2012, J MED ENTOMOL, V49, P122, DOI 10.1603/ME11106; Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.R07-02; Harrison TL, 2001, ARCH INSECT BIOCHEM, V48, P179, DOI 10.1002/arch.1070; Hu XP, 2005, PEST MANAG SCI, V61, P1209, DOI 10.1002/ps.1124; Huang Cheng-hua, 2006, Chinese Journal of Rice Science, V20, P447; JIANG Dongrong, 2008, GUANGXI PLANT PROTEC, V21, P20; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kuriachan I, 2000, ENVIRON ENTOMOL, V29, P943, DOI 10.1603/0046-225X-29.5.943; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Liu NN, 2004, GENE, V327, P81, DOI 10.1016/j.gene.2003.11.002; Liu XN, 2006, PESTIC BIOCHEM PHYS, V84, P127, DOI 10.1016/j.pestbp.2005.06.002; Londono DK, 2007, PESTIC BIOCHEM PHYS, V89, P104, DOI 10.1016/j.pestbp.2007.04.001; Londono DK, 2004, CHEMOSPHERE, V56, P701, DOI 10.1016/j.chemosphere.2003.12.001; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992; Marr R.M., 2003, ASSESSMENT NONTARGET; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nikou D, 2003, GENE, V318, P91, DOI 10.1016/S0378-1119(03)00763-7; OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Scott J.G, 2008, RECENT ADV INSECT PH, V1, P17; Sutherland TD, 2000, J INSECT PHYSIOL, V46, P1219, DOI 10.1016/S0022-1910(00)00042-1; Tarver MR, 2012, ARCH INSECT BIOCHEM, V80, P92, DOI 10.1002/arch.21030; Tufts DM, 2014, FLA ENTOMOL, V97, P1251, DOI 10.1653/024.097.0336; Vinson S. Bradleigh, 1997, American Entomologist, V43, P23; Wang L., 2013, COMPLEMENTARY ALTERN, V2013, P1; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Zhang B, 2015, J INTEGR AG IN PRESS, V15, P1; Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	46	19	22	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150915	10.1371/journal.pone.0150915	http://dx.doi.org/10.1371/journal.pone.0150915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982576	Green Published, gold			2022-12-27	WOS:000372574900057
J	Chu, C; Nielsen, R; Wu, YF				Chu, Chong; Nielsen, Rasmus; Wu, Yufeng			REPdenovo: Inferring De Novo Repeat Motifs from Short Sequence Reads	PLOS ONE			English	Article							RETROTRANSPOSONS; DATABASE; IMPACT	Repeat elements are important components of eukaryotic genomes. One limitation in our understanding of repeat elements is that most analyses rely on reference genomes that are incomplete and often contain missing data in highly repetitive regions that are difficult to assemble. To overcome this problem we develop a new method, REPdenovo, which assembles repeat sequences directly from raw shotgun sequencing data. REPdenovo can construct various types of repeats that are highly repetitive and have low sequence divergence within copies. We show that REPdenovo is substantially better than existing methods both in terms of the number and the completeness of the repeat sequences that it recovers. The key advantage of REPdenovo is that it can reconstruct long repeats from sequence reads. We apply the method to human data and discover a number of potentially new repeats sequences that have been missed by previous repeat annotations. Many of these sequences are incorporated into various parasite genomes, possibly because the filtering process for host DNA involved in the sequencing of the parasite genomes failed to exclude the host derived repeat sequences. REPdenovo is a new powerful computational tool for annotating genomes and for addressing questions regarding the evolution of repeat families. The software tool, REPdenovo, is available for download at https://github.com/Reedwarbler/REPdenovo.	[Chu, Chong; Wu, Yufeng] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Connecticut; University of California System; University of California Berkeley	Wu, YF (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.; Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rasmus_nielsen@berkeley.edu; ywu@engr.uconn.edu	Nielsen, Rasmus/D-4405-2009; Chu, Chong/AAA-4613-2022	Nielsen, Rasmus/0000-0003-0513-6591; Chu, Chong/0000-0002-0796-2339	US National Science Foundation [IIS-0953563, IIS-1447711, IIS-1526415]; Div Of Information & Intelligent Systems [1526415, 0953563, 1447711] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by grants IIS-0953563 and IIS-1447711 from US National Science Foundation (http://www.nsf.gov/) to YW and grant IIS-1526415 from US National Science Foundation to YW and RN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cormen T. H., 1992, INTRO ALGORITHMS; Durbin R., 1999, BIOL SEQUENCE ANAL P; Fiston-Lavier AS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1291; Hubley R., 2013, REPEATMASKER OPEN 40; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Keane TM, 2013, BIOINFORMATICS, V29, P389, DOI 10.1093/bioinformatics/bts697; Koch P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku210; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Nakagome M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-71; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; Witherspoon DJ, 2013, GENOME RES, V23, P1170, DOI 10.1101/gr.148973.112; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhuang JL, 2014, NUCLEIC ACIDS RES, V42, P6826, DOI 10.1093/nar/gku323	25	32	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150719	10.1371/journal.pone.0150719	http://dx.doi.org/10.1371/journal.pone.0150719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977803	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800033
J	Guclu, H; Read, J; Vukotich, CJ; Galloway, DD; Gao, H; Rainey, JJ; Uzicanin, A; Zimmer, SM; Cummings, DAT				Guclu, Hasan; Read, Jonathan; Vukotich, Charles J., Jr.; Galloway, David D.; Gao, Hongjiang; Rainey, Jeanette J.; Uzicanin, Amra; Zimmer, Shanta M.; Cummings, Derek A. T.			Social Contact Networks and Mixing among Students in K-12 Schools in Pittsburgh, PA	PLOS ONE			English	Article							PANDEMIC INFLUENZA; INFECTIOUS-DISEASE; SPREAD; CHILDREN; TRANSMISSION; CLOSURE; ADULTS	Students attending schools play an important role in the transmission of influenza. In this study, we present a social network analysis of contacts among 1,828 students in eight different schools in urban and suburban areas in and near Pittsburgh, Pennsylvania, United States of America, including elementary, elementary-middle, middle, and high schools. We collected social contact information of students who wore wireless sensor devices that regularly recorded other devices if they are within a distance of 3 meters. We analyzed these networks to identify patterns of proximal student interactions in different classes and grades, to describe community structure within the schools, and to assess the impact of the physical environment of schools on proximal contacts. In the elementary and middle schools, we observed a high number of intra-grade and intra-classroom contacts and a relatively low number of inter-grade contacts. However, in high schools, contact networks were well connected and mixed across grades. High modularity of lower grades suggests that assumptions of homogeneous mixing in epidemic models may be inappropriate; whereas lower modularity in high schools suggests that homogenous mixing assumptions may be more acceptable in these settings. The results suggest that interventions targeting subsets of classrooms may work better in elementary schools than high schools. Our work presents quantitative measures of age-specific, school-based contacts that can be used as the basis for constructing models of the transmission of infections in schools.	[Guclu, Hasan] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Guclu, Hasan; Galloway, David D.] Univ Pittsburgh, Grad Sch Publ Hlth, Publ Hlth Dynam Lab, Pittsburgh, PA USA; [Guclu, Hasan] Istanbul Medeniyet Univ, Dept Stat, Fac Sci, Istanbul, Turkey; [Read, Jonathan] Univ Liverpool, Inst Infect & Global Hlth, Farr Inst HeRC, Dept Epidemiol & Populat Hlth, Liverpool L69 3GL, Merseyside, England; [Read, Jonathan] Univ Lancaster, Lancaster Med Sch, Lancaster LA1 4YG, England; [Vukotich, Charles J., Jr.; Zimmer, Shanta M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Gao, Hongjiang; Rainey, Jeanette J.; Uzicanin, Amra] US Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; [Cummings, Derek A. T.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Istanbul Medeniyet University; University of Liverpool; Lancaster University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Guclu, H (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA.; Guclu, H (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Publ Hlth Dynam Lab, Pittsburgh, PA USA.; Guclu, H (corresponding author), Istanbul Medeniyet Univ, Dept Stat, Fac Sci, Istanbul, Turkey.	guclu@pitt.edu	Guclu, Hasan/B-7080-2008	Guclu, Hasan/0000-0003-3582-9460; Read, Jonathan/0000-0002-9697-0962	US Centers for Disease Control and Prevention (CDC) [1U01CK00179-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Cooperative Agreement number 1U01CK00179-01 from the US Centers for Disease Control and Prevention (CDC, www.cdc.gov). Its contents are solely the responsibility of the authors and do not necessarily represent the official position of CDC.	Barclay VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087042; Benavides J., 2011, 2011 IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology, P182, DOI 10.1109/HISB.2011.2; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Cauchemez SA, 2009, PNAS, V108, P2825, DOI [10.1073/pnas.1008895108, DOI 10.1073/PNAS.1008895108]; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Danon Leon, 2011, Interdiscip Perspect Infect Dis, V2011, P284909, DOI 10.1155/2011/284909; Dargie W., 2010, FUNDAMENTALS WIRELES; deNooy W, 2005, EXPLAROTARY SOCIAL N; Eames K T D, 2010, Health Technol Assess, V14, P267, DOI 10.3310/hta14340-04; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Effler PV, 2010, EMERG INFECT DIS, V16, P205, DOI 10.3201/eid1602.091372; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; Gauvin L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03099; Gay D, 2014, ACM SIGPLAN NOTICES, V49, P41, DOI 10.1145/2641638.2641652; Gemmetto V, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0695-9; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Gog JR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003635; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Jackson C, 2011, EMERG INFECT DIS, V17, P245, DOI 10.3201/eid1702.100458; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; Meyers LA, 2003, EMERG INFECT DIS, V9, P204, DOI 10.3201/eid0902.020188; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Miller JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010425; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Paradiso JA, 2010, PERS UBIQUIT COMPUT, V14, P137, DOI 10.1007/s00779-009-0239-2; Polastre J, 2005, 4 INT S INF PROC SEN; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Smieszek T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-136; Stehle J, 2013, SOC NETWORKS, V35, P604, DOI 10.1016/j.socnet.2013.08.003; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Vestergaard CL, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042805; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	48	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151139	10.1371/journal.pone.0151139	http://dx.doi.org/10.1371/journal.pone.0151139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978780	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000372572800047
J	Towse, JN; Towse, AS; Saito, S; Maehara, Y; Miyake, A				Towse, John Nicholas; Towse, Andrea Sarah; Saito, Satoru; Maehara, Yukio; Miyake, Akira			Joint Cognition: Thought Contagion and the Consequences of Cooperation when Sharing the Task of Random Sequence Generation	PLOS ONE			English	Article							RANDOM NUMBER GENERATION; EXECUTIVE FUNCTIONS; PERFORMANCE; INHIBITION; BEHAVIOR	Generating random number sequences is a popular psychological task often used to measure executive functioning. We explore random generation under "joint cognition" instructions; pairs of participants take turns to compile a shared response sequence. Across three studies, we point to six key findings from this novel format. First, there are both costs and benefits from group performance. Second, repetition avoidance occurs in dyadic as well as individual production settings. Third, individuals modify their choices in a dyadic situation such that the pair becomes the unit of psychological function. Fourth, there is immediate contagion of sequence stereotypy amongst the pairs (i.e., each contributor "owns" their partner's response). Fifth, dyad effects occur even when participants know their partner is not interacting with them (Experiment 2). Sixth, ironically, directing participants' efforts away from their shared task responsibility can actually benefit conjoint performance (Experiment 3). These results both constrain models of random generation and illuminate processes of joint cognition.	[Towse, John Nicholas; Towse, Andrea Sarah] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Saito, Satoru] Kyoto Univ, Grad Sch Educ, Kyoto, Japan; [Maehara, Yukio] Nagasaki Univ, Fac Educ, Nagasaki 852, Japan; [Miyake, Akira] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Lancaster University; Kyoto University; Nagasaki University; University of Colorado System; University of Colorado Boulder	Towse, JN (corresponding author), Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England.	j.towse@lancs.ac.uk	Towse, John/E-9269-2010	Towse, John/0000-0003-1183-5508; MIYAKE, AKIRA/0000-0003-4671-7843; SAITO, Satoru/0000-0002-0403-3606; Towse, Andrea/0000-0002-6411-6577	Japan's Ministry of Education, Culture, Sports, Science, and Technology [D07]	Japan's Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Parts of this project were supported by a Grant-in-Aid for Global COE (Centers of Excellence) Program (D07) by Japan's Ministry of Education, Culture, Sports, Science, and Technology. This facilitated design meetings and data collection and analysis.	Arbuthnott KD, 1996, J EXP PSYCHOL GEN, V125, P261, DOI 10.1037/0096-3445.125.3.261; Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Baddeley A. D, 1986, WORKING MEMORY; BOUCHARD TJ, 1970, J APPL PSYCHOL, V54, P51, DOI 10.1037/h0028621; Brugger P, 1997, PERCEPT MOTOR SKILL, V84, P627, DOI 10.2466/pms.1997.84.2.627; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cooper RP, 2012, Q J EXP PSYCHOL, V65, P587, DOI 10.1080/17470218.2011.629053; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; EVANS FJ, 1978, B PSYCHONOMIC SOC, V12, P35; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Gigone D, 1997, PSYCHOL BULL, V121, P149, DOI 10.1037/0033-2909.121.1.149; Guagnano D, 2010, COGNITION, V114, P348, DOI 10.1016/j.cognition.2009.10.008; HILL GW, 1982, PSYCHOL BULL, V91, P517, DOI 10.1037/0033-2909.91.3.517; Houghton G., 1996, PSYCHE, V2, P1; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Liefooghe B, 2016, J COGN PSYCHOL, V28, P60, DOI 10.1080/20445911.2015.1084311; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2001, MEMORY, V9, P445, DOI 10.1080/09658210143000029; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Nijstad BA, 2006, PERS SOC PSYCHOL REV, V10, P186, DOI 10.1207/s15327957pspr1003_1; Pickering MJ, 2009, EUR J SOC PSYCHOL, V39, P1162, DOI 10.1002/ejsp.663; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Towse JN, 1997, EUR J COGN PSYCHOL, V9, P381, DOI 10.1080/713752566; Towse JN, 1998, BRIT J PSYCHOL, V89, P77, DOI 10.1111/j.2044-8295.1998.tb02674.x; Towse JN, 1999, BRIT J DEV PSYCHOL, V17, P363, DOI 10.1348/026151099165348; Towse JN, 1998, BEHAV RES METH INS C, V30, P583, DOI 10.3758/BF03209475; Towse JN, 2007, EUR J COGN PSYCHOL, V19, P374, DOI 10.1080/09541440600764570; Weldon MS, 2001, PSYCHOL LEARN MOTIV, V40, P67	30	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151306	10.1371/journal.pone.0151306	http://dx.doi.org/10.1371/journal.pone.0151306			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977923	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000372572800058
J	Ding, T; Melcher, U				Ding, Tao; Melcher, Ulrich			Influences of Plant Species, Season and Location on Leaf Endophytic Bacterial Communities of Non-Cultivated Plants	PLOS ONE			English	Article							GROWTH PROMOTION; HUMAN MICROBIOME; DIVERSITY; PHYTOREMEDIATION; PHYLLOSPHERE; COLONIZATION; SUGARCANE; PATHOGENS; LETTUCE; GINSENG	Bacteria are known to be associated endophytically with plants. Research on endophytic bacteria has identified their importance in food safety, agricultural production and phytoremediation. However, the diversity of endophytic bacterial communities and the forces that shape their compositions in non-cultivated plants are largely uncharacterized. In this study, we explored the diversity, community structure, and dynamics of endophytic bacteria in different plant species in the Tallgrass Prairie Preserve of northern Oklahoma, USA. High throughput sequencing of amplified segments of bacterial rDNA from 81 samples collected at four sampling times from five plant species at four locations identified 335 distinct OTUs at 97% sequence similarity, representing 16 phyla. Proteobacteria was the dominant phylum in the communities, followed by the phyla Bacteriodetes and Actinobacteria. Bacteria from four classes of Proteobacteria were detected with Alphaproteobacteria as the dominant class. Analysis of molecular variance revealed that host plant species and collecting date had significant influences on the compositions of the leaf endophytic bacterial communities. The proportion of Alphaproteobacteria was much higher in the communities from Asclepias viridis than from other plant species and differed from month to month. The most dominant bacterial groups identified in LDA Effect Size analysis showed host-specific patterns, indicating mutual selection between host plants and endophytic bacteria and that leaf endophytic bacterial compositions were dynamic, varying with the host plant's growing season in three distinct patterns. In summary, next generation sequencing has revealed variations in the taxonomic compositions of leaf endophytic bacterial communities dependent primarily on the nature of the plant host species.	[Ding, Tao; Melcher, Ulrich] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Ding, Tao] NYU, Dept Biol, New York, NY 10003 USA	Oklahoma State University System; Oklahoma State University - Stillwater; New York University	Melcher, U (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	u-melcher-4@alumni.uchicago.edu			Oklahoma Agricultural Experiment Station; R. J. Sirny Professorship at Oklahoma State University; National Science Foundation [EPS-0447262]	Oklahoma Agricultural Experiment Station; R. J. Sirny Professorship at Oklahoma State University; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Oklahoma Agricultural Experiment Station, whose Director has approved this publication, the R. J. Sirny Professorship at Oklahoma State University and the National Science Foundation through EPS-0447262. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Bent E, 1998, CAN J MICROBIOL, V44, P980, DOI 10.1139/cjm-44-10-980; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Chanway CP, 1997, FOREST SCI, V43, P99; Chelius MK, DIVERSITY ARCHAEA BA; Cho KM, 2007, MICROB ECOL, V54, P341, DOI 10.1007/s00248-007-9208-3; Cole JR, 2013, NUCLEIC ACIDS RES, DOI [10.1093/nar/gkt1244, DOI 10.1093/NAR/GKT1244]; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Ding T, COMMUNITY TERMINAL R; Ding T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-1; Duijff BJ, 1997, NEW PHYTOL, V135, P325, DOI 10.1046/j.1469-8137.1997.00646.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EXCOFFIER L, 1992, GENETICS, V131, P479; Fletcher J, 2013, PHYTOPATHOLOGY, V103, P306, DOI 10.1094/PHYTO-09-12-0236-IA; Germaine KJ, 2006, FEMS MICROBIOL ECOL, V57, P302, DOI 10.1111/j.1574-6941.2006.00121.x; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Guo XA, 2002, APPL ENVIRON MICROB, V68, P3639, DOI 10.1128/AEM.68.7.3639-3643.2002; Hamady M, ERROR CORRECTING BAR; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ingham SC, 2005, J FOOD PROTECT, V68, P1134, DOI 10.4315/0362-028X-68.6.1134; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Lee S, 2004, J BACTERIOL, V186, P5384, DOI 10.1128/JB.186.16.5384-5391.2004; Lindow SE, 2003, APPL ENV MICROBIOL; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Magnani GS, 2010, GENET MOL RES, V9, P250, DOI 10.4238/vol9-1gmr703; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Methe B. A., 2012, NATURE, V486, P215, DOI DOI 10.1038/NATURE11209; Moore FP, 2006, SYST APPL MICROBIOL, V29, P539, DOI 10.1016/j.syapm.2005.11.012; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Newman LA, 2005, TRENDS BIOTECHNOL, V23, P6, DOI 10.1016/j.tibtech.2004.11.010; Pavlo A, 2011, BIOL CONTROL, V56, P43, DOI 10.1016/j.biocontrol.2010.09.014; Petrosino JF, METAGENOMIC PYROSEQU; QuadtHallmann A, 1997, CAN J MICROBIOL, V43, P577, DOI 10.1139/m97-081; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quecine MC, 2012, APPL ENVIRON MICROB, V78, P7511, DOI 10.1128/AEM.00836-12; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon C. E., 1949, MATH THEORY COMMUNIC; Vendan RT, 2010, J MICROBIOL, V48, P559, DOI 10.1007/s12275-010-0082-1; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898	47	61	64	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150895	10.1371/journal.pone.0150895	http://dx.doi.org/10.1371/journal.pone.0150895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974817	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600037
J	Huang, XY; He, ZY; Jiang, XW; Hou, MJ; Tang, ZH; Zhen, XZ; Liang, YM; Ma, J				Huang, Xiaoyan; He, Zhiying; Jiang, Xinwei; Hou, Mengjun; Tang, Zhihong; Zhen, Xiaozhou; Liang, Yuming; Ma, Jing			Folic Acid Represses Hypoxia-Induced Inflammation in THP-1 Cells through Inhibition of the PI3K/Akt/HIF-1 alpha Pathway	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FACTOR-I HIF-1; INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL FUNCTION; OXYGEN-TENSION; EXPRESSION; ACTIVATION; INTERLEUKIN-1; RECEPTOR; DISEASE	Though hypoxia has been implicated as a cause of inflammation, the underlying mechanism is not well understood. Folic acid has been shown to provide protection against oxidative stress and inflammation in patients with cardiovascular disease and various models approximating insult to tissue via inflammation. It has been reported that hypoxia-induced inflammation is associated with oxidative stress, upregulation of hypoxia-inducible factor 1-alpha (HIF-1 alpha), and production of pro-inflammatory molecules. Whether folic acid protects human monocytic cells (THP-1 cells) against hypoxia-induced damage, however, remains unknown. We used THP-1 cells to establish a hypoxia-induced cellular injury model. Pre-treating THP-1 cells with folic acid attenuated hypoxia-induced inflammatory responses, including a decrease in protein and mRNA levels of interleukin (IL)-1 beta and tumor necrosis factor-alpha (TNF-alpha), coupled with increased levels of IL-10. Folic acid also reduced hypoxia-induced Akt phosphorylation and decreased nuclear accumulation of HIF-1 alpha protein. Both LY294002 (a selective inhibitor of phosphatidyl inositol-3 kinase, PI3K) and KC7F2 (a HIF-1 alpha inhibitor) reduced levels of hypoxia-induced inflammatory cytokines. We also found that insulin (an Akt activator) and dimethyloxallyl glycine (DMOG, a HIF-1 alpha activator) induced over-expression of inflammatory cytokines, which could be blocked by folic acid. Taken together, these findings demonstrate how folic acid attenuates the hypoxia-induced inflammatory responses of THP-1 cells through inhibition of the PI3K/Akt/HIF-1 alpha pathway.	[Huang, Xiaoyan; He, Zhiying; Jiang, Xinwei; Zhen, Xiaozhou; Liang, Yuming; Ma, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Hou, Mengjun; Tang, Zhihong] Sun Yat Sen Univ, Sch Publ Hlth, Expt & Teaching Ctr Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China.	majing@mail.sysu.edu.cn			National Science Foundation of China [81372977]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by General Project of National Science Foundation of China (81372977) (URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA JE, 1995, J IMMUNOL, V155, P4391; Angele MK, 1999, AM J PHYSIOL-CELL PH, V276, pC285, DOI 10.1152/ajpcell.1999.276.2.C285; BEUTLER B, 1995, J INVEST MED, V43, P227; BLAKE DR, 1994, ANN NY ACAD SCI, V723, P308, DOI 10.1111/j.1749-6632.1994.tb36736.x; Bosco MC, 2008, IMMUNOBIOLOGY, V213, P733, DOI 10.1016/j.imbio.2008.07.031; Chachami G, 2009, BIOCHEM BIOPH RES CO, V390, P235, DOI 10.1016/j.bbrc.2009.09.093; Chiarello PG, 2009, DIGEST DIS SCI, V54, P627, DOI 10.1007/s10620-008-0398-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Depping R, 2015, J MOL MED, V93, P599, DOI 10.1007/s00109-015-1276-0; DINARELLO CA, 1991, BLOOD, V77, P1627; Doshi SN, 2002, CIRCULATION, V105, P22, DOI 10.1161/hc0102.101388; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Feng D, 2011, INFLAMM RES, V60, P817, DOI 10.1007/s00011-011-0337-2; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Galindo M, 2001, CLIN EXP IMMUNOL, V123, P36, DOI 10.1046/j.1365-2249.2001.01412.x; GHEZZI P, 1991, CYTOKINE, V3, P189, DOI 10.1016/1043-4666(91)90015-6; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Hoffbrand AV, 2001, BRIT J HAEMATOL, V113, P579, DOI 10.1046/j.1365-2141.2001.02822.x; Hong Soon-Sun, 2004, Cancer Res Treat, V36, P343, DOI 10.4143/crt.2004.36.6.343; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer R, 2009, J FOOD SCI, V74, pR114, DOI 10.1111/j.1750-3841.2009.01359.x; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Joshi S, 2014, J BIOL CHEM, V289, P22785, DOI 10.1074/jbc.M114.587493; Kaluz S, 2002, CANCER RES, V62, P4469; KARAKURUM M, 1994, J CLIN INVEST, V93, P1564, DOI 10.1172/JCI117135; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu YN, 2009, SHOCK, V32, P263, DOI 10.1097/SHK.0b013e31819940cb; Mandl M, 2014, MOL MED, V20, P215, DOI 10.2119/molmed.2014.00032; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Peyssonnaux C, 2004, CELL CYCLE, V3, P168; Royle C, 2009, CYTOKINE, V47, P56, DOI 10.1016/j.cyto.2009.04.006; Scannell G, 1996, New Horiz, V4, P179; Scott J M, 1998, J Cardiovasc Risk, V5, P223, DOI 10.1097/00043798-199808000-00003; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shafee N, 2009, CANCER LETT, V282, P109, DOI 10.1016/j.canlet.2009.03.004; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Solini A, 2006, INT J OBESITY, V30, P1197, DOI 10.1038/sj.ijo.0803265; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wani NA, 2008, IUBMB LIFE, V60, P834, DOI 10.1002/iub.133; Whayne TF, 2014, CURR OPIN CARDIOL, V29, P396, DOI 10.1097/HCO.0000000000000064; Woo KS, 1999, J AM COLL CARDIOL, V34, P2002, DOI 10.1016/S0735-1097(99)00469-6; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yu F, 2001, CANCER RES, V61, P4136; Zhang WD, 2006, J NEUROIMMUNOL, V174, P63, DOI 10.1016/j.jneuroim.2006.01.014	51	28	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151553	10.1371/journal.pone.0151553	http://dx.doi.org/10.1371/journal.pone.0151553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974319	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600089
J	Zhang, FG; Meng, XH; Feng, CL; Ran, W; Yu, GH; Zhang, YJ; Shen, QR				Zhang, Fengge; Meng, Xiaohui; Feng, Chenglong; Ran, Wei; Yu, Guanghui; Zhang, Yingjun; Shen, Qirong			Hydrolytic Amino Acids Employed as a Novel Organic Nitrogen Source for the Preparation of PGPF-Containing Bio-Organic Fertilizer for Plant Growth Promotion and Characterization of Substance Transformation during BOF Production	PLOS ONE			English	Article							TRICHODERMA-HARZIANUM; FLUORESCENCE EXCITATION; MATTER; WATER; OPTIMIZATION; COMPOST; SLUDGE; FORMULATIONS; SPECTROSCOPY; BIOCONTROL	Opportunity costs seriously limit the large-scale production of bio-organic fertilizers (BOFs) both in China and internationally. This study addresses the utilization of amino acids resulting from the acidic hydrolysis of pig corpses as organic nitrogen sources to increase the density of TrichodermaharzianumT-E5 (a typical plant growth-promoting fungi, PGPF). This results in a novel, economical, highly efficient and environmentally friendly BOF product. Fluorescence excitation-emission matrix (EEM) spectroscopy combined with fluorescence regional integration (FRI) was employed to monitor compost maturity levels, while pot experiments were utilized to test the effects of this novel BOF on plant growth. An optimization experiment, based on response surface methodologies (RSMs), showed that a maximum T-E5 population (3.72 x 10(8) ITS copies g(-1)) was obtained from a mixture of 65.17% cattle manure compost (W/W), 19.33% maggot manure (W/W), 15.50% (V/W) hydrolytic amino acid solution and 4.69%(V/W) inoculum at 28.7 degrees C after a 14 day secondary solid fermentation. Spectroscopy analysis revealed that the compost transformation process involved the degradation of protein-like substances and the formation of fulvic-like and humic-like substances. FRI parameters (P-I,P- n, P-II,P- n, P-III,P- n and P-V,P- n) were used to characterize the degree of compost maturity. The BOF resulted in significantly higher increased chlorophyll content, shoot length, and shoot and root dry weights of three vegetables (cucumber, tomato and pepper) by 9.9%similar to 22.4%, 22.9%similar to 58.5%, 31.0%similar to 84.9%, and 24.2%similar to 34.1%, respectively. In summary, this study presents an operational means of increasing PGPF T-E5 populations in BOF to promote plant growth with a concomitant reduction in production cost. In addition, a BOF compost maturity assessment using fluorescence EEM spectroscopy and FRI ensured its safe field application.	[Zhang, Fengge; Meng, Xiaohui; Feng, Chenglong; Ran, Wei; Yu, Guanghui; Shen, Qirong] Nanjing Agr Univ, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing 210095, Jiangsu, Peoples R China; [Zhang, Fengge] Nanjing Agr Univ, Grassland & Environm Engn Lab, Nanjing 210095, Jiangsu, Peoples R China; [Ran, Wei; Yu, Guanghui; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Shen, QR (corresponding author), Nanjing Agr Univ, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing 210095, Jiangsu, Peoples R China.; Shen, QR (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing 210095, Jiangsu, Peoples R China.	shenqirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Yu, Guanghui/H-4968-2013	Yu, Guanghui/0000-0002-5699-779X; Zhang, Yingjun/0000-0001-5776-4392	973 project [2015CB150506]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	973 project(National Basic Research Program of China); Innovative Research Team Development Plan of the Ministry of Education of China; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was financially supported by 973 project (2015CB150506), Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256), and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.	Abid N, 2006, WASTE MANAGE, V26, P1099, DOI 10.1016/j.wasman.2005.06.015; Ahmed Mushtaq, 2011, Journal of Mycology and Plant Pathology, V41, P77; [Anonymous], 1983, WASTE MANAGE RES, DOI [DOI 10.1177/0734242X8300100118, DOI 10.1016/0734-242X(83)90055-1]; Antizar-Ladislao B, 2006, CHEMOSPHERE, V64, P839, DOI 10.1016/j.chemosphere.2005.10.036; Baddi GA, 2004, BIORESOURCE TECHNOL, V93, P285, DOI 10.1016/j.biortech.2003.10.026; Benitez C, 1998, BIORESOURCE TECHNOL, V63, P147, DOI 10.1016/S0960-8524(97)00072-2; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Chen LH, 2011, BIORESOURCE TECHNOL, V102, P3900, DOI 10.1016/j.biortech.2010.11.126; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; De Souza JT, 2008, BIOL CONTROL, V46, P36, DOI 10.1016/j.biocontrol.2008.01.010; Doni F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-532; FRAVEL DR, 1995, PHYTOPATHOLOGY, V85, P165, DOI 10.1094/Phyto-85-165; Gone DL, 2009, J HAZARD MATER, V172, P693, DOI 10.1016/j.jhazmat.2009.07.052; Guo WQ, 2009, BIORESOURCE TECHNOL, V100, P1192, DOI 10.1016/j.biortech.2008.07.070; Halim SFA, 2009, BIORESOURCE TECHNOL, V100, P710, DOI 10.1016/j.biortech.2008.07.031; Henderson RK, 2009, WATER RES, V43, P863, DOI 10.1016/j.watres.2008.11.027; Huang XQ, 2011, APPL MICROBIOL BIOT, V91, P741, DOI 10.1007/s00253-011-3259-6; Huang Y, 2014, ENVIRON TECHNOL, V35, P1658, DOI 10.1080/09593330.2013.878397; Lugtenberg BJJ, 1999, ENVIRON MICROBIOL, V1, P439, DOI 10.1046/j.1462-2920.1999.00054.x; Marhuenda-Egea FC, 2007, CHEMOSPHERE, V68, P301, DOI 10.1016/j.chemosphere.2006.12.075; Masunaka A, 2011, MICROBES ENVIRON, V26, P128, DOI 10.1264/jsme2.ME10176; MATHUR SP, 1993, BIOL AGRIC HORTIC, V10, P65, DOI 10.1080/01448765.1993.9754655; Mirhosseini H, 2009, CARBOHYD POLYM, V75, P512, DOI 10.1016/j.carbpol.2008.08.022; Provenzano MR, 2001, J AGR FOOD CHEM, V49, P5874, DOI 10.1021/jf0106796; Said-Pullicino D, 2007, BIORESOURCE TECHNOL, V98, P1822, DOI 10.1016/j.biortech.2006.06.018; Santamaria RS, 2001, AGROCIENCIA, V35, P377; Shao ZH, 2009, J HAZARD MATER, V164, P1191, DOI 10.1016/j.jhazmat.2008.09.035; Tan JY, 2012, J FOOD AGRIC ENVIRON, V10, P1205; Tang Z, 2011, CHEMOSPHERE, V82, P1202, DOI 10.1016/j.chemosphere.2010.11.032; Tiquia SM, 2000, BIORESOURCE TECHNOL, V72, P1, DOI 10.1016/S0960-8524(99)90092-5; Wong JWC, 2001, BIORESOURCE TECHNOL, V76, P99, DOI 10.1016/S0960-8524(00)00103-6; Wu MJ, 2012, J RESIDUALS SCI TECH, V9, P65; Xu HC, 2010, WATER SCI TECHNOL, V61, P2931, DOI 10.2166/wst.2010.197; Yu GH, 2010, WATER RES, V44, P797, DOI 10.1016/j.watres.2009.10.021; Zhang FG, 2014, FEMS MICROBIOL LETT, V359, P116, DOI 10.1111/1574-6968.12582; Zhang FG, 2013, APPL SOIL ECOL, V72, P41, DOI 10.1016/j.apsoil.2013.05.016; Zhang FG, 2013, IND CROP PROD, V49, P619, DOI 10.1016/j.indcrop.2013.05.037; Zhang FG, 2013, PLANT SOIL, V368, P433, DOI 10.1007/s11104-012-1519-6	38	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149447	10.1371/journal.pone.0149447	http://dx.doi.org/10.1371/journal.pone.0149447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974549	Green Submitted, gold, Green Published			2022-12-27	WOS:000372570600011
J	Steuer, AE; Schmidhauser, C; Tingelhoff, EH; Schmid, Y; Rickli, A; Kraemer, T; Liechti, ME				Steuer, Andrea E.; Schmidhauser, Corina; Tingelhoff, Eva H.; Schmid, Yasmin; Rickli, Anna; Kraemer, Thomas; Liechti, Matthias E.			Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans	PLOS ONE			English	Article							DESIGNER DRUGS; CLINICAL TOXICOLOGY; HUMAN PHARMACOLOGY; MAIN METABOLITES; H-3 DOPAMINE; ECSTASY MDMA; MDA ANALOGS; BUPROPION; 3,4-DIHYDROXYMETHAMPHETAMINE; CYP2D6	3,4-methylenedioxymethamphetamine (MDMA; ecstasy) metabolism is known to be stereoselective, with preference for S-stereoisomers. Its major metabolic step involves CYP2D6-catalyzed demethylenation to 3,4-dihydroxymethamphetamine (DHMA), followed by methylation and conjugation. Alterations in CYP2D6 genotype and/or phenotype have been associated with higher toxicity. Therefore, the impact of CYP2D6 function on the plasma pharmacokinetics of MDMA and its phase I and II metabolites was tested by comparing extensive metabolizers (EMs), intermediate metabolizers (IMs), and EMs that were pre-treated with bupropion as a metabolic inhibitor in a controlled MDMA administration study. Blood plasma samples were collected from 16 healthy participants (13 EMs and three IMs) up to 24 h after MDMA administration in a double-blind, placebo-controlled, four-period, cross-over design, with subjects receiving 1 week placebo or bupropion pretreatment followed by a single placebo or MDMA (125 mg) dose. Bupropion pretreatment increased the maximum plasma concentration (C-max) and area under the plasma concentration-time curve from 0 to 24 h (AUC(24)) of R-MDMA (9% and 25%, respectively) and S-MDMA (16% and 38%, respectively). Bupropion reduced the C-max and AUC(24) of the CYP2D6-dependently formed metabolite stereoisomers of DHMA 3-sulfate, DHMA 4-sulfate, and 4-hydroxy-3-methoxymethamphetamine (HMMA sulfate and HMMA glucuronide) by approximately 40%. The changes that were observed in IMs were generally comparable to bupropion-pretreated EMs. Although changes in stereoselectivity based on CYP2D6 activity were observed, these likely have low clinical relevance. Bupropion and hydroxybupropion stereoisomer pharmacokinetics were unaltered by MDMA co-administration. The present data might aid further interpretations of toxicity based on CYP2D6-dependent MDMA metabolism.	[Steuer, Andrea E.; Schmidhauser, Corina; Tingelhoff, Eva H.; Kraemer, Thomas] Univ Zurich, Zurich Inst Forens Med, Dept Forens Pharmacol & Toxicol, Zurich, Switzerland; [Schmid, Yasmin; Rickli, Anna; Liechti, Matthias E.] Univ Basel Hosp, Psychopharmacol Res, Div Clin Pharmacol & Toxicol, Dept Biomed, CH-4031 Basel, Switzerland; [Schmid, Yasmin; Rickli, Anna; Liechti, Matthias E.] Univ Basel Hosp, Dept Clin Res, CH-4031 Basel, Switzerland	University of Zurich; University of Basel; University of Basel	Steuer, AE (corresponding author), Univ Zurich, Zurich Inst Forens Med, Dept Forens Pharmacol & Toxicol, Zurich, Switzerland.	andrea.steuer@irm.uzh.ch	Kraemer, Thomas/R-8407-2018; Schmid, Yasmin/A-9698-2019	Kraemer, Thomas/0000-0002-3283-606X; Schmid, Yasmin/0000-0002-3618-584X; Steuer, Andrea Eva/0000-0001-8983-2353	Swiss National Science Foundation SNF [320030_149493]	Swiss National Science Foundation SNF(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation SNF (www.snf.ch), Grant Number 320030_149493, to MEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolino-Lobo I, 2010, DRUG METAB DISPOS, V38, P1105, DOI 10.1124/dmd.110.032359; Bai FJ, 1999, CHEM RES TOXICOL, V12, P1150, DOI 10.1021/tx990084t; Baker LE, 1997, PHARMACOL BIOCHEM BE, V57, P737, DOI 10.1016/S0091-3057(96)00334-6; Capela JP, 2009, MOL NEUROBIOL, V39, P210, DOI 10.1007/s12035-009-8064-1; Carvalho M, 2012, ARCH TOXICOL, V86, P1167, DOI 10.1007/s00204-012-0815-5; Coles R, 2007, J CHROMATOGR B, V857, P67, DOI 10.1016/j.jchromb.2007.07.007; de la Torre R, 2005, EUR J CLIN PHARMACOL, V61, P551, DOI 10.1007/s00228-005-0965-y; de la Torre R, 2004, THER DRUG MONIT, V26, P137, DOI 10.1097/00007691-200404000-00009; de la Torre R, 2000, BRIT J CLIN PHARMACO, V49, P104, DOI 10.1046/j.1365-2125.2000.00121.x; de la Torre R, 2000, ANN NY ACAD SCI, V914, P225, DOI 10.1111/j.1749-6632.2000.tb05199.x; Easton N, 2006, J PSYCHOPHARMACOL, V20, P194, DOI 10.1177/0269881106061153; Esteban B, 2001, PSYCHOPHARMACOLOGY, V154, P251, DOI 10.1007/s002130000645; Fallon JK, 1999, CLIN CHEM, V45, P1058; Farre M, 2015, EUR NEUROPSYCHOPHARM, V25, P1637, DOI 10.1016/j.euroneuro.2015.05.007; Felim A, 2010, CHEM RES TOXICOL, V23, P211, DOI 10.1021/tx9003374; Gill JR, 2002, J FORENSIC SCI, V47, P121; GLENNON RA, 1988, PHARMACOL BIOCHEM BE, V29, P443, DOI 10.1016/0091-3057(88)90001-9; GOLLAMUDI R, 1989, NEUROTOXICOLOGY, V10, P455; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Hicks JK, 2013, CLIN PHARMACOL THER, V93, P402, DOI 10.1038/clpt.2013.2; HIRAMATSU M, 1990, J PHARMACOL EXP THER, V254, P521; HIRAMATSU M, 1990, NEUROPHARMACOLOGY, V29, P269, DOI 10.1016/0028-3908(90)90012-G; Hughes JR, 1999, JAMA-J AM MED ASSOC, V281, P72, DOI 10.1001/jama.281.1.72; Hysek CM, 2014, SOC COGN AFFECT NEUR, V9, P1645, DOI 10.1093/scan/nst161; Hysek CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036476; Jefferson JW, 2005, CLIN THER, V27, P1685, DOI 10.1016/j.clinthera.2005.11.011; JOHNSON MP, 1986, EUR J PHARMACOL, V132, P269, DOI 10.1016/0014-2999(86)90615-1; Kalant H, 2001, CAN MED ASSOC J, V165, P917; Kharasch ED, 2008, J CLIN PHARMACOL, V48, P464, DOI 10.1177/0091270008314254; Kotlyar M, 2005, J CLIN PSYCHOPHARM, V25, P226, DOI 10.1097/01.jcp.0000162805.46453.e3; Kraemer T, 2002, THER DRUG MONIT, V24, P277, DOI 10.1097/00007691-200204000-00009; Kreth KP, 2000, BIOCHEM PHARMACOL, V59, P1563, DOI 10.1016/S0006-2952(00)00284-7; Laine R, 2008, CURR DRUG METAB, V9, P921, DOI 10.2174/138920008786485146; Liu YP, 2011, J ENZYM INHIB MED CH, V26, P386, DOI 10.3109/14756366.2010.518965; Martinez CM, 2012, ORG BIOMOL CHEM, V10, P3739, DOI 10.1039/c2ob25245g; Maurer HH, 2000, TOXICOL LETT, V112, P133, DOI 10.1016/S0378-4274(99)00207-6; Maurer HH, 1996, THER DRUG MONIT, V18, P465, DOI 10.1097/00007691-199608000-00027; McCann UD, 2008, PSYCHOPHARMACOLOGY, V200, P439, DOI 10.1007/s00213-008-1218-4; MCKENNA DJ, 1991, PHARMACOL BIOCHEM BE, V38, P505, DOI 10.1016/0091-3057(91)90005-M; Meyer MR, 2008, DRUG METAB DISPOS, V36, P2345, DOI 10.1124/dmd.108.021543; Meyer MR, 2009, CHEM RES TOXICOL, V22, P1205, DOI 10.1021/tx900134e; Miller RT, 1997, EUR J PHARMACOL, V323, P173, DOI 10.1016/S0014-2999(97)00044-7; Monks TJ, 2004, THER DRUG MONIT, V26, P132, DOI 10.1097/00007691-200404000-00008; Mueller M, 2009, DRUG METAB DISPOS, V37, P2079, DOI 10.1124/dmd.109.028340; Peters F.T., 2009, TOXICHEM KRIMTECH, V76, P185; Peters FT, 2005, CLIN CHEM, V51, P1811, DOI 10.1373/clinchem.2005.052746; Peters FT, 2003, J ANAL TOXICOL, V27, P552, DOI 10.1093/jat/27.8.552; Peters FT, 2002, ACCREDIT QUAL ASSUR, V7, P441, DOI 10.1007/s00769-002-0516-5; Pizarro N, 2004, DRUG METAB DISPOS, V32, P1001; Reese MJ, 2008, DRUG METAB DISPOS, V36, P1198, DOI 10.1124/dmd.107.020198; Rietjens SJ, 2012, CRIT REV TOXICOL, V42, P854, DOI 10.3109/10408444.2012.725029; SCHECHTER MD, 1987, PHARMACOL BIOCHEM BE, V27, P41, DOI 10.1016/0091-3057(87)90474-6; Schindler CW, 2014, BRIT J PHARMACOL, V171, P83, DOI 10.1111/bph.12423; Schmid Y, 2015, J PHARMACOL EXP THER, V353, P102, DOI 10.1124/jpet.114.222356; Schwaninger AE, 2011, CLIN CHEM, V57, P1748, DOI 10.1373/clinchem.2011.172254; Schwaninger AE, 2011, DRUG METAB DISPOS, V39, P1998, DOI 10.1124/dmd.111.041129; Schwaninger AE, 2009, DRUG METAB DISPOS, V37, P2212, DOI 10.1124/dmd.109.029215; Segura M, 2005, CLIN PHARMACOKINET, V44, P649, DOI 10.2165/00003088-200544060-00006; Segura M, 2001, CHEM RES TOXICOL, V14, P1203, DOI 10.1021/tx010051p; Steuer AE, 2015, DRUG METAB DISPOS, V43, P1864, DOI 10.1124/dmd.115.066340; Steuer AE, 2015, DRUG TEST ANAL, V7, P592, DOI 10.1002/dta.1740; Trojan A, 2012, BREAST CARE, V7, P25, DOI 10.1159/000336551; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P761, DOI 10.2165/11318070-000000000-00000	63	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150955	10.1371/journal.pone.0150955	http://dx.doi.org/10.1371/journal.pone.0150955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967321	Green Published, Green Accepted, gold			2022-12-27	WOS:000371989200023
J	McGill, M; Sussman, H; Byrd, CT				McGill, Megann; Sussman, Harvey; Byrd, Courtney T.			From Grapheme to Phonological Output: Performance of Adults Who Stutter on a Word Jumble Task	PLOS ONE			English	Article							NONWORD REPETITION; PHONEME ELISION; WORKING-MEMORY; SPEECH; LANGUAGE; CHILDREN; ABILITIES; ANATOMY	Purpose The purpose of the present study was to extend previous research by analyzing the ability of adults who stutter to use phonological working memory in conjunction with lexical access to perform a word jumble task. Method Forty English words consisting of 3-, 4-, 5-, and 6-letters (n = 10 per letter length category) were randomly jumbled using a web-based application. During the experimental task, 26 participants were asked to silently manipulate the scrambled letters to form a real word. Each vocal response was coded for accuracy and speech reaction time (SRT). Results Adults who stutter attempted to solve fewer word jumble stimuli than adults who do not stutter at the 4-letter, 5-letter, and 6-letter lengths. Additionally, adults who stutter were significantly less accurate solving word jumble tasks at the 4-letter, 5-letter, and 6-letter lengths compared to adults who do not stutter. At the longest word length (6-letter), SRT was significantly slower for the adults who stutter than the fluent controls. Conclusion Results of the current study lend further support to the notion that differences in various aspects of phonological processing, including vision-to-sound conversions, sub-vocal stimulus manipulation, and/or lexical access are compromised in adults who stutter.	[McGill, Megann; Sussman, Harvey; Byrd, Courtney T.] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	McGill, M (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA.	megannmcgill@gmail.com			Michael and Tami Lang Stuttering Institute	Michael and Tami Lang Stuttering Institute	We would like to sincerely thank the Michael and Tami Lang Stuttering Institute and Dr. Jennifer and Emanuel Bodner for their endowed support of our research efforts. We would also like to thank Elizabeth Hampton, M.S., CCC-SLP and Zoi Gkalitsiou, M.A., CCC-SLP who assisted us with the recruitment and testing of participants as well as the graduate students who assisted with the testing, and data collection/analysis process. Most of all, we would like to thank the adults who do and do not stutter who were willing to give their time to participate in this study and help us to further our knowledge of the underlying nature of stuttering.	American Speech-Language-Hearing Association, 1997, GUID AUD SCREEN; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Bajaj A, 2007, J FLUENCY DISORD, V32, P218, DOI 10.1016/j.jfludis.2007.03.002; Bloodstein O., 2008, HDB STUTTERING; BOSSHARDT HG, 1993, J SPEECH HEAR RES, V36, P286, DOI 10.1044/jshr.3602.286; Brocklehurst PH, 2011, J COMMUN DISORD, V44, P246, DOI 10.1016/j.jcomdis.2010.11.004; Byrd CT, 2015, J FLUENCY DISORD, V44, P17, DOI 10.1016/j.jfludis.2015.01.004; Byrd CT, 2012, J FLUENCY DISORD, V37, P188, DOI 10.1016/j.jfludis.2012.03.003; Cai S, 2014, FRONT HUM NEUROSCI, V8, P1; Chang SE, 2013, BRAIN, V136, P3709, DOI 10.1093/brain/awt275; Chang SE, 2011, CEREB CORTEX, V21, P2507, DOI 10.1093/cercor/bhr028; Cieslak M, 2015, J SPEECH LANG HEAR R, V58, P268, DOI 10.1044/2015_JSLHR-S-14-0193; Connally EL, 2014, BRAIN LANG, V131, P25, DOI 10.1016/j.bandl.2013.05.013; Conture E. G., 2001, STUTTERING ITS NATUR; Craig-McQuaide A, 2014, FRONT HUM NEUROSCI, V8, P1; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Dunn L.M., 2007, PEABODY PICTURE VOCA, DOI [DOI 10.1037/T15144-000, 10.1037/t15144-000]; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guitar B., 2013, STUTTERING INTEGRATE; Hakim HB, 2004, J FLUENCY DISORD, V29, P179, DOI 10.1016/j.jfludis.2004.06.001; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Juhasz BJ, 2014, BEHAV RES METHODS, V1, P1; Ludlow CL, 1997, INT CONGR SER, V1146, P221; Namasivayam AK, 2008, J FLUENCY DISORD, V33, P32, DOI 10.1016/j.jfludis.2007.11.005; Nippold MA, 2002, AM J SPEECH-LANG PAT, V11, P99, DOI 10.1044/1058-0360(2002/011); POSTMA A, 1990, J FLUENCY DISORD, V15, P49, DOI 10.1016/0094-730X(90)90032-N; Riley G., 1994, STUTTERING SEVERITY; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Sasisekaran J, 2006, J FLUENCY DISORD, V31, P1, DOI 10.1016/j.jfludis.2005.11.005; Sasisekaran J, 2006, J FLUENCY DISORD, V31, P284, DOI 10.1016/j.jfludis.2006.08.001; Sasisekaran J, 2014, J FLUENCY DISORD, V41, P55, DOI 10.1016/j.jfludis.2014.02.004; Sasisekaran J, 2014, SEMIN SPEECH LANG, V35, DOI 10.1055/s-0034-1371754; Sasisekaran J, 2013, J FLUENCY DISORD, V38, P275, DOI 10.1016/j.jfludis.2013.06.001; Saygin ZM, 2013, J NEUROSCI, V33, P13251, DOI 10.1523/JNEUROSCI.4383-12.2013; Smith A, 2010, J FLUENCY DISORD, V35, P1, DOI 10.1016/j.jfludis.2009.12.001; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; Weber-Fox C, 2004, J SPEECH LANG HEAR R, V47, P1244, DOI 10.1044/1092-4388(2004/094); Williams K, EXPRESSIVE VOCABULAR, P207; Yairi E., 2005, EARLY CHILDHOOD STUT, V1st; Yairi E, 2015, STUTTERING FDN CLIN	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151107	10.1371/journal.pone.0151107	http://dx.doi.org/10.1371/journal.pone.0151107			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26963917	Green Published, gold			2022-12-27	WOS:000371993000105
J	Tsai, MC; Chen, CH; Tseng, PL; Hung, CH; Chiu, KW; Chang, KC; Yen, YH; Lin, MT; Hu, TH				Tsai, Ming-Chao; Chen, Chien-Hung; Tseng, Po-Lin; Hung, Chao-Hung; Chiu, King-Wah; Chang, Kuo-Chin; Yen, Yi-Hao; Lin, Ming-Tsung; Hu, Tsung-Hui			Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; TENOFOVIR DISOPROXIL FUMARATE; KIDNEY-FUNCTION DECLINE; ADEFOVIR DIPIVOXIL; TELBIVUDINE; IMPACT; RISK; PREDICTION; NUCLEOSIDE; CREATININE	This study aimed to assess the renal function in chronic hepatitis B (CHB) patients who received nucleos(t)ide analogues (NAs) therapy using estimated glomerular filtration rate (eGFR) titer. We performed a longitudinal observational study of 37 tenofovir-, 42 telbivudine-, and 62 entecavir-naive CHB patients, who had impaired renal function (eGFR, 90-30 ml/min/1.73m(2)) without history of diabetes, hypertension, and chemotherapy. Calculation and evaluation of eGFR was performed with the Modification of Diet in Renal Disease, Chronic Kidney Disease Epidemiology Collaboration, and Cockcroft-Gault formula at pretreatment, at baseline, and after the 1st and 2nd year of treatment. The eGFR was significantly increased in patients given telbivudine or entecavir (p = 0.003 and p = 0.012, respectively), but the eGFR was decreased in patients given tenofovir (p = 0.001) after 2 years of treatment. Of all patients, eGFR was stable one year prior to treatment. If we analyzed the renal function by change of chronic kidney disease (CKD) category with a change of 25% of eGFR, the proportion of uncertain drop (drop in CKD category with <25% decrease in eGFR) and certain drop (drop in CKD category with >= 25% decrease in eGFR) in tenofovir group was smaller (5.4%) than those of telbivudine (12.9%) or entecavir (6.5%). Furthermore, telbivudine had the lowest stable rate (76.2%), the highest certain rise rate (9.5%), and certain drop rate (7.1%) compared to the other groups (p = 0.049). In conclusion, in NAs-naive CHB patients with impaired renal function, telbivudine and entecavir resulted in a significant increase in eGFR while tenofovir resulted in a significant decrease after a 2-year treatment. Interestingly, TDF had the lowest proportion of patients reclassified to certain and uncertain drop groups; in contrast, LdT had a higher proportion in both raise and drop groups. The outcomes of this renal effect remain to be determined.	[Tsai, Ming-Chao; Chen, Chien-Hung; Tseng, Po-Lin; Hung, Chao-Hung; Chiu, King-Wah; Chang, Kuo-Chin; Yen, Yi-Hao; Lin, Ming-Tsung; Hu, Tsung-Hui] Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Hepatogastroenterol,Dept Internal Med,Coll Me, Kaohsiung, Taiwan; [Tsai, Ming-Chao; Tseng, Po-Lin; Yen, Yi-Hao; Lin, Ming-Tsung] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Hu, TH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Hepatogastroenterol,Dept Internal Med,Coll Me, Kaohsiung, Taiwan.	dr.hu@msa.hinet.net	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051; Chiu, King-Wah/0000-0003-2108-6539	Chang Gung Memorial Hospital, Taiwan [CMRPG8D0221]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was supported by contract grants CMRPG8D0221 from Chang Gung Memorial Hospital, Taiwan. No additional funding sources for this study.	Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Amet S, 2015, LIVER INT, V35, P148, DOI 10.1111/liv.12480; Bhimma R, 2004, AM J NEPHROL, V24, P198, DOI 10.1159/000077065; Cheng TYD, 2008, AM J KIDNEY DIS, V52, P1051, DOI 10.1053/j.ajkd.2008.05.030; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coppolino G, 2015, J NEPHROL, V28, P393, DOI 10.1007/s40620-015-0214-0; Gallant JE, 2005, CLIN INFECT DIS, V40, P1194, DOI 10.1086/428840; Gane EJ, 2014, GASTROENTEROLOGY, V146, P138, DOI 10.1053/j.gastro.2013.09.031; Gish RG, 2012, CLIN GASTROENTEROL H, V10, P941, DOI 10.1016/j.cgh.2012.04.008; Ha NB, 2016, J CLIN GASTROENTEROL, V50, P169, DOI 10.1097/MCG.0000000000000345; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Huang JF, 2006, J INTERN MED, V260, P255, DOI 10.1111/j.1365-2796.2006.01686.x; Koklu S, 2015, ALIMENT PHARM THER, V41, P310, DOI 10.1111/apt.13036; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2013, CLIN LIVER DIS, V17, P413, DOI 10.1016/j.cld.2013.05.005; Malik Amyn, 2005, J Infect, V51, pE61, DOI 10.1016/j.jinf.2004.08.031; Mallet V, 2015, CLIN GASTROENTEROL H, V13, P1181, DOI 10.1016/j.cgh.2014.11.021; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Pipili C, 2014, ALIMENT PHARM THER, V39, P35, DOI 10.1111/apt.12538; Piratvisuth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054279; Qi X, 2015, J VIRAL HEPATITIS, V22, P46, DOI 10.1111/jvh.12229; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tsai MC, 2014, CLIN MICROBIOL INFEC, V20, pO90, DOI 10.1111/1469-0691.12220; Turan I, 2015, LIVER TRANSPLANT, V21, P1066, DOI 10.1002/lt.24131; Turin TC, 2012, AM J NEPHROL, V36, P41, DOI 10.1159/000339289; Wong GLH, 2015, HEPATOLOGY, V62, P684, DOI 10.1002/hep.27894; Xie DW, 2008, CLIN J AM SOC NEPHRO, V3, P1332, DOI 10.2215/CJN.05631207	32	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0149761	10.1371/journal.pone.0149761	http://dx.doi.org/10.1371/journal.pone.0149761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964034	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000018
J	Hwang, Y; Lee, KE; Weiderpass, E; Park, YJ; Chai, YJ; Kwon, H; Park, DJ; Cho, B; Choi, HC; Kang, D; Park, SK				Hwang, Yunji; Lee, Kyu Eun; Weiderpass, Elisabete; Park, Young Joo; Chai, Young Jun; Kwon, Hyungju; Park, Do Joon; Cho, BeLong; Choi, Ho-Chun; Kang, Daehee; Park, Sue K.			Acute High-Dose and Chronic Lifetime Exposure to Alcohol Consumption and Differentiated Thyroid Cancer: T-CALOS Korea	PLOS ONE			English	Article							RISK-FACTORS; CIGARETTE-SMOKING; POOLED ANALYSIS; PHARMACOKINETICS; CARCINOMA; MORTALITY; DRINKING; GENDER	Background This study evaluated the effects of acute high-dose and chronic lifetime exposure to alcohol and exposure patterns on the development of differentiated thyroid cancer (DTC). Methods The Thyroid Cancer Longitudinal Study (T-CALOS) included 2,258 DTC patients (449 men and 1,809 women) and 22,580 healthy participants (4,490 men and 18,090 women) who were individually matched by age, gender, and enrollment year. In-person interviews were conducted with a structured questionnaire to obtain epidemiologic data. Clinicopathologic features of the patients were obtained by chart reviews. Odds ratios (ORs) and 95% confidence intervals (95%CI) were estimated using conditional regression models. Results While light or moderate drinking behavior was related to a reduced risk of DTC, acute heavy alcohol consumption (151 g or more per event or on a single occasion) was associated with increased risks in men (OR = 2.22, 95% CI = 1.27-3.87) and women (OR = 3.61, 95% CI = 1.52-8.58) compared with never-drinkers. The consumption of alcohol for 31 or more years was a significant risk factor for DTC for both men (31-40 years: OR = 1.58, 95% CI = 1.10-2.28; 41 + years: OR = 3.46, 95% CI = 2.06-5.80) and women (31-40 years: OR = 2.18, 95% CI = 1.62-2.92; 41 + years: OR = 2.71, 95% CI = 1.36-5.05) compared with never-drinkers. The consumption of a large amount of alcohol on a single occasion was also a significant risk factor, even after restricting DTC outcomes to tumor size, lymph node metastasis, extrathyroidal extension and TNM stage. Conclusion The findings of this study suggest that the threshold effects of acute high-dose alcohol consumption and long-term alcohol consumption are linked to an increased risk of DTC.	[Hwang, Yunji; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hwang, Yunji; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Hwang, Yunji; Lee, Kyu Eun; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Kyu Eun; Kwon, Hyungju] Seoul Natl Univ Hosp & Coll Med, Dept Surg, Seoul, South Korea; [Lee, Kyu Eun] Seoul Natl Univ, Canc Hosp, Div Surg, Thyroid Ctr, Seoul, South Korea; [Weiderpass, Elisabete] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Dept Genet Epidemiol, Helsinki, Finland; [Park, Young Joo; Park, Do Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Chai, Young Jun] Seoul Natl Univ, Boramae Med Ctr, Dept Surg, Seoul, South Korea; [Kwon, Hyungju] Ewha Womans Univ, Coll Med, Breast & Thyroid Canc Ctr, Seoul, South Korea; [Cho, BeLong] Seoul Natl Univ Hosp, Dept Family Med, Hlth Promot Ctr Canc Survivor, Seoul 110744, South Korea; [Cho, BeLong] Seoul Natl Univ, Adv Inst Convergence Technol, 145 Gwanggyo Ro, Suwon, Gyeonggi Do, South Korea; [Choi, Ho-Chun] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Folkhalsan Research Center; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Park, SK (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.; Park, SK (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	suepark@snu.ac.kr	Weiderpass, Elisabete/AAP-2747-2021; Park, Young Joo/J-4161-2012; Cho, Belong/GLU-3443-2022; Chai, Young/AAW-6684-2021; Weiderpass, Elisabete/M-4029-2016	Weiderpass, Elisabete/0000-0003-2237-0128; Park, Young Joo/0000-0002-3671-6364; Cho, Belong/0000-0001-9558-689X; Weiderpass, Elisabete/0000-0003-2237-0128; Kwon, Hyungju/0000-0003-4979-8749; Kang, Daehee/0000-0003-4031-5878; Chai, Young Jun/0000-0001-8830-3433	Korean Foundation for Cancer Research [CB-2011-03-01]; Basic Research Laboratory Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2011-0001564]; Education and Research Encouragement Fund of Seoul National University Hospital; Brain Korea 21 PLUS Program	Korean Foundation for Cancer Research; Basic Research Laboratory Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Education and Research Encouragement Fund of Seoul National University Hospital; Brain Korea 21 PLUS Program	This study was conducted with research grants from the Korean Foundation for Cancer Research (Grant Number: CB-2011-03-01) and the Basic Research Laboratory Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant Number: 2011-0001564). This study was also supported by the Education and Research Encouragement Fund of Seoul National University Hospital and the Brain Korea 21 PLUS Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; BAUMGARTNER A, 1994, ALCOHOL CLIN EXP RES, V18, P284, DOI 10.1111/j.1530-0277.1994.tb00016.x; Chai YJ, 2014, CLIN ENDOCRINOL, V81, P432, DOI 10.1111/cen.12433; Franceschi S, 2015, INT J CANCER, V136, P2738, DOI 10.1002/ijc.29311; Guignard R, 2007, AM J EPIDEMIOL, V166, P1140, DOI 10.1093/aje/kwm204; Im HJ, 2014, KOREAN J FAM MED, V35, P173, DOI 10.4082/kjfm.2014.35.4.173; Jang SN, 2010, J AM GERIATR SOC, V58, P592, DOI 10.1111/j.1532-5415.2010.02744.x; Jung KW, 2015, CANCER RES TREAT, V47, P142, DOI 10.4143/crt.2015.066; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Jung SH, 2014, ASIAN PAC J CANCER P, V15, P3675, DOI 10.7314/APJCP.2014.15.8.3675; Kabat GC, 2012, CANCER EPIDEMIOL, V36, P335, DOI 10.1016/j.canep.2012.03.013; Kim SJ, 2012, WORLD J SURG, V36, P310, DOI 10.1007/s00268-011-1383-1; Kitahara CM, 2012, CANCER CAUSE CONTROL, V23, P1615, DOI 10.1007/s10552-012-0039-2; Lee KE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007234; Li TK, 2000, ALCOHOL CLIN EXP RES, V24, P415, DOI 10.1097/00000374-200004000-00009; Mack WJ, 2003, CANCER CAUSE CONTROL, V14, P773, DOI 10.1023/A:1026349702909; Mack WJ, 2002, ANN EPIDEMIOL, V12, P395, DOI 10.1016/S1047-2797(01)00281-2; Meinhold CL, 2009, BRIT J CANCER, V101, P1630, DOI 10.1038/sj.bjc.6605337; Mezey E, 2000, ALCOHOL CLIN EXP RES, V24, P421, DOI 10.1097/00000374-200004000-00012; Nagano J, 2007, J EPIDEMIOL, V17, P76, DOI 10.2188/jea.17.76; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Razzak AA, 2011, CANCER PREV RES, V4, P2035, DOI 10.1158/1940-6207.CAPR-11-0276; Roswall Nina, 2015, J Prev Med Public Health, V48, P1, DOI 10.3961/jpmph.14.052; Ryu M, 2010, EPIDEMIOL HEALTH, V32, DOI 10.4178/epih/e2010007; Sato N, 2001, ALCOHOL CLIN EXP RES, V25, p40S, DOI 10.1111/j.1530-0277.2001.tb02371.x; Schernhammer ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021102; Sobin L, 2009, TNM CLASSIFICATION M; Tufano RP, 2015, JAMA OTOLARYNGOL, V141, P566, DOI 10.1001/jamaoto.2015.0647; WILLIAMS RR, 1976, LANCET, V1, P996; Xhaard C, 2014, ASIAN PAC J CANCER P, V15, P2675, DOI 10.7314/APJCP.2014.15.6.2675	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151562	10.1371/journal.pone.0151562	http://dx.doi.org/10.1371/journal.pone.0151562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985827	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300087
J	Tjernlund, A; Burgener, A; Lindvall, JM; Peng, T; Zhu, J; Ohrmalm, L; Picker, LJ; Broliden, K; McElrath, MJ; Corey, L				Tjernlund, Annelie; Burgener, Adam; Lindvall, Jessica M.; Peng, Tao; Zhu, Jia; Oehrmalm, Lars; Picker, Louis J.; Broliden, Kristina; McElrath, M. Juliana; Corey, Lawrence			In Situ Staining and Laser Capture Microdissection of Lymph Node Residing SIV Gag-Specific CD8(+) T cells-A Tool to Interrogate a Functional Immune Response Ex Vivo	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-EXPRESSION; TRANSCRIPTIONAL PROFILES; ANTIRETROVIRAL THERAPY; INFECTED MACAQUES; SYSTEMS BIOLOGY; PLASMA VIREMIA; HIV-INFECTION; LYMPHOCYTES; REVEALS	While a plethora of data describes the essential role of systemic CD8(+) T cells in the control of SIV replication little is known about the local in situ CD8(+) T cell immune responses against SIV at the intact tissue level, due to technical limitations. In situ staining, using GagCM9 Qdot 655 multimers, were here combined with laser capture microdissection to detect and collect SIV Gag CM9 specific CD8(+) T cells in lymph node tissue from SIV infected rhesus macaques. CD8(+) T cells from SIV infected and uninfected rhesus macaques were also collected and compared to the SIV GagCM9 specific CD8(+) T cells. Illumina bead array and transcriptional analyses were used to assess the transcriptional profiles and the three different CD8(+) T cell populations displayed unique transcriptional patterns. This pilot study demonstrates that rapid and specific immunostaining combined with laser capture microdissection in concert with transcriptional profiling may be used to elucidate phenotypic differences between CD8(+) T cells in SIV infection. Such technologies may be useful to determine differences in functional activities of HIV/SIV specific T cells.	[Tjernlund, Annelie; Burgener, Adam; Oehrmalm, Lars; Broliden, Kristina] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med Solna,Unit Infect Dis, L8-01, S-17176 Stockholm, Sweden; [Burgener, Adam] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada; [Burgener, Adam] Univ Manitoba, Dept Med Microbiol, 730 William Ave, Winnipeg, MB, Canada; [Lindvall, Jessica M.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Biosci & Nutr, Stockholm, Sweden; [Peng, Tao; Zhu, Jia; McElrath, M. Juliana; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Peng, Tao; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Zhu, Jia; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Pathol, Beaverton, OR USA; [Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Karolinska Institutet; Karolinska University Hospital; Public Health Agency of Canada; University of Manitoba; Karolinska Institutet; Karolinska University Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Tjernlund, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med Solna,Unit Infect Dis, L8-01, S-17176 Stockholm, Sweden.	Annelie.Tjernlund@ki.se	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436; Lindvall, Jessica/0000-0002-5042-8481; Zhu, Jia/0000-0002-8676-5105	Swedish Research Council; Swedish Society for Medical Research; Swedish Society of Medicine; Swedish Physicians Against AIDS Research Foundation; Bill & Melinda Gates Foundation "Immune Correlates of Protection Against HIV and SIV Infection" [41185]; National Institutes of Health grant [R01 AI-42528, PO1 AI-30731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, R01AI111780, R01AI042528] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Swedish Society of Medicine; Swedish Physicians Against AIDS Research Foundation; Bill & Melinda Gates Foundation "Immune Correlates of Protection Against HIV and SIV Infection"; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Swedish Research Council, http://www.vr.se/(A.T.), the Swedish Society for Medical Research, http://www.ssmf.se/(A.T.), the Swedish Society of Medicine, http://www.sls.se/(A.T.), the Swedish Physicians Against AIDS Research Foundation http://www.aidsfond.se/(A.T.), the Bill & Melinda Gates Foundation #41185 "Immune Correlates of Protection Against HIV and SIV Infection", http://www.gatesfoundation.org/(M.J.M.) and National Institutes of Health grant R01 AI-42528 and PO1 AI-30731, http://www.nih.gov/(L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 1998, J IMMUNOL, V160, P6062; Belisle SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019681; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Bosinger SE, 2012, CURR OPIN HIV AIDS, V7, P71, DOI 10.1097/COH.0b013e32834dde01; Burgener A, 2013, J VIROL, V87, P5141, DOI 10.1128/JVI.03347-12; Chowdhury A, 2015, J VIROL, V89, P8677, DOI 10.1128/JVI.00869-15; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; George MD, 2006, J MED PRIMATOL, V35, P261, DOI 10.1111/j.1600-0684.2006.00180.x; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; George MD, 2014, VIROLOGY, V468, P581, DOI 10.1016/j.virol.2014.09.013; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gupta B, 2012, J IMMUNOTHER, V35, P488, DOI 10.1097/CJI.0b013e31826183a7; Horiike M, 2012, VIROLOGY, V423, P107, DOI 10.1016/j.virol.2011.11.024; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Iancu EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/452606; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 2000, BLOOD, V96, P1474, DOI 10.1182/blood.V96.4.1474.h8001474_1474_1479; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; Lederer S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000296; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Loffredo JT, 2006, MAMU A 01 INDIAN RHE; Mao HW, 2005, J VIROL, V79, P14887, DOI 10.1128/JVI.79.23.14887-14898.2005; Martinez-Marino B, 2007, VIROLOGY, V362, P217, DOI 10.1016/j.virol.2006.12.007; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Palermo RE, 2011, J VIROL, V85, P1099, DOI 10.1128/JVI.01522-10; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Pereyra F, 2014, J VIROL, V88, P12937, DOI 10.1128/JVI.01004-14; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Sasikala-Appukuttan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081623; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Smith AJ, 2010, J IMMUNOL, V185, P5417, DOI 10.4049/jimmunol.1002197; TENNERRACZ K, 1986, AM J PATHOL, V123, P9; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Tjernlund A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-12; Tsukamoto T, 2007, J VIROL, V81, P11640, DOI 10.1128/JVI.01475-07; Vojnov L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023515; Wu JQ, 2008, VIROLOGY, V380, P124, DOI 10.1016/j.virol.2008.06.039; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	57	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0149907	10.1371/journal.pone.0149907	http://dx.doi.org/10.1371/journal.pone.0149907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986062	Green Published, gold			2022-12-27	WOS:000372580300017
J	McKay, CP; Rask, JC; Detweiler, AM; Bebout, BM; Everroad, RC; Lee, JZ; Chanton, JP; Mayer, MH; Caraballo, AAL; Kapili, B; Al-Awar, M; Al-Farraj, A				McKay, Christopher P.; Rask, Jon C.; Detweiler, Angela M.; Bebout, Brad M.; Everroad, R. Craig; Lee, Jackson Z.; Chanton, Jeffrey P.; Mayer, Marisa H.; Caraballo, Adrian A. L.; Kapili, Bennett; Al-Awar, Meshgan; Al-Farraj, Asma			An Unusual Inverted Saline Microbial Mat Community in an Interdune Sabkha in the Rub' al Khali (the Empty Quarter), United Arab Emirates	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DEATH-VALLEY; HALOPHILIC BACTERIUM; SUBSTRATE LIMITATION; EVAPORITE DEPOSITS; GENOME SEQUENCE; METHANE; BIOSIGNATURES; CLIMATE; LIFE	Salt flats (sabkha) are a recognized habitat for microbial life in desert environments and as analogs of habitats for possible life on Mars. Here we report on the physical setting and microbiology of interdune sabkhas among the large dunes in the Rub' al Khali (the Empty Quarter) in Liwa Oasis, United Arab Emirates. The salt flats, composed of gypsum and halite, are moistened by relatively fresh ground water. The result is a salinity gradient that is inverted compared to most salt flat communities with the hypersaline layer at the top and freshwater layers below. We describe and characterize a rich photosynthetically-based microbial ecosystem that is protected from the arid outside environment by a translucent salt crust. Gases collected from sediments under shallow ponds in the sabkha contain methane in concentrations as high as 3400 ppm. The salt crust could preserve biomarkers and other evidence for life in the salt after it dries out. Chloride-filled depressions have been identified on Mars and although surface flow of water is unlikely on Mars today, ground water is possible. Such a near surface system with modern groundwater flowing under ancient salt deposits could be present on Mars and could be accessed by surface rovers.	[McKay, Christopher P.; Rask, Jon C.; Detweiler, Angela M.; Bebout, Brad M.; Everroad, R. Craig; Lee, Jackson Z.; Mayer, Marisa H.; Caraballo, Adrian A. L.; Kapili, Bennett] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Detweiler, Angela M.; Everroad, R. Craig; Lee, Jackson Z.] Bay Area Environm Res Inst, Petaluma, CA USA; [Chanton, Jeffrey P.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Al-Awar, Meshgan] Dubai Police Acad, Res & Studies Ctr, Dubai, U Arab Emirates; [Al-Farraj, Asma] United Arab Emirates Univ, Dept Geog, Al Ain, U Arab Emirates	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; State University System of Florida; Florida State University; United Arab Emirates University	McKay, CP (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	Chris.McKay@NASA.gov			NASA; NASA ASTEP Program; Arab Youth Venture Foundation	NASA(National Aeronautics & Space Administration (NASA)); NASA ASTEP Program(National Aeronautics & Space Administration (NASA)); Arab Youth Venture Foundation	NASA funded this work.; This work was supported by the NASA ASTEP Program. Field work in the UAE was part of a NASA Spaceward Bound program and was supported by the Arab Youth Venture Foundation. We thank Lisa LaBonte, Hussain Al Ansari, and Annie Ortiz of the AYV Foundation and Michael Wing, Matt Reyes, and Lucinda Land for assistance in the field activities. We also thank Claire Langford for running the gas samples on the GC-IRMS. We thank the reviewers for the detailed and comprehensive reviews that greatly improved the paper.	Al-Farraj A, 2005, J ARID ENVIRON, V63, P740, DOI 10.1016/j.jaridenv.2005.01.025; Al-Katheeri ES, 2009, ENVIRON EARTH SCI, V59, P581, DOI 10.1007/s12665-009-0056-y; [Anonymous], 1970, P GEOLOGIST ASSOC, DOI DOI 10.1016/S0016-7878(70)80010-4; Antony CP, 2012, FEMS MICROBIOL ECOL, V81, P43, DOI 10.1111/j.1574-6941.2011.01274.x; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Barbieri R, 2006, PLANET SPACE SCI, V54, P726, DOI 10.1016/j.pss.2006.04.003; Bebout BM, 2004, GEOBIOLOGY, V2, P87, DOI 10.1111/j.1472-4677.2004.00024.x; Boer B, 1997, J ARID ENVIRON, V35, P3, DOI 10.1006/jare.1996.0162; CONRAD R, 1995, FEMS MICROBIOL ECOL, V16, P297, DOI 10.1111/j.1574-6941.1995.tb00294.x; Davila AF, 2011, ICARUS, V212, P579, DOI 10.1016/j.icarus.2010.12.023; Davila AF, 2010, ASTROBIOLOGY, V10, P617, DOI 10.1089/ast.2009.0421; Douglas S, 2004, PLANET SPACE SCI, V52, P223, DOI 10.1016/j.pss.2003.08.005; Douglas S, 2002, GEOLOGY, V30, P1075, DOI 10.1130/0091-7613(2002)030<1075:MBIEPO>2.0.CO;2; Douglas S, 2008, ICARUS, V193, P620, DOI 10.1016/j.icarus.2007.08.019; Edwards HGM, 2006, ANAL BIOANAL CHEM, V385, P46, DOI 10.1007/s00216-006-0396-3; El-Sayed MI, 1999, SEDIMENT GEOL, V123, P219, DOI 10.1016/S0037-0738(98)00116-X; El-Sayed MI, 2000, SEDIMENT GEOL, V134, P305, DOI 10.1016/S0037-0738(00)00052-X; Garcia-Maldonado JQ, 2015, MICROB ECOL, V69, P106, DOI 10.1007/s00248-014-0473-7; Glennie KW, 1998, QUATERNARY DESERTS AND CLIMATIC CHANGE, P279; Kelley CA, 2014, APPL ENVIRON MICROB, V80, P7316, DOI 10.1128/AEM.02641-14; Kelley CA, 2012, ASTROBIOLOGY, V12, P89, DOI 10.1089/ast.2011.0703; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lollar BS, 2006, CHEM GEOL, V226, P328, DOI 10.1016/j.chemgeo.2005.09.027; Lorenz RD, 2015, 4 INT PLAN DUN WORKS; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Ojha L, 2015, NAT GEOSCI, V8, P829, DOI [10.1038/ngeo2546, 10.1038/NGEO2546]; OREN A, 1988, A VAN LEEUW J MICROB, V54, P267, DOI 10.1007/BF00443585; Oren A, 2013, FEMS MICROBIOL LETT, V342, P1, DOI 10.1111/1574-6968.12094; Osterloo MM, 2008, SCIENCE, V319, P1651, DOI 10.1126/science.1150690; Osterloo MM, 2010, J GEOPHYS RES; Pagani I, 2011, STAND GENOMIC SCI, V4, P154, DOI 10.4056/sigs.1623941; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rice AL, 2001, ANAL CHEM, V73, P4104, DOI 10.1021/ac0155106; Riedel T, 2012, STAND GENOMIC SCI, V7, P120, DOI 10.4056/sigs.3296896; ROTHSCHILD LJ, 1994, J PHYCOL, V30, P431, DOI 10.1111/j.0022-3646.1994.00431.x; ROTHSCHILD LJ, 1990, ICARUS, V88, P246, DOI 10.1016/0019-1035(90)90188-F; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHINN EA, 1983, J SEDIMENT PETROL, V53, P595; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tazaz AM, 2013, ICARUS, V224, P268, DOI 10.1016/j.icarus.2012.06.008; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wang YX, 2013, INT J SYST EVOL MICR, V63, P3989, DOI 10.1099/ijs.0.052043-0; Webster CR, 2015, SCIENCE, V347, P415, DOI 10.1126/science.1261713; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Wierzchos J, 2006, ASTROBIOLOGY, V6, P415, DOI 10.1089/ast.2006.6.415; WILHARM T, 1991, INT J SYST BACTERIOL, V41, P558, DOI 10.1099/00207713-41-4-558; Wood WW, 2011, HYDROGEOL J, V19, P155, DOI 10.1007/s10040-010-0626-9; WOOD WW, 1995, J HYDROL, V164, P263, DOI 10.1016/0022-1694(94)02551-L; Wood WW, 2003, DEV WATER SCI, V50, P379; Wood WW, 2003, DEV WATER SCI, V50, P295; Wood WW, 2002, GEOL SOC AM BULL, V114, P259, DOI 10.1130/0016-7606(2002)114<0259:SOSTTC>2.0.CO;2; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; ZHILINA TN, 1990, FEMS MICROBIOL LETT, V87, P315, DOI 10.1111/j.1574-6968.1990.tb04930.x	56	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150342	10.1371/journal.pone.0150342	http://dx.doi.org/10.1371/journal.pone.0150342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982497	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900036
J	Nalpas, B; Ichai, P; Jamot, L; Carbonell, N; Rudler, M; Mathurin, P; Durand, F; Gerken, G; Manns, M; Trautwein, C; Larrey, D; Radenne, S; Duvoux, C; Leroy, V; Bernuau, J; Faivre, J; Moniaux, N; Brechot, C; Amouyal, G; Amouyal, P; Samuel, D				Nalpas, Bertrand; Ichai, Philippe; Jamot, Laure; Carbonell, Nicolas; Rudler, Marika; Mathurin, Philippe; Durand, Francois; Gerken, Guido; Manns, Michael; Trautwein, Christian; Larrey, Dominique; Radenne, Sylvie; Duvoux, Christophe; Leroy, Vincent; Bernuau, Jacques; Faivre, Jamila; Moniaux, Nicolas; Brechot, Christian; Amouyal, Gilles; Amouyal, Paul; Samuel, Didier			A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; INTRAVENOUS ACETYLCYSTEINE; SURVIVAL; CENTERS	Objective No efficient medical treatment is available for severe acute hepatitis (SAH) except N-acetyl-cysteine for acetaminophen-induced acute liver failure. The human C-type lectin Reg3 alpha, referred to as ALF-5755, improved survival in an animal model of acute liver failure and was well tolerated in a phase 1 trial in humans. We performed a phase 2a trial of ALF5755 in non-acetaminophen induced SAH. Design double-blind, randomized, placebo-controlled study. The primary end-point was the improvement in the coagulation protein synthesis assessed by the change of Prothrombin (PR) during the 72 hours following treatment initiation calculated as PRH0 minus PRH72 divided by 72 (PR slope H0H72). Intention to treat (ITT) and per-protocol (PP) analysis of the entire group and the Hepatitis B virus (HBV)/AIH (auto-immune hepatitis) sub-group were done separately. Results 57 patients were included. Twenty-eight received ALF-5755, 29 the placebo. Etiologies were: Hepatitis A (n = 10), HBV (n = 13), AIH (n = 9), drug-induced (n = 8), other (n = 17). On the whole group, nor the PR slope H0H72 (0.18 +/- 0.31 vs 0.25 +/- 0.32), nor the transplant-free survival rate at day 21 (75 vs 86%) differed between groups. Conversely, in the HBV-AIH subgroup, in which ALF was more severe, PR slope H0-H72 was higher in the ALF-5755 arm, the difference being significant in PP analysis (0.048 +/- 0.066 vs -0.040 +/- 0.099, p = 0.04); the median length of hospitalization was lower in the ALF-5755 group (8 vs 14 days, p = 0.02). Conclusion ALF-5755 was not efficient in a ITT analysis performed on the whole sample; however it led to a significant, although moderate, clinical benefit in a PP analysis of the sub-group of patients with HBV or AIH related SAH. As HBV is the major cause of SAH in Asia and Africa and AIH a growing cause, this study emphasizes the need to pursuit the evaluation of this novel medical treatment of SAH.	[Nalpas, Bertrand] INSERM, Dept Informat Sci & Commun, Paris, France; [Ichai, Philippe; Faivre, Jamila; Moniaux, Nicolas; Samuel, Didier] Ctr Hepatobiliaire Paul Brousse, Villejuif, France; [Ichai, Philippe; Faivre, Jamila; Moniaux, Nicolas; Samuel, Didier] INSERM, U1193, Villejuif, France; [Ichai, Philippe; Faivre, Jamila; Samuel, Didier] Hop Univ Paul Brousse, Villejuif, France; [Jamot, Laure; Amouyal, Gilles; Amouyal, Paul] Alfact Innovat, Paris, France; [Carbonell, Nicolas] Hop St Antoine, Serv Hepatogastroenterol, F-75571 Paris, France; [Mathurin, Philippe] Hop Claude Huriez, Serv Malad Appareil Digestif, Lille, France; [Durand, Francois; Bernuau, Jacques] Hop Beaujon, Serv Hepatol, Clichy, France; [Gerken, Guido] Univ Essen Gesamthsch, Gastroenterol & Hepatol Unit, Essen, Germany; [Manns, Michael] Leibniz Univ Hannover, Gastroenterol & Hepatol Unit, Hannover, Germany; [Trautwein, Christian] Rhein Westfal TH Aachen, Univ Clin, Med Klin 3, D-52062 Aachen, Germany; [Larrey, Dominique] Hop St Eloi, Serv Hepatogastroenterol, Montpellier, France; [Radenne, Sylvie] Hop Croix Rousse, Serv Hepatol & Gastroenterol, F-69317 Lyon, France; [Duvoux, Christophe] Hop Henri Mondor, Serv Hepato Gastroenterol, F-94010 Creteil, France; [Leroy, Vincent] Hop Grenoble, Dept Hepatogastroenterol, Grenoble, France; [Brechot, Christian] Inst Pasteur, Paris, France; [Rudler, Marika] Hop La Pitie Salpetriere, Serv Hepatol & Gastroenterol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Duisburg Essen; Leibniz University Hannover; RWTH Aachen University; RWTH Aachen University Hospital; Universite de Montpellier; CHU de Montpellier; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Nalpas, B (corresponding author), INSERM, Dept Informat Sci & Commun, Paris, France.	bertrand.nalpas@inserm.fr	BRECHOT, Christian/S-2011-2018; Nalpas, Bertrand/M-4981-2018; Moniaux, Nicolas/Y-3243-2018; Duvoux, Christophe/CAF-3432-2022; Mathurin, Philippe/A-9121-2018	Moniaux, Nicolas/0000-0001-9718-1386; Mathurin, Philippe/0000-0003-3447-2025; Durand, Francois/0000-0002-0357-1090; Nalpas, Bertrand/0000-0002-8215-2942	ANR (Agence Nationale de la Recherche) (RIB: HIP/PAP and Hepatitis); German Research Foundation (DFG) [TR 285/10-1]	ANR (Agence Nationale de la Recherche) (RIB: HIP/PAP and Hepatitis)(French National Research Agency (ANR)); German Research Foundation (DFG)(German Research Foundation (DFG))	Alfact Innovation is an independent French biotech. This work was supported by a grant from the ANR (Agence Nationale de la Recherche) (RIB 2007: HIP/PAP and Hepatitis) and by a grant of the German Research Foundation (DFG: TR 285/10-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass S, 2013, AM J HEALTH-SYST PH, V70, P1496, DOI 10.2146/ajhp120645; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; BERNUAU J, 1986, SEMIN LIVER DIS, V6, P97, DOI 10.1055/s-2008-1040593; Elinav E, 2005, J HEPATOL, V42, P82, DOI 10.1016/j.jhep.2004.09.009; HARRISON PM, 1990, BMJ-BRIT MED J, V301, P964, DOI 10.1136/bmj.301.6758.964; Ichai P, 2007, LIVER TRANSPLANT, V13, P996, DOI 10.1002/lt.21036; Jalan R, 2014, GASTROENTEROLOGY, V147, P4, DOI 10.1053/j.gastro.2014.05.005; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Mendizabal M, 2014, LIVER TRANSPLANT, V20, P483, DOI 10.1002/lt.23823; Moniaux N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125584; Moniaux N, 2011, HEPATOLOGY, V53, P618, DOI 10.1002/hep.24087; Nalpas B, 2012, GUT, V61, P1098, DOI 10.1136/gutjnl-2011-301316; O'Grady J, 2014, J HEPATOL, V60, P663, DOI 10.1016/j.jhep.2013.10.024; OGRADY JG, 1993, LANCET, V342, P273; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703; Sales I, 2013, ANN HEPATOL, V12, P6, DOI 10.1016/S1665-2681(19)31379-1; Seto WK, 2012, J GASTROEN HEPATOL, V27, P662, DOI 10.1111/j.1440-1746.2011.06971.x; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Xu GL, 2014, HEPATOLOGY, V60, P114, DOI 10.1002/hep.27114	26	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150733	10.1371/journal.pone.0150733	http://dx.doi.org/10.1371/journal.pone.0150733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983031	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900050
J	Bogamuwa, S; Jang, JC				Bogamuwa, Srimathi; Jang, Jyan-Chyun			Plant Tandem CCCH Zinc Finger Proteins Interact with ABA, Drought, and Stress Response Regulators in Processing-Bodies and Stress Granules	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MESSENGER-RNA; ARABIDOPSIS; TTP; EXPRESSION; BINDING; FAMILY; PHOSPHORYLATION; RECRUITMENT; ACTIVATION	Although multiple lines of evidence have indicated that Arabidopsis thaliana Tandem CCCH Zinc Finger proteins, AtTZF4, 5 and 6 are involved in ABA, GA and phytochrome mediated seed germination responses, the interacting proteins involved in these processes are unknown. Using yeast two-hybrid screens, we have identified 35 putative AtTZF5 interacting protein partners. Among them, Mediator of ABA-Regulated Dormancy 1 (MARD1) is highly expressed in seeds and involved in ABA signal transduction, while Responsive to Dehydration 21A (RD21A) is a well-documented stress responsive protein. Co-immunoprecipitation (Co-IP) and bimolecular fluorescence complementation (BiFC) assays were used to confirm that AtTZF5 can interact with MARD1 and RD21A in plant cells, and the interaction is mediated through TZF motif. In addition, AtTZF4 and 6 could also interact with MARD1 and RD21A in Y-2-H and BiFC assay, respectively. The protein-protein interactions apparently take place in processing bodies (PBs) and stress granules (SGs), because AtTZF5, MARD1 and RD21A could interact and co-localize with each other and they all can co-localize with the same PB and SG markers in plant cells.	[Bogamuwa, Srimathi; Jang, Jyan-Chyun] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Jang, Jyan-Chyun] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Jang, Jyan-Chyun] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Jang, Jyan-Chyun] Ohio State Univ, Ohio Agr Res & Dev Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Jang, JC (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.; Jang, JC (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.; Jang, JC (corresponding author), Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA.; Jang, JC (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Columbus, OH 43210 USA.	jang.40@osu.edu			National Science Foundation [IOB-0543751]; Ohio Plant Biotech Consortium [OHOA0794]; Ohio Agricultural Research and Development Center [OHOA1387, OHOA1006]	National Science Foundation(National Science Foundation (NSF)); Ohio Plant Biotech Consortium; Ohio Agricultural Research and Development Center	This work was supported by grants from National Science Foundation (IOB-0543751), Ohio Plant Biotech Consortium (OHOA0794), and Ohio Agricultural Research and Development Center (OHOA1387) to J.-C.J. and Ohio Agricultural Research and Development Center (OHOA1006) to S.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Belostotsky DA, 2003, GENETICS, V163, P311; Bogamuwa S, 2013, PLANT CELL ENVIRON, V36, P1507, DOI 10.1111/pce.12084; Bogamuwa SP, 2014, PLANT CELL PHYSIOL, V55, P1367, DOI 10.1093/pcp/pcu074; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chai G., 2012, BMC GENOMICS, V13, P1471; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fujiwara S, 2008, J BIOL CHEM, V283, P23073, DOI 10.1074/jbc.M803471200; Gu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032422; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; He YH, 2004, PLANT MOL BIOL, V54, P1, DOI 10.1023/B:PLAN.0000028730.10834.e3; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; Jackman MR, 1997, CANCER SURV, V29, P47; James P, 1996, GENETICS, V144, P1425; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jang JC, 2000, GENE DEV, V14, P1485; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; John PCL, 2001, PROTOPLASMA, V216, P119, DOI 10.1007/BF02673865; Kang SG, 2010, MOL PLANT, V3, P361, DOI 10.1093/mp/ssp115; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Kedar VP, 2010, PLOS ONE, V5, pA213, DOI 10.1371/journal.pone.0009588; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Maldonado-Bonilla LD, 2014, PLANT CELL PHYSIOL, V55, P412, DOI 10.1093/pcp/pct175; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pawson T, 2000, GENE DEV, V14, P1027; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Qu J, 2014, PLANT J, V78, P452, DOI 10.1111/tpj.12485; Shindo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029317; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Stoecklin G, 2007, GENE DEV, V21, P627, DOI 10.1101/gad.1538807; Su YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034250; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang L, 2010, EMBO J, V29, P1903, DOI 10.1038/emboj.2010.76; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xu J, 2012, IET RADAR SONAR NAV, V6, P2, DOI 10.1049/iet-rsn.2010.0375; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang CQ, 2013, PLANT CELL REP, V32, P1543, DOI 10.1007/s00299-013-1466-6; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	53	33	35	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151574	10.1371/journal.pone.0151574	http://dx.doi.org/10.1371/journal.pone.0151574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978070	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800091
J	Harris, LG; Murray, S; Pascoe, B; Bray, J; Meric, G; Magerios, L; Wilkinson, TS; Jeeves, R; Rohde, H; Schwarz, S; de Lencastre, H; Miragaia, M; Rolo, J; Bowden, R; Jolley, KA; Maiden, MCJ; Mack, D; Sheppard, SK				Harris, Llinos G.; Murray, Susan; Pascoe, Ben; Bray, James; Meric, Guillaume; Magerios, Leonardos; Wilkinson, Thomas S.; Jeeves, Rose; Rohde, Holger; Schwarz, Stefan; de Lencastre, Herminia; Miragaia, Maria; Rolo, Joana; Bowden, Rory; Jolley, Keith A.; Maiden, Martin C. J.; Mack, Dietrich; Sheppard, Samuel K.			Biofilm Morphotypes and Population Structure among Staphylococcus epidermidis from Commensal and Clinical Samples	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI; ACCUMULATION-ASSOCIATED PROTEIN; PHENOTYPIC VARIATION; VIRULENCE; STRAINS; AUREUS; IDENTIFICATION; EVOLUTION; GENES	Bacterial species comprise related genotypes that can display divergent phenotypes with important clinical implications. Staphylococcus epidermidis is a common cause of nosocomial infections and, critical to its pathogenesis, is its ability to adhere and form biofilms on surfaces, thereby moderating the effect of the host's immune response and antibiotics. Commensal S. epidermidis populations are thought to differ from those associated with disease in factors involved in adhesion and biofilm accumulation. We quantified the differences in biofilm formation in 98 S. epidermidis isolates from various sources, and investigated population structure based on ribosomal multilocus typing (rMLST) and the presence/absence of genes involved in adhesion and biofilm formation. All isolates were able to adhere and form biofilms in in vitro growth assays and confocal microscopy allowed classification into 5 biofilm morphotypes based on their thickness, biovolume and roughness. Phylogenetic reconstruction grouped isolates into three separate clades, with the isolates in the main disease associated clade displaying diversity in morphotype. Of the biofilm morphology characteristics, only biofilm thickness had a significant association with clade distribution. The distribution of some known adhesion-associated genes (aap and sesE) among isolates showed a significant association with the species clonal frame. These data challenge the assumption that biofilm-associated genes, such as those on the ica operon, are genetic markers for less invasive S. epidermidis isolates, and suggest that phenotypic characteristics, such as adhesion and biofilm formation, are not fixed by clonal descent but are influenced by the presence of various genes that are mobile among lineages.	[Harris, Llinos G.; Murray, Susan; Pascoe, Ben; Meric, Guillaume; Magerios, Leonardos; Wilkinson, Thomas S.; Jeeves, Rose; Mack, Dietrich; Sheppard, Samuel K.] Swansea Univ, Sch Med, Inst Life Sci, Med Microbiol & Infect Dis, Swansea, W Glam, Wales; [Pascoe, Ben; Sheppard, Samuel K.] Swansea Univ, Inst Life Sci, MRC CLIMB Consortium, Swansea, W Glam, Wales; [Bray, James; Jolley, Keith A.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Rohde, Holger] Univ Hamburg, Univ Klinikum Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hyg, Hamburg, Germany; [Schwarz, Stefan] Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany; [de Lencastre, Herminia; Miragaia, Maria; Rolo, Joana] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Miragaia, Maria; Rolo, Joana] Inst Tecnol Quim & Biol Antonio Xavier, Lab Bacterial Evolut & Mol Epidemiol, Oeiras, Portugal; [Bowden, Rory] Wellcome Trust Ctr Human Genet, Oxford Genom Ctr, Oxford, England; [Mack, Dietrich] Inst Med Diagnost GmbH, Mikrobiol Infektiol, Ingelheim, Germany; [Jeeves, Rose] Publ Hlth England, Microbiol Serv, Salisbury SP4 0JG, Wilts, England	Swansea University; Swansea University; University of Oxford; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Loeffler Institute; Universidade Nova de Lisboa; Rockefeller University; University of Oxford; Wellcome Centre for Human Genetics; Public Health England	Sheppard, SK (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Med Microbiol & Infect Dis, Swansea, W Glam, Wales.; Sheppard, SK (corresponding author), Swansea Univ, Inst Life Sci, MRC CLIMB Consortium, Swansea, W Glam, Wales.	s.k.sheppard@swansea.ac.uk	Pascoe, Ben/AAD-2728-2019; Jolley, Keith/ABE-8587-2020; Harris, Llinos/AAQ-9477-2021; Maiden, Martin/N-6805-2019; Wilkinson, Thomas S/C-5237-2013; Pascoe, Ben/C-2253-2009; Harris, Llinos G/AAR-5927-2021; Méric, Guillaume/R-3947-2017; Méric, Guillaume/AAD-2364-2019; Maiden, Martin C J/C-5055-2014; Rolo, Joana/G-4447-2011; Miragaia, Maria/J-2704-2015	Jolley, Keith/0000-0002-0751-0287; Maiden, Martin/0000-0001-6321-5138; Wilkinson, Thomas S/0000-0003-0397-6079; Pascoe, Ben/0000-0001-6376-5121; Harris, Llinos G/0000-0002-0295-3038; Méric, Guillaume/0000-0001-6288-9958; Méric, Guillaume/0000-0001-6288-9958; Maiden, Martin C J/0000-0001-6321-5138; Rolo, Joana/0000-0002-5291-212X; Murray, Susan/0000-0002-3310-651X; Rohde, Holger/0000-0001-8587-4433; Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; BRAY, JAMES/0000-0003-3554-4254; Bowden, Rory/0000-0001-8596-0366	Medical Research Council [MR/M501608/1, MR/L015080/1, G0801929]; Wellcome Trust [088786/C/09/Z, 090532/Z/09/Z]; MRC [G0801929, MR/L015080/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council grant numbers MR/M501608/1 and MR/L015080/1 awarded to SKS, and G0801929 awarded to LGH and DM (www.mrc.ac.uk); Wellcome Trust grant number 088786/C/09/Z awarded to SKS, and grant number 090532/Z/09/Z awarded to RB and KAJ (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrecubieta C, 2007, J BIOL CHEM, V282, P18767, DOI 10.1074/jbc.M610940200; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0; Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200; Chokr A, 2007, MICROB PATHOGENESIS, V42, P94, DOI 10.1016/j.micpath.2006.09.001; CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870, DOI 10.1128/IAI.55.12.2870-2877.1987; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Conlon BP, 2014, J BACTERIOL, V196, P4268, DOI 10.1128/JB.01946-14; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Galdbart JO, 1999, J CLIN MICROBIOL, V37, P1306, DOI 10.1128/JCM.37.5.1306-1312.1999; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gomes AR, 2005, ANTIMICROB AGENTS CH, V49, P366, DOI 10.1128/AAC.49.1.366-379.2005; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Handke LD, 2004, J MED MICROBIOL, V53, P367, DOI 10.1099/jmm.0.05372-0; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Klingenberg C, 2007, CLIN MICROBIOL INFEC, V13, P1100, DOI 10.1111/j.1469-0691.2007.01818.x; Kozitskaya S, 2005, J CLIN MICROBIOL, V43, P4751, DOI 10.1128/JCM.43.9.4751-4757.2005; LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991; Los R, 2010, FEMS MICROBIOL LETT, V310, P97, DOI 10.1111/j.1574-6968.2010.02050.x; Mack D, 2006, INT J ARTIF ORGANS, V29, P343, DOI 10.1177/039139880602900404; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Mack D, 2005, BIOFILMS, INFECTION, AND ANTIMICROBIAL THERAPY, P109; Meric G, 2015, GENOME BIOL EVOL, V7, P1313, DOI 10.1093/gbe/evv066; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; MURGA R, 1995, BIOTECHNOL BIOENG, V45, P503, DOI 10.1002/bit.260450607; Nilsson M, 1998, INFECT IMMUN, V66, P2666, DOI 10.1128/IAI.66.6.2666-2673.1998; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Piette A, 2009, VET MICROBIOL, V134, P45, DOI 10.1016/j.vetmic.2008.09.009; Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Rolo J, 2012, J ANTIMICROB CHEMOTH, V67, P1333, DOI 10.1093/jac/dks068; Schommer NN, 2011, INFECT IMMUN, V79, P2267, DOI 10.1128/IAI.01142-10; Scott RD, 2009, DIRECT MED COSTS HEA; Sheppard SK, 2012, GENES-BASEL, V3, P261, DOI 10.3390/genes3020261; Sheppard SK, 2011, MOL ECOL, V20, P3484, DOI 10.1111/j.1365-294X.2011.05179.x; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Weiss S, 2013, VET MICROBIOL, V167, P680, DOI 10.1016/j.vetmic.2013.07.036; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x	56	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151240	10.1371/journal.pone.0151240	http://dx.doi.org/10.1371/journal.pone.0151240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978068	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800051
J	Isetta, V; Montserrat, JM; Santano, R; Wimms, AJ; Ramanan, D; Woehrle, H; Navajas, D; Farre, R				Isetta, Valentina; Montserrat, Josep M.; Santano, Raquel; Wimms, Alison J.; Ramanan, Dinesh; Woehrle, Holger; Navajas, Daniel; Farre, Ramon			Novel Approach to Simulate Sleep Apnea Patients for Evaluating Positive Pressure Therapy Devices	PLOS ONE			English	Article							AIRWAY PRESSURE; GENDER-DIFFERENCES; CONSTANT; EFFICACY; EVENTS; ADULTS; BENCH; TRIAL; STAGE; CPAP	Bench testing is a useful method to characterize the response of different automatic positive airway pressure (APAP) devices under well-controlled conditions. However, previous models did not consider the diversity of obstructive sleep apnea (OSA) patients' characteristics and phenotypes. The objective of this proof-of-concept study was to design a new bench test for realistically simulating an OSA patient's night, and to implement a one-night example of a typical female phenotype for comparing responses to several currently-available APAP devices. We developed a novel approach aimed at replicating a typical night of sleep which includes different disturbed breathing events, disease severities, sleep/wake phases, body postures and respiratory artefacts. The simulated female OSA patient example that we implemented included periods of wake, light sleep and deep sleep with positional changes and was connected to ten different APAP devices. Flow and pressure readings were recorded; each device was tested twice. The new approach for simulating female OSA patients effectively combined a wide variety of disturbed breathing patterns to mimic the response of a predefined patient type. There were marked differences in response between devices; only three were able to overcome flow limitation to normalize breathing, and only five devices were associated with a residual apnea-hypopnea index of <5/h. In conclusion, bench tests can be designed to simulate specific patient characteristics, and typical stages of sleep, body position, and wake. Each APAP device behaved differently when exposed to this controlled model of a female OSA patient, and should lead to further understanding of OSA treatment.	[Isetta, Valentina; Santano, Raquel; Farre, Ramon] Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain; [Isetta, Valentina; Navajas, Daniel; Farre, Ramon] CIBERES, Madrid, Spain; [Montserrat, Josep M.] Hosp Clin Barcelona, Dept Pneumol, Sleep Lab, Barcelona, Spain; [Montserrat, Josep M.; Farre, Ramon] IDIBAPS, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Wimms, Alison J.; Ramanan, Dinesh; Woehrle, Holger] ResMed Sci Ctr, Munich, Germany; [Navajas, Daniel] IBEC, Inst Bioengn Catalonia, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ResMed; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Farre, R (corresponding author), Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain.; Farre, R (corresponding author), CIBERES, Madrid, Spain.; Farre, R (corresponding author), IDIBAPS, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	rfarre@ub.edu	Farre, Ramon/L-2664-2017; Navajas, Daniel/E-4233-2010	Farre, Ramon/0000-0002-9084-7824; Navajas, Daniel/0000-0001-7150-9363; MONTSERRAT, Josep Maria/0000-0003-3098-4605	ResMed Science Centre [307990]; Universitat de Barcelona [307990]; Ministerio de Economia y Competitividad [PI14/0004]; ResMed	ResMed Science Centre; Universitat de Barcelona; Ministerio de Economia y Competitividad(Spanish Government); ResMed	The work presented here has been partially supported by a research agreement (number 307990) between ResMed Science Centre and Universitat de Barcelona (PI: Ramon Farre). The work has been also partially funded by Ministerio de Economia y Competitividad (PI14/0004). There was no additional funding received for this study. ResMed Science Centre provided support in the form of salaries for authors AJW, DR, and HW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Authors wish to thank Mr. Miguel Angel Rodriguez for his technical support. English language medical writing assistance was provided by Nicola Ryan, independent medical writer, funded by ResMed.	Ayas NT, 2004, SLEEP, V27, P249, DOI 10.1093/sleep/27.2.249; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Behbehani K, 1998, SLEEP; Brown LK, 2006, CHEST, V130, P312, DOI 10.1016/S0012-3692(15)51841-2; d'Ortho MP, 2000, CHEST, V118, P1010, DOI 10.1378/chest.118.4.1010; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Eiseman NA, 2012, J CLIN SLEEP MED, V8, P655, DOI 10.5664/jcsm.2258; Farre R, 1999, LANCET, V353, P1154, DOI 10.1016/S0140-6736(99)01056-9; Farre R, 2002, AM J RESP CRIT CARE, V166, P469, DOI 10.1164/rccm.2111050; Gibson GJ, 2005, BRIT MED BULL, V72, P49, DOI 10.1093/bmb/ldh044; Gozal D, 2015, CHEST; Isetta Valentina, 2015, ERJ Open Res, V1; Jayaraman G, 2011, SLEEP BREATH, V15, P781, DOI 10.1007/s11325-010-0436-2; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Levy P, 2015, NAT REV DIS PRI 0625, P15015; Marrone O, 2002, CHEST, V121, P759, DOI 10.1378/chest.121.3.759; Massie CA, 2003, AM J RESP CRIT CARE, V167, P20, DOI 10.1164/rccm.200201-022OC; Nolan GM, 2006, EUR RESPIR J, V28, P159, DOI 10.1183/09031936.06.00127205; Noseda A, 2004, CHEST, V126, P31, DOI 10.1378/chest.126.1.31; O'Connor C, 2000, AM J RESP CRIT CARE, V161, P1465, DOI 10.1164/ajrccm.161.5.9904121; Oksenberg A, 1999, CHEST, V116, P1000, DOI 10.1378/chest.116.4.1000; Penzel T, 2001, SLEEP, V24, P90, DOI 10.1093/sleep/24.1.90; Pevernagie DA, 2004, CHEST, V126, P25, DOI 10.1378/chest.126.1.25; Randerath Winfried J, 2003, Med Sci Monit, V9, pCR353; Rigau J, 2006, CHEST, V130, P350, DOI 10.1378/chest.130.2.350; Russell T, 2011, AM J MED, V124, P1123, DOI 10.1016/j.amjmed.2011.04.017; Series F, 2001, EUR RESPIR J, V18, P170, DOI 10.1183/09031936.01.98103501; Tan HL, 2013, NAT SCI SLEEP, V5, P109, DOI 10.2147/NSS.S51907; Teschler H, 2000, EUR RESPIR J, V15, P990, DOI 10.1034/j.1399-3003.2000.01503.x; Teschler H, 1996, AM J RESP CRIT CARE, V154, P734, DOI 10.1164/ajrccm.154.3.8810613; Valencia-Flores, 1992, J Sleep Res, V1, P51; Ware JC, 2000, SLEEP, V23, P165; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151530	10.1371/journal.pone.0151530	http://dx.doi.org/10.1371/journal.pone.0151530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978077	gold, Green Published, Green Submitted			2022-12-27	WOS:000372572800083
J	Lan, H; Chen, CL; Miao, Y; Yu, CX; Guo, WW; Xu, Q; Deng, XX				Lan, Hong; Chen, Chun-Li; Miao, Yin; Yu, Chang-Xiu; Guo, Wen-Wu; Xu, Qiang; Deng, Xiu-Xin			Fragile Sites of 'Valencia' Sweet Orange (Citrus sinensis) Chromosomes Are Related with Active 45s rDNA	PLOS ONE			English	Article							BANDING-PATTERNS; RIBOSOMAL GENES; HETEROCHROMATIN; PONCIRUS; REGIONS; GENOME; FISH; AURANTIOIDEAE; EVOLUTION; RUTACEAE	Citrus sinensis chromosomes present a morphological differentiation of bands after staining by the fluorochromes CMA and DAPI, but there is still little information on its chromosomal characteristics. In this study, the chromosomes in 'Valencia' C. sinensis were analyzed by fluorescence in situ hybridization (FISH) using telomere DNA and the 45S rDNA gene as probes combining CMA/DAPI staining, which showed that there were two fragile sites in sweet orange chromosomes co-localizing at distended 45S rDNA regions, one proximally locating on B-type chromosome and the other subterminally locating on D-type chromosome. While the chromosomal CMA banding and 45S rDNA FISH mapping in the doubled haploid line of 'Valencia' C. sinensis indicated six 45S rDNA regions, four were identified as fragile sites as doubled comparing its parental line, which confirmed the cytological heterozygosity and chromosomal heteromorphisms in sweet orange. Furthermore, Ag-NOR identified two distended 45S rDNA regions to be active nucleolar organizing regions (NORs) in diploid 'Valencia' C. sinensis. The occurrence of quadrivalent in meiosis of pollen mother cells (PMCs) in 'Valencia' sweet orange further confirmed it was a chromosomal reciprocal translocation line. We speculated this chromosome translocation was probably related to fragile sites. Our data provide insights into the chromosomal characteristics of the fragile sites in 'Valencia' sweet orange and are expected to facilitate the further investigation of the possible functions of fragile sites.	[Lan, Hong; Guo, Wen-Wu; Xu, Qiang; Deng, Xiu-Xin] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan 430070, Peoples R China; [Chen, Chun-Li; Miao, Yin; Yu, Chang-Xiu] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Deng, XX (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan 430070, Peoples R China.; Chen, CL (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	chenchunli@mail.hzau.edu.cn; xxdeng@mail.hzau.edu.cn		Chen, Chunli/0000-0002-6464-4580; Xiuxin, Deng/0000-0003-4490-4514	National Natural Science Foundation of China [31330066, 31221062]; Fundamental Research Funds for the Central Universities [2013PY084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (Nos. 31330066, 31221062) to X. Deng, and the Fundamental Research Funds for the Central Universities (2013PY084) to C. Chen.	Silva AEBE, 2013, CYTOGENET GENOME RES, V140, P62, DOI 10.1159/000350695; Silva AEBE, 2010, CHROMOSOME RES, V18, P503, DOI 10.1007/s10577-010-9130-2; Brown JD, 2010, ANNU REV GENOM HUM G, V11, P291, DOI 10.1146/annurev-genom-082509-141554; Bustamante FO, 2014, CROP SCI, V54, P617, DOI 10.2135/cropsci2013.05.0325; Cao HB, 2011, PLANT CELL TISS ORG, V104, P415, DOI 10.1007/s11240-010-9860-z; Carvalho R, 2005, CYTOGENET GENOME RES, V109, P276, DOI 10.1159/000082410; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chung MC, 2008, THEOR APPL GENET, V116, P745, DOI 10.1007/s00122-007-0705-z; Cimprich KA, 2003, CURR BIOL, V13, pR231, DOI 10.1016/S0960-9822(03)00158-1; Cornelio MTMN, 2003, PLANT SYST EVOL, V240, P149, DOI 10.1007/s00606-003-0012-3; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; de Moraes AP, 2007, CHROMOSOME RES, V15, P115, DOI 10.1007/s10577-006-1101-2; Debacker K, 2007, HUM MOL GENET, V16, pR150, DOI 10.1093/hmg/ddm136; Deng X., 1992, 7 INT CITR C AC IT, V1, P190; Dvorackova M, 2015, PLANT J, V83, P18, DOI 10.1111/tpj.12822; Fann JY, 2001, THEOR APPL GENET, V103, P1068, DOI 10.1007/s001220100719; Gao G, 2014, CELL MOL LIFE SCI, V71, P4601, DOI 10.1007/s00018-014-1753-6; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; Gong ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084284; Grabowska-Joachimiak A, 2015, PROTOPLASMA, V252, P301, DOI 10.1007/s00709-014-0681-5; GUERRA M, 1993, HEREDITY, V71, P234, DOI 10.1038/hdy.1993.131; Guerra M, 2000, AM J BOT, V87, P735, DOI 10.2307/2656860; HARRISON CJ, 1983, J MED GENET, V20, P280, DOI 10.1136/jmg.20.4.280; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Huang J, 2009, PROTOPLASMA, V236, P59, DOI 10.1007/s00709-009-0051-x; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002167; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035139; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; IWAMASA M., 1966, Bulletin of the Horticultural Research Station, P1; Kang L, 2014, PLANT CELL REP, V33, P1355, DOI 10.1007/s00299-014-1621-8; Lu X, 2010, BIOL PLANTARUM, V54, P798, DOI 10.1007/s10535-010-0146-4; Marques A, 2011, CYTOGENET GENOME RES, V134, P72, DOI 10.1159/000323971; Matsuyama T, 1996, GENOME, V39, P941, DOI 10.1139/g96-118; Mendes S, 2011, CHROMOSOME RES, V19, P521, DOI 10.1007/s10577-011-9203-x; Miranda M, 1997, CHROMOSOME RES, V5, P86, DOI 10.1023/A:1018409922843; Moraes AP, 2008, CYTOGENET GENOME RES, V121, P277, DOI 10.1159/000138897; Ozeri-Galai E, 2014, CELL MOL LIFE SCI, V71, P4495, DOI 10.1007/s00018-014-1719-8; Pedrosa A, 2000, THEOR APPL GENET, V100, P361, DOI 10.1007/s001220050047; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; ROBERTFORTEL I, 1993, CHROMOSOMA, V102, P146, DOI 10.1007/BF00387729; Rosen DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003817; Ruiz-Herrera A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-199; Sbrana I, 1998, HUM GENET, V102, P409, DOI 10.1007/s004390050713; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Silva S. da C., 2011, Tropical Plant Biology, V4, P99, DOI 10.1007/s12042-011-9072-7; Silva SD, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0811-4; Song W, 2014, P NATL ACAD SCI USA, V111, pE2210, DOI 10.1073/pnas.1406847111; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Tchurikov NA, 2015, J MOL CELL BIOL, V7, P366, DOI 10.1093/jmcb/mju038; Waminal NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074060; Wang SM, 2015, PLANT CELL TISS ORG, V123, P633, DOI 10.1007/s11240-015-0866-4; Wang YH, 2006, CANCER LETT, V232, P70, DOI 10.1016/j.canlet.2005.07.040; Wang YH, 1996, J BIOL CHEM, V271, P22937, DOI 10.1074/jbc.271.38.22937; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yamamoto M, 2008, GENET RESOUR CROP EV, V55, P1167, DOI 10.1007/s10722-008-9317-y; Yamamoto M, 2007, J JPN SOC HORTIC SCI, V76, P36, DOI 10.2503/jjshs.76.36; Younis A, 2015, PLANT CELL REP, V34, P1477, DOI 10.1007/s00299-015-1828-3	58	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151512	10.1371/journal.pone.0151512	http://dx.doi.org/10.1371/journal.pone.0151512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977938	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800082
J	Roncarolo, F; Bisset, S; Potvin, L				Roncarolo, Federico; Bisset, Sherri; Potvin, Louise			Short-Term Effects of Traditional and Alternative Community Interventions to Address Food Insecurity	PLOS ONE			English	Article							LOW-INCOME; HEALTH SURVEY; HOUSEHOLD; SECURITY; CANADA; BANKS; PARTICIPANTS; FAMILIES; INSUFFICIENCY; RESPONSES	Background Despite the effects of food insecurity on health are well documented, clear governmental policies to face food insecurity do not exist in western countries. In Canada, interventions to face food insecurity are developed at the community level and can be categorized into two basic strategies: those providing an immediate response to the need for food, defined "traditional" and those targeting the improvement of participants' social cohesion, capabilities and management of their own nutrition, defined "alternative". Objective The objective of this study was to evaluate the effects of food insecurity interventions on food security status and perceived health of participants. Design This was a longitudinal multilevel study implemented in Montreal, Quebec, Canada. Participants were recruited in a two-stage cluster sampling frame. Clustering units were community organizations working on food insecurity; units of analysis were participants in community food security interventions. A total of 450 participants were interviewed at the beginning and after 9 months of participation in traditional or alternative food security interventions. Food security and perceived health were investigated as dependent variables. Differences overtime were assessed through multilevel regression models. Results Participants in traditional interventions lowered their food insecurity at follow-up. Decreases among participants in alternative interventions were not statistically significant. Participants in traditional interventions also improved physical (B coefficient 3.00, CI 95% 0.42-5.59) and mental health (B coefficient 6.25, CI 95% 4.15-8.35). Conclusions Our results challenge the widely held view suggesting the ineffectiveness of traditional interventions in the short term. Although effects may be intervention-dependent, food banks decreased food insecurity and, in so doing, positively affected perceived health. Although study findings demonstrate that food banks offer short term reprise from the effects of food insecurity, the question as to whether food banks are the most appropriate solution to food insecurity still needs to be addressed.	[Roncarolo, Federico; Potvin, Louise] Univ Montreal IRSPUM, Publ Hlth Res Inst, Montreal, PQ, Canada; [Roncarolo, Federico; Potvin, Louise] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada; [Roncarolo, Federico; Potvin, Louise] Univ Montreal, Canada Res Chair Community Approaches & Hlth Ineq, Montreal, PQ, Canada; [Bisset, Sherri] Agence Sante & Serv Sociaux Monteregie, Quebec City, PQ, Canada; [Potvin, Louise] Lea Roback Res Ctr, Montreal Publ Hlth Directorate, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Roncarolo, F (corresponding author), Univ Montreal IRSPUM, Publ Hlth Res Inst, Montreal, PQ, Canada.; Roncarolo, F (corresponding author), Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada.; Roncarolo, F (corresponding author), Univ Montreal, Canada Res Chair Community Approaches & Hlth Ineq, Montreal, PQ, Canada.	federico.roncarolo@umontreal.ca	Roncarolo, Federico/W-6490-2019	Roncarolo, Federico/0000-0002-3938-9178	CIHR, Canadian Institute of Health Research [GIR-112691]; PHIRNET postdoctoral award [CIHR: TGF-96112]; FRQ-S postdoctoral research award [28518]	CIHR, Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); PHIRNET postdoctoral award; FRQ-S postdoctoral research award	The project on food security was founded in 2010 by CIHR, Canadian Institute of Health Research with the grant n. GIR-112691. CIHR had no role in the design, analysis or writing of this article. Louise Potvin holds a Canada Research Chair (CIHR: 950-228295) and Federico Roncarolo was funded through PHIRNET postdoctoral award (CIHR: TGF-96112) and FRQ-S postdoctoral research award (28518).	Bickel G., 2000, J COOK GUIDE MEASURI; Brannon EE, 2013, CHILD HEALTH CARE, V42, P198, DOI 10.1080/02739615.2013.816590; Carter KN, 2011, SOC SCI MED, V72, P1463, DOI 10.1016/j.socscimed.2011.03.009; Che J, 2001, Health Rep, V12, P11; Collins PA, 2014, CAN J PUBLIC HEALTH, V105, pE138, DOI 10.17269/cjph.105.4224; Draper C, 2010, J COMMUNITY PRACT, V18, P458, DOI 10.1080/10705422.2010.519682; Engler-Stringer R, 2007, QUAL HEALTH RES, V17, P75, DOI 10.1177/1049732306296451; Food and Agriculture Organization of the United Nations, 2013, STAT FOOD INS WORLD; Food Banks Canada, 2014, HUMG COUNTS 2014; Goldstein H, MULTILEVEL STAT MODE; Hamelin AM, 2002, SOC SCI MED, V54, P119, DOI 10.1016/S0277-9536(01)00013-2; Health Canada Canadian Community Health Survey Cycle 2.2 Nutrition, 2004, CAN COMM HLTH SURV C; Leung CW, 2015, J NUTR, V145, P622, DOI 10.3945/jn.114.199414; Loopstra R, 2012, CAN PUBLIC POL, V38, P497, DOI 10.3138/CPP.38.4.497; McLeod L, 2006, APPL ECON, V38, P2131, DOI 10.1080/00036840500427429; Muldoon KA, 2013, SOC PSYCH PSYCH EPID, V48, P795, DOI 10.1007/s00127-012-0597-3; Nicholson LM, 2011, CONTEMP CLIN TRIALS, V32, P353, DOI 10.1016/j.cct.2011.01.007; Nord M, 2014, PUBLIC HEALTH NUTR, V17, P2, DOI 10.1017/S1368980013003091; Perry J, 2014, EMERGENCY USE ONLY U; Poppendieck J., 1994, Agriculture and Human Values, V11, P69, DOI 10.1007/BF01530418; Riches G, 2002, SOC POLICY ADMIN, V36, P648, DOI 10.1111/1467-9515.00309; Riches G, 2011, DEV PRACT, V21, P768, DOI 10.1080/09614524.2011.561295; Roncarolo F, 2015, HEALTH PROMOT INT, DOI [10.1093/heapro/dav085, DOI 10.1093/HEAPRO/DAV085]; Roncarolo F, 2015, J COMMUN HEALTH, V40, P199, DOI 10.1007/s10900-014-9917-8; Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Sharkey JR, 2011, WOMEN HEALTH, V51, P442, DOI 10.1080/03630242.2011.584367; Stuff JE, 2004, J NUTR, V134, P2330, DOI 10.1093/jn/134.9.2330; Tarasuk V., 2005, Topics in Clinical Nutrition, V20, P299; Tarasuk V, 1999, CAN J DIET PRACT RES, V60, P11; Tarasuk V, 2001, HEALTH EDUC BEHAV, V28, P487, DOI 10.1177/109019810102800408; Tarasuk V., 2012, REPORT OLIVIER SCHUT; Tarasuk V, 2014, HOUSEHOLD FOOD INSEC; Tarasuk V, 2014, BRIT FOOD J, V116, P1405, DOI 10.1108/BFJ-02-2014-0077; Tarasuk V, 2013, J NUTR, V143, P1785, DOI 10.3945/jn.113.178483; Tarasuk V, 2009, CAN J PUBLIC HEALTH, V100, P184, DOI 10.1007/BF03405537; Tarasuk VS, 1999, CAN J PUBLIC HEALTH, V90, P109, DOI 10.1007/BF03404112; Vozoris NT, 2003, J NUTR, V133, P120, DOI 10.1093/jn/133.1.120; Wakefield S, 2013, CRIT SOC POLICY, V33, P427, DOI 10.1177/0261018312458487; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 1995, SCORE SF 12 PHYS MEN; Webb KL, 2013, J HUNGER ENVIRON NUT, V8, P257, DOI 10.1080/19320248.2013.817169	43	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150250	10.1371/journal.pone.0150250	http://dx.doi.org/10.1371/journal.pone.0150250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26974826	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600021
J	Wu, XL; He, XX; Li, S; Xu, XQ; Chen, XJ; Zhu, H				Wu, Xiaoli; He, Xixi; Li, Shi; Xu, Xiaoqun; Chen, Xiangjian; Zhu, Hua			Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; CD44; EXPRESSION; INVASIVENESS; CARCINOMA; DNA	In addition to protein-coding genes, the human genome makes a large amount of noncoding RNAs. Long non-coding RNAs (lncRNAs) have been described as the largest subclass of the non-coding transcriptome in human noncoding RNAs. In recent years, lncRNAs have been considered to be the key regulators of tumor behavior. In this study, based on previous research, we investigated the expression and biological role of a newly identified cancerrelated lncRNA, lncRNA-uc002kmd.1. We analyzed the relationship between lncRNAuc002kmd.1 and colorectal cancer (CRC) in a total 45 CRC and paired adjacent, non-tumor tissue samples. We found that lncRNA-uc002kmd. 1 expression was usually highly expressed in carcinoma compared with the tissue adjacent to the carcinoma. Through a series of experiments, the results showed that lncRNA-uc002kmd. 1 regulates CD44 as a molecular decoy for miR211-3p. Our data indicated that the overexpression of lncRNAuc002kmd.1 enhanced cell proliferation in CRC.	[Wu, Xiaoli; He, Xixi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China; [Li, Shi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Urol, Wenzhou, Zhejiang, Peoples R China; [Xu, Xiaoqun] Wenzhou Med Univ, Affiliated Hosp 1, Operating Room, Wenzhou, Zhejiang, Peoples R China; [Chen, Xiangjian] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endoscop Surg, Wenzhou, Zhejiang, Peoples R China; [Zhu, Hua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Chen, XJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Endoscop Surg, Wenzhou, Zhejiang, Peoples R China.; Zhu, H (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China.	wz1370666@126.com; zhuhua06@sohu.com			Natural Science Foundation of Zhejiang Province of China [LY16H160048]; Wenzhou Public Welfare Science and Technology Project [Y20140707]; Incubation Project of The First Affiliated Hospital of Wenzhou Medical University [FHY2014009]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Wenzhou Public Welfare Science and Technology Project; Incubation Project of The First Affiliated Hospital of Wenzhou Medical University	The Project was supported by a grant from Natural Science Foundation of Zhejiang Province of China (LY16H160048). Also this work was supported by a grant from Wenzhou Public Welfare Science and Technology Project (Y20140707), also was supported by a grant from Incubation Project of The First Affiliated Hospital of Wenzhou Medical University (FHY2014009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cao WJ, 2013, WORLD J GASTROENTERO, V19, P3658, DOI 10.3748/wjg.v19.i23.3658; Chen S, 2013, J SURG ONCOL, V107, P799, DOI 10.1002/jso.23337; Fang XY, 2015, CANCER LETT, V356, P357, DOI 10.1016/j.canlet.2014.11.005; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Hu Y, 2014, CANCER RES, V74, P6890, DOI 10.1158/0008-5472.CAN-14-0686; Huang GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131225; Kozovska Z, 2014, BIOMED PHARMACOTHER, V68, P911, DOI 10.1016/j.biopha.2014.10.019; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Li N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098251; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Ma MZ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-156; Ma YL, 2016, GUT, V65, P1494, DOI 10.1136/gutjnl-2014-308392; Mattheolabakis G, 2015, J DRUG TARGET, V23, P605, DOI 10.3109/1061186X.2015.1052072; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Shang ZQ, 2015, ONCOTARGET, V6, P1202, DOI 10.18632/oncotarget.2841; STEELE G, 1991, ARCH SURG-CHICAGO, V126, P696; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Vinson KE, 2016, INT J CANCER, V138, P1835, DOI 10.1002/ijc.29800; Wu H, 2015, ONCOGENE, V34, P4723, DOI 10.1038/onc.2014.400; Wu HC, 2015, MOL CARCINOGEN, V54, P102, DOI 10.1002/mc.22078; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252; Wu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127557; Wu Y, 2015, INT J CLIN EXP MED, V8, P3595; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yin DD, 2015, TUMOR BIOL, V36, P4851, DOI 10.1007/s13277-015-3139-2; Yu FJ, 2015, J BIOL CHEM, V290, P28286, DOI 10.1074/jbc.M115.683813	30	53	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151287	10.1371/journal.pone.0151287	http://dx.doi.org/10.1371/journal.pone.0151287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974151	Green Submitted, gold, Green Published			2022-12-27	WOS:000372570600064
J	Tan, DY; Zhu, HD; Fu, YY; Tong, F; Yao, DQ; Walline, J; Xu, J; Yu, XZ				Tan, Dingyu; Zhu, Huadong; Fu, Yangyang; Tong, Fei; Yao, Dongqi; Walline, Joseph; Xu, Jun; Yu, Xuezhong			Severe Community-Acquired Pneumonia Caused by Human Adenovirus in Immunocompetent Adults: A Multicenter Case Series	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; C-REACTIVE PROTEIN; OUTBREAK; DISEASE; MORTALITY; CHILDREN; THERAPY; CHINA	Background Severe community-acquired pneumonia (CAP) caused by human adenovirus (HAdV), especially HAdV type 55 (HAdV-55) in immunocompetent adults has raised increasing concerns. Clinical knowledge of severe CAP and acute respiratory distress syndrome induced by HAdV-55 is still limited, though the pathogen has been fully characterized by whole-genome sequencing. Methods We conducted a multicentre retrospective review of all consecutive patients with severe CAP caused by HAdV in immunocompetent adults admitted to the Emergency Department Intensive Care Unit of two hospitals in Northern China between February 2012 and April 2014. Clinical, laboratory, radiological characteristics, treatments and outcomes of these patients were collected and analyzed. Results A total of 15 consecutive severe CAP patients with laboratory-confirmed adenovirus infections were included. The median age was 30 years and all cases were identified during the winter and spring seasons. HAdV-55 was the most frequently (11/15) detected HAdV type. Persistent high fever, cough and rapid progression of dyspnea were typically reported in these patients. Significantly increased pneumonia severity index (PSI), respiratory rate, and lower PaO2/FiO(2), hypersensitive CRP were reported in non-survivors compared to survivors (P = 0.013, 0.022, 0.019 and 0.026, respectively). The rapid development of bilateral consolidations within 10 days after illness onset were the most common radiographic finding, usually accompanied by adjacent ground glass opacities and pleural effusions. Total mortality was 26.7% in this study. Corticosteroids were prescribed to 14 patients in this report, but the utilization rate between survivors and non-survivors was not significant. Conclusions HAdV and the HAdV-55sub-type play an important role among viral pneumonia pathogens in hospitalized immunocompetent adults in Northern China. HAdV should be tested in severe CAP patients with negative bacterial cultures and a lack of response to antibiotic treatment, even if radiologic imaging and clinical presentation initially suggest bacterial pneumonia.	[Tan, Dingyu; Zhu, Huadong; Tong, Fei; Xu, Jun; Yu, Xuezhong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Emergency, Beijing 100730, Peoples R China; [Tong, Fei; Yao, Dongqi] Hebei Med Univ, Hosp 2, Dept Emergency, Shijiazhuang, Hebei Province, Peoples R China; [Walline, Joseph] St Louis Univ Hosp, Dept Surg, Div Emergency Med, St Louis, MO USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Hebei Medical University; Saint Louis University	Xu, J; Yu, XZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Emergency, Beijing 100730, Peoples R China.	xujunfree@126.com; yxzpumch@126.com	Walline, Joseph/A-4001-2019; Walline, Joseph/K-6667-2019	Walline, Joseph/0000-0001-9582-1044; Walline, Joseph/0000-0001-9582-1044; Zhu, Huadong/0000-0002-1592-3188	Ministry of Health Public Service Sector [201302017]	Ministry of Health Public Service Sector	This work was supported by Ministry of Health Public Service Sector funded project (201302017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Cao B, 2014, CHEST, V145, P79, DOI 10.1378/chest.13-1186; Chmielewicz B, 2005, J MED VIROL, V77, P232, DOI 10.1002/jmv.20441; Clark Tristan W, 2011, J Med Case Rep, V5, P259, DOI 10.1186/1752-1947-5-259; Ewig S, 1998, AM J RESP CRIT CARE, V158, P1102, DOI 10.1164/ajrccm.158.4.9803114; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jin Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-271; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Kim SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122642; Lee JY, 2014, HEPATO-GASTROENTEROL, V61, P1331, DOI 10.5754/hge12548; Lewis PF, 2009, J INFECT DIS, V199, P1427, DOI 10.1086/598521; Lu QB, 2014, INFLUENZA OTHER RESP, V8, P302, DOI 10.1111/irv.12232; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; Park SY, 2013, ANTIMICROB AGENTS CH, V57, P983, DOI 10.1128/AAC.01961-12; Qu JX, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0808-0; Que YA, 2015, INFECTION, V43, P193, DOI 10.1007/s15010-015-0755-0; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Strauss R, 2014, DTSCH ARZTEBL INT, V111, P503, DOI 10.3238/arztebl.2014.0503; Sun B, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0456-6; Takahashi I, 2006, TOHOKU J EXP MED, V209, P69, DOI 10.1620/tjem.209.69; van Woensel JBM, 2011, CRIT CARE MED, V39, P1779, DOI 10.1097/CCM.0b013e318218a030; Wan YD, 2016, CHEST, V149, P209, DOI 10.1378/chest.15-1733; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	29	60	66	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151199	10.1371/journal.pone.0151199	http://dx.doi.org/10.1371/journal.pone.0151199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967644	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200034
J	Wolf, P; Winhofer, Y; Smajis, S; Jankovic, D; Anderwald, CH; Trattnig, S; Luger, A; Krebs, M; Krssak, M				Wolf, Peter; Winhofer, Yvonne; Smajis, Sabina; Jankovic, Drazenka; Anderwald, Christian-Heinz; Trattnig, Siegfried; Luger, Anton; Krebs, Michael; Krssak, Martin			Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans	PLOS ONE			English	Article							MYOCARDIAL TRIGLYCERIDE CONTENT; EPICARDIAL ADIPOSE-TISSUE; INSULIN-RESISTANCE; LIPID-ACCUMULATION; DIASTOLIC FUNCTION; DIABETES-MELLITUS; STEATOSIS; VELOCITY; SHIFT	Background Obesity is a major risk factor to develop heart failure, in part due to possible lipotoxic effects of increased intramyocardial (MYCL) and/or local or paracrine effects of pericardial (PERI) lipid accumulation. Recent evidence suggests that MYCL is highly dynamic and might rather be a surrogate marker for disturbed energy metabolism than the underlying cause of cardiac dysfunction. On the other hand, PERI might contribute directly by mechanic and paracrine effects. Therefore, we hypothesized that PERI rather than MYCL is associated with myocardial function. Methods To avoid potential confounding of metabolic disease 31 metabolically healthy subjects (age: 29 +/- 10yrs; BMI: 23 +/- 3kg/m(2)) were investigated using H-1-magnetic resonance spectroscopy and imaging. MYCL and PERI, as well as systolic and diastolic left ventricular heart function were assessed. Additionally, anthropometric data and parameters of glucose and lipid metabolism were analyzed. Correlation analysis was performed using Pearson's correlation coefficient. Linear regression model was used to show individual effects of PERI and MYCL on myocardial functional parameters. Results Correlation analysis with parameters of systolic heart function revealed significant associations for PERI (Stroke Volume (SV): R = -0.513 p = 0.001; CardiacIndex (CI): R = -0.442 p = 0.014), but not for MYCL (SV: R = -0.233; p = 0.207; CI: R = -0.130; p = 0.484). No significant correlations were found for E/A ratio as a parameter of diastolic heart function. In multiple regression analysis CI was negatively predicted by PERI, whereas no impact of MYCL was observed in direct comparison. Conclusions Cardiac fat depots impact left ventricular heart function in a metabolically healthy population. Direct comparison of different lipid stores revealed that PERI is a more important predictor than MYCL for altered myocardial function.	[Wolf, Peter; Winhofer, Yvonne; Smajis, Sabina; Jankovic, Drazenka; Anderwald, Christian-Heinz; Luger, Anton; Krebs, Michael; Krssak, Martin] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria; [Jankovic, Drazenka] Wilhelminenspital Stadt Wien, Div Oncol Hematol & Palliat Care, Dept Internal Med 1, Vienna, Austria; [Trattnig, Siegfried; Krssak, Martin] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Ctr Excellence High Field MR, Vienna, Austria; [Anderwald, Christian-Heinz] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy; [Anderwald, Christian-Heinz] Specialized Hosp Complex Agathenhof, Med Direct, A-9322 Micheldorf, Carinthia, Austria	Medical University of Vienna; Wilhelminenspital; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR)	Krebs, M (corresponding author), Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria.	michael.krebs@meduniwien.ac.at	Krssak, Martin/AAU-8183-2020; Anderwald, Christian Heinz/AAG-2271-2021	Krssak, Martin/0000-0001-9717-803X; Anderwald, Christian Heinz/0000-0001-7485-0815; Wolf, Peter/0000-0001-6779-734X; Winhofer, Yvonne/0000-0002-0555-9044; Krebs, Michael/0000-0002-9265-7274; Trattnig, Siegfried/0000-0003-1623-3303	Austrian Association of Endocrinology and Metabolism (OGES); Austrian Heart Foundation; Medical Scientific Fund of the Mayor of the City of Vienna [12023]; Austrian National Bank [13249, 15363]	Austrian Association of Endocrinology and Metabolism (OGES); Austrian Heart Foundation; Medical Scientific Fund of the Mayor of the City of Vienna; Austrian National Bank	This study was in part funded by grants from the Austrian Association of Endocrinology and Metabolism (OGES) to PW as well as the Austrian Heart Foundation and the Medical Scientific Fund of the Mayor of the City of Vienna (Grant 12023), both to MKre and by the Austrian National Bank (Nr. 13249 and 15363) to MKrs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAER FM, 1994, HERZ, V19, P51; Barkhausen J, 2001, RADIOLOGY, V219, P264, DOI 10.1148/radiology.219.1.r01ap12264; Bayeva M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000433; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; Gaborit B, 2013, HORM METAB RES, V45, P991, DOI 10.1055/s-0033-1358669; Gaborit B, 2012, J AM COLL CARDIOL, V60, P1381, DOI 10.1016/j.jacc.2012.06.016; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Graner M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001979; Greulich S, 2012, CIRCULATION, V126, P2324, DOI 10.1161/CIRCULATIONAHA.111.039586; Guzzardi MA, 2014, DIABETOLOGIA, V57, P1937, DOI 10.1007/s00125-014-3307-8; Hammer S, 2008, AM J PHYSIOL-ENDOC M, V295, pE714, DOI 10.1152/ajpendo.90413.2008; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Hua N, 2014, J CARDIOVASCULAR MAG, V16, P1; Iacobellis G, 2005, J CLIN ENDOCR METAB, V90, P6300, DOI 10.1210/jc.2005-1087; Iacobellis G, 2014, OBESITY, V22, P332, DOI 10.1002/oby.20624; Iozzo P, 2009, J CLIN ENDOCR METAB, V94, P4472, DOI 10.1210/jc.2009-0436; Jankovic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050077; Kankaanpaa M, 2006, J CLIN ENDOCR METAB, V91, P4689, DOI 10.1210/jc.2006-0584; Krssak M, 2004, MAGN RESON MATER PHY, V16, P155, DOI 10.1007/s10334-003-0029-1; Krssak M, 2011, DIABETOLOGIA, V54, P1871, DOI 10.1007/s00125-011-2146-0; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; MOHIADDIN RH, 1991, J COMPUT ASSIST TOMO, V15, P237, DOI 10.1097/00004728-199103000-00009; Nyman K, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-103; Perseghin G, 2008, HEPATOLOGY, V47, P51, DOI 10.1002/hep.21983; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rijzewijk LJ, 2010, J AM COLL CARDIOL, V56, P225, DOI 10.1016/j.jacc.2010.02.049; Scherer T, 2014, J CLIN ENDOCR METAB, V99, pE2341, DOI 10.1210/jc.2014-2112; SHEHADEH A, 1995, CLIN CARDIOL, V18, P301, DOI 10.1002/clc.4960180604; van der Meer RW, 2007, J CARDIOVASC MAGN R, V9, P645, DOI 10.1080/10976640601093703; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Winhofer Y, 2015, AM J PHYSIOL-ENDOC M, V308, pE631, DOI 10.1152/ajpendo.00371.2014; Winhofer Y, 2014, J CLIN ENDOCR METAB, V99, P4299, DOI 10.1210/jc.2014-2242; Winhofer Y, 2012, DIABETES, V61, P1210, DOI 10.2337/db11-1275; Wolf P, 2014, WIEN MED WOCHENSCHR, V164, P320, DOI 10.1007/s10354-014-0292-y; Wolf P, 2014, J CLIN ENDOCR METAB, V99, pE1721, DOI 10.1210/jc.2014-1541	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151301	10.1371/journal.pone.0151301	http://dx.doi.org/10.1371/journal.pone.0151301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967641	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200043
J	Oosugi, N; Yanagawa, T; Nagasaka, Y; Fujii, N				Oosugi, Naoya; Yanagawa, Toru; Nagasaka, Yasuo; Fujii, Naotaka			Social Suppressive Behavior Is Organized by the Spatiotemporal Integration of Multiple Cortical Regions in the Japanese Macaque	PLOS ONE			English	Article							PREFRONTAL CORTEX; ASPERGER-SYNDROME; DECISION-MAKING; INFORMATION; BRAIN; MECHANISMS; COGNITION; NEURONS; MONKEYS; AUTISM	Under social conflict, monkeys develop hierarchical positions through social interactions. Once the hierarchy is established, the dominant monkey dominates the space around itself and the submissive monkey tries not to violate this space. Previous studies have shown the contributions of the frontal and parietal cortices in social suppression, but the contributions of other cortical areas to suppressive functions remain elusive. We recorded neural activity in large cortical areas using electrocorticographic (ECoG) arrays while monkeys performed a social food-grab task in which a target monkey was paired with either a dominant or a submissive monkey. If the paired monkey was dominant, the target monkey avoided taking food in the shared conflict space, but not in other areas. By contrast, when the paired monkey was submissive, the target monkey took the food freely without hesitation. We applied decoding analysis to the ECoG data to see when and which cortical areas contribute to social behavioral suppression. Neural information discriminating the social condition was more evident when the conflict space was set in the area contralateral to the recording hemisphere. We found that the information increased as the social pressure increased during the task. Before food presentation, when the pressure was relatively low, the parietal and somatosensory-motor cortices showed sustained discrimination of the social condition. After food presentation, when the monkey faced greater pressure to make a decision as to whether it should take the food, the prefrontal and visual cortices started to develop buildup responses. The social representation was found in a sustained form in the parietal and somatosensory-motor regions, followed by additional buildup form in the visual and prefrontal cortices. The representation was less influenced by reward expectation. These findings suggest that social adaptation is achieved by a higher-order self-regulation process (incorporating motor preparation/execution processes) in accordance with the embodied social contexts.	[Oosugi, Naoya; Yanagawa, Toru; Nagasaka, Yasuo; Fujii, Naotaka] RIKEN, BSI, Lab Adapt Intelligence, Wako, Saitama, Japan; [Oosugi, Naoya] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	RIKEN; University of Tokyo	Fujii, N (corresponding author), RIKEN, BSI, Lab Adapt Intelligence, Wako, Saitama, Japan.	na@brain.riken.jp			JSPS KAKENHI [23118003, 23650225]; RIKEN internal research budget	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN internal research budget	A part of this study was supported by JSPS KAKENHI Grant Numbers 23118003 and 23650225 (http://www.jsps.go.jp/english/index.html), and "Brain Machine Interface Development" performed under the Strategic Research Program for Brain Sciences by MEXT, Japan (http://www.mext.go.jp/english/). Rest part of the study was supported by RIKEN internal research budget. There is no other research funding source for this study.	Alexander R., 2008, ESSAYS PEDAGOGY; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fujii N, 2012, THE PRIMATE MIND, P48; Fujii N, 2009, SOC NEUROSCI-UK, V4, P73, DOI 10.1080/17470910802046230; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Nagasaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022561; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Passingham R. E., 1993, OXFORD PSYCHOL SERIE; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Sakagami M, 2007, CURR OPIN NEUROBIOL, V17, P228, DOI 10.1016/j.conb.2007.02.008; Santos GS, 2012, SOC NEUROSCI-UK, V7, P42, DOI 10.1080/17470919.2011.578465; Shannon BJ, 2011, P NATL ACAD SCI USA, V108, P11241, DOI 10.1073/pnas.1108241108; Sharma J., 2014, CEREB CORTEX; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Takahashi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094657; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Tsuchiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003892; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008	32	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150934	10.1371/journal.pone.0150934	http://dx.doi.org/10.1371/journal.pone.0150934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963915	Green Published, gold			2022-12-27	WOS:000371993000083
J	Tong, CF; Li, HG; Wang, Y; Li, XR; Ou, JJ; Wang, DY; Xu, HX; Ma, C; Lang, XY; Liu, GX; Zhang, B; Shi, JS				Tong, Chunfa; Li, Huogen; Wang, Ying; Li, Xuran; Ou, Jiajia; Wang, Deyuan; Xu, Houxi; Ma, Chao; Lang, Xianye; Liu, Guangxin; Zhang, Bo; Shi, Jisen			Construction of High-Density Linkage Maps of Populus deltoides x P. simonii Using Restriction-Site Associated DNA Sequencing	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC-MAP; GENOME; MODEL; ARABIDOPSIS; COTTONWOOD; FORMAT; RFLP; AFLP	Although numerous linkage maps have been constructed in the genus Populus, they are typically sparse and thus have limited applications due to low throughput of traditional molecular markers. Restriction-site associated DNA sequencing (RADSeq) technology allows us to identify a large number of single nucleotide polymorphisms (SNP) across genomes of many individuals in a fast and cost-effective way, and makes it possible to construct high-density genetic linkage maps. We performed RADSeq for 299 progeny and their two parents in an F-1 hybrid population generated by crossing the female Populus deltoides 'I-69' and male Populus simonii 'L3'. A total of 2,545 high quality SNP markers were obtained and two parent-specific linkage maps were constructed. The female genetic map contained 1601 SNPs and 20 linkage groups, spanning 4,249.12 cM of the genome with an average distance of 2.69 cM between adjacent markers, while the male map consisted of 940 SNPs and also 20 linkage groups with a total length of 3,816.24 cM and an average marker interval distance of 4.15 cM. Finally, our analysis revealed that synteny and collinearity are highly conserved between the parental linkage maps and the reference genome of P. trichocarpa. We demonstrated that RAD sequencing is a powerful technique capable of rapidly generating a large number of SNPs for constructing genetic maps in outbred forest trees. The high-quality linkage maps constructed here provided reliable genetic resources to facilitate locating quantitative trait loci (QTLs) that control growth and wood quality traits in the hybrid population.	[Tong, Chunfa; Li, Huogen; Wang, Ying; Li, Xuran; Ou, Jiajia; Wang, Deyuan; Xu, Houxi; Ma, Chao; Lang, Xianye; Liu, Guangxin; Zhang, Bo; Shi, Jisen] Nanjing Forestry Univ, Coll Forestry, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing 210037, Jiangsu, Peoples R China	Nanjing Forestry University	Tong, CF (corresponding author), Nanjing Forestry Univ, Coll Forestry, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing 210037, Jiangsu, Peoples R China.	tongchf@njfu.edu.cn		, Chunfa/0000-0001-9795-211X	National Natural Science Foundation of China [31270706]; Priority Academic Program Development of the Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of the Jiangsu Higher Education Institutions (PAPD)	Funding for this research was provided by the National Natural Science Foundation of China (No. 31270706) and the Priority Academic Program Development of the Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P167, DOI 10.1007/BF00225137; Bradshaw HD, 2000, J PLANT GROWTH REGUL, V19, P306, DOI 10.1007/s003440000030; Cervera MT, 2001, GENETICS, V158, P787; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Doerge RW, 1996, GENETICS, V142, P285; Doyle J. J., 1987, PHYTOCHEM B, P11; Eckenwalder James E., 1996, P7; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; FALK CT, 1989, PROG CLIN BIOL RES, V329, P17; Frewen BE, 2000, GENETICS, V154, P837; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; HULBERT SH, 1988, GENETICS, V120, P947; Kakioka R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-32; Kuang H, 1999, THEOR APPL GENET, V98, P697, DOI 10.1007/s001220051123; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Muchero W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1215-z; Pakull B, 2011, CAN J FOREST RES, V41, P245, DOI 10.1139/X10-206; Pakull B, 2009, TREE GENET GENOMES, V5, P505, DOI 10.1007/s11295-009-0204-2; Paolucci I, 2010, TREE GENET GENOMES, V6, P863, DOI 10.1007/s11295-010-0297-7; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Su XiaoHua, 1998, Scientia Silvae Sinicae, V34, P29; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; Tong CF, 2012, GENET MOL BIOL, V35, P622, DOI 10.1590/S1415-47572012005000044; Tong CF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-148; Tong CF, 2010, TREE GENET GENOMES, V6, P651, DOI 10.1007/s11295-010-0281-2; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wang YX, 2011, GENES GENET SYST, V86, P257, DOI 10.1266/ggs.86.257; Wang YX, 2010, EUPHYTICA, V173, P193, DOI 10.1007/s10681-009-0085-3; Wei ZunZheng, 2011, Forestry Studies in China, V13, P97, DOI 10.1007/s11632-011-0203-x; Woolbright SA, 2008, HEREDITY, V100, P59, DOI 10.1038/sj.hdy.6801063; Wu RL, 2000, THEOR APPL GENET, V100, P1249, DOI 10.1007/s001220051431; Yang SH, 2012, P NATL ACAD SCI USA, V109, P20992, DOI 10.1073/pnas.1211827110; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yin TM, 2002, GENOME, V45, P541, DOI [10.1139/g02-013, 10.1139/G02-013]; Yin TM, 2001, GENOME, V44, P602, DOI 10.1139/gen-44-4-602; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang B, 2009, TREE GENET GENOMES, V5, P539, DOI 10.1007/s11295-009-0207-z; Zhang D, 2004, THEOR APPL GENET, V108, P657, DOI 10.1007/s00122-003-1478-7	52	22	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150692	10.1371/journal.pone.0150692	http://dx.doi.org/10.1371/journal.pone.0150692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964097	gold, Green Published, Green Submitted			2022-12-27	WOS:000371993000052
J	Benko, Z; Elder, RT; Li, G; Liang, D; Zhao, RY				Benko, Zsigmond; Elder, Robert T.; Li, Ge; Liang, Dong; Zhao, Richard Y.			HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-DAMAGE CHECKPOINT; CELL-DEATH; G(2) ARREST; TYPE-1 VPR; IN-VIVO; R VPR; APOPTOSIS; EXPRESSION; THIAMINE	Background HIV-1 protease (PR) is an essential viral enzyme. Its primary function is to proteolyze the viral Gag-Pol polyprotein for production of viral enzymes and structural proteins and for maturation of infectious viral particles. Increasing evidence suggests that PR cleaves host cellular proteins. However, the nature of PR-host cellular protein interactions is elusive. This study aimed to develop a fission yeast (Schizosaccharomyces pombe) model system and to examine the possible interaction of HIV-1 PR with cellular proteins and its potential impact on cell proliferation and viability. Results A fission yeast strain RE294 was created that carried a single integrated copy of the PR gene in its chromosome. The PR gene was expressed using an inducible nmt1 promoter so that PR-specific effects could be measured. HIV-1 PR from this system cleaved the same indigenous viral p6/MA protein substrate as it does in natural HIV-1 infections. HIV-1 PR expression in fission yeast cells prevented cell proliferation and induced cellular oxidative stress and changes in mitochondrial morphology that led to cell death. Both these PR activities can be prevented by a PR-specific enzymatic inhibitor, indinavir, suggesting that PR-mediated proteolytic activities and cytotoxic effects resulted from enzymatic activities of HIV-1 PR. Through genome-wide screening, a serine/threonine kinase, Hhp2, was identified that suppresses HIV-1 PR-induced protease cleavage and cell death in fission yeast and in mammalian cells, where it prevented PR-induced apoptosis and cleavage of caspase-3 and caspase-8. Conclusions This is the first report to show that HIV-1 protease is functional as an enzyme in fission yeast, and that it behaves in a similar manner as it does in HIV-1 infection. HIV-1 PR-induced cell death in fission yeast could potentially be used as an endpoint for mechanistic studies, and this system could be used for developing a high-throughput system for drug screenings.	[Benko, Zsigmond; Li, Ge; Liang, Dong; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Immunol Microbiol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Elder, Robert T.] Northwestern Univ, Feinberg Sch Med, Chicago Mem Inst Educ & Res, Chicago, IL 60611 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine	Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Immunol Microbiol, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	rzhao@som.umaryland.edu		Zhao, Richard Y./0000-0003-3424-2852	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH-NINDS) [NS063880]; University of Maryland Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063880] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH-NINDS); University of Maryland Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH-NINDS; NS063880) and a research fund from the University of Maryland Medical Center (to RYZ).; This study was supported in part by a research grant from the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH-NINDS; NS063880), and a research fund from the University of Maryland Medical Center (to RYZ).	[Anonymous], 2008, PE ANN V AP DET KIT; BARBET N, 1992, GENE, V114, P59, DOI 10.1016/0378-1119(92)90707-V; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Benko Z, 2004, J VIROL, V78, P11016, DOI 10.1128/JVI.78.20.11016-11029.2004; Benko Z., 2010, INT J HIGH THROUGHPU, V1, P151; Blanco R, 2003, J BIOL CHEM, V278, P1086, DOI 10.1074/jbc.M205636200; Bren GD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002112; BTX, 2011, EL MAN ECM600 PROT 0; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; Coffin JM, 1996, SCIENCE, V271, P671, DOI 10.1126/science.271.5249.671; Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996; Cummings RT, 2002, P NATL ACAD SCI USA, V99, P6603, DOI 10.1073/pnas.062171599; Devroe E, 2005, VIROLOGY, V331, P181, DOI 10.1016/j.virol.2004.10.023; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; Dunn BM, 2002, GENOME BIOL, V3; Elder RT, 2000, VIRUS RES, V68, P161, DOI 10.1016/S0168-1702(00)00167-2; Foucher AL, 2013, ANTIMICROB AGENTS CH, V57, P1252, DOI 10.1128/AAC.01983-12; Frei M., 2011, CENTRIFUGATION, V6; Gatlin J, 1998, VIROLOGY, V244, P87, DOI 10.1006/viro.1998.9083; Gianotti N, 2007, NEW MICROBIOL, V30, P79; Haneda E, 2000, BIOCHEM BIOPH RES CO, V275, P434, DOI 10.1006/bbrc.2000.3319; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Huard S, 2008, CELL RES, V18, P961, DOI 10.1038/cr.2008.272; Huard S, 2008, J VIROL, V82, P2904, DOI 10.1128/JVI.01098-07; Invitrogen, 2001, PROB YEAST VIAB; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; KAPLAN AH, 1994, P NATL ACAD SCI USA, V91, P5597, DOI 10.1073/pnas.91.12.5597; KEARNEY PH, 1994, BIOCHEM BIOPH RES CO, V203, P231, DOI 10.1006/bbrc.1994.2172; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Korant BD, 1998, ADV EXP MED BIOL, V436, P27; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Li G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011371; LILLEHOJ EP, 1988, J VIROL, V62, P3053, DOI 10.1128/JVI.62.8.3053-3058.1988; Madeo F, 2002, CURR GENET, V41, P208, DOI 10.1007/s00294-002-0310-2; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Masuda M, 2000, J VIROL, V74, P2636, DOI 10.1128/JVI.74.6.2636-2646.2000; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MIYAKAWA I, 1984, J CELL SCI, V66, P21; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nie Z, 2002, CELL DEATH DIFFER, V9, P1172, DOI 10.1038/sj.cdd.4401094; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Nkeze J, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0037-7; Nurse PM, 2002, BIOSCIENCE REP, V22, P487, DOI 10.1023/A:1022017701871; Olsson I, 2011, CURR GENET, V57, P1, DOI 10.1007/s00294-010-0327-x; Perez MAS, 2010, J PHYS CHEM B, V114, P2525, DOI 10.1021/jp910958u; Ravaux I, 2014, J VIROL METHODS, V195, P180, DOI 10.1016/j.jviromet.2013.08.019; Rumlova M, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-37; Ventoso L, 2005, ANTIVIR RES, V66, P47, DOI 10.1016/j.antiviral.2004.12.008; Wagner RN, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0200-6; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664; Yang HL, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-32; Zelenak C, 2012, CELL PHYSIOL BIOCHEM, V29, P171, DOI 10.1159/000337598; Zelivianski S, 2006, APOPTOSIS, V11, P377, DOI 10.1007/s10495-006-4030-9; Zhang CS, 1997, VIROLOGY, V230, P103, DOI 10.1006/viro.1997.8459; Zhao Y, 2000, FRONT BIOSCI, P905; ZHAO YQ, 1995, DNA CELL BIOL, V14, P359, DOI 10.1089/dna.1995.14.359; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996; Zhao YQ, 1998, VIROLOGY, V246, P266, DOI 10.1006/viro.1998.9208; Zhao YQ, 1998, BIOTECHNIQUES, V25, P438, DOI 10.2144/98253st06	62	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151286	10.1371/journal.pone.0151286	http://dx.doi.org/10.1371/journal.pone.0151286			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982200	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900074
J	Carlus, SJ; Sarkar, S; Bansal, SK; Singh, V; Singh, K; Jha, RK; Sadasivam, N; Sadasivam, R; Gireesha, PS; Thangaraj, K; Rajender, S				Carlus, S. Justin; Sarkar, Saumya; Bansal, Sandeep Kumar; Singh, Vertika; Singh, Kiran; Jha, Rajesh Kumar; Sadasivam, Nirmala; Sadasivam, Revathy; Gireesha, P. S.; Thangaraj, Kumarasamy; Rajender, Singh			Is MTHFR 677 C > T Polymorphism Clinically Important in Polycystic Ovarian Syndrome (PCOS)? A Case-Control Study, Meta-Analysis and Trial Sequential Analysis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; GENOME-WIDE ASSOCIATION; METHYLENETETRAHYDROFOLATE REDUCTASE; PLASMA HOMOCYSTEINE; C677T POLYMORPHISM; MALE-INFERTILITY; FOLIC-ACID; WOMEN; RISK; SUSCEPTIBILITY	Background Optimum efficiency of the folate pathway is considered essential for adequate ovarian function. 677 C>T substitution in the 5, 10-methylene tertrahydrofolatereductase (MTHFR) gene compromises activity of the MTHFR enzyme by about 50%. The significance of correlation between 677C>T substitution and PCOS remains dubious due to the low power of published studies. Methods and Results We analyzed MTHFR 677 C>T site in ethnically two different PCOS case-control groups (total 261 cases and 256 controls) from India. The data analysis revealed a lack of association between this polymorphism and PCOS [OR = 1.11 (95% CI = 0.71-1.72), P = 0.66]. Group-wise analysis on the basis of ethnicity also revealed no association in any of the ethnic groups [Indo-Europeans, P = 1; Dravidians, P = 0.70]. Homocysteine levels did not differ significantly between cases (15.51 mu mol/L, SD = 2.89) and controls (15.89 mu mol/L, SD = 2.23). We also undertook a meta-analysis on 960 cases and 1028 controls, which suggested a significant association of the substitution with PCOS in the dominant model of analysis (OR = 1.47 (95% CI = 1.04-2.09), P = 0.032]. Trial sequential analysis corroborated findings of the traditional meta-analysis. However, we found that the conclusions of meta-analysis were strongly influenced by studies that deviated from the Hardy Weinberg equilibrium. A careful investigation of each study and a trial sequential analysis suggested that 677 C>T substitution holds no clinical significance in PCOS in most of the populations. Conclusion In conclusion, MTHFR 677 C>T polymorphism does not affect PCOS risk in India. The association seen in the meta-analysis is due to an outlier study and studies showing deviation from the Hardy Weinberg equilibrium.	[Carlus, S. Justin; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Carlus, S. Justin] Taibah Univ, Ctr Genet & Inherited Dis CGID, Al Madinah, Saudi Arabia; [Sarkar, Saumya; Bansal, Sandeep Kumar; Jha, Rajesh Kumar; Rajender, Singh] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Singh, Vertika; Singh, Kiran] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Sadasivam, Nirmala; Sadasivam, Revathy] Maaruthi Med Ctr & Hosp, Erode, Tamil Nadu, India; [Gireesha, P. S.] Yogi Vemana Univ, Kadapa, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Taibah University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU); Yogi Vemana University	Thangaraj, K (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.; Rajender, S (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	thangs@ccmb.res.in; rajender_singh@cdri.res.in	Carlus S, Justin/AEJ-6606-2022; Singh, Rajender/ABE-3512-2020; SINGH, VERTIKA/AAM-5761-2020	SINGH, VERTIKA/0000-0003-1960-1028; Thangaraj, Kumarasamy/0000-0002-0075-0106	Council of Scientific and Industrial Research (CSIR), Govt. of India [BSC0101]	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by a financial grant from the Council of Scientific and Industrial Research (CSIR), Govt. of India under network scheme of project with reference number BSC0101 (PROGRAM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Badawy A, 2007, EUR J OBSTET GYN R B, V131, P68, DOI 10.1016/j.ejogrb.2006.10.015; Bagos PG, 2009, MOL HUM REPROD, V15, P19, DOI 10.1093/molehr/gan072; Bayraktar F, 2004, ENDOCR J, V51, P601, DOI 10.1507/endocrj.51.601; Castellini Greta, 2014, Trials, V15, P512, DOI 10.1186/1745-6215-15-512; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Choi SW, 2009, EUR J OBSTET GYN R B, V145, P85, DOI 10.1016/j.ejogrb.2009.04.013; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; Cortese C, 2001, Public Health Nutr, V4, P493; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Fu LY, 2014, EUR J OBSTET GYN R B, V172, P56, DOI 10.1016/j.ejogrb.2013.10.001; Glueck CJ, 1999, METABOLISM, V48, P1589, DOI 10.1016/S0026-0495(99)90250-0; Gupta N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022277; Harmon DL, 1966, QJM, V89, P571; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Idali F, 2012, AM J REPROD IMMUNOL, V68, P400, DOI 10.1111/aji.12002; Jain Madhu, 2012, J Hum Reprod Sci, V5, P52, DOI 10.4103/0974-1208.97802; Joshi Beena, 2014, Indian J Endocrinol Metab, V18, P317, DOI 10.4103/2230-8210.131162; Karadeniz M, 2010, ENDOCRINE, V38, P127, DOI 10.1007/s12020-010-9370-0; Kazerooni T, 2008, INT J GYNECOL OBSTET, V101, P156, DOI 10.1016/j.ijgo.2007.10.024; Lee YH, 2014, EUR J OBSTET GYN R B, V175, P8, DOI 10.1016/j.ejogrb.2013.12.030; McQuillan BM, 1999, CIRCULATION, V99, P2383, DOI 10.1161/01.CIR.99.18.2383; MOHANTY D, 1982, J NUTR, V112, P1565, DOI 10.1093/jn/112.8.1565; Nidhi R, 2011, J PEDIATR ADOL GYNEC, V24, P223, DOI 10.1016/j.jpag.2011.03.002; Orio F, 2003, J CLIN ENDOCR METAB, V88, P673, DOI 10.1210/jc.2002-021142; Palep-Singh M, 2007, Hum Fertil (Camb), V10, P33, DOI 10.1080/14647270600950157; POLSON DW, 1988, LANCET, V1, P870; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rojas Joselyn, 2014, Int J Reprod Med, V2014, P719050, DOI 10.1155/2014/719050; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Sills ES, 2001, J OBSTET GYNAECOL RE, V27, P163, DOI 10.1111/j.1447-0756.2001.tb01241.x; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thangaraj K, 2002, J ANDROL, V23, P815; Thorlund K., 2011, USER MANUAL TRIAL SE, P1, DOI DOI 10.1158/1055-9965.EPI-08-0169; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Tsanadis G, 2002, HUM REPROD, V17, P314, DOI 10.1093/humrep/17.2.314; WHO, 1998, WHO TECH REP SER, V894, P1; Wijeyaratne Chandrika N., 2002, Ceylon Medical Journal, V47, P22; WILLMOTT M, 1968, J ENDOCRINOL, V41, P439, DOI 10.1677/joe.0.0410439; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Zhang SM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04642	42	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151510	10.1371/journal.pone.0151510	http://dx.doi.org/10.1371/journal.pone.0151510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983014	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900090
J	Lihoreau, M; Chittka, L; Raine, NE				Lihoreau, Mathieu; Chittka, Lars; Raine, Nigel E.			Monitoring Flower Visitation Networks and Interactions between Pairs of Bumble Bees in a Large Outdoor Flight Cage	PLOS ONE			English	Article							FORAGING BUMBLEBEES; NECTAR; OPTIMIZATION; COMPETITION; CONSPECIFICS; POLLINATORS; HYMENOPTERA; RESPONSES; ECOLOGY; APIDAE	Pollinators, such as bees, often develop multi-location routes (traplines) to exploit subsets of flower patches within larger plant populations. How individuals establish such foraging areas in the presence of other foragers is poorly explored. Here we investigated the foraging patterns of pairs of bumble bees (Bombus terrestris) released sequentially into an 880m(2) outdoor flight cage containing 10 feeding stations (artificial flowers). Using motion-sensitive video cameras mounted on flowers, we mapped the flower visitation networks of both foragers, quantified their interactions and compared their foraging success over an entire day. Overall, bees that were released first (residents) travelled 37% faster and collected 77% more nectar, thereby reaching a net energy intake rate 64% higher than bees released second (newcomers). However, this prior-experience advantage decreased as newcomers became familiar with the spatial configuration of the flower array. When both bees visited the same flower simultaneously, the most frequent outcome was for the resident to evict the newcomer. On the rare occasions when newcomers evicted residents, the two bees increased their frequency of return visits to that flower. These competitive interactions led to a significant (if only partial) spatial overlap between the foraging patterns of pairs of bees. While newcomers may initially use social cues (such as olfactory footprints) to exploit flowers used by residents, either because such cues indicate higher rewards and/or safety from predation, residents may attempt to preserve their monopoly over familiar resources through exploitation and interference. We discuss how these interactions may favour spatial partitioning, thereby maximising the foraging efficiency of individuals and colonies.	[Lihoreau, Mathieu; Chittka, Lars; Raine, Nigel E.] Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, Mile End Rd, London E1 4NS, England; [Raine, Nigel E.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Lihoreau, Mathieu] Toulouse Univ, Res Ctr Anim Cognit CRCA, Ctr Integrat Biol CBI, CNRS,UPS, Toulouse, France; [Raine, Nigel E.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	University of London; Queen Mary University London; University of London; Royal Holloway University London; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Guelph	Lihoreau, M (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, Mile End Rd, London E1 4NS, England.; Lihoreau, M (corresponding author), Toulouse Univ, Res Ctr Anim Cognit CRCA, Ctr Integrat Biol CBI, CNRS,UPS, Toulouse, France.	mathieu.lihoreau@univ-tlse3.fr	Chittka, Lars/C-3110-2012; Raine, Nigel/AAK-6425-2020	Chittka, Lars/0000-0001-8153-1732; Raine, Nigel/0000-0001-6343-2829; Lihoreau, Mathieu/0000-0002-2463-2040	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council [BB/F52765X/1]; IDEX of the Federal University of Toulouse; Fyssen foundation; CNRS; W. Garfield Weston Foundation; ERC Advanced Grant SpaceRadarPollinator; Royal Society Wolfson Research Merit Award; BBSRC [BB/F52765X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F52765X/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); IDEX of the Federal University of Toulouse; Fyssen foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); W. Garfield Weston Foundation; ERC Advanced Grant SpaceRadarPollinator; Royal Society Wolfson Research Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a combined grant from the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, and the Engineering and Physical Sciences Research Council (BB/F52765X/1). While writing, ML was supported by the IDEX of the Federal University of Toulouse (Starting and Emergence grants), the Fyssen foundation and the CNRS. NER was supported as the Rebanks Family Chair in Pollinator Conservation by The W. Garfield Weston Foundation. LC was supported by ERC Advanced Grant SpaceRadarPollinator and by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Balfour NJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1731, DOI 10.1007/s00265-015-1985-y; Bergman M, 2010, P ROY SOC B-BIOL SCI, V277, P3027, DOI 10.1098/rspb.2010.0646; CARTAR RV, 1990, BEHAV ECOL SOCIOBIOL, V26, P121, DOI 10.1007/BF00171581; Charlton NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012186; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DREISIG H, 1995, OIKOS, V72, P161, DOI 10.2307/3546218; DUCHATEAU MJ, 1989, J ETHOL, V7, P141, DOI 10.1007/BF02350036; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gilbert L.E., 1980, COEVOLUTION ANIMALS, P210; GILL FB, 1988, ECOLOGY, V69, P1933, DOI 10.2307/1941170; Giraldeau L.A., 2000, MG BEH ECOL; Giurfa M, 2013, TRENDS NEUROSCI, V36, P285, DOI 10.1016/j.tins.2012.12.011; Goulson D, 1998, ANIM BEHAV, V55, P199, DOI 10.1006/anbe.1997.0570; HARDER LD, 1986, OECOLOGIA, V69, P309, DOI 10.1007/BF00377639; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Kapustjansky A, 2010, NATURWISSENSCHAFTEN, V97, P229, DOI 10.1007/s00114-009-0627-5; Kawaguchi LG, 2007, P ROY SOC B-BIOL SCI, V274, P2661, DOI 10.1098/rspb.2007.0860; Leadbeater E, 2005, CURR BIOL, V15, pR447, DOI 10.1016/j.cub.2005.06.011; Leadbeater E, 2011, ANIM COGN, V14, P915, DOI 10.1007/s10071-011-0423-4; LEMKE TO, 1984, ECOLOGY, V65, P538, DOI 10.2307/1941416; Lichtenberg EM, 2010, INSECT SOC, V57, P105, DOI 10.1007/s00040-009-0055-8; Lihoreau M, 2015, ECOL LETT, V18, P273, DOI 10.1111/ele.12406; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Lihoreau M, 2012, BIOL LETTERS, V8, P13, DOI 10.1098/rsbl.2011.0661; Lihoreau M, 2011, FUNCT ECOL, V25, P1284, DOI 10.1111/j.1365-2435.2011.01881.x; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Makino TT, 2005, BEHAV ECOL SOCIOBIOL, V57, P617, DOI 10.1007/s00265-004-0877-3; Morrell LJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P385, DOI 10.1007/s00265-003-0663-7; MORSE DH, 1977, SCIENCE, V197, P678, DOI 10.1126/science.197.4304.678; Muller H, 2012, ENTOMOL GEN, V34, P1; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Ohashi K, 2008, BEHAV ECOL, V19, P936, DOI 10.1093/beheco/arn048; Ohashi K, 2007, BEHAV ECOL, V18, P1, DOI [10.1093/beheco/ar1053, 10.1093/beheco/arl053]; Ohashi K, 2013, BEHAV ECOL, V24, P182, DOI 10.1093/beheco/ars152; Ohashi K, 2009, ANN BOT-LONDON, V103, P1365, DOI 10.1093/aob/mcp088; Opler P.A., 1983, P30; POSSINGHAM HP, 1989, AM NAT, V133, P42, DOI 10.1086/284900; PYKE GH, 1980, THEOR POPUL BIOL, V17, P232, DOI 10.1016/0040-5809(80)90008-8; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, ENTOMOL GEN, V30, P191; Raine NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045096; ROUBIK DW, 1980, ECOLOGY, V61, P836, DOI 10.2307/1936754; Simpson SJ, 2012, NATURE NUTR UNIYING; Stamps JA, 2001, AM NAT, V157, P154, DOI 10.1086/318634; Stephens D., 2007, FORAGING BEHAV ECOLO; Stout JC, 2002, BEHAV ECOL SOCIOBIOL, V52, P239, DOI 10.1007/s00265-002-0510-2; THOMSON JD, 1987, OECOLOGIA, V71, P295, DOI 10.1007/BF00377298; Thomson JD, 1997, BEHAV ECOL, V8, P199, DOI 10.1093/beheco/8.2.199; Thomson JD, 1996, BEHAV ECOL, V7, P158, DOI 10.1093/beheco/7.2.158; Venables WN., 2002, MODERN APPL STAT S 4; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368	59	21	21	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150844	10.1371/journal.pone.0150844	http://dx.doi.org/10.1371/journal.pone.0150844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982030	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900053
J	O'Neill, KE; Bredenkamp, N; Tischner, C; Vaidya, HJ; Stenhouse, FH; Peddie, CD; Nowell, CS; Gaskell, T; Blackburn, CC				O'Neill, Kathy E.; Bredenkamp, Nicholas; Tischner, Christin; Vaidya, Harsh J.; Stenhouse, Frances H.; Peddie, C. Diana; Nowell, Craig S.; Gaskell, Terri; Blackburn, C. Clare			Foxn1 Is Dynamically Regulated in Thymic Epithelial Cells during Embryogenesis and at the Onset of Thymic Involution	PLOS ONE			English	Article							FUNCTIONAL THYMUS; PROGENITOR-CELL; ADULT THYMUS; STEM-CELLS; MOUSE; NUDE; EXPRESSION; MICROENVIRONMENT; DIFFERENTIATION; THYMOPOIESIS	Thymus function requires extensive cross-talk between developing T-cells and the thymic epithelium, which consists of cortical and medullary TEC. The transcription factor FOXN1 is the master regulator of TEC differentiation and function, and declining Foxn1 expression with age results in stereotypical thymic involution. Understanding of the dynamics of Foxn1 expression is, however, limited by a lack of single cell resolution data. We have generated a novel reporter of Foxn1 expression, Foxn1(G), to monitor changes in Foxn1 expression during embryogenesis and involution. Our data reveal that early differentiation and maturation of cortical and medullary TEC coincides with precise sub-lineage-specific regulation of Foxn1 expression levels. We further show that initiation of thymic involution is associated with reduced cTEC functionality, and proportional expansion of FOXN1-negative TEC in both cortical and medullary sub-lineages. Cortex-specific down-regulation of Foxn1 between 1 and 3 months of age may therefore be a key driver of the early stages of age-related thymic involution.	[O'Neill, Kathy E.; Bredenkamp, Nicholas; Tischner, Christin; Vaidya, Harsh J.; Stenhouse, Frances H.; Peddie, C. Diana; Nowell, Craig S.; Gaskell, Terri; Blackburn, C. Clare] Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland; [Bredenkamp, Nicholas] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England; [Tischner, Christin] Univ Cologne, Inst Genet, Cologne, Germany; [Nowell, Craig S.] UKNSCB, S Mimms EN6 3QG, Herts, England; [Gaskell, Terri] Guys Hosp, Cell Therapy Catapult, London SE1 9RT, England	University of Edinburgh; University of Cambridge; University of Cologne; Guy's & St Thomas' NHS Foundation Trust	Blackburn, CC (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Inst Stem Cell Res, Sch Biol Sci, SCRM Bldg,5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	c.blackburn@ed.ac.uk	Vaidya, Harsh/L-4903-2019; Blackburn, Clare/AAM-7954-2020; Blackburn, Clare/B-2847-2009	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X	Biotechnology and Biological Sciences Research Council [BB/H021183/1BBSRC]; Leukaemia and Lymphoma Research grant [12012]; School of Biological Sciences, University of Edinburgh; Medical Research Council [71380]; European Union; EuroSyStem; ThymiStem [223098, 200720, 602587]; BBSRC [BB/H021183/1] Funding Source: UKRI; MRC [MR/L012766/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021183/1] Funding Source: researchfish; Medical Research Council [MR/L012766/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia and Lymphoma Research grant; School of Biological Sciences, University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); EuroSyStem(European Commission); ThymiStem; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results received funding from the Biotechnology and Biological Sciences Research Council grant number BB/H021183/1BBSRC (CCB, KO'N), Leukaemia and Lymphoma Research grant number 12012 (CCB, NB, KO'N), the School of Biological Sciences, University of Edinburgh (HV), the Medical Research Council grant number 71380 (CCB, FHS, TG), and the European Union Seventh Framework Programme (FP7/2007-2013) collaborative projects OptiStem (CCB), EuroSyStem (CCB and NB) and ThymiStem (CCB, KO'N) under grant agreement numbers (223098, 200720 and 602587 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Jenkinson WE, 2008, J IMMUNOL, V181, P6101, DOI 10.4049/jimmunol.181.9.6101; JONES B, 1995, TRENDS GENET, V11, P257, DOI 10.1016/S0168-9525(00)89068-X; Ki S, 2014, CELL REP, V9, P402, DOI 10.1016/j.celrep.2014.08.070; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; Metzger TC, 2013, CELL REP, V5, P166, DOI 10.1016/j.celrep.2013.08.038; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Rode I, 2015, J IMMUNOL, V195, P5678, DOI 10.4049/jimmunol.1502010; Sekai M, 2014, IMMUNITY, V41, P753, DOI 10.1016/j.immuni.2014.10.011; Ucar A, 2014, IMMUNITY, V41, P257, DOI 10.1016/j.immuni.2014.07.005; Velardi E, 2014, J EXP MED, V211, P2341, DOI 10.1084/jem.20131289; Wang XP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00019; Wong K, 2014, CELL REP, V8, P1198, DOI 10.1016/j.celrep.2014.07.029; Zook EC, 2011, BLOOD, V118, P5723, DOI 10.1182/blood-2011-03-342097	29	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151666	10.1371/journal.pone.0151666	http://dx.doi.org/10.1371/journal.pone.0151666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983083	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900110
J	Kashi, Z; Mahrooz, A; Kianmehr, A; Alizadeh, A				Kashi, Zahra; Mahrooz, Abdolkarim; Kianmehr, Anvarsadat; Alizadeh, Ahad			The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; INSULIN-RESISTANCE; OCT1; POLYMORPHISMS; PROFILES	Background In this study, we investigated whether response to metformin, the most frequently drug for diabetes treatment, influences the therapeutic effects of antilipidemic medication in newly diagnosed patients with type 2 diabetes mellitus (T2DM). Methods A total of 150 patients with T2DM were classified into two groups following 3 months of metformin therapy (1000 mg twice daily): responders (patients showing >= 1% reduction in HbA1c from baseline) and nonresponders (patients showing <1% reduction in HbA1c from baseline). The patients received atorvastatin 20 mg, gemfibrozil 300 mg, or atorvastatin 20 mg and gemfibrozil 300 mg daily. Principal Findings HbA1c and fasting glucose levels were significantly different between baseline and 3 months among responders receiving atorvastatin; however, these differences were not statistically significant in nonresponders. Atherogenic ratios of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LDL-C/HDL-C; p = 0.002), total cholesterol to HDL-C (TC/HDL-C; p<0.001) and AIP (the atherogenic index of plasma; p = 0.004) decreased significantly in responders receiving atorvastatin than in nonresponders. Moreover, responders receiving atorvastatin showed a significant increase in HDL-C levels but nonresponders receiving atorvastatin did not (p = 0.007). The multivariate model identified a significant association between metformin response (as the independent variable) and TG, TC, HDL-C and LDL-C (dependent variables; Wilk's lambda = 0.927, p = 0.036). Conclusions Metformin response affects therapeutic outcomes of atorvastatin on atherogenic lipid markers in patients newly diagnosed with T2DM. Metformin has a greater impact on BMI in responders of metformin compared to nonresponders. Adoption of better therapeutic strategies for reducing atherogenic lipid markers may be necessary for metformin nonresponders.	[Kashi, Zahra] Mazandaran Univ Med Sci, Imam Teaching Hosp, Diabet Res Ctr, Sari, Iran; [Mahrooz, Abdolkarim] Mazandaran Univ Med Sci, Immunogenet Res Ctr, Sari, Iran; [Mahrooz, Abdolkarim] Mazandaran Univ Med Sci, Dept Clin Biochem & Genet, Fac Med, Sari, Iran; [Kianmehr, Anvarsadat] Golestan Univ Med Sci, Biochem & Metab Disorders Res Ctr, Gorgan, Iran; [Kianmehr, Anvarsadat] Golestan Univ Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Gorgan, Iran; [Alizadeh, Ahad] Royan Inst Reprod Biomed, Dept Epidemiol & Reprod Hlth, Reprod Epidemiol Res Ctr, ACECR, Tehran, Iran	Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Golestan University of Medical Sciences; Golestan University of Medical Sciences; Academic Center for Education, Culture & Research (ACECR)	Mahrooz, A (corresponding author), Mazandaran Univ Med Sci, Immunogenet Res Ctr, Sari, Iran.; Mahrooz, A (corresponding author), Mazandaran Univ Med Sci, Dept Clin Biochem & Genet, Fac Med, Sari, Iran.; Kianmehr, A (corresponding author), Golestan Univ Med Sci, Biochem & Metab Disorders Res Ctr, Gorgan, Iran.; Kianmehr, A (corresponding author), Golestan Univ Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Gorgan, Iran.	kmahrooz@yahoo.com; kiabiotpro@yahoo.com	Alizadeh, Ahad/E-8960-2013; Kianmehr, Anvarsadat/J-6749-2016; Kashi, Zahra/F-3428-2017; Mahrooz, Abdolkarim/L-1492-2019; Mahrooz, Abdolkarim/F-3414-2017	Kianmehr, Anvarsadat/0000-0001-5604-1870; Kashi, Zahra/0000-0002-4683-1323; Mahrooz, Abdolkarim/0000-0002-4389-4169; Alizadeh, Ahad/0000-0002-0385-463X; Mahrooz, Abdolkarim/0000-0003-0620-375X	Mazandaran University of Medical Sciences	Mazandaran University of Medical Sciences	This study was funded by Mazandaran University of Medical Sciences.	Bell D S, 2001, Curr Diab Rep, V1, P133, DOI 10.1007/s11892-001-0025-7; Bennett PH, 1999, DIABETES OBES METAB, V1, pS1; Bosi E, 2009, DIABETES OBES METAB, V11, P3, DOI 10.1111/j.1463-1326.2008.01031.x; Brehm A, 2004, CLIN CHEM, V50, P2316, DOI 10.1373/clinchem.2004.037556; Buse JB, 2004, DIABETES OBES METAB, V6, P133, DOI 10.1111/j.1462-8902.2004.00325.x; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Grisouard J, 2010, BIOCHEM PHARMACOL, V80, P1736, DOI 10.1016/j.bcp.2010.08.021; Hanefeld M, 2004, DIABETES CARE, V27, P141, DOI 10.2337/diacare.27.1.141; Holstein A, 2011, BR J DIABETES VASC D, V11, P10, DOI [10.1177/1474651410397583, DOI 10.1177/1474651410397583]; Hosain GMM, 2010, DIABETES METAB, V36, P278, DOI 10.1016/j.diabet.2010.01.010; Kashi Z, 2015, DIABETES RES CLIN PR, V108, P78, DOI 10.1016/j.diabres.2015.01.024; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kerb R, 2006, CANCER LETT, V234, P4, DOI 10.1016/j.canlet.2005.06.051; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; Mahrooz A, 2015, CLIN EXP MED, V15, P159, DOI 10.1007/s10238-014-0283-8; Niemi M, 2005, CLIN PHARMACOL THER, V77, P468, DOI 10.1016/j.clpt.2005.01.018; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Rubenfire M, 2010, AM J MED, V123, P892, DOI 10.1016/j.amjmed.2010.03.024; Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727; Shikata E, 2007, J HUM GENET, V52, P117, DOI 10.1007/s10038-006-0087-0; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Takane H, 2008, PHARMACOGENOMICS, V9, P415, DOI 10.2217/14622416.9.4.415; Zolk O, 2012, ANN MED, V44, P119, DOI 10.3109/07853890.2010.549144	26	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151543	10.1371/journal.pone.0151543	http://dx.doi.org/10.1371/journal.pone.0151543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978661	Green Submitted, gold, Green Published			2022-12-27	WOS:000372572800086
J	Lee, J; Han, K; Song, JJ; Im, GJ; Chae, SW				Lee, Jieun; Han, Kyungdo; Song, Jae Jun; Im, Gi Jung; Chae, Sung Won			Sarcopenia and Hearing Loss in Older Koreans: Findings from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; COCHLEAR BLOOD-FLOW; NEUROTROPHIC FACTOR; BODY-COMPOSITION; IMPAIRMENT; BRAIN; ASSOCIATION; EXERCISE; ADULTS; THRESHOLDS	Age-related hearing impairment (ARHI) is becoming a more significant issue as geriatric population increases. Sarcopenia in older people is known to have a diverse health problem in various circumstances in recent studies. We assessed whether the decrease in muscle mass is related to ARHI. We used the 2010 data of the Korea National Health and Nutrition Examination Survey (KNHANES) to examine the associations between sarcopenia and ARHI. A total number of participants was 1,622 including 746 males and 876 females aged 60 years or older. Muscle mass was assessed as an appendicular skeletal muscle mass, and hearing loss was defined as the pure-tone averages (PTA) of test frequencies 0.5, 1, 2, 4 kHz at a threshold of 40 dB or higher in worse hearing side of the ear. Among 1,622 participants, 298 men and 256 women had hearing loss. Appendicular muscle mass (ASM), expressed as kg, was categorized in tertiles. In female population, after adjusting for age, smoking, drinking, amount of exercise, total body fat, education level, income level, and tinnitus, the odds ratio (OR) for hearing loss was 1.57 (95% confidence interval (CI) = 0.922.68) in the middle tertile and 1.79 (1.03-3.08) in the lowest tertile, compared with the highest tertile. P for trend in this model was 0.036. Controlling further for hypertension, diabetes mellitus, chronic kidney disease, and three types of noise exposure did not change the association. Larger muscle mass is associated with lower prevalence of hearing loss in elderly Korean females.	[Lee, Jieun] Korea Univ, Sch Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Sch Med, Dept Biostat, Seoul, South Korea; [Song, Jae Jun; Im, Gi Jung; Chae, Sung Won] Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine)	Chae, SW (corresponding author), Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	schae@kumc.or.kr	IM, GI JUNG/AAI-9755-2020	IM, GI JUNG/0000-0002-9457-4253				Brink P, 2007, GERONTOLOGIST, V47, P633, DOI 10.1093/geront/47.5.633; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Choi KM, 2013, ENDOCRINOL METAB, V28, P86, DOI 10.3803/EnM.2013.28.2.86; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Han K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086902; Hegarty JL, 1997, J NEUROSCI, V17, P1959; Helzner EP, 2005, J AM GERIATR SOC, V53, P2119, DOI 10.1111/j.1532-5415.2005.00525.x; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Hwang JH, 2009, OBESITY, V17, P1796, DOI 10.1038/oby.2009.66; Iolascon G, 2014, CLIN CASES MINER BON, V11, P215, DOI 10.11138/ccmbm/2014.11.3.215; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kim JH, 2013, J KOREAN MED SCI, V28, P1041, DOI 10.3346/jkms.2013.28.7.1041; Kim TS, 2014, CLIN ENDOCRINOL, V80, P368, DOI 10.1111/cen.12184; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Malgrange B, 1996, NEUROREPORT, V7, P913, DOI 10.1097/00001756-199603220-00016; Mom T, 1999, HEARING RES, V133, P40, DOI 10.1016/S0378-5955(99)00056-8; Mom T, 1997, BRAIN RES, V751, P20, DOI 10.1016/S0006-8993(96)01388-1; Morley JE, 2012, FAM PRACT, V29, pi44, DOI 10.1093/fampra/cmr063; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Pratesi A, 2013, CLIN CASES MINER BON, V10, P11, DOI 10.11138/ccmbm/2013.10.1.011; Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Snijder MB, 2004, J HYPERTENS, V22, P2339, DOI 10.1097/00004872-200412000-00016; Telischi FF, 1998, LARYNGOSCOPE, V108, P837, DOI 10.1097/00005537-199806000-00011; Torre P, 2005, J SPEECH LANG HEAR R, V48, P473, DOI 10.1044/1092-4388(2005/032); Tseng LA, 2014, J GERONTOL A-BIOL, V69, P93, DOI 10.1093/gerona/glt027; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2; Woo KJ, 2012, 11124000000012513 KR, P38; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008	34	10	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150281	10.1371/journal.pone.0150281	http://dx.doi.org/10.1371/journal.pone.0150281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978776	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800023
J	Lee, JH; Kang, MS; Mahapatra, C; Kim, HW				Lee, Jung-Hwan; Kang, Min-Sil; Mahapatra, Chinmaya; Kim, Hae-Won			Effect of Aminated Mesoporous Bioactive Glass Nanoparticles on the Differentiation of Dental Pulp Stem Cells	PLOS ONE			English	Article							IN-VITRO; MECHANICAL-PROPERTIES; ODONTOGENIC DIFFERENTIATION; FIBROUS SCAFFOLDS; 45S5 BIOGLASS(R); DRUG-DELIVERY; BONE-MARROW; COMPOSITES; NANOCARRIERS; PARTICLES	Mesoporous bioactive nanoparticles (MBNs) have been developed as promising additives to various types of bone or dentin regenerative material. However, biofunctionality of MBNs as dentin regenerative additive to dental materials have rarely been studied. We investigated the uptake efficiency of MBNs-NH2 with their endocytosis pathway and the role of MBNs-NH2 in odontogenic differentiation to clarify inherent biofunctionality. MBNs were fabricated by sol-gel synthesis, and 3% APTES was used to aminate these nanoparticles (MBNs-NH2) to reverse their charge from negative to positive. To characterize the MBNs-NH2, TEM, XRD, FTIR, zeta(xi)-potential measurements, and Brunauer-Emmett-Teller analysis were performed. After primary cultured rat dental pulp stem cells (rDPSCs) were incubated with various concentrations of MBNs-NH2, stem cell viability (24 hours) with or without differentiated media, internalization of MBNs-NH2 in rDPSCs (similar to 4 hours) via specific endocytosis pathway, intra or extracellular ion concentration and odontoblastic differentiation (similar to 28 days) were investigated. Incubation with up to 50 mu g/mL of MBNs-NH2 had no effect on rDPSCs viability with differentiated media (p>0.05). The internalization of MBNs-NH2 in rDPSCs was determined about 92% after 4 hours of incubation. Uptake was significantly decreased with ATP depletion and after 1 hour of pre-treatment with the inhibitor of macropinocytosis (p<0.05). There was significant increase of intracellular Ca and Si ion concentration in MBNs-NH2 treated cells compared to no-treated counterpart (p<0.05). The expression of odontogenic-related genes (BSP, COL1A, DMP-1, DSPP, and OCN) and the capacity for biomineralization (based on alkaline phosphatase activity and alizarin red staining) were significantly upregulated with MBNs-NH2. These results indicate that MBNs-NH2 induce odontogenic differentiation of rDPSCs and may serve as a potential dentin regenerative additive to dental material for promoting odontoblast differentiation.	[Lee, Jung-Hwan; Kang, Min-Sil; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 31116, South Korea; [Kang, Min-Sil; Mahapatra, Chinmaya; Kim, Hae-Won] Dankook Univ, Ctr Regenerat Med, Dept Nanobiomed Sci, Cheonan 31116, South Korea; [Kang, Min-Sil; Mahapatra, Chinmaya; Kim, Hae-Won] Dankook Univ, Ctr Regenerat Med, PLUS NBM Global Res BK21, Cheonan 31116, South Korea; [Kim, Hae-Won] Dankook Univ, Dept Biomat Sci, Coll Dent, Cheonan 31116, South Korea	Dankook University; Dankook University; Dankook University; Dankook University	Lee, JH; Kim, HW (corresponding author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 31116, South Korea.; Kim, HW (corresponding author), Dankook Univ, Ctr Regenerat Med, Dept Nanobiomed Sci, Cheonan 31116, South Korea.; Kim, HW (corresponding author), Dankook Univ, Ctr Regenerat Med, PLUS NBM Global Res BK21, Cheonan 31116, South Korea.; Kim, HW (corresponding author), Dankook Univ, Dept Biomat Sci, Coll Dent, Cheonan 31116, South Korea.	ducious@gmail.com; kimhw@dku.edu	Lee, Jung-Hwan/AFK-0831-2022; mahapatra, chinmaya/N-5911-2018	Lee, Jung-Hwan/0000-0001-8678-5459; mahapatra, chinmaya/0000-0001-8819-6682	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2009-0093829]; Ministry of Science, ICT & Future Planning [NRF-2015R1C1A1A01052127]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2009-0093829) and by the Ministry of Science, ICT & Future Planning (NRF-2015R1C1A1A01052127).	About I, 2000, EXP CELL RES, V258, P33, DOI 10.1006/excr.2000.4909; Bae WJ, 2012, DENT MATER, V28, P1271, DOI 10.1016/j.dental.2012.09.011; Banga AK, 2005, THERAPEUTIC PEPTIDES; Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059; Cao Y, 2015, J DENT RES, V94, P1544, DOI 10.1177/0022034515601658; Carvalho S.M., 2011, DENT MAT S1, V27, pe42; Chang CC, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/367157; Chang SJ, 1999, ARTIF CELL BLOOD SUB, V27, P229, DOI 10.3109/10731199909117696; Chiari MDS, 2015, DENT MATER, V31, P726, DOI 10.1016/j.dental.2015.03.015; Ding Y, 2015, J NONLINEAR FUNCT AN; Doostmohammadi A, 2011, CERAM INT, V37, P2311, DOI 10.1016/j.ceramint.2011.03.026; Eidi H, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0388-2; El-Fiqi A, 2015, J MATER CHEM B, V3, P1321, DOI 10.1039/c4tb01634c; El-Fiqi A, 2015, ACS APPL MATER INTER, V7, P1140, DOI 10.1021/am5077759; El-Fiqi A, 2014, RSC ADV, V4, P4444, DOI 10.1039/c3ra45858j; El-Fiqi A, 2013, ACTA BIOMATER, V9, P9508, DOI 10.1016/j.actbio.2013.07.036; El-Fiqi A, 2012, NANOSCALE, V4, P7475, DOI 10.1039/c2nr31775c; Epple M, 2010, J MATER CHEM, V20, P18, DOI 10.1039/b910885h; Faraji AH, 2009, BIOORGAN MED CHEM, V17, P2950, DOI 10.1016/j.bmc.2009.02.043; Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74; Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3; Gong WY, 2014, J ENDODONT, V40, P83, DOI 10.1016/j.joen.2013.08.018; Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010; Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45; Jo JH, 2009, J BIOMED MATER RES B, V91B, P213, DOI 10.1002/jbm.b.31392; Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023; Kang J, 2001, AM J PHYSIOL-ENDOC M, V280, pE428, DOI 10.1152/ajpendo.2001.280.3.E428; Kang MS, 2015, ACTA BIOMATER, V16, P103, DOI 10.1016/j.actbio.2014.12.028; Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kwon S, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413503357; Landgraf L, 2015, BEILSTEIN J NANOTECH, V6, P300, DOI 10.3762/bjnano.6.28; Li ST, 2015, J CELL PHYSIOL, V230, P2164, DOI 10.1002/jcp.24945; Lim SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9210; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Meiszterics A., 2011, 5B EUR C INT FEB MED; Mitchell JC, 2011, DENT MATER, V27, P386, DOI 10.1016/j.dental.2010.11.019; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Noh KT, 2010, MATER LETT, V64, P802, DOI 10.1016/j.matlet.2010.01.014; Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592; Oral O, 2014, DENT MATER, V30, P570, DOI 10.1016/j.dental.2014.02.017; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; ROUQUEROL J, 1994, STUD SURF SCI CATAL, V87, P1; Salehi S, 2015, DENT MATER, V31, P195, DOI 10.1016/j.dental.2014.12.004; Samberg M, 2012, NANOMEDICINE-UK, V7, P1197, DOI [10.2217/nnm.12.18, 10.2217/NNM.12.18]; Serigano K, 2010, J ORTHOP RES, V28, P1267, DOI 10.1002/jor.21147; Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3; Sing KSW, 2008, HDB HETEROGENEOUS CA; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Tao ZM, 2009, CHEM RES TOXICOL, V22, P1869, DOI 10.1021/tx900276u; Torii I, 2001, IMMUNOLOGY, V103, P70, DOI 10.1046/j.1365-2567.2001.01218.x; Tousi NS, 2013, MAT SCI ENG C-MATER, V33, P2757, DOI 10.1016/j.msec.2013.02.044; Tsigkou O, 2014, ADV HEALTHC MATER, V3, P115, DOI 10.1002/adhm.201300126; Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019; TSUKAMOTO Y, 1992, ARCH ORAL BIOL, V37, P1045, DOI 10.1016/0003-9969(92)90037-9; Vallittu PK, 2015, DENT MATER, V31, P371, DOI 10.1016/j.dental.2015.01.003; Varanasi VG, 2012, J ORAL IMPLANTOL, V38, P325, DOI 10.1563/AAID-JOI-D-11-00108; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wang HY, 2012, ADV MATER, V24, P3315, DOI 10.1002/adma.201104967; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034; Wang SN, 2014, ACTA BIOMATER, V10, P2792, DOI 10.1016/j.actbio.2014.02.013; Wei W, 2012, J ENDODONT, V38, P936, DOI 10.1016/j.joen.2012.03.020; Won JE, 2015, BIOTECHNOL LETT, V37, P935, DOI 10.1007/s10529-014-1745-5; Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101; Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002; Xia W, 2008, J NON-CRYST SOLIDS, V354, P1338, DOI 10.1016/j.jnoncrysol.2006.10.084; Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598; Yang SY, 2013, DENT MATER, V29, P1228, DOI 10.1016/j.dental.2013.09.007; Yang XC, 2007, J TISSUE ENG REGEN M, V1, P66, DOI 10.1002/term.16; Zaborina O, 1999, INFECT IMMUN, V67, P5231, DOI 10.1128/IAI.67.10.5231-5242.1999; Zhang HY, 2011, ACS NANO, V5, P2756, DOI 10.1021/nn200328m; Zhang J, 2009, J TISSUE ENG REGEN M, V3, P63, DOI 10.1002/term.135; Zhang YY, 2010, BIOMATERIALS, V31, P8465, DOI 10.1016/j.biomaterials.2010.07.060	80	46	50	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150727	10.1371/journal.pone.0150727	http://dx.doi.org/10.1371/journal.pone.0150727			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974668	gold, Green Submitted, Green Published			2022-12-27	WOS:000372570600028
J	Lindstrom, R; Lindholm, P; Kallijarvi, J; Palgi, M; Saarma, M; Heino, TI				Lindstrom, Riitta; Lindholm, Paivi; Kallijarvi, Jukka; Palgi, Mari; Saarma, Mart; Heino, Tapio I.			Exploring the Conserved Role of MANF in the Unfolded Protein Response in Drosophila melanogaster	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROTROPHIC FACTOR MANF; DOPAMINERGIC-NEURONS; GENE-EXPRESSION; CDNF PROTECTS; ERSE-II; CELLS; MODEL; BRAIN; YEAST	Disturbances in the homeostasis of endoplasmic reticulum (ER) referred to as ER stress is involved in a variety of human diseases. ER stress activates unfolded protein response (UPR), a cellular mechanism the purpose of which is to restore ER homeostasis. Previous studies show that Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) is an important novel component in the regulation of UPR. In vertebrates, MANF is upregulated by ER stress and protects cells against ER stress-induced cell death. Biochemical studies have revealed an interaction between mammalian MANF and GRP78, the major ER chaperone promoting protein folding. In this study we discovered that the upregulation of MANF expression in response to drug-induced ER stress is conserved between Drosophila and mammals. Additionally, by using a genetic in vivo approach we found genetic interactions between Drosophila Manf and genes encoding for Drosophila homologues of GRP78, PERK and XBP1, the key components of UPR. Our data suggest a role for Manf in the regulation of Drosophila UPR.	[Lindstrom, Riitta; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Lindstrom, Riitta; Lindholm, Paivi; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Kallijarvi, Jukka] Univ Helsinki, Folkhalsan Res Ctr, Helsinki, Finland; [Palgi, Mari] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Tallinn University of Technology	Lindstrom, R; Heino, TI (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.; Lindstrom, R (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	riitta.lindstrom@helsinki.fi; tapio.heino@helsinki.fi	Kallijarvi, Jukka/AAV-5091-2021; Lindstrom, Riitta/K-4448-2015	Kallijarvi, Jukka/0000-0003-3773-7025; Palgi, Mari/0000-0001-6142-6142; Lindstrom, Riitta/0000-0001-5177-0564; Pulkkila, Paivi/0000-0003-3022-5035	Viikki Doctoral Programme in Molecular Biosciences; Finnish Parkinson Foundation; Ella and Georg Ehrnrooth Foundation; University of Helsinki Funds; Alfred Kordelin Foundation; Academy of Finland [139910]; Estonian Research Council [IUT19-18]	Viikki Doctoral Programme in Molecular Biosciences; Finnish Parkinson Foundation; Ella and Georg Ehrnrooth Foundation; University of Helsinki Funds; Alfred Kordelin Foundation; Academy of Finland(Academy of Finland); Estonian Research Council(Estonian Research Council)	RL was supported by Viikki Doctoral Programme in Molecular Biosciences (http://www.helsinki.fi/vgsb/), The Finnish Parkinson Foundation (http://www.parkinsonsaatio.fi/), The Ella and Georg Ehrnrooth Foundation (http://www.ellageorg.fi/), and The University of Helsinki Funds, and Alfred Kordelin Foundation (http://www.kordelin.fi/). PL was supported by The Academy of Finland (grant No. 139910; http://www.aka.fi/en-GB/A/). MP was supported by Estonian Research Council (grant No. IUT19-18, http://www.etag.ee/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Airavaara M, 2010, EXP NEUROL, V225, P104, DOI 10.1016/j.expneurol.2010.05.020; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Benosman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064256; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dufey E, 2014, AM J PHYSIOL-CELL PH, V307, pC582, DOI 10.1152/ajpcell.00258.2014; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Kim AY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1518-0; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; Loewen CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013084; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Maor G, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-140; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nundlall S, 2010, CELL STRESS CHAPERON, V15, P835, DOI 10.1007/s12192-010-0193-y; Oh-hashi K, 2015, BIOL PHARM BULL, V38, P722, DOI 10.1248/bpb.b14-00825; Oh-Hashi K, 2013, CELL MOL BIOL LETT, V18, P398, DOI 10.2478/s11658-013-0096-x; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Plongthongkum N, 2007, BIOCHEM BIOPH RES CO, V354, P789, DOI 10.1016/j.bbrc.2007.01.056; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Ryoo HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075774; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sekine SU, 2013, NAT NEUROSCI, V16, P683, DOI 10.1038/nn.3389; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Stratoulias V, 2015, GENE EXPR PATTERNS, V18, P8, DOI 10.1016/j.gep.2015.04.002; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002	61	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151550	10.1371/journal.pone.0151550	http://dx.doi.org/10.1371/journal.pone.0151550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975047	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600087
J	Meunier, SM; Todorovic, B; Dare, EV; Begum, A; Guillemette, S; Wenger, A; Saxena, P; Campbell, JL; Sasges, M; Aucoin, MG				Meunier, Sarah M.; Todorovic, Biljana; Dare, Emma V.; Begum, Afroza; Guillemette, Simon; Wenger, Andrew; Saxena, Priyanka; Campbell, J. Larry; Sasges, Michael; Aucoin, Marc G.			Impact of Dissolved Oxygen during UV-Irradiation on the Chemical Composition and Function of CHO Cell Culture Media	PLOS ONE			English	Article							FELINE CALICIVIRUS; INACTIVATION; RIBOFLAVIN; VIRUSES; TRYPTOPHAN; RADIATION; BACTERIA; LIGHT; WATER	Ultraviolet (UV) irradiation is advantageous as a sterilization technique in the biopharmaceutical industry since it is capable of targeting non-enveloped viruses that are typically challenging to destroy, as well as smaller viruses that can be difficult to remove via conventional separation techniques. In this work, we investigated the influence of oxygen in the media during UV irradiation and characterized the effect on chemical composition using NMR and LC-MS, as well as the ability of the irradiated media to support cell culture. Chemically defined Chinese hamster ovary cell growth media was irradiated at high fluences in a continuous-flow UV reactor. UV-irradiation caused the depletion of pyridoxamine, pyridoxine, pyruvate, riboflavin, tryptophan, and tyrosine; and accumulation of acetate, formate, kynurenine, lumichrome, and sarcosine. Pyridoxamine was the only compound to undergo complete degradation within the fluences considered; complete depletion of pyridoxamine was observed at 200 mJ/cm(2). Although in both oxygen-and nitrogen-saturated media, the cell culture performance was affected at fluences above 200 mJ/cm(2), there was less of an impact on cell culture performance in the nitrogen-saturated media. Based on these results, minimization of oxygen in cell culture media prior to UV treatment is recommended to minimize the negative impact on sensitive media.	[Meunier, Sarah M.; Todorovic, Biljana; Dare, Emma V.; Guillemette, Simon; Wenger, Andrew; Aucoin, Marc G.] Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada; [Meunier, Sarah M.; Begum, Afroza; Saxena, Priyanka; Sasges, Michael] Trojan Technol, London, ON, Canada; [Campbell, J. Larry] SCIEX Ltd, Concord, ON, Canada	University of Waterloo; SCIEX	Aucoin, MG (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada.	maucoin@uwaterloo.ca	Aucoin, Marc/AAA-8450-2019	Aucoin, Marc/0000-0001-9393-5558	Natural Sciences and Engineering Research Council of Canada [NSERC] ENGAGE Plus [EGP2 460753-13]; NSERC Strategic Network (MabNet) [NETGP 380070-08]; Natural Sciences and Engineering Research Council of Canada [NSERC]; MITACS Accelerate Post-Doctoral Fellowships; Undergraduate Student Research Assistantships; Trojan Technologies; Chenomx Inc.; SCIEX	Natural Sciences and Engineering Research Council of Canada [NSERC] ENGAGE Plus; NSERC Strategic Network (MabNet); Natural Sciences and Engineering Research Council of Canada [NSERC](Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS Accelerate Post-Doctoral Fellowships; Undergraduate Student Research Assistantships; Trojan Technologies; Chenomx Inc.; SCIEX	This work was supported by the Natural Sciences and Engineering Research Council of Canada [NSERC, (www.nserccrsng.gc.ca)] ENGAGE Plus (EGP2 460753-13), and NSERC Strategic Network (MabNet, NETGP 380070-08) Grants to MGA. This work was also supported by the Natural Sciences and Engineering Research Council of Canada [NSERC, (www.nserc-crsng.gc.ca)] MITACS (www.mitacs.ca) Accelerate Post-Doctoral Fellowships to SMM, BT, EVD, AB and PS. This work was also supported by the Natural Sciences and Engineering Research Council of Canada [NSERC, (www.nserc-crsng.gc.ca), Undergraduate Student Research Assistantships to SG and AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also partially funded by Trojan Technologies, which also provided UV reactors and other in-kind support. This work was also supported in part by the generous contribution of Chenomx Inc. in the form of Chenomx NMR Suite 7.0-7.7 software to the Aucoin Lab. Trojan Technologies and SCIEX provided support in the form of salaries for authors MS and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad I, 2004, INT J PHARMACEUT, V280, P199, DOI 10.1016/j.ijpharm.2004.05.020; ANG CYW, 1979, J ASSOC OFF ANA CHEM, V62, P1170; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aranha H., 2011, CONTRACT PHARM, P82; Baylis SA, 2011, VACCINE, V29, P690, DOI 10.1016/j.vaccine.2010.11.028; Berting A, 2010, BIOTECHNOL BIOENG, V106, P598, DOI 10.1002/bit.22723; Cabaj A, 1996, WATER RES, V30, P1003, DOI 10.1016/0043-1354(95)00256-1; Chen Joseph, 2012, PDA J Pharm Sci Technol, V66, P580, DOI 10.5731/pdajpst.2012.00892; Chevrefils G., 2006, IUVA NEWS, V8, P38; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; FURNESS G, 1969, APPL MICROBIOL, V18, P360, DOI 10.1128/AEM.18.3.360-364.1969; Grzelak A, 2001, FREE RADICAL BIO MED, V30, P1418, DOI 10.1016/S0891-5849(01)00545-7; Hamdy MS, 2012, CATAL LETT, V142, P338, DOI 10.1007/s10562-012-0775-7; Hart R, 2012, US Pat Application, Patent No. [20,120,214,204, 20120214204, 2012/0214204]; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Holt LA, 1997, BIOCHIM BIOPHYS ACTA, V1, P131; Insinska-Rak M, 2012, J PHYS CHEM A, V116, P1199, DOI 10.1021/jp2094593; Moody Mark, 2011, PDA J Pharm Sci Technol, V65, P580, DOI 10.5731/pdajpst.2011.00824; Natera J, 2012, PHOTOCH PHOTOBIO SCI, V11, P938, DOI 10.1039/c2pp05318g; Nuanualsuwan S, 2002, PHOTOCHEM PHOTOBIOL, V76, P406, DOI 10.1562/0031-8655(2002)076&lt;0406:UIOFCH&gt;2.0.CO;2; Pirnie M., 2006, ENV PROT, V2, P1; Schmidt S, 2007, CHEM ENG TECHNOL, V30, P945, DOI 10.1002/ceat.200700056; Sokolenko S, 2014, ANAL CHEM, V86, P3330, DOI 10.1021/ac4033966; Thurston-Enriquez JA, 2013, APPL ENVIRON MICROB, V69, P577; Yen S, 2014, BIOTECHNOL PROGR, V30, P1190, DOI 10.1002/btpr.1942; YU LZ, 1982, INT J RADIAT BIOL, V41, P119, DOI 10.1080/09553008214550131; Zang L, 2011, ANAL CHEM, V83, P5422, DOI 10.1021/ac2009492	27	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150957	10.1371/journal.pone.0150957	http://dx.doi.org/10.1371/journal.pone.0150957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975046	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600039
J	Gatidis, S; Schmidt, H; Pfannenberg, CA; Nikolaou, K; Schick, F; Schwenzer, NF				Gatidis, Sergios; Schmidt, Holger; Pfannenberg, Christina A.; Nikolaou, Konstantin; Schick, Fritz; Schwenzer, Nina F.			Is It Possible to Detect Activated Brown Adipose Tissue in Humans Using Single-Time-Point Infrared Thermography under Thermoneutral Conditions? Impact of BMI and Subcutaneous Adipose Tissue Thickness	PLOS ONE			English	Article							FAT; MICE	Purpose To evaluate the feasibility to detect activated brown adipose tissue (BAT) using single-time-point infrared thermography of the supraclavicular skin region under thermoneutral conditions. To this end, infrared thermography was compared with 18-F-FDG PET, the current reference standard for the detection of activated BAT. Methods 120 patients were enrolled in this study. After exclusion of 18 patients, 102 patients (44 female, 58 male, mean age 58 +/- 17 years) were included for final analysis. All patients underwent a clinically indicated 18F-FDG-PET/CT examination. Immediately prior to tracer injection skin temperatures of the supraclavicular, presternal and jugular regions were measured using spatially resolved infrared thermography at room temperature. The presence of activated BAT was determined in PET by typical FDG uptake within the supraclavicular adipose tissue compartments. Local thickness of supraclavicular subcutaneous adipose tissue (SCAT) was measured on CT. Measured skin temperatures were statistically correlated with the presence of activated BAT and anthropometric data. Results Activated BAT was detected in 9 of 102 patients (8.8%). Local skin temperature of the supraclavicular region was significantly higher in individuals with active BAT compared to individuals without active BAT. However, after statistical correction for the influence of BMI, no predictive value of activated BAT on skin temperature of the supraclavicular region could be observed. Supraclavicular skin temperature was significantly negatively correlated with supraclavicular SCAT thickness. Conclusion We conclude that supraclavicular SCAT thickness influences supraclavicular skin temperature and thus makes a specific detection of activated BAT using single-time-point thermography difficult. Further studies are necessary to evaluate the possibility of BAT detection using alternative thermographic methods, e.g. dynamic thermography or MR-based thermometry taking into account BMI as a confounding factor.	[Gatidis, Sergios; Schmidt, Holger; Pfannenberg, Christina A.; Nikolaou, Konstantin; Schwenzer, Nina F.] Univ Tubingen, Dept Radiol Diagnost & Intervent Radiol, Tubingen, Germany; [Schick, Fritz] Univ Tubingen, Dept Radiol, Sect Expt Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Gatidis, S (corresponding author), Univ Tubingen, Dept Radiol Diagnost & Intervent Radiol, Tubingen, Germany.	sergios.gatidis@med.uni-tuebingen.de	Gatidis, Sergios/AAF-4858-2020	Gatidis, Sergios/0000-0002-6928-4967; Schick, Fritz/0000-0002-4231-3406	intramural grant of the Medical Faculty of the University of Tubingen (FORTuNE Grant ) [2147-0-0]	intramural grant of the Medical Faculty of the University of Tubingen (FORTuNE Grant )	This study was funded by an intramural grant of the Medical Faculty of the University of Tubingen supporting junior researchers (FORTuNE Grant 2147-0-0;http://www.med.uni-tuebingen.de/). The position of S.G. was funded for a period of 8 months. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branca RT, 2014, P NATL ACAD SCI USA, V111, P18001, DOI 10.1073/pnas.1403697111; Crane JD, 2014, MOL METAB, V3, P490, DOI 10.1016/j.molmet.2014.04.007; Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gifford A, ISMRM2012 MELB; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Jang C, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12167; Kim MS, 2014, J CLIN ENDOCR METAB, V99, pE1686, DOI 10.1210/jc.2014-1343; Lahesmaa M, 2014, J CLIN ENDOCR METAB, V99, pE28, DOI 10.1210/jc.2013-2312; Lee P, 2011, DIABETES OBES METAB, V13, P92, DOI 10.1111/j.1463-1326.2010.01318.x; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nirengi S, 2015, OBESITY, V23, P973, DOI 10.1002/oby.21012; Perkins AC, 2013, NUCL MED COMMUN, V34, P168, DOI 10.1097/MNM.0b013e32835bbbf0; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Robinson LJ, 2016, EXPT PHYSL; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Symonds ME, 2012, J PEDIAT; van der Lans AAJJ, 2016, J PHYSIOL SCI, V66, P77, DOI 10.1007/s12576-015-0398-z; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123795	24	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151152	10.1371/journal.pone.0151152	http://dx.doi.org/10.1371/journal.pone.0151152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967519	gold, Green Published, Green Submitted			2022-12-27	WOS:000371989200033
J	Lowlaavar, N; Larson, CP; Kumbakumba, E; Zhou, GH; Ansermino, JM; Singer, J; Kissoon, N; Wong, H; Ndamira, A; Kabakyenga, J; Kiwanuka, J; Wiens, MO				Lowlaavar, Nasim; Larson, Charles P.; Kumbakumba, Elias; Zhou, Guohai; Ansermino, J. Mark; Singer, Joel; Kissoon, Niranjan; Wong, Hubert; Ndamira, Andrew; Kabakyenga, Jerome; Kiwanuka, Julius; Wiens, Matthew O.			Pediatric in-Hospital Death from Infectious Disease in Uganda: Derivation of Clinical Prediction Models	PLOS ONE			English	Article							MORTALITY; CHILDREN; INDEX	Background Pediatric hospital mortality from infectious diseases in resource constrained countries remains unacceptably high. Improved methods of risk-stratification can assist in referral decision making and resource allocation. The purpose of this study was to create prediction models for in-hospital mortality among children admitted with suspected infectious diseases. Methods This two-site prospective observational study enrolled children between 6 months and 5 years admitted with a proven or suspected infection. Baseline clinical and laboratory variables were collected on enrolled children. The primary outcome was death during admission. Stepwise logistic regression minimizing Akaike's information criterion was used to identify the most promising multivariate models. The final model was chosen based on parsimony. Results 1307 children were enrolled consecutively, and 65 (5%) of whom died during their admission. Malaria, pneumonia and gastroenteritis were diagnosed in 50%, 31% and 8% of children, respectively. The primary model included an abnormal Blantyre coma scale, HIV and weight-for-age z-score. This model had an area under the curve (AUC) of 0.85 (95% CI, 0.80-0.89) with a sensitivity and specificity of 83% and 76%, respectively. The positive and negative predictive values were 15% and 99%, respectively. Two alternate models with similar performance characteristics were developed withholding HIV and weight-for-age z-score, for use when these variables are not available. Conclusions Risk stratification of children admitted with infectious diseases can be calculated based on several easily measured variables. Risk stratification at admission can be used for allocation of scarce human and physical resources and to guide referral among children admitted to lower level health facilities.	[Lowlaavar, Nasim; Ansermino, J. Mark] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Larson, Charles P.] British Columbia Childrens Hosp, Child & Family Res Inst, Ctr Int Child Hlth, Vancouver, BC V6H 3V4, Canada; [Kumbakumba, Elias; Ndamira, Andrew; Kiwanuka, Julius] Mbarara Univ Sci & Technol, Dept Pediat, Mbarara, Uganda; [Zhou, Guohai] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Singer, Joel; Wong, Hubert; Wiens, Matthew O.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Singer, Joel] St Pauls Hosp, Canadian HIV Trials Network, Vancouver, BC V6Z 1Y6, Canada; [Singer, Joel; Kissoon, Niranjan] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Kissoon, Niranjan] British Columbia Childrens Hosp, Dept Pediat, Vancouver, BC V6H 3V4, Canada; [Kabakyenga, Jerome] Mbarara Univ Sci & Technol, Maternal Newborn & Child Hlth Inst, Mbarara, Uganda	University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; Mbarara University of Science & Technology; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; BC Childrens Hospital; University of British Columbia; Mbarara University of Science & Technology	Wiens, MO (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	mowiens@outlook.com	Kissoon, Niranjan/AAC-6140-2021; Wiens, Matthew/J-9249-2019	Kissoon, Niranjan/0000-0001-8847-9973; Wiens, Matthew/0000-0002-3287-5181; Ansermino, J Mark/0000-0001-8427-2035; Wong, Hubert/0000-0001-8840-4509	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Canadian Child Health Clinician Scientist Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Child Health Clinician Scientist Program	The authors received no specific funding for this work. Matthew Wiens was supported by fellowships from the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the Canadian Child Health Clinician Scientist Program.	[Anonymous], 2006, WHO CHILD GROWTH STA; BENATAR SR, 1973, BRIT J ANAESTH, V45, P711, DOI 10.1093/bja/45.7.711; Clifton DC, 2012, ARCH DIS CHILD, V97, P889, DOI 10.1136/archdischild-2012-301812; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092968; English LL, JMIR MHEALT IN PRESS; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Izadnegahdar R, 2013, LANCET RESP MED, V1, P574, DOI 10.1016/S2213-2600(13)70075-4; Karlen W, 2011, HEALTHINF 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P433; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Shibata R, 1997, STAT SINICA, V7, P375; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2006, HDB IMCI INT MAN CHI	21	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150683	10.1371/journal.pone.0150683	http://dx.doi.org/10.1371/journal.pone.0150683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963914	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000050
J	Oliver, SV; Brooke, BD				Oliver, Shuene V.; Brooke, Basil D.			The Role of Oxidative Stress in the Longevity and Insecticide Resistance Phenotype of the Major Malaria Vectors Anopheles arabiensis and Anopheles funestus	PLOS ONE			English	Article							PYRETHROID RESISTANCE; LABORATORY STRAINS; BLOOD MEAL; ANTIOXIDANTS; MOSQUITOS; AFRICA; ASSAY; DDT; TRANSMISSION; POPULATION	Oxidative stress plays numerous biological roles, both functional and pathological. The role of oxidative stress in various epidemiologically relevant biological traits in Anopheles mosquitoes is not well established. In this study, the effects of oxidative stress on the longevity and insecticide resistance phenotype in the major malaria vector species An. arabiensis and An. funestus were examined. Responses to dietary copper sulphate and hydrogen peroxide were used as proxies for the oxidative stress phenotype by determining the effect of copper on longevity and hydrogen peroxide lethal dose. Glutathione peroxidase and catalase activities were determined colorimetrically. Oxidative burden was quantified as protein carbonyl content. Changes in insecticide resistance phenotype were monitored by WHO bioassay. Insecticide resistant individuals showed an increased capacity for coping with oxidative stress, mediated by increased glutathione peroxidase and catalase activity. This effect was observed in both species, as well as in laboratory strains and F-1 individuals derived from wild-caught An. funestus mothers. Phenotypic capacity for coping with oxidative stress was greatest in strains with elevated Cytochrome P450 activity. Synergism of oxidative stress defence enzymes by dietary supplementation with haematin, 3-Amino-1, 2, 4-triazole and Sodium diethyldithiocarbamate significantly increased pyrethroid-induced mortality in An. arabiensis and An. funestus. It is therefore concluded that defence against oxidative stress underlies the augmentation of the insecticide resistance phenotype associated with multiple blood-feeding. This is because multiple blood-feeding ultimately leads to a reduction of oxidative stress in insecticide resistant females, and also reduces the oxidative burden induced by DDT and pyrethroids, by inducing increased glutathione peroxidase activity. This study highlights the importance of oxidative stress in the longevity and insecticide resistance phenotype in malaria vectors.	[Oliver, Shuene V.; Brooke, Basil D.] Natl Inst Communicable Dis, Vector Control Reference Lab, Ctr Opportunist Trop & Hosp Infect, Johannesburg, South Africa; [Oliver, Shuene V.; Brooke, Basil D.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand	Oliver, SV (corresponding author), Natl Inst Communicable Dis, Vector Control Reference Lab, Ctr Opportunist Trop & Hosp Infect, Johannesburg, South Africa.; Oliver, SV (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa.	shuneo@nicd.ac.za	Oliver, Shune/AAH-4961-2019	Oliver, Shune/0000-0003-0658-6658; Brooke, Basil/0000-0002-8857-1304	National Health Laboratory Services Research trust; National Research Foundation Thuthuka funding instrument	National Health Laboratory Services Research trust; National Research Foundation Thuthuka funding instrument	The authors wish to acknowledge funding from the National Health Laboratory Services Research trust (BDB, SVO) and the National Research Foundation Thuthuka funding instrument (SVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD S, 1990, FREE RADICAL BIO MED, V8, P401, DOI 10.1016/0891-5849(90)90107-T; AHMED HMS, 1994, TOXICOL LETT, V70, P109, DOI 10.1016/0378-4274(94)90150-3; Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; Bahia AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057014; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Choi KS, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0464-z; Choi KS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-173; Chouaibou M, 2014, ACTA TROP, V130, P108, DOI 10.1016/j.actatropica.2013.10.020; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; Gupta SC, 2005, BBA-GEN SUBJECTS, V1725, P81, DOI 10.1016/j.bbagen.2005.04.033; HALLIDAY WR, 1987, PESTIC BIOCHEM PHYS, V28, P172, DOI 10.1016/0048-3575(87)90016-2; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Kaneuchi T, 2003, BIOGERONTOLOGY, V4, P157, DOI 10.1023/A:1024145822785; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Korsloot A, 2004, PLOS ONE; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mesbah H. A., 2002, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V67, P487; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Nardini L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-113; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390; Oliver SV, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-44; OPPENOORTH FJ, 1971, B WORLD HEALTH ORGAN, V44, P195; Otali D, 2014, B ENTOMOL RES, V104, P323, DOI 10.1017/S0007485314000091; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; SHARP BL, 1990, J AM MOSQUITO CONTR, V6, P197; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Spillings BL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-226; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; WHO, 2013, TEST PROC INREMO; Wondji CS, 2014, MALARIA J, V13, pP46; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	41	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151049	10.1371/journal.pone.0151049	http://dx.doi.org/10.1371/journal.pone.0151049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964046	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000095
J	Aribam, SD; Harada, T; Elsheimer-Matulova, M; Iwata, T; Kanehira, K; Hikono, H; Matsui, H; Ogawa, Y; Shimoji, Y; Eguchi, M				Aribam, Swarmistha Devi; Harada, Tomoyuki; Elsheimer-Matulova, Marta; Iwata, Taketoshi; Kanehira, Katsushi; Hikono, Hirokazu; Matsui, Hidenori; Ogawa, Yohsuke; Shimoji, Yoshihiro; Eguchi, Masahiro			Specific Monoclonal Antibody Overcomes the Salmonella enterica Serovar Typhimurium's Adaptive Mechanisms of Intramacrophage Survival and Replication	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; PROTECTIVE IMMUNITY; MEDIATED IMMUNITY; CUTTING EDGE; NONTYPHOIDAL SALMONELLA; POLYACRYLAMIDE-GELS; DENDRITIC CELLS; ORAL CHALLENGE; MOUSE MODEL; IN-VIVO	Salmonella-specific antibodies play an important role in host immunity; however, the mechanisms of Salmonella clearance by pathogen-specific antibodies remain to be completely elucidated since previous studies on antibody-mediated protection have yielded inconsistent results. These inconsistencies are at least partially attributable to the use of polyclonal antibodies against Salmonella antigens. Here, we developed a new monoclonal antibody (mAb)-449 and identified its related immunogen that protected BALB/c mice from infection with Salmonella enterica serovar Typhimurium. In addition, these data indicate that the mAb-449 immunogen is likely a major protective antigen. Using in vitro infection studies, we also analyzed the mechanism by which mAb-449 conferred host protection. Notably, macrophages infected with mAb-449-treated S. Typhimurium showed enhanced pathogen uptake compared to counterparts infected with control IgG-treated bacteria. Moreover, these macrophages produced elevated levels of pro-inflammatory cytokine TNF alpha and nitric oxide, indicating that mAb-449 enhanced macrophage activation. Finally, the number of intracellular bacteria in mAb-449-activated macrophages decreased considerably, while the opposite was found in IgG-treated controls. Based on these findings, we suggest that, although S. Typhimurium has the potential to survive and replicate within macrophages, host production of a specific antibody can effectively mediate macrophage activation for clearance of intracellular bacteria.	[Aribam, Swarmistha Devi; Harada, Tomoyuki; Elsheimer-Matulova, Marta; Iwata, Taketoshi; Kanehira, Katsushi; Hikono, Hirokazu; Ogawa, Yohsuke; Shimoji, Yoshihiro; Eguchi, Masahiro] NARO, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan; [Matsui, Hidenori] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan; [Matsui, Hidenori] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kitasato University; Kitasato University	Eguchi, M (corresponding author), NARO, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	egumaro@affrc.go.jp			Japan Society for the Promotion of Science (JSPS) [25-03213, 15F15099]; JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research to ME (25-03213 and 15F15099) from the Japan Society for the Promotion of Science (JSPS). This work was supported by a postdoctoral fellowship for foreign researchers (to SD Aribam and M Elsheimer-Matulova) provided by the JSPS.; We thank K. Shiraiwa (National Institute of Animal Health) for technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research to ME (25-03213 and 15F15099) from the Japan Society for the Promotion of Science (JSPS). This work was supported by a postdoctoral fellowship for foreign researchers (to SD Aribam and M Elsheimer-Matulova) provided by the JSPS.	Aribam SD, 2014, J MICROBIOL METH, V98, P64, DOI 10.1016/j.mimet.2013.11.012; Barat S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002966; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; Casadevall A, 2004, INFECT IMMUN, V72, P6191, DOI 10.1128/IAI.72.11.6191-6196.2004; Casadevall A, 2003, INFECT IMMUN, V71, P4225, DOI 10.1128/IAI.71.8.4225-4228.2003; DING HF, 1990, J MED MICROBIOL, V31, P95, DOI 10.1099/00222615-31-2-95; Edelson BT, 1999, J IMMUNOL, V163, P4087; Eguchi M, 2007, FEMS IMMUNOL MED MIC, V50, P411, DOI 10.1111/j.1574-695X.2007.00275.x; Eguchi M, 2010, J INFECT DIS, V201, P62, DOI 10.1086/648615; FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627, DOI 10.1128/JCM.28.12.2627-2631.1990; GAHRING LC, 1990, INFECT IMMUN, V58, P443, DOI 10.1128/IAI.58.2.443-448.1990; Goh YS, 2011, IMMUNOLOGY, V133, P74, DOI 10.1111/j.1365-2567.2011.03411.x; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Grant AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003070; Iankov ID, 2004, MICROBES INFECT, V6, P901, DOI 10.1016/j.micinf.2004.05.007; Killion J W, 1988, FEMS Microbiol Immunol, V1, P41; Ko HJ, 2009, J IMMUNOL, V182, P2305, DOI 10.4049/jimmunol.0801980; Lalmanach AC, 1999, MICROBES INFECT, V1, P719, DOI 10.1016/S1286-4579(99)80073-2; Lee SJ, 2012, P NATL ACAD SCI USA, V109, P4998, DOI 10.1073/pnas.1111413109; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; MASTROENI P, 1993, MICROB PATHOGENESIS, V14, P473, DOI 10.1006/mpat.1993.1046; MASTROENI P, 1993, INFECT IMMUN, V61, P3981, DOI 10.1128/IAI.61.9.3981-3984.1993; McSorley SJ, 2000, INFECT IMMUN, V68, P3344, DOI 10.1128/IAI.68.6.3344-3348.2000; Menager N, 2007, IMMUNOLOGY, V120, P424, DOI 10.1111/j.1365-2567.2006.02527.x; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; NIWA M, 1969, J BACTERIOL, V97, P1069, DOI 10.1128/JB.97.3.1069-1077.1969; OBRIEN AD, 1979, J IMMUNOL, V123, P720; Pontes MH, 2015, P NATL ACAD SCI USA, V112, P5183, DOI 10.1073/pnas.1500989112; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rondini S, 2013, MICROB PATHOGENESIS, V63, P19, DOI 10.1016/j.micpath.2013.05.014; Siggins MK, 2011, J IMMUNOL, V186, P2365, DOI 10.4049/jimmunol.1000284; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Svensson M, 2000, INFECT IMMUN, V68, P6311, DOI 10.1128/IAI.68.11.6311-6320.2000; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Trebicka E, 2013, CLIN VACCINE IMMUNOL, V20, P1491, DOI 10.1128/CVI.00289-13; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Uppington H, 2006, IMMUNOLOGY, V119, P147, DOI 10.1111/j.1365-2567.2006.02416.x; Vassiloyanakopoulos AP, 1998, P NATL ACAD SCI USA, V95, P7676, DOI 10.1073/pnas.95.13.7676; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Yamamoto T, 2001, INFECT IMMUN, V69, P3164, DOI 10.1128/IAI.69.5.3164-3174.2001	49	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151352	10.1371/journal.pone.0151352	http://dx.doi.org/10.1371/journal.pone.0151352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986057	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300065
J	Palermo, GD; Neri, QV; Cozzubbo, T; Cheung, S; Pereira, N; Rosenwaks, Z				Palermo, Gianpiero D.; Neri, Queenie V.; Cozzubbo, Tyler; Cheung, Stephanie; Pereira, Nigel; Rosenwaks, Zev			Shedding Light on the Nature of Seminal Round Cells	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; PREGNANCY RATES; GOOD-SAMARITANS; SEMEN ANALYSIS; INFERTILE MEN; LEUKOCYTOSPERMIA; LEUKOCYTES; FERTILIZATION; QUALITY; SPERMATOZOA	Introduction In this investigation we assess the incidence of round cells (RCs) in semen samples in our infertile patient population and their significance on intracytoplasmic sperm injection (ICSI) cycle outcomes. We also evaluate the usefulness of RCs as indicators of bacterial infection and highlight the origin of this cell-type, as well as its role in the human ejaculate. Patients and Methods In a prospective fashion, a total of 4,810 ejaculated samples were included in the study during a period of 24 months. RCs were characterized for white blood cell (WBC) components versus exfoliated germ cells by testing for multiple markers of ploidy as well as protamine assays. Cases displaying >= 2 x 10(6)/ml RCs were screened for bacteria. Raw specimens containing RC were processed by peroxidase and other leukocyte assays, specific stains for protamines were used to identify spermiogenic stage, aneuploidy (FISH) assessment was carried out, and the presence of various Sertoli-cell cytoplasmic remnants was analyzed to identify and characterize immature germ cells. The effect of RC on clinical outcome was assessed in specimens used for ICSI. Results The average age of the men involved was 39.2 +/- 7 years. Semen samples had a mean concentration of 40.7 +/- 31 x 10(6)/ml, motility of 42.6 +/- 35%, and morphology of 2.3 +/- 2%. RCs were identified in 261 specimens, representing a proportion of 5.4%. Men with RCs had comparable age but lower sperm concentration and morphology than the control group (P<0.001). The aneuploidy rate of 4.3% in RCs group was remarkably higher than the control group (2.3%; P<0.001). Sperm aneuploidy rate positively correlated with the number of RCs (P<0.001). Of 44 men, 17 of them in 18 cycles had up to 1.9 x 10(6)/ml RCs without affecting fertilization and clinical pregnancy rates when compared to controls (n = 365 cycles). In 27 men undergoing 33 ICSI cycles with >= 2 x 10(6)/ml RCs, the fertilization rate trended lower and the miscarriage rate was significantly increased (P = 0.05). There was lack of correlation between RC and bacteriological growth. Specific markers indicated that seminal RCs are mostly immature germ cells encased in the remnants of Sertoli cell cytoplasm. Moreover, their modest protamine content and their haploid status confirm that they are post-meiotic. Sequential observation in the same man showed that RC episodes were followed by an amelioration of semen parameters, and interestingly, the episodic occurrence of RCs often coincides with flu season peaks. Conclusions Seminal RCs are not a marker of infectiousness but rather a transient indicator of spermatogenic insult that possibly occurs in most men following a mild and transient ailment such as the flu.	[Palermo, Gianpiero D.; Neri, Queenie V.; Cozzubbo, Tyler; Cheung, Stephanie; Pereira, Nigel; Rosenwaks, Zev] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA	Cornell University	Palermo, GD (corresponding author), Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA.	gdpalerm@med.cornell.edu		Cheung, Stephanie/0000-0002-2092-7001				Agarwal A, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-126; Agarwal A, 2014, WORLD J MENS HEALTH, V32, P1, DOI 10.5534/wjmh.2014.32.1.1; AITKEN RJ, 1992, J REPROD FERTIL, V94, P451; AITKEN RJ, 1995, HUM REPROD, V10, P1736, DOI 10.1093/oxfordjournals.humrep.a136165; [Anonymous], 2010, WHO LAB MAN EX PROC; Aziz N, 2004, FERTIL STERIL, V81, P349, DOI 10.1016/j.fertnstert.2003.06.026; Bachir BG, 2014, UROL CLIN N AM, V41, P67, DOI 10.1016/j.ucl.2013.08.008; Barraud-Lange V, 2011, FERTIL STERIL, V96, P1315, DOI 10.1016/j.fertnstert.2011.09.035; BERGMANN M, 1994, ANAT EMBRYOL, V190, P515; Bugge M, 2007, HUM MOL GENET, V16, P2004, DOI 10.1093/hmg/ddm148; Cavagna M, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-44; Colombero LT, 1999, FERTIL STERIL, V72, P90, DOI 10.1016/S0015-0282(99)00158-2; Domes T, 2012, FERTIL STERIL, V97, P1050, DOI 10.1016/j.fertnstert.2012.01.124; Duan YG, 2014, FERTIL STERIL, V101, P70, DOI 10.1016/j.fertnstert.2013.09.006; Elder K, 2004, INFECT FERTILITY ASS; Focacci M, 1997, HUM REPROD, V12, P39, DOI 10.1093/humrep/12.1.39; Gambera L, 2007, HUM REPROD, V22, P1047, DOI 10.1093/humrep/del490; Gosden LV, 2014, METHODS MOL BIOL, V1154, P343, DOI 10.1007/978-1-4939-0659-8_16; Huang JYJ, 2012, BEST PRACT RES CL OB, V26, P777, DOI 10.1016/j.bpobgyn.2012.08.017; Irving C, 2011, J MATERN-FETAL NEO M, V24, P137, DOI 10.3109/14767051003758879; Johanisson E, 2000, HUM REPROD UPDATE, V6, P404, DOI 10.1093/humupd/6.4.404; KIESSLING AA, 1995, FERTIL STERIL, V64, P196, DOI 10.1016/S0015-0282(16)57681-X; Lackner JE, 2008, FERTIL STERIL, V90, P869, DOI 10.1016/j.fertnstert.2007.07.1310; Lackner JE, 2006, FERTIL STERIL, V86, P601, DOI 10.1016/j.fertnstert.2006.01.032; Ludwig M, 2003, WORLD J UROL, V21, P82, DOI 10.1007/s00345-003-0330-7; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Neri QV, 2014, CELL CALCIUM, V55, P24, DOI 10.1016/j.ceca.2013.10.006; Nicolaidis P, 1998, HUM REPROD, V13, P313, DOI 10.1093/humrep/13.2.313; Nistal M, 2011, HISTOPATHOLOGY, V58, P1019, DOI 10.1111/j.1365-2559.2011.03858.x; Palermo GD, 1996, HUM REPROD, V11, P1023; Palermo GD, 2002, HUM REPROD, V17, P570, DOI 10.1093/humrep/17.3.570; PALERMO GD, 1995, FERTIL STERIL, V63, P1231, DOI 10.1016/S0015-0282(16)57603-1; Palermo GD, 2014, FERTIL STERIL, V102, P1508, DOI 10.1016/j.fertnstert.2014.10.008; Palermo GD, 2008, REPROD BIOMED ONLINE, V17, P820, DOI 10.1016/S1472-6483(10)60411-7; Patil PS, 2013, J CYTOL, V30, P185, DOI 10.4103/0970-9371.117682; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; POLITCH JA, 1993, FERTIL STERIL, V60, P372; Ramesh KH, 1996, ANN GENET-PARIS, V39, P110; Rodin DM, 2003, FERTIL STERIL, V79, P1555, DOI 10.1016/S0015-0282(03)00340-6; Rosenwaks Z, 2014, METHODS MOL BIOL, V1154, P1, DOI 10.1007/978-1-4939-0659-8; Saleh RA, 2002, FERTIL STERIL, V78, P491, DOI 10.1016/S0015-0282(02)03294-6; Thomas J, 1997, HUM REPROD, V12, P2418, DOI 10.1093/humrep/12.11.2418; Trum JW, 1998, FERTIL STERIL, V70, P315, DOI 10.1016/S0015-0282(98)00163-0; Wolff H, 1998, ANDROLOGIA, V30, P35; Yanushpolsky EH, 1996, FERTIL STERIL, V66, P822, DOI 10.1016/S0015-0282(16)58643-9	45	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151640	10.1371/journal.pone.0151640	http://dx.doi.org/10.1371/journal.pone.0151640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982590	gold, Green Submitted, Green Published			2022-12-27	WOS:000372574900107
J	Avilov, S; Magnus, J; Cusack, S; Naffakh, N				Avilov, Sergiy; Magnus, Julie; Cusack, Stephen; Naffakh, Nadia			Time-Resolved Visualisation of Nearly-Native Influenza A Virus Progeny Ribonucleoproteins and Their Individual Components in Live Infected Cells	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; H5N1 NUCLEOPROTEIN; VIRAL POLYMERASE; RNA-POLYMERASE; AMINO-ACID; PROTEIN; OLIGOMERIZATION; REPLICATION; COMPLEXES; TRANSPORT	Influenza viruses are a global health concern because of the permanent threat of novel emerging strains potentially capable of causing pandemics. Viral ribonucleoproteins (vRNPs) containing genomic RNA segments, nucleoprotein oligomers, and the viral polymerase, play a central role in the viral replication cycle. Our knowledge about critical events such as vRNP assembly and interactions with other viral and cellular proteins is poor and could be substantially improved by time lapse imaging of the infected cells. However, such studies are limited by the difficulty to achieve live-cell compatible labeling of active vRNPs. Previously we designed the first unimpaired recombinant influenza WSN-PB2-GFP11 virus allowing fluorescent labeling of the PB2 subunit of the viral polymerase (Avilov et al., J. Virol. 2012). Here, we simultaneously labeled the viral PB2 protein using the above-mentioned strategy, and virus-encoded progeny RNPs through spontaneous incorporation of transiently expressed NP-mCherry fusion proteins during RNP assembly in live infected cells. This dual labeling enabled us to visualize progeny vRNPs throughout the infection cycle and to characterize independently the mobility, oligomerization status and interactions of vRNP components in the nuclei of live infected cells.	[Avilov, Sergiy; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France; [Avilov, Sergiy; Cusack, Stephen] Univ Grenoble Alpes, CNRS, UMI 3265, EMBL Int Unit Virus Host Cell Interact, Grenoble, France; [Magnus, Julie; Naffakh, Nadia] Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, Paris, France; [Magnus, Julie; Naffakh, Nadia] CNRS, UMR 3569, Paris, France; [Magnus, Julie; Naffakh, Nadia] Univ Paris Diderot, Sorbonne Paris Cite, Unite Genet Mol Virus ARN, Paris, France; [Avilov, Sergiy] Max Planck Inst Immunobiol & Epigenet, Stuebeweg 51, Freiburg, Germany	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society	Avilov, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France.; Avilov, S (corresponding author), Univ Grenoble Alpes, CNRS, UMI 3265, EMBL Int Unit Virus Host Cell Interact, Grenoble, France.; Naffakh, N (corresponding author), Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, Paris, France.; Naffakh, N (corresponding author), CNRS, UMR 3569, Paris, France.; Naffakh, N (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Unite Genet Mol Virus ARN, Paris, France.; Avilov, S (corresponding author), Max Planck Inst Immunobiol & Epigenet, Stuebeweg 51, Freiburg, Germany.	avilov@ie-freiburg.mpg.de; nadia.naffakh@pasteur.fr		Cusack, Stephen/0000-0002-9324-0796; Naffakh, Nadia/0000-0002-0424-0277	European Community [PIEF-GA-2009-236959]; EIPOD fellowship (EMBL); EU [259751]	European Community(European Commission); EIPOD fellowship (EMBL); EU(European Commission)	S.A. was supported by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (Grant Agreement PIEF-GA-2009-236959), and by an EIPOD fellowship (EMBL). This work was supported in part by the EU FP7 funded FLUPHARM project (FP7-INFLUENZA-2010 grant 259751, http://flupharm.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Amorim MJ, 2013, J VIROL, V87, P4694, DOI 10.1128/JVI.03123-12; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Avilov SV, 2012, VACCINE, V30, P7411, DOI 10.1016/j.vaccine.2012.09.077; Avilov SV, 2012, J VIROL, V86, P1433, DOI 10.1128/JVI.05820-11; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cauldwell AV, 2013, J VIROL, V87, P1278, DOI 10.1128/JVI.02597-12; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Chase GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002187; Chenavas S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003275; Chou YY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003358; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; Goldman R. D., 2010, LIVE CELL IMAGING; Gui X, 2014, VIROLOGY, V464, P11, DOI 10.1016/j.virol.2014.06.033; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Hutchinson EC, 2013, VIRUSES-BASEL, V5, P2424, DOI 10.3390/v5102424; Keppler A, 2009, ACS CHEM BIOL, V4, P127, DOI 10.1021/cb800298u; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lakdawala SS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003971; Loucaides EM, 2009, VIROLOGY, V394, P154, DOI 10.1016/j.virol.2009.08.015; Marklund JK, 2012, J VIROL, V86, P7292, DOI 10.1128/JVI.00014-12; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Moisy D, 2012, J VIROL, V86, P9122, DOI 10.1128/JVI.00789-12; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Mondal A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004826; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036415; Noda T, 2010, REV MED VIROL, V20, P380, DOI 10.1002/rmv.666; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Paterson D, 2014, J VIROL, V88, P339, DOI 10.1128/JVI.02022-13; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takizawa N, 2006, MICROBES INFECT, V8, P823, DOI 10.1016/j.micinf.2005.10.005; Tarus B, 2012, BIOCHIMIE, V94, P776, DOI 10.1016/j.biochi.2011.11.009; Turrell L, 2015, J VIROL, V89, P1452, DOI 10.1128/JVI.02332-14; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Vreede FT, 2010, VIROLOGY, V396, P125, DOI 10.1016/j.virol.2009.10.003; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396	52	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149986	10.1371/journal.pone.0149986	http://dx.doi.org/10.1371/journal.pone.0149986			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978069	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800019
J	Liu, XL; Gai, SS; Zhou, J				Liu, Xue-Li; Gai, Shuang-Shuang; Zhou, Jing			Journal Impact Factor: Do the Numerator and Denominator Need Correction?	PLOS ONE			English	Article							LABELED EDITORIAL MATERIAL; CITATION-REPORTS; SOCIAL-SCIENCES; CRITIQUE; INDEX	To correct the incongruence of document types between the numerator and denominator in the traditional impact factor (IF), we make a corresponding adjustment to its formula and present five corrective IFs: IFTotal/Total, IFTotal/AREL, IFAR/AR, IFAREL/AR, and IFAREL/AREL. Based on a survey of researchers in the fields of ophthalmology and mathematics, we obtained the real impact ranking of sample journals in the minds of peer experts. The correlations between various IFs and questionnaire score were analyzed to verify their journal evaluation effects. The results show that it is scientific and reasonable to use five corrective IFs for journal evaluation for both ophthalmology and mathematics. For ophthalmology, the journal evaluation effects of the five corrective IFs are superior than those of traditional IF: the corrective effect of IFAR/AR is the best, IFAREL/AR is better than IFTotal/Total, followed by IFTotal/AREL, and IFAREL/AREL. For mathematics, the journal evaluation effect of traditional IF is superior than those of the five corrective IFs: the corrective effect of IFTotal/Total is best, IFAREL/AR is better than IFTotal/AREL and IFAREL/AREL, and the corrective effect of IFAR/AR is the worst. In conclusion, not all disciplinary journal IF need correction. The results in the current paper show that to correct the IF of ophthalmologic journals may be valuable, but it seems to be meaningless for mathematic journals.	[Liu, Xue-Li] Xinxiang Med Univ, Henan Res Ctr Sci Journals, Xinxiang, Henan Province, Peoples R China; [Liu, Xue-Li; Gai, Shuang-Shuang; Zhou, Jing] Xinxiang Med Univ, Period Publishing House, Xinxiang, Henan Province, Peoples R China; [Gai, Shuang-Shuang; Zhou, Jing] Xinxiang Med Univ, Management Inst, Xinxiang, Henan Province, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University	Liu, XL (corresponding author), Xinxiang Med Univ, Henan Res Ctr Sci Journals, Xinxiang, Henan Province, Peoples R China.; Liu, XL (corresponding author), Xinxiang Med Univ, Period Publishing House, Xinxiang, Henan Province, Peoples R China.	hrcsj2009@163.com			National Social Science Found of China [15BTQ061]	National Social Science Found of China	This work was supported by grant number: 15BTQ061 from theNational Social Science Found of China. The URLs of funder's website: http://www.npopss-cn.gov.cn/n/2015/0625/c219469-27206694.html.	[Anonymous], 2015, J CITATION REPORTS; Bensman SJ, 2008, J AM SOC INF SCI TEC, V59, P1366, DOI 10.1002/asi.20810; Bornmann L, 2011, SCIENTOMETRICS, V86, P93, DOI 10.1007/s11192-010-0250-4; Brzezinski M, 2014, J INFORMETR, V8, P362, DOI 10.1016/j.joi.2014.01.009; Dorta-Gonzalez P, 2014, J INFORMETR, V8, P406, DOI 10.1016/j.joi.2014.01.013; Fersht A, 2009, P NATL ACAD SCI USA, V106, P6883, DOI 10.1073/pnas.0903307106; Fleck C, 2013, ARCH EUR SOCIOL, V54, P327, DOI 10.1017/S0003975613000167; Gai SS, 2014, CHINESE J SCI TECHNO, V25, P980; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; GARFIELD E, 1963, AM DOC, V14, P195, DOI 10.1002/asi.5090140304; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Gonzalez L, 2007, J AM SOC INF SCI TEC, V58, P252, DOI 10.1002/asi.20424; Gonzalez-Pereira B, 2010, J INFORMETR, V4, P379, DOI 10.1016/j.joi.2010.03.002; Harnad S, 2008, ETHICS SCI ENV POLIT, V11, P103; Hernan MA, 2008, EPIDEMIOLOGY, V19, P366, DOI 10.1097/EDE.0b013e31816a9e28; Jackson A, 2010, BRIT J RADIOL, V83, P93, DOI 10.1259/bjr/18689409; Jacso P, 2009, ONLINE INFORM REV, V33, P603, DOI 10.1108/14684520910969989; Jones AW, 2007, FORENSIC SCI INT, V165, P115, DOI 10.1016/j.forsciint.2006.05.013; Liu XL, 2015, ACTA EDITOLOGICA, V27, P495; Liu XL, 2014, ACTA EDITOLOGICA, V26, P296; Lozano GA, 2012, J AM SOC INF SCI TEC, V63, P2140, DOI 10.1002/asi.22731; McKerahan TL, 2012, CLIN ANAT, V25, P283, DOI 10.1002/ca.21291; Campanario JM, 2006, SCIENTOMETRICS, V69, P365, DOI 10.1007/s11192-006-0158-1; Campanario JM, 2011, J AM SOC INF SCI TEC, V62, P230, DOI 10.1002/asi.21457; Moed HF, 1996, SCIENTOMETRICS, V37, P105, DOI 10.1007/BF02093487; MOED HF, 1995, J AM SOC INFORM SCI, V46, P461, DOI 10.1002/(SICI)1097-4571(199507)46:6<461::AID-ASI5>3.0.CO;2-G; Opthof T, 2014, NETHERLANDS HEART J, V22, P167; Pendlebury DA, 2012, SCIENTOMETRICS, V92, P395, DOI 10.1007/s11192-012-0689-6; Reynolds JC, 2012, ACAD EMERG MED, V19, P1248, DOI 10.1111/acem.12017; Tort ABL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053374; van Leeuwen T, 2012, SCIENTOMETRICS, V92, P443, DOI 10.1007/s11192-012-0677-x; van Nierop E, 2010, STAT NEERL, V64, P71, DOI 10.1111/j.1467-9574.2009.00448.x; Wan H, 2015, LIB INFORM SERVICE, V59, P120; Wang P, 2013, CHINESE J SCI TECHNI, V24, P838; Weale AR, 2004, BMC MED RES METHODOL, V4, P1; Wu XF, 2008, J ZHEJIANG UNIV-SC B, V9, P582, DOI 10.1631/jzus.B0840001; Wu YS, 2014, DEFINITION IMPACT FA; Xu HY, 2012, J INTELLIGENCE, V31, P50	39	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151414	10.1371/journal.pone.0151414	http://dx.doi.org/10.1371/journal.pone.0151414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977697	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800072
J	Tong, HY; Davila-Fajardo, CL; Borobia, AM; Martinez-Gonzalez, LJ; Lubomirov, R; Leon, LMP; Banares, MJB; Diaz-Villamarin, X; Fernandez-Capitan, C; Barrera, JC; Carcas, AJ				Tong, Hoi Y.; Lucia Davila-Fajardo, Cristina; Borobia, Alberto M.; Javier Martinez-Gonzalez, Luis; Lubomirov, Rubin; Perea Leon, Laura Maria; Blanco Banares, Maria J.; Diaz-Villamarin, Xando; Fernandez-Capitan, Carmen; Cabeza Barrera, Jose; Carcas, Antonio J.		PGX-ACE Investigators Grp	A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population	PLOS ONE			English	Article							WARFARIN DOSE REQUIREMENTS; ACUTE PULMONARY-EMBOLISM; ATRIAL-FIBRILLATION; RANDOMIZED-TRIAL; DOSING ALGORITHM; THERAPY; VKORC1; CYP2C9; POLYMORPHISMS; ASSOCIATION	There is a strong association between genetic polymorphisms and the acenocoumarol dosage requirements. Genotyping the polymorphisms involved in the pharmacokinetics and pharmacodynamics of acenocoumarol before starting anticoagulant therapy would result in a better quality of life and a more efficient use of healthcare resources. The objective of this study is to develop a new algorithm that includes clinical and genetic variables to predict the most appropriate acenocoumarol dosage for stable anticoagulation in a wide range of patients. We recruited 685 patients from 2 Spanish hospitals and 1 primary healthcare center. We randomly chose 80% of the patients (n = 556), considering an equitable distribution of genotypes to form the generation cohort. The remaining 20% (n = 129) formed the validation cohort. Multiple linear regression was used to generate the algorithm using the acenocoumarol stable dosage as the dependent variable and the clinical and genotypic variables as the independent variables. The variables included in the algorithm were age, weight, amiodarone use, enzyme inducer status, international normalized ratio target range and the presence of CYP2C9*2 (rs1799853), CYP2C9*3 (rs1057910), VKORC1 (rs9923231) and CYP4F2 (rs2108622). The coefficient of determination (R-2) explained by the algorithm was 52.8% in the generation cohort and 64% in the validation cohort. The following R-2 values were evaluated by pathology: atrial fibrillation, 57.4%; valve replacement, 56.3%; and venous thromboembolic disease, 51.5%. When the patients were classified into 3 dosage groups according to the stable dosage (<11 mg/week, 11-21 mg/week, >21 mg/week), the percentage of correctly classified patients was higher in the intermediate group, whereas differences between pharmacogenetic and clinical algorithms increased in the extreme dosage groups. Our algorithm could improve acenocoumarol dosage selection for patients who will begin treatment with this drug, especially in extreme-dosage patients. The predictability of the pharmacogenetic algorithm did not vary significantly between diseases.	[Tong, Hoi Y.; Borobia, Alberto M.; Carcas, Antonio J.] IdiPAZ, La Paz Univ Hosp, Dept Clin Pharmacol, Madrid, Spain; [Lucia Davila-Fajardo, Cristina; Perea Leon, Laura Maria; Diaz-Villamarin, Xando; Cabeza Barrera, Jose] San Cecilio Univ Hosp, Dept Clin Pharm, Inst Biomed Res, Granada, Spain; [Javier Martinez-Gonzalez, Luis] Pfizer Univ Granada Andalusian Reg Govt, Ctr Genom & Oncol Res GENYO, Genom Unit, Hlth Sci Technol Pk, Granada, Spain; [Borobia, Alberto M.; Lubomirov, Rubin; Carcas, Antonio J.] Autonomous Univ Madrid, IdiPAZ, Sch Med, Dept Pharmacol, E-28049 Madrid, Spain; [Blanco Banares, Maria J.] La Paz Univ Hosp, Dept Hematol, Madrid, Spain; [Fernandez-Capitan, Carmen] La Paz Univ Hosp, IdiPAZ, Dept Internal Med, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario San Cecilio; Pfizer; University of Granada; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz	Borobia, AM; Carcas, AJ (corresponding author), IdiPAZ, La Paz Univ Hosp, Dept Clin Pharmacol, Madrid, Spain.; Borobia, AM; Carcas, AJ (corresponding author), Autonomous Univ Madrid, IdiPAZ, Sch Med, Dept Pharmacol, E-28049 Madrid, Spain.	a.borobia@gmail.com; antonio.carcas@uam.es	Martinez-Gonzalez, Luis Javier/L-6136-2014; Carcas, Antonio J/E-1149-2012; diaz-villamarin, xando/AAA-7223-2020; Borobia, Alberto M./H-6887-2013	Martinez-Gonzalez, Luis Javier/0000-0003-2202-0662; Carcas, Antonio J/0000-0003-1823-4174; diaz-villamarin, xando/0000-0003-0849-9902; DAVILA-FAJARDO, CRISTINA LUCIA/0000-0003-3339-239X; Borobia, Alberto M./0000-0002-8584-3263	Spanish Ministry of Health and Social Policy (Instituto de Salud Carlos III) [PI07/0710]; Andalusian Regional Ministry of Health (Progress and Health Foundation) [PI-0717-2013]	Spanish Ministry of Health and Social Policy (Instituto de Salud Carlos III); Andalusian Regional Ministry of Health (Progress and Health Foundation)	This study was funded by a grant from the Spanish Ministry of Health and Social Policy (Instituto de Salud Carlos III, PI07/0710) and the Andalusian Regional Ministry of Health (Progress and Health Foundation, PI-0717-2013). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Borobia AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041360; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Cerezo-Manchado JJ, 2013, THROMB HAEMOSTASIS, V109, P146, DOI 10.1160/TH12-08-0631; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Go AS, 2000, CIRCULATION, V102, P11, DOI 10.1161/01.CIR.102.1.11; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Gomez-Martin A, 2015, CHEMOSPHERE, V139, P534, DOI 10.1016/j.chemosphere.2015.07.079; HERMANS JJR, 1993, BRIT J PHARMACOL, V110, P482, DOI 10.1111/j.1476-5381.1993.tb13836.x; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Jimenez-Varo E, 2015, VASC PHARMACOL, V74, P151, DOI 10.1016/j.vph.2015.06.010; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kumar DK, 2015, EUR J CLIN PHARMACOL, V71, P173, DOI 10.1007/s00228-014-1791-x; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Michaud V, 2008, CLIN PHARMACOL THER, V83, P740, DOI 10.1038/sj.clpt.6100434; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Moreau C, 2011, J THROMB HAEMOST, V9, P711, DOI 10.1111/j.1538-7836.2011.04213.x; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Rathore SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037844; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; Thijssen HH, 2000, DRUG METAB DISPOS, V28, P1284; van Schie RMF, 2011, EUR HEART J, V32, P1909, DOI 10.1093/eurheartj/ehr116; Verde Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011210; Verhoef TI, 2013, NEW ENGL J MED, V369, P2304, DOI 10.1056/NEJMoa1311388; Zambon CF, 2011, PHARMACOGENOMICS, V12, P15, DOI [10.2217/pgs.10.162, 10.2217/PGS.10.162]	35	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150456	10.1371/journal.pone.0150456	http://dx.doi.org/10.1371/journal.pone.0150456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977927	Green Submitted, gold, Green Published			2022-12-27	WOS:000372572800026
J	Vodenska, I; Aoyama, H; Fujiwara, Y; Iyetomi, H; Arai, Y				Vodenska, Irena; Aoyama, Hideaki; Fujiwara, Yoshi; Iyetomi, Hiroshi; Arai, Yuta			Interdependencies and Causalities in Coupled Financial Networks	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; EXCHANGE-RATES; STOCK-PRICES; EQUITY; PREDICTABILITY; RETURNS; RISK; SYSTEM; TRADE	We explore the foreign exchange and stock market networks for 48 countries from 1999 to 2012 and propose a model, based on complex Hilbert principal component analysis, for extracting significant lead-lag relationships between these markets. The global set of countries, including large and small countries in Europe, the Americas, Asia, and the Middle East, is contrasted with the limited scopes of targets, e.g., G5, G7 or the emerging Asian countries, adopted by previous works. We construct a coupled synchronization network, perform community analysis, and identify formation of four distinct network communities that are relatively stable over time. In addition to investigating the entire period, we divide the time period into into "mild crisis," (1999-2002), "calm," (2003-2006) and "severe crisis" (2007-2012) sub-periods and find that the severe crisis period behavior dominates the dynamics in the foreign exchange-equity synchronization network. We observe that in general the foreign exchange market has predictive power for the global stock market performances. In addition, the United States, German and Mexican markets have forecasting power for the performances of other global equity markets.	[Vodenska, Irena] Boston Univ, Metropolitan Coll, 808 Commonwealth Ave, Boston, MA 02215 USA; [Vodenska, Irena] Boston Univ, Ctr Polymer Studies, 590 Commonwealth Ave, Boston, MA 02215 USA; [Aoyama, Hideaki] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; [Fujiwara, Yoshi] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo 6500047, Japan; [Iyetomi, Hiroshi; Arai, Yuta] Niigata Univ, Dept Math, Niigata 9502181, Japan	Boston University; Boston University; Kyoto University; University of Hyogo; Niigata University	Vodenska, I (corresponding author), Boston Univ, Metropolitan Coll, 808 Commonwealth Ave, Boston, MA 02215 USA.; Vodenska, I (corresponding author), Boston Univ, Ctr Polymer Studies, 590 Commonwealth Ave, Boston, MA 02215 USA.	vodenska@bu.edu	Vodenska, Irena/AAR-7025-2021		JSPS [25282094, 25400393]; Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS; National Science Foundation (NSF) [SES 1452061]; European Community under Socio-economic Sciences and Humanities [255987, 297149]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); European Community under Socio-economic Sciences and Humanities	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) Grant Numbers 25282094 and 25400393 by JSPS, the Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the JSPS, the National Science Foundation (NSF) Grant SES 1452061, and the European Community Seventh Framework Programme (FP7/2007-2013) under Socio-economic Sciences and Humanities, grant agreement no. 255987 (FOC-II) and 297149 (FOC-INCO).	Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; Ang A, 2007, REV FINANC STUD, V20, P651, DOI 10.1093/rfs/hhl021; [Anonymous], [No title captured]; [Anonymous], 2008, ECONOMIST; Aoyama H, 2013, RIETI DISCUSSION PAP, P1; Arai Y, 2013, FRONT ARTIF INTEL AP, V255, P111, DOI 10.3233/978-1-61499-264-6-111; Bae KH, 2003, REV FINANC STUD, V16, P717, DOI 10.1093/rfs/hhg012; BARNETT TP, 1983, MON WEATHER REV, V111, P756, DOI 10.1175/1520-0493(1983)111<0756:IOTMAP>2.0.CO;2; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; BEKAERT G, 1992, J FINANC, V47, P467, DOI 10.2307/2329113; Bekaert G, 2009, J FINANC, V64, P2591, DOI 10.1111/j.1540-6261.2009.01512.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bollerslev T, 2012, STOCK RETURN PREDICT; BREEN W, 1989, J FINANC, V44, P1177, DOI 10.2307/2328638; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016112; Bussiere M, 2006, J INT MONEY FINANC, V25, P953, DOI 10.1016/j.jimonfin.2006.07.007; Cappiello L, 2005, CITESEER; Cochrane JH, 2008, REV FINANC STUD, V21, P1533, DOI 10.1093/rfs/hhm046; Dahlquist M, 2013, J INT ECON, V90, P17, DOI 10.1016/j.jinteco.2012.11.008; Davis EP, 2008, J FINANC STABIL, V4, P89, DOI 10.1016/j.jfs.2007.12.004; Dehmamy N, 2014, ARXIV14100104; DOOLEY M, 1982, J INT ECON, V12, P257, DOI 10.1016/0022-1996(82)90039-3; DORNBUSCH R, 1980, AM ECON REV, V70, P960; Elliott M, 2014, FINANCIAL NETWORKS C; FAMA EF, 1989, J FINANC ECON, V25, P23, DOI 10.1016/0304-405X(89)90095-0; FAMA EF, 1988, J FINANC ECON, V22, P3, DOI 10.1016/0304-405X(88)90020-7; Ferreira MA, 2011, J FINANC ECON, V100, P514, DOI 10.1016/j.jfineco.2011.02.003; FERSON WE, 1993, REV FINANC STUD, V6, P527, DOI 10.1093/rfs/5.3.527; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Frenkel D., 2001, UNDERSTANDING MOL SI, V1, DOI DOI 10.1016/B978-012267351-1/50003-; Gagnon L., 2006, FINANC MARKETS I INS, V15, P107, DOI DOI 10.1111/J.1468-0416.2006.00115.X; Gai P, 2011, J MONETARY ECON, V58, P453, DOI 10.1016/j.jmoneco.2011.05.005; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Granger C.W., 2000, Q REV ECON FINANC, V40, P337, DOI DOI 10.1016/S1062-9769(00)00042-9; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hannachi A, 2007, INT J CLIMATOL, V27, P1119, DOI 10.1002/joc.1499; HARVEY CR, 1991, J FINANC, V46, P111, DOI 10.2307/2328691; Hjalmarsson E., 2010, PREDICTING GLOBAL ST; Hong H, 2007, J FINANC ECON, V83, P367, DOI 10.1016/j.jfineco.2005.09.010; HOREL JD, 1984, J CLIM APPL METEOROL, V23, P1660, DOI 10.1175/1520-0450(1984)023<1660:CPCATA>2.0.CO;2; Hu Y, 2005, MATH J 10, V10, P37, DOI DOI 10.3402/QHW.V6I2.5918; Huang XQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01219; Huang XQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046101; Ingram P, 2005, AM J SOCIOL, V111, P824, DOI 10.1086/497350; Iyetomi H, 2011, J JPN INT ECON, V25, P246, DOI 10.1016/j.jjie.2011.06.002; Iyetomi H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016103; Katechos G, 2011, J INT FINANC MARK I, V21, P550, DOI 10.1016/j.intfin.2011.03.001; Lin CH, 2012, INT REV ECON FINANC, V22, P161, DOI 10.1016/j.iref.2011.09.006; Majdandzic A, 2015, ARXIV150200244; Marcenko V. A., 1967, MATH USSR SB, V1, P457, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Minoiu C, 2013, J FINANC STABIL, V9, DOI 10.1016/j.jfs.2013.03.001; Morley B, 2002, J POLICY MODEL, V24, P523, DOI 10.1016/S0161-8938(02)00126-6; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nieh C.C., 2002, Q REV EC FINANCE, V41, P477, DOI [DOI 10.1016/S1062-9769(01)00085-0, 10.1016/S1062-9769]; Ning C, 2010, J INT MONEY FINANC, V29, P743, DOI 10.1016/j.jimonfin.2009.12.002; Pan M.S., 2007, INT REV ECON FINANC, V16, P503, DOI DOI 10.1016/J.IREF.2005.09.003; Patro D. K., 2004, J EMPIR FINANC, V11, P553, DOI DOI 10.1016/J.JEMPFIN.2004.02.003; Pelizzon L., 2010, ECONOMETRIC MEASURES; Rapach David, 2006, J EMPIR FINANC, V13, P231, DOI DOI 10.1016/J.JEMPFIN.2005.08.001; Rapach DE, 2013, J FINANC, V68, P1633, DOI 10.1111/jofi.12041; RASMUSSON EM, 1981, MON WEATHER REV, V109, P587, DOI 10.1175/1520-0493(1981)109<0587:BVISTO>2.0.CO;2; Stein K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128501; Vodenska I, 2014, SUPPLEMENTARY INFORM; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Welch I, 2008, REV FINANC STUD, V21, P1455, DOI 10.1093/rfs/hhm014; Zhao H, 2010, RES INT BUS FINANC, V24, P103, DOI 10.1016/j.ribaf.2009.09.001	69	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150994	10.1371/journal.pone.0150994	http://dx.doi.org/10.1371/journal.pone.0150994			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977806	Green Published, gold			2022-12-27	WOS:000372572800041
J	Reinbott, A; Jordan, I; Herrmann, J; Kuchenbecker, J; Kevanna, O; Krawinkel, MB				Reinbott, Anika; Jordan, Irmgard; Herrmann, Johannes; Kuchenbecker, Judith; Kevanna, Ou; Krawinkel, Michael B.			Role of Breastfeeding and Complementary Food on Hemoglobin and Ferritin Levels in a Cambodian Cross-Sectional Sample of Children Aged 3 to 24 Months	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; IRON-DEFICIENCY; VITAMIN-A; MICRONUTRIENT DEFICIENCIES; PLASMA FERRITIN; INFANTS; INFECTION; STORES; INFLAMMATION; DISORDERS	Background Iron deficiency derives from a low intake of dietary iron, poor absorption of iron, and high requirements due to growth as well as blood loss. An estimated number of about 50% of all anemia may be attributed to iron deficiency among young children in Cambodia. Methods A cross-sectional survey was conducted in rural Cambodia in September 2012. Villages in pre-selected communes were randomly chosen using stunting as a primary indicator of nutritional status. In total, 928 randomly selected households with children aged 3-23 months were included. Hemoglobin, ferritin, soluble transferrin receptor (sTfR), and retinol binding protein (RBP) were assessed from capillary blood samples. In addition, length/height and weight of mothers and children were taken and data on dietary diversity was collected. A child feeding index (CFI) was created. Associations between biomarkers of iron and vitamin A status and nutritional status or food intake were explored. Results Anemia prevalence was highest among 6- to 12-months-olds (71%). Ferritin and sTfR inversely correlated and were significantly associated with hemoglobin concentrations. The consumption of animal source foods (ASF) significantly impacts on the interaction between ferritin, sTfR and hemoglobin. Concentrations of RBP were significantly higher in children who had received a vitamin A supplement. The CFI was associated with sTfR and hemoglobin. Lower length and weight were associated with lower ferritin levels and showed an indirect effect on hemoglobin through ferritin. Conclusion Nutrition programs targeting children under 2 years of age need to focus on the preparation of complementary foods with high nutrient density to sustainably prevent micronutrient deficiency and generally improve nutritional status. Future assessments of the micronutrient status should include identification of hemoglobinopathies and parasitic infections to better understand all causes of anemia in Cambodian infants and young children.	[Reinbott, Anika; Jordan, Irmgard; Herrmann, Johannes; Kuchenbecker, Judith; Krawinkel, Michael B.] Univ Giessen, Wilhelmstr 20, D-35392 Giessen, Germany; [Reinbott, Anika; Jordan, Irmgard; Herrmann, Johannes; Kuchenbecker, Judith; Kevanna, Ou; Krawinkel, Michael B.] Natl Maternal & Child Hlth Ctr, Phnom Penh 31A,Rue France St 47, France 12202, Phnom Penh, Cambodia	Justus Liebig University Giessen	Jordan, I (corresponding author), Univ Giessen, Wilhelmstr 20, D-35392 Giessen, Germany.; Jordan, I (corresponding author), Natl Maternal & Child Hlth Ctr, Phnom Penh 31A,Rue France St 47, France 12202, Phnom Penh, Cambodia.	Irmgard.Jordan@ernaehrung.uni-giessen.de	Krawinkel, Michael/J-7916-2019; Krawinkel, Michael/AAI-8358-2021; Jordan, Irmgard/AFN-6697-2022	Krawinkel, Michael/0000-0001-5801-4876; Jordan, Irmgard/0000-0002-8822-1021	Food and Agricultural Organization of the United Nations; German Federal Ministry of Food and Agriculture	Food and Agricultural Organization of the United Nations; German Federal Ministry of Food and Agriculture	The study was funded by the Food and Agricultural Organization of the United Nations with support of the German Federal Ministry of Food and Agriculture. The funders had no role in data collection and analysis, the decision to publish, or preparation of the mansucript.	Anderson VP, 2008, ASIA PAC J CLIN NUTR, V17, P72; [Anonymous], 2008, WORLDWIDE PREVALENCE; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BLOEM MW, 1990, AM J CLIN NUTR, V51, P76, DOI 10.1093/ajcn/51.1.76; Branca F, 2002, ANN NUTR METAB, V46, P8, DOI 10.1159/000066397; Bruus M., 2003, EPIDATA VERSION 3 CO; Chaparro CM, 2008, J NUTR, V138, P2529, DOI 10.1093/jn/138.12.2529; Chaparro CM, 2008, ENSURING HLTH START; Cogill B, 2003, ANTHROPOMETRIC INDIC; Domellof M., 2002, Scandinavian Journal of Nutrition/Naringsforskning, V46, P20, DOI 10.1080/110264802753704091; Domellof M, 2002, J NUTR, V132, P3680, DOI 10.1093/jn/132.12.3680; Ejezie FE, 2011, ANN MED HEALTH SCI R, V1, P85; Engle-Stone R, 2013, J NUTR, V143, P369, DOI 10.3945/jn.112.167775; Erhardt J., 2010, MEASUREMENT VITAMIN, V3; Erhardt J.G., 2010, MEASUREMENT VITAMIN; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; George J, 2012, J NUTR, V142, P781, DOI 10.3945/jn.111.148189; Golden M., 2006, MEASURING MORTALITY; Grant FKE, 2012, J NUTR, V142, P105, DOI 10.3945/jn.111.146316; HANSON LA, 1972, ARCH DIS CHILD, V47, P845, DOI 10.1136/adc.47.256.845; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Helen Keller International, 2001, NUTR B, V2; HOWIE PW, 1990, BRIT MED J, V300, P11, DOI 10.1136/bmj.300.6716.11; Johnston R, 2008, MICRONUCTRIENT DEFIC; Kennedy G., 2010, GUIDELINES MEASURING; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; McDonald SJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004074.pub3; Measure DHS, 2011, CAMB DEM HLTH SURV 2; Moore CE, 2012, J TROP PEDIATRICS, V58, P509, DOI 10.1093/tropej/fms024; Perez EM, 2005, J NUTR, V135, P850, DOI 10.1093/jn/135.4.850; Reinbott A, 2015, PAEDIATR INT CHILD H, V35, P124, DOI 10.1179/2046905514Y.0000000155; Rosenthal R., 2000, CONTRASTS EFFECT SIZ; Shao J, 2012, J NUTR, V142, P2004, DOI 10.3945/jn.112.162362; Skau JKH, 2015, AM J CLIN NUTR, V101, P742, DOI 10.3945/ajcn.114.084889; Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417; STAAB DB, 1984, J NUTR, V114, P840, DOI 10.1093/jn/114.5.840; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; THURNHAM DI, 1993, LANCET, V342, P1312, DOI 10.1016/0140-6736(93)92239-P; Thurnham DI, 2012, REPORT PRIORITIES AS; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; West KP, 2007, NUTR ANEMIA; Wharf SG, 1997, EUR J CLIN NUTR, V51, P504, DOI 10.1038/sj.ejcn.1600428; WHO, 2011, SER FERR CONC ASS IR; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; WHO, 2010, ASS INF YOUNG CHIL 2; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 1995, 2 WHO MDIS; World Health Organization, 2014, GUID DEL UMB CORD CL; World Health Organization, 2010, ASS INF YOUNG CHIL 1; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS; Zimmermann MB, 2006, AM J CLIN NUTR, V84, P580, DOI 10.1093/ajcn/84.3.580	52	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150750	10.1371/journal.pone.0150750	http://dx.doi.org/10.1371/journal.pone.0150750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975053	gold, Green Submitted, Green Published			2022-12-27	WOS:000372570600031
J	van Mourik, PM; de Jong, J; Agpalo, D; Claussin, C; Rothstein, R; Chang, M				van Mourik, Paula M.; de Jong, Jannie; Agpalo, Danielle; Claussin, Clemence; Rothstein, Rodney; Chang, Michael			Recombination-Mediated Telomere Maintenance in Saccharomyces cerevisiae Is Not Dependent on the Shu Complex	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; RAD51 PARALOGUES; YEAST TELOMERES; DNTP POOLS; ABSENCE; GENES; SENESCENCE; PATHWAYS; DNA; ELONGATION	In cells lacking telomerase, telomeres shorten progressively during each cell division due to incomplete end-replication. When the telomeres become very short, cells enter a state that blocks cell division, termed senescence. A subset of these cells can overcome senescence and maintain their telomeres using telomerase-independent mechanisms. In Saccharomyces cerevisiae, these cells are called 'survivors' and are dependent on Rad52-dependent homologous recombination and Pol32-dependent break-induced replication. There are two main types of survivors: type I and type II. The type I survivors require Rad51 and maintain telomeres by amplification of subtelomeric elements, while the type II survivors are Rad51-independent, but require the MRX complex and Sgs1 to amplify the C(1-3)A/TG(1-3) telomeric sequences. Rad52, Pol32, Rad51, and Sgs1 are also important to prevent accelerated senescence, indicating that recombination processes are important at telomeres even before the formation of survivors. The Shu complex, which consists of Shu1, Shu2, Psy3, and Csm2, promotes Rad51-dependent homologous recombination and has been suggested to be important for break-induced replication. It also promotes the formation of recombination intermediates that are processed by the Sgs1-Top3-Rmi1 complex, as mutations in the SHU genes can suppress various sgs1, top3, and rmi1 mutant phenotypes. Given the importance of recombination processes during senescence and survivor formation, and the involvement of the Shu complex in many of the same processes during DNA repair, we hypothesized that the Shu complex may also have functions at telomeres. Surprisingly, we find that this is not the case: the Shu complex does not affect the rate of senescence, does not influence survivor formation, and deletion of SHU1 does not suppress the rapid senescence and type II survivor formation defect of a telomerase-negative sgs1 mutant. Altogether, our data suggest that the Shu complex is not important for recombination processes at telomeres.	[van Mourik, Paula M.; de Jong, Jannie; Claussin, Clemence; Chang, Michael] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Agpalo, Danielle; Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY USA	University of Groningen; Columbia University	Chang, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands.	m.chang@umcg.nl	Chang, Michael/B-9279-2012	Chang, Michael/0000-0002-1706-3337; Rothstein, Rodney/0000-0002-4107-9654	National Institutes of Health [GM50237]; Netherlands Organisation for Scientific Research Vidi grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050237, R01GM050237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research Vidi grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM50237 (RR) and a Netherlands Organisation for Scientific Research Vidi grant (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010397; Bernstein KA, 2011, MOL BIOL CELL, V22, P1599, DOI 10.1091/mbc.E10-08-0691; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Chang M, 2011, CELL CYCLE, V10, P3798, DOI 10.4161/cc.10.21.18095; Chang M, 2011, NAT STRUCT MOL BIOL, V18, P451, DOI 10.1038/nsmb.2034; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Claussin C, 2015, MICROB CELL, V2, P308, DOI 10.15698/mic2015.09.224; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Fallet E, 2014, NUCLEIC ACIDS RES, V42, P3648, DOI 10.1093/nar/gkt1328; Gaines WA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8834; Godin S, 2013, NUCLEIC ACIDS RES, V41, P4525, DOI 10.1093/nar/gkt138; Gupta A, 2013, GENETICS, V193, P1095, DOI 10.1534/genetics.112.149120; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Le S, 1999, GENETICS, V152, P143; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Poschke H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002960; Sasanuma H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2678; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Signon L, 2001, MOL CELL BIOL, V21, P2048, DOI 10.1128/MCB.21.6.2048-2056.2001; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Treco D A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1301s23; Vasianovich Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004679; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151314	10.1371/journal.pone.0151314	http://dx.doi.org/10.1371/journal.pone.0151314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974669	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600068
J	Wu, XJ; Shen, DH; Li, T; Zhang, B; Li, CR; Mao, M; Zhao, JX; Liu, KD; Zhang, HL				Wu, Xiujuan; Shen, Donghui; Li, Ting; Zhang, Bing; Li, Chunrong; Mao, Mei; Zhao, Jixue; Liu, Kangding; Zhang, Hong-Liang			Distinct Clinical Characteristics of Pediatric Guillain-Barre Syndrome: A Comparative Study between Children and Adults in Northeast China	PLOS ONE			English	Article							SHORT-TERM PROGNOSIS; RESPIRATORY-FAILURE; RISK-FACTORS; CHILDHOOD; CRITERIA	Objective Clinical characteristics of pediatric Guillain-Barre syndrome (GBS) have been extensively studied whereas scarcely been compared with those of adult GBS. Herein we compared the clinical features of GBS between pediatric and adult patients. Methods We retrospectively collected the clinical data of 750 patients with GBS (541 adults and 209 children), and compared the clinical characteristics between children and adults. Results Pain was a more frequent complaint in children (17.2% vs 9.6%, p < 0.01), who were also found with shorter interval from disease onset to nadir (6.3d vs 7.3d, p < 0.01) and higher incidence of bulbar dysfunction (22.0% vs 14.8%, p < 0.05). The disease severity in children was comparable with adults. In addition, a higher incidence of pediatric GBS was found in summer, especially in July and August (both p < 0.01). However, the incidence of antecedent infections of different seasons in adult and pediatric patients was comparable (p > 0.05). The clinical features of acute motor axonal neuropathy (AMAN) and acute inflammatory demyelinating polyneuropathy (AIDP) in children were overall comparable with adult ones (p > 0.05). Similar to adults, bulbar dysfunction (odds ratio [OR]: 4.621, 95% confidence interval [CI]: 1.240-17.218, p < 0.05) and lower nadir Medical Research Council (MRC) sum score (OR: 0.897, 95% CI: 0.855-0.941, p < 0.01) were also risk factors for mechanical ventilation in children. However, distinct from adult ones, autonomic dysfunction was significantly higher in mechanically ventilated childhood GBS (39.1% vs 8.8%, p < 0.01), which also served as a predictor for mechanical ventilation in pediatric GBS (OR: 70.415, 95% CI: 9.265-535.158, p < 0.01). As to the efficacy of intravenous immunoglobulin, insignificant difference was identified between children and adults. Conclusion The clinical features of pediatric GBS differ from those of adults. Autonomic dysfunction is an independent risk factor for mechanical ventilation in pediatric patients.	[Wu, Xiujuan; Shen, Donghui; Li, Ting; Zhang, Bing; Li, Chunrong; Mao, Mei; Liu, Kangding; Zhang, Hong-Liang] Jilin Univ, Hosp 1, Dept Neurol, Neurosci Ctr, Changchun 130023, Peoples R China; [Zhao, Jixue] Jilin Univ, Hosp 1, Dept Pediat Surg, Changchun 130023, Peoples R China	Jilin University; Jilin University	Liu, KD; Zhang, HL (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Neurosci Ctr, Changchun 130023, Peoples R China.	kangdingliu@163.com; drzhl@hotmail.com	Zhang, Hongliang/AAN-3077-2020	Zhang, Hongliang/0000-0001-9205-5559	National Natural Science Foundation of China [81271294, 81241147]; Norman Bethune Health Science Center of Jilin University [2013205035]; First Hospital of Jilin University [JDYY42013003]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [3C113BK73428]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Norman Bethune Health Science Center of Jilin University; First Hospital of Jilin University; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The work was supported by grants from the National Natural Science Foundation of China (No. 81271294 and 81241147), the Young Scholars Program of Norman Bethune Health Science Center of Jilin University (No. 2013205035), the Young Scholars Program of the First Hospital of Jilin University (No. JDYY42013003), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (3C113BK73428).	ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; DiMario FJ, 2012, J CHILD NEUROL, V27, P581, DOI 10.1177/0883073811420872; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Hicks CW, 2010, J CHILD NEUROL, V25, P1504, DOI 10.1177/0883073810370481; Hu MH, 2012, PEDIATR NEONATOL, V53, P295, DOI 10.1016/j.pedneo.2012.07.003; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Hung PL, 2004, PEDIATR NEUROL, V30, P86, DOI 10.1016/S0887-8994(03)00403-X; Incecik F, 2011, NEUROL SCI, V32, P381, DOI 10.1007/s10072-010-0434-y; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Korinthenberg R, 2007, NEUROPEDIATRICS, V38, P10, DOI 10.1055/s-2007-981686; Koul RL, 2008, INDIAN J PEDIATR, V75, P787, DOI 10.1007/s12098-008-0099-1; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; Lee JH, 2008, J PAEDIATR CHILD H, V44, P449, DOI 10.1111/j.1440-1754.2008.01325.x; Mathew T, 2014, ANN INDIAN ACAD NEUR, V17, P239, DOI 10.4103/0972-2327.132662; Molinero MR, 2003, J CHILD NEUROL, V18, P741, DOI 10.1177/08830738030180110801; Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd; Paradiso G, 1999, ANN NEUROL, V46, P701, DOI 10.1002/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7; Rantala H, 1995, PEDIATR NEUROL, V13, P289, DOI 10.1016/0887-8994(95)00189-1; Ryan MM, 2005, J PAEDIATR CHILD H, V41, P237, DOI 10.1111/j.1440-1754.2005.00602.x; Samadi M, 2013, J CARDIOVASC THORAC, V5, P81, DOI 10.5681/jcvtr.2013.018; SARADA C, 1994, ANN TROP PAEDIATR, V14, P281, DOI 10.1080/02724936.1994.11747730; Sharma G, 2013, NEUROSCI MED, V4, P23, DOI [DOI 10.1109/N0F.2013.6724526, 10.4236/nm.2013.41004, DOI 10.4236/NM.2013.41004]; Tang J, 2011, PEDIATR NEUROL, V45, P233, DOI 10.1016/j.pediatrneurol.2011.06.007; Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025; van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121; Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119; Wu XJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001898; Wu XJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1037-z; Zhou CK, 2014, NEURAL REGEN RES, V9, P101, DOI 10.4103/1673-5374.125337	29	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151611	10.1371/journal.pone.0151611	http://dx.doi.org/10.1371/journal.pone.0151611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974666	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600092
J	Gompert, Z				Gompert, Zachariah			A Continuous Correlated Beta Process Model for Genetic Ancestry in Admixed Populations	PLOS ONE			English	Article							HYBRID SPECIATION; LOCAL-ANCESTRY; PRINCIPAL-COMPONENTS; BACKGROUND SELECTION; GENOMIC ISOLATION; ADMIXTURE; INFERENCE; EVOLUTION; PATTERNS; INTROGRESSION	Admixture and recombination create populations and genomes with genetic ancestry from multiple source populations. Analyses of genetic ancestry in admixed populations are relevant for trait and disease mapping, studies of speciation, and conservation efforts. Consequently, many methods have been developed to infer genome-average ancestry and to deconvolute ancestry into continuous local ancestry blocks or tracts within individuals. Current methods for local ancestry inference perform well when admixture occurred recently or hybridization is ongoing, or when admixture occurred in the distant past such that local ancestry blocks have fixed in the admixed population. However, methods to infer local ancestry frequencies in isolated admixed populations still segregating for ancestry do not exist. In the current paper, I develop and test a continuous correlated beta process model to fill this analytical gap. The method explicitly models autocorrelations in ancestry frequencies at the population-level and uses discriminant analysis of SNP windows to take advantage of ancestry blocks within individuals. Analyses of simulated data sets show that the method is generally accurate such that ancestry frequency estimates exhibited low root-mean-square error and were highly correlated with the true values, particularly when large (+/- 10 or +/- 20) SNP windows were used. Along these lines, the proposed method outperformed post hoc inference of ancestry frequencies from a traditional hidden Markov model (i.e., the linkage model in structure), particularly when admixture occurred more distantly in the past with little on-going gene flow or was followed by natural selection. The reliability and utility of the method was further assessed by analyzing genetic ancestry in an admixed human population (Uyghur) and three populations from a hybrid zone between Mus domesticus and M. musculus. Considerable variation in ancestry frequencies was detected within and among chromosomes in the Uyghur, with a large region of excess French ancestry harboring a gene with a known disease association. Similar variation was detected in the mouse hybrid zone, with notable constancy in regions of excess ancestry among admixed populations. By filling what has been an analytical gap, the proposed method should be a useful tool for many biologists. A computer program (popanc), written in C++, has been developed based on the proposed method and is available on-line at http://sourceforge.net/projects/popanc/.	[Gompert, Zachariah] Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Gompert, Z (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	zach.gompert@usu.edu		Gompert, Zachariah/0000-0003-2248-2488				[Anonymous], [No title captured]; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; BARTON N, 1986, HEREDITY, V57, P357, DOI 10.1038/hdy.1986.135; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Buerkle CA, 2008, EVOLUTION, V62, P266, DOI 10.1111/j.1558-5646.2007.00267.x; Buerkle CA, 2008, TRENDS ECOL EVOL, V23, P686, DOI 10.1016/j.tree.2008.07.008; Buerkle CA, 2001, EVOLUTION, V55, P684, DOI 10.1554/0014-3820(2001)055[0684:LIVFGI]2.0.CO;2; Chapman NH, 2002, GENETICS, V162, P449; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cucchi T, 2005, BIOL J LINN SOC, V84, P429, DOI 10.1111/j.1095-8312.2005.00445.x; da Barbiano LA, 2013, P NATL ACAD SCI USA, V110, P13797, DOI 10.1073/pnas.1303730110; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Deo RC, 2007, PLOS GENET, V3, P2200, DOI 10.1371/journal.pgen.0030196; Dufkova P, 2011, EVOLUTION, V65, P993, DOI 10.1111/j.1558-5646.2011.01222.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ewens WJ., 2004, MATH POPULATION GENE, V27; Falush D, 2003, GENETICS, V164, P1567; Fitzpatrick BM, 2010, P NATL ACAD SCI USA, V107, P3606, DOI 10.1073/pnas.0911802107; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Galassi M., 2009, GNU SCI LIB REFERENC, DOI [10.5555/1538674, DOI 10.5555/1538674]; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Gese EM, 2015, CURR ZOOL, V61, P191, DOI 10.1093/czoolo/61.1.191; Gompert Z, 2015, MOL ECOL, V24, P2777, DOI 10.1111/mec.13199; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Gompert Z, 2013, MOL ECOL, V22, P5278, DOI 10.1111/mec.12488; Gompert Z, 2012, EVOLUTION, V66, P2167, DOI 10.1111/j.1558-5646.2012.01587.x; Gompert Z, 2012, PHILOS T R SOC B, V367, P439, DOI 10.1098/rstb.2011.0196; Gompert Z, 2011, MOL ECOL, V20, P2111, DOI 10.1111/j.1365-294X.2011.05074.x; Gompert Z, 2009, MOL ECOL, V18, P1207, DOI 10.1111/j.1365-294X.2009.04098.x; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; Gravel S, 2012, GENETICS, V191, P607, DOI 10.1534/genetics.112.139808; Hahn MW, 2008, EVOLUTION, V62, P255, DOI 10.1111/j.1558-5646.2007.00308.x; Hermansen JS, 2011, MOL ECOL, V20, P3812, DOI 10.1111/j.1365-294X.2011.05183.x; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016616; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Janousek V, 2012, MOL ECOL, V21, P3032, DOI 10.1111/j.1365-294X.2012.05583.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Liang M, 2014, GENETICS, V197, P953, DOI 10.1534/genetics.114.162362; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nice CC, 2013, EVOLUTION, V67, P1055, DOI 10.1111/evo.12019; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Nolte AW, 2009, MOL ECOL, V18, P2615, DOI 10.1111/j.1365-294X.2009.04208.x; Parchman TL, 2013, MOL ECOL, V22, P3304, DOI 10.1111/mec.12201; Parchman TL, 2011, AM J BOT, V98, P669, DOI 10.3732/ajb.1000378; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Payseur BA, 2004, EVOLUTION, V58, P2064; Pinero J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav028; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Pritchard JK, 2000, GENETICS, V155, P945; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Rieseberg LH, 1999, GENETICS, V152, P713; Rieseberg LH, 2003, PHILOS T R SOC B, V358, P1141, DOI 10.1098/rstb.2003.1283; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Salcedo T, 2007, GENETICS, V177, P2277, DOI 10.1534/genetics.107.079988; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Smadja C, 2004, J EVOLUTION BIOL, V17, P165, DOI 10.1046/j.1420-9101.2003.00647.x; Sohn KA, 2012, GENETICS; Soria-Carrasco V, 2014, SCIENCE, V344, P738, DOI 10.1126/science.1252136; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Teeter KC, 2010, EVOLUTION, V64, P472, DOI 10.1111/j.1558-5646.2009.00846.x; The HDF5 Group, 2010, HIER DAT FORM VERS 5; Turner LM, 2014, ELIFE, V3, DOI 10.7554/eLife.02504; Turner LM, 2012, EVOLUTION, V66, P443, DOI 10.1111/j.1558-5646.2011.01445.x; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vernot B, 2014, CURR BIOL, V24, pR845, DOI 10.1016/j.cub.2014.07.079; WHITTEMORE AT, 1991, P NATL ACAD SCI USA, V88, P2540, DOI 10.1073/pnas.88.6.2540; Wijsman EM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001308; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Zaitlen N, 2014, NAT GENET, V46, P1356, DOI 10.1038/ng.3139; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	93	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151047	10.1371/journal.pone.0151047	http://dx.doi.org/10.1371/journal.pone.0151047			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966908	Green Submitted, Green Published, gold			2022-12-27	WOS:000371989200030
J	Jiang, YL; Li, B; Chen, J				Jiang, Yulin; Li, Bin; Chen, Jie			Analysis of the Velocity Distribution in Partially-Filled Circular Pipe Employing the Principle of Maximum Entropy	PLOS ONE			English	Article							INFORMATION-THEORY; BOUNDARY SHEAR; CULVERTS	The flow velocity distribution in partially-filled circular pipe was investigated in this paper. The velocity profile is different from full-filled pipe flow, since the flow is driven by gravity, not by pressure. The research findings show that the position of maximum flow is below the water surface, and varies with the water depth. In the region of near tube wall, the fluid velocity is mainly influenced by the friction of the wall and the pipe bottom slope, and the variation of velocity is similar to full-filled pipe. But near the free water surface, the velocity distribution is mainly affected by the contractive tube wall and the secondary flow, and the variation of the velocity is relatively small. Literature retrieval results show relatively less research has been shown on the practical expression to describe the velocity distribution of partially-filled circular pipe. An expression of two-dimensional (2D) velocity distribution in partially-filled circular pipe flow was derived based on the principle of maximum entropy (POME). Different entropies were compared according to fluid knowledge, and non-extensive entropy was chosen. A new cumulative distribution function (CDF) of partially-filled circular pipe velocity in terms of flow depth was hypothesized. Combined with the CDF hypothesis, the 2D velocity distribution was derived, and the position of maximum velocity distribution was analyzed. The experimental results show that the estimated velocity values based on the principle of maximum Tsallis wavelet entropy are in good agreement with measured values.	[Jiang, Yulin; Li, Bin; Chen, Jie] Shanghai Univ, Coll Mechatron Engn & Automat, Shanghai, Peoples R China; [Jiang, Yulin] Jiujiang Univ, Coll Elect Engn, Jiujiang, Peoples R China	Shanghai University; Jiujiang University	Jiang, YL (corresponding author), Shanghai Univ, Coll Mechatron Engn & Automat, Shanghai, Peoples R China.; Jiang, YL (corresponding author), Jiujiang Univ, Coll Elect Engn, Jiujiang, Peoples R China.	ghostjiang@sina.com	Jiang, Yulin/AAI-7111-2020					Adrove A, 2013, PHYS FLUIDS, V25, P708; BARBE DE, 1991, J HYDRAUL ENG-ASCE, V117, P1389, DOI 10.1061/(ASCE)0733-9429(1991)117:10(1389); Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; CHEN NH, 1979, IND ENG CHEM FUND, V18, P296, DOI 10.1021/i160071a019; Chen ZQ, 2015, ENTROPY-SWITZ, V17, P3710, DOI 10.3390/e17063710; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Chen ZQ, 2014, APPL MATH COMPUT, V242, P462, DOI 10.1016/j.amc.2014.05.105; Chiu CL, 2006, J HYDROL, V316, P28, DOI 10.1016/j.jhydrol.2005.04.011; Chiu CL, 2005, HYDROL PROCESS, V19, P3935, DOI 10.1002/hyp.5857; CHIU CL, 1991, J HYDRAUL ENG-ASCE, V117, P615, DOI 10.1061/(ASCE)0733-9429(1991)117:5(615); Chiu CL, 2003, J HYDRAUL RES, V41, P589, DOI 10.1080/00221680309506891; CHIU CL, 1989, J HYDRAUL ENG-ASCE, V115, P576, DOI 10.1061/(ASCE)0733-9429(1989)115:5(576); CHIU CL, 1995, J HYDRAUL ENG-ASCE, V121, P26, DOI 10.1061/(ASCE)0733-9429(1995)121:1(26); CHIU CL, 1992, J HYDRAUL ENG-ASCE, V118, P989; CHIU CL, 1988, J HYDRAUL ENG-ASCE, V114, P738, DOI 10.1061/(ASCE)0733-9429(1988)114:7(738); Clark SP, 2011, J HYDRAUL RES, V49, P676, DOI 10.1080/00221686.2011.596399; Cui HJ, 2013, J HYDROL ENG, V18, P331, DOI 10.1061/(ASCE)HE.1943-5584.0000610; Furuichi S, 2004, J MATH PHYS, V45, P4868, DOI 10.1063/1.1805729; Guo JK, 2013, J HYDRAUL RES, V51, P408, DOI 10.1080/00221686.2013.784881; Hager WH, 2010, WASTEWATER HYDRAULICS: THEORY AND PRACTICE, SECOND EDITION, P1, DOI 10.1007/978-3-642-11383-3; House MR, 2005, J AM WATER RESOUR AS, V41, P209, DOI 10.1111/j.1752-1688.2005.tb03729.x; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Knight DW, 2000, J HYDRAUL ENG-ASCE, V126, P263, DOI 10.1061/(ASCE)0733-9429(2000)126:4(263); Luo H, 2011, J HYDROL ENG, V16, P303, DOI 10.1061/(ASCE)HE.1943-5584.0000319; Marini G, 2011, J HYDRAUL RES, V49, P784, DOI 10.1080/00221686.2011.635889; Nezu I., 1993, IAHR MONOGRAPH SERIE; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sterling M, 2000, P I CIVIL ENG-WATER, V142, P229, DOI 10.1680/wame.2000.142.4.229; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C, 1998, PHYSICA A, V261, P534, DOI 10.1016/S0378-4371(98)00437-3; Yang SQ, 2004, J HYDRAUL ENG-ASCE, V130, P1179, DOI 10.1061/(ASCE)0733-9429(2004)130:12(1179); Yoon JI, 2012, J HYDRAUL RES, V50, P304, DOI 10.1080/00221686.2012.673745	33	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151578	10.1371/journal.pone.0151578	http://dx.doi.org/10.1371/journal.pone.0151578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986064	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300089
J	Clarke, AT; Johnson, PCD; Hall, GC; Ford, I; Mills, PR				Clarke, Alan T.; Johnson, Paul C. D.; Hall, Gillian C.; Ford, Ian; Mills, Peter R.			High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort	PLOS ONE			English	Article							INDUCED LIVER-INJURY; ACUTE CORONARY SYNDROMES; ACUTE CHOLESTATIC HEPATITIS; RANDOMIZED CONTROLLED-TRIAL; AUTOIMMUNE HEPATITIS; SECONDARY PREVENTION; LUPUS-ERYTHEMATOSUS; HEART-DISEASE; UNITED-STATES; STATINS	Background & Aims Occasional risk of serious liver dysfunction and autoimmune hepatitis during atorvastatin therapy has been reported. We compared the risk of hepatotoxicity in atorvastatin relative to simvastatin treatment. Methods The UK GPRD identified patients with a first prescription for simvastatin [164,407] or atorvastatin [76,411] between 1997 and 2006, but with no prior record of liver disease, alcoholrelated diagnosis, or liver dysfunction. Incident liver dysfunction in the following six months was identified by biochemical value and compared between statin groups by Cox regression model adjusting for age, sex, year treatment started, dose, alcohol consumption, smoking, body mass index and comorbid conditions. Results Moderate to severe hepatotoxicity [bilirubin >60 mu mol/L, AST or ALT >200U/L or alkaline phosphatase >1200U/L] developed in 71 patients on atorvastatin versus 101 on simvastatin. Adjusted hazard ratio [AHR] for all atorvastatin relative to simvastatin was 1.9 [95% confidence interval 1.4-2.6]. High dose was classified as 40-80mg daily and low dose 10-20mg daily. Hepatotoxicity occurred in 0.44% of 4075 patients on high dose atorvastatin [HDA], 0.07% of 72,336 on low dose atorvastatin [LDA], 0.09% of 44,675 on high dose simvastatin [HDS] and 0.05% of 119,732 on low dose simvastatin [LDS]. AHRs compared to LDS were 7.3 [4.2-12.7] for HDA, 1.4 [0.9-2.0] for LDA and 1.5 [1.0-2.2] for HDS. Conclusions The risk of hepatotoxicity was increased in the first six months of atorvastatin compared to simvastatin treatment, with the greatest difference between high dose atorvastatin and low dose simvastatin. The numbers of events in the analyses were small.	[Clarke, Alan T.] Queen Elizabeth Univ Hosp, Dept Gastroenterol, Glasgow, Lanark, Scotland; [Johnson, Paul C. D.; Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Hall, Gillian C.] Grimsdyke House London, London, England; [Mills, Peter R.] Gartnavel Royal Hosp, Dept Gastroenterol, Glasgow, Lanark, Scotland; [Johnson, Paul C. D.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Queen Elizabeth University Hospital (QEUH); University of Glasgow; Gartnavel Royal Hospital; University of Glasgow	Clarke, AT (corresponding author), Queen Elizabeth Univ Hosp, Dept Gastroenterol, Glasgow, Lanark, Scotland.	aclarke1972@gmail.com	Ford, Ian/ABE-6145-2020; Johnson, Paul/O-9695-2014	Johnson, Paul/0000-0001-6663-7520	Medical Research Council; UK Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The initial data extraction from the General Practice Research Database was supported by an Medical Research Council grant. http://www.mrc.ac.uk.; This study was funded by a grant awarded by the UK Medical Research Council for data extraction from the General Practice Research Database.	Alla V, 2006, J CLIN GASTROENTEROL, V40, P757, DOI 10.1097/00004836-200609000-00018; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006; Bays H, 2014, J CLIN LIPIDOL, V8, pS47, DOI 10.1016/j.jacl.2014.02.011; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Bjornsson E, 2012, J HEPATOL, V56, P374, DOI [10.1016/j.jhep.2011.08.016, 10.1016/j.jhep.2011.07.023]; BRADFORD RH, 1991, ARCH INTERN MED, V151, P43, DOI 10.1001/archinte.151.1.43; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carrascosa MF, 2015, J HEPATOL, V62, P751, DOI 10.1016/j.jhep.2014.11.019; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Clarke AT, 2006, DIGEST LIVER DIS, V38, P772, DOI 10.1016/j.dld.2006.04.013; Czaja AJ, 2011, DIGEST DIS SCI, V56, P958, DOI 10.1007/s10620-011-1611-4; de Castro M L, 2006, Gastroenterol Hepatol, V29, P21; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Desai CS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3743; Geoghegan M, 2004, GUT, V53, pA123; Gershovich OE, 2004, PHARMACOTHERAPY, V24, P150, DOI 10.1592/phco.24.1.150.34803; Godlee F, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5038; Goldacre B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4745; Graziadei IW, 2003, LUPUS, V12, P409, DOI 10.1191/0961203303lu313cr; Jimenez-Alonso J, 1999, ARCH INTERN MED, V159, P1811, DOI 10.1001/archinte.159.15.1811-a; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lata Stanislaw, 2006, Przegl Lek, V63 Suppl 7, P97; Nakad A, 1999, LANCET, V353, P1763, DOI 10.1016/S0140-6736(99)00569-3; NAWROCKI JW, 1995, ARTERIOSCL THROM VAS, V15, P678, DOI 10.1161/01.ATV.15.5.678; Newman C, 2006, AM J CARDIOL, V97, P61, DOI 10.1016/j.amjcard.2005.07.108; Noel B, 2007, J EUR ACAD DERMATOL, V21, P17, DOI 10.1111/j.1468-3083.2006.01838.x; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Pelli N, 2003, EUR J GASTROEN HEPAT, V15, P921, DOI 10.1097/00042737-200308000-00014; Perger L, 2003, J HEPATOL, V39, P1095, DOI 10.1016/S0168-8278(03)00464-1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabar S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4356; Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937; Ridruejo E, 2002, J HEPATOL, V37, P165, DOI 10.1016/S0168-8278(02)00092-2; Russo MW, 2009, SEMIN LIVER DIS, V29, P412, DOI 10.1055/s-0029-1240010; Russo MW, 2004, LIVER TRANSPLANT, V10, P1018, DOI 10.1002/lt.20204; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sreenarasimhaiah J, 2002, AM J MED, V113, P348, DOI 10.1016/S0002-9343(02)01178-6; van Heyningen C, 2005, ANN CLIN BIOCHEM, V42, P402, DOI 10.1258/0004563054890105; Wolters LMM, 2005, EUR J GASTROEN HEPAT, V17, P589, DOI 10.1097/00042737-200505000-00019	43	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151587	10.1371/journal.pone.0151587	http://dx.doi.org/10.1371/journal.pone.0151587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983033	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000372574900100
J	Kabilova, TO; Sen'kova, AV; Nikolin, VP; Popova, NA; Zenkova, MA; Vlassov, VV; Chernolovskaya, EL				Kabilova, Tatyana O.; Sen'kova, Aleksandra V.; Nikolin, Valeriy P.; Popova, Nelly A.; Zenkova, Marina A.; Vlassov, Valentin V.; Chernolovskaya, Elena L.			Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INTERFERON-PRODUCTION; ADAPTIVE IMMUNITY; REFRACTORY STATE; SIRNA DELIVERY; IFN-ALPHA; IN-VIVO; CELLS; INNATE; 5'-TRIPHOSPHATE-SIRNA	Small interfering RNAs, depending on their structure, delivery system and sequence, can stimulate innate and adaptive immunity. The aim of this study was to investigate the antitumor and antimetastatic effects of immunostimulatory 19-bp dsRNA with 3'-trinucleotide overhangs (isRNA) on melanoma B16 in C57Bl/6 mice. Recently developed novel cationic lipo-somes 2X3-DOPE were used for the in vivo delivery of isRNA. Administration of isRNA/2X3-DOPE complexes significantly inhibits melanoma tumor growth and metastasis. Histopathological analysis of spleen cross sections showed hyperplasia of the lymphoid white pulp and formation of large germinal centers after isRNA/2X3-DOPE administration, indicating activation of the immune system. The treatment of melanoma-bearing mice with isRNA/2X3-DOPE decreases the destructive changes in the liver parenchyma. Thus, the developed isRNA displays pronounced immunostimulatory, antitumor and antimetastatic properties against melanoma B16 and may be considered a potential agent in the immunotherapy of melanoma.	[Kabilova, Tatyana O.; Sen'kova, Aleksandra V.; Zenkova, Marina A.; Vlassov, Valentin V.; Chernolovskaya, Elena L.] Inst Chem Biol & Fundamental Med SB RAS, 8 Lavrentiev Ave, Novosibirsk 630090, Russia; [Nikolin, Valeriy P.; Popova, Nelly A.] Inst Cytol & Genet SB RAS, 10 Lavrentiev Ave, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Chernolovskaya, EL (corresponding author), Inst Chem Biol & Fundamental Med SB RAS, 8 Lavrentiev Ave, Novosibirsk 630090, Russia.	elena_ch@niboch.nsc.ru	Zenkova, Marina A/G-5088-2013; Zenkova, Marina A./H-4666-2014; Kabilova, Tatyana/G-3494-2013; Vlassov, Valentin/F-4720-2013	Vlassov, Valentin/0000-0003-2845-2992; Zenkova, Marina/0000-0003-4044-1049	Russian Academy of Science [22-1, 44]; Russian Foundation for Basic Research [13-04-40181-H]; grant of Scientific Schools [1350.2014.4]	Russian Academy of Science(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); grant of Scientific Schools	This research was supported by the Russian Academy of Science under the programs "Molecular and Cellular Biology" (no. 22-1), "Science to Medicine" (no. 44) and "Nanostructures: Physics, Chemistry, Biology, Technology"; by the Russian Foundation for Basic Research (no. 13-04-40181-H); by the grant of Scientific Schools (no. 1350.2014.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Russian Academy of Science under the programs "Molecular and Cellular Biology" (no. 22-1), "Science to Medicine" (no. 44) and "Nanostructures: Physics, Chemistry, Biology, Technology"; by the Russian Foundation for Basic Research (no. 13-04-40181-H); by the grant of Scientific Schools (no. 1350.2014.4).	Adams S, 2009, IMMUNOTHERAPY-UK, V1, P949, DOI [10.2217/imt.09.70, 10.2217/IMT.09.70]; Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; BORDEN EC, 1971, J IMMUNOL, V106, P134; Braun FCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135444; Brown L, 2006, SURGERY, V140, P297, DOI 10.1016/j.surg.2006.05.005; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chang CI, 2011, NUCLEIC ACID THER, V21, P149, DOI 10.1089/nat.2011.0296; Chen XJ, 2013, EUR J PHARMACOL, V721, P86, DOI 10.1016/j.ejphar.2013.09.050; Currie AJ, 2008, J IMMUNOL, V180, P1535, DOI 10.4049/jimmunol.180.3.1535; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Du HY, 2012, ACTA PHARMACOL SIN, V33, P1047, DOI 10.1038/aps.2012.54; Eggert T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112717; Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117; Gantier MP, 2010, MOL THER, V18, P785, DOI 10.1038/mt.2010.4; Gantier MP, 2009, NAT BIOTECHNOL, V27, P911, DOI 10.1038/nbt1009-911; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111920; Jiang G, 2011, BIOCHEM BIOPH RES CO, V406, P311, DOI 10.1016/j.bbrc.2011.02.042; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kabilova TO, 2011, DOKL BIOCHEM BIOPHYS, V436, P8, DOI 10.1134/S1607672911010042; Kabilova TO, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-338; Kabilova TO, 2012, NUCLEIC ACID THER, V22, P196, DOI 10.1089/nat.2011.0328; Kariko K, 2004, CELLS TISSUES ORGANS, V177, P132, DOI 10.1159/000079987; Khairuddin N, 2012, IMMUNOL CELL BIOL, V90, P187, DOI 10.1038/icb.2011.19; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Latifynia A, 2010, J MICROBIOL IMMUNOL, V43, P138, DOI 10.1016/S1684-1182(10)60022-9; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Markov OO, 2012, J CONTROL RELEASE, V160, P200, DOI 10.1016/j.jconrel.2011.11.034; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Maslov MA, 2012, J CONTROL RELEASE, V160, P182, DOI 10.1016/j.jconrel.2011.11.023; McBride S, 2006, J IMMUNOL, V177, P6122, DOI 10.4049/jimmunol.177.9.6122; Mitchell MS, 2003, INT IMMUNOPHARMACOL, V3, P1051, DOI 10.1016/S1567-5769(03)00019-5; Najar HM, 2008, J INVEST DERMATOL, V128, P2204, DOI 10.1038/jid.2008.59; Olejniczak M, 2012, RNA, V18, P930, DOI 10.1261/rna.025627.110; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Prins RM, 2006, J IMMUNOL, V176, P157, DOI 10.4049/jimmunol.176.1.157; Puthenveetil S, 2006, NUCLEIC ACIDS RES, V34, P4900, DOI 10.1093/nar/gkl464; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; ROUSSET S, 1974, J GEN VIROL, V22, P9, DOI 10.1099/0022-1317-22-1-9; Sajeesh S, 2014, MOL PHARMACEUT, V11, P872, DOI 10.1021/mp400541z; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sasse AD, 2007, COCHRANE DB SYST REV, V1, P1; Sen'kova AV, 2014, BIOCHIMIE, V101, P256, DOI 10.1016/j.biochi.2014.02.006; Sharma S, 2003, BIOTECHNOL LETT, V25, P149, DOI 10.1023/A:1021927621813; Shin D, 2007, BIOCHEM BIOPH RES CO, V364, P436, DOI 10.1016/j.bbrc.2007.10.012; Stewart CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021552; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Wang K, 2013, J IMMUNOTHER, V36, P294, DOI 10.1097/CJI.0b013e318294183b; Zhang QF, 2013, BLOOD, V121, P1304, DOI 10.1182/blood-2012-07-442590; Zhang ZR, 2006, J CELL BIOCHEM, V97, P1217, DOI 10.1002/jcb.20716	55	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150751	10.1371/journal.pone.0150751	http://dx.doi.org/10.1371/journal.pone.0150751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981617	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900051
J	Mugge, W; Kuling, IA; Brenner, E; Smeets, JBJ				Mugge, Winfred; Kuling, Irene A.; Brenner, Eli; Smeets, Jeroen B. J.			Haptic Guidance Needs to Be Intuitive Not Just Informative to Improve Human Motor Accuracy	PLOS ONE			English	Article							SHARED CONTROL; PERFORMANCE; MOVEMENTS; SHOULDER; FEEDBACK; INTEGRATION; TORQUES	Humans make both random and systematic errors when reproducing learned movements. Intuitive haptic guidance that assists one to make the movements reduces such errors. Our study examined whether any additional haptic information about the location of the target reduces errors in a position reproduction task, or whether the haptic guidance needs to be assistive to do so. Holding a haptic device, subjects made reaches to visible targets without time constraints. They did so in a no-guidance condition, and in guidance conditions in which the direction of the force with respect to the target differed, but the force scaled with the distance to the target in the same way. We examined whether guidance forces directed towards the target would reduce subjects' errors in reproducing a prior position to the same extent as do forces rotated by 90 degrees or 180 degrees, as it might because the forces provide the same information in all three cases. Without vision of the arm, both the accuracy and precision were significantly better with guidance directed towards the target than in all other conditions. The errors with rotated guidance did not differ from those without guidance. Not surprisingly, the movements tended to be faster when guidance forces directed the reaches to the target. This study shows that haptic guidance significantly improved motor performance when using it was intuitive, while non-intuitively presented information did not lead to any improvements and seemed to be ignored even in our simple paradigm with static targets and no time constraints.	[Mugge, Winfred; Kuling, Irene A.; Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Mugge, W (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	w.mugge@vu.nl	Kuling, Irene/ABC-4022-2021; Smeets, Jeroen/B-4198-2008	Kuling, Irene/0000-0003-3556-0393; Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO): STW grant [12160]	Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO): STW grant	This research is part of the H-Haptics perspective program supported by the Dutch Technology Foundation STW (www.stw.nl), which is part of the Netherlands Organization for Scientific Research (NWO): STW grant 12160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank MotekForce Link for support using D-Flow and for developing the driver for interfacing the control software suite with the Phantom haptic device. This research is part of the H-Haptics perspective program supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO): STW grant 12160.	Abbink DA, 2012, COGN TECHNOL WORK, V14, P19, DOI 10.1007/s10111-011-0192-5; Aisen ML, 1997, ARCH NEUROL-CHICAGO, V54, P443, DOI 10.1001/archneur.1997.00550160075019; Boessenkool H, 2013, IEEE T HAPTICS, V6, P2, DOI [10.1109/ToH.2012.22, 10.1109/TOH.2012.22]; CORDO PJ, 1989, TRENDS NEUROSCI, V12, P110, DOI 10.1016/0166-2236(89)90167-7; Draper JV, 1987, P INT TOP M REM SYST; Dvorkin AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-92; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Griffiths PG, 2005, HUM FACTORS, V47, P574, DOI 10.1518/001872005774859944; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; HANNAFORD B, 1991, IEEE T SYST MAN CYB, V21, P620, DOI 10.1109/21.97455; Hesse S, 2003, ARCH PHYS MED REHAB, V84, P915, DOI 10.1016/S0003-9993(02)04954-7; Heuer H, 2014, EXP BRAIN RES, V232, P2229, DOI 10.1007/s00221-014-3914-0; Heuer H, 2014, EXP BRAIN RES, V232, P675, DOI 10.1007/s00221-013-3775-y; Heuer H, 2011, EXP BRAIN RES, V211, P97, DOI 10.1007/s00221-011-2656-5; Kuling IA, 2015, EXP BRAIN RES, V233, P61, DOI 10.1007/s00221-014-4086-7; Kuling IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074236; Kurtzer I, 2009, J NEUROPHYSIOL, V102, P3004, DOI 10.1152/jn.00453.2009; Lynch D, 2005, CLIN REHABIL, V19, P594, DOI 10.1191/0269215505cr901oa; Mars F, 2014, IEEE T HAPTICS, V7, P324, DOI 10.1109/TOH.2013.2295095; Massimino M. J., 1989, P NASA C SPAC ROB, P89; Mulder M, 2012, HUMAN FACTORS J HUMA, V54, P681; Mulder M, 2008, IEEE SYS MAN CYBERN, P804, DOI 10.1109/ICSMC.2008.4811377; Novakovic V, 2011, EXP BRAIN RES, V209, P425, DOI 10.1007/s00221-011-2573-7; O'Malley MK, 2006, J DYN SYST-T ASME, V128, P75, DOI 10.1115/1.2168160; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Rosenberg LB, 1993, P VIRT REAL ANN INT; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; SHERIDAN TB, 2002, HUMANS AUTOMATION SY; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Asseldonk EHF, 2009, J PHYSIOL-PARIS, V103, P276, DOI 10.1016/j.jphysparis.2009.08.010; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Vitense HS, 2003, ERGONOMICS, V46, P68, DOI 10.1080/00140130303534; Wildenbeest JGW, 2013, IEEE T HAPTICS, V6, P242, DOI [10.1109/ToH.2012.19, 10.1109/TOH.2012.19]; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; Wu HG, 2013, J NEUROSCI, V33, P10772, DOI 10.1523/JNEUROSCI.3761-12.2013	37	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150912	10.1371/journal.pone.0150912	http://dx.doi.org/10.1371/journal.pone.0150912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982481	Green Published, gold			2022-12-27	WOS:000372574900056
J	Singh, KK; Qin, M; Brummel, SS; Angelidou, K; Trout, RN; Fenton, T; Spector, SA				Singh, Kumud K.; Qin, Min; Brummel, Sean S.; Angelidou, Konstantia; Trout, Rodney N.; Fenton, Terence; Spector, Stephen A.			Killer Cell Immunoglobulin-Like Receptor Alleles Alter HIV Disease in Children	PLOS ONE			English	Article							HUMAN NATURAL-KILLER; CLASS-I MOLECULES; INFECTED CHILDREN; HLA-B; IMMUNODEFICIENCY VIRUS; KIR2DL4 CD158D; NK CELLS; PROGRESSION; INNATE; RECOGNITION	Background HLA class I molecules are ligands for killer cell immunoglobin like receptors (KIR) that control the antiviral response of natural killer (NK) cells. However, the effects of KIR and HLA (KIR/HLA) alleles on HIV disease of children have not been studied. Methods 993 antiretroviral naive children with symptomatic HIV infection from PACTG protocols P152 and P300 were genotyped for KIR and HLA alleles using the Luminex platform. Linear regression was used to test the association between genotypes and baseline pre-ART HIV RNA, CD4(+) lymphocyte count, and cognitive score, adjusting for age, race/ethnicity and study. The interaction between genetic markers and age was investigated. To account for multiple testing the false discovery rate (FDR) was controlled at 0.05. Results Children with the KIR2DS4*ALL FULL LENGTH (KIR2DS4*AFL) allele had higher CD4(+) lymphocyte counts. Among children <= 2 years of age, the KIR2DS4*AFL was associated with lower plasma HIV RNA and higher cognitive index scores. KIR Cent2DS3/5_1 had lower CD4(+) lymphocyte counts in children <= 2 years of age, while the presence of Tel1, Tel2DS4_2, Tel2DS4_4, Tel8, Tel2DS4_6 had higher CD4(+) lymphocyte counts in all children. Presence of Cent2, Cent4 and Cent8 was associated with increased HIV RNA load in children <= 2 years. Presence of KIR3DL1+Bw4 was associated with higher CD4(+) lymphocyte counts in all children. Among children >2 years old, KIR3DS1+Bw4-80I was associated with higher plasma HIV RNA, and Bw6/Bw6 was associated with lower plasma HIV RNA compared to children with KIR3DS1+Bw4-80I. Conclusions Presented data show for the first time that specific KIR alleles independently or combined with HLA ligands are associated with HIV RNA and CD4(+) lymphocyte counts in infected, antiretroviral naive children; and many of these effect estimates appear to be age dependent. These data support a role for specific KIR alleles in HIV pathogenesis in children.	[Singh, Kumud K.; Trout, Rodney N.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Qin, Min; Brummel, Sean S.; Angelidou, Konstantia; Fenton, Terence] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA; [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; Harvard University; Harvard T.H. Chan School of Public Health; Rady Childrens Hospital San Diego	Singh, KK; Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Spector, SA (corresponding author), Rady Childrens Hosp, San Diego, CA USA.	kusingh@ucsd.edu; saspector@ucsd.edu			International Maternal Perinatal Adolescent AIDS Clinical Trials (IMPAACT) Network [1R01NS077874, UM1AI068616]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068616, UM1AI068632, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); Pediatric AIDS Clinical Trials Group (PACTG); NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068616, UM1AI106716, UM1AI069536, UM1AI068632, UM1AI069477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077874] Funding Source: NIH RePORTER	International Maternal Perinatal Adolescent AIDS Clinical Trials (IMPAACT) Network; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pediatric AIDS Clinical Trials Group (PACTG); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by 1R01NS077874 (SAS), UM1AI068616 (MQ, SSB, TF), the International Maternal Perinatal Adolescent AIDS Clinical Trials (IMPAACT) Network. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH).; The authors acknowledge and thank the P152/P300 participants and their families as well as site personnel for their contributions to the studies. The authors also acknowledge the Pediatric AIDS Clinical Trials Group (PACTG) for the support. This research was supported in part by 1R01NS077874 (SAS), UM1AI068616 (MQ, SSB, TF), the International Maternal Perinatal Adolescent AIDS Clinical Trials (IMPAACT) Network. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Bayley N., 1993, BAYLEY SCALES INFANT, Vsecond; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Boyington JC, 2002, MOL IMMUNOL, V38, P1007, DOI 10.1016/S0161-5890(02)00030-5; Carrington M, 2008, TRENDS MICROBIOL, V16, P620, DOI 10.1016/j.tim.2008.09.002; De Maria A, 2000, IMMUNOL LETT, V72, P179, DOI 10.1016/S0165-2478(00)00186-3; De Re V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117420; Englund JA, 1997, NEW ENGL J MED, V336, P1704, DOI 10.1056/NEJM199706123362403; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; de Sorrentino AH, 2013, IMMUNOLOGY, V140, P273, DOI 10.1111/imm.12137; Hong HA, 2013, CLIN IMMUNOL, V149, P498, DOI 10.1016/j.clim.2013.09.005; Igarashi T, 2004, BLOOD, V104, P170, DOI 10.1182/blood-2003-12-4438; Jiang YJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-405; Korner C, CROI 2016 FEB 22 25; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Li H, 2010, PROTEIN PEPTIDE LETT, V17, P547, DOI 10.2174/092986610791112657; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lopez-Vazquez A, 2005, HUM IMMUNOL, V66, P285, DOI 10.1016/j.humimm.2005.01.001; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; McCarthy D., 1972, MANUAL MCCARTHY SCAL; McKinney RE, 1998, J PEDIATR-US, V133, P500, DOI 10.1016/S0022-3476(98)70057-5; Merino AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099353; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Mori M, 2015, AIDS, V29, P1607, DOI 10.1097/QAD.0000000000000747; Olvera A, 2015, AIDS, V29, P507, DOI 10.1097/QAD.0000000000000574; Pan W, 2001, BIOMETRIKA, V88, P901, DOI 10.1093/biomet/88.3.901; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Paximadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016541; Ponte M, 1999, P NATL ACAD SCI USA, V96, P5674, DOI 10.1073/pnas.96.10.5674; Rajagopalan S, 2001, J IMMUNOL, V167, P1877, DOI 10.4049/jimmunol.167.4.1877; Raskino C, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e32; RAULET DH, 1995, CELL, V82, P697, DOI 10.1016/0092-8674(95)90466-2; Shieh TM, 2001, J NEUROVIROL, V7, P11; Singh KK, 2007, CLIN GENET, V72, P156, DOI 10.1111/j.1399-0004.2007.00808.x; Singh KK, 2011, JAIDS-J ACQ IMM DEF, V57, P32, DOI 10.1097/QAI.0b013e3182119244; Tiemessen CT, 2011, JAIDS-J ACQ IMM DEF, V57, P181, DOI 10.1097/QAI.0b013e3182174a76; Trichieri G, 1989, ADV IMMUNOL, V47, P87; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wechsler D., 2003, MANUAL WECHSLER INTE, V4th; Wechsler D., 2014, WECHSLER PRESCHOOL P; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Winchester R, 2004, JAIDS-J ACQ IMM DEF, V36, P659, DOI 10.1097/00126334-200406010-00002	50	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151364	10.1371/journal.pone.0151364	http://dx.doi.org/10.1371/journal.pone.0151364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983081	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900080
J	Wang, JH; Wong, JXH; Kwok, H; Li, XC; Yu, HZ				Wang, Jianhua; Wong, Jessica X. H.; Kwok, Honoria; Li, Xiaochun; Yu, Hua-Zhong			Facile Preparation of Nanostructured, Superhydrophobic Filter Paper for Efficient Water/Oil Separation	PLOS ONE			English	Article							FABRICATION; MEMBRANES; SURFACES; LIQUIDS	In this paper, we present a facile and cost-effective method to obtain superhydrophobic filter paper and demonstrate its application for efficient water/oil separation. By coupling structurally distinct organosilane precursors (e.g., octadecyltrichlorosilane and methyltrichlorosilane) to paper fibers under controlled reaction conditions, we have formulated a simple, inexpensive, and efficient protocol to achieve a desirable superhydrophobic and superoleophilic surface on conventional filter paper. The silanized superhydrophobic filter paper showed nanostructured morphology and demonstrated great separation efficiency (up to 99.4%) for water/oil mixtures. The modified filter paper is stable in both aqueous solutions and organic solvents, and can be reused multiple times. The present study shows that our newly developed binary silanization is a promising method of modifying cellulose-based materials for practical applications, in particular the treatment of industrial waste water and ecosystem recovery.	[Wang, Jianhua; Li, Xiaochun; Yu, Hua-Zhong] Taiyuan Univ Technol, Key Lab Adv Transducers & Intelligent Control Sys, Minist Educ & Shanxi Prov, Coll Phys & Optoelect, Taiyuan 030024, Shanxi, Peoples R China; [Wong, Jessica X. H.; Kwok, Honoria; Yu, Hua-Zhong] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Taiyuan University of Technology; Simon Fraser University	Li, XC; Yu, HZ (corresponding author), Taiyuan Univ Technol, Key Lab Adv Transducers & Intelligent Control Sys, Minist Educ & Shanxi Prov, Coll Phys & Optoelect, Taiyuan 030024, Shanxi, Peoples R China.; Yu, HZ (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	lixiaochun@tyut.edu.cn; hogan_yu@sfu.ca		Yu (yu hua zhong), Hua-Zhong "Hogan"/0000-0003-1411-3156	Natural Sciences and Engineering Research Council (NSERC) of Canada; Natural Science Foundation of China [21575098, 21505098, 11504259]; Shanxi Provincial government ("100-talents program"); Shanxi province international cooperation project [2015081019]; Scholarship Council of China [2013-038]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Provincial government ("100-talents program"); Shanxi province international cooperation project; Scholarship Council of China	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada (HY); the Natural Science Foundation of China (Grant Nos. 21575098, 21505098, 11504259) (HY and XL); the Shanxi Provincial government ("100-talents program") (HY); the Shanxi province international cooperation project (Grant No. 2015081019) (XL); and the Scholarship Council of China (Grant No. 2013-038) (XL).; We gratefully acknowledge the financial support from the Natural Sciences and Engineering Research Council (NSERC) of Canada; this research was also jointly supported by the Natural Science Foundation of China (Grant No. 21575098; 21505098; 11504259); Shanxi Provincial government ("100-talents program"); Shanxi province international cooperation project (Grant No. 2015081019); Scholarship Council of China (Grant No. 2013-038).	Arbatan T, 2012, CHEM ENG J, V210, P74, DOI 10.1016/j.cej.2012.08.074; ATLAS RM, 1981, MICROBIOL REV, V45, P180, DOI 10.1128/MMBR.45.1.180-209.1981; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Chen PC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02776; Dai W, 2013, SCI REP-UK, V3, DOI 10.1038/srep03304; Du C, 2014, APPL SURF SCI, V313, P304, DOI 10.1016/j.apsusc.2014.05.207; Fan JB, 2015, ADV FUNCT MATER, V25, P5368, DOI 10.1002/adfm.201501066; Ge B, 2015, APPL PHYS A-MATER, V121, P1291, DOI 10.1007/s00339-015-9509-1; GE Healthcare Life Sciences, STAND GRAD; Guo ZG, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2745251; He QH, 2013, ANAL CHEM, V85, P1327, DOI 10.1021/ac303138x; Huang XX, 2012, APPL SURF SCI, V258, P8739, DOI 10.1016/j.apsusc.2012.05.083; Inagaki M, 2002, CARBON, V40, P1487, DOI 10.1016/S0008-6223(01)00319-0; Jin MH, 2005, ADV MATER, V17, P1977, DOI 10.1002/adma.200401726; Kong L, 2014, IND ENG CHEM RES, V53, P16516, DOI 10.1021/ie502864u; Li J, 2012, APPL SURF SCI, V261, P470, DOI 10.1016/j.apsusc.2012.08.034; Li SH, 2008, LANGMUIR, V24, P5585, DOI 10.1021/la800157t; MCGOVERN ME, 1994, LANGMUIR, V10, P3607, DOI 10.1021/la00022a038; Pan QM, 2008, APPL SURF SCI, V254, P6002, DOI 10.1016/j.apsusc.2008.03.034; Radetic MM, 2003, ENVIRON SCI TECHNOL, V37, P1008, DOI 10.1021/es0201303; Rao AV, 2007, J COLLOID INTERF SCI, V305, P124, DOI 10.1016/j.jcis.2006.09.025; Teisala H, 2011, J NANOMATER, V2011, DOI 10.1155/2011/818707; Wang HX, 2008, CHEM COMMUN, P877, DOI 10.1039/b714352d; Wang L, 2015, ANGEW CHEM INT EDIT, V54, P14732, DOI 10.1002/anie.201506866; Wang SH, 2010, ACS APPL MATER INTER, V2, P677, DOI 10.1021/am900704u; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Wong JXH, 2013, J CHEM EDUC, V90, P1203, DOI 10.1021/ed300809m; Wong JXH, 2012, THIN SOLID FILMS, V522, P159, DOI 10.1016/j.tsf.2012.08.033; Xue ZX, 2011, ADV MATER, V23, P4270, DOI 10.1002/adma.201102616; Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h; Zhang M, 2013, CARBOHYD POLYM, V97, P59, DOI 10.1016/j.carbpol.2012.08.118; Zhang M, 2012, APPL SURF SCI, V261, P764, DOI 10.1016/j.apsusc.2012.08.097; Zhang YL, 2009, NANO TODAY, V4, P135, DOI 10.1016/j.nantod.2009.02.010; Zhu Q, 2011, J PHYS CHEM C, V115, P17464, DOI 10.1021/jp2043027	34	19	21	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151439	10.1371/journal.pone.0151439	http://dx.doi.org/10.1371/journal.pone.0151439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982055	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900083
J	Yang, TY; Dehghantanha, A; Choo, KKR; Muda, Z				Yang, Teing Yee; Dehghantanha, Ali; Choo, Kim-Kwang Raymond; Muda, Zaiton			Windows Instant Messaging App Forensics: Facebook and Skype as Case Studies	PLOS ONE			English	Article							ARTIFACTS LEFT	Instant messaging (IM) has changed the way people communicate with each other. However, the interactive and instant nature of these applications (apps) made them an attractive choice for malicious cyber activities such as phishing. The forensic examination of IM apps for modern Windows 8.1 (or later) has been largely unexplored, as the platform is relatively new. In this paper, we seek to determine the data remnants from the use of two popular Windows Store application software for instant messaging, namely Facebook and Skype on a Windows 8.1 client machine. This research contributes to an in-depth understanding of the types of terrestrial artefacts that are likely to remain after the use of instant messaging services and application software on a contemporary Windows operating system. Potential artefacts detected during the research include data relating to the installation or uninstallation of the instant messaging application software, log-in and log-off information, contact lists, conversations, and transferred files.	[Yang, Teing Yee; Muda, Zaiton] Univ Putra Malaysia, Fac Comp Sci & Informat Technol, Dept Comp Sci, Upm Serdang, Selangor, Malaysia; [Dehghantanha, Ali] Univ Salford, Sch Comp Sci & Engn, Newton Bldg, Salford, Greater Manches, England; [Choo, Kim-Kwang Raymond] Univ S Australia, Informat Assurance Res Grp, Adelaide, SA 5001, Australia	Universiti Putra Malaysia; University of Salford; University of South Australia	Choo, KKR (corresponding author), Univ S Australia, Informat Assurance Res Grp, Adelaide, SA 5001, Australia.	raymond.choo@fulbrightmail.org	Choo, Kim-Kwang Raymond/A-3634-2009	Choo, Kim-Kwang Raymond/0000-0001-9208-5336				Al Barghuthi Nedaa B., 2013, Journal of Communications, V8, P708; Al Mutawa N., 2011, 2011 6th International Conference for Internet Technology and Secured Transactions (ICITST), P771; Al Mutawa N, 2012, DIGIT INVEST, V9, pS24, DOI 10.1016/j.diin.2012.05.007; Ali D, 2015, J INFORM PRIVACY SEC, V11, P137; Azab A, 2012, 2012 THIRD CYBERCRIME AND TRUSTWORTHY COMPUTING WORKSHOP (CTC 2012), P19, DOI 10.1109/CTC.2012.14; Azfar A, 2015, P AM C INF SYST AMCI; Azfar A, 2016, P ANN HAW INT C SYST; Azfar A, 2016, J FORENSIC IN PRESS; Azfar A, 2016, ELECTRON COMMER RES, V16, P73, DOI 10.1007/s10660-015-9208-1; Barnes T., 2014, MARGATE PEDOPHILE JA; Baset Salman, 2005, P IEEE INFOCOM, DOI [10.1109/INFOCOM.2006.312., DOI 10.1109/INFOCOM.2006.312, 10.1109/INFOCOM.2006.312]; Brockschmidt K., 2014, PROGRAMMING WINDOWS; Broujerdi H. G., 2011, INT J DIGITAL INFORM, V1, P651; Carvey H., 2014, WINDOWS FORENSIC ANA; Carvey H., 2004, DIGIT INVEST, V1, P256, DOI DOI 10.1016/J.DIIN.2004.10.003; Chu HC, 2011, IEEE J SEL AREA COMM, V29, P1368, DOI 10.1109/JSAC.2011.110804; Dezfouli F.N., 2015, J FORENSIC SCI, P1, DOI DOI 10.1080/00450618.2015.1066854; Di Leom M, 2015, 2015 IEEE TRUSTCOM/BIGDATASE/ISPA, VOL 1, P1059, DOI 10.1109/Trustcom.2015.483; Dickson M, 2007, DIGIT INVEST, V4, P36, DOI 10.1016/j.diin.2007.01.003; Dickson M, 2006, DIGIT INVESTIG, V3, P227, DOI 10.1016/j.diin.2006.10.004; Dickson M, 2006, DIGIT INVESTIG, V3, P159, DOI 10.1016/j.diin.2006.08.009; Dickson M, 2006, DIGIT INVESTIG, V3, P79, DOI 10.1016/j.diin.2006.04.002; Do Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138449; ENISA, 2012, PROC SEC GUID MON SE; Farnden J, 2015, P AM C INF SYST AMCI; Fleming R., 2013, MANY DEVICES CAN YOU; Ganji M, 2013, ADV INFORM SCI SERVI, V5, P1; Godfrey M., 2014, PEDOPHILES COERCING; Immanuel F, 2015, 2015 IEEE TRUSTCOM/BIGDATASE/ISPA, VOL 1, P1094, DOI 10.1109/Trustcom.2015.488; Iqbal A, 2014, DIGIT INVEST, V11, pS87, DOI 10.1016/j.diin.2014.03.011; Kiley M, 2008, INT FED INFO PROC, V285, P129; Kuhlee L, 2012, COMPUTER FORENSIK HA; Lee C., 2015, COMPUTER SCI ITS APP, P1037, DOI [10.1007/978-3- 662- 45402-2, DOI 10.1007/978-3-662-45402-2]; Levendoski M, 2012, DIGITAL FORENSICS CY, P172; Levinson A., 2011, INTRO POLITICAL COMP, P1; Martini B, 2012, DIGIT INVEST, V9, P71, DOI 10.1016/j.diin.2012.07.001; McCallum N., 2013, PEDOPHILE POSED BIEB; McKemmish R, 1999, WHAT IS FORENSIC COM; McQuaid J., 2012, SKYPE FORENSICS ANAL; Mehreen S, 2015, WINDOWS 8 CLOUD STOR, P312; Meyers SL, 2014, SPECIAL REPORT 1; Pill J.S., 2011, GUIDE FORENSIC ACCOU; Quick D., 2013, CLOUD STORAGE FORENS; Quick D, 2014, J NETW COMPUT APPL, V40, P179, DOI 10.1016/j.jnca.2013.09.016; Quick D, 2013, FUTURE GENER COMP SY, V29, P1378, DOI 10.1016/j.future.2013.02.001; Quick D, 2013, DIGIT INVEST, V10, P3, DOI 10.1016/j.diin.2013.02.003; Rasmussen B, 2014, HIGH PERFORMANCE WIN; Reisinger D, 2013, WINDOWS 8 1 APP UPDA; Reust J, 2006, DIGIT INVESTIG, V3, P238, DOI 10.1016/j.diin.2006.10.009; Said H, 2011, IPHONE FORENSICS TEC, P120; Sanna P, 2013, WINDOWS 8 1 ABSOLUTE; Sgaras Christos, 2015, Computational Forensics. 5th International Workshop, IWCF 2012 and 6th International Workshop, IWCF 2014. Revised Selected Papers: LNCS 8915, P188, DOI 10.1007/978-3-319-20125-2_16; Simon M, 2010, FIFTH INTERNATIONAL CONFERENCE ON AVAILABILITY, RELIABILITY, AND SECURITY: ARES 2010, PROCEEDINGS, P283, DOI 10.1109/ARES.2010.73; Teng SY, 2012, COMM COM INF SC, V350, P108; The Radicati Group Releases, 2015, INST MESS STAT REP 2; Thomson A, 2012, WINDOWS 8 FORENSIC G; Timoney N, 2014, CONSUMER CONTACT JOB; Tso Y-C, 2012, P 6 INT C UB INF MAN; U.S: National Criminal Justice Reference Service (NCJRS), 2007, INV US TECHN DEV TOO; van Dongen WS, 2007, DIGIT INVEST, V4, P138, DOI 10.1016/j.diin.2008.01.002; van Dongen WS, 2007, DIGIT INVEST, V4, P73, DOI 10.1016/j.diin.2007.06.019; Walnycky D, 2015, DIGIT INVEST, V14, pS77, DOI 10.1016/j.diin.2015.05.009; Wong K., 2011, FACEBOOK FORENSICS; Wongyai W., 2012, 2012 International Joint Conference on Computer Science and Software Engineering (JCSSE 2012), P77, DOI 10.1109/JCSSE.2012.6261929; Wurm K, 2012, SKYPE NEW AUDIO CODE; Yasin M, 2012, LECT NOTES ELECT ENG, P119; Yasin M, 2013, DIGIT INVEST, V9, P222, DOI 10.1016/j.diin.2012.11.003; Yasin M, 2014, ELECTRON COMMER RES, V14, P369, DOI 10.1007/s10660-014-9145-4	68	39	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150300	10.1371/journal.pone.0150300	http://dx.doi.org/10.1371/journal.pone.0150300			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982207	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900034
J	Bokkasam, H; Ott, A				Bokkasam, Harish; Ott, Albrecht			Information Limited Oligonucleotide Amplification Assay for Affinity-Based, Parallel Detection Studies	PLOS ONE			English	Article							NONSPECIFIC HYBRIDIZATION; MICROARRAY; DNA; POSITION; NUMBER; SIZE	Molecular communication systems encounter similar constraints as telecommunications. In either case, channel crosstalk at the receiver end will result in information loss that statistical analysis cannot compensate. This is because in any communication channel there is a physical limit to the amount of information that can be transmitted. We present a novel and simple modified end amplification (MEA) technique to generate reduced and defined amounts of specific information in form of short fragments from an oligonucleotide source that also contains unrelated and redundant information. Our method can be a valuable tool to investigate information overflow and channel capacity in biomolecular recognition systems.	[Bokkasam, Harish; Ott, Albrecht] Univ Saarland, Inst Biol Expt Phys, D-66123 Saarbrucken, Germany	Saarland University	Ott, A (corresponding author), Univ Saarland, Inst Biol Expt Phys, D-66123 Saarbrucken, Germany.	albrecht.ott@uni-saarland.de			Deutsche Forschungsgemeinschaft (DFG) graduate college [GRK 1276]; collaborative research center "Physical Modeling of non-Equilibrium Processes in Biological Systems" [SFB 1027]	Deutsche Forschungsgemeinschaft (DFG) graduate college(German Research Foundation (DFG)); collaborative research center "Physical Modeling of non-Equilibrium Processes in Biological Systems"	The authors gratefully acknowledge the financial support provided by Deutsche Forschungsgemeinschaft (DFG) graduate college (GRK 1276) "Structure Formation and Transport in Complex Systems" and the collaborative research center (SFB 1027) "Physical Modeling of non-Equilibrium Processes in Biological Systems". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhanot G, 2003, BIOPHYS J, V84, P124, DOI 10.1016/S0006-3495(03)74837-1; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Greiner O, 2004, ANAL BIOCHEM, V324, P197, DOI 10.1016/j.ab.2003.10.030; Harrison A, 2013, NUCLEIC ACIDS RES, V41, P2779, DOI 10.1093/nar/gks1358; Huang XZ, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0037-5; Itzkovitz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-239; Klur S, 2004, GENOMICS, V83, P508, DOI 10.1016/j.ygeno.2003.09.005; Letowski J, 2004, J MICROBIOL METH, V57, P269, DOI 10.1016/j.mimet.2004.02.002; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Mehlmann M, 2005, ANAL BIOCHEM, V347, P316, DOI 10.1016/j.ab.2005.09.036; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Naiser T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-509; Pierce KE, 2007, METHODS MOL MED, P65, DOI [10.1007/978-1-59745-298-4_7, DOI 10.1007/978-1-59745-298-4_7]; Pozhitkov AE, 2008, J MICROBIOL METH, V75, P92, DOI 10.1016/j.mimet.2008.05.013; Riva A, 2005, COMPUT BIOL CHEM, V29, P319, DOI 10.1016/j.compbiolchem.2005.08.006; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schneider TD, 2000, NUCLEIC ACIDS RES, V28, P2794, DOI 10.1093/nar/28.14.2794; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Tarca AL, 2006, AM J OBSTET GYNECOL, V195, P373, DOI 10.1016/j.ajog.2006.07.001; Trapp C, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-20	20	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151072	10.1371/journal.pone.0151072	http://dx.doi.org/10.1371/journal.pone.0151072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978653	gold, Green Published, Green Submitted			2022-12-27	WOS:000372572800046
J	Fujita, M; Sato, Y; Nagashima, K; Takahashi, S; Hata, A				Fujita, Misuzu; Sato, Yasunori; Nagashima, Kengo; Takahashi, Sho; Hata, Akira			Income Related Inequality of Health Care Access in Japan: A Retrospective Cohort Study	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; SOCIOECONOMIC-STATUS; AMBULATORY-CARE; MEDICAL-CARE; MORTALITY; POPULATION; ADULTS; HYPERTENSION; BEHAVIORS; INSURANCE	The purpose of this retrospective cohort study was to analyze the association between income level and health care access in Japan. Data from a total of 222,259 subjects (age range, 0-74 years) who submitted National Health Insurance claims in Chiba City from April 2012 to March 2014 and who declared income for the tax period from January 1 to December 31, 2012 were integrated and analyzed. The generalized estimating equation, in which household was defined as a cluster, was used to evaluate the association between equivalent income and utilization and duration of hospitalization and outpatient care services. A significant positive linear association was observed between income level and outpatient visit rates among all age groups of both sexes; however, a significantly higher rate and longer period of hospitalization, and longer outpatient care, were observed among certain lower income subgroups. To control for decreased income due to hospitalization, subjects hospitalized during the previous year were excluded, and the data was then reanalyzed. Significant inverse associations remained in the hospitalization rate among 40-59-year-oldmen and 60-69-year-old women, and in duration of hospitalization among 40-59 and 60-69-year-olds of both sexes and 70-74-year-old women. These results suggest that low-income individuals in Japan have poorer access to outpatient care and more serious health conditions than their higher income counterparts.	[Fujita, Misuzu; Hata, Akira] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Chiba, Japan; [Sato, Yasunori; Nagashima, Kengo] Chiba Univ, Grad Sch Med, Dept Global Clin Res, Chiba, Chiba, Japan; [Sato, Yasunori; Nagashima, Kengo; Takahashi, Sho] Chiba Univ Hosp, Clin Res Ctr, Chiba, Chiba, Japan	Chiba University; Chiba University; Chiba University	Fujita, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Chiba, Japan.	fujitam@chiba-u.jp	Nagashima, Kengo/I-1726-2013; Nagashima, Kengo/I-4258-2019	Nagashima, Kengo/0000-0003-4529-9045; Nagashima, Kengo/0000-0003-4529-9045; Fujita, Misuzu/0000-0001-5308-4744	Japan Society for the Promotion of Science KAKENHI [26460826]; Chiba Foundation for Health Promotion & Disease Prevention	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Chiba Foundation for Health Promotion & Disease Prevention	This work was supported by a Japan Society for the Promotion of Science KAKENHI grant (URL: https://www.jsps.go.jp/j-grantsinaid/, Number: 26460826, author: MF) and the Chiba Foundation for Health Promotion & Disease Prevention (URL: http://www.kenko-chiba.or.jp/, author: MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2013, PATIENT EDUC COUNS, V91, P206, DOI 10.1016/j.pec.2012.12.001; Agabiti N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-457; Antonelli-Incalzi R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-227; Coeli CM, 2009, DIABETES RES CLIN PR, V86, P134, DOI 10.1016/j.diabres.2009.08.003; Dinca-Panaitescu S, 2011, HEALTH POLICY, V99, P116, DOI 10.1016/j.healthpol.2010.07.018; Fraser SDS, 2014, J PUBLIC HEALTH-UK, V36, P577, DOI 10.1093/pubmed/fdt117; Fukuda Y, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-53; Hadley J, 2007, JAMA-J AM MED ASSOC, V297, P1073, DOI 10.1001/jama.297.10.1073; Hanibuchi T, 2010, JGSS RES SERIES, V10, P99; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hirai Hiroshi, 2012, Curr Gerontol Geriatr Res, V2012, P701583, DOI 10.1155/2012/701583; Honjo K, 2014, INT J BEHAV MED, V21, P737, DOI 10.1007/s12529-013-9337-7; Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2; Ishida Y, 2012, PEDIATRICS, V129, pE113, DOI 10.1542/peds.2011-1321; Jung Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057109; Kahn RS, 2000, BRIT MED J, V321, P1311, DOI 10.1136/bmj.321.7272.1311; Kullgren JT, 2012, HEALTH SERV RES, V47, P462, DOI 10.1111/j.1475-6773.2011.01308.x; Kuo RN, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-69; Lammintausta A, 2012, ANN EPIDEMIOL, V22, P87, DOI 10.1016/j.annepidem.2011.10.012; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Matsuyama Y, 2014, COMMUNITY DENT ORAL, V42, P122, DOI 10.1111/cdoe.12074; Mielck A, 2006, EXP CLIN ENDOCR DIAB, V114, P240, DOI 10.1055/s-2006-924228; Ministry of Health Labour and Welfare, TABL INT CLASS DIS U; Ministry of Health Labour and Welfare, 2010, SURV BEN COND HLTH C; Ministry of Health Labour and Welfare, ANN HLTH LAB WELF RE; Murata C, 2010, INT J ENV RES PUB HE, V7, P1330, DOI 10.3390/ijerph7041330; OECD, 2014, TERMS REF OECD PROJ; Osler M, 2002, BRIT MED J, V324, P13, DOI 10.1136/bmj.324.7328.13; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Rosengren A, 1998, SCAND J SOC MED, V26, P272, DOI 10.1177/14034948980260040801; Segnan N, 1997, IARC Sci Publ, P369; Steenland K, 2004, AM J EPIDEMIOL, V159, P1047, DOI 10.1093/aje/kwh129; Toyokawa S, 2012, IRYO TO SHAKAI, V22, P69; Trachtenberg AJ, 2014, ANN FAM MED, V12, P402, DOI 10.1370/afm.1683; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; Walker RL, 2014, CAN J CARDIOL, V30, P1640, DOI 10.1016/j.cjca.2014.09.035; Wang ZD, 2014, INT J CARDIOL, V173, P544, DOI 10.1016/j.ijcard.2014.03.082	38	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151690	10.1371/journal.pone.0151690	http://dx.doi.org/10.1371/journal.pone.0151690			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978270	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800100
J	Nierat, MC; Demiri, S; Dupuis-Lozeron, E; Allali, G; Morelot-Panzini, C; Similowski, T; Adler, D				Nierat, Marie-Cecile; Demiri, Suela; Dupuis-Lozeron, Elise; Allali, Gilles; Morelot-Panzini, Capucine; Similowski, Thomas; Adler, Dan			When Breathing Interferes with Cognition: Experimental Inspiratory Loading Alters Timed Up-and-Go Test in Normal Humans	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; WALKING-WHILE-TALKING; MOTOR IMAGERY; ELECTROENCEPHALOGRAPHIC EVIDENCE; PREMOTOR POTENTIALS; SELF-CONSCIOUSNESS; CORTEX ACTIVATION; GAIT VARIABILITY; DISORDERS; FMRI	Human breathing stems from automatic brainstem neural processes. It can also be operated by cortico-subcortical networks, especially when breathing becomes uncomfortable because of external or internal inspiratory loads. How the "irruption of breathing into consciousness" interacts with cognition remains unclear, but a case report in a patient with defective automatic breathing (Ondine's curse syndrome) has shown that there was a cognitive cost of breathing when the respiratory cortical networks were engaged. In a pilot study of putative breathing-cognition interactions, the present study relied on a randomized design to test the hypothesis that experimentally loaded breathing in 28 young healthy subjects would have a negative impact on cognition as tested by "timed up-and-go" test (TUG) and its imagery version (iTUG). Progressive inspiratory threshold loading resulted in slower TUG and iTUG performance. Participants consistently imagined themselves faster than they actually were. However, progressive inspiratory loading slowed iTUG more than TUG, a finding that is unexpected with regard to the known effects of dual tasking on TUG and iTUG (slower TUG but stable iTUG). Insofar as the cortical networks engaged in response to inspiratory loading are also activated during complex locomotor tasks requiring cognitive inputs, we infer that competition for cortical resources may account for the breathing-cognition interference that is evidenced here.	[Nierat, Marie-Cecile; Demiri, Suela; Morelot-Panzini, Capucine; Similowski, Thomas] UPMC Univ Paris 06, Univ Sorbonne, INSERM, Neurophysiol Resp Expt & Clin UMRS1158, Paris, France; [Dupuis-Lozeron, Elise; Adler, Dan] Univ Hosp Geneva, Div Pulm Dis, Geneva, Switzerland; [Dupuis-Lozeron, Elise; Allali, Gilles; Adler, Dan] Univ Geneva, Geneva, Switzerland; [Dupuis-Lozeron, Elise] Univ Geneva, Geneva Sch Econ & Management, Res Ctr Stat, Geneva, Switzerland; [Allali, Gilles] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Allali, Gilles] Albert Einstein Coll Med, Div Cognit & Motor Aging, Dept Neurol, Bronx, NY 10467 USA; [Morelot-Panzini, Capucine; Similowski, Thomas] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Dept R3S, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Geneva; University of Geneva; University of Geneva; University of Geneva; Yeshiva University; Albert Einstein College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Similowski, T (corresponding author), UPMC Univ Paris 06, Univ Sorbonne, INSERM, Neurophysiol Resp Expt & Clin UMRS1158, Paris, France.; Similowski, T (corresponding author), Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Dept R3S, F-75013 Paris, France.	thomas.similowski@psl.aphp.fr	Allali, Gilles/D-1500-2009	Allali, Gilles/0000-0002-4455-6719; Dupuis Lozeron, Elise/0000-0002-3300-1363	program "Investissement d'Avenir" of the French Government [ANR-10-AIHU 06]; Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil (ADOREPS), Paris, France; Centre d'Assistance Respiratoire a Domicile d'Ile-de-France (CARDIF), Fontenay-aux-Roses, France	program "Investissement d'Avenir" of the French Government; Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil (ADOREPS), Paris, France; Centre d'Assistance Respiratoire a Domicile d'Ile-de-France (CARDIF), Fontenay-aux-Roses, France	This work was supported by the program "Investissement d'Avenir ANR-10-AIHU 06" of the French Government, and the Association pour le Developpement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil (ADOREPS), Paris, France. Suela Demiri was the recipient of a research scholarship granted by the Centre d'Assistance Respiratoire a Domicile d'Ile-de-France (CARDIF), Fontenay-aux-Roses, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2014, RESP PHYSIOL NEUROBI, V203, P68, DOI 10.1016/j.resp.2014.08.003; Allali G, 2014, RESP PHYSIOL NEUROBI, V201, P31, DOI 10.1016/j.resp.2014.06.012; Allali G, 2012, EUR NEUROL, V67, P116, DOI 10.1159/000334394; Allali G, 2014, J GERONTOL A-BIOL, V69, P1389, DOI 10.1093/gerona/glt207; [Anonymous], 2002, AM J RESP CRIT CARE, V166, P518; Beauchet O, 2015, EXP GERONTOL, V61, P98, DOI 10.1016/j.exger.2014.11.002; Beauchet O, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-66; Beauchet O, 2014, DRUG AGING, V31, P363, DOI 10.1007/s40266-014-0175-3; Beauchet O, 2010, J NEUROL SCI, V294, P102, DOI 10.1016/j.jns.2010.03.021; Blumen HM, 2014, HUM BRAIN MAPP, V35, P4090, DOI 10.1002/hbm.22461; Bridenbaugh SA, 2013, AGING CLIN EXP RES, V25, P283, DOI 10.1007/s40520-013-0046-5; Celle S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-140; De Sanctis P, 2014, NEUROIMAGE, V94, P55, DOI 10.1016/j.neuroimage.2014.03.016; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Georges M, 2016, EUR RESP J IN PRESS, DOI [10.1183/13993003.01686-201, DOI 10.1183/13993003.01686-201]; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Kannape OA, 2012, INT J PSYCHOPHYSIOL, V83, P191, DOI 10.1016/j.ijpsycho.2011.12.006; Lahousse L, 2015, EUR RESPIR J, V46, P88, DOI 10.1183/09031936.00213214; Lallart E, 2012, PSYCHIAT RES, V198, P366, DOI 10.1016/j.psychres.2011.12.013; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Launois C, 2015, SLEEP, V38, P1743, DOI 10.5665/sleep.5156; Morawiec E, 2015, J APPL PHYSIOL, V118, P1023, DOI 10.1152/japplphysiol.00201.2014; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Peiffer C, 2001, AM J RESP CRIT CARE, V163, P951, DOI 10.1164/ajrccm.163.4.2005057; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raux M, 2007, ANESTHESIOLOGY, V107, P746, DOI 10.1097/01.anes.0000287005.58761.e8; Raux M, 2007, J PHYSIOL-LONDON, V578, P569, DOI 10.1113/jphysiol.2006.120246; Raux M, 2013, RESP PHYSIOL NEUROBI, V189, P571, DOI 10.1016/j.resp.2013.08.005; Raux M, 2010, RESP PHYSIOL NEUROBI, V171, P67, DOI 10.1016/j.resp.2010.01.002; Sharman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107850; Snijders AH, 2007, LANCET NEUROL, V6, P63, DOI 10.1016/S1474-4422(06)70678-0; Tremoureux L, 2014, RESP PHYSIOL NEUROBI, V204, P64, DOI 10.1016/j.resp.2014.06.018; Tremoureux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084534; Tremoureux L, 2010, J APPL PHYSIOL, V108, P1127, DOI 10.1152/japplphysiol.91449.2008; Vallabhajosula S, 2015, J BIOMECH, V48, P921, DOI 10.1016/j.jbiomech.2015.02.024; Wang CH, 2008, J NEURAL TRANSM, V115, P1149, DOI 10.1007/s00702-008-0058-z; Yuan J, 2015, HUM BRAIN MAPP, V36, P1484, DOI 10.1002/hbm.22717	37	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151625	10.1371/journal.pone.0151625	http://dx.doi.org/10.1371/journal.pone.0151625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978782	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800095
J	Reinisova, M; Plachy, J; Kucerova, D; Senigl, F; Vinkler, M; Hejnar, J				Reinisova, Marketa; Plachy, Jiri; Kucerova, Dana; Senigl, Filip; Vinkler, Michal; Hejnar, Jiri			Genetic Diversity of NHE1, Receptor for Subgroup J Avian Leukosis Virus, in Domestic Chicken and Wild Anseriform Species	PLOS ONE			English	Article							BROILER BREEDER CHICKENS; ROUS-SARCOMA VIRUS; DECREASED SUSCEPTIBILITY; HOST-RANGE; INFECTION; TVA; RETROVIRUSES; TRANSMISSION; GLYCOPROTEIN; BINDING	J subgroup avian leukosis virus (ALV-J) infects domestic chicken, jungle fowl, and turkey and enters the host cell through a receptor encoded by tvj locus and identified as Na+/H+ exchanger 1 (NHE1). The resistance to ALV-J in a great majority of examined galliform species was explained by deletions or substitutions of the critical tryptophan 38 in the first extracellular loop of NHE1, and genetic polymorphisms around this site predict the susceptibility or resistance of a given species or individual. In this study, we examined the NHE1 polymorphism in domestic chicken breeds and documented quantitative differences in their susceptibility to ALV-J in vitro. In a panel of chicken breeds assembled with the aim to cover the maximum variability encountered in domestic chickens, we found a completely uniform sequence of NHE1 extracellular loop 1 (ECL1) without any source of genetic variation for the selection of ALV-J-resistant poultry. In parallel, we studied the natural polymorphisms of NHE1 in wild ducks and geese because of recent reports on ALV-J positivity in feral Asian species. In anseriform species, we demonstrate a specific and highly conserved critical ECL1 sequence without any homologue of tryptophan 38 in accordance with the resistance of duck cells to prototype ALV-J. Last, we demonstrated that the new Asian strains of ALV-J have not evolved their envelope glycoprotein to the entry the duck cells. Our results contribute substantially to the current discussion of possible heterotransmission of ALV-J and its spill-over into the wild ducks and geese.	[Reinisova, Marketa; Plachy, Jiri; Kucerova, Dana; Senigl, Filip; Hejnar, Jiri] Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CZ-14220 Prague 4, Czech Republic; [Vinkler, Michal] Charles Univ Prague, Fac Sci, Dept Zool, CZ-12844 Vinicna 7 2, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague	Hejnar, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	hejnar@img.cas.cz	Vinkler, Michal/G-2072-2011	Vinkler, Michal/0000-0003-3572-9494	Czech Science Foundation [13-309835-P502, P502/12/P179]; NPU [I: LO1419];  [RVO: 68378050]	Czech Science Foundation(Grant Agency of the Czech Republic); NPU; 	This research was supported by the Czech Science Foundation, project No. 13-309835-P502. M. V. was supported by the Czech Science Foundation grant No. P502/12/P179. The work was also institutionally supported by RVO: 68378050 and NPU I: LO1419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI J, 1995, J VIROL, V69, P779, DOI 10.1128/JVI.69.2.779-784.1995; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Benson SJ, 1998, J VIROL, V72, P10157, DOI 10.1128/JVI.72.12.10157-10164.1998; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; Chai N, 2006, P NATL ACAD SCI USA, V103, P5531, DOI 10.1073/pnas.0509785103; Chesters PM, 2001, J VIROL, V75, P4219, DOI 10.1128/JVI.75.9.4219-4225.2001; Elleder D, 2005, J VIROL, V79, P10408, DOI 10.1128/JVI.79.16.10408-10419.2005; Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110; Gingerich E, 2002, AVIAN DIS, V46, P745, DOI 10.1637/0005-2086(2002)046[0745:DOMLIB]2.0.CO;2; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Jiang LL, 2014, ARCH VIROL, V159, P1821, DOI 10.1007/s00705-014-2004-8; Kucerova D, 2013, J VIROL, V87, P8399, DOI 10.1128/JVI.03180-12; Liu CN, 2011, AVIAN PATHOL, V40, P269, DOI 10.1080/03079457.2011.560932; Lupiani B, 2006, AVIAN DIS, V50, P572, DOI 10.1637/7656-053006R.1; Malhotra S., 2015, Genome Announcements, V3, pe01586; NEHYBA J, 1990, J GEN VIROL, V71, P1937, DOI 10.1099/0022-1317-71-9-1937; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995; Plachy J, 2000, FOLIA BIOL-PRAGUE, V46, P17; Reinisova M, 2008, J VIROL, V82, P2097, DOI 10.1128/JVI.02206-07; Reinisova M, 2012, J VIROL, V86, P2021, DOI 10.1128/JVI.05771-11; Rong LJ, 1998, J VIROL, V72, P4552, DOI 10.1128/JVI.72.6.4552-4559.1998; Shen YW, 2014, J GEN VIROL, V95, P691, DOI 10.1099/vir.0.059915-0; Silva RF, 2000, VIROLOGY, V272, P106, DOI 10.1006/viro.2000.0352; Stepanets V, 2001, AVIAN PATHOL, V30, P33, DOI 10.1080/03079450020023177; Venugopal K, 2000, AVIAN PATHOL, V29, P497, DOI 10.1080/030794500750047252; Venugopal K, 1999, RES VET SCI, V67, P113, DOI 10.1053/rvsc.1998.0283; Witter RL, 2001, AVIAN PATHOL, V30, P641, DOI 10.1080/03079450120092134; Witter RL, 2000, AVIAN DIS, V44, P913, DOI 10.2307/1593066; Zeng XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094980; Zingler K, 1996, J VIROL, V70, P7510, DOI 10.1128/JVI.70.11.7510-7516.1996	32	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150589	10.1371/journal.pone.0150589	http://dx.doi.org/10.1371/journal.pone.0150589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978658	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800030
J	Schrutka, L; Goliasch, G; Meyer, B; Wurm, R; Koller, L; Kriechbaumer, L; Heinz, G; Pacher, R; Lang, IM; Distelmaier, K; Hulsmann, M				Schrutka, Lore; Goliasch, Georg; Meyer, Brigitte; Wurm, Raphael; Koller, Lorenz; Kriechbaumer, Lukas; Heinz, Gottfried; Pacher, Richard; Lang, Irene M.; Distelmaier, Klaus; Huelsmann, Martin			Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill Patients	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; APOLIPOPROTEIN-A-I; LONG-TERM SURVIVAL; OXIDATIVE STRESS; CARDIAC-SURGERY; HDL; SUPPLEMENTATION; METABOLISM; ACTIVATION; CAPACITY	Introduction Oxidative stress affects clinical outcome in critically ill patients. Although high-density lipoprotein (HDL) particles generally possess anti-oxidant capacities, deleterious properties of HDL have been described in acutely ill patients. The impact of anti-oxidant HDL capacities on clinical outcome in critically ill patients is unknown. We therefore analyzed the predictive value of anti-oxidant HDL function on mortality in an unselected cohort of critically ill patients. Method We prospectively enrolled 270 consecutive patients admitted to a university-affiliated intensive care unit (ICU) and determined anti-oxidant HDL function using the HDL oxidant index (HOI). Based on their HOI, the study population was stratified into patients with impaired anti-oxidant HDL function and the residual study population. Results During a median follow-up time of 9.8 years (IQR: 9.2 to 10.0), 69% of patients died. Cox regression analysis revealed a significant and independent association between impaired antioxidant HDL function and short-term mortality with an adjusted HR of 1.65 (95% CI 1.22-2.24; p = 0.001) as well as 10-year mortality with an adj. HR of 1.19 (95% CI 1.02-1.40; p = 0.032) when compared to the residual study population. Anti-oxidant HDL function correlated with the amount of oxidative stress as determined by Cu/Zn superoxide dismutase (r = 0.38; p < 0.001). Conclusion Impaired anti-oxidant HDL function represents a strong and independent predictor of 30-day mortality as well as long-term mortality in critically ill patients.	[Schrutka, Lore; Goliasch, Georg; Wurm, Raphael; Koller, Lorenz; Heinz, Gottfried; Pacher, Richard; Lang, Irene M.; Distelmaier, Klaus; Huelsmann, Martin] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Meyer, Brigitte] Kaiser Franz Josef Hosp Vienna, Dept Internal Med 4, Vienna, Austria; [Kriechbaumer, Lukas] Paracelsus Med Univ Salzburg, Univ Clin Orthoped, Salzburg, Austria	Medical University of Vienna; Paracelsus Private Medical University	Distelmaier, K (corresponding author), Med Univ Vienna, Dept Internal Med 2, Vienna, Austria.	klaus.distelmaier@meduniwien.ac.at	Wurm, Raphael/X-9952-2019	Wurm, Raphael/0000-0003-3027-7775; Schrutka, Lore/0000-0002-2731-2667; Goliasch, Georg/0000-0002-6219-6104; Lang, Irene/0000-0003-0485-2692	Medical Scientific Fund of the Mayor of the City of Vienna; Hans and Blanca Moser Stiftung	Medical Scientific Fund of the Mayor of the City of Vienna; Hans and Blanca Moser Stiftung	This project has been funded by the Medical Scientific Fund of the Mayor of the City of Vienna (2015; to KD) and by the Hans and Blanca Moser Stiftung (2014; to KD).	Adabag AS, 2009, EUR HEART J, V30, P1910, DOI 10.1093/eurheartj/ehp053; Adams V, 2013, CIRC RES, V113, P1345, DOI 10.1161/CIRCRESAHA.113.301684; Badimon JJ, 2015, J AM COLL CARDIOL, V66, P1486, DOI 10.1016/j.jacc.2015.08.008; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Crimi E, 2006, FREE RADICAL RES, V40, P665, DOI 10.1080/10715760600669612; Cuesta JM, 2012, CRIT CARE MED, V40, P3283, DOI 10.1097/CCM.0b013e31826567eb; Damuth E, 2015, LANCET RESP MED, V3, P544, DOI 10.1016/S2213-2600(15)00150-2; de Vega JMA, 2002, CRIT CARE MED, V30, P1782, DOI 10.1097/00003246-200208000-00018; Distelmaier K, 2015, THROMB HAEMOSTASIS, V114, P133, DOI 10.1160/TH14-10-0834; Distelmaier K, 2015, EUR J CLIN INVEST, V45, P731, DOI 10.1111/eci.12466; Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015; Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543, DOI 10.4037/ajcc2002.11.6.543; Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011; Graf J, 2008, CRIT CARE, V12, DOI 10.1186/cc6963; Griendling KK, 1998, J LAB CLIN MED, V132, P9, DOI 10.1016/S0022-2143(98)90019-1; Hardy G, 2012, NUTR CLIN PRACT, V27, P21, DOI 10.1177/0884533611434116; Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044; Himmelfarb J, 2004, J AM SOC NEPHROL, V15, P2449, DOI 10.1097/01.ASN.0000138232.68452.3B; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Kelesidis T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-87; Kelesidis T, 2011, J LIPID RES, V52, P2341, DOI 10.1194/jlr.D018937; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Lassnigg A, 2003, BRIT J ANAESTH, V90, P148, DOI 10.1093/bja/aeg042; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; McDonald CI, 2012, ASAIO J, V58, P217, DOI 10.1097/MAT.0b013e31824cc856; Metnitz PGH, 1999, INTENS CARE MED, V25, P180, DOI 10.1007/s001340050813; Meyer B, 2007, CRIT CARE MED, V35, P2268, DOI 10.1097/01.CCM.0000284509.23439.5B; Navab M, 2001, J LIPID RES, V42, P1308; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nobecourt E, 2005, DIABETOLOGIA, V48, P529, DOI 10.1007/s00125-004-1655-5; Oldham KM, 1998, J AM DIET ASSOC, V98, P1001, DOI 10.1016/S0002-8223(98)00230-2; Patel PJ, 2011, J AM COLL CARDIOL, V58, P2068, DOI 10.1016/j.jacc.2011.08.030; Pawlak K, 2005, CLIN BIOCHEM, V38, P700, DOI 10.1016/j.clinbiochem.2005.02.009; Riwanto M, 2013, CIRCULATION, V127, P891, DOI 10.1161/CIRCULATIONAHA.112.108753; Rohatgi A., 2014, N ENGL J MED; Santos-Gallego CG, 2016, CIRCULATION, V134; Sattler K, 2015, J AM COLL CARDIOL, V66, P1470, DOI 10.1016/j.jacc.2015.07.057; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shekar K, 2012, CRIT CARE, V16, DOI 10.1186/cc11679; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Watt DG, 2015, SURGERY, V157, P362, DOI 10.1016/j.surg.2014.09.009; Weichhart T, 2012, J AM SOC NEPHROL, V23, P934, DOI 10.1681/ASN.2011070668; Wraith KS, 2013, BLOOD, V122, P580, DOI 10.1182/blood-2013-04-491688; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	49	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151706	10.1371/journal.pone.0151706	http://dx.doi.org/10.1371/journal.pone.0151706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978526	gold, Green Published, Green Submitted			2022-12-27	WOS:000372572800101
J	Dong, SS; Liu, Y; Yu, CG; Zhang, ZH; Chen, M; Wang, CY				Dong, Shanshan; Liu, Yan; Yu, Cigang; Zhang, Zhenhua; Chen, Ming; Wang, Changyong			RETRACTED: Investigating Pollen and Gene Flow of WYMV-Resistant Transgenic Wheat N12-1 Using a Dwarf Male-Sterile Line as the Pollen Receptor (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							TRITICUM-AESTIVUM L.; BREAD WHEAT; BRASSICA-NAPUS; MOSAIC-VIRUS; HYBRIDIZATION; DISPERSAL; DROUGHT; PLANTS	Pollen-mediated gene flow (PMGF) is the main mode of transgene flow in flowering plants. The study of pollen and gene flow of transgenic wheat can help to establish the corresponding strategy for preventing transgene escape and contamination between compatible genotypes in wheat. To investigate the pollen dispersal and gene flow frequency in various directions and distances around the pollen source and detect the association between frequency of transgene flow and pollen density from transgenic wheat, a concentric circle design was adopted to conduct a field experiment using transgenic wheat with resistance to wheat yellow mosaic virus (WYMV) as the pollen donor and dwarf male-sterile wheat as the pollen receptor. The results showed that the pollen and gene flow of transgenic wheat varied significantly among the different compass sectors. A higher pollen density and gene flow frequency was observed in the downwind SW and W sectors, with average frequencies of transgene flow of 26.37 and 23.69% respectively. The pollen and gene flow of transgenic wheat declined dramatically with increasing distance from its source. Most of the pollen grains concentrated within 5 m and only a few pollen grains were detected beyond 30 m. The percentage of transgene flow was the highest where adjacent to the pollen source, with an average of 48.24% for all eight compass directions at 0 m distance. Transgene flow was reduced to 50% and 95% between 1.61 to 3.15 m, and 10.71 to 20.93 m, respectively. Our results suggest that climate conditions, especially wind direction, may significantly affect pollen dispersal and gene flow of wheat. The isolation-by-distance model is one of the most effective methods for achieving stringent transgene confinement in wheat. The frequency of transgene flow is directly correlated with the relative density of GM pollen grains in air currents, and pollen competition may be a major factor influencing transgene flow.	[Dong, Shanshan; Liu, Yan; Yu, Cigang; Zhang, Zhenhua; Wang, Changyong] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Dong, Shanshan; Liu, Yan; Yu, Cigang; Zhang, Zhenhua; Wang, Changyong] Minist Environm Protect, Key Lab Biosafety Environm Protect, Nanjing, Jiangsu, Peoples R China; [Chen, Ming] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Liu, Y (corresponding author), Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.; Liu, Y (corresponding author), Minist Environm Protect, Key Lab Biosafety Environm Protect, Nanjing, Jiangsu, Peoples R China.	liuyan@nies.org	zhang, zh/GWV-4677-2022		Key Project for Breeding Genetically Modified Organisms [2014ZX08011-003, 2013ZX08011-003, 2014ZX08012-005, 2013ZX08012-005]; National Environmental Protection Public Welfare Science and Technology Research Program [201309038]; Fundamental Research Program for Central Public Welfare Research Institutes [20160204]	Key Project for Breeding Genetically Modified Organisms; National Environmental Protection Public Welfare Science and Technology Research Program; Fundamental Research Program for Central Public Welfare Research Institutes	Funding was provided by Key Project for Breeding Genetically Modified Organisms (Grant nos. 2014ZX08011-003, 2013ZX08011-003, 2014ZX08012-005 and 2013ZX08012-005), http://program.most.gov.cn/; National Environmental Protection Public Welfare Science and Technology Research Program (Grant number 201309038), http://kjs.mep.gov.cn/gyxhykyzx/; and Fundamental Research Program for Central Public Welfare Research Institutes (Grant number 20160204), http://www.most.gov.cn/ztzl/gjzctx/ptzckjtr/200802/t20080222_59209.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckie HJ, 2011, CROP SCI, V51, P306, DOI 10.2135/cropsci2010.03.0176; Chamberlain D, 1999, NAT BIOTECHNOL, V17, P330, DOI 10.1038/7882; Chauhan H, 2011, PLANT BIOTECHNOL J, V9, P408, DOI 10.1111/j.1467-7652.2010.00561.x; Chen M, 2014, PLANT BIOTECHNOL J, V12, P447, DOI [10.1111/pbi.12151, 10.1111/pbi.12270]; DiFazio SP, 2012, NEW PHYTOL, V193, P903, DOI 10.1111/j.1469-8137.2011.04012.x; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; Fahim M, 2010, PLANT BIOTECHNOL J, V8, P821, DOI 10.1111/j.1467-7652.2010.00513.x; Foetzki Andrea, 2012, GM Crops Food, V3, P115, DOI 10.4161/gmcr.19512; Galan C, 2000, INT J BIOMETEOROL, V43, P191, DOI 10.1007/s004840050008; Gustafson DI, 2005, CROP SCI, V45, P1286, DOI 10.2135/cropsci2004.0137; Hanson BD, 2005, CROP SCI, V45, P1610, DOI 10.2135/cropsci2004.0443; Hen CG, 2000, PLANT DIS, V84, P627, DOI 10.1094/PDIS.2000.84.6.627; Heuberger S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014128; Hucl P, 2001, CROP SCI, V41, P1348, DOI 10.2135/cropsci2001.4141348x; Jhala AJ, 2011, HEREDITY, V106, P557, DOI 10.1038/hdy.2010.81; Kwit C, 2011, TRENDS BIOTECHNOL, V29, P284, DOI 10.1016/j.tibtech.2011.02.003; LIU BH, 1991, CHINESE SCI BULL, V36, P1562; Liu WH, 2005, THEOR APPL GENET, V111, P651, DOI 10.1007/s00122-005-2012-x; Londo JP, 2011, NEW PHYTOL, V191, P840, DOI 10.1111/j.1469-8137.2011.03706.x; Loureiro I, 2007, EUPHYTICA, V156, P25, DOI 10.1007/s10681-006-9345-7; Loureiro I, 2012, TRANSGENIC RES, V21, P1329, DOI 10.1007/s11248-012-9619-x; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; MARTIN TJ, 1990, CROP SCI, V30, P59, DOI 10.2135/cropsci1990.0011183X003000010013x; Matus-Cadiz MA, 2007, CROP SCI, V47, P573, DOI 10.2135/cropsci06.07.0441; Matus-Cadiz MA, 2004, CROP SCI, V44, P718, DOI 10.2135/cropsci2004.0718; McPherson Marc A., 2009, Environmental Biosafety Research, V8, P19, DOI 10.1051/ebr/2008023; Rieben S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029730; Rong J, 2007, NEW PHYTOL, V173, P346, DOI 10.1111/j.1469-8137.2006.01906.x; Rong J, 2012, ANN APPL BIOL, V161, P3, DOI 10.1111/j.1744-7348.2012.00545.x; Song ZP, 2004, BIODIVERS CONSERV, V13, P579, DOI 10.1023/B:BIOC.0000009491.24573.1d; VASIL V, 1992, BIO-TECHNOL, V10, P667, DOI 10.1038/nbt0692-667; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wheeler TR, 1996, J EXP BOT, V47, P623, DOI 10.1093/jxb/47.5.623; Wilkinson MJ, 2003, SCIENCE, V302, P457, DOI 10.1126/science.1088200; Willenborg CJ, 2009, TRANSGENIC RES, V18, P841, DOI 10.1007/s11248-009-9267-y; Yuan QH, 2007, THEOR APPL GENET, V115, P549, DOI 10.1007/s00122-007-0588-z; Zaharieva M, 2006, CROP SCI, V46, P512, DOI 10.2135/cropsci2005.0023; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693	38	13	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151373	10.1371/journal.pone.0151373	http://dx.doi.org/10.1371/journal.pone.0151373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26975052	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600071
J	Trovero, F; David, S; Bernard, P; Puech, A; Bizot, JC; Tassin, JP				Trovero, Fabrice; David, Sabrina; Bernard, Philippe; Puech, Alain; Bizot, Jean-Charles; Tassin, Jean-Pol			The Combination of Marketed Antagonists of alpha 1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence	PLOS ONE			English	Article							SEROTONERGIC NEURONS; ETHANOL; PRAZOSIN; DRINKING; DRUGS; AMPHETAMINE; NALTREXONE; BLOCKADE; C57BL/6J; COCAINE	Alcohol-dependence is a chronic disease with a dramatic and expensive social impact. Previous studies have indicated that the blockade of two monoaminergic receptors, alpha 1b-adrenergic and 5-HT2A, could inhibit the development of behavioral sensitization to drugs of abuse, a hallmark of drug-seeking and drug-taking behaviors in rodents. Here, in order to develop a potential therapeutic treatment of alcohol dependence in humans, we have blocked these two monoaminergic receptors by a combination of antagonists already approved by Health Agencies. We show that the association of ifenprodil (1 mg/kg) and cyproheptadine (1 mg/kg) (alpha 1-adrenergic and 5-HT2 receptor antagonists marketed as Vadilex (R) and Periactine (R) in France, respectively) blocks behavioral sensitization to amphetamine in C57Bl6 mice and to alcohol in DBA2 mice. Moreover, this combination of antagonists inhibits alcohol intake in mice habituated to alcohol (10% v/v) and reverses their alcohol preference. Finally, in order to verify that the effect of ifenprodil was not due to its anti-NMDA receptors property, we have shown that a combination of prazosin (0.5 mg/kg, an alpha 1b-adrenergic antagonist, Mini-Press (R) in France) and cyproheptadine (1 mg/kg) could also reverse alcohol preference. Altogether these findings strongly suggest that combined prazosin and cyproheptadine could be efficient as a therapy to treat alcoholismin humans. Finally, because alpha 1b-adrenergic and 5-HT2A receptors blockade also inhibits behavioral sensitization to psychostimulants, opioids and tobacco, it cannot be excluded that this combination will exhibit some efficacy in the treatment of addiction to other abused drugs.	[Trovero, Fabrice; David, Sabrina; Bizot, Jean-Charles] Key Obs SAS, Orleans, France; [Bernard, Philippe] Greenpharma SAS, Orleans, France; [Puech, Alain] Grp Hosp Pitie Salpetriere, Serv pharmacol, F-75634 Paris, France; [Tassin, Jean-Pol] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, Neurosci Paris Seine UM119, Paris, France; [Tassin, Jean-Pol] INSERM, Neurosci Paris Seine, UMR S 1130, Paris, France; [Tassin, Jean-Pol] CNRS, Neurosci Paris Seine, UMR 8246, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Trovero, F (corresponding author), Key Obs SAS, Orleans, France.	fabrice.trovero@key-obs.com		Tassin, Jean-Pol/0000-0001-6658-9581; BERNARD, Philippe/0000-0002-4420-617X	Agence Nationale de la Recherche (ANR-SENSIBALCO); Association pour la Recherche sur les Nicotianees (ARN); Key-Obs; Greenpharma	Agence Nationale de la Recherche (ANR-SENSIBALCO)(French National Research Agency (ANR)); Association pour la Recherche sur les Nicotianees (ARN); Key-Obs; Greenpharma	JPT wishes to thank Agence Nationale de la Recherche (ANR-SENSIBALCO) and Association pour la Recherche sur les Nicotianees (ARN) for their financial support. The funders (Key-Obs and Greenpharma) provided support in the form of salaries for authors FT, SD, JCB and PB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r JPT wishes to thank Agence Nationale de la Recherche (ANR-SENSIBALCO) and Association pour la Recherche sur les Nicotianees (ARN) for their support.	Auclair A, 2004, EUR J NEUROSCI, V20, P3073, DOI 10.1111/j.1460-9568.2004.03805.x; Bellot RG, 1996, EUR J PHARMACOL, V313, P175, DOI 10.1016/0014-2999(96)00641-3; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Broadbent J, 1999, PSYCHOPHARMACOLOGY, V141, P197, DOI 10.1007/s002130050825; CHENARD BL, 1991, J MED CHEM, V34, P3085, DOI 10.1021/jm00114a018; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Finn DA, 2005, PSYCHOPHARMACOLOGY, V178, P471, DOI 10.1007/s00213-004-2039-8; Fish EW, 2002, PSYCHOPHARMACOLOGY, V160, P39, DOI 10.1007/s00213-001-0934-9; Franck J, 2013, CURR OPIN NEUROBIOL, V23, P692, DOI 10.1016/j.conb.2013.05.005; Froehlich JC, 2015, ALCOHOL CLIN EXP RES, V39, P1538, DOI 10.1111/acer.12789; Froehlich JC, 2013, ALCOHOL CLIN EXP RES, V37, P1763, DOI 10.1111/acer.12148; Grahame NJ, 2000, PHARMACOL BIOCHEM BE, V67, P759, DOI 10.1016/S0091-3057(00)00411-1; Honrubia MA, 1997, CHEM PHARM BULL, V45, P842; Itzhak Y, 2000, BRAIN RES, V858, P402, DOI 10.1016/S0006-8993(00)01940-5; KARLER R, 1989, LIFE SCI, V45, P599, DOI 10.1016/0024-3205(89)90045-3; Lanteri C, 2014, MOL PSYCHIATR, V19, P823, DOI 10.1038/mp.2013.97; Lanteri C, 2008, NEUROPSYCHOPHARMACOL, V33, P1724, DOI 10.1038/sj.npp.1301548; Lanteri C, 2009, J NEUROSCI, V29, P987, DOI 10.1523/JNEUROSCI.3315-08.2009; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Moore EM, 2010, ALCOHOL CLIN EXP RES, V34, P734, DOI 10.1111/j.1530-0277.2009.01143.x; NESTOROS JN, 1980, SCIENCE, V209, P708, DOI 10.1126/science.7394531; Rasmussen DD, 2014, ALCOHOL CLIN EXP RES, V38, P1532, DOI 10.1111/acer.12441; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Salomon L, 2006, P NATL ACAD SCI USA, V103, P7476, DOI 10.1073/pnas.0600839103; Simpson TL, 2009, ALCOHOL CLIN EXP RES, V33, P255, DOI 10.1111/j.1530-0277.2008.00807.x; Tassin JP, 2008, BIOCHEM PHARMACOL, V75, P85, DOI 10.1016/j.bcp.2007.06.038; WALLACH M B, 1971, Psychopharmacology Bulletin, V7, P30; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7	30	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151242	10.1371/journal.pone.0151242	http://dx.doi.org/10.1371/journal.pone.0151242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968030	gold, Green Published, Green Submitted			2022-12-27	WOS:000371989200038
J	Uddin, K; Murthy, MSR; Wahid, SM; Matin, MA				Uddin, Kabir; Murthy, M. S. R.; Wahid, Shahriar M.; Matin, Mir A.			Estimation of Soil Erosion Dynamics in the Koshi Basin Using GIS and Remote Sensing to Assess Priority Areas for Conservation	PLOS ONE			English	Article							LANDSAT TM; SEDIMENT; INDIA; USLE; DEGRADATION; CATCHMENT; HIMALAYA; PLAINS; SYSTEM; COVER	High levels of water-induced erosion in the transboundary Himalayan river basins are contributing to substantial changes in basin hydrology and inundation. Basin-wide information on erosion dynamics is needed for conservation planning, but field-based studies are limited. This study used remote sensing (RS) data and a geographic information system (GIS) to estimate the spatial distribution of soil erosion across the entire Koshi basin, to identify changes between 1990 and 2010, and to develop a conservation priority map. The revised universal soil loss equation (RUSLE) was used in an ArcGIS environment with rainfall erosivity, soil erodibility, slope length and steepness, cover-management, and support practice factors as primary parameters. The estimated annual erosion from the basin was around 40 million tonnes (40 million tonnes in 1990 and 42 million tonnes in 2010). The results were within the range of reported levels derived from isolated plot measurements and model estimates. Erosion risk was divided into eight classes from very low to extremely high and mapped to show the spatial pattern of soil erosion risk in the basin in 1990 and 2010. The erosion risk class remained unchanged between 1990 and 2010 in close to 87% of the study area, but increased over 9.0% of the area and decreased over 3.8%, indicating an overall worsening of the situation. Areas with a high and increasing risk of erosion were identified as priority areas for conservation. The study provides the first assessment of erosion dynamics at the basin level and provides a basis for identifying conservation priorities across the Koshi basin. The model has a good potential for application in similar river basins in the Himalayan region.	[Uddin, Kabir; Murthy, M. S. R.; Wahid, Shahriar M.; Matin, Mir A.] Int Ctr Integrated Mt Dev, GPO Box 3226, Kathmandu, Nepal		Uddin, K (corresponding author), Int Ctr Integrated Mt Dev, GPO Box 3226, Kathmandu, Nepal.	Kabir.Uddin@icimod.org	Wahid, Shahriar/C-3739-2008; Uddin, Kabir/M-5019-2019	Uddin, Kabir/0000-0003-2711-5791	Australian Government through the Koshi Basin Programme; NASA-USAID through the SERVIR-Himalaya initiative	Australian Government through the Koshi Basin Programme(Australian Government); NASA-USAID through the SERVIR-Himalaya initiative(United States Agency for International Development (USAID))	The authors acknowledge the support of the Australian Government for the research through funding of the Koshi Basin Programme (http://www.icimod.org/kbp), and the support of NASA-USAID through the SERVIR-Himalaya initiative which provided the land cover data.	Acharya A. K., 2009, Journal of Agriculture and Environment, V10, P115; [Anonymous], 2010, IRAN J ENERGY ENV; Bagarello V, 2011, J HYDROL, V400, P267, DOI 10.1016/j.jhydrol.2011.01.029; Bajracharya B, 2010, MT RES DEV, V30, P143, DOI 10.1659/MRD-JOURNAL-D-09-00044.1; Bakker MM, 2008, GEOMORPHOLOGY, V98, P213, DOI 10.1016/j.geomorph.2006.12.027; Baptista I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134244; BHANDARI G., 2013, INT J ENV PROT, V3, P33; Chandra S, 1981, CENTRAL SOIL WATER C; Dabral PP, 2008, WATER RESOUR MANAG, V22, P1783, DOI 10.1007/s11269-008-9253-9; Dang YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095548; de Roo A. P., 2001, LANDSCAPE EROSION EV, P429, DOI [10.1007/978-1-4615-0575-4_14, DOI 10.1007/978-1-4615-0575-4_14]; de Vente J, 2005, EARTH-SCI REV, V71, P95, DOI 10.1016/j.earscirev.2005.02.002; DEJONG SM, 1994, EARTH SURF PROC LAND, V19, P165, DOI 10.1002/esp.3290190207; Desmet PJJ, 1996, J SOIL WATER CONSERV, V51, P427; Foster G. R., 2003, P 1 INT C RES WAT BE, V27, P154; Franklin S.E., 2001, REMOTE SENSING SUSTA, DOI 10.1201/9781420032857; Gardner RAM, 2003, APPL GEOGR, V23, P23, DOI 10.1016/S0143-6228(02)00069-3; Ghimire SK, 2013, LAND-BASEL, V2, P370, DOI 10.3390/land2030370; Gibling MR, 2005, J SEDIMENT RES, V75, P369, DOI 10.2110/jsr.2005.029; GLOVIS, USGS GLOB VIS VIEW G; Hazaymeh K, 2015, J APPL REMOTE SENS, V9, DOI 10.1117/1.JRS.9.096095; Higaki Daisuke, 2005, Aquatic Ecosystem Health & Management, V8, P243, DOI 10.1080/14634980500208184; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jain SK, 2001, WATER RESOUR MANAG, V15, P41, DOI 10.1023/A:1012246029263; Jain V, 2004, GEOMORPHOLOGY, V60, P147, DOI 10.1016/j.geomorph.2003.07.008; Jha M.K., 2010, J SPATIAL HYDROLOGY, V10, P89; Karen F, 2011, IRRIGATION SO E ASIA, P1; Knisel W. G., 1980, USDA Conservation Research Report; Kunwar LB, 2002, P 12 INT SOIL CONS O; Lal R, 2008, WASTE MANAGE, V28, P747, DOI 10.1016/j.wasman.2007.09.023; LANE LJ, 1992, AUST J SOIL RES, V30, P893, DOI 10.1071/SR9920893; Lves JD, 1989, HIMALAYAN DILEMMA; McGarigal K., 2002, ENCY ENVIRONMETRIC L, VVolume 2, P1135, DOI DOI 10.1002/9780470057339.VAL006.PUB2; Meusburger K, 2012, HYDROL EARTH SYST SC, V16, P167, DOI 10.5194/hess-16-167-2012; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Nayak JN, 1996, IAHS-AISH P, P583; Nearing MA, 1997, SOIL SCI SOC AM J, V61, P917, DOI 10.2136/sssaj1997.03615995006100030029x; Nibanupudiand HK, 2012, ENV CONCERNS DRR HIN; Pandey A, 2007, WATER RESOUR MANAG, V21, P729, DOI 10.1007/s11269-006-9061-z; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Perovic V, 2013, ENVIRON EARTH SCI, V68, P115, DOI 10.1007/s12665-012-1720-1; Pimentel D, 2000, ECOSYST HEALTH, V6, P221, DOI 10.1046/j.1526-0992.2000.006004221.x; Prasannakumar V, 2012, GEOSCI FRONT, V3, P209, DOI 10.1016/j.gsf.2011.11.003; Quan B, 2011, FRONT ENVIRON SCI EN, V5, P564, DOI 10.1007/s11783-011-0348-9; Quincey DJ, 2007, GLOBAL PLANET CHANGE, V56, P137, DOI 10.1016/j.gloplacha.2006.07.013; Rabia RA, 2012, 8 INT SOIL SCI C LAN; Ramsey W. J. H., 1987, INT ASS HYDROLOGICAL, V165, P461; Reed R, 2010, FRAGMENTATION FOREST; RENARD KG, 1991, J SOIL WATER CONSERV, V46, P30; Renard KG., 1997, AGR HDB, DOI DOI 10.1201/9780203739358-5; Ries JB, 1995, PHYS CHEM EARTH/DELT, V20, P251, DOI 10.1016/0079-1946(95)00036-4; Roo A.D., 1993, MODELLING SURFACE RU; Sah B., 1996, 9620 NR AIT; Sherchan DP, 1992, REV CURRENT SOIL REL; Shrestha D.P., 1997, LAND HUSBANDRY, V2, P59; Shrestha DP, 2004, CATENA, V57, P135, DOI 10.1016/j.catena.2003.11.003; Shrestha S., 2004, ENV INDICATORS S ASI; Singh S.L., 2004, WATERSHED MANAGEMENT; Sonneveld BGJS, 2003, CATENA, V52, P9, DOI 10.1016/S0341-8162(02)00150-9; SRTM, HOL FILL SRTM GLOB V; Uddin K., 2014, International Journal of Geosciences, V5, P383, DOI 10.4236/ijg.2014.54037; Uddin K., 2011, 4 INT C WAT FLOOD MA, P293; Uddin K, 2015, LANDSCAPE URBAN PLAN, V141, P1, DOI 10.1016/j.landurbplan.2015.04.003; Uddin K, 2015, J ENVIRON MANAGE, V148, P82, DOI 10.1016/j.jenvman.2014.07.047; Van der Knijff JM, 1999, SOIL EROSION RISK AS; Wahid S, 2013, KOSHI BASIN PROGRAMM, P4; Wang LH, 2013, REMOTE SENS-BASEL, V5, P3826, DOI 10.3390/rs5083826; Williams J.R., 1975, PRESENT PROSPECTIVE, P244; Wischmeier W. H., 1978, U. S. Department of Agriculture, Agriculture Handbook; Yamamoto K, 2013, SE ASIAN WATER ENV; YOUNG RA, 1989, J SOIL WATER CONSERV, V44, P168; Zhang XW, 2010, CATENA, V83, P76, DOI 10.1016/j.catena.2010.06.012	72	62	64	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150494	10.1371/journal.pone.0150494	http://dx.doi.org/10.1371/journal.pone.0150494			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964039	gold, Green Published			2022-12-27	WOS:000371993000040
J	Cariveau, DP; Nayak, GK; Bartomeus, I; Zientek, J; Ascher, JS; Gibbs, J; Winfree, R				Cariveau, Daniel P.; Nayak, Geetha K.; Bartomeus, Ignasi; Zientek, Joseph; Ascher, John S.; Gibbs, Jason; Winfree, Rachael			The Allometry of Bee Proboscis Length and Its Uses in Ecology	PLOS ONE			English	Article							BUMBLE BEES; BODY-SIZE; EVOLUTION; HYMENOPTERA; PHYLOGENY; CONSTRAINTS; EFFICIENCY; BOMBUS; PLANTS; LIFE	Allometric relationships among morphological traits underlie important patterns in ecology. These relationships are often phylogenetically shared; thus quantifying allometric relationships may allow for estimating difficult-to-measure traits across species. One such trait, proboscis length in bees, is assumed to be important in structuring bee communities and plant-pollinator networks. However, it is difficult to measure and thus rarely included in ecological analyses. We measured intertegular distance (as a measure of body size) and proboscis length (glossa and prementum, both individually and combined) of 786 individual bees of 100 species across 5 of the 7 extant bee families (Hymenoptera: Apoidea: Anthophila). Using linear models and model selection, we determined which parameters provided the best estimate of proboscis length. We then used coefficients to estimate the relationship between intertegular distance and proboscis length, while also considering family. Using allometric equations with an estimation for a scaling coefficient between intertegular distance and proboscis length and coefficients for each family, we explain 91% of the variance in species-level means for bee proboscis length among bee species. However, within species, individual-level intertegular distance was a poor predictor of individual proboscis length. To make our findings easy to use, we created an R package that allows estimation of proboscis length for individual bee species by inputting only family and intertegular distance. The R package also calculates foraging distance and body mass based on previously published equations. Thus by considering both taxonomy and intertegular distance we enable accurate estimation of an ecologically and evolutionarily important trait.	[Cariveau, Daniel P.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Cariveau, Daniel P.; Nayak, Geetha K.; Zientek, Joseph; Winfree, Rachael] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Bartomeus, Ignasi] Estac Biol Donana EDB CSIC, Dept Ecol Integrat, Avda Americo Vespucio S-N, Seville 41092, Spain; [Ascher, John S.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Gibbs, Jason] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); National University of Singapore; Michigan State University	Cariveau, DP (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN USA.; Cariveau, DP (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	dcarivea@umn.edu	Cariveau, Daniel/AAB-9336-2020; Gibbs, Jason/H-6963-2012	Gibbs, Jason/0000-0002-4945-5423; Bartomeus, Ignasi/0000-0001-7893-4389	United States Department of Agriculture, Natural Resources Conservation Service Conservation Innovation Grant, NRCS [69-3A75-10-163]; Fulbright-Nehru Postdoctoral Fellowship; Rutgers University Aresty Undergraduate Research Award	United States Department of Agriculture, Natural Resources Conservation Service Conservation Innovation Grant, NRCS; Fulbright-Nehru Postdoctoral Fellowship; Rutgers University Aresty Undergraduate Research Award	This work was supported by the United States Department of Agriculture, Natural Resources Conservation Service Conservation Innovation Grant, NRCS Agreement #69-3A75-10-163 (to RW) (URL: nrcs.usda.gov/wps/portal/nrcs/main/national/programs/financial/cig/); a Fulbright-Nehru Postdoctoral Fellowship (to GN) (URL: cies.org/grantee/geetha-nayak); and a Rutgers University Aresty Undergraduate Research Award (to JZ) (URL: https://aresty.rutgers.edu/our-programs/funding/undergraduate-research-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maglianesi MA, 2014, ECOLOGY, V95, P3325, DOI 10.1890/13-2261.1; Benjamin FE, 2014, J APPL ECOL, V51, P440, DOI 10.1111/1365-2664.12198; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Borrell BJ, 2005, BIOTROPICA, V37, P664, DOI 10.1111/j.1744-7429.2005.00084.x; Borrell BJ, 2007, AM NAT, V169, P569, DOI 10.1086/512689; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Carvell C, 2011, ECOL APPL, V21, P1760, DOI 10.1890/10-0677.1; Clough Y, 2014, ECOL LETT, V17, P1168, DOI 10.1111/ele.12325; Corbet SA, 2000, ENTOMOL EXP APPL, V96, P289, DOI 10.1023/A:1004096432758; DANFORTH BN, 1989, J ZOOL, V218, P247, DOI 10.1111/j.1469-7998.1989.tb02536.x; Danforth BN, 1999, INSECT SOC, V46, P18, DOI 10.1007/s000400050107; Danforth BN, 2013, ANNU REV ENTOMOL, V58, P57, DOI 10.1146/annurev-ento-120811-153633; Dorchin A, 2013, APIDOLOGIE, V44, P90, DOI 10.1007/s13592-012-0159-4; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; GIBSON RL, 1989, INSECT SOC, V36, P28, DOI 10.1007/BF02225878; Goulson D, 2008, BIODIVERS CONSERV, V17, P3269, DOI 10.1007/s10531-008-9428-y; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; HARDER LD, 1983, CAN J ZOOL, V61, P1580, DOI 10.1139/z83-212; HARDER LD, 1982, CAN J ZOOL, V60, P1073, DOI 10.1139/z82-148; Harmon-Threatt AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060446; Hedtke SM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-138; Huxley J., 1932, PROBLEMS RELATIVE GR; Inouye D., 1977, The role of arthropods in forest ecosystems, P35; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Kawakita A, 2004, MOL PHYLOGENET EVOL, V31, P799, DOI 10.1016/j.ympev.2003.12.003; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Krenn HW, 2005, ARTHROPOD STRUCT DEV, V34, P1, DOI 10.1016/j.asd.2004.10.002; Kunte K, 2007, FUNCT ECOL, V21, P982, DOI 10.1111/j.1365-2435.2007.01299.x; MEDLER JOHN T., 1962, ANN ENTOMOL SOC AMER, V55, P212; Michener C. D., 2000, The bees of the world; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; MORSE DH, 1977, ANN ENTOMOL SOC AM, V70, P311, DOI 10.1093/aesa/70.3.311; Owen RE, 1995, J EVOLUTION BIOL, V8, P725, DOI 10.1046/j.1420-9101.1995.8060725.x; Peat J, 2005, ECOL ENTOMOL, V30, P176, DOI 10.1111/j.0307-6946.2005.00676.x; Rodriguez-Girones MA, 2007, AM NAT, V170, P455, DOI 10.1086/520121; Sacchi R, 2013, ZOOMORPHOLOGY, V132, P23, DOI 10.1007/s00435-012-0172-1; Shimizu A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03988; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Sommer S, 2012, ARTHROPOD STRUCT DEV, V41, P71, DOI 10.1016/j.asd.2011.08.002; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Taskinen S, 2013, J THEOR BIOL, V333, P38, DOI 10.1016/j.jtbi.2013.05.010; Vizentin-Bugoni J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2397; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x	52	62	62	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151482	10.1371/journal.pone.0151482	http://dx.doi.org/10.1371/journal.pone.0151482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986000	Green Published, gold			2022-12-27	WOS:000372580300076
J	Tan, C; Poggio, T				Tan, Cheston; Poggio, Tomaso			Neural Tuning Size in a Model of Primate Visual Processing Accounts for Three Key Markers of Holistic Face Processing	PLOS ONE			English	Article							OBJECT RECOGNITION; PERCEPTION; INFORMATION; MECHANISMS; FEATURES; NEURONS; MACAQUE; CORTEX; SHAPE	Faces are an important and unique class of visual stimuli, and have been of interest to neuroscientists for many years. Faces are known to elicit certain characteristic behavioral markers, collectively labeled "holistic processing", while non-face objects are not processed holistically. However, little is known about the underlying neural mechanisms. The main aim of this computational simulation work is to investigate the neural mechanisms that make face processing holistic. Using a model of primate visual processing, we show that a single key factor, "neural tuning size", is able to account for three important markers of holistic face processing: the Composite Face Effect (CFE), Face Inversion Effect (FIE) and Whole-Part Effect (WPE). Our proof-of-principle specifies the precise neurophysiological property that corresponds to the poorly-understood notion of holism, and shows that this one neural property controls three classic behavioral markers of holism. Our work is consistent with neurophysiological evidence, and makes further testable predictions. Overall, we provide a parsimonious account of holistic face processing, connecting computation, behavior and neurophysiology.	[Tan, Cheston; Poggio, Tomaso] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Tan, Cheston; Poggio, Tomaso] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Tan, Cheston] Inst Infocomm Res, Visual Comp Dept, Singapore, Singapore	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Tan, C; Poggio, T (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tan, C; Poggio, T (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tan, C (corresponding author), Inst Infocomm Res, Visual Comp Dept, Singapore, Singapore.	cheston-tan@i2r.a-star.edu.sg; tp@ai.mit.edu		Tan, Cheston/0000-0003-1248-4906	A*STAR (Agency for Science, Technology and Research) [1335h00098]; National Science Foundation STC award [CCF-1231216]	A*STAR (Agency for Science, Technology and Research)(Agency for Science Technology & Research (A*STAR)); National Science Foundation STC award(National Science Foundation (NSF))	This work was funded by A*STAR (Agency for Science, Technology and Research), Joint Council Office grant #1335h00098, and National Science Foundation STC award CCF-1231216. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; Cottrell GW, 2002, P 24 ANN C COGN SCI, P238; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Farzmahdi A, 2015, PREPRINT; Freiwald WA, 2009, NAT NEUROSCI, V12, P1187, DOI 10.1038/nn.2363; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gauthier I, 2000, COGN NEUROPSYCHOL, V17, P125, DOI 10.1080/026432900380535; Gauthier I, 2007, COGNITION, V103, P322, DOI 10.1016/j.cognition.2006.05.003; Mangini MC, 2004, COGNITIVE SCI, V28, P209, DOI 10.1016/j.cogsci.2003.11.004; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2011, OXFORD HDB FACE PERC, P149, DOI [DOI 10.1093/OXFORDHB/9780199559053.013.0009, 10.1093/oxfordhb/9780199559053.013.0009]; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; PERRETT DI, 1993, IMAGE VISION COMPUT, V11, P317, DOI 10.1016/0262-8856(93)90011-5; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Richler JJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00553; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Riesenhuber M, 2009, ACTA PSYCHOL, V132, P286, DOI 10.1016/j.actpsy.2009.07.004; Robbins R, 2007, COGNITION, V103, P34, DOI 10.1016/j.cognition.2006.02.008; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Tanaka J.W., 2011, OXFORD HDB FACE PERC, P177, DOI [DOI 10.1093/OXFORDHB/9780199559053.013.0010, 10.1093/oxfordhb/9780199559053.013.0010]; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Xu X, 2014, NEUROCOMPUTATIONAL A, V14, P1; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150980	10.1371/journal.pone.0150980	http://dx.doi.org/10.1371/journal.pone.0150980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985989	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300040
J	Zhang, DZ; Liu, XY; Xiao, WL; Xu, YX				Zhang, Dai-Zun; Liu, Xiao-Ya; Xiao, Wen-Lin; Xu, Yao-Xiang			Botulinum Toxin Type A and the Prevention of Hypertrophic Scars on the Maxillofacial Area and Neck: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CLEFT-LIP REPAIR; FACIAL WOUNDS; DERMATOLOGY; KELOIDS	Background The purpose of the meta-analysis was to evaluate the efficiency of therapeutic botulinum toxin type A (BTX-A) in the prevention of maxillofacial and neck scars. Methods and Findings Information came from the following electronic databases: Medline, PubMed, Cochrane Library, and EMBASE (time was ended by August 31, 2015) to retrieve RCTs evaluating the effect of the BTX-A for hypertrophic scar on the maxillofacial or neck. All languages were included as long as they met the inclusion criteria. Here the effects of BTX-A were evaluated by comparing the width of the scar, patient satisfaction, and the visual analysis scores (VAS), respectively. Pooled weighted mean differences (WMDs), pooled odds ratios (ORs), and 95% confidence intervals (CI) were calculated. Nine RCTs covering a total of 539 patients were included. A statistically significant difference in scar width was identified between the BTX-A group and control group (non-BTX-A used) (WMD = -0.41, 95% CI = -0.68 to -0.14, P = 0.003). A statistically significant difference in patient satisfaction was observed between the BTX-A group and control group (OR = 25.76, 95% CI = 2.58 to 256.67, P = 0.006). And in patients regarding visual analysis scores (VAS), a statistically significant difference was also observed between the BTX-A group and control group (WMD = 1.30, 95% CI = 1.00 to 1.60, P < 0.00001). Conclusions This meta-analysis evaluates the efficacy of the BTX-A and confirms that BTX-A is a suitable potential therapy for the prevention of hypertrophic scars in patients in the maxillofacial and neck areas.	[Zhang, Dai-Zun; Xiao, Wen-Lin; Xu, Yao-Xiang] Qingdao Univ, Affiliated Hosp, Dept Stomatol, Qingdao 266003, Peoples R China; [Zhang, Dai-Zun; Liu, Xiao-Ya; Xiao, Wen-Lin] Qingdao Univ, Affiliated Hosp, Key Lab Oral Clin Med Shandong Prov, Qingdao 266003, Peoples R China	Qingdao University; Qingdao University	Xiao, WL (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Stomatol, Qingdao 266003, Peoples R China.; Xiao, WL (corresponding author), Qingdao Univ, Affiliated Hosp, Key Lab Oral Clin Med Shandong Prov, Qingdao 266003, Peoples R China.	wenlinxiao@sina.com			Sci-Tech Research Projects of Huangdao District of Qingdao City [2014-1-84]; Natural Science foundation of Shandong Province [ZR2015HM022]	Sci-Tech Research Projects of Huangdao District of Qingdao City; Natural Science foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by 1) Sci-Tech Research Projects of Huangdao District of Qingdao City (2014-1-84), and 2) Natural Science foundation of Shandong Province (ZR2015HM022). Both projects were government-funded plans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Sci-Tech Research Projects of Huangdao District of Qingdao City (2014-1-84) and Natural Science Foundation of Shandong Province (ZR2015HM022).	Al-Qattan MM, 2013, ANN SAUDI MED, V33, P482, DOI 10.5144/0256-4947.2013.482; Atkinson JAM, 2005, PLAST RECONSTR SURG, V116, P1648, DOI 10.1097/01.prs.0000187147.73963.a5; Babuccu B, 2009, ANN PLAS SURG, V63, P449, DOI 10.1097/SAP.0b013e31818d4559; Berman Brian, 2004, J Cutan Med Surg, V8 Suppl 3, P32; Carruthers A, 1996, J AM ACAD DERMATOL, V34, P788, DOI 10.1016/S0190-9622(96)90016-X; Chang CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115690; Chang CS, 2014, PLAST RECONSTR SURG, V134, P511, DOI 10.1097/PRS.0000000000000416; Feily A, 2011, J COSMET DERMATOL-US, V10, P58, DOI 10.1111/j.1473-2165.2010.00545.x; Flynn TC, 2009, DERMATOL SURG, V35, P182, DOI 10.1111/j.1524-4725.2008.34407.x; Gassner HG, 2000, PLAST RECONSTR SURG, V105, P1948, DOI 10.1097/00006534-200005000-00005; Gassner HG, 2006, MAYO CLIN PROC, V81, P1023, DOI 10.4065/81.8.1023; Gassner HG, 2009, ARCH FACIAL PLAST S, V11, P140, DOI 10.1001/archfacial.2009.3; Gauglitz GG, 2012, SKIN PHARMACOL PHYS, V25, P313, DOI 10.1159/000342125; Goodman Greg J, 2010, J Cutan Aesthet Surg, V3, P90, DOI 10.4103/0974-2077.69019; Hallett M, 1999, NEW ENGL J MED, V341, P118, DOI 10.1056/NEJM199907083410209; Jablonka EM, 2012, FACIAL PLAST SURG, V28, P525, DOI 10.1055/s-0032-1325641; Kim YS, 2014, WOUND REPAIR REGEN, V22, P605, DOI 10.1111/wrr.12204; Lam Samuel M, 2003, Facial Plast Surg Clin North Am, V11, P431, DOI 10.1016/S1064-7406(03)00073-7; Laskawi Rainer, 2008, Head Face Med, V4, P5, DOI 10.1186/1746-160X-4-5; Lee BJ, 2009, CLIN EXP OTORHINOLAR, V2, P20, DOI 10.3342/ceo.2009.2.1.20; LI WH, 2014, CHIN J AESTH PLAST S, V25, P426; Liu A, 2011, DERMATOL SURG, V37, P1740, DOI 10.1111/j.1524-4725.2011.02166.x; Park TH, 2015, ANN PLAS SURG, V74, P100, DOI 10.1097/SAP.0b013e31828d706f; Robinson AJ, 2013, J PLAST RECONSTR AES, V66, P439, DOI 10.1016/j.bjps.2012.08.042; SCOTT AB, 1980, OPHTHALMOLOGY, V87, P1044; Shaarawy E, 2015, J COSMET DERMATOL-US, V14, P161, DOI 10.1111/jocd.12134; Tollefson TT, 2006, ARCH FACIAL PLAST S, V8, P221, DOI 10.1001/archfaci.8.3.221; Uyesugi B, 2010, AM J PHYS MED REHAB, V89, P153, DOI 10.1097/PHM.0b013e3181c1ec11; Verheyden J, 2002, DM-DIS MON, V48, P357, DOI 10.1053/mda.2001.25136; Viera Martha H, 2010, J Clin Aesthet Dermatol, V3, P20; WANG XY, 2013, J PRACT DERMATOL, V5, P271; Wilson AM, 2006, PLAST RECONSTR SURG, V117, P1758, DOI 10.1097/01.prs.0000209944.45949.d1; Xiao ZB, 2012, MOLECULES, V17, P2169, DOI 10.3390/molecules17022169; Xiao ZB, 2009, AESTHET PLAST SURG, V33, P409, DOI 10.1007/s00266-009-9334-z; Young VL, 2009, PLAST RECONSTR SURG, V124, P256, DOI 10.1097/PRS.0b013e3181a80747; Ziade M, 2013, J PLAST RECONSTR AES, V66, P209, DOI 10.1016/j.bjps.2012.09.012; Zimbler M S, 2001, Arch Facial Plast Surg, V3, P165, DOI 10.1001/archfaci.3.3.165	37	17	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151627	10.1371/journal.pone.0151627	http://dx.doi.org/10.1371/journal.pone.0151627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985661	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300098
J	Branger, P; Parienti, JJ; Sormani, MP; Defer, G				Branger, Pierre; Parienti, Jean-Jacques; Sormani, Maria Pia; Defer, Gilles			The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis	PLOS ONE			English	Article							GOLD STANDARD; 1ST YEAR; CLINICAL-RELEVANCE; EFFECTIVE THERAPY; END-POINT; MRI; INTERFERON; IMPAIRMENT; FINGOLIMOD; DISABILITY	Background The quantification of brain atrophy in relapsing-remitting multiple sclerosis (RRMS) may serve as a marker of disease progression and treatment response. We compared the association between first-line (FL) or second-line (SL) disease-modifying drugs (DMDs) and brain volume changes over time in RRMS. Materials and Methods We reviewed clinical trials in RRMS between January 1, 1995 and June 1, 2014 that assessed the effect of DMDs and reported data on brain atrophy in Medline, Embase, the Cochrane database and meeting abstracts. First, we designed a meta-analysis to directly compare the percentage brain volume change (PBVC) between FLDMDs and SLDMDs at 24 months. Second, we conducted an observational and longitudinal linear regression analysis of a 48-month follow-up period. Sensitivity analyses considering PBVC between 12 and 48 months were also performed. Results Among the 272 studies identified, 117 were analyzed and 35 (18,140 patients) were included in the analysis. Based on the meta-analysis, atrophy was greater for the use of an FLDMD than that of an SLDMD at 24 months (primary endpoint mean difference, -0.86; 95% confidence interval: -1.57--0.15; P = 0.02). Based on the linear regression analysis, the annual PBVC significantly differed between SLDMDs and placebo (-0.27%/y and -0.50%/y, respectively, P = 0.046) but not between FLDMDs (-0.33%/y) and placebo (P = 0.11) or between FLDMDs and SLDMDs (P = 0.49). Based on sensitivity analysis, the annual PBVC was reduced for SLDMDs compared with placebo (-0.14%/y and -0.56%/y, respectively, P<0.001) and FLDMDs (-0.46%/y, P<0.005), but no difference was detected between FLDMDs and placebo (P = 0.12). Conclusions SLDMDs were associated with reduced PBVC slope over time in RRMS, regardless of the period considered. These results provide new insights into the mechanisms underlying atrophy progression in RRMS.	[Branger, Pierre; Defer, Gilles] Univ Hosp Caen, Dept Neurol, Caen, France; [Parienti, Jean-Jacques] Univ Hosp Caen, Biostat & Clin Res Unit, Caen, France; [Sormani, Maria Pia] Univ Genoa, Biostat Unit, Dept Hlth Sci, Genoa, Italy	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Genoa	Defer, G (corresponding author), Univ Hosp Caen, Dept Neurol, Caen, France.	defer-gi@chu-caen.fr	DEFER, Gilles/AAM-4393-2020; Parienti, Jean-Jacques/AAD-1701-2021; Sormani, Maria Pia/ABH-8756-2020	Parienti, Jean-Jacques/0000-0002-4774-5590; SORMANI, MARIA PIA/0000-0001-6892-104X				Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Arnold DL, 2013, MULT SCLER J, V19, P1007, DOI 10.1177/1352458513490550; Arnold DL, 2013, J NEUROL, V260, P1901, DOI 10.1007/s00415-013-6903-5; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; De Stefano N, 2010, NEUROLOGY, V74, P1868, DOI 10.1212/WNL.0b013e3181e24136; De Stefano N, 2014, CNS DRUGS, V28, P147, DOI 10.1007/s40263-014-0140-z; Deloire MSA, 2011, NEUROLOGY, V76, P1161, DOI 10.1212/WNL.0b013e318212a8be; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Figueira F, 2013, NEUROLOGY, V80; Filippi M, 2013, MULT SCLER J, V19, P1005, DOI 10.1177/1352458513482387; Fisher E, 2009, 25 C EUR COM TREATM; Fox RJ, 2014, CURR MED RES OPIN, V30, P251, DOI 10.1185/03007995.2013.849236; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Grassiot B, 2009, J NEUROL, V256, P1397, DOI 10.1007/s00415-009-5108-4; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jones JL, 2010, BRAIN, V133, P2232, DOI 10.1093/brain/awq176; Kappos L, 1999, LANCET, V353, P964, DOI 10.1016/S0140-6736(98)03053-0; Kappos L, 2014, 2014 JOINT ACTRIMS E; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Milo R, 2014, THER ADV NEUROL DISO, V7, P7, DOI 10.1177/1756285613504021; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Rinaldi F, 2012, MULT SCLER J, V18, P1760, DOI 10.1177/1352458512447704; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Rudick RA, 2006, ANN NEUROL, V60, P236, DOI 10.1002/ana.20883; Rudick RA, 2013, MULT SCLER J, V19, P1003, DOI 10.1177/1352458513482385; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Sorensen PS, 2014, CURR OPIN NEUROL, V27, P246, DOI 10.1097/WCO.0000000000000096; Sormani MP, 2013, MULT SCLER J, V19, P466, DOI 10.1177/1352458512457841; Sormani MP, 2014, MULT SCLER J, V20, P280, DOI 10.1177/1352458513507360; Sormani MP, 2014, ANN NEUROL, V75, P43, DOI 10.1002/ana.24018; Sormani MP, 2004, NEUROLOGY, V62, P1432, DOI 10.1212/01.WNL.0000120663.85143.B3; van den Elskamp IJ, 2011, AM J NEURORADIOL, V32, P2093, DOI 10.3174/ajnr.A2691; Vidal-Jordana A, 2013, MULT SCLER J, V19, P1175, DOI 10.1177/1352458512473190; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Zivadinov R, 2005, J NEUROIMAGING, V15, p10S, DOI 10.1177/1051228405283291	41	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149685	10.1371/journal.pone.0149685	http://dx.doi.org/10.1371/journal.pone.0149685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983008	gold, Green Submitted, Green Published			2022-12-27	WOS:000372574900019
J	Fiasconaro, A; Strano, E; Nicosia, V; Porta, S; Latora, V				Fiasconaro, Alessandro; Strano, Emanuele; Nicosia, Vincenzo; Porta, Sergio; Latora, Vito			Spatio-Temporal Analysis of Micro Economic Activities in Rome Reveals Patterns of Mixed-Use Urban Evolution	PLOS ONE			English	Article							STREET CENTRALITY; NETWORKS; RETAIL	Understanding urban growth is one with understanding how society evolves to satisfy the needs of its individuals in sharing a common space and adapting to the territory. We propose here a quantitative analysis of the historical development of a large urban area by investigating the spatial distribution and the age of commercial activities in the whole city of Rome. We find that the age of activities of various categories presents a very interesting double exponential trend, with a transition possibly related to the long-term economical effects determined by the oil crisis of the Seventies. The diversification of commercial categories, studied through various measures of entropy, shows, among other interesting features, a saturating behaviour with the density of activities. Moreover, different couples of commercial categories exhibit over the years a tendency to attract in space. Our results demonstrate that the spatio-temporal distribution of commercial activities can provide important insights on the urbanisation processes at work, revealing specific and non trivial socio-economical dynamics, as the presence of crisis periods and expansion trends, and contributing to the characterisation of the maturity of urban areas.	[Fiasconaro, Alessandro; Nicosia, Vincenzo; Latora, Vito] Queen Mary Univ London, Sch Math Sci, Mile End Rd, London E1 4NS, England; [Strano, Emanuele] Ecole Polytech Fed Lausanne EPFL, Lab Geog Informat Syst LASIG, Sch Architecture Civil & Environm Engn ENAC, Lausanne, Switzerland; [Porta, Sergio] Univ Strathclyde, Urban Design Studies Unit, Glasgow, Lanark, Scotland; [Latora, Vito] Univ Catania, Dipartimento Fis & Astron, I-95123 Catania, Italy; [Latora, Vito] Ist Nazl Fis Nucl, I-95123 Catania, Italy	University of London; Queen Mary University London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Strathclyde; University of Catania; Istituto Nazionale di Fisica Nucleare (INFN)	Fiasconaro, A (corresponding author), Queen Mary Univ London, Sch Math Sci, Mile End Rd, London E1 4NS, England.	A.Fiasconaro@qmul.ac.uk	Fiasconaro, Alessandro/K-6085-2017	Fiasconaro, Alessandro/0000-0001-6859-099X; Porta, Sergio/0000-0003-1458-9517; Latora, Vito/0000-0002-0984-8038; Strano, Emanuele/0000-0002-2339-6824	Engineering and Physical Sciences Research Council project GALE [EP/K020633/1, EP/K020552/1]; Project LASAGNE - European Commission [318132]; EPSRC project GALE [EP/K020633/1, EP/K020552/1]; EPSRC [EP/K020552/1, EP/K020633/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K020633/1, EP/K020552/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council project GALE(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Project LASAGNE - European Commission(European Commission); EPSRC project GALE(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The project has been supported by the Engineering and Physical Sciences Research Council project GALE, EP/K020633/1 and EP/K020552/1. VL and VN acknowledge support from the Project LASAGNE, Contract No. 318132 (STREP), funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support from the EPSRC project GALE, EP/K020633/1 and EP/K020552/1. V.L. and V.N. acknowledge support from the Project LASAGNE, Contract No. 318132 (STREP), funded by the European Commission.	Arentze TA, 2005, J MARKETING RES, V42, P109, DOI 10.1509/jmkr.42.1.109.56884; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M., 2013, NEW SCI CITIES; Batty M, 2009, TOWN PLANNING REV, V79; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BROWN S, 1987, AREA, V19, P131; Caniggia G., 2001, ARCHITECTURAL COMPOS; Carmona M, 2015, PROG PLANN, V100, P1, DOI 10.1016/j.progress.2014.03.001; Christaller W., 1933, ZENTRALEN ORTE SUDDE; Coe N., 2007, EC GEOGRAPHY CONT IN, P87; Glaeser EL, 2007, NBER WORKING PAPERS; Griffiths S, 2008, GEOGR COMPASS, V2, P1155, DOI 10.1111/j.1749-8198.2008.00117.x; Jacobs, 1961, DEATH LIFE GREAT AM; Jensen P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.035101; Launhardt W., 1882, Z VEREINS DTSCH INGE, V26, P105; Louf R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0924; Noulas A, 2011, 8 INT C WEBL SOC MED; O'Flaherty Brendan., 2005, CITY EC; Porta S, 2012, URBAN STUD, V49, P1471, DOI 10.1177/0042098011422570; Porta S, 2009, ENVIRON PLANN B, V36, P450, DOI 10.1068/b34098; Ravulaparthy SK, 2014, TRANSPORT RES REC, P95, DOI 10.3141/2430-10; Rui YK, 2014, INT J GEOGR INF SCI, V28, P1425, DOI 10.1080/13658816.2014.893347; Strano E, 2013, ENVIRON PLANN B, V40, P1071, DOI 10.1068/b38216; Strano E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00296; Wang FH, 2011, J TRANSP GEOGR, V19, P285, DOI 10.1016/j.jtrangeo.2010.01.004; Weber A., 1929, A WEBERS THEORY LOCA; Wilson G, 2000, COMPLEX SPATIAL SYST	28	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151681	10.1371/journal.pone.0151681	http://dx.doi.org/10.1371/journal.pone.0151681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982028	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000372574900113
J	Kasprak, A; Hough-Snee, N; Beechie, T; Bouwes, N; Brierley, G; Camp, R; Fryirs, K; Imaki, H; Jensen, M; O'Brien, G; Rosgen, D; Wheaton, J				Kasprak, Alan; Hough-Snee, Nate; Beechie, Tim; Bouwes, Nicolaas; Brierley, Gary; Camp, Reid; Fryirs, Kirstie; Imaki, Hiroo; Jensen, Martha; O'Brien, Gary; Rosgen, David; Wheaton, Joseph			The Blurred Line between Form and Process: A Comparison of Stream Channel Classification Frameworks	PLOS ONE			English	Article							UPPER HUNTER CATCHMENT; LARGE WOODY DEBRIS; NEW-SOUTH-WALES; RIPARIAN VEGETATION; RIVER; VARIABILITY; (DIS)CONNECTIVITY; GEOMORPHOLOGY; DYNAMICS; PATTERNS	Stream classification provides a means to understand the diversity and distribution of channels and floodplains that occur across a landscape while identifying links between geomorphic form and process. Accordingly, stream classification is frequently employed as a watershed planning, management, and restoration tool. At the same time, there has been intense debate and criticism of particular frameworks, on the grounds that these frameworks classify stream reaches based largely on their physical form, rather than direct measurements of their component hydrogeomorphic processes. Despite this debate surrounding stream classifications, and their ongoing use in watershed management, direct comparisons of channel classification frameworks are rare. Here we implement four stream classification frameworks and explore the degree to which each make inferences about hydrogeomorphic process from channel form within the Middle Fork John Day Basin, a watershed of high conservation interest within the Columbia River Basin, U.S.A. We compare the results of the River Styles Framework, Natural Channel Classification, Rosgen Classification System, and a channel form-based statistical classification at 33 field-monitored sites. We found that the four frameworks consistently classified reach types into similar groups based on each reach or segment's dominant hydrogeomorphic elements. Where classified channel types diverged, differences could be attributed to the (a) spatial scale of input data used, (b) the requisite metrics and their order in completing a framework's decision tree and/or, (c) whether the framework attempts to classify current or historic channel form. Divergence in framework agreement was also observed at reaches where channel planform was decoupled from valley setting. Overall, the relative agreement between frameworks indicates that criticism of individual classifications for their use of form in grouping stream channels may be overstated. These form-based criticisms may also ignore the geomorphic tenet that channel form reflects formative hydrogeomorphic processes across a given landscape.	[Kasprak, Alan; Hough-Snee, Nate; Camp, Reid; Jensen, Martha; O'Brien, Gary; Wheaton, Joseph] Utah State Univ, Dept Watershed Sci, Logan, UT 84322 USA; [Hough-Snee, Nate; Jensen, Martha; Wheaton, Joseph] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Beechie, Tim] NOAA, Fish Ecol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98112 USA; [Bouwes, Nicolaas; Camp, Reid] Eco Log Res, Providence, UT USA; [Brierley, Gary] Univ Auckland, Sch Environm, Auckland 1, New Zealand; [Fryirs, Kirstie] Macquarie Univ, Dept Environm Sci, Sydney, NSW 2109, Australia; [Imaki, Hiroo] Pacific Spatial Solut, Reston, VA USA; [Rosgen, David] Wildland Hydrol, Ft Collins, CO 80524 USA; [Kasprak, Alan] US Geol Survey, Grand Canyon Monitoring & Res Ctr, Flagstaff, AZ 86001 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Auckland; Macquarie University; United States Department of the Interior; United States Geological Survey	Kasprak, A; Hough-Snee, N (corresponding author), Utah State Univ, Dept Watershed Sci, Logan, UT 84322 USA.; Hough-Snee, N (corresponding author), Utah State Univ, Ctr Ecol, Logan, UT 84322 USA.; Kasprak, A (corresponding author), US Geol Survey, Grand Canyon Monitoring & Res Ctr, Flagstaff, AZ 86001 USA.	akasprak@usgs.gov; nate@natehough-snee.org	Wheaton, Joseph Michael/F-1965-2010; Hough-Snee, Nate/E-9598-2011	Wheaton, Joseph Michael/0000-0002-8361-8150; Hough-Snee, Nate/0000-0003-4581-0931; Bouwes, Nicolaas/0000-0003-0249-3593; Fryirs, Kirstie/0000-0003-0541-3384; Rosgen, David/0000-0003-1187-7601	Bonneville Power Administration (BPA Project), Inc. [2003-017]; ELR (USU Award) [100652]; STAR Fellowship - U.S. Environmental Protection Agency (EPA) [91768201 - 0]	Bonneville Power Administration (BPA Project), Inc.; ELR (USU Award); STAR Fellowship - U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	Support for this manuscript was provided by grants from the Bonneville Power Administration to Eco Logical Research (BPA Project Number: 2003-017), Inc. and subsequent grants from ELR to Utah State University (USU Award ID: 100652). NH-S was supported in part by STAR Fellowship Assistance Agreement no. 91768201 - 0 awarded by the U.S. Environmental Protection Agency (EPA). This research has not been formally reviewed by the EPA, NOAA or BPA and the views expressed herein are solely those of the authors. The EPA, NOAA, and BPA do not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1957, RIVER CHANNEL PATTER; Beechie T, 2013, STREAM WATERSHED RES, P316; Beechie T, 2014, WATER RESOUR RES, V50, P39, DOI 10.1002/2013WR013629; Beechie TJ, 2006, GEOMORPHOLOGY, V78, P124, DOI 10.1016/j.geomorph.2006.01.030; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Beschta RL, 2013, ENVIRON MANAGE, V51, P474, DOI 10.1007/s00267-012-9964-9; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bridge J.S., 2003, RIVERS FLOODPLAINS F; Brierley G, 2002, APPL GEOGR, V22, P91, DOI 10.1016/S0143-6228(01)00016-9; Brierley G, 2013, PROG PHYS GEOG, V37, P601, DOI 10.1177/0309133313490007; Brierley G, 2011, APPL GEOGR, V31, P1132, DOI 10.1016/j.apgeog.2011.03.002; Brierly G.J., 2005, GEOMORPHOLOGY RIVER; Bristow C.S., 1993, GEOLOGICAL SOC LONDO, V75, P1, DOI [10.1144/GSL.SP.1993.075.01.01, DOI 10.1144/GSL.SP.1993.075.01.01]; Brooks AP, 2003, GEOMORPHOLOGY, V51, P7, DOI 10.1016/S0169-555X(02)00323-9; Buffington J.M., 2013, TREATISE GEOMORPHOLO, P730, DOI [10.1016/B978-0-12-374739-6.00263-3, DOI 10.1016/B978-0-12-374739-6.00263-3]; Buffington JM, 1997, WATER RESOUR RES, V33, P1993, DOI 10.1029/96WR03190; Butt AZ, 1999, THESIS U NEVADA RENO; CHaMP, 2013, COL HAB MON PROGR 20; Chessman BC, 2006, AQUAT CONSERV, V16, P267, DOI 10.1002/aqc.724; Coopersmith EJ, 2014, WATER RESOUR RES, V50, P1960, DOI 10.1002/2012WR013320; COSTA JE, 1983, GEOL SOC AM BULL, V94, P986, DOI 10.1130/0016-7606(1983)94<986:PROFPF>2.0.CO;2; Costigan KH, 2014, GEOMORPHOLOGY, V210, P48, DOI 10.1016/j.geomorph.2013.12.017; Davis W. M., 1899, GEOGR J, V14, P481, DOI [10.2307/1774538, DOI 10.2307/1774538]; DIETRICH WE, 1989, NATURE, V340, P215, DOI 10.1038/340215a0; ERSKINE WD, 1992, REGUL RIVER, V7, P261, DOI 10.1002/rrr.3450070305; Fryirs K, 2001, GEOMORPHOLOGY, V38, P237, DOI 10.1016/S0169-555X(00)00093-3; Fryirs K, 2010, GEOMORPHOLOGY, V117, P106, DOI 10.1016/j.geomorph.2009.11.015; Fryirs K, 2009, EARTH SURF PROC LAND, V34, P897, DOI 10.1002/esp.1771; Fryirs KA, 2007, CATENA, V70, P49, DOI 10.1016/j.catena.2006.07.007; Fryirs KA, 2007, GEOMORPHOLOGY, V84, P297, DOI 10.1016/j.geomorph.2006.01.044; Grabowski RC, 2014, WILEY INTERDISCIPLIN, P1; GRAF WL, 1983, WATER RESOUR RES, V19, P643, DOI 10.1029/WR019i003p00643; Grant GE, 2003, PECULIAR RIVER GEOLO, V7, P209, DOI DOI 10.1029/007WS13; Hey RD, 2006, J AM WATER RESOUR AS, V42, P357, DOI 10.1111/j.1752-1688.2006.tb03843.x; Hough-Snee N, 2015, RIVER RES APPL, V31, P1151, DOI 10.1002/rra.2815; Hough-Snee N., 2014, RIPARIAN ECOLOGY CON, V2, P14; Hupp CR, 1996, GEOMORPHOLOGY, V14, P277, DOI 10.1016/0169-555X(95)00042-4; Kasprak A, 2012, RIVER RES APPL, V28, P1462, DOI 10.1002/rra.1532; Kasprak A, 2013, GEOMORPHOLOGY, V185, P67, DOI 10.1016/j.geomorph.2012.12.005; Kershner JL, 2013, GUIDE EFFECTIVE MONI; Knighton D., 1998, FLUVIAL FORMS PROCES; Kondolf G. M., 2003, TOOLS FLUVIAL GEOMOR, P133, DOI [10.1002/0470868333, DOI 10.1002/9781118648551.CH7]; Kondolf G.M., 2003, TOOLS FLUVIAL GEOMOR; Kuo CW, 2013, GEOMORPHOLOGY, V180, P255, DOI 10.1016/j.geomorph.2012.10.015; Lane E., 1955, AM SOC CIV ENG, V81, P1, DOI [10.1061/JYCEAJ.0000048, DOI 10.1061/JYCEAJ.0000048, DOI 10.1016/J.GEOMORPH.2006.06.031]; Laub BG, 2012, FRESHWATER BIOL, V57, P1076, DOI 10.1111/j.1365-2427.2012.02763.x; Lave R, 2009, THESIS U CALIFORNIA; Lave R, 2009, J AM WATER RESOUR AS, V45, P1519, DOI 10.1111/j.1752-1688.2009.00385.x; Lecce SA, 1997, ANN ASSOC AM GEOGR, V87, P471, DOI 10.1111/1467-8306.00064; Legleiter CJ, 2013, GEOMORPHOLOGY, V200, P1, DOI 10.1016/j.geomorph.2013.06.004; Maechler M., CLUSTER ANAL BASICS; MAGILLIGAN FJ, 1992, GEOMORPHOLOGY, V5, P373, DOI 10.1016/0169-555X(92)90014-F; McDavitt WN, 2004, THESIS UTAH STATE U; McKean J, 2009, REMOTE SENS-BASEL, V1, P1065, DOI 10.3390/rs1041065; MIALL AD, 1985, EARTH-SCI REV, V22, P261, DOI 10.1016/0012-8252(85)90001-7; Millar RG, 2005, GEOMORPHOLOGY, V64, P207, DOI 10.1016/j.geomorph.2004.07.001; Miller A.J., 1995, NATURAL ANTHROPOGENI, V89, P57, DOI DOI 10.1029/GM089P0057; Montgomery D. R., 1998, RIVER ECOLOGY MANAGE, P13, DOI DOI 10.1007/978-1-4612-1652-0_2; Montgomery DR, 1997, GEOL SOC AM BULL, V109, P596, DOI 10.1130/0016-7606(1997)109<0596:CRMIMD>2.3.CO;2; Montgomery DR, 1999, J AM WATER RESOUR AS, V35, P397, DOI 10.1111/j.1752-1688.1999.tb03598.x; Nehlsen W, 1997, RESTOR ECOL, V5, P25, DOI 10.1111/j.1526-100X.1997.00025.x; Newman S, 2008, J AM WATER RESOUR AS, V44, P1, DOI 10.1111/j.1752-1688.2007.00134.x; O'Brien G, 2014, RIV STYL REP MIDDL F; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Piegay H, 1999, CATENA, V35, P19, DOI 10.1016/S0341-8162(98)00120-9; Polvi LE, 2013, BIOSCIENCE, V63, P439, DOI 10.1525/bio.2013.63.6.6; PRISM Climate Group, 2013, PRISM GRIDD CLIM DAT; R Team, 2014, R LANG ENV STAT COMP; Reinhardt L, 2010, EARTH SURF PROC LAND, V35, P78, DOI 10.1002/esp.1912; Rinaldi M, 2008, DEV EARTH S, V11, P213, DOI 10.1016/S0928-2025(07)11126-3; Roper BB, 2008, J AM WATER RESOUR AS, V44, P417, DOI 10.1111/j.1752-1688.2008.00171.x; Rosgen D., 1996, APPL RIVER MORPHOLOG; Rosgen D.L., 2001, P 7 FED INT SED C RE; Rosgen DL, 2011, GEOPHYS MONOGR SER, V194, P69, DOI 10.1029/2010GM000990; Rosgen DL, 2009, J AM WATER RESOUR AS, V45, P1290, DOI 10.1111/j.1752-1688.2009.00332.x; Rosgen DL, 1996, CATENA, V27, P301, DOI 10.1016/0341-8162(96)00018-5; ROSGEN DL, 1994, CATENA, V22, P169, DOI 10.1016/0341-8162(94)90001-9; Schmidt JC, 2008, WATER RESOUR RES, P44; SCHUMM SA, 1965, AM J SCI, V263, P110, DOI 10.2475/ajs.263.2.110; SCHUMM SA, 1985, ANNU REV EARTH PL SC, V13, P5, DOI 10.1146/annurev.ea.13.050185.000253; Simon A, 2007, J AM WATER RESOUR AS, V43, P1117, DOI 10.1111/j.1752-1688.2007.00091.x; Snyder NP, 2009, GEOMORPHOLOGY, V103, P430, DOI 10.1016/j.geomorph.2008.07.013; Southerland WB, 2003, THESIS WASHINGTON ST; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Sutfin NA, 2014, GEOMORPHOLOGY, V221, P164, DOI 10.1016/j.geomorph.2014.06.005; Thomson JR, 2004, AQUAT CONSERV, V14, P25, DOI 10.1002/aqc.585; Topping DJ, 2015, P 10 FED INT SED C R; United States Geological Survey, 2014, NAT EL DAT; Walter RC, 2008, SCIENCE, V319, P299, DOI 10.1126/science.1151716; Waples RS, 2009, ECOL SOC, V14; Ward JV, 2002, FRESHWATER BIOL, V47, P517, DOI 10.1046/j.1365-2427.2002.00893.x; Wilcock P.R., 1997, EOS T AM GEOPHYS UN, V78, P454, DOI [10.1029/97EO00286, DOI 10.1029/97EO00286]	93	45	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150293	10.1371/journal.pone.0150293	http://dx.doi.org/10.1371/journal.pone.0150293			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982076	Green Published, gold			2022-12-27	WOS:000372574900033
J	Kwon, YJ; Baek, HS; Ye, DJ; Shin, S; Kim, D; Chun, YJ				Kwon, Yeo-Jung; Baek, Hyoung-Seok; Ye, Dong-Jin; Shin, Sangyun; Kim, Donghak; Chun, Young-Jin			CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/beta-Catenin Signaling via Sp1 Upregulation	PLOS ONE			English	Article							PRIMARY CONGENITAL GLAUCOMA; BREAST-CANCER CELLS; ESTROGEN METABOLISM; E-CADHERIN; MESENCHYMAL TRANSITION; CYTOCHROME-P450 CYP1B1; GENE-EXPRESSION; TUMOR-CELLS; TRANSCRIPTION; INVASION	Cytochrome P450 1B1 (CYP1B1) is a major E2 hydroxylase involved in the metabolism of potential carcinogens. CYP1B1 expression has been reported to be higher in tumors compared to normal tissues, especially in hormone-related cancers including breast, ovary, and prostate tumors. To explore the role of CYP1B1 in cancer progression, we investigated the action of CYP1B1 in cells with increased CYP1B1 via the inducer 7,12-dimethylbenz[alpha] anthracene (DMBA) or an overexpression vector, in addition to decreased CYP1B1 via the inhibitor tetramethoxystilbene (TMS) or siRNA knockdown. We observed that CYP1B1 promoted cell proliferation, migration, and invasion in MCF-7 and MCF-10A cells. To understand its molecular mechanism, we measured key oncogenic proteins including beta-catenin, c-Myc, ZEB2, and matrix metalloproteinases following CYP1B1 modulation. CYP1B1 induced epithelial-mesenchymal transition (EMT) and activated Wnt/beta-catenin signaling via upregulation of CTNNB1, ZEB2, SNAI1, and TWIST1. Sp1, a transcription factor involved in cell growth and metastasis, was positively regulated by CYP1B1, and suppression of Sp1 expression by siRNA or DNA binding activity using mithramycin A blocked oncogenic transformation by CYP1B1. Therefore, we suggest that Sp1 acts as a key mediator for CYP1B1 action. Treatment with 4-hydroxyestradiol (4-OHE2), a major metabolite generated by CYP1B1, showed similar effects as CYP1B1 overexpression, indicating that CYP1B1 activity mediated various oncogenic events in cells. In conclusion, our data suggests that CYP1B1 promotes cell proliferation and metastasis by inducing EMT and Wnt/beta-catenin signaling via Sp1 induction.	[Kwon, Yeo-Jung; Baek, Hyoung-Seok; Ye, Dong-Jin; Shin, Sangyun; Chun, Young-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Kim, Donghak] Konkuk Univ, Dept Biol Sci, Seoul, South Korea	Chung Ang University; Konkuk University	Chun, YJ (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	yjchun@cau.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Korean government [NRF-2012R1A1A2041536, NRF-2015R1A5A1008958]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2012R1A1A2041536, NRF-2015R1A5A1008958]	Basic Science Research Program through the National Research Foundation of Korea - Korean government; National Research Foundation of Korea (NRF) - Korean government (MSIP)	This research was supported by the Basic Science Research Program (NRF-2012R1A1A2041536 and NRF-2015R1A5A1008958) through the National Research Foundation of Korea funded by the Korean government to YJC (http://www.nrf.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (NRF-2012R1A1A2041536 and NRF-2015R1A5A1008958).	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Belous AR, 2007, CANCER RES, V67, P812, DOI 10.1158/0008-5472.CAN-06-2133; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Campos-Mollo E, 2009, MOL VIS, V15, P417; Carvell MJ, 2007, CELL PHYSIOL BIOCHEM, V20, P617, DOI 10.1159/000107545; Chavarria-Soley G, 2008, HUM MUTAT, V29, P1147, DOI 10.1002/humu.20786; Chen B, 2010, LUNG CANCER, V70, P247, DOI 10.1016/j.lungcan.2010.03.011; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Vivo I, 2002, CANCER EPIDEM BIOMAR, V11, P489; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098651; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hachey DL, 2003, CANCER RES, V63, P8492; Hernandez-Perez M, 2012, AM J DERMATOPATH, V34, P723, DOI 10.1097/DAD.0b013e31824b1ddf; Hong M, 2014, BIOMOL THER, V22, P519, DOI 10.4062/biomolther.2014.112; Jiang WF, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-113; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Le Marchand L, 2005, CANCER EPIDEM BIOMAR, V14, P1998, DOI 10.1158/1055-9965.EPI-05-0076; Li DN, 2000, PHARMACOGENETICS, V10, P343, DOI 10.1097/00008571-200006000-00008; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; McFadyen MCE, 2001, BRIT J CANCER, V85, P242, DOI 10.1054/bjoc.2001.1907; MCKAY JA, 1995, FEBS LETT, V374, P270, DOI 10.1016/0014-5793(95)01126-Y; Murray GI, 1997, CANCER RES, V57, P3026; Nam EH, 2014, CARCINOGENESIS, V35, P302, DOI 10.1093/carcin/bgt340; Ohkuma M, 2007, BIOCHEM BIOPH RES CO, V352, P925, DOI 10.1016/j.bbrc.2006.11.114; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park JH, 2009, J GENE MED, V11, P824, DOI 10.1002/jgm.1355; Patel SAA, 2015, TOXICOL RES-UK, V4, P858, DOI 10.1039/c5tx00068h; Polakis P, 2000, GENE DEV, V14, P1837; Poplineau M, 2015, MOL CARCINOGEN, V54, P24, DOI 10.1002/mc.22071; Ragavan N, 2004, CANCER LETT, V215, P69, DOI 10.1016/j.canlet.2004.06.051; Saini S, 2009, CANCER RES, V69, P7038, DOI 10.1158/0008-5472.CAN-09-1691; Shimada T, 1996, CANCER RES, V56, P2979; Singh PB, 2010, ASIAN J ANDROL, V12, P203, DOI 10.1038/aja.2009.71; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; SPINK DC, 1994, J STEROID BIOCHEM, V51, P251, DOI 10.1016/0960-0760(94)90037-X; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Tang WM, 1996, J BIOL CHEM, V271, P28324, DOI 10.1074/jbc.271.45.28324; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Tokizane T, 2005, CLIN CANCER RES, V11, P5793, DOI 10.1158/1078-0432.CCR-04-2545; Turner NA, 2012, IUBMB LIFE, V64, P143, DOI 10.1002/iub.594; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Yuan JH, 2011, HEPATOLOGY, V54, P2025, DOI 10.1002/hep.24606; Zhang JP, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0222-1	52	62	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151598	10.1371/journal.pone.0151598	http://dx.doi.org/10.1371/journal.pone.0151598			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981862	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900102
J	Tidball, AM; Neely, MD; Chamberlin, R; Aboud, AA; Kumar, KK; Han, BY; Bryan, MR; Aschner, M; Ess, KC; Bowman, AB				Tidball, Andrew M.; Neely, M. Diana; Chamberlin, Reed; Aboud, Asad A.; Kumar, Kevin K.; Han, Bingying; Bryan, Miles R.; Aschner, Michael; Ess, Kevin C.; Bowman, Aaron B.			Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; INCREASED OXIDATIVE DAMAGE; SUPPRESSION; DYSFUNCTION; APOPTOSIS; PROTEINS; MUTATION; PATHWAY	Alterations in DNA damage response and repair have been observed in Huntington's disease (HD). We generated induced pluripotent stem cells (iPSC) from primary dermal fibroblasts of 5 patients with HD and 5 control subjects. A significant fraction of the HD iPSC lines had genomic abnormalities as assessed by karyotype analysis, while none of our control lines had detectable genomic abnormalities. We demonstrate a statistically significant increase in genomic instability in HD cells during reprogramming. We also report a significant association with repeat length and severity of this instability. Our karyotypically normal HD iPSCs also have elevated ATM-p53 signaling as shown by elevated levels of phosphorylated p53 and H2AX, indicating either elevated DNA damage or hypersensitive DNA damage signaling in HD iPSCs. Thus, increased DNA damage responses in the HD genotype is coincidental with the observed chromosomal aberrations. We conclude that the disease causing mutation in HD increases the propensity of chromosomal instability relative to control fibroblasts specifically during reprogramming to a pluripotent state by a commonly used episomal-based method that includes p53 knockdown.	[Tidball, Andrew M.; Neely, M. Diana; Aboud, Asad A.; Kumar, Kevin K.; Han, Bingying; Bryan, Miles R.; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37240 USA; [Tidball, Andrew M.; Neely, M. Diana; Kumar, Kevin K.; Bryan, Miles R.; Ess, Kevin C.; Bowman, Aaron B.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Chamberlin, Reed] Genet Associates Inc, Nashville, TN 37203 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Ess, Kevin C.] Vanderbilt Univ, Dept Pediat, Med Ctr, Nashville, TN 37240 USA; [Bowman, Aaron B.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University; Vanderbilt University	Bowman, AB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37240 USA.; Bowman, AB (corresponding author), Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA.; Bowman, AB (corresponding author), Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37232 USA.	aaron.bowman@vanderbilt.edu		Kumar, Kevin/0000-0002-0704-1492; Tidball, Andrew/0000-0002-1666-4106	National Institute of Environmental Health Sciences [ES016931, ES010563]; National Institute of Neurological Disorders and Stroke [F31 NS077632]; Vanderbilt Medical Scientist Training Program - National Institute of General Medical Sciences [T32 GM07347]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016931, R01ES010563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077632, R01NS078289] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Vanderbilt Medical Scientist Training Program - National Institute of General Medical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Environmental Health Sciences: ES016931 (ABB) and ES010563 (ABB/MA); the National Institute of Neurological Disorders and Stroke: F31 NS077632 (AMT) as well as additional support from the Vanderbilt Medical Scientist Training Program funded by the National Institute of General Medical Sciences: T32 GM07347 (KKK).	Alam ZI, 2000, J NEUROCHEM, V75, P840, DOI 10.1046/j.1471-4159.2000.0750840.x; An MC, 2012, CELL STEM CELL; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Chae JI, 2012, BIOCHEM J, V446, P359, DOI 10.1042/BJ20111495; Chattopadhyay B, 2005, NEUROSCI LETT, V374, P81, DOI 10.1016/j.neulet.2004.10.018; De Luca G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000266; Ehrnhoefer DE, 2014, HUM MOL GENET, V23, P717, DOI 10.1093/hmg/ddt458; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Ferlazzo ML, 2013, MOL NEUROBIOL, P1; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Illuzzi J, 2009, J NEUROSCI RES, V87, P733, DOI 10.1002/jnr.21881; Illuzzi JL, 2011, J MOL NEUROSCI, V45, P256, DOI 10.1007/s12031-011-9516-4; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Lu XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010523; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; MOSHELL AN, 1980, LANCET, V1, P9; Neely MD, 2011, NEUROMETHODS, V56, P27, DOI 10.1007/978-1-61779-077-5_2; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Raskin S, 2000, ARQ NEURO-PSIQUIAT, V58, P977, DOI 10.1590/S0004-282X2000000600001; Rasmussen MA, 2014, STEM CELL REP, V3, P404, DOI 10.1016/j.stemcr.2014.07.006; Ruiz S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9036; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tidball AM, 2015, HUM MOL GENET, V24, P1929, DOI 10.1093/hmg/ddu609; Tomasevic G, 1999, MOL BRAIN RES, V70, P304, DOI 10.1016/S0169-328X(99)00146-1; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799	40	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150372	10.1371/journal.pone.0150372	http://dx.doi.org/10.1371/journal.pone.0150372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982737	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900038
J	Warren, RJ				Warren, Robert J., II			Ghosts of Cultivation Past - Native American Dispersal Legacy Persists in Tree Distribution	PLOS ONE			English	Article							PLANT-POPULATIONS; SEED DISPERSAL; GENETIC-STRUCTURE; NICHE; CHEROKEE; VEGETATION; MIGRATION	A long-term assumption in ecology is that species distributions correspond with their niche requirements, but evidence that species can persist in unsuitable habitat for centuries undermines the link between species and habitat. Moreover, species may be more dependent on mutualist partners than specific habitats. Most evidence connecting indigenous cultures with plant dispersal is anecdotal, but historical records suggest that Native Americans transported and cultivated many species, including Gleditsia triacanthos ("Honey locust"). Gleditsia triacanthos was an important medicinal/culinary (e.g., sugar), cultural (e.g., game sticks) and spiritual tree for the Cherokee (southeastern U.S. Native Americans). This study tests the hypothesis that a Cherokee cultivation legacy drives current regional G. triacanthos distribution patterns. Gleditsia triacanthos occurs in rocky uplands and xeric fields, but inexplicably also occurs in mesic riverine corridors and floodplains where Cherokee once settled and farmed. I combined field experiments and surveys in the Southern Appalachian Mountain region (U.S.) to investigate G. triacanthos recruitment requirements and distribution patterns to determine whether there is a quantifiable G. triacanthos association with former Cherokee settlements. Moreover, I also investigated alternate dispersal mechanisms, such as stream transport and domestic cattle. The results indicate that a centuries-old legacy of Native American cultivation remains intact as G. triacanthos' current southern Appalachian distribution appears better explained Cherokee settlement patterns than habitat. The data indicate that the tree is severely dispersal limited in the region, only moving appreciable distances from former Cherokee settlements where cattle grazing is prevalent. Human land use legacy may play a long-term role in shaping species distributions, and pre-European settlement activity appears underrated as a factor influencing modern tree species distributions.	[Warren, Robert J., II] SUNY Coll Buffalo, Dept Biol, 1300 Elmwood Ave, Buffalo, NY 14222 USA	State University of New York (SUNY) System; Buffalo State College	Warren, RJ (corresponding author), SUNY Coll Buffalo, Dept Biol, 1300 Elmwood Ave, Buffalo, NY 14222 USA.	hexastylis@gmail.com			National Science Foundation [DEB-0823293]; Division Of Environmental Biology [1440485] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Science Foundation award DEB-0823293 to the Coweeta LTER Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2008, HOLOCENE, V18, P1123, DOI 10.1177/0959683608095581; [Anonymous], 2007, TECHNICAL NOTE NO 2; Ashe SA, 1904, N CAROLINA BOOKLET, V4, P3; Barlow C, 2000, GHOSTS EVOLUATION NO; Bartram W., 1794, TRAVELS N S CAROLINA; Bass II Q R, 1977, PREHISTORIC SETTLEME; Beck R, 2013, CHIEFDOMS, COLLAPSE, AND COALESCENCE IN THE EARLY AMERICAN SOUTH, P1, DOI 10.1017/CBO9781139135429; Blair RM, 1990, SILVICS N AM, V654, P358; Blitz JH, 2004, AM ANTIQUITY, V69, P291, DOI 10.2307/4128421; Boulanger MT, 2014, QUATERNARY SCI REV, V85, P35, DOI 10.1016/j.quascirev.2013.11.024; BRONSTEIN JL, 1989, EXPERIENTIA, V45, P622, DOI 10.1007/BF01975679; Campbell Lyle, 2000, AM INDIAN LANGUAGES, P396; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Crosby A.W., 1986, ECOLOGICAL IMPERIALI, DOI DOI 10.1017/CBO9780511805554; Davis R. P. S, 1998, ABBREVIATED NAGPRA I; DELCOURT PA, 1986, QUATERNARY RES, V25, P330, DOI 10.1016/0033-5894(86)90005-0; Delcourt PA, 2004, PREHISTORIC NATIVE A; Dickens Roy S., 1976, CHEROKEE PREHISTORY; Dickens RS, 1967, SO INDIANA STUDIES, V14, P25; Diez JM, 2007, J ECOL, V95, P159, DOI 10.1111/j.1365-2745.2006.01194.x; Ehrlen J, 2000, ECOLOGY, V81, P1667, DOI 10.1890/0012-9658(2000)081[1667:DLAPOI]2.0.CO;2; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Evans R, 1977, J CHEROKEE STUDIES, P2; Fogelson Raymond D, 2004, HDB N AM INDIANS, V14; Gilmore M.R., 1930, MICHIGAN ACAD SCI AR, V13, P89; Gordon D, 1966, REVISION GENUS GLEDI; Gragson TL, 2007, SOC SCI HIST, V31, P435, DOI 10.1215/01455532-2007-005; Graham EH, 1941, LEGUMES EROSION CONT, P412; Guiden Peter W., 2013, Ecological Restoration, V31, P356, DOI 10.3368/er.31.4.356; Hamel PB, 1975, CHEOKEE PLANTS THEIR; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Janzen DH, 1982, GARDEN, V6, P12; Keener C, 1997, N AM ARCHAEOL, V18, P326; King DH, 2005, CHEROKEE INDIAN NATI; King Duane H., 1979, CHEROKEE INDIAN NATI, P3; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lawson J, 1709, NEW VOYAGE CAROLINA; Lindbladh M, 1998, J BIOGEOGR, V25, P463, DOI 10.1046/j.1365-2699.1998.2530463.x; LIU NY, 1981, J AM SOC HORTIC SCI, V106, P691; Loeb RE, 1998, J TORREY BOT SOC, V125, P74, DOI 10.2307/2997233; Lounsbury FD, 1961, BUREAU AM ETHNOLOGY, V180; MacDougall A, 2003, J BIOGEOGR, V30, P633, DOI 10.1046/j.1365-2699.2003.00842.x; Martin PS, 1974, ARCTIC ALPINE ENV; McLauchlan K, 2003, HOLOCENE, V13, P557, DOI 10.1191/0959683603hl646rp; Mooney J., 1900, 19 ANN REP BUR AM ET; Mooney J., 1932, SWIMMER UNPUB; Mooney J., 1890, CHEROKEE BALL PLAY A, V3; Murphy HT, 2007, OIKOS, V116, P99, DOI 10.1111/j.2006.0030-1299.15050.x; Murphy JL, 2001, N AM ARCHAEOL, V22, P93, DOI 10.2190/TT5Y-YAXJ-0KAU-GUFK; Myers JA, 2004, OECOLOGIA, V139, P35, DOI 10.1007/s00442-003-1474-2; Pearson SM, 1999, ECOL APPL, V9, P1288, DOI 10.1890/1051-0761(1999)009[1288:LCAHAI]2.0.CO;2; Perry MJ, 1975, FOOD USE WILD PLANTS; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Prasad A.M., 2003, LITTLES RANGE FIA IM; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Rodning Christopher, 2008, N CAROLINA ARCHAEOLO, V57, P1; Rodning CB, 2011, N AM ARCHAEOL, V32, P131, DOI 10.2190/NA.32.2.b; Rodning Christopher B., 2002, SE ARCHAEOLOGY, V21, P10; Schnabel A, 1998, MOL ECOL, V7, P819, DOI 10.1046/j.1365-294x.1998.00397.x; SCHNABEL A, 1990, AM J BOT, V77, P1060, DOI 10.2307/2444577; SCHNABEL A, 1991, HEREDITY, V67, P357, DOI 10.1038/hdy.1991.99; SCWDS, 1980, SE COOP WILDL DIS ST; SINGH D P, 1991, New Forests, V5, P139, DOI 10.1007/BF00029304; Smith BA., 1979, CHEROKEE INDIAN NATI; Smith H.H., 1928, B PUBLIC MUSEUM CITY, P175; Speck FG, 1942, P DELAWARE COUNTY IN, V10, P175; Swanton JR, 1928, 42 BUR AM ETHN ANN R, P473; Swanton JR., 1946, INDIANS SE US; Tantaquidgeon G, 1972, FOLK MED DELEWARE RE; Taylor LA., 1940, PLANTS USED CURATIVE; Tulowiecki SJ, 2015, ECOL MONOGR, V85, P557, DOI 10.1890/14-2259.1; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; VanDerwarker AM, 2000, N CAROLINA ARCHAEOLO, V49, P59; VanDerwarker AM, 2006, ENCY APPALACHIA, P944; VanDerwarker AM, 2013, AM ANTIQUITY, V78, P68, DOI 10.7183/0002-7316.78.1.68; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Warren RJ, 2011, P ROY SOC B-BIOL SCI, V278, P1390, DOI 10.1098/rspb.2010.1886; Warren RJ, 2010, J ECOL, V98, P1178, DOI 10.1111/j.1365-2745.2010.01694.x	81	16	16	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150707	10.1371/journal.pone.0150707	http://dx.doi.org/10.1371/journal.pone.0150707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982877	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900049
J	Dandapat, A; Perrin, BJ; Cabelka, C; Razzoli, M; Ervasti, JM; Bartolomucci, A; Lowe, DA; Kyba, M				Dandapat, Abhijit; Perrin, Benjamin J.; Cabelka, Christine; Razzoli, Maria; Ervasti, James M.; Bartolomucci, Alessandro; Lowe, Dawn A.; Kyba, Michael			High Frequency Hearing Loss and Hyperactivity in DUX4 Transgenic Mice	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; DNA REARRANGEMENTS; MUS-MUSCULUS; FSHD; EXPRESSION; TORPOR; GENE; D4Z4; PATHOLOGIES; DELETIONS	Facioscapulohumeral muscular dystrophy (FSHD) is caused by mutations leading to ectopic expression of the transcription factor DUX4, and encompasses both muscle-related and non-muscle phenotypes. Mouse models bearing this gene represent valuable tools to investigate which pathologies are due to DUX4 expression, and how DUX4 leads to these pathologies. The iDUX4(2.7) mouse contains an X-linked doxycycline-inducible DUX4 gene that shows low level basal expression in the absence of doxycycline, leading to male lethality, generally in embryo, but always before 8 weeks of age. Here, we describe additional non-muscle phenotypes in this animal model. We find that iDUX4(2.7) female carriers are extremely hyperactive, spending large amounts of time ambulating and much less time resting. Rare 3-week old males, although hypophagic, runted and extremely fragile, are capable of high activity, but show periods of catatonic torpor in which animals appear dead and respiration is virtually absent. We also examine a non-muscle phenotype of interest to FSHD, high frequency hearing loss. We find that young iDUX4(2.7) females are significantly impaired in their ability to hear at frequencies above 8 kHz. These phenotypes make the iDUX4(2.7) mouse an attractive model in which to study non-muscle activities of DUX4.	[Dandapat, Abhijit; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Dandapat, Abhijit; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Perrin, Benjamin J.; Ervasti, James M.] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Cabelka, Christine; Lowe, Dawn A.] Univ Minnesota, Program Phys Med & Rehabil, Minneapolis, MN 55455 USA; [Razzoli, Maria; Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kyba, M (corresponding author), Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA.; Kyba, M (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	kyba@umn.edu	Ervasti, James/AAZ-4786-2020	RAZZOLI, Maria/0000-0001-5911-4633; Lowe, Dawn/0000-0002-5784-9289; Cabelka, Christine/0000-0002-6106-5794; Kyba, Michael/0000-0002-5579-7534	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR055685, RO1 AR049899]; National Institute on Deafness and Other Communication Disorders [R03 DC12354]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK102496]; National Institute on Aging [R01 AG031743]; Bob and Jean Smith Foundation; NIH [R01 AR055685, RO1 AR049899, R03 DC12354, R01 DK102496, R01 AG031743]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055685, R01AR049899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC012354] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bob and Jean Smith Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the following agencies and foundations: National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 AR055685 (to M.K.) and RO1 AR049899 (to J.E.); National Institute on Deafness and Other Communication Disorders R03 DC12354 (to B.P.); National Institute of Diabetes and Digestive and Kidney Diseases R01 DK102496 (to A.B.); National Institute on Aging R01 AG031743 (to D.L.); and The Bob and Jean Smith Foundation (to M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants R01 AR055685 (to M.K.), R03 DC12354 (to B.P.), RO1 AR049899 (to J.E.), R01 DK102496 (to A.B.) and R01 AG031743 (to D.L.). The metabolic experiments were conducted at the IBP Phenotyping Core, University of Minnesota. We thank Jarod A. Call for help with activity cages. We thank the Bob and Jean Smith Foundation for their generous support.	Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bradford EM, 2010, AM J PHYSIOL-REG I, V298, pR1531, DOI 10.1152/ajpregu.00849.2009; BROUWER OF, 1991, NEUROLOGY, V41, P1878, DOI 10.1212/WNL.41.12.1878; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Dandapat A, 2014, CELL REP, V8, P1484, DOI 10.1016/j.celrep.2014.07.056; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; FITZSIMONS RB, 1987, BRAIN, V110, P631, DOI 10.1093/brain/110.3.631; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Greising SM, 2011, J APPL PHYSIOL, V110, P109, DOI 10.1152/japplphysiol.00852.2010; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; HUDSON JW, 1979, PHYSIOL ZOOL, V52, P205, DOI 10.1086/physzool.52.2.30152564; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krom YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003415; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lutz KL, 2013, NEUROLOGY, V81, P1374, DOI 10.1212/WNL.0b013e3182a84140; Lyon M. F., 1961, GENE ACTION X CHROMO; PADBERG GW, 1995, MUSCLE NERVE, pS73; Perrin BJ, 2013, J NEUROSCI, V33, P8114, DOI 10.1523/JNEUROSCI.0238-13.2013; Rickard AM, 2015, HUM MOL GENET, V24, P5901, DOI 10.1093/hmg/ddv315; Schutz Y, 1997, Z ERNAHRUNGSWISS, V36, P255, DOI 10.1007/BF01617794; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Trevisan CP, 2008, EUR J NEUROL, V15, P1353, DOI 10.1111/j.1468-1331.2008.02314.x; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; WEBB GP, 1982, COMP BIOCHEM PHYS A, V72, P211, DOI 10.1016/0300-9629(82)90035-4; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhang Y, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0080-z	37	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151467	10.1371/journal.pone.0151467	http://dx.doi.org/10.1371/journal.pone.0151467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978271	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800076
J	Gerard, A; Jourdan, H; Millon, A; Vidal, E				Gerard, Agathe; Jourdan, Herve; Millon, Alexandre; Vidal, Eric			Knocking on Heaven's Door: Are Novel Invaders Necessarily Facing Naive Native Species on Islands?	PLOS ONE			English	Article							ECO-EVOLUTIONARY EXPERIENCE; SMALL INDIAN MONGOOSE; TOADS BUFO-MARINUS; NEW-CALEDONIA; CHEMICAL-DISCRIMINATION; HERPESTES-JAVANICUS; SMALL MAMMALS; PREDATOR; PHYLOGENY; CARNIVORA	The impact of alien predator species on insular native biota has often been attributed to island prey naivete (i.e. lack of, or inefficient, anti-predator behavior). Only rarely, however, has the concept of island prey naivete been tested, and then only a posteriori (i.e. hundreds or thousands of years after alien species introduction). The presence of native or anciently introduced predators or competitors may be crucial for the recognition and development of adaptive behavior toward unknown predators or competitors of the same archetype (i.e. a set of species that occupy a similar ecological niche and show similar morphological and behavioral traits when interacting with other species). Here, we tested whether two squamates endemic to New Caledonia, a skink, Caledoniscincus austrocaledonicus, and a gecko, Bavayia septuiclavis, recognized and responded to the odor of two major invaders introduced into the Pacific islands, but not yet into New Caledonia. We chose one predator, the small Indian mongoose Herpestes javanicus and one competitor, the cane toad Rhinella marina, which belong respectively to the same archetype as the following two species already introduced into New Caledonia in the nineteenth century: the feral cat Felis catus and the golden bell frog Litoria aurea. Our experiment reveals that geckos are naive with respect to the odors of both an unknown predator and an unknown competitor, as well as to the odors of a predator and a competitor they have lived with for centuries. In contrast, skinks seem to have lost some naivete regarding the odor of a predator they have lived with for centuries and seem "predisposed" to avoid the odor of an unknown potential competitor. These results indicate that insular species living in contact with invasive alien species for centuries may be, although not systematically, predisposed toward developing adaptive behavior with respect to species belonging to the same archetype and introduced into their native range.	[Gerard, Agathe; Jourdan, Herve; Vidal, Eric] Aix Marseille Univ, UMR CNRS IRD UAPV, UMR IRD 237,Ctr IRD Noumea, Inst Mediterraneen Biodiversite & Ecol Marine & C, BP A5, Noumea 98848, New Caledonia; [Millon, Alexandre] Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, UMR CNRS IRD UAPV, Europole Arbois, BP 80, F-13545 Aix En Provence, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Gerard, A (corresponding author), Aix Marseille Univ, UMR CNRS IRD UAPV, UMR IRD 237,Ctr IRD Noumea, Inst Mediterraneen Biodiversite & Ecol Marine & C, BP A5, Noumea 98848, New Caledonia.	agathe.gerard@ird.fr	Millon, Alexandre/AAF-8624-2020; Jourdan, Herve/D-1452-2011; Millon, Alexandre/R-6464-2017	Millon, Alexandre/0000-0002-9475-4123; Jourdan, Herve/0000-0002-3756-4008; Millon, Alexandre/0000-0002-9475-4123	Centre National de la Recherche Scientifique (CNRS); Institut Ecologie et Environnement (INEE); Province Sud in New Caledonia; Ph.D. scholarship [EDSE251]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Ecologie et Environnement (INEE); Province Sud in New Caledonia; Ph.D. scholarship	This study was funded by the Centre National de la Recherche Scientifique (CNRS), Institut Ecologie et Environnement (INEE) [Projets Exploratoires Pluridisciplinaires (PEPS Programme)] and by Province Sud in New Caledonia. A. G. was funded by a Ph.D. scholarship (EDSE251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks PB, 1998, J MAMMAL, V79, P1260, DOI 10.2307/1383017; Banks Peter B., 2003, Australian Zoologist, V32, P406; Barriere P, 2010, RAPPORT AUTOPSIE 2 M; Barrio IC, 2010, BEHAV ECOL, V21, P986, DOI 10.1093/beheco/arq103; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BAUER A M, 1990, Proceedings of the California Academy of Sciences, V47, P17; Bauer Aaron M., 2006, Proceedings of the California Academy of Sciences, V57, P503; Bauer AM, 2012, ZOOTAXA, P1; Beauvais ML, 2006, ESPECES ENVAHISSANTE, P163; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P1376, DOI 10.1111/geb.12228; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Blumstein DT, 2002, J BIOGEOGR, V29, P685, DOI 10.1046/j.1365-2699.2002.00717.x; Carthey AJR, 2014, BIOL REV, V89, P932, DOI 10.1111/brv.12087; Catling PC, 1999, WILDLIFE RES, V26, P161, DOI 10.1071/WR98025; Cirovic D, 2011, BIOL INVASIONS, V13, P393, DOI 10.1007/s10530-010-9831-7; Comite francais de l'UICN O, 2011, VERT TERR INTR OUTR; COOPER WE, 1995, ANIM BEHAV, V50, P973, DOI 10.1016/0003-3472(95)80098-0; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Diamond J., 1986, COMMUNITY ECOL, P65; DICKMAN CR, 1984, J ZOOL, V204, P521, DOI 10.1111/j.1469-7998.1984.tb02384.x; Downes S, 1998, ANIM BEHAV, V55, P1387, DOI 10.1006/anbe.1997.0705; Downes S, 1998, ANIM BEHAV, V55, P1373, DOI 10.1006/anbe.1997.0704; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Feit B, 2015, BIODIVERS CONSERV, V24, P1017, DOI 10.1007/s10531-014-0850-z; Ferrari MCO, 2007, P ROY SOC B-BIOL SCI, V274, P1853, DOI 10.1098/rspb.2007.0297; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Gerard A, 2014, NATURWISSENSCHAFTEN, V101, P921, DOI 10.1007/s00114-014-1233-8; GOSLING LM, 1990, BEHAV ECOL SOCIOBIOL, V26, P415; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Hayes RA, 2006, ANIM BEHAV, V71, P1307, DOI 10.1016/j.anbehav.2005.08.017; Hays WST, 2007, PAC SCI, V61, P3, DOI 10.1353/psc.2007.0006; Heavener SJ, 2014, OECOLOGIA, V175, P73, DOI 10.1007/s00442-013-2874-6; Hughes RG, 2005, ASIA PAC J CLIN NUTR, V14, P298; Krishnakumar K, 2009, CURR SCI INDIA, V97, P474; Leal M, 2012, BIOL LETTERS, V8, P28, DOI 10.1098/rsbl.2011.0480; Lenaerts C, 2013, CLIN CHIM ACTA, V421, P193, DOI 10.1016/j.cca.2013.02.028; Lloyd R, 2009, AUSTRAL ECOL, V34, P50, DOI 10.1111/j.1442-9993.2008.01881.x; Mella VSA, 2010, AUST J ZOOL, V58, P16, DOI 10.1071/ZO09083; Mitchell MD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13918; Morley CG, 2004, ORYX, V38, P457, DOI 10.1017/S0030605304000857; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicolas V, 2015, AMPHIBIA-REPTILIA, V36, P65, DOI 10.1163/15685381-00002978; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; Paolucci EM, 2013, DIVERS DISTRIB, V19, P988, DOI 10.1111/ddi.12073; Pascal M, 2006, ESPECES ENVAHISSANTE, P116, DOI DOI 10.4000/BOOKS.IRDEDITIONS.7664; Perrings C, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P1; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Pyke Graham H., 2001, Australian Zoologist, V31, P563; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Reed Robert N., 2007, Pacific Conservation Biology, V13, P219; Russell BG, 2007, AUSTRAL ECOL, V32, P277, DOI 10.1111/j.1442-9993.2007.01685.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Saul WC, 2015, ECOL LETT, V18, P236, DOI 10.1111/ele.12408; Saul Wolf-Christian, 2013, NeoBiota, V17, P57; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Simberloff Daniel, 1995, Pacific Science, V49, P87; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Smith SA, 2007, MOL PHYLOGENET EVOL, V43, P1151, DOI 10.1016/j.ympev.2007.02.007; Solis F, 2009, RHINELLA MARINA IUCN; Stapley J, 2003, ETHOLOGY, V109, P785, DOI 10.1046/j.1439-0310.2003.00920.x; Sutherst RW, 1995, INVASIVE SPECIES CHA, P211; TAYLOR R, 2005, REV IMPACT CONTROL C; Team RDC, 2012, R LANG ENV STAT COMP; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wozencraft C, 2008, HERPESTES JAVANICUS; Zug GR, 1991, LIZARDS FIJI NATURAL	67	5	5	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151545	10.1371/journal.pone.0151545	http://dx.doi.org/10.1371/journal.pone.0151545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978784	Green Published, gold			2022-12-27	WOS:000372572800087
J	Honda, H; Kobayashi, Y; Onuma, S; Shibagaki, K; Yuza, T; Hirao, K; Yamamoto, T; Tomosugi, N; Shibata, T				Honda, Hirokazu; Kobayashi, Yasuna; Onuma, Shoko; Shibagaki, Keigo; Yuza, Toshitaka; Hirao, Keiichi; Yamamoto, Toshinori; Tomosugi, Naohisa; Shibata, Takanori			Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis	PLOS ONE			English	Article							HEPCIDIN	Background We aimed to identify associations between erythroferrone (ERFE), a regulator of hepcidin 25, and biomarkers of erythropoiesis and iron metabolism. We also aimed to determine the effects of erythropoiesis-stimulating agents (ESA), continuous erythropoietin receptor activator (CERA) and darbepoetin-a (DA) on ERFE production in patients on hemodialysis (HD). Methods Blood samples were obtained from 59 patients before HD sessions on day 0 (baseline). Twenty patients who were injected with either CERA (N = 10) or DA (N = 10) at the end of the dialysis week (day 0), who had ferritin >= 100 ng/mL and/or transferrin saturation >= 20%, and hemoglobin > 9 g/dL were selected from among the 59 patients. Blood was sampled serially before HD sessions on days 3, 5, 7 from patients on DA and on the same days plus day 14 from those on CERA. Results Levels of ERFE correlated inversely with those of hepcidin 25 and ferritin, and positively with those of soluble transferrin receptor. The hepcidin 25: ERFE ratio and hepcidin 25 levels positively correlated with ferritin levels. Levels of ERFE significantly increased from day 3 of treatment with DA and CERA and decreased by days 7 and 14, respectively. Erythropoiesis-stimulating agents concomitantly decreased levels of hepcidin 25 as those of ERFE increased. Conclusion We identified a novel association between ESA and ERFE in patients on HD. Both DA and CERA increased levels of ERFE that regulated hepcidin 25 and led to iron mobilization from body stores during erythropoiesis.	[Honda, Hirokazu] Showa Univ, Koto Toyusu Hosp, Dept Med, Div Nephrol, Tokyo, Japan; [Kobayashi, Yasuna; Yamamoto, Toshinori] Showa Univ, Sch Pharm, Dept Pharmacotherapeut, Div Clin Pharm, Tokyo, Japan; [Onuma, Shoko; Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Shibagaki, Keigo; Yuza, Toshitaka] Shibagaki Dialysis Clin Jiyugaoka, Tokyo, Japan; [Hirao, Keiichi] Shibagaki Dialysis Clin Togoshi, Tokyo, Japan; [Tomosugi, Naohisa] Kanazawa Med Univ, Aging Res Unit, Dept Adv Med, Med Res Inst, Kanazawa, Ishikawa, Japan	Showa University; Showa University; Showa University; Kanazawa Medical University	Honda, H (corresponding author), Showa Univ, Koto Toyusu Hosp, Dept Med, Div Nephrol, Tokyo, Japan.	hondah@med.showa-u.ac.jp			Kidney Foundation, Japan [JKFB 13-18, JKFB 15-11]; Private University High Technology Research Center Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Kidney Foundation, Japan(Kidney Foundation, Japan); Private University High Technology Research Center Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Kidney Foundation, Japan provided funding to HH (Grant No. JKFB 13-18). This study was supported in part by Grants-in-Aid from the Private University High Technology Research Center Project's matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) The Kidney Foundation, Japan provided funding to HH (Grant No. JKFB 13-18, JKFB from the Private University High Technology Research Center Project's matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Kidney Foundation, Japan provided funding to H.H. (Grant No. JKFB 13-18, JKFB 15-11). This study was supported in part by Grants-in-Aid from a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) for the Private University High Technology Research Center Project.	Ciniselli CM, 2015, EXPERT REV PROTEOMIC, V12, DOI 10.1586/14789450.2015.1099436; Kakimoto-Shino M, 2014, THER APHER DIAL, V18, P421, DOI 10.1111/1744-9987.12161; Kautz L, 2014, BLOOD, V124, P479, DOI 10.1182/blood-2014-05-516252; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kuragano T, 2010, AM J NEPHROL, V31, P534, DOI 10.1159/000312381; Lankhorst CE, 2010, BLOOD REV, V24, P39, DOI 10.1016/j.blre.2009.09.001; Morikami Y, 2014, THER APHER DIAL, V18, P414, DOI 10.1111/1744-9987.12164; Onuma S, 2015, THER APHER DIAL, V19, P582, DOI 10.1111/1744-9987.12322; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shoji S, 2013, EUR J HAEMATOL, V90, P237, DOI 10.1111/ejh.12067; Tessitore N, 2010, NEPHROL DIAL TRANSPL, V25, P3996, DOI 10.1093/ndt/gfq321; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; van der Weerd NC, 2013, NEPHROL DIAL TRANSPL, V28, P3062, DOI 10.1093/ndt/gfs488; van der Weerd NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039783; Zumbrennen-Bullough K, 2014, NEPHROL DIAL TRANSPL, V29, P263, DOI 10.1093/ndt/gft443	16	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151601	10.1371/journal.pone.0151601	http://dx.doi.org/10.1371/journal.pone.0151601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978524	Green Submitted, gold, Green Published			2022-12-27	WOS:000372572800093
J	Palucci, I; Camassa, S; Cascioferro, A; Sali, M; Anoosheh, S; Zumbo, A; Minerva, M; Iantomasi, R; De Maio, F; Di Sante, G; Ria, F; Sanguinetti, M; Palu, G; Brennan, MJ; Manganelli, R; Delogu, G				Palucci, Ivana; Camassa, Serena; Cascioferro, Alessandro; Sali, Michela; Anoosheh, Saber; Zumbo, Antonella; Minerva, Mariachiara; Iantomasi, Raffaella; De Maio, Flavio; Di Sante, Gabriele; Ria, Francesco; Sanguinetti, Maurizio; Palu, Giorgio; Brennan, Michael J.; Manganelli, Riccardo; Delogu, Giovanni			PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2	PLOS ONE			English	Article							PE-PGRS PROTEINS; PORPHYROMONAS-GINGIVALIS; LIPOARABINOMANNAN; EXPRESSION; VIRULENCE; NECROSIS; BINDING; GENE; CD14; INTERNALIZATION	PE_PGRS represent a large family of proteins typical of pathogenic mycobacteria whose members are characterized by an N-terminal PE domain followed by a large Gly-Ala repeatrich C-terminal domain. Despite the abundance of PE_PGRS-coding genes in the Mycobacterium tuberculosis (Mtb) genome their role and function in the biology and pathogenesis still remains elusive. In this study, we generated and characterized an Mtb H37Rv mutant (Mtb Delta 33) in which the structural gene of PE_PGRS33, a prototypical member of the protein family, was inactivated. We showed that this mutant entered macrophages with an efficiency up to ten times lower than parental or complemented strains, while its efficiency in infecting pneumocytes remained unaffected. Interestingly, the lack of PE_PGRS33 did not affect the intracellular growth of this mutant in macrophages. Using a series of functional deletion mutants of the PE_PGRS33 gene to complement the Mtb Delta 33 strain, we demonstrated that the PGRS domain is required to mediate cell entry into macrophages, with the key domain encompassing position 140-260 amino acids of PE_PGRS33. PE_PGRS33-mediated entry into macrophages was abolished in TLR2-deficient mice, as well as following treatment with wortmannin or an antibody against the complement receptor 3 (CR3), indicating that PE_PGRS33-mediated entry of Mtb in macrophages occurs through interaction with TLR2.	[Palucci, Ivana; Camassa, Serena; Sali, Michela; Zumbo, Antonella; Minerva, Mariachiara; Iantomasi, Raffaella; De Maio, Flavio; Sanguinetti, Maurizio; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, L Go A Gemelli 8, I-00168 Rome, Italy; [Di Sante, Gabriele; Ria, Francesco] Univ Cattolica Sacro Cuore, Inst Gen Pathol, L Go A Gemelli 8, I-00168 Rome, Italy; [Cascioferro, Alessandro; Anoosheh, Saber; Palu, Giorgio; Manganelli, Riccardo] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy; [Brennan, Michael J.] Aeras, Rockville, MD USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua	Delogu, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Microbiol, L Go A Gemelli 8, I-00168 Rome, Italy.	giovanni.delogu@unicatt.it	Di Sante, Gabriele/K-8629-2016; De Maio, Flavio/J-9452-2018; Manganelli, Riccardo/A-7361-2009; De Maio, Flavio/AAL-7355-2021; De Maio, Flavio/AAD-1076-2022; Cascioferro, Alessandro/E-3445-2017; Di Sante, Gabriele/N-5294-2018; Di Sante, Gabriele/N-5280-2018; Ria, Francesco/AAD-1174-2022; anoosheh, saber/D-1891-2011; Sanguinetti, Maurizio/A-1453-2019; Anoosheh, Saber/AAK-3400-2021; Di Sante, Gabriele/AHD-9850-2022; palucci, ivana/J-8542-2018	Di Sante, Gabriele/0000-0001-6608-3388; De Maio, Flavio/0000-0002-4744-9820; Manganelli, Riccardo/0000-0003-0940-7336; De Maio, Flavio/0000-0002-4744-9820; Cascioferro, Alessandro/0000-0001-7751-7348; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Ria, Francesco/0000-0001-7455-4290; anoosheh, saber/0000-0003-4614-0757; Sanguinetti, Maurizio/0000-0002-9780-7059; Di Sante, Gabriele/0000-0001-6608-3388; Minerva, Mariachiara/0000-0003-1518-7050; palucci, ivana/0000-0003-2106-1761	EU [201762]; MIUR PRIN [2008 Y8RZTF]	EU(European Commission); MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	Funded by EU (FP7/2007-2013) under grant agreement no201762 awarded to GD and RM and by MIUR PRIN (project number 2008 Y8RZTF) awarded to GD and RM.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Borrello S, 2011, INT J IMMUNOPATH PH, V24, P549, DOI 10.1177/039463201102400301; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dai SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003114; De Maio F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112482; Delogu G, 2014, CLIN MICROBIOL INFEC, V20, P59, DOI 10.1111/1469-0691.12460; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2008, HDB TUBERCULOSIS, P131; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dheenadhayalan V, 2006, J BACTERIOL, V188, P3721, DOI 10.1128/JB.188.10.3721-3725.2006; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Fenton MJ, 2008, BS TUBERCLE BACILLUS, P405; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Greco E, 2010, IMMUNOLOGY, V129, P125, DOI 10.1111/j.1365-2567.2009.03145.x; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Hajishengallis G, 2006, INFECT IMMUN, V74, P5658, DOI 10.1128/IAI.00784-06; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Harokopakis E, 2005, EUR J IMMUNOL, V35, P1201, DOI 10.1002/eji.200425883; Harokopakis E, 2006, J IMMUNOL, V176, P7645, DOI 10.4049/jimmunol.176.12.7645; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Klink M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073333; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; Means TK, 1999, J IMMUNOL, V163, P6748; Oliva C, 2009, P NATL ACAD SCI USA, V106, P13957, DOI 10.1073/pnas.0902392106; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Sendide K, 2005, J IMMUNOL, V174, P4210, DOI 10.4049/jimmunol.174.7.4210; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Talarico S, 2005, J CLIN MICROBIOL, V43, P4954, DOI 10.1128/JCM.43.10.4954-4960.2005; Talarico S, 2008, TUBERCULOSIS, V88, P283, DOI 10.1016/j.tube.2008.01.001; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Wang J, 2011, TUBERCULOSIS, V91, P287, DOI 10.1016/j.tube.2011.05.001; *WHO, 2004, GLOB TUB CONTR SURV; ZHANG YH, 1993, J CLIN INVEST, V91, P2076, DOI 10.1172/JCI116430; Zumbo A, 2013, PATHOG DIS, V69, P232, DOI 10.1111/2049-632X.12096	56	44	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150800	10.1371/journal.pone.0150800	http://dx.doi.org/10.1371/journal.pone.0150800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978522	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800037
J	Alves, AV; Sanjinez-Argandona, EJ; Linzmeier, AM; Cardoso, CAL; Macedo, MLR				Alves, Ariana Vieira; Sanjinez-Argandona, Eliana Janet; Linzmeier, Adelita Maria; Lima Cardoso, Claudia Andrea; Rodrigues Macedo, Maria Ligia			Food Value of Mealworm Grown on Acrocomia aculeata Pulp Flour	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ANTIOXIDANT CAPACITY; TENEBRIO-MOLITOR; FATTY-ACIDS; SUPPLEMENTATION; INSECTS; FEED; OIL	Insects have played an important role as human food throughout history, especially in Africa, Asia and Latin America. A good example of edible insects is the mealworm, Tenebrio molitor Linnaeus, 1758 (Coleoptera, Tenebrionidae), which are eaten in Africa, Asia, the Americas and Australia. This species is easily bred in captivity, requiring simple management. The bocaiuva (Acrocomia aculeata (Jacq.) Lodd) is an abundant palm tree found in the Brazilian Cerrado, providing fruits with high nutritional value. The aim of this work was to determine the chemical composition of T. molitor grown in different artificial diets with bocaiuva pulp flour. The nutritional composition, fatty acid composition, antioxidant activity, trypsin activity and anti-nutritional factors of larvae were analyzed. The results showed that mealworms grown on artificial diet with bocaiuva are a good source of protein (44.83%) and lipid (40.45%), with significant levels of unsaturated fatty acids (65.99%), antioxidant activity (4.5 mu M Trolox/g of oil extracted from larvae) and absence of anti-nutritional factors. This study indicates a new source of biomass for growing mealworms and shows that it is possible to breed mealworms in artificial diet with bocaiuva flour without compromising the nutritional quality of the larvae.	[Alves, Ariana Vieira; Sanjinez-Argandona, Eliana Janet] Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dourados, MS, Brazil; [Linzmeier, Adelita Maria] Fed Univ Fronteira Sul, Realeza, Parana, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Course Chem, Dourados, MS, Brazil; [Rodrigues Macedo, Maria Ligia] Univ Fed Mato Grosso do Sul, Dept Nat Sci, Lab Prot Purificat & Biol Funct, Campo Grande, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Fronteira Sul; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Alves, AV (corresponding author), Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dourados, MS, Brazil.	arianavieiralves@gmail.com	Cardoso, Claudia Andrea Lima/AAK-5578-2020; Linzmeier, Adelita/A-9239-2013; Argandoña, Eliana Janet EJSA Sanjinez/J-6524-2012	Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Argandoña, Eliana Janet EJSA Sanjinez/0000-0001-9377-8839; Macedo, Maria Ligia/0000-0001-6969-6307; Linzmeier, Adelita Maria/0000-0002-2979-8728	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Masters scholarship (Benefitted: AVA): Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) [http://fundect.ledes.net/]. Additional financial support was provided for equipments (Benefitted: EJSA): Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [http://www.capes.gov.br/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Miranda ED, 2002, J AGR FOOD CHEM, V50, P192, DOI 10.1021/jf010691y; [Anonymous], 2010, FAO Food Nutr Pap, V91, P1; [Anonymous], 2010, ESTUDO POTENCIAL ANT; [Anonymous], 2011, TAB BRAS COMP AL; [Anonymous], 2003, OFFICIAL METHODS ANA, P17; AOAC Association of Official Analytical Chemists, 2005, OFFICIAL METHODS ANA, P18; Araujo J.M.A., 2011, QUIMICA ALIMENTOS TE, V5; Atwater WO, 1896, FARMERS B, P28; Bednarova M, 2013, ACTA U AGR SILVICULT, V16; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bovera F, 2015, BRIT POULTRY SCI, V56, P569, DOI 10.1080/00071668.2015.1080815; Costa Neto Eraldo M., 2006, Boletin de la SEA, V38, P423; Costa-Neto EM, 2002, THESIS SOC ENTOMOLOG; Decker E.A., 2000, ANTIOXIDANTS MUSCLE; DeFoliart GR, 2012, HUMAN USE INSECTS FO; Dessimoni-Pinto N. A. V., 2010, Alimentos e Nutricao, V21, P79; Durst P. B., 2010, Forest insects as food: humans bite back. Proceedings of a workshop on Asia-Pacific resources and their potential for development, Chiang Mai, Thailand, 19-21 February, 2008, P1; Dutra-De-Oliveira JED, 2008, CIENCIAS NUTR APREND; FAO, 2010, FOR INS FOOD HUM BIT; FAO, 2009, ETUDES TRAVAUX LASDE; GraphPad, 1999, GRAPHPAD PRISM VERS; 유정미, 2013, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V42, P249; Ingram J, 2011, FOOD SECUR, V3, P417, DOI 10.1007/s12571-011-0149-9; Johnson V. D., 2010, FOREST INSECTS FOOD, P5; Jongema Y, 2012, LIST EDIBLE INSECTS; Karasov WH., 1997, HDB COMP PHYSL, P409, DOI 10.1002/cphy.cp130107; Kralik G, 2010, ACTA VET BRNO, V79, P363, DOI 10.2754/avb201079030363; Lescano CH, 2014, J MED FOOD, V00, P1; Ramos MIL, 2008, CIENCIA TECNOL ALIME, V28, P90, DOI 10.1590/S0101-20612008000500015; Longvah T, 2011, FOOD CHEM, V128, P400, DOI 10.1016/j.foodchem.2011.03.041; Marineli RD, 2012, FOOD RES INT, V49, P487, DOI 10.1016/j.foodres.2012.07.022; Marono S., 2015, Italian Journal of Animal Science, V14, P338; Mitsuhashi J., 2010, Forest insects as food: humans bite back. Proceedings of a workshop on Asia-Pacific resources and their potential for development, Chiang Mai, Thailand, 19-21 February, 2008, P115; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Premalatha M, 2011, RENEW SUST ENERG REV, V15, P4357, DOI 10.1016/j.rser.2011.07.115; de Oliveira CFR, 2011, PROCESS BIOCHEM, V46, P498, DOI 10.1016/j.procbio.2010.09.025; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Rumpold BA, 2013, INNOV FOOD SCI EMERG, V17, P1, DOI 10.1016/j.ifset.2012.11.005; Ruppert EE., 2005, ZOOLOGIA INVERTEBRAD; Sanjinez-Argandona EJ, 2011, REV BRAS FRUTIC, V33, P1023, DOI 10.1590/S0100-29452011000300040; Schiefenhovel W., 2009, Consuming the inedible: neglected dimensions of food choice, P163; Shockley M, 2013, MASS PRODUCTION BENE, P764; Siemianowska E., 2013, Agricultural Sciences, V4, P287; StatSoft, 2008, STAT DAT AN SOFTW SY; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Willhelm F. F., 2014, Nutrire - Revista da Sociedade Brasileira de Alimentacao e Nutricao, V39, P179, DOI 10.4322/nutrire.2014.016; Worldwatch Institute, 2010, EST MUND 2010 TRANSF; Yehuda S, 2002, NEUROBIOL AGING, V23, P843, DOI 10.1016/S0197-4580(02)00074-X; Zuo RT, 2013, BRIT J NUTR, V110, P1220, DOI 10.1017/S0007114513000378	51	35	36	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151275	10.1371/journal.pone.0151275	http://dx.doi.org/10.1371/journal.pone.0151275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974840	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600061
J	Rose, JB; Correa-Gallego, C; Li, Y; Nelson, J; Alseidi, A; Helton, WS; Allen, PJ; D'Angelica, MI; DeMatteo, RP; Fong, YM; Kingham, TP; Kowdley, KV; Jarnagin, WR; Rocha, FG				Rose, J. Bart; Correa-Gallego, Camilo; Li, Yu; Nelson, James; Alseidi, Adnan; Helton, W. Scott; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Fong, Yuman; Kingham, T. Peter; Kowdley, Kris V.; Jarnagin, William R.; Rocha, Flavio G.			The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; PANCREATIC ADENOCARCINOMA CELLS; IN-SITU HYBRIDIZATION; GROWTH-FACTOR-I; PROTEOMIC ANALYSIS; COLORECTAL-CANCER; FAMILY-MEMBERS; GENE FAMILY; CEA FAMILY; BILE	Objective The aim of the present study is to determine if CEACAM6 can be detected in the bile of patients with biliary cancer and can serve as a diagnostic biomarker for cholangiocarcinoma. Summary Background Data Distinguishing bile duct carcinoma from other diagnoses is often difficult using endoscopic or percutaneous techniques. The cell surface protein CEACAM6 is over-expressed in many gastrointestinal cancers and may be selectively elevated in biliary adenocarcinoma. Methods Bile from patients with benign biliary disease and cholangiocarcinoma (hilar, intrahepatic and distal) was collected at the time of index operation. The concentration of CEACAM6 was quantified by sandwich enzyme-linked immunosorbent assay (ELISA) and correlated to pathologic diagnosis. Diagnostic capability of CEACAM6 was evaluated by Wilcoxon rank-sum, linear regression, multiple regression, and receiver operating characteristic (ROC) curve analysis. Results Bile from 83 patients was analyzed: 42 with benign disease and 41 with cholangiocarcinoma. Patients in the benign cohort were younger, predominantly female, and had lower median biliary CEACAM6 levels than patients in the malignant cohort (7.5 ng/ml vs. 40 ng/ml; p = < .001). ROC curve analysis determined CEACAM6 to be a positive predictor cholangiocarcinoma with a CEACAM6 level >14 ng/ml associated with 87.5% sensitivity, 69.1% specificity, and a likelihood ratio of 2.8 (AUC 0.74). Multiple regression analysis suggested elevated alkaline phosphatase and the presence of biliary endoprostheses may influence CEACAM6 levels. Conclusion Biliary CEACAM6 can identify patients with extrahepatic cholangiocarcinoma with a high degree of sensitivity and should be investigated further as a potential screening tool.	[Rose, J. Bart; Alseidi, Adnan; Helton, W. Scott; Kowdley, Kris V.; Rocha, Flavio G.] Virginia Mason Med Ctr, Dept Surg, Sect Gen Thorac & Vasc Surg, Seattle, WA 98101 USA; [Rose, J. Bart; Li, Yu; Nelson, James; Kowdley, Kris V.] Benaroya Res Inst, Seattle, WA USA; [Correa-Gallego, Camilo; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Kingham, T. Peter; Jarnagin, William R.] Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatopancreatobiliary Serv, 1275 York Ave, New York, NY 10021 USA; [Fong, Yuman] City Hope Canc Ctr, Dept Surg, Duarte, CA USA	Virginia Mason Medical Center; Benaroya Research Institute; Memorial Sloan Kettering Cancer Center; City of Hope	Rocha, FG (corresponding author), Virginia Mason Med Ctr, Dept Surg, Sect Gen Thorac & Vasc Surg, Seattle, WA 98101 USA.	flavio.rocha@virginiamason.org	Kowdley, Kris/AAF-5202-2019; Rocha, Flavio/AAV-3411-2020	Correa, Juan Camilo/0000-0002-9776-0246; Rose, J. Bart/0000-0002-0471-3978; alseidi, adnan/0000-0002-0365-1955	Conquer Cancer Foundation; Cholangiocarcinoma Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Conquer Cancer Foundation; Cholangiocarcinoma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by Conquer Cancer Foundation, www.conquercancerfoundation.org, and Cholangiocarcinoma Foundation, www.cholangiocarcinoma.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Ghulam, 2009, J Gastrointest Cancer, V40, P19, DOI 10.1007/s12029-009-9085-8; Alvaro D, 2007, ANN INTERN MED, V147, P451, DOI 10.7326/0003-4819-147-7-200710020-00003; Alvaro D, 2009, CURR OPIN GASTROEN, V25, P279, DOI 10.1097/MOG.0b013e328325a894; Ayaru L, 2008, BRIT J CANCER, V98, P1548, DOI 10.1038/sj.bjc.6604342; Bangarulingam SY, 2010, HEPATOLOGY, V51, P174, DOI 10.1002/hep.23277; Burak K, 2004, AM J GASTROENTEROL, V99, P523, DOI 10.1111/j.1572-0241.2004.04067.x; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Duxbury MS, 2005, ANN SURG, V241, P491, DOI 10.1097/01.sla.0000154455.86404.e9; Duxbury MS, 2004, ONCOGENE, V23, P5834, DOI 10.1038/sj.onc.1207775; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, CLIN CANCER RES, V10, P2307, DOI 10.1158/1078-0432.CCR-1183-3; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Farina A, 2014, BBA-PROTEINS PROTEOM, V1844, P1018, DOI 10.1016/j.bbapap.2013.06.010; Farina A, 2009, J PROTEOME RES, V8, P159, DOI 10.1021/pr8004925; Gatto M, 2010, DIGEST LIVER DIS, V42, P253, DOI 10.1016/j.dld.2009.12.008; Gonda TA, 2012, GASTROINTEST ENDOSC, V75, P74, DOI 10.1016/j.gie.2011.08.022; Hemming AW, 2005, ANN SURG, V241, P693, DOI 10.1097/01.sla.0000160701.38945.82; Ieta K, 2006, BRIT J CANCER, V95, P532, DOI 10.1038/sj.bjc.6603276; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Kipp BR, 2004, AM J GASTROENTEROL, V99, P1675, DOI 10.1111/j.1572-0241.2004.30281.x; Kondo S, 2008, J HEPATO-BILIARY-PAN, V15, P41, DOI 10.1007/s00534-007-1279-5; Koopmann J, 2004, CANCER-AM CANCER SOC, V101, P1609, DOI 10.1002/cncr.20469; KUROKI M, 1992, J LEUKOCYTE BIOL, V52, P551, DOI 10.1002/jlb.52.5.551; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Narimatsu H, 1998, CANCER RES, V58, P512; Ordonez C, 2000, CANCER RES, V60, P3419; Patel AH, 2000, AM J GASTROENTEROL, V95, P204; Patel T, 2011, NAT REV GASTRO HEPAT, V8, P189, DOI 10.1038/nrgastro.2011.20; Rimola J, 2009, HEPATOLOGY, V50, P791, DOI 10.1002/hep.23071; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; STOCKS SC, 1993, BIOCHEM BIOPH RES CO, V195, P478, DOI 10.1006/bbrc.1993.2068; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; THOMPSON JA, 1995, TUMOR BIOL, V16, P10, DOI 10.1159/000217923; TURLEY SD, 1978, J LIPID RES, V19, P924; Vestergaard EM, 1999, CLIN CHEM, V45, P54	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150195	10.1371/journal.pone.0150195	http://dx.doi.org/10.1371/journal.pone.0150195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974538	Green Submitted, gold, Green Published			2022-12-27	WOS:000372570600019
J	Adebiyi, OA; Adebiyi, OO; Owira, PMO				Adebiyi, Olubunmi A.; Adebiyi, Oluwafeyisetan O.; Owira, Peter M. O.			Naringin Reduces Hyperglycemia-Induced Cardiac Fibrosis by Relieving Oxidative Stress	PLOS ONE			English	Article							ISOPROTERENOL-INDUCED CARDIOTOXICITY; DIABETIC CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; HIGH GLUCOSE; REGULATING ENZYMES; COLLAGEN-SYNTHESIS; NADPH OXIDASE; WISTAR RATS; DYSFUNCTION; ANTIOXIDANTS	Introduction Hyperglycemia promotes myocardial fibrotic lesions through upregulation of PKC and p38 in response to redox changes. The effects of naringin on hyperglycemia-induced myocardial fibrotic changes and its putative effects on PKC-beta and p38 protein expression in type 1 rat model of diabetes are hereby investigated. Methods Male Sprague-Dawley rats were divided into six groups I-VI. Groups I and II, were orally treated with distilled water {3.0 ml/kg body weight (BW)} and naringin (50 mg/kg BW), respectively. Groups III, IV, V and VI were rendered diabetic by a single intraperitoneal injection of streptozotocin (60 mg/kg, BW) and were similarly treated with subcutaneous insulin (8.0 I. U/kg BW, twice daily), naringin (50 mg/kg BW), distilled water (3.0 ml/Kg BW) and ramipril (3.0 mg/kg/BW), respectively. The animals were sacrificed after 56 days by halothane overdose; blood and heart samples removed for further analysis. Results The untreated diabetic rats exhibited significantly increased oxidative stress, NADPH oxidase activity, increased cardiac fibrosis, PKC-beta and p38 mitogen activated protein kinase expression compared to controls. Naringin treatment significantly ameliorated these changes in diabetic rats compared to the untreated diabetic controls. Conclusions Naringin's amelioration of myocardial fibrosis by modulating p38 and PKC-beta protein expression possibly through its known antioxidant actions and may therefore be useful in retarding the progression of fibrosis in a diabetic heart.	[Adebiyi, Olubunmi A.; Adebiyi, Oluwafeyisetan O.; Owira, Peter M. O.] Univ KwaZulu Natal, Sch Hlth Sci, Dept Pharmacol, Mol & Clin Pharmacol Res Lab,Discipline Pharmaceu, POB X5401, Durban, South Africa	University of Kwazulu Natal	Owira, PMO (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Dept Pharmacol, Mol & Clin Pharmacol Res Lab,Discipline Pharmaceu, POB X5401, Durban, South Africa.	owirap@ukzn.ac.za			Grants and Scholarships Administration of the Medical Research Council of South Africa; College of Health Sciences, University of KwaZulu-Natal; office of Grants and Scholarships Administration of the Medical Research Council of South Africa	Grants and Scholarships Administration of the Medical Research Council of South Africa; College of Health Sciences, University of KwaZulu-Natal; office of Grants and Scholarships Administration of the Medical Research Council of South Africa	This study was supported partially by funding from the Grants and Scholarships Administration of the Medical Research Council of South Africa through Career Development award and the College of Health Sciences, University of KwaZulu-Natal. There was no additional external funding received for this work. The funders did not participate in the study, nor did they have any influence on the conduct or reporting of this study.; Special thanks to the technical staff of the biomedical resource unit of the University of KwaZulu-Natal, for their kind technical assistance in carrying out the animal experiments. We are indebted to the office of Grants and Scholarships Administration of the Medical Research Council of South Africa for the Career Development award that partially funded this project.	Adel AM, 2011, NAT SCI, V7, P134; Ahmed OM, 2011, LIFE SCI J, V8, P91; Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Baker KM, 2004, REGUL PEPTIDES, V120, P5, DOI 10.1016/j.regpep.2004.04.004; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959; Chen JF, 2014, BASIC CLIN PHARMACOL, V114, P293, DOI 10.1111/bcpt.12153; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Huang HL, 2013, INT J MOL MED, V32, P396, DOI 10.3892/ijmm.2013.1403; Huynh K, 2014, PHARMACOL THERAPEUT, V142, P375, DOI 10.1016/j.pharmthera.2014.01.003; Huynh K, 2013, FREE RADICAL BIO MED, V60, P307, DOI 10.1016/j.freeradbiomed.2013.02.021; Jagetia G. C., 2002, MUTAT RES, V19, P37; Jellis C, 2010, J AM COLL CARDIOL, V56, P89, DOI 10.1016/j.jacc.2010.02.047; Jeon SM, 2004, CLIN NUTR, V23, P1025, DOI 10.1016/j.clnu.2004.01.006; Jeon SM, 2002, CLIN CHIM ACTA, V317, P181, DOI 10.1016/S0009-8981(01)00778-1; Johar S, 2004, CIRCULATION, V110, P188; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Jung UJ, 2004, J NUTR, V134, P2499, DOI 10.1093/jn/134.10.2499; Kanno S, 2003, J PHARMACOL SCI, V92, P166, DOI 10.1254/jphs.92.166; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Ogata T, 2004, J AM COLL CARDIOL, V43, P1481, DOI 10.1016/j.jacc.2003.11.043; Pari L, 2010, INT J BIOL MED RES, V1, P206; Pitt B, 2012, CIRC-CARDIOVASC IMAG, V5, P9, DOI 10.1161/CIRCIMAGING.111.971143; Punithavathi VR, 2008, J APPL TOXICOL, V28, P806, DOI 10.1002/jat.1343; Qin FZ, 2007, FREE RADICAL BIO MED, V43, P271, DOI 10.1016/j.freeradbiomed.2007.04.021; Rajadurai M, 2007, TOXICOLOGY, V232, P216, DOI 10.1016/j.tox.2007.01.006; Rajadurai M, 2006, TOXICOLOGY, V228, P259, DOI 10.1016/j.tox.2006.09.005; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; Spinale FG, 2002, CIRC RES, V91, P1082, DOI 10.1161/01.RES.0000047874.80576.5A; Tokudome T, 2004, METABOLISM, V53, P710, DOI 10.1016/j.metabol.2004.01.006; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Xulu S, 2012, J CARDIOVASC PHARM, V59, P133, DOI 10.1097/FJC.0b013e31823827a4; Zhao WY, 2008, MOL CELL BIOCHEM, V317, P43, DOI 10.1007/s11010-008-9803-8	38	35	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0149890	10.1371/journal.pone.0149890	http://dx.doi.org/10.1371/journal.pone.0149890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967518	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200006
J	Bromnimann, D; Djukic, T; Triet, R; Dellenbach, C; Saveljic, I; Rieger, M; Rohr, S; Filipovic, N; Djonov, V				Broemnimann, Daniel; Djukic, Tijana; Triet, Ramona; Dellenbach, Christian; Saveljic, Igor; Rieger, Michael; Rohr, Stephan; Filipovic, Nenad; Djonov, Valentin			Pharmacological Modulation of Hemodynamics in Adult Zebrafish In Vivo	PLOS ONE			English	Article							PLAQUE-FORMATION; NITRIC-OXIDE; FLOW; HEART; ELECTROCARDIOGRAM; REGENERATION; MECHANISMS; DISEASE; SYSTEM; MODEL	Introduction Hemodynamic parameters in zebrafish receive increasing attention because of their important role in cardiovascular processes such as atherosclerosis, hematopoiesis, sprouting and intussusceptive angiogenesis. To study underlying mechanisms, the precise modulation of parameters like blood flow velocity or shear stress is centrally important. Questions related to blood flow have been addressed in the past in either embryonic or ex vivo-zebrafish models but little information is available for adult animals. Here we describe a pharmacological approach to modulate cardiac and hemodynamic parameters in adult zebrafish in vivo. Materials and Methods Adult zebrafish were paralyzed and orally perfused with salt water. The drugs isoprenaline and sodium nitroprusside were directly applied with the perfusate, thus closely resembling the preferred method for drug delivery in zebrafish, namely within the water. Drug effects on the heart and on blood flow in the submental vein were studied using electrocardiograms, in vivo-microscopy and mathematical flow simulations. Results Under control conditions, heart rate, blood flow velocity and shear stress varied less than +/- 5%. Maximal chronotropic effects of isoprenaline were achieved at a concentration of 50 mu mol/L, where it increased the heart rate by 22.6 +/- 1.3% (n = 4; p < 0.0001). Blood flow velocity and shear stress in the submental vein were not significantly increased. Sodium nitroprusside at 1 mmol/L did not alter the heart rate but increased blood flow velocity by 110.46 +/- 19.64% (p = 0.01) and shear stress by 117.96 +/- 23.65% (n = 9; p = 0.03). Discussion In this study, we demonstrate that cardiac and hemodynamic parameters in adult zebrafish can be efficiently modulated by isoprenaline and sodium nitroprusside. Together with the suitability of the zebrafish for in vivo-microscopy and genetic modifications, the methodology described permits studying biological processes that are dependent on hemodynamic alterations.	[Broemnimann, Daniel; Triet, Ramona; Djonov, Valentin] Univ Bern, Inst Anat, Baltzerstr 2, CH-3012 Bern, Switzerland; [Djukic, Tijana; Saveljic, Igor; Filipovic, Nenad] BioIRC R&D Bioengn Ctr, Prvoslava Stojanovica 6, Kragujevac 34000, Serbia; [Djukic, Tijana; Saveljic, Igor; Filipovic, Nenad] Univ Kragujevac, Fac Engn, Sestre Janjic 6, Kragujevac 34000, Serbia; [Dellenbach, Christian; Rieger, Michael; Rohr, Stephan] Univ Bern, Inst Physiol, Buhlpl 5, CH-3012 Bern, Switzerland; [Filipovic, Nenad] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA	University of Bern; University of Kragujevac; University of Bern; Harvard University; Harvard T.H. Chan School of Public Health	Djonov, V (corresponding author), Univ Bern, Inst Anat, Baltzerstr 2, CH-3012 Bern, Switzerland.	djonov@ana.unibe.ch; djonov@ana.unibe.ch	Filipovic, Nenad/GSN-0499-2022; Djukic, Tijana/T-1570-2019; Rohr, Stephan/B-9166-2008	Rohr, Stephan/0000-0003-4358-7035; Filipovic, Nenad/0000-0001-9964-5615; Djonov, Valentin/0000-0002-5062-1169; Rieger, Michael/0000-0002-6729-0888; Djukic, Tijana/0000-0002-9913-6527; Bronnimann, Daniel/0000-0003-0476-2590; Saveljic, Igor/0000-0002-0707-5174	Swiss National Foundation; Ministry of Education, Science and Technological Development of the Republic of Serbia [III41007, ON174028]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This project was supported by the Swiss National Foundation (www.snf.ch) and the Ministry of Education, Science and Technological Development (www.mpn.gov.rs) of the Republic of Serbia (projects number III41007 and ON174028).	Arnaout R, 2007, P NATL ACAD SCI USA, V104, P11316, DOI 10.1073/pnas.0702724104; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chaudhari GH, 2013, J PHARMACOL TOX MET, V67, P115, DOI 10.1016/j.vascn.2013.01.007; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; De Luca E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04898; Denvir MA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-21; Dhillon SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060552; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; Djonov VG, 2002, DEV DYNAM, V224, P391, DOI 10.1002/dvdy.10119; Djukic T, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/8/084012; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Filipovic N, 2014, MICROFLUID NANOFLUID, V16, P455, DOI 10.1007/s10404-013-1238-1; Filipovic N, 2006, COMPUT METHOD APPL M, V195, P6347, DOI 10.1016/j.cma.2005.12.009; Filipovic N, 2014, COMPUT METH PROG BIO, V115, P162, DOI 10.1016/j.cmpb.2014.04.013; Filipovic N, 2013, MED BIOL ENG COMPUT, V51, P607, DOI 10.1007/s11517-012-1031-4; Filipovic N, 2012, IEEE T INF TECHNOL B, V16, P272, DOI 10.1109/TITB.2011.2168418; Filipovic N, 2012, IEEE T BIO-MED ENG, V59, P50, DOI 10.1109/TBME.2011.2166264; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; Goran Rakocevic TD, 2013, COMPUTATIONAL MED DA, P376; Hassel D, 2008, CIRCULATION, V117, P866, DOI 10.1161/CIRCULATIONAHA.107.752220; Hirai DM, 2013, MICROVASC RES, V85, P104, DOI 10.1016/j.mvr.2012.11.006; Hoefer IE, 2013, CARDIOVASC RES, V99, P276, DOI 10.1093/cvr/cvt089; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Kang BJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1154; Kojic M., 2008, COMPUTER MODELING BI, DOI [10.1002/9780470751763, DOI 10.1002/9780470751763]; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu TY, 2013, IEEE T ULTRASON FERR, V60, P1827, DOI 10.1109/TUFFC.2013.2769; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Musialek P, 1997, CIRC RES, V81, P60, DOI 10.1161/01.RES.81.1.60; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Orfanidou T, 2013, TOXICOL IN VITRO, V27, P1440, DOI 10.1016/j.tiv.2013.03.004; Parodi O, 2012, IEEE T INF TECHNOL B, V16, P952, DOI 10.1109/TITB.2012.2201732; Pieperhoff S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096771; Pitkanen OP, 1999, J PHYSIOL-LONDON, V521, P729, DOI 10.1111/j.1469-7793.1999.00729.x; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Schmidt VJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117407; Schwerte T, 2006, J EXP BIOL, V209, P1093, DOI 10.1242/jeb.02117; Steele SL, 2011, J EXP BIOL, V214, P1445, DOI 10.1242/jeb.052803; Tsai CT, 2011, CLIN CHIM ACTA, V412, P1963, DOI 10.1016/j.cca.2011.07.002; Vulesevic B, 2006, RESP PHYSIOL NEUROBI, V154, P396, DOI 10.1016/j.resp.2006.01.001; Watkins SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044018; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Xu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6758; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502	46	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150948	10.1371/journal.pone.0150948	http://dx.doi.org/10.1371/journal.pone.0150948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967155	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200022
J	Morales, ME; Derbes, RS; Ade, CM; Ortego, JC; Stark, J; Deininger, PL; Roy-Engel, AM				Morales, Maria E.; Derbes, Rebecca S.; Ade, Catherine M.; Ortego, Jonathan C.; Stark, Jeremy; Deininger, Prescott L.; Roy-Engel, Astrid M.			Heavy Metal Exposure Influences Double Strand Break DNA Repair Outcomes	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; MAMMALIAN-CELLS; GENE-EXPRESSION; PATHWAY CHOICE; ALU ELEMENTS; CADMIUM; INHIBITION; PROTEINS; LEUKEMIA; GENOME	Heavy metals such as cadmium, arsenic and nickel are classified as carcinogens. Although the precise mechanism of carcinogenesis is undefined, heavy metal exposure can contribute to genetic damage by inducing double strand breaks (DSBs) as well as inhibiting critical proteins from different DNA repair pathways. Here we take advantage of two previously published culture assay systems developed to address mechanistic aspects of DNA repair to evaluate the effects of heavy metal exposures on competing DNA repair outcomes. Our results demonstrate that exposure to heavy metals significantly alters how cells repair double strand breaks. The effects observed are both specific to the particular metal and dose dependent. Low doses of NiCl2 favored resolution of DSBs through homologous recombination (HR) and single strand annealing (SSA), which were inhibited by higher NiCl2 doses. In contrast, cells exposed to arsenic trioxide preferentially repaired using the "error prone" non-homologous end joining (alt-NHEJ) while inhibiting repair by HR. In addition, we determined that low doses of nickel and cadmium contributed to an increase in mutagenic recombination-mediated by Alu elements, the most numerous family of repetitive elements in humans. Sequence verification confirmed that the majority of the genetic deletions were the result of Alu-mediated non-allelic recombination events that predominantly arose from repair by SSA. All heavy metals showed a shift in the outcomes of alt-NHEJ repair with a significant increase of non-templated sequence insertions at the DSB repair site. Our data suggest that exposure to heavy metals will alter the choice of DNA repair pathway changing the genetic outcome of DSBs repair.	[Morales, Maria E.; Derbes, Rebecca S.; Ortego, Jonathan C.; Deininger, Prescott L.; Roy-Engel, Astrid M.] Dept Epidemiol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Morales, Maria E.; Derbes, Rebecca S.; Ortego, Jonathan C.; Deininger, Prescott L.; Roy-Engel, Astrid M.] Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Morales, Maria E.; Derbes, Rebecca S.; Ortego, Jonathan C.; Deininger, Prescott L.; Roy-Engel, Astrid M.] Tulane Univ, Hlth Sci Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Ade, Catherine M.] Tulane Univ, Dept Cellular & Mol Biol, 6400 Freret St, New Orleans, LA 70118 USA; [Stark, Jeremy] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA	Tulane University; Tulane University; Tulane University; Tulane University; City of Hope; Beckman Research Institute of City of Hope	Roy-Engel, AM (corresponding author), Dept Epidemiol, 1430 Tulane Ave, New Orleans, LA 70112 USA.; Roy-Engel, AM (corresponding author), Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.; Roy-Engel, AM (corresponding author), Tulane Univ, Hlth Sci Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.	aengel@tulane.edu			National Institutes of Health (NIH) [R01GM079709A, R01GM045668, P20GM103518/P20RR020152, R01CA120954]; Office of Research of Tulane University; NATIONAL CANCER INSTITUTE [R01CA120954] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045668, P20GM103518, R01GM079709] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research of Tulane University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) R01GM079709A (AMR-E), R01GM045668 (PLD), P20GM103518/P20RR020152 (AMR-E and PLD) and R01CA120954 to JMS. Bridge funds from the Office of Research of Tulane University were also awarded to AMR-E. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or Tulane University.	Ade C, 2013, CURR OPIN VIROL, V3, P639, DOI 10.1016/j.coviro.2013.09.002; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Andrew AS, 2003, INT J CANCER, V104, P263, DOI 10.1002/ijc.10968; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Arita A, 2013, CANCER EPIDEM BIOMAR, V22, P261, DOI 10.1158/1055-9965.EPI-12-1011; Asara Y, 2013, INT J MOL SCI, V14, P16600, DOI 10.3390/ijms140816600; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; de Smith AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003104; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Ding J, 2009, CANCER EPIDEM BIOMAR, V18, P1720, DOI 10.1158/1055-9965.EPI-09-0115; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; HARTWIG A, 1994, CANCER RES, V54, P4045; Hartwig A, 2002, FOOD CHEM TOXICOL, V40, P1179, DOI 10.1016/S0278-6915(02)00043-1; Hartwig A, 2001, ANTIOXID REDOX SIGN, V3, P625, DOI 10.1089/15230860152542970; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kitada K, 2013, CYTOGENET GENOME RES, V139, P1, DOI 10.1159/000342885; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee PC, 2010, NEOPLASIA, V12, P376, DOI 10.1593/neo.10110; Martinez VD, 2013, J THORAC ONCOL, V8, P1451, DOI 10.1097/JTO.0b013e3182a4dd8e; McNeill DR, 2004, ENVIRON HEALTH PERSP, V112, P799, DOI 10.1289/ehp.7038; Morales ME, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005016; NISHIOKA H, 1975, MUTAT RES, V31, P185, DOI 10.1016/0165-1161(75)90088-6; NORDBERG GF, 1981, ENVIRON HEALTH PERSP, V40, P65, DOI 10.2307/3429221; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Sakai C, 2014, ANTICANCER RES, V34, P6489; Schwerdtle T, 2010, CHEM RES TOXICOL, V23, P432, DOI 10.1021/tx900444w; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; VAINIO H, 1993, SCAND J WORK ENV HEA, V19, P360; Vargas-Poussou R, 2011, J AM SOC NEPHROL, V22, P693, DOI 10.1681/ASN.2010090907; Viau M, 2008, MUTAT RES-GEN TOX EN, V654, P13, DOI 10.1016/j.mrgentox.2008.04.009; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; White TB, 2015, MOB GENET ELEMENTS, V5; Witherspoon DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-530; Zhou ZH, 2012, TOXICOL SCI, V125, P412, DOI 10.1093/toxsci/kfr320	47	92	94	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151367	10.1371/journal.pone.0151367	http://dx.doi.org/10.1371/journal.pone.0151367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966913	Green Submitted, gold, Green Published			2022-12-27	WOS:000371989200048
J	Arrighi, P; Bonfiglio, L; Minichilli, F; Cantore, N; Carboncini, MC; Piccotti, E; Rossi, B; Andre, P				Arrighi, Pieranna; Bonfiglio, Luca; Minichilli, Fabrizio; Cantore, Nicoletta; Carboncini, Maria Chiara; Piccotti, Emily; Rossi, Bruno; Andre, Paolo			EEG Theta Dynamics within Frontal and Parietal Cortices for Error Processing during Reaching Movements in a Prism Adaptation Study Altering Visuo-Motor Predictive Planning	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; ANTERIOR CINGULATE CORTEX; SPATIAL ALIGNMENT; INTERNAL-MODEL; MIDLINE THETA; OSCILLATIONS; CEREBELLUM; ADJUSTMENTS; PERFORMANCE; ACTIVATION	Modulation of frontal midline theta (fm theta) is observed during error commission, but little is known about the role of theta oscillations in correcting motor behaviours. We investigate EEG activity of healthy partipants executing a reaching task under variable degrees of prism-induced visuo-motor distortion and visual occlusion of the initial arm trajectory. This task introduces directional errors of different magnitudes. The discrepancy between predicted and actual movement directions (i.e. the error), at the time when visual feedback (hand appearance) became available, elicits a signal that triggers on-line movement correction. Analysis were performed on 25 EEG channels. For each participant, the median value of the angular error of all reaching trials was used to partition the EEG epochs into high-and low-error conditions. We computed event-related spectral perturbations (ERSP) time-locked either to visual feedback or to the onset of movement correction. ERSP time-locked to the onset of visual feedback showed that fm. increased in the high-but not in the low-error condition with an approximate time lag of 200 ms. Moreover, when single epochs were sorted by the degree of motor error, fm. started to increase when a certain level of error was exceeded and, then, scaled with error magnitude. When ERSP were time-locked to the onset of movement correction, the fm. increase anticipated this event with an approximate time lead of 50 ms. During successive trials, an error reduction was observed which was associated with indices of adaptations (i.e., aftereffects) suggesting the need to explore if theta oscillations may facilitate learning. To our knowledge this is the first study where the EEG signal recorded during reaching movements was time-locked to the onset of the error visual feedback. This allowed us to conclude that theta oscillations putatively generated by anterior cingulate cortex activation are implicated in error processing in semi-naturalistic motor behaviours.	[Arrighi, Pieranna; Bonfiglio, Luca; Cantore, Nicoletta; Carboncini, Maria Chiara; Piccotti, Emily; Rossi, Bruno] Univ Pisa, Neurorehabil Unit, Pisa, Italy; [Andre, Paolo] Univ Siena, Dept Med Surg & Neurosci, Via Laterina 8, I-53100 Siena, Italy; [Minichilli, Fabrizio] CNR, Inst Clin Physiol, Environm Epidemiol Unit, Via Savi 8, I-56100 Pisa, Italy	University of Pisa; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Andre, P (corresponding author), Univ Siena, Dept Med Surg & Neurosci, Via Laterina 8, I-53100 Siena, Italy.	andre@unisi.it	Carboncini, Maria Chiara/I-9445-2018	Carboncini, Maria Chiara/0000-0002-3345-1524; Bonfiglio, Luca/0000-0001-5097-1014; Minichilli, Fabrizio/0000-0003-0007-4731				Andre P, 2003, CEREBELLUM, V2, P84, DOI 10.1080/14734220309403; Andre P, 2006, NEUROIMAGE, V31, pe1; Anguera JA, 2009, J NEUROPHYSIOL, V102, P1868, DOI 10.1152/jn.00063.2009; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Bonfiglio L, 2011, INT J PSYCHOPHYSIOL, V80, P44, DOI 10.1016/j.ijpsycho.2011.01.002; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Chapman HL, 2010, NEUROPSYCHOLOGIA, V48, P2595, DOI 10.1016/j.neuropsychologia.2010.05.006; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Contreras-Vidal JL, 2004, NEUROIMAGE, V21, P936, DOI 10.1016/j.neuroimage.2003.10.037; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2006, ENCYCL MED DEVICES I, DOI [10.1002/0471732877.emd318, DOI 10.1002/0471732877.EMD318]; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Fiehler K, 2004, EUR J NEUROSCI, V19, P3081, DOI 10.1111/j.0953-816X.2004.03414.x; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Huang RS, 2008, NEUROIMAGE, V39, P1896, DOI 10.1016/j.neuroimage.2007.10.036; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kipping JA, 2013, NEUROIMAGE, V83, P837, DOI 10.1016/j.neuroimage.2013.07.027; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Murphy PR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00065; Mutha PK, 2011, BRAIN, V134, P3644, DOI 10.1093/brain/awr275; Nadig KG, 2010, EXP BRAIN RES, V202, P45, DOI 10.1007/s00221-009-2108-7; Newport R, 2006, NEUROPSYCHOLOGIA, V44, P2757, DOI 10.1016/j.neuropsychologia.2006.01.007; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pizzagalli DA, 2003, PSYCHOPHYSIOLOGY, V40, P939, DOI 10.1111/1469-8986.00112; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Redding GM, 2002, J MOTOR BEHAV, V34, P126, DOI 10.1080/00222890209601935; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Schutter DJL, 2006, NEUROIMAGE, V33, P1227, DOI 10.1016/j.neuroimage.2006.06.055; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Torrecillos F, 2014, J NEUROSCI, V34, P4845, DOI 10.1523/JNEUROSCI.4390-13.2014; Trujillo LT, 2007, CLIN NEUROPHYSIOL, V118, P645, DOI 10.1016/j.clinph.2006.11.009; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Tsujimoto T, 2006, J NEUROPHYSIOL, V95, P2987, DOI 10.1152/jn.00730.2005; Twisk JW, 2013, APPL LONGITUDINAL DA; Tzur G, 2007, NEUROPSYCHOLOGIA, V45, P3122, DOI 10.1016/j.neuropsychologia.2007.05.004; Tzur G, 2010, PSYCHOPHYSIOLOGY, V47, P758, DOI 10.1111/j.1469-8986.2010.00967.x; Vocat R, 2011, NEUROPSYCHOLOGIA, V49, P360, DOI 10.1016/j.neuropsychologia.2010.12.027; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040	67	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150265	10.1371/journal.pone.0150265	http://dx.doi.org/10.1371/journal.pone.0150265			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963919	Green Published, gold			2022-12-27	WOS:000371993000028
J	Lee, YS; Hwang, MK; Song, JS; Li, CY; Joung, B; Sobie, EA; Pak, HN				Lee, Young-Seon; Hwang, Minki; Song, Jun-Seop; Li, Changyong; Joung, Boyoung; Sobie, Eric A.; Pak, Hui-Nam			The Contribution of Ionic Currents to Rate-Dependent Action Potential Duration and Pattern of Reentry in a Mathematical Model of Human Atrial Fibrillation	PLOS ONE			English	Article							PARAMETER SENSITIVITY-ANALYSIS; VENTRICULAR-FIBRILLATION; ELECTRICAL RESTITUTION; PHASE SINGULARITIES; DOWN-REGULATION; SPIRAL WAVES; MECHANISMS; REFRACTORINESS; EXCITABILITY; INSIGHTS	Persistent atrial fibrillation (PeAF) in humans is characterized by shortening of action potential duration (APD) and attenuation of APD rate-adaptation. However, the quantitative influences of particular ionic current alterations on rate-dependent APD changes, and effects on patterns of reentry in atrial tissue, have not been systematically investigated. Using mathematical models of human atrial cells and tissue and performing parameter sensitivity analysis, we evaluated the quantitative contributions to action potential (AP) shortening and APD rate-adaptation of ionic current remodeling seen with PeAF. Ionic remodeling in PeAF was simulated by reducing L-type Ca2+ channel current (I-CaL), increasing inward rectifier K+ current (I-K1) and modulating five other ionic currents. Parameter sensitivity analysis, which quantified how each ionic current influenced APD in control and PeAF conditions, identified interesting results, including a negative effect of Na+/Ca2+ exchange on APD only in the PeAF condition. At high pacing rate (2 Hz), electrical remodeling in I-K1 alone accounts for the APD reduction of PeAF, but at slow pacing rate (0.5 Hz) both electrical remodeling in I-CaL alone (-70%) and I-K1 alone (+100%) contribute equally to the APD reduction. Furthermore, AP rate-adaptation was affected by I-Kur in control and by I-NaCa in the PeAF condition. In a 2D tissue model, a large reduction (-70%) of I-CaL becomes a dominant factor leading to a stable spiral wave in PeAF. Our study provides a quantitative and unifying understanding of the roles of ionic current remodeling in determining rate-dependent APD changes at the cellular level and spatial reentry patterns in tissue.	[Lee, Young-Seon; Hwang, Minki; Song, Jun-Seop; Li, Changyong; Joung, Boyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Seoul, South Korea; [Sobie, Eric A.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Yonsei University; Yonsei University Health System; Icahn School of Medicine at Mount Sinai	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Seoul, South Korea.; Sobie, EA (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	eric.sobie@mssm.edu; hnpak@yuhs.ac	Lee, Young-Seon/L-3636-2013; Pak, Hui-Nam/C-4266-2015	Lee, Young-Seon/0000-0003-1396-2172; Pak, Hui-Nam/0000-0002-3256-3620; Joung, Boyoung/0000-0001-9036-7225; Song, Jun-Seop/0000-0002-5886-4210	Korea Health 21 R&D Project, Ministry of Health and Welfare [A085136]; Basic Science Research Program run by the National Research Foundation of Korea (NRF) [NRF-2013R1A2A2A01014634]; Ministry of Science, ICT & Future Planning (MSIP); National Institutes of Health [HL122564, GM071558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL122564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	Korea Health 21 R&D Project, Ministry of Health and Welfare; Basic Science Research Program run by the National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning (MSIP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (A085136) from the Korea Health 21 R&D Project, Ministry of Health and Welfare, and by NRF-2013R1A2A2A01014634 from the Basic Science Research Program run by the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science, ICT & Future Planning (MSIP). This work was also supported by the National Institutes of Health (HL122564 and GM071558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; ATTUEL P, 1982, INT J CARDIOL, V2, P179, DOI 10.1016/0167-5273(82)90032-8; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Chang KC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1004011; Christ T, 2004, CIRCULATION, V110, P2651, DOI 10.1161/01.CIR.0000145659.80212.6A; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Cummins MA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003543; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dobrev D, 2003, BASIC RES CARDIOL, V98, P137, DOI 10.1007/s00395-003-0409-8; Dobrev D, 2001, CIRCULATION, V104, P2551, DOI 10.1161/hc4601.099466; Franz MR, 1997, J AM COLL CARDIOL, V30, P1785, DOI 10.1016/S0735-1097(97)00385-9; Garfinkel A, 2000, P NATL ACAD SCI USA, V97, P6061, DOI 10.1073/pnas.090492697; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Iyer AN, 2001, ANN BIOMED ENG, V29, P47, DOI 10.1114/1.1335538; Jalife J, 2003, J CARDIOVASC ELECTR, V14, P776, DOI 10.1046/j.1540-8167.2003.03136.x; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Keener JP, 2009, MATH PHYSL; Keldermann RH, 2009, AM J PHYSIOL-HEART C, V296, pH370, DOI 10.1152/ajpheart.00952.2008; Kharche S, 2008, PROG BIOPHYS MOL BIO, V98, P186, DOI 10.1016/j.pbiomolbio.2008.10.010; Kneller J, 2002, CARDIOVASC RES, V54, P416, DOI 10.1016/S0008-6363(02)00274-2; Koivumaki JT, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003620; Lee YS, 2013, BIOPHYS J, V104, P1142, DOI 10.1016/j.bpj.2012.12.055; Levy S, 2000, CURR OPIN CARDIOL, V15, P54, DOI 10.1097/00001573-200001000-00007; Li GR, 1999, AM J PHYSIOL-HEART C, V276, pH98, DOI 10.1152/ajpheart.1999.276.1.H98; Liu YB, 2003, J CARDIOVASC ELECTR, V14, P1103, DOI 10.1046/j.1540-8167.2003.03218.x; Pandit SV, 2005, BIOPHYS J, V88, P3806, DOI 10.1529/biophysj.105.060459; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Qu ZL, 1999, IEEE T BIO-MED ENG, V46, P1166, DOI 10.1109/10.784149; Riccio ML, 1999, CIRC RES, V84, P955; Sanchez C, 2012, AM J PHYSIOL-HEART C, V302, pH1146, DOI 10.1152/ajpheart.00668.2011; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Sato D, 2009, MED BIOL ENG COMPUT, V47, P1011, DOI 10.1007/s11517-009-0514-4; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Sossalla S, 2010, J AM COLL CARDIOL, V55, P2330, DOI 10.1016/j.jacc.2009.12.055; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wilhelms Mathias, 2012, Front Physiol, V3, P487, DOI 10.3389/fphys.2012.00487; Williams BA, 1999, BRIT J PHARMACOL, V126, P1426, DOI 10.1038/sj.bjp.0702443; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Workman AJ, 2001, CARDIOVASC RES, V52, P226, DOI 10.1016/S0008-6363(01)00380-7; Wu TJ, 2002, CIRCULATION, V106, P1859, DOI 10.1161/01.CIR.0000031334.49170.FB; Yang T, 1996, CIRCULATION, V93, P407, DOI 10.1161/01.CIR.93.3.407; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020	50	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150779	10.1371/journal.pone.0150779	http://dx.doi.org/10.1371/journal.pone.0150779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964092	Green Published, gold, Green Submitted			2022-12-27	WOS:000371993000063
J	Molnar, J; Szakacs, G; Tusnady, GE				Molnar, Janos; Szakacs, Gergely; Tusnady, Gabor E.			Characterization of Disease-Associated Mutations in Human Transmembrane Proteins	PLOS ONE			English	Article							MEMBRANE-PROTEINS; DATA-BANK; TOPOLOGY; PREDICTION; TRANSPORTER; DISCOVERY; VARIANTS; DOMAIN; GENES	Transmembrane protein coding genes are commonly associated with human diseases. We characterized disease causing mutations and natural polymorphisms in transmembrane proteins by mapping missense genetic variations from the UniProt database on the transmembrane protein topology listed in the Human Transmembrane Proteome database. We found characteristic differences in the spectrum of amino acid changes within transmembrane regions: in the case of disease associated mutations the non-polar to non-polar and non-polar to charged amino acid changes are equally frequent. In contrast, in the case of natural polymorphisms non-polar to charged amino acid changes are rare while non-polar to non-polar changes are common. The majority of disease associated mutations result in glycine to arginine and leucine to proline substitutions. Mutations to positively charged amino acids are more common in the center of the lipid bilayer, where they cause more severe structural and functional anomalies. Our analysis contributes to the better understanding of the effect of disease associated mutations in transmembrane proteins, which can help prioritize genetic variations in personal genomic investigations.	[Molnar, Janos; Szakacs, Gergely; Tusnady, Gabor E.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Tusnady, GE (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary.	tusnady.gabor@ttk.mta.hu	Szakacs, Gergely/A-2580-2009; Tusnády, Gábor E./AAI-1136-2021; Tusnády, Gábor E/A-3207-2009	Szakacs, Gergely/0000-0002-9311-7827; Tusnády, Gábor E./0000-0001-8105-0285; Tusnády, Gábor E/0000-0001-8105-0285	Hungarian Scientific Research Fund (OTKA) [K104586]; "Momentum" Program of the Hungarian Academy of Sciences [LP2015-35]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "Momentum" Program of the Hungarian Academy of Sciences; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian Scientific Research Fund (OTKA, K104586), and the "Momentum" Program of the Hungarian Academy of Sciences to GET (LP2015-35). Funding for open access charge: Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bamshad MJ, 2012, AM J MED GENET A, V158A, P1523, DOI 10.1002/ajmg.a.35470; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007; Dobson L, 2015, BIOL DIRECT UNPUB; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pD283, DOI 10.1093/nar/gku1119; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Fromme P, 2011, CURR OPIN STRUC BIOL, V21, P509, DOI 10.1016/j.sbi.2011.06.001; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Hristova K, 2011, J MEMBRANE BIOL, V239, P49, DOI 10.1007/s00232-010-9323-9; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P1049, DOI 10.3324/haematol.2008.002873; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kitterman JA, 2005, PEDIATRICS, V116, pE654, DOI 10.1542/peds.2005-0469; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; Liu H, 2015, AM J MED GENET A, V167, P1337, DOI 10.1002/ajmg.a.36969; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Newstead S, 2008, PROTEIN SCI, V17, P466, DOI 10.1110/ps.073263108; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; PRUSINER SB, 1994, WESTERN J MED, V161, P264; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Shu Y, 2003, P NATL ACAD SCI USA, V100, P5902, DOI 10.1073/pnas.0730858100; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Tompa P, 2001, P NATL ACAD SCI USA, V98, P4431, DOI 10.1073/pnas.071308398; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Vihinen M, 2015, NATURE, V521, P261, DOI 10.1038/521261a; Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	44	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151760	10.1371/journal.pone.0151760	http://dx.doi.org/10.1371/journal.pone.0151760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986070	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000372580300125
J	Vedel-Krogh, S; Nielsen, SF; Schnohr, P; Nordestgaard, BG				Vedel-Krogh, Signe; Nielsen, Sune F.; Schnohr, Peter; Nordestgaard, Borge G.			Morbidity and Mortality in 7,684 Women According to Personal Hair Dye Use: The Copenhagen City Heart Study followed for 37 Years	PLOS ONE			English	Article							NONFASTING TRIGLYCERIDES; INFLAMMATORY BIOMARKERS; RISK; CANCER; CARCINOGENICITY; HAIRDRESSERS; EXPOSURE; MELANOMA; ALCOHOL; DISEASE	Background Permanent hair dye contains aromatic amines which are carcinogenic, and can cause allergic skin reactions. In the long term personal use of hair dye might therefore influence both morbidity and mortality. Objectives We tested the hypothesis that personal use of hair dye in women is associated with increased morbidity and mortality in the general population. Methods We included 7,684 women from the Copenhagen City Heart Study with information on the use of personal hair dye. We assessed the risk of cancer, skin diseases, other morbidities, and mortality during a median follow-up of 27 years (range 0-37). Results The multivariable adjusted hazard ratio for malignant melanoma in women with versus without personal use of hair dye was 2.07 (95% confidence interval 1.25-3.42). There was no increased risk of other cancer types. For other skin diseases and other major causes of morbidity we found no differences between the two groups, except for a minor excess of digestive diseases and increased risk of Parkinson's disease among women using hair dye. Finally, we found no difference in all-cause mortality comparing women using personal hair dye or not. After correction for multiple comparisons, none of the results remained significant. However, in sensitivity analysis the excess risk of malignant melanoma remained increased with a hazard ratio of 2.58 (95% CI 1.33-5.03) among users of personal hair dye. Conclusions Personal use of hair dye does not have major influences on morbidity and mortality. Our finding of a 2-fold risk of malignant melanoma in women using hair dye is hypothesis generating.	[Vedel-Krogh, Signe; Nielsen, Sune F.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Vedel-Krogh, Signe; Nielsen, Sune F.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Vedel-Krogh, Signe; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Schnohr, Peter; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark.; Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark.; Nordestgaard, BG (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.; Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark.	Boerge.Nordestgaard@regionh.dk	Vedel-Krogh, Signe/AAH-5195-2019; Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220; Vedel-Krogh, Signe/0000-0002-0435-1110	Lundbeck Foundation, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen	Lundbeck Foundation, Denmark(Lundbeckfonden); Faculty of Health and Medical Sciences, University of Copenhagen	The study was funded by the Lundbeck Foundation, Denmark (www.lundbeckfonden.com) and the Faculty of Health and Medical Sciences, University of Copenhagen (www.sund.ku.dk). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the paper.	AMES BN, 1975, P NATL ACAD SCI USA, V72, P2423, DOI 10.1073/pnas.72.6.2423; APPLEYARD M, 1989, SCAND J SOC MED S, V41, P1; Axmon A, 2006, SCAND J WORK ENV HEA, V32, P51, DOI 10.5271/sjweh.976; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; Bolt HM, 2007, CRIT REV TOXICOL, V37, P521, DOI 10.1080/10408440701385671; Corbett JF, 1999, DYES PIGMENTS, V41, P127, DOI 10.1016/S0143-7208(98)00075-8; Corpechot C, 2010, J HEPATOL, V53, P162, DOI 10.1016/j.jhep.2010.02.019; Czene K, 2003, INT J CANCER, V105, P108, DOI 10.1002/ijc.11040; Dahl M, 1998, LANCET, V351, P1911, DOI 10.1016/S0140-6736(97)11419-2; Feizy V, 2009, J AM ACAD DERMATOL, V61, P532, DOI 10.1016/j.jaad.2009.01.040; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; Gao X, 2009, ANN NEUROL, V65, P76, DOI 10.1002/ana.21535; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Harling M, 2010, OCCUP ENVIRON MED, V67, P351, DOI 10.1136/oem.2009.050195; HOLMAN CDJ, 1983, BRIT J CANCER, V48, P599, DOI 10.1038/bjc.1983.234; IARC Monographs Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V99, P1; International Agency for Research on Cancer, 2004, IARC MONOGR EVAL CAR, V83, P1; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; McFadden JP, 2007, BRIT MED J, V334, P220, DOI 10.1136/bmj.39042.643206.BE; Moscato G, 2005, CHEST, V128, P3590, DOI 10.1378/chest.128.5.3590; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nielsen SF, 2012, CAN MED ASSOC J, V184, pE57, DOI 10.1503/cmaj.110167; Nikolaou V, 2014, BRIT J DERMATOL, V170, P11, DOI 10.1111/bjd.12492; Nohynek GJ, 2010, TOXICOL APPL PHARM, V243, P239, DOI 10.1016/j.taap.2009.12.001; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Olsson AR, 2001, ANN RHEUM DIS, V60, P934, DOI 10.1136/ard.60.10.934; OSTERLIND A, 1988, INT J CANCER, V42, P825, DOI 10.1002/ijc.2910420604; Pan TH, 2011, INT J CANCER, V128, P2251, DOI 10.1002/ijc.25912; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; SanchezGuerrero J, 1996, ARTHRITIS RHEUM, V39, P657, DOI 10.1002/art.1780390418; Schmidt JD, 2014, BRIT J DERMATOL, V170, P352, DOI 10.1111/bjd.12676; SONTAG JM, 1981, JNCI-J NATL CANCER I, V66, P591; Sosted H, 2004, CONTACT DERMATITIS, V50, P344, DOI 10.1111/j.0105-1873.2004.00362.x; Takkouche B, 2005, JAMA-J AM MED ASSOC, V293, P2516, DOI 10.1001/jama.293.20.2516; Takkouche B, 2009, INT J EPIDEMIOL, V38, P1512, DOI 10.1093/ije/dyp283; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Tokumoto Y, 2003, INTERNAL MED, V42, P1104, DOI 10.2169/internalmedicine.42.1104; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Varbo A, 2011, ANN NEUROL, V69, P628, DOI 10.1002/ana.22384; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Whiteman DC, 2006, J CLIN ONCOL, V24, P3172, DOI 10.1200/JCO.2006.06.1325; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang Y, 2008, AM J EPIDEMIOL, V167, P1321, DOI 10.1093/aje/kwn058	46	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151636	10.1371/journal.pone.0151636	http://dx.doi.org/10.1371/journal.pone.0151636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986063	Green Published, gold			2022-12-27	WOS:000372580300101
J	Di Bartolo, N; Compton, ELR; Warne, T; Edwards, PC; Tate, CG; Schertler, GFX; Booth, PJ				Di Bartolo, Natalie; Compton, Emma L. R.; Warne, Tony; Edwards, Patricia C.; Tate, Christopher G.; Schertler, Gebhard F. X.; Booth, Paula J.			Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support	PLOS ONE			English	Article							POTASSIUM CHANNEL KCSA; MEMBRANE-PROTEIN; IN-VITRO; TRANSPORT PROTEIN; LIGAND-BINDING; STABILITY; CRYSTALLIZATION; PURIFICATION; PROTEOLYSIS; EXPRESSION	The factors defining the correct folding and stability of integral membrane proteins are poorly understood. Folding of only a few select membrane proteins has been scrutinised, leaving considerable deficiencies in knowledge for large protein families, such as G protein coupled receptors (GPCRs). Complete reversible folding, which is problematic for any membrane protein, has eluded this dominant receptor family. Moreover, attempts to recover receptors from denatured states are inefficient, yielding at best 40-70% functional protein. We present a method for the reversible unfolding of an archetypal family member, the beta(1)-adrenergic receptor, and attain 100% recovery of the folded, functional state, in terms of ligand binding, compared to receptor which has not been subject to any unfolding and retains its original, folded structure. We exploit refolding on a solid support, which could avoid unwanted interactions and aggregation that occur in bulk solution. We determine the changes in structure and function upon unfolding and refolding. Additionally, we employ a method that is relatively new to membrane protein folding; pulse proteolysis. Complete refolding of beta(1)-adrenergic receptor occurs in n-decyl-beta-D-maltoside (DM) micelles from a urea-denatured state, as shown by regain of its original helical structure, ligand binding and protein fluorescence. The successful refolding strategy on a solid support offers a defined method for the controlled refolding and recovery of functional GPCRs and other membrane proteins that suffer from instability and irreversible denaturation once isolated from their native membranes.	[Di Bartolo, Natalie; Booth, Paula J.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Compton, Emma L. R.] Univ Strathclyde, Org & Staff Dev Unit, Glasgow, Lanark, Scotland; [Warne, Tony; Edwards, Patricia C.; Tate, Christopher G.] MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England; [Schertler, Gebhard F. X.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland	University of Bristol; University of Strathclyde; MRC Laboratory Molecular Biology; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Di Bartolo, N (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	natalie.dibartolo@bristol.ac.uk		Booth, Paula Jane/0000-0003-3893-360X; Warne, Tony/0000-0001-9646-6080; Schertler, Gebhard F.X./0000-0002-5846-6810; Compton-Daw, Emma/0000-0002-3832-7194	BBSRC [BB/G002037/1]; Wellcome Trust [72075]; Royal Society; Leverhulme Trust; Medical Research Council [MRC U10519215]; BBSRC [BB/G003653/1] Funding Source: UKRI; MRC [MC_U105197215] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003653/1, BB/G002037/1] Funding Source: researchfish; Medical Research Council [MC_U105197215] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge funding from BBSRC grant BB/G002037/1. PJB also thanks the Wellcome Trust (grant 72075) as well as the Royal Society for a Woflson Research Merit Award and Leverhulme Trust for a Research Fellowship. Research in CGT's laboratory was funded by a core grant from the Medical Research Council [MRC U10519215].	Baneres JL, 2011, TRENDS BIOTECHNOL, V29, P314, DOI 10.1016/j.tibtech.2011.03.002; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Barrera FN, 2005, BIOCHEMISTRY-US, V44, P14344, DOI 10.1021/bi050845t; Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Curnow P, 2011, P NATL ACAD SCI USA, V108, P14133, DOI 10.1073/pnas.1012594108; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Dahmane T, 2009, BIOCHEMISTRY-US, V48, P6516, DOI 10.1021/bi801729z; Ezure T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112874; Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107; Harris NJ, 2014, J MOL BIOL, V426, P1812, DOI 10.1016/j.jmb.2014.01.012; Hwa J, 2001, P NATL ACAD SCI USA, V98, P4872, DOI 10.1073/pnas.061632798; Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Miller D, 2009, J MOL BIOL, V393, P815, DOI 10.1016/j.jmb.2009.08.039; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Park Chiwook, 2006, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2011s46; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4; Sachse R, 2014, FEBS LETT, V588, P2774, DOI 10.1016/j.febslet.2014.06.007; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Skach WR, 2007, J CELL BIOL, V179, P1333, DOI 10.1083/jcb.200711107; vanKlompenburg W, 1997, FEBS LETT, V413, P109, DOI 10.1016/S0014-5793(97)00888-0; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014	32	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151582	10.1371/journal.pone.0151582	http://dx.doi.org/10.1371/journal.pone.0151582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982879	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000372574900099
J	Eckert, NR; Poston, B; Riley, ZA				Eckert, Nathanial R.; Poston, Brach; Riley, Zachary A.			Modulation of the Cutaneous Silent Period in the Upper-Limb with Whole-Body Instability	PLOS ONE			English	Article							NOCICEPTIVE WITHDRAWAL REFLEXES; OPTIMAL FEEDBACK-CONTROL; FUNCTIONAL-ORGANIZATION; UPPER EXTREMITY; MOTOR CONTROL; SPINAL-CORD; STIMULATION; HUMANS; RESPONSES; MOVEMENT	The silent period induced by cutaneous electrical stimulation of the digits has been shown to be task-dependent, at least in the grasping muscles of the hand. However, it is unknown if the cutaneous silent period is adaptable throughout muscles of the entire upper limb, in particular when the task requirements are substantially altered. The purpose of the present study was to examine the characteristics of the cutaneous silent period in several upper limb muscles when introducing increased whole-body instability. The cutaneous silent period was evoked in 10 healthy individuals with electrical stimulation of digit II of the right hand when the subjects were seated, standing, or standing on a wobble board while maintaining a background elbow extension contraction with the triceps brachii of similar to 5% of maximal voluntary contraction (MVC) strength. The first excitatory response (E1), first inhibitory response (CSP), and second excitatory response (E2) were quantified as the percent change from baseline and by their individual durations. The results showed that the level of CSP suppression was lessened (47.7 +/- 7.7% to 33.8 +/- 13.2% of baseline, p = 0.019) and the duration of the CSP inhibition decreased (p = 0.021) in the triceps brachii when comparing the seated and wobble board tasks. For the wobble board task the amount of cutaneous afferent inhibition of EMG activity in the triceps brachii decreased; which is proposed to be due to differential weighting of cutaneous feedback relative to the corticospinal drive, most likely due to presynaptic inhibition, to meet the demands of the unstable task.	[Eckert, Nathanial R.] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Poston, Brach] Univ Nevada, Dept Kinesiol & Nutr Sci, Las Vegas, NV 89154 USA; [Riley, Zachary A.] Indiana Univ Purdue Univ, Dept Kinesiol, Indianapolis, IN 46202 USA; [Eckert, Nathanial R.] Univ Florida, Dept Dent, Gainesville, FL USA	Indiana University System; Indiana University Bloomington; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of Florida	Riley, ZA (corresponding author), Indiana Univ Purdue Univ, Dept Kinesiol, Indianapolis, IN 46202 USA.	zariley@iupui.edu	Eckert, Nathanial/AGI-4504-2022	Eckert, Nathanial/0000-0002-0236-1809				Brinkworth RSA, 2003, J NEUROSCI METH, V122, P179, DOI 10.1016/S0165-0270(02)00321-7; CACCIA G, 1974, MINERVA MED, V64, P4884; Don R, 2008, EUR J NEUROSCI, V28, P559, DOI 10.1111/j.1460-9568.2008.06330.x; Floeter MK, 1998, MUSCLE NERVE, V21, P591, DOI 10.1002/(SICI)1097-4598(199805)21:5<591::AID-MUS5>3.0.CO;2-3; GARNETT R, 1980, J PHYSIOL-LONDON, V303, P351, DOI 10.1113/jphysiol.1980.sp013290; Inghilleri M, 1997, ELECTROMYOGR MOTOR C, V105, P109, DOI 10.1016/S0924-980X(97)96579-6; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Kofler M, 2004, CLIN NEUROPHYSIOL, V115, P1052, DOI 10.1016/j.clinph.2003.12.005; Kofler M, 2004, NEUROSCI LETT, V360, P69, DOI 10.1016/j.neulet.2004.02.035; Kofler M, 2003, J NEUROL SCI, V216, P67, DOI 10.1016/S0022-510X(03)00211-9; Kofler M, 2003, CLIN NEUROPHYSIOL, V114, P973, DOI 10.1016/S1388-2457(03)00060-9; Kofler M, 2001, CLIN NEUROPHYSIOL, V112, P1053, DOI 10.1016/S1388-2457(01)00540-5; Kofler M, 2008, EXP BRAIN RES, V188, P399, DOI 10.1007/s00221-008-1372-2; LEIS AA, 1992, MUSCLE NERVE, V15, P1345, DOI 10.1002/mus.880151209; Rose PK, 2003, NAT NEUROSCI, V6, P1243, DOI 10.1038/nn1203-1243; Schomburg E D, 2001, Acta Physiol Pharmacol Bulg, V26, P193; SCHOUENBORG J, 1990, EXP BRAIN RES, V83, P67; SCHOUENBORG J, 1992, EXP BRAIN RES, V90, P469; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Serrao M, 2006, J NEUROSCI, V26, P3505, DOI 10.1523/JNEUROSCI.5160-05.2006; Serrao M, 2001, CLIN NEUROPHYSIOL, V112, P2007, DOI 10.1016/S1388-2457(01)00675-7; SHEFNER JM, 1993, MUSCLE NERVE, V16, P278, DOI 10.1002/mus.880160306; Staude G, 1999, MED ENG PHYS, V21, P449, DOI 10.1016/S1350-4533(99)00067-3; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNCINI A, 1991, ELECTROEN CLIN NEURO, V81, P344, DOI 10.1016/0168-5597(91)90023-Q	26	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151520	10.1371/journal.pone.0151520	http://dx.doi.org/10.1371/journal.pone.0151520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981863	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900092
J	Hromadnikova, I; Li, S; Kotlabova, K; Dickinson, AM				Hromadnikova, Ilona; Li, Shuang; Kotlabova, Katerina; Dickinson, Anne M.			Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; TUMOR-CELLS; MEMBRANE EXPRESSION; CANCER-PATIENTS; IMMUNE-SYSTEM; CUTTING EDGE; STIMULATION; LYMPHOCYTES; NKG2D; HSP70	Previous studies from Multhoff and colleagues reported that plasma membrane Hsp70 acts as a tumour-specific recognition structure for activated NK cells, and that the incubation of NK cells with Hsp70 and/or a 14-mer peptide derived from the N-terminal sequence of Hsp70 (TKDNNLLGRFELSG, TKD, aa 450-463) plus a low dose of IL-2 triggers NK cell proliferation and migration, and their capacity to kill cancer cells expressing membrane Hsp70. Herein, we have used flow cytometry to determine the influence of in vitro stimulation of peripheral blood mononuclear cells from healthy individuals with IL-2 or IL-15, either alone or in combination with TKD peptide on the cell surface expression of CD94, NK cell activatory receptors (CD16, NK2D, NKG2C, NKp30, NKp44, NKp46, NKp80, KIR2DL4, DNAM-1 and LAMP1) and NK cell inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2 and NKR-P1A) by CD3+CD56+ (NKT), CD3+CD4+, CD3+CD8+ and CD19+ populations. NKG2D, DNAM-1, LAMP1 and NKR-P1A expression was upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD in NKT, CD8+ T cells and B cells. CD94 was upregulated in NKT and CD8+ T cells. Concurrently, an increase in a number of CD8+ T cells expressing LIR1/ILT-2 and CD4+ T cells positive for NKR-P1A was observed. The proportion of CD8+ T cells that expressed NKG2D was higher after IL-2/TKD treatment, when compared with IL-2 treatment alone. In comparison with IL-15 alone, IL-15/TKD treatment increased the proportion of NKT cells that were positive for CD94, LAMP1 and NKRP-1A. The more potent effect of IL-15/TKD on cell surface expression of NKG2D, LIR1/ILT-2 and NKRP-1A was observed in B cells compared with IL-15 alone. However, this increase was not of statistical significance. IL-2/TKD induced significant upregulation of LAMP1 in CD8+ T cells compared with IL-2 alone. Besides NK cells, other immunocompetent cells present within the fraction of peripheral blood mononuclear cells were influenced by the treatment with low-dose interleukins themselves or in combination with hsp70 derived (TKD) peptide.	[Hromadnikova, Ilona; Li, Shuang; Kotlabova, Katerina] Charles Univ Prague, Dept Mol Biol & Cell Pathol, Fac Med 3, Ruska 87, Prague 10000, Czech Republic; [Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Haematol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Charles University Prague; Newcastle University - UK	Hromadnikova, I (corresponding author), Charles Univ Prague, Dept Mol Biol & Cell Pathol, Fac Med 3, Ruska 87, Prague 10000, Czech Republic.	ilona.hromadnikova@lf3.cuni.cz	Hromadnikova, Ilona/E-1957-2017	Hromadnikova, Ilona/0000-0002-4396-3304; Dickinson, Anne/0000-0002-7356-7636; Kotlabova, Katerina/0000-0002-8824-4653	CellEurope project (FP7-People-ITN) [315963]	CellEurope project (FP7-People-ITN)	Work was supported by CellEurope project (FP7-People-2012-ITN, No. 315963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was done under the framework of CellEurope project (FP7-People-2012-ITN, No. 315963) coordinated by Professor Anne Dickinson from University of Newcastle upon Tyne, UK.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Bai YY, 2014, CLIN LAB, V60, P717, DOI 10.7754/Clin.Lab.2013.130435; Bjorkstrom NK, 2008, J IMMUNOL, V181, P4219, DOI 10.4049/jimmunol.181.6.4219; Bonanno G, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-129; Botzler C, 1999, EXP HEMATOL, V27, P470, DOI 10.1016/S0301-472X(98)00055-1; Brehm C, 2014, CANCER IMMUNOL IMMUN, V63, P821, DOI 10.1007/s00262-014-1556-5; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Dhanji S, 2003, J IMMUNOL, V171, P3442, DOI 10.4049/jimmunol.171.7.3442; Dunne J, 2001, J IMMUNOL, V167, P3129, DOI 10.4049/jimmunol.167.6.3129; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fouchaq B, 1999, EUR J BIOCHEM, V259, P379, DOI 10.1046/j.1432-1327.1999.00053.x; Franceschetti M, 2009, EXP HEMATOL, V37, P616, DOI 10.1016/j.exphem.2009.01.010; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Hantschel M, 2000, CELL STRESS CHAPERON, V5, P438, DOI 10.1379/1466-1268(2000)005<0438:HPMEOP>2.0.CO;2; Hodge G, 2013, RESPIROLOGY, V18, P369, DOI 10.1111/j.1440-1843.2012.02287.x; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/405295; Huenecke S, 2010, J IMMUNOTHER, V33, P200, DOI 10.1097/CJI.0b013e3181bb46f7; Iliopoulou EG, 2006, CLIN CANCER RES, V12, P6901, DOI 10.1158/1078-0432.CCR-06-0977; Jabri B, 2002, IMMUNITY, V17, P487, DOI 10.1016/S1074-7613(02)00427-2; Joshi SK, 2013, INT IMMUNOPHARMACOL, V17, P260, DOI 10.1016/j.intimp.2013.05.022; Kang N, 2005, TRANSPL P, V37, P782, DOI 10.1016/j.transproceed.2004.12.196; Kawamura T, 2009, J IMMUNOL, V182, P250, DOI 10.4049/jimmunol.182.1.250; Krause SW, 2004, CLIN CANCER RES, V10, P3699, DOI 10.1158/1078-0432.CCR-03-0683; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Kuylenstierna C, 2011, EUR J IMMUNOL, V41, P1913, DOI 10.1002/eji.200940278; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lin H, 2006, J LEUKOCYTE BIOL, V80, P164, DOI 10.1189/jlb.0705421; Malhotra A, 2011, IMMUNOTHERAPY-UK, V3, P1143, DOI [10.2217/IMT.11.102, 10.2217/imt.11.102]; Milani V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-50; Mingari MC, 1998, P NATL ACAD SCI USA, V95, P1172, DOI 10.1073/pnas.95.3.1172; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; Multhoff G, 1997, J IMMUNOL, V158, P4341; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Ota T, 2005, BLOOD, V106, P184, DOI 10.1182/blood-2004-11-4257; Payne KK, 2013, BREAST CANCER RES TR, V142, P45, DOI 10.1007/s10549-013-2733-5; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Rausch A, 2006, EUR J IMMUNOL, V36, P1156, DOI 10.1002/eji.200535290; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Romero P, 2001, J LEUKOCYTE BIOL, V70, P219; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sivori S, 2000, HUM IMMUNOL, V61, P1055, DOI 10.1016/S0198-8859(00)00201-9; Stangl S, 2006, J IMMUNOL, V176, P6270, DOI 10.4049/jimmunol.176.10.6270; Stangl S, 2011, P NATL ACAD SCI USA, V108, P733, DOI 10.1073/pnas.1016065108; Strauss-Albee DM, 2014, J IMMUNOL, V193, P4871, DOI 10.4049/jimmunol.1401821; Sugita J, 2010, ANN HEMATOL, V89, P115, DOI 10.1007/s00277-009-0780-0; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; TOPALIAN SL, 1987, ACTA HAEMATOL-BASEL, V78, P75, DOI 10.1159/000205907; Uldrich AP, 2005, J IMMUNOL, V175, P3092, DOI 10.4049/jimmunol.175.5.3092; Wang Jing, 2012, Zhonghua Er Ke Za Zhi, V50, P386; Wu MR, 2015, CANCER IMMUNOL IMMUN, V64, P409, DOI 10.1007/s00262-014-1648-2; Yang D, 2009, MOL IMMUNOL, V46, P1432, DOI 10.1016/j.molimm.2008.12.010; Zhou JJ, 2013, J REPROD IMMUNOL, V97, P197, DOI 10.1016/j.jri.2012.12.006	56	21	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151535	10.1371/journal.pone.0151535	http://dx.doi.org/10.1371/journal.pone.0151535			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982331	Green Published, gold			2022-12-27	WOS:000372574900095
J	Leighton, GM; Vander Meiden, L				Leighton, Gavin M.; Vander Meiden, Laura			Sociable Weavers Increase Cooperative Nest Construction after Suffering Aggression	PLOS ONE			English	Article							PHILETAIRUS-SOCIUS; PRACTICAL GUIDE; HELPERS PAY; EVOLUTION; BEHAVIOR; SEX; REPRODUCTION; PUNISHMENT; TRAGEDY; RELATEDNESS	The major transitions in evolution rely on the formation of stable groups that are composed of previously independent units, and the stability of these groups requires both cooperation and reduced conflict. Conflict over group resources may be common, as suggested by work in both cichlids and humans that has investigated how societies resolve conflict regarding investment in group resources, i.e. public goods. We investigated whether sociable weavers (Philetairus socius) use aggressive behaviors to modulate the cooperative behavior of group mates. We find that the individuals that build the communal thatch of the nest, i.e. the individuals most at risk of exploitation, are the most aggressive individuals. We show that individuals that invest in interior chamber maintenance, possibly a more selfish behavior, suffer relatively more aggression. After suffering aggression individuals significantly increase cooperative construction of the communal nest thatch. We show that cooperative individuals target aggression towards selfish individuals, and the individuals suffering aggression perform cooperative behaviors subsequent to suffering aggression. In addition to other evolutionary mechanisms, these results suggest that aggression, possibly via the pay-to-stay mechanism, is possibly being used to maintain a public good.	[Leighton, Gavin M.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Vander Meiden, Laura] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	Cornell University; University of Miami	Leighton, GM (corresponding author), Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA.	gml86@cornell.edu			National Science Foundation (IOS) [121500]; National Geographic [9274-13]; Robert E. Maytag Endowment	National Science Foundation (IOS)(National Science Foundation (NSF)); National Geographic(National Geographic Society); Robert E. Maytag Endowment	This work was funded by a National Science Foundation (http://www.nsf.gov/) grant to GML (IOS #121500), a National Geographic (www.nationalgeographic.com) Young Explorer's grant (#9274-13) awarded to GML, and the Robert E. Maytag Endowment.; The research performed here was approved by the University of Miami IACUC under protocol 12-098. We thank the Kuzikus property who housed us while we collected the data. This manuscript was improved by comments from J. David Van Dyken, M. Taborsky, and several anonymous referees. This work was funded by a National Science Foundation grant to GML (IOS #121500), a National Geographic Young Explorer's grant (#9274-13) awarded to GML, and the Robert E. Maytag Endowment.	[Anonymous], 2014, R LANG ENV STAT COMP; Bates D, LME4 LINEAR MIXED EF; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell MBV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5499; Bell MBV, 2012, P ROY SOC B-BIOL SCI, V279, P619, DOI 10.1098/rspb.2011.1093; Bergmuller R, 2005, ANIM BEHAV, V69, P19, DOI 10.1016/j.anbehav.2004.05.009; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Bush KL, 2005, CONSERV GENET, V6, P867, DOI 10.1007/s10592-005-9040-6; Cant MA, 2014, P NATL ACAD SCI USA, V111, P326, DOI 10.1073/pnas.1312626111; Cant MA, 2011, P ROY SOC B-BIOL SCI, V278, P170, DOI 10.1098/rspb.2010.1241; Clutton-Brock TH, 2002, SCIENCE, V297, P253, DOI 10.1126/science.1071412; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; COLLIAS EC, 1978, IBIS, V120, P1, DOI 10.1111/j.1474-919X.1978.tb04994.x; Cordero OX, 2012, P NATL ACAD SCI USA, V109, P20059, DOI 10.1073/pnas.1213344109; Covas R, 2008, BEHAV ECOL SOCIOBIOL, V63, P103, DOI 10.1007/s00265-008-0640-2; EMLEN ST, 1992, NATURE, V356, P331, DOI 10.1038/356331a0; FISCHER S, 2014, P BIOL SCI, V281, P1; Fisher RM, 2013, CURR BIOL, V23, P1120, DOI 10.1016/j.cub.2013.05.004; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Han JI, 2009, AUK, V126, P779, DOI 10.1525/auk.2009.08203; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Jackson DE, 2007, CURR BIOL, V17, pR650, DOI 10.1016/j.cub.2007.06.003; Johnson BR, 2013, CURR BIOL, V23, P2058, DOI 10.1016/j.cub.2013.08.050; Johnstone RA, 1999, P ROY SOC B-BIOL SCI, V266, P275, DOI 10.1098/rspb.1999.0633; Lacey E.A., 1991, P275; Leighton GM, 2015, BEHAV ECOL SOCIOBIOL, V69, P1835, DOI 10.1007/s00265-015-1996-8; Leighton GM, 2015, AVIAN BIOL RES, V8, P104, DOI 10.3184/175815515X14289391219157; Leighton GM, 2014, AVIAN BIOL RES, V7, P255, DOI 10.3184/175815514X14151918723245; Leighton GM, 2014, J ORNITHOL, V155, P927, DOI 10.1007/s10336-014-1075-3; Leighton GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091725; Leighton GM, 2015, J ORNITHOL, P1; MACLEAN G L, 1973, Ostrich, V44, P176, DOI 10.1080/00306525.1973.9639158; Monnin T, 2002, NATURE, V419, P61, DOI 10.1038/nature00932; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Quinones AE, 2016, P ROYAL SOC B, V371, P1; Raihani NJ, 2012, TRENDS ECOL EVOL, V27, P288, DOI 10.1016/j.tree.2011.12.004; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rat M, 2015, BEHAV ECOL SOCIOBIOL, V69, P437, DOI 10.1007/s00265-014-1856-y; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; REEVE HK, 1992, NATURE, V358, P147, DOI 10.1038/358147a0; REEVE HK, 1992, NATURE, V359, P823, DOI 10.1038/359823a0; Reeve HK, 1997, BEHAV ECOL, V8, P75, DOI 10.1093/beheco/8.1.75; Riehl C, 2010, CURR BIOL, V20, P1830, DOI 10.1016/j.cub.2010.09.005; SMITH JM, MAJOR TRANSITIONS EV; Stankowich T, 2002, ETHOLOGY, V108, P975, DOI 10.1046/j.1439-0310.2002.00830.x; Strassmann JE, 2011, P NATL ACAD SCI USA, V108, P10855, DOI 10.1073/pnas.1102451108; Taborsky M., 2016, COOPERATIVE BREEDING; Thompson FJ, 2014, BEHAV ECOL, V25, P706, DOI 10.1093/beheco/aru063; van Dijk RE, 2014, ECOL LETT, V17, P1141, DOI 10.1111/ele.12320; van Dijk RE, 2013, J AVIAN BIOL, V44, P102, DOI 10.1111/j.1600-048X.2012.05797.x; WHITE FN, 1975, IBIS, V117, P171, DOI 10.1111/j.1474-919X.1975.tb04205.x; Zottl M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2344; Zuur Alain F., 2009, P1	60	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150953	10.1371/journal.pone.0150953	http://dx.doi.org/10.1371/journal.pone.0150953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982704	Green Published, gold			2022-12-27	WOS:000372574900058
J	Qi, ZY; Wang, XL; Hao, S; Zhu, CL; He, WQ; Luo, WB				Qi, Zhengyang; Wang, Xiaolong; Hao, Shuang; Zhu, Chuanlin; He, Weiqi; Luo, Wenbo			Correlations of Electrophysiological Measurements with Identification Levels of Ancient Chinese Characters	PLOS ONE			English	Article							EXPERT OBJECT RECOGNITION; COGNITIVE-PROCESSES; FACE RECOGNITION; THETA; ALPHA; DELTA; COMPETITION; PERCEPTION; WORD; EEG	Studies of event-related potential (ERP) in the human brain have shown that the N170 component can reliably distinguish among different object categories. However, it is unclear whether this is true for different identifiable levels within a single category. In the present study, we used ERP recording to examine the neural response to different identification levels and orientations (upright vs. inverted) of Chinese characters. The results showed that P1, N170, and P250 were modulated by different identification levels of Chinese characters. Moreover, time frequency analysis showed similar results, indicating that identification levels were associated with object recognition, particularly during processing of a single categorical stimulus.	[Qi, Zhengyang; Wang, Xiaolong; Hao, Shuang; Zhu, Chuanlin; He, Weiqi; Luo, Wenbo] Liaoning Normal Univ, Res Ctr Brain & Cognit Neurosci, Dalian, Peoples R China; [Luo, Wenbo] Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China	Liaoning Normal University; Chongqing University of Arts & Sciences	He, WQ; Luo, WB (corresponding author), Liaoning Normal Univ, Res Ctr Brain & Cognit Neurosci, Dalian, Peoples R China.; Luo, WB (corresponding author), Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China.	weiqi79920686@sina.com; wenbo9390@sina.com			National Natural Science Foundation of China [31371033, 31170984]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	WL received the funding of the National Natural Science Foundation of China (31371033 and 31170984, http://www.nsfc.gov.cn/) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Campbell R, 2001, COGNITIVE BRAIN RES, V12, P233, DOI 10.1016/S0926-6410(01)00054-4; Cao XH, 2011, NEUROSCI LETT, V492, P165, DOI 10.1016/j.neulet.2011.02.002; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fan C, 2015, NEUROIMAGE, V110, P32, DOI 10.1016/j.neuroimage.2015.01.047; FARAH MJ, 1995, VISION RES, V35, P2089, DOI 10.1016/0042-6989(94)00273-O; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Hu L, 2014, J NEUROSCI, V34, P11439, DOI 10.1523/JNEUROSCI.1355-14.2014; Hu L, 2014, NEUROIMAGE, V84, P876, DOI 10.1016/j.neuroimage.2013.09.055; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kim KH, 2004, NEUROREPORT, V15, P1099, DOI 10.1097/00001756-200405190-00003; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Koyama S, 1998, NEUROPSYCHOLOGIA, V36, P83, DOI 10.1016/S0028-3932(97)00097-3; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rossion B, 2004, P NATL ACAD SCI USA, V101, P14521, DOI 10.1073/pnas.0405613101; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Rossion B, 2007, J COGNITIVE NEUROSCI, V19, P543, DOI 10.1162/jocn.2007.19.3.543; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Wang MY, 2011, BRAIN COGNITION, V77, P419, DOI 10.1016/j.bandc.2011.08.016; Wong ACN, 2005, COGN AFFECT BEHAV NE, V5, P306, DOI 10.3758/CABN.5.3.306; Wong ACN, 2007, VIS COGN, V15, P854, DOI 10.1080/13506280600948350; Yi SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118924; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zhang MX, 2011, PSYCHOPHYSIOLOGY, V48, P950, DOI 10.1111/j.1469-8986.2010.01153.x	35	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151133	10.1371/journal.pone.0151133	http://dx.doi.org/10.1371/journal.pone.0151133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982215	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900064
J	Rio-Rodriguez, D; Iglesias-Soler, E; del Olmo, MF				Rio-Rodriguez, Dan; Iglesias-Soler, Eliseo; Fernandez del Olmo, Miguel			Set Configuration in Resistance Exercise: Muscle Fatigue and Cardiovascular Effects	PLOS ONE			English	Article							K+-ATPASE ACTIVITY; BAROREFLEX SENSITIVITY; BLOOD-PRESSURE; PERCEIVED EXERTION; MOTOR CORTEX; STRENGTH; INHIBITION; INTENSITY; RESPONSES; RATINGS	Purpose Cardiovascular responses of traditional resistance (TS) training have been extensively explored. However, the fatigue mechanisms associated with an intra-set rest configuration (ISR) have not been investigated. This study compares two modalities of set configurations for resistance exercise that equates work to rest ratios and measures the central and peripheral fatigue in combination with cortical, hemodynamic and cardiovascular measures. Methods 11 subjects performed two isometric knee extension training sessions using TS and ISR configurations. Voluntary activation (VA), single twitch amplitude, low frequency fatigue (LFF), Mwave, motor evoked potential (MEP), short intracortical inhibition (SICI), intracortical facilitation (ICF) and heart rate variability were evaluated before and after each training session. During each session beat to beat heart rate, blood pressure and rate pressure product (RPP) were also evaluated. Results After exercise VA decreased significantly for TS but not for ISR (P < 0.001), single twitch amplitude and LFF values were lower for TS than ISR (P < 0.004), and SICI was reduced only for the TS configuration (P = 0.049). During exercise RPP values were significantly higher for the TS than for ISR (P = 0.001). RPP correlated with VA for TS (r = -.85 P < 0.001) suggesting a relationship between central fatigue and cardiovascular stress. Conclusions We conclude that ISR induced lower central and peripheral fatigue as well as lower cardiovascular stress in comparison with TS configuration. Our study suggests that set configuration is a key factor in the regulation of the neuromuscular and cardiovascular responses of resistance training.	[Rio-Rodriguez, Dan; Fernandez del Olmo, Miguel] Univ A Coruna, Fac Sports Sci & Phys Educ, Dept Phys Educ & Sport, Learning & Human Movement Control Grp, La Coruna, Spain; [Iglesias-Soler, Eliseo] Univ A Coruna, Fac Sports Sci & Phys Educ, Dept Phys Educ & Sport, Performance & Hlth Grp, La Coruna, Spain	Universidade da Coruna; Universidade da Coruna	del Olmo, MF (corresponding author), Univ A Coruna, Fac Sports Sci & Phys Educ, Dept Phys Educ & Sport, Learning & Human Movement Control Grp, La Coruna, Spain.	mafo@udc.es	Iglesias-Soler, Eliseo/G-5144-2010; Rio-Rodriguez, Dan/C-6775-2014	Iglesias-Soler, Eliseo/0000-0002-1212-4188; Fernandez del Olmo, Miguel/0000-0001-5325-503X; Rio-Rodriguez, Dan/0000-0002-1790-9013				Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Aughey RJ, 2007, J APPL PHYSIOL, V103, P39, DOI 10.1152/japplphysiol.00236.2006; Baum K, 2003, INT J SPORTS MED, V24, P441; Baumer T, 2002, EXP BRAIN RES, V146, P467, DOI 10.1007/s00221-002-1202-x; Bianchi AM, 1997, IEEE ENG MED BIOL, V16, P64, DOI 10.1109/51.620497; Bolgar MR, 2010, J SPORT SCI MED, V9, P557; Buchheit M, 2006, AM J PHYSIOL-HEART C, V291, pH451, DOI 10.1152/ajpheart.00008.2006; Buharin VE, 2014, J NEUROPHYSIOL, V111, P2656, DOI 10.1152/jn.00778.2013; Camm AJ, 1996, CIRCULATION, V93, P1043; Chin ER, 2006, CONTRIBUTION PH DEPE, P831; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Fisher JP, 2004, EXP PHYSIOL, V89, P639, DOI 10.1113/expphysiol.2004.028639; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gruet M, 2013, NEUROSCIENCE, V231, P384, DOI 10.1016/j.neuroscience.2012.10.058; Hardee JP, 2012, EUR J APPL PHYSIOL, V112, P3141, DOI 10.1007/s00421-011-2300-x; Heffernan KS, 2008, INT J SPORTS MED, V29, P289, DOI 10.1055/s-2007-965363; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Iglesias-Soler E, 2012, INT J SPORTS MED, V33, P351, DOI 10.1055/s-0031-1299699; Iglesias-Soler E, 2016, J SPORT SCI, V34, P1473, DOI 10.1080/02640414.2015.1119299; Iglesias-Soler E, 2015, CLIN PHYSIOL FUNCT I, V35, P250, DOI 10.1111/cpf.12158; Izquierdo M, 2006, J APPL PHYSIOL, V100, P1647, DOI 10.1152/japplphysiol.01400.2005; Kardos A, 2001, HYPERTENSION, V37, P911, DOI 10.1161/01.HYP.37.3.911; Keller-Ross ML, 2014, J APPL PHYSIOL, V116, P767, DOI 10.1152/japplphysiol.01129.2013; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Lagally KM, 2006, J STRENGTH COND RES, V20, P252, DOI 10.1519/00124278-200605000-00003; Leppik JA, 2004, J APPL PHYSIOL, V97, P1414, DOI 10.1152/japplphysiol.00964.2003; Maruyama A, 2006, CLIN NEUROPHYSIOL, V117, P864, DOI 10.1016/j.clinph.2005.12.019; Mayo X, 2014, PERCEPT MOTOR SKILL, V119, P825, DOI 10.2466/25.29.PMS.119c30z3; McCartney N, 1999, MED SCI SPORT EXER, V31, P31, DOI 10.1097/00005768-199901000-00007; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Millar PJ, 2014, SPORTS MED, V44, P345, DOI 10.1007/s40279-013-0118-x; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Mitchell JH, 2013, EXP PHYSIOL, V98, P867, DOI 10.1113/expphysiol.2012.071001; Morris MG, 2012, EUR J APPL PHYSIOL, V112, P337, DOI 10.1007/s00421-011-1970-8; Niemela TH, 2008, MED SCI SPORT EXER, V40, P864, DOI 10.1249/MSS.0b013e3181666f08; Ridding MC, 1999, EXP BRAIN RES, V126, P536, DOI 10.1007/s002210050762; SCHOTT J, 1995, EUR J APPL PHYSIOL O, V71, P337, DOI 10.1007/BF00240414; Stanley J, 2013, SPORTS MED, V43, P1259, DOI 10.1007/s40279-013-0083-4; Taylor AC, 2003, MED SCI SPORT EXER, V35, P251, DOI 10.1249/01.MSS.0000048725.15026.B5; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Tergau F, 2000, MED SCI SPORT EXER, V32, P1942, DOI 10.1097/00005768-200011000-00019; WESTERBLAD H, 1993, J APPL PHYSIOL, V75, P382, DOI 10.1152/jappl.1993.75.1.382	44	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151163	10.1371/journal.pone.0151163	http://dx.doi.org/10.1371/journal.pone.0151163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982500	gold, Green Submitted, Green Published			2022-12-27	WOS:000372574900066
J	Shaeib, F; Khan, SN; Thakur, M; Kohan-Ghadr, HR; Drewlo, S; Saed, GM; Pennathur, S; Abu-Soud, HM				Shaeib, Faten; Khan, Sana N.; Thakur, Mili; Kohan-Ghadr, Hamid-Reza; Drewlo, Sascha; Saed, Ghassan M.; Pennathur, Subramaniam; Abu-Soud, Husam M.			The Impact of Myeloperoxidase and Activated Macrophages on Metaphase II Mouse Oocyte Quality	PLOS ONE			English	Article							OXIDATIVE STRESS; HYDROGEN-PEROXIDE; NITRIC-OXIDE; PERITONEAL-FLUID; INFLAMMATORY MARKERS; FEMALE REPRODUCTION; MELATONIN; ENDOMETRIOSIS; INFERTILITY; IRON	Myeloperoxidase (MPO), an abundant heme-containing enzyme present in neutrophils, monocytes, and macrophages, is produced in high levels during inflammation, and associated with poor reproductive outcomes. MPO is known to generate hypochlorous acid (HOCl), a damaging reactive oxygen species (ROS) utilizing hydrogen peroxide (H2O2) and chloride (Cl-). Here we investigate the effect of activated immune cells and MPO on oocyte quality. Mouse metaphase II oocytes were divided into the following groups: 1) Incubation with a catalytic amount of MPO (40 nM) for different incubation periods in the presence of 100 mM Cl- with and without H2O2 and with and without melatonin (100 mu M), at 37 degrees C (n = 648/648 total number of oocytes in each group for oocytes with and without cumulus cells); 2) Co-cultured with activated mouse peritoneal macrophage and neutrophils cells (1.0 x 10(6) cells/ml) in the absence and presence ofmelatonin (200 mu M), an MPO inhibitor/ROS scavenger, for different incubation periods in HTF media, at 37 degrees C (n = 200/200); 3) Untreated oocytes incubated for 4 hrs as controls (n = 73/64). Oocytes were then fixed, stained and scored based on the microtubule morphology and chromosomal alignment. All treatments were found to negatively affect oocyte quality in a time dependent fashion as compared to controls. In all cases the presence of cumulus cells offered no protection; however significant protection was offered by melatonin. Similar results were obtained with oocytes treated with neutrophils. This work provides a direct link between MPO and decreased oocyte quality. Therefore, strategies to decrease MPO mediated inflammation may influence reproductive outcomes.	[Shaeib, Faten; Khan, Sana N.; Thakur, Mili; Kohan-Ghadr, Hamid-Reza; Drewlo, Sascha; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Shaeib, Faten; Khan, Sana N.; Thakur, Mili; Kohan-Ghadr, Hamid-Reza; Drewlo, Sascha; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA; [Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; University of Michigan System; University of Michigan; Wayne State University	Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA.; Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA.; Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	habusoud@med.wayne.edu	Kohan-Ghadr, Hamid-Reza/ABB-4848-2020; Drewlo, Sascha/AAS-9890-2020		National Institutes of Health [RO1HL066367, R01HL094230]; Children's Hospital of Michigan; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center [DK089503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094230, R01HL066367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant RO1HL066367 and R01HL094230, the Children's Hospital of Michigan, and the Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center (DK089503).	Agarwal A, 2004, REPROD BIOMED ONLINE, V9, P338, DOI 10.1016/S1472-6483(10)62151-7; Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Alvarez C, 2013, INDIAN J MED RES, V137, P331; Amjadi Fatemehsadat, 2014, Adv Biomed Res, V3, P1, DOI 10.4103/2277-9175.124626; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; [Anonymous], 1989, NEW ENGL J MED, V321, P327, DOI [10.1056/NEJM198908033210513, DOI 10.1056/NEJM198908033210513]; Arain F, 2015, PAK J MED SCI, V31, P694, DOI 10.12669/pjms.313.8003; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Banerjee J, 2013, FERTIL STERIL, V100, P578, DOI 10.1016/j.fertnstert.2013.04.030; Banerjee J, 2012, J PINEAL RES, V53, P122, DOI 10.1111/j.1600-079X.2012.00977.x; Banerjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035535; BEERS RF, 1952, J BIOL CHEM, V195, P133; Blair SA, 2013, J REPROD MED, V58, P107; Buyalos RP, 2000, CURR OPIN OBSTET GYN, V12, P377, DOI 10.1097/00001703-200010000-00006; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067; Cohen J, 2015, J ASSIST REPROD GEN, V32, P263, DOI 10.1007/s10815-014-0390-1; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; D'Angiolella V, 2007, CELL CYCLE, V6, P576, DOI 10.4161/cc.6.5.3934; da Silva CM, 2014, BIOMED PHARMACOTHER, V68, P899, DOI 10.1016/j.biopha.2014.08.005; Dalla Sega FV, 2014, BBA-MOL CELL RES, V1843, P806, DOI 10.1016/j.bbamcr.2014.01.011; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; DXTaRJR Annia Galano, 2013, AMFK AMK J PINEAL RE, V54, P245, DOI [10.1111/jpi.12010, DOI 10.1111/JPI.12010]; Edelstam G, 1998, INFLAMMATION, V22, P341, DOI 10.1023/A:1022322814288; EDELSTAM GAB, 1994, INFLAMMATION, V18, P141, DOI 10.1007/BF01534555; Eroglu A, 1998, FERTIL STERIL, V69, P944, DOI 10.1016/S0015-0282(98)00030-2; Eryilmaz OG, 2011, J ASSIST REPROD GEN, V28, P815, DOI 10.1007/s10815-011-9604-y; Fenton P J.., 2007, PURE APPL CHEM, V79, P2325; Findlay JK, 1994, MOL BIOL FEMALE REPR; Galijasevic S, 2008, BIOCHEMISTRY-US, V47, P2668, DOI 10.1021/bi702016q; Gazvani R, 2002, REPRODUCTION, V123, P217, DOI 10.1530/rep.0.1230217; Gorudko I. V., 2012, Biomeditsinskaya Khimiya, V58, P475; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Goud AP, 2006, BIOCHEMISTRY-US, V45, P11366, DOI 10.1021/bi060910e; Goud AP, 2005, BIOCHEMISTRY-US, V44, P11361, DOI 10.1021/bi050711f; Goud PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098720; Goud PT, 2014, FERTIL STERIL, V102, P151, DOI 10.1016/j.fertnstert.2014.03.053; Grulke S, 2008, CAN J VET RES, V72, P37; Gulcin I, 2003, J PINEAL RES, V34, P278; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HANEY AF, 1983, FERTIL STERIL, V39, P310; HONDA R, 1994, HUM REPROD, V9, P692, DOI 10.1093/oxfordjournals.humrep.a138573; Hugentobler SA, 2007, THERIOGENOLOGY, V68, P538, DOI 10.1016/j.theriogenology.2007.04.049; Imirzalioglu P, 2005, J PERIODONTOL, V76, P737, DOI 10.1902/jop.2005.76.5.737; Janeway A. A., 2001, IMMUNOBIOLOGY IMMUNE; Johnson JL, 2011, INFECT IMMUN, V79, P3607, DOI 10.1128/IAI.05043-11; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Khan SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132388; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kurdoglu Z, 2012, GYNECOL ENDOCRINOL, V28, P115, DOI 10.3109/09513590.2011.583959; Lamaita RM, 2012, REPROD SCI, V19, P704, DOI 10.1177/1933719111428518; Lamaita RM, 2012, J OBSTET GYNAECOL RE, V38, P810, DOI 10.1111/j.1447-0756.2011.01805.x; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lee SA, 2010, FERTIL STERIL, V93, P1260, DOI 10.1016/j.fertnstert.2008.11.024; Lindley EM, 2001, J ASSIST REPROD GEN, V18, P534, DOI 10.1023/A:1011991806423; LONDON SN, 1985, FERTIL STERIL, V43, P274; Lord T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106450; Lu T, 2008, BRIT J PHARMACOL, V154, P1308, DOI 10.1038/bjp.2008.173; Machado JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/350195; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Malpaux B, 2002, REPRODUCTION, P167; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Miyake Y, 2006, BIOL REPROD, V74, P501, DOI 10.1095/biolreprod.105.045641; MOTTA PM, 1995, HUM REPROD, V10, P2361; Ogino T, 2009, ADV EXP MED BIOL, V643, P451, DOI 10.1007/978-0-387-75681-3_47; OLIVE DL, 1985, FERTIL STERIL, V44, P772; Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Proteasa G, 2007, BIOCHEMISTRY-US, V46, P398, DOI 10.1021/bi0609725; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; Rambow J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00199; Rees MD, 2014, FREE RADICAL BIO MED, V72, P91, DOI 10.1016/j.freeradbiomed.2014.03.037; Reiter R J, 1980, Endocr Rev, V1, P109; Reiter RJ, 2012, MUTAT RES-REV MUTAT, V751, P7, DOI 10.1016/j.mrrev.2011.12.002; Riley CF, 2007, ACTA OBSTET GYN SCAN, V86, P877, DOI 10.1080/00016340701417398; Ruder EH, 2009, CURR OPIN OBSTET GYN, V21, P219, DOI 10.1097/GCO.0b013e32832924ba; Shaeib F, 2016, REPROD SCI, V23, P498, DOI 10.1177/1933719115607993; Shaeib F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120737; Shaeib F, 2013, FREE RADICAL BIO MED, V58, P154, DOI 10.1016/j.freeradbiomed.2012.12.007; Sliskovic I, 2009, FREE RADICAL BIO MED, V47, P1005, DOI 10.1016/j.freeradbiomed.2009.07.007; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Surrey ES, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/482959; Szaboova R, 2015, LONDON J PRIM CARE, V7, P55, DOI 10.1080/17571472.2015.11494378; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Talwar, MANUAL ASSISTED REPR, P280; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Tamura H, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-5; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Trinder D, 2002, GUT, V51, P290, DOI 10.1136/gut.51.2.290; Tripathi A, 2009, FREE RADICAL RES, V43, P287, DOI 10.1080/10715760802695985; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Valavanidis A, 2013, INT J ENV RES PUB HE, V10, P3886, DOI 10.3390/ijerph10093886; Gomez FJV, 2012, J PINEAL RES, V52, P349, DOI 10.1111/j.1600-079X.2011.00949.x; Wiersma JJ, 2008, MED SCI MONITOR, V14, pCR406; Wu RJ, 2004, HUM REPROD UPDATE, V10, P119, DOI 10.1093/humupd/dmh011; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200; ZELLER JM, 1987, AM J REPROD IMMUNOL, V13, P78	101	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151160	10.1371/journal.pone.0151160	http://dx.doi.org/10.1371/journal.pone.0151160			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982351	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900065
J	Goodger, JQD; Seneratne, SL; Nicolle, D; Woodrow, IE				Goodger, Jason Q. D.; Seneratne, Samiddhi L.; Nicolle, Dean; Woodrow, Ian E.			Foliar Essential Oil Glands of Eucalyptus Subgenus Eucalyptus (Myrtaceae) Are a Rich Source of Flavonoids and Related Non-Volatile Constituents	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PHENOLIC-COMPOUNDS; SECRETORY CAVITIES; LEAVES; PINOCEMBRIN; FLAVANONES; METABOLITES; AGLYCONES; IDENTIFICATION; COMPONENTS	The sub-dermal secretory cavities (glands) embedded within the leaves of Eucalyptus (Myrtaceae) were once thought to be the exclusive repositories of monoterpene and sesquiterpene oils. Recent research has debunked this theory and shown that abundant non-volatile compounds also occur within foliar glands. In particular, glands of four species in subgenus Eucalyptus contain the biologically active flavanone pinocembrin. Pinocembrin shows great promise as a pharmaceutical and is predominantly plant-sourced, so Eucalyptus could be a potential commercial source of such compounds. To explore this we quantified and assessed the purity of pinocembrin in glands of 11 species of E. subg. Eucalyptus using Electro-Spray Ionisation Liquid Chromatography Mass Spectrometry of acetonitrile extracts and Gas Chromatography Mass Spectrometry analyses of hexane extracts of isolated glands which were free from other leaf tissues. Our results showed that the glands of subgenus Eucalyptus contain numerous flavanones that are structurally related to pinocembrin and often present in much greater abundance. The maximum concentration of pinocembrin was 2 mg g(-1) dry leaf found in E. stellulata, whereas that of dimethylpinocembrin (5,7-dimethoxyflavanone) was 10 mg g(-1) in E. oreades and that of pinostrobin (5-hydroxy-7-methoxyflavanone) was 12 mg g(-1) in E. nitida. We also found that the flavanones are exclusively located within the foliar glands rather than distributed throughout leaf tissues. The flavanones differ from the non-methylated pinocembrin in the degree and positions of methylation. This finding is particularly important given the attractiveness of methylated flavonoids as pharmaceuticals and therapeutics. Another important finding was that glands of some members of the subgenus also contain flavanone O-glucosides and flavanone-beta-triketone conjugates. In addition, glands contain free beta-triketones, beta-triketone heterodimers and chromone C-glucosides. Therefore, the foliar glands of this taxonomically distinct group of plants are a rich source of a range of flavonoids and other biologically active compounds with great commercial potential.	[Goodger, Jason Q. D.; Seneratne, Samiddhi L.; Woodrow, Ian E.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Nicolle, Dean] Currency Creek Arboretum, POB 808 Melrose Pk, Currency Creek, SA 5039, Australia	University of Melbourne	Goodger, JQD (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia.	jgoodger@unimelb.edu.au		Goodger, Jason/0000-0001-7392-3891	Australian Research Council [DP1094530, LP150100798]; Holsworth Wildlife Research Fund	Australian Research Council(Australian Research Council); Holsworth Wildlife Research Fund	This research was funded by the Australian Research Council (DP1094530 to JG and LP150100798 to IW) and the Holsworth Wildlife Research Fund (to SS; managed by Equity Trustees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib AM, 2014, PHARM BIOL, V52, P698; Agrawal A.D, 2011, INT J PHARM SCI NANO, V4, P1394, DOI DOI 10.1056/NEJM197302222880814; Al-Sayed E, 2014, PHARM BIOL, V52, P698, DOI 10.3109/13880209.2013.865240; [Anonymous], 2015, PHAS 2 STUD PIN INJ; Appendino G, 2002, J NAT PROD, V65, P334, DOI 10.1021/np010441b; Aziz N, 2005, PLANTA, V221, P28, DOI 10.1007/s00425-004-1424-1; BICK IRC, 1972, AUST J CHEM, V25, P449, DOI 10.1071/CH9720449; BLOOR SJ, 1992, J NAT PROD, V55, P43, DOI 10.1021/np50079a006; Bosabalidis A, 1998, PHYTOCHEMISTRY, V49, P1549, DOI 10.1016/S0031-9422(98)00186-1; Brooker MIH, 2013, ATLAS LEAF VENATION; Costa DC, 2015, TRENDS FOOD SCI TECH, V45, P336, DOI 10.1016/j.tifs.2015.06.009; Chen ZJ, 2014, CURR DRUG METAB, V15, P48, DOI 10.2174/138920021501140218125020; Coutinho I. D., 2008, Ecletica Quimica, V33, P53, DOI 10.1590/S0100-46702008000400007; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; Feld H, 2003, PHYTOCHEMISTRY, V64, P1335, DOI 10.1016/j.phytochem.2003.08.021; Fiorini-Puybaret C, 2011, PLANTA MED, V77, P1582, DOI 10.1055/s-0030-1270955; Fowler ZL, 2009, APPL MICROBIOL BIOT, V83, P799, DOI 10.1007/s00253-009-2039-z; Goodger JQD, 2008, FUNCT PLANT BIOL, V35, P247, DOI 10.1071/FP07241; Goodger JQD, 2007, FOREST ECOL MANAG, V250, P196, DOI 10.1016/j.foreco.2007.05.015; Goodger JQD, 2012, TREES-STRUCT FUNCT, V26, P1951, DOI 10.1007/s00468-012-0744-1; Goodger JQD, 2011, PHYTOCHEMISTRY, V72, P2259, DOI 10.1016/j.phytochem.2011.08.026; Goodger JQD, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-20; Goodger JQD, 2009, PHYTOCHEMISTRY, V70, P1187, DOI 10.1016/j.phytochem.2009.06.004; Guo WW, 2015, J SEP SCI, V38, P2789, DOI 10.1002/jssc.201500303; Haberlein H, 1998, BIOCHEM SYST ECOL, V26, P97, DOI 10.1016/S0305-1978(97)00084-7; Han AR, 2010, J KOREAN SOC APPL BI, V53, P847, DOI 10.3839/jksabc.2010.129; Harris SM, 2011, NAT PROD COMMUN, V6, P1421; Heskes AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040856; Ito H, 2004, TETRAHEDRON, V60, P9971, DOI 10.1016/j.tet.2004.08.027; Ito H, 2004, J NAT PROD, V67, P411, DOI 10.1021/np030367s; Ito H, 2000, J NAT PROD, V63, P1253, DOI 10.1021/np0001981; JAIPETCH T, 1983, PHYTOCHEMISTRY, V22, P625, DOI 10.1016/0031-9422(83)83075-1; Kamiya K, 2010, FITOTERAPIA, V81, P185, DOI 10.1016/j.fitote.2009.08.021; Khambay BPS, 2002, PHYTOCHEMISTRY, V59, P69, DOI 10.1016/S0031-9422(01)00410-1; Killeen DP, 2015, NEW PHYTOL, V205, P339, DOI 10.1111/nph.12970; Kim HJ, 2001, PLANTA MED, V67, P277, DOI 10.1055/s-2001-11993; Kuo YC, 2004, PLANTA MED, V70, P1237, DOI 10.1055/s-2004-835859; Labbe C, 2002, COLLECT CZECH CHEM C, V67, P115, DOI 10.1135/cccc20020115; LAN X, 2016, MOL NEUROBIOL, V53, P1794, DOI DOI 10.1007/S12035-015-9125-2; Lee CK, 1999, TETRAHEDRON LETT, V40, P7255, DOI 10.1016/S0040-4039(99)01489-6; Li AF, 2012, J LIQ CHROMATOGR R T, V35, P2900, DOI 10.1080/10826076.2011.643523; Ma YL, 1997, RAPID COMMUN MASS SP, V11, P1357; March RE, 2006, INT J MASS SPECTROM, V248, P61, DOI 10.1016/j.ijms.2005.09.011; Massaro CF, 2014, FITOTERAPIA, V95, P247, DOI 10.1016/j.fitote.2014.03.024; MAYER R, 1990, PHYTOCHEMISTRY, V29, P1340, DOI 10.1016/0031-9422(90)85462-O; Mohammed AMA, 2009, BIOCHEM SYST ECOL, V37, P241, DOI 10.1016/j.bse.2009.03.006; Peluso I, 2015, CRIT REV FOOD SCI, V55, P383, DOI 10.1080/10408398.2012.656770; Portet B, 2008, J CHROMATOGR A, V1210, P45, DOI 10.1016/j.chroma.2008.09.055; Rameshkumar KB, 2015, NAT PROD RES, V29, P1276, DOI 10.1080/14786419.2014.994210; Rasul A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379850; Santos SAO, 2012, IND CROP PROD, V39, P120, DOI 10.1016/j.indcrop.2012.02.003; Saraf I, 2015, NAT PROD COMMUN, V10, P379; Sayre CL, 2013, BIOMED CHROMATOGR, V27, P681, DOI 10.1002/bmc.2853; Simirgiotis MJ, 2008, FOOD CHEM, V107, P813, DOI 10.1016/j.foodchem.2007.08.086; Solanki L, 2015, ADV NUTR, V6, P64, DOI 10.3945/an.114.007500; Tattini M, 1999, CAN J BOT, V77, P969, DOI 10.1139/cjb-77-7-969; Terahara N, 2015, NAT PROD COMMUN, V10, P521; Tian LW, 2012, CHEM BIODIVERS, V9, P123, DOI 10.1002/cbdv.201100021; Tsui WY, 1996, TETRAHEDRON, V52, P9735, DOI 10.1016/0040-4020(96)00510-8; Tucker DJ, 2010, J CHEM ECOL, V36, P727, DOI 10.1007/s10886-010-9803-5; VOIRIN B, 1993, PHYTOCHEMISTRY, V34, P85, DOI 10.1016/S0031-9422(00)90787-8; Waridel P, 2001, J CHROMATOGR A, V926, P29, DOI 10.1016/S0021-9673(01)00806-8; Wen X, 2006, XENOBIOTICA, V36, P387, DOI 10.1080/00498250600630636; Wen X, 2006, DRUG METAB DISPOS, V34, P1786, DOI 10.1124/dmd.106.011122; Wilson Mark A., 2008, BMC Pharmacology, V8, P15, DOI 10.1186/1471-2210-8-15; Yamamoto N, 2011, PHYTOTHER RES, V25, P1218, DOI 10.1002/ptr.3416; Yang QY, 2012, CHINESE J CHEM, V30, P1315, DOI 10.1002/cjoc.201200201; Yang ZH, 2012, J ASIAN NAT PROD RES, V14, P14, DOI 10.1080/10286020.2011.620393	69	28	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151432	10.1371/journal.pone.0151432	http://dx.doi.org/10.1371/journal.pone.0151432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977933	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800074
J	Hellmund, A; Berg, C; Geipel, A; Bludau, M; Heydweiller, A; Bachour, H; Muller, A; Muller, A; Gembruch, U				Hellmund, Astrid; Berg, Christoph; Geipel, Annegret; Bludau, Meike; Heydweiller, Andreas; Bachour, Haitham; Mueller, Andreas; Mueller, Annette; Gembruch, Ulrich			Prenatal Diagnosis and Evaluation of Sonographic Predictors for Intervention and Adverse Outcome in Congenital Pulmonary Airway Malformation	PLOS ONE			English	Article							CYSTIC ADENOMATOID MALFORMATION; FETAL LUNG LESIONS; EXTRACORPOREAL MEMBRANE-OXYGENATION; HEAD CIRCUMFERENCE RATIO; DIAPHRAGMATIC-HERNIA; BRONCHIOLOALVEOLAR CARCINOMA; PLEUROPULMONARY BLASTOMA; MANAGEMENT; HYDROPS; EXPERIENCE	Objective To describe antenatal findings and evaluate prenatal risk parameters for adverse outcome or need for intervention in fetuses with congenital pulmonary airway malformation (CPAM). Methods In our retrospective study all fetuses with a prenatal diagnosis of CPAM detected in our tertiary referral center between 2002 and 2013 were analyzed. Sonographic findings were noted and measurements of mass-to-thorax-ratio (MTR), congenital pulmonary airway malformation volume-ratio (CVR) and observed to expected lung-to head-ratio (o/e LHR) were conducted and correlated to fetal or neonatal morbidity and mortality and/or need for prenatal intervention. Results 67 fetuses with CPAM were included in the study. Hydropic fetuses were observed in 16.4% (11/67) of cases, prenatal intervention was undertaken in 9 cases; 7 pregnancies were terminated. The survival rate of non-hydropic fetuses with conservatively managed CPAM was 98.0%(50/51), the survival rate for hydropic fetuses with intention to treat was 42.9% (3/7). 10 (18.2%) children needed respiratory assistance. Fetuses with a CVR of <0.91 were significantly less likely to experience adverse outcome or need for prenatal intervention with sensitivity, specificity and positive/negative predictive value of 0.89, 0.71, 0.62 and 0.93, respectively. A MTR (mass-to-thorax-ratio) of <0.51 had a positive predictive value of 0.54 and a negative predictive value of 0.96 of adverse events with a sensitivity of 0.95 and a specificity of 0.63. The negative predictive value for o/e LHR of 45% was 0.84 with sensitivity, specificity and positive predictive value of 0.73, 0.68 and 0.52, respectively. Conclusions The majority of cases with CPAM have a favorable outcome. MTR and CVR are able to identify fetuses at risk, the o/e LHR is less sensitive.	[Hellmund, Astrid; Berg, Christoph; Geipel, Annegret; Bludau, Meike; Gembruch, Ulrich] Univ Bonn, Dept Obstet & Prenatal Med, Bonn, Germany; [Berg, Christoph] Univ Cologne, Div Prenatal Med & Gynecol Sonog, Dept Obstet & Gynecol, D-50931 Cologne, Germany; [Heydweiller, Andreas; Bachour, Haitham] Univ Bonn, Div Pediat Surg, Bonn, Germany; [Mueller, Andreas] Univ Bonn, Dept Neonatol, Bonn, Germany; [Mueller, Annette] Univ Bonn, Dept Pathol, Bonn, Germany	University of Bonn; University of Cologne; University of Bonn; University of Bonn; University of Bonn	Hellmund, A (corresponding author), Univ Bonn, Dept Obstet & Prenatal Med, Bonn, Germany.	Astrid.Hellmund@ukb.uni-bonn.de	Gembruch, Ulrich/Q-8228-2017	Gembruch, Ulrich/0000-0001-8284-4669				Achiron R, 2004, ULTRASOUND OBST GYN, V24, P107, DOI 10.1002/uog.1110; Adzick N Scott, 2003, Semin Pediatr Surg, V12, P10, DOI 10.1016/S1055-8586(03)70003-1; Adzick NS, 2010, SEMIN FETAL NEONAT M, V15, P1, DOI 10.1016/j.siny.2009.05.003; Adzick NS, 2009, CLIN PERINATOL, V36, P363, DOI 10.1016/j.clp.2009.03.001; Adzick NS, 1998, AM J OBSTET GYNECOL, V179, P884, DOI 10.1016/S0002-9378(98)70183-8; ADZICK NS, 1993, WORLD J SURG, V17, P342, DOI 10.1007/BF01658702; Aziz D, 2004, J PEDIATR SURG, V39, P329, DOI 10.1016/j.jpedsurg.2003.11.021; Baird R, 2014, SEMIN PEDIATR SURG, V23, P270, DOI 10.1053/j.sempedsurg.2014.09.007; Bebbington M, 2014, ULTRASOUND OBST GYN, V43, P670, DOI 10.1002/uog.13271; Bunduki V, 2000, PRENATAL DIAG, V20, P459, DOI 10.1002/1097-0223(200006)20:6<459::AID-PD851>3.0.CO;2-F; Cavoretto P, 2008, ULTRASOUND OBST GYN, V32, P769, DOI 10.1002/uog.6218; Crombleholme TM, 2002, J PEDIATR SURG, V37, P331, DOI 10.1053/jpsu.2002.30832; Cruz-Martinez R, 2015, ULTRASOUND OBST GYN, V46, P627, DOI 10.1002/uog.14921; Cruz-Martinez R, 2010, ULTRASOUND OBST GYN, V36, P32, DOI 10.1002/uog.7577; Cruz-Martinez R, 2015, FETAL DIAGN THER, V37, P75, DOI 10.1159/000361015; Curran PF, 2010, J PEDIATR SURG, V45, P145, DOI 10.1016/j.jpedsurg.2009.10.025; Davenport M, 2004, J PEDIATR SURG, V39, P549, DOI 10.1016/j.jpedsurg.2003.12.021; Dommergues M, 1997, AM J OBSTET GYNECOL, V177, P953, DOI 10.1016/S0002-9378(97)70300-4; Durell J, 2014, EARLY HUM DEV, V90, P935, DOI 10.1016/j.earlhumdev.2014.09.014; Ehrenberg-Buchner S, 2013, AM J OBSTET GYNECOL, V208, pe151; Grabowska K, 2013, FETAL THERAPY SCI BA; Granata C, 1998, PEDIATR PULM, V25, P62, DOI 10.1002/(SICI)1099-0496(199801)25:1<62::AID-PPUL8>3.0.CO;2-Q; Grethel EJ, 2007, J PEDIATR SURG, V42, P117, DOI 10.1016/j.jpedsurg.2006.09.060; Hadchouel A, 2011, ULTRASOUND OBST GYN, V38, P88, DOI 10.1002/uog.8909; Heling KS, 2005, ULTRASOUND OBST GYN, V25, P112, DOI 10.1002/uog.1837; Ierullo AM, 2005, ULTRASOUND OBST GYN, V26, P150, DOI 10.1002/uog.1920; Jani J, 2007, ULTRASOUND OBST GYN, V30, P67, DOI 10.1002/uog.4052; Kilian AK, 2009, KLIN PADIATR, V221, P295, DOI 10.1055/s-0029-1192022; Kunisaki SM, 2007, J PEDIATR SURG, V42, P404, DOI 10.1016/j.jpedsurg.2006.10.014; Kunisaki SM, 2015, J PEDIATR SURG, V50, P978, DOI 10.1016/j.jpedsurg.2015.03.025; Laberge Jean-Martin, 2005, Semin Pediatr Surg, V14, P16, DOI 10.1053/j.sempedsurg.2004.10.022; Laberge JM, 2001, FETAL DIAGN THER, V16, P178, DOI 10.1159/000053905; Li J, 2014, FETAL PEDIATR PATHOL, V33, P29, DOI 10.3109/15513815.2013.842272; Lima JS, 2014, J MATERN-FETAL NEO M, V27, P228, DOI 10.3109/14767058.2013.807236; Loh KC, 2012, J PEDIATR SURG, V47, P36, DOI 10.1016/j.jpedsurg.2011.10.015; Miniati DN, 2006, J PEDIATR SURG, V41, P66, DOI 10.1016/j.jpedsurg.2005.10.074; Miyoshi T, 2013, FETAL DIAGN THER, V34, P19, DOI 10.1159/000348776; Morris LM, 2009, J PEDIATR SURG, V44, P60, DOI 10.1016/j.jpedsurg.2008.10.012; Nasr A, 2010, J PEDIATR SURG, V45, P1086, DOI 10.1016/j.jpedsurg.2010.02.067; Ng C, 2014, ARCH DIS CHILD, V99, P432, DOI 10.1136/archdischild-2013-304048; Odibo AO, 2010, PRENATAL DIAG, V30, P518, DOI 10.1002/pd.2508; Ozcan C, 2001, J PEDIATR SURG, V36, P1062, DOI 10.1053/jpsu.2001.24747; Papagiannopoulos K, 2002, ANN THORAC SURG, V73, P1594, DOI 10.1016/S0003-4975(02)03469-0; Priest JR, 2009, PEDIATR PULM, V44, P14, DOI 10.1002/ppul.20917; RICE HE, 1994, J PEDIATR SURG, V29, P692, DOI 10.1016/0022-3468(94)90743-9; Ruano R, 2012, PRENATAL DIAG, V32, P1127, DOI 10.1002/pd.3969; Sauvat F, 2003, J PEDIATR SURG, V38, P548, DOI 10.1053/jpsu.2003.50119; Schrey S, 2012, ULTRASOUND OBST GYN, V39, P515, DOI 10.1002/uog.11084; Stanton M, 2009, J PEDIATR SURG, V44, P1027, DOI 10.1016/j.jpedsurg.2008.10.118; STOCKER JT, 1977, HUM PATHOL, V8, P155, DOI 10.1016/S0046-8177(77)80078-6; Stoiber B, 2015, ULTRASCHALL MED; THORPEBEESTON JG, 1994, PRENATAL DIAG, V14, P677, DOI 10.1002/pd.1970140807; Vu L, 2007, J PEDIATR SURG, V42, P1351, DOI 10.1016/j.jpedsurg.2007.03.039; Wall J, 2014, CURR OPIN PEDIATR, V26, P315, DOI 10.1097/MOP.0000000000000091; Wilson RD, 2006, AM J MED GENET A, V140A, P151, DOI 10.1002/ajmg.a.31031; Witlox RS, 2011, PRENATAL DIAG, V31, P628, DOI 10.1002/pd.2778; Yamashita A, 2015, J CLIN ULTRASOUND, V43, P451, DOI 10.1002/jcu.22214; Yinon Y, 2010, ULTRASOUND OBST GYN, V36, P58, DOI 10.1002/uog.7507; Yong PJ, 2012, FETAL DIAGN THER, V31, P94, DOI 10.1159/000331936	59	36	43	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150474	10.1371/journal.pone.0150474	http://dx.doi.org/10.1371/journal.pone.0150474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978067	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800027
J	Kwak, J; Strasser, E; Luzynski, K; Thoss, M; Penn, DJ				Kwak, Jae; Strasser, Eva; Luzynski, Ken; Thoss, Michaela; Penn, Dustin J.			Are MUPs a Toxic Waste Disposal System?	PLOS ONE			English	Article							MAJOR URINARY PROTEINS; PHEROMONE BINDING; VOLATILE LIGANDS; MULTIPLE ROLES; HOUSE MOUSE; LIPOCALINS; 2,4-DI-TERT-BUTYLPHENOL; TOXICOKINETICS; MICE; RAT	Male house mice produce large quantities of major urinary proteins (MUPs), which function to bind and transport volatile pheromones, though they may also function as scavengers that bind and excrete toxic compounds ('toxic waste hypothesis'). In this study, we demonstrate the presence of an industrial chemical, 2,4-di-tert-butylphenol (DTBP), in the urine of wild-derived house mice (Mus musculus musculus). Addition of guanidine hydrochloride to male and female urine resulted in an increased release of DTBP. This increase was only observed in the high molecular weight fractions (HMWF; > 3 kDa) separated from male or female urine, suggesting that the increased release of DTBP was likely due to the denaturation of MUPs and the subsequent release of MUP-bound DTBP. Furthermore, when DTBP was added to a HMWF isolated from male urine, an increase in 2-sec-butyl-4,5-dihydrothiazole (SBT), the major ligand of MUPs and a male-specific pheromone, was observed, indicating that DTBP was bound to MUPs and displaced SBT. These results suggest that DTBP is a MUP ligand. Moreover, we found evidence for competitive ligand binding between DTBP and SBT, suggesting that males potentially face a tradeoff between eliminating toxic wastes versus transporting pheromones. Our findings support the hypothesis that MUPs bind and eliminate toxic wastes, which may provide the most important fitness benefits of excreting large quantities of these proteins.	[Kwak, Jae] Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria; [Strasser, Eva; Luzynski, Ken; Thoss, Michaela; Penn, Dustin J.] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Kwak, J (corresponding author), Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria.	jaekwak@hotmail.com	Kwak, Jae/E-5781-2011	Kwak, Jae/0000-0003-4216-2019	Austrian Science Fund [FWF: P24711-B21]; Austrian Science Fund (FWF) [P 24711] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by a grant from the Austrian Science Fund https://www.fwf.ac.at (FWF: P24711-B21) to D.J. Penn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Choi SJ, 2013, J MED FOOD, V16, P977, DOI 10.1089/jmf.2012.2739; Flower DR, 1996, BIOCHEM J, V318, P1; Hagemeyer P, 2011, J CHEM ECOL, V37, P687, DOI 10.1007/s10886-011-9971-y; Hakk H, 2009, TOXICOL APPL PHARM, V241, P119, DOI 10.1016/j.taap.2009.08.009; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Kwak J, 2013, PHYSIOL BEHAV, V120, P211, DOI 10.1016/j.physbeh.2013.08.011; Kwak J, 2012, PHYSIOL BEHAV, V107, P112, DOI 10.1016/j.physbeh.2012.06.008; Kwak J, 2011, CHEM SENSES, V36, P443, DOI 10.1093/chemse/bjr015; LARSEN GL, 1990, XENOBIOTICA, V20, P1343, DOI 10.3109/00498259009046632; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Phelan MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108415; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Robertson D, 1998, J CHEM ECOL, V24, P1127, DOI 10.1023/A:1022434300449; Sharrow SD, 2002, PROTEIN SCI, V11, P2247, DOI 10.1110/ps.0204202; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Staskal DF, 2006, TOXICOL SCI, V94, P28, DOI 10.1093/toxsci/kfl091; Staskal DF, 2005, TOXICOL SCI, V83, P215, DOI 10.1093/toxsci/kfi018; Stopkova R, 2014, BIOCHEM SOC T, V42, P893, DOI 10.1042/BST20140053; Stopkova R, 2009, FOLIA ZOOL, V58, P29; TELFORD IR, 1962, AM J ANAT, V110, P29, DOI 10.1002/aja.1001100104; Thoss M, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00071; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; Yoon MA, 2006, BIOL PHARM BULL, V29, P735, DOI 10.1248/bpb.29.735	27	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151474	10.1371/journal.pone.0151474	http://dx.doi.org/10.1371/journal.pone.0151474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966901	Green Submitted, gold, Green Published			2022-12-27	WOS:000371989200057
J	Gao, Z; Sierra, A; Zhu, ZY; Koganti, SRK; Subbotina, E; Maheshwari, A; Anderson, ME; Zingman, LV; Hodgson-Zingman, DM				Gao, Zhan; Sierra, Ana; Zhu, Zhiyong; Koganti, Siva Rama Krishna; Subbotina, Ekaterina; Maheshwari, Ankit; Anderson, Mark E.; Zingman, Leonid V.; Hodgson-Zingman, Denice M.			Loss of ATP-Sensitive Potassium Channel Surface Expression in Heart Failure Underlies Dysregulation of Action Potential Duration and Myocardial Vulnerability to Injury	PLOS ONE			English	Article							KINASE-II; PHOSPHOLAMBAN PHOSPHORYLATION; K+ CHANNELS; ISCHEMIA/REPERFUSION INJURY; INHIBITION PROTECTS; CARDIAC-HYPERTROPHY; INTRACELLULAR CA2+; CAMKII; ISCHEMIA; KIR6.2	The search for new approaches to treatment and prevention of heart failure is a major challenge in medicine. The adenosine triphosphate-sensitive potassium (K-ATP) channel has been long associated with the ability to preserve myocardial function and viability under stress. High surface expression of membrane K-ATP channels ensures a rapid energy-sparing reduction in action potential duration (APD) in response to metabolic challenges, while cellular signaling that reduces surface K-ATP channel expression blunts APD shortening, thus sacrificing energetic efficiency in exchange for greater cellular calcium entry and increased contractile force. In healthy hearts, calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates the Kir6.2 K-ATP channel subunit initiating a cascade responsible for K-ATP channel endocytosis. Here, activation of CaMKII in a transaortic banding (TAB) model of heart failure is coupled with a 35-40% reduction in surface expression of K-ATP channels compared to hearts from sham-operated mice. Linkage between K-ATP channel expression and CaMKII is verified in isolated cardiomyocytes in which activation of CaMKII results in downregulation of K-ATP channel current. Accordingly, shortening of monophasic APD is slowed in response to hypoxia or heart rate acceleration in failing compared to nonfailing hearts, a phenomenon previously shown to result in significant increases in oxygen consumption. Even in the absence of coronary artery disease, failing myocardium can be further injured by ischemia due to a mismatch between metabolic supply and demand. Ischemia-reperfusion injury, following ischemic preconditioning, is diminished in hearts with CaMKII inhibition compared to wild-type hearts and this advantage is largely eliminated when myocardial K-ATP channel expression is absent, supporting that the myocardial protective benefit of CaMKII inhibition in heart failure may be substantially mediated by K-ATP channels. Recognition of CaMKII-dependent downregulation of K-ATP channel expression as a mechanism for vulnerability to injury in failing hearts points to strategies targeting this interaction for potential preventives or treatments.	[Gao, Zhan; Sierra, Ana; Zhu, Zhiyong; Koganti, Siva Rama Krishna; Subbotina, Ekaterina; Maheshwari, Ankit; Anderson, Mark E.; Zingman, Leonid V.; Hodgson-Zingman, Denice M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Anderson, Mark E.; Zingman, Leonid V.; Hodgson-Zingman, Denice M.] Univ Iowa, Francois Abboud Cardiovasc Res Ctr, Iowa City, IA USA; [Zingman, Leonid V.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA; [Zingman, Leonid V.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Koganti, Siva Rama Krishna] Texas Tech Univ, Hlth Sci Ctr, Abilene, TX USA; [Maheshwari, Ankit] Univ Minnesota, Minneapolis, MN USA; [Anderson, Mark E.] Johns Hopkins Univ, Baltimore, MD USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Texas Tech University System; Texas Tech University; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University	Hodgson-Zingman, DM (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.; Hodgson-Zingman, DM (corresponding author), Univ Iowa, Francois Abboud Cardiovasc Res Ctr, Iowa City, IA USA.	denice-zingman@uiowa.edu	Sierra, Ana/U-5997-2019; Zingman, Leonid V/GXG-0136-2022; Subbotina, Ekaterina/AAB-9670-2020	Zingman, Leonid V/0000-0002-7566-4616; Subbotina, Ekaterina/0000-0002-9659-6261; Hodgson-Zingman, Denice/0000-0002-6875-1367	National Institutes of Health [HL113089, DK092412, HL079031, HL070250, HL096652, HL113001]; VA Merit Review Program [1I0BX000718]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096652, R01HL113001, R01HL070250, R01HL113089, R01HL079031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Program(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [HL113089 to DMH-Z, DK092412 to LVZ, and HL079031, HL070250, HL096652, HL113001 to MEA] and the VA Merit Review Program [1I0BX000718 to LVZ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Alekseev AE, 2005, J MOL CELL CARDIOL, V38, P895, DOI 10.1016/j.yjmcc.2005.02.022; Alekseev AE, 2010, CELL METAB, V11, P58, DOI 10.1016/j.cmet.2009.11.009; Anderson ME, 2011, JMOLCELLCARDIOL; Ashcroft FM, 2000, TRENDS PHARMACOL SCI, V21, P439; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Bell JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00096; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Carmeliet E, 2004, CELL CALCIUM, V35, P557, DOI 10.1016/j.ceca.2004.01.010; Coronel R, 2013, BBA-MOL BASIS DIS, V1832, P2432, DOI 10.1016/j.bbadis.2013.04.002; Di Carlo MN, 2014, J MOL CELL CARDIOL, V74, P274, DOI 10.1016/j.yjmcc.2014.06.004; Eisner DA, 2009, EXP PHYSIOL, V94, P520, DOI 10.1113/expphysiol.2008.044008; Elrod JW, 2008, CIRCULATION, V117, P1405, DOI 10.1161/CIRCULATIONAHA.107.745539; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Foster MN, 2016, PHYSIOL REV, V96, P177, DOI 10.1152/physrev.00003.2015; Gumina RJ, 2007, AM J PHYSIOL-HEART C, V292, pH1706, DOI 10.1152/ajpheart.01305.2006; Hidalgo CG, 2013, J MOL CELL CARDIOL, V54, P90, DOI 10.1016/j.yjmcc.2012.11.012; Hodgson DM, 2003, EMBO J, V22, P1732, DOI 10.1093/emboj/cdg192; Huffman MD, 2013, J AM COLL CARDIOL, V61, P1510, DOI 10.1016/j.jacc.2013.01.022; Jahangir A, 2005, J MOL CELL CARDIOL, V39, P99, DOI 10.1016/j.yjmcc.2005.04.006; Kane GC, 2006, HUM MOL GENET, V15, P2285, DOI 10.1093/hmg/ddl154; Kronenberg MW, 2006, J NUCL CARDIOL, V13, P544, DOI 10.1016/j.nuclcard.2006.04.002; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Ling HY, 2013, CIRC RES, V112, P935, DOI 10.1161/CIRCRESAHA.112.276915; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu XK, 2004, DIABETES, V53, pS165, DOI 10.2337/diabetes.53.suppl_3.S165; Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268; Maier LS, 2009, FRONT BIOSCI-LANDMRK, V14, P486, DOI 10.2741/3257; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Moore RL, 2007, AM J PHYSIOL-HEART C, V292, pH1692, DOI 10.1152/ajpheart.00076.2007; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Neef Stefan, 2007, Curr Heart Fail Rep, V4, P11, DOI 10.1007/s11897-007-0020-7; NICHOLS CG, 1991, CIRC RES, V68, P280, DOI 10.1161/01.RES.68.1.280; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Purohit A, 2013, CIRCULATION, V128, P1748, DOI 10.1161/CIRCULATIONAHA.113.003313; Said M, 2011, J MOL CELL CARDIOL, V51, P936, DOI 10.1016/j.yjmcc.2011.08.010; Said M, 2003, AM J PHYSIOL-HEART C, V285, pH1198, DOI 10.1152/ajpheart.00209.2003; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Sierra A, 2013, J BIOL CHEM, V288, P1568, DOI 10.1074/jbc.M112.429548; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Tong XY, 2006, AM J PHYSIOL-HEART C, V291, pH543, DOI 10.1152/ajpheart.00051.2006; Valverde CA, 2006, CARDIOVASC RES, V70, P335, DOI 10.1016/j.cardiores.2006.01.018; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Vila-Petroff M, 2010, J MOL CELL CARDIOL, V49, P106, DOI 10.1016/j.yjmcc.2009.12.007; Vittone L, 2002, J MOL CELL CARDIOL, V34, P39, DOI 10.1006/jmcc.2001.1488; Wang YG, 2010, J MOL CELL CARDIOL, V48, P619, DOI 10.1016/j.yjmcc.2010.01.009; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; WEISS JN, 1993, CARDIOVASC DRUG THER, V7, P499, DOI 10.1007/BF00877614; Wickenden AD, 1998, CARDIOVASC RES, V37, P312, DOI 10.1016/S0008-6363(97)00256-3; Yamada S, 2006, J PHYSIOL-LONDON, V577, P1053, DOI 10.1113/jphysiol.2006.119511; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhu ZY, 2014, J GEN PHYSIOL, V143, P119, DOI 10.1085/jgp.201311063; Zhu ZY, 2011, BIOCHEM BIOPH RES CO, V415, P637, DOI 10.1016/j.bbrc.2011.10.125; Zingman LV, 2007, J APPL PHYSIOL, V103, P1888, DOI 10.1152/japplphysiol.00747.2007; Zingman LV, 2011, J MOL CELL CARDIOL, V51, P72, DOI 10.1016/j.yjmcc.2011.03.010; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	64	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151337	10.1371/journal.pone.0151337	http://dx.doi.org/10.1371/journal.pone.0151337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964104	gold, Green Submitted, Green Published			2022-12-27	WOS:000371993000140
J	Rasila, T; Lehtonen, A; Kanerva, K; Makitie, LT; Haglund, C; Andersson, LC				Rasila, Tiina; Lehtonen, Alexandra; Kanerva, Kristiina; Makitie, Laura T.; Haglund, Caj; Andersson, Leif C.			Expression of ODC Antizyme Inhibitor 2 (AZIN2) in Human Secretory Cells and Tissues	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE PARALOGUE; POLYAMINES; REGULATORS; GENE	Ornithine decarboxylase (ODC) antizyme inhibitor 2 (AZIN2), originally called ODCp, is a regulator of polyamine synthesis that we originally identified and cloned. High expression of ODCp mRNA was found in brain and testis. We reported that AZIN2 is involved in regulation of cellular vesicle transport and/or secretion, but the ultimate physiological role(s) of AZIN2 is still poorly understood. In this study we used a peptide antibody (K3) to human AZIN2 and by immunohistochemistry mapped its expression in various normal tissues. We found high expression in the nervous system, in type 2 pneumocytes in the lung, in megakaryocytes, in gastric parietal cells co-localized with H, K-ATPase beta subunit, in selected enteroendocrine cells, in acinar cells of sweat glands, in podocytes, in macula densa cells and epithelium of collecting ducts in the kidney. The high expression of AZIN2 in various cells with secretory or vesicle transport activity indicates that the polyamine metabolism regulated by AZIN2 is more significantly involved in these events than previously appreciated.	[Rasila, Tiina; Lehtonen, Alexandra; Makitie, Laura T.; Andersson, Leif C.] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Kanerva, Kristiina] Univ Helsinki, Anat, Inst Biomed, Helsinki, Finland; [Haglund, Caj] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland; [Makitie, Laura T.] Univ Helsinki, Dept Neurol, Cent Hosp, Helsinki, Finland; [Haglund, Caj] Univ Helsinki, Dept Surg, Cent Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Andersson, LC (corresponding author), Univ Helsinki, Dept Pathol, Helsinki, Finland.	Leif.Andersson@helsinki.fi	Haglund, Caj/N-1240-2019	Kanerva, Kristiina/0000-0003-1680-9448	Academy of Finland; Sigrid Juselius Foundation; Finska Lakaresallskapet; Magnus Ehrnrooth Foundation; Medicinska understodsforeningen Liv och Halsa; Novo Nordisk Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Magnus Ehrnrooth Foundation; Medicinska understodsforeningen Liv och Halsa; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The Academy of Finland LCA, The Sigrid Juselius Foundation LCA, Finska Lakaresallskapet LCA, The Magnus Ehrnrooth Foundation LCA, Medicinska understodsforeningen Liv och Halsa LCA, Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscritpt.	Auvinen M, 1997, CANCER RES, V57, P3016; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; BROWN D, 1989, ANNU REV PHYSIOL, V51, P771, DOI 10.1146/annurev.physiol.51.1.771; Chen JC, 2013, J AM SOC NEPHROL, V24, P198, DOI 10.1681/ASN.2012010101; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Kanerva K, 2010, EXP CELL RES, V316, P1896, DOI 10.1016/j.yexcr.2010.02.021; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; Lescuyer P, 2008, PROTEOM CLIN APPL, V2, P1008, DOI 10.1002/prca.200800033; Lopez-Contreras AJ, 2006, J BIOL CHEM, V281, P30896, DOI 10.1074/jbc.M602840200; Lopez-Garcia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069188; Makitie LT, 2010, BRAIN PATHOL, V20, P571, DOI 10.1111/j.1750-3639.2009.00334.x; Makitie LT, 2009, HISTOCHEM CELL BIOL, V132, P633, DOI 10.1007/s00418-009-0636-7; Makitie LT, 2009, EXP CELL RES, V315, P1008, DOI 10.1016/j.yexcr.2009.01.029; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Olsen RR, 2011, MOL CANCER RES, V9, P1285, DOI 10.1158/1541-7786.MCR-11-0178; Pegg AE, 2007, BIOCHEM SOC T, V35, P295, DOI 10.1042/BST0350295; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Persson AEG, 2004, ACTA PHYSIOL SCAND, V181, P471, DOI 10.1111/j.1365-201X.2004.01320.x; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; Ramani D, 2014, CLIN NUTR, V33, P14, DOI 10.1016/j.clnu.2013.09.019; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; Snapir Z, 2008, BIOCHEM J, V410, P613, DOI 10.1042/BJ20071423; Steer H, 2009, ANAT REC, V292, P79, DOI 10.1002/ar.20762; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327	29	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151175	10.1371/journal.pone.0151175	http://dx.doi.org/10.1371/journal.pone.0151175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963840	Green Published, gold			2022-12-27	WOS:000371993000115
J	Naveda-Rodriguez, A; Vargas, FH; Kohn, S; Zapata-Rios, G				Naveda-Rodriguez, Adrian; Hernan Vargas, Felix; Kohn, Sebastian; Zapata-Rios, Galo			Andean Condor (Vultur gryphus) in Ecuador: Geographic Distribution, Population Size and Extinction Risk	PLOS ONE			English	Article							CONSERVATION; AREAS; BOLIVIA; CHILE	The Andean Condor (Vultur gryphus) in Ecuador is classified as Critically Endangered. Before 2015, standardized and systematic estimates of geographic distribution, population size and structure were not available for this species, hampering the assessment of its current status and hindering the design and implementation of effective conservation actions. In this study, we performed the first quantitative assessment of geographic distribution, population size and population viability of Andean Condor in Ecuador. We used a methodological approach that included an ecological niche model to study geographic distribution, a simultaneous survey of 70 roosting sites to estimate population size and a population viability analysis (PVA) for the next 100 years. Geographic distribution in the form of extent of occurrence was 49 725 km(2). During a two-day census, 93 Andean Condors were recorded and a population of 94 to 102 individuals was estimated. In this population, adult-to-immature ratio was 1:0.5. In the modeled PVA scenarios, the probability of extinction, mean time to extinction and minimum population size varied from zero to 100%, 63 years and 193 individuals, respectively. Habitat loss is the greatest threat to the conservation of Andean Condor populations in Ecuador. Population size reduction in scenarios that included habitat loss began within the first 15 years of this threat. Population reinforcement had no effects on the recovery of Andean Condor populations given the current status of the species in Ecuador. The population size estimate presented in this study is the lower than those reported previously in other countries where the species occur. The inferences derived from the population viability analysis have implications for Condor management in Ecuador. This study highlights the need to redirect efforts from captive breeding and population reinforcement to habitat conservation.	[Naveda-Rodriguez, Adrian; Zapata-Rios, Galo] Wildlife Conservat Soc, Ecuador Program, Quito, Pichincha, Ecuador; [Hernan Vargas, Felix] Peregrine Fund, Boise, ID USA; [Kohn, Sebastian] Ctr Rescate Ilitio, Quito, Pichincha, Ecuador; [Naveda-Rodriguez, Adrian; Hernan Vargas, Felix; Kohn, Sebastian; Zapata-Rios, Galo] Grp Nacl Trabajo Condor Andino Ecuador, Quito, Pichincha, Ecuador		Naveda-Rodriguez, A (corresponding author), Wildlife Conservat Soc, Ecuador Program, Quito, Pichincha, Ecuador.; Naveda-Rodriguez, A (corresponding author), Grp Nacl Trabajo Condor Andino Ecuador, Quito, Pichincha, Ecuador.	anaveda@wcs.org	Naveda-Rodríguez, Adrián/AAD-7163-2020; Zapata-Ríos, Galo/H-8722-2019	Naveda-Rodríguez, Adrián/0000-0002-7557-2893; Zapata-Ríos, Galo/0000-0003-3508-5078; Vargas, Felix Hernan/0000-0002-0035-7670	Peregrine Fund; Wolf Creek Charitable Foundation; Butler Foundation; Centro de Rescate Ilitio; Ministry of Environment of Ecuador; Global Environmental Facility; United Nations Development Programme; Wildlife Conservation Society [00086648]	Peregrine Fund; Wolf Creek Charitable Foundation; Butler Foundation; Centro de Rescate Ilitio; Ministry of Environment of Ecuador; Global Environmental Facility; United Nations Development Programme; Wildlife Conservation Society	This work received financial support by The Peregrine Fund, Wolf Creek Charitable Foundation, The Butler Foundation, Centro de Rescate Ilitio, Barbara Butler (private donor), and Project: "Advancing Landscape Approaches in Ecuador's National Protected Area System to Improve Conservation of Globally Endangered Wildlife" of the Ministry of Environment of Ecuador, Global Environmental Facility, United Nations Development Programme and Wildlife Conservation Society (Project ID 00086648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; [Anonymous], [No title captured]; Astudillo PX, 2011, ORNITOL NEOTROP, V22, P257; BirdLife International, IUCN RED LIST THREAT; Douglass LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023843; Escobar-Gimpel V, 2014, CHIRICOCA, V18, P14; Escobar-Gimpel V, 2015, CHIRICOCA, V16, P38; Escobar-Gimpel V, 2015, ORNITOL NEOTROP, V26, P157; ESRI, 2011, ARCGIS DESKT REL 10; Ferguson-Lees J, 2001, RAPTORS WORLD; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Granizo T, 2002, LIBRO ROJO AVES ECUA; Hendrickson SL, 2003, CONDOR, V105, P1, DOI 10.1650/0010-5422(2003)105[1:LGVITG]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, IUCN RED LIST THREAT; IUCN/SSC, 2014, GUID US EXS MAN SPEC; Jarvis A, 2008, HOLE FILLED SEAMLESS; Koenen TM, 2000, J RAPTOR RES, V34, P933; Lacy R.C., 2014, VORTEX STOCHASTIC SI; Lambertucci SA, 2014, BIOL CONSERV, V170, P145, DOI 10.1016/j.biocon.2013.12.041; Lambertucci SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075821; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; McDonald J.H., 2014, HDB BIOL STAT; Mena-Vasconez P., 2006, BOT EC ANDES CENTRAL, P91; Mendez DR, 2015, J FIELD ORNITHOL, V86, P205, DOI 10.1111/jofo.12114; Meza-Saltos P, 2009, MEM 1 C INT AV RAP C; Ministerio del Ambiente del Ecuador, 1990, MAP COB US TIERR EC; Ministerio del Ambiente del Ecuador, 2014, MAP COB US TIERR EC; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Narvaez F., 2012, INFORME CENSO CONDOR; NASA, 2013, MODIS MCD12QQ; Naveda-Rodriguez A, 2015, J RAPTOR RES, V49, P441, DOI 10.3356/rapt-49-04-441-449.1; Panchi T., 2012, THESIS U GUAYAQUIL; Pearce JL, 2008, BIOL CONSERV, V141, P908, DOI 10.1016/j.biocon.2007.12.033; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIANA RP, 2015, B UNOP, V10, P9; Renjifo LM, 2002, LIBRO ROJO AVES COLO; Rios-Uzeda B, 2007, J FIELD ORNITHOL, V78, P170, DOI 10.1111/j.1557-9263.2007.00100.x; Rodriguez J, 2008, LIBRO ROJO FAUNA VEN; Sarno RJ, 2000, REV CHIL HIST NAT, V73, P3; SCOTT JM, 1993, WILDLIFE MONOGR, P1; SERFOR, 2015, PLAN NAC CONS COND A; Vargas FH, 2013, COMMUNICATION   1021; Vargas FH, MOVEBANK STUDY ANDEA; WALLACE MP, 1988, BIOTROPICA, V20, P144, DOI 10.2307/2388187; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Yanez M, 2002, CONSERVACION CONDOR	47	21	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151827	10.1371/journal.pone.0151827	http://dx.doi.org/10.1371/journal.pone.0151827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986004	Green Published, gold			2022-12-27	WOS:000372580300136
J	Barbone, D; Van Dam, L; Follo, C; Jithesh, PV; Zhang, SD; Richards, WG; Bueno, R; Fennell, DA; Broaddus, VC				Barbone, Dario; Van Dam, Loes; Follo, Carlo; Jithesh, Puthen V.; Zhang, Shu-Dong; Richards, William G.; Bueno, Raphael; Fennell, Dean A.; Broaddus, V. Courtney			Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; ARGININOSUCCINATE SYNTHETASE; ARGININE DEPRIVATION; CELL-LINES; PROMOTER METHYLATION; RESISTANCE; APOPTOSIS; IDENTIFICATION; CANCER; OVEREXPRESSION	To investigate the underlying causes of chemoresistance in malignant pleural mesothelioma, we have studied mesothelioma cell lines as 3D spheroids, which acquire increased chemoresistance compared to 2D monolayers. We asked whether the gene expression of 3D spheroids would reveal mechanisms of resistance. To address this, we measured gene expression of three mesothelioma cell lines, M28, REN and VAMT, grown as 2D monolayers and 3D spheroids. A total of 209 genes were differentially expressed in common by the three cell lines in 3D (138 upregulated and 71 downregulated), although a clear resistance pathway was not apparent. We then compared the list of 3D genes with two publicly available datasets of gene expression of 56 pleural mesotheliomas compared to normal tissues. Interestingly, only three genes were increased in both 3D spheroids and human tumors: argininosuccinate synthase 1 (ASS1), annexin A4 (ANXA4) and major vault protein (MVP); of these, ASS1 was the only consistently upregulated of the three genes by qRT-PCR. To measure ASS1 protein expression, we stained 2 sets of tissue microarrays (TMA): one with 88 pleural mesothelioma samples and the other with additional 88 pleural mesotheliomas paired with matched normal tissues. Of the 176 tumors represented on the two TMAs, ASS1 was expressed in 87 (50%; staining greater than 1 up to 3+). For the paired samples, ASS1 expression in mesothelioma was significantly greater than in the normal tissues. Reduction of ASS1 expression by siRNA significantly sensitized mesothelioma spheroids to the pro-apoptotic effects of bortezomib and of cisplatin plus pemetrexed. Although mesothelioma is considered by many to be an ASS1-deficient tumor, our results show that ASS1 is elevated at the mRNA and protein levels in mesothelioma 3D spheroids and in human pleural mesotheliomas. We also have uncovered a survival role for ASS1, which may be amenable to targeting to undermine mesothelioma multicellular resistance.	[Barbone, Dario; Follo, Carlo; Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Pulm, San Francisco, CA USA; [Van Dam, Loes] Univ Med Ctr Utrecht, Dept Mol Canc Res, Ctr Mol Med, Utrecht, Netherlands; [Jithesh, Puthen V.] Sidra Med & Res Ctr, Doha, Qatar; [Zhang, Shu-Dong] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Richards, William G.; Bueno, Raphael] Brigham & Womens Hosp, Div Thorac Surg, 75 Francis St, Boston, MA 02115 USA; [Fennell, Dean A.] Univ Leicester, Dept Canc Studies, Canc Res UK Leicester Ctr, Leicester, Leics, England	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Sidra Medical & Research Center; Queens University Belfast; Harvard University; Brigham & Women's Hospital; Cancer Research UK; University of Leicester	Barbone, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Pulm, San Francisco, CA USA.	dario.barbone@ucsf.edu	Zhang, Shu-Dong/G-1269-2010; Jithesh, Puthen Veettil/O-6262-2019	Zhang, Shu-Dong/0000-0002-7721-0167; Jithesh, Puthen Veettil/0000-0001-7747-0930; van Dam, Loes/0000-0002-5724-7632; Follo, Carlo/0000-0001-9711-2655	Mesothelioma Applied Research Foundation (MARF) [A121342]; Simmons Mesothelioma Foundation; Simmons Fellowship in Mesothelioma Research	Mesothelioma Applied Research Foundation (MARF); Simmons Mesothelioma Foundation; Simmons Fellowship in Mesothelioma Research	The work was supported by the following: Mesothelioma Applied Research Foundation (MARF) grant to DB (A121342) [http://www.curemeso.org/]; Simmons Mesothelioma Foundation gift to VCB [http://www.simmonsmesotheliomafoundation.org/]; and Simmons Fellowship in Mesothelioma Research to CF [http://www.simmonsmesotheliomafoundation.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Agnes Paquet (CNRS and University Nice Sophia Antipolis, IPMC, Valbonne, France) for helping with the gene expression microarray and Ingenuity analysis, and Rebecca A. Barbeau and the Sandler Asthma Basic Research (SABRE) Center Functional Genomics Core Facility, University of California San Francisco, Mission Bay for performing the gene expression microarrays. This work was supported by a Mesothelioma Applied Research Foundation (MARF) grant to DB (A121342) and by the Simmons Mesothelioma Foundation. CF was supported by a Simmons Fellowship in Mesothelioma Research.	Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Barbone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052753; Barczak A, 2003, GENOME RES, V13, P1775, DOI 10.1101/gr.1048803; Battisti S, 2012, AM J RESP CELL MOL, V46, P498, DOI 10.1165/rcmb.2011-0195OC; Broaddus VC, 2005, J BIOL CHEM, V280, P12486, DOI 10.1074/jbc.M408190200; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; Daubriac J, 2009, CELL DEATH DIFFER, V16, P1146, DOI 10.1038/cdd.2009.32; De Rienzo A, 2011, CLIN CANCER RES, V17, P310, DOI 10.1158/1078-0432.CCR-10-0806; Delage B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.83; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Fennell DA, 2004, LANCET ONCOL, V5, P354, DOI 10.1016/S1470-2045(04)01492-5; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gordon GJ, 2009, JNCI-J NATL CANCER I, V101, P678, DOI 10.1093/jnci/djp061; Gordon GJ, 2005, CLIN CANCER RES, V11, P4406, DOI 10.1158/1078-0432.CCR-04-2181; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Gordon GJ, 2003, J NATL CANCER I, V95, P598, DOI 10.1093/jnci/95.8.598; Guo GW, 2015, CANCER RES, V75, P264, DOI 10.1158/0008-5472.CAN-14-1008; HARASAWA R, 1993, RES MICROBIOL, V144, P489, DOI 10.1016/0923-2508(93)90057-9; Huang HY, 2013, CLIN CANCER RES, V19, P2861, DOI 10.1158/1078-0432.CCR-12-2641; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039556; Lind DS, 2004, J NUTR, V134, p2837S, DOI 10.1093/jn/134.10.2837S; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Melaiu O, 2015, MUTAT RES-FUND MOL M, V771, P6, DOI 10.1016/j.mrfmmm.2014.11.002; Melaiu O, 2012, MUTAT RES-REV MUTAT, V750, P132, DOI 10.1016/j.mrrev.2011.12.003; METCALF RA, 1992, CANCER RES, V52, P2610; NAGY JA, 1993, CANCER RES, V53, P2631; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Nicholson LJ, 2009, INT J CANCER, V125, P1454, DOI 10.1002/ijc.24546; Pinton G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036856; POPESCU NC, 1988, CANCER RES, V48, P142; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Sakai Y, 2010, CELLS TISSUES ORGANS, V191, P281, DOI 10.1159/000272316; Shan YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09783; Singhal S, 2003, CLIN CANCER RES, V9, P3080; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Syed N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.197; Szlosarek PW, 2006, CLIN CANCER RES, V12, P7126, DOI 10.1158/1078-0432.CCR-06-1101; Szlosarek PW, 2013, J CLIN ONCOL, V31, pE111, DOI 10.1200/JCO.2012.42.1784; Wangpaichitr M, 2014, ANTICANCER RES, V34, P6991; Watson PM, 2008, AM J RESP CELL MOL, V38, P671, DOI 10.1165/rcmb.2007-0205OC; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	47	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150044	10.1371/journal.pone.0150044	http://dx.doi.org/10.1371/journal.pone.0150044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982031	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900023
J	Blair, JA; Wang, C; Hernandez, D; Siedlak, SL; Rodgers, MS; Achar, RK; Fahmy, LM; Torres, SL; Petersen, RB; Zhu, XW; Casadesus, G; Lee, HG				Blair, Jeffrey A.; Wang, Chunyu; Hernandez, Damarys; Siedlak, Sandra L.; Rodgers, Mark S.; Achar, Rojan K.; Fahmy, Lara M.; Torres, Sandy L.; Petersen, Robert B.; Zhu, Xiongwei; Casadesus, Gemma; Lee, Hyoung-gon			Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation	PLOS ONE			English	Article							GENE-EXPRESSION; QUALITY-CONTROL; PROTEINS; DISEASE; PHOSPHORYLATION; MOUSE; TAU	At autopsy, the time that has elapsed since the time of death is routinely documented and noted as the postmortem interval (PMI). The PMI of human tissue samples is a parameter often reported in research studies and comparable PMI is preferred when comparing different populations, i.e., disease versus control patients. In theory, a short PMI may alleviate non-experimental protein denaturation, enzyme activity, and other chemical changes such as the pH, which could affect protein and nucleic acid integrity. Previous studies have compared PMI en masse by looking at many different individual cases each with one unique PMI, which may be affected by individual variance. To overcome this obstacle, in this study human hippocampal segments from the same individuals were sampled at different time points after autopsy creating a series of PMIs for each case. Frozen and fixed tissue was then examined by Western blot, RT-PCR, and immunohistochemistry to evaluate the effect of extended PMI on proteins, nucleic acids, and tissue morphology. In our results, immunostaining profiles for most proteins remained unchanged even after PMI of over 50 h, yet by Western blot distinctive degradation patterns were observed in different protein species. Finally, RNA integrity was lower after extended PMI; however, RNA preservation was variable among cases suggesting antemortem factors may play a larger role than PMI in protein and nucleic acid integrity.	[Blair, Jeffrey A.; Casadesus, Gemma] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Blair, Jeffrey A.; Casadesus, Gemma] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Wang, Chunyu; Hernandez, Damarys; Siedlak, Sandra L.; Rodgers, Mark S.; Achar, Rojan K.; Fahmy, Lara M.; Torres, Sandy L.; Petersen, Robert B.; Zhu, Xiongwei; Lee, Hyoung-gon] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Wang, Chunyu] Cent S Univ, Dept Neurol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Central South University	Casadesus, G (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.; Casadesus, G (corresponding author), Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA.; Zhu, XW; Lee, HG (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	xiongwei.zhu@case.edu; gcasades@kent.edu; hyoung-gon.lee@case.edu	Zhu, Xiongwei/A-9629-2009	Zhu, Xiongwei/0000-0003-2092-6508; Casadesus, Gemma/0000-0002-5206-5637	Alzheimer's Association [IIRG-11-205527]	Alzheimer's Association(Alzheimer's Association)	This study was supported by the Alzheimer's Association (IIRG-11-205527 to HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barksdale KA, 2010, FASEB J, V24, P3590, DOI 10.1096/fj.09-152108; Chandana R, 2009, INDIAN J MED RES, V129, P189; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; Halim ND, 2003, MOL PSYCHIATR, V8, P797, DOI 10.1038/sj.mp.4001319; Hynd MR, 2003, J NEUROCHEM, V85, P543, DOI 10.1046/j.1471-4159.2003.01747.x; Kim TH, 2009, ANAT REC, V292, P234, DOI 10.1002/ar.20823; Kolasinski J, 2012, BRAIN, V135, P2938, DOI 10.1093/brain/aws242; KOSIK KS, 1982, J NEUROCHEM, V39, P1529, DOI 10.1111/j.1471-4159.1982.tb07985.x; Li JL, 2003, NEUROPSYCHOPHARMACOL, V28, P1017, DOI 10.1038/sj.npp.1300112; Li XH, 2005, J NEUROCHEM, V92, P701, DOI 10.1111/j.1471-4159.2004.02898.x; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Monoranu CM, 2009, NEUROPATH APPL NEURO, V35, P329, DOI 10.1111/j.1365-2990.2008.01003a.x; PERRY RH, 1977, LANCET, V1, P38; Popova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-91; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Soltys DT, 2015, MUTAT RES-FUND MOL M, V776, P48, DOI 10.1016/j.mrfmmm.2015.01.003; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15709; Williams WM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-127; Zhang F, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0030-4	22	53	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151615	10.1371/journal.pone.0151615	http://dx.doi.org/10.1371/journal.pone.0151615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982086	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900103
J	Dhanyalakshmi, KH; Naika, MBN; Sajeevan, RS; Mathew, OK; Shafi, KM; Sowdhamini, R; Nataraja, KN				Dhanyalakshmi, K. H.; Naika, Mahantesha B. N.; Sajeevan, R. S.; Mathew, Oommen K.; Shafi, K. Mohamed; Sowdhamini, Ramanathan; Nataraja, Karaba N.			An Approach to Function Annotation for Proteins of Unknown Function (PUFs) in the Transcriptome of Indian Mulberry	PLOS ONE			English	Article							UNIVERSAL STRESS-PROTEIN; FOLD RECOGNITION; GENES; TOLERANCE; NETWORKS; DATABASE; DROUGHT; DOMAINS	The modern sequencing technologies are generating large volumes of information at the transcriptome and genome level. Translation of this information into a biological meaning is far behind the race due to which a significant portion of proteins discovered remain as proteins of unknown function (PUFs). Attempts to uncover the functional significance of PUFs are limited due to lack of easy and high throughput functional annotation tools. Here, we report an approach to assign putative functions to PUFs, identified in the transcriptome of mulberry, a perennial tree commonly cultivated as host of silkworm. We utilized the mulberry PUFs generated from leaf tissues exposed to drought stress at whole plant level. A sequence and structure based computational analysis predicted the probable function of the PUFs. For rapid and easy annotation of PUFs, we developed an automated pipeline by integrating diverse bioinformatics tools, designated as PUFs Annotation Server (PUFAS), which also provides a web service API (Application Programming Interface) for a large-scale analysis up to a genome. The expression analysis of three selected PUFs annotated by the pipeline revealed abiotic stress responsiveness of the genes, and hence their potential role in stress acclimation pathways. The automated pipeline developed here could be extended to assign functions to PUFs from any organism in general. PUFAS web server is available at http://caps.ncbs.res.in/pufas/ and the web service is accessible at http://capservices.ncbs.res.in/help/pufas.	[Dhanyalakshmi, K. H.; Sajeevan, R. S.; Nataraja, Karaba N.] Univ Agr Sci, Dept Crop Physiol, GKVK, Bengaluru 560065, India; [Naika, Mahantesha B. N.; Mathew, Oommen K.; Shafi, K. Mohamed; Sowdhamini, Ramanathan] TIFR, Natl Ctr Biol Sci, GKVK Campus, Bengaluru 560065, India; [Naika, Mahantesha B. N.] Univ Hort Sci, KRCCH Arabhavi 591218, Dept Biotechnol & Crop Improvement, Bagalkot, Karnataka, India	University of Agricultural Sciences Bangalore; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Nataraja, KN (corresponding author), Univ Agr Sci, Dept Crop Physiol, GKVK, Bengaluru 560065, India.; Sowdhamini, R (corresponding author), TIFR, Natl Ctr Biol Sci, GKVK Campus, Bengaluru 560065, India.	mini@ncbs.res.in; nataraja_karaba@yahoo.com	RADHA SIVARAJAN, SAJEEVAN/AAA-2479-2021; Naika, Mahantesha BN/AAI-5724-2020; Kaleeckal Mathew, Oommen/AAC-4217-2022	RADHA SIVARAJAN, SAJEEVAN/0000-0002-8671-4981; Kaleeckal Mathew, Oommen/0000-0002-6312-3118; B N Naika, Mahantesha/0000-0003-0753-792X; Nataraja, Karaba N./0000-0002-9766-3622; Shafi, Mohamed/0000-0002-2029-5016; K H, Dhanyalakshmi/0000-0002-6521-3774	Department of Biotechnology, Government of India [BT/PR13457/PBD/19/214/2010]; Department of Science and Technology (DST), Government of India; Department of Science and Technology, (DST), Government of India; NCBS	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Department of Science and Technology, (DST), Government of India(Department of Science & Technology (India)); NCBS	The research is supported by the Department of Biotechnology, Government of India grant no. BT/PR13457/PBD/19/214/2010 to KNN. KHD would like to thank Department of Science and Technology (DST), Government of India for DST-INSPIRE Fellowship.; The research is supported by the Department of Biotechnology, Government of India grant No. BT/PR13457/PBD/19/214/2010 to KNN. KHD would like to thank Department of Science and Technology, (DST), Government of India for DST-INSPIRE Fellowship. MBNN and RS thank the National Center for Biological Sciences (NCBS), Bengaluru for infrastructure, MBNN also thank NCBS for Bridge Postdoctoral Fellowship. KNN would like to thank Department of Science and Technology-Fund for Improvement of Science and Technology (DST-FIST) for the infrastructure facilities. KHD, MBNN, OKM, KMS, RSS and KNN thank NCBS and University of Agricultural Sciences (UAS), Bengaluru for the general facilities.	Aguilera F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-96; Ambrosone A, 2012, PLANT SCI, V182, P12, DOI 10.1016/j.plantsci.2011.02.004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Chang C, 2010, J BACTERIOL, V192, P1156, DOI 10.1128/JB.01508-09; de Vega-Bartol JJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-123; Diaz-Riquelme J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092339; Doerks T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034302; Ellison CE, 2014, MBIO, V5, DOI 10.1128/mBio.01046-13; Gollery M, 2007, TRENDS PLANT SCI, V12, P492, DOI 10.1016/j.tplants.2007.08.018; Gollery M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r57; Guengerich FP, 2010, MOL INTERV, V10, P153, DOI 10.1124/mi.10.3.6; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Jiang JF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003625; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kelly WP, 2008, CURR OPIN BIOTECH, V19, P396, DOI 10.1016/j.copbio.2008.06.010; Kerk D, 2003, PLANT PHYSIOL, V131, P1209, DOI 10.1104/pp.102.016006; Kitsios G, 2011, PLANT SIGNAL BEHAV, V6, P204, DOI 10.4161/psb.6.2.14835; Kumar K, 2014, GENE, V543, P93, DOI 10.1016/j.gene.2014.03.060; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Loukehaich R, 2012, J EXP BOT, V63, P5593, DOI 10.1093/jxb/ers220; Luhua S, 2008, PLANT PHYSIOL, V148, P280, DOI 10.1104/pp.108.124875; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mayer ML, 2000, NAT BIOTECHNOL, V18, P1242, DOI 10.1038/82342; Mckay T, 2015, ANNOTATION PROTEINS, P43; Meier M, 2013, P NATL ACAD SCI USA, V110, P477, DOI 10.1073/pnas.1210634110; Nagano Y, 2011, NUCLEIC ACIDS RES, V29, P4097; Naika M, 2013, MOL BIOSYST, V9, P1888, DOI 10.1039/c3mb70072k; Nokso-koivisto J, 2015, PANNZER HIGH THROUGH, V31, P1544; Pandey SP, 2011, NUCLEIC ACIDS RES, V39, P4691, DOI 10.1093/nar/gkr060; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Sajeevan R. S., 2014, American Journal of Plant Sciences, V5, P2057; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuller A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/103132; Schuppler U, 1998, PLANT PHYSIOL, V117, P667, DOI 10.1104/pp.117.2.667; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Ye YZ, 2004, PROTEIN SCI, V13, P1841, DOI 10.1110/ps.03602304	49	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151323	10.1371/journal.pone.0151323	http://dx.doi.org/10.1371/journal.pone.0151323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982336	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900075
J	Mankowski, C; Patel, S; Trueman, D; Bentley, A; Poole, C				Mankowski, Colette; Patel, Sachin; Trueman, David; Bentley, Anthony; Poole, Chris			Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland	PLOS ONE			English	Article							DOUBLE-BLIND; MULTICENTER; NGX-4010	We evaluated the cost-effectiveness of capsaicin 8% patch (QUTENZA (TM)) versus pregabalin in patients with PNP from the perspective of the National Health Service (NHS) and Personal and Social Services in Scotland, UK. A decision-tree cost-effectiveness model was developed for non-diabetic patients with peripheral neuropathic pain (PNP) who were pregabalin-naive and had not achieved adequate pain relief or tolerated conventional first-or second-line treatments. Patients entering the model received either a single application of capsaicin 8% patch or titrated daily dosing with pregabalin; after 8 weeks patients were classified as responders, non-responders, or were assumed to discontinue treatment due to intolerable adverse events. Responders continued to receive baseline treatment at intervals observed in clinical practice. Non-responders and those who discontinued treatment were assumed to receive last-line therapy (duloxetine). The base-case time horizon was 2 years. Model inputs for effectiveness, discontinuations and health-state utilities were taken from a head-to-head non-inferiority study (ELEVATE, NCT01713426). Other inputs were obtained from published sources or clinical expert opinion. Costs were expressed in GBP 2013/14. Results were presented as incremental cost-effectiveness ratios (ICER), i.e. cost per quality-adjusted life-year (QALY) gained. Model assumptions were tested with scenario analyses. Parameter uncertainty was tested using one-way and probabilistic sensitivity analyses. Compared with dose-optimized pregabalin, capsaicin 8% patch was the dominant treatment strategy (total cost difference, -11; pound total QALY gain, 0.049). Capsaicin 8% patch was also the dominant treatment strategy versus pregabalin in 6 out of 7 scenario analyses. The model was most sensitive to variation in time to capsaicin 8% patch retreatment (maximum ICER, 7,951 pound/QALY at lower-bound 95% confidence interval). At a willingness-to-pay threshold of 20,000 pound/QALY, the probability of capsaicin 8% patch being cost-effective versus pregabalin was 97%. Capsaicin 8% patch is a cost-effective treatment option compared with dose-optimized pregabalin in patients with PNP who have failed one or more previous systemic treatments.	[Mankowski, Colette; Poole, Chris] Astellas Pharma Europe Ltd, Chertsey, Surrey, England; [Patel, Sachin] Astellas Pharma UK Ltd, Chertsey, Surrey, England; [Trueman, David; Bentley, Anthony] Abacus Int, Bicester, Oxon, England	Astellas Pharmaceuticals; Astellas Pharmaceuticals	Mankowski, C (corresponding author), Astellas Pharma Europe Ltd, Chertsey, Surrey, England.	colette.mankowski@astellas.com		Trueman, David/0000-0002-7886-6467	Astellas	Astellas(Astellas Pharmaceuticals)	Astellas funded the analyses performed by Abacus International and the medical writing assistance performed by Bioscript Medical. Astellas provided support in the form of salaries for authors CM, SP and CP. Employees of Astellas participated in the study design, analysis, decision to publish, and preparation of the manuscript, as articulated in the 'author contributions' section.	Armstrong EP, 2011, CURR MED RES OPIN, V27, P939, DOI 10.1185/03007995.2011.562885; Astellas Pharma Europe BV, 2014, QUT 179 MG CUT PATCH; Attal N, 2001, ACTA NEUROL BELG, V101, P53; Attal N, 2011, PAIN, V152, P2836, DOI 10.1016/j.pain.2011.09.014; Backonja M, 2008, LANCET NEUROL, V7, P1106, DOI 10.1016/S1474-4422(08)70228-X; Bentley A, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-18; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Briggs AH, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/hta3020; Castle Cleaning and Safety, 2014, BLUE POWD FREE NITR; Chambers C, 2014, TREATMENT NEUROPATHI; Curtis L, 2013, UNIT COSTS HLTH SOCI; Department of Health, 2013, NAT TAR 2013 14; Derry S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003227.pub3; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Eli Lilly Nederland BV, 2009, DUL AR SUMM PROD CHA; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Haanpaa M, 2016, EUR J PAIN, V20, P316, DOI 10.1002/ejp.731; Horsley W, 2011, QUTENZA CAPSAICIN CU; International Association for the Study of Pain, 2012, IASP TAX; Irving GA, 2011, PAIN MED, V12, P99, DOI 10.1111/j.1526-4637.2010.01004.x; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jensen TS, 2014, EUR J PAIN, V18, P1240, DOI 10.1002/j.1532-2149.2014.00479.x; Latimer N, 2011, NICE DSC TECHNICAL S; Nixon RM, 2010, HEALTH ECON, V19, P316, DOI 10.1002/hec.1477; Pfizer Limited, 2009, LYR 25 MG HARD CAPS; Poole CD, 2013, 8 C EUR PAIN FED EFI; Revicki DA, 1998, J AFFECT DISORDERS, V48, P25, DOI 10.1016/S0165-0327(97)00117-1; Scottish Intercollegiate Guidelines Network, 2013, SIGN 136 MAN CHRON P; Scottish Medicine Consortium, 2014, GUID MAN COMPL NEW P; Scottish Medicines Consortium, 2014, CAPS 179MG CUT PATCH; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Sullivan PW, 2004, CNS DRUGS, V18, P911, DOI 10.2165/00023210-200418130-00006; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Zhao Y, 2011, CURR MED RES OPIN, V27, P785, DOI 10.1185/03007995.2011.554807	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150973	10.1371/journal.pone.0150973	http://dx.doi.org/10.1371/journal.pone.0150973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26983018	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900060
J	Zizlsperger, L; Kummel, F; Haarmeier, T				Zizlsperger, Leopold; Kuemmel, Florian; Haarmeier, Thomas			Metacognitive Confidence Increases with, but Does Not Determine, Visual Perceptual Learning	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; BAND EEG ACTIVITY; MOTION PERCEPTION; OSCILLATIONS; DECISION; COHERENCE; FEEDBACK; PHASE; EXCITABILITY; PERFORMANCE	While perceptual learning increases objective sensitivity, the effects on the constant interaction of the process of perception and its metacognitive evaluation have been rarely investigated. Visual perception has been described as a process of probabilistic inference featuring metacognitive evaluations of choice certainty. For visual motion perception in healthy, naive human subjects here we show that perceptual sensitivity and confidence in it increased with training. The metacognitive sensitivity-estimated from certainty ratings by a bias-free signal detection theoretic approach-in contrast, did not. Concomitant 3Hz transcranial alternating current stimulation (tACS) was applied in compliance with previous findings on effective high-low cross-frequency coupling subserving signal detection. While perceptual accuracy and confidence in it improved with training, there were no statistically significant tACS effects. Neither metacognitive sensitivity in distinguishing between their own correct and incorrect stimulus classifications, nor decision confidence itself determined the subjects' visual perceptual learning. Improvements of objective performance and the metacognitive confidence in it were rather determined by the perceptual sensitivity at the outset of the experiment. Post-decision certainty in visual perceptual learning was neither independent of objective performance, nor requisite for changes in sensitivity, but rather covaried with objective performance. The exact functional role of metacognitive confidence in human visual perception has yet to be determined.	[Zizlsperger, Leopold] Univ Zurich Hosp, Dept Neurol, Div Vasc Neurol & Neurorehabil, CH-8091 Zurich, Switzerland; [Zizlsperger, Leopold] Univ Zurich, Zurich, Switzerland; [Zizlsperger, Leopold] Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland; [Kuemmel, Florian; Haarmeier, Thomas] Hertie Inst Clin Brain Res, Cognit Neurol, Tubingen, Germany; [Haarmeier, Thomas] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Haarmeier, Thomas] HELIOS Clin Krefeld, Dept Neurol, Krefeld, Germany	University of Zurich; University Zurich Hospital; University of Zurich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; RWTH Aachen University	Zizlsperger, L (corresponding author), Univ Zurich Hosp, Dept Neurol, Div Vasc Neurol & Neurorehabil, CH-8091 Zurich, Switzerland.; Zizlsperger, L (corresponding author), Univ Zurich, Zurich, Switzerland.; Zizlsperger, L (corresponding author), Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland.	leopold@zizlsperger.com						al-Haytham I., 1989, OPTICS I ALHAYTHAM; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00317; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Bar M, 1998, PSYCHOL SCI, V9, P464, DOI 10.1111/1467-9280.00086; Bower JD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00066; Bruno N, 2012, COGN NEUROPSYCHIATRY, V17, P1, DOI 10.1080/13546805.2011.562071; Burnett KE, 2013, Q J EXP PSYCHOL, V66, P2363, DOI 10.1080/17470218.2013.780086; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Dholakia UM, 2002, J BEHAV DECIS MAKING, V15, P167, DOI 10.1002/bdm.408; Fleming Stephen M, 2014, Front Hum Neurosci, V8, P443, DOI 10.3389/fnhum.2014.00443; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, CONSCIOUS COGN, V19, P352, DOI 10.1016/j.concog.2009.11.002; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grimaldi P, 2015, NEUROSCI BIOBEHAV R, V55, P88, DOI 10.1016/j.neubiorev.2015.04.006; Handel B, 2008, CEREB CORTEX, V18, P2902, DOI 10.1093/cercor/bhn049; Handel B, 2007, CEREB CORTEX, V17, P1542, DOI 10.1093/cercor/bhl063; Handel B, 2009, NEUROIMAGE, V45, P1040, DOI 10.1016/j.neuroimage.2008.12.013; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Herzog MH, 1999, VISION RES, V39, P4232, DOI 10.1016/S0042-6989(99)00138-8; Jakel F, 2006, J VISION, V6, P1307, DOI 10.1167/6.11.13; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Neuling T, 2012, NEUROIMAGE, V63, P771, DOI 10.1016/j.neuroimage.2012.07.024; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00161; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Overgaard M, 2012, PHILOS T R SOC B, V367, P1287, DOI 10.1098/rstb.2011.0425; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schurger A, 2008, TRENDS COGN SCI, V12, P209, DOI 10.1016/j.tics.2008.02.012; Schwiedrzik CM, 2011, P NATL ACAD SCI USA, V108, P4506, DOI 10.1073/pnas.1009147108; Seitz A, 2005, CURR BIOL, V15, pR753, DOI 10.1016/j.cub.2005.09.009; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Spence ML, 2016, J EXP PSYCHOL HUMAN, V42, P671, DOI 10.1037/xhp0000179; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; Zhang JY, 2014, VISION RES, V99, P93, DOI 10.1016/j.visres.2013.10.011; Zito GA, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00257; Zizlsperger L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4940; Zizlsperger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041136	62	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151218	10.1371/journal.pone.0151218	http://dx.doi.org/10.1371/journal.pone.0151218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26981702	Green Submitted, gold, Green Published			2022-12-27	WOS:000372574900071
J	Bilgin, CC; Fontenay, G; Cheng, QS; Chang, H; Han, J; Parvin, B				Bilgin, Cemal Cagatay; Fontenay, Gerald; Cheng, Qingsu; Chang, Hang; Han, Ju; Parvin, Bahram			BioSig3D: High Content Screening of Three-Dimensional Cell Culture Models	PLOS ONE			English	Article							VISUALIZATION; ELEGANS; SYSTEM	BioSig3D is a computational platform for high-content screening of three-dimensional (3D) cell culture models that are imaged in full 3D volume. It provides an end-to-end solution for designing high content screening assays, based on colony organization that is derived from segmentation of nuclei in each colony. BioSig3D also enables visualization of raw and processed 3D volumetric data for quality control, and integrates advanced bioinformatics analysis. The system consists of multiple computational and annotation modules that are coupled together with a strong use of controlled vocabularies to reduce ambiguities between different users. It is a web-based system that allows users to: design an experiment by defining experimental variables, upload a large set of volumetric images into the system, analyze and visualize the dataset, and either display computed indices as a heatmap, or phenotypic subtypes for heterogeneity analysis, or download computed indices for statistical analysis or integrative biology. BioSig3D has been used to profile baseline colony formations with two experiments: (i) morphogenesis of a panel of human mammary epithelial cell lines (HMEC), and (ii) heterogeneity in colony formation using an immortalized non-transformed cell line. These experiments reveal intrinsic growth properties of well-characterized cell lines that are routinely used for biological studies. BioSig3D is being released with seed datasets and video-based documentation.	[Cheng, Qingsu; Chang, Hang; Han, Ju; Parvin, Bahram] Univ Nevada, Dept Elect & Biomed Engn, Reno, NV 89557 USA; [Bilgin, Cemal Cagatay; Fontenay, Gerald; Cheng, Qingsu; Chang, Hang; Han, Ju; Parvin, Bahram] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Parvin, B (corresponding author), Univ Nevada, Dept Elect & Biomed Engn, Reno, NV 89557 USA.; Parvin, B (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	bparvin@unr.edu			National Cancer Institute [RO1CA140663]; Parvin's startup funds at UNR; NATIONAL CANCER INSTITUTE [R01CA140663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Parvin's startup funds at UNR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute (Grant RO1CA140663) and Parvin's startup funds at UNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman E, 2015, ACM COMPUT SURV, V48, DOI 10.1145/2775111; Bilgin C, 2013, BIOINFORMATICS; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang H, 2015, IEEE WORKSH APPL COM; Chen S, 2009, TRANSLATIONAL SYSTEM; Coelho L, 2009, IEEE INT S BIOM IM N; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Goldberg I, 2005, CELL SCI, V6; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Han J, 2010, PLOS COMPUTATIONAL B; Han J, 2010, MICROSCOPY, V241, P315; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee GY, 2007, NATURE METH IN PRESS; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Pampaloni F, 2013, CELL TISSUE RES, V352, P161, DOI 10.1007/s00441-013-1589-7; Parvin B, 2003, IEEE T SYST MAN CY B, V33, P814, DOI 10.1109/TSMCB.2003.816929; Peng HC, 2014, NAT PROTOC, V9, P193, DOI 10.1038/nprot.2014.011; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Stelzer EHK, 2015, NAT METHODS, V12, P23, DOI 10.1038/nmeth.3219; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; Stoeckert CJ, 2003, COMP FUNCT GENOM, V4, P127, DOI 10.1002/cfg.234; Sumanas Saulius, 2004, Drug Discovery Today Targets, V3, P89, DOI 10.1016/S1741-8372(04)02428-4; Swedlow JR, 2003, SCIENCE, V300, P100, DOI 10.1126/science.1082602; Wahlby C, 2012, NAT METHODS, V9, P714, DOI [10.1038/nmeth.1984, 10.1038/NMETH.1984]; Wenzel C, 2014, EXP CELL RES, V323, P131, DOI 10.1016/j.yexcr.2014.01.017; Zhang XF, 2016, IEEE J BIOMED HEALTH, V20, DOI 10.1109/JBHI.2015.2461671	33	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0148379	10.1371/journal.pone.0148379	http://dx.doi.org/10.1371/journal.pone.0148379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978075	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800011
J	Boyer, BE; Doove, LL; Geurts, HM; Prins, PJM; Van Mechelen, I; Van der Oord, S				Boyer, Bianca E.; Doove, Lisa L.; Geurts, Hilde M.; Prins, Pier J. M.; Van Mechelen, Iven; Van der Oord, Saskia			Qualitative Treatment-Subgroup Interactions in a Randomized Clinical Trial of Treatments for Adolescents with ADHD: Exploring What Cognitive-Behavioral Treatment Works for Whom	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; AGE-DEPENDENT DECLINE; FOLLOW-UP; PSYCHOMETRIC PROPERTIES; TEACHER RATINGS; CHILDREN; ANXIETY; PARENT; MODERATORS	Objective This study explored qualitative treatment-subgroup interactions within data of a RCT with two cognitive behavioral treatments (CBT) for adolescents with ADHD: a planning-focused (PML) and a solution-focused CBT (SFT). Qualitative interactions imply that which treatment is best differs across subgroups of patients, and are therefore most relevant for personalized medicine. Methods Adolescents with ADHD (N = 159) received either PML or SFT. Pre-, post-and three-month follow-up data were gathered on parent-rated ADHD symptoms and planning problems. Pretreatment characteristics were explored as potential qualitative moderators of pretest to follow-up treatment effects, using an innovative analyses technique (QUINT; Dusseldorp & Van Mechelen, 2014). In addition, qualitative treatment-subgroup interactions for the therapeutic changes from pre-to posttest and from post-to follow-up test were investigated. Results For the entire time span from pretest to follow-up only a quantitative interaction was found, while from posttest to follow-up qualitative interactions were found: Adolescents with less depressive symptoms but more anxiety symptoms showed more improvement when receiving PML than SFT, while for other adolescents the effects of PML and SFT were comparable. Discussion Whereas subgroups in both treatments followed different trajectories, no subgroup was found for which SFT outperformed PML in terms of the global change in symptoms from pretest to three months after treatment. This implies that, based on this exploratory study, there is no need for personalized treatment allocation with regard to the CBTs under study for adolescents with ADHD. However, for a subgroup with comorbid anxiety symptoms but low depression PML clearly appears the treatment of preference.	[Van der Oord, Saskia] Katholieke Univ Leuven, Clin Psychol, Leuven, Belgium; [Boyer, Bianca E.; Prins, Pier J. M.; Van der Oord, Saskia] Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [Geurts, Hilde M.; Prins, Pier J. M.; Van der Oord, Saskia] Univ Amsterdam, Ctr Cognit Sci, Amsterdam, Netherlands; [Boyer, Bianca E.; Geurts, Hilde M.] Univ Amsterdam, Dept Brain & Cognit, Dutch Autism & ADHD Res Ctr dArc, Amsterdam, Netherlands; [Doove, Lisa L.; Van Mechelen, Iven] Katholieke Univ Leuven, Res Grp Quantitat Psychol & Individual Difference, Leuven, Belgium	KU Leuven; University of Amsterdam; University of Amsterdam; University of Amsterdam; KU Leuven	Van der Oord, S (corresponding author), Katholieke Univ Leuven, Clin Psychol, Leuven, Belgium.; Van der Oord, S (corresponding author), Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands.; Van der Oord, S (corresponding author), Univ Amsterdam, Ctr Cognit Sci, Amsterdam, Netherlands.	saskia.vanderoord@ppw.kuleuven.be		Boyer, Bianca E./0000-0003-2344-7334	Netherlands Organization for Health Research Development [157003006]; Research Fund of KU Leuven [GOA/15/003]; Interuniversity Attraction Poles programme - Belgian government [IAP/P7/06]	Netherlands Organization for Health Research Development; Research Fund of KU Leuven; Interuniversity Attraction Poles programme - Belgian government	The research leading to the results reported in this paper was supported in part by the Netherlands Organization for Health Research & Development (Grant #157003006), by the Research Fund of KU Leuven (GOA/15/003), and by the Interuniversity Attraction Poles programme financed by the Belgian government (IAP/P7/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abikoff H, 2013, J CONSULT CLIN PSYCH, V81, P113, DOI 10.1037/a0029648; Airaksinen E, 2005, J PSYCHIAT RES, V39, P207, DOI 10.1016/j.jpsychires.2004.06.001; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2002, CHILDRENS DEPRESSION; Antshel KM, 2014, CHILD ADOL PSYCH CL, V23, P825, DOI 10.1016/j.chc.2014.05.001; Antshel KM, 2014, J ATTEN DISORD, V18, P483, DOI 10.1177/1087054712443155; Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Boyer BE, 2014, EUROPEAN CHILD ADOLE; Boyer BE, 2014, SOLUTION FOCUSED TRE; BYAR DP, 1985, STAT MED, V4, P255, DOI 10.1002/sim.4780040304; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daley D, 2014, J AM ACAD CHILD PSY, V53, P835, DOI 10.1016/j.jaac.2014.05.013; DIXON DO, 1991, BIOMETRICS, V47, P871, DOI 10.2307/2532645; Doove LL, 2014, ADV DATA ANAL CLASSI, V8, P403, DOI 10.1007/s11634-013-0159-x; Doove LL, 2015, PSYCHOTHERAPY RES; DUPAUL GJ, 1991, J CLIN CHILD PSYCHOL, V20, P245, DOI 10.1207/s15374424jccp2003_3; Dusseldorp E, 2015, BEHAV RES METHODS; Dusseldorp E, 2013, QUINT QUALITATIVE IN; Dusseldorp E, 2014, STAT MED, V33, P219, DOI 10.1002/sim.5933; Evans SW, 2018, J CLIN CHILD ADOLESC, V47, P157, DOI 10.1080/15374416.2017.1390757; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fabiano GA, 2002, ADHD REPORT, V10, P6, DOI DOI 10.HTTPS://D0I.0RG/10.1521/ADHD.10.2.6.20560; Fabiano GA, 2006, J CLIN CHILD ADOLESC, V35, P369, DOI 10.1207/s15374424jccp3503_3; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Gershon J, 2002, J Atten Disord, V5, P143, DOI 10.1177/108705470200500302; Gioa G., 2000, BEHAV RATING INVENTO; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 2004, PEDIATRICS, V113, P754; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1088, DOI 10.1001/archpsyc.56.12.1088; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; King MW, 2014, J CONSULT CLIN PSYCH, V82, P895, DOI 10.1037/a0035886; Kort W., 2005, WISC 3 NL WECHSLER I; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kuin M, 2013, PLAN MY LIFE PML COG; Lee S, 2015, PSYCHOL METHODS, V20, P245, DOI 10.1037/met0000033; March JS, 2000, J ABNORM CHILD PSYCH, V28, P527, DOI 10.1023/A:1005179014321; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Muris P, 2007, SCARED NL HANDLEIDIN; Ogrodniczuk J S, 2001, J Psychother Pract Res, V10, P69; Oosterlaan J., 2000, HANDLEIDING BIJ VRAG; Owens EB, 2003, J CONSULT CLIN PSYCH, V71, P540, DOI 10.1037/0022-006X.71.3.540; PELHAM WE, 1992, J AM ACAD CHILD PSY, V31, P210, DOI 10.1097/00004583-199203000-00006; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rieppi R, 2002, J AM ACAD CHILD PSY, V41, P269, DOI 10.1097/00004583-200203000-00006; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Safren S. A., 2005, MASTERING YOUR ADULT; Sattler, 2018, ASSESSMENT CHILDREN; SAYLOR CF, 1984, J CONSULT CLIN PSYCH, V52, P955, DOI 10.1037/0022-006X.52.6.955; Schatz David Beck, 2006, J Atten Disord, V10, P141, DOI 10.1177/1087054706286698; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; SHAFFER JP, 1991, PSYCHOMETRIKA, V56, P29, DOI 10.1007/BF02294583; Sibley MH, 2014, CLIN PSYCHOL REV, V34, P218, DOI 10.1016/j.cpr.2014.02.001; Sitarenios G., 1999, USE PSYCHOL TESTING, V2nd, P267; Smidts DP, 2009, HANDLEIDING EXECUTIE; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; TUCKER DM, 1992, NEUROPSY NEUROPSY BE, V5, P233; Van Brunt K, 2011, PATIENT PREFER ADHER, V5, DOI 10.2147/PPA.S6389; van den Hoofdakker BJ, 2014, EUR CHILD ADOLES PSY, V23, P1071, DOI 10.1007/s00787-014-0557-4; van den Hoofdakker BJ, 2012, DEV PSYCHOL, V48, P567, DOI 10.1037/a0026564; van den Hoofdakker BJ, 2010, J PEDIATR PSYCHOL, V35, P317, DOI 10.1093/jpepsy/jsp060; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Yoshimasu K, 2012, J CHILD PSYCHOL PSYC, V53, P1036, DOI 10.1111/j.1469-7610.2012.02567.x	71	10	11	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150698	10.1371/journal.pone.0150698	http://dx.doi.org/10.1371/journal.pone.0150698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977602	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800032
J	Du, QX; Jin, JM; Liu, XF; Sun, YC				Du, Qingxia; Jin, Jianmin; Liu, Xiaofang; Sun, Yongchang			Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PSEUDOMONAS-AERUGINOSA; COPD; EXACERBATIONS; RESOLUTION; COLONIZATION; INFLAMMATION; PHENOTYPES; SEVERITY; BACTERIA	Background Bronchiectasis revealed by chest computed tomography in COPD patients and its comorbid effect on prognosis have not been addressed by large-sized studies. Understanding the presence of bronchiectasis in COPD is important for future intervention and preventing disease progression. Methods Observational studies were identified from electronic literature searches in Cochrane library, PubMed, ScienceDirect databases, American Thoracic Society and European Respiratory Society meeting abstracts. A systematic review and meta-analysis of studies was performed to summarize the factors associated with bronchiectasis in COPD patients. Primary outcomes included the risks for exacerbation frequency, isolation of a potentially pathogenic microorganism, severe airway obstruction and mortality. Odds ratios (ORs) were pooled by random effects models. Results Fourteen observational studies were eligible for the study. Compared with COPD without bronchiectasis, comorbid bronchiectasis in COPD increased the risk of exacerbation (1.97, 95% CI, 1.29-3.00), isolation of a potentially pathogenic microorganism (4.11, 95% CI, 2.16-7.82), severe airway obstruction (1.31, 95% CI, 1.09-1.58) and mortality (1.96, 95% CI, 1.04-3.70). Conclusions The presence of bronchiectasis in patients with COPD was associated with exacerbation frequency, isolation of a potentially pathogenic microorganism, severe airway obstruction and mortality.	[Du, Qingxia; Jin, Jianmin; Liu, Xiaofang; Sun, Yongchang] Capital Med Univ, Beijing Tongren Hosp, Dept Resp Med, Beijing 100730, Peoples R China; [Du, Qingxia; Jin, Jianmin; Liu, Xiaofang; Sun, Yongchang] Capital Med Univ, Beijing Tongren Hosp, Dept Emergency, Beijing 100730, Peoples R China; [Sun, Yongchang] Peking Univ, Hosp 3, Dept Resp & Crit Care Med, Beijing 100191, Peoples R China	Capital Medical University; Capital Medical University; Peking University	Sun, YC (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Resp Med, Beijing 100730, Peoples R China.; Sun, YC (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Emergency, Beijing 100730, Peoples R China.; Sun, YC (corresponding author), Peking Univ, Hosp 3, Dept Resp & Crit Care Med, Beijing 100191, Peoples R China.	suny@ccmu.edu.cn		du, qingxia/0000-0002-8347-3772	National Natural Science Foundation of China [81170039, 81470239]; Beijing Natural Science Foundation [7152037, 7153163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (81170039 and 81470239) and the Beijing Natural Science Foundation (7152037 and 7153163).	ADLER KB, 1986, AM J PATHOL, V125, P501; Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; Arram EO, 2012, EGYPT J CHEST DIS TU, V61, P307, DOI 10.1016/j.ejcdt.2012.07.001; Aziz ZA, 2005, AM J ROENTGENOL, V185, P1509, DOI 10.2214/AJR.04.1578; Bafadhel M, 2011, CHEST, V140, P634, DOI 10.1378/chest.10-3007; Berger JS, 2004, AM J CARDIOL, V94, P649, DOI 10.1016/j.amjcard.2004.05.034; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fujimoto K, 2006, RESPIROLOGY, V11, P731, DOI 10.1111/j.1440-1843.2006.00930.x; Gallego M, 2014, BMC PULM MED, V14, P48; Garcia-Vidal C, 2009, EUR RESPIR J, V34, P1072, DOI 10.1183/09031936.00003309; Gatheral T, 2014, COPD, V11, P605, DOI 10.3109/15412555.2014.922174; Habesoglu MA, 2011, MULTIDISCIP RESP MED, V6, P284, DOI 10.1186/2049-6958-6-5-284; Han MeiLan K, 2013, Ann Am Thorac Soc, V10 Suppl, pS131, DOI 10.1513/AnnalsATS.201303-046AW; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jairam PM, 2015, THORAX, V70, P725, DOI 10.1136/thoraxjnl-2014-206160; Katsura H, 2001, Monaldi Arch Chest Dis, V56, P195; Mannino DM, 2002, CHEST, V121, p121S, DOI 10.1378/chest.121.5_suppl.121S; Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murray MP, 2009, EUR RESPIR J, V33, P312, DOI 10.1183/09031936.00122508; Ni YM, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S83910; Novosad SA, 2013, CURR OPIN PULM MED, V19, P133, DOI 10.1097/MCP.0b013e32835d8312; Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Roche N, 2006, RESPIRATION, V74, P19; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sadigov AS, 2014, AM J RESP CRIT CARE, V189; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Steward JI, 2012, AM J RESP CRIT CARE, V185, pA3656; Tulek B, 2013, CAN RESPIR J, V20, P91, DOI 10.1155/2013/727523; Valderrey AD, 2010, DIAGN MICR INFEC DIS, V68, P20, DOI 10.1016/j.diagmicrobio.2010.04.008; Wedzicha Jadwiga A, 2007, Proc Am Thorac Soc, V4, P602, DOI 10.1513/pats.200707-106TH; White AJ, 2003, THORAX, V58, P680, DOI 10.1136/thorax.58.8.680; Wilson R, 2012, EUR RESPIR J, V40, P17, DOI 10.1183/09031936.00090311	42	84	91	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150532	10.1371/journal.pone.0150532	http://dx.doi.org/10.1371/journal.pone.0150532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978269	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800028
J	Altadill, T; Campoy, I; Lanau, L; Gill, K; Rigau, M; Gil-Moreno, A; Reventos, J; Byers, S; Colas, E; Cheema, AK				Altadill, Tatiana; Campoy, Irene; Lanau, Lucia; Gill, Kirandeep; Rigau, Marina; Gil-Moreno, Antonio; Reventos, Jaume; Byers, Stephen; Colas, Eva; Cheema, Amrita K.			Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR; IN-VITRO; ACID; FUTURE; COENZYME-Q10; MARKERS; SERINE; BRAIN	Identification of sensitive and specific biomarkers with clinical and translational utility will require smart experimental strategies that would augment expanding the breadth and depth of molecular measurements within the constraints of currently available technologies. Exosomes represent an information rich matrix to discern novel disease mechanisms that are thought to contribute to pathologies such as dementia and cancer. Although proteomics and transcriptomic studies have been reported using Exosomes-Like Vesicles (ELVs) from different sources, exosomal metabolome characterization and its modulation in health and disease remains to be elucidated. Here we describe methodologies for UPLC-ESI-MS based small molecule profiling of ELVs from human plasma and cell culture media. In this study, we present evidence that indeed ELVs carry a rich metabolome that could not only augment the discovery of low abundance biomarkers but may also help explain the molecular basis of disease progression. This approach could be easily translated to other studies seeking to develop predictive biomarkers that can subsequently be used with simplified targeted approaches.	[Altadill, Tatiana; Campoy, Irene; Lanau, Lucia; Colas, Eva] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, Biomed Res Grp Ginecol, E-08193 Barcelona, Spain; [Gill, Kirandeep; Byers, Stephen; Cheema, Amrita K.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Gill, Kirandeep; Byers, Stephen; Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Biochem Mol & Cellular Biol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Rigau, Marina; Reventos, Jaume] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Gil-Moreno, Antonio] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Dept Gynecol, E-08193 Barcelona, Spain; [Colas, Eva] Univ Lleida, IRBLleida, Hosp Univ Arnau de Vilanova, Dept Pathol & Mol Genet,Oncol Pathol Grp, Lleida, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Georgetown University; Georgetown University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Universitat de Lleida; University Hospital Arnau de Vilanova	Cheema, AK (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA.; Cheema, AK (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem Mol & Cellular Biol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	akc27@georgetown.edu	Gil-Moreno, Antonio/C-1122-2016	Gil-Moreno, Antonio/0000-0003-1106-5590; Cheema, Amrita/0000-0003-4877-7583	Spanish Ministry of Health [RD12/0036/0035]; Spanish Ministry of Economy and Competitivy [PI14/02043]; AECC (Grupos Estables de Investi-gacion) [2011 - AECC- GCB 110333 REVE]; Fundacio La Marato TV3 [2/C/2013]; CIRIT Generalitat de Catalunya [2014 SGR 1330]; European Commission, 7th Framework Programe, IRSES - Belgium [PROTBIOFLUID -269285]; NIH/NCI [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Economy and Competitivy; AECC (Grupos Estables de Investi-gacion); Fundacio La Marato TV3; CIRIT Generalitat de Catalunya(Generalitat de Catalunya); European Commission, 7th Framework Programe, IRSES - Belgium; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Spanish Ministry of Health (RD12/0036/0035), the Spanish Ministry of Economy and Competitivy (PI14/02043), the AECC (Grupos Estables de Investi-gacion 2011 - AECC- GCB 110333 REVE), the Fundacio La Marato TV3 (2/C/2013), the CIRIT Generalitat de Catalunya (2014 SGR 1330) and the European Commission, 7th Framework Programe, IRSES (PROTBIOFLUID -269285) - Belgium. The authors would like to acknowledge the Proteomics and Metabolomics Shared Resource partially supported by Cancer Center Support Grant NIH/NCI grant P30-CA051008.	Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Colas E, 2011, INT J CANCER, V129, P2435, DOI 10.1002/ijc.25901; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Diamandis EP, 2014, CLIN CHEM LAB MED, V52, P791, DOI 10.1515/cclm-2014-0317; Franquesa M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00525; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Guidetti P, 2003, MOL BRAIN RES, V118, P132, DOI 10.1016/j.molbrainres.2003.08.004; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Healy ZR, 2011, CANCER EPIDEM BIOMAR, V20, P1516, DOI 10.1158/1055-9965.EPI-11-0279; Ho WSV, 2010, BRIT J PHARMACOL, V160, P1580, DOI 10.1111/j.1476-5381.2010.00788.x; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Krantz Seth B, 2010, Cancers (Basel), V2, P2084, DOI 10.3390/cancers2042084; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Mabert K, 2014, INT J RADIAT BIOL, V90, P659, DOI 10.3109/09553002.2014.892229; Makabi-Panzu B, 1998, VACCINE, V16, P1504, DOI 10.1016/S0264-410X(98)00018-8; Mazzeo C, 2015, J ALLERGY CLIN IMMUN; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Mizutani K, 2014, ANTICANCER RES, V34, P3419; Omri A, 2000, J DRUG TARGET, V7, P383; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pfeifer P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/161393; Pham H, 2004, INT J CANCER, V111, P192, DOI 10.1002/ijc.20245; Pocsfalvi G, 2016, MASS SPECTROM REV, V35, P3, DOI 10.1002/mas.21457; Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63; Sheikh Kathryn D, 2011, J Biomol Tech, V22, P1; Stahl W, 1996, ADV EXP MED BIOL, V387, P121; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Szajnik Marta, 2013, Gynecol Obstet (Sunnyvale), VSuppl 4, P3; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wei Ru, 2014, Methods Mol Biol, V1198, P171, DOI 10.1007/978-1-4939-1258-2_12; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yang Y, 2015, CURRENT MED CHEM; Zeczycki TN, 2014, BIOCHEM BIOPH RES CO, V450, P366, DOI 10.1016/j.bbrc.2014.05.133	42	58	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151339	10.1371/journal.pone.0151339	http://dx.doi.org/10.1371/journal.pone.0151339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974972	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600070
J	Fang, H; Dong, H; Cai, T; Zheng, P; Li, HX; Zhang, DW; Sun, JB				Fang, Huan; Dong, Huina; Cai, Tao; Zheng, Ping; Li, Haixing; Zhang, Dawei; Sun, Jibin			In Vitro Optimization of Enzymes Involved in Precorrin-2 Synthesis Using Response Surface Methodology	PLOS ONE			English	Article							UROPORPHYRINOGEN-III METHYLTRANSFERASE; ADENOSYL-L-METHIONINE; HEME D(1) BIOSYNTHESIS; ESCHERICHIA-COLI; BACILLUS-MEGATERIUM; FATTY-ACID; EXPRESSION; PATHWAY; GENE; OVERPRODUCTION	In order to maximize the production of biologically-derived chemicals, kinetic analyses are first necessary for predicting the role of enzyme components and coordinating enzymes in the same reaction system. Precorrin-2 is a key precursor of cobalamin and siroheme synthesis. In this study, we sought to optimize the concentrations of several molecules involved in precorrin-2 synthesis in vitro: porphobilinogen synthase (PBGS), porphobilinogen deaminase (PBGD), uroporphyrinogen III synthase (UROS), and S-adenosyl-l-methionine-dependent urogen III methyltransferase (SUMT). Response surface methodology was applied to develop a kinetic model designed to maximize precorrin-2 productivity. The optimal molar ratios of PBGS, PBGD, UROS, and SUMT were found to be approximately 1: 7: 7: 34, respectively. Maximum precorrin-2 production was achieved at 0.1966 +/- 0.0028 mu M/min, agreeing with the kinetic model's predicted value of 0.1950 mu M/min. The optimal concentrations of the cofactor S-adenosyl-L-methionine (SAM) and substrate 5-aminolevulinic acid (ALA) were also determined to be 200 mu M and 5 mM, respectively, in a tandem-enzyme assay. By optimizing the relative concentrations of these enzymes, we were able to minimize the effects of substrate inhibition and feedback inhibition by S-adenosylhomocysteine on SUMT and thereby increase the production of precorrin-2 by approximately five-fold. These results demonstrate the effectiveness of kinetic modeling via response surface methodology for maximizing the production of biologically-derived chemicals.	[Fang, Huan; Dong, Huina; Cai, Tao; Zheng, Ping; Zhang, Dawei; Sun, Jibin] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Fang, Huan; Dong, Huina; Zheng, Ping; Zhang, Dawei; Sun, Jibin] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Fang, Huan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Haixing] Nanchang Univ, Sinogerman Joint Res Inst, Nanchang, Jiangxi, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanchang University	Zhang, DW (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China.; Zhang, DW (corresponding author), Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China.	zhang_dw@tib.cas.cn		Sun, Jibin/0000-0002-0208-504X	State Key Development Program for Basic Research of China (973 Program) [2013CB733600]; National Nature Science Foundation of China [31370089]; Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences	State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences	This work was supported by the State Key Development Program for Basic Research of China (973 Program, 2013CB733600) (http://www.most.gov.cn/), the National Nature Science Foundation of China (31370089) (http://www.nsfc.gov.cn/), and the Key Laboratory of Systems Microbial Biotechnology, Chinese Academy of Sciences (http://www.sysbio.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha N, 2015, J IND MICROBIOL BIOT, V42, P21, DOI 10.1007/s10295-014-1542-0; Alper H, 2006, P NATL ACAD SCI USA, V103, P3006, DOI 10.1073/pnas.0511314103; BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989; Box GE., 1978, STAT EXPT; Comba S, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0172-0; Gadhe A, 2011, J CHEM TECHNOL BIOT, V86, P1535, DOI 10.1002/jctb.2671; Guo DY, 2014, METAB ENG, V22, P69, DOI 10.1016/j.ymben.2014.01.003; He J, 2009, BIORESOURCE TECHNOL, V100, P5922, DOI 10.1016/j.biortech.2009.06.087; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Juminaga D, 2012, APPL ENVIRON MICROB, V78, P89, DOI 10.1128/AEM.06017-11; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Larentis AL, 2012, J IND MICROBIOL BIOT, V39, P897, DOI 10.1007/s10295-012-1099-8; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; Liu Q, 2015, METAB ENG, V28, P82, DOI 10.1016/j.ymben.2014.12.004; Liu R, 2014, METAB ENG, V22, P10, DOI 10.1016/j.ymben.2013.12.004; Liu TG, 2010, METAB ENG, V12, P378, DOI 10.1016/j.ymben.2010.02.003; Lobo SAL, 2009, BIOCHEM J, V420, P317, DOI 10.1042/BJ20090151; Lopez-Gallego F, 2010, CURR OPIN CHEM BIOL, V14, P174, DOI 10.1016/j.cbpa.2009.11.023; Na D, 2010, CURR OPIN MICROBIOL, V13, P363, DOI 10.1016/j.mib.2010.02.004; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; ROBIN C, 1991, J BACTERIOL, V173, P4893, DOI 10.1128/jb.173.15.4893-4896.1991; Rodrigues RCLB, 2012, BIORESOURCE TECHNOL, V108, P134, DOI 10.1016/j.biortech.2011.09.026; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SATTLER I, 1995, J BACTERIOL, V177, P1564, DOI 10.1128/jb.177.6.1564-1569.1995; Schubert HL, 2008, BIOCHEM J, V415, P257, DOI 10.1042/BJ20080785; Storbeck S, 2011, J BIOL CHEM, V286, P26754, DOI 10.1074/jbc.M111.239855; Storbeck S, 2009, FEBS J, V276, P5973, DOI 10.1111/j.1742-4658.2009.07306.x; Yin L, 2013, BIOL SCI, V368, DOI [10.1098/rstb.2012.0262, DOI 10.1098/RSTB.2012.0262]; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Zajicek RS, 2009, FEBS J, V276, P6399, DOI 10.1111/j.1742-4658.2009.07354.x; Zhu FY, 2014, BIOTECHNOL BIOENG, V111, P1396, DOI 10.1002/bit.25198	32	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151149	10.1371/journal.pone.0151149	http://dx.doi.org/10.1371/journal.pone.0151149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974652	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600052
J	Kent, IA; Rane, PS; Dickinson, RB; Ladd, AJC; Lele, TP				Kent, Ian A.; Rane, Parag S.; Dickinson, Richard B.; Ladd, Anthony J. C.; Lele, Tanmay P.			Transient Pinning and Pulling: A Mechanism for Bending Microtubules	PLOS ONE			English	Article							LIVING CELLS; TRANSITION FREQUENCIES; DYNAMIC INSTABILITY; CYTOPLASMIC DYNEIN; EPITHELIAL-CELLS; MIGRATING CELLS; MINUS END; IN-VIVO; TENSEGRITY; DYNACTIN	Microtubules have a persistence length of the order of millimeters in vitro, but inside cells they bend over length scales of microns. It has been proposed that polymerization forces bend microtubules in the vicinity of the cell boundary or other obstacles, yet bends develop even when microtubules are polymerizing freely, unaffected by obstacles and cell boundaries. How these bends are formed remains unclear. By tracking the motions of microtubules marked by photobleaching, we found that in LLC-PK1 epithelial cells local bends develop primarily by plus-end directed transport of portions of the microtubule contour towards stationary locations (termed pinning points) along the length of the microtubule. The pinning points were transient in nature, and their eventual release allowed the bends to relax. The directionality of the transport as well as the overall incidence of local bends decreased when dynein was inhibited, while myosin inhibition had no observable effect. This suggests that dynein generates a tangential force that bends microtubules against stationary pinning points. Simulations of microtubule motion and polymerization accounting for filament mechanics and dynein forces predict the development of bends of size and shape similar to those observed in cells. Furthermore, simulations show that dynein-generated bends at a pinning point near the plus end can cause a persistent rotation of the tip consistent with the observation that bend formation near the tip can change the direction of microtubule growth. Collectively, these results suggest a simple physical mechanism for the bending of growing microtubules by dynein forces accumulating at pinning points.	[Kent, Ian A.; Rane, Parag S.; Dickinson, Richard B.; Ladd, Anthony J. C.; Lele, Tanmay P.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lele, TP (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	tlele@che.ufl.edu	Dickinson, Richard B/A-4435-2012; Ladd, Anthony/AAC-8602-2019	Dickinson, Richard B/0000-0002-7415-2889; 	National Institutes of Health [RO1 GM102486]; National Science Foundation [1236616]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health RO1 GM102486 (T.P.L. and R.B. D.) and National Science Foundation 1236616.	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Brangwynne CP, 2007, P NATL ACAD SCI USA, V104, P16128, DOI 10.1073/pnas.0703094104; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; Howard J., 2001, MECH MOTOR PROTEINS; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ingber DE, 2000, J APPL PHYSIOL, V89, P1663, DOI 10.1152/jappl.2000.89.4.1663; Jolly Amber L, 2010, Commun Integr Biol, V3, P589, DOI 10.4161/cib.3.6.13212; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Komarova YA, 2002, J CELL SCI, V115, P3527; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Llopis I, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061901; Odde DJ, 1999, J CELL SCI, V112, P3283; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; Shekhar N, 2013, CELL MOL BIOENG, V6, P120, DOI 10.1007/s12195-013-0281-z; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; Stamenovic D, 2002, AM J PHYSIOL-CELL PH, V282, pC617, DOI 10.1152/ajpcell.00271.2001; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wu J, 2011, MOL BIOL CELL, V22, P4834, DOI 10.1091/mbc.E11-07-0611; Wu J, 2011, J CELL PHYSIOL, V226, P2666, DOI 10.1002/jcp.22616; Yvon AMC, 1997, J CELL SCI, V110, P2391	38	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151322	10.1371/journal.pone.0151322	http://dx.doi.org/10.1371/journal.pone.0151322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974838	Green Published, gold			2022-12-27	WOS:000372570600069
J	Reudink, MW; Kyle, CJ; McKellar, AE; Somers, CM; Reudink, RLF; Kyser, TK; Franks, SE; Nocera, JJ				Reudink, Matthew W.; Kyle, Christopher J.; McKellar, Ann E.; Somers, Christopher M.; Reudink, Robyn L. F.; Kyser, T. Kurt; Franks, Samantha E.; Nocera, Joseph J.			Linking Isotopes and Panmixia: High WithinColony Variation in Feather delta 2H, delta 13C, and delta 15N across the Range of the American White Pelican	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENE FLOW; MICROSATELLITE LOCI; NITROGEN ISOTOPES; LAKE; ASSIGNMENT; MIGRATION; PATTERNS; HYDROGEN; ECOLOGY	Complete panmixia across the entire range of a species is a relatively rare phenomenon; however, this pattern may be found in species that have limited philopatry and frequent dispersal. American white pelicans (Pelecanus erythrorhyncos) provide a unique opportunity to examine the role of long-distance dispersal in facilitating gene flow in a species recently reported as panmictic across its broad breeding range. This species is also undergoing a range expansion, with new colonies arising hundreds of kilometers outside previous range boundaries. In this study, we use a multiple stable isotope (delta H-2, delta C-13, delta N-15) approach to examine feather isotopic structuring at 19 pelican colonies across North America, with the goal of establishing an isotopic basemap that could be used for assigning individuals at newly established breeding sites to source colonies. Within-colony isotopic variation was extremely high, exceeding 100% in delta H-2 within some colonies (with relatively high variation also observed for delta C-13 and delta N-15). The high degree of within-site variation greatly limited the utility of assignment-based approaches (42% cross-validation success rate; range: 0-90% success). Furthermore, clustering algorithms identified four likely isotopic clusters; however, those clusters were generally unrelated to geographic location. Taken together, the high degree of within-site isotopic variation and lack of geographically-defined isotopic clusters preclude the establishment of an isotopic basemap for American white pelicans, but may indicate that a high incidence of long-distance dispersal is facilitating gene flow, leading to genetic panmixia.	[Reudink, Matthew W.; Kyle, Christopher J.] Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada; [McKellar, Ann E.] Environm Canada, Saskatoon, SK, Canada; [Somers, Christopher M.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Reudink, Robyn L. F.] British Columbia Minist Forests Lands & Nat Resou, Kamloops, BC, Canada; [Kyser, T. Kurt] Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON, Canada; [Franks, Samantha E.] British Trust Ornithol, Thetford, Norfolk, England; [Reudink, Matthew W.; Nocera, Joseph J.] Trent Univ, Ontario Minist Nat Resources & Forestry, Peterborough, ON K9J 7B8, Canada; [Reudink, Matthew W.] Thompson Rivers Univ, Dept Biol Sci, Kamloops, BC, Canada	Trent University; Environment & Climate Change Canada; University of Regina; Queens University - Canada; British Trust for Ornithology; Ministry of Natural Resources & Forestry; Trent University	Reudink, MW (corresponding author), Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada.; Reudink, MW (corresponding author), Trent Univ, Ontario Minist Nat Resources & Forestry, Peterborough, ON K9J 7B8, Canada.; Reudink, MW (corresponding author), Thompson Rivers Univ, Dept Biol Sci, Kamloops, BC, Canada.	mreudink@tru.ca	Somers, Christopher/AAE-6390-2019	McKellar, Ann/0000-0002-7032-3759; Nocera, Joseph/0000-0002-5913-8851; Reudink, Matthew/0000-0001-8956-5849	Climate Change Fund for Ontario; Explorer's Club; MITACS; Canada Research Chairs Program; Natural Sciences and Engineering Research Council of Canada; Saskatchewan Ministry of the Environment's Fish and Wildlife Development Fund	Climate Change Fund for Ontario; Explorer's Club; MITACS; Canada Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Ministry of the Environment's Fish and Wildlife Development Fund	Funding for this project was provided by the Climate Change Fund for Ontario (JJN), the Explorer's Club (MWR; https://explorers.org/expeditions/funding/expedition_grants), MITACS (https://www.mitacs.ca/en/programs/accelerate), the Canada Research Chairs Program (CMS; http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx), the Natural Sciences and Engineering Research Council of Canada (CMS; http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp), and the Saskatchewan Ministry of the Environment's Fish and Wildlife Development Fund (CMS; http://www.environment.gov.sk.ca/fwdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DW, 2005, WATERBIRDS, V28, P1, DOI 10.1675/1524-4695(2005)28[1:IBACOT]2.0.CO;2; Bergek S, 2012, J FISH BIOL, V80, P2302, DOI 10.1111/j.1095-8649.2012.03286.x; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Beveridge M, 2006, MOL ECOL, V15, P951, DOI 10.1111/j.1365-294X.2006.02846.x; BOELLSTORFF DE, 1988, COLON WATERBIRD, V11, P215, DOI 10.2307/1521002; Bond AL, 2012, WATERBIRDS, V35, P324, DOI 10.1675/063.035.0213; Bugajski A, 2012, CANADIAN J FISHERIES, V91, P589; Bunnell F.L., 1981, Colonial Waterbirds, V4, P2, DOI 10.2307/1521105; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; CHAPMAN BR, 1988, COLON WATERBIRD, V11, P275, DOI 10.2307/1521009; Chessel D., 2004, R NEWS, V4, P5; Coltman DW, 2007, MOL ECOL, V16, P1639, DOI 10.1111/j.1365-294X.2007.03229.x; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Franks SE, 2012, J AVIAN BIOL, V43, P155, DOI 10.1111/j.1600-048X.2012.05573.x; FreemanGallant GR, 1996, EVOLUTION, V50, P1631, DOI 10.1111/j.1558-5646.1996.tb03935.x; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Genz A., 2009, COMPUTATION MULTIVAR, V195; Genz A., 2021, MVTNORM MULTIVARIATE; Gomez-Diaz E, 2007, ECOL APPL, V17, P1484, DOI 10.1890/06-1232.1; Hickman CR, 2008, MOL ECOL RESOUR, V8, P1439, DOI 10.1111/j.1755-0998.2008.02191.x; Hoarau G, 2002, MOL ECOL, V11, P1165, DOI 10.1046/j.1365-294X.2002.01515.x; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Keith JO, 2005, WATERBIRDS, V28, P9, DOI 10.1675/1524-4695(2005)28[9:AOOTAW]2.0.CO;2; Knopf F. L., 2004, BIRDS N AM; Lajtha K, 1994, STABLE ISOTOPES ECOL, P1; Lake JL, 2001, CAN J FISH AQUAT SCI, V58, P870, DOI 10.1139/cjfas-58-5-870; Machado MD, 2009, CONSERV GENET, V10, P1033, DOI 10.1007/s10592-008-9681-3; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Miller NG, 2011, BIOL LETTERS, V7, P43, DOI 10.1098/rsbl.2010.0525; Morat F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086585; Murphy EC, 2005, WATERBIRDS, V28, P61, DOI 10.1675/1524-4695(2005)28[61:CIOIHW]2.0.CO;2; Neethling M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-325; Oomen RA, 2011, J HERED, V102, P584, DOI 10.1093/jhered/esr055; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pekarik Cynthia, 2009, Ontario Birds, V27, P42; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poupin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028046; Pyle P, 2008, IDENTIFICATION GUIDE; R Development Core Team, 2012, R LANG ENV STAT COMP; Reudink MW, 2011, BIOL J LINN SOC, V102, P583, DOI 10.1111/j.1095-8312.2010.01608.x; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Royle JA, 2004, ECOL APPL, V14, P1780; Ruegg KC, 2014, MOL ECOL, V23, P5726, DOI 10.1111/mec.12977; Rundel CW, 2013, MOL ECOL, V22, P4163, DOI 10.1111/mec.12393; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Sellick MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004735; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Somers Christopher M., 2010, Blue Jay, V68, P75; Sovada MA, 2005, WATERBIRDS, V28, P27, DOI 10.1675/1524-4695(2005)28[27:HACSOT]2.0.CO;2; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; Todorov V, 2009, J STAT SOFTW, V32, P1; WARD RD, 1992, EVOL BIOL, V26, P73; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Welch AJ, 2012, HEREDITY, V109, P19, DOI 10.1038/hdy.2012.7; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1; Wunder MB, 2012, J ANIM ECOL, V81, P1223, DOI 10.1111/j.1365-2656.2012.01998.x; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135	62	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150810	10.1371/journal.pone.0150810	http://dx.doi.org/10.1371/journal.pone.0150810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974163	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600032
J	Gao, ZY; Huo, LJ; Cui, DM; Yang, X; Zeng, JW				Gao, Zhenya; Huo, Lijun; Cui, Dongmei; Yang, Xiao; Zeng, Junwen			The Expression of Bone Morphogenetic Protein 2 and Matrix Metalloproteinase 2 through Retinoic Acid Receptor Beta Induced by All-Trans Retinoic Acid in Cultured ARPE-19 Cells	PLOS ONE			English	Article							HUMAN SCLERAL FIBROBLASTS; FORM-DEPRIVATION MYOPIA; PIGMENT EPITHELIUM; GUINEA-PIG; EYE GROWTH; IN-VITRO; DIFFERENTIATION; CHICK; PREVALENCE; ACTIVATION	Purpose All-trans retinoic acid (ATRA) plays an important role in ocular development. Previous studies found that retinoic acid could influence the metabolism of scleral remodeling by promoting retinal pigment epithelium (RPE) cells to secrete secondary signaling factors. The purpose of this study was to investigate whether retinoic acid affected secretion of bone morphogenetic protein 2 (BMP-2) and matrix metalloproteinase 2 (MMP-2) and to explore the signaling pathway of retinoic acid in cultured acute retinal pigment epithelial 19 (ARPE-19) cells. Methods The effects of ATRA (concentrations from 10(-9) to 10(-5) mol/l) on the expression of retinoic acid receptors (RARs) in ARPE-19 cells were examined at the mRNA and protein levels using reverse transcription-polymerase chain reaction (RT-PCR) and western blot assay, respectively. The effects of treating ARPE-19 cells with ATRA concentrations ranging from 10(-9) to 10(-5) mol/l for 24 h and 48 h or with 10(-6) mol/l ATRA at different times ranging from 6h to 72h were assessed using real-time quantitative PCR (qPCR) and enzyme-linked immunosorbent assay (ELISA). The contribution of RAR beta-induced activation of ARPE-19 cells was confirmed using LE135, an antagonist of RAR beta. Results RAR beta mRNA levels significantly increased in the ARPE-19 cells treated with ATRA for 24h and 48h. These increases in RAR beta mRNA levels were dose dependent (at concentrations of 10(-9) to 10(-5) mol/l) with a maximum effect observed at 10(-6) mol/l. There were no significant changes in the mRNA levels of RAR alpha and RAR gamma. Western blot assay revealed that RAR beta protein levels were increased significantly in a time-dependent manner in ARPE-19 cells treated with 10(-6) mol/l ATRA from 12 h to 72 h, with a marked increase observed at 24 h and 48 h. The upregulation of RAR beta and the ATRA-induced secretion in ARPE-19 cells could be inhibited by the RAR beta antagonist LE135. Conclusion ATRA induced upregulation of RAR beta in ARPE-19 cells and stimulated these cells to secrete BMP-2 and MMP-2.	[Gao, Zhenya; Cui, Dongmei; Yang, Xiao; Zeng, Junwen] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China; [Huo, Lijun] Sun Yat Sen Univ, Affiliated Hosp 1, 58 Zhong Shan Er Rd, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zeng, JW (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China.	cier72@163.com	gao, zhenya/AAP-5080-2021		National Natural Science Foundation of China [81170872, 81200716]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81170872 and 81200716), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China (81170872 and 81200716)	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Bitzer M, 2000, EXP EYE RES, V70, P97, DOI 10.1006/exer.1999.0762; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cheung B, 1998, ONCOGENE, V17, P751, DOI 10.1038/sj.onc.1201982; Gao ZY, 2012, INT J OPHTHALMOL-CHI, V5, P661, DOI 10.3980/j.issn.2222-3959.2012.06.02; Geisen C, 1997, CANCER RES, V57, P1460; Guggenheim JA, 1996, INVEST OPHTH VIS SCI, V37, P1380; HEBERLEIN U, 1995, CELL, V81, P987, DOI 10.1016/S0092-8674(05)80003-0; Hu JM, 2008, MOL VIS, V14, P2373; Hu XT, 2014, CELL PROLIFERAT, V47, P200, DOI 10.1111/cpr.12100; Huang Jia, 2011, Zhonghua Yan Ke Za Zhi, V47, P938; Huo LJ, 2013, MOL VIS, V19, P1795; Ju J, 2015, AM J TRANSL RES, V7, P856; Li CX, 2010, MOL VIS, V16, P689; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mao JF, 2012, INT J OPHTHALMOL-CHI, V5, P670, DOI 10.3980/j.issn.2222-3959.2012.06.04; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; McFadden SA, 2006, EXP EYE RES, V83, P949, DOI 10.1016/j.exer.2006.05.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pavan B, 2006, CURR MED CHEM, V13, P3553, DOI 10.2174/092986706779026183; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; RADA JA, 1995, INVEST OPHTH VIS SCI, V36, P1555; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Seko Y, 1996, EXP EYE RES, V63, P443, DOI 10.1006/exer.1996.0134; Shelton L, 2007, EXP EYE RES, V84, P314, DOI 10.1016/j.exer.2006.10.004; Shirakami Y, 2012, CARCINOGENESIS, V33, P268, DOI 10.1093/carcin/bgr275; SI SP, 1995, EXP CELL RES, V219, P243, DOI 10.1006/excr.1995.1224; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI DOI 10.1001/ARCH0PHTHALM0L.2009.303; Wang Q, 2011, MOL VIS, V17, P647; Xu XC, 1999, CANCER RES, V59, P2477	36	3	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150831	10.1371/journal.pone.0150831	http://dx.doi.org/10.1371/journal.pone.0150831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967733	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200017
J	Hossain, ME; Jassim, WA; Zilany, MSA				Hossain, Mohammad E.; Jassim, Wissam A.; Zilany, Muhammad S. A.			Reference-Free Assessment of Speech Intelligibility Using Bispectrum of an Auditory Neurogram	PLOS ONE			English	Article							HIGHER-ORDER SPECTRA; NERVE-FIBERS; COCHLEAR NEUROPATHY; IMPAIRED LISTENERS; WORD RECOGNITION; ACOUSTIC TRAUMA; HAIR CELL; HEARING; NOISE; MODEL	Sensorineural hearing loss occurs due to damage to the inner and outer hair cells of the peripheral auditory system. Hearing loss can cause decreases in audibility, dynamic range, frequency and temporal resolution of the auditory system, and all of these effects are known to affect speech intelligibility. In this study, a new reference-free speech intelligibility metric is proposed using 2-D neurograms constructed from the output of a computational model of the auditory periphery. The responses of the auditory-nerve fibers with a wide range of characteristic frequencies were simulated to construct neurograms. The features of the neurograms were extracted using third-order statistics referred to as bispectrum. The phase coupling of neurogram bispectrum provides a unique insight for the presence (or deficit) of supra-threshold nonlinearities beyond audibility for listeners with normal hearing (or hearing loss). The speech intelligibility scores predicted by the proposed method were compared to the behavioral scores for listeners with normal hearing and hearing loss both in quiet and under noisy background conditions. The results were also compared to the performance of some existing methods. The predicted results showed a good fit with a small error suggesting that the subjective scores can be estimated reliably using the proposed neural-response-based metric. The proposed metric also had a wide dynamic range, and the predicted scores were well-separated as a function of hearing loss. The proposed metric successfully captures the effects of hearing loss and supra-threshold nonlinearities on speech intelligibility. This metric could be applied to evaluate the performance of various speech-processing algorithms designed for hearing aids and cochlear implants.	[Hossain, Mohammad E.; Jassim, Wissam A.; Zilany, Muhammad S. A.] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Zilany, MSA (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	zilany@um.edu.my	Zilany, Muhammad S/C-1541-2012	Zilany, Muhammad S/0000-0003-0181-0737; Jassim, Wissam/0000-0001-5998-142X; Hossain, Md Ekramul/0000-0001-6913-8313	 [UM.C/625/1/HIR/152];  [RP016B-13AET]	; 	This study was supported by the grants UM.C/625/1/HIR/152 and RP016B-13AET. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILGER RC, 1976, J SPEECH HEAR RES, V19, P718, DOI 10.1044/jshr.1904.718; BRADLEY JS, 1986, J ACOUST SOC AM, V80, P837, DOI 10.1121/1.393907; Bruce IC, 2004, PHYSIOL MEAS, V25, P945, DOI 10.1088/0967-3334/25/4/013; Bruce IC, 2003, J ACOUST SOC AM, V113, P369, DOI 10.1121/1.1519544; CHANDRAN V, 1991, IEEE T SIGNAL PROCES, V39, P2640, DOI 10.1109/78.107414; Chandran V, 1997, IEEE T IMAGE PROCESS, V6, P703, DOI 10.1109/83.568927; Chandran V, 1993, INT J BIFURCAT CHAOS, V3, P551, DOI 10.1142/S021812749300043X; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; CHIANG HH, 1990, IEEE T AUTOMAT CONTR, V35, P36, DOI 10.1109/9.45141; Chow TWS, 1997, SIGNAL PROCESS, V61, P23, DOI 10.1016/S0165-1684(97)00089-3; Chua K. C., 2008, Journal of Medical Engineering & Technology, V32, P145, DOI 10.1080/03091900601050862; Chua KC, 2010, MED ENG PHYS, V32, P679, DOI 10.1016/j.medengphy.2010.04.009; Davies-Venn E, 2009, EAR HEARING, V30, P494, DOI 10.1097/AUD.0b013e3181aec5bc; Donohue K., 2009, AUDIO SYSTEMS ARRAY; Dubno JR, 2005, J ACOUST SOC AM, V118, P914, DOI 10.1121/1.1953107; DUBNO JR, 1982, J SPEECH HEAR RES, V25, P141, DOI 10.1044/jshr.2501.141; DURLACH NI, 1981, AUDIOLOGY, V20, P181; El-Khamy SE, 1995, COMP COMM 1995 P IEE; Falk TH, 2010, IEEE T AUDIO SPEECH, V18, P1766, DOI 10.1109/TASL.2010.2052247; FRENCH NR, 1947, J ACOUST SOC AM, V19, P90, DOI 10.1121/1.1916407; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; GABRIEL KJ, 1992, J ACOUST SOC AM, V91, P336, DOI 10.1121/1.402776; Garofolo JS, 1993, TIMIT ACOUSTIC PHONE; Heinz MG, 2009, JARO-J ASSOC RES OTO, V10, P407, DOI 10.1007/s10162-009-0169-8; HELME BI, 1985, IEEE T ACOUST SPEECH, V33, P903, DOI 10.1109/TASSP.1985.1164635; Hines A, 2012, SPEECH COMMUN, V54, P306, DOI 10.1016/j.specom.2011.09.004; Hines A, 2010, SPEECH COMMUN, V52, P736, DOI 10.1016/j.specom.2010.04.006; Hornsby BWY, 2005, J ACOUST SOC AM, V118, P1719, DOI 10.1121/1.1993128; Ibrahim RA, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P429, DOI 10.1007/978-1-4419-5686-6_40; Institute ANS, 1997, AM NAT STAND METH CA; Jorgensen S, 2013, J ACOUST SOC AM, V134, P436, DOI 10.1121/1.4807563; Khadra L, 2005, IEEE T BIO-MED ENG, V52, P1840, DOI 10.1109/TBME.2005.856281; KIANG NYS, 1976, ANN OTO RHINOL LARYN, V85, P752, DOI 10.1177/000348947608500605; KIANG NYS, 1990, HEARING RES, V49, P1, DOI 10.1016/0378-5955(90)90091-3; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; LIBERMAN MC, 1982, J ACOUST SOC AM, V72, P1441, DOI 10.1121/1.388677; Maison SF, 2013, J NEUROSCI, V33, P5542, DOI 10.1523/JNEUROSCI.5027-12.2013; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Muthuswamy J, 1999, IEEE T BIO-MED ENG, V46, P92, DOI 10.1109/10.736762; Ng T-T, 2004, CIRC SYST 2004 ISCAS; NIKIAS CL, 1987, P IEEE, V75, P869, DOI 10.1109/PROC.1987.13824; Oxenham AJ, 2003, JARO-J ASSOC RES OTO, V4, P541, DOI 10.1007/s10162-002-3058-y; Plack CJ, 2004, J ACOUST SOC AM, V115, P1684, DOI 10.1121/1.1675812; RAGHUVEER MR, 1985, IEEE T ACOUST SPEECH, V33, P1213, DOI 10.1109/TASSP.1985.1164679; Rhode W, 1973, INVESTIGATION POST M, P49; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; SCHMIEDT RA, 1980, J NEUROPHYSIOL, V43, P1367, DOI 10.1152/jn.1980.43.5.1367; Shen C, 1997, SIGNAL PROCESS, V61, P39, DOI 10.1016/S0165-1684(97)00090-X; Shera CA, 2010, JARO-J ASSOC RES OTO, V11, P343, DOI 10.1007/s10162-010-0217-4; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; STEENEKEN HJM, 1980, J ACOUST SOC AM, V67, P318, DOI 10.1121/1.384464; Studebaker GA, 1999, J ACOUST SOC AM, V105, P2431, DOI 10.1121/1.426848; Studebaker GA, 2002, J ACOUST SOC AM, V111, P1422, DOI 10.1121/1.1445788; Swami A, 2000, HIGHER ORDER SPECTRA, V2, P3; Taal CH, 2011, IEEE T AUDIO SPEECH, V19, P2125, DOI 10.1109/TASL.2011.2114881; THORNTON AR, 1978, J SPEECH HEAR RES, V21, P507, DOI 10.1044/jshr.2103.507; Tillman TW, 1966, 1966 DTIC NW U; Yang L, 2008, AUD LANG IM PROC 200; Zhang JW, 2000, IEEE T BIO-MED ENG, V47, P352, DOI 10.1109/10.827296; Zhou SM, 2008, INFORM SCIENCES, V178, P1629, DOI 10.1016/j.ins.2007.11.012; Zilany MSA, 2007, J ACOUST SOC AM, V122, P402, DOI 10.1121/1.2735117; Zilany MSA, 2006, J ACOUST SOC AM, V120, P1446, DOI 10.1121/1.2225512; Zilany MSA, 2014, J ACOUST SOC AM, V135, P283, DOI 10.1121/1.4837815; Zilany MSA, 2009, J ACOUST SOC AM, V126, P2390, DOI 10.1121/1.3238250	67	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150415	10.1371/journal.pone.0150415	http://dx.doi.org/10.1371/journal.pone.0150415			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967160	gold, Green Submitted, Green Published			2022-12-27	WOS:000371989200013
J	Mahdy, MAK; Al-Mekhlafi, AM; Abdul-Ghani, R; Saif-Ali, R; Al-Mekhlafi, HM; Al-Eryani, SM; Lim, YAL; Mahmud, R				Mahdy, Mohammed A. K.; Al-Mekhlafi, Abdulsalam M.; Abdul-Ghani, Rashad; Saif-Ali, Reyadh; Al-Mekhlafi, Hesham M.; Al-Eryani, Samira M.; Lim, Yvonne A. L.; Mahmud, Rohela			First Molecular Characterization of Leishmania Species Causing Visceral Leishmaniasis among Children in Yemen	PLOS ONE			English	Article							DONOVANI COMPLEX; CUTANEOUS LEISHMANIASIS; KALA-AZAR; INFANTUM; DIAGNOSIS; EPIDEMIOLOGY; HETEROGENEITY; EVOLUTIONARY; SENSITIVITY; REGION	Visceral leishmaniasis (VL) is a debilitating, often fatal disease caused by Leishmania donovani complex; however, it is a neglected tropical disease. L. donovani complex comprises two closely related species, L. donovani that is mostly anthroponotic and L. infantum that is zoonotic. Differentiation between these two species is critical due to the differences in their epidemiology and pathology. However, they cannot be differentiated morphologically, and their speciation using isoenzyme-based methods poses a difficult task and may be unreliable. Molecular characterization is now the most reliable method to differentiate between them and to determine their phylogenetic relationships. The present study aims to characterize Leishmania species isolated from bone marrows of Yemeni pediatric patients using sequence analysis of the ribosomal internal transcribed spacer-1 (ITS1) gene. Out of 41 isolates from Giemsa-stained bone marrow smears, 25 isolates were successfully amplified by nested polymerase chain reaction and sequenced in both directions. Phylogenetic analysis using neighbor joining method placed all study isolates in one cluster with L. donovani complex (99% bootstrap). The analysis of ITS1 for microsatellite repeat numbers identified L. infantum in 11 isolates and L. donovani in 14 isolates. These data suggest the possibility of both anthroponotic and zoonotic transmission of VL-causing Leishmania species in Yemen. Exploring the possible animal reservoir hosts is therefore needed for effective control to be achieved.	[Mahdy, Mohammed A. K.; Abdul-Ghani, Rashad] Univ Sci & Technol, Trop Dis Res Ctr, Fac Med, Sanaa, Yemen; [Mahdy, Mohammed A. K.; Abdul-Ghani, Rashad; Saif-Ali, Reyadh; Al-Mekhlafi, Hesham M.; Al-Eryani, Samira M.] Sanaa Univ, Fac Med & Hlth Sci, Dept Parasitol, Sanaa, Yemen; [Saif-Ali, Reyadh] Sanaa Univ, Fac Med & Hlth Sci, Dept Biochem, Sanaa, Yemen; [Al-Mekhlafi, Hesham M.; Lim, Yvonne A. L.; Mahmud, Rohela] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Mahdy, MAK (corresponding author), Univ Sci & Technol, Trop Dis Res Ctr, Fac Med, Sanaa, Yemen.	alsharaby9@yahoo.com	Mahdy, Mohammed A.K./C-1187-2010; LIM, YVONNE AL/B-5276-2010; Abdul-Ghani, Rashad/N-3289-2013; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016	Mahdy, Mohammed A.K./0000-0002-8340-5219; LIM, YVONNE AL/0000-0003-4050-6332; Abdul-Ghani, Rashad/0000-0001-7181-1108; Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410; kamal, amera/0000-0002-9154-9415; Saif-Ali, Riyadh/0000-0002-0246-3856	University of Malaya [RG302/11HTM]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya (RG302/11HTM).; The authors thank the management and personnel of Al-Sabeen Hospital for their cooperation and for giving the permission to use the archived samples. This work was supported by University of Malaya (RG302/11HTM).	Al-Kamel MA, 2015, INT J DERMA IN PRESS; Al-Shamahy HA, 1998, ANN SAUDI MED, V18, P66, DOI 10.5144/0256-4947.1998.66; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Cao DP, 2011, PARASITOL RES, V109, P163, DOI 10.1007/s00436-010-2239-6; Chance ML, 1982, P WORKSH HELD PAN AM; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Haidar NA, 2001, SAUDI MED J, V22, P516; Hamid GA, 2009, TURK J HEMATOL, V26, P25; Hide M, 2001, PARASITOLOGY, V123, P425, DOI 10.1017/S003118200100871X; Hide M, 2006, ACTA TROP, V100, P241, DOI 10.1016/j.actatropica.2006.10.012; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; Jamjoom MB, 2004, PARASITOLOGY, V129, P399, DOI 10.1017/S0031182004005955; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kolaczinski JH, 2008, EMERG INFECT DIS, V14, P664, DOI 10.3201/eid1404.071099; Kuhls K, 2005, MICROBES INFECT, V7, P1224, DOI 10.1016/j.micinf.2005.04.009; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Mahdy MAK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012879; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; Mauricio IL, 2001, PARASITOLOGY, V122, P393, DOI 10.1017/S0031182001007466; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Oskam L, 1998, T ROY SOC TROP MED H, V92, P120, DOI 10.1016/S0035-9203(98)90982-8; Palumbo E, 2010, MINERVA PEDIATR, V62, P389; Postigo JAR, 2010, INT J ANTIMICROB AG, V36, pS62, DOI 10.1016/j.ijantimicag.2010.06.023; PRATLONG F, 1995, T ROY SOC TROP MED H, V89, P398, DOI 10.1016/0035-9203(95)90025-X; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Raguenaud ME, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000085; Ramirez JR, 2000, J CLIN MICROBIOL, V38, P3768; RIOUX JA, 1989, B SOC PATHOL EXOT, V82, P658; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMAZSOCCOL V, 1993, ANN PARASIT HUM COMP, V68, P107; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toz SO, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002205; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang BB, 2010, PARASITOL RES, V107, P1049, DOI 10.1007/s00436-010-1969-9; Zemanova E, 2004, AM J TROP MED HYG, V70, P613, DOI 10.4269/ajtmh.2004.70.613	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151265	10.1371/journal.pone.0151265	http://dx.doi.org/10.1371/journal.pone.0151265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26966902	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200039
J	Troche, JR; Mayne, ST; Freedman, ND; Shebl, FM; Guertin, KA; Cross, AJ; Abnet, CC				Troche, Jose Ramon; Mayne, Susan T.; Freedman, Neal D.; Shebl, Fatma M.; Guertin, Kristin A.; Cross, Amanda J.; Abnet, Christian C.			Alcohol Consumption-Related Metabolites in Relation to Colorectal Cancer and Adenoma: Two Case-Control Studies Using Serum Biomarkers	PLOS ONE			English	Article							DOSE-RESPONSE METAANALYSIS; CIGARETTE-SMOKING; UNITED-STATES; RISK; EPIDEMIOLOGY; METABOLOMICS; MORTALITY; MIGRANTS; TOBACCO	Alcohol is a known carcinogen that may be associated with colorectal cancer. However, most epidemiologic studies assess alcoholic beverage consumption using self-reported data, leading to potential exposure misclassification. Biomarkers of alcohol consumption may provide an alternative, complementary approach that reduces misclassification and incorporates individual differences in alcohol metabolism. Therefore, we evaluated the relationship between previously identified alcohol consumption-related metabolites and colorectal cancer and adenoma using serum metabolomics data from two studies. Data on colorectal cancer were obtained from a nested case-control study of 502 US adults (252 cases, 250 controls) within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Data on colorectal adenoma were obtained from a case-control study of 197 US adults (120 cases, 77 controls) from the Navy Colon Adenoma Study. Unconditional multivariable logistic regression models were fit to calculate odds ratios (OR) and 95% confidence intervals (CI) for eight alcohol consumption-related metabolites identified in a previous analysis: ethyl glucuronide; 4-androstene-3beta, 17beta-diol disulfate 1; 5-alpha-androstan-3beta, 17beta-diol disulfate; 16-hydroxypalmitate; bilirubin (E, Z or Z, E); cyclo (-leu-pro); dihomo-linoleate (20: 2n6); and palmitoleate (16: 1n7). We found no clear association between these alcohol consumption-related metabolites and either endpoint. However, we did observe an inverse association between cyclo (-leu-pro) and colorectal adenoma that was only observed in the highest metabolite quantile (OR4th vs. 1st Quantile = 0.30, 95% CI: 0.12-0.78; P-trend = 0.047), but no association for colorectal cancer. In conclusion, there were no adverse associations between alcohol consumption-related metabolites and colorectal cancer or adenoma.	[Troche, Jose Ramon; Mayne, Susan T.; Shebl, Fatma M.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Troche, Jose Ramon; Freedman, Neal D.; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Rockville, MD USA; [Mayne, Susan T.; Shebl, Fatma M.] Yale Canc Ctr, New Haven, CT USA; [Guertin, Kristin A.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Cross, Amanda J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Biostat, Sch Publ Hlth, St Marys Campus,Norfolk Pl, London, England; [Mayne, Susan T.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University; University of Virginia; Imperial College London; US Food & Drug Administration (FDA)	Troche, JR (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT USA.; Troche, JR (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Rockville, MD USA.	joseramon.troche@yale.edu	Abnet, Christian C/C-4111-2015; Freedman, Neal David/B-9741-2015	Abnet, Christian C/0000-0002-3008-7843; Freedman, Neal David/0000-0003-0074-1098; Guertin, Kristin/0000-0003-2255-3928	Intramural Research Program of the National Cancer Institute at the National Institutes of Health; National Institutes of Health [T32 CA105666]	Intramural Research Program of the National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by the Intramural Research Program of the National Cancer Institute at the National Institutes of Health (http://www.cancer.gov/research/nci-role/intramural) and the National Institutes of Health (http://www.nih.gov/), grant T32 CA105666.	American Cancer Society, 2014, COL CANC FACTS FIG 2; American Cancer Society, 2015, CANC FACTS FIG 2015; American Cancer Society, 2014, COL CANC OV; American Cancer Society, 2013, WHAT AR RISK FACT CO; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Bardou M, 2002, GUT, V50, P38, DOI 10.1136/gut.50.1.38; Baron JA, 1998, J NATL CANCER I, V90, P57, DOI 10.1093/jnci/90.1.57; Breuer-Katschinski B, 2000, DIGEST DIS SCI, V45, P487, DOI 10.1023/A:1005432804902; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; Cnattingius S, 2009, BRIT J CANCER, V100, P803, DOI 10.1038/sj.bjc.6604918; COPE GF, 1991, GUT, V32, P70, DOI 10.1136/gut.32.1.70; Cross AJ, 2014, CARCINOGENESIS, V35, P1516, DOI 10.1093/carcin/bgu071; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Flood DM, 2000, CANCER CAUSE CONTROL, V11, P403, DOI 10.1023/A:1008955722425; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Guertin KA, 2014, AM J CLIN NUTR; Haznadar M, 2014, METABOLOMICS, V10, P176, DOI 10.1007/s11306-014-0636-z; Inoue M, 2013, CURR NUTR REP, V2, P71; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KLATSKY AL, 1988, AM J EPIDEMIOL, V128, P1007; KUNE GA, 1992, NUTR CANCER, V18, P97, DOI 10.1080/01635589209514210; Lee Joanne, 2007, Cancer Control, V14, P78; Lee W C, 1993, Ann Epidemiol, V3, P239, DOI 10.1016/1047-2797(93)90025-Y; LONGNECKER MP, 1990, CANCER CAUSE CONTROL, V1, P59, DOI 10.1007/BF00053184; McCarl M, 2006, CANCER EPIDEM BIOMAR, V15, P892, DOI 10.1158/1055-9965.EPI-05-0700; MIDANIK L, 1982, BRIT J ADDICT, V77, P357; MIDANIK LT, 1994, ADDICTION, V89, P407, DOI 10.1111/j.1360-0443.1994.tb00914.x; Moore SC, 2014, METABOLOMICS, V10, P259, DOI 10.1007/s11306-013-0574-1; Moskal A, 2007, INT J CANCER, V120, P664, DOI 10.1002/ijc.22299; OLSEN J, 1993, INT J EPIDEMIOL, V22, P398, DOI 10.1093/ije/22.3.398; Park JY, 2009, CANCER EPIDEMIOL, V33, P347, DOI 10.1016/j.canep.2009.10.015; PEIPINS LA, 1994, EPIDEMIOL REV, V16, P273, DOI 10.1093/oxfordjournals.epirev.a036154; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Research WCRFAIfC, 2011, CONT UPD PROJ REP, P20; Sampson JN, 2013, CANCER EPIDEM BIOMAR, V22, P631, DOI 10.1158/1055-9965.EPI-12-1109; Sinha R, 1999, CANCER RES, V59, P4320; Sobell L. C., 2003, ASSESSING ALCOHOL PR; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Williams G, 2013, CANCER CAUSE CONTROL, V24, P1375, DOI 10.1007/s10552-013-0217-x; World Cancer Research Fund/American Institute for Cancer Research, 2010, WCRF AICR SYST LIT R, p[243, 393]; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P, P164; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yannai S., 2004, DICT FOOD COMPOUNDS	47	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150962	10.1371/journal.pone.0150962	http://dx.doi.org/10.1371/journal.pone.0150962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967509	Green Published, gold			2022-12-27	WOS:000371989200024
J	Nie, ZY; Kang, GJ; Duan, CF; Li, Y; Dai, LJ; Zeng, RZ				Nie, Zhiyi; Kang, Guijuan; Duan, Cuifang; Li, Yu; Dai, Longjun; Zeng, Rizhong			Profiling Ethylene-Responsive Genes Expressed in the Latex of the Mature Virgin Rubber Trees Using cDNA Microarray	PLOS ONE			English	Article							HEVEA-BRASILIENSIS LATEX; NATURAL-RUBBER; ISOPRENOID BIOSYNTHESIS; DIPHOSPHATE SYNTHASE; ACTIN CYTOSKELETON; STRESS RESPONSES; ARABIDOPSIS; STIMULATION; CELLS; YIELD	Ethylene is commonly used as a latex stimulant of Hevea brasiliensis by application of ethephon (chloro-2-ethylphosphonic acid); however, the molecular mechanism by which ethylene increases latex production is not clear. To better understand the effects of ethylene stimulation on the laticiferous cells of rubber trees, a latex expressed sequence tag (EST)based complementary DNA microarray containing 2,973 unique genes (probes) was first developed and used to analyze the gene expression changes in the latex of the mature virgin rubber trees after ethephon treatment at three different time-points: 8, 24 and 48 h. Transcript levels of 163 genes were significantly altered with fold-change values >= 2 or <=-2 (q-value < 0.05) in ethephon-treated rubber trees compared with control trees. Of the 163 genes, 92 were up-regulated and 71 down-regulated. The microarray results were further confirmed using real-time quantitative reverse transcript-PCR for 20 selected genes. The 163 ethylene-responsive genes were involved in several biological processes including organic substance metabolism, cellular metabolism, primary metabolism, biosynthetic process, cellular response to stimulus and stress. The presented data suggest that the laticifer water circulation, production and scavenging of reactive oxygen species, sugar metabolism, and assembly and depolymerization of the latex actin cytoskeleton might play important roles in ethylene-induced increase of latex production. The results may provide useful insights into understanding the molecular mechanism underlying the effect of ethylene on latex metabolism of H. brasiliensis.	[Nie, Zhiyi; Kang, Guijuan; Duan, Cuifang; Li, Yu; Dai, Longjun; Zeng, Rizhong] CATAS, Key Lab Biol & Genet Resources Rubber Tree, Minist Agr, Rubber Res Inst, Danzhou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Zeng, RZ (corresponding author), CATAS, Key Lab Biol & Genet Resources Rubber Tree, Minist Agr, Rubber Res Inst, Danzhou, Hainan, Peoples R China.	hnzrz@aliyun.com			 [31201143];  [1630022011023];  [1630022012008]	; ; 	The work was supported by the following: http://www.nsfc.gov.cn/, No. 31201143, Guijuan Kang; http://rri.catas.cn/, No. 1630022011023, Guijuan Kang; and http://rri.catas.cn/, No. 1630022012008, Cuifang Duan.	Adiwilaga K, 1996, PLANT MOL BIOL, V30, P935, DOI 10.1007/BF00020805; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; AMALOU Z, 1992, PLANT PHYSIOL, V98, P1270, DOI 10.1104/pp.98.4.1270; An F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125595; APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Chrestin H., 1989, PHYSL RUBBER TREE LA, P431; CHYE ML, 1992, PLANT MOL BIOL, V19, P473, DOI 10.1007/BF00023395; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; Coupe M., 1989, PHYSL RUBBER TREE LA, P295; D'Auzac J., 1997, Recent Research Developments in Plant Physiology, V1, P273; D'Auzac J., 1989, PHYSL RUBBER TREE LA, P257, DOI [10.1590/S0104-14282006000300015, DOI 10.1590/S0104-14282006000300015]; Dai LJ, 2013, PLANT MOL BIOL, V82, P155, DOI 10.1007/s11103-013-0047-y; Dat JF, 2003, PLANT J, V33, P621, DOI 10.1046/j.1365-313X.2003.01655.x; DAUZAC J, 1989, PHYSL RUBBER TREE LA, P221; De Paepe A, 2004, PLANT J, V39, P537, DOI 10.1111/j.1365-313X.2004.02156.x; DENNIS MS, 1989, J BIOL CHEM, V264, P18608; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066; [段翠芳 Duan Cuifang], 2007, [热带作物学报, Chinese Journal of Tropical Crops], V28, P46; Dusotoit-Coucaud A, 2010, TREE PHYSIOL, V30, P1586, DOI 10.1093/treephys/tpq088; Dusotoit-Coucaud A, 2009, ANN BOT-LONDON, V104, P635, DOI 10.1093/aob/mcp150; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ESCHBACH JM, 1984, PHYSIOL VEG, V22, P295; Faridah Y, 1996, J RUBBER RES, V10, P182; Gao ZQ, 2008, PESQUI AGROPECU BRAS, V43, P275, DOI 10.1590/S0100-204X2008000200018; GIDROL X, 1988, PLANT PHYSIOL, V86, P899, DOI 10.1104/pp.86.3.899; GOMEZ JB, 1979, ULTRACYTOLOGY LATEX; GOODING EGB, 1952, NEW PHYTOL, V51, P11, DOI 10.1111/j.1469-8137.1952.tb06112.x; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo Y, 2005, J VIROL, V79, P14392, DOI 10.1128/JVI.79.22.14392-14403.2005; Hao BingZhong, 2004, Journal of Rubber Research, V7, P281; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacob JL, 1989, PHYSL RUBBER TREE LA, P345; KEKWICK RGO, 1989, PHYSL RUBBER TREE LA, P146; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Krishnakumar R., 2008, Journal of Plantation Crops, V36, P315; KRISHNAKUMAR R, 2006, TAPPING PANEL DRYNES, P116; KUSH A, 1994, PLANT PHYSIOL BIOCH, V32, P761; Lacote R, 2010, FIELD CROP RES, V115, P94, DOI 10.1016/j.fcr.2009.10.007; Li DJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-140; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; LIEBERMAN M, 1979, ANNU REV PLANT PHYS, V30, P533, DOI 10.1146/annurev.pp.30.060179.002533; Liu Y, 2005, J INTEGR PLANT BIOL, V47, P769, DOI 10.1111/j.1744-7909.2005.00111.x; LUSTINEC J, 1968, BIOL PLANTARUM, V10, P284, DOI 10.1007/BF02921011; Martinez-Godoy MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-318; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Mesquita Alessandro Carlos, 2006, Braz. J. Plant Physiol., V18, P263, DOI 10.1590/S1677-04202006000200002; MILFORD G F J, 1969, Journal of the Rubber Research Institute of Malaysia, V21, P274; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nie ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116857; Oh SK, 1999, J BIOL CHEM, V274, P17132, DOI 10.1074/jbc.274.24.17132; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Privat I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-5; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sakdapipanich JT, 2007, J BIOSCI BIOENG, V103, P287, DOI 10.1263/jbb.103.287; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Silpi U, 2007, TREE PHYSIOL, V27, P881, DOI 10.1093/treephys/27.6.881; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Takaya A, 2003, BBA-GENE STRUCT EXPR, V1625, P214, DOI 10.1016/S0167-4781(02)00602-4; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Tungngoen K, 2011, J PLANT PHYSIOL, V168, P253, DOI 10.1016/j.jplph.2010.06.009; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; TUPY J, 1976, BIOL PLANTARUM, V18, P373, DOI 10.1007/BF02922474; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valster AH, 1997, PLANT CELL, V9, P1815; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Van Zhong G, 2003, PLANT MOL BIOL, V53, P117, DOI 10.1023/B:PLAN.0000009270.81977.ef; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Zeng RZ, 2009, PLANT SCI, V176, P602, DOI 10.1016/j.plantsci.2009.01.009; Zhu JH, 2009, PLANT SIGNAL BEHAV, V4, P1072, DOI 10.4161/psb.4.11.9738	88	8	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0152039	10.1371/journal.pone.0152039	http://dx.doi.org/10.1371/journal.pone.0152039			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985821	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300159
J	Chomel, BB; Molia, S; Kasten, RW; Borgo, GM; Stuckey, MJ; Maruyama, S; Chang, CC; Haddad, N; Koehler, JE				Chomel, Bruno B.; Molia, Sophie; Kasten, Rickie W.; Borgo, Gina M.; Stuckey, Matthew J.; Maruyama, Soichi; Chang, Chao-chin; Haddad, Nadia; Koehler, Jane E.			Isolation of Bartonella henselae and Two New Bartonella Subspecies, Bartonella koehlerae Subspecies boulouisii subsp nov and Bartonella koehlerae Subspecies bothieri subsp nov from Free-Ranging Californian Mountain Lions and Bobcats	PLOS ONE			English	Article							DOMESTIC CATS; ROCHALIMAEA-HENSELAE; PCR AMPLIFICATION; FELIS-CONCOLOR; GRAY FOXES; INFECTION; PREVALENCE; IDENTIFICATION; PATHOGENS; ANTIBODY	Domestic cats are the natural reservoir of Bartonella henselae, B. clarridgeiae and B. koehlerae. To determine the role of wild felids in the epidemiology of Bartonella infections, blood was collected from 14 free-ranging California mountain lions (Puma concolor) and 19 bobcats (Lynx rufus). Bartonella spp. were isolated from four (29%) mountain lions and seven (37%) bobcats. These isolates were characterized using growth characteristics, biochemical reactions, molecular techniques, including PCR-RFLP of selected genes or interspacer region, pulsed-field gel electrophoresis (PFGE), partial sequencing of several genes, and DNA-DNA hybridization. Two isolates were identical to B. henselae genotype II. All other isolates were distinguished from B. henselae and B. koehlerae by PCR-RFLP of the gltA gene using endonucleases HhaI, TaqI and AciI, with the latter two discriminating between the mountain lion and the bobcat isolates. These two novel isolates displayed specific PFGE profiles distinct from B. henselae, B. koehlerae and B. clarridgeiae. Sequences of amplified gene fragments from the three mountain lion and six bobcat isolates were closely related to, but distinct from, B. henselae and B. koehlerae. Finally, DNA-DNA hybridization studies demonstrated that the mountain lion and bobcat strains are most closely related to B. koehlerae. We propose naming the mountain lion isolates B. koehlerae subsp. boulouisii subsp. nov. (type strain: L-42-94), and the bobcat isolates B. koehlerae subsp. bothieri subsp. nov. (type strain: L-17-96), and to emend B. koehlerae as B. koehlerae subsp.koehlerae. The mode of transmission and the zoonotic potential of these new Bartonella subspecies remain to be determined.	[Chomel, Bruno B.; Molia, Sophie; Kasten, Rickie W.; Stuckey, Matthew J.] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA; [Molia, Sophie] Ctr Cooperat Int Rech Agron Dev, Campus Int Baillarguet,TA C-22-E, Montpellier, France; [Borgo, Gina M.; Koehler, Jane E.] Univ Calif San Francisco, Microbial Pathogenesis & Host Def Program, San Francisco, CA 94143 USA; [Borgo, Gina M.; Koehler, Jane E.] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA; [Maruyama, Soichi] Nihon Univ, Lab Vet Publ Hlth, Dept Vet Med, Coll Bioresource Sci, Tokyo, Japan; [Chang, Chao-chin] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Sch Vet Med, Taichung 40227, Taiwan; [Haddad, Nadia] LERPAZ, UPE, Ecole Natl Vet Alfort, UMR BIPAR,ENVA,ANSES,UPEC,USC INRA, Maisons Alfort, France	University of California System; University of California Davis; CIRAD; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nihon University; National Chung Hsing University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Chomel, BB (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA.	bbchomel@ucdavis.edu		Molia, Sophie/0000-0002-5695-7464; Borgo, Gina/0000-0002-5583-1675	George and Phyllis Miller Feline Research Fund; Center for Companion Animal Health, University of California, Davis; Master of Preventive Veterinary Medicine Research Project Fund (University of California, Davis); Merial Inc., Athens, GA; Lavoisier grant (French Ministry of Foreign Affairs); Barron fellowship (University of California, Davis); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; California HIV Research Program Award; NIH from the NIAID [U54AI065359, R01AI103299]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, R01AI103299] Funding Source: NIH RePORTER	George and Phyllis Miller Feline Research Fund; Center for Companion Animal Health, University of California, Davis(University of California System); Master of Preventive Veterinary Medicine Research Project Fund (University of California, Davis); Merial Inc., Athens, GA; Lavoisier grant (French Ministry of Foreign Affairs); Barron fellowship (University of California, Davis); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); California HIV Research Program Award; NIH from the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part by the George and Phyllis Miller Feline Research Fund, Center for Companion Animal Health, University of California, Davis, the Master of Preventive Veterinary Medicine Research Project Fund (University of California, Davis) and Merial Inc., Athens, GA. Sophie Molia was a recipient of a Lavoisier grant (French Ministry of Foreign Affairs) and a Barron fellowship (University of California, Davis). Jane E. Koehler received funding support from a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, a California HIV Research Program Award, and NIH grants U54AI065359 and R01AI103299 from the NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Darren Simpson for trapping the mountain lions and bobcats in central California and Dr. Pamela Swift for allowing access to the animals kept at the Wildlife Investigations Laboratory, California Department of Fish and Wildlife, Rancho Cordova, CA, as well as Walter Boyce and Grace Lee for providing the blood of the mountain lions from the San Diego Mountains. The authors also thank K.R. Jones, California Department of Fish and Wildlife, and K.A. Floyd-Hawkins, Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, for their technical assistance. The authors thank Arnold G. Steigerwalt for performing the DNA-DNA hybridization, and Don J. Brenner for his thoughtful comments on the manuscript. This project was funded in part by the George and Phyllis Miller Feline Research Fund, Center for Companion Animal Health, University of California, Davis, the Master of Preventive Veterinary Medicine Research Project Fund (University of California, Davis) and Merial Inc., Athens, GA. Sophie Molia was a recipient of a Lavoisier grant (French Ministry of Foreign Affairs) and a Barron fellowship (University of California, Davis). Jane E. Koehler received funding support from a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, a California HIV Research Program Award, and NIH grants U54AI065359 and R01AI103299 from the NIAID.	Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2; Avidor B, 2004, J CLIN MICROBIOL, V42, P3462, DOI 10.1128/JCM.42.8.3462-3468.2004; Bevins SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031403; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Breitschwerdt EB, 2007, J CLIN MICROBIOL, V45, P270, DOI 10.1128/JCM.01451-06; Breitschwerdt EB, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-76; BRENNER DJ, 1993, INT J SYST BACTERIOL, V43, P777, DOI 10.1099/00207713-43-4-777; BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982; Chang CC, 2000, J CLIN MICROBIOL, V38, P4193, DOI 10.1128/JCM.38.11.4193-4200.2000; Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931; Chomel BB, 2004, VET RES, V35, P233, DOI 10.1051/vetres:2004001; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Chomel BB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001843; Droz S, 1999, J CLIN MICROBIOL, V37, P1117, DOI 10.1128/JCM.37.4.1117-1122.1999; Girard YA, 2012, VECTOR-BORNE ZOONOT, V12, P913, DOI 10.1089/vbz.2011.0858; Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2; Henn JB, 2007, J CLIN MICROBIOL, V45, P2411, DOI 10.1128/JCM.02539-06; Henn JB, 2009, EMERG INFECT DIS, V15, P1984, DOI 10.3201/eid1512.081692; Johnson G, 2003, J CLIN MICROBIOL, V41, P1069, DOI 10.1128/JCM.41.3.1069-1072.2003; Kadesky KM, 1998, J PEDIATR SURG, V33, P863, DOI 10.1016/S0022-3468(98)90661-3; Kelly PJ, 1998, LANCET, V351, P1706, DOI 10.1016/S0140-6736(05)77744-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIZER KW, 1989, WESTERN J MED, V150, P87; KOEHLER JE, 1994, JAMA-J AM MED ASSOC, V271, P531, DOI 10.1001/jama.271.7.531; La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4; MacFadding JF, 1980, BIOCH TESTS IDENTIFI; Marston EL, 1999, INT J SYST BACTERIOL, V49, P1015, DOI 10.1099/00207713-49-3-1015; Molia S, 2004, VET MICROBIOL, V100, P31, DOI 10.1016/j.vetmic.2004.01.007; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; PAULMURPHY J, 1994, J WILDLIFE DIS, V30, P205, DOI 10.7589/0090-3558-30.2.205; Pretorius AM, 2004, EMERG INFECT DIS, V10, P2257, DOI 10.3201/eid1012.031054; REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; Riley SPD, 2004, J WILDLIFE DIS, V40, P11, DOI 10.7589/0090-3558-40.1.11; Rolain JM, 2003, CLIN DIAGN LAB IMMUN, V10, P686, DOI 10.1128/CDLI.10.4.686-691.2003; Rotstein DS, 2000, J WILDLIFE DIS, V36, P157, DOI 10.7589/0090-3558-36.1.157; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; WELCH DF, 1993, J CLIN MICROBIOL, V31, P2381, DOI 10.1128/JCM.31.9.2381-2386.1993; Yamamoto K, 2002, J CLIN MICROBIOL, V40, P466, DOI 10.1128/JCM.40.2.466-474.2002; Yamamoto K, 1998, J WILDLIFE DIS, V34, P56, DOI 10.7589/0090-3558-34.1.56; Yamamoto K, 1998, VET IMMUNOL IMMUNOP, V65, P191, DOI 10.1016/S0165-2427(98)00154-8; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P3641, DOI 10.1128/JCM.40.10.3641-3647.2002	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0148299	10.1371/journal.pone.0148299	http://dx.doi.org/10.1371/journal.pone.0148299			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981874	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900012
J	Manjili, HK; Ma'mani, L; Tavaddod, S; Mashhadikhan, M; Shafiee, A; Naderi-Manesh, H				Manjili, Hamidreza Kheiri; Ma'mani, Leila; Tavaddod, Sharareh; Mashhadikhan, Maedeh; Shafiee, Abbas; Naderi-Manesh, Hossein			D, L-Sulforaphane Loaded Fe3O4@ Gold Core Shell Nanoparticles: A Potential Sulforaphane Delivery System	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; SILICA NANOPARTICLE; CYCLE ARREST; IRON-OXIDE; THERAPY; IMMOBILIZATION; ACTIVATION; PREVENTION	A novel design of gold-coated iron oxide nanoparticles was fabricated as a potential delivery system to improve the efficiency and stability of d, l-sulforaphane as an anticancer drug. To this purpose, the surface of gold-coated iron oxide nanoparticles was modified for sulforaphane delivery via furnishing its surface with thiolated polyethylene glycol-folic acid and thiolated polyethylene glycol-FITC. The synthesized nanoparticles were characterized by different techniques such as FTIR, energy dispersive X-ray spectroscopy, UV-visible spectroscopy, scanning and transmission electron microscopy. The average diameters of the synthesized nanoparticles before and after sulforaphane loading were obtained similar to 33 nm and similar to 38 nm, respectively, when similar to 2.8 mmol/g of sulforaphane was loaded. The result of cell viability assay which was confirmed by apoptosis assay on the human breast cancer cells (MCF-7 line) as a model of in vitro-cancerous cells, proved that the bare nanoparticles showed little inherent cytotoxicity, whereas the sulforaphane-loaded nanoparticles were cytotoxic. The expression rate of the anti-apoptotic genes (bcl-2 and bcl-x(L)), and the proapoptotic genes (bax and bak) were quantified, and it was found that the expression rate of bcl-2 and bcl-x(L) genes significantly were decreased when MCF-7 cells were incubated by sulforaphane-loaded nanoparticles. The sulforaphane-loaded into the designed gold-coated iron oxide nanoparticles, acceptably induced apoptosis in MCF-7 cells.	[Manjili, Hamidreza Kheiri; Tavaddod, Sharareh; Naderi-Manesh, Hossein] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran; [Ma'mani, Leila] AREEO, ABRII, Dept Nanotechnol, Karaj, Iran; [Mashhadikhan, Maedeh] Islamic Azad Univ, Fac Sci, Sci & Res Branch, Dept Biol, Tehran, Iran; [Shafiee, Abbas] Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran 14176, Iran; [Shafiee, Abbas] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran 14176, Iran	Tarbiat Modares University; Islamic Azad University; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Naderi-Manesh, H (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran.; Shafiee, A (corresponding author), Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran 14176, Iran.	ashafiee@ams.ac.ir; naderman@modares.ac.ir	Tavaddod, Sharareh/H-1384-2016; manjili, hamidreza kheiri/J-9876-2016; Ma'mani, Leila/J-5069-2017	Tavaddod, Sharareh/0000-0001-6871-1595; manjili, hamidreza kheiri/0000-0001-7981-4629; 				Almeida AJ, 2007, ADV DRUG DELIVER REV, V59, P478, DOI 10.1016/j.addr.2007.04.007; Bao CC, 2014, NANOMEDICINE-UK, V9, P2353, DOI [10.2217/nnm.14.155, 10.2217/NNM.14.155]; Chacko RT, 2012, ADV DRUG DELIVER REV, V64, P836, DOI 10.1016/j.addr.2012.02.002; Chen M, 2003, J APPL PHYS, V93, P7551, DOI 10.1063/1.1555312; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Cui YL, 2005, BIOMED MICRODEVICES, V7, P153, DOI 10.1007/s10544-005-1596-x; Falahati M, 2011, BBA-PROTEINS PROTEOM, V1814, P1195, DOI 10.1016/j.bbapap.2011.04.005; Fallah-Bagheri A, 2012, INT J BIOL MACROMOL, V51, P933, DOI 10.1016/j.ijbiomac.2012.07.023; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Hahm ER, 2010, CANCER PREV RES, V3, P484, DOI 10.1158/1940-6207.CAPR-09-0250; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jin Y, 1999, J AGR FOOD CHEM, V47, P3121, DOI 10.1021/jf990082e; Johansson NL, 2008, PLANTA MED, V74, P747, DOI 10.1055/s-2008-1074520; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; Mahmoud WE, 2013, LANGMUIR, V29, P13095, DOI 10.1021/la403158d; Mahou R, 2012, POLYMERS-BASEL, V4, P561, DOI 10.3390/polym4010561; Mi P, 2014, J CONTROL RELEASE, V174, P63, DOI 10.1016/j.jconrel.2013.10.038; Pan Xiaogang, 2004, Expert Opin Drug Deliv, V1, P7, DOI 10.1517/17425247.1.1.7; Parnaud G, 2004, NUTR CANCER, V48, P198, DOI 10.1207/s15327914nc4802_10; Pedrosa P, 2015, NANOMATERIALS-BASEL, V5, P1853, DOI 10.3390/nano5041853; Rausch V, 2010, CANCER RES, V70, P5004, DOI 10.1158/0008-5472.CAN-10-0066; Rudolf E, 2009, FOOD CHEM TOXICOL, V47, P2366, DOI 10.1016/j.fct.2009.06.034; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Smolensky ED, 2011, CHEM COMMUN, V47, P2149, DOI 10.1039/c0cc03746j; Subramani K, 2009, CURR NANOSCI, V5, P135, DOI 10.2174/157341309788185406; Tanner P, 2011, ACCOUNTS CHEM RES, V44, P1039, DOI 10.1021/ar200036k; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Wu W., 2009, CHEMINFORM, V40, pi; Xiao Q., 2007, EFFECT TEMPERATURE P; Xu ZC, 2007, J AM CHEM SOC, V129, P8698, DOI 10.1021/ja073057v; Yang CS, 2013, CANCER PREV RES, V6, P1011, DOI 10.1158/1940-6207.CAPR-13-0312; Yang J, 2006, INT J PHARMACEUT, V324, P185, DOI 10.1016/j.ijpharm.2006.06.029; Zeng LY, 2013, NANOSCALE, V5, P2107, DOI 10.1039/c3nr33978e; Zhang L, 2013, INT J NANOMED, V8, P1517, DOI 10.2147/IJN.S43263; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhou T, 2012, J MATER CHEM, V22, P470, DOI 10.1039/c1jm13692e; Zhu YF, 2010, J PHYS CHEM C, V114, P16382, DOI 10.1021/jp106685q	39	34	34	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151344	10.1371/journal.pone.0151344	http://dx.doi.org/10.1371/journal.pone.0151344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982588	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000372574900077
J	Mazzone, ES; Coratti, G; Sormani, MP; Messina, S; Pane, M; D'Amico, A; Colia, G; Fanelli, L; Berardinelli, A; Gardani, A; Lanzillotta, V; D'Ambrosio, P; Petillo, R; Cavallaro, F; Frosini, S; Bello, L; Bonfiglio, S; De Sanctis, R; Rolle, E; Forcina, N; Magri, F; Vita, G; Palermo, C; Donati, MA; Procopio, E; Arnoldi, MT; Baranello, G; Mongini, T; Pini, A; Battini, R; Pegoraro, E; Torrente, Y; Previtali, SC; Bruno, C; Politano, L; Comi, GP; D'Angelo, MG; Bertini, E; Mercuri, E				Mazzone, Elena S.; Coratti, Giorgia; Sormani, Maria Pia; Messina, Sonia; Pane, Marika; D'Amico, Adele; Colia, Giulia; Fanelli, Lavinia; Berardinelli, Angela; Gardani, Alice; Lanzillotta, Valentina; D'Ambrosio, Paola; Petillo, Roberta; Cavallaro, Filippo; Frosini, Silvia; Bello, Luca; Bonfiglio, Serena; De Sanctis, Roberto; Rolle, Enrica; Forcina, Nicola; Magri, Francesca; Vita, Gianluca; Palermo, Concetta; Donati, Maria Alice; Procopio, Elena; Arnoldi, Maria Teresa; Baranello, Giovanni; Mongini, Tiziana; Pini, Antonella; Battini, Roberta; Pegoraro, Elena; Torrente, Yvan; Previtali, Stefano C.; Bruno, Claudio; Politano, Luisa; Comi, Giacomo P.; D'Angelo, Maria Grazia; Bertini, Enrico; Mercuri, Eugenio			Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study	PLOS ONE			English	Article							6-MINUTE WALK TEST; BOYS	Background The role of timed items, and more specifically, of the time to rise from the floor, has been reported as an early prognostic factor for disease progression and loss of ambulation. The aim of our study was to investigate the possible effect of the time to rise from the floor test on the changes observed on the 6MWT over 12 months in a cohort of ambulant Duchenne boys. Subjects and methods A total of 487 12-month data points were collected from 215 ambulant Duchenne boys. The age ranged between 5.0 and 20.0 years (mean 8.48 +/- 2.48 DS). Results The results of the time to rise from the floor at baseline ranged from 1.2 to 29.4 seconds in the boys who could perform the test. 49 patients were unable to perform the test at baseline and 87 at 12 month The 6MWT values ranged from 82 to 567 meters at baseline. 3 patients lost the ability to perform the 6mwt at 12 months. The correlation between time to rise from the floor and 6MWT at baseline was high (r = 0.6, p<0.01). Conclusions Both time to rise from the floor and baseline 6MWT were relevant for predicting 6MWT changes in the group above the age of 7 years, with no interaction between the two measures, as the impact of time to rise from the floor on 6MWT change was similar in the patients below and above 350 m. Our results suggest that, time to rise from the floor can be considered an additional important prognostic factor of 12 month changes on the 6MWT and, more generally, of disease progression.	[Mazzone, Elena S.; Coratti, Giorgia; Pane, Marika; Fanelli, Lavinia; De Sanctis, Roberto; Forcina, Nicola; Palermo, Concetta; Mercuri, Eugenio] Catholic Univ, Dept Paediat Neurol, Rome, Italy; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy; [Messina, Sonia; Cavallaro, Filippo; Vita, Gianluca] Univ Messina, Dept Neurosci, Messina, Italy; [Messina, Sonia; Cavallaro, Filippo; Vita, Gianluca] Univ Messina, Nemo & Clin Ctr, Psychiat & Anaesthesiol, Messina, Italy; [D'Amico, Adele; Colia, Giulia; Bertini, Enrico] Bambino Gesu Pediat Hosp, Unit Neuromuscular & Neurodegenerat Dis, Dept Neurosci, Rome, Italy; [Berardinelli, Angela; Gardani, Alice] C Mondino Fdn, Child Neurol & Psychiat Unit, Pavia, Italy; [Lanzillotta, Valentina; Bruno, Claudio] G Gaslini Inst Children, Neuromuscular Dis Unit, Genoa, Italy; [D'Ambrosio, Paola; Petillo, Roberta; Politano, Luisa] Univ Naples 2, Dipartimento Med Sperimentale, Cardiomiol & Genet Med, Naples, Italy; [Frosini, Silvia; Battini, Roberta] Stella Maris Inst, Dept Dev Neurosci, Pisa, Italy; [Bello, Luca; Pegoraro, Elena] Univ Padua, Dept Neurosci, Padua, Italy; [Bonfiglio, Serena; Pini, Antonella] IRCCS Ist Sci Neurol Bologna, Child Neurol & Psychiat Unit, Bologna, Italy; [Rolle, Enrica; Mongini, Tiziana] Univ Turin, SG Battista Hosp, Neuromuscular Ctr, Turin, Italy; [Magri, Francesca; Torrente, Yvan; Comi, Giacomo P.] Univ Milan, Dept Pathophysiol & Transplantat DEPT, Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr,Neurosci Sect,Neurol Unit,IRCSS, Milan, Italy; [Donati, Maria Alice; Procopio, Elena] Meyer Hosp, Metab & Neuromuscular Unit, Florence, Italy; [Arnoldi, Maria Teresa; Baranello, Giovanni] Ist Neurol Besta Milan, Dev Neurol Unit, Milan, Italy; [Previtali, Stefano C.] IRCSS San Raffaele Sci Inst, Neuromuscular Repair Unit, Inspe, Milan, Italy; [Previtali, Stefano C.] IRCSS San Raffaele Sci Inst, Div Neurosci, Milan, Italy; [D'Angelo, Maria Grazia] Sci Inst IRCCS E Medea, Neuromuscular Disorders Unit, I-23842 Bosisio Parini, Lecco, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Genoa; University of Messina; University of Messina; IRCCS Bambino Gesu; IRCCS Fondazione Casimiro Mondino; University of Genoa; IRCCS Istituto Giannina Gaslini; Universita della Campania Vanvitelli; IRCCS Fondazione Stella Maris; University of Padua; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Eugenio Medea	Mercuri, E (corresponding author), Catholic Univ, Dept Paediat Neurol, Rome, Italy.	mercuri@rm.unicatt.it	D'Ambrosio, Paola/AAC-6109-2021; Bertini, Enrico/A-2284-2014; Coratti, Giorgia/Y-6292-2019; Mazzone, Elena/AAF-4444-2020; D'Angelo, Maria Grazia/K-4685-2016; Comi, Giacomo P/K-5702-2016; Sormani, Maria Pia/ABH-8756-2020; Vita, Gianluca/AAR-4587-2020; d'amico, adele/J-9203-2016; Previtali, Stefano/Z-1962-2019; Magri, Francesca/K-5739-2016; pini, antonella/AAB-9171-2020; Bruno, Claudio/A-3148-2015; Arnoldi, Maria Teresa/AAJ-2217-2021; POLITANO, LUISA/AAK-6885-2020; Coratti, Giorgia/AAV-3224-2021; battini, roberta/P-9095-2017; Bertini, Enrico/ABG-1278-2020; Berardinelli, angela/AAA-9496-2019; Mercuri, Eugenio/G-1351-2015	D'Ambrosio, Paola/0000-0002-9204-5622; Bertini, Enrico/0000-0001-9276-4590; Coratti, Giorgia/0000-0001-6666-5628; D'Angelo, Maria Grazia/0000-0003-1241-4350; Comi, Giacomo P/0000-0002-1383-5248; Vita, Gianluca/0000-0003-4190-8042; d'amico, adele/0000-0003-2438-2624; Previtali, Stefano/0000-0003-2546-4357; Magri, Francesca/0000-0001-8974-9453; pini, antonella/0000-0003-3603-5478; Bruno, Claudio/0000-0002-3426-2901; Arnoldi, Maria Teresa/0000-0002-3920-5869; Coratti, Giorgia/0000-0001-6666-5628; battini, roberta/0000-0002-7889-1355; Messina, Sonia/0000-0001-7994-3391; Mercuri, Eugenio/0000-0002-9851-5365; Pane, Marika/0000-0002-4851-6124; Frosini, Silvia/0000-0001-6169-4382; MARIA ALICE, DONATI/0000-0003-4769-5025; Bello, Luca/0000-0002-3075-6525; berardinelli, angela/0000-0002-4645-8055; SORMANI, MARIA PIA/0000-0001-6892-104X; COLIA, GIULIA/0000-0002-4261-5877	Telethon-Uildm [GUP070009]; Parent Project Italy	Telethon-Uildm(Fondazione Telethon); Parent Project Italy	This work was supported by Telethon-Uildm (Award number: GUP070009) http://www.telethon.t/, and Parent Project Italy (Award number: not available) http://www.parentproject.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P618, DOI 10.1016/j.nmd.2013.05.006; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P19, DOI 10.1016/j.nmd.2012.10.019; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone E, 2010, NEUROMUSCULAR DISORD, V20, P712, DOI 10.1016/j.nmd.2010.06.014; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Pane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108205	11	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151445	10.1371/journal.pone.0151445	http://dx.doi.org/10.1371/journal.pone.0151445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982196	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900084
J	Zhao, FX; Sun, HJ; Wu, JJ; Gao, ZY; Liu, RH				Zhao, Fangxia; Sun, Huijun; Wu, Jianjun; Gao, Ziyou; Liu, Ronghui			Analysis of Road Network Pattern Considering Population Distribution and Central Business District	PLOS ONE			English	Article							RELATIVE NEIGHBORHOOD GRAPH; DESIGN PROBLEM; TRANSPORTATION; MODELS; EQUILIBRIUM; DENSITY	This paper proposes a road network growing model with the consideration of population distribution and central business district (CBD) attraction. In the model, the relative neighborhood graph (RNG) is introduced as the connection mechanism to capture the characteristics of road network topology. The simulation experiment is set up to illustrate the effects of population distribution and CBD attraction on the characteristics of road network. Moreover, several topological attributes of road network is evaluated by using coverage, circuitness, treeness and total length in the experiment. Finally, the suggested model is verified in the simulation of China and Beijing Highway networks.	[Zhao, Fangxia; Sun, Huijun; Wu, Jianjun] Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China; [Zhao, Fangxia; Gao, Ziyou] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Liu, Ronghui] Univ Leeds, Inst Transport Studies, Leeds LS2 9JT, W Yorkshire, England	Beijing Jiaotong University; Beijing Jiaotong University; University of Leeds	Sun, HJ (corresponding author), Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China.	hjsun1@bjtu.edu.cn		Liu, Ronghui/0000-0003-0627-3184	China National Funds for Distinguished Young Scientists [71525002]; National Science Foundation of China [71271024]; Research Foundation of State Key Laboratory of Rail Traffic Control and Safety [RCS2016ZT002]; National Basic Research Program of China [2012CB725401]; UK Rail Safety and Standards Board [T1071]	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of State Key Laboratory of Rail Traffic Control and Safety; National Basic Research Program of China(National Basic Research Program of China); UK Rail Safety and Standards Board	J. Wu was supported by the China National Funds for Distinguished Young Scientists under Grant No. 71525002, the National Science Foundation of China under Grant No. 71271024, Research Foundation of State Key Laboratory of Rail Traffic Control and Safety under Grant No. RCS2016ZT002. Z. Gao was supported by National Basic Research Program of China under Grant No. 2012CB725401. R. Liu was supported by UK Rail Safety and Standards Board under Grant No. T1071.	Barthelemy M, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/07/L07002; Barthelemy M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.138702; Barthelemy M, 2009, NETW SPAT ECON, V9, P401, DOI 10.1007/s11067-008-9068-5; BOYCE DE, 1984, ENVIRON PLANN A, V16, P1445, DOI 10.1068/a161445; Buckwalter DW, 2013, APPL GEOGR, V41, P158, DOI 10.1016/j.apgeog.2013.04.008; Chen AT, 2011, TRANSPORT REV, V31, P743, DOI 10.1080/01441647.2011.589539; Combinido JSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048151; Ding Y, 1998, J SHANGHAI MARITIME, V19, P7; Farahani RZ, 2013, EUR J OPER RES, V229, P281, DOI 10.1016/j.ejor.2013.01.001; FRIESZ TL, 1985, TRANSPORT RES A-POL, V19, P413, DOI 10.1016/0191-2607(85)90041-X; Garcia-Lopez MA, 2012, J URBAN ECON, V72, P176, DOI 10.1016/j.jue.2012.05.003; Huang H, 2014, APPL GEOGR, V47, P78, DOI 10.1016/j.apgeog.2013.11.012; HWANG FK, 1992, NETWORKS, V22, P55, DOI 10.1002/net.3230220105; JAROMCZYK JW, 1992, P IEEE, V80, P1502, DOI 10.1109/5.163414; Lee M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140152; Levinson D, 2007, ISTTT17, p[111, 839]; Levinson D, 2008, J ECON GEOGR, V8, P55, DOI 10.1093/jeg/lbm038; Levinson D, 2006, TRANSPORT SCI, V40, P179, DOI 10.1287/trsc.1050.0132; Levinson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029721; Lin D, 2013, PROCD SOC BEHV, V96, P461, DOI 10.1016/j.sbspro.2013.08.054; LINGAS A, 1994, COMP GEOM-THEOR APPL, V4, P199, DOI 10.1016/0925-7721(94)90018-3; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; MAGNANTI TL, 1984, TRANSPORT SCI, V18, P1, DOI 10.1287/trsc.18.1.1; Migdalas A, 1995, J GLOBAL OPTIM, V7, P381, DOI 10.1007/BF01099649; Parthasarathi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077718; Rui YK, 2009, EUR PHYS J B, V71, P259; Shao FJ, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114400014; SUPOWIT KJ, 1983, J ACM, V30, P428, DOI 10.1145/2402.322386; Szeto WY, 2015, NETW SPAT ECON, V15, P791, DOI 10.1007/s11067-013-9191-9; TOUSSAINT GT, 1980, PATTERN RECOGN, V12, P261, DOI 10.1016/0031-3203(80)90066-7; Wang DZW, 2015, TRANSPORT RES E-LOG, V79, P213, DOI 10.1016/j.tre.2015.04.005; Xie F, 2007, GEOGR ANAL, V39, P336, DOI 10.1111/j.1538-4632.2007.00707.x; Xie F, 2009, COMPUT ENVIRON URBAN, V33, P211, DOI 10.1016/j.compenvurbsys.2008.09.009; Xie YB, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036106; Yamins D, 2003, NETW SPAT ECON, V3, P69, DOI 10.1023/A:1022001117715; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016; Yang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116551; Zhao FX, 2016, NETW SPAT ECON, V16, P997, DOI 10.1007/s11067-015-9308-4	38	11	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151676	10.1371/journal.pone.0151676	http://dx.doi.org/10.1371/journal.pone.0151676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26981857	Green Published, gold			2022-12-27	WOS:000372574900112
J	Jiang, ZD; Zhang, K; Huang, WX; Yuan, QX				Jiang, Zidong; Zhang, Kai; Huang, Wanxia; Yuan, Qingxi			A Preliminary Study on Sinus Fungus Ball with MicroCT and X-Ray Fluorescence Technique	PLOS ONE			English	Article							PARANASAL SINUSES; MAXILLARY SINUS; ASPERGILLOSIS; DIAGNOSIS; CRITERIA; RISK	Background Sinus fungus ball, an accumulation of fungal dense concretions, is a common disease in practice, and might cause fatal complications or lead to death once converted into invasive type. Early preoperative diagnosis of this disease can lead to appropriate treatment for patients and prevent multiple surgical procedures. Up to now, the diagnostic criteria of sinus fungus ball have been defined and computed tomography (CT) scan was considered as a valuable preoperative diagnostic tool. However, the sensitivity of clinical CT is only about 62%. Thus, investigating the factors which influence sensitivity is necessary for clinical CT to be a more valuable preoperative diagnosis tool. Furthermore, CT scan usually presents micro-calcifications or spots with metallic density in sinus fungus ball. Previous literatures show that there are some metallic elements such as calciumand zinc in fungus ball, and they concluded that endodontic treatment has a strong correlation with the development of maxillary sinus fungus ball and zinc ion was an exogenous risk factor. But the pathogenesis of sinus fungus ball still remains unclear because fungus ball can also develop in other non-maxillary sinuses or the maxillary sinus without root canal treatment. Is zinc ion the endogenous factor? Study on this point might be also helpful for investigating the pathogenesis of sinus fungus ball. In this paper, we tried to investigate the factors which influence the sensitivity of clinical CT by imaging sinus fungus ball with microCT. The origin of zinc ion was also studied through elements test for different fungal ball samples using x-ray fluorescence technique. Methods Specimens including fungal ball material and sinus mucosa from patients confirmed by pathological findings were extracted after surgery. All fungal ball specimens came from sphenoid sinus, ethmoidal sinus and maxillary sinus with or without previous endodontic treatment respectively. All of them were imaged by microCT with spatial resolution up to 5 mu m to acquire three-dimensional structure, and then the heavy metal elements were detected with x-ray fluorescence spectrometer analysis. Result High concentration of zinc and calcium were detected in all fungal ball specimens compared to sinus mucosa membrane. Particles with different size varied from disperse to density, which have similar shape to the result of clinical CT but with different size, were found in three-dimensional reconstruction results of microCT. Conclusions Spatial resolution is an influent factor of clinical CT sensitivity for sinus fungus ball. Improving the resolution of clinical CT will help to improve its sensitivity. Besides iatrogenic endodontic materials, endogenous metal elements of zinc and calcium might associate with the growth of fungal ball and the micro-calcifications or spots with metallic density of CT imaging.	[Jiang, Zidong] Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Zhang, Kai; Huang, Wanxia; Yuan, Qingxi] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Jiang, ZD (corresponding author), Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing, Peoples R China.; Yuan, QX (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China.	zidongjiangcn@aliyun.com; yuanqx@ihep.ac.cn	huang, wanxia/AAE-6861-2020	Yuan, Qingxi/0000-0002-2997-7654; Zhang, Kai/0000-0001-5058-9077	National Natural Science Foundation of China [81441032, 11205189, U1332109, 81271574]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Numbers 81441032(ZJ), 11205189(KZ), U1332109 (QY), and 81271574, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-341; BECKMANNAGETTA J, 1983, LANCET, V2, P1260; Bosi GR, 2012, INT ARCH OTORHINOLAR, V16, P286, DOI 10.7162/S1809-97772012000200020; Broglie MA, 2009, RHINOLOGY, V47, P379, DOI 10.4193/Rhin09.026; Chakrabarti A, 2009, LARYNGOSCOPE, V119, P1809, DOI 10.1002/lary.20520; Chobillon MAJ, 2004, RHINOLOGY, V42, P230; Costa F, 2007, ORAL SURG ORAL MED O, V103, pE23, DOI 10.1016/j.tripleo.2006.12.015; deShazo RD, 1997, ARCH OTOLARYNGOL, V123, P1181, DOI 10.1001/archotol.1997.01900110031005; deShazo RD, 1997, J ALLERGY CLIN IMMUN, V99, P475, DOI 10.1016/S0091-6749(97)70073-3; DeShazo RD, 1997, NEW ENGL J MED, V337, P254, DOI 10.1056/NEJM199707243370407; Dhong HJ, 2000, AM J RHINOL, V14, P227, DOI 10.2500/105065800779954446; Douglas G, 1994, BMJ-BRIT MED J, V308, P1552; Falworth MS, 1996, ORAL SURG ORAL MED O, V81, P255, DOI 10.1016/S1079-2104(96)80426-4; Fanucci E, 2013, Oral Implantol (Rome), V6, P63; Grosjean P, 2007, EUR ARCH OTO-RHINO-L, V264, P461, DOI 10.1007/s00405-007-0281-5; JAKSE R, 1982, HNO, V30, P45; Mackenzie J. J., 1893, J HOPKINS HOSP B, V4, P9; McComb JQ, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2169-5; Mensi M, 2004, ORAL SURG ORAL MED O, V98, P119, DOI 10.1016/j.tripleo.2003.12.035; Mensi M, 2007, ORAL SURG ORAL MED O, V103, P433, DOI 10.1016/j.tripleo.2006.08.014; Nicolai P, 2015, ACTA OTORHINOLARYNGO, V35, P93; Nicolai P, 2009, LARYNGOSCOPE, V119, P2275, DOI 10.1002/lary.20578; Nomura Kazuhiro, 2013, Int J Otolaryngol, V2013, P731640, DOI 10.1155/2013/731640; Pagella F, 2007, MYCOSES, V50, P451, DOI 10.1111/j.1439-0507.2007.01416.x; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Seo YJ, 2011, ACTA RADIOL, V52, P790, DOI 10.1258/ar.2011.110021; STAMMBERGER H, 1984, ANN OTO RHINOL LARYN, V93, P251, DOI 10.1177/000348948409300313; Tsai TL, 2006, OTOLARYNG HEAD NECK, V134, P494, DOI 10.1016/j.otohns.2005.10.009	28	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0148515	10.1371/journal.pone.0148515	http://dx.doi.org/10.1371/journal.pone.0148515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978273	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800012
J	Velusamy, SK; Sampathkumar, V; Godboley, D; Fine, DH				Velusamy, Senthil Kumar; Sampathkumar, Vandana; Godboley, Dipti; Fine, Daniel H.			Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments	PLOS ONE			English	Article							LOCALIZED AGGRESSIVE PERIODONTITIS; BUCCAL EPITHELIAL-CELLS; OLD-WORLD PRIMATES; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; EXHIBITS SPECIFICITY; BIOFILM FORMATION; ENDOCARDITIS; DISEASE; GENE; POLYSACCHARIDE	Leukotoxin (Ltx) is a prominent virulence factor produced by Aggregatibacter actinomycetemcomitans, an oral microorganism highly associated with aggressive periodontitis. Ltx compromises host responsiveness by altering the viability of neutrophils, lymphocytes, and macrophages. Previously, we developed a Rhesus (Rh) monkey colonization model designed to determine the effect of virulence gene mutations on colonization of A. actinomycetemcomitans. Unexpectedly, an A. actinomycetemcomitans leukotoxin (ltxA) mutant (RhAa-VS2) failed to colonize in the Rh model. No previous literature suggested that Ltx was associated with A. actinomycetemcomitans binding to tooth surfaces. These results led us to explore the broad effects of the ltxA mutation in vitro. Results indicated that LtxA activity was completely abolished in RhAa-VS2 strain, while complementation significantly (P<0.0001) restored leukotoxicity compared to RhAa-VS2 strain. RT-PCR analysis of ltx gene expression ruled out polar effects. Furthermore, binding of RhAa-VS2 to salivary-coated hydroxyapatite (SHA) was significantly decreased (P<0.0001) compared to wild type RhAa3 strain. Real time RT-PCR analysis of the genes related to SHA binding in RhAa-VS2 showed that genes related to binding were downregulated [rcpA (P = 0.018), rcpB (P = 0.02), tadA (P = 0.002)] as compared to wild type RhAa3. RhAa-VS2 also exhibited decreased biofilm depth (P = 0.008) and exo-polysaccharide production (P<0.0001). Buccal epithelial cell (BEC) binding of RhAa-VS2 was unaffected. Complementation with ltxA restored binding to SHA (P<0.002) but had no effect on biofilm formation when compared to RhAa3. In conclusion, mutation of ltxA diminished hard tissue binding in vitro, which helps explain the previous in vivo failure of a ltxA knockout to colonize the Rh oral cavity. These results suggest that; 1) one specific gene knockout (in this case ltxA) could affect other seemingly unrelated genes (such as rcpA, rcpB tadA etc), and 2) some caution should be used when interpreting the effect attributed to targeted gene mutations when seen in a competitive in vivo environment.	[Velusamy, Senthil Kumar; Sampathkumar, Vandana; Godboley, Dipti; Fine, Daniel H.] Rutgers Sch Dent Med, Dept Oral Biol, 185 S Orange Ave, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Fine, DH (corresponding author), Rutgers Sch Dent Med, Dept Oral Biol, 185 S Orange Ave, Newark, NJ USA.	finedh@sdm.rutgers.edu			National Institute of Dental and Craniofacial Research (NIDCR) [1R21DE021172-01A1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021172] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	DHF would like to acknowledge support derived from grant 1R21DE021172-01A1 from the National Institute of Dental and Craniofacial Research (NIDCR) to support the work performed in this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashova NV, 2006, INFECT IMMUN, V74, P2015, DOI 10.1128/IAI.74.4.2015-2021.2006; Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07; Cortelli SC, 2009, J CLIN MICROBIOL, V47, P2018, DOI 10.1128/JCM.00338-09; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Das M, 1997, ANNU REV MED, V48, P25, DOI 10.1146/annurev.med.48.1.25; DiFranco KM, 2012, J BIOL CHEM, V287, P17618, DOI 10.1074/jbc.M111.314674; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; ELLNER JJ, 1979, MEDICINE, V58, P145, DOI 10.1097/00005792-197903000-00003; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Fine DH, 2013, J CLIN MICROBIOL, V51, P2850, DOI 10.1128/JCM.00729-13; Fine DH, 2010, J CLIN MICROBIOL, V48, P4464, DOI 10.1128/JCM.00964-10; Fine DH, 2005, INFECT IMMUN, V73, P1947, DOI 10.1128/IAI.73.4.1947-1953.2005; Fine DH, 2015, J ORAL BIOL NORTHBOR, V2; Fives-Taylor PM, 1999, PERIODONTOL 2000, V20, P136, DOI 10.1111/j.1600-0757.1999.tb00161.x; Haubek D, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23980; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Inoue T, 2003, MICROBIOL IMMUNOL, V47, P877, DOI 10.1111/j.1348-0421.2003.tb03454.x; Izano EA, 2007, J DENT RES, V86, P618, DOI 10.1177/154405910708600707; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Johansson A, 2000, EUR J ORAL SCI, V108, P136, DOI 10.1034/j.1600-0722.2000.00790.x; Juarez-Rodriguez MD, 2013, PLASMID, V69, P211, DOI 10.1016/j.plasmid.2013.01.002; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Karched M, 2012, J BACTERIOL, V194, P1275, DOI 10.1128/JB.06710-11; KOLODRUBETZ D, 1989, INFECT IMMUN, V57, P1465, DOI 10.1128/IAI.57.5.1465-1469.1989; LALLY ET, 1989, J BIOL CHEM, V264, P15451; LEAR JD, 1995, BBA-BIOMEMBRANES, V1238, P34, DOI 10.1016/0005-2736(95)00086-I; Lim YM, 2008, INFECT IMMUN, V76, P5110, DOI 10.1128/IAI.00445-08; Muller HP, 1996, J PERIODONTAL RES, V31, P373, DOI 10.1111/j.1600-0765.1996.tb00506.x; Paturel L, 2004, CLIN MICROBIOL INFEC, V10, P98, DOI 10.1111/j.1469-0691.2004.00794.x; Planet PJ, 2003, NAT GENET, V34, P193, DOI 10.1038/ng1154; Sambrook J., 2001, MOL CLONING LAB MANU; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Shanmugam M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134285; Shanmugam M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117487; SLOTS J, 1976, SCAND J DENT RES, V84, P1; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Thomson VJ, 1999, J BACTERIOL, V181, P7298, DOI 10.1128/JB.181.23.7298-7307.1999; Venketaraman V, 2008, MICROB PATHOGENESIS, V45, P173, DOI 10.1016/j.micpath.2008.05.007; Xu K, 2012, FEMS MICROBIOL LETT, V337, P97, DOI 10.1111/1574-6968.12016; Yue G, 2007, INFECT IMMUN, V75, P4440, DOI 10.1128/IAI.02020-06; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x	43	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151361	10.1371/journal.pone.0151361	http://dx.doi.org/10.1371/journal.pone.0151361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977924	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800066
J	Canal, F; Charawi, S; Grimber, G; Houbron, C; Drouet, V; Colnot, S; Terris, B; Cavard, C; Perret, C				Canal, Frederic; Charawi, Sara; Grimber, Gisele; Houbron, Christophe; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine			Generation of Mice with Hepatocyte-Specific Conditional Deletion of Notum	PLOS ONE			English	Article							HEPATOCELLULAR CARCINOMAS; SOMATIC MUTATIONS; SIGNALING PATHWAY; LIVER; GENE; METABOLISM; HOMOLOG; TCF7L2; WINGLESS; ZONATION	Background Fine tuning of the Wnt/beta-catenin signaling pathway is essential for the proper development and function of the liver. Aberrant activation of this pathway is observed in 20%-40% of hepatocellular carcinomas (HCC). Notum encodes a secreted Wnt deacylase that inhibits Wnt activity and thereby restricts the zone of activation of Wnt/beta-catenin signaling. An important role of NOTUM has been described in development in drosophila, planaria and zebrafish, but its role in the mammalian liver is unknown. Notum is required for spatial control of the Wnt/beta-catenin signaling in several animal models and the Wnt/beta-catenin pathway contributes to liver patterning involved in metabolic zonation. Therefore, Notum may be involved in the liver patterning induced by the Wnt/beta-catenin signaling during the adult stage. Methodology/principal findings We generated a conditional Notum knockout mouse mutant to study the effect of the deletion of Notum in the liver. We show that Notum is a direct target of the Wnt/beta-catenin signaling in the liver. Liver-specific deletion of Notum did not modify liver zonation, but Notum deletion had a long-term effect on mouse physiology. In particular, male mutant mice developed metabolic disorders. Conclusion We show that Notum is not a key actor of Wnt/beta-catenin-dependent liver patterning of adult mice, but has role in liver glucose homeostasis. Male mice deficient in Notum specifically in the liver develop metabolic dysfunctions implicating Notum in the development of Type 2 diabetes.	[Canal, Frederic; Charawi, Sara; Grimber, Gisele; Houbron, Christophe; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Canal, Frederic; Charawi, Sara; Grimber, Gisele; Houbron, Christophe; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine] CNRS, UMR8104, F-75014 Paris, France; [Canal, Frederic; Charawi, Sara; Grimber, Gisele; Houbron, Christophe; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine] Univ Paris 05, F-75014 Paris, France; [Canal, Frederic; Charawi, Sara; Grimber, Gisele; Drouet, Valerie; Colnot, Sabine; Terris, Benoit; Cavard, Catherine; Perret, Christine] Equipe Labellisee LNCC, Paris, France; [Terris, Benoit] Hop Cochin, Pathol Unit, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Perret, C (corresponding author), Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France.; Perret, C (corresponding author), CNRS, UMR8104, F-75014 Paris, France.; Perret, C (corresponding author), Univ Paris 05, F-75014 Paris, France.; Perret, C (corresponding author), Equipe Labellisee LNCC, Paris, France.	christine.perret@inserm.fr	Terris, Benoit/P-1497-2017; Perret-Mayeux, Christine/L-3297-2017; Colnot, Sabine/A-9169-2008	Colnot, Sabine/0000-0002-3949-9107; perret, christine/0000-0003-4710-7051	INSERM; CNRS; Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer"; INCA; LABEX Who am I ?	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer"; INCA(Institut National du Cancer (INCA) France); LABEX Who am I ?	Core fundings came from INSERM, CNRS, grants from Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer", INCA grants and LABEX Who am I ?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audard V, 2007, J PATHOL, V212, P345, DOI 10.1002/path.2169; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Cantu JA, 2013, J NEUROSCI, V33, P2177, DOI 10.1523/JNEUROSCI.3694-12.2013; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Ip W, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-28; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Nobrega MA, 2013, DIABETES, V62, P706, DOI 10.2337/db12-1418; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Torisu Y, 2008, CANCER SCI, V99, P1139, DOI 10.1111/j.1349-7006.2008.00814.x; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Zhang XJ, 2015, DEV CELL, V32, P719, DOI 10.1016/j.devcel.2015.02.014	23	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150997	10.1371/journal.pone.0150997	http://dx.doi.org/10.1371/journal.pone.0150997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974334	Green Submitted, Green Published, gold			2022-12-27	WOS:000372570600041
J	Carroll, CS; Amankwa, LN; Pinto, LJ; Fuller, JD; Moore, MM				Carroll, Cassandra S.; Amankwa, Lawrence N.; Pinto, Linda J.; Fuller, Jeffrey D.; Moore, Margo M.			Detection of a Serum Siderophore by LC-MS/MS as a Potential Biomarker of Invasive Aspergillosis	PLOS ONE			English	Article							LATERAL-FLOW DEVICE; BRONCHOALVEOLAR LAVAGE FLUID; REAL-TIME PCR; BETA-D-GLUCAN; PULMONARY ASPERGILLOSIS; FUNGAL-INFECTIONS; TRANSPLANT RECIPIENTS; CLINICAL-PERFORMANCE; TESTING SERUM; DIAGNOSIS	Invasive aspergillosis (IA) is a life-threatening systemic mycosis caused primarily by Aspergillus fumigatus. Early diagnosis of IA is based, in part, on an immunoassay for circulating fungal cell wall carbohydrate, galactomannan (GM). However, a wide range of sensitivity and specificity rates have been reported for the GM test across various patient populations. To obtain iron in vivo, A. fumigatus secretes the siderophore, N, N', N ''-triacetylfusarinine C (TAFC) and we hypothesize that TAFC may represent a possible biomarker for early detection of IA. We developed an ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method for TAFC analysis from serum, and measured TAFC in serum samples collected from patients at risk for IA. The method showed lower and upper limits of quantitation (LOQ) of 5 ng/ml and 750 ng/ml, respectively, and complete TAFC recovery from spiked serum. As proof of concept, we evaluated 76 serum samples from 58 patients with suspected IA that were investigated for the presence of GM. Fourteen serum samples obtained from 11 patients diagnosed with probable or proven IA were also analyzed for the presence of TAFC. Control sera (n = 16) were analyzed to establish a TAFC cut-off value (>= 6 ng/ml). Of the 36 GM-positive samples (>= 0.5 GM index) from suspected IA patients, TAFC was considered positive in 25 (69%). TAFC was also found in 28 additional GM-negative samples. TAFC was detected in 4 of the 14 samples (28%) from patients with proven/probable aspergillosis. Log-transformed TAFC and GM values from patients with proven/probable IA, healthy individuals and SLE patients showed a significant correlation with a Pearson r value of 0.77. In summary, we have developed a method for the detection of TAFC in serum that revealed this fungal product in the sera of patients at risk for invasive aspergillosis. A prospective study is warranted to determine whether this method provides improved early detection of IA.	[Carroll, Cassandra S.; Pinto, Linda J.; Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Amankwa, Lawrence N.] Ctr Drug Res & Dev, Vancouver, BC V6T 1Z3, Canada; [Fuller, Jeffrey D.] Alberta Hlth Serv, Prov Lab Publ Hlth & Microbiol, Edmonton, AB T6G 2R7, Canada	Simon Fraser University; Alberta Health Services (AHS)	Moore, MM (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	mmoore@sfu.ca			Natural Sciences and Engineering Research Council of Canada [105704]; Merck Canada Inc. [569192]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Merck Canada Inc.	This work was supported by (1) Natural Sciences and Engineering Research Council of Canada (105704), http://www.nserc.ca, to MM and (2) Merck Canada Inc. (569192) (formerly Schering-Plough Canada Inc.), http://www.merck.ca, to MM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta J, 2011, CLIN MICROBIOL INFEC, V17, P1053, DOI 10.1111/j.1469-0691.2010.03357.x; Alothman AF, 2014, J INFECT PUBLIC HEAL, V7, P6, DOI 10.1016/j.jiph.2013.08.002; Ashbee HR, 2014, J ANTIMICROB CHEMOTH, V69, P1162, DOI 10.1093/jac/dkt508; Bertrand S, 2010, MED MYCOL, V48, pS98, DOI 10.3109/13693786.2010.503972; Bio-Rad, PLAT ASP EIA; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brasier AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143165; Buess M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-237; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerqueira LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092851; CHARLANG G, 1981, MOL CELL BIOL, V1, P94, DOI 10.1128/MCB.1.2.94; Dannaoui E, 2010, J CLIN MICROBIOL, V48, P2043, DOI 10.1128/JCM.02319-09; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; De Vlieger G, 2011, J CLIN MICROBIOL, V49, P3783, DOI 10.1128/JCM.00879-11; Doyle J, 2012, METHOD DETECTING INF; Dufresne SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042736; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Hinckson EA, 2005, MED SCI SPORT EXER, V37, P696, DOI 10.1249/01.MSS.0000159023.06934.53; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; Hoenigl M, 2014, J CLIN MICROBIOL, V52, P2039, DOI 10.1128/JCM.00467-14; Hoenigl M, 2012, J INFECTION, V65, P588, DOI 10.1016/j.jinf.2012.10.003; Husain S, 2003, CLIN INFECT DIS, V37, P221, DOI 10.1086/375822; Khan ZU, 2008, J MED MICROBIOL, V57, P36, DOI 10.1099/jmm.0.47301-0; Lass-Florl C, 2009, CLIN MICROBIOL INFEC, V15, P60, DOI 10.1111/j.1469-0691.2009.02999.x; Lass-Florl C, 2007, CLIN INFECT DIS, V45, pE101, DOI 10.1086/521245; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; da Silva TVM, 2014, MYCOPATHOLOGIA, V177, P111, DOI 10.1007/s11046-013-9718-0; MIYAZAKI T, 1995, J CLIN MICROBIOL, V33, P3115, DOI 10.1128/JCM.33.12.3115-3118.1995; Morgan J, 2005, MED MYCOL, V43, pS49, DOI 10.1080/13693780400020113; Neofytos D, 2013, TRANSPL INFECT DIS, V15, P233, DOI 10.1111/tid.12060; Nguyen MH, 2011, BIOL BLOOD MARROW TR, V17, P1043, DOI 10.1016/j.bbmt.2010.11.013; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Panda NK, 2008, AM J OTOLARYNG, V29, P24, DOI 10.1016/j.amjoto.2006.12.004; Petrik M, 2010, J NUCL MED, V51, P639, DOI 10.2967/jnumed.109.072462; Racil Z, 2011, INT J INFECT DIS, V15, pE874, DOI 10.1016/j.ijid.2011.09.011; Raymond-Bouchard I, 2012, EUKARYOT CELL, V11, P1333, DOI 10.1128/EC.00159-12; Rogers TR, 2007, J ANTIMICROB CHEMOTH, V61, pI35, DOI 10.1093/jac/dkm429; Rogers TR, 2013, BRIT J HAEMATOL, V161, P517, DOI 10.1111/bjh.12285; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Singh N, 2005, CLIN MICROBIOL REV, V18, P44, DOI 10.1128/CMR.18.1.44-69.2005; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; Sulahian A, 2014, J CLIN MICROBIOL, V52, P2328, DOI 10.1128/JCM.03567-13; Thornton CR, 2008, CLIN VACCINE IMMUNOL, V15, P1095, DOI 10.1128/CVI.00068-08; Tucholska M, 2009, J PROTEOME RES, V8, P1143, DOI 10.1021/pr8005217; White PL, 2015, J CLIN MICROBIOL, V53, P2832, DOI 10.1128/JCM.00905-15; White PL, 2013, J CLIN MICROBIOL, V51, P1510, DOI 10.1128/JCM.03189-12; White PL, 2011, J CLIN MICROBIOL, V49, P2169, DOI 10.1128/JCM.00101-11; White PL, 2010, J CLIN MICROBIOL, V48, P3753, DOI 10.1128/JCM.01466-10; Yasuoka A, 1996, CLIN VACCINE IMMUNOL, V3, P3	53	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151260	10.1371/journal.pone.0151260	http://dx.doi.org/10.1371/journal.pone.0151260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974544	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600059
J	Chang, J; Choi, J; Rah, YC; Yoo, MH; Oh, KH; Im, GJ; Lee, SH; Kwon, SY; Park, HC; Chae, SW; Jung, HH				Chang, Jiwon; Choi, June; Rah, Yoon Chan; Yoo, Myung Hoon; Oh, Kyoung Ho; Im, Gi Jung; Lee, Seung Hoon; Kwon, Soon Young; Park, Hae-Chul; Chae, Sung Won; Jung, Hak Hyun			Sodium Selenite Acts as an Otoprotectant against Neomycin-Induced Hair Cell Damage in a Zebrafish Model	PLOS ONE			English	Article							AMINOGLYCOSIDE-INDUCED OTOTOXICITY; SYSTEMIC INFLAMMATORY RESPONSE; RERIO LATERAL-LINE; DANIO-RERIO; THIOREDOXIN REDUCTASE; PROTECTIVE ROLE; DEATH; REGENERATION; REVEALS; SCREEN	Sodium selenite is a trace element essential for many physiological functions in the body. It is involved in various biological processes; it acts as a cofactor for antioxidant enzymes that protect against free radicals and is reported to limit metal-mediated oxidative DNA damage. In the present study, we investigated the effect of sodium selenite on neomycin ototoxicity in wild-type and transgenic zebrafish (Brn3C: EGFP). Five or six days post-fertilization, zebrafish larvae were co-exposed to 125 mu M neomycin and various concentrations (10 mu M, 100 mu M, 250 mu M, and 500 mu M) of sodium selenite for 1 h. Hair cells within neuromasts of the supraorbital (SO1 and SO2), otic (O1), and occipital (OC1) lateral lines were analyzed by fluorescence microscopy (n = 10 fish per treatment). Hair cell survival was estimated as the ratio of the hair cell numbers in each group compared to those of the control group that were not exposed to neomycin. Apoptosis and hair cell damage of neuromasts were evaluated using the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) assay and 2-[4-(dimethylamino)styryl]-N-ethylpyridinium iodide (DASPEI) assay, respectively. Ultrastructural changes were evaluated using scanning electron microscopy and transmission electron microscopy. Neuromast hair cells were preserved in zebrafish exposed to 125 mu M neomycin and 500 mu M sodium selenite for 1 h. Sodium selenite protected against neomycin-induced hair cell loss of neuromasts, reduced apoptosis, and prevented zebrafish ultrastructural changes. We propose that sodium selenite protects against neomycin-induced hair cell damage by inhibiting apoptosis, decreasing the disarray of stereocilia, and preventing ultrastructural changes in the neuromast hair cells of the zebrafish.	[Chang, Jiwon] Hallym Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Choi, June; Rah, Yoon Chan; Yoo, Myung Hoon; Oh, Kyoung Ho; Im, Gi Jung; Lee, Seung Hoon; Kwon, Soon Young; Chae, Sung Won; Jung, Hak Hyun] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea; [Park, Hae-Chul] Korea Univ, Grad Sch Med, Lab Neurodev Genet, Seoul, South Korea	Hallym University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Choi, J (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea.	mednlaw@korea.ac.kr	ho, oh kyoung/AAZ-3407-2020; IM, GI JUNG/AAI-9755-2020	Yoo, Myung Hoon/0000-0002-9158-8924; IM, GI JUNG/0000-0002-9457-4253; CHOI, JUNE/0000-0002-6330-279X	Department Foundation of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine; Soo ENT Clinic	Department Foundation of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine; Soo ENT Clinic	This research was supported by a Grant-in-Aid from the Department Foundation of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, and the Soo ENT Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Battin EE, 2011, METALLOMICS, V3, P503, DOI 10.1039/c0mt00063a; Battin EE, 2009, CELL BIOCHEM BIOPHYS, V55, P1, DOI 10.1007/s12013-009-9054-7; Berger MM, 2006, CRIT CARE, V10, DOI 10.1186/cc5084; Broome CS, 2004, AM J CLIN NUTR, V80, P154; Buck LMJ, 2012, HEARING RES, V284, P67, DOI 10.1016/j.heares.2011.12.001; Chiu LL, 2008, JARO-J ASSOC RES OTO, V9, P178, DOI 10.1007/s10162-008-0118-y; Choi J, 2014, J APPL TOXICOL, V34, P554, DOI 10.1002/jat.2964; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; GOVAERTS PJ, 1990, TOXICOL LETT, V52, P227, DOI 10.1016/0378-4274(90)90033-I; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Huth M E, 2011, Int J Otolaryngol, V2011, P937861, DOI 10.1155/2011/937861; Kim TY, 2002, KOREAN J ELECT MICRO, V32, P57; Kohrle J, 2009, BEST PRACT RES CL EN, V23, P815, DOI 10.1016/j.beem.2009.08.002; Lee S, 2015, HUM EXP TOXICOL; LENOIR M, 1987, HEARING RES, V26, P199, DOI 10.1016/0378-5955(87)90112-2; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Ma Y, 2012, FOOD CHEM TOXICOL, V50, P2854, DOI 10.1016/j.fct.2012.04.037; Naik HRP, 2009, EUR J MED CHEM, V44, P981, DOI 10.1016/j.ejmech.2008.07.006; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; Ou H, 2012, HEARING RES, V288, P58, DOI 10.1016/j.heares.2012.01.009; Ou HC, 2007, HEARING RES, V233, P46, DOI 10.1016/j.heares.2007.07.003; Ou HC, 2012, JARO-J ASSOC RES OTO, V13, P759, DOI 10.1007/s10162-012-0353-0; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Owens KN, 2007, J COMP NEUROL, V502, P522, DOI 10.1002/cne.21345; Park C.B.C.H., 1999, KOREAN J ELECT MICRO, V29, P437; Park MK, 2014, INT J PEDIATR OTORHI, V78, P1311, DOI 10.1016/j.ijporl.2014.05.018; Phillips JS, 2007, CLIN OTOLARYNGOL, V32, P330, DOI 10.1111/j.1749-4486.2007.01532.x; Priuska EM, 1995, BIOCHEM PHARMACOL, V50, P1749, DOI 10.1016/0006-2952(95)02160-4; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Roland Peter S, 2004, Ear Nose Throat J, V83, P15; Roland Peter S, 2003, Ear Nose Throat J, V82 Suppl 1, P3; Rotstein C, 2004, OTOXICITY, P81; Rybak Leonard P, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P328, DOI 10.1097/00020840-200310000-00004; Rybak LP, 2005, OTOLARYNGOLOGY HEAD, P2933; Sakr Y, 2007, BRIT J ANAESTH, V98, P775, DOI 10.1093/bja/aem091; Selimoglu E, 2003, YONSEI MED J, V44, P517, DOI 10.3349/ymj.2003.44.3.517; Selimoglu E, 2007, CURR PHARM DESIGN, V13, P119, DOI 10.2174/138161207779313731; Staecker H, 2007, OTOL NEUROTOL, V28, P223, DOI 10.1097/MAO.0b013e31802b3225; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Sugahara K, 2006, HEARING RES, V221, P128, DOI 10.1016/j.heares.2006.08.009; Vlasits AL, 2012, HEARING RES, V294, P153, DOI 10.1016/j.heares.2012.08.002; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whanger PD, 2004, BRIT J NUTR, V91, P11, DOI 10.1079/BJN20031015; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Winterstein AG, 2013, OTOLARYNG HEAD NECK, V148, P277, DOI 10.1177/0194599812471499; Wu CY, 2015, J APPL TOXICOL, V35, P273, DOI 10.1002/jat.3043; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861	53	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151557	10.1371/journal.pone.0151557	http://dx.doi.org/10.1371/journal.pone.0151557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974429	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600090
J	Hess, MK; Hess, AS; Garrick, DJ				Hess, Melanie K.; Hess, Andrew S.; Garrick, Dorian J.			The Effect of Calf Gender on Milk Production in Seasonal Calving Cows and Its Impact on Genetic Evaluations	PLOS ONE			English	Article							BIRTH-WEIGHT; SEXED SEMEN; DAIRY-COWS; CATTLE; LACTATION; YIELD; HOLSTEINS; ECONOMICS; HISTORY; RECORDS	Gender of the calf whose birth initiates lactation could influence whole lactation milk yield of the dam due to hormonal influences on mammary gland development, or through calf gender effects on gestation length. Fetal gender could influence late lactation yields because cows become pregnant at peak lactation. The effects of calf gender sequences in parities 1-3 were assessed by separately fitting animal models to datasets from New Zealand comprising 274 000 Holstein Friesian and 85 000 Jersey cows, decreasing to 12 000 and 4 000 cows by parity 3. The lactation initiated by the birth of a female rather than a male calf was associated with a 0.33-1.1% (p <= 0.05) higher milk yield. Female calf gender had carryover effects associated with higher milk yield in second lactations for Holstein Friesians (0.24%; p = 0.01) and third lactations for Jerseys (1.1%; p = 0.01). Cows giving birth to bull calves have 2 day longer gestations, which reduces lactation length in seasonal calving herds. Adding a covariate for lactation length to the animal model eroded some of these calf gender effects, such that calving a female led to higher milk yield only for second lactation Holstein Friesians (1.6%; p = 0.002). The interval centering method generates lower estimates of whole lactation yield when Wood's lactation curves are shifted to the right by 2 days for male calves and this explained the higher yield in female calves when differences in lactation length were considered. Correlations of estimated breeding values between models including or excluding calf gender sequence were 1.00 for bulls or cows. Calf gender primarily influences milk yield through increased gestation length of male calves, and bias associated with the interval centering method used to estimate whole lactation milk yields. Including information on calf gender is unlikely to have an effect on selection response in New Zealand dairy cattle.	[Hess, Melanie K.; Hess, Andrew S.; Garrick, Dorian J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Hess, Melanie K.] Livestock Improvement Corp, Hamilton, New Zealand; [Garrick, Dorian J.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	Iowa State University; Livestock Improvement Corporation; Massey University	Hess, MK (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA USA.; Hess, MK (corresponding author), Livestock Improvement Corp, Hamilton, New Zealand.	mhayr@lic.co.nz	Garrick, Dorian/P-9628-2019; Garrick, Dorian/Q-3239-2019	Garrick, Dorian/0000-0001-8640-5372; Hess, Melanie/0000-0002-7502-0036; Hess, Andrew/0000-0001-6738-3817	Iowa State University Foundation through the Jay L. Lush Chair in Animal Breeding and Genetics	Iowa State University Foundation through the Jay L. Lush Chair in Animal Breeding and Genetics	The project received no direct funding but authors were supported by the Iowa State University Foundation through the Jay L. Lush Chair in Animal Breeding and Genetics. Livestock Improvement Corporation (LIC) did not fund this project nor have any role in the study design, analysis, decision to publish or preparation of the manuscript. LIC undertakes artificial insemination, progeny testing and herd testing so most of the milk record data was collected by that organization. The specific roles of the authors arearticulated in the 'author contributions' section.	Adham IM, 2002, MOL ENDOCRINOL, V16, P244, DOI 10.1210/me.16.2.244; Alberghina D, 2015, ARCH TIERZUCHT, V58, P73, DOI 10.5194/aab-58-73-2015; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; [Anonymous], 2014, REPLICATION STUDY FR; Beavers L, 2014, IS SEX BIASED MILK P; Borchersen S, 2009, THERIOGENOLOGY, V71, P59, DOI 10.1016/j.theriogenology.2008.09.026; Bradford BJ, 2014, RE REPLICATION STUDY; Butler ST, 2014, ANIMAL, V8, P165, DOI 10.1017/S1751731114000664; Chegini A, 2015, SPAN J AGRIC RES, V13, DOI 10.5424/sjar/2015132-6320; CHEW BP, 1981, J DAIRY SCI, V64, P2401, DOI 10.3168/jds.S0022-0302(81)82863-9; Daly S E, 1995, J Hum Lact, V11, P21, DOI 10.1177/089033449501100119; DeJarnette JM, 2009, THERIOGENOLOGY, V71, P49, DOI 10.1016/j.theriogenology.2008.09.042; Dematawewa CMB, 1997, J DAIRY SCI, V80, P754, DOI 10.3168/jds.S0022-0302(97)75995-2; Elzhov TV, MINPACK LM R INTERFA; ERB RE, 1980, J ANIM SCI, V51, P143, DOI 10.2527/jas1980.511143x; Ettema JF, 2015, J DAIRY SCI, V98, P1078, DOI 10.3168/jds.2014-8774; Fitch J.B., 1924, J DAIRY SCI, V7, P222, DOI DOI 10.3168/JDS.S0022-0302(24)94016-1; Garner DL, 2008, THERIOGENOLOGY, V69, P886, DOI 10.1016/j.theriogenology.2008.01.006; GIANOLA D, 1974, J DAIRY SCI, V57, P235, DOI 10.3168/jds.S0022-0302(74)84864-2; Gilmour A. R., ASREML USER GUIDE RE; Graesboll K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124051; Guo Z, 2002, J DAIRY SCI, V85, P1596, DOI 10.3168/jds.S0022-0302(02)74230-6; Hadsell DL, 2004, ADV EXP MED BIOL, V554, P229; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Hinde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086169; Ivell R, 2002, BIOL REPROD, V67, P699, DOI 10.1095/biolreprod.102.005199; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Landete-Castillejos T, 2005, BEHAV ECOL SOCIOBIOL, V57, P267, DOI 10.1007/s00265-004-0848-8; PTAK E, 1993, LIVEST PROD SCI, V34, P23, DOI 10.1016/0301-6226(93)90033-E; Robert-Granie C, 1999, LIVEST PROD SCI, V60, P343, DOI 10.1016/S0301-6226(99)00105-0; SARGENT FD, 1968, J DAIRY SCI, V51, P170, DOI 10.3168/jds.S0022-0302(68)86943-7; Searle S.R., 1971, LINEAR MODELS; Seidel GE, 2007, THERIOGENOLOGY, V68, P443, DOI 10.1016/j.theriogenology.2007.04.005; Seidel GE, 2003, THERIOGENOLOGY, V59, P585, DOI 10.1016/S0093-691X(02)01242-6; Twigger AJ, 2015, SCI REPORTS, V5, P14; Weigel K. A., 2004, J DAIRY SCI, V87, pE120, DOI DOI 10.3168/JDS.S0022-0302(04)70067-3; WOOD PDP, 1967, NATURE, V216, P164, DOI 10.1038/216164a0	37	18	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151236	10.1371/journal.pone.0151236	http://dx.doi.org/10.1371/journal.pone.0151236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974166	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600056
J	Ambe, CM; Mahipal, A; Fulp, J; Chen, L; Malafa, MP				Ambe, Chenwi M.; Mahipal, Amit; Fulp, Jimmy; Chen, Lu; Malafa, Mokenge P.			Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature	PLOS ONE			English	Article							DIABETES-MELLITUS; RISK; PROMOTION; DIAGNOSIS; THERAPIES; MORTALITY; COHORT; LIVER; MTOR	Observational studies have demonstrated that metformin use in diabetic patients is associated with reduced cancer incidence and mortality. Here, we aimed to determine whether metformin use was associated with improved survival in patients with resected pancreatic cancer. All patients with diabetes who underwent resection for pancreatic adenocarcinoma between 12/1/1986 and 4/30/2013 at our institution were categorized by metformin use. Survival analysis was done using the Kaplan-Meier method, with log-rank test and Cox proportional hazards multivariable regression models. For analyses of our data and the only other published study, we used Meta-Analysis version 2.2. We identified 44 pancreatic cancer patients with diabetes who underwent resection of the primary tumor (19 with ongoing metformin use, 25 never used metformin). There were no significant differences in major clinical and demographic characteristics between metformin and non-metformin users. Metformin users had a better median survival than nonusers, but the difference was not statistically significant (35.3 versus 20.2 months; P = 0.3875). The estimated 2-, 3-, and 5-year survival rates for non-metformin users were 42%, 28%, and 14%, respectively. Metformin users fared better with corresponding rates of 68%, 34%, and 34%, respectively. In our literature review, which included 111 patients from the two studies (46 metformin users and 65 non-users), overall hazard ratio was 0.668 (95% CI 0.397-1.125), with P = 0.129. Metformin use was associated with improved survival outcomes in patients with resected pancreatic cancer, but the difference was not statistically significant. The potential benefit of metformin should be investigated in adequately powered prospective studies.	[Ambe, Chenwi M.; Mahipal, Amit; Malafa, Mokenge P.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA; [Fulp, Jimmy; Chen, Lu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Malafa, MP (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA.	Mokenge.malafa@moffitt.org	Mahipal, Amit/ABD-8395-2020	Mahipal, Amit/0000-0002-1111-8333				American Cancer Society, 2014, CANC FACTS FIG; Bartosch-Harlid A, 2010, PANCREATOLOGY, V10, P423, DOI 10.1159/000264676; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Burney S, 2014, J PANCREAS, V15, P313, DOI 10.6092/1590-8577/2677; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Donadon V, 2009, WORLD J GASTROENTERO, V15, P2506, DOI 10.3748/wjg.15.2506; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feng YH, 2011, J CELL MOL MED, V15, P825, DOI 10.1111/j.1582-4934.2010.01083.x; Godsland IF, 2010, CLIN SCI, V118, P315, DOI 10.1042/CS20090399; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982; Incio J, 2016, CLIN CANC RES; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Koohestani N, 1997, NUTR CANCER, V29, P69, DOI 10.1080/01635589709514604; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; McAuliffe JC, 2013, SURG CLIN N AM, V93, P619, DOI 10.1016/j.suc.2013.02.003; Nair V, 2014, J BIOL CHEM; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Reni M, 2015, CLIN CANC RES; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tran TT, 1996, CANCER EPIDEM BIOMAR, V5, P1013; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151632	10.1371/journal.pone.0151632	http://dx.doi.org/10.1371/journal.pone.0151632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967162	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200067
J	Ma, GM; He, TP; Yu, Y; Duan, HF; Yang, CB				Ma, Guangming; He, Taiping; Yu, Yong; Duan, Haifeng; Yang, Chuangbo			Improving Image Quality of Bronchial Arteries with Virtual Monochromatic Spectral CT Images	PLOS ONE			English	Article							NONBRONCHIAL SYSTEMIC ARTERIES; ROW CT; ANGIOGRAPHY; EXPERIENCE; DIAGNOSIS	Objective To evaluate the clinical value of using monochromatic images in spectral CT pulmonary angiography to improve image quality of bronchial arteries. Methods We retrospectively analyzed the chest CT images of 38 patients who underwent contrast-enhanced spectral CT. These images included a set of 140kVp polychromatic images and the default 70keV monochromatic images. Using the standard Gemstone Spectral Imaging (GSI) viewer on an advanced workstation (AW4.6, GE Healthcare), an optimal energy level (in keV) for obtaining the best contrast-to-noise ratio (CNR) for the artery could be automatically obtained. The signal-to-noise ratio (SNR), CNR and objective image quality score (15) for these 3 image sets (140kVp, 70keV and optimal energy level) were obtained and, statistically compared. The image quality score consistency between the two observers was also evaluated using Kappa test. Results The optimal energy levels for obtaining the best CNR were 62.58 +/- 2.74keV. SNR and CNR from the 140kVp polychromatic, 70keV and optimal keV monochromatic images were (16.44 +/- 5.85, 13.24 +/- 5.52), (20.79 +/- 7.45, 16.69 +/- 6.27) and (24.9 +/- 9.91, 20.53 +/- 8.46), respectively. The corresponding subjective image quality scores were 1.97 +/- 0.82, 3.24 +/- 0.75, and 4.47 +/- 0.60. SNR, CNR and subjective scores had significant difference among groups (all p<0.001). The optimal keV monochromatic images were superior to the 70keV monochromatic and 140kVp polychromatic images, and there was high agreement between the two observers on image quality score (kappa>0.80). Conclusions Virtual monochromatic images at approximately 63keV in dual-energy spectral CT pulmonary angiography yielded the best CNR and highest diagnostic confidence for imaging bronchial arteries.	[Ma, Guangming; He, Taiping; Yu, Yong; Duan, Haifeng; Yang, Chuangbo] Shannxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Radiol, Xianyang City, Shaanxi, Peoples R China		He, TP (corresponding author), Shannxi Univ Tradit Chinese Med, Affiliated Hosp, Dept Radiol, Xianyang City, Shaanxi, Peoples R China.	513119536@qq.com						Boe K, 2012, WATER SCI TECHNOL, V66, P2146, DOI 10.2166/wst.2012.438; Chenuel B, 2002, EUR RESPIR J, V20, P710, DOI 10.1183/09031936.02.00892001; Cui Y, 2012, BRIT J RADIOL, V85, pE887, DOI 10.1259/bjr/27844842; Fuchs TA, 2013, J CARDIOVASC COMPUT, V7, P25, DOI 10.1016/j.jcct.2013.01.004; Lin XZ, 2012, EUR J RADIOL, V81, P2487, DOI 10.1016/j.ejrad.2011.10.028; McCrum-Gardner E, 2008, BRIT J ORAL MAX SURG, V46, P38, DOI 10.1016/j.bjoms.2007.09.002; Murthy N, 2007, J BIOL CHEM, V282, P18254, DOI 10.1074/jbc.M701428200; Pinho DF, 2013, EUR RADIOL, V23, P351, DOI 10.1007/s00330-012-2624-x; Potretzke TA, 2015, RADIOLOGY, V275, P119, DOI 10.1148/radiol.14140875; Raju R, 2014, J CARDIOVASC COMPUT, V8, P282, DOI 10.1016/j.jcct.2014.06.003; Remy-Jardin M, 2004, RADIOLOGY, V233, P741, DOI 10.1148/radiol.2333040031; Tanaka Osamu, 2006, Diagn Interv Radiol, V12, P201; Yoon YC, 2005, RADIOLOGY, V234, P292, DOI 10.1148/radiol.2341032079; Zhao LQ, 2012, EUR J RADIOL, V81, P1677, DOI 10.1016/j.ejrad.2011.02.063	14	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150985	10.1371/journal.pone.0150985	http://dx.doi.org/10.1371/journal.pone.0150985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967737	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200026
J	Martinson, BC; Nelson, D; Hagel-Campbell, E; Mohr, D; Charns, MP; Bangerter, A; Thrush, CR; Ghilardi, JR; Bloomfield, H; Owen, R; Wells, JA				Martinson, Brian C.; Nelson, David; Hagel-Campbell, Emily; Mohr, David; Charns, Martin P.; Bangerter, Ann; Thrush, Carol R.; Ghilardi, Joseph R.; Bloomfield, Hanna; Owen, Richard; Wells, James A.			Initial Results from the Survey of Organizational Research Climates (SOuRCe) in the US Department of Veterans Affairs Healthcare System	PLOS ONE			English	Article							RESEARCH INTEGRITY; JUSTICE; MODEL	Background In service to its core mission of improving the health and well-being of veterans, Veterans Affairs (VA) leadership is committed to supporting research best practices in the VA. Recognizing that the behavior of researchers is influenced by the organizational climates in which they work, efforts to assess the integrity of research climates and share such information with research leadership in VA may be one way to support research best practices. The Survey of Organizational Research Climate (SOuRCe) is the first validated survey instrument specifically designed to assess the organizational climate of research integrity in academic research organizations. The current study reports on an initiative to use the SOuRCe in VA facilities to characterize the organizational research climates and pilot test the effectiveness of using SOuRCe data as a reporting and feedback intervention tool. Methods We administered the SOuRCe using a cross-sectional, online survey, with mailed follow-up to non-responders, of research-engaged employees in the research services of a random selection of 42 VA facilities (e.g., Hospitals/Stations) believed to employ 20 or more research staff. We attained a 51% participation rate, yielding more than 5,200 usable surveys. Results We found a general consistency in organizational research climates across a variety of subgroups in this random sample of research services in the VA. We also observed similar SOuRCe scale score means, relative rankings of these scales and their internal reliability, in this VA-based sample as we have previously documented in more traditional academic research settings. Results also showed more substantial variability in research climate scores within than between facilities in the VA research service as reflected in meaningful subgroup differences. These findings suggest that the SOuRCe is suitable as an instrument for assessing the research integrity climates in VA and that the tool has similar patterns of results that have been observed in more traditional academic research settings. Conclusions The local and specific nature of organizational climates in VA research services, as reflected in variability across sub-groups within individual facilities, has important policy implications. Global, "one-size-fits-all" type initiatives are not likely to yield as much benefit as efforts targeted to specific organizational units or sub-groups and tailored to the specific strengths and weaknesses documented in those locations.	[Martinson, Brian C.; Nelson, David; Hagel-Campbell, Emily; Bangerter, Ann; Ghilardi, Joseph R.; Bloomfield, Hanna] Minneapolis VA Hlth Care Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Martinson, Brian C.] HealthPartners Inst, Bloomington, MN USA; [Mohr, David; Charns, Martin P.] Boston VA, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Thrush, Carol R.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Owen, Richard] Little Rock VA, Ctr Mental Healthcare & Outcomes Res, Little Rock, AR USA; [Wells, James A.] James Wells Consulting, Edgerton, WI USA	HealthPartners Institute for Education & Research; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Martinson, BC (corresponding author), Minneapolis VA Hlth Care Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA.; Martinson, BC (corresponding author), HealthPartners Inst, Bloomington, MN USA.	brian.martinson@va.gov	Martinson, Brian C/AAX-2860-2020; Mohr, David/ABD-4341-2020; Nelson, David/G-7142-2011	Martinson, Brian C/0000-0002-4255-5595; Mohr, David/0000-0002-3184-6338; Nelson, David/0000-0003-1163-1222; Charns, Martin/0000-0002-7102-5331; bloomfield, hanna/0000-0002-0756-7064	U.S. Veterans Health Administration, Health Services Research Development [GRANT11155301]	U.S. Veterans Health Administration, Health Services Research Development	This research was funded in whole by a grant (GRANT11155301) to BCM from the U.S. Veterans Health Administration, Health Services Research & Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors BCM, DN, EH-C, DM, MPC, AB, and JRC. The funder also provided support in the form of consultancy fees for CRT and JAW. The specific roles of these authors are articulated in the "author contributions" section.	Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; BURKE WW, 1992, J MANAGE, V18, P523, DOI 10.1177/014920639201800306; Committee on Assessing Integrity in Research Environments, 2002, INT SCI RES CREAT EN; Crain AL, 2013, SCI ENG ETHICS, V19, P835, DOI 10.1007/s11948-012-9409-0; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Ehrhart MG, 2013, ORG CLIMATE CULTURE; Geller G, 2010, ACAD MED, V85, P1296, DOI 10.1097/ACM.0b013e3181e5f0e5; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; GUNSALUS CK, 1993, ACAD MED, V68, pS33, DOI 10.1097/00001888-199309000-00031; Harrison MI, 2009, HEALTH CARE MANAGE R, V34, P42, DOI 10.1097/01.HMR.0000342979.91931.d9; Korenman S.G., 2006, TEACHING RESPONSIBLE; Lukas CV, 2007, HEALTH CARE MANAGE R, V32, P309, DOI 10.1097/01.HMR.0000296785.29718.5d; Lundberg C. C., 1985, ORG CULTURE, P169; Martinson BC, 2013, SCI ENG ETHICS, V19, P813, DOI 10.1007/s11948-012-9410-7; Martinson BC, 2010, J EMPIR RES HUM RES, V5, P67, DOI 10.1525/jer.2010.5.3.67; Mayer D, 2007, PERS PSYCHOL, V60, P929, DOI 10.1111/j.1744-6570.2007.00096.x; Mumford MD, 2007, ETHICS BEHAV, V17, P337, DOI 10.1080/10508420701519510; Pettigrew A. M., 1990, ORG CLIMATE CULTURE, P413; PFEFFER J, 1993, ADMIN SCI QUART, V38, P382, DOI 10.2307/2393373; Pfeffer J., 2015, FIXING WORKPLACES CA; Schein E.H., HDB ORGANISATIONAL C, pxxiii; Steneck Nicholas H, 2002, Am J Bioeth, V2, P51, DOI 10.1162/152651602320957574; Vasgird DR, 2007, ACAD MED, V82, P835, DOI 10.1097/ACM.0b013e31812f7e0b; Wells JA, 2014, J EMPIR RES HUM RES, V9, P72, DOI 10.1177/1556264614552798	24	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151571	10.1371/journal.pone.0151571	http://dx.doi.org/10.1371/journal.pone.0151571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3SC	26967736	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200062
J	McNarry, MA; Mackintosh, KA				McNarry, Melitta A.; Mackintosh, Kelly A.			Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis	PLOS ONE			English	Article							LONG-TERM REPRODUCIBILITY; FREQUENCY-DOMAIN; RELIABILITY; MORTALITY; EXERCISE; ADULTS; REST	Fundamental to the potential utilisation of heart rate variability (HRV) indices as a prognostic tool is the reproducibility of these measures. The purpose of the present study was therefore to investigate the reproducibility of 24-hour derived HRV indices in a clinical paediatric population. Eighteen children (10 boys; 12.4 +/- 2.8 years) with mild to moderate Cystic Fibrosis (CF; FVC: 83 +/- 12% predicted; FEV1: 80 +/- 9% predicted) and eighteen age-and sex-matched controls (10 boys; 12.5 +/- 2.7 years) wore a combined ECG and accelerometer for two consecutive days. Standard time and frequency domain indices of HRV were subsequently derived. Reproducibility was assessed by Bland-Altman plots, 95% limits of agreement and intra-class correlation coefficients (ICC). In both groups, there was no systematic difference between days, with the variables demonstrating a symmetrical, homoscedastic distribution around the zero line. The time domain parameters demonstrated a good to excellent reproducibility irrespective of the population considered (ICC: 0.56 to 0.86). In contrast, whilst the frequency domain parameters similarly showed excellent reproducibility in the healthy children (ICC: 0.70 to 0.96), the majority of the frequency domain parameters illustrated a poor to moderate reproducibility in those with CF (ICC: 0.22 to 0.43). The exceptions to this trend were the normalised LF and HF components which were associated with a good to excellent reproducibility. These findings thereby support the utilisation of time and relative frequency domain HRV indices as a prognostic tool in children with CF. Furthermore, the present results highlight the excellent reproducibility of HRV in healthy children, indicating that this may be a useful tool to assess intervention effectiveness in this population.	[McNarry, Melitta A.; Mackintosh, Kelly A.] Swansea Univ, Coll Engn, Swansea SA2 8PP, W Glam, Wales	Swansea University	McNarry, MA (corresponding author), Swansea Univ, Coll Engn, Swansea SA2 8PP, W Glam, Wales.	m.mcnarry@swansea.ac.uk	McNarry, Melitta/G-9032-2016; McNarry, Melitta/AAC-6899-2020	McNarry, Melitta/0000-0003-0813-7477; McNarry, Melitta/0000-0003-0813-7477; Mackintosh, Kelly/0000-0003-0355-6357				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ASMUSSEN E, 1968, ACTA PHYSIOL SCAND, V73, P527, DOI 10.1111/j.1365-201X.1968.tb10892.x; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Burger AJ, 1997, AM J CARDIOL, V80, P1198, DOI 10.1016/S0002-9149(97)00639-5; Camm AJ, 1996, CIRCULATION, V93, P1043; CASOLO G, 1989, AM J CARDIOL, V64, P1162, DOI 10.1016/0002-9149(89)90871-0; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; DAVIS PB, 1983, J CHRON DIS, V36, P269, DOI 10.1016/0021-9681(83)90062-0; DAVIS PB, 1978, PEDIATR RES, V12, P703, DOI 10.1203/00006450-197806000-00005; Department of Health PAHIaP, 2011, START ACT STAY ACT R; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Florencio R, 2013, BRAZ J PHYS THER, V17, P419, DOI 10.1590/S1413-35552012005000109; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Konrady A O, 2001, Med Sci Monit, V7, P58; Leicht AS, 2008, BRAZ J MED BIOL RES, V41, P627, DOI 10.1590/S0100-879X2008000700013; Lord SW, 2001, CLIN SCI, V100, P43, DOI 10.1042/CS20000111; MALIK M, 1990, CLIN CARDIOL, V13, P570, DOI 10.1002/clc.4960130811; McNarry MA, 2012, PHYSIOL MEAS, V33, P1123, DOI 10.1088/0967-3334/33/7/1123; Nolan J, 1996, AM J CARDIOL, V77, P154, DOI 10.1016/S0002-9149(96)90587-1; PAGANI M, 1988, J AUTONOM NERV SYST, V23, P143, DOI 10.1016/0165-1838(88)90078-1; Perandini LA, 2009, REV BRAS CIN DES HUM, V12, P8; Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055; Pitzalis MV, 1996, CARDIOVASC RES, V32, P226, DOI 10.1016/0008-6363(96)00086-7; Rich C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067206; Sandercock GRH, 2004, CLIN PHYSIOL FUNCT I, V24, P359, DOI 10.1111/j.1475-097X.2004.00584.x; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; Stanojevic S, 2009, AM J RESP CRIT CARE, V180, P547, DOI 10.1164/rccm.200903-0323OC; STEIN PK, 1995, AM HEART J, V129, P975, DOI 10.1016/0002-8703(95)90119-1; Szollosi I, 2011, INTERN MED J, V41, P455, DOI 10.1111/j.1445-5994.2009.02039.x; WATKINS PJ, 1980, ANN INTERN MED, V92, P304, DOI 10.7326/0003-4819-92-2-304; Winsley R, 2002, PEDIATR EXERC SCI, V14, P328, DOI 10.1123/pes.14.4.328; Ziegler D, 1999, HORM METAB RES, V31, P672, DOI 10.1055/s-2007-978819; ZUANETTI G, 1991, J AM COLL CARDIOL, V17, P604, DOI 10.1016/S0735-1097(10)80172-X	34	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151464	10.1371/journal.pone.0151464	http://dx.doi.org/10.1371/journal.pone.0151464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968039	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200056
J	Kim, SW; Jhon, M; Kim, JM; Smesny, S; Rice, S; Berk, M; Klier, CM; McGorry, PD; Schafer, MR; Amminger, GP				Kim, Sung-Wan; Jhon, Min; Kim, Jae-Min; Smesny, Stefan; Rice, Simon; Berk, Michael; Klier, Claudia M.; McGorry, Patrick D.; Schaefer, Miriam R.; Amminger, G. Paul			Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study	PLOS ONE			English	Article							ULTRA-HIGH-RISK; NEGATIVE SYNDROME SCALE; AGE-RELATED-CHANGES; LINOLENIC ACID; SEROTONINERGIC NEUROTRANSMISSION; SCHIZOPHRENIC-PATIENTS; 1ST-EPISODE PSYCHOSIS; EICOSAPENTAENOIC ACID; INDICATED PREVENTION; EVOLUTIONARY ASPECTS	This study investigated the relationship between erythrocyte membrane fatty acid (FA) levels and the severity of symptoms of individuals at ultra-high risk (UHR) for psychosis. Subjects of the present study consisted of 80 neuroleptic-naive UHR patients. Partial correlation coefficients were calculated between baseline erythrocyte membrane FA levels, measured by gas chromatography, and scores on the Positive and Negative Syndrome Scale (PANSS), Global Assessment of Functioning Scale, and Montgomery-Asberg Depression Rating Scale (MADRS) after controlling for age, sex, smoking and cannabis use. Subjects were into three groups according to the predominance of positive or negative symptoms based on PANSS subscale scores; membrane FA levels in the three groups were then compared. More severe negative symptoms measured by PANSS were negatively correlated with two saturated FAs (myristic and margaric acids), one omega-9 mono-unsaturated FA (MUFA; nervonic acid), and one omega-3 polyunsaturated FA (PUFA; docosapentaenoic acid), and were positively correlated with two omega-9 MUFAs (eicosenoic and erucic acids) and two omega-6 PUFAs (omega-linolenic and docosadienoic acids). More severe positive symptoms measured by PANSS were correlated only with nervonic acid. No associations were observed between FAs and MADRS scores. In subjects with predominant negative symptoms, the sum of the omega-9 MUFAs and the omega-6:omega-3 FA ratio were both significantly higher than in those with predominant positive symptoms, whereas the sum of omega-3 PUFAs was significantly lower. In conclusion, abnormalities in FA metabolism may contribute to the neurobiology of psychopathology in UHR individuals. In particular, membrane FA alterations may play a role in negative symptoms, which are primary psychopathological manifestations of schizophrenia-related disability.	[Kim, Sung-Wan; Jhon, Min; Kim, Jae-Min] Chonnam Natl Univ, Dept Psychiat, Sch Med, Gwangju, South Korea; [Smesny, Stefan] Univ Hosp Jena, Dept Psychiat, Jena, Germany; [Rice, Simon; Berk, Michael; McGorry, Patrick D.; Schaefer, Miriam R.; Amminger, G. Paul] Univ Melbourne, Orygen, Natl Ctr Excellence Youth Mental Hlth, Ctr Youth Mental Hlth, Parkville, Vic 3052, Australia; [Berk, Michael] Deakin Univ, IMPACT Strateg Res Ctr, Sch Med, Geelong, Vic 3217, Australia; [Klier, Claudia M.; Amminger, G. Paul] Med Univ Vienna, Dept Child & Adolescent Med, Vienna, Austria	Chonnam National University; Friedrich Schiller University of Jena; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Deakin University; Medical University of Vienna	Kim, SW (corresponding author), Chonnam Natl Univ, Dept Psychiat, Sch Med, Gwangju, South Korea.; Amminger, GP (corresponding author), Univ Melbourne, Orygen, Natl Ctr Excellence Youth Mental Hlth, Ctr Youth Mental Hlth, Parkville, Vic 3052, Australia.; Amminger, GP (corresponding author), Med Univ Vienna, Dept Child & Adolescent Med, Vienna, Austria.	swkim@chonnam.ac.kr; amminger@unimelb.edu.au	Berk, Michael/M-7891-2013; KIM, Jae-Min/S-7637-2019; McGorry, Patrick/O-4115-2019; Berk, Michael/M-3585-2019; Rice, Simon/J-5656-2014; Amminger, G. Paul/ABE-1579-2020	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Rice, Simon/0000-0003-4045-8553; Amminger, G. Paul/0000-0001-8969-4595; McGorry, Patrick/0000-0002-3789-6168; Klier, Claudia/0000-0003-0696-8904	Stanley Medical Research Institute [03T-315]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2014R1A1A4A01005245]; National Health and Medical Research Council Australia (NHMRC) [1059660]; Society for Mental Health Research; NHMRC [1080963]	Stanley Medical Research Institute; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning(National Research Foundation of Korea); National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Society for Mental Health Research; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grant 03T-315 from the Stanley Medical Research Institute. SWK was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A1A4A01005245). MB was supported by National Health and Medical Research Council Australia (NHMRC) Senior Principal Research Fellowship 1059660. SR was supported by an Early Career Fellowship from the Society for Mental Health Research. GPA was supported by NHMRC Senior Research Fellowship 1080963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2004, INT J NEUROPSYCHOPH, V7, pS1, DOI 10.1017/S1461145704004110; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amminger GP, 2012, MOL PSYCHIATR, V17, P1150, DOI 10.1038/mp.2011.167; Amminger GP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8934; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Assies J, 2001, BIOL PSYCHIAT, V49, P510, DOI 10.1016/S0006-3223(00)00986-0; BABIN F, 1993, LIPIDS, V28, P627, DOI 10.1007/BF02536057; Bentsen H, 2012, PROSTAG LEUKOTR ESS, V87, P35, DOI 10.1016/j.plefa.2012.05.005; Berger GE, 2008, NEUROPSYCHOPHARMACOL, V33, P2467, DOI 10.1038/sj.npp.1301628; Bu B, 2006, PROSTAG LEUKOTR ESS, V74, P215, DOI 10.1016/j.plefa.2006.02.001; Burridge S., 2011, MYRISTIC ACID LINKAG; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; Carlson RV, 2004, BRIT J CLIN PHARMACO, V57, P695, DOI 10.1111/j.1365-2125.2004.02103.x; CARLSON SE, 1986, J NUTR, V116, P718, DOI 10.1093/jn/116.5.718; Chalon S, 1998, J NUTR, V128, P2512, DOI 10.1093/jn/128.12.2512; Chalon S, 2001, LIPIDS, V36, P937, DOI 10.1007/s11745-001-0804-7; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; CONNOR WE, 1993, FASEB J, V7, pA152; CROW TJ, 1980, BRIT J PSYCHIAT, V137, P383, DOI 10.1192/S0007125000071919; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Davis J, 2015, MOL PSYCHIATR, V20, P152, DOI 10.1038/mp.2014.139; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Delion S, 1996, J NEUROCHEM, V66, P1582; DELION S, 1994, J NUTR, V124, P2466, DOI 10.1093/jn/124.12.2466; FOLCH J, 1958, Exp Cell Res, V14, P58; FOLCH J, 1951, J BIOL CHEM, V191, P833; FOLCH J, 1957, J BIOL CHEM, V226, P497; GLEN AIM, 1994, SCHIZOPHR RES, V12, P53, DOI 10.1016/0920-9964(94)90084-1; Grima G, 2003, SCHIZOPHR RES, V62, P213, DOI 10.1016/S0920-9964(02)00405-X; Hafner H, 1999, ACTA PSYCHIAT SCAND, V100, P105, DOI 10.1111/j.1600-0447.1999.tb10831.x; Hoen WP, 2013, PSYCHIAT RES, V207, P1, DOI 10.1016/j.psychres.2012.09.041; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Iuliano L, 2013, J ALZHEIMERS DIS, V36, P545, DOI 10.3233/JAD-122224; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Kim SW, 2014, SCHIZOPHR RES, V158, P39, DOI 10.1016/j.schres.2014.06.032; Kitajka K, 2004, P NATL ACAD SCI USA, V101, P10931, DOI 10.1073/pnas.0402342101; Lang FU, 2015, COMPR PSYCHIAT, V61, P115, DOI 10.1016/j.comppsych.2015.05.014; Laugharne JDE, 1996, LIPIDS, V31, pS163, DOI 10.1007/BF02637070; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Mighdoll MI, 2015, SCHIZOPHR RES, V161, P85, DOI 10.1016/j.schres.2014.09.040; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morrison AP, 2004, BRIT J PSYCHIAT, V185, P291, DOI 10.1192/bjp.185.4.291; Nakamura K, 1997, J NEUROCHEM, V69, P1850; Ohara K, 2007, PROG NEURO-PSYCHOPH, V31, P469, DOI 10.1016/j.pnpbp.2006.11.013; Paik MJ, 2009, CLIN CHIM ACTA, V402, P25, DOI 10.1016/j.cca.2008.12.022; PERALTA V, 1994, PSYCHIAT RES, V53, P31, DOI 10.1016/0165-1781(94)90093-0; Peters BD, 2013, SCHIZOPHRENIA BULL, V39, P830, DOI 10.1093/schbul/sbs089; Rajasekaran A, 2015, NEUROSCI BIOBEHAV R, V48, P10, DOI 10.1016/j.neubiorev.2014.11.005; Rice SM, 2015, PSYCHIAT RES, V228, P174, DOI 10.1016/j.psychres.2015.04.036; Sethom MM, 2010, PROSTAG LEUKOTR ESS, V83, P131, DOI 10.1016/j.plefa.2010.07.001; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2009, WORLD REV NUTR DIET, V100, P1, DOI 10.1159/000235706; Smesny S, 2014, MOL PSYCHIATR, V19, P317, DOI 10.1038/mp.2013.7; Startup M, 2002, BRIT J CLIN PSYCHOL, V41, P417, DOI 10.1348/014466502760387533; van Rensburg SJ, 2009, METAB BRAIN DIS, V24, P659, DOI 10.1007/s11011-009-9160-7; Xiu MH, 2014, SCHIZOPHR RES, V156, P9, DOI 10.1016/j.schres.2014.03.024; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yao JK, 2000, PSYCHIAT RES, V97, P137, DOI 10.1016/S0165-1781(00)00230-4; Yung AR, 1998, BRIT J PSYCHIAT, V172, P14, DOI 10.1192/S0007125000297602; Zimmer L, 1999, Nutr Neurosci, V2, P257, DOI 10.1080/1028415X.1999.11747282; Zimmer L, 1998, NEUROSCI LETT, V240, P177, DOI 10.1016/S0304-3940(97)00938-5; Zimmer L, 2002, AM J CLIN NUTR, V75, P662, DOI 10.1093/ajcn/75.4.662	67	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151417	10.1371/journal.pone.0151417	http://dx.doi.org/10.1371/journal.pone.0151417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963912	Green Published, gold			2022-12-27	WOS:000371993000149
J	Schmidt, JR; Liefooghe, B				Schmidt, James R.; Liefooghe, Baptist			Feature Integration and Task Switching: Diminished Switch Costs after Controlling for Stimulus, Response, and Cue Repetitions	PLOS ONE			English	Article							PROPORTION CONGRUENT; CONFLICT ADAPTATION; COGNITIVE-COMPLEXITY; ATTENTIONAL CAPTURE; CLEVER HOMUNCULUS; SET; SELECTION; RECONFIGURATION; RETRIEVAL; REPRESENTATION	This report presents data from two versions of the task switching procedure in which the separate influence of stimulus repetitions, response key repetitions, conceptual response repetitions, cue repetitions, task repetitions, and congruency are considered. Experiment 1 used a simple alternating runs procedure with parity judgments of digits and consonant/ vowel decisions of letters as the two tasks. Results revealed sizable effects of stimulus and response repetitions, and controlling for these effects reduced the switch cost. Experiment 2 was a cued version of the task switch paradigm with parity and magnitude judgments of digits as the two tasks. Results again revealed large effects of stimulus and response repetitions, in addition to cue repetition effects. Controlling for these effects again reduced the switch cost. Congruency did not interact with our novel "unbiased" measure of switch costs. We discuss how the task switch paradigm might be thought of as a more complex version of the feature integration paradigm and propose an episodic learning account of the effect. We further consider to what extent appeals to higher-order control processes might be unnecessary and propose that controls for feature integration biases should be standard practice in task switching experiments.	[Schmidt, James R.; Liefooghe, Baptist] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University	Schmidt, JR (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	james.schmidt@ugent.be	Liefooghe, Baptist/C-7336-2018; Schmidt, James/C-9704-2010	Liefooghe, Baptist/0000-0001-5896-2884; Schmidt, James/0000-0002-0412-396X	Research Foundation - Flanders (FWO - Vlaanderen) [1211814N]; Ghent University [BOF09/01M00209]	Research Foundation - Flanders (FWO - Vlaanderen)(FWO); Ghent University(Ghent University)	This research was supported by a postdoctoral researcher mandate (1211814N) of the Research Foundation - Flanders (FWO - Vlaanderen) to JRS, and funds from Grant BOF09/01M00209 from Ghent University to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Allport A, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P35; Altmann EM, 2007, J EXP PSYCHOL LEARN, V33, P475, DOI 10.1037/0278-7393.33.3.475; Altmann EM, 2011, J EXP PSYCHOL LEARN, V37, P935, DOI 10.1037/a0022931; Arbuthnott KD, 2002, CAN J EXP PSYCHOL, V56, P18, DOI 10.1037/h0087382; Arrington CM, 2007, J EXP PSYCHOL LEARN, V33, P484, DOI 10.1037/0278-7393.33.3.484; Arrington CM, 2005, J EXP PSYCHOL LEARN, V31, P683, DOI 10.1037/0278-7393.31.4.683; Arrington CM, 2004, MEM COGNITION, V32, P965, DOI 10.3758/BF03196874; Arrington CM, 2004, PSYCHOL SCI, V15, P610, DOI 10.1111/j.0956-7976.2004.00728.x; BERTELSON P, 1965, NATURE, V206, P217, DOI 10.1038/206217a0; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; DALRYMPLEALFORD EC, 1966, PERCEPT MOTOR SKILL, V23, P1211, DOI 10.2466/pms.1966.23.3f.1211; Druey MD, 2008, PSYCHOL RES-PSYCH FO, V72, P515, DOI 10.1007/s00426-007-0127-1; Druey MD, 2014, J EXP PSYCHOL LEARN, V40, P125, DOI 10.1037/a0033868; Forstmann BU, 2007, PSYCHOL RES-PSYCH FO, V71, P393, DOI 10.1007/s00426-005-0040-4; Goschke T, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P331; Grange JA, 2010, PSYCHOL RES-PSYCH FO, V74, P481, DOI 10.1007/s00426-009-0270-y; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Horoufchin H, 2011, J EXP PSYCHOL HUMAN, V37, P455, DOI 10.1037/a0020557; Hubner R, 2008, PSYCHOL RES-PSYCH FO, V72, P415, DOI 10.1007/s00426-007-0118-2; Hubner R, 2006, PSYCHOL RES-PSYCH FO, V70, P245, DOI 10.1007/s00426-005-0219-8; Hughes S, 2015, J EXPT PSYCHOL GEN; Jersild AT, 1927, ARCH PSYCHOL, V14; Jimenez L, 2013, J EXP PSYCHOL HUMAN, V39, P271, DOI 10.1037/a0027734; Jost K, 2013, Z PSYCHOL, V221, P5, DOI 10.1027/2151-2604/a000125; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kim S, 2014, ACTA PSYCHOL, V149, P60, DOI 10.1016/j.actpsy.2014.03.004; Kleinsorge T, 2004, PSYCHOL RES-PSYCH FO, V68, P31, DOI 10.1007/s00426-003-0134-9; Kleinsorge T, 1999, ACTA PSYCHOL, V103, P295, DOI 10.1016/S0001-6918(99)00047-5; Kleinsorge T, 1999, PSYCHOL RES-PSYCH FO, V62, P300, DOI 10.1007/s004260050060; Koch I, 2006, MEM COGNITION, V34, P433, DOI 10.3758/BF03193420; Logan GD, 2006, J EXP PSYCHOL LEARN, V32, P347, DOI 10.1037/0278-7393.32.3.347; Logan GD, 2004, PSYCHON B REV, V11, P832, DOI 10.3758/BF03196709; Logan GD, 2003, J EXP PSYCHOL HUMAN, V29, P575, DOI 10.1037/0096-1523.29.3.575; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Logan GD, 2007, J EXP PSYCHOL HUMAN, V33, P978, DOI 10.1037/0096-1523.33.4.978; Logan GD, 2006, MEM COGNITION, V34, P1250, DOI 10.3758/BF03193269; Mayr U, 2003, J EXP PSYCHOL LEARN, V29, P362, DOI 10.1037/0278-7393.29.3.362; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Mayr U, 2000, J EXP PSYCHOL LEARN, V26, P1124, DOI 10.1037/0278-7393.26.5.1124; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004; Meiran N, 2008, PSYCHOL RES-PSYCH FO, V72, P473, DOI 10.1007/s00426-008-0136-8; Miyake A, 2004, ACTA PSYCHOL, V115, P123, DOI 10.1016/j.actpsy.2003.12.004; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Monsell S, 2006, J EXP PSYCHOL HUMAN, V32, P493, DOI 10.1037/0096-1523.32.3.493; Mordkoff JT, 2012, PSYCHON B REV, V19, P750, DOI 10.3758/s13423-012-0257-3; Notebaert W, 2007, J EXP PSYCHOL HUMAN, V33, P1256, DOI 10.1037/0096-1523.33.5.1256; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rothermund K, 2005, J EXP PSYCHOL LEARN, V31, P482, DOI 10.1037/0278-7393.31.3.482; Schmidt JR, 2008, J EXP PSYCHOL LEARN, V34, P514, DOI 10.1037/0278-7393.34.3.514; Schmidt JR, 2015, ACTA PSYCHOL, V159, P61, DOI 10.1016/j.actpsy.2015.05.007; Schmidt JR, 2014, J EXP PSYCHOL HUMAN, V40, P2392, DOI 10.1037/a0038073; Schmidt JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102337; Schmidt JR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00540; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Schmidt JR, 2011, ACTA PSYCHOL, V138, P176, DOI 10.1016/j.actpsy.2011.06.002; Schmidt JR, PSYCHOL RES IN PRESS; Schneider D.W., 2014, TASK SWITCHING COGNI, P27, DOI DOI 10.1093/ACPROF:OSOBL/9780199921959.003.0002; Schneider DW, 2007, J EXP PSYCHOL LEARN, V33, P370, DOI 10.1037/0278-7393.33.2.370; Schneider DW, 2015, J EXP PSYCHOL LEARN, V41, P235, DOI 10.1037/xlm0000049; Schneider DW, 2009, J EXP PSYCHOL LEARN, V35, P122, DOI 10.1037/a0013744; Schneider DW, 2005, J EXP PSYCHOL GEN, V134, P343, DOI 10.1037/0096-3445.134.3.343; Schuch S, 2004, J EXP PSYCHOL HUMAN, V30, P566, DOI 10.1037/0096-1523.30.3.566; SCOTT WA, 1962, SOCIOMETRY, V25, P405, DOI 10.2307/2785779; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Stephan DN, 2011, PSYCHOL RES-PSYCH FO, V75, P491, DOI 10.1007/s00426-011-0353-4; Stephan DN, 2010, J EXP PSYCHOL LEARN, V36, P1075, DOI 10.1037/a0019695; Stephan DN, PSYCHOL RES IN PRESS; Vandierendonck A, 2010, PSYCHOL BULL, V136, P601, DOI 10.1037/a0019791; Verguts T, 2008, PSYCHOL REV, V115, P518, DOI 10.1037/0033-295X.115.2.518; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007; Waszak F, 2003, COGNITIVE PSYCHOL, V46, P361, DOI 10.1016/S0010-0285(02)00520-0; Weissman DH, 2014, J EXP PSYCHOL HUMAN, V40, P2022, DOI 10.1037/a0037454; Zelazo PD, 1998, CURR DIR PSYCHOL SCI, V7, P121, DOI 10.1111/1467-8721.ep10774761	78	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151188	10.1371/journal.pone.0151188	http://dx.doi.org/10.1371/journal.pone.0151188			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG3TL	26964102	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000118
J	Roy, HE; Baxter, E; Saunders, A; Pocock, MJO				Roy, Helen E.; Baxter, Elizabeth; Saunders, Aoine; Pocock, Michael J. O.			Focal Plant Observations as a Standardised Method for Pollinator Monitoring: Opportunities and Limitations for Mass Participation Citizen Science	PLOS ONE			English	Article							BIOLOGICAL RECORDS CENTER; EMERGING TECHNOLOGIES; ECOLOGICAL RESEARCH; DECLINES; GARDENS; SCALE; TOOL; CONSERVATION; COMMUNITIES; BUMBLEBEES	Background Recently there has been increasing focus on monitoring pollinating insects, due to concerns about their declines, and interest in the role of volunteers in monitoring pollinators, particularly bumblebees, via citizen science. Methodology / Principal Findings The Big Bumblebee Discovery was a one-year citizen science project run by a partnership of EDF Energy, the British Science Association and the Centre for Ecology & Hydrology which sought to assess the influence of the landscape at multiple scales on the diversity and abundance of bumblebees. Timed counts of bumblebees (Bombus spp.; identified to six colour groups) visiting focal plants of lavender (Lavendula spp.) were carried out by about 13 000 primary school children (7-11 years old) from over 4000 schools across the UK. 3948 reports were received totalling 26 868 bumblebees. We found that while the wider landscape type had no significant effect on reported bumblebee abundance, the local proximity to flowers had a significant effect (fewer bumblebees where other flowers were reported to be >5m away from the focal plant). However, the rate of mis-identifcation, revealed by photographs uploaded by participants and a photo-based quiz, was high. Conclusions / Significance Our citizen science results support recent research on the importance of local flocal resources on pollinator abundance. Timed counts of insects visiting a lure plant is potentially an effective approach for standardised pollinator monitoring, engaging a large number of participants with a simple protocol. However, the relatively high rate of mis-identifications (compared to reports from previous pollinator citizen science projects) highlights the importance of investing in resources to train volunteers. Also, to be a scientifically valid method for enquiry, citizen science data needs to be sufficiently high quality, so receiving supporting evidence (such as photographs) would allow this to be tested and for records to be verified.	[Roy, Helen E.; Pocock, Michael J. O.] Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England; [Baxter, Elizabeth; Saunders, Aoine] British Sci Assoc, Wellcome Wolfson Bldg,165 Queens Gate, London SW7 5HD, England	UK Centre for Ecology & Hydrology (UKCEH)	Roy, HE (corresponding author), Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	hele@ceh.ac.uk	Pocock, Michael/A-5632-2012; Roy, Helen/A-1488-2010	Pocock, Michael/0000-0003-4375-0445; 	EDF Energy; Joint Nature Conservation Committee; Natural Environment Research Council; NERC [ceh020002, ceh020009] Funding Source: UKRI; Natural Environment Research Council [ceh020009, ceh020002] Funding Source: researchfish	EDF Energy; Joint Nature Conservation Committee; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	EDF Energy provided financial support to the British Science Association who subcontracted the Centre for Ecology & Hydrology. The Centre for Ecology & Hydrology led the study design, data collection and analysis, decision to publish and preparation of the manuscript. EDF Energy and the British Science Association played a major role in recruiting participants through their web portals and networks. Additionally educational resources were developed by EDF Energy in consultation with the authors. The authors reviewed all the resources prior to publication. Inclusion of additional insect flower visitors beyond bumblebees, such as the honeybee, Apis mellifera, and stripey hoverflies, was considered but the design of the log book constrained the number of fields. The infrastructure of the EDF Energy web portal "The Pod" was used to disseminate the educational resources and for on-line data collection. The British Science Association are represented within the authorship in recognition of their contributions throughout the study. One of the aims of the study was to submit a manuscript for peer-review and this was disclosed within the subcontract to the Centre for Ecology & Hydrology. HER and MJOP through the Biological Records Centre receive support from the Joint Nature Conservation Committee and the Natural Environment Research Council.	August T, 2015, BIOL J LINN SOC, V115, P731, DOI 10.1111/bij.12534; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Ball S.G., 2011, ATLAS HOVERFLIES GRE; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Birkin L, 2015, ECOL ENTOMOL, V40, P3, DOI 10.1111/een.12227; Bonney R, 2009, PUBLIC PARTICIPATION; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Crall AW, 2010, BIOL INVASIONS, V12, P3419, DOI 10.1007/s10530-010-9740-9; Defra, 2014, NAT POLL STRAT BEES; Defra, 2015, UK BIOD IND; DEFRA, 2011, NAT CHOIC SEC VAL NA; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; FUSSELL M, 1992, J APPL ECOL, V29, P451, DOI 10.2307/2404513; Garbuzov M, 2015, ACTA OECOL, V62, P53, DOI 10.1016/j.actao.2014.12.002; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Goulson Dave, 2001, British Journal of Entomology and Natural History, V14, P129; Goulson D, 2011, J APPL ECOL, V48, P3, DOI 10.1111/j.1365-2664.2010.01929.x; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Levrel H, 2010, ECOL ECON, V69, P1580, DOI 10.1016/j.ecolecon.2010.03.001; Losey JE, 2007, J INSECT CONSERV, V11, P415, DOI 10.1007/s10841-007-9077-6; Lye GC, 2012, J INSECT CONSERV, V16, P697, DOI 10.1007/s10841-011-9450-3; Mackechnie C, 2011, J ENVIRON MONITOR, V13, P2687, DOI 10.1039/c1em10615e; MARDEN JH, 1981, PHYSIOL ENTOMOL, V6, P431, DOI 10.1111/j.1365-3032.1981.tb00658.x; Mason SC, 2015, BIOL J LINN SOC, V115, P586, DOI 10.1111/bij.12574; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Nov O, 2011, ICONFERENCE SEATTLE2; Oberhauser K, 2012, FRONT ECOL ENVIRON, V10, P318, DOI 10.1890/110274; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Pescott OL, 2015, BIOL J LINN SOC, V115, P611, DOI 10.1111/bij.12541; Phillips AL, 2008, AM SCI, V96, P375, DOI 10.1511/2008.74.375; Pocock MJO, 2015, BIOL J LINN SOC, V115, P475, DOI 10.1111/bij.12548; Pocock MJO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086226; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Powney GD, 2015, BIOL J LINN SOC, V115, P532, DOI 10.1111/bij.12517; Pywell RF, 2012, BIOL LETTERS, V8, P772, DOI 10.1098/rsbl.2012.0367; Roy D. B., 2014, CELEBRATING 50 YEARS; Roy H., 2011, LADYBIRDS COCCINELLI; Roy HE, UNDERSTANDING CITIZE; Roy HE, 2015, ECOL ENTOMOL, V40, P336, DOI 10.1111/een.12203; Roy HE, 2015, BIOL J LINN SOC, V115, P678, DOI 10.1111/bij.12518; Roy HE, 2015, BIOL J LINN SOC, V115, P469, DOI 10.1111/bij.12575; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Scheper J, 2015, J APPL ECOL, V52, P1165, DOI 10.1111/1365-2664.12479; Silvertown J, 2015, ZOOKEYS, P125, DOI 10.3897/zookeys.480.8803; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Stewart AJA, 2015, BIOL J LINN SOC, V115, P647, DOI 10.1111/bij.12543; Thomas JA, 2015, BIOL J LINN SOC, V115, P636, DOI 10.1111/bij.12527; UK Environmental Observation Framework, 2011, CIT SCI OBS MON SCOP; Woodcock BA, 2013, AGR ECOSYST ENVIRON, V171, P1, DOI 10.1016/j.agee.2013.03.005; Worthington JP, 2012, METHODS ECOL EVOL, V3, P303, DOI 10.1111/j.2041-210X.2011.00164.x	59	28	29	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150794	10.1371/journal.pone.0150794	http://dx.doi.org/10.1371/journal.pone.0150794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985824	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300027
J	Sergeant, ES; Grewar, JD; Weyer, CT; Guthrie, AJ				Sergeant, Evan S.; Grewar, John D.; Weyer, Camilla T.; Guthrie, Alan J.			Quantitative Risk Assessment for African Horse Sickness in Live Horses Exported from South Africa	PLOS ONE			English	Article							VIRUS; ASSAY	5 African horse sickness (AHS) is a severe, often fatal, arbovirus infection of horses, transmitted by Culicoides spp. midges. AHS occurs in most of sub-Saharan Africa and is a significant impediment to export of live horses from infected countries, such as South Africa. A stochastic risk model was developed to estimate the probability of exporting an undetected AHS-infected horse through a vector protected pre-export quarantine facility, in accordance with OIE recommendations for trade from an infected country. The model also allows for additional risk management measures, including multiple PCR tests prior to and during pre-export quarantine and optionally during post-arrival quarantine, as well as for comparison of risk associated with exports from a demonstrated low-risk area for AHS and an area where AHS is endemic. If 1 million horses were exported from the low-risk area with no post-arrival quarantine we estimate the median number of infected horses to be 5.4 (95% prediction interval 0.5 to 41). This equates to an annual probability of 0.0016 (95% PI: 0.00015 to 0.012) assuming 300 horses exported per year. An additional PCR test while in vector-protected post-arrival quarantine reduced these probabilities by approximately 12-fold. Probabilities for horses exported from an area where AHS is endemic were approximately 15 to 17 times higher than for horses exported from the low-risk area under comparable scenarios. The probability of undetected AHS infection in horses exported from an infected country can be minimised by appropriate risk management measures. The final choice of risk management measures depends on the level of risk acceptable to the importing country.	[Sergeant, Evan S.] AusVet Anim Hlth Serv, Canberra, ACT, Australia; [Grewar, John D.] Western Cape Dept Agr, Vet Serv, Elsenburg, South Africa; [Weyer, Camilla T.; Guthrie, Alan J.] Univ Pretoria, Equine Res Ctr, Fac Vet Sci, ZA-0002 Pretoria, South Africa	University of Pretoria	Sergeant, ES (corresponding author), AusVet Anim Hlth Serv, Canberra, ACT, Australia.	evan@ausvet.com.au	Guthrie, Alan/J-6375-2013	Guthrie, Alan/0000-0001-7729-9918; Grewar, John/0000-0002-4496-8051	Equine Health Fund of South Africa, a division of Wits Health Consortium (Pty) Ltd; South African horse industry through the Equine Equine Health Fund; AusVet Animal Health Services	Equine Health Fund of South Africa, a division of Wits Health Consortium (Pty) Ltd; South African horse industry through the Equine Equine Health Fund; AusVet Animal Health Services	The participation of ES in this research was funded by private donors through the Equine Health Fund of South Africa, a division of Wits Health Consortium (Pty) Ltd (http://www.equinehealthfund.co.za/Home.aspx). The Equine Research Centre is supported by South African horse industry funding, through the Equine Health Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ES is employed by AusVet Animal Health Services. AusVet Animal Health Services provided support in the form of salary for author ES, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aguero M, 2008, J VET DIAGN INVEST, V20, P325, DOI 10.1177/104063870802000310; Alexander J, 2008, EFSA J, V6; [Anonymous], 2014, R LANG ENV STAT COMP; Coetzer J., 2004, INFECT DIS LIVESTOCK; de Vos CJ, 2012, PREV VET MED, V106, P108, DOI 10.1016/j.prevetmed.2012.01.019; Faverjon C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0435-4; Grewar J. D., 2013, J S AFR VET ASSOC, V84, DOI DOI 10.4102/jsava.v84i1.973; Guthrie AJ, 2013, J VIROL METHODS, V189, P30, DOI 10.1016/j.jviromet.2012.12.014; Guthrie AJ, 2009, VACCINE, V27, P4434, DOI 10.1016/j.vaccine.2009.05.044; Lee CCD, 2014, J VIROL, V88, P5677, DOI 10.1128/JVI.00139-14; Maja M, 2014, STANDARD REGISTRATIO; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; Nomikou K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005056; OIE, 2012, MANUAL DIAGNOSTIC TE; OiE, 2015, OIE LIST DIS INF INF; OIE, 2013, OIE TECHNICAL DIS CA; OIE World Organisation for Animal Health, 2014, TERR AN HLTH COD; OIE (World Organization for Animal Health), 2014, MAN DIAGN TESTS VACC; Page PC, 2015, VET PARASITOL, V210, P84, DOI 10.1016/j.vetpar.2015.02.007; Sergeant E, 2013, EPITOOLS EPIDEMIOLOG; Sinclair M, 2006, J S AFR VET ASSOC, V77, P191; Weyer CT, 2013, EQUINE VET J, V45, P117, DOI 10.1111/j.2042-3306.2012.00590.x	22	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151757	10.1371/journal.pone.0151757	http://dx.doi.org/10.1371/journal.pone.0151757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986002	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300124
J	Di Sanzo, M; Aversa, I; Santamaria, G; Gagliardi, M; Panebianco, M; Biamonte, F; Zolea, F; Faniello, MC; Cuda, G; Costanzo, F				Di Sanzo, Maddalena; Aversa, Ilenia; Santamaria, Gianluca; Gagliardi, Monica; Panebianco, Mariafranca; Biamonte, Flavia; Zolea, Fabiana; Faniello, Maria Concetta; Cuda, Giovanni; Costanzo, Francesco			FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation	PLOS ONE			English	Article							GENE; CLONING; CHAIN	Ferritin, the major iron storage protein, performs its essential functions in the cytoplasm, nucleus and mitochondria. The variable assembly of 24 subunits of the Heavy (H) and Light (L) type composes the cytoplasmic molecule. In humans, two distinct genes code these subunits, both belonging to complex multigene families. Until now, one H gene has been identified with the coding sequence interrupted by three introns and more than 20 intronless copies widely dispersed on different chromosomes. Two of the intronless genes are actively transcribed in a tissue-specific manner. Herein, we report that FTH1P3, another intronless pseudogene, is transcribed. FTH1P3 transcript was detected in several cell lines and tissues, suggesting that its transcription is ubiquitary, as it happens for the parental ferritin H gene. Moreover, FTH1P3 expression is positively regulated during the cell differentiation process.	[Di Sanzo, Maddalena; Aversa, Ilenia; Santamaria, Gianluca; Panebianco, Mariafranca; Biamonte, Flavia; Zolea, Fabiana; Faniello, Maria Concetta; Cuda, Giovanni; Costanzo, Francesco] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Res Ctr Adv Biochem & Mol Biol, Salvatore Venuta Campus, Catanzaro, Italy; [Gagliardi, Monica] Magna Graecia Univ Catanzaro, IBFM CNR, Catanzaro, Italy	Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Magna Graecia University of Catanzaro	Costanzo, F (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Res Ctr Adv Biochem & Mol Biol, Salvatore Venuta Campus, Catanzaro, Italy.	fsc@unicz.it	Biamonte, Flavia/AAC-4934-2019; Costanzo, Francesco Saverio/K-3168-2018; Aversa, Ilenia/AAK-5501-2020; Cuda, Giovanni/AAC-2821-2019; Cuda, Giovanni/F-5359-2012; Biamonte, Flavia/AAF-2092-2020	Biamonte, Flavia/0000-0003-3248-3863; Costanzo, Francesco Saverio/0000-0002-3096-9416; Aversa, Ilenia/0000-0003-4721-6792; Cuda, Giovanni/0000-0001-6313-1866; Cuda, Giovanni/0000-0001-6313-1866; FANIELLO, Concetta Maria/0000-0001-6938-2754; SANTAMARIA, Gianluca/0000-0001-9284-7492	PROMETEO (Design and development of innovative technological Platforms for tissue Regeneration in the Oral-Maxillo facial, haematopoietic, neuronal and cardiac system) [PON01_02834]; ICaRe - Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biobanche per la criopreservazione di cellule staminali umane e di tessuto osseo per uso clinico e design e sviluppo di bioscaffold innovative [PON03PE_00009_2]	PROMETEO (Design and development of innovative technological Platforms for tissue Regeneration in the Oral-Maxillo facial, haematopoietic, neuronal and cardiac system); ICaRe - Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biobanche per la criopreservazione di cellule staminali umane e di tessuto osseo per uso clinico e design e sviluppo di bioscaffold innovative	This research was supported by PON01_02834 PROMETEO (Design and development of innovative technological Platforms for tissue Regeneration in the Oral-Maxillo facial, haematopoietic, neuronal and cardiac system), and Progetto PON03PE_00009_2 ICaRe - Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biobanche per la criopreservazione di cellule staminali umane e di tessuto osseo per uso clinico e design e sviluppo di bioscaffold innovative.; This research was supported by: PON01_02834 PROMETEO (Design and development of innovative technological Platforms for tissue Regeneration in the Oral-Maxillo facial, haematopoietic, neuronal and cardiac system). Progetto PON03PE_00009_2 ICaRe-Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biobanche per la criopreservazione di cellule staminali umane e di tessuto osseo per uso clinico e design e sviluppo di bioscaffold innovative.	Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bevilacqua MA, 1997, BIOCHEM BIOPH RES CO, V240, P179, DOI 10.1006/bbrc.1997.7632; BEVILACQUA MA, 1995, BIOCHEM J, V311, P769, DOI 10.1042/bj3110769; Biamonte F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122105; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Chwalisz Marina, 2014, BMC Res Notes, V7, P378, DOI 10.1186/1756-0500-7-378; COSTANZO F, 1984, EMBO J, V3, P23, DOI 10.1002/j.1460-2075.1984.tb01756.x; COSTANZO F, 1986, NUCLEIC ACIDS RES, V14, P721, DOI 10.1093/nar/14.2.721; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; De Maria S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-264; Di Sanzo M, 2011, J PROTEOME RES, V10, P5444, DOI 10.1021/pr200705z; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esposito F, 2015, CELL CYCLE, V14, P1471, DOI 10.1080/15384101.2015.1021520; Faniello MC, 2008, INT J BIOCHEM CELL B, V40, P2110, DOI 10.1016/j.biocel.2008.02.010; Faniello MC, 2009, CLIN BIOCHEM, V42, P911, DOI 10.1016/j.clinbiochem.2009.02.013; GATTI RA, 1987, AM J HUM GENET, V41, P654; HENTZE MW, 1986, P NATL ACAD SCI USA, V83, P7226, DOI 10.1073/pnas.83.19.7226; Jez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089546; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; Li W, 2013, J GENET GENOMICS, V40, P171, DOI 10.1016/j.jgg.2013.03.003; Misaggi R, 2014, GENE, V535, P327, DOI 10.1016/j.gene.2013.10.067; MURRAY MT, 1987, P NATL ACAD SCI USA, V84, P7438, DOI 10.1073/pnas.84.21.7438; Palazzo AF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004351; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Quaresima B, 1994, PCR Methods Appl, V4, P85; Quaresima B, 2008, CLIN CANCER RES, V14, P6797, DOI 10.1158/1078-0432.CCR-07-5208; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rutnam ZJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3914; Ruzzenenti P, 2015, BBA-GEN SUBJECTS, V1850, P1267, DOI 10.1016/j.bbagen.2015.02.016; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; SANTORO C, 1986, NUCLEIC ACIDS RES, V14, P2863, DOI 10.1093/nar/14.7.2863; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; STEVENS PW, 1987, MOL CELL BIOL, V7, P1751, DOI 10.1128/MCB.7.5.1751; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wen YZ, 2012, RNA BIOL, V9, P27, DOI 10.4161/rna.9.1.18277; WORWOOD M, 1985, HUM GENET, V69, P371, DOI 10.1007/BF00291657; Zhang SC, 2015, ARCH ORAL BIOL, V60, P1581, DOI 10.1016/j.archoralbio.2015.08.003; Zheng H, 1997, BBA-GENE STRUCT EXPR, V1351, P150, DOI 10.1016/S0167-4781(96)00188-1	42	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151359	10.1371/journal.pone.0151359	http://dx.doi.org/10.1371/journal.pone.0151359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982978	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900079
J	Karlsson, OE; Larsson, J; Hayer, J; Berg, M; Jacobson, M				Karlsson, Oskar E.; Larsson, Jenny; Hayer, Juliette; Berg, Mikael; Jacobson, Magdalena			The Intestinal Eukaryotic Virome in Healthy and Diarrhoeic Neonatal Piglets	PLOS ONE			English	Article							VIRAL METAGENOMICS; MOLECULAR CHARACTERIZATION; PORCINE KOBUVIRUSES; VIRUSES; PIGS; DIVERSITY; SWINE; ASTROVIRUS; INFECTION; SEQUENCE	Neonatal porcine diarrhoea of uncertain aetiology has been reported from a number of European countries. The aim of the present study was to use viral metagenomics to examine a potential viral involvement in this diarrhoea and to describe the intestinal virome with focus on eukaryotic viruses. Samples from the distal jejunum of 50 diarrhoeic and 19 healthy piglets from 10 affected herds were analysed. The viral fraction of the samples was isolated and nucleic acids (RNA and DNA fractions) were subjected to sequence independent amplification. Samples from diarrhoeic piglets from the same herds were pooled whereas samples from healthy piglets were analysed individually. In total, 29 clinical samples, plus two negative controls and one positive control consisting of a mock metagenome were sequenced using the Ion Torrent platform. The resulting sequence data was subjected to taxonomic classification using Kraken, Diamond and HMMER. In the healthy specimens, eight different mammalian virus families were detected (Adenoviridae, Anelloviridae, Astroviridae, Caliciviridae, Circoviridae, Parvoviridae, Picornaviridae, and Reoviridae) compared to four in the pooled diarrhoeic samples (Anelloviridae, Circoviridae, Picornaviridae, and Reoviridae). It was not possible to associate a particular virus family with the investigated diarrhoea. In conclusion, this study does not support the hypothesis that the investigated diarrhoea was caused by known mammalian viruses. The results do, however, indicate that known mammalian viruses were present in the intestine as early as 24-48 hours after birth, indicating immediate infection post-partum or possibly transplacental infection.	[Karlsson, Oskar E.; Berg, Mikael] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden; [Karlsson, Oskar E.; Hayer, Juliette] SLU, Dept Anim Breeding & Genet HGEN, SLU Global Bioinformat Ctr, Uppsala, Sweden; [Karlsson, Oskar E.; Berg, Mikael] OIE Collaborating Ctr Biotechnol Based Diag Infec, Uppsala, Sweden; [Larsson, Jenny; Jacobson, Magdalena] Swedish Univ Agr Sci SLU, Dept Clin Sci KV, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Karlsson, OE (corresponding author), Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden.; Karlsson, OE (corresponding author), SLU, Dept Anim Breeding & Genet HGEN, SLU Global Bioinformat Ctr, Uppsala, Sweden.; Karlsson, OE (corresponding author), OIE Collaborating Ctr Biotechnol Based Diag Infec, Uppsala, Sweden.	oskar.e.karlsson@slu.se	Hayer, Juliette/ABG-5814-2021	Hayer, Juliette/0000-0003-4899-9637; Berg, Mikael/0000-0001-5779-3345; Karlsson Lindsjo, Oskar/0000-0003-1068-981X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas [221-2012-586]; EU project AniBioThreat [Home/2009/ISEC/AG/191]; Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs; Swedish Farmers' Foundation for Agricultural Research [H1050154]; RFI/VR; Science for Life Laboratory, Sweden; SLU Global Bioinformatics Centre, part of the infrastructure at faculty Veterinary Medicine and Animal Science, SLU, Uppsala, Sweden	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas(Swedish Research Council Formas); EU project AniBioThreat; Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs; Swedish Farmers' Foundation for Agricultural Research; RFI/VR; Science for Life Laboratory, Sweden; SLU Global Bioinformatics Centre, part of the infrastructure at faculty Veterinary Medicine and Animal Science, SLU, Uppsala, Sweden	Financial support was obtained from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas (221-2012-586) awarded to MB, http://www.formas.se/. This work has been supported by grants from the framework of the EU project AniBioThreat (grant agreement: Home/2009/ISEC/AG/191) with financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs. This publication reflects views only of the authors, and the European Commission cannot be held responsible for any use that may be made of the information contained therein (awarded to MB, http://ec.europa.eu/dgs/home-affairs/index_en.htm); Swedish Farmers' Foundation for Agricultural Research, grant H1050154, Neonatal diarrhoea in piglets-an emergent problem in modern pig production, awarded to MJ, http://www.lantbruksforskning.se/. The authors would like to acknowledge support of the National Genomics Infrastructure (NGI) / Uppsala Genome Center and UPPMAX for providing assistance in massive parallel sequencing and computational infrastructure. Work performed at NGI / Uppsala Genome Center has been funded by RFI/VR and Science for Life Laboratory, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for the analyses of this project was provided by the SLU Global Bioinformatics Centre, part of the infrastructure at faculty Veterinary Medicine and Animal Science, SLU, Uppsala, Sweden.	An DJ, 2011, VIRUS GENES, V42, P208, DOI 10.1007/s11262-010-0561-9; Barry AF, 2011, INFECT GENET EVOL, V11, P1811, DOI 10.1016/j.meegid.2011.06.020; Belak S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/j.vetmic.2013.01.022; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879; Delwart E, 2012, VIRUS RES, V164, P114, DOI 10.1016/j.virusres.2011.11.021; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Di Bartolo I, 2015, ARCH VIROL, V160, P1533, DOI 10.1007/s00705-015-2397-z; Dumarest M, 2015, BIOLOGICALS, V43, P31, DOI 10.1016/j.biologicals.2014.10.004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ganesh B, 2012, INDIAN J VIROL, V23, P387, DOI 10.1007/s13337-012-0106-z; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Gin T, 2010, P 21 IPVS C, P758; Granberg F, 2015, METHODS MOL BIOL, V1247, P491, DOI 10.1007/978-1-4939-2004-4_33; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Karlsson OE, 2013, BIOSECUR BIOTERROR, V11, pS227, DOI 10.1089/bsp.2013.0008; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khamrin P, 2009, EMERG INFECT DIS, V15, P2075, DOI 10.3201/eid1512.090724; Kongsted H, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-206; Kraberger S, 2015, INFECT GENET EVOL, V31, P73, DOI 10.1016/j.meegid.2015.01.001; Lager KM, 2012, J VET DIAGN INVEST, V24, P1177, DOI 10.1177/1040638712463212; Lan DL, 2011, ARCH VIROL, V156, P1567, DOI 10.1007/s00705-011-1035-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsson J, 2014, J COMP PATHOL, V151, P137, DOI 10.1016/j.jcpa.2014.04.003; Larsson J, 2015, J MED MICROBIOL, V64, P916, DOI 10.1099/jmm.0.000108; Li B, 2012, J VIROL, V86, P1286, DOI 10.1128/JVI.06589-11; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Martinez LC, 2010, INFECT GENET EVOL, V10, P984, DOI 10.1016/j.meegid.2010.06.004; Mor SK, 2012, J VET DIAGN INVEST, V24, P1064, DOI 10.1177/1040638712458781; MORIN M, 1990, CAN J VET RES, V54, P385; Munnink BBO, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-22; Park SJ, 2010, ARCH VIROL, V155, P1803, DOI 10.1007/s00705-010-0774-1; Pruitt K., 2002, NCBI HDB, P307; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rosario K, 2012, J GEN VIROL, V93, P2668, DOI 10.1099/vir.0.045948-0; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Rosseel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076144; Sachsenroder J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088888; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; SHIMIZU M, 1990, J CLIN MICROBIOL, V28, P201, DOI 10.1128/JCM.28.2.201-206.1990; Sjolund M, 2014, P 6 EUR S PORC HLTH, P111; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; SVENSMARK B, 1989, ACTA VET SCAND, V30, P43; Thomson JR., 2012, DIS SWINE, P216; Phan TG, 2015, VIROLOGY, V482, P98, DOI 10.1016/j.virol.2015.03.011; Verma H, 2013, VIRUS GENES, V46, P551, DOI 10.1007/s11262-013-0879-1; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wallgren P, 2012, P 22 IPVS C JEJ KOR, P76; WILL LA, 1994, J VET DIAGN INVEST, V6, P416, DOI 10.1177/104063879400600403; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang B, 2014, J GEN VIROL, V95, P1603, DOI 10.1099/vir.0.063743-0; Zhang W, 2008, J VIROL, V82, P8239, DOI 10.1128/JVI.01020-08	57	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151481	10.1371/journal.pone.0151481	http://dx.doi.org/10.1371/journal.pone.0151481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982708	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900088
J	Moeckel, S; Vollmann-Zwerenz, A; Proescholdt, M; Brawanski, A; Riemenschneider, MJ; Bogdahn, U; Bosserhoff, AK; Spang, R; Hau, P				Moeckel, Sylvia; Vollmann-Zwerenz, Arabel; Proescholdt, Martin; Brawanski, Alexander; Riemenschneider, Markus J.; Bogdahn, Ulrich; Bosserhoff, Anja-Katrin; Spang, Rainer; Hau, Peter			Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro	PLOS ONE			English	Article							RECURRENT MALIGNANT GLIOMA; CONTINUOUS DAILY SUNITINIB; GLIOBLASTOMA; TRIAL; IDH1	Background In a previous publication we introduced a novel approach to identify genes that hold predictive information about treatment outcome. A linear regression model was fitted by using the least angle regression algorithm (LARS) with the expression profiles of a construction set of 18 glioma progenitor cells enhanced for brain tumor initiating cells (BTIC) before and after in vitro treatment with the tyrosine kinase inhibitor Sunitinib. Profiles from treated progenitor cells allowed predicting therapy-induced impairment of proliferation in vitro. Prediction performance was validated in leave one out cross validation. Methods In this study, we used an additional validation set of 18 serum-free short-term treated in vitro cell cultures to test the predictive properties of the signature in an independent cohort. We assessed proliferation rates together with transcriptome-wide expression profiles after Sunitinib treatment of each individual cell culture, following the methods of the previous publication. Results We confirmed treatment-induced expression changes in our validation set, but our signature failed to predict proliferation inhibition. Neither re-calculation of the combined dataset with all 36 BTIC cultures nor separation of samples into TCGA subclasses did generate a proliferation prediction. Conclusion Although the gene signature published from our construction set exhibited good prediction accuracy in cross validation, we were not able to validate the signature in an independent validation data set. Reasons could be regression to the mean, the moderate numbers of samples, or too low differences in the response to proliferation inhibition in the validation set. At this stage and based on the presented results, we conclude that the signature does not warrant further developmental steps towards clinical application.	[Moeckel, Sylvia; Vollmann-Zwerenz, Arabel; Bogdahn, Ulrich; Hau, Peter] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany; [Moeckel, Sylvia; Vollmann-Zwerenz, Arabel; Bogdahn, Ulrich; Hau, Peter] Univ Hosp Regensburg, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany; [Proescholdt, Martin; Brawanski, Alexander] Univ Hosp Regensburg, Dept Neurosurg, Regensburg, Germany; [Riemenschneider, Markus J.] Regensburg Univ Hosp, Dept Neuropathol, Regensburg, Germany; [Bosserhoff, Anja-Katrin] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Zentrum, D-91054 Erlangen, Germany; [Spang, Rainer] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Erlangen Nuremberg; University of Regensburg	Hau, P (corresponding author), Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany.; Hau, P (corresponding author), Univ Hosp Regensburg, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany.	peter.hau@ukr.de	Reifenberger, Guido/AAE-3599-2019; Bosserhoff, Anja/GNH-4801-2022	Hau, Peter/0000-0003-3894-5053; Bosserhoff, Anja/0000-0001-8147-394X; Spang, Rainer/0000-0002-1326-4297	Wilhelm Sander-Stiftung, Munich, Germany [2009.803.1, 2009.803.2]; Wilhelm Sander-Stiftung, Ingolstadt, Germany [2009.803.1, 2009.803.2]	Wilhelm Sander-Stiftung, Munich, Germany; Wilhelm Sander-Stiftung, Ingolstadt, Germany	The study was supported by research grants of the Wilhelm Sander-Stiftung, Munich and Ingolstadt, Germany (no. 2009.803.1 and 2009.803.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Hutterer M, 2014, NEURO-ONCOLOGY, V16, P92, DOI 10.1093/neuonc/not161; Kreisl TN, 2013, J NEURO-ONCOL, V111, P41, DOI 10.1007/s11060-012-0988-z; Moeckel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108632; Neyns B, 2011, J NEURO-ONCOL, V103, P491, DOI 10.1007/s11060-010-0402-7; Pan E, 2012, J NEURO-ONCOL, V110, P111, DOI 10.1007/s11060-012-0943-z; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Reardon DA, 2011, J NEURO-ONCOL, V105, P621, DOI 10.1007/s11060-011-0631-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weller M, 2012, NEURO-ONCOLOGY, V14, P100, DOI 10.1093/neuonc/nos206	13	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151312	10.1371/journal.pone.0151312	http://dx.doi.org/10.1371/journal.pone.0151312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978262	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800060
J	Song, YJ; Li, JS; Meng, S; Yin, L; Xue, YF; Ma, YH				Song, Yajian; Li, Jinshan; Meng, Shan; Yin, Liang; Xue, Yanfen; Ma, Yanhe			A Novel Manno-Oligosaccharide Binding Protein Identified in Alkaliphilic Bacillus sp N16-5 Is Involved in Mannan Utilization	PLOS ONE			English	Article							ABC TRANSPORT-SYSTEMS; GEOBACILLUS-STEAROTHERMOPHILUS; CASSETTE TRANSPORTERS; SUBTILIS; ETHANOL; BIOMASS; ENERGY	ManH, a novel substrate-binding protein of an ABC transporter, was identified from the mannan utilization gene cluster of Bacillus sp. N16-5. We cloned, overexpressed, and purified ManH and measured its binding affinity to different substrates by isothermal titration calorimetry. ManH binds to mannotriose, mannotetraose, mannopentose, and galactosylmannotriose with dissociation constants in the micromolar range. Deletion of manH led to decreased growth ability of the strain when cultivated in medium with manno-oligosaccharides or mannan as the carbon source. ManH belongs to a manno-oligosaccharide transporter and plays an important role in mannan utilization by Bacillus sp. N16-5.	[Song, Yajian; Meng, Shan; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China; [Song, Yajian] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Tianjin Key Lab Ind Microbiol,Coll Biotechnol, Tianjin 300457, Peoples R China; [Li, Jinshan; Yin, Liang; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China; [Ma, Yanhe] Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Tianjin University Science & Technology; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Ma, YH (corresponding author), Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China.; Ma, YH (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.; Ma, YH (corresponding author), Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.	mayanhe@im.ac.cn	MA, YAN/HHN-2912-2022		National Natural Science Foundation of China [31400031]; Ministry of Sciences and Technology of China [2011CBA00800, 2013CBA733900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (No. 31400031) and the Ministry of Sciences and Technology of China (Nos. 2011CBA00800 and 2013CBA733900). YS received the funding from the National Natural Science Foundation of China (No. 31400031), YM received the funding from the Ministry of Sciences and Technology of China (No. 2011CBA00800), and YX received the funding from the Ministry of Sciences and Technology of China (No. 2013CBA733900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Chekan JR, 2014, J BIOL CHEM, V289, P34965, DOI 10.1074/jbc.M114.579904; Connelly MB, 2004, J BACTERIOL, V186, P4159, DOI 10.1128/JB.186.13.4159-4167.2004; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Ferreira MJ, 2010, J BACTERIOL, V192, P5312, DOI 10.1128/JB.00832-10; Gao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028148; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; HORIKOSHI K, 1971, AGR BIOL CHEM TOKYO, V35, P1407, DOI 10.1080/00021369.1971.10860094; Ito M, 2001, BIOSCI BIOTECH BIOCH, V65, P2773, DOI 10.1271/bbb.65.2773; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nataf Y, 2009, J BACTERIOL, V191, P203, DOI 10.1128/JB.01190-08; Ouyang Jia, 2006, Biotechnol J, V1, P1266, DOI 10.1002/biot.200600103; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; Song YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054090; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Tsujibo H, 2004, J BACTERIOL, V186, P1029, DOI 10.1128/JB.186.4.1029-1037.2004; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8	27	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150059	10.1371/journal.pone.0150059	http://dx.doi.org/10.1371/journal.pone.0150059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978267	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800020
J	Wieten, RW; Jonker, EFF; van Leeuwen, EMM; Remmerswaal, EBM; ten Berge, IJM; de Visser, AW; van Genderen, PJJ; Goorhuis, A; Visser, LG; Grobusch, MP; de Bree, GJ				Wieten, Rosanne W.; Jonker, Emile F. F.; van Leeuwen, Ester M. M.; Remmerswaal, Ester B. M.; ten Berge, Ineke J. M.; de Visser, Adriette W.; van Genderen, Perry J. J.; Goorhuis, Abraham; Visser, Leo G.; Grobusch, Martin P.; de Bree, Godelieve J.			A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ELDERLY PERSONS; VIRUS 17D; MEMORY; EFFECTOR; INFECTION; BET; DIFFERENTIATION; EXPRESSION; INFLUENZA	Introduction Prompted by recent amendments of Yellow Fever (YF) vaccination guidelines from boost to single vaccination strategy and the paucity of clinical data to support this adjustment, we used the profile of the YF-specific CD8(+) T-cell subset profiles after primary vaccination and neutralizing antibodies as a proxy for potentially longer lasting immunity. Methods and Findings PBMCs and serum were collected in six individuals on days 0, 3, 5, 12, 28 and 180, and in 99 individuals >10 years after YF-vaccination. Phenotypic characteristics of YF-tetramer(+) CD8(+) T-cells were determined using class I tetramers. Antibody responses were measured using a standardized plaque reduction neutralization test (PRNT). Also, characteristics of YF-tetramer positive CD8(+) T-cells were compared between individuals who had received a primary-and a booster vaccination. YF-tetramer(+) CD8(+) T-cells were detectable on day 12 (median tetramer(+) cells as percentage of CD8(+) T-cells 0.2%, range 0.07-3.1%). On day 180, these cells were still present (median 0.06%, range 0.02-0.78%). The phenotype of YF-tetramer positive CD8(+) T-cells shifted from acute phase effector cells on day 12, to late differentiated or effector memory phenotype (CD45RA(-/+) CD27(-)) on day 28. Two subsets of YF-tetramer positive T-cells (CD45RA(+)CD27(-) and CD45RA(+)CD27(+)) persisted until day 180. Within all phenotypic subsets, the T-bet: Eomes ratio tended to be high on day 28 after vaccination and shifted towards predominant Eomes expression on day 180 (median 6.0 (day 28) vs. 2.2 (day 180) p = 0.0625), suggestive of imprinting compatible with long-lived memory properties. YF-tetramer positive CD8(+) T-cells were detectable up to 18 years post vaccination, YF-specific antibodies were detectable up to 40 years after single vaccination. Booster vaccination did not increase titers of YF-specific antibodies (mean 12.5 vs. 13.1, p = 0.583), nor induce frequencies or alter phenotypes of YF-tetramer(+) CD8(+) T-cells. Conclusion The presence of a functionally competent YF-specific memory T-cell pool 18 years and sufficient titers of neutralizing antibodies 35-40 years after first vaccination suggest that single vaccination may be sufficient to provide long-term immunity.	[Wieten, Rosanne W.; Goorhuis, Abraham; Grobusch, Martin P.; de Bree, Godelieve J.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [de Bree, Godelieve J.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Jonker, Emile F. F.; de Visser, Adriette W.; Visser, Leo G.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [van Leeuwen, Ester M. M.; Remmerswaal, Ester B. M.; ten Berge, Ineke J. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Remmerswaal, Ester B. M.; ten Berge, Ineke J. M.] Univ Amsterdam, Acad Med Ctr, Renal Transplant Unit, Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van Genderen, Perry J. J.] Travel Clin Havenziekenhuis, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Visser, LG (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	l.g.visser@lumc.nl	Kuijper, ed/AAB-7853-2022; Remmerswaal, Ester/ABF-3596-2020; Visser, Leo/AAH-5755-2021	Kuijper, ed/0000-0001-5726-2405; Remmerswaal, Ester/0000-0003-4694-6048; Jonker, Emile/0000-0001-6104-0688; Goorhuis, Abraham/0000-0001-7423-6217				Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay van Lier, 2008, CYTOM PART A, V73, P975; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605; Blom K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004622; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021; Co MDT, 2009, IMMUNOLOGY, V128, pe718, DOI 10.1111/j.1365-2567.2009.03070.x; Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; Coulange Bodilis H, 2011, Bull Soc Pathol Exot, V104, P260, DOI 10.1007/s13149-011-0135-7; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; de Bree GJ, 2005, J INFECT DIS, V191, P1710, DOI 10.1086/429695; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dolfi DV, 2013, J LEUKOCYTE BIOL, V93, P825, DOI 10.1189/jlb.0912438; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Gómez Sergio Y, 2008, Rev. salud pública, V10, P796; Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264; Grobusch MP, 2013, CLIN MICROBIOL INFEC, V19, P885, DOI 10.1111/1469-0691.12332; Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Hoji A, 2005, IMMUNOLOGY, V115, P239, DOI 10.1111/j.1365-2567.2005.02135.x; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Knox JJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00217; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Monath T. P., 2008, VACCINES, P959; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nabeshima S, 2002, CLIN EXP IMMUNOL, V128, P339, DOI 10.1046/j.1365-2249.2002.01819.x; Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Patel D, 2013, TRAVEL MED INFECT DI, V11, P266, DOI 10.1016/j.tmaid.2013.08.007; Plotkin S., 2008, VACCINES, V6th ed., P17; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; Popescu I, 2014, J IMMUNOL, V193, P5709, DOI 10.4049/jimmunol.1401436; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Strategic Advisory Group of Experts, 2013, BACKGR PAP YELL FEV; van Aalderen MC, 2015, J VIROL, V89, P5110, DOI 10.1128/JVI.03478-14; van Aalderen MC, 2014, EUR J IMMUNOL, V44, P934, DOI 10.1002/eji.201344269; Wherry EJ, 1999, J IMMUNOL, V163, P3735; Wieten RW, 17D YELLOW FEV UNPUB; Wirth TC, 2010, EUR J IMMUNOL, V40, P1916, DOI 10.1002/eji.201040310; Wrammert J, 2009, J CLIN IMMUNOL, V29, P151, DOI 10.1007/s10875-008-9267-3	63	56	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149871	10.1371/journal.pone.0149871	http://dx.doi.org/10.1371/journal.pone.0149871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977808	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800017
J	Lucchi, NW; Ljolje, D; Silva-Flannery, L; Udhayakumar, V				Lucchi, Naomi W.; Ljolje, Dragan; Silva-Flannery, Luciana; Udhayakumar, Venkatachalam			Use of Malachite Green-Loop Mediated Isothermal Amplification for Detection of Plasmodium spp. Parasites	PLOS ONE			English	Article							MALARIA ELIMINATION; FALCIPARUM-MALARIA; DIAGNOSIS; LAMP; ZANZIBAR; ASSAY	Malaria elimination efforts are hampered by the lack of sensitive tools to detect infections with low-level parasitemia, usually below the threshold of standard diagnostic methods, microscopy and rapid diagnostic tests. Isothermal nucleic acid amplification assays such as the loop-mediated isothermal amplification (LAMP), are well suited for field use as they do not require thermal cyclers to run the test. However, the use of specialized equipment, as described by many groups, reduces the versatility of the LAMP technique as a simple tool for use in endemic countries. In this study, the use of the malachite green (MG) dye, as a visual endpoint readout, together with a simple mini heat block was evaluated for the detection of malaria parasites. The assay was performed for 1 hour at 63 degrees C and the results scored by 3 independent human readers. The limit of detection of the assay was determined using well-quantified Plasmodium spp. infected reference samples and its utility in testing clinical samples was determined using 190 pre-treatment specimens submitted for reference diagnosis of imported malaria in the United States. Use of a simplified boil and spin methods of DNA extraction from whole blood and filter paper was also investigated. We demonstrate the accurate and sensitive detection of malaria parasites using this assay with a detection limit ranging between 1-8 parasites/mu L, supporting its applicability for the detection of infections with low parasite burden. This assay is compatible with the use of a simple boil and spin sample preparation method from both whole blood and filter papers without a loss of sensitivity. The MG-LAMP assay described here has great potential to extend the reach of molecular tools to settings where they are needed.	[Lucchi, Naomi W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Ctr Global Hlth, Atlanta, GA USA; [Ljolje, Dragan; Silva-Flannery, Luciana] Atlanta Res & Educ Fdn, Vet Affairs Med Ctr, Decatur, GA USA	Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lucchi, NW (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Ctr Global Hlth, Atlanta, GA USA.	NLucchi@cdc.gov		Lucchi, Naomi/0000-0001-8789-8041	Malaria Branch at the Centers for Disease Control and Prevention; Atlanta Research and Education Foundation	Malaria Branch at the Centers for Disease Control and Prevention; Atlanta Research and Education Foundation	This report was made possible through support provided by the Malaria Branch at the Centers for Disease Control and Prevention and the Atlanta Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This report was made possible through support provided by the Malaria Branch at the Centers for Disease Control and Prevention and the Atlanta Research and Education Foundation. We would like to thank Dr. John Barnwell for providing the quantified Plasmodium samples for the study and technical support of the project. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Abdul-Ghani R, 2012, ACTA TROP, V122, P233, DOI 10.1016/j.actatropica.2012.02.004; Britton S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0848-3; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Jothikumar P, 2014, J MICROBIOL METH, V98, P122, DOI 10.1016/j.mimet.2014.01.002; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Mohon A, 2014, ACTA TROP, V134, P52, DOI 10.1016/j.actatropica.2014.02.016; Morris U, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0731-2; Notomi Tsugunori, 2007, Nihon Rinsho, V65, P957; Nzelu CO, 2014, ACTA TROP, V132, P1, DOI 10.1016/j.actatropica.2013.12.016; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Patel JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054986; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Poon LLM, 2006, CLIN CHEM, V52, P303; Proux S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-323; Roth JM, 2016, CRIT REV CL LAB SCI, V53, P87, DOI 10.3109/10408363.2015.1084991; Sema M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0559-9; Yamamura M, 2009, JPN J INFECT DIS, V62, P20	22	52	54	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151437	10.1371/journal.pone.0151437	http://dx.doi.org/10.1371/journal.pone.0151437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967908	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200054
J	McGovern, G; Martin, S; Jeffrey, M; Dexter, G; Hawkins, SAC; Bellworthy, SJ; Thurston, L; Algar, L; Gonzalez, L				McGovern, Gillian; Martin, Stuart; Jeffrey, Martin; Dexter, Glenda; Hawkins, Steve A. C.; Bellworthy, Sue J.; Thurston, Lisa; Algar, Lynne; Gonzalez, Lorenzo			Minimum Effective Dose of Cattle and Sheep BSE for Oral Sheep Infection	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRION PROTEIN; TRANSGENIC MICE; SCRAPIE; DISEASE; PATHOGENESIS; PHENOTYPE; VARIANT; AGENT; SUSCEPTIBILITY	The minimum dose required to cause infection of Romney and Suffolk sheep of the ARQ/ARQ or ARQ/ARR prion protein gene genotypes following oral inoculation with Romney or Suffolk a sheep Bovine spongiform encephalopathy (BSE)-derived or cattle BSE-derived agent was investigated using doses ranging from 0.0005g to 5g. ARQ/ARQ sheep which were methionine (M) / threonine (T) heterozygous or T/T homozygous at codon 112 of the Prnp gene, dosed ARQ/ARR sheep and undosed controls did not show any evidence of infection. Within groups of susceptible sheep, the minimum effective oral dose of BSE was found to be 0.05g, with higher attack rates following inoculation with the 5g dose. Surprisingly, this study found no effect of dose on survival time suggesting a possible lack of homogeneity within the inoculum. All clinical BSE cases showed PrPd accumulation in brain; however, following cattle BSE inoculation, LRS involvement within Romney recipients was found to be significantly lower than within the Suffolk sheep inoculated group which is in agreement with previous reports.	[McGovern, Gillian; Martin, Stuart; Jeffrey, Martin; Algar, Lynne; Gonzalez, Lorenzo] Anim & Plant Hlth Agcy APHA Lasswade, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Dexter, Glenda; Hawkins, Steve A. C.; Bellworthy, Sue J.; Thurston, Lisa] APHA Weybridge, Addlestone KT15 3NB, Surrey, England		Gonzalez, L (corresponding author), Anim & Plant Hlth Agcy APHA Lasswade, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland.	Lorenzo.Gonzalez@apha.gsi.gov.uk	González, Lorenzo/A-5325-2010	González, Lorenzo/0000-0003-4199-4526	Department for Environment, Food and Rural affairs [SE1945, SE1846]; Defra [SE1945, SE1846]	Department for Environment, Food and Rural affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural affairs, grant numbers: SE1945, SE1846, received by SM and LG, respectively.; These experiments were funded by Defra projects SE1846 and SE1945. The authors are indebted to Hugh Simmons (APHA, Weybridge) for the provision of TSE-free sheep, to the staff at ARSU (APHA, Weybridge) for husbandry, Janey Witz for assistance with statistical analyses and to Ann Dunachie and Maria Oliva for immunohistochemistry work. Critical appraisal of the manuscript by Jim Hope (APHA) is also acknowledged.	Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Espinosa JC, 2007, J VIROL, V81, P835, DOI 10.1128/JVI.01356-06; Espinosa JC, 2007, J GEN VIROL, V88, P1379, DOI 10.1099/vir.0.82647-0; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2014, J COMP PATHOL, V150, P57, DOI 10.1016/j.jcpa.2013.10.001; Gonzalez L, 2007, J GEN VIROL, V88, P714, DOI 10.1099/vir.0.82426-0; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Houston F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143251; Hunter N, 2012, J VIROL, V86, P11856, DOI 10.1128/JVI.01573-12; Jeffrey M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0269-x; Jeffrey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091026; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; McGovern G, 2015, J COMP PATHOL, V152, P28, DOI 10.1016/j.jcpa.2014.09.004; McGovern G, 2009, VET PATHOL, V46, P233, DOI 10.1354/vp.46-2-233; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saunders GC, 2009, J GEN VIROL, V90, P2569, DOI 10.1099/vir.0.012724-0; Stack M, 2009, J GEN VIROL, V90, P764, DOI 10.1099/vir.0.005983-0; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103; Wilesmith J W, 1991, Curr Top Microbiol Immunol, V172, P21; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	29	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151440	10.1371/journal.pone.0151440	http://dx.doi.org/10.1371/journal.pone.0151440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968011	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200055
J	Downing, J; Karter, A; Rodriguez, H; Dow, WH; Adler, N; Schillinger, D; Warton, M; Laraia, B				Downing, Janelle; Karter, Andrew; Rodriguez, Hector; Dow, William H.; Adler, Nancy; Schillinger, Dean; Warton, Margaret; Laraia, Barbara			No Spillover Effect of the Foreclosure Crisis on Weight Change: The Diabetes Study of Northern California (DISTANCE)	PLOS ONE			English	Article							HOME FORECLOSURE; HEALTH; MORBIDITY; STRESS; IMPACT; RISK	The emerging body of research suggests the unprecedented increase in housing foreclosures and unemployment between 2007 and 2009 had detrimental effects on health. Using data from electronic health records of 105,919 patients with diabetes in Northern California, this study examined how increases in foreclosure rates from 2006 to 2010 affected weight change. We anticipated that two of the pathways that explain how the spike in foreclosure rates affects weight gain-increasing stress and declining salutary health behaviors- would be acute in a population with diabetes because of metabolic sensitivity to stressors and health behaviors. Controlling for unemployment, housing prices, temporal trends, and time-invariant confounders with individual fixed effects, we found no evidence of an association between the foreclosure rate in each patient's census block of residence and body mass index. Our results suggest, although more than half of the population was exposed to at least one foreclosure within their census block, the foreclosure crisis did not independently impact weight change.	[Downing, Janelle; Rodriguez, Hector; Dow, William H.; Laraia, Barbara] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Karter, Andrew; Warton, Margaret] Kaiser Permanente, Div Res, Oakland, CA USA; [Adler, Nancy] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Schillinger, Dean] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California Berkeley; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Downing, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	jdowning@berkeley.edu	RODRIGUEZ, HECTOR/Q-7996-2019; Laraia, Barbara/GXG-1829-2022	RODRIGUEZ, HECTOR/0000-0002-6564-2229; Downing, Jae/0000-0002-2382-5537; Dow, William/0000-0002-4080-1668	Neighborhood Effects on Weight Change and Diabetes Risk Factors grant from the NIDDK [R01DK080744]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080744] Funding Source: NIH RePORTER	Neighborhood Effects on Weight Change and Diabetes Risk Factors grant from the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Neighborhood Effects on Weight Change and Diabetes Risk Factors grant R01DK080744 from the NIDDK at www.niddk.nih.gov. These authors have no support or funding to report.	Arcaya M, 2014, CIRCULATION; Arcaya M, 2013, AM J PUBLIC HEALTH, V103, pE50, DOI 10.2105/AJPH.2013.301460; Arnio AN, 2012, SOC SCI RES, V41, P1598, DOI 10.1016/j.ssresearch.2012.05.013; Baumer EP, 2012, SOC SCI QUART, V93, P577, DOI 10.1111/j.1540-6237.2012.00888.x; Bennett GG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000087; Bindman AB, 2008, ANN INTERN MED, V149, P854, DOI 10.7326/0003-4819-149-12-200812160-00004; Buiter W.H, 2008, HOUSING WEALTH ISNT; Burgard SA, 2012, SOC SCI MED, V75, P2215, DOI 10.1016/j.socscimed.2012.08.020; Cagney KA, 2014, J INFORM, V104; Campbell JY, 2009, FORCED SALES HOUSE P; Cannuscio CC, 2012, NURS OUTLOOK, V60, P134, DOI 10.1016/j.outlook.2011.08.004; Catalano R, 2011, ANNU REV PUBL HEALTH, V32, P431, DOI 10.1146/annurev-publhealth-031210-101146; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cui L, 2015, J URBAN EC; Currie J., 2011, IS THERE LINK FORECL; Ellen IG, 2013, J URBAN ECON, V74, P59, DOI 10.1016/j.jue.2012.09.003; Estevao MM, 2011, HAS GREAT RECESSION; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gerardi K., 2013, UNEMPLOYMENT NEGATIV, DOI 10.2139/ssrn.2293152; Goodstein R, 2010, DO FORECLOSURES INCR; Houle JN, 2014, SOC SCI MED, V118, P1, DOI 10.1016/j.socscimed.2014.07.054; Houle JN, 2014, AM J PUBLIC HEALTH, V104, P1073, DOI 10.2105/AJPH.2013.301774; Houle JN, 2014, J EPIDEMIOLOGY COMMU; Immergluck D, 2006, HOUSING STUD, V21, P851, DOI 10.1080/02673030600917743; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Karahan F, 2013, FRB NEW YORK STAFF R; Katz CM, 2011, J RES CRIME DELINQ; Kingsley G. Thomas, 2009, IMPACTS FORECLOSURES; Lacoe J, 2015, J RES CRIME DELINQ; Lin ZG, 2009, J REAL ESTATE FINANC, V38, P387, DOI 10.1007/s11146-007-9093-z; Lindblad MR, 2015, HOUSING STUDIES, P1; McLaughlin KA, 2012, PSYCHOL MED, V42, P1441, DOI 10.1017/S0033291711002613; Moffet HH, 2009, INT J EPIDEMIOL, V38, P38, DOI 10.1093/ije/dyn040; Oliver G, 1999, PHYSIOL BEHAV, V66, P511, DOI 10.1016/S0031-9384(98)00322-9; Pevalin DJ, 2009, J EPIDEMIOL COMMUN H, V63, P949, DOI 10.1136/jech.2008.083477; Pollack CE, 2011, J URBAN HEALTH, V88, P469, DOI 10.1007/s11524-011-9564-7; Pollack CE, 2009, AM J PUBLIC HEALTH, V99, P1833, DOI 10.2105/AJPH.2009.161380; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Ruhm CJ, 2005, J HEALTH ECON, V24, P341, DOI 10.1016/j.jhealeco.2004.09.007; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stucky T. D., 2012, SOCIAL SCI Q, V93, P602; Systems DI, 2006, ADDRESS LEVEL FORECL; Taylor MP, 2007, PSYCHOL MED, V37, P1027, DOI 10.1017/S0033291706009767; Wang SS, 2004, INT J OBESITY, V28, P1333, DOI 10.1038/sj.ijo.0802730; Winkler AE., 2013, MON LABOR REV, V136, P1; Wood JN, 2012, PEDIATRICS, V130, pE358, DOI 10.1542/peds.2011-3755; Yilmazer T, 2015, SOC SCI MED, V130, P234, DOI 10.1016/j.socscimed.2015.02.028	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151334	10.1371/journal.pone.0151334	http://dx.doi.org/10.1371/journal.pone.0151334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26985671	gold, Green Published			2022-12-27	WOS:000372580300062
J	Machisa, MT; Christofides, N; Jewkes, R				Machisa, Mercilene T.; Christofides, Nicola; Jewkes, Rachel			Structural Pathways between Child Abuse, Poor Mental Health Outcomes and Male-Perpetrated Intimate Partner Violence (IPV)	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SOUTH-AFRICAN STRESS; PHYSICAL VIOLENCE; EASTERN CAPE; ALCOHOL; TRAUMA; RISK; SYMPTOMS; BEHAVIOR; AUDIT	Background Violent trauma exposures, including child abuse, are risk factors for PTSD and comorbid mental health disorders. Child abuse experiences of men exacerbate adult male-perpetrated intimate partner violence (IPV). The relationship between child abuse, poor mental health and IPV perpetration is complex but research among the general population is lacking. This study describes the relationship and pathways between history of child abuse exposure and male-perpetrated IPV while exploring the potentially mediating effect of poor mental health. Methods We analysed data from a randomly selected, two-stage clustered, cross-sectional household survey conducted with 416 adult men in Gauteng Province of South Africa. We used multinomial regression modelling to identify associated factors and Structural Equation Modelling (SEM) to test the primary hypothesis that poor mental health (defined as abusing alcohol or having PTSD or depressive symptoms) mediates the relationship between child abuse and IPV perpetration. Results Eighty eight percent of men were physically abused, 55% were neglected, 63% were emotionally abused and 20% were sexually abused at least once in their childhood. Twenty four percent of men had PTSD symptoms, 24% had depressive symptoms and 36% binge drank. Fifty six percent of men physically abused and 31% sexually abused partners at least once in their lifetime. Twenty two percent of men had one episode and 40% had repeat episodes of IPV perpetration. PTSD symptomatology risk increased with severity of child trauma and other trauma. PTSD severity increased the risk for binge drinking. Child trauma, other trauma and PTSD symptomatology increased the severity of depressive symptoms. PTSD symptomatology was comorbid with alcohol abuse and depressive symptoms. Child trauma, having worked in the year before the survey, other trauma and PTSD increased the risk of repeat episodes of IPV perpetration. Highly equitable gender attitudes were protective against single and repeat episodes of IPV perpetration. There was a direct path between the history of child trauma and IPV perpetration and three other indirect paths showing the mediating effects of PTSD, other trauma and gender attitudes. Conclusions Child trauma is a risk factor for both poor mental health and male-perpetrated IPV among men in Gauteng. Male-perpetrated IPV in these settings should be explained through a combination of the Trauma, Feminist, and Intergenerational Transmission of Family Violence theories. Prevention interventions for male-perpetrated IPV in South Africa need to incorporate strategies and therapies to address poor mental health conditions.	[Machisa, Mercilene T.; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Machisa, Mercilene T.; Christofides, Nicola; Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Witwatersrand	Machisa, MT (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Machisa, MT (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	Mercilene.Machisa@mrc.ac.za	Machisa, Mercilene/ABD-2257-2020	Machisa, Mercilene/0000-0001-7275-1100; Jewkes, Rachel/0000-0002-4330-6267				Abrahams N, 2005, AM J PUBLIC HEALTH, V95, P1811, DOI 10.2105/AJPH.2003.035006; Abrahams Naeemah, 2006, Violence Vict, V21, P247; Anderson KL, 1997, J MARRIAGE FAM, V59, P655, DOI 10.2307/353952; Atwoli L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-182; Bell KM, 2009, JAMA-J AM MED ASSOC, V302, P562, DOI 10.1001/jama.2009.1126; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blanchet A, 2012, EUROPEAN J PSYCHOTRA, V3, DOI [10.3402/ejpt.v3403i3400.19225, DOI 10.3402/EJPT.V3403I3400.19225]; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Daigneault I, 2009, CHILD ABUSE NEGLECT, V33, P638, DOI 10.1016/j.chiabu.2009.04.003; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; DUTTON DG, 1995, J TRAUMA STRESS, V8, P299, DOI 10.1007/BF02109566; Edwards D. J. A., 2005, J PSYCHOL AFR, V15, P125; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Frank D, 2008, J GEN INTERN MED, V23, P781, DOI 10.1007/s11606-008-0594-0; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Gevers A, 2014, ROLE MENTAL HLTH PRI, V2014, P7, DOI [10.3402/gha.v7.24741, DOI 10.3402/GHA.V7.24741]; Gupta J, 2008, CAN MED ASSOC J, V179, P535, DOI 10.1503/cmaj.071655; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1007/BF00977235; Holmes WC, 2005, J URBAN HEALTH, V82, pI89, DOI 10.1093/jurban/jti028; Iverson KM, 2011, BEHAV THER, V42, P236, DOI 10.1016/j.beth.2010.06.003; Iverson KM, 2011, PSYCHOSOCIAL TREATME; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R., 2010, CHILD ABUSE NEGLECT; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; Machisa M. T. JR, 2011, WAR HOME GAUTENG GBV; Maneta E, 2012, VIOLENCE VICTIMS, V27, P315, DOI 10.1891/0886-6708.27.3.315; Maniglio R, 2009, CLIN PSYCHOL REV, V29, P647, DOI 10.1016/j.cpr.2009.08.003; Meneses-Gaya C, 2010, ALCOHOL CLIN EXP RES, V34, P1417, DOI 10.1111/j.1530-0277.2010.01225.x; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Orcutt HK, 2003, J TRAUMA STRESS, V16, P381, DOI 10.1023/A:1024470103325; Parry CDH, 2005, ADDICTION, V100, P426, DOI 10.1111/j.1360-0443.2005.01015.x; Peltzer K, 1999, PSYCHOL REP, V85, P646, DOI 10.2466/PR0.85.6.646-650; Peltzer K, 2011, AFRICAN J PSYCHIAT, P14; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Russell M, 2013, PREV SCI; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seedat S, 2000, S AFR J CHILD ADOLES, V12, P38, DOI DOI 10.1080/16826108.2000.9632366; Seedat Soraya, 2005, Violence Vict, V20, P87, DOI 10.1891/vivi.2005.20.1.87; Seth P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120850; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Suliman S., 2005, ANN GEN PSYCHIAT, V4; Taft CT, 2005, J CONSULT CLIN PSYCH, V73, P151, DOI 10.1037/0022-006X.73.1.151; Tomlinson M, 2009, SAMJ S AFR MED J, V99, P368; van der Kolk B. A, 2003, PSYCHOL TRAUMA; Vinck P, 2013, SOC SCI MED, V77, P41, DOI 10.1016/j.socscimed.2012.10.026; Walby Sylvia, 1990, THEORISING PATRIARCH; Watt MH, 2012, J STUD ALCOHOL DRUGS, V73, P549, DOI 10.15288/jsad.2012.73.549; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; Wolf EJ, 2013, J TRAUMA STRESS, V26, P329, DOI 10.1002/jts.21805; Women D. V. A., 2001, PUTTING WOMEN 1; World Health Organization, 2000, WHO MULTICOUNTRY STU	57	52	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150986	10.1371/journal.pone.0150986	http://dx.doi.org/10.1371/journal.pone.0150986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26986056	Green Published, gold			2022-12-27	WOS:000372580300041
J	Assimes, TL; Lee, IT; Juang, JM; Guo, XQ; Wang, TD; Kim, ET; Lee, WJ; Absher, D; Chiu, YF; Hsu, CC; Chuang, LM; Quertermous, T; Hsiung, CA; Rotter, JI; Sheu, WHH; Chen, YDI; Taylor, KD				Assimes, Themistocles L.; Lee, I. -T.; Juang, Jyh-Ming; Guo, Xiuqing; Wang, Tzung-Dau; Kim, Eric T.; Lee, Wen-Jane; Absher, Devin; Chiu, Yen-Feng; Hsu, Chih-Cheng; Chuang, Lee-Ming; Quertermous, Thomas; Hsiung, Chao A.; Rotter, Jerome I.; Sheu, Wayne H. -H.; Chen, Yii-Der Ida; Taylor, Kent D.			Genetics of Coronary Artery Disease in Taiwan: A Cardiometabochip Study by the Taichi Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HAN CHINESE; VISUALIZATION; POPULATION; VARIANTS	By means of a combination of genome-wide and follow-up studies, recent large-scale association studies of populations of European descent have now identified over 46 loci associated with coronary artery disease (CAD). As part of the TAICHI Consortium, we have collected and genotyped 8556 subjects from Taiwan, comprising 5423 controls and 3133 cases with coronary artery disease, for 9087 CAD SNPs using the CardioMetaboChip. We applied penalized logistic regression to ascertain the top SNPs that contribute together to CAD susceptibility in Taiwan. We observed that the 9p21 locus contributes to CAD at the level of genome-wide significance (rs1537372, with the presence of C, the major allele, the effect estimate is -0.216, standard error 0.033, p value 5.8x10(-10)). In contrast to a previous report, we propose that the 9p21 locus is a single genetic contribution to CAD in Taiwan because: 1) the penalized logistic regression and the follow-up conditional analysis suggested that rs1537372 accounts for all of the CAD association in 9p21, and 2) the high linkage disequilibrium observed for all associated SNPs in 9p21. We also observed evidence for the following loci at a false discovery rate > 5%: SH2B3, ADAMTS7, PHACTR1, GGCX, HTRA1, COL4A1, and LARP6-LRRC49. We also took advantage of the fact that penalized methods are an efficient approach to search for gene-by-gene interactions, and observed that two-way interactions between the PHACTR1 and ADAMTS7 loci and between the SH2B3 and COL4A1 loci contribute to CAD risk. Both the similarities and differences between the significance of these loci when compared with significance of loci in studies of populations of European descent underscore the fact that further genetic association of studies in additional populations will provide clues to identify the genetic architecture of CAD across all populations worldwide.	[Assimes, Themistocles L.; Quertermous, Thomas] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Lee, I. -T.; Sheu, Wayne H. -H.] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrine & Metab, Taichung, Taiwan; [Juang, Jyh-Ming; Wang, Tzung-Dau] Natl Univ, Coll Med, Cardiovasc Ctr, Dept Internal Med,Natl Taiwan Univ Hosp, Taipei, Taiwan; [Juang, Jyh-Ming; Wang, Tzung-Dau] Natl Univ, Coll Med, Div Cardiol, Dept Internal Med,Natl Taiwan Univ Hosp, Taipei, Taiwan; [Guo, Xiuqing; Kim, Eric T.; Rotter, Jerome I.; Chen, Yii-Der Ida; Taylor, Kent D.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Guo, Xiuqing; Kim, Eric T.; Rotter, Jerome I.; Chen, Yii-Der Ida; Taylor, Kent D.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Lee, Wen-Jane] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Absher, Devin; Hsiung, Chao A.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Chiu, Yen-Feng; Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan Town, Miaoli County, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrine & Metab, Taipei 100, Taiwan	Stanford University; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; Taichung Veterans General Hospital; HudsonAlpha Institute for Biotechnology; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital	Taylor, KD (corresponding author), Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.; Taylor, KD (corresponding author), Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.	ktaylor@labiomed.org	Assimes, Themistocles Leonard/D-9696-2015; Rotter, Jerome/AAY-6598-2021; Chuang, Lee-Ming/AAF-3324-2019	Assimes, Themistocles Leonard/0000-0003-2349-0009; Quertermous, Thomas/0000-0002-7645-9067; Juang, Jyh-Ming Jimmy/0000-0003-4767-7636; Lee, I-Te/0000-0003-2665-3635; CHUANG, LEE-MING/0000-0003-0978-2662; WANG, TZUNG-DAU/0000-0002-7180-3607	NHLBI [HL087647]; NIH [K23DK088942]; National Science Council [NSC 98-2314-B-075A-002-MY3]; Taichung Veterans General Hospital, Taichung, Taiwan [TCVGH-1013001C, TCVGH-1013002D]; National Health Research Institutes [BS-094-PP-01, PH-100-PP-03, PH-100-SP-01]; National Center for Advancing Translational Sciences, CTSI grant [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) [DK063491]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109512, R33HL120757, R01HL087647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK088942, P30DK063491] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital, Taichung, Taiwan; National Health Research Institutes(National Health Research Institutes, Japan); National Center for Advancing Translational Sciences, CTSI grant; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The TAICHI study was supported by a grant from NHLBI grant HL087647. TLA is supported by an NIH career development award K23DK088942. The Taiwan Dragon was supported by grants from National Science Council (NSC 98-2314-B-075A-002-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan (TCVGH-1013001C; TCVGH-1013002D). The TCAD was supported by grants from National Science Council (NSC 98-2314-B-075A-002-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan (TCVGH-1013001C; TCVGH-1013002D). The SAPPHIRe was supported by grants from National Health Research Institutes (BS-094-PP-01 & PH-100-PP-03). HALST was supported by grants from National Health Research Institutes (PH-100-SP-01). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.; The TAICHI study was supported by a grant from NHLBI grant HL087647. TLA is support by an NIH career development award K23DK088942. The Taiwan Dragon was supported by grants from National Science Council (NSC 98-2314-B-075A-002-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan (TCVGH-1013001C; TCVGH-1013002D). The TCAD was supported by grants from National Science Council (NSC 98-2314-B-075A-002-MY3) and Taichung Veterans General Hospital, Taichung, Taiwan (TCVGH-1013001C; TCVGH-1013002D). The SAPPHIRe was supported by grants from National Health Research Institutes (BS-094-PP-01 & PH-100-PP-03). HALST was supported by grants from National Health Research Institutes (PH-100-SP-01). The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chang YC, 2012, CLIN ENDOCRINOL, V76, P365, DOI 10.1111/j.1365-2265.2011.04175.x; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Chen HH, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0502-7; Crawley M.J., 2007, R BOOK; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erbilgin A, 2013, J LIPID RES, V54, P1894, DOI 10.1194/jlr.M037085; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Johnson AD, 2013, CIRCULATION, V127, P799, DOI 10.1161/CIRCULATIONAHA.112.111559; Kuo JZ, 2013, DIABETOLOGIA, V56, P2619, DOI 10.1007/s00125-013-3047-1; Lange K, 2014, ANNU REV STAT APPL, V1, P279, DOI 10.1146/annurev-statistics-022513-115638; Lange K, 2013, BIOINFORMATICS, V29, P1568, DOI 10.1093/bioinformatics/btt187; Lee IT, 2014, CHROMOSOME 9P21 VARI, V2014, DOI [10.1155/2014/626907, DOI 10.1155/2014/626907]; Lemmens R, 2013, HUM MOL GENET, V22, P391, DOI 10.1093/hmg/dds436; Liang KW, 2013, J CHIN MED ASSOC, V76, P312, DOI 10.1016/j.jcma.2013.03.005; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Makinen VP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004502; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sheu WHH, 2007, CLIN CHIM ACTA, V382, P117, DOI 10.1016/j.cca.2007.04.013; Sheu WHH, 2013, HUM MOL GENET, V22, P3165, DOI 10.1093/hmg/ddt161; Tsai HJ, 2010, CLIN CHIM ACTA, V411, P2009, DOI 10.1016/j.cca.2010.08.025; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Zhou H, 2011, BIOCOMPUT-PAC SYM, P106	37	19	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0138014	10.1371/journal.pone.0138014	http://dx.doi.org/10.1371/journal.pone.0138014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982883	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900009
J	Miller, RL; Yaesoubi, M; Turner, JA; Mathalon, D; Preda, A; Pearlson, G; Adali, T; Calhoun, VD				Miller, Robyn L.; Yaesoubi, Maziar; Turner, Jessica A.; Mathalon, Daniel; Preda, Adrian; Pearlson, Godfrey; Adali, Tulay; Calhoun, Vince D.			Higher Dimensional Meta-State Analysis Reveals Reduced Resting fMRI Connectivity Dynamism in Schizophrenia Patients	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; TIME-VARYING CONNECTIVITY; FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; ABNORMALITIES; ORGANIZATION; INDIVIDUALS; BIPOLAR; EEG	Resting-state functional brain imaging studies of network connectivity have long assumed that functional connections are stationary on the timescale of a typical scan. Interest in moving beyond this simplifying assumption has emerged only recently. The great hope is that training the right lens on time-varying properties of whole-brain network connectivity will shed additional light on previously concealed brain activation patterns characteristic of serious neurological or psychiatric disorders. We present evidence that multiple explicitly dynamical properties of time-varying whole-brain network connectivity are strongly associated with schizophrenia, a complex mental illness whose symptomatic presentation can vary enormously across subjects. As with so much brain-imaging research, a central challenge for dynamic network connectivity lies in determining transformations of the data that both reduce its dimensionality and expose features that are strongly predictive of important population characteristics. Our paper introduces an elegant, simple method of reducing and organizing data around which a large constellation of mutually informative and intuitive dynamical analyses can be performed. This framework combines a discrete multidimensional data-driven representation of connectivity space with four core dynamism measures computed from large-scale properties of each subject's trajectory, ie., properties not identifiable with any specific moment in time and therefore reasonable to employ in settings lacking inter-subject time-alignment, such as resting-state functional imaging studies. Our analysis exposes pronounced differences between schizophrenia patients (N-sz = 151) and healthy controls (N-hc = 163). Time-varying whole-brain network connectivity patterns are found to be markedly less dynamically active in schizophrenia patients, an effect that is even more pronounced in patients with high levels of hallucinatory behavior. To the best of our knowledge this is the first demonstration that high-level dynamic properties of whole-brain connectivity, generic enough to be commensurable under many decompositions of time-varying connectivity data, exhibit robust and systematic differences between schizophrenia patients and healthy controls.	[Miller, Robyn L.; Yaesoubi, Maziar; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Yaesoubi, Maziar; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Turner, Jessica A.] Georgia State Univ, Dept Psychol & Neurosci, Atlanta, GA 30303 USA; [Mathalon, Daniel] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Preda, Adrian] Univ Calif Irvine, Dept Psychiat & Human Behav, Sch Med, Irvine, CA 92717 USA; [Pearlson, Godfrey; Calhoun, Vince D.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Pearlson, Godfrey] Olin Neuropyschiat Res Ctr, New Haven, CT USA; [Adali, Tulay] Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21228 USA	Lovelace Respiratory Research Institute; University of New Mexico; University System of Georgia; Georgia State University; University of California System; University of California San Francisco; University of California System; University of California Irvine; Yale University; University System of Maryland; University of Maryland Baltimore County	Miller, RL (corresponding author), Mind Res Network, Albuquerque, NM USA.	rmiller@mrn.org	Turner, Jessica A/H-7282-2015; Mathalon, Daniel H/AEE-5878-2022; Preda, Adrian/K-8889-2013; Calhoun, Vince D./ACN-9399-2022	Turner, Jessica A/0000-0003-0076-8434; Mathalon, Daniel H/0000-0001-6090-4974; Preda, Adrian/0000-0003-3373-2438; Calhoun, Vince D./0000-0001-9058-0747	NIH grants [P20GM103472, R01EB005846, R01EB020407]; NSF grant [1539067]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020407, R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103472] Funding Source: NIH RePORTER; Office Of The Director [1539067] Funding Source: National Science Foundation	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by NIH grants [P20GM103472, R01EB005846, R01EB020407] and NSF grant [1539067]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Calhoun V.D., 2012, FRONT PSYCHIATRY, V2, P1, DOI DOI 10.3389/-; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Chanraud S, 2011, CEREB CORTEX, V21, P2272, DOI 10.1093/cercor/bhq297; Cole MW, 2011, BIOL PSYCHIAT, V70, P43, DOI 10.1016/j.biopsych.2011.02.010; Damaraju E, 2012, STATIC DYNAMIC FUNCT; Damaraju E., 2014, NEUROIMAGE IN PRESS; Das P, 2014, NEUROIMAGE, V98, P73, DOI 10.1016/j.neuroimage.2014.04.062; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Di X, 2015, BRAIN STRUCT FUNCT, V220, P37, DOI 10.1007/s00429-013-0634-3; Ding XY, 2013, NEUROSCI LETT, V548, P110, DOI 10.1016/j.neulet.2013.05.029; Dziobek I, 2011, NERVENARZT, V82, P564, DOI 10.1007/s00115-010-3240-0; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gonzalez-Castillo J, 2015, P NATL ACAD SCI USA, V112, P8762, DOI 10.1073/pnas.1501242112; Guo ZL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044847, 10.1371/journal.pone.0028196]; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Kay SR, 1989, BRIT J PSYCHIAT; Keilholz S. D., 2014, BRAIN CONN, V4, P1, DOI DOI 10.1089/BRAIN.2014.0250; Keilholz SD, 2013, BRAIN CONNECT, V3, P31, DOI 10.1089/brain.2012.0115; Kikuch M, 2007, SCHIZOPHR RES, V97, P163, DOI 10.1016/j.schres.2007.07.012; Kindler J, 2011, CLIN NEUROPHYSIOL, V122, P1179, DOI 10.1016/j.clinph.2010.10.042; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Kuhn S, 2013, SCHIZOPHRENIA BULL, V39, P358, DOI 10.1093/schbul/sbr151; Lehmann D, 2014, FRONT HUM NEUROSCI, V8; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Ma S, 2014, NEUROIMAGE, V90, P196, DOI 10.1016/j.neuroimage.2013.12.063; Maximo JO, 2014, NEUROPSYCHOL REV, V24, P16, DOI 10.1007/s11065-014-9250-0; Miller R, 2014, HIGHER DIMENSIONAL F; Miller RL, 2014, HIGHER DIMENSIONAL A; Mueller S, 2012, AM J NEURORADIOL, V33, P2033, DOI 10.3174/ajnr.A2800; Oldehinkel M, 2013, EUR CHILD ADOLES PSY, V22, P757, DOI 10.1007/s00787-013-0480-0; Patriat R, 2014, BIOL PSYCHIAT, V75, p356S; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Pujol J, 2014, J PSYCHIATR RES, V51, P68, DOI 10.1016/j.jpsychires.2013.12.008; Rashid B, 2013, P HBM SEATTL WA; Rish I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050625; Rubia K, 2014, REV NEUROLOGIA, V58, pS3, DOI 10.33588/rn.58S01.2013570; Rubinov M, 2011, J NEUROSCI, V31, P6263, DOI 10.1523/JNEUROSCI.0382-11.2011; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Schmidt A, 2013, NEUROIMAGE, V81, P119, DOI 10.1016/j.neuroimage.2013.05.035; Shen H, 2014, NEUROREPORT, V25, P1344, DOI 10.1097/WNR.0000000000000267; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Strelets V, 2003, CLIN NEUROPHYSIOL, V114, P2043, DOI 10.1016/S1388-2457(03)00211-6; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Turner JA, 2012, PSYCHIAT RES-NEUROIM, V201, P253, DOI 10.1016/j.pscychresns.2011.09.012; van den Heuvel MP, 2014, NEUROPSYCHOL REV, V24, P32, DOI 10.1007/s11065-014-9248-7; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; Vargas C, 2013, J AFFECT DISORDERS, V150, P727, DOI 10.1016/j.jad.2013.05.083; Venkataraman A, 2012, SCHIZOPHR RES, V139, P7, DOI 10.1016/j.schres.2012.04.021; Yaesoubi M, 2014, P ORG HUM BRAIN MAPP; Yang GJ, 2014, P NATL ACAD SCI USA, V111, P7438, DOI 10.1073/pnas.1405289111; Yu QB, 2015, NEUROIMAGE, V107, P345, DOI 10.1016/j.neuroimage.2014.12.020; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068250; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111	59	134	137	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149849	10.1371/journal.pone.0149849	http://dx.doi.org/10.1371/journal.pone.0149849			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981625	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900021
J	Vaughan, D; Brogioli, M; Maier, T; White, A; Waldron, S; Rittweger, J; Toigo, M; Wettstein, J; Laczko, E; Fluck, M				Vaughan, David; Brogioli, Michael; Maier, Thomas; White, Andy; Waldron, Sarah; Rittweger, Joern; Toigo, Marco; Wettstein, Jessica; Laczko, Endre; Flueck, Martin			The Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Modifies Exercise-Induced Muscle Metabolism	PLOS ONE			English	Article							GENE I/D POLYMORPHISM; GLUCOSE-UPTAKE; ACE GENE; SERUM; INSULIN; CHROMATOGRAPHY; CARBOHYDRATE; INTENSITY; SYSTEM; FAT	Objective A silencer region (I-allele) within intron 16 of the gene for the regulator of vascular perfusion, angiotensin-converting enzyme (ACE), is implicated in phenotypic variation of aerobic fitness and the development of type II diabetes. We hypothesised that the reportedly lower aerobic performance in non-carriers compared to carriers of the ACE I-allele, i.e. ACE-DD vs. ACE-ID/ACE-II genotype, is associated with alterations in activity-induced glucose metabolism and capillarisation in exercise muscle. Methods Fifty-three, not-specifically trained Caucasian men carried out a one-legged bout of cycling exercise to exhaustion and/or participated in a marathon, the aim being to identify and validate genotype effects on exercise metabolism. Respiratory exchange ratio (RER), serum glucose and lipid concentration, glycogen, and metabolite content in vastus lateralis muscle based on ultra-performance lipid chromatography-mass spectrometry (UPLC-MS), were assessed before and after the cycling exercise in thirty-three participants. Serum metabolites were measured in forty subjects that completed the marathon. Genotype effects were assessed post-hoc. Results Cycling exercise reduced muscle glycogen concentration and this tended to be affected by the ACE I-allele (p = 0.09). The ACE-DD genotype showed a lower maximal RER and a selective increase in serum glucose concentration after exercise compared to ACE-ID and ACE-II genotypes (+24% vs. +2% and -3%, respectively). Major metabolites of mitochondrial metabolism (i.e. phosphoenol pyruvate, nicotinamide adenine dinucleotide phosphate, L-Aspartic acid, glutathione) were selectively affected in vastus lateralis muscle by exercise in the ACE-DD genotype. Capillary-to-fibre ratio was 24%-lower in the ACE-DD genotype. Individuals with the ACE-DD genotype demonstrated an abnormal increase in serum glucose to 7.7 mM after the marathon. Conclusion The observations imply a genetically modulated role for ACE in control of glucose import and oxidation in working skeletal muscle. ACE-DD genotypes thereby transit into a pre-diabetic state with exhaustive exercise, which relates to a lowered muscle capillarisation, and deregulation of mitochondria-associated metabolism.	[Vaughan, David; Brogioli, Michael; Maier, Thomas; Waldron, Sarah; Rittweger, Joern; Flueck, Martin] Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, Manchester M15 6BH, Lancs, England; [Brogioli, Michael; Maier, Thomas] ETH, Inst Human Movement Sci & Sport, Zurich, Switzerland; [White, Andy] Chester Marathon, Chester, Cheshire, England; [Toigo, Marco; Wettstein, Jessica; Flueck, Martin] Univ Zurich, Univ Hosp Balgrist, Zurich, Switzerland; [Laczko, Endre] UZH ETHZ, Funct Genom Ctr Zurich, Zurich, Switzerland; [Brogioli, Michael] Univ Zurich, Univ Hosp Balgrist, Spinal Cord Injury Ctr, Zurich, Switzerland; [Rittweger, Joern] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany	Manchester Metropolitan University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Helmholtz Association; German Aerospace Centre (DLR)	Fluck, M (corresponding author), Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, Manchester M15 6BH, Lancs, England.; Fluck, M (corresponding author), Univ Zurich, Univ Hosp Balgrist, Zurich, Switzerland.	mflueck@research.balgrist.ch	Rittweger, Jörn/A-4308-2009	Rittweger, Jörn/0000-0002-2223-8963; Laczko, Endre/0000-0003-0271-3971				Ahmed SK, 1997, EXP PHYSIOL, V82, P231, DOI 10.1113/expphysiol.1997.sp004012; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bergeron R, 2001, AM J PHYSIOL-REG I, V281, pR1854, DOI 10.1152/ajpregu.2001.281.6.R1854; Bird SR, 2012, MATURITAS, V72, P311, DOI 10.1016/j.maturitas.2012.05.015; Brothers RM, 2006, J PHYSIOL-LONDON, V577, P727, DOI 10.1113/jphysiol.2006.113977; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Carlson BE, 2008, AM J PHYSIOL-HEART C, V295, pH1572, DOI 10.1152/ajpheart.00262.2008; Clifford PS, 2004, J APPL PHYSIOL, V97, P393, DOI 10.1152/japplphysiol.00179.2004; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Essen-Gustavsson B, 2002, ACTA PHYSIOL SCAND, V174, P275, DOI 10.1046/j.1365-201x.2002.00942.x; Flueck M, 2010, EUR J APPL PHYSIOL, V110, P1095, DOI 10.1007/s00421-010-1662-9; Graham TE, 1998, ADV EXP MED BIOL, V441, P271; Halliwill J R, 2001, Exerc Sport Sci Rev, V29, P65, DOI 10.1097/00003677-200104000-00005; Harriss DJ, 2011, INT J SPORTS MED, V32, P819, DOI 10.1055/s-0031-1287829; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; Huang XH, 1998, HUM GENET, V102, P372, DOI 10.1007/s004390050707; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Jamerson KA, 1996, HYPERTENSION, V27, P854, DOI 10.1161/01.HYP.27.4.854; Li RW, 2013, J ANAT, V223, P525, DOI 10.1111/joa.12101; LITHELL H, 1981, DIABETES, V30, P19, DOI 10.2337/diabetes.30.1.19; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McPhee JS, 2009, EXP PHYSIOL, V94, P684, DOI 10.1113/expphysiol.2008.045658; Myerson S, 1999, J APPL PHYSIOL, V87, P1313, DOI 10.1152/jappl.1999.87.4.1313; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; PANAHLOO A, 1995, CIRCULATION, V92, P3390, DOI 10.1161/01.CIR.92.12.3390; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Puthucheary Z, 2011, SPORTS MED, V41, P433, DOI 10.2165/11588720-000000000-00000; Ramos-Jimenez Arnulfo, 2008, Clin Med Circ Respirat Pulm Med, V2, P1; Rieder MJ, 1997, CIRC RES, V80, P312, DOI 10.1161/01.RES.80.3.312; RIFAI N, 1992, CLIN CHEM, V38, P150; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Roberts TJ, 1996, J EXP BIOL, V199, P1651; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Salem Abdel Halim, 2009, BMC Res Notes, V2, P99, DOI 10.1186/1756-0500-2-99; SCHWIELER JH, 1991, N-S ARCH PHARMACOL, V343, P166, DOI 10.1007/BF00168605; Sowers JR, 1997, HYPERTENSION, V29, P691, DOI 10.1161/01.HYP.29.3.691; STAESSEN J, 1987, J APPL PHYSIOL, V63, P188, DOI 10.1152/jappl.1987.63.1.188; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Ginkel S, 2015, SCAND J MED SCI SPOR, V25, pe360, DOI 10.1111/sms.12324; van Ginkel S, 2014, 19 ANN ECSS C AMST N; van Ginkel S, 2015, APPL TRANSL GENOM, V4, P33, DOI 10.1016/j.atg.2015.03.002; Vaughan D, 2013, EUR J APPL PHYSIOL, V113, P1719, DOI 10.1007/s00421-012-2583-6; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; Yang M, 2006, BIOMED ENVIRON SCI, V19, P323	47	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0149046	10.1371/journal.pone.0149046	http://dx.doi.org/10.1371/journal.pone.0149046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982073	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900013
J	Kress-Bennett, JM; Hiller, NL; Eutsey, RA; Powell, E; Longwell, MJ; Hillman, T; Blackwell, T; Byers, B; Mell, JC; Post, JC; Hu, FZ; Ehrlich, GD; Janto, BA				Kress-Bennett, Jennifer M.; Hiller, N. Luisa; Eutsey, Rory A.; Powell, Evan; Longwell, Mark J.; Hillman, Todd; Blackwell, Tenisha; Byers, Barbara; Mell, Joshua C.; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.; Janto, Benjamin A.			Identification and Characterization of msf, a Novel Virulence Factor in Haemophilus influenzae	PLOS ONE			English	Article							RICH PROTEIN-A; ACUTE OTITIS-MEDIA; MIDDLE-EAR MUCOSA; UROPATHOGENIC ESCHERICHIA-COLI; LEGIONELLA-PNEUMOPHILA ENHC; BRONCHIAL EPITHELIAL-CELLS; HELICOBACTER-PYLORI; SINORHIZOBIUM-MELILOTI; BIOFILM FORMATION; GENE-EXPRESSION	Haemophilus influenzae is an opportunistic pathogen. The emergence of virulent, non-typeable strains (NTHi) emphasizes the importance of developing new interventional targets. We screened the NTHi supragenome for genes encoding surface-exposed proteins suggestive of immune evasion, identifying a large family containing Sel1-like repeats (SLRs). Clustering identified ten SLR-containing gene subfamilies, each with various numbers of SLRs per gene. Individual strains also had varying numbers of SLR-containing genes from one or more of the subfamilies. Statistical genetic analyses of gene possession among 210 NTHi strains typed as either disease or carriage found a significant association between possession of the SlrVA subfamily (which we have termed, macrophage survival factor, msf) and the disease isolates. The PittII strain contains four chromosomally contiguous msf genes. Deleting all four of these genes (msfA1-4) (KO) resulted in a highly significant decrease in phagocytosis and survival in macrophages; which was fully complemented by a single copy of the msfA1 gene. Using the chinchilla model of otitis media and invasive disease, the KO strain displayed a significant decrease in fitness compared to the WT in coinfections; and in single infections, the KO lost its ability to invade the brain. The singly complemented strain showed only a partial ability to compete with theWT suggesting gene dosage is important in vivo. The transcriptional profiles of the KO and WT in planktonic growth were compared using the NTHi supragenome array, which revealed highly significant changes in the expression of operons involved in virulence and anaerobiosis. These findings demonstrate that the msfA1-4 genes are virulence factors for phagocytosis, persistence, and trafficking to non-mucosal sites.	[Kress-Bennett, Jennifer M.; Hiller, N. Luisa; Eutsey, Rory A.; Powell, Evan; Longwell, Mark J.; Hillman, Todd; Blackwell, Tenisha; Byers, Barbara; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.; Janto, Benjamin A.] Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA; [Kress-Bennett, Jennifer M.; Mell, Joshua C.; Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.; Janto, Benjamin A.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Mell, Joshua C.; Ehrlich, Garth D.; Janto, Benjamin A.] Drexel Univ, Coll Med, Ctr Genom Sci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA; [Hiller, N. Luisa] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Post, J. Christopher; Hu, Fen Z.; Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Allegheny Campus, Pittsburgh, PA USA	Allegheny General Hospital; Drexel University; Drexel University; Carnegie Mellon University; Drexel University	Janto, BA (corresponding author), Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA.; Janto, BA (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.; Janto, BA (corresponding author), Drexel Univ, Coll Med, Ctr Genom Sci, Inst Mol Med & Infect Dis, Philadelphia, PA 19104 USA.	bjanto@drexelmed.edu	Janto, Benjamin/E-7459-2010; Hiller, N. Luisa/A-3739-2016	Janto, Benjamin/0000-0002-3841-4917; Hiller, N. Luisa/0000-0001-6572-1368; Ehrlich, Garth/0000-0003-1140-6594	Allegheny General Hospital, Allegheny-Singer Research Institute; Drexel University College of Medicine; National Institute on Deafness and Other Communication Disorders [DC002148, DC002148-16S1]; National Institute of Allergy and Infectious Diseases [AI080935]; National Institutes of Health [DC002148, AI080935, DC02148-16S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002148] Funding Source: NIH RePORTER	Allegheny General Hospital, Allegheny-Singer Research Institute; Drexel University College of Medicine; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Allegheny General Hospital, Allegheny-Singer Research Institute, Drexel University College of Medicine, National Institute on Deafness and Other Communication Disorders, http://www.nidcd.nih.gov, grant#DC002148 (GDE), National Institute on Deafness and Other Communication Disorders, http://www.nidcd.nih.gov, grant#DC002148-16S1 (GDE), and National Institute of Allergy and Infectious Diseases, http://www.niaid.nih.gov, grant#AI080935 (GDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Allegheny General Hospital, Allegheny-Singer Research Institute, Drexel University College of Medicine and National Institutes of Health grant numbers [DC002148, DC02148-16S1, AI080935 to GDE]. The authors thank Drs. Robert Munson and Lauren Bakaletz for the prsm2211 plasmid used for GFP expression; Dr. William Swords for rabbit anti-NTHi antiserum; Drs. Arnold Smith, Helena Zemlickova, Janet Gilsdorf, Michael Apicella, and Timothy Murphy for NTHi strains; Joshua Earl for bioinformatic assistance; Chandana Batchu for her analysis of the SlrV locus 1; Kortney Marszalek for her help analyzing data from the single infections; Suzanne Ezzo and Amy Cupps for their help caring for and monitoring chinchillas; and Mary O'Toole and Carol Hope for their help with the preparation of the manuscript.	Ahren IL, 2001, MICROB PATHOGENESIS, V31, P151, DOI 10.1006/mpat.2001.0456; Ahren IL, 2001, J INFECT DIS, V184, P150, DOI 10.1086/322016; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Baker M, 2012, NAT METHODS, V9, P23, DOI 10.1038/nmeth.1807; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bandi V, 2001, AM J RESP CRIT CARE, V164, P2114, DOI 10.1164/ajrccm.164.11.2104093; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Bayles KW, 2000, TRENDS MICROBIOL, V8, P274, DOI 10.1016/S0966-842X(00)01762-5; Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; Block SL, 2001, INT J PEDIATR OTORHI, V61, P47, DOI 10.1016/S0165-5876(01)00550-X; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; Brook I, 1998, ACTA OTO-LARYNGOL, V118, P206; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Buchinsky FJ, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-56; CAMMACK R, 1990, BIOCHEMISTRY-US, V29, P8410, DOI 10.1021/bi00488a030; Chen EJ, 2008, MOL MICROBIOL, V69, P1290, DOI 10.1111/j.1365-2958.2008.06362.x; Cheong JWS, 2015, EPIDEMIOL INFECT, V143, P2993, DOI 10.1017/S0950268815000345; Chong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067965; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001; COTTER PA, 1989, J BACTERIOL, V171, P3817, DOI 10.1128/jb.171.7.3817-3823.1989; Craig JE, 2001, FEMS MICROBIOL LETT, V203, P55, DOI 10.1016/S0378-1097(01)00328-7; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dagan R, 2001, J INFECT DIS, V183, P880, DOI 10.1086/319250; Deml L, 2005, INFECT IMMUN, V73, P4732, DOI 10.1128/IAI.73.8.4732-4742.2005; Dohar JE, 2005, LARYNGOSCOPE, V115, P1469, DOI 10.1097/01.mlg.0000172036.82897.d4; DUIM B, 1994, MOL MICROBIOL, V11, P1181, DOI 10.1111/j.1365-2958.1994.tb00394.x; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Erwin AL, 2005, INFECT IMMUN, V73, P5853, DOI 10.1128/IAI.73.9.5853-5863.2005; Eutsey RA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-484; Farjo RS, 2004, PEDIATR INFECT DIS J, V23, P41, DOI 10.1097/01.inf.0000106981.89572.d1; FARLEY MM, 1986, J INFECT DIS, V154, P752, DOI 10.1093/infdis/154.5.752; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FORSGREN J, 1994, INFECT IMMUN, V62, P673, DOI 10.1128/IAI.62.2.673-679.1994; Forsgren J, 1996, ACTA OTO-LARYNGOL, V116, P766, DOI 10.3109/00016489609137922; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004; Gilsdorf JR, 1998, INFECT IMMUN, V66, P5053, DOI 10.1128/IAI.66.11.5053-5059.1998; Gon S, 2000, J BACTERIOL, V182, P5779, DOI 10.1128/JB.182.20.5779-5786.2000; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P137, DOI 10.1016/j.anl.2009.03.012; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janto BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105493; Kelly L, 2011, J MED MICROBIOL, V60, P384, DOI 10.1099/jmm.0.026914-0; Ketterer MR, 1999, INFECT IMMUN, V67, P4161, DOI 10.1128/IAI.67.8.4161-4170.1999; Klein JO, 2000, J LAB CLIN MED, V135, P220, DOI 10.1067/mlc.2000.105614; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Liu MY, 2008, CELL MICROBIOL, V10, P1906, DOI 10.1111/j.1462-5822.2008.01180.x; Liu MY, 2012, CELL HOST MICROBE, V12, P166, DOI 10.1016/j.chom.2012.06.004; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Livorsi DJ, 2012, J INFECTION, V65, P496, DOI 10.1016/j.jinf.2012.08.005; Luthy L, 2002, J BIOL CHEM, V277, P10187, DOI 10.1074/jbc.M108993200; MacNeil JR, 2011, CLIN INFECT DIS, V53, P1230, DOI 10.1093/cid/cir735; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Mittl PRE, 2003, CLIN DIAGN LAB IMMUN, V10, P542, DOI 10.1128/CDLI.10.4.542-545.2003; Mittl PRE, 2000, J BIOL CHEM, V275, P17693, DOI 10.1074/jbc.M001869200; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Murphy TF, 2015, CLIN VACCINE IMMUNOL; MUSSER JM, 1986, INFECT IMMUN, V52, P183, DOI 10.1128/IAI.52.1.183-191.1986; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Newton HJ, 2006, INFECT IMMUN, V74, P1683, DOI 10.1128/IAI.74.3.1683-1691.2006; Nizet V, 1996, J INFECT DIS, V173, P180, DOI 10.1093/infdis/173.1.180; Norton PM, 1999, FEMS IMMUNOL MED MIC, V26, P25, DOI 10.1111/j.1574-695X.1999.tb01369.x; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pastorello I, 2013, MBIO, V4, DOI 10.1128/mBio.00206-13; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettigrew MM, 2002, INFECT IMMUN, V70, P3551, DOI 10.1128/IAI.70.7.3551-3556.2002; Pittman MS, 2005, BIOCHEM SOC T, V33, P190, DOI 10.1042/BST0330190; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Poock SR, 2002, J BIOL CHEM, V277, P23664, DOI 10.1074/jbc.M200731200; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Potter L, 2001, ADV MICROB PHYSIOL, V45, P51, DOI 10.1016/S0065-2911(01)45002-8; Ravcheev DA, 2005, MOL BIOL+, V39, P832; Ravcheev DA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-54; Read TD, 1998, INFECT IMMUN, V66, P1622, DOI 10.1128/IAI.66.4.1622-1631.1998; Resman F, 2011, CLIN MICROBIOL INFEC, V17, P1638, DOI 10.1111/j.1469-0691.2010.03417.x; Roschitzki B, 2011, CURR MICROBIOL, V63, P239, DOI 10.1007/s00284-011-9969-2; Saeed-Kothe A, 2004, APPL ENVIRON MICROB, V70, P4136, DOI 10.1128/AEM.70.7.4136-4143.2004; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shen K, 2005, INFECT IMMUN, V73, P3479, DOI 10.1128/IAI.73.6.3479-3491.2005; Shuel M, 2010, FEMS IMMUNOL MED MIC, V58, P277, DOI 10.1111/j.1574-695X.2009.00634.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIKKEMA DJ, 1992, INFECT IMMUN, V60, P5204, DOI 10.1128/IAI.60.12.5204-5211.1992; St Geme JW, 2002, CELL MICROBIOL, V4, P191; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STGEME JW, 1990, INFECT IMMUN, V58, P4036, DOI 10.1128/IAI.58.12.4036-4044.1990; Strouts FR, 2012, EMERG INFECT DIS, V18, P449, DOI 10.3201/eid1803.110728; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Swords WE, 2003, J ENDOTOXIN RES, V9, P131, DOI 10.1179/096805103125001531; Swords WE, 2001, CELL MICROBIOL, V3, P525, DOI 10.1046/j.1462-5822.2001.00132.x; Tanapongpipat S, 1998, BIOCHEM J, V334, P355, DOI 10.1042/bj3340355; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlich GA, 2002, INFECT IMMUN, V70, P395, DOI 10.1128/IAI.70.1.395-399.2002; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Urosev D, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-19; von Ohle C, 2010, APPL ENVIRON MICROB, V76, P2326, DOI 10.1128/AEM.02090-09; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; WEINER JH, 1988, J BACTERIOL, V170, P1505, DOI 10.1128/jb.170.4.1505-1510.1988; Wells DH, 2007, MOL MICROBIOL, V64, P647, DOI 10.1111/j.1365-2958.2007.05680.x; WILLIAMS AE, 1991, J INFECT DIS, V163, P1366, DOI 10.1093/infdis/163.6.1366; Yao SY, 2004, J BACTERIOL, V186, P6042, DOI [10.1128/JB.186.18.6042-6049.2004, 10.1128/jb.186.18.6042-6049.2004]; Zhang LX, 2000, INFECT IMMUN, V68, P2009, DOI 10.1128/IAI.68.4.2009-2015.2000	127	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149891	10.1371/journal.pone.0149891	http://dx.doi.org/10.1371/journal.pone.0149891			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977929	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800018
J	Liu, ZW; Yu, Y; Hu, M; Liu, HM; Zhou, L; Xiao, SY				Liu, Zi-wei; Yu, Yu; Hu, Mi; Liu, Hui-ming; Zhou, Liang; Xiao, Shui-yuan			PHQ-9 and PHQ-2 for Screening Depression in Chinese Rural Elderly	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; LATE-LIFE DEPRESSION; PRIMARY-CARE; MAJOR DEPRESSION; OLDER-ADULTS; VALIDITY; PREVALENCE; POPULATION; VALIDATION; DISABILITY	Objectives This study aimed to explore cut-off scores of the 9-item Patient Health Questionnaire (PHQ-9) and 2-item Patient Health Questionnaire (PHQ-2) for depression screening in Chinese rural elderly. Methods A cross-sectional study was conducted on 839 residents aged 60 years and above in rural areas of Liuyang County. PHQ-9 was adopted to evaluate depression. The Structured Clinical Interview for DSM Disorders (SCID-I) was adopted to diagnose major depressive disorder (MDD) as a golden standard. Sensitivity, specificity, positive and negative predictive value, positive and negative likelihood ratio, Youden's index and the receiver operating characteristic (ROC) curve were analyzed on PHQ-9 and PHQ-2. Results The Cronbach's alphas of PHQ-9 and PHQ-2 were 0.82 and 0.76, respectively. The score of 8 of the PHQ-9 showed the highest Youden's index of 0.85, with a sensitivity of 0.97 and specificity of 0.89 respectively, and the area under the ROC curve (AUC) was 0.97 (95% CI: 0.96-0.98). The score of 3 of PHQ-2 showed the highest Youden's index of 0.79, with both sensitivity and specificity were 0.90 and the AUC was 0.94 (95% CI: 0.90-0.97). Conclusions Both PHQ-9 and PHQ-2 are valid screening instruments for depression in the rural elderly in China, with recommended cut-off scores of 8 and 3 respectively.	[Liu, Zi-wei; Yu, Yu; Hu, Mi; Liu, Hui-ming; Zhou, Liang; Xiao, Shui-yuan] Cent S Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China	Central South University	Xiao, SY (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	xiaosy@csu.edu.cn	ZHOU, LIANG/AAG-7587-2020	ZHOU, LIANG/0000-0003-3207-7419	National Science and Technology Support Program, China [2009BAI77B01, 2009BAI77B03]	National Science and Technology Support Program, China	This work was supported by the National Science and Technology Support Program, China (SYX, No. 2009BAI77B01 and LZ, 2009BAI77B03).	Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Beekman ATF, 2002, ACTA PSYCHIAT SCAND, V105, P20, DOI 10.1034/j.1600-0447.2002.10078.x; Bland Phillip, 2012, Practitioner, V256, P17; Bureau of Statistics of Changsha, 2012, AG LIUYANG COUNT; Bureau of Statistics of Changsha, 2011, STAT COMM LIUYANG CO; Chen SL, 2012, J AFFECT DISORDERS, V141, P86, DOI 10.1016/j.jad.2012.02.027; Daniulaityte R, 2010, J PSYCHOACTIVE DRUGS, V42, P435; Hall CA, 2014, MATURITAS, V79, P147, DOI 10.1016/j.maturitas.2014.05.026; Inagaki M, 2013, GEN HOSP PSYCHIAT, V35, P592, DOI 10.1016/j.genhosppsych.2013.08.001; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lakkis NA, 2015, POSTGRAD MED, V127, P99, DOI 10.1080/00325481.2015.992721; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; [李振华 Li Zhenhua], 2011, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V19, P171; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; Maurer DM, 2012, AM FAM PHYSICIAN, V85, P139; McGuire AW, 2013, AM J CRIT CARE, V22, P12, DOI 10.4037/ajcc2013899; Naik AD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-37; Phelan E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-63; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Qin XX, 2008, J AFFECT DISORDERS, V110, P46, DOI 10.1016/j.jad.2007.12.237; Reinlieb M, 2014, AM J GERIAT PSYCHIAT, V22, P1487, DOI 10.1016/j.jagp.2013.10.010; Schulz R, 2002, BIOL PSYCHIAT, V52, P205, DOI 10.1016/S0006-3223(02)01423-3; Su D, 2012, ARCH GERONTOL GERIAT, V55, P564, DOI 10.1016/j.archger.2012.06.006; Suzuki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119147; Wang WZ, 2014, GEN HOSP PSYCHIAT, V36, P539, DOI 10.1016/j.genhosppsych.2014.05.021; Wu XL, 2010, POPULATION J, V183, P43; Xu J., 2011, J INT PSYCHIAT, V38, P201; Yeung A, 2008, COMPR PSYCHIAT, V49, P211, DOI 10.1016/j.comppsych.2006.06.002; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu XN, 2011, J AFFECT DISORDERS, V134, P444, DOI 10.1016/j.jad.2011.05.007; Zhang L, 2012, INT J GERIATR PSYCH, V27, P900, DOI 10.1002/gps.2821	34	89	91	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151042	10.1371/journal.pone.0151042	http://dx.doi.org/10.1371/journal.pone.0151042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978264	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800044
J	Liu, X; Li, JL; Tian, YP; Liao, MG; Zhang, ZW				Liu, Xu; Li, Jinlu; Tian, Yuping; Liao, Mingan; Zhang, Zhenwen			Influence of Berry Heterogeneity on Phenolics and Antioxidant Activity of Grapes and Wines: A Primary Study of the New Winegrape Cultivar Meili (Vitis vinifera L.)	PLOS ONE			English	Article							ANTHOCYANIN EXTRACTABILITY; VARIETAL DIFFERENCES; SUNLIGHT EXPOSURE; PINOT-NOIR; CAPACITY; SKIN; ACCUMULATION; PROFILES; TEMPERATURE; POLYPHENOLS	Wine grapes are usually harvested in vineyards when they ripen. However, not all of the berries in a vineyard ripen homogeneously because of different microclimates around the clusters and berries. In this study, the influence of berry heterogeneity on the phenolic content and antioxidant capacity of grapes and wines under a continental monsoon climate was evaluated for a new wine grape cultivar Meili (Vitis vinifera L.). The total phenolic, flavonoid, flavanol, and monomeric anthocyanin contents in the skin and wine significantly increased with grape density; however, there was no significant difference in the seeds between the two lower densities. The highest values of DPPH free radical-scavenging activity, cupric-reducing antioxidant capacity, and hydroxyl radical-scavenging activity in the skin, seed and wine were detected for the densest berries. The sum of individual phenolic compounds in skin, seed and wine increased with berry density, though no significant difference for skin was observed between the two higher density classes. Hence, the chemical components of Meili grapes and wines were positively associated with the berry density at harvest under the continental monsoon climate.	[Liu, Xu; Li, Jinlu; Tian, Yuping; Zhang, Zhenwen] Northwest A&F Univ, Coll Enol, Yangling, Shaanxi, Peoples R China; [Liu, Xu; Zhang, Zhenwen] Shaanxi Engn Res Ctr Vitiviniculture, Yangling, Shaanxi, Peoples R China; [Liao, Mingan] Sichuan Agr Univ, Dept Hort, Yaan, Sichuan, Peoples R China	Northwest A&F University - China; Sichuan Agricultural University	Zhang, ZW (corresponding author), Northwest A&F Univ, Coll Enol, Yangling, Shaanxi, Peoples R China.; Zhang, ZW (corresponding author), Shaanxi Engn Res Ctr Vitiviniculture, Yangling, Shaanxi, Peoples R China.	zhangzhenwenwine@126.com	Atak, Arif/J-2913-2018	Atak, Arif/0000-0001-7251-2417	National Natural Science Foundation of China [31401819]; National Technology System of Grape Industry [CARS-30-zp-9]; Key Science and Technology Program of Shaanxi Province, China [2014K01-08-01]; National Twelfth Five-Year Plan for Science & Technology Support [2012BAD31B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technology System of Grape Industry; Key Science and Technology Program of Shaanxi Province, China; National Twelfth Five-Year Plan for Science & Technology Support	This work was supported by the National Natural Science Foundation of China (31401819, http://www.nsfc.gov.cn), the National Technology System of Grape Industry (CARS-30-zp-9, http://www.qgqj.com.cn/), the Key Science and Technology Program of Shaanxi Province, China (2014K01-08-01, http://www.sninfo.gov.cn/), and the National Twelfth Five-Year Plan for Science & Technology Support (2012BAD31B07, http://program.most.gov.cn/).	Apak R, 2004, J AGR FOOD CHEM, V52, P7970, DOI 10.1021/jf048741x; Azuma A, 2012, PLANTA, V236, P1067, DOI 10.1007/s00425-012-1650-x; Baiano A, 2011, J AGR FOOD CHEM, V59, P9815, DOI 10.1021/jf203003c; Bavaresco L, 2012, MINI-REV MED CHEM, V12, P1366; Bergqvist J, 2001, AM J ENOL VITICULT, V52, P1; Bindon KA, 2014, J AGR FOOD CHEM, V62, P1130, DOI 10.1021/jf4050606; Boido E, 2011, AUST J GRAPE WINE R, V17, P383, DOI 10.1111/j.1755-0238.2011.00164.x; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Burns J, 2000, J AGR FOOD CHEM, V48, P220, DOI 10.1021/jf9909757; Cheng YF, 2008, THESIS NW A F U; Chorti E, 2010, AM J ENOL VITICULT, V61, P23; Cohen SD, 2012, J EXP BOT, V63, P2655, DOI 10.1093/jxb/err449; Cohen SD, 2010, CRIT REV FOOD SCI, V50, P620, DOI 10.1080/10408390802603441; Coombe B. G., 2004, VITICULTURE, V1, P210; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; Cortell JM, 2006, J AGR FOOD CHEM, V54, P8510, DOI 10.1021/jf0616560; Cortell JM, 2005, J AGR FOOD CHEM, V53, P5798, DOI 10.1021/jf0504770; Di Majo D, 2008, FOOD CHEM, V111, P45, DOI 10.1016/j.foodchem.2008.03.037; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Downey MO, 2004, AUST J GRAPE WINE R, V10, P55, DOI 10.1111/j.1755-0238.2004.tb00008.x; Fanzone M, 2011, J AGR FOOD CHEM, V59, P6120, DOI 10.1021/jf200073k; Casassa LF, 2014, ANNU REV FOOD SCI T, V5, P83, DOI 10.1146/annurev-food-030713-092438; Fournand D, 2006, J AGR FOOD CHEM, V54, P7331, DOI 10.1021/jf061467h; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hara M, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P235, DOI 10.1007/978-1-4614-0634-1_13; Haselgrove L., 2000, Australian Journal of Grape and Wine Research, V6, P141, DOI 10.1111/j.1755-0238.2000.tb00173.x; Jayaprakasha GK, 2001, FOOD CHEM, V73, P285, DOI 10.1016/S0308-8146(00)00298-3; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kontoudakis N, 2011, FOOD CHEM, V124, P767, DOI 10.1016/j.foodchem.2010.06.093; Kreft S, 2002, J EXP BOT, V53, P1801, DOI 10.1093/jxb/erf032; Letaief H, 2008, AM J ENOL VITICULT, V59, P323; Li H, 2008, J FOOD DRUG ANAL, V16, P67; Li YG, 1996, J SCI FOOD AGR, V70, P89, DOI 10.1002/(SICI)1097-0010(199601)70:1&lt;89::AID-JSFA470&gt;3.0.CO;2-N; Lo Scalzo R, 2007, ITAL J FOOD SCI, V19, P329; Lutz M, 2011, J FOOD SCI, V76, pC1088, DOI 10.1111/j.1750-3841.2011.02298.x; Mavi A, 2004, BIOL PHARM BULL, V27, P702, DOI 10.1248/bpb.27.702; Meng JF., 2011, THESIS NW A F U; Meng JF, 2012, FOOD CHEM, V134, P2049, DOI 10.1016/j.foodchem.2012.04.005; *OIV, 2005, REC METH INT AN VINS, V1; Poudel PR, 2008, J FOOD COMPOS ANAL, V21, P622, DOI 10.1016/j.jfca.2008.07.003; Segade SR, 2011, LWT-FOOD SCI TECHNOL, V44, P392, DOI 10.1016/j.lwt.2010.09.004; Rolle L, 2015, FOOD CHEM, V173, P105, DOI 10.1016/j.foodchem.2014.10.033; Rolle L, 2012, AM J ENOL VITICULT, V63, P195, DOI 10.5344/ajev.2012.11069; Rolle L, 2011, J AGR FOOD CHEM, V59, P8796, DOI 10.1021/jf201318x; Rolle L, 2011, J SCI FOOD AGR, V91, P505, DOI 10.1002/jsfa.4213; Rolle L, 2009, AM J ENOL VITICULT, V60, P93; Segade SR, 2013, INT J FOOD SCI TECH, V48, P103, DOI 10.1111/j.1365-2621.2012.03164.x; Song Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0078566, 10.1371/journal.pone.0088106]; Sroka Z, 2003, FOOD CHEM TOXICOL, V41, P753, DOI 10.1016/S0278-6915(02)00329-0; Stojanovic J, 2007, FOOD CHEM, V101, P898, DOI 10.1016/j.foodchem.2006.02.044; Tang K, 2015, J FOOD SCI, V80, pC20, DOI 10.1111/1750-3841.12691; Torchio F, 2010, ANAL CHIM ACTA, V660, P183, DOI 10.1016/j.aca.2009.10.017; Van Leeuw R, 2014, J FOOD COMPOS ANAL, V36, P40, DOI 10.1016/j.jfca.2014.07.001; Vidal S, 2004, ANAL CHIM ACTA, V513, P57, DOI 10.1016/j.aca.2003.10.017; vonGadow A, 1997, FOOD CHEM, V60, P73, DOI 10.1016/S0308-8146(96)00312-3; Wood LG, 2006, J SCI FOOD AGR, V86, P2057, DOI 10.1002/jsfa.2604; Xanthopoulou MN, 2010, FOOD CHEM, V120, P665, DOI 10.1016/j.foodchem.2009.10.058; Xu CM, 2010, FOOD CHEM, V119, P1557, DOI 10.1016/j.foodchem.2009.09.042; Yeh CW, 2003, PHARMACOGENOMICS J, V3, P267, DOI 10.1038/sj.tpj.6500192; Yilmaz Y, 2015, J FOOD PROCESS PRES, V39, P1682, DOI 10.1111/jfpp.12399; Zouid I, 2013, J TEXTURE STUD, V44, P95, DOI 10.1111/jtxs.12001	61	11	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151276	10.1371/journal.pone.0151276	http://dx.doi.org/10.1371/journal.pone.0151276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974974	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600062
J	Maier-Noth, A; Schaal, B; Leathwood, P; Issanchou, S				Maier-Noeth, Andrea; Schaal, Benoist; Leathwood, Peter; Issanchou, Sylvie			The Lasting Influences of Early Food-Related Variety Experience: A Longitudinal Study of Vegetable Acceptance from 5 Months to 6 Years in Two Populations	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; REPEATED EXPOSURE; FLAVOR-FLAVOR; PRESCHOOL-CHILDREN; INCREASE; INFANTS; LIFE; PREFERENCES; PATTERNS; CHILDHOOD	Children's vegetable consumption falls below current recommendations, highlighting the need to identify strategies that can successfully promote better acceptance of vegetables. Recently, experimental studies have reported promising interventions that increase acceptance of vegetables. The first, offering infants a high variety of vegetables at weaning, increased acceptance of new foods, including vegetables. The second, offering an initially disliked vegetable at 8 subsequent meals markedly increased acceptance for that vegetable. So far, these effects have been shown to persist for at least several weeks. We now present follow-up data at 15 months, 3 and 6 years obtained through questionnaire (15 mo, 3y) and experimental (6y) approaches. At 15 months, participants who had been breast-fed were reported as eating and liking more vegetables than those who had been formula-fed. The initially disliked vegetable that became accepted after repeated exposure was still liked and eaten by 79% of the children. At 3 years, the initially disliked vegetable was still liked and eaten by 73% of the children. At 6 years, observations in an experimental setting showed that children who had been breast-fed and children who had experienced high vegetable variety at the start of weaning ate more of new vegetables and liked them more. They were also more willing to taste vegetables than formula-fed children or the no or low variety groups. The initially disliked vegetable was still liked by 57% of children. This follow-up study suggests that experience with chemosensory variety in the context of breastfeeding or at the onset of complementary feeding can influence chemosensory preferences for vegetables into childhood.	[Maier-Noeth, Andrea; Leathwood, Peter] Nestle Res Ctr, POB 44, CH-1000 Lausanne 26, Switzerland; [Schaal, Benoist; Issanchou, Sylvie] CNRS, Ctr Sci Gout & Alimentat UMR6265, F-21000 Dijon, France; [Schaal, Benoist; Issanchou, Sylvie] INRA, Ctr Sci Gout & Alimentat UMR1324, F-21000 Dijon, France; [Schaal, Benoist; Issanchou, Sylvie] Univ Bourgogne Franche Comte, UMR Ctr Sci Gout & Alimentat, F-21000 Dijon, France; [Maier-Noeth, Andrea] Lebensmittelforschung GmbH, Dept Consumer LINK, Nestle Prod Technol Ctr, Singen, Germany	Nestle SA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Nestle SA	Issanchou, S (corresponding author), CNRS, Ctr Sci Gout & Alimentat UMR6265, F-21000 Dijon, France.; Issanchou, S (corresponding author), INRA, Ctr Sci Gout & Alimentat UMR1324, F-21000 Dijon, France.; Issanchou, S (corresponding author), Univ Bourgogne Franche Comte, UMR Ctr Sci Gout & Alimentat, F-21000 Dijon, France.	Sylvie.Issanchou@dijon.inra.fr			Nestle Nutrition	Nestle Nutrition(Nestle SA)	Nestle Nutrition provided funds to Inra to conduct the study. Authors AM and PL were employed by Nestle Research Center when the studies were designed and executed. Nestle provided support in the form of salaries for authors AM and PL. The specific roles of these authors are articulated in the 'author contributions' section. Nestle did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EC, 2012, PUBLIC HEALTH NUTR, V15, P1705, DOI 10.1017/S1368980012002686; Ahern SM, 2014, APPETITE, V80, P154, DOI 10.1016/j.appet.2014.04.016; Allam MDE, 2010, DEVELOPMENTAL SCI, V13, P849, DOI 10.1111/j.1467-7687.2009.00941.x; [Anonymous], 2004, YOUNG PEOPLES HLTH C; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Bouhlal S, 2014, APPETITE, V83, P209, DOI 10.1016/j.appet.2014.07.032; Burnier D, 2011, EUR J CLIN NUTR, V65, P196, DOI 10.1038/ejcn.2010.238; Carruth BR, 2004, J AM DIET ASSOC, V104, pS57, DOI 10.1016/j.jada.2003.10.024; CASHDAN E, 1994, HUM NATURE-INT BIOS, V5, P279, DOI 10.1007/BF02692155; Caton SJ, 2013, BRIT J NUTR, V109, P2089, DOI 10.1017/S0007114512004126; Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527; de Lauzon-Guillain B, 2013, AM J CLIN NUTR, V98, P804, DOI 10.3945/ajcn.112.057026; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Wild V, 2015, PEDIATR OBES, V10, P205, DOI 10.1111/ijpo.244; Gerrish CJ, 2001, AM J CLIN NUTR, V73, P1080; Grieger JA, 2011, PUBLIC HEALTH NUTR, V14, P1939, DOI 10.1017/S1368980011001030; Haller R, 1999, CHEM SENSES, V24, P465, DOI 10.1093/chemse/24.4.465; Hausner H, 2012, APPETITE, V58, P1152, DOI 10.1016/j.appet.2012.03.009; Hausner H, 2010, CLIN NUTR, V29, P141, DOI 10.1016/j.clnu.2009.11.007; Hepper PG, 2013, DEV PSYCHOBIOL, V55, P568, DOI 10.1002/dev.21059; KIMMEL SA, 1994, FOOD TECHNOL-CHICAGO, V48, P92; KUCZYNSKI L, 1990, DEV PSYCHOL, V26, P398, DOI 10.1037/0012-1649.26.3.398; Lin JiaRong, 2003, Nutritional Sciences Journal, V28, P104; Maier A, 2007, APPETITE, V49, P429, DOI 10.1016/j.appet.2007.02.007; Maier A, 2007, FOOD QUAL PREFER, V18, P1023, DOI 10.1016/j.foodqual.2007.04.005; Maier AS, 2008, CLIN NUTR, V27, P849, DOI 10.1016/j.clnu.2008.08.002; Mennella JA, 2002, EARLY HUM DEV, V68, P71, DOI 10.1016/S0378-3782(02)00008-7; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Nicklaus S, 2005, ACTA PAEDIATR, V94, P1023, DOI 10.1080/08035250510025761; Nicklaus S, 2004, FOOD QUAL PREFER, V15, P805, DOI 10.1016/j.foodqual.2004.02.010; Remy E, 2013, J NUTR, V143, P1194, DOI 10.3945/jn.113.175646; Schaal B, 2006, WOODHEAD PUBL FOOD S, P403, DOI 10.1533/9781845691400.3.403; SCHAAL B, 2005, PRENATAL DEV POSTNAT, V2, P51; Scott JA, 2012, NUTRIENTS, V4, P1464, DOI 10.3390/nu4101464; Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9; SULLIVAN SA, 1994, PEDIATRICS, V93, P271; Wardle J, 2003, APPETITE, V40, P155, DOI 10.1016/S0195-6663(02)00135-6; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	38	62	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151356	10.1371/journal.pone.0151356	http://dx.doi.org/10.1371/journal.pone.0151356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968029	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200047
J	Wu, CK; Chang, KC; Tseng, PL; Lu, SN; Chen, CH; Wang, JH; Lee, CM; Lin, MT; Yen, YH; Hung, CH; Hu, TH				Wu, Cheng-Kung; Chang, Kuo-Chin; Tseng, Po-Lin; Lu, Sheng-Nan; Chen, Chien-Hung; Wang, Jing-Houng; Lee, Chuan-Mo; Lin, Ming-Tsung; Yen, Yi-Hao; Hung, Chao-Hung; Hu, Tsung-Hui			Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; NORMAL AMINOTRANSFERASE LEVELS; KDA PLUS RIBAVIRIN; VIRUS CARRIERS; DISEASE; INTERFERON-ALPHA-2B; COMBINATION; PROGRESSION; MANAGEMENT; DIAGNOSIS	Background and Aims Patients with chronic hepatitic C (HCV) infection and normal serum alanine transaminase (ALT) levels were considered to have mild disease. In Taiwan, these patients were not suggested for interferon (IFN) based therapies. The aim of study is to compare therapeutic outcomes between HCV patients with normal and elevated ALT levels. Methods We conducted a retrospective study on 3241 HCV patients treated by IFN based therapies. Patients with normal ALT levels were classified as group A (n = 186) while those with elevated ALT levels were group B (n = 3055). Results At baseline, incidence of diabetes mellitus, low platelet counts and cirrhosis were significantly higher in group B patients. The sustained virologic response (SVR) rate was comparable between the 2 groups (65.3% vs. 65.3%, P = .993). But significantly higher incidence of HCC development after HCV treatment was observed in group B (7.4% vs. 3.2%, P = .032). No significant differences with respect to the outcome of liver decompensation, spontaneous bacterial peritonitis, and mortality were noted between 2 groups. Multivariate analysis showed younger age, female gender, non-HCV genotype 1, lower viral load, higher platelet counts and non-cirrhosis were favorable factors for achieving SVR, rather than ALT levels. Further analysis revealed older age, cirrhosis, lower platelet levels and non-peg-interferon treatment are risk factors of HCC development. Conclusions HCV patients with normal ALT levels had similar response to antiviral therapy and low rate of HCC development after therapy. Antiviral therapies begun at early course of HCV infection may be beneficial to prevent disease progression.	[Hu, Tsung-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	dr.hu@msa.hinet.net						Arora S, 2006, J GASTROEN HEPATOL, V21, P406, DOI 10.1111/j.1440-1746.2005.04059.x; Bacon BR, 2002, HEPATOLOGY, V36, pS179, DOI 10.1053/jhep.2002.36386; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Deuffic-Burban S, 2009, HEPATOLOGY, V50, P1351, DOI 10.1002/hep.23159; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; HEALEY CJ, 1995, GUT, V37, P274, DOI 10.1136/gut.37.2.274; Hornberger J, 2006, J VIRAL HEPATITIS, V13, P377, DOI 10.1111/j.1365-2893.2005.00700.x; Hui CK, 2007, ALIMENT PHARM THER, V25, P1283, DOI 10.1111/j.1365-2036.2007.03318.x; Hui CK, 2003, J HEPATOL, V38, P511, DOI 10.1016/S0168-8278(03)00004-7; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Inglesby TV, 1999, HEPATOLOGY, V29, P590, DOI 10.1002/hep.510290219; Jacobson IM, 2004, AM J GASTROENTEROL, V99, P1700, DOI 10.1111/j.1572-0241.2004.30049.x; Jamal MM, 1999, HEPATOLOGY, V30, P1307, DOI 10.1002/hep.510300526; Kumada T, 2009, J HEPATOL, V50, P729, DOI 10.1016/j.jhep.2008.11.019; Kyrlagkitsis L, 2003, AM J GASTROENTEROL, V98, P1588, DOI [10.1016/S0002-9270(03)00368-X, 10.1111/j.1572-0241.2003.07539.x]; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Marcellin P, 1997, HEPATOLOGY, V26, pS133, DOI 10.1002/hep.510260723; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Okanoue T, 2005, J HEPATOL, V43, P599, DOI 10.1016/j.jhep.2005.04.008; Persico M, 2006, J VIRAL HEPATITIS, V13, P290, DOI 10.1111/j.1365-2893.2005.00667.x; Prati D, 2010, DIGEST LIVER DIS, V42, P81, DOI 10.1016/j.dld.2009.08.001; Puoti C, 2000, DIGEST LIVER DIS, V32, P634, DOI 10.1016/S1590-8658(00)80850-6; Puoti C, 2003, J HEPATOL, V38, P529, DOI 10.1016/S0168-8278(03)00018-7; Sanai FM, 2008, LIVER INT, V28, P1011, DOI 10.1111/j.1478-3231.2008.01733.x; Shiffman ML, 2006, CLIN GASTROENTEROL H, V4, P645, DOI 10.1016/j.cgh.2006.02.002; Simin M, 2007, ALIMENT PHARM THER, V25, P1153, DOI 10.1111/j.1365-2036.2007.03294.x; Tassopoulos NC, 1999, J HEPATOL, V30, P956; Yu ML, 2006, LIVER INT, V26, P1187, DOI 10.1111/j.1478-3231.2006.01358a.x; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0142378	10.1371/journal.pone.0142378	http://dx.doi.org/10.1371/journal.pone.0142378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968010	Green Published, gold, Green Submitted			2022-12-27	WOS:000371989200001
J	De Gasperin, O; Kilner, RM				De Gasperin, Ornela; Kilner, Rebecca M.			Interspecific Interactions and the Scope for Parent-Offspring Conflict: High Mite Density Temporarily Changes the Trade-Off between Offspring Size and Number in the Burying Beetle, Nicrophorus vespilloides	PLOS ONE			English	Article							PHORETIC MITES; CLUTCH SIZE; EGG SIZE; TACTICS; SILPHIDAE; ASSOCIATIONS; NECROPHORUS; ENVIRONMENT; COMPETITION; COLEOPTERA	Parents have a limited amount of resources to invest in reproduction and commonly trade-off how much they invest in offspring size (or quality) versus brood size. A negative relationship between offspring size and number has been shown in numerous taxa and it underpins evolutionary conflicts of interest between parents and their young. For example, previous work on vertebrates shows that selection favours mothers that produce more offspring, at the expense of individual offspring size, yet favours offspring that have relatively few siblings and therefore attain a greater size at independence. Here we analyse how this trade-off is temporarily affected by stochastic variation in the intensity of interspecific interactions. We examined the effect of the mite Poecilochirus carabi on the relationship between offspring size and number in the burying beetle, Nicrophorus vespilloides. We manipulated the initial number of mites in the reproductive event (by introducing either no mites, 4 mites, 10 mites, or 16 mites), and assessed the effect on the brood. We found a similar trade-off between offspring size and number in all treatments, except in the '16 mite' treatment where the correlation between offspring number and size flattened considerably. This effect arose because larvae in small broods failed to attain a high mass by dispersal. Our results show that variation in the intensity of interspecific interactions can temporarily change the strength of the trade-off between offspring size and number. In this study, high densities of mites prevented individual offspring from attaining their optimal weight, thus potentially temporarily biasing the outcome of parent-offspring conflict in favour of parents.	[De Gasperin, Ornela; Kilner, Rebecca M.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England	University of Cambridge	De Gasperin, O (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	ornela.gasperin@gmail.com	Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758; De Gasperin, Ornela/0000-0003-3415-2072	Cambridge Trust; Mexican Council for Science and Technology (CONACyT); European Research Council (ERC) [310785]; Royal Society	Cambridge Trust; Mexican Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); European Research Council (ERC)(European Research Council (ERC)European Commission); Royal Society(Royal Society of London)	ODeG was supported by the Cambridge Trust and by the Mexican Council for Science and Technology (CONACyT). RMK was supported in part by the European Research Council (ERC) Consolidators grant 310785 BALDWINIAN_BEETLES and by a Wolfson Merit Award from the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BARTLETT J, 1987, BEHAV ECOL SOCIOBIOL, V21, P179, DOI 10.1007/BF00303208; Bates D., 2012, IME4 LINEAR MIXED EF; Boncoraglio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031713; BROWN JM, 1992, ECOLOGY, V73, P463, DOI 10.2307/1940753; De Gasperin O, 2015, ECOL EVOL, V5, P5552, DOI 10.1002/ece3.1795; De Gasperin O, 2015, ECOL ENTOMOL, V40, P787, DOI 10.1111/een.12259; De Gasperin O, 2015, ANIM BEHAV, V109, P199, DOI 10.1016/j.anbehav.2015.08.014; EBERT D, 1993, ARCH HYDROBIOL, P453; EGGERT AK, 1992, BEHAV ECOL SOCIOBIOL, V31, P237, DOI 10.1007/BF00171678; EGGERT AK, 1992, BEHAV ECOL, V3, P243, DOI 10.1093/beheco/3.3.243; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Fleming I. A., 1990, ECOLOGY, V71, P2, DOI DOI 10.2307/1940241; Fox J, 2015, CAR COMPANION APPL R; GLIWICZ ZM, 1992, OECOLOGIA, V91, P463, DOI 10.1007/BF00650317; Godfray HCJ, 1995, AM NAT, P1; Guisande C, 1996, MAR ECOL PROG SER, V143, P37, DOI 10.3354/meps143037; Hopwood PE, 2016, ECOL ENTOMOL, V41, P96, DOI 10.1111/een.12275; House CM, 2007, P ROY SOC B-BIOL SCI, V274, P1309, DOI 10.1098/rspb.2007.0054; Janzen FJ, 2009, J EVOLUTION BIOL, V22, P2222, DOI 10.1111/j.1420-9101.2009.01838.x; Kilner RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07340; Kilner RM, 2012, EVOLUTION OF PARENTAL CARE, P119; Kilner RM, 2012, ADV STUD BEHAV, V38, P283; Lyon BE, 1998, NATURE, V392, P380, DOI 10.1038/32878; MOCK DW, 1992, TRENDS ECOL EVOL, V7, P409, DOI 10.1016/0169-5347(92)90022-4; Muller JK, 2007, BEHAV ECOL, V18, P196, DOI 10.1093/beheco/arl073; Muller J.K., 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P23; Muller JK, 2003, BEHAV ECOL, V14, P212, DOI 10.1093/beheco/14.2.212; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; PUKOWSKI ERNA, 1933, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V27, P518, DOI 10.1007/BF00403155; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauter CM, 2010, BIOSCENE J COLL BIOL, V36, P6; Rozen DE, 2008, P NATL ACAD SCI USA, V105, P17890, DOI 10.1073/pnas.0805403105; Schrader M, 2015, EVOLUTION, V69, P1077, DOI 10.1111/evo.12615; SCHWARZ HH, 1992, OECOLOGIA, V89, P487, DOI 10.1007/BF00317154; Schwarz HH, 1998, J NAT HIST, V32, P159, DOI 10.1080/00222939800770101; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; Smiseth PT, 2005, ANIM BEHAV, V69, P551, DOI 10.1016/j.anbehav.2004.06.004; Smith HG, 1989, PARUS MAJOR J ANIM E, V58, P383, DOI [10.2307/ 4837), DOI 10.2307/4837)]; SPRINGETT BP, 1968, J ANIM ECOL, V37, P417, DOI 10.2307/2957; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; TRUMBO ST, 1990, J INSECT BEHAV, V3, P491, DOI 10.1007/BF01052013; Ward RJ, 2009, BEHAV ECOL; Wilson AJ, 2009, J ANIM ECOL, V78, P354, DOI 10.1111/j.1365-2656.2008.01489.x; Wilson AJ, 2005, J EVOLUTION BIOL, V18, P405, DOI 10.1111/j.1420-9101.2004.00824.x; Wilson DS, 1987, EVOL ECOL, V1, P139, DOI 10.1007/BF02067397	46	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150969	10.1371/journal.pone.0150969	http://dx.doi.org/10.1371/journal.pone.0150969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985819	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300039
J	Husseneder, C; Donaldson, JR; Foil, LD				Husseneder, Claudia; Donaldson, Jennifer R.; Foil, Lane D.			Genetically Engineered Yeast Expressing a Lytic Peptide from Bee Venom (Melittin) Kills Symbiotic Protozoa in the Gut of Formosan Subterranean Termites	PLOS ONE			English	Article							ISOPTERA; RHINOTERMITIDAE; BACTERIA	The Formosan subterranean termite, Coptotermes formosanus Shiraki, is a costly invasive urban pest in warm and humid regions around the world. Feeding workers of the Formosan subterranean termite genetically engineered yeast strains that express synthetic protozoacidal lytic peptides has been shown to kill the cellulose digesting termite gut protozoa, which results in death of the termite colony. In this study, we tested if Melittin, a natural lytic peptide from bee venom, could be delivered into the termite gut via genetically engineered yeast and if the expressed Melittin killed termites via lysis of symbiotic protozoa in the gut of termite workers and/or destruction of the gut tissue itself. Melittin expressing yeast did kill protozoa in the termite gut within 56 days of exposure. The expressed Melittin weakened the gut but did not add a synergistic effect to the protozoacidal action by gut necrosis. While Melittin could be applied for termite control via killing the cellulose-digesting protozoa in the termite gut, it is unlikely to be useful as a standalone product to control insects that do not rely on symbiotic protozoa for survival.	[Husseneder, Claudia; Donaldson, Jennifer R.; Foil, Lane D.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Husseneder, C (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	chusseneder@agcenter.lsu.edu		Husseneder, Claudia/0000-0001-5962-9354	Louisiana Agricultural Experiment Station	Louisiana Agricultural Experiment Station	This research was supported by funds from the Louisiana Agricultural Experiment Station to CH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechinger B, 1997, J MEMBRANE BIOL, V156, P197, DOI 10.1007/s002329900201; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; Culliney TW, 2000, B ENTOMOL RES, V90, P9, DOI 10.1017/S0007485300000031; Damianoglou A, 2010, PROTEIN PEPTIDE LETT, V17, P1351, DOI 10.2174/0929866511009011351; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; HIDER RC, 1988, ENDEAVOUR, V12, P60, DOI 10.1016/0160-9327(88)90082-8; Hurwitz I, 2011, INT J BIOL SCI, V7, P1334, DOI 10.7150/ijbs.7.1334; Husseneder C, 2005, APPL MICROBIOL BIOT, V68, P360, DOI 10.1007/s00253-005-1914-5; Husseneder C, 2005, CURR MICROBIOL, V50, P119, DOI 10.1007/s00284-004-4428-y; Husseneder C, 2009, INSECT SYMBIOSIS, V3, P361; Husseneder Claudia, 2010, J Vis Exp, DOI 10.3791/2190; IBM Corporation, 2014, IBM SPSS STAT WIND V; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; LAI P Y, 1983, Proceedings of the Hawaiian Entomological Society, V24, P271; Mutwiri GK, 2000, J PARASITOL, V86, P1355, DOI 10.1645/0022-3395(2000)086[1355:EOTAPD]2.0.CO;2; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Sethi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106199; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; Su N. Y., 1987, Research Extension Series, Hawaii Institute of Tropical Agriculture and Human Resources, P3; Valderrama MJ, 1999, J FOOD PROTECT, V62, P189, DOI 10.4315/0362-028X-62.2.189; YAMIN MA, 1979, SOCIOBIOLOGY, V4, P3; YOSHIMURA T, 1995, MOKUZAI GAKKAISHI, V41, P206; Yoshimura Tsuyoshi, 1995, Wood Research, V82, P68	25	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151675	10.1371/journal.pone.0151675	http://dx.doi.org/10.1371/journal.pone.0151675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985663	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300110
J	Matsubara, K; Yamamoto, E; Kobayashi, N; Ishii, T; Tanaka, J; Tsunematsu, H; Yoshinaga, S; Matsumura, O; Yonemaru, J; Mizobuchi, R; Yamamoto, T; Kato, H; Yano, M				Matsubara, Kazuki; Yamamoto, Eiji; Kobayashi, Nobuya; Ishii, Takuro; Tanaka, Junichi; Tsunematsu, Hiroshi; Yoshinaga, Satoshi; Matsumura, Osamu; Yonemaru, Jun-ichi; Mizobuchi, Ritsuko; Yamamoto, Toshio; Kato, Hiroshi; Yano, Masahiro			Improvement of Rice Biomass Yield through QTL-Based Selection	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; ORYZA-SATIVA L.; MARKER-ASSISTED SELECTION; COMPLEX TRAITS; ARABIDOPSIS-THALIANA; CULTIVARS; EPISTASIS; DISCOVERY; ALLELES	Biomass yield of rice (Oryza sativa L.) is an important breeding target, yet it is not easy to improve because the trait is complex and phenotyping is laborious. Using progeny derived from a cross between two high-yielding Japanese cultivars, we evaluated whether quantitative trait locus (QTL)-based selection can improve biomass yield. As a measure of biomass yield, we used plant weight (aboveground parts only), which included grain weight and stem and leaf weight. We measured these and related traits in recombinant inbred lines. Phenotypic values for these traits showed a continuous distribution with transgressive segregation, suggesting that selection can affect plant weight in the progeny. Four significant QTLs were mapped for plant weight, three for grain weight, and five for stem and leaf weight (at alpha = 0.05); some of them overlapped. Multiple regression analysis showed that about 43% of the phenotypic variance of plant weight was significantly explained (P < 0.0001) by six of the QTLs. From F-2 plants derived from the same parental cross as the recombinant inbred lines, we divergently selected lines that carried alleles with positive or negative additive effects at these QTLs, and performed successive selfing. In the resulting F-6 lines and parents, plant weight significantly differed among the genotypes (at alpha = 0.05). These results demonstrate that QTL-based selection is effective in improving rice biomass yield.	[Matsubara, Kazuki; Kobayashi, Nobuya; Ishii, Takuro; Tanaka, Junichi; Tsunematsu, Hiroshi; Kato, Hiroshi; Yano, Masahiro] NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Yamamoto, Eiji; Yonemaru, Jun-ichi; Mizobuchi, Ritsuko; Yamamoto, Toshio; Kato, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Yoshinaga, Satoshi; Matsumura, Osamu] NARO Agr Res Ctr, Niigata 9430154, Japan; [Yamamoto, Eiji] NARO Inst Vegetable & Tea Sci, Tsu, Mie 5142392, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Matsubara, K (corresponding author), NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan.	vague@affrc.go.jp	Matsubara, Kazuki/S-9378-2019; Yamamoto, Toshio/AAX-7146-2020; Yano, Masahiro/AAC-5441-2019	Matsubara, Kazuki/0000-0002-2084-8362; Yamamoto, Toshio/0000-0002-5209-7735; Yano, Masahiro/0000-0003-1510-4622	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan; Ministry of Agriculture, Forestry and Fisheries, Japan	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan; Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This project was supported by funding from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan, and Ministry of Agriculture, Forestry and Fisheries, Japan to Hiroshi KATO and Masahiro YANO.	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; CHURCHILL GA, 1994, GENETICS, V138, P963; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Goto A, 2009, JARQ-JPN AGR RES Q, V43, P13, DOI 10.6090/jarq.43.13; Grenier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136594; Hill WG, 2010, PHILOS T R SOC B, V365, P73, DOI 10.1098/rstb.2009.0203; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; JIANG CJ, 1995, GENETICS, V140, P1111; Juenger T, 2000, GENETICS, V156, P1379; LANDE R, 1990, GENETICS, V124, P743; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li ZK, 1997, GENETICS, V145, P453; Matsubara K, 2015, J HERED, V106, P113, DOI 10.1093/jhered/esu065; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Ohta H., 2010, B NATL I CROP SCI, V11, P67; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Poland J, 2015, CURR OPIN PLANT BIOL, V24, P119, DOI 10.1016/j.pbi.2015.02.009; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Wang S, 2012, WINDOWS QTL CARTOGRA; Xiao JH, 1998, GENETICS, V150, P899; Yamamoto E, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-50; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yamamoto T, 2009, DNA RES, V16, P141, DOI 10.1093/dnares/dsp006; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112; Yonemaru J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-346; Yonemaru J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032982; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151830	10.1371/journal.pone.0151830	http://dx.doi.org/10.1371/journal.pone.0151830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986071	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300137
J	Schafer, T				Schaefer, Thomas			The Goals and Effects of Music Listening and Their Relationship to the Strength of Music Preference	PLOS ONE			English	Article							EVERYDAY LIFE; PERSONALITY; ADOLESCENTS	Individual differences in the strength of music preference are among the most intricate psychological phenomena. While one person gets by very well without music, another person needs to listen to music every day and spends a lot of temporal and financial resources on listening to music, attending concerts, or buying concert tickets. Where do these differences come from? The hypothesis presented in this article is that the strength of music preference is mainly informed by the functions that music fulfills in people's lives (e.g., to regulate emotions, moods, or physiological arousal; to promote self-awareness; to foster social relatedness). Data were collected with a diary study, in which 121 respondents documented the goals they tried to attain and the effects that actually occurred for up to 5 music-listening episodes per day for 10 successive days. As expected, listeners reporting more intense experience of the functional use of music in the past (1) had a stronger intention to listen to music to attain specific goals in specific situations and (2) showed a larger overall strength of music preference. It is concluded that the functional effectiveness of music listening should be incorporated in existing models and frameworks of music preference to produce better predictions of interindividual differences in the strength of music preference. The predictability of musical style/genre preferences is also discussed with regard to the present results.	[Schaefer, Thomas] Tech Univ Chemnitz, Dept Psychol, Chemnitz, Germany	Technische Universitat Chemnitz	Schafer, T (corresponding author), Tech Univ Chemnitz, Dept Psychol, Chemnitz, Germany.	thomas.schaefer@psychologie.tu-chemnitz.de	Schäfer, Thomas/AEX-9673-2022	Schäfer, Thomas/0000-0002-9910-2642	Chemnitz University of Technology	Chemnitz University of Technology	The publication costs of this article were funded by the Chemnitz University of Technology (www.tu-chemnitz.de) in the funding programme Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R; ARNETT J, 1991, YOUTH SOC, V23, P76, DOI 10.1177/0044118X91023001004; ARNETT JJ, 1995, J YOUTH ADOLESCENCE, V24, P519, DOI 10.1007/BF01537054; BEHNE K.-E., 1997, PERCEPTION COGNITION, P143; Bonneville-Roussy A, 2013, J PERS SOC PSYCHOL, V105, P703, DOI 10.1037/a0033770; Chamorro-Premuzic T, 2012, PSYCHOL MUSIC, V40, P285, DOI 10.1177/0305735610381591; Chamorro-Premuzic T, 2010, PSYCHOL AESTHET CREA, V4, P205, DOI 10.1037/a0019210; Chemnitz University of Technology, 2002, COD COND ASS GOOD SC; Christensen T. C., 2003, J HAPPINESS STUD, V4, P53, DOI [10.1023/A:1023609306024, DOI 10.1023/A:1023609306024]; Cross I., 2008, OXFORD HDB MUSIC PSY, DOI [/10.1093/oxfordhb/9780199298457.001.0001, DOI 10.1093/OXFORDHB/9780199298457.001.0001]; Deutsch D, 2008, PSYCHOL MUSIC; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Finnas L., 1989, B COUNCIL RES MUSIC, V102, P1; Frith S., 1996, PERFORMING RITES VAL; German Psychological Society, 2005, ETH RICHTL DGPS BDP; Getz LM, 2012, PSYCHOL MUSIC, V40, P164, DOI 10.1177/0305735610381818; Hargreaves D. J., 1999, PSYCHOL MUSIC, V27, P71, DOI [10.1177/0305735699271007, DOI 10.1177/0305735699271007]; Hargreaves D. J., 2005, MUSICAL COMMUNICATIO, P1, DOI DOI 10.1093/ACPROF:OSO/9780198529361.003.0001; Hargreaves D. J., 1982, PSYCHOL MUSIC; Harter S., 1999, CONSTRUCTION SELF; HARTUP WW, 1989, AM PSYCHOL, V44, P120, DOI 10.1037/0003-066X.44.2.120; HOLBROOK MB, 1989, J CONSUM RES, V16, P119, DOI 10.1086/209200; Kleinen G, 1994, PSYCHOL WIRKLICHKEIT; Kopiez R., 2008, BRIT J MUSIC EDUC, V25, P121, DOI [10.1017/S0265051708007882, DOI 10.1017/S0265051708007882]; Langmeyer A, 2012, J INDIVID DIFFER, V33, P119, DOI 10.1027/1614-0001/a000082; LARSON R, 1995, J YOUTH ADOLESCENCE, V24, P535, DOI 10.1007/BF01537055; LEBLANC A, 1982, J MUSIC THER, V19, P28, DOI 10.1093/jmt/19.1.28; Lehmann Andreas C., 1994, HABITUELLE SITUATIVE; McNamara L, 1999, GENET SOC GEN PSYCH, V125, P229; North A., 2008, SOCIAL APPL PSYCHOL; Rentfrow PJ, 2012, SOC PERSONAL PSYCHOL, V6, P402, DOI 10.1111/j.1751-9004.2012.00434.x; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; Schafer T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00511; Schafer T, 2010, PSYCHOL AESTHET CREA, V4, P223, DOI 10.1037/a0018374; Schafer T, 2009, PSYCHOL MUSIC, V37, P279, DOI 10.1177/0305735608097247; Schafer T, 2015, MUSIC SCI; van Goethem A, 2011, MUSIC SCI, V15, P208, DOI 10.1177/1029864911401174; Zweigenhaft RL, 2008, J INDIVID DIFFER, V29, P45, DOI 10.1027/1614-0001.29.1.45	38	28	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151634	10.1371/journal.pone.0151634	http://dx.doi.org/10.1371/journal.pone.0151634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26985998	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300100
J	Luchsinger, H; Sandbakk, O; Schubert, M; Ettema, G; Baumeister, J				Luchsinger, Harri; Sandbakk, Oyvind; Schubert, Michael; Ettema, Gertjan; Baumeister, Jochen			A Comparison of Frontal Theta Activity During Shooting among Biathletes and Cross-Country Skiers before and after Vigorous Exercise	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; WORKING-MEMORY; MIDLINE-THETA; CORTICAL ACTIVATION; EEG DYNAMICS; TASK; PERFORMANCE; NETWORKS; CORTEX; POWER	Background Previous studies using electroencephalography (EEG) to monitor brain activity have linked higher frontal theta activity to more focused attention and superior performance in goal-directed precision tasks. In biathlon, shooting performance requires focused attention after high-intensity cross-country skiing. Purpose To compare biathletes (serving as experts) and cross-country skiers (novices) and examine the effect of vigorous exercise on frontal theta activity during shooting. Methods EEG frontal theta (4-7 Hz) activity was compared between nine biathletes and eight cross-country skiers at comparable skiing performance levels who fired 100 shots on a 5-m indoor shooting range in quiescent condition followed by 20 shots after each of five 6-min high-intensity roller skiing sessions in the skating technique on a treadmill. Results Biathletes hit 80 +/- 14% and 81 +/- 10% before and after the roller skiing sessions, respectively. For the cross-country skiers these values were significantly lower than for the biathletes and amounted to 39 +/- 13% and 44 +/- 11% (p<0.01). Biathletes had on average 6% higher frontal theta activity during shooting as compared to cross-country skiers (F1,15 = 4.82, p = 0.044), but no significant effect of vigorous exercise on frontal theta activity in either of the two groups were found (F1,15 = 0.14, p = 0.72). Conclusions Biathletes had significantly higher frontal theta activity than cross-country skiers during shooting, indicating higher focused attention in biathletes. Vigorous exercise did not decrease shooting performance or frontal theta activity during shooting in biathletes and cross-country skiers.	[Luchsinger, Harri; Sandbakk, Oyvind; Ettema, Gertjan] Norwegian Univ Sci & Technol, Dept Neurosci, Ctr Elite Sports Res, N-7034 Trondheim, Norway; [Schubert, Michael; Baumeister, Jochen] Univ Paderborn, Inst Sports Med, Dept Exercise & Hlth, Warburger Str, D-33098 Paderborn, Germany	Norwegian University of Science & Technology (NTNU); University of Paderborn	Sandbakk, O (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Ctr Elite Sports Res, N-7034 Trondheim, Norway.	oyvind.sandbakk@ntnu.no	Baumeister, Jochen/ABI-1269-2020; Ettema, Gertjan/C-2104-2018	Baumeister, Jochen/0000-0003-2683-5826; 				Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baumeister J, 2008, EUR J APPL PHYSIOL, V104, P625, DOI 10.1007/s00421-008-0811-x; Baumeister J, 2012, EUR J APPL PHYSIOL, V112, P2475, DOI 10.1007/s00421-011-2215-6; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Chuang LY, 2013, INT J PSYCHOPHYSIOL, V90, P321, DOI 10.1016/j.ijpsycho.2013.10.002; Cohen MX, 2013, CEREB CORTEX, V23, P1061, DOI 10.1093/cercor/bhs069; Del Percio C, 2009, HUM BRAIN MAPP, V30, P3527, DOI 10.1002/hbm.20776; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doppelmayr A, 2008, NEUROPSYCHOLOGIA, V46, P1463, DOI 10.1016/j.neuropsychologia.2007.12.026; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gudmundsson S, 2007, CLIN NEUROPHYSIOL, V118, P2162, DOI 10.1016/j.clinph.2007.06.018; Haufler AJ, 2000, BIOL PSYCHOL, V53, P131, DOI 10.1016/S0301-0511(00)00047-8; HOFFMAN MD, 1992, INT J SPORTS MED, V13, P390, DOI 10.1055/s-2007-1021286; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ihalainen S, 2016, SCAND J MED SCI SPOR, V26, P266, DOI 10.1111/sms.12440; International Biathlon Union, BIATHL RUL AD 2012 1; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Janelle CM, 2000, J SPORT EXERCISE PSY, V22, P167, DOI 10.1123/jsep.22.2.167; Janer K, 1990, J COGNITIVE NEUROSCI, V3, P231; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Loze GM, 2001, J SPORT SCI, V19, P727, DOI 10.1080/02640410152475856; Makeig S, 1996, ADV NEUR IN, V8, P145; Miyakoshi M, 2013, IEEE ENG MED BIO, P3282, DOI 10.1109/EMBC.2013.6610242; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Tsujimoto T, 2006, J NEUROPHYSIOL, V95, P2987, DOI 10.1152/jn.00730.2005; Ullsperger M, 2014, TRENDS COGN SCI, V18, P259, DOI 10.1016/j.tics.2014.02.009; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a	30	25	25	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150461	10.1371/journal.pone.0150461	http://dx.doi.org/10.1371/journal.pone.0150461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981639	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900041
J	Shah, NS; Ridgway, JP; Pettit, N; Fahrenbach, J; Robicsek, A				Shah, Nirav S.; Ridgway, Jessica P.; Pettit, Natasha; Fahrenbach, John; Robicsek, Ari			Documenting Penicillin Allergy: The Impact of Inconsistency	PLOS ONE			English	Article							IMMEDIATE HYPERSENSITIVITY REACTIONS; HOSPITALIZED-PATIENTS; CARE; PREVALENCE; VARIABILITY	Background Allergy documentation is frequently inconsistent and incomplete. The impact of this variability on subsequent treatment is not well described. Objective To determine how allergy documentation affects subsequent antibiotic choice. Design Retrospective, cohort study. Participants 232,616 adult patients seen by 199 primary care providers (PCPs) between January 1, 2009 and January 1, 2014 at an academic medical system. Main Measures Inter-physician variation in beta-lactam allergy documentation; antibiotic treatment following beta-lactam allergy documentation. Key Results 15.6% of patients had a reported beta-lactam allergy. Of those patients, 39.8% had a specific allergen identified and 22.7% had allergic reaction characteristics documented. Variation between PCPs was greater than would be expected by chance (all p<0.001) in the percentage of their patients with a documented beta-lactam allergy (7.9% to 24.8%), identification of a specific allergen (e.g. amoxicillin as opposed to "penicillins") (24.0% to 58.2%) and documentation of the reaction characteristics (5.4% to 51.9%). After beta-lactam allergy documentation, patients were less likely to receive penicillins (Relative Risk [RR] 0.16 [95% Confidence Interval: 0.15-0.17]) and cephalosporins (RR 0.28 [95% CI 0.27-0.30]) and more likely to receive fluoroquinolones (RR 1.5 [95% CI 1.5-1.6]), clindamycin (RR 3.8 [95% CI 3.6-4.0]) and vancomycin (RR 5.0 [95% CI 4.3-5.8]). Among patients with beta-lactam allergy, rechallenge was more likely when a specific allergen was identified (RR 1.6 [95% CI 1.5-1.8]) and when reaction characteristics were documented (RR 2.0 [95% CI 1.8-2.2]). Conclusions Provider documentation of beta-lactam allergy is highly variable, and details of the allergy are infrequently documented. Classification of a patient as beta-lactam allergic and incomplete documentation regarding the details of the allergy lead to beta-lactam avoidance and use of other antimicrobial agents, behaviors that may adversely impact care quality and cost.	[Shah, Nirav S.; Ridgway, Jessica P.; Pettit, Natasha; Robicsek, Ari] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Fahrenbach, John; Robicsek, Ari] Northshore Univ HealthSyst, Dept Clin Analyt, Evanston, IL USA; [Robicsek, Ari] Northshore Univ HealthSyst, Dept Med, Evanston, IL USA	University of Chicago; NorthShore University Health System; NorthShore University Health System	Shah, NS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	Nss197@gmail.com		fahrenbach, john/0000-0001-6785-9707	NorthShore University HealthSystems	NorthShore University HealthSystems	AR received funding through NorthShore University HealthSystems, (http://www.northshore.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABSY M, 1994, SOUTHERN MED J, V87, P805, DOI 10.1097/00007611-199408000-00007; Albin S, 2014, ALLERGY ASTHMA PROC, V35, P489, DOI 10.2500/aap.2014.35.3791; Borch JE, 2006, BASIC CLIN PHARMACOL, V98, P357, DOI 10.1111/j.1742-7843.2006.pto_230.x; deShazo RD, 1997, JAMA-J AM MED ASSOC, V278, P1895, DOI 10.1001/jama.278.22.1895; Edelson DP, 2014, J HOSP MED, V9, P353, DOI 10.1002/jhm.2174; GADDE J, 1993, JAMA-J AM MED ASSOC, V270, P2456, DOI 10.1001/jama.270.20.2456; Hart JL, 2015, JAMA INTERN MED, V175, P1019, DOI 10.1001/jamainternmed.2015.0372; KERR JR, 1994, BRIT J CLIN PRACT, V48, P5; Lee CE, 2000, ARCH INTERN MED, V160, P2819, DOI 10.1001/archinte.160.18.2819; Likosky DS, 2014, J THORAC CARDIOV SUR, V148, P3084, DOI 10.1016/j.jtcvs.2014.07.106; LIN RY, 1992, ARCH INTERN MED, V152, P930, DOI 10.1001/archinte.152.5.930; MacLaughlin EJ, 2000, ARCH FAM MED, V9, P722, DOI 10.1001/archfami.9.8.722; Macy E, 2011, CLIN EXP ALLERGY, V41, P1498, DOI 10.1111/j.1365-2222.2011.03837.x; Macy E, 2009, PERM J, V13, P12; Macy E, 2014, J ALLERGY CLIN IMMUN, V133, P790, DOI 10.1016/j.jaci.2013.09.021; Macy E, 2013, J ALLER CL IMM-PRACT, V1, P258, DOI 10.1016/j.jaip.2013.02.002; Macy E, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.01.034; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; OSWALD NTA, 1983, BRIT MED J, V287, P265, DOI 10.1136/bmj.287.6387.265; PRESTON SL, 1994, AM J HOSP PHARM, V51, P79, DOI 10.1093/ajhp/51.1.79; Robinson JL, 2002, CLIN INFECT DIS, V35, P26, DOI 10.1086/340740; Sade K, 2003, CLIN EXP ALLERGY, V33, P501, DOI 10.1046/j.1365-2222.2003.01638.x; Salkind AR, 2001, JAMA-J AM MED ASSOC, V285, P2498, DOI 10.1001/jama.285.19.2498; SAXON A, 1987, ANN INTERN MED, V107, P204, DOI 10.7326/0003-4819-107-2-204; SOGN DD, 1992, ARCH INTERN MED, V152, P1025, DOI 10.1001/archinte.152.5.1025; Solensky R, 2000, ANN ALLERG ASTHMA IM, V84, P329, DOI 10.1016/S1081-1206(10)62782-2; Solensky R, 2003, CLIN REV ALLERG IMMU, V24, P201, DOI 10.1385/CRIAI:24:3:201; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Soto CM, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-22; SURTEES SJ, 1991, BRIT MED J, V302, P1051, DOI 10.1136/bmj.302.6784.1051; WEISS ME, 1988, CLIN ALLERGY, V18, P515, DOI 10.1111/j.1365-2222.1988.tb02904.x; WICKERN GM, 1994, J ALLERGY CLIN IMMUN, V94, P725, DOI 10.1016/0091-6749(94)90180-5; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; Wyatt JP, 1996, J ACCID EMERG MED, V13, P114	34	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150514	10.1371/journal.pone.0150514	http://dx.doi.org/10.1371/journal.pone.0150514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981866	gold, Green Published			2022-12-27	WOS:000372574900042
J	Barnard, S; Marshall-Pescini, S; Passalacqua, C; Beghelli, V; Capra, A; Normando, S; Pelosi, A; Valsecchi, P				Barnard, Shanis; Marshall-Pescini, Sarah; Passalacqua, Chiara; Beghelli, Valentina; Capra, Alexa; Normando, Simona; Pelosi, Annalisa; Valsecchi, Paola			Does Subjective Rating Reflect Behavioural Coding? Personality in 2 Month-Old Dog Puppies: An Open-Field Test and Adjective-Based Questionnaire	PLOS ONE			English	Article							CANIS-FAMILIARIS; DOMESTIC DOG; GUIDE DOGS; PREDICTIVE-VALIDITY; SERVICE DOGS; TEMPERAMENT; TRAITS; DIMENSIONS; BOLDNESS; METHODOLOGY	A number of studies have recently investigated personality traits in non-human species, with the dog gaining popularity as a subject species for research in this area. Recent research has shown the consistency of personality traits across both context and time for adult dogs, both when using questionnaire based methods of investigation and behavioural analyses of the dogs' behaviour. However, only a few studies have assessed the correspondence between these two methods, with results varying considerably across studies. Furthermore, most studies have focused on adult dogs, despite the fact that an understanding of personality traits in young puppies may be important for research focusing on the genetic basis of personality traits. In the current study, we sought to evaluate the correspondence between a questionnaire based method and the in depth analyses of the behaviour of 2-month old puppies in an open-field test in which a number of both social and non-social stimuli were presented to the subjects. We further evaluated consistency of traits over time by re-testing a subset of puppies. The correspondence between methods was high and test-retest consistency (for the main trait) was also good using both evaluation methods. Results showed clear factors referring to the two main personality traits 'extroversion,' (i.e. the enthusiastic, exuberant approach to the stimuli) and 'neuroticism,' (i.e. the more cautious and fearful approach to the stimuli), potentially similar to the shyness-boldness dimension found in previous studies. Furthermore, both methods identified an 'amicability' dimension, expressing the positive interactions the pups directed at the humans stranger, and a 'reservedness' dimension which identified pups who largely chose not to interact with the stimuli, and were defined as quiet and not nosey in the questionnaire.	[Barnard, Shanis; Pelosi, Annalisa; Valsecchi, Paola] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Marshall-Pescini, Sarah] Univ Vienna, Comparat Cognit, Messerli Res Inst, Univ Vet Med,Med Univ Vienna, Vienna, Austria; [Marshall-Pescini, Sarah] Wolf Sci Ctr, Ernstbrunn, Austria; [Passalacqua, Chiara] Univ Milan, Sez Neurosci, Dipartimento Fisiopatol Med Chirurg & Trapianti, Milan, Italy; [Beghelli, Valentina] Univ Bologna, Dipartimento Sci Med Vet, Bologna, Italy; [Capra, Alexa] Assoc Sport Dilettantist, Gentle Team, Asti, Italy; [Normando, Simona] Univ Padua, Dipartimento Biomed Comparata & Alimentaz, Padua, Italy; [Barnard, Shanis] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	University of Parma; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Milan; University of Bologna; University of Padua; Queens University Belfast	Marshall-Pescini, S (corresponding author), Univ Vienna, Comparat Cognit, Messerli Res Inst, Univ Vet Med,Med Univ Vienna, Vienna, Austria.; Marshall-Pescini, S (corresponding author), Wolf Sci Ctr, Ernstbrunn, Austria.	sarah.marshall@vetmeduni.ac.at	Barnard, Shanis/J-7151-2012	Valsecchi, Paola/0000-0002-0491-9845; Marshall-Pescini, Sarah/0000-0002-5944-4701	Universita di Parma; Universita di Milano; Universita di Bologna; Universita di Milan; European Research Council under the European Union [311870]	Universita di Parma; Universita di Milano; Universita di Bologna; Universita di Milan; European Research Council under the European Union(European Research Council (ERC))	Shanis Barnard, Chiara Passalacqua and Valentina Beghelli were supported by a doctoral grant from the Universita di Parma, Universita di Milano and Universita di Bologna respectively. Sarah Marshall-Pescini was supported by a postdoctoral grant from the Universita di Milan and funds from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. [311870]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrier LO, 2013, APPL ANIM BEHAV SCI, V146, P96, DOI 10.1016/j.applanim.2013.04.002; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; De Meester RH, 2008, J VET BEHAV, V3, P161, DOI 10.1016/j.jveb.2007.10.005; Diederich C, 2006, APPL ANIM BEHAV SCI, V97, P51, DOI 10.1016/j.applanim.2005.11.018; Dowling-Guyer S, 2011, APPL ANIM BEHAV SCI, V130, P107, DOI 10.1016/j.applanim.2010.12.004; Duffy D. L., 2008, J VET BEHAV, V3, P186, DOI DOI 10.1016/j.jveb.2007.12.010; Duffy DL, 2012, APPL ANIM BEHAV SCI, V138, P99, DOI 10.1016/j.applanim.2012.02.011; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; FUNDER DC, 1995, PSYCHOL REV, V102, P652, DOI 10.1037/0033-295X.102.4.652; Godbout M, 2011, EXCESSIVE MOUTHING P, V6, P93; Godbout M, 2007, J VET BEHAV, V2, P126, DOI 10.1016/j.jveb.2007.06.002; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; Goodmann P.A., 2002, WOLF ETHOGRAM; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Handelman B., 2012, CANINE BEHAV PHOTO I; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; JOHN OP, 1994, CHILD DEV, V65, P160, DOI 10.2307/1131373; John OP, 2007, IMPORTANCE BEING VAL, P461; Jolliffe IT, 1972, DISCARDING VARIABLES, P160; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kenny D. A, 1994, INTERPERSONAL PERCEP; Kline P., 2014, EASY GUIDE FACTOR AN; KOLER-MATZNICK J., 2005, ETHOGRAM NEW GUINEA; KRUGLANSKI AW, 1989, PSYCHOL BULL, V106, P395, DOI 10.1037/0033-2909.106.3.395; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kubinyi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030271; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2009, APPL ANIM BEHAV SCI, V119, P85, DOI 10.1016/j.applanim.2009.02.027; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; McDonald RP., 2014, FACTOR ANAL RELATED, DOI 10.4324/9781315802510; McGarrity ME, 2015, BEHAV PROCESS, V110, P117, DOI 10.1016/j.beproc.2014.09.029; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Mirko E, 2013, APPL ANIM BEHAV SCI, V149, P45, DOI 10.1016/j.applanim.2013.10.003; Mirko E, 2012, APPL ANIM BEHAV SCI, V138, P88, DOI 10.1016/j.applanim.2012.02.016; Netto WJ, 1997, APPL ANIM BEHAV SCI, V52, P243, DOI 10.1016/S0168-1591(96)01126-4; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Robins RW, 1997, QUEST SELF INSIGHT T; Saetre P, 2006, GENES BRAIN BEHAV, V5, P240, DOI 10.1111/j.1601-183X.2005.00155.x; Scott J.P., 2012, GENETICS SOCIAL BEHA; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Sokal RR, 1963, PRINCIPLES NUMERICAL; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Valsecchi P, 2011, J VET BEHAV, V6, P161, DOI 10.1016/j.jveb.2011.01.002; van den Berg L, 2003, BEHAV GENET, V33, P469, DOI 10.1023/A:1025714431089; VANDERBORG JAM, 1991, APPL ANIM BEHAV SCI, V32, P237, DOI 10.1016/S0168-1591(05)80047-4; Vazire S., 2007, MEASURING PERSONALIT, P190; Walker J, 2010, ANIM WELFARE, V19, P75; Wiggins J.S., 1973, PERSONALITY PREDICTI; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012; Zeigler-Hill V, 2010, APPL ANIM BEHAV SCI, V124, P104, DOI 10.1016/j.applanim.2010.02.012	64	13	13	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0149831	10.1371/journal.pone.0149831	http://dx.doi.org/10.1371/journal.pone.0149831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26977588	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800016
J	Huang, TM; Zhao, ZY; Yan, C; Lu, J; Li, XZ; Tang, CZ; Fan, MX; Luo, YL				Huang, Tianming; Zhao, Zhiyong; Yan, Chao; Lu, Jing; Li, Xuzhou; Tang, Chaozheng; Fan, Mingxia; Luo, Yanli			Altered Spontaneous Activity in Patients with Persistent Somatoform Pain Disorder Revealed by Regional Homogeneity	PLOS ONE			English	Article							RESTING-STATE; CEREBRAL ACTIVATION; NEURAL ACTIVITY; BRAIN ACTIVITY; FMRI; REPRESENTATION; PERCEPTION; CONNECTIVITY; HYPERALGESIA; EPILEPSY	Persistent somatoform pain disorder (PSPD) is a mental disorder un-associated with any somatic injury and can cause severe somatosensory and emotional impairments in patients. However, so far, the neuro-pathophysiological mechanism of the functional impairments in PSPD is still unclear. The present study assesses the difference in regional spontaneous activity between PSPD and healthy controls (HC) during a resting state, in order to elucidate the neural mechanisms underlying PSPD. Resting-state functional Magnetic Resonance Imaging data were obtained from 13 PSPD patients and 23 age-and gender-matched HC subjects in this study. Kendall's coefficient of concordance was used to measure regional homogeneity (ReHo), and a two-sample t-test was subsequently performed to investigate the ReHo difference between PSPD and HC. Additionally, the correlations between the mean ReHo of each survived area and the clinical assessments were further analyzed. Compared with the HC group, patients with PSPD exhibited decreased ReHo in the bilateral primary somatosensory cortex, posterior cerebellum, and occipital lobe, while increased ReHo in the prefrontal cortex (PFC) and default mode network (including the medial PFC, right inferior parietal lobe (IPL), and left supramarginal gyrus). In addition, significant positive correlations were found between the mean ReHo of both right IPL and left supramarginal gyrus and participants' Self-Rating Anxiety Scale (SAS) scores, and between the mean ReHo of the left middle frontal gyrus and Visual Analogue Scale (VAS) scores. Our results suggest that abnormal spontaneous brain activity in specific brain regions during a resting state may be associated with the dysfunctions in pain, memory and emotional processing commonly observed in patients with PSPD. These findings help us to understand the neural mechanisms underlying PSPD and suggest that the ReHo metric could be used as a clinical marker for PSPD.	[Huang, Tianming] Shanghai Changning Mental Hlth Ctr, Dept Psychiat, Shanghai, Peoples R China; [Zhao, Zhiyong; Fan, Mingxia] E China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Yan, Chao] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China; [Yan, Chao] E China Normal Univ, Sch Psychol & Cognit Sci, STCSM, Shanghai 200062, Peoples R China; [Lu, Jing] Tongji Univ, Tongji Hosp, Dept Tradit Chinese Med, Shanghai 200092, Peoples R China; [Li, Xuzhou] E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, Key Lab Brain Funct Genom,MOE, Shanghai 200062, Peoples R China; [Li, Xuzhou] E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, STCSM, Shanghai 200062, Peoples R China; [Tang, Chaozheng] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai 200433, Peoples R China; [Luo, Yanli] Tongji Univ, Dept Psychiat, Tongji Hosp, Shanghai 200092, Peoples R China	East China Normal University; East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM); Tongji University; East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM); Fudan University; Tongji University	Fan, MX (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.; Luo, YL (corresponding author), Tongji Univ, Dept Psychiat, Tongji Hosp, Shanghai 200092, Peoples R China.	mxfan@phy.ecnu.edu.cn; luoluoyanli@163.com			National Natural Science Foundation of China [81100821]; Shanghai Changning District Committee of Health and Family Planning [20144Y011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Changning District Committee of Health and Family Planning	This research was supported by the National Natural Science Foundation of China (Contract grant number: 81100821) and Shanghai Changning District Committee of Health and Family Planning (Contract grant number: 20144Y011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antognini JF, 1997, LIFE SCI, V61, pPL349, DOI 10.1016/S0024-3205(97)00960-0; Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Apkarian AV, 2001, NEUROSCI LETT, V311, P193, DOI 10.1016/S0304-3940(01)02122-X; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baron R, 1999, NEUROLOGY, V52, P923, DOI 10.1212/WNL.52.5.923; Burba B, 2006, CAN J PSYCHIAT, V51, P468, DOI 10.1177/070674370605100709; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Casey KL, 2003, EXP NEUROL, V184, pS80, DOI 10.1016/j.expneurol.2003.07.006; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Craig A, 1996, FUNCTIONAL IMAGING I; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; Egloff N, 2014, GEN HOSP PSYCHIAT, V36, P284, DOI 10.1016/j.genhosppsych.2014.01.011; GIBBONS JD, 1990, RANK CORRELATION MET; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Helmchen C, 2003, NEUROSCI LETT, V335, P202, DOI 10.1016/S0304-3940(02)01164-3; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang L., 2015, NEUROSCIENTIST; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Karibe H, 2010, PSYCHIAT CLIN NEUROS, V64, P476, DOI 10.1111/j.1440-1819.2010.02119.x; Li HJ, 2015, J CHILD PSYCHOL PSYC, V56, P432, DOI 10.1111/jcpp.12307; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Luo Youtian, 2014, 2014 17th International Symposium on Electromagnetic Launch Technology (EML), P1, DOI 10.1109/EML.2014.6920147; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nikendei C, 2009, J PSYCHOSOM RES, V67, P199, DOI 10.1016/j.jpsychores.2009.01.017; Oshiro Y, 1998, NEUROREPORT, V9, P2285, DOI 10.1097/00001756-199807130-00026; Otti A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-84; Petrak F, 2003, EUR J PAIN, V7, P463, DOI 10.1016/S1090-3801(03)00014-4; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Qiu EC, 2012, CHINESE MED J-PEKING, V125, P705, DOI 10.3760/cma.j.issn.0366-6999.2012.04.027; Quintero GC, 2013, J PAIN RES, V6, P713, DOI 10.2147/JPR.S45958; Reips UD, 2008, BEHAV RES METHODS, V40, P699, DOI 10.3758/BRM.40.3.699; Reis GM, 2010, J PAIN, V11, P1015, DOI 10.1016/j.jpain.2010.01.269; Schonenberg M, 2014, EUR J PAIN, V18, P949, DOI 10.1002/j.1532-2149.2013.00440.x; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Seifert F, 2011, CURR OPIN ANESTHESIO, V24, P515, DOI 10.1097/ACO.0b013e32834a1079; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Shi Y, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/210120; Shibasaki Hiroshi, 2004, Suppl Clin Neurophysiol, V57, P39; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sokolov AA, 2009, CEREB CORTEX; Stefanie K, 2011, EUR ARCH PSY CLIN N, V261, P267, DOI 10.1007/s00406-010-0148-4; Stoeter P, 2007, NEUROIMAGE, V36, P418, DOI 10.1016/j.neuroimage.2007.01.052; SVEINBJORNSDOTTIR S, 1993, EPILEPSIA, V34, P493, DOI 10.1111/j.1528-1157.1993.tb02590.x; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Wang YP, 2015, NEUROPSYCH DIS TREAT, V11, P2659, DOI 10.2147/NDT.S94877; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xie YF, 2009, ACTA PHARMACOL SIN, V30, P31, DOI 10.1038/aps.2008.14; Yang TH, 2014, J NEUROL SCI, V340, P58, DOI 10.1016/j.jns.2014.02.025; Yoshino A, 2014, PSYCHIAT RES-NEUROIM, V221, P246, DOI 10.1016/j.pscychresns.2013.12.006; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang SS, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-115; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhao L, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-85; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007; Zung W, 1973, MODERN PROBLEMS PHAR, V7, P170; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	70	16	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151360	10.1371/journal.pone.0151360	http://dx.doi.org/10.1371/journal.pone.0151360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977802	gold, Green Published			2022-12-27	WOS:000372572800065
J	Komiya, C; Tsuchiya, K; Shiba, K; Miyachi, Y; Furuke, S; Shimazu, N; Yamaguchi, S; Kanno, K; Ogawa, Y				Komiya, Chikara; Tsuchiya, Kyoichiro; Shiba, Kumiko; Miyachi, Yasutaka; Furuke, Shunsaku; Shimazu, Noriko; Yamaguchi, Shinobu; Kanno, Kazuo; Ogawa, Yoshihiro			Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITION; ELEMENT-BINDING PROTEIN-1; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ADIPOCYTE DEATH; DOUBLE-BLIND; GLUCOSE; DAPAGLIFLOZIN; DISEASE; HYPERGLYCEMIA	Type 2 diabetes mellitus (T2DM) is associated with a high incidence of non-alcoholic fatty liver disease (NAFLD) related to obesity and insulin resistance. Currently, medical interventions for NAFLD have focused on diet control and exercise to reduce body weight, and there is a requirement for effective pharmacological therapies. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are oral antidiabetic drugs that promote the urinary excretion of glucose by blocking its reabsorption in renal proximal tubules. SGLT2 inhibitors lower blood glucose independent of insulin action and are expected to reduce body weight because of urinary calorie loss. Here we show that an SGLT2 inhibitor ipragliflozin improves hepatic steatosis in high-fat diet-induced and leptin-deficient (ob/ob) obese mice irrespective of body weight reduction. In the obese mice, ipragliflozin-induced hyperphagia occurred to increase energy intake, attenuating body weight reduction with increased epididymal fat mass. There is an inverse correlation between weights of liver and epididymal fat in ipragliflozin-treated obese mice, suggesting that ipragliflozin treatment promotes normotopic fat accumulation in the epididymal fat and prevents ectopic fat accumulation in the liver. Despite increased adiposity, ipragliflozin ameliorates obesity-associated inflammation and insulin resistance in epididymal fat. Clinically, ipragliflozin improves liver dysfunction in patients with T2DM irrespective of body weight reduction. These findings provide new insight into the effects of SGLT2 inhibitors on energy homeostasis and fat accumulation and indicate their potential therapeutic efficacy in T2DM-associated hepatic steatosis.	[Komiya, Chikara; Tsuchiya, Kyoichiro; Shiba, Kumiko; Miyachi, Yasutaka; Furuke, Shunsaku; Shimazu, Noriko; Yamaguchi, Shinobu; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Dept Grad Sch Med & Dent Sci, Tokyo, Japan; [Kanno, Kazuo] Kanno Clin, Tokyo, Japan; [Ogawa, Yoshihiro] Japan Agcy Med Res & Dev, CREST, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Tsuchiya, K (corresponding author), Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Dept Grad Sch Med & Dent Sci, Tokyo, Japan.	ktsuchiya.mem@tmd.ac.jp		Ogawa, Yoshihiro/0000-0002-0834-2836	Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Pharma Inc.	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Pharma Inc.(Astellas Pharmaceuticals)	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Ipragliflozin was provided by Astellas Pharma Inc. The clinical study at Kanno clinic was financially supported by Astellas Pharma Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Del Prato S, 2015, DIABETES OBES METAB, V17, P581, DOI 10.1111/dom.12459; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Ferrannini G, 2015, DIABETES CARE, V38, P1730, DOI 10.2337/dc15-0355; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Iizuka Takashi, 2016, J Clin Med Res, V8, P116, DOI 10.14740/jocmr2417w; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Morley TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8906; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nakano S, 2015, J CLIN EXP HEPATOL, V5, P190, DOI 10.1016/j.jceh.2015.02.005; Obata A, 2015, ENDOCRINOLO IN PRESS; Qiang S, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0102-8; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stenlof K, 2013, DIABETES OBES METAB, V15, P372, DOI 10.1111/dom.12054; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Tanaka M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5982; Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093; Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010; Watanabe Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116851; Waterson MJ, 2015, CELL METAB, V22, P962, DOI 10.1016/j.cmet.2015.09.026; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	41	148	155	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151511	10.1371/journal.pone.0151511	http://dx.doi.org/10.1371/journal.pone.0151511			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977813	Green Submitted, Green Published, gold			2022-12-27	WOS:000372572800081
J	Zurek, M; Sladen, L; Johansson, E; Olsson, M; Jackson, S; Zhang, H; Mayer, G; Hockings, PD				Zurek, Magdalena; Sladen, Louise; Johansson, Edvin; Olsson, Marita; Jackson, Sonya; Zhang, Hui; Mayer, Gaell; Hockings, Paul D.			Assessing the Relationship between Lung Density and Function with Oxygen-Enhanced Magnetic Resonance Imaging in a Mouse Model of Emphysema	PLOS ONE			English	Article							ULTRA-SHORT; NONINVASIVE ASSESSMENT; MRI; COPD; VENTILATION; RATS; T-1	Purpose A magnetic resonance imaging method is presented that allows for the simultaneous assessment of oxygen delivery, oxygen uptake, and parenchymal density. The technique is applied to a mouse model of porcine pancreatic elastase (PPE) induced lung emphysema in order to investigate how structural changes affect lung function. Method Nine-week-old female C57BL6 mice were instilled with saline or PPE at days 0 and 7. At day 19, oxygen delivery, oxygen uptake, and lung density were quantified from T1 and proton-density measurements obtained via oxygen-enhanced magnetic resonance imaging (OE-MRI) using an ultrashort echo-time imaging sequence. Subsequently, the lungs were sectioned for histological observation. Blood-gas analyses and pulmonary functional tests via FlexiVent were performed in separate cohorts. Principal Findings PPE-challenged mice had reduced density when assessed via MRI, consistent with the parenchyma loss observed in the histology sections, and an increased lung compliance was detected via FlexiVent. The oxygenation levels, as assessed via the blood-gas analysis, showed no difference between PPE-challenged animals and control. This finding was mirrored in the global MRI assessments of oxygen delivery and uptake, where the changes in relaxation time indices were matched between the groups. The heterogeneity of the same parameters however, were increased in PPE-challenged animals. When the oxygenation status was investigated in regions of varying density, a reduced oxygen-uptake was found in low-density regions of PPE-challenged mice. In high-density regions the uptake was higher than that of regions of corresponding density in control animals. The oxygen delivery was proportional to the oxygen uptake in both groups. Conclusions The proposed method allowed for the regional assessment of the relationship between lung density and two aspects of lung function, the oxygen delivery and uptake. When compared to global indices of lung function, an increased sensitivity for detecting heterogeneous lung disorders was found. This indicated that the technique has potential for early detection of lung dysfunction-before global changes occur.	[Zurek, Magdalena; Johansson, Edvin; Hockings, Paul D.] AstraZeneca, Personalised Healthcare & Biomarkers, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden; [Sladen, Louise; Jackson, Sonya; Mayer, Gaell] AstraZeneca, Resp Inflammat & Autoimmun, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden; [Olsson, Marita] AstraZeneca, Discovery Sci, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden; [Zhang, Hui] AstraZeneca, Drug Safety & Metab, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden; [Hockings, Paul D.] Chalmers Univ Technol, MedTech West, S-41296 Gothenburg, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Chalmers University of Technology	Zurek, M (corresponding author), AstraZeneca, Personalised Healthcare & Biomarkers, Innovat Med & Early Dev Biotech Unit, Gothenburg, Sweden.	magdalena.zurek@astrazeneca.com	Hockings, Paul D/AAM-7950-2020; Zurek, Magdalena/A-6064-2012	Hockings, Paul D/0000-0002-7154-9047; Johansson, Edvin/0000-0003-2515-2054	ITN Marie Curie, FP7-ITN PINET [PITN-GA-2010-264864]	ITN Marie Curie, FP7-ITN PINET	This work was supported by ITN Marie Curie, FP7-ITN PINET; Grant number: PITN-GA-2010-264864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PERMUTATION TESTS PR; Bianchi A, 2015, NMR BIOMED, V28, P1471, DOI 10.1002/nbm.3417; Cazzola M, 2008, REV PORT PNEUMOL, V14, P579, DOI 10.1016/S0873-2159(15)30266-X; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Efron B., 1994, INTRO BOOTSTRAP; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Inoue K, 2010, INT IMMUNOPHARMACOL, V10, P1380, DOI 10.1016/j.intimp.2010.07.016; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; Jacono FJ, 2013, RESP PHYSIOL NEUROBI, V189, P371, DOI 10.1016/j.resp.2013.07.010; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137282; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121520; Jogi J, 2015, INT J CHRONIC OBSTR, V10, P25, DOI 10.2147/COPD.S73423; Johnson KM, 2013, MAGN RESON MED, V70, P1241, DOI 10.1002/mrm.24570; Kruger SJ, 2016, J MAGN RESON IMAGING, V43, P295, DOI 10.1002/jmri.25002; Kruger SJ, 2014, NMR BIOMED, V27, P1535, DOI 10.1002/nbm.3158; Luthje L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-7; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Ma WJ, 2015, J MAGN RESON IMAGING, V41, P1465, DOI 10.1002/jmri.24680; Mahadeva R, 2002, THORAX, V57, P908, DOI 10.1136/thorax.57.10.908; Mills GH, 2003, BRIT J ANAESTH, V91, P16, DOI 10.1093/bja/aeg149; Milne S, 2014, J THORAC DIS, V6, P1570, DOI 10.3978/j.issn.2072-1439.2014.11.30; Morgan AR, 2014, EUR J RADIOL, V83, P2093, DOI 10.1016/j.ejrad.2014.08.004; Ohno Y, 2002, MAGN RESON MED, V47, P1139, DOI 10.1002/mrm.10168; Ohno Y, 2007, EUR J RADIOL, V64, P320, DOI 10.1016/j.ejrad.2007.08.006; Ohno Y, 2011, EUR J RADIOL, V77, P85, DOI 10.1016/j.ejrad.2009.06.027; Pracht ED, 2005, MAGNET RESON MED, V53, P1193, DOI 10.1002/mrm.20448; Quintana HK, 2006, MAGN RESON MED, V56, P1242, DOI 10.1002/mrm.21051; Sandek K, 2002, RESP MED, V96, P934, DOI 10.1053/rmed.2002.1371; SATO S, 1994, EUR RESPIR J, V7, P1294, DOI 10.1183/09031936.94.07071294; Stadler A, 2008, MAGN RESON MED, V59, P96, DOI 10.1002/mrm.21446; Stadler A, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/23624; Szabari MV, 2015, RESP PHYSIOL NEUROBI, V215, P13, DOI 10.1016/j.resp.2015.04.005; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Togao O, 2011, J MAGN RESON IMAGING, V34, P539, DOI 10.1002/jmri.22645; Triphan SMF, 2015, J MAGN RESON IMAGING, V41, P1708, DOI 10.1002/jmri.24692; Waterton JC, 2013, NEW DEV NMR, P333, DOI 10.1039/9781849737661-00333; Watt KN, 2008, MAGN RESON MED, V59, P1412, DOI 10.1002/mrm.21517; Weingartner S, 2014, MAGN RESON MED; West J.B., 2011, PULMONARY PATHOPHYSI; Zhang WJ, 2015, RADIOLOGY, V275, P579, DOI 10.1148/radiol.14132953; Zurek M, 2014, MAGN RESON MED, V71, P2180, DOI 10.1002/mrm.24876; Zurek M, 2012, MAGN RESON MED, V68, P898, DOI 10.1002/mrm.23281	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151211	10.1371/journal.pone.0151211	http://dx.doi.org/10.1371/journal.pone.0151211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977928	Green Submitted, gold, Green Published			2022-12-27	WOS:000372572800050
J	Chen, YG; Zhang, Y; Deng, LQ; Chen, H; Zhang, YJ; Zhou, NJ; Yuan, K; Yu, LZ; Xiong, ZH; Gui, XM; Yu, YR; Wu, XM; Min, WP				Chen, Yi-Guo; Zhang, Yong; Deng, Lin-Qiang; Chen, Hui; Zhang, Yu-Juan; Zhou, Nan-Jin; Yuan, Keng; Yu, Li-Zhi; Xiong, Zhang-Hua; Gui, Xiao-Mei; Yu, Yan-Rong; Wu, Xiao-Mu; Min, Wei-Ping			Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4	PLOS ONE			English	Article							IMPROVES BACTERIAL CLEARANCE; INNATE IMMUNE-RESPONSES; DECREASES INFLAMMATION; ECONOMIC OUTCOMES; ALPHA-HEMOLYSIN; MICE; EPIDEMIOLOGY; PRETREATMENT; NEUTROPHILS; MORTALITY	The spread of methicillin-resistant Staphylococcus aureus (MRSA) is a critical health issue that has drawn greater attention to the potential use of immunotherapy. Toll-like receptor 2 (TLR2), a pattern recognition receptor, is an essential component in host innate defense system against S. aureus infection. However, little is known about the innate immune response, specifically TLR2 activation, against MRSA infection. Here, we evaluate the protective effect and the mechanism of MRSA murine pneumonia after pretreatment with Pam3CSK4, a TLR2 agonist. We found that the MRSA-pneumonia mouse model, pre-treated with Pam3CSK4, had reduced bacteria and mortality in comparison to control mice. As well, lower protein and mRNA levels of TNF-alpha, IL-1 beta and IL-6 were observed in lungs and bronchus of the Pam3CSK4 pretreatment group. Conversely, expression of anti-inflammatory cytokine IL-10, but not TGF-beta, increased in Pam3CSK4-pretreated mice. Our additional studies showed that CXCL-2 and CXCL1, which are necessary for neutrophil recruitment, were less evident in the Pam3CSK4-pretreated group compared to control group, whereas the expression of Fc gamma receptors (Fc gamma I/II) and complement receptors (CR1/3) increased in murine lungs. Furthermore, we found that increased survival and improved bacterial clearance were not a result of higher levels of neutrophil infiltration, but rather a result of enhanced phagocytosis and bactericidal activity of neutrophils in vitro and in vivo as well as increased robust oxidative activity and release of lactoferrin. Our cumulative findings suggest that Pam3CSK4 could be a novel immunotherapeutic candidate against MRSA pneumonia.	[Chen, Yi-Guo; Deng, Lin-Qiang; Chen, Hui; Zhang, Yu-Juan; Yu, Li-Zhi; Xiong, Zhang-Hua; Gui, Xiao-Mei; Wu, Xiao-Mu; Min, Wei-Ping] Nanchang Univ, Jiangxi Prov Peoples Hosp, Med Lab, Nanchang 330008, Jiangxi, Peoples R China; [Chen, Yi-Guo; Deng, Lin-Qiang; Chen, Hui; Zhang, Yu-Juan; Yu, Li-Zhi; Xiong, Zhang-Hua; Gui, Xiao-Mei; Wu, Xiao-Mu; Min, Wei-Ping] Nanchang Univ, Inst Immunotherapy, Nanchang 330008, Jiangxi, Peoples R China; [Zhang, Yong; Zhang, Yu-Juan; Zhou, Nan-Jin; Yuan, Keng; Yu, Yan-Rong; Min, Wei-Ping] Jiangxi Acad Med Sci, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Yong; Zhang, Yu-Juan; Zhou, Nan-Jin; Yuan, Keng; Yu, Yan-Rong; Min, Wei-Ping] Jiangxi Prov Key Lab Immunotherapy, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Wu, XM; Min, WP (corresponding author), Nanchang Univ, Jiangxi Prov Peoples Hosp, Med Lab, Nanchang 330008, Jiangxi, Peoples R China.; Wu, XM; Min, WP (corresponding author), Nanchang Univ, Inst Immunotherapy, Nanchang 330008, Jiangxi, Peoples R China.; Min, WP (corresponding author), Jiangxi Acad Med Sci, Nanchang 330006, Jiangxi, Peoples R China.; Min, WP (corresponding author), Jiangxi Prov Key Lab Immunotherapy, Nanchang 330006, Jiangxi, Peoples R China.	wuxm79@163.com; weiping.min@gmail.com		Yu, Yanrong/0000-0002-0989-5432	National Nature Scientific Foundation of China [81360454]; Natural Science Foundation of Jiangxi Province [20132BAB205049]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was supported by the National Nature Scientific Foundation of China ( grant number 81360454) to YGC ( http://www.nsfc.gov.cn/) and The Natural Science Foundation of Jiangxi Province ( grant number 20132BAB205049) to YGC ( www.jxstc.gov.cn).	Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; [Anonymous], EURASIP J WIRELESS C, DOI DOI 10.11646/Z00TAXA.3989.1.1; Anstead GM, 2013, METHODS MOL BIOL, V185, P259, DOI 10.1007/978-1-62703-664-1_16; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Bal AM, 2005, EXPERT OPIN PHARMACO, V6, P2257, DOI 10.1517/14656566.6.13.2257; Bennett JW, 2008, DIAGN MICR INFEC DIS, V60, P437, DOI 10.1016/j.diagmicrobio.2007.11.002; Bommineni YR, 2014, MOL IMMUNOL, V59, P55, DOI 10.1016/j.molimm.2014.01.004; Brett M, 2015, CURR PHARM DESIGN, V21, P2131, DOI 10.2174/1381612821666150310101347; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen YH, 2014, EUR J CLIN MICROBIOL, V33, P233, DOI 10.1007/s10096-013-1949-y; Cheng CW, 2013, CLIN CHIM ACTA, V419, P19, DOI 10.1016/j.cca.2013.01.011; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Cremieux AC, 2014, J INFECT DIS, V209, P1773, DOI 10.1093/infdis/jit840; Delaloye J, 2013, CURR VASC PHARMACOL, V11, P123; Falugi F, 2013, MBIO, V4, DOI 10.1128/mBio.00575-13; Feterowski C, 2005, INT IMMUNOL, V17, P1035, DOI 10.1093/intimm/dxh282; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Haghighat Setareh, 2013, Avicenna Journal of Medical Biotechnology, V5, P204; Harrison C J, 2009, Minerva Pediatr, V61, P503; Joice R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068940; Joshi T, 2006, INT J HEMATOL, V84, P210, DOI 10.1532/IJH97.06140; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Lilius EM, 2012, SCI WORLD J, DOI 10.1100/2012/527347; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Loftspring MC, 2012, TRANSL STROKE RES, V3, pS147, DOI 10.1007/s12975-012-0184-7; Lu T, 2014, J INNATE IMMUN, V6, P639, DOI 10.1159/000360478; Luna CM, 2010, CURR OPIN INFECT DIS, V23, P178, DOI 10.1097/QCO.0b013e328336a23f; Mahfood Haddad Toufik, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-209003; Manda-Handzlik A, 2015, ADV EXP MED BIOL, V857, P51, DOI 10.1007/5584_2015_117; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McIntire CR, 2009, APOPTOSIS, V14, P522, DOI 10.1007/s10495-009-0312-3; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mocca CP, 2014, CLIN VACCINE IMMUNOL, V21, P622, DOI 10.1128/CVI.00051-14; Murphey ED, 2008, CRIT CARE MED, V36, P3067, DOI 10.1097/CCM.0b013e31818c6fb7; Murphey ED, 2008, MICROBES INFECT, V10, P1244, DOI 10.1016/j.micinf.2008.07.021; Nandi A, 2015, INFLAMMATION, V38, P224, DOI 10.1007/s10753-014-0026-8; O'Brien GC, 2005, J IMMUNOL, V174, P1020, DOI 10.4049/jimmunol.174.2.1020; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pier GB, 2013, HUM VACC IMMUNOTHER, V9, P1865, DOI 10.4161/hv.25182; Qiao YH, 2013, ACTA PAEDIATR, V102, P1081, DOI 10.1111/apa.12386; Ramirez P, 2011, CRIT CARE MED, V39, P2211, DOI 10.1097/CCM.0b013e3182257445; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Rodvold KA, 2014, CLIN INFECT DIS, V58, pS20, DOI 10.1093/cid/cit614; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Shorr AF, 2010, J CLIN MICROBIOL, V48, P3258, DOI 10.1128/JCM.02529-09; Sonego F, 2014, EXPERT REV CLIN IMMU, V10, P1019, DOI 10.1586/1744666X.2014.922876; Taneja C, 2010, J HOSP MED, V5, P528, DOI 10.1002/jhm.704; Tarai Bansidhar, 2013, J Lab Physicians, V5, P71, DOI 10.4103/0974-2727.119843; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Varrone JJ, 2014, J ORTHOP RES, V32, P1389, DOI 10.1002/jor.22672; Wang J, 2014, ANN NY ACAD SCI, V1319, P66, DOI 10.1111/nyas.12445; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Yimin, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074287	61	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0149233	10.1371/journal.pone.0149233	http://dx.doi.org/10.1371/journal.pone.0149233			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974438	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600010
J	Furuya, M; Tanaka, R; Okudela, K; Nakamura, S; Yoshioka, H; Tsuzuki, T; Shibuya, R; Yatera, K; Shirasaki, H; Sudo, Y; Kimura, N; Yamada, K; Uematsu, S; Kunimura, T; Kato, I; Nakatani, Y				Furuya, Mitsuko; Tanaka, Reiko; Okudela, Koji; Nakamura, Satoko; Yoshioka, Hiromu; Tsuzuki, Toyonori; Shibuya, Ryo; Yatera, Kazuhiro; Shirasaki, Hiroki; Sudo, Yoshiko; Kimura, Naoko; Yamada, Kazuaki; Uematsu, Shugo; Kunimura, Toshiaki; Kato, Ikuma; Nakatani, Yukio			Pulmonary Neoplasms in Patients with Birt-Hogg-Dube Syndrome: Histopathological Features and Genetic and Somatic Events	PLOS ONE			English	Article							RENAL TUMORS; LUNG CANCERS; FOLLICULIN; CYSTS; MUTATIONS; PROTEIN; FAMILIES; DISEASE; FNIP2; FLCN	Birt-Hogg-Dube syndrome (BHD) is an inherited disorder caused by genetic mutations in the folliculin (FLCN) gene. Individuals with BHD have multiple pulmonary cysts and are at a high risk for developing renal cell carcinomas (RCCs). Currently, little information is available about whether pulmonary cysts are absolutely benign or if the lungs are at an increased risk for developing neoplasms. Herein, we describe 14 pulmonary neoplastic lesions in 7 patients with BHD. All patients were confirmed to have germline FLCN mutations. Neoplasm histologies included adenocarcinoma in situ (n = 2), minimally invasive adenocarcinoma (n = 1), papillary adenocarcinoma (n = 1), micropapillary adenocarcinoma (n = 1), atypical adenomatous hyperplasia (n = 8), and micronodular pneumocyte hyperplasia (MPH)-like lesion (n = 1). Five of the six adenocarcinoma/MPH-like lesions (83.3%) demonstrated a loss of heterozygosity (LOH) of FLCN. All of these lesions lacked mutant alleles and preserved wild-type alleles. Three invasive adenocarcinomas possessed additional somatic events: 2 had a somatic mutation in the epidermal growth factor receptor gene (EGFR) and another had a somatic mutation in KRAS. Immunohistochemical analysis revealed that most of the lesions were immunostained for phospho-mammalian target of rapamycin (p-mTOR) and phospho-S6. Collective data indicated that pulmonary neoplasms of peripheral adenocarcinomatous lineage in BHD patients frequently exhibit LOH of FLCN with mTOR pathway signaling. Additional driver gene mutations were detected only in invasive cases, suggesting that FLCN LOH may be an underlying abnormality that cooperates with major driver gene mutations in the progression of pulmonary adenocarcinomas in BHD patients.	[Furuya, Mitsuko; Kato, Ikuma] Yokohama City Univ, Dept Mol Pathol, Grad Sch Med, Yokohama, Kanagawa, Japan; [Tanaka, Reiko] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Okudela, Koji] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; [Nakamura, Satoko] Kagawa Prefectural Cent Hosp, Dept Pathol, Takamatsu, Kagawa, Japan; [Yoshioka, Hiromu] Japanese Red Cross Nagoya Daini Hosp, Dept Thorac Surg, Nagoya, Aichi, Japan; [Tsuzuki, Toyonori] Japanese Red Cross Nagoya Daini Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Yatera, Kazuhiro] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka, Japan; [Shibuya, Ryo] Univ Occupat & Environm Hlth, Pathol & Oncol, Kitakyushu, Fukuoka, Japan; [Shirasaki, Hiroki] Saiseikai Fukui Hosp, Dept Internal Med, Fukui, Japan; [Sudo, Yoshiko] Saiseikai Fukui Hosp, Dept Pathol, Fukui, Japan; [Kimura, Naoko] Natl Disaster Med Ctr, Dept Thorac Surg, Tokyo, Japan; [Yamada, Kazuaki] Natl Disaster Med Ctr, Dept Pathol, Tokyo, Japan; [Uematsu, Shugo] Showa Univ, Dept Thorac Surg, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan; [Kunimura, Toshiaki] Showa Univ, Dept Pathol, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan; [Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan	Yokohama City University; Chiba University; Yokohama City University; Japanese Red Cross Nagoya Daini Hospital; Japanese Red Cross Nagoya Daini Hospital; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Showa University; Showa University; Chiba University	Furuya, M (corresponding author), Yokohama City Univ, Dept Mol Pathol, Grad Sch Med, Yokohama, Kanagawa, Japan.	mfuruya@yokohama-cu.ac.jp	Tsuzuki, Toyonori/GRJ-7409-2022; Kato, Ikuma/AAF-5926-2020; Uematsu, Shugo/AAP-7856-2020	Tsuzuki, Toyonori/0000-0002-4855-4366; Kato, Ikuma/0000-0002-7731-9509; Shugo, Uematsu/0000-0002-3713-6986	JSPS KAKENHI [26460422, 15K08374]; Yokohama Foundation for Advancement of Medical Science; Yokohama Academic Foundation; Project Mirai Cancer Research Grants; Mitsubishi Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yokohama Foundation for Advancement of Medical Science; Yokohama Academic Foundation; Project Mirai Cancer Research Grants; Mitsubishi Foundation	This work is supported by JSPS KAKENHI Grant Number 26460422 (M.F.) and 15K08374 (Y.N.), Yokohama Foundation for Advancement of Medical Science (M.F.), Yokohama Academic Foundation (M.F.), Project Mirai Cancer Research Grants (M.F.), and the Mitsubishi Foundation (M.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayo DS, 2007, CHEST, V132, P679, DOI 10.1378/chest.07-0042; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Butnor KJ, 2006, AM J SURG PATHOL, V30, P395; Furuya M, 2012, J CLIN PATHOL; Furuya M, 2015, CANCER SCI, V106, P315, DOI 10.1111/cas.12601; Furuya M, 2013, J CLIN PATHOL, V66, P178, DOI 10.1136/jclinpath-2012-201200; Furuya M, 2012, AM J SURG PATHOL, V36, P589, DOI 10.1097/PAS.0b013e3182475240; Gunji Y, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049874; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi H, 2015, P NATL ACAD SCI USA, V112, pE1624, DOI 10.1073/pnas.1419502112; Hasumi H, 2012, JNCI-J NATL CANCER I, V104, P1750, DOI 10.1093/jnci/djs418; Hayashi T, 2010, MODERN PATHOL, V23, P1251, DOI 10.1038/modpathol.2010.114; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Iribe Y, 2016, AM J PATHOL, V186, P337, DOI 10.1016/j.ajpath.2015.10.013; Iribe Y, 2015, PATHOL INT, V65, P126, DOI 10.1111/pin.12254; Koga S, 2009, PATHOL INT, V59, P720, DOI 10.1111/j.1440-1827.2009.02434.x; Kumasaka T, 2014, HISTOPATHOLOGY, V65, P100, DOI 10.1111/his.12368; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nishida C, 2015, RESP MED, V109, P923, DOI 10.1016/j.rmed.2015.05.005; Nishii T, 2013, PATHOL INT, V63, P45, DOI 10.1111/pin.12028; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Vocke CD, 2005, J NATL CANCER I, V97, P931, DOI 10.1093/jnci/dji154; Yoshida A, 2014, MODERN PATHOL, V27, P711, DOI 10.1038/modpathol.2013.192	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151476	10.1371/journal.pone.0151476	http://dx.doi.org/10.1371/journal.pone.0151476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974543	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600083
J	Idris, K; Shaffril, HAM; Md Yassin, S; Abu Samah, A; Hamzah, A; Abu Samah, B				Idris, Khairuddin; Shaffril, Hayrol Azril Mohamed; Md Yassin, Sulaiman; Abu Samah, Asnarulkhadi; Hamzah, Azimi; Abu Samah, Bahaman			Quality of Life in Rural Communities: Residents Living Near to Tembeling, Pahang and Muar Rivers, Malaysia	PLOS ONE			English	Article							EDUCATION; PEOPLE	The main aim of this study is to identify the quality of life (QoL) among communities residing near the Tembeling, Pahang and Muar Rivers in Malaysia. This quantitative study used a constructed questionnaire as main tool to collect data on the QoL of river communities. A total of 240 villagers were selected as respondents. The results indicated that the dimensions of settlement, safety, involvement and social relationships, as well as education scored highest, while dimensions of physical environment, financial and job security yielded moderate scores. Dimensions of infrastructure facilities yielded a low mean score. Recommendations are provided, in the hope that our results may be useful for strategies that could enhance QoL of these river communities.	[Idris, Khairuddin; Shaffril, Hayrol Azril Mohamed; Md Yassin, Sulaiman; Abu Samah, Asnarulkhadi; Hamzah, Azimi; Abu Samah, Bahaman] Univ Putra Malaysia, Inst Social Sci Studies, Serdang, Malaysia; [Idris, Khairuddin; Hamzah, Azimi; Abu Samah, Bahaman] Univ Putra Malaysia, Fac Educ Studies, Dept Profess Dev & Continuing Educ, Serdang, Malaysia; [Abu Samah, Asnarulkhadi] Univ Putra Malaysia, Fac Human Ecol, Dept Social & Dev Sci, Serdang, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Idris, K (corresponding author), Univ Putra Malaysia, Inst Social Sci Studies, Serdang, Malaysia.; Idris, K (corresponding author), Univ Putra Malaysia, Fac Educ Studies, Dept Profess Dev & Continuing Educ, Serdang, Malaysia.	majudesa.desa1@gmail.com	Shaffril, Hayrol Azril Mohamed/I-2463-2019		Universiti Putra Malaysia under Research University Grant Scheme (RUGS) [06-02-12-1929RU]	Universiti Putra Malaysia under Research University Grant Scheme (RUGS)	The grant number of 06-02-12-1929RU was provided by Universiti Putra Malaysia under Research University Grant Scheme (RUGS) under scheme number 3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceleanu M. I., 2012, CASE ROMANIA, V17, P717; Agenor PR, 2015, J MACROECON, V43, P155, DOI 10.1016/j.jmacro.2014.10.004; [Anonymous], 2014, HUMAN DEV INDEX; [Anonymous], 2013, ECONOMIST; Bahaman Abu Samah, 2011, American Journal of Environmental Sciences, V7, P362, DOI 10.3844/ajessp.2011.362.369; Bilgili N, 2014, ARCH GERONTOL GERIAT, V59, P415, DOI 10.1016/j.archger.2014.07.005; David-Barrett T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118329; Department of Fisheries Malaysia, 2010, EST NUMB AR FRESHW P; Department of Statistics Malaysia, 2012, HOUS INC BAS AM SURV; Deutsche Bank, 2006, MEAS WELL BEING; Economic Planning Unit, 1999, MAL QUAL LIF IND; Economic Planning Unit, 2011, MAL QUAL LIF IND; Economic Planning Unit, 2002, MAL QUAL LIF IND; Economic Planning Unit, 2004, MAL QUAL LIF IND; Elisia L, 2010, ARTS SOC SCI J, V01, P1, DOI [10.4172/2151-6200.1000004, DOI 10.4172/2151-6200.1000004]; FERRANS CE, 1985, ADV NURS SCI, V8, P15, DOI 10.1097/00012272-198510000-00005; Gasim M. B., 2012, Asian Journal of Earth Sciences, V5, P25, DOI 10.3923/ajes.2012.25.35; Habibah A., 2010, Journal of Sustainable Development, V3, P184; Haq R, 2013, SOC INDIC RES, V114, P997, DOI 10.1007/s11205-012-0186-6; Howell SE, 1997, BLACK ATTITUDES NEW; IMD, 2013, WORLD COMP SCOR 2013; Inoguchi T., 2012, QUALITY LIFE ASIA CO; International HR Adviser, 2012, 2012 QUAL LIV WORLDW; International Living, 2012, 2011 QUAL LIF IND; Jamieson A, 2007, QUAL AGEING OLDER AD, V8, P15, DOI 10.1108/14717794200700017; Jongudomkarn D, 2006, SOC INDIC RES, V78, P489, DOI 10.1007/s11205-005-1947-2; Karim HA, 2012, PROCD SOC BEHV, V35, P44, DOI 10.1016/j.sbspro.2012.02.061; Leelakulthanit O, 1990, SOCIAL INDICATORS RE, V27, P41; Legatum Institute, 2013, LEG PROP IND; Mohammad Najib A.G., 1999, PENYELIDIKAN PENDIDI; Nelson G., 2010, HDB DIS BURDENS QUAL, P3363, DOI [10.1007/978-0-387-78665-0_194, DOI 10.1007/978-0-387-78665-0_194]; New Economic Foundation (NEF), 2013, MEAS NAT WELL BEING; Ng TP, 2005, QUAL LIFE RES, V14, P1755, DOI 10.1007/s11136-005-1741-2; Huong NT, 2013, GLOBAL HEALTH ACTION, V6, P87, DOI 10.3402/gha.v5i0.18874; Numbeo, 2015, QUAL LIF IND COUNTR; Nunnally J., 1978, PSYCHOMETRIC THEORY; OECD, 2013, MEAS SUST WELL BEING; Pajaziti A, 2014, PROCD SOC BEHV, V116, P4737, DOI 10.1016/j.sbspro.2014.01.1018; Paskulin LMG, 2007, WESTERN J NURS RES, V29, P10, DOI 10.1177/0193945906292550; Ramli SA, 2013, INT J BUSINESS MANAG, V7, P114; Sallehand AG, 2012, J CONSTR DEV CTRIES, V17, P117; Shaffril HAM, 2013, INT J CLIM CHANG STR, V5, P38, DOI 10.1108/17568691311299354; Stimson R., 2011, SOCIAL INDICATORS RE, P33; Sulaiman Md. Yassin, 2011, Australian Journal of Basic and Applied Sciences, V5, P868; Barcelo MV, 2012, PROCD SOC BEHV, V46, P4598, DOI 10.1016/j.sbspro.2012.06.303; Knesebeck OV, 2007, AGEING SOC, V27, P269, DOI 10.1017/S0144686X06005484; Wells MM, 2000, J ENVIRON PSYCHOL, V20, P239, DOI 10.1006/jevp.1999.0166; Zakirova V, 2014, REPROD HEALTH MATTER, V22, P202, DOI 10.1016/S0968-8080(14)44806-7	48	13	13	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150741	10.1371/journal.pone.0150741	http://dx.doi.org/10.1371/journal.pone.0150741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26974837	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600029
J	O'Connell, S; Lillis, D; Cotter, A; O'Dea, S; Tuite, H; Fleming, C; Crowley, B; Fitzgerald, I; Dalby, L; Barry, H; Shields, D; Norris, S; Plunkett, PK; Bergin, C				O'Connell, Sarah; Lillis, Darren; Cotter, Aoife; O'Dea, Siobhan; Tuite, Helen; Fleming, Catherine; Crowley, Brendan; Fitzgerald, Ian; Dalby, Linda; Barry, Helen; Shields, Darragh; Norris, Suzanne; Plunkett, Patrick K.; Bergin, Colm			Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study	PLOS ONE			English	Article							BURDEN; VIRUS	Objectives Studies suggest 2 per 1000 people in Dublin are living with HIV, the level above which universal screening is advised. We aimed to assess the feasibility and acceptability of a universal opt-out HIV, Hepatitis B and Hepatitis C testing programme for Emergency Department patients and to describe the incidence and prevalence of blood-borne viruses in this population. Methods An opt-out ED blood borne virus screening programme was piloted from March 2014 to January 2015. Patients undergoing blood sampling during routine clinical care were offered HIV 1&2 antibody/antigen assay, HBV surface antigen and HCV antibody tests. Linkage to care where necessary was co-ordinated by the study team. New diagnosis and prevalence rates were defined as the new cases per 1000 tested and number of positive tests per 1000 tested respectively. Results Over 45 weeks of testing, of 10,000 patient visits, 8,839 individual patient samples were available for analysis following removal of duplicates. A sustained target uptake of >50% was obtained after week 3.97(1.09%), 44(0.49%) and 447(5.05%) HIV, Hepatitis B and Hepatitis C tests were positive respectively. Of these, 7(0.08%), 20(0.22%) and 58(0.66%) were new diagnoses of HIV, Hepatitis B and Hepatitis C respectively. The new diagnosis rate for HIV, Hepatitis B and Hepatitis C was 0.8, 2.26 and 6.5 per 1000 and study prevalence for HIV, Hepatitis B and Hepatitis C was 11.0, 5.0 and 50.5 per 1000 respectively. Conclusions Opt-out blood borne viral screening was feasible and acceptable in an inner-city ED. Blood borne viral infections were prevalent in this population and newly diagnosed cases were diagnosed and linked to care. These results suggest widespread blood borne viral testing in differing clinical locations with differing population demographic risks may be warranted.	[O'Connell, Sarah; Cotter, Aoife; O'Dea, Siobhan; Bergin, Colm] St James Hosp, Dept Genitourinary Med & Infect Dis, Dublin 8, Ireland; [Lillis, Darren; Shields, Darragh] St James Hosp, Dept Emergency Med, Dublin 8, Ireland; [Norris, Suzanne] St James Hosp, Hepatol Dept, Dublin 8, Ireland; [Tuite, Helen; Fleming, Catherine] Galway Univ Hosp, Dept Infect Dis, Dublin, Ireland; [Crowley, Brendan; Fitzgerald, Ian; Dalby, Linda; Barry, Helen] St James Hosp, Dept Microbiol, Dublin 8, Ireland; [Norris, Suzanne; Bergin, Colm] Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	O'Connell, S (corresponding author), St James Hosp, Dept Genitourinary Med & Infect Dis, Dublin 8, Ireland.	soconnell@stjames.ie		Plunkett, Patrick/0000-0003-0714-2717	MSD pharmaceuticals; Gilead; GlaxoSmithKline/Viiv; MSD pharmaceuticals; Gilead; GlaxoSmithKline/Viiv	MSD pharmaceuticals; Gilead(Gilead Sciences); GlaxoSmithKline/Viiv; MSD pharmaceuticals; Gilead(Gilead Sciences); GlaxoSmithKline/Viiv	An unrestricted grant was received by CB from MSD pharmaceuticals (http://www.msd-ireland.com/), Gilead (http://www.gilead.com/about/worldwide-operations/europe/Ireland) and GlaxoSmithKline/Viiv (http://ie.gsk.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHIVA, UK NAT GUID HIV TEST; Block TM, 2015, ANTIVIR RES, V121, P69, DOI 10.1016/j.antiviral.2015.06.014; Burns F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035212; CDC, 2006, REV REC HIV TEST AD; CDC, 2013, MMWR, V62; Centers for Disease Control and Prevention, 2015, HIV INF US GLANC; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, P9; El Khoury AC, 2012, J VIRAL HEPATITIS, V19, P153, DOI 10.1111/j.1365-2893.2011.01563.x; European Centre for Disease Prevention and Control, 2015, ANN EP REP 2014 SEX; HSE, 2015, HIV IR 2014; HSE. Health Protection Surveillance Centre, 2015, EP HEP C IR 2013; HSE. Health Protection Surveillance Centre, 2015, EP HEP B IR 2013; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Lambert J, 2013, Ir Med J, V106, P136; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Martyn F, 2011, Ir Med J, V104, P144; Nardone A, 2009, EPIDEMIOL INFECT, V137, P961, DOI 10.1017/S0950268808001672; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; The INSIGHT START Study Group, 2015, N ENGL J MED; Thornton L, 2012, EPIDEMIOL INFECT, V140, P1461, DOI 10.1017/S0950268811001920; Tuite H, 2015, Ir Med J, V108, P199; White DAE, 2011, ANN EMERG MED, V58, pS89, DOI 10.1016/j.annemergmed.2011.03.032	23	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150546	10.1371/journal.pone.0150546	http://dx.doi.org/10.1371/journal.pone.0150546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967517	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200015
J	Paik, KJ; Maan, ZN; Zielins, ER; Duscher, D; Whittam, AJ; Morrison, SD; Brett, EA; Ransom, RC; Hu, MS; Wu, JC; Gurtner, GC; Longaker, MT; Wan, DC				Paik, Kevin J.; Maan, Zeshaan N.; Zielins, Elizabeth R.; Duscher, Dominik; Whittam, Alexander J.; Morrison, Shane D.; Brett, Elizabeth A.; Ransom, Ryan C.; Hu, Michael S.; Wu, Joseph C.; Gurtner, Geoffrey C.; Longaker, Michael T.; Wan, Derrick C.			Short Hairpin RNA Silencing of PHD-2 Improves Neovascularization and Functional Outcomes in Diabetic Wounds and Ischemic Limbs	PLOS ONE			English	Article							PROLYL HYDROXYLASE; HIF-1-ALPHA; RESPONSES; VECTORS; THERAPY	The transcription factor hypoxia-inducible factor 1-alpha (HIF-1 alpha) is responsible for the downstream expression of over 60 genes that regulate cell survival and metabolism in hypoxic conditions as well as those that enhance angiogenesis to alleviate hypoxia. However, under normoxic conditions, HIF-1 alpha is hydroxylated by prolyl hydroxylase 2, and subsequently degraded, with a biological half-life of less than five minutes. Here we investigated the therapeutic potential of inhibiting HIF-1 alpha degradation through short hairpin RNA silencing of PHD-2 in the setting of diabetic wounds and limb ischemia. Treatment of diabetic mouse fibroblasts with shPHD-2 in vitro resulted in decreased levels of PHD-2 transcript demonstrated by qRT-PCR, higher levels of HIF-1 alpha as measured by western blot, and higher expression of the downstream angiogenic genes SDF-1 and VEGF alpha, as measured by qRT-PCR. In vivo, shPHD-2 accelerated healing of full thickness excisional wounds in diabetic mice compared to shScr control, (14.33 +/- 0.45 days vs. 19 +/- 0.33 days) and was associated with an increased vascular density. Delivery of shPHD-2 also resulted in improved perfusion of ischemic hind limbs compared to shScr, prevention of distal digit tip necrosis, and increased survival of muscle tissue. Knockdown of PHD-2 through shRNA treatment has the potential to stimulate angiogenesis through overexpression of HIF-1 alpha and upregulation of pro-angiogenic genes downstream of HIF-1 alpha, and may represent a viable, non-viral approach to gene therapy for ischemia related applications.	[Paik, Kevin J.; Maan, Zeshaan N.; Zielins, Elizabeth R.; Duscher, Dominik; Whittam, Alexander J.; Morrison, Shane D.; Brett, Elizabeth A.; Ransom, Ryan C.; Hu, Michael S.; Gurtner, Geoffrey C.; Longaker, Michael T.; Wan, Derrick C.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Plast & Reconstruct Surg Div, Dept Surg,Sch Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA; [Wu, Joseph C.; Longaker, Michael T.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wan, DC (corresponding author), Stanford Univ, Hagey Lab Pediat Regenerat Med, Plast & Reconstruct Surg Div, Dept Surg,Sch Med, Stanford, CA 94305 USA.	dwan@stanford.edu	Duscher, Dominik/AAH-5330-2020; Wu, Joseph/H-1067-2013	Morrison, Shane/0000-0003-3868-3532; Ransom, Ryan/0000-0001-6696-1793; Maan, Zeshaan/0000-0002-7683-1914; Wu, Joseph/0000-0002-6068-8041; Wan, Derrick/0000-0003-4666-1683	Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health [NIHR21DE019274, NIHR01DE019434, NIHR01DE021683, NIHU01HL099776]; American College of Surgeons Franklin H. Martin Faculty Research Fellowship; Stanford University Child Health Research Institute Faculty Scholar Award; Howard Hughes Medical Institute Medical Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019434, R01DE021683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019274] Funding Source: NIH RePORTER	Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Franklin H. Martin Faculty Research Fellowship; Stanford University Child Health Research Institute Faculty Scholar Award; Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Oak Foundation, the Hagey Laboratory for Pediatric Regenerative Medicine, and the National Institutes of Health, Grants NIHR21DE019274, NIHR01DE019434, NIHR01DE021683, and NIHU01HL099776 to M.T.L. and G.C.G. D.C.W. was supported by the American College of Surgeons Franklin H. Martin Faculty Research Fellowship, the Hagey Laboratory for Pediatric Regenerative Medicine, and the Stanford University Child Health Research Institute Faculty Scholar Award. S.D.M. was supported by the Howard Hughes Medical Institute Medical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bader HL, 2012, FEBS LETT, V586, P1562, DOI 10.1016/j.febslet.2012.04.032; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; El-Ftesi S, 2009, PLAST RECONSTR SURG, V123, P475, DOI 10.1097/PRS.0b013e3181954d08; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Huang M, 2011, CIRCULATION, V124, pS46, DOI 10.1161/CIRCULATIONAHA.110.014019; Huang NF, 2009, JOVE-J VIS EXP, DOI [10.3791/1034, DOI 10.3791/1034]; Lan F, 2012, CIRCULATION, V126, pS20, DOI 10.1161/CIRCULATIONAHA.111.084913; Lijkwan MA, 2014, HUM GENE THER, V25, P41, DOI 10.1089/hum.2013.110; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Nauta AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059167; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Rennert RC, 2013, EXPERT OPIN BIOL TH, V13, P1523, DOI 10.1517/14712598.2013.842972; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Stenler S, 2014, HUM VACCIN IMMUNOTHE, V10; Thangarajah H, 2010, CELL CYCLE, V9, P75, DOI 10.4161/cc.9.1.10371; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wu W, 2013, PLAST RECONSTR SURG, V131, P27, DOI 10.1097/PRS.0b013e3182729cfc; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084548; Zimmermann AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093373	29	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150927	10.1371/journal.pone.0150927	http://dx.doi.org/10.1371/journal.pone.0150927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967994	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200019
J	Vega-Gorgojo, G; Giese, M; Heggestoyl, S; Soylu, A; Waaler, A				Vega-Gorgojo, Guillermo; Giese, Martin; Heggestoyl, Simen; Soylu, Ahmet; Waaler, Arild			PepeSearch: Semantic Data for the Masses	PLOS ONE			English	Article							LINKED DATA	With the emergence of the Web of Data, there is a need of tools for searching and exploring the growing amount of semantic data. Unfortunately, such tools are scarce and typically require knowledge of SPARQL/RDF. We propose here PepeSearch, a portable tool for searching semantic datasets devised for mainstream users. PepeSearch offers a multiclass search form automatically constructed from a SPARQL endpoint. We have tested PepeSearch with 15 participants searching a Linked Open Data version of the Norwegian Register of Business Enterprises for non-trivial challenges. Retrieval performance was encouragingly high and usability ratings were also very positive, thus suggesting that PepeSearch is effective for searching semantic datasets by mainstream users. We also assessed its portability by configuring PepeSearch to query other SPARQL endpoints.	[Vega-Gorgojo, Guillermo; Giese, Martin; Heggestoyl, Simen; Waaler, Arild] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Soylu, Ahmet] Norwegian Univ Sci & Technol, Fac Comp Sci & Media Technol, Gjovik, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU)	Vega-Gorgojo, G (corresponding author), Univ Oslo, Dept Informat, N-0316 Oslo, Norway.	guiveg@ifi.uio.no	; Vega-Gorgojo, Guillermo/B-3984-2012	Soylu, Ahmet/0000-0001-6034-4137; Vega-Gorgojo, Guillermo/0000-0002-6916-9213	Norwegian Research Council; European Commission [FP7 GA 318338, FP7 GA 619551]	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been partially funded by the Norwegian Research Council through the Semicolon II project (http://www.semicolon.no/), and the European Commission through the Optique (FP7 GA 318338), and BYTE (FP7 GA 619551) projects.	Araujo S, 2009, P LINK DAT WEB LODW; Berners-Lee T., 2006, LINKED DATA; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1201/9781498710411-35; Brunetti JM, 2013, INT J SEMANT WEB INF, V9, P1, DOI 10.4018/jswis.2013010101; Brunk S, 2011, P INT WORKSH DAT CTR; Campinas S, 2012, INT WORKSHOP DATABAS, P261, DOI 10.1109/DEXA.2012.38; Dadzie AS, 2011, SEMANT WEB, V2, P89, DOI 10.3233/SW-2011-0037; Ding L, 2012, IEEE INTELL SYST, V27, P11, DOI 10.1109/MIS.2012.56; Elbedweihy Khadija, 2012, The Semantic Web. 11th International Semantic Web Conference (ISWC 2012). Proceedings, P274, DOI 10.1007/978-3-642-35173-0_18; Freitas A, 2012, IEEE INTERNET COMPUT, V16, P24, DOI 10.1109/MIC.2011.141; Haag F., 2015, P 12 EUR SEM WEB C E; Hachey G., 2011, THESIS ATHABASCA U; Hearst M. A., 2009, SEARCH USER INTERFAC; Heath T., 2011, LINKED DATA EVOLVING; Hogan A, 2011, J WEB SEMANT, V9, P365, DOI 10.1016/j.websem.2011.06.004; Kaufmann E, 2010, J WEB SEMANT, V8, P377, DOI 10.1016/j.websem.2010.06.001; Klyne G., 2004, RESOURCE DESCRIPTION; Lopez V, 2004, P 3 EUR SEM WEB C ES, V4011, P393; Lopez V, 2013, J WEB SEMANT, V21, P3, DOI 10.1016/j.websem.2013.05.006; Miller CS, ETHICS CONDUCTING US; Oard D. W., 2001, Cross-Language Information Retrieval and Evaluation. Workshop of the Cross-Language Evaluation Forum, CLEF 2000. Revised Papers (Lecture Notes in Computer Science Vol.2069), P57; PRUDHOMMEAUX E, 2008, SPARQL QUERY LANGUAG; Roman D, 2012, P 4 INT C INF PROC K, P93; Russell A, 2008, P SEM WEB US INT WOR; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Skjaeveland MG, 2013, LECT NOTES COMPUT SC, V8219, P162, DOI 10.1007/978-3-642-41338-4_11; Viegas FB, 2014, P 2006 20 ANN C COMP, V4, P6	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151573	10.1371/journal.pone.0151573	http://dx.doi.org/10.1371/journal.pone.0151573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967899	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200063
J	Dewland, TA; Bibbins-Domingo, K; Lin, F; Vittinghoff, E; Foster, E; Ogunyankin, KO; Lima, JA; Jacobs, DR; Hu, DL; Burchard, EG; Marcus, GM				Dewland, Thomas A.; Bibbins-Domingo, Kirsten; Lin, Feng; Vittinghoff, Eric; Foster, Elyse; Ogunyankin, Kofo O.; Lima, Joao A.; Jacobs, David R.; Hu, Donglei; Burchard, Esteban G.; Marcus, Gregory M.			Racial Differences in Left Atrial Size: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) Study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; ALCOHOL-CONSUMPTION; FIBRILLATION; VOLUME; HEART; PREVALENCE; ANCESTRY; DESIGN; STROKE; MEN	Whites have an increased risk of atrial fibrillation (AF) compared to Blacks. The mechanism underlying this association is unknown. Left atrial (LA) size is an important AF risk factor, and studies in older adults suggest Whites have larger LA diameters. However, because AF itself causes LA dilation, LA size differences may be due to greater subclinical AF among older Whites. We therefore assessed for racial differences in LA size among young adults at low AF risk. The Coronary Artery Risk Development in Young Adults (CARDIA) study enrolled White and Black participants between 18 and 30 years of age. LA diameter was measured in a subset of participants using echocardiography at Year 5 (n = 4,201) and Year 25 (n = 3,373) of follow up. LA volume was also assessed at Year 5 (n = 2,489). Multivariate linear regression models were used to determine the adjusted association between race and LA size. In unadjusted analyses, mean LA diameter was significantly larger among Blacks compared to Whites both at Year 5 (35.5 +/- 4.8 mm versus 35.1 +/- 4.5 mm, p = 0.01) and Year 25 (37.4 +/- 5.1 mm versus 36.8 +/- 4.9 mm, p = 0.002). After adjusting for demographics, comorbidities, and echocardiographic parameters, Whites demonstrated an increased LA diameter (0.7 mm larger at Year 5, 95% CI 0.3-1.1, p<0.001; 0.6 mm larger at Year 25, 95% CI 0.3-1.0, p<0.001). There was no significant association between race and adjusted Year 5 LA volume. In conclusion, in a young, well-characterized cohort, the larger adjusted LA diameter among White participants suggests inherent differences in atrial structure may partially explain the higher risk of AF in Whites. The incongruent associations between race, LA diameter, and LA volume suggest that LA geometry, rather than size alone, may have implications for AF risk.	[Dewland, Thomas A.; Marcus, Gregory M.] Univ Calif San Francisco, Dept Med, Div Cardiol, Electrophysiol Sect, San Francisco, CA 94143 USA; [Dewland, Thomas A.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Bibbins-Domingo, Kirsten; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bibbins-Domingo, Kirsten; Lin, Feng; Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Foster, Elyse] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA USA; [Ogunyankin, Kofo O.] First Cardiol Consultants, Lagos, Nigeria; [Lima, Joao A.] Johns Hopkins Hosp & Sch Med, Dept Med, Div Cardiol, Baltimore, MD USA; [Jacobs, David R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Hu, Donglei] Univ Calif San Francisco, Dept Med, Inst Human Genet, San Francisco, CA USA	University of California System; University of California San Francisco; Oregon Health & Science University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, Electrophysiol Sect, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Ogunyankin, Kofo/AAZ-4013-2020; Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696; Jacobs, David/0000-0002-7232-0543	American Heart Association [12POST11810036, 12GRNT11780061]; Joseph Drown Foundation; National Heart, Lung, and Blood Institute (NHLBI); Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; Intramural Research Program of the National Institute on Aging (NIA); University of Alabama at Birmingham [HHSN268201300025C, HHSN268201300026C]; NIA [AG0005]; NHLBI [AG0005]	American Heart Association(American Heart Association); Joseph Drown Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); Intramural Research Program of the National Institute on Aging (NIA); University of Alabama at Birmingham; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was made possible by grant numbers 12POST11810036 (TAD) and 12GRNT11780061 (GMM) from the American Heart Association and by the Joseph Drown Foundation (GMM). The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201300025C & HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content. First Cardiology Consultants provided support in the form of salaries for authors KOO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Armstrong AC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004001; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Cioffi G, 2004, J HYPERTENS, V22, P1589, DOI 10.1097/01.hjh.0000125454.28861.76; Desai CS, 2013, AM J EPIDEMIOL, V177, P20, DOI 10.1093/aje/kws224; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GOTTDIENER JS, 1994, J AM COLL CARDIOL, V24, P1492, DOI 10.1016/0735-1097(94)90145-7; Gottdiener JS, 1998, CIRCULATION, V98, P140, DOI 10.1161/01.CIR.98.2.140; Kishi S, 2014, AM J CARDIOL, V113, P377, DOI 10.1016/j.amjcard.2013.08.052; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Manolio TA, 2002, AM J CARDIOL, V90, P983, DOI 10.1016/S0002-9149(02)02665-6; Marcus GM, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.05.019; Marcus GM, 2010, CIRCULATION, V122, P2009, DOI 10.1161/CIRCULATIONAHA.110.958306; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Pletcher MJ, 2005, AM J EPIDEMIOL, V161, P423, DOI 10.1093/aje/kwi062; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; Psaty BM, 1997, CIRCULATION, V96, P2455; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Singh KJ, 2013, J CARD FAIL, V19, P183, DOI 10.1016/j.cardfail.2012.12.005; SUAREZ GS, 1991, CLIN CARDIOL, V14, P652, DOI 10.1002/clc.4960140806; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tsang TSM, 2001, MAYO CLIN PROC, V76, P467, DOI 10.4065/76.5.467; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wozakowska-Kaplon B, 2005, INT J CARDIOL, V101, P47, DOI 10.1016/j.ijcard.2004.03.010	30	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151559	10.1371/journal.pone.0151559	http://dx.doi.org/10.1371/journal.pone.0151559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985672	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300086
J	Mauro-Herrera, M; Doust, AN				Mauro-Herrera, Margarita; Doust, Andrew N.			Development and Genetic Control of Plant Architecture and Biomass in the Panicoid Grass, Setaria	PLOS ONE			English	Article							AXILLARY BUD OUTGROWTH; FOXTAIL MILLET; TILLER NUMBER; MULTIPLE LOCI; MAIZE; RICE; MUTANT; HEIGHT; MODEL; YIELD	The architecture of a plant affects its ability to compete for light and to respond to environmental stresses, thus affecting overall fitness and productivity. Two components of architecture, branching and height, were studied in 182 F-7 recombinant inbred lines (RILs) at the vegetative, flowering and mature developmental stages in the panicoid C-4 model grass system, Setaria. The RIL population was derived from a cross between domesticated S. italica (foxtail millet) and its wild relative S. viridis (green foxtail). In both field and greenhouse trials the wild parent was taller initially, started branching earlier, and flowered earlier, while the domesticated parent was shorter initially, but flowered later, producing a robust tall plant architecture with more nodes and leaves on the main culm and few or no branches. Biomass was highly correlated with height of the plant and number of nodes on the main culm, and generally showed a negative relationship with branch number. However, several of the RILs with the highest biomass in both trials were significantly more branched than the domesticated parent of the cross. Quantitative trait loci (QTL) analyses indicate that both height and branching are controlled by multiple genetic regions, often with QTL for both traits colocalizing in the same genomic regions. Genomic positions of several QTL colocalize with QTL in syntenic regions in other species and contain genes known to control branching and height in sorghum, maize, and switchgrass. Included in these is the ortholog of the rice SD-1 semi-dwarfing gene, which underlies one of the major Setaria height QTL. Understanding the relationships between height and branching patterns in Setaria, and their genetic control, is an important step to gaining a comprehensive knowledge of the development and genetic regulation of panicoid grass architecture.	[Mauro-Herrera, Margarita; Doust, Andrew N.] Oklahoma State Univ, Dept Plant Biol Ecol & Evolut, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Doust, AN (corresponding author), Oklahoma State Univ, Dept Plant Biol Ecol & Evolut, Stillwater, OK 74078 USA.	andrew.doust@okstate.edu			Oklahoma Center of the Advancement of Science [PSB09-7, PSB11-35]; NSF Plant Genome [IOS-1339332]; Division Of Integrative Organismal Systems [1339332] Funding Source: National Science Foundation	Oklahoma Center of the Advancement of Science; NSF Plant Genome(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Oklahoma Center of the Advancement of Science PSB09-7, PSB11-35 to AD; and NSF Plant Genome, IOS-1339332 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; BASTEN CJ, 1994, 5 WORLD C GEN APPL L; Basten CJ., 2002, QTL CARTOGRAPHER VER; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bhandari HS, 2011, CROP SCI, V51, P1525, DOI 10.2135/cropsci2010.10.0588; Bian YL, 2015, EUPHYTICA, V205, P85, DOI 10.1007/s10681-015-1397-0; Bonser SP, 1996, OIKOS, V77, P347, DOI 10.2307/3546076; Braun N, 2012, PLANT PHYSIOL, V158, P225, DOI 10.1104/pp.111.182725; Brutnell TP, 2015, ANNU REV PLANT BIOL, V66, P465, DOI 10.1146/annurev-arplant-042811-105528; Cassani E, 2009, MOL BREEDING, V24, P375, DOI 10.1007/s11032-009-9298-3; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chen YN, 2012, PLANT BIOTECHNOL J, V10, P139, DOI 10.1111/j.1467-7652.2011.00637.x; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Choi MS, 2012, PLANT CELL REP, V31, P57, DOI 10.1007/s00299-011-1139-2; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; CHURCHILL GA, 1994, GENETICS, V138, P963; COYNE DP, 1980, HORTSCIENCE, V15, P244; Dabbert T, 2010, THEOR APPL GENET, V121, P705, DOI 10.1007/s00122-010-1342-5; Daverdin G, 2015, BIOENERG RES, V8, P137, DOI 10.1007/s12155-014-9508-7; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doerge RW, 1996, GENETICS, V142, P285; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Doust AN, 2006, MOL ECOL, V15, P1335, DOI 10.1111/j.1365-294X.2005.02791.x; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Doust A, 2007, ANN BOT-LONDON, V100, P941, DOI 10.1093/aob/mcm040; Doust AN, 2007, CURR OPIN PLANT BIOL, V10, P21, DOI 10.1016/j.pbi.2006.11.015; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Finlayson SA, 2007, PLANT CELL PHYSIOL, V48, P667, DOI 10.1093/pcp/pcm044; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Garg AK, 2006, PLANTA, V223, P627, DOI 10.1007/s00425-005-0101-3; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo SL, 2013, J INEQUAL APPL, DOI 10.1186/1029-242X-2013-67; Holland JB, 1998, J HERED, V89, P374, DOI 10.1093/jhered/89.4.374; Hubbard L, 2002, GENETICS, V162, P1927; Hutchings M. J., 1990, CLONAL GROWTH PLANTS, V57, P76; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; JANSEN RC, 1994, GENETICS, V136, P1447; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jiang H, 2008, PROG NAT SCI-MATER, V18, P1539, DOI 10.1016/j.pnsc.2008.05.025; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Kebrom TH, 2013, TRENDS PLANT SCI, V18, P41, DOI 10.1016/j.tplants.2012.07.001; Kebrom TH, 2006, PLANT PHYSIOL, V140, P1109, DOI 10.1104/pp.105.074856; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; Kong WQ, 2014, THEOR APPL GENET, V127, P2387, DOI 10.1007/s00122-014-2384-x; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Lewis JM, 2008, PLANT CELL REP, V27, P1217, DOI 10.1007/s00299-008-0543-8; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu GF, 2010, GENETICA, V138, P885, DOI 10.1007/s10709-010-9471-y; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Lowry DB, 2015, BIOENERG RES, V8, P1856, DOI 10.1007/s12155-015-9629-7; Lukens LN, 1999, GENET RES, V74, P291, DOI 10.1017/S0016672399004073; Lynch M., 1998, GENETICS ANAL QUANTI; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Mauro-Herrera M, 2013, G3-GENES GENOM GENET, V3, P283, DOI 10.1534/g3.112.005207; McGarry RC, 2012, PLANT SCI, V188, P71, DOI 10.1016/j.plantsci.2012.03.002; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Morgan PW, 2002, CROP SCI, V42, P1791, DOI 10.2135/cropsci2002.1791; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Poncet V, 2000, THEOR APPL GENET, V100, P147, DOI 10.1007/s001220050020; Qie LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101868; Sakamoto T, 2003, NAT BIOTECHNOL, V21, P909, DOI 10.1038/nbt847; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Salvi S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-4; Schnable JC, 2011, MAYDICA, V56, P183; Serba DD, 2015, BIOENERG RES, V8, P307, DOI 10.1007/s12155-014-9523-8; Solbrig OT, 1994, BIODIVERSITY ECOSYST, V99, P97; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tong HN, 2009, PLANT J, V58, P803, DOI 10.1111/j.1365-313X.2009.03825.x; Wan CG, 1998, ENVIRON EXP BOT, V40, P247, DOI 10.1016/S0098-8472(98)00044-6; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wang Z, 2010, EUPHYTICA, V174, P447, DOI 10.1007/s10681-010-0166-3; WILK MB, 1968, BIOMETRIKA, V55, P1; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; Wu XS, 2010, J EXP BOT, V61, P2923, DOI 10.1093/jxb/erq117; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Yan JQ, 1998, THEOR APPL GENET, V97, P267, DOI 10.1007/s001220050895; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang D, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0477-6; Zou JH, 2005, PLANTA, V222, P604, DOI 10.1007/s00425-005-0007-0	100	36	38	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151346	10.1371/journal.pone.0151346	http://dx.doi.org/10.1371/journal.pone.0151346			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985990	Green Published, gold			2022-12-27	WOS:000372580300064
J	Shinneman, DJ; Means, RE; Potter, KM; Hipkins, VD				Shinneman, Douglas J.; Means, Robert E.; Potter, Kevin M.; Hipkins, Valerie D.			Exploring Climate Niches of Ponderosa Pine (Pinus ponderosa Douglas ex Lawson) Haplotypes in the Western United States: Implications for Evolutionary History and Conservation	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; GENETIC-STRUCTURE; ICE-AGES; POPULATION; FOREST; CONSEQUENCES; POLLEN; SEED; SYSTEMATICS; PREDICTION	Ponderosa pine (Pinus ponderosa Douglas ex Lawson) occupies montane environments throughout western North America, where it is both an ecologically and economically important tree species. A recent study using mitochondrial DNA analysis demonstrated substantial genetic variation among ponderosa pine populations in the western U.S., identifying 10 haplotypes with unique evolutionary lineages that generally correspond spatially with distributions of the Pacific (P. p. var. ponderosa) and Rocky Mountain (P. p. var. scopulorum) varieties. To elucidate the role of climate in shaping the phylogeographic history of ponderosa pine, we used nonparametric multiplicative regression to develop predictive climate niche models for two varieties and 10 haplotypes and to hindcast potential distribution of the varieties during the last glacial maximum (LGM), similar to 22,000 yr BP. Our climate niche models performed well for the varieties, but haplotype models were constrained in some cases by small datasets and unmeasured microclimate influences. The models suggest strong relationships between genetic lineages and climate. Particularly evident was the role of seasonal precipitation balance in most models, with winter- and summer-dominated precipitation regimes strongly associated with P. p. vars. ponderosa and scopulorum, respectively. Indeed, where present-day climate niches overlap between the varieties, introgression of two haplotypes also occurs along a steep clinal divide in western Montana. Reconstructed climate niches for the LGM suggest potentially suitable climate existed for the Pacific variety in the California Floristic province, the Great Basin, and Arizona highlands, while suitable climate for the Rocky Mountain variety may have existed across the southwestern interior highlands. These findings underscore potentially unique phylogeographic origins of modern ponderosa pine evolutionary lineages, including potential adaptations to Pleistocene climates associated with discrete temporary glacial refugia. Our predictive climate niche models may inform strategies for further genetic research (e.g., sampling design) and conservation that promotes haplotype compatibility with projected changes in future climate.	[Shinneman, Douglas J.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA; [Means, Robert E.] Bur Land Management Wyoming, Cheyenne, WY USA; [Potter, Kevin M.] N Carolina State Univ, Dept Forestry & Environm Resources, Res Triangle Pk, NC USA; [Hipkins, Valerie D.] US Forest Serv, Natl Forest Genet Lab, USDA, Placerville, CA USA	United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Forest Service	Shinneman, DJ (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA.	dshinneman@usgs.gov	Potter, Kevin M./I-4455-2019	Potter, Kevin M./0000-0002-7330-5345	Southern Research Station of the USDA Forest Service [14-CS-11330110-042, 15-CS-11330110-067]; North Carolina State University [14-CS-11330110-042, 15-CS-11330110-067]; U.S. Bureau of Land Management [L12PG00219]; U.S. Geological Survey [L12PG00219]	Southern Research Station of the USDA Forest Service; North Carolina State University; U.S. Bureau of Land Management; U.S. Geological Survey(United States Geological Survey)	This work was supported in part through Cost Share Agreements 14-CS-11330110-042 and 15-CS-11330110-067 between the Southern Research Station of the USDA Forest Service and North Carolina State University (Kevin Potter). Funding for developing the climate niche models presented in this paper was provided through an Interagency Agreement (L12PG00219) between the U.S. Bureau of Land Management and the U.S. Geological Survey (Douglas Shinneman). Robert Means (BLM) helped to collect and analyze data, prepare the manuscript, and was involved in the decision to publish.	Anderson RS, 2000, PALAEOGEOGR PALAEOCL, V155, P31, DOI 10.1016/S0031-0182(99)00093-0; Anderson RS, 1989, MULTIRESOURCE MANAGE, P15; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Betancourt J.L., 1990, PACKRAT MIDDENS LAST; Brayshaw T. C., 1997, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V99, P673; Callaham RZ, 2013, PSWRP264 USDA FOR SE; Charlet David Alan, 2007, Aliso, V24, P31; COLE K, 1983, QUATERNARY RES, V19, P117, DOI 10.1016/0033-5894(83)90031-5; Conkle MT, 1998, P POND PIN SPEC MAN, P27; CRITCHFIELD W. B., 1965, MADRONO, V18, P63; Critchfield W. B., 1984, Madrono, V31, P144; Critchfield W. B., 1966, MISCELLANEOUS PUBLIC, V991; Crookston N. L, 2008, CLIMATE ESTIMATES PL; Dodson EK, 2013, FOREST ECOL MANAG, V302, P163, DOI 10.1016/j.foreco.2013.03.050; DONG JS, 1994, GENETICS, V136, P1187; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellenwood JR, 2015, FHTET1501 USDA FOR S; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Evans J.S., 2014, ARCGIS TOOLBOX SURFA; Gotelli NJ, 2015, J BIOGEOGR, V42, P1577, DOI 10.1111/jbi.12562; Gray LK, 2013, CLIMATIC CHANGE, V117, P289, DOI 10.1007/s10584-012-0548-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hibbs DE, 2002, NORTHWEST SCI, V76, P80; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Johansen AD, 2003, MOL ECOL, V12, P293, DOI 10.1046/j.1365-294X.2003.01723.x; Johnstone JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00102.1; Kaye MW, 2010, J BIOGEOGR, V37, P1668, DOI 10.1111/j.1365-2699.2010.02327.x; Lascoux M, 2004, PHILOS T ROY SOC B, V359, P197, DOI 10.1098/rstb.2003.1390; Latta RG, 1998, EVOLUTION, V52, P61, DOI [10.2307/2410920, 10.1111/j.1558-5646.1998.tb05138.x]; Latta RG, 1999, EVOLUTION, V53, P769, DOI 10.2307/2640717; Lauria F., 1997, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V99, P655; Lintz HE, 2011, ECOL MODEL, V222, P427, DOI 10.1016/j.ecolmodel.2010.10.017; Littell JS, 2010, CLIMATIC CHANGE, V102, P129, DOI 10.1007/s10584-010-9858-x; Little E., 1971, CONIFERS IMPORTANT H, V1; MacDonald Glen M., 1998, P122; McCune B, 2006, J VEG SCI, V17, P819, DOI 10.1111/j.1654-1103.2006.tb02505.x; MCKEE A, 1987, GREAT BASIN NAT, V47, P163; Minnich RA, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P43; Mitton JB, 2000, MOL ECOL, V9, P91, DOI 10.1046/j.1365-294x.2000.00840.x; Norris JR, 2016, J BIOGEOGR, V43, P778, DOI 10.1111/jbi.12670; Norris JR, 2006, J BIOGEOGR, V33, P342, DOI 10.1111/j.1365-2699.2005.01396.x; Norris JR, 2006, THESIS U WYOMING US; Oliver W.W., 1990, AGR HDB, P413; PELOQUIN RL, 1984, SOUTHWEST NAT, V29, P115, DOI 10.2307/3670776; Perry JP., 1991, PINES MEXICO CENTRAL; PETIT RJ, 1993, HEREDITY, V71, P630, DOI 10.1038/hdy.1993.188; Potter KM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0865-y; Potter KM, 2013, AM J BOT, V100, P1562, DOI 10.3732/ajb.1300039; Potter KM, 2014, GENETIC ASSESSMENT P; Rehfeldt GE, 1999, AM J BOT, V86, P741, DOI 10.2307/2656584; Rehfeldt GE, 1999, SILVAE GENET, V48, P167; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P126, DOI 10.1016/j.foreco.2014.02.035; Roberts DR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2903; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sinclair WT, 1999, MOL ECOL, V8, P83, DOI 10.1046/j.1365-294X.1999.00527.x; Spaulding W.G., 1983, LATE QUATERNARY ENV, V1, P259; Spaulding WG, 1984, P 8 N AM FOR BIOL WO, P42; Thomassen HA, 2010, MOL ECOL, V19, P3532, DOI 10.1111/j.1365-294X.2010.04737.x; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; Van Devender T. R., 1987, N AM ADJACENT OCEANS, P323; Van Devender T.R., 1990, PACKRAT MIDDENS LAST, P104; Wang C-W, 1977, WO34 USDA FOR SERV; Westfall RD, 2004, FOREST ECOL MANAG, V197, P159, DOI 10.1016/j.foreco.2004.05.011; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011	71	27	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151811	10.1371/journal.pone.0151811	http://dx.doi.org/10.1371/journal.pone.0151811			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985674	Green Published, gold			2022-12-27	WOS:000372580300134
J	Vreede, KS; Sunnerhagen, KS				Vreede, Katarina Skough; Sunnerhagen, Katharina S.			Characteristics of Patients at First Visit to a Polio Clinic in Sweden	PLOS ONE			English	Article							POSTPOLIO SYNDROME; MUSCLE-FIBERS; POLIOMYELITIS; STRENGTH; NETHERLANDS; PERFORMANCE; MANAGEMENT; SAMPLE; FORCE	Aim Describe polio patients visiting a polio clinic in Sweden, a country where vaccination was introduced in 1957. Design A consecutive cohort study. Patients Prior polio patients. Methods All patients (n = 865) visiting the polio clinic at Sahlgrenska University Hospital, Gothenburg Sweden, between 1994 and 2012 were included in this study. Data at first visit regarding patient characteristics, polio classification, data of electromyography, origin, assistive devices and gait speed as well as muscle strength were collected for these patients. Twenty-three patients were excluded because no polio diagnosis could be established. A total of 842 patients with confirmed polio remained in the study. Results More than twenty percent of the patients were from countries outside the Nordic region and considerably younger than those from the Nordic region. The majority of the emigrants were from Asia and Africa followed by Europe (outside the Nordic region). Of all patients included ninety-seven percent (n = 817) had polio in the lower extremity and almost 53% (n = 444) had polio in the upper extremity while 28% (n = 238) had polio in the trunk, according to clinical classification of polio. Compared with a sample of the normal population, the polio patients walked 61-71% slower, and were 53-77% weaker in muscle strength of the knee and foot as well as grip strength. Conclusion The younger patients with polio emigrating from countries with different cultures may lead to a challenge for the multi professional teams working with post-polio rehabilitation and are of importance when planning for the care of polio patients the coming years.	[Vreede, Katarina Skough; Sunnerhagen, Katharina S.] Univ Gothenburg, Dept Clin Neurosci, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Vreede, KS (corresponding author), Univ Gothenburg, Dept Clin Neurosci, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	katarina.skough@ki.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400				Andreasson CGG, 1999, LAKARTIDNINGEN, V41, P4446; [Anonymous], 1991, BIOMECHANICS MOTOR C; Bickerstaffe A, 2015, MUSCLE NERVE, V51, P24, DOI 10.1002/mus.24272; BORG K, 1989, J NEUROL NEUROSUR PS, V52, P1141, DOI 10.1136/jnnp.52.10.1141; BORG K, 1991, J NEUROL NEUROSUR PS, V54, P236, DOI 10.1136/jnnp.54.3.236; Farbu E, 2006, EUR J NEUROL, V13, P795, DOI 10.1111/j.1468-1331.2006.01385.x; Gonzalez H, 2010, LANCET NEUROL, V9, P634, DOI 10.1016/S1474-4422(10)70095-8; Grimby G, 1998, MUSCLE NERVE, V21, P1428, DOI 10.1002/(SICI)1097-4598(199811)21:11<1428::AID-MUS10>3.3.CO;2-D; Halstead LS, 1998, SCI AM, V278, P42, DOI 10.1038/scientificamerican0498-42; HALSTEAD LS, 1985, ORTHOPEDICS, V8, P845; Ivanyi B, 1999, ARCH PHYS MED REHAB, V80, P687, DOI 10.1016/S0003-9993(99)90173-9; Lagerstrom C, 1998, SCAND J REHABIL MED, V30, P113; Lehmann K, 2006, ACTA NEUROL SCAND, V113, P55, DOI 10.1111/j.1600-0404.2006.00443.x; LUNDGRENLINDQUIST B, 1983, SCAND J REHABIL MED, V15, P125; Nollet F, 2002, J NEUROL NEUROSUR PS, V73, P695, DOI 10.1136/jnnp.73.6.695; NORDENSKIOLD UM, 1993, SCAND J RHEUMATOL, V22, P14, DOI 10.3109/03009749309095105; Sandberg A, 2004, ARCH PHYS MED REHAB, V85, P1174, DOI 10.1016/j.apmr.2003.08.101; Sunnehagen KS, 2000, SCAND J REHABIL MED, V32, P159; WEINSTEIN L, 1957, NEW ENGL J MED, V257, P47, DOI 10.1056/NEJM195707112570201; Wekre LL, 1998, SPINAL CORD, V36, P280, DOI 10.1038/sj.sc.3100557; WINDEBANK AJ, 1991, NEUROLOGY, V41, P501, DOI 10.1212/WNL.41.4.501	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150286	10.1371/journal.pone.0150286	http://dx.doi.org/10.1371/journal.pone.0150286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981623	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900031
J	Xiao, M; Du, GK; Zhong, GB; Yan, DJ; Zeng, HZ; Cai, WW				Xiao, Man; Du, Guankui; Zhong, Guobing; Yan, Dongjing; Zeng, Huazong; Cai, Wangwei			Gas Chromatography/Mass Spectrometry-Based Metabolomic Profiling Reveals Alterations in Mouse Plasma and Liver in Response to Fava Beans	PLOS ONE			English	Article							LINOLEIC-ACID; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; COMPARATIVE TOXICITY; LIPID-PEROXIDATION; HUMAN ERYTHROCYTES; OXIDATIVE STRESS; FATTY-ACIDS; CELLS; DEFICIENCY; DIVICINE	Favism is a life-threatening hemolytic anemia resulting from the intake of fava beans by susceptible individuals with low erythrocytic glucose 6-phosphate dehydrogenase (G6PD) activity. However, little is known about the metabolomic changes in plasma and liver after the intake of fava beans in G6PD normal and deficient states. In this study, gas chromatography/mass spectrometry was used to analyze the plasma and liver metabolic alterations underlying the effects of fava beans in C3H- and G6PD-deficient (G6PDx) mice, and to find potential biomarkers and metabolic changes associated with favism. Our results showed that fava beans induced oxidative stress in both C3H and G6PDx mice. Significantly, metabolomic differences were observed in plasma and liver between the control and fava bean treated groups of both C3H and G6PDx mice. The levels of 7 and 21 metabolites in plasma showed significant differences between C3H-control (C3H-C)- and C3H fava beans-treated (C3H-FB) mice, and G6PDx-control (G6PDx-C)- and G6PDx fava beans-treated (G6PDx-FB) mice, respectively. Similarly, the levels of 7 and 25 metabolites in the liver showed significant differences between C3H and C3H-FB, and G6PDx and G6PDx-FB, respectively. The levels of oleic acid, linoleic acid, and creatinine were significantly increased in the plasma of both C3H-FB and G6PDx-FB mice. In the liver, more metabolic alterations were observed in G6PDx-FB mice than in C3H-FB mice, and were involved in a sugar, fatty acids, amino acids, cholesterol biosynthesis, the urea cycle, and the nucleotide metabolic pathway. These findings suggest that oleic acid, linoleic acid, and creatinine may be potential biomarkers of the response to fava beans in C3H and G6PDx mice and therefore that oleic acid and linoleic acid may be involved in oxidative stress induced by fava beans. This study demonstrates that G6PD activity in mice can affect their metabolic pathways in response to fava beans.	[Xiao, Man; Du, Guankui; Zhong, Guobing; Yan, Dongjing; Cai, Wangwei] Hainan Med Coll, Dept Biochem & Mol Biol, Haikou 571199, Peoples R China; [Zeng, Huazong] Shanghai Sensichip Infotech Co Ltd, Shanghai 200433, Peoples R China	Hainan Medical University	Cai, WW (corresponding author), Hainan Med Coll, Dept Biochem & Mol Biol, Haikou 571199, Peoples R China.	caiww591020@163.com	Du, Guankui/AAG-7628-2019	Du, Guankui/0000-0002-1117-8299	National Key Basic Research Program of China [2012CB526600]; National Natural Science Foundation of China [30960171, 81260092]; Natural Science Foundation of Hainan Province [812195]; Shanghai Sensichip Infotech Co., Ltd.	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province; Shanghai Sensichip Infotech Co., Ltd.	The National Key Basic Research Program of China (2012CB526600) (WWC), National Natural Science Foundation of China (No. 30960171, No. 81260092) (WWC) and Natural Science Foundation of Hainan Province (No. 812195) (MX) had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shanghai Sensichip Infotech Co., Ltd. provided support in the form of salaries for author HZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Astarita G, 2013, J NUTRIGENET NUTRIGE, V6, P181, DOI 10.1159/000354403; AYDROYD W R, 1964, FAO Nutr Stud, V19, P1; Beger RD, 2010, TOXICOL APPL PHARM, V243, P154, DOI 10.1016/j.taap.2009.11.019; BELSEY MA, 1973, B WORLD HEALTH ORGAN, V48, P1; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Birdsall T C, 1998, Altern Med Rev, V3, P128; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CHEVION M, 1982, EUR J BIOCHEM, V127, P405, DOI 10.1111/j.1432-1033.1982.tb06886.x; COPLEY SD, 1992, ANAL BIOCHEM, V201, P152, DOI 10.1016/0003-2697(92)90188-D; Cury-Boaventura MF, 2006, LIFE SCI, V78, P1448, DOI 10.1016/j.lfs.2005.07.038; Cury-Boaventura MF, 2005, NUTRITION, V21, P395, DOI 10.1016/j.nut.2004.07.007; Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014; Hatanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058626; Healy DA, 2003, CLIN SCI, V104, P171, DOI 10.1042/CS20020223; Ho HY, 2013, FREE RADICAL BIO MED, V54, P71, DOI 10.1016/j.freeradbiomed.2012.10.557; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Innis Sheila M, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P359, DOI 10.1097/MED.0b013e3282be90b9; Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; MAGER J, 1965, BIOCHEM BIOPH RES CO, V20, P235, DOI 10.1016/0006-291X(65)90352-9; McMillan DC, 1999, TOXICOL SCI, V51, P310, DOI 10.1093/toxsci/51.2.310; McMillan DC, 2001, TOXICOL SCI, V62, P353, DOI 10.1093/toxsci/62.2.353; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Putri SP, 2013, J BIOSCI BIOENG, V115, P579, DOI 10.1016/j.jbiosc.2012.12.007; Reiterer G, 2004, J NUTR, V134, P771, DOI 10.1093/jn/134.4.771; Richard D, 2008, PHARMACOL RES, V57, P451, DOI 10.1016/j.phrs.2008.05.002; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; SATOH H, 1994, ADV EXP MED BIOL, V359, P181; Spiteller G, 1998, CHEM PHYS LIPIDS, V95, P105, DOI 10.1016/S0009-3084(98)00091-7; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Takada E, 2008, CANCER CHEMOTH PHARM, V62, P569, DOI 10.1007/s00280-007-0638-x; Tang HY, 2015, ANTIOXID REDOX SIGN, V22, P744, DOI 10.1089/ars.2014.6142; Tavazzi B, 2000, EUR J BIOCHEM, V267, P684, DOI 10.1046/j.1432-1327.2000.01042.x; TOBOREK M, 1994, AM J CLIN NUTR, V59, P60, DOI 10.1093/ajcn/59.1.60; WINTERBOURN CC, 1989, BIOCHEM PHARMACOL, V38, P611, DOI 10.1016/0006-2952(89)90206-2; Wu H, 2009, J CHROMATOGR B, V877, P3111, DOI 10.1016/j.jchromb.2009.07.039; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xu EY, 2009, CURR OPIN DRUG DISC, V12, P40	39	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151103	10.1371/journal.pone.0151103	http://dx.doi.org/10.1371/journal.pone.0151103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26981882	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900062
J	Kamei, K; Harada, R; Hamada, R; Sakai, T; Hamasaki, Y; Hataya, H; Ito, S; Ishikura, K; Honda, M				Kamei, Koichi; Harada, Ryoko; Hamada, Riku; Sakai, Tomoyuki; Hamasaki, Yuko; Hataya, Hiroshi; Ito, Shuichi; Ishikura, Kenji; Honda, Masataka			Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PROGNOSTIC INDICATORS; CONTROLLED-TRIAL; NATURAL-HISTORY; PREDICTING PROGRESSION; NEPHROTIC SYNDROME; CHILDREN; CHINESE; DISEASE; CREATININE	Background Proteinuria is the most important risk factor for IgA nephropathy progression. The purpose of this study is to evaluate the long-term outcome and risk factors for poor prognosis in childhood IgA nephropathy. Methods Patients who were diagnosed with IgA nephropathy between 1972 and 1992 at the Tokyo Metropolitan Kiyose Children's Hospital were included. We analyzed risk factors for progression to end-stage kidney disease (ESKD) and chronic renal insufficiency (CRI) using Kaplan-Meier method and multivariate analyses of Cox proportional hazard model. Results One hundred patients were included and the median observation period was 11.8 years. Twelve and 17 patients progressed to ESKD and CRI, respectively. The survival probabilities were 90.0% at 10 years and 79.8% at 20 years for ESKD, and 86.1% at 10 years and 72.3% at 20 years for CRI. Notably, patients with heavy proteinuria with hypoalbuminemia during follow-up period showed extremely poor prognosis. In this group, the survival rate at 10 years from ESKD and CRI was 40.6% and 20.8%, respectively. By multivariate analysis, proteinuria at diagnosis and proteinuria during follow-up period were risk factors for ESKD, whereas glomeruli showing mesangial proliferation >= 50% and proteinuria during follow-up period were risk factors for CRI. Patients without heavy proteinuria during follow-up period did not develop CRI and 63% of patients with mild proteinuria during follow-up period showed no proteinuria at the last observation. Conclusions The degree of proteinuria during follow-up period is the strongest risk factor for ESKD and CRI.	[Kamei, Koichi; Ishikura, Kenji] Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Tokyo, Japan; [Harada, Ryoko; Hamada, Riku; Hataya, Hiroshi; Ishikura, Kenji; Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Fuchu, Tokyo, Japan; [Sakai, Tomoyuki] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan; [Hamasaki, Yuko] Toho Univ, Fac Med, Dept Pediat Nephrol, Tokyo, Japan; [Ito, Shuichi] Yokohama City Univ, Dept Pediat, Yokohama, Kanagawa 232, Japan	National Center for Child Health & Development - Japan; Tokyo Metropolitan Children's Medical Center; Shiga University of Medical Science; Toho University; Yokohama City University	Kamei, K (corresponding author), Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Tokyo, Japan.	kamei-k@ncchd.go.jp	Ito, Shuichi/AAD-1962-2022					Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Coppo R, 2005, J NEPHROL, V18, P503; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Halling SE, 2012, NEPHROL DIAL TRANSPL, V27, P715, DOI 10.1093/ndt/gfr339; Han SH, 2011, NEPHROL DIAL TRANSPL, V26, P1570, DOI 10.1093/ndt/gfq559; HOGG RJ, 1994, PEDIATR NEPHROL, V8, P15, DOI 10.1007/BF00868251; Kamei K, 2011, CLIN J AM SOC NEPHRO, V6, P1301, DOI 10.2215/CJN.08630910; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Matsushita S, CLIN EXP NEPHROL; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Ronkainen J, 2006, PEDIATR NEPHROL, V21, P1266, DOI 10.1007/s00467-006-0163-x; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Shen PC, 2007, NEPHRON CLIN PRACT, V106, P157, DOI 10.1159/000104426; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; To KF, 2000, AM J KIDNEY DIS, V35, P392, DOI 10.1016/S0272-6386(00)70191-0; Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y; Wakai K, 2006, NEPHROL DIAL TRANSPL, V21, P2800, DOI 10.1093/ndt/gfl342; WYATT RJ, 1995, J PEDIATR-US, V127, P913, DOI 10.1016/S0022-3476(95)70027-7; YOSHIKAWA N, 1992, NEPHRON, V60, P60, DOI 10.1159/000186706; Yoshikawa N, 1999, J AM SOC NEPHROL, V10, P101; Yoshikawa N, 2001, PEDIATR NEPHROL, V16, P446, DOI 10.1007/s004670100582; Yoshikawa N, 2006, CLIN J AM SOC NEPHRO, V1, P511, DOI 10.2215/CJN.01120905	28	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150885	10.1371/journal.pone.0150885	http://dx.doi.org/10.1371/journal.pone.0150885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978656	Green Published, Green Submitted, gold			2022-12-27	WOS:000372572800038
J	Surmik, D; Boczarowski, A; Balin, K; Dulski, M; Szade, J; Kremer, B; Pawlicki, R				Surmik, Dawid; Boczarowski, Andrzej; Balin, Katarzyna; Dulski, Mateusz; Szade, Jacek; Kremer, Barbara; Pawlicki, Roman			Spectroscopic Studies on Organic Matter from Triassic Reptile Bones, Upper Silesia, Poland	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; INFRARED-SPECTROSCOPY; AMINO-ACID; ADSORBED PROTEINS; DINOSAUR BONES; SOFT-TISSUES; IRON; OSTEOCYTES; DIAGENESIS; COLLAGEN	Fossil biomolecules from an endogenous source were previously identified in Cretaceous to Pleistocene fossilized bones, the evidence coming from molecular analyses. These findings, however, were called into question and an alternative hypothesis of the invasion of the bone by bacterial biofilm was proposed. Herewith we report a new finding of morphologically preserved blood-vessel-like structures enclosing organic molecules preserved in iron-oxide-mineralized vessel walls from the cortical region of nothosaurid and tanystropheid (aquatic and terrestrial diapsid reptiles) bones. These findings are from the Early/Middle Triassic boundary (Upper Roetian/Lowermost Muschelkalk) strata of Upper Silesia, Poland. Multiple spectroscopic analyses (FTIR, ToF-SIMS, and XPS) of the extracted "blood vessels" showed the presence of organic compounds, including fragments of various amino acids such as hydroxyproline and hydroxylysine as well as amides, that may suggest the presence of collagen protein residues. Because these amino acids are absent from most proteins other than collagen, we infer that the proteinaceous molecules may originate from endogenous collagen. The preservation of molecular signals of proteins within the "blood vessels" was most likely made possible through the process of early diagenetic iron oxide mineralization. This discovery provides the oldest evidence of in situ preservation of complex organic molecules in vertebrate remains in a marine environment.	[Surmik, Dawid; Boczarowski, Andrzej] Univ Silesia, Fac Earth Sci, Bedzinska 60, Sosnowiec, Poland; [Surmik, Dawid; Boczarowski, Andrzej] Pk Sci & Human Evolut, 1 Maja 10, PL-46040 Krasiejow, Poland; [Balin, Katarzyna; Szade, Jacek] Univ Silesia, A Chelkowski Inst Phys, Uniwersytecka 4, PL-40007 Katowice, Poland; [Balin, Katarzyna; Dulski, Mateusz; Szade, Jacek] Silesian Ctr Educ & Interdisciplinary Res, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland; [Dulski, Mateusz] Univ Silesia, Inst Mat Sci, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland; [Kremer, Barbara] Polish Acad Sci, Inst Paleobiol, Twarda 51-55, PL-00818 Warsaw, Poland; [Pawlicki, Roman] Jagiellonian Univ, Coll Med, Dept Histol, Kopernika 7, PL-31034 Krakow, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University	Surmik, D (corresponding author), Univ Silesia, Fac Earth Sci, Bedzinska 60, Sosnowiec, Poland.; Surmik, D (corresponding author), Pk Sci & Human Evolut, 1 Maja 10, PL-46040 Krasiejow, Poland.	dawid@surmik.pl	Balin, Katarzyna/D-6225-2017; Kremer, Barbara/ABB-1201-2020; Szade, Jacek/W-6169-2018	Balin, Katarzyna/0000-0002-1811-3033; Kremer, Barbara/0000-0002-0464-1265; Surmik, Dawid/0000-0003-0121-9592; Dulski, Mateusz/0000-0001-8686-1853; Szade, Jacek/0000-0003-2083-4275	National Science Center [2011/01/N/ST10/06989]	National Science Center(National Science Centre, Poland)	This research project is supported by National Science Center (www.ncn.gov.pl) grant no. 2011/01/N/ST10/06989.	ADAMS E, 1978, SCIENCE, V202, P591, DOI 10.1126/science.212833; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Assmann P., 1944, STRATIGRAPHIE OBERSC; Atzei D, 2014, APPL SURF SCI, V307, P120, DOI 10.1016/j.apsusc.2014.03.178; Baltrusaitis J, 2007, PHYS CHEM CHEM PHYS, V9, P5542, DOI 10.1039/b709167b; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bell LS, 2008, AM J PHYS ANTHROPOL, V137, P449, DOI 10.1002/ajpa.20886; Bertazzo S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8352; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; CAMBIER P, 1986, CLAY MINER, V21, P191, DOI 10.1180/claymin.1986.021.2.08; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Cleland TP, 2015, J PROTEOME RES, V14, P5252, DOI 10.1021/acs.jproteome.5b00675; Cleland TP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0015; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; DELORENZO V, 1986, J BACTERIOL, V165, P570, DOI 10.1128/jb.165.2.570-578.1986; Diedrich CG, 2009, GLOBAL PLANET CHANGE, V65, P27, DOI 10.1016/j.gloplacha.2008.11.002; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; FYSH SA, 1983, CLAY CLAY MINER, V31, P377, DOI 10.1346/CCMN.1983.0310507; Graat P, 1998, SURF INTERFACE ANAL, V26, P773, DOI 10.1002/(SICI)1096-9918(199810)26:11<773::AID-SIA419>3.0.CO;2-#; Graham DJ, 2006, APPL SURF SCI, V252, P6860, DOI 10.1016/j.apsusc.2006.02.149; Greenwalt DE, 2013, P NATL ACAD SCI USA, V110, P18496, DOI 10.1073/pnas.1310885110; Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984; GURLEY LR, 1991, J PROTEIN CHEM, V10, P75, DOI 10.1007/BF01024658; Hagdorn H, 2007, PAN EUROPEAN CORRELA, P46; Henss A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0332; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; Ivarsson M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03487; JANSEN RJJ, 1995, CARBON, V33, P1021, DOI 10.1016/0008-6223(95)00030-H; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Kowal-Linka M., 2008, GEOLOGOS, V14, P125; Kowal-Linka Monika, 2012, Przeglad Geologiczny, V60, P646; Kowal-Linka M, 2014, CHEM GEOL, V363, P213, DOI 10.1016/j.chemgeo.2013.10.038; Kremer B, 2012, J RAMAN SPECTROSC, V43, P32, DOI 10.1002/jrs.2985; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lagant P, 1998, BIOSPECTROSCOPY, V4, P379, DOI 10.1002/(SICI)1520-6343(1998)4:6<379::AID-BSPY3>3.0.CO;2-2; Leefmann T, 2013, RAPID COMMUN MASS SP, V27, P565, DOI 10.1002/rcm.6483; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindgren J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0614; Lindgren J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1819; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Mansour A. N., 1996, Surface Science Spectra, V4, P357, DOI 10.1116/1.1247825; Muramoto S, 2011, J PHYS CHEM C, V115, P24247, DOI 10.1021/jp208035x; MUYZER G, 1992, GEOLOGY, V20, P871, DOI 10.1130/0091-7613(1992)020<0871:POTBPO>2.3.CO;2; NAKAJIMA T, 1970, BIOCHEM BIOPH RES CO, V39, P28, DOI 10.1016/0006-291X(70)90752-7; NAKAJIMA T, 1969, SCIENCE, V164, P1400, DOI 10.1126/science.164.3886.1400; National Academy of Science. Iron, 1979, IR REP SUBC IR; NAWROCKI J, 2000, PRZ GEOL, V48, P236; Oberg KA, 2004, EUR J BIOCHEM, V271, P2937, DOI 10.1111/j.1432-1033.2004.04220.x; PAWLICKI R, 1977, ACTA HISTOCHEM, V58, P75, DOI 10.1016/S0065-1281(77)80110-4; PAWLICKI R, 1995, FOLIA HISTOCHEM CYTO, V33, P183; PAWLICKI R, 1977, ACTA HISTOCHEM, V59, P40, DOI 10.1016/S0065-1281(77)80077-9; PAWLICKI R, 1966, NATURE, V211, P655, DOI 10.1038/211655a0; PAWLICKI R, 1983, FOL HISTOCH CYTOCHEM, V21, P253; Pfretzschner HU, 2006, PALAEONTOGR ABT A, V278, P135, DOI 10.1127/pala/278/2006/135; Piga G, 2011, PALAEOGEOGR PALAEOCL, V310, P92, DOI 10.1016/j.palaeo.2011.05.018; POVARENNYKH AS, 1978, AM MINERAL, V63, P956; Rahmelow K, 1998, ANAL BIOCHEM, V257, P1, DOI 10.1006/abio.1997.2502; Reisz RR, 2013, NATURE, V496, P210, DOI 10.1038/nature11978; Rieppel O, 1999, PALAEOGEOGR PALAEOCL, V153, P1, DOI 10.1016/S0031-0182(99)00067-X; Rieppel O, 2000, HDB PALAHERPETOLOGIE; Rieppel Olivier, 1997, P121, DOI 10.1016/B978-012155210-7/50009-0; Rieppel Olivier, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V197, P383; ROTHSCHILD KJ, 1986, P NATL ACAD SCI USA, V83, P347, DOI 10.1073/pnas.83.2.347; ROTHSCHILD KJ, 1989, P NATL ACAD SCI USA, V86, P9832, DOI 10.1073/pnas.86.24.9832; Ruiz-Herrera J., 2012, FUNGAL CELL WALL STR, Vsecond; Sanni OD, 2002, SURF INTERFACE ANAL, V33, P715, DOI 10.1002/sia.1438; Sawlowicz Z, 2006, MINERALOGIA POLONICA, V29, P184; Schweitzer MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2741; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2008, CR PALEVOL, V7, P159, DOI 10.1016/j.crpv.2008.02.005; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2013, BONE, V52, P414, DOI 10.1016/j.bone.2012.10.010; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Schweitzer MH, 1999, J VERTEBR PALEONTOL, V19, P712, DOI 10.1080/02724634.1999.10011183; Sommer-Knudsen J, 1998, PHYTOCHEMISTRY, V47, P483, DOI 10.1016/S0031-9422(97)00724-3; Stathopoulou ET, 2008, PALAEOGEOGR PALAEOCL, V266, P168, DOI 10.1016/j.palaeo.2008.03.022; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Stuart B. H., 1997, BIOL APPL INFRARED S; Surmik D., 2010, FOSSIL VERTEBRATES M, P110; Szulc Joachim, 2000, Annales Societatis Geologorum Poloniae, V70, P1; Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Thiel V, 2014, ORG GEOCHEM, V68, P71, DOI 10.1016/j.orggeochem.2013.12.006; Turner-Walker G., 1999, B GEOL SOC NORFOLK, V48, P3; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Wagner MS, 2004, APPL SURF SCI, V231, P366, DOI 10.1016/j.apsusc.2004.03.100; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; WELSH ID, 1989, PHYS REV B, V40, P6386, DOI 10.1103/PhysRevB.40.6386; Wu H, 2001, CELL MOL LIFE SCI, V58, P1418, DOI 10.1007/PL00000785; ZAWIDZKA K, 1975, Acta Geologica Polonica, V25, P217	93	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151143	10.1371/journal.pone.0151143	http://dx.doi.org/10.1371/journal.pone.0151143			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26977600	Green Submitted, gold, Green Published			2022-12-27	WOS:000372572800048
J	Pai, CH; Yen, CT; Chen, CP; Yu, IS; Lin, SW; Lin, SR				Pai, Chen-Hsueh; Yen, Ching-Tzu; Chen, Chie-Pein; Yu, I-Shing; Lin, Shu-Wha; Lin, Shu-Rung			Lack of Thromboxane Synthase Prevents Hypertension and Fetal Growth Restriction after High Salt Treatment during Pregnancy	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; LINKING PLACENTAL ISCHEMIA; OXIDATIVE STRESS; PREECLAMPTIC PREGNANCIES; INFLAMMATORY CYTOKINES; VASCULAR EXPRESSION; PATHOPHYSIOLOGY; PROSTACYCLIN; A(2); ENDOTHELIUM	Preeclampsia (PE) is a potentially fatal pregnancy-related hypertensive disorder characterized by poor placenta development that can cause fetal growth restriction. PE-associated pathologies, including thrombosis, hypertension, and impaired placental development, may result from imbalances between thromboxane A(2) (TXA(2)) and prostacyclin. Low-dose aspirin, which selectively inhibits TXA(2) production, is used to prevent high-risk PE. However, the role of TXA(2) in aspirin-mediated protective effects in women with PE is not understood fully. In this study, we examined the role of prostanoids in PE using human samples and an induced PE mouse model. We demonstrated that the administration of salted drinking water (2.7% NaCl) to wild-type mice resulted in elevated placental TXA(2) synthase (TXAS) and plasma TXA(2), but not prostacyclin, levels, which was also found in our clinical PE placenta samples. The high salt-treated wild-type pregnant mice had shown unchanged maternal body weight, hypertension (MAP increase 15 mmHg), and decreased pup weight (similar to 50%) and size (similar to 24%), but these adverse effects were ameliorated in TXAS knockout (KO) mice. Moreover, increased expression of interleukin-1 beta and downstream phosphorylated-p38-mitogen-activated protein kinase were concordant with apoptosis induction in the placentas of salt water-treated wild-type mice. These alterations were not observed in TXAS KO mice. Together, our data suggest that TXA(2) depletion has anti-PE effects due to the prevention of hypertension and placental damage through downregulation of the interleukin-1 beta pathway.	[Pai, Chen-Hsueh; Yen, Ching-Tzu; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yen, Ching-Tzu] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Chen, Chie-Pein] Mackay Mem Hosp, Dept Obstet & Gynecol, Div High Risk Pregnancy, Taipei, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Coll Med, Lab Anim Ctr, Taipei 10764, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Coll Sci, Dept Biosci Technol, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Biomed Technol, Taoyuan, Taiwan	National Taiwan University; National Taiwan University; Mackay Memorial Hospital; National Taiwan University; Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University	Lin, SW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.; Lin, SR (corresponding author), Chung Yuan Christian Univ, Coll Sci, Dept Biosci Technol, Taoyuan, Taiwan.; Lin, SR (corresponding author), Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan.; Lin, SR (corresponding author), Chung Yuan Christian Univ, Ctr Biomed Technol, Taoyuan, Taiwan.	mtshuwha@ntu.edu.tw; shurung@cycu.edu.tw	CHEN, CHEN/HDM-6657-2022	LIN, SHU-WHA/0000-0001-6748-5581; Pai, Chen-Hsueh/0000-0001-5425-897X	National Science Council of Taiwan [NSC 100-2632-M-033-001-MY3, NSC 101-2632-M-033-001-MY2, NSC 102-2632-M-033-001-MY3, NSC 102-2320-B-033 -003, MOST 104-2319-B-002-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan, www.most.gov.tw/ (Grant No. No. NSC 100-2632-M-033-001-MY3, NSC 101-2632-M-033-001-MY2, NSC 102-2632-M-033-001-MY3 and NSC 102-2320-B-033 -003, MOST 104-2319-B-002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; ALLY AI, 1980, PROSTAG LEUKOTR ESS, V4, P431, DOI 10.1016/0161-4630(80)90051-8; Beausejour A, 2007, PLACENTA, V28, P52, DOI 10.1016/j.placenta.2005.12.003; Beausejour A, 2003, AM J PHYSIOL-HEART C, V285, pH375, DOI 10.1152/ajpheart.01132.2002; Benyo DF, 2001, J CLIN ENDOCR METAB, V86, P2505, DOI 10.1210/jc.86.6.2505; Bowen RS, 2005, PLACENTA, V26, P402, DOI 10.1016/j.placenta.2004.07.007; Briceno-Perez C, 2009, HYPERTENS PREGNANCY, V28, P138, DOI 10.1080/10641950802022384; Chen CP, 2013, PLACENTA, V34, P913, DOI 10.1016/j.placenta.2013.06.311; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Elmahashi Mohamed O, 2014, BMC Res Notes, V7, P23, DOI 10.1186/1756-0500-7-23; Fung C, 2011, J DEV ORIG HLTH DIS, V2, P291, DOI 10.1017/S2040174411000535; Furuya M, 2008, VASC HEALTH RISK MAN, V4, P1301, DOI 10.2147/VHRM.S4009; Gilbert JS, 2008, AM J PHYSIOL-HEART C, V294, pH541, DOI 10.1152/ajpheart.01113.2007; GOESCHEN K, 1993, J PERINAT MED, V21, P481, DOI 10.1515/jpme.1993.21.6.481; Granger JP, 2002, MICROCIRCULATION, V9, P147, DOI 10.1038/sj.mn.7800137; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Hayakawa M, 2006, J SOC GYNECOL INVEST, V13, P566, DOI 10.1016/j.jsgi.2006.09.007; Kalinderis M, 2011, AM J REPROD IMMUNOL, V66, P468, DOI 10.1111/j.1600-0897.2011.01019.x; Knight M, 2000, Cochrane Database Syst Rev, pCD000492; Kriston T, 1999, AM J PHYSIOL-REG I, V276, pR831, DOI 10.1152/ajpregu.1999.276.3.R831; LeFevre ML, 2014, ANN INTERN MED, V161, P819, DOI 10.7326/M14-1884; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Llinas MT, 2002, AM J HYPERTENS, V15, P793, DOI 10.1016/S0895-7061(02)02975-8; Lockwood CJ, 2008, AM J PATHOL, V172, P1571, DOI 10.2353/ajpath.2008.070629; LOSONCZY G, 1995, AM J PHYSIOL-REG I, V269, pR720, DOI 10.1152/ajpregu.1995.269.3.R720; Lyall F, 2002, PLACENTA, V23, pS142, DOI 10.1053/plac.2002.0803; Mccoy S, 2009, AM J HEALTH-SYST PH, V66, P337, DOI 10.2146/ajhp080104; Mousa AA, 2012, HYPERTENSION, V59, P1249, DOI 10.1161/HYPERTENSIONAHA.111.188730; Nilkaeo A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/79359; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Raghupathy R, 2013, MED PRIN PRACT, V22, P8, DOI 10.1159/000354200; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Reslan Ossama M., 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P204; Roberge S, 2012, AM J PERINAT, V29, P551, DOI 10.1055/s-0032-1310527; Rocca B, 2000, NAT MED, V6, P219, DOI 10.1038/72334; Schramm AM, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/920467; Schurigt Uta, 2005, Arthritis Res Ther, V7, pR174, DOI 10.1186/ar1466; Seki H, 1999, HYPERTENS PREGNANCY, V18, P157, DOI 10.3109/10641959909023075; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Shah DA, 2015, BIOCHEM PHARMACOL, V95, P211, DOI 10.1016/j.bcp.2015.04.012; Sibai BM, 2015, NAT REV ENDOCRINOL, V11, P6, DOI 10.1038/nrendo.2014.199; SIBAI BM, 1989, OBSTET GYNECOL, V74, P551; Sidaway Peter, 2014, Nat Rev Nephrol, V10, P613, DOI 10.1038/nrneph.2014.166; Trivedi NA, 2011, J POSTGRAD MED, V57, P91, DOI 10.4103/0022-3859.81858; Usha K, 2011, J OBSTET GYN INDIA, V61, P505, DOI 10.1007/s13224-011-0092-x; Vaughan JE, 2006, AM J OBSTET GYNECOL, V195, P1415, DOI 10.1016/j.ajog.2006.02.053; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Walsh SW, 2004, PROSTAG LEUKOTR ESS, V70, P223, DOI 10.1016/j.plefa.2003.04.010; WALSH SW, 1985, AM J OBSTET GYNECOL, V152, P335, DOI 10.1016/S0002-9378(85)80223-4; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; WEINER CP, 1992, AM J OBSTET GYNECOL, V166, P1171, DOI 10.1016/S0002-9378(11)90603-6; WOODWORTH SH, 1994, J CLIN ENDOCR METAB, V78, P1225, DOI 10.1210/jc.78.5.1225; Xu TT, 2015, J CLIN HYPERTENS, V17, P567, DOI 10.1111/jch.12541; Yang YL, 2010, LEUKEMIA RES, V34, P18, DOI 10.1016/j.leukres.2009.07.023; Yu IS, 2004, BLOOD, V104, P135, DOI 10.1182/blood-2003-10-3661; Yusuf K, 2001, PEDIATR RES, V50, P203, DOI 10.1203/00006450-200108000-00007; Zhao S, 2008, PLACENTA, V29, P81, DOI 10.1016/j.placenta.2007.08.007	58	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151617	10.1371/journal.pone.0151617	http://dx.doi.org/10.1371/journal.pone.0151617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974824	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600093
J	Song, MH; Godoy, RI				Song, Min-Ho; Godoy, Rolf Inge			How Fast Is Your Body Motion? Determining a Sufficient Frame Rate for an Optical Motion Tracking System Using Passive Markers	PLOS ONE			English	Article								This paper addresses how to determine a sufficient frame (sampling) rate for an optical motion tracking system using passive reflective markers. When using passive markers for the optical motion tracking, avoiding identity confusion between the markers becomes a problem as the speed of motion increases, necessitating a higher frame rate to avoid a failure of the motion tracking caused by marker confusions and/or dropouts. Initially, one might believe that the Nyquist-Shannon sampling rate estimated from the assumed maximal temporal variation of a motion (i.e. a sampling rate at least twice that of the maximum motion frequency) could be the complete solution to the problem. However, this paper shows that also the spatial distance between the markers should be taken into account in determining the suitable frame rate of an optical motion tracking with passive markers. In this paper, a frame rate criterion for the optical tracking using passive markers is theoretically derived and also experimentally verified using a high-quality optical motion tracking system. Both the theoretical and the experimental results showed that the minimum frame rate is proportional to the ratio between the maximum speed of the motion and the minimum spacing between markers, and may also be predicted precisely if the proportional constant is known in advance. The inverse of the proportional constant is here defined as the tracking efficiency constant and it can be easily determined with some test measurements. Moreover, this newly defined constant can provide a new way of evaluating the tracking algorithm performance of an optical tracking system.	[Song, Min-Ho; Godoy, Rolf Inge] Univ Oslo, Dept Musicol, fourMs Grp, Oslo, Norway	University of Oslo	Song, MH (corresponding author), Univ Oslo, Dept Musicol, fourMs Grp, Oslo, Norway.	minho.song@imv.uio.no		Song, Minho/0000-0003-0249-1723				Allen BD, 2005, VRST 05 P ACM S VIRT, P201, DOI DOI 10.1145/1101616.1101658; [Anonymous], 2015, QUAL TRACKMANAGER QT; Bishop, 2007, P TRENDS ISS TRACK V; Bishop G, 2001, SIGGRAPH COURSE PACK; BRUGGER W, 1978, MED BIOL ENG COMPUT, V16, P207, DOI 10.1007/BF02451923; Goebl W., 2014, EXPRESSIVENESS MUSIC, P221; Guerra-filho G. B., 2005, RITA, V12, P61; Herda L, 2001, HUM MOVEMENT SCI, V20, P313, DOI 10.1016/S0167-9457(01)00050-1; Jensenius A.R., 2010, MUSICAL GESTURES SOU, P12, DOI DOI 10.4324/9780203863411; Kolahi A, 2007, BIOMED SIGNAL PROCES, V2, P59, DOI 10.1016/j.bspc.2007.02.001; Lu TW, 2012, KAOHSIUNG J MED SCI, V28, pS13, DOI 10.1016/j.kjms.2011.08.004; MacRitchie J, 2015, MUSIC SCI, V19, P171, DOI 10.1177/1029864915572813; MacRitchie J, 2013, J NEW MUSIC RES, V42, P79, DOI 10.1080/09298215.2012.762529; MALIK NA, 1993, EXP FLUIDS, V15, P279; Menache A., 1999, UNDERSTANDING MOTION, P15; Moeslund TB, 2001, COMPUT VIS IMAGE UND, V81, P231, DOI 10.1006/cviu.2000.0897; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mulder A., 1994, 941 TR S FRAS U SCH; Muller M., 2007, INFORM RETRIEVAL MUS, P187; Nyquist H, 2002, P IEEE, V90, P280, DOI 10.1109/5.989875; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Wang LA, 2003, PATTERN RECOGN, V36, P585, DOI 10.1016/S0031-3203(02)00100-0; Zhou HY, 2008, BIOMED SIGNAL PROCES, V3, P1, DOI 10.1016/j.bspc.2007.09.001	23	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0150993	10.1371/journal.pone.0150993	http://dx.doi.org/10.1371/journal.pone.0150993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967900	gold, Green Published, Green Submitted			2022-12-27	WOS:000371989200027
J	Moesker, FM; van Kampen, JJA; van Rossum, AMC; de Hoog, M; Koopmans, MPG; Osterhaus, ADME; Fraaij, PLA				Moesker, Fleur M.; van Kampen, Jeroen J. A.; van Rossum, Annemarie M. C.; de Hoog, Matthijs; Koopmans, Marion P. G.; Osterhaus, Albert D. M. E.; Fraaij, Pieter L. A.			Viruses as Sole Causative Agents of Severe Acute Respiratory Tract Infections in Children	PLOS ONE			English	Article							SYNCYTIAL VIRUS; YOUNG-CHILDREN; VIRAL LOAD; HUMAN METAPNEUMOVIRUS; BACTERIAL-INFECTIONS; DISEASE SEVERITY; RISK; PCR; BRONCHIOLITIS; PATHOGENS	Background Respiratory syncytial virus (RSV) and influenza A viruses are known to cause severe acute respiratory tract infections (SARIs) in children. For other viruses like human rhinoviruses (HRVs) this is less well established. Viral or bacterial co-infections are often considered essential for severe manifestations of these virus infections. Objective The study aims at identifying viruses that may cause SARI in children in the absence of viral and bacterial co-infections, at identifying disease characteristics associated with these single virus infections, and at identifying a possible correlation between viral loads and disease severities. Study Design Between April 2007 and March 2012, we identified children (<18 year) with or without a medical history, admitted to our paediatric intensive care unit (PICU) with SARI or to the medium care (MC) with an acute respiratory tract infection (ARTI) (controls). Data were extracted from the clinical and laboratory databases of our tertiary care paediatric hospital. Patient specimens were tested for fifteen respiratory viruses with real-time reverse transcriptase PCR assays and we selected patients with a single virus infection only. Typical bacterial co-infections were considered unlikely to have contributed to the PICU or MC admission based on C-reactive protein-levels or bacteriological test results if performed. Results We identified 44 patients admitted to PICU with SARI and 40 patients admitted to MC with ARTI. Twelve viruses were associated with SARI, ten of which were also associated with ARTI in the absence of typical bacterial and viral co-infections, with RSV and HRV being the most frequent causes. Viral loads were not different between PICU-SARI patients and MCARTI patients. Conclusion Both SARI and ARTI may be caused by single viral pathogens in previously healthy children as well as in children with a medical history. No relationship between viral load and disease severity was identified.	[Moesker, Fleur M.; van Kampen, Jeroen J. A.; Koopmans, Marion P. G.; Osterhaus, Albert D. M. E.; Fraaij, Pieter L. A.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [van Rossum, Annemarie M. C.; Fraaij, Pieter L. A.] Erasmus MC Sophia, Dept Paediat, Rotterdam, Netherlands; [de Hoog, Matthijs] Erasmus MC Sophia, Dept Paediat, Paediat Intens Care Unit, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.] Univ Vet Med, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Veterinary Medicine Hannover, Foundation	Moesker, FM (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	fleur.moesker@gmail.com	van Rossum, Annemarie/AAC-7050-2019; Fraaij, Pieter/AAU-9783-2021; Koopmans, Marion/Y-9170-2019	Koopmans, Marion/0000-0002-5204-2312; van Kampen, Jeroen/0000-0002-7625-8230; van Rossum, Annemarie/0000-0002-1259-477X	EU [602525]; VIRGO project NWO The Netherlands [FES0908]; N-RENNT DFG Germany; Sophia research Foundation; Hoffmann-La Roche; Erasmus MC	EU(European Commission); VIRGO project NWO The Netherlands; N-RENNT DFG Germany(German Research Foundation (DFG)); Sophia research Foundation; Hoffmann-La Roche(Hoffmann-La Roche); Erasmus MC	PLAF, MPGK and ADMEO's institutions received funding from EU FP7 project PREPARE (grant number 602525) for studies on the pathogenesis of viruses in children. PLAF and ADMEO received funding from VIRGO project NWO The Netherlands (grant number FES0908). ADMEO receives funding from N-RENNT DFG Germany. AMCVR's institution received funding from the Sophia research Foundation. PLAF and ADMEO participated in the IRIS trial sponsored by Hoffmann-La Roche expenses were paid to their institution. GSK paid a speaker's fee to the Erasmus MC for PLAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams O, 2015, J MED VIROL, V87, P275, DOI 10.1002/jmv.24025; Ambrosioni J, 2014, CLIN MICROBIOL INFEC, V20, pO578, DOI 10.1111/1469-0691.12525; Confalonieri Marco, 2010, Ther Adv Respir Dis, V4, P233, DOI 10.1177/1753465810376951; Cox DW, 2013, AM J RESP CRIT CARE, V188, P1358, DOI 10.1164/rccm.201303-0498OC; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Esposito S, 2014, EUR J CLIN MICROBIOL, V33, P41, DOI 10.1007/s10096-013-1926-5; Esposito S, 2002, CLIN INFECT DIS, V35, P1345, DOI 10.1086/344191; Fawkner-Corbett DW, 2016, J MED VIROL, V88, P58, DOI 10.1002/jmv.24300; Fraaij PLA, 2011, J INFECT DIS, V204, P777, DOI 10.1093/infdis/jir397; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Fuller JA, 2013, J MED VIROL, V85, P924, DOI 10.1002/jmv.23455; Gerna G, 2008, J CLIN VIROL, V41, P49, DOI 10.1016/j.jcv.2007.10.018; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hasegawa K, 2015, J INFECT DIS, V211, P1550, DOI 10.1093/infdis/jiu658; Hoek RAS, 2013, SCAND J INFECT DIS, V45, P65, DOI 10.3109/00365548.2012.708942; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Kim SH, 2011, AM J RESP CRIT CARE, V183, P1207, DOI 10.1164/rccm.201101-0110OC; Launes C, 2012, INFLUENZA OTHER RESP, V6, pe89, DOI 10.1111/j.1750-2659.2012.00383.x; Martin ET, 2008, DIAGN MICR INFEC DIS, V62, P382, DOI 10.1016/j.diagmicrobio.2008.08.002; Martin-Loeches I, 2011, INTENS CARE MED, V37, P272, DOI 10.1007/s00134-010-2078-z; Mathew JL, 2015, PEDIATR CRIT CARE ME, V16, P186, DOI 10.1097/PCC.0000000000000333; Quispe-Laime AM, 2010, INTENS CARE MED, V36, P33, DOI 10.1007/s00134-009-1727-6; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Moesker FM., 2015, CLIN MICROBIOL INFEC, V21, p946., DOI [10.1016/j.cmi.2015.06.014, DOI 10.1016/j.cmi.2015.06.014]; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nijman RG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1706; Oostenbrink R, 2013, EUR J EMERG MED, V20, P273, DOI 10.1097/MEJ.0b013e32835771fd; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Prill MM, 2012, PEDIATR INFECT DIS J, V31, P235, DOI 10.1097/INF.0b013e31823e07fe; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Ricart S, 2013, PEDIATR PULM, V48, P456, DOI 10.1002/ppul.22633; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Smit PM, 2013, PEDIATR RES, V73, P355, DOI 10.1038/pr.2012.176; Spaeder MC, 2015, PEDIATR CRIT CARE ME, V16, P119, DOI 10.1097/PCC.0000000000000308; Spuesens EBM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001444; Takeyama A, 2012, J MED VIROL, V84, P1135, DOI 10.1002/jmv.23306; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; Vandini S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/875723; Viasus D, 2011, J INFECTION, V62, P193, DOI 10.1016/j.jinf.2011.01.014; Wu UI, 2012, INFLUENZA OTHER RESP, V6, P367, DOI 10.1111/j.1750-2659.2011.00300.x; Zhao BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062318	46	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150776	10.1371/journal.pone.0150776	http://dx.doi.org/10.1371/journal.pone.0150776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964038	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000062
J	Potapov, A; Merrill, E; Pybus, M; Lewis, MA				Potapov, Alex; Merrill, Evelyn; Pybus, Margo; Lewis, Mark A.			Chronic Wasting Disease: Transmission Mechanisms and the Possibility of Harvest Management	PLOS ONE			English	Article							WHITE-TAILED DEER; MULE DEER; DYNAMICS; VULNERABILITY; EPIDEMIOLOGY; RECRUITMENT; PREVALENCE; PREDATION; PATTERNS; ECOLOGY	We develop a model of CWD management by nonselective deer harvest, currently the most feasible approach available for managing CWD in wild populations. We use the model to explore the effects of 6 common harvest strategies on disease prevalence and to identify potential optimal harvest policies for reducing disease prevalence without population collapse. The model includes 4 deer categories (juveniles, adult females, younger adult males, older adult males) that may be harvested at different rates, a food-based carrying capacity, which influences juvenile survival but not adult reproduction or survival, and seasonal force of infection terms for each deer category under differing frequency-dependent transmission dynamics resulting from environmental and direct contact mechanisms. Numerical experiments show that the interval of transmission coefficients beta where the disease can be controlled is generally narrow and efficiency of a harvest policy to reduce disease prevalence depends crucially on the details of the disease transmission mechanism, in particular on the intensity of disease transmission to juveniles and the potential differences in the behavior of older and younger males that influence contact rates. Optimal harvest policy to minimize disease prevalence for each of the assumed transmission mechanisms is shown to depend on harvest intensity. Across mechanisms, a harvest that focuses on antlered deer, without distinguishing between age classes reduces disease prevalence most consistently, whereas distinguishing between young and older antlered deer produces higher uncertainty in the harvest effects on disease prevalence. Our results show that, despite uncertainties, a modelling approach can determine classes of harvest strategy that are most likely to be effective in combatting CWD.	[Potapov, Alex; Merrill, Evelyn; Pybus, Margo; Lewis, Mark A.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Potapov, Alex; Lewis, Mark A.] Univ Alberta, Ctr Math Biol, Edmonton, AB, Canada; [Potapov, Alex; Lewis, Mark A.] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada; [Pybus, Margo] Alberta Sustainable Resource Dev, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Potapov, A (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.; Potapov, A (corresponding author), Univ Alberta, Ctr Math Biol, Edmonton, AB, Canada.; Potapov, A (corresponding author), Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada.	apotapov@ualberta.ca	Lewis, Mark A/C-5015-2008; Merrill, Evelyn/N-5801-2015	Lewis, Mark A/0000-0002-7155-7426; Merrill, Evelyn/0000-0001-7737-958X	 [RES0004230]		This work was supported by RES0004230 from http://www.prioninstitute.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; Ballesteros C, 2011, EUR J WILDLIFE RES, V57, P749, DOI 10.1007/s10344-010-0483-9; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; Cross ML, 2007, VET J, V174, P472, DOI 10.1016/j.tvjl.2006.10.005; Cullingham CI, 2011, CAN J ZOOL, V89, P134, DOI 10.1139/Z10-104; deVosJr J. C., 2003, MULE DEER CONSERVATI; Feng ZL, 2007, B MATH BIOL, V69, P1511, DOI 10.1007/s11538-006-9174-9; Fowler C.W., 1981, P437; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Habib TJ, 2011, ECOL MODEL, V222, P2722, DOI 10.1016/j.ecolmodel.2011.05.007; Heisey DM, 2010, ECOL MONOGR, V80, P221, DOI 10.1890/09-0052.1; Jenks JA, 2002, J WILDLIFE MANAGE, V66, P528, DOI 10.2307/3803186; Jennelle CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091043; Joly DO, 2006, J WILDLIFE DIS, V42, P578, DOI 10.7589/0090-3558-42.3.578; Kie JG, 1999, J MAMMAL, V80, P1004, DOI 10.2307/1383271; Krumm CE, 2005, J WILDLIFE DIS, V41, P503, DOI 10.7589/0090-3558-41.3.503; Lang KR, 2012, J WILDLIFE MANAGE, V76, P832, DOI 10.1002/jwmg.292; Manjerovic MB, 2014, PREV VET MED, V113, P139, DOI 10.1016/j.prevetmed.2013.09.011; Mateus-Pinilla N, 2013, PREV VET MED, V110, P541, DOI 10.1016/j.prevetmed.2013.03.002; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Potapov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140024; Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012; Potapov A, 2012, P ROY SOC B-BIOL SCI, V279, P3139, DOI 10.1098/rspb.2012.0520; POWER ME, 1995, GEOMORPHOLOGY, V13, P301, DOI 10.1016/0169-555X(95)00039-8; Rasmussen J, 2014, PRION, V8, P135, DOI 10.4161/pri.27963; Rees EE, 2012, PREV VET MED, V104, P149, DOI 10.1016/j.prevetmed.2011.10.016; Ruiz MO, 2013, GEOSPATIAL HEALTH, V8, P215, DOI 10.4081/gh.2013.68; Sargeant GA, 2011, J WILDLIFE MANAGE, V75, P171, DOI 10.1002/jwmg.27; Storm DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00141.1; Van Deelen TR, 2010, J WILDLIFE MANAGE, V74, P1693, DOI 10.2193/2009-551; Villarreal-Ramos B, 2007, VET J, V174, P454, DOI 10.1016/j.tvjl.2006.12.019; Walsh DP, 2010, J WILDLIFE DIS, V46, P118, DOI 10.7589/0090-3558-46.1.118; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Wild MA, 2011, J WILDLIFE DIS, V47, P78, DOI 10.7589/0090-3558-47.1.78; Williams AL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00013.1; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340	41	24	24	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0151039	10.1371/journal.pone.0151039	http://dx.doi.org/10.1371/journal.pone.0151039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26963921	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000094
J	Chang, YL; Miyazawa, Y; Beguer-Pon, M				Chang, Yu-Lin; Miyazawa, Yasumasa; Beguer-Pon, Melanie			Simulating the Oceanic Migration of Silver Japanese Eels	PLOS ONE			English	Article							EUROPEAN EEL; RECRUITMENT; TRANSPORT; SALINITY; MOVEMENT; BEHAVIOR; COLLAPSE; CLIMATE	The oceanic migration of silver Japanese eels starts from their continental growth habitats in East Asia and ends at the spawning area near the West Mariana Ridge seamount chain. However, the actual migration routes remain unknown. In this study, we examined the possible oceanic migration routes and strategies of silver Japanese eels using a particle tracking method in which virtual eels (v-eels) were programmed to move vertically and horizontally in an ocean circulation model (Japan Coastal Ocean Predictability Experiment 2, JCOPE2). Four horizontal swimming strategies were tested: random heading, true navigation (readjusted heading), orientation toward the spawning area (fixed heading), and swimming against the Kuroshio. We found that all strategies, except random swimming, allowed v-eels swimming at 0.65 m s(-1) to reach the spawning area within eight months after their departure from the south coast of Japan (end of the spawning season). The estimated minimum swimming speed required to reach the area spawning within eight months was 0.1 m s(-1) for true navigation, 0.12 m s(-1) for constant compass heading, and 0.35 m s(-1) for swimming against the Kuroshio. The lowest swimming speed estimated from tracked Japanese eels at sea was 0.03 m. s(-1), which would not allow them to reach the spawning area within eight months, through any of the tested orientation strategies. Our numerical experiments also showed that ocean circulation significantly affected the migration of Japanese v-eels. A strong Kuroshio could advect v-eels further eastward. In addition, western Pacific ocean currents accelerated the migration of navigating v-eels. The migration duration was shortened in years with a stronger southward flow, contributed by a stronger recirculation south of Japan, an enhanced subtropical gyre, or a higher southward Kuroshio velocity.	[Chang, Yu-Lin] Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei 11677, Taiwan; [Miyazawa, Yasumasa] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa 2360001, Japan; [Beguer-Pon, Melanie] Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4R2, Canada	National Taiwan Normal University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Dalhousie University	Chang, YL (corresponding author), Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei 11677, Taiwan.	ychang@ntnu.edu.tw	Miyazawa, Yasumasa/J-3196-2014	Miyazawa, Yasumasa/0000-0002-0107-6272	Ministry of Science and Technology of Taiwan [102-2611-M-003-003-MY3]; JSPS KAKENHI [26287116]; Ocean Tracking Network (OTN) through a network project grant (NETGP) from the Canadian Natural Sciences and Engineering Research Council (NSERC) [375118-08]; Canadian Foundation for Innovation (CFI) [13011]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ocean Tracking Network (OTN) through a network project grant (NETGP) from the Canadian Natural Sciences and Engineering Research Council (NSERC); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	YLC was supported by the Ministry of Science and Technology of Taiwan under grant 102-2611-M-003-003-MY3. YM is supported by JSPS KAKENHI (26287116). MB-P was supported by the Ocean Tracking Network (OTN) through a network project grant (NETGP #375118-08) from the Canadian Natural Sciences and Engineering Research Council (NSERC) with additional support from the Canadian Foundation for Innovation (CFI, Project #13011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Aida K, 2003, EEL BIOL, P497, DOI DOI 10.1007/978-4-431-65907-5; Aoyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088759; Baltazar-Soares M, 2014, CURR BIOL, V24, P104, DOI 10.1016/j.cub.2013.11.031; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Beguer-Pon M, 2015, NAT COMMUN, V6; Beguer-Pon M, 2015, ICES J MARINE SCI J; Beguer-Pon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046830; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Chang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144423; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Chow S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121801; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Durif CMF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059212; Gentleman W, 2002, HYDROBIOLOGIA, V480, P69, DOI 10.1023/A:1021289119442; HAIN JHW, 1975, HELGOLAND WISS MEER, V27, P211, DOI 10.1007/BF01611808; Jacoby D., 2014, IUCN RED LIST THREAT, V2, P2019; Kawabe M, 1995, J PHYS OCEANOGR, V25, P3103, DOI 10.1175/1520-0485(1995)025<3103:VOCPVA>2.0.CO;2; Kida S, 2015, J OCEANOGR, P1; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; Mellor G, 2002, OCEAN FORECASTING CO, P55, DOI DOI 10.1007/978-3-662-22648-3_4; Methling C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020797; Miyazawa Y, 2009, J OCEANOGR, V65, P737, DOI 10.1007/s10872-009-0063-3; Nagano A, 2013, J OCEANOGR, V69, P259, DOI 10.1007/s10872-013-0170-z; Ohashi K, 2015, ATMOS OCEAN, P1, DOI [10.1080/07055900.2015.1090390, DOI 10.1080/07055900.2015.1090390]; Okamura AK, 2002, MAR ECOL PROG SER, V234, P281, DOI 10.3354/meps234281; Palstra A, 2008, COMP BIOCHEM PHYS A, V151, P37, DOI 10.1016/j.cbpa.2008.05.011; Press W., 1992, NUMERICAL RECIPES FO; Putman NF, 2014, CURR BIOL, V24, P446, DOI 10.1016/j.cub.2014.01.017; Russon IJ, 2011, J FISH BIOL, V78, P1965, DOI 10.1111/j.1095-8649.2011.02965.x; Rypina II, 2014, LIMNOL OCEANOGR, V59, P1704, DOI 10.4319/lo.2014.59.5.1704; Shan SL, 2014, OCEAN DYNAM, V64, P117, DOI 10.1007/s10236-013-0672-7; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; Tesch F, 2003, THE EEL, P408; TESCH FW, 1974, HELGOLAND WISS MEER, V26, P382, DOI 10.1007/BF01627623; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; Tsukamoto K, 1994, FRESHWATER FISHES MI, P2; Yokose H, 2008, KAIYO MONTHLY, V48, P45	40	17	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150187	10.1371/journal.pone.0150187	http://dx.doi.org/10.1371/journal.pone.0150187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982484	Green Published, gold, Green Submitted			2022-12-27	WOS:000372574900026
J	Porreca, I; Severino, LU; D'Angelo, F; Cuomo, D; Ceccarelli, M; Altucci, L; Amendola, E; Nebbioso, A; Mallardo, M; De Felice, M; Ambrosino, C				Porreca, Immacolata; Severino, Luisa Ulloa; D'Angelo, Fulvio; Cuomo, Danila; Ceccarelli, Michele; Altucci, Lucia; Amendola, Elena; Nebbioso, Angela; Mallardo, Massimo; De Felice, Mario; Ambrosino, Concetta			"Stockpile" of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells	PLOS ONE			English	Article							URINARY BISPHENOL-A; NUCLEOTIDE EXCISION-REPAIR; P53 PROMOTER; DNA-DAMAGE; PROLIFERATION; APOPTOSIS; EXPOSURE; BINDING; HEALTH; ALPHA	Epidemiological and experimental data highlighted the thyroid-disrupting activity of bisphenol A (BPA). Although pivotal to identify the mechanisms of toxicity, direct low-dose BPA effects on thyrocytes have not been assessed. Here, we report the results of microarray experiments revealing that the transcriptome reacts dynamically to low-dose BPA exposure, adapting the changes in gene expression to the exposure duration. The response involves many genes, enriching specific pathways and biological functions mainly cell death/proliferation or DNA repair. Their expression is only slightly altered but, since they enrich specific pathways, this results in major effects as shown here for transcripts involved in the DNA repair pathway. Indeed, even though no phenotypic changes are induced by the treatment, we show that the exposure to BPA impairs the cell response to further stressors. We experimentally verify that prolonged exposure to low doses of BPA results in a delayed response to UV-C-induced DNA damage, due to impairment of p21-Tp53 axis, with the BPA-treated cells more prone to cell death and DNA damage accumulation. The present findings shed light on a possible mechanism by which BPA, not able to directly cause genetic damage at environmental dose, may exert an indirect genotoxic activity.	[Porreca, Immacolata; D'Angelo, Fulvio; Ceccarelli, Michele; Ambrosino, Concetta] IRGS, Biogem, Via Camporeale, I-83031 Avellino, Italy; [Severino, Luisa Ulloa] Univ Trieste, PhD Sch Nanotechnol, I-34127 Trieste, Italy; [Cuomo, Danila; Ceccarelli, Michele; Ambrosino, Concetta] Univ Sannio, Dept Sci & Technol, Via Port Arsa 11, I-82100 Benevento, Italy; [Altucci, Lucia; Nebbioso, Angela] Univ Naples 2, Dept Biophys & Gen Pathol, Via L De Crecchio 7, I-80138 Naples, Italy; [Amendola, Elena; Mallardo, Massimo; De Felice, Mario] Univ Naples Federico II, Mol Med & Med Biotechnol, Via Pansini 6, I-80131 Naples, Italy; [De Felice, Mario] IEOS CNR, Via Pansini 6, I-80131 Naples, Italy	University of Trieste; University of Sannio; Universita della Campania Vanvitelli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Ambrosino, C (corresponding author), IRGS, Biogem, Via Camporeale, I-83031 Avellino, Italy.; Ambrosino, C (corresponding author), Univ Sannio, Dept Sci & Technol, Via Port Arsa 11, I-82100 Benevento, Italy.	coambros@unisannio.it	NEBBIOSO, ANGELA/GVS-1294-2022; ambrosino, concetta/AAB-3452-2019; Ulloa Severino, Luisa/GVR-8532-2022; Ceccarelli, Michele/AGP-1739-2022; Amendola, Elena/P-2434-2016; Altucci, Lucia/S-8031-2019; Cuomo, Danila/AAS-8567-2021; D'Angelo, Fulvio/AAG-9788-2020	D'Angelo, Fulvio/0000-0002-4940-4693; Ceccarelli, Michele/0000-0002-4702-6617; Cuomo, Danila/0000-0003-4752-5819; MALLARDO, Massimo/0000-0002-4001-3856; Porreca, Immacolata/0000-0003-2008-0477	Italian Workers' Compensation Authority [12010]; Italian Ministry of Health [RF 2010-2309484]; Sensor Regione Campania [23]	Italian Workers' Compensation Authority; Italian Ministry of Health(Ministry of Health, Italy); Sensor Regione Campania	This work was funded by the Italian Workers' Compensation Authority (grant no. 12010), the Italian Ministry of Health (grant no. RF 2010-2309484) and Sensor Regione Campania (grant no. 23).	Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; Ambrosino C, 2010, MOL CELL PROTEOMICS, V9, P1352, DOI 10.1074/mcp.M900519-MCP200; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Braun JM, 2011, CURR OPIN PEDIATR, V23, P233, DOI 10.1097/MOP.0b013e3283445675; Brucker-Davis F, 2011, THYROID, V21, P1133, DOI 10.1089/thy.2010.0459; Carchia E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.319; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chevrier J, 2013, ENVIRON HEALTH PERSP, V121, P138, DOI 10.1289/ehp.1205092; Choi M, 2002, IUBMB LIFE, V53, P309, DOI 10.1080/15216540213466; Dairkee SH, 2013, CARCINOGENESIS, V34, P703, DOI 10.1093/carcin/bgs379; Del Terra E, 2003, THYROID, V13, P747, DOI 10.1089/105072503768499635; Delclos KB, 2014, TOXICOL SCI, V139, P174, DOI 10.1093/toxsci/kfu022; Delfosse V, 2014, VITAM HORM, V94, P229, DOI 10.1016/B978-0-12-800095-3.00009-2; Dunkern TR, 2002, MOL BIOL CELL, V13, P348, DOI 10.1091/mbc.01-05-0225; Durando M, 2007, ENVIRON HEALTH PERSP, V115, P80, DOI 10.1289/ehp.9282; Gentilcore D, 2013, TOXICOLOGY, V304, P21, DOI 10.1016/j.tox.2012.12.001; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Ito Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050481; Jenkins S, 2009, ENVIRON HEALTH PERSP, V117, P910, DOI 10.1289/ehp.11751; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Meir M, 2015, NUCLEIC ACIDS RES, V43, P4517, DOI 10.1093/nar/gkv270; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Porreca I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1067; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; REISMAN D, 1993, CELL GROWTH DIFFER, V4, P57; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Romano ME, 2015, ENVIRON RES, V138, P453, DOI 10.1016/j.envres.2015.03.003; Sheng ZG, 2012, TOXICOL APPL PHARM, V259, P133, DOI 10.1016/j.taap.2011.12.018; Takagi H, 2002, CANCER LETT, V178, P1, DOI 10.1016/S0304-3835(01)00804-7; Takahashi S, 2001, MUTAT RES-GEN TOX EN, V490, P199, DOI 10.1016/S1383-5718(00)00161-3; Tarapore P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090332; Tiwari D, 2012, MUTAT RES-GEN TOX EN, V743, P83, DOI 10.1016/j.mrgentox.2011.12.023; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Wang F, 2012, OCCUP ENVIRON MED, V69, P679, DOI 10.1136/oemed-2011-100529; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Xin F, 2014, MUTAT RES-GEN TOX EN, V769, P29, DOI 10.1016/j.mrgentox.2014.04.019; Yin R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098635; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058; Zhang Yawei, 2008, Biosci Hypotheses, V1, P195, DOI 10.1016/j.bihy.2008.06.003	47	25	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151618	10.1371/journal.pone.0151618	http://dx.doi.org/10.1371/journal.pone.0151618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982218	Green Published, gold			2022-12-27	WOS:000372574900104
J	Karim, A; Salleh, R; Khan, MK				Karim, Ahmad; Salleh, Rosli; Khan, Muhammad Khurram			SMARTbot: A Behavioral Analysis Framework Augmented with Machine Learning to Identify Mobile Botnet Applications	PLOS ONE			English	Article							CLASSIFICATION; EXECUTABLES	Botnet phenomenon in smartphones is evolving with the proliferation in mobile phone technologies after leaving imperative impact on personal computers. It refers to the network of computers, laptops, mobile devices or tablets which is remotely controlled by the cybercriminals to initiate various distributed coordinated attacks including spam emails, ad-click fraud, Bitcoin mining, Distributed Denial of Service (DDoS), disseminating other malwares and much more. Likewise traditional PC based botnet, Mobile botnets have the same operational impact except the target audience is particular to smartphone users. Therefore, it is import to uncover this security issue prior to its widespread adaptation. We propose SMARTbot, a novel dynamic analysis framework augmented with machine learning techniques to automatically detect botnet binaries from malicious corpus. SMARTbot is a component based off-device behavioral analysis framework which can generate mobile botnet learning model by inducing Artificial Neural Networks' back-propagation method. Moreover, this framework can detect mobile botnet binaries with remarkable accuracy even in case of obfuscated program code. The results conclude that, a classifier model based on simple logistic regression outperform other machine learning classifier for botnet apps' detection, i. e 99.49% accuracy is achieved. Further, from manual inspection of botnet dataset we have extracted interesting trends in those applications. As an outcome of this research, a mobile botnet dataset is devised which will become the benchmark for future studies.	[Karim, Ahmad; Salleh, Rosli] Univ Malaya, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia; [Khan, Muhammad Khurram] King Saud Univ, Ctr Excellence Informat Assurance CoEIA, Riyadh, Saudi Arabia	Universiti Malaya; King Saud University	Karim, A (corresponding author), Univ Malaya, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia.	ahmadkarim@um.edu.my	KHAN, MUHAMMAD KHURRAM/E-4836-2014; SALLEH, ROSLI/B-9611-2010	KHAN, MUHAMMAD KHURRAM/0000-0001-6636-0533; SALLEH, ROSLI/0000-0002-7379-8397	RAMP;D program (IPPP) of the University of Malaya [FP034-2012A]; Deanship of Scientific Research at King Saud University [PRG-1436-16]	RAMP;D program (IPPP) of the University of Malaya; Deanship of Scientific Research at King Saud University(King Saud University)	This research was supported by a research grant from the R&D program (IPPP) of the University of Malaya - Project No. FP034-2012A. The authors also extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this Prolific Research Group (PRG-1436-16).	Aafer Y, 2013, L N INST COMP SCI SO, V127, P86; AB SC, 2015, TROJ LIST SORT TROJ; Ahmad Karim RS, 2015, 7 INT S UBICOM FRONT; Arp D., 2014, DREBIN EFFICIENT EXP; Bailey M, 2007, LECT NOTES COMPUT SC, V4637, P178; Bayer U, 2009, BEHAV BASED MALWARE, P8; Bhargava N, 2013, P INT J ADV RES COMP, V3; Blagov M, 2015, HTTP FLOOD DDOS ATTA; Chakradeo S, 2013, MAST TRIAGE MARKET S, P13; Chuang H-Y, 2015, MAHCINE LEARNING BAS, P201; Danchev D, 2013, CYBERCRIMINALS CREAT; Desnos A., 2011, DROIDBOX ANDROID APP; Developers A, 2012, MONKEYR; Dietrich CJ, 2011, BOTNETS USE DNS COMM, P9; Dullien Thomas, 2005, SSTIC, V5, P1; F-Secure, 2009, THREAT DESCR WORM IP; F-Secure, 2014, THREAT DESCR TROJAN; Flake H., 2004, STRUCTURAL COMP EXEC, P161; Frank E, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P1269, DOI 10.1007/978-0-387-09823-4_66; Goyvaerts J, 2015, REGULAR EXPRSSIONS T; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hutchins M., 1994, ICSE-16. 16th International Conference on Software Engineering (Cat. No.94CH3409-0), P191, DOI 10.1109/ICSE.1994.296778; Ingram M, 2015, MOBILE BOTNETS ARE C; Inozemtseva L., 2014, COVERAGE IS NOT STRE, P435, DOI [10.1145/2568225.2568271, DOI 10.1145/2568225.2568271]; Jiang X, 2012, SECURITY ALERT NEW T; Kang B., 2011, ENCY CRYPTOGRAPHY SE, P362, DOI [10.1007/978-1-4419-5906-5_845, DOI 10.1007/978-1-4419-5906-5_845]; Karim A, 2016, SMARTBOT DATASET; Karim ME, 2005, J COMPUT VIROL HACKI, V1, P13, DOI 10.1007/s11416-005-0002-9; Kelly G., 2014, REPORT 97 MOBILE MAL; Kolter JZ, 2006, J MACH LEARN RES, V7, P2721; Krmicek V., 2011, GEANT3 JRA2 T4 INTER, V1, P1; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; Leyden J, 2014, SECLUDED HIJACKRAT M; Lindorfer M, 2014, MARVIN EFFICIENT COM; Lookout, 2011, SEC AL NEW MALW FOUN; Lookout, 2012, SEC AL SPAMSOLDIER; Mahaffey K, 2011, SECURITY ALERT DROID; McLachlan GJ., 2005, ANAL MICROARRAY GENE; Melville P, 2004, ACTIVE FEATRURE VALU, P483; Mullaney C., 2012, ANDROID BMASTER MILL; Muttik I, 2011, MALWARE MINING VIRUS; NVISO, 2014, APKSCAN; papagelis AJ, 2013, MULTILAYER PERCEPT; Parkour M., 2011, CONTAGIO MALWARE DUM; Pawlak Z, 2002, EUR J OPER RES, V136, P181, DOI 10.1016/S0377-2217(01)00029-7; Peiravian N, 2013, MACHIEN LEARNING AND, P300; Perdisci R, 2008, PATTERN RECOGN LETT, V29, P1941, DOI 10.1016/j.patrec.2008.06.016; Petsas T, 2014, RAGE VIRTUAL MACHINE, P5; Python, 2015, ELEMENTTREE XMAL PA; Quinlan JR, 1996, BAGGING BOSSTING C4, P725; Rieck K, 2009, AUTOMATIC ANAL MALWA; Ross K.A., 2009, ENCYCL DATABASE SYST, P532, DOI [DOI 10.1007/978-0-387-39940-9_565, 10.1007/978-0-387-39940-9]; Sahs J., 2012, 2012 European Intelligence and Security Informatics Conference (EISIC), P141, DOI 10.1109/EISIC.2012.34; Schwartz MJ, 2012, ZEUS BOTNET; Sookhak M., 2015, DYNAMIC REMOTE DATA; Sookhak M, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2764465; Sookhak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115324; Sookhak M, 2014, J NETW COMPUT APPL, V43, P121, DOI 10.1016/j.jnca.2014.04.011; SpeedGuide, 2015, SPEEDGUIDE; Spreitzenbarth M, 2013, MOBILE SANDBOX HAVIN, P1808; StackExchange, 2014, WEAK MD5 PASSWORD HE; Strazzere T., 2011, GEINIMI TROJAN TECHN; Strazzere T, 2014, NEW NOTCOMPATIBLE SO; Svajcer V, 2011, PLANKTON MALWARE DRI; Svajcer V, 2014, SOPHOS MOBILE SEUCIE; Symantec, 2012, ANDR FAK; Symantec, 2014, ANDR HIPP B; Syverson P, 1994, TAXONOMY REPLAY ATTA, P187; Technology VUo, 2012, ANDR AN ANDR APKS; Unuchek R, 2013, OBADA TROJEN NOW BEI; Unuchek R, 2013, OBAD TROJAN NOW BEIN; Vidas T, 2014, EVADING ANDRIOD RUNT, P447; Wang X, 2015, IJITEE, V4, P1, DOI DOI 10.1021/TX5004326; Wang XY, 2005, LECT NOTES COMPUT SC, V3494, P19; Weichselbaum L., 2014, TRISECLAB0414001; Wicherski G., 2009, PEHASH NOVEL APPROAC; Wu D-J, 2012, DROIDMAT ANDROID MAL, P62; wyatt t, 2011, SECURITY ALERT GEINI; Yan L. K., 2012, DROIDSCOPE SEAMLESSL, P569; Yerima SY, 2014, IET INFORM SECUR, V8, P25, DOI 10.1049/iet-ifs.2013.0095; Zhang Y, 2013, VETTING UNDESIRABLE, P611; Zheng C., 2012, PROC 2 ACM WORKSHOP, P93, DOI DOI 10.1145/2381934.2381950; Zhou Y, 2012, HEY YOU GET OFF OF M	84	22	24	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0150077	10.1371/journal.pone.0150077	http://dx.doi.org/10.1371/journal.pone.0150077			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978523	gold, Green Submitted, Green Published			2022-12-27	WOS:000372572800021
J	Pujades-Rodriguez, M; Duyx, B; Thomas, SL; Stogiannis, D; Rahman, A; Smeeth, L; Hemingway, H				Pujades-Rodriguez, Mar; Duyx, Bram; Thomas, Sara L.; Stogiannis, Dimitris; Rahman, Anisur; Smeeth, Liam; Hemingway, Harry			Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; LIFETIME RISKS; EVENTS; ASSOCIATIONS; STROKE; GLUCOCORTICOIDS; METAANALYSIS; MORTALITY; SMOKING	Introduction While rheumatoid arthritis is an established risk factor for cardiovascular disease (CVD), our knowledge of how the pattern of risk varies for different cardiovascular phenotypes is incomplete. The association between rheumatoid arthritis and the initial presentation of 12 types of CVDs were examined in a contemporary population of men and women of a wide age range. Methods CALIBER data, which links primary care, hospital and mortality data in England, was analysed. A cohort of people aged >= 18 years and without history of CVD was assembled and included all patients with prospectively recorded rheumatoid arthritis from January 1997, until March 2010, matched with up to ten people without rheumatoid arthritis by age, sex and general practice. The associations between rheumatoid arthritis and the initial presentation of 12 types of CVDs were estimated using multivariable random effects Poisson regression models. Results The analysis included 12,120 individuals with rheumatoid arthritis and 121,191 comparators. Of these, 2,525 patients with and 18,146 without rheumatoid arthritis developed CVDs during a median of 4.2 years of follow-up. Patients with rheumatoid arthritis had higher rates of myocardial infarction (adjusted incidence ratio [IRR] = 1.43, 95% CI 1.21-1.70), unheralded coronary death (IRR = 1.60, 95% CI 1.18-2.18), heart failure (IRR = 1.61, 95% CI 1.43-1.83), cardiac arrest (HR = 2.26, 95% CI 1.69-3.02) and peripheral arterial disease (HR = 1.36, 95% CI1.14- 1.62); and lower rates of stable angina (HR = 0.83, 95% CI 0.73-0.95). There was no evidence of association with cerebrovascular diseases, abdominal aortic aneurysm or unstable angina, or of interactions with sex or age. Conclusions The observed associations with some but not all types of CVDs inform both clinical practice and the selection of cardiovascular endpoints for trials and for the development of prognostic models for patients with rheumatoid arthritis.	[Pujades-Rodriguez, Mar; Duyx, Bram; Stogiannis, Dimitris; Smeeth, Liam; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, 222 Euston Rd, London NW1 2DA, England; [Pujades-Rodriguez, Mar] Univ Leeds, MRC Med Bioinformat Ctr, Leeds Inst Biomed & Clin Sci, Worsley Bldg, Leeds LS2 9JT, W Yorkshire, England; [Thomas, Sara L.; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England; [Rahman, Anisur] UCL, Fac Med Sci, Ctr Rheumatol Res, Div Med, London WC1E 6JF, England	University of London; University College London; University of Leeds; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Pujades-Rodriguez, M (corresponding author), UCL, Farr Inst Hlth Informat Res, 222 Euston Rd, London NW1 2DA, England.; Pujades-Rodriguez, M (corresponding author), Univ Leeds, MRC Med Bioinformat Ctr, Leeds Inst Biomed & Clin Sci, Worsley Bldg, Leeds LS2 9JT, W Yorkshire, England.	M.D.M.PujadesRodriguez@leeds.ac.uk	Duyx, Bram/W-8668-2019; Pujades-Rodriguez, Mar/T-1129-2018; Hemingway, Harry/C-1219-2009; Smeeth, Liam/X-5862-2018	Duyx, Bram/0000-0002-8879-5391; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Hemingway, Harry/0000-0003-2279-0624; Smeeth, Liam/0000-0002-9168-6022	Welcome Trust [WT 086091/Z/08/Z]; UK National Institute for Health Research [RP-PG-0407-10314]; Farr Institute of Health Informatics Research from the Medical Research Council [MR/K006584/1]; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust; Wellcome Trust [098504/Z/12/Z]; MRC [MR/L01629X/1] Funding Source: UKRI; Medical Research Council [MR/K006584/1, MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Welcome Trust(Wellcome Trust); UK National Institute for Health Research(National Institute for Health Research (NIHR)); Farr Institute of Health Informatics Research from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by grants from the Welcome Trust [WT 086091/Z/08/Z]; the UK National Institute for Health Research (RP-PG-0407-10314); and by awards establishing the Farr Institute of Health Informatics Research from the Medical Research Council (MR/K006584/1), in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientific Office (Scottish Government Health Directorates), and the Wellcome Trust. LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science [098504/Z/12/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the National Institute for Health Research Public Health Research Programme or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avina-Zubieta JA, 2011, ANN RHEUM DIS, V70, P990, DOI 10.1136/ard.2010.140210; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Bergstrom U, 2011, RHEUMATOLOGY, V50, P2005, DOI 10.1093/rheumatology/ker258; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Rodriguez LAG, 2009, SCAND J RHEUMATOL, V38, P173, DOI 10.1080/03009740802448825; Germano G, 2012, EUR HEART J, V33, P137; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gonzalez A, 2008, J RHEUMATOL, V35, P1009; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Holmqvist ME, 2010, J INTERN MED, V268, P578, DOI 10.1111/j.1365-2796.2010.02260.x; Holmqvist M, 2013, ANN RHEUM DIS, V72, P541, DOI 10.1136/annrheumdis-2012-201387; Kerola AM, 2012, ANN RHEUM DIS, V71, P1606, DOI 10.1136/annrheumdis-2012-201334; Kremers HM, 2008, ARTHRITIS RHEUM-US, V58, P2268, DOI 10.1002/art.23650; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Lindhardsen J, 2011, ANN RHEUM DIS, V70, P929, DOI 10.1136/ard.2010.143396; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; National Institute for Health and Clinical Excellence (NICE), 2009, RHEUMATOID ARTHRITIS; Nicola PJ, 2005, ARTHRITIS RHEUM-US, V52, P412, DOI 10.1002/art.20855; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Pujades-Rodriguez M, 2015, INT J EPIDEMIOL, V44, P129, DOI 10.1093/ije/dyu218; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rodriguez-Rodriguez L, 2011, ATHEROSCLEROSIS, V216, P125, DOI 10.1016/j.atherosclerosis.2010.10.052; Roifman I, 2011, CAN J CARDIOL, V27, P174, DOI 10.1016/j.cjca.2010.12.040; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Sparks JA, 2015, ARTHRITIS CARE RES H; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Watson DJ, 2002, ARCH INTERN MED, V162, P1105, DOI 10.1001/archinte.162.10.1105; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007	43	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151245	10.1371/journal.pone.0151245	http://dx.doi.org/10.1371/journal.pone.0151245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978266	Green Published, gold, Green Accepted			2022-12-27	WOS:000372572800052
J	Fancourt, D; Perkins, R; Ascenso, S; Carvalho, LA; Steptoe, A; Williamon, A				Fancourt, Daisy; Perkins, Rosie; Ascenso, Sara; Carvalho, Livia A.; Steptoe, Andrew; Williamon, Aaron			Effects of Group Drumming Interventions on Anxiety, Depression, Social Resilience and Inflammatory Immune Response among Mental Health Service Users	PLOS ONE			English	Article							MUSIC-THERAPY; CYTOKINES; SUPPORT; SCALE; METAANALYSIS; MECHANISMS; DISEASE; STRESS; TH1	Growing numbers of mental health organizations are developing community music-making interventions for service users; however, to date there has been little research into their efficacy or mechanisms of effect. This study was an exploratory examination of whether 10 weeks of group drumming could improve depression, anxiety and social resilience among service users compared with a non-music control group (with participants allocated to group by geographical location.) Significant improvements were found in the drumming group but not the control group: by week 6 there were decreases in depression (-2.14 SE 0.50 CI -3.16 to -1.11) and increases in social resilience (7.69 SE 2.00 CI 3.60 to 11.78), and by week 10 these had further improved (depression: -3.41 SE 0.62 CI -4.68 to -2.15; social resilience: 10.59 SE 1.78 CI 6.94 to 14.24) alongside significant improvements in anxiety (-2.21 SE 0.50 CI -3.24 to -1.19) and mental wellbeing (6.14 SE 0.92 CI 4.25 to 8.04). All significant changes were maintained at 3 months follow-up. Furthermore, it is now recognised that many mental health conditions are characterised by underlying inflammatory immune responses. Consequently, participants in the drumming group also provided saliva samples to test for cortisol and the cytokines interleukin (IL) 4, IL6, IL17, tumour necrosis factor alpha (TNF alpha), and monocyte chemoattractant protein (MCP) 1. Across the 10 weeks there was a shift away from a pro-inflammatory towards an anti-inflammatory immune profile. Consequently, this study demonstrates the psychological benefits of group drumming and also suggests underlying biological effects, supporting its therapeutic potential for mental health.	[Fancourt, Daisy; Perkins, Rosie; Ascenso, Sara; Williamon, Aaron] Royal Coll Mus, Ctr Performance Sci, Prince Consort Rd, London SW7 2BS, England; [Fancourt, Daisy; Perkins, Rosie; Williamon, Aaron] Univ London Imperial Coll Sci Technol & Med, Fac Med, South Kensington Campus, London SW7 2AZ, England; [Fancourt, Daisy; Carvalho, Livia A.; Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, Psychobiol Grp, 1-19 Torrington Pl, London WC1E 7HB, England	Royal College of Music - UK; Imperial College London; University of London; University College London	Williamon, A (corresponding author), Royal Coll Mus, Ctr Performance Sci, Prince Consort Rd, London SW7 2BS, England.; Williamon, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, South Kensington Campus, London SW7 2AZ, England.	aaron.williamon@rcm.ac.uk	Carvalho, Livia/Y-1032-2019; Steptoe, Andrew/Y-2440-2019; Williamon, Aaron/C-5796-2013	Carvalho, Livia/0000-0001-8862-0148; Ascenso, Sara/0000-0002-6896-1719; Perkins, Rosie/0000-0002-8917-7974; Williamon, Aaron/0000-0002-1713-6161; Fancourt, Daisy/0000-0002-6952-334X	UK's Arts and Humanities Research Council [AH/K003364/1]; CW +; Society for Education, Music and Psychology Research (SEMPRE); Maurice-Marks Foundation; British Heart Foundation; Arts and Humanities Research Council [AH/K003364/1] Funding Source: researchfish	UK's Arts and Humanities Research Council; CW +; Society for Education, Music and Psychology Research (SEMPRE); Maurice-Marks Foundation; British Heart Foundation(British Heart Foundation); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was carried out as part of 'Creative Practice as Mutual Recovery', a Connected Communities project funded by the UK's Arts and Humanities Research Council (grant ref. AH/K003364/1). It was also supported by grants from CW + and an Arnold Bentley New Initiatives Award from the Society for Education, Music and Psychology Research (SEMPRE). DF is supported by the Maurice-Marks Foundation, and AS and LAC are supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RS, 1990, J PERS SOC PSYCHOL, V59, P344, DOI 10.1037/0022-3514.59.2.344; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bosch JA, 2014, MONOGR ORAL SCI, V24, P99, DOI 10.1159/000358864; Byrne ML, 2013, BRAIN BEHAV IMMUN, V34, P164, DOI 10.1016/j.bbi.2013.08.010; Choi P, 1998, CLIN EXP IMMUNOL, V113, P317; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Coulton S, 2015, BRIT J PSYCHIAT, V207, P250, DOI 10.1192/bjp.bp.113.129908; Dahl J, 2014, PSYCHONEUROENDOCRINO, V45, P77, DOI 10.1016/j.psyneuen.2014.03.019; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; Erkkila J, 2011, BRIT J PSYCHIAT, V199, P132, DOI 10.1192/bjp.bp.110.085431; Fagundes CP, 2012, ANNU REV GERONTOL GE, V32, P29, DOI 10.1891/0198-8794.32.29; Fancourt D, 2016, PSYCHOTHER PSYCHOSOM, V85, P53, DOI 10.1159/000431257; Fancourt D, 2014, BRAIN BEHAV IMMUN, V36, P15, DOI 10.1016/j.bbi.2013.10.014; Hickey MJ, 1997, J IMMUNOL, V158, P3391; Hicks K, 2014, MED ANTHROPOL Q, V28, P440, DOI 10.1111/maq.12102; Huron D, 2001, ANN NY ACAD SCI, V930, P43, DOI 10.1111/j.1749-6632.2001.tb05724.x; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Knell J, ARTS FUNDING, P27; Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611; Kubera N, 2001, J CLIN PSYCHOPHARM, V21, P199, DOI 10.1097/00004714-200104000-00012; Maes M, 1999, ADV EXP MED BIOL, V461, P25; Mindell J., 2012, HLTH SURVEY ENGLAND; Myint AM, 2005, J AFFECT DISORDERS, V88, P167, DOI 10.1016/j.jad.2005.07.008; O'Leary K, 2015, J HLTH PSYCHOL; Rosenkranz MA, 2013, BRAIN BEHAV IMMUN, V27, P174, DOI 10.1016/j.bbi.2012.10.013; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Song C, 2009, PHARMACOPSYCHIATRY, V42, P182, DOI 10.1055/s-0029-1202263; Talwar N, 2006, BRIT J PSYCHIAT, V189, P405, DOI 10.1192/bjp.bp.105.015073; Tarr B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01096; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; WALK A, 1928, J MENT SCI, V74, P521; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Williamson S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/246178; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	72	72	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151136	10.1371/journal.pone.0151136	http://dx.doi.org/10.1371/journal.pone.0151136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1UO	26974430	Green Published, gold, Green Submitted			2022-12-27	WOS:000372570600050
J	Horner, PJ; Wills, GS; Righarts, A; Vieira, S; Kounali, D; Samuel, D; Winston, A; Muir, D; Dickson, NP; McClure, MO				Horner, Patrick J.; Wills, Gillian S.; Righarts, Antoinette; Vieira, Sueli; Kounali, Daphne; Samuel, Dhanraj; Winston, Alan; Muir, David; Dickson, Nigel P.; McClure, Myra O.			Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; GENERAL-POPULATION; ANTIGEN; IMMUNOASSAY; SPECIFICITY; SENSITIVITY; PREVALENCE; HEALTH; WOMEN; TIME	Chlamydia trachomatis (Ct) serological studies in populations could help monitor changes in lifetime cumulative risk of infection. We developed a double-antigen sandwich ELISA based on the Ct-specific Pgp3 antigen, then tested blind stored sera from over 800 participants in a New Zealand birth cohort from Dunedin at ages 26, 32 and 38. The double-antigen sandwich ELISA was more sensitive than our previously characterised indirect Pgp3 ELISA. Pgp3 antibody was detected more often in women compared to men and correlated with increasing numbers of sexual partners, self-reported Ct, and younger age at sexual debut in both women and men. At age 26, 24.1% (99/411) of women were Pgp3 seropositive, as were 79.5%(35/44) of those reporting Ct infection; Pgp3 antibody persisted to age 38 in 96.5%(83/86). In men at age 26, the figures were 10.7%(47/442) and 25.0% (6/24), respectively, with high (83.9%) antibody persistence to age 38. At age 38, among those Pgp3 seropositive, 63.3% of women and 83.1% of men had not reported Ct infection. Thus, Ct-specific Pgp3 antibody was detected in most women reporting Ct infection and correlated with risk of infection in those who did not, with most infections remaining undetected. As this antibody persisted for at least twelve years in 96% of these women, serology could be used to evaluate Ct prevention programmes among women.	[Horner, Patrick J.; Wills, Gillian S.; Vieira, Sueli; Winston, Alan; McClure, Myra O.] Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, Jefferiss Trust Labs, London, England; [Horner, Patrick J.; Kounali, Daphne] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Righarts, Antoinette; Dickson, Nigel P.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Kounali, Daphne] Univ Bristol, Natl Inst Hlth Res Hlth Protect Res Unit NIHR HPR, Bristol, Avon, England; [Samuel, Dhanraj] Publ Hlth England, London, England; [Muir, David] Imperial Coll Healthcare Trust, Dept Infect & Immun, London, England	Imperial College London; University of Bristol; University of Otago; University of Bristol; Public Health England	McClure, MO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, Jefferiss Trust Labs, London, England.	m.mcclure@imperial.ac.uk	Righarts, Antoinette/N-1889-2019; Kounali, Daphne/AAE-3630-2020; Winston, Alan/AGZ-3015-2022	Righarts, Antoinette/0000-0003-2822-4842; Kounali, Daphne/0000-0002-6392-6690; Winston, Alan/0000-0002-5847-8416; Horner, Paddy/0000-0003-0411-8332	Health Research Council of New Zealand [09/086]; NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol [HPRU-2012-10026]; Public Health England	Health Research Council of New Zealand(Health Research Council of New Zealand); NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol; Public Health England	This work was supported by The Health Research Council of New Zealand. 09/086, www.hrc.govt.nz/ (NPD); NIHR Health Protection Research Unit in Evaluation of Interventions at the University of Bristol, www.nihr.ac.uk/funding/health-protection-research-units.htm, HPRU-2012-10026 (PH and DK); Health Protection Agency (now Public Health England) funded the testing of stored sera (GW and SV). The funders played no part in the design, conduct, analysis or reporting of this study, nor in the decision to submit the manuscript for publication.	Black CM, 1997, CLIN MICROBIOL REV, V10, P160, DOI 10.1128/CMR.10.1.160; Brabin L, 2005, SEX TRANSM INFECT, V81, P128, DOI 10.1136/sti.2004.010223; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Brunham RC, 2008, SEX TRANSM DIS, V35, P53, DOI 10.1097/OLQ.0b013e31815e41a3; Burgisser P, 1996, J CLIN MICROBIOL, V34, P634, DOI 10.1128/JCM.34.3.634-637.1996; Castro AR, 2002, CLIN DIAGN LAB IMMUN, V9, P1376, DOI 10.1128/CDLI.9.6.1376-1378.2002; CDC, 2010, GUIDELINES TREATMENT; COMANDUCCI M, 1993, J GEN MICROBIOL, V139, P1083, DOI 10.1099/00221287-139-5-1083; Crowther John R., 2009, V516, P1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dickson N, 2014, SEX TRANSM INFECT, V90, P243, DOI 10.1136/sextrans-2013-051235; ECDC, 2009, CHLAM CONTR EUR; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Horner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072001; Horner PJ, 2013, SEX TRANSM INFECT, V89, P398, DOI 10.1136/sextrans-2011-050386; Hu WP, 2008, CLIN VACCINE IMMUNOL, V15, P1151, DOI 10.1128/CVI.00186-07; Johnson AM, 2008, SEX TRANSM INFECT, V84, P79, DOI 10.1136/sti.2007.028472; Li A, 2010, CLIN VACCINE IMMUNOL, V17, P464, DOI 10.1128/CVI.00457-09; Li Z, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-90; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lyytikainen E, 2007, SEX TRANSM INFECT, V84, P19, DOI 10.1136/sti.2007.027409; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; Milliken G.A., 2009, ANAL MESSY DATA, V1; Morre SA, 2002, J CLIN MICROBIOL, V40, P584, DOI 10.1128/JCM.40.2.584-587.2002; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Narvanen A, 1997, Infect Dis Obstet Gynecol, V5, P349; Nwokolo NC, 2015, 2015 UK NATL GUIDELI; Pimenta J, 2000, BRIT MED J, V321, P629, DOI 10.1136/bmj.321.7261.629; Poulton Richie, 2006, N Z Med J, V119, pU2002; Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Price MJ, 2013, STAT MED, V32, P1547, DOI 10.1002/sim.5603; Price MJ, 2012, SEX TRANSM DIS, V39, P608, DOI 10.1097/OLQ.0b013e3182572475; Price MJ, 2014, EPIDEMIOLOGY INFECT, V142, P15; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; van Aar F, 2014, SEX TRANSM INFECT, V90, P434, DOI 10.1136/sextrans-2013-051074; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09; Woodhall SC, 2015, PLOS ONE; Wu FB, 2008, J MED MICROBIOL, V57, P947, DOI 10.1099/jmm.0.47835-0	42	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0151497	10.1371/journal.pone.0151497	http://dx.doi.org/10.1371/journal.pone.0151497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974653	gold, Green Published, Green Submitted			2022-12-27	WOS:000372570600084
J	Lasso, P; Beltran, L; Guzman, F; Rosas, F; Thomas, MC; Lopez, MC; Gonzalez, JM; Cuellar, A; Puerta, CJ				Lasso, Paola; Beltran, Lina; Guzman, Fanny; Rosas, Fernando; Carmen Thomas, M.; Carlos Lopez, Manuel; Mario Gonzalez, John; Cuellar, Adriana; Puerta, Concepcion J.			Promiscuous Recognition of a Trypanosoma cruzi CD8(+) T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients	PLOS ONE			English	Article							CLASS-I SUPERTYPES; KMP-11 PROTEIN; PEPTIDE; ANTIGEN; MICE; IDENTIFICATION; SPECIFICITY; DEFINITION; RESPONSES; SUSCEPTIBILITY	Background TcTLE is a nonamer peptide from Trypanosoma cruzi KMP-11 protein that is conserved among different parasite strains and that is presented by different HLA-A molecules from the A2 supertype. Because peptides presented by several major histocompatibility complex (MHC) supertypes are potential targets for immunotherapy, the aim of this study was to determine whether MHC molecules other than the A2 supertype present the TcTLE peptide. Methodology/Principal Findings From 36 HLA-A2-negative chagasic patients, the HLA-A genotypes of twenty-eight patients with CD8(+) T cells that recognized the TcTLE peptide using tetramer (twenty) or functional (eight) assays, were determined. SSP-PCR was used to identify the A locus and the allelic variants. Flow cytometry was used to analyze the frequency of TcTLE-specific CD8(+) T cells, and their functional activity (IFN-gamma, TNF alpha, IL-2, perforin, granzyme and CD107a/b production) was induced by exposure to the TcTLE peptide. All patients tested had TcTLE-specific CD8(+) T cells with frequencies ranging from 0.07-0.37%. Interestingly, seven of the twenty-eight patients had HLA-A homozygous alleles: A*24 (5 patients), A*23 (1 patient) and A*01 (1 patient), which belong to the A24 and A1 supertypes. In the remaining 21 patients with HLA-A heterozygous alleles, the most prominent alleles were A24 and A68. The most common allele sub-type was A*2402 (sixteen patients), which belongs to the A24 supertype, followed by A*6802 (six patients) from the A2 supertype. Additionally, the A*3002/A*3201 alleles from the A1 supertype were detected in one patient. All patients presented CD8(+) T cells producing at least one cytokine after TcTLE peptide stimulation. Conclusion/Significance These results show that TcTLE is a promiscuous peptide that is presented by the A24 and A1 supertypes, in addition to the A2 supertype, suggesting its potential as a target for immunotherapy.	[Lasso, Paola; Beltran, Lina; Puerta, Concepcion J.] Pontificia Univ Javeriana, Lab Parasitol Mol, Bogota, Colombia; [Lasso, Paola; Cuellar, Adriana] Pontificia Univ Javeriana, Grp Inmunobiol & Biol Celular, Bogota, Colombia; [Lasso, Paola; Carmen Thomas, M.; Carlos Lopez, Manuel] PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Guzman, Fanny] Pontificia Univ Catolica Valparaiso, NBC, Valparaiso, Chile; [Rosas, Fernando] Fdn Clin Abood Shaio, Inst Arritmias Joseph Brugada, Bogota, Colombia; [Mario Gonzalez, John] Univ Los Andes, Fac Med, Grp Ciencias Basicas Med, Bogota, Colombia	Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Pontificia Universidad Catolica de Valparaiso; Universidad de los Andes (Colombia)	Puerta, CJ (corresponding author), Pontificia Univ Javeriana, Lab Parasitol Mol, Bogota, Colombia.	cpuerta@javeriana.edu.co	Zaky, Mohammad/I-3187-2017; Puerta, Concepcion J/AAG-4912-2019; Lopez, Manuel/Z-5641-2019; Cuellar, Adriana/AAF-2958-2019; Guzman, Fanny fg/K-5592-2013; Thomas, María Carmen PhD/D-9065-2016	Zaky, Mohammad/0000-0003-3547-2588; Guzman, Fanny fg/0000-0003-1537-0904; Thomas, M Carmen/0000-0003-3586-9657; Cuellar, Adriana/0000-0003-0834-8442; Puerta Bula, Concepcion Judith/0000-0002-3449-3961; Mursalin, Adi/0000-0002-1867-0868; Lopez, Manuel Carlos/0000-0003-0002-3678; Lasso, Paola/0000-0002-2976-3277	Pontificia Universidad Javeriana [00004536]; Colciencias [120349326159]; Programa Estatal I+D+i (MINECO) [SAF2012-35777, SAF2013-48527-R, RTC-2014-2130]; Network of Tropical Diseases Research RICET [RD12/0018/0021]; FEDER	Pontificia Universidad Javeriana; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET; FEDER(European Commission)	This work was supported by the grants "Analisis de la respuesta inmune celular frente a epitopos analogos del peptido K1 de Trypanosoma cruzi" and "Estados de activacion y actividad funcional de linfocitos T CD8+ en pacientes chagasicos con diferentes grados de severidad de la enfermedad" from Pontificia Universidad Javeriana (ID propuesta No. 00004536) and Colciencias (Code No. 120349326159), respectively. The authors are grateful to the Programa de Jovenes Investigadores e Innovadores of the Departamento Administrativo de Ciencia, Tecnologia e Innovacion, Colciencias, Bogota, Colombia. MCT and MCL were supported by grants SAF2012-35777, SAF2013-48527-R and RTC-2014-2130 from Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET, grants RD12/0018/0021 and FEDER.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P519; Arrunategui Ana María, 2013, Acta Med Colomb, V38, P16; Axelsson-Robertson R, 2011, CLIN VACCINE IMMUNOL, V18, P125, DOI 10.1128/CVI.00302-10; Bardi Marlene Silva, 2012, Rev. Bras. Hematol. Hemoter., V34, P25, DOI 10.5581/1516-8484.20120010; Beltran M, 2001, MANUAL PROCEDIMIENTO, P32; BF A., 2010, ADAPTIVE IMMUNITY; Bortolotto AS, 2012, HUM IMMUNOL, V73, P180, DOI 10.1016/j.humimm.2011.11.009; Burrows SR, 2003, J IMMUNOL, V171, P1407, DOI 10.4049/jimmunol.171.3.1407; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Diez H, 2006, PARASITE IMMUNOL, V28, P101, DOI 10.1111/j.1365-3024.2005.00815.x; Diez H, 2005, PARASITOLOGY, V130, P643, DOI 10.1017/S0031182004006936; Doytchinova I, 2003, ORG BIOMOL CHEM, V1, P2648, DOI 10.1039/b300707c; Egui A, 2012, MOL IMMUNOL, V52, P289, DOI 10.1016/j.molimm.2012.05.021; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fonseca SG, 2005, MICROBES INFECT, V7, P688, DOI 10.1016/j.micinf.2005.01.001; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Giraldo NA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001294; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Hertz T, 2007, BIOINFORMATICS, V23, pE148, DOI 10.1093/Bioinformatics/btl324; KUBO RT, 1994, J IMMUNOL, V152, P3913; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Lasso P, 2015, J IMMUNOL, V195, P3748, DOI 10.4049/jimmunol.1500459; Lasso P, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-198; Liu J, 2012, J VIROL, V86, P13281, DOI 10.1128/JVI.01841-12; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Maranon C, 2001, MOL IMMUNOL, V38, P279, DOI 10.1016/S0161-5890(01)00059-1; Maranon C, 2011, MICROBES INFECT, V13, P1025, DOI 10.1016/j.micinf.2011.05.010; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Martinez-Laso J, 2006, EUR J MED GENET, V49, P169, DOI 10.1016/j.ejmg.2005.04.005; Mohamed ER, 2009, INT J ONCOL, V34, P529, DOI 10.3892/ijo_00000178; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Moscoso J, 2006, MOL IMMUNOL, V43, P1881, DOI 10.1016/j.molimm.2005.10.013; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Pereira IR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004594; Arias-Murillo YR, 2010, COLOMB MEDICA, V41, P336; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; ROTTENBERG ME, 1993, INFECT IMMUN, V61, P5129, DOI 10.1128/IAI.61.12.5129-5133.1993; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 1996, HUM IMMUNOL, V45, P79, DOI 10.1016/0198-8859(95)00173-5; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Silverio JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002645; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0; TARLETON RL, 1990, J IMMUNOL, V144, P717; Terasaki Y, 2009, CANCER IMMUNOL IMMUN, V58, P1879, DOI 10.1007/s00262-009-0699-2; Thomsen M, 2013, IMMUNOGENETICS, V65, P655, DOI 10.1007/s00251-013-0714-9; Vasconcelos JR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002699; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	54	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150996	10.1371/journal.pone.0150996	http://dx.doi.org/10.1371/journal.pone.0150996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974162	Green Published, Green Submitted, gold			2022-12-27	WOS:000372570600040
J	Zahavi, AY; Sabbagh, MA; Washburn, D; Mazurka, R; Bagby, RM; Strauss, J; Kennedy, JL; Ravindran, A; Harkness, KL				Zahavi, Arielle Y.; Sabbagh, Mark A.; Washburn, Dustin; Mazurka, Raegan; Bagby, R. Michael; Strauss, John; Kennedy, James L.; Ravindran, Arun; Harkness, Kate L.			Serotonin and Dopamine Gene Variation and Theory of Mind Decoding Accuracy in Major Depression: A Preliminary Investigation	PLOS ONE			English	Article							THEORY-OF-MIND; TRANSPORTER GENE; METHYLTRANSFERASE COMT; BIASED ATTENTION; CANDIDATE GENE; WORD STIMULI; POLYMORPHISM; ASSOCIATION; AMYGDALA; BRAIN	Theory of mind-the ability to decode and reason about others' mental states-is a universal human skill and forms the basis of social cognition. Theory of mind accuracy is impaired in clinical conditions evidencing social impairment, including major depressive disorder. The current study is a preliminary investigation of the association of polymorphisms of the serotonin transporter (SLC6A4), dopamine transporter (DAT1), dopamine receptor D4 (DRD4), and catechol-O-methyl transferase (COMT) genes with theory of mind decoding in a sample of adults with major depression. Ninety-six young adults (38 depressed, 58 non-depressed) completed the 'Reading the Mind in the Eyes task' and a non-mentalistic control task. Genetic associations were only found for the depressed group. Specifically, superior accuracy in decoding mental states of a positive valence was seen in those homozygous for the long allele of the serotonin transporter gene, 9-allele carriers of DAT1, and long-allele carriers of DRD4. In contrast, superior accuracy in decoding mental states of a negative valence was seen in short-allele carriers of the serotonin transporter gene and 10/10 homozygotes of DAT1. Results are discussed in terms of their implications for integrating social cognitive and neurobiological models of etiology in major depression.	[Zahavi, Arielle Y.; Sabbagh, Mark A.; Washburn, Dustin; Mazurka, Raegan; Harkness, Kate L.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Bagby, R. Michael] Univ Toronto Scarborough, Dept Psychol, Toronto, ON, Canada; [Strauss, John; Kennedy, James L.; Ravindran, Arun] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada	Queens University - Canada; University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Harkness, KL (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	harkness@queensu.ca	Kennedy, James Lowery/AAZ-6947-2020	Kennedy, James Lowery/0000-0002-8733-3806; Harkness, Kate/0000-0002-0319-8994	Canadian Institutes of Health Research operating grant [79320]	Canadian Institutes of Health Research operating grant(Canadian Institutes of Health Research (CIHR))	This study was funded by a Canadian Institutes of Health Research operating grant #79320 http://www.cihr-irsc.gc.ca/e/193.html awarded to KLH ( principal investigator), RMB, JS, JLK, and AR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19; Abu-Akel A, 2003, MED HYPOTHESES, V60, P382, DOI 10.1016/S0306-9877(02)00406-1; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barnes JJM, 2011, BIOL PSYCHIAT, V69, pE127, DOI 10.1016/j.biopsych.2010.12.040; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beck A. T., 1996, BECK DEPRESSION INVE; Beevers CG, 2007, J ABNORM PSYCHOL, V116, P208, DOI 10.1037/0021-843X.116.1.208; Bosia M, 2015, NEUROL SCI, V36, P215, DOI 10.1007/s10072-014-1936-9; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Creswell KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028914; Dannlowski U, 2008, NEUROPSYCHOPHARMACOL, V33, P418, DOI 10.1038/sj.npp.1301411; Defrancesco M, 2011, J INT NEUROPSYCH SOC, V17, P1014, DOI 10.1017/S135561771100097X; Demaree HA, 2009, MAGN RESON IMAGING, V27, P441, DOI 10.1016/j.mri.2008.08.006; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Diamond A, 2007, CEREB CORTEX, V17, pI161, DOI [10.1093/cercor/bhm082, 10.1093/cercor/blini082]; DiCiccio TJ, 1996, STAT SCI, V11, P189; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; First MB, 2002, STRUCTURED CLIN INTE; Garcia JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014162; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Harkness KL, 2015, J ABNORM PSYCHOL, V124, P275, DOI 10.1037/abn0000034; Harkness KL, 2011, PSYCHIAT RES, V189, P91, DOI 10.1016/j.psychres.2011.06.007; Harkness KL, 2005, COGNITION EMOTION, V19, P999, DOI 10.1080/02699930541000110; Hart AB, 2013, NEUROPSYCHOPHARMACOL, V38, P802, DOI 10.1038/npp.2012.245; Hindmarch T, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-54; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hu YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033968; Inoue Y, 2006, J AFFECT DISORDERS, V95, P125, DOI 10.1016/j.jad.2006.04.018; Kwang T, 2010, DEPRESS ANXIETY, V27, P746, DOI 10.1002/da.20708; Lackner C, 2012, DEVELOPMENTAL SCI, V15, P272, DOI 10.1111/j.1467-7687.2011.01124.x; Lee L, 2005, J AFFECT DISORDERS, V86, P247, DOI 10.1016/j.jad.2005.02.007; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Little K, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.85; Moses LJ, 2001, CHILD DEV, V72, P688, DOI 10.1111/1467-8624.00306; Muller DJ, 2008, AM J MED GENET B, V147B, P1461, DOI 10.1002/ajmg.b.30706; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Sabbagh MA, 2004, J COGNITIVE NEUROSCI, V16, P415, DOI 10.1162/089892904322926755; Sabbagh MA, 2013, UNDERSTANDING OTHER; Sabbagh MA, 2008, DEVELOPMENTAL SCI, V11, P354, DOI 10.1111/j.1467-7687.2008.00680.x; Sabbagh MA, 2009, CHILD DEV, V80, P1147, DOI 10.1111/j.1467-8624.2009.01322.x; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Tsuchimine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076763; Uher R, 2012, DEPRESS ANXIETY, V29, P1043, DOI 10.1002/da.21993; Webb CA, 2014, PSYCHOL MED, V44, P2833, DOI 10.1017/S0033291714000348; Wellman H. M, 1990, CHILDS THEORY MIND; Xia HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049768	54	15	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2016	11	3							e0150872	10.1371/journal.pone.0150872	http://dx.doi.org/10.1371/journal.pone.0150872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1UO	26974654	Green Published, gold			2022-12-27	WOS:000372570600036
J	Chruscinski, A; Huang, FYY; Nguyen, A; Lioe, J; Tumiati, LC; Kozuszko, S; Tinckam, KJ; Rao, V; Dunn, SE; Persinger, MA; Levy, GA; Ross, HJ				Chruscinski, Andrzej; Huang, Flora Y. Y.; Nguyen, Albert; Lioe, Jocelyn; Tumiati, Laura C.; Kozuszko, Stella; Tinckam, Kathryn J.; Rao, Vivek; Dunn, Shannon E.; Persinger, Michael A.; Levy, Gary A.; Ross, Heather J.			Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation	PLOS ONE			English	Article							ANTIBODY-MEDIATED REJECTION; DILATED CARDIOMYOPATHY; CARDIAC TRANSPLANTATION; IGM ANTIBODIES; MYOCARDITIS; PRETRANSPLANT; DYSFUNCTION; ALLOGRAFTS; RECIPIENTS; DIAGNOSIS	Autoantibodies directed against endogenous proteins including contractile proteins and endothelial antigens are frequently detected in patients with heart failure and after heart transplantation. There is evidence that these autoantibodies contribute to cardiac dysfunction and correlate with clinical outcomes. Currently, autoantibodies are detected in patient sera using individual ELISA assays (one for each antigen). Thus, screening for many individual autoantibodies is laborious and consumes a large amount of patient sample. To better capture the broad-scale antibody reactivities that occur in heart failure and post-transplant, we developed a custom antigen microarray technique that can simultaneously measure IgM and IgG reactivities against 64 unique antigens using just five microliters of patient serum. We first demonstrated that our antigen microarray technique displayed enhanced sensitivity to detect autoantibodies compared to the traditional ELISA method. We then piloted this technique using two sets of samples that were obtained at our institution. In the first retrospective study, we profiled pre-transplant sera from 24 heart failure patients who subsequently received heart transplants. We identified 8 antibody reactivities that were higher in patients who developed cellular rejection (2 or more episodes of grade 2R rejection in first year after transplant as defined by revised criteria from the International Society for Heart and Lung Transplantation) compared with those who did have not have rejection episodes. In a second retrospective study with 31 patients, we identified 7 IgM reactivities that were higher in heart transplant recipients who developed antibody-mediated rejection (AMR) compared with control recipients, and in time course studies, these reactivities appeared prior to overt graft dysfunction. In conclusion, we demonstrated that the autoantibody microarray technique outperforms traditional ELISAs as it uses less patient sample, has increased sensitivity, and can detect autoantibodies in a multiplex fashion. Furthermore, our results suggest that this autoantibody array technology may help to identify patients at risk of rejection following heart transplantation and identify heart transplant recipients with AMR.	[Chruscinski, Andrzej; Huang, Flora Y. Y.; Lioe, Jocelyn; Kozuszko, Stella; Tinckam, Kathryn J.; Rao, Vivek; Levy, Gary A.; Ross, Heather J.] Univ Hlth Network, Multiorgan Transplant Program, Toronto, ON, Canada; [Chruscinski, Andrzej; Ross, Heather J.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Nguyen, Albert; Dunn, Shannon E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Tumiati, Laura C.; Rao, Vivek] Univ Hlth Network, Div Cardiac Surg, Toronto, ON, Canada; [Dunn, Shannon E.] Toronto Gen Res Inst, Toronto, ON, Canada; [Dunn, Shannon E.] Res Inst, Womens Coll, Toronto, ON, Canada; [Persinger, Michael A.] Laurentian Univ, Behav Neurosci Program, Sudbury, ON P3E 2C6, Canada; [Persinger, Michael A.] Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada; [Persinger, Michael A.] Laurentian Univ, Human Studies Programs, Sudbury, ON P3E 2C6, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Women's College Research Institute; Laurentian University; Laurentian University; Laurentian University	Chruscinski, A (corresponding author), Univ Hlth Network, Multiorgan Transplant Program, Toronto, ON, Canada.; Chruscinski, A (corresponding author), Univ Hlth Network, Div Cardiol, Toronto, ON, Canada.	andrzej.chruscinski@uhn.ca		Nguyen, Albert An/0000-0001-8724-7476; Tinckam, Kathryn/0000-0002-6638-2887	Heart and Stroke Foundation of Canada; Training Program in Regenerative Medicine (Canadian Institutes of Health Research); Training Program in Regenerative Medicine; Astellas Pharma Canada Inc.	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Training Program in Regenerative Medicine (Canadian Institutes of Health Research); Training Program in Regenerative Medicine; Astellas Pharma Canada Inc.	AC was supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada and the Training Program in Regenerative Medicine (Canadian Institutes of Health Research). FH was supported by the Training Program in Regenerative Medicine. This work was funded by a grant from Astellas Pharma Canada Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboni I, 2008, PROTEOMICS, V8, P3443, DOI 10.1002/pmic.200800146; Caforio ALP, 2002, EUR J HEART FAIL, V4, P411, DOI 10.1016/S1388-9842(02)00010-7; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Chih S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/210210; Colvin MM, 2015, CIRCULATION, V131, P1608, DOI 10.1161/CIR.0000000000000093; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Doesch AO, 2010, J CLIN APHERESIS, V25, P315, DOI 10.1002/jca.20263; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ghayour-Mobarhan M, 2008, INT J EXP PATHOL, V89, P209, DOI 10.1111/j.1365-2613.2008.00586.x; Giannessi D, 2007, CELL STRESS CHAPERON, V12, P265, DOI 10.1379/CSC-272.1; Gronwall C, 2014, J CLIN IMMUNOL, V34, pS12, DOI 10.1007/s10875-014-0025-4; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Hagedorn PH, 2010, IMMUNOLOGY, V130, P427, DOI 10.1111/j.1365-2567.2010.03246.x; HAMMOND EH, 1989, J HEART TRANSPLANT, V8, P430; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; Kaya Z, 2012, CIRC RES, V110, P145, DOI 10.1161/CIRCRESAHA.111.243360; Kaya Z, 2010, CLIN IMMUNOL, V134, P80, DOI 10.1016/j.clim.2009.04.008; Kobashigawa J, 2011, J HEART LUNG TRANSPL, V30, P252, DOI 10.1016/j.healun.2010.11.003; KUBO SH, 1995, J HEART LUNG TRANSPL, V14, P409; Li L, 2009, P NATL ACAD SCI USA, V106, P4148, DOI 10.1073/pnas.0900563106; LIAO L, 1995, J EXP MED, V181, P1123, DOI 10.1084/jem.181.3.1123; Mahesh B, 2007, AM J PATHOL, V170, P1415, DOI 10.2353/ajpath.2007.060728; Morgun A, 2004, J HEART LUNG TRANSPL, V23, P204, DOI 10.1016/S1053-2498(03)00114-1; Nath DS, 2010, J HEART LUNG TRANSPL, V29, P1277, DOI 10.1016/j.healun.2010.05.025; NEU N, 1987, J IMMUNOL, V139, P3630; Nwakanma LU, 2007, ANN THORAC SURG, V84, P1556, DOI 10.1016/j.athoracsur.2007.05.095; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Patel PA, 2013, EUR J HEART FAIL, V15, P724, DOI 10.1093/eurjhf/hft065; Porcheray F, 2010, TRANSPLANTATION, V89, P1239, DOI 10.1097/TP.0b013e3181d72091; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Raichlin E, 2009, J HEART LUNG TRANSPL, V28, P320, DOI 10.1016/j.healun.2009.01.006; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veillette GR, 2011, TRANSPLANTATION, V91, P1187, DOI 10.1097/TP.0b013e318218415d; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Zhu JH, 2001, CIRCULATION, V103, P1071, DOI 10.1161/01.CIR.103.8.1071	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151224	10.1371/journal.pone.0151224	http://dx.doi.org/10.1371/journal.pone.0151224			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967734	gold, Green Published, Green Submitted			2022-12-27	WOS:000371989200035
J	Dorsch, M; Behmenburg, F; Raible, M; Blase, D; Grievink, H; Hollmann, MW; Heinen, A; Huhn, R				Dorsch, Marianne; Behmenburg, Friederike; Raible, Miriam; Blase, Dominic; Grievink, Hilbert; Hollmann, Markus W.; Heinen, Andre; Huhn, Ragnar			Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore	PLOS ONE			English	Article							K-ATP-CHANNELS; ISCHEMIA-REPERFUSION INJURY; GENERATING FREE-RADICALS; INFARCT SIZE; RAT-HEART; IN-VIVO; CARDIOPROTECTION; ACTIVATION; TRIGGERS; PATHWAY	Background Morphine induces myocardial preconditioning (M-PC) via activation of mitochondrial large conductance Ca2+-sensitive potassium (mK(Ca)) channels. An upstream regulator of mK(Ca) channels is protein kinase A (PKA). Furthermore, mK(Ca) channel activation regulates mitochondrial bioenergetics and thereby prevents opening of the mitochondrial permeability transition pore (mPTP). Here, we investigated in the rat heart in vivo whether 1) M-PC is mediated by activation of PKA, and 2) pharmacological opening of the mPTP abolishes the cardioprotective effect of M-PC and 3) M-PC is critically dependent on STAT3 activation, which is located upstream of mPTP within the signalling pathway. Methods Male Wistar rats were randomised to six groups (each n = 6). All animals underwent 25 minutes of regional myocardial ischemia and 120 minutes of reperfusion. Control animals (Con) were not further treated. Morphine preconditioning was initiated by intravenous administration of 0.3 mg/kg morphine (M-PC). The PKA blocker H-89 (10 mu g/kg) was investigated with and without morphine (H-89+M-PC, H-89). We determined the effect of mPTP opening with atractyloside (5 mg/kg) with and without morphine (Atr+M-PC, Atr). Furthermore, the effect of morphine on PKA activity was tested in isolated adult rat cardiomyocytes. In further experiments in isolated hearts we tested the protective properties of morphine in the presence of STAT3 inhibition, and whether pharmacological prevention of the mPTP-opening by cyclosporine A (CsA) is cardioprotective in the presence of STAT3 inhibition. Results Morphine reduced infarct size from 64 +/- 5% to 39 +/- 9% (P<0.05 vs. Con). H-89 completely blocked preconditioning by morphine (64 +/- 9%; P<0.05 vs. M-PC), but H-89 itself had not effect on infarct size (61 +/- 10%; P>0.05 vs. Con). Also, atractyloside abolished infarct size reduction of morphine completely (65 +/- 9%; P<0.05 vs. M-PC) but had no influence on infarct size itself (64 +/- 5%; P>0.05 vs. Con). In isolated hearts STAT3 inhibitor Stattic completely abolished morphine-induced preconditioning. Administration of Stattic and mPTP inhibitor cyclosporine A reduced infarct size to 31 +/- 6% (Stat+CsA, P<0.05 vs. Con). Cyclosporine A alone reduced infarct size to 26 +/- 7% (CsA P<0.05 vs. Con). In cardiomyocytes, PKA activity was increased by morphine. Conclusion Our data suggest that morphine-induced cardioprotection is mediated by STAT3-activation and inhibition of mPTP, with STA3 located upstream of mPTP. There is some evidence that protein kinase A is involved within the signalling pathway.	[Dorsch, Marianne; Behmenburg, Friederike; Raible, Miriam; Blase, Dominic; Grievink, Hilbert; Heinen, Andre; Huhn, Ragnar] Univ Hosp Duesseldorf, Dept Anesthesiol, Moorenstr 5, D-40225 Dusseldorf, Germany; [Hollmann, Markus W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Dept Anesthesiol, Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands; [Heinen, Andre] Univ Dusseldorf, Inst Cardiovasc Physiol, Univ Str 1, D-40225 Dusseldorf, Germany; [Grievink, Hilbert] Hadassah Univ Hosp, Dept Anesthesiol & Crit Care Med, IL-91120 Jerusalem, Israel; [Grievink, Hilbert] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Ein Kerem Campus, Jerusalem, Israel	University of Amsterdam; Academic Medical Center Amsterdam; Heinrich Heine University Dusseldorf; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Behmenburg, F (corresponding author), Univ Hosp Duesseldorf, Dept Anesthesiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	Friederike.Behmenburg@med.uni-duesseldorf.de	Huhn, Ragnar/X-6466-2018	Huhn, Ragnar/0000-0002-3114-7190	Heinrich-Heine-University Duesseldorf, Germany [SFF 701301765]	Heinrich-Heine-University Duesseldorf, Germany	This work was supported by a research fund (SFF 701301765) from the Heinrich-Heine-University Duesseldorf, Germany.	Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Cao CM, 2005, J PHARMACOL EXP THER, V312, P644, DOI 10.1124/jpet.104.074476; Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023; Cohen MV, 2001, CIRC RES, V89, P273, DOI 10.1161/hh1501.094266; Frassdorf J, 2010, CAN J ANESTH, V57, P767, DOI 10.1007/s12630-010-9325-1; Gross ER, 2006, AM J PHYSIOL-HEART C, V291, pH827, DOI 10.1152/ajpheart.00003.2006; Gross ER, 2006, CARDIOVASC RES, V70, P212, DOI 10.1016/j.cardiores.2005.12.019; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Heinen A, 2008, ANESTHESIOLOGY, V109, P830, DOI 10.1097/ALN.0b013e3181895aa0; Heinen A, 2014, EXP GERONTOL, V56, P99, DOI 10.1016/j.exger.2014.03.029; Huhn R, 2010, BRIT J ANAESTH, V105, P589, DOI 10.1093/bja/aeq213; Huhn R, 2012, EXP GERONTOL, V47, P116, DOI 10.1016/j.exger.2011.11.003; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Makaula S, 2005, J CARDIOVASC PHARM, V45, P341, DOI 10.1097/01.fjc.0000156825.80951.14; Mullenheim J, 2002, ANESTHESIOLOGY, V96, P934; MURAKI T, 1984, J PHARM PHARMACOL, V36, P490, DOI 10.1111/j.2042-7158.1984.tb04436.x; Murphy E, 2007, ANNU REV PHYSIOL, V69, P51, DOI 10.1146/annurev.physiol.69.031905.163645; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Obal D, 2005, ANESTH ANALG, V101, P1252, DOI 10.1213/01.ANE.0000181336.96511.32; Pain T, 2000, CIRC RES, V87, P460; Park SY, 2013, TOXICOL APPL PHARM, V268, P68, DOI 10.1016/j.taap.2013.01.017; Puana R, 2008, ANESTH ANALG, V106, P480, DOI 10.1213/ane.0b013e318160648b; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Sanada S, 2004, CIRCULATION, V110, P51, DOI 10.1161/01.CIR.0000133390.12306.C7; Sato T, 2005, CIRCULATION, V111, P198, DOI 10.1161/01.CIR.0000151099.15706.B1; Skyschally A, 2015, CIRC RES, V117, P279, DOI 10.1161/CIRCRESAHA.117.306878; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; Toma O, 2004, ANESTHESIOLOGY, V101, P1372; Zhang SZ, 2006, ANESTHESIOLOGY, V105, P550, DOI 10.1097/00000542-200609000-00019; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	32	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151025	10.1371/journal.pone.0151025	http://dx.doi.org/10.1371/journal.pone.0151025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26968004	gold, Green Submitted, Green Published			2022-12-27	WOS:000371989200028
J	Chen, YZ; Huang, YK; Qin, DD; Liu, WC; Song, C; Lou, KY; Wang, W; Gao, F				Chen, Yanzuo; Huang, Yukun; Qin, Dongdong; Liu, Wenchao; Song, Chao; Lou, Kaiyan; Wang, Wei; Gao, Feng			beta-Cyclodextrin-Based Inclusion Complexation Bridged Biodegradable Self-Assembly Macromolecular Micelle for the Delivery of Paclitaxel	PLOS ONE			English	Article							DRUG-DELIVERY; POLYMERIC MICELLES; TARGETED DELIVERY; CO-DELIVERY; NANOPARTICLES; TUMOR; NANOCARRIERS; STABILITY; LIPOSOMES; SYSTEMS	In this study, a novel adamantanamine-paclitaxel (AD-PTX) incorporated oligochitosan-carboxymethyl-beta-cyclodextrin (CSO-g-CM-beta-CD) self-assembly macromolecular (CSO-gCM-beta-CD@AD-PTX) micelle was successfully prepared in water through sonication. The formed molecules were characterized by Fourier transform infrared spectroscopy, proton nuclear magnetic resonance (NMR) spectroscopy, two-dimensional NMR, elemental analysis, and liquid chromatography-mass spectrometry, while the correspondent micelles were characterized by dynamic light scattering and transmission electron microscopy. We showed that the macromolecular micelle contained a spherical core-shell structure with a diameter of 197.1 +/- 3.3 nm and zeta potential of -19.1 +/- 4.3 mV. The CSO-g-CM-beta-CD@AD-PTX micelle exhibited a high drug-loading efficacy up to 31.3%, as well as a critical micelle concentration of 3.4 x 10(-7) M, which indicated good stability. Additionally, the in vitro release profile of the CSO-g-CM-beta-CD@AD-PTX micelle demonstrated a long-term release pattern, 63.1% of AD-PTX was released from the micelle during a 30-day period. Moreover, the CSO-g-CM-beta-CD@AD-PTX micelle displayed cytotoxicity at a sub-mu M scale similar to PTX in U87 MG cells, and CSO-g-CM-beta-CD exhibited a good safety profile by not manifesting significant toxicity at concentrations up to 100 mu M. These results indicated that beta-CD-based inclusion complexation resulting in biodegradable self-assembled macromolecular micelles can be utilized as nanocarrier, and may provide a promising platform for drug delivery in the future medical applications.	[Chen, Yanzuo; Huang, Yukun; Qin, Dongdong; Liu, Wenchao; Gao, Feng] E China Univ Sci & Technol, Shanghai Key Lab Funct Mat Chem, Shanghai 200237, Peoples R China; [Chen, Yanzuo; Gao, Feng] E China Univ Sci & Technol, Sch Pharm, Dept Pharmaceut, Shanghai 200237, Peoples R China; [Song, Chao; Lou, Kaiyan; Wang, Wei; Gao, Feng] E China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China; [Song, Chao; Lou, Kaiyan] E China Univ Sci & Technol, Shanghai Key Lab Chem Biol, Shanghai 200237, Peoples R China; [Song, Chao; Lou, Kaiyan] E China Univ Sci & Technol, State Key Lab Bioengn Reactor, Shanghai 200237, Peoples R China; [Wang, Wei] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	East China University of Science & Technology; East China University of Science & Technology; East China University of Science & Technology; East China University of Science & Technology; East China University of Science & Technology; University of New Mexico	Gao, F (corresponding author), E China Univ Sci & Technol, Shanghai Key Lab Funct Mat Chem, Shanghai 200237, Peoples R China.; Gao, F (corresponding author), E China Univ Sci & Technol, Sch Pharm, Dept Pharmaceut, Shanghai 200237, Peoples R China.; Lou, KY; Gao, F (corresponding author), E China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China.	kylou@ecust.edu.cn; fgao@ecust.edu.cn			Fundamental Research Funds for the Central Universities [WY1213013, 22A201514055]; National Natural Science Foundation of China [81503021]; School of Pharmacy, Fudan University & the Open Project Program of Key Lab of Smart Drug Delivery (Fudan University), Ministry of Education [SDD2014-2]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); School of Pharmacy, Fudan University & the Open Project Program of Key Lab of Smart Drug Delivery (Fudan University), Ministry of Education	This work was supported by Fundamental Research Funds for the Central Universities (WY1213013 ECUST) KL study design (http://en.moe.gov.cn/), Fundamental Research Funds for the Central Universities(22A201514055 ECUST) YC data collection and analysis (http://en.moe.gov.cn/), National Natural Science Foundation of China (81503021) YC decision to publish (http://www.nsfc.gov.cn/publish/portal1/), School of Pharmacy, Fudan University & the Open Project Program of Key Lab of Smart Drug Delivery (Fudan University), Ministry of Education (SDD2014-2) YC preparation of the manuscript (http://smartdds.fudan.edu.cn/).	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Bae YH, 2008, J CONTROL RELEASE, V131, P2, DOI 10.1016/j.jconrel.2008.06.015; Chen G, 2011, CHEM SOC REV, V40, P2254, DOI 10.1039/c0cs00153h; Chen YZ, 2015, CHINESE CHEM LETT, V26, P909, DOI 10.1016/j.cclet.2015.05.044; Chen YZ, 2015, INT J PHARMACEUT, V488, P44, DOI 10.1016/j.ijpharm.2015.04.048; Fukushima K, 2008, BIOMACROMOLECULES, V9, P3051, DOI 10.1021/bm800526k; Furusaki E, 1996, CARBOHYD POLYM, V29, P29, DOI 10.1016/0144-8617(95)00133-6; Gao HJ, 2014, BIOMACROMOLECULES, V15, P3634, DOI 10.1021/bm5009348; Gao SS, 2012, INT J PHARMACEUT, V427, P410, DOI 10.1016/j.ijpharm.2012.01.054; Gregoriadis G, 1995, TRENDS BIOTECHNOL, V13, P527, DOI 10.1016/S0167-7799(00)89017-4; Hu QD, 2014, ACCOUNTS CHEM RES, V47, P2017, DOI 10.1021/ar500055s; Hu QL, 2012, BIOMATERIALS, V33, P6580, DOI 10.1016/j.biomaterials.2012.05.060; Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9; Kataoka K, 2012, ADV DRUG DELIVER REV, V64, P37, DOI 10.1016/j.addr.2012.09.013; Li JF, 2015, BIOCONJUGATE CHEM, V26, P418, DOI 10.1021/acs.bioconjchem.5b00030; Liu YY, 2014, BIOMATERIALS, V35, P4835, DOI 10.1016/j.biomaterials.2014.02.031; Lv PP, 2012, MOL PHARMACEUT, V9, P1736, DOI 10.1021/mp300051h; Ma X, 2015, CHEM REV, V115, P7794, DOI 10.1021/cr500392w; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; Prabaharan M, 2005, MACROMOL BIOSCI, V5, P965, DOI 10.1002/mabi.200500087; Shao Y, 2014, ACS APPL MATER INTER, V6, P10381, DOI 10.1021/am501913m; Shi Y, 2015, ACS NANO, V9, P3740, DOI 10.1021/acsnano.5b00929; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Yang C, 2015, J CONTROL RELEASE, V208, P93, DOI 10.1016/j.jconrel.2015.03.027; Yang C, 2012, BIOMATERIALS, V33, P2971, DOI 10.1016/j.biomaterials.2011.11.035; Yu d, 2015, BIOCONJUG CHEM; Zhang FW, 2015, J AM CHEM SOC, V137, P2056, DOI 10.1021/ja512616s	28	19	20	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150877	10.1371/journal.pone.0150877	http://dx.doi.org/10.1371/journal.pone.0150877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26964047	Green Submitted, Green Published, gold			2022-12-27	WOS:000371993000073
J	He, J; Liu, W; Huang, YX				He, Jiang; Liu, Wei; Huang, Yao-Xiong			Simultaneous Determination of Glass Transition Temperatures of Several Polymers	PLOS ONE			English	Article							THERMAL LAG; MICROSPHERES; COEFFICIENTS; DEPENDENCE; DSC	Aims A simple and easy optical method is proposed for the determination of glass transition temperature (T-g) of polymers. Methods & Results T-g was determined using the technique of microsphere imaging to monitor the variation of the refractive index of polymer microsphere as a function of temperature. It was demonstrated that the method can eliminate most thermal lag and has sensitivity about six fold higher than the conventional method in T-g determination. So the determined T-g is more accurate and varies less with cooling/heating rate than that obtained by conventional methods. The most attractive character of the method is that it can simultaneously determine the T-g of several polymers in a single experiment, so it can greatly save experimental time and heating energy. Conclusion The method is not only applicable for polymer microspheres, but also for the materials with arbitrary shapes. Therefore, it is expected to be broadly applied to different fundamental researches and practical applications of polymers.	[Huang, Yao-Xiong] Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China; Ji Nan Univ, Key Lab Biomat, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Huang, YX (corresponding author), Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	tyxhuang@jnu.edu.cn			Chinese National Natural Science Foundation [30940019, 60377043]; Guang Dong Provincial and Guang Zhou City Science and Technology Foundations	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guang Dong Provincial and Guang Zhou City Science and Technology Foundations	This work was supported by the Chinese National Natural Science Foundation (Nos. 30940019 and 60377043) and Guang Dong Provincial and Guang Zhou City Science and Technology Foundations.	BEAUCAGE G, 1993, J POLYM SCI POL PHYS, V31, P319, DOI 10.1002/polb.1993.090310310; Ciosek P, 2007, ANALYST, V132, P963, DOI 10.1039/b705107g; Dobkowski Z, 2006, POLYM DEGRAD STABIL, V91, P488, DOI 10.1016/j.polymdegradstab.2005.01.051; Dupaix RB, 2005, POLYMER, V46, P4827, DOI 10.1016/j.polymer.2005.03.083; Efremov MY, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2901601; Efremov MY, 2004, MACROMOLECULES, V37, P4607, DOI 10.1021/ma035909r; Fiaz M, 1996, POLYMER, V37, P755, DOI 10.1016/0032-3861(96)87250-8; GUSEV AS, 1970, POLARIZABILITY GREAT; Haynes W. M., 2012, CRC HDB CHEM PHYS; HUTCHINSON JM, 1992, PHILOS MAG B, V66, P449, DOI 10.1080/13642819208220114; Hutchinson JM, 2009, J THERM ANAL CALORIM, V98, P579, DOI 10.1007/s10973-009-0268-0; Kang ES, 2003, J SOL-GEL SCI TECHN, V26, P981, DOI 10.1023/A:1020761430016; Kawaguchi S, 2005, ADV POLYM SCI, V175, P299, DOI 10.1007/b100118; Lacik I, 2000, POLYM TEST, V19, P755, DOI 10.1016/S0142-9418(99)00046-X; Moynihan CT, 1996, THERMOCHIM ACTA, V280, P153, DOI 10.1016/0040-6031(95)02781-5; MOYNIHAN CT, 1974, J PHYS CHEM-US, V78, P2673, DOI 10.1021/j100619a008; ODonnell PB, 1997, ADV DRUG DELIVER REV, V28, P25, DOI 10.1016/S0169-409X(97)00049-5; Okubo N, 1995, TA, V68, P1; Patsidis A, 2008, EXPRESS POLYM LETT, V2, P718, DOI 10.3144/expresspolymlett.2008.85; Priyadarshi A, 2005, J APPL POLYM SCI, V98, P950, DOI 10.1002/app.22003; Rieger J, 1996, J THERM ANAL, V46, P965, DOI 10.1007/BF01983614; Sun W, 2014, INT J ADHES ADHES, V52, P31, DOI 10.1016/j.ijadhadh.2014.03.009; Thomas LC, 2001, AM LAB, V33, P26; WALLACE WE, 1995, PHYS REV E, V52, pR3329, DOI 10.1103/PhysRevE.52.R3329; Yue LY, 2011, BIOSENS BIOELECTRON, V30, P216, DOI 10.1016/j.bios.2011.09.015	25	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151454	10.1371/journal.pone.0151454	http://dx.doi.org/10.1371/journal.pone.0151454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985670	Green Published, gold			2022-12-27	WOS:000372580300074
J	Chadaga, AR; Villines, D; Krikorian, A				Chadaga, Amar R.; Villines, Dana; Krikorian, Armand			Bullying in the American Graduate Medical Education System: A National Cross-Sectional Survey	PLOS ONE			English	Article							JUNIOR DOCTORS; QUESTIONNAIRE; SATISFACTION; MISTREATMENT; RESIDENTS	Objectives To deliver an estimate of bullying among residents and fellows in the United States graduate medical education system and to explore its prevalence within unique subgroups. Design/Setting/Participants A national cross-sectional survey from a sample of residents and fellows who completed an online bullying survey conducted in June 2015. The survey was distributed using a chain sampling method that relied on electronic referrals from 4,055 training programs, with 1,791 residents and fellows completing the survey in its entirety. Survey respondents completed basic demographic and programmatic information plus four general bullying and 20 specific bullying behavior questions. Between-group differences were compared for demographic and programmatic stratifications. Main Outcomes/Measures Self-reported subjected to workplace bullying from peers, attendings, nurses, ancillary staff, or patients in the past 12 months. Results Almost half of the respondents (48%) reported being subjected to bullying although both those subjected and not subjected reported experiencing >= 1 bullying behaviors (95% and 39% respectively). Attendings (29%) and nurses (27%) were the most frequently identified source of bullying, followed by patients, peers, consultants and staff. Attempts to belittle and undermine work and unjustified criticism and monitoring of work were the most frequently reported bullying behaviors (44% each), followed by destructive innuendo and sarcasm (37%) and attempts to humiliate (32%). Specific bullying behaviors were more frequently reported by female, non-white, shorter than <5'8 and BMI >= 25 individuals. Conclusions/Relevance Many trainees report experiencing bullying in the United States graduate medical education programs. Including specific questions on bullying in the Accreditation Council for Graduate Medical Education annual resident/fellow survey, implementation of anti-bullying policies, and a multidisciplinary approach engaging all stakeholders may be of great value to eliminate these pervasive behaviors in the field of healthcare.	[Chadaga, Amar R.; Krikorian, Armand] Advocate Hlth Care, Dept Internal Med, Oak Lawn, IL USA; [Villines, Dana] Advocate Hlth Care, Dept Adm, Chicago, IL USA; [Chadaga, Amar R.; Krikorian, Armand] Univ Illinois, Dept Med, Chicago, IL USA; [Chadaga, Amar R.] Rosalind Franklin Univ Med & Sci, Dept Med, N Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rosalind Franklin University Medical & Science	Chadaga, AR (corresponding author), Advocate Hlth Care, Dept Internal Med, Oak Lawn, IL USA.; Chadaga, AR (corresponding author), Univ Illinois, Dept Med, Chicago, IL USA.; Chadaga, AR (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Med, N Chicago, IL USA.	amar.chadaga@advocatehealth.com	Krikorian, Armand/AAH-1571-2020					[Anonymous], 2015, J POSTGRAD MED; [Anonymous], 1995, BULLYING WORK TACKLE; Askew DA, 2012, AUST HEALTH REV, V36, P197, DOI 10.1071/AH11048; Bairy KL, 2007, J POSTGRAD MED, V53, P87, DOI 10.4103/0022-3859.32206; Baldwin DC, 1997, ACAD MED, V72, pS51, DOI 10.1097/00001888-199710001-00018; Cheema S, 2005, Ir Med J, V98, P274; Daugherty SR, 1998, JAMA-J AM MED ASSOC, V279, P1194, DOI 10.1001/jama.279.15.1194; Fnais N, 2013, ANN SAUDI MED, V33, P134, DOI 10.5144/0256-4947.2013.134; Imran N, 2010, SINGAP MED J, V51, P592; Nabi H, 2013, J SURG EDUC, V70, P265, DOI 10.1016/j.jsurg.2012.09.004; November WS, 2014, 2014 PHYS SPECIALTY; Park M, 2015, J NURS SCHOLARSHIP, V47, P87, DOI 10.1111/jnu.12112; Quine L, 2003, CAMB Q HEALTHC ETHIC, V12, P91, DOI 10.1017/S0963180103121111; Quine L, 1999, BRIT MED J, V318, P228, DOI 10.1136/bmj.318.7178.228; Quine L, 2002, BRIT MED J, V324, P878, DOI 10.1136/bmj.324.7342.878; SILVER HK, 1990, JAMA-J AM MED ASSOC, V263, P527, DOI 10.1001/jama.263.4.527; SILVER HK, 1982, JAMA-J AM MED ASSOC, V247, P309, DOI 10.1001/jama.247.3.309; van Geel M, 2014, INT J OBESITY, V38, P1263, DOI 10.1038/ijo.2014.117; Voss LD, 2000, BMJ-BRIT MED J, V320, P612, DOI 10.1136/bmj.320.7235.612; Woolum A., 2015, J APPL PSYCHOL, DOI [10.1037apl0000037, DOI 10.1037APL0000037]	20	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150246	10.1371/journal.pone.0150246	http://dx.doi.org/10.1371/journal.pone.0150246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982705	Green Published, Green Submitted, gold			2022-12-27	WOS:000372574900028
J	Estrada, M; Delgado, M; Blasco, D; Latasa, M; Cabello, AM; Benitez-Barrios, V; Fraile-Nuez, E; Mozetic, P; Vidal, M				Estrada, Marta; Delgado, Maximino; Blasco, Dolors; Latasa, Mikel; Mara Cabello, Ana; Benitez-Barrios, Veronica; Fraile-Nuez, Eugenio; Mozetic, Patricija; Vidal, Montserrat			Phytoplankton across Tropical and Subtropical Regions of the Atlantic, Indian and Pacific Oceans	PLOS ONE			English	Article							DIATOM LEPTOCYLINDRUS-MEDITERRANEUS; NORTH PACIFIC; SOLENICOLA-SETIGERA; SPECIES STRUCTURE; CHLOROPHYLL; DIVERSITY; ECOLOGY; BIOGEOGRAPHY; VARIABILITY; ABUNDANCE	We examine the large-scale distribution patterns of the nano-and microphytoplankton collected from 145 oceanic stations, at 3 m depth, the 20% light level and the depth of the subsurface chlorophyll maximum, during the Malaspina-2010 Expedition (December 2010-July 2011), which covered 15 biogeographical provinces across the Atlantic, Indian and Pacific oceans, between 35 degrees N and 40 degrees S. In general, the water column was stratified, the surface layers were nutrient-poor and the nano-and microplankton (hereafter phytoplankton, for simplicity, although it included also heterotrophic protists) community was dominated by dinoflagellates, other flagellates and coccolithophores, while the contribution of diatoms was only important in zones with shallow nutriclines such as the equatorial upwelling regions. We applied a principal component analysis to the correlation matrix among the abundances (after logarithmic transform) of the 76 most frequent taxa to synthesize the information contained in the phytoplankton data set. The main trends of variability identified consisted of: 1) A contrast between the community composition of the upper and the lower parts of the euphotic zone, expressed respectively by positive or negative scores of the first principal component, which was positively correlated with taxa such as the dinoflagellates Oxytoxum minutum and Scrippsiella spp., and the coccolithophores Discosphaera tubifera and Syracosphaera pulchra (HOL and HET), and negatively correlated with taxa like Ophiaster hydroideus (coccolithophore) and several diatoms, 2) a general abundance gradient between phytoplankton-rich regions with high abundances of dinoflagellate, coccolithophore and ciliate taxa, and phytoplankton-poor regions (second principal component), 3) differences in dominant phytoplankton and ciliate taxa among the Atlantic, the Indian and the Pacific oceans (third principal component) and 4) the occurrence of a diatom-dominated assemblage (the fourth principal component assemblage), including several pennate taxa, Planktoniella sol, Hemiaulus hauckii and Pseudo-nitzschia spp., in the divergence regions. Our findings indicate that consistent assemblages of co-occurring phytoplankton taxa can be identified and that their distribution is best explained by a combination in different degrees of both environmental and historical influences.	[Estrada, Marta; Delgado, Maximino; Blasco, Dolors; Mara Cabello, Ana] Inst Ciencies Mar CSIC, Barcelona, Catalunya, Spain; [Latasa, Mikel] Inst Espanol Oceanog, Ctr Oceanog Gijon Xixon, Gijon Xixon, Asturias, Spain; [Benitez-Barrios, Veronica; Fraile-Nuez, Eugenio] Inst Espanol Oceanog, Ctr Oceanog Canarias, Tenerife, Canarias, Spain; [Mozetic, Patricija] Natl Inst Biol, Marine Biol Stn, Piran, Slovenia; [Vidal, Montserrat] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Catalunya, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Spanish Institute of Oceanography; Spanish Institute of Oceanography; National Institute of Biology - Slovenia; University of Barcelona	Estrada, M (corresponding author), Inst Ciencies Mar CSIC, Barcelona, Catalunya, Spain.	marta@icm.csic.es	Fraile-Nuez, Eugenio/D-1521-2010; Nuez, Eugenio Fraile/R-2258-2019; Latasa, Mikel/D-2202-2011; Estrada, Marta/L-6207-2014; Vidal, Montserrat/L-6051-2014	Fraile-Nuez, Eugenio/0000-0003-4250-4445; Nuez, Eugenio Fraile/0000-0003-4250-4445; Latasa, Mikel/0000-0002-8202-0923; Estrada, Marta/0000-0001-5769-9498; Vidal, Montserrat/0000-0002-7878-3290; Mozetic, Patricija/0000-0002-4668-4511; Cabello Perez, Ana Maria/0000-0002-7165-5632	Consolider-Ingenio, Ministerio de Economia y Competitividad [CSD2008-00077]; Consejo Superior de Investigaciones Cientificas (CSIC)	Consolider-Ingenio, Ministerio de Economia y Competitividad; Consejo Superior de Investigaciones Cientificas (CSIC)	This work was supported by Consolider-Ingenio 2010, CSD2008-00077 of the former Spanish Ministerio de Ciencia e Innovacion (ES) (Now Ministerio de Economia y Competitividad, www.mineco.gob.es); Consejo Superior de Investigaciones Cientificas (CSIC) (ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvain S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003154; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Andersen RA, 1996, DEEP-SEA RES PT II, V43, P517, DOI 10.1016/0967-0645(95)00095-X; Balech E., 1988, DINOFLAGELADOS ATLAN; Balech E, 1995, GENUS ALEXANDRIUM HA; BEERS J R, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P607; BERARD-THERRIAULT L., 1999, PUBLICATION SPECIALE, V128, P1; BLASCO D, 1980, DEEP-SEA RES, V27, P799, DOI 10.1016/0198-0149(80)90045-X; Blasco D, 2012, EXPEDICION DE CIRCUNNAVEGACION MALASPINA 2010: CAMBIO GLOBAL Y EXPLORACION DE LA BIODIVERSIDAD DEL OCEANO: LIBRO BLANCO DE METODOS Y TECNICAS DE TRABAJO OCEANOGRAFICO, P107; Cermeno P, 2008, LIMNOL OCEANOGR, V53, P312, DOI 10.4319/lo.2008.53.1.0312; Chretiennot-Dinet M.-J., 1990, ATLAS PHYTOPLANCTON; Cortes MY, 2001, DEEP-SEA RES PT II, V48, P1957, DOI 10.1016/S0967-0645(00)00165-X; Cros L, 2002, SCI MAR, V66, P5; Cullen JJ, 2015, ANNU REV MAR SCI, V7, P207, DOI 10.1146/annurev-marine-010213-135111; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; DELGADO M, 1991, Scientia Marina, V55, P1; Duarte C.M., 2015, LIMNOL OCEANOGR B, V24, P11, DOI [10.1002/lob.10008, DOI 10.1002/L0B.10008]; Edwards M, 2002, MAR ECOL PROG SER, V239, P1, DOI 10.3354/meps239001; Estrada M, 2012, EXPEDICION DE CIRCUNNAVEGACION MALASPINA 2010: CAMBIO GLOBAL Y EXPLORACION DE LA BIODIVERSIDAD DEL OCEANO: LIBRO BLANCO DE METODOS Y TECNICAS DE TRABAJO OCEANOGRAFICO, P399; Estrada M., 1985, NATO Conference Series I Ecology, V8, P247; Estrada M., 1991, OECOLOGIA AQUATICA, V10, P157; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fernandez-Castro B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9002; Fiedler PC, 2002, DEEP-SEA RES PT I, V49, P321, DOI 10.1016/S0967-0637(01)00057-7; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fukuyo Y., 1990, RED TIDE ORGANISMS J; Gomez F, 2007, BIOGEOSCIENCES, V4, P1101, DOI 10.5194/bg-4-1101-2007; Gomez F., 2013, CICIMAR Oceanides, V28, P1; Gomez F, 2008, MAR POLLUT BULL, V56, P620, DOI 10.1016/j.marpolbul.2007.12.014; Gomez Fernando, 2006, Algae, V21, P445; Gomez F, 2007, ACTA PROTOZOOL, V46, P15; GOULD RW, 1988, J MAR RES, V46, P399; Grasshoff K, 1999, METHODS SEAWATER ANA; Gregg WW, 2007, DEEP-SEA RES PT II, V54, P447, DOI 10.1016/j.dsr2.2006.12.007; Guiry MD, 2012, J PHYCOL, V48, P1057, DOI 10.1111/j.1529-8817.2012.01222.x; Haidar AT, 2001, DEEP-SEA RES PT II, V48, P1925, DOI 10.1016/S0967-0645(00)00169-7; Hallegraeff GM, 2003, MANUAL HARMFUL MARIN; Herbland A., 1987, OCEANOL ACTA SP ISS, P115; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Jeffrey S.W., 2006, ALGAL CULTURES ANALO, P33, DOI [10.5860/choice.43-6522, DOI 10.5860/CHOICE.43-6522]; Jolicoeur P, 1960, GROWTH, V24, P359; Kaczmarska I, 2014, AM J BOT, V101, P267, DOI 10.3732/ajb.1300306; Kamykowski D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001640; Latasa M, 2005, LIMNOL OCEANOGR, V50, P1447, DOI 10.4319/lo.2005.50.5.1447; Legendre P., 2012, NUMERICAL ECOLOGY; Levandowsky M., 1987, BIOL DINOFLAGELLATES, P360; Li BL, 2013, DEEP-SEA RES PT II, V93, P84, DOI 10.1016/j.dsr2.2013.03.007; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Medlin LK, 2007, GENE, V406, P180, DOI 10.1016/j.gene.2007.09.011; Monterey G, 1997, SEASONAL VARIABILITY; Padmakumar KB, 2012, SYMBIOSIS, V56, P97, DOI 10.1007/s13199-012-0160-8; Percopo I, 2011, BOT MAR, V54, P243, DOI 10.1515/BOT.2011.033; Rampi L., 1980, CNEN RT BIO, V8, P1; Rousseaux CS, 2015, GLOBAL BIOGEOCHEM CY, V29, P1674, DOI 10.1002/2015GB005139; Saldarriaga JF, 2003, J PHYCOL, V39, P368, DOI 10.1046/j.1529-8817.2003.02113.x; Schlitzer R., 2013, OCEAN DATA VIEW; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Sournia A., 1986, ATLAS PHYTOPLANCTON, VI; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Tomas C., 1995, IDENTIFYING MARINE D; Tomas CR, 1993, MARINE PHYTOPLANKTON; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; VENRICK EL, 1990, ECOLOGY, V71, P1547, DOI 10.2307/1938291; Venrick EL, 1999, J PLANKTON RES, V21, P1029, DOI 10.1093/plankt/21.6.1029; VENRICK EL, 1988, J PLANKTON RES, V10, P987, DOI 10.1093/plankt/10.5.987; Young J.R., 2003, J NANNOPLANKTON RES, V1, P1	70	49	50	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151699	10.1371/journal.pone.0151699	http://dx.doi.org/10.1371/journal.pone.0151699			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982180	Green Published, gold			2022-12-27	WOS:000372574900114
J	Hutchison, ZL; Hendrick, VJ; Burrows, MT; Wilson, B; Last, KS				Hutchison, Zoe L.; Hendrick, Vicki J.; Burrows, Michael T.; Wilson, Ben; Last, Kim S.			Buried Alive: The Behavioural Response of the Mussels, Modiolus modiolus and Mytilus edulis to Sudden Burial by Sediment	PLOS ONE			English	Article							INDIGENOUS PERNA-PERNA; DREDGED MATERIAL; MECHANICAL-PROPERTIES; ENVIRONMENTAL-IMPACT; THERMAL TOLERANCE; MARINE BIVALVE; SAND; INVERTEBRATES; COASTAL; OXYGEN	Sedimentation in the sea occurs through natural processes, such as wave and tidal action, which can be exacerbated during storms and floods. Changes in terrestrial land use, marine aggregate extraction, dredging, drilling and mining are known to result in substantial sediment deposition. Research suggests that deposition will also occur due to the modern development of marine renewable energy. The response to individual burial under three depths of sediment, three sediment fractions and five burial durations was investigated in two mussel species, Modiolus modiolus and Mytilus edulis in specialist mesocosms. Both mussel species showed substantial mortality, which increased with duration of burial and burial by finer sediment fractions. M. modiolus was better able to survive short periods of burial than M. edulis, but at longer durations mortality was more pronounced. No mortality was observed in M. modiolus in burial durations of eight days or less but by 16 days of burial, over 50% cumulative mortality occurred. Under variable temperature regimes, M. edulis mortality increased from 20% at 8 degrees C to over 60% at 14.5 and 20 degrees C. Only M. edulis was able to emerge from burial, facilitated by increased byssus production, laid mostly on vertical surfaces but also on sediment particles. Emergence was higher from coarse sediment and shallow burials. Byssus production in M. edulis was not related to the condition index of the mussels. Results suggest that even marginal burial would result in mortality and be more pronounced in warm summer periods. Our results suggest that in the event of burial, adult M. modiolus would not be able to emerge from burial unless local hydrodynamics assist, whereas a small proportion of M. edulis may regain contact with the sediment water interface. The physiological stress resulting in mortality, contribution of local hydrodynamics to survival and other ecological pressures such as mussels existing in aggregations, are discussed.	[Hutchison, Zoe L.] Cranfield Univ, Ctr Offshore Renewable Energy Engn, Cranfield MK43 0AL, Beds, England; [Hendrick, Vicki J.; Burrows, Michael T.; Wilson, Ben; Last, Kim S.] Scottish Assoc Marine Sci SAMS, Dept Ecol, Oban PA37 1QA, Argyll, Scotland	Cranfield University	Last, KS (corresponding author), Scottish Assoc Marine Sci SAMS, Dept Ecol, Oban PA37 1QA, Argyll, Scotland.	kim.last@sams.ac.uk	Burrows, Michael/ABF-4844-2020	Burrows, Michael/0000-0003-4620-5899; Hutchison, Zoe/0000-0003-1866-7877	Marine Aggregate Levy Sustainability Fund (MALSF); research consortium Marine Renewable Energy and the Environment (MaREE) - European Regional Development Fund; FP7 Tidal Demonstration for Energy Scheme (TIDES) [322428]; Marine Aggregate Levy Sustainability Fund (MePF) [08/P76]; Marine Renewable Energy and the Environment (MaREE) [RE011]; Highlands and Island Enterprise; Scottish Funding Council; European Regional Development Fund; Natural Environment Research Council [NE/L003058/1] Funding Source: researchfish; NERC [NE/L003058/1] Funding Source: UKRI	Marine Aggregate Levy Sustainability Fund (MALSF); research consortium Marine Renewable Energy and the Environment (MaREE) - European Regional Development Fund; FP7 Tidal Demonstration for Energy Scheme (TIDES); Marine Aggregate Levy Sustainability Fund (MePF); Marine Renewable Energy and the Environment (MaREE); Highlands and Island Enterprise; Scottish Funding Council; European Regional Development Fund(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KSL recieved funding from the Marine Aggregate Levy Sustainability Fund (MePF; 08/P76) and the FP7 Tidal Demonstration for Energy Scheme (TIDES; 322428). BW recieved funding from a project called Marine Renewable Energy and the Environment (MaREE; RE011). This project was supported by funding from Highlands and Island Enterprise, the Scottish Funding Council and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge funding from the Marine Aggregate Levy Sustainability Fund (MALSF) and the research consortium Marine Renewable Energy and the Environment (MaREE) which was supported by the European Regional Development Fund. The work was also supported by the FP7 Tidal Demonstration for Energy Scheme (TIDES). The authors thank the MASTS Marine Energy Forum for their contribution to the writing retreat where part of this paper was written. We thank Jose Farinas-Franco for the provision of small M. modiolus. The authors are extremely grateful to aquarium manager, the late John Kershaw, for his assistance with the development and set-up of the pVoRT mesocosm facility. We would also like to thank the contributions of Harriet Condie, Christine Lockwood and Chris Beveridge (aquarium technician) for experimental assistance, and collaborator Andrew J. Davies for invaluable discussions in the experimental design.	Abanades J, 2015, RENEW ENERG, V75, P572, DOI 10.1016/j.renene.2014.10.048; [Anonymous], 2014, R LANG ENV STAT COMP; Babarro JMF, 2010, J COMP PHYSIOL B, V180, P95, DOI 10.1007/s00360-009-0392-y; BAYNE B, 1973, Netherlands Journal of Sea Research, V7, P399, DOI 10.1016/0077-7579(73)90061-6; BAYNE BL, 1978, OECOLOGIA, V37, P137, DOI 10.1007/BF00344987; Boyd SE, 2005, ICES J MAR SCI, V62, P145, DOI 10.1016/j.icesjms.2004.11.014; Boyd SE, 2003, ESTUAR COAST SHELF S, V57, P209, DOI 10.1016/S0272-7714(02)00346-3; Boyd SE, 2000, ESTUAR COAST SHELF S, V51, P805, DOI 10.1006/ecss.2000.0722; Brazee SL, 2006, BIOL BULL-US, V211, P263, DOI 10.2307/4134548; Burnham K. P., 2002, MODEL SELECTION MUTI; CASTILLA JC, 1978, MAR POLLUT BULL, V9, P67, DOI 10.1016/0025-326X(78)90451-4; Chapple JP, 1998, J EXP MAR BIOL ECOL, V229, P53, DOI 10.1016/S0022-0981(98)00040-9; Cottrell RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147534; CROSBY M P, 1990, Journal of Shellfish Research, V9, P233; DALY MA, 1977, MAR BIOL, V43, P45, DOI 10.1007/BF00392570; Davies AJ, 2009, J EXP MAR BIOL ECOL, V370, P35, DOI 10.1016/j.jembe.2008.11.015; DEVOOYS CGN, 1987, NETH J SEA RES, V21, P75, DOI 10.1016/0077-7579(87)90023-8; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dinesen GE, 2014, MAR BIOL RES, V10, P845, DOI 10.1080/17451000.2013.866250; Dolmer P, 1998, J EXP MAR BIOL ECOL, V228, P137, DOI 10.1016/S0022-0981(98)00024-0; Essink Karel, 1999, Journal of Coastal Conservation, V5, P69, DOI 10.1007/BF02802741; FAMME P, 1981, MAR BIOL LETT, V2, P345; FAO, 2014, FISH AQ INF STAT SER; Ginzburg LR, 2004, TRENDS ECOL EVOL, V19, P121, DOI 10.1016/j.tree.2003.11.004; Gormley KSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068263; Gosling E.M., 2003, CIRCULATION RESP EXC; HELCOM, 1999, MAR SED EXTR BALT SE; Hendrick VJ, 2011, BIOGENIC REEFS MARIN; Hendrick VJ, PLOS ONE IN PRESS; Hinchey EK, 2006, HYDROBIOLOGIA, V556, P85, DOI 10.1007/s10750-005-1029-0; Holt TJ, 1998, OVERVIEW DYNAMIC SEN; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jones C., 2014, WAVE ENERGY CONVERTE; JORGENSEN BB, 1980, OIKOS, V34, P68, DOI 10.2307/3544551; KRANZ PM, 1974, J GEOL, V82, P237, DOI 10.1086/627961; MAURER D, 1981, MAR ENVIRON RES, V4, P299, DOI 10.1016/0141-1136(81)90043-X; MEADOWS PS, 1989, MAR BIOL, V101, P219, DOI 10.1007/BF00391461; MILLER DC, 1992, J MAR RES, V50, P489, DOI 10.1357/002224092784797601; Miller RG, 2013, FRONT ECOL ENVIRON, V11, P433, DOI 10.1890/120089; Mytilus Tyler-Walters H., 2008, MARINE LIFE INFORM N; Neill SP, 2012, RENEW ENERG, V37, P387, DOI 10.1016/j.renene.2011.07.003; Neill SP, 2009, RENEW ENERG, V34, P2803, DOI 10.1016/j.renene.2009.06.015; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; Newell RC, 1999, MAR POLLUT BULL, V38, P809, DOI 10.1016/S0025-326X(99)00045-4; Newell RIE., 1989, 8211102; OKAMURA B, 1986, OECOLOGIA, V69, P341, DOI 10.1007/BF00377054; OLSGARD F, 1993, J EXP MAR BIOL ECOL, V172, P185, DOI 10.1016/0022-0981(93)90097-8; Owen SF, 2001, COMP BIOCHEM PHYS A, V128, P631, DOI 10.1016/S1095-6433(00)00340-8; Pearce T, 2009, J EXP BIOL, V212, P1449, DOI 10.1242/jeb.025551; Pearce T, 2009, J EXP BIOL, V212, P1442, DOI 10.1242/jeb.025544; PRICE HA, 1982, J MAR BIOL ASSOC UK, V62, P147, DOI 10.1017/S0025315400020178; READ KRH, 1967, COMP BIOCHEM PHYSIOL, V22, P149, DOI 10.1016/0010-406X(67)90176-4; Rees I., 2009, ASSESSMENT MODIOLUS; RIISGARD H. U., 2011, J MAR BIOL, DOI [DOI 10.1155/2011/312459, 10.1155/2011/312459]; Roberts D, 2011, MODIOLUS RESTORATION; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Strong JA, 2008, BIOL ENVIRON, V108B, P109, DOI 10.3318/BIOE.2008.108.2.109; Stronkhorst J, 2003, ENVIRON POLLUT, V124, P17, DOI 10.1016/S0269-7491(02)00430-X; Suchanek T.H., 1992, MUSSEL MYTILUS ECOLO, P87; THEEDE H, 1969, MAR BIOL, V2, P325, DOI 10.1007/BF00355712; THEEDE H, 1973, Netherlands Journal of Sea Research, V7, P244, DOI 10.1016/0077-7579(73)90048-3; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Trannum HC, 2010, J EXP MAR BIOL ECOL, V383, P111, DOI 10.1016/j.jembe.2009.12.004; Trembanis A, 2013, GEOCHEM GEOPHY GEOSY, V14, P4334, DOI 10.1002/ggge.20260; Trueman E. R., 1966, Proceedings of the Malacological Society of London, V37, P97; TRUEMAN ER, 1966, J EXP BIOL, V44, P469; Tyler-Walters H, 2007, HORSE MUSSEL MARINE; van Duren LA, 2006, J SEA RES, V55, P3, DOI 10.1016/j.seares.2005.08.001; van Leeuwen B, 2010, ECOL ENG, V36, P145, DOI 10.1016/j.ecoleng.2009.01.002; Walkington I, 2009, APPL OCEAN RES, V31, P239, DOI 10.1016/j.apor.2009.10.007; WANG WX, 1991, MAR ECOL PROG SER, V70, P223, DOI 10.3354/meps070223; Widdows J, 2002, HELGOLAND MAR RES, V56, P3, DOI 10.1007/s10152-001-0100-0; WIDDOWS J, 1989, PHYSIOL ZOOL, V62, P764, DOI 10.1086/physzool.62.3.30157926; Wilber DH, 2007, MAR POLLUT BULL, V54, P42, DOI 10.1016/j.marpolbul.2006.08.042; WITMAN JD, 1984, MAR ECOL PROG SER, V16, P259, DOI 10.3354/meps016259; YOUNG GA, 1985, MAR ECOL PROG SER, V24, P261, DOI 10.3354/meps024261; ZANDEE DI, 1986, NETH J ZOOL, V36, P322; Zardi GI, 2008, MAR BIOL, V153, P853, DOI 10.1007/s00227-007-0857-z; Zardi GI, 2006, MAR BIOL, V148, P1031, DOI 10.1007/s00227-005-0155-6; Zhang W, 2014, ENCY MARINE GEOSCIEN	82	16	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151471	10.1371/journal.pone.0151471	http://dx.doi.org/10.1371/journal.pone.0151471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982582	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900087
J	Ross, DE; Marshall, CW; May, HD; Norman, RS				Ross, Daniel E.; Marshall, Christopher W.; May, Harold D.; Norman, R. Sean			Comparative Genomic Analysis of Sulfurospirillum cavolei MES Reconstructed from the Metagenome of an Electrosynthetic Microbiome	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; SP-NOV.; DEHALOSPIRILLUM-MULTIVORANS; WOLINELLA-SUCCINOGENES; GENE-CLUSTER; SEQUENCE; BACTERIAL; COMMUNITY; PROTEOBACTERIA; IDENTIFICATION	Sulfurospirillum spp. play an important role in sulfur and nitrogen cycling, and contain metabolic versatility that enables reduction of a wide range of electron acceptors, including thiosulfate, tetrathionate, polysulfide, nitrate, and nitrite. Here we describe the assembly of a Sulfurospirillum genome obtained from the metagenome of an electrosynthetic microbiome. The ubiquity and persistence of this organismin microbial electrosynthesis systems suggest it plays an important role in reactor stability and performance. Understanding why this organism is present and elucidating its genetic repertoire provide a genomic and ecological foundation for future studies where Sulfurospirillum are found, especially in electrode-associated communities. Metabolic comparisons and in-depth analysis of unique genes revealed potential ecological niche-specific capabilities within the Sulfurospirillum genus. The functional similarities common to all genomes, i.e., core genome, and unique gene clusters found only in a single genome were identified. Based upon 16S rRNA gene phylogenetic analysis and average nucleotide identity, the Sulfurospirillum draft genome was found to be most closely related to Sulfurospirillum cavolei. Characterization of the draft genome described herein provides pathway-specific details of the metabolic significance of the newly described Sulfurospirillum cavolei MES and, importantly, yields insight to the ecology of the genus as a whole. Comparison of eleven sequenced Sulfurospirillum genomes revealed a total of 6246 gene clusters in the pan-genome. Of the total gene clusters, 18.5% were shared among all eleven genomes and 50% were unique to a single genome. While most Sulfurospirillum spp. reduce nitrate to ammonium, five of the eleven Sulfurospirillum strains encode for a nitrous oxide reductase (nos) cluster with an atypical nitrous-oxide reductase, suggesting a utility for this genus in reduction of the nitrous oxide, and as a potential sink for this potent greenhouse gas.	[Ross, Daniel E.; Norman, R. Sean] Univ S Carolina, Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC 29208 USA; [Marshall, Christopher W.; May, Harold D.] Med Univ S Carolina, Dept Microbiol & Immunol, Marine Biomed & Environm Sci Ctr, Charleston, SC 29425 USA; [Ross, Daniel E.] Natl Energy Technol Lab, Pittsburgh, PA USA; [Marshall, Christopher W.] Argonne Natl Lab, Lemont, IL USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; United States Department of Energy (DOE); National Energy Technology Laboratory - USA; United States Department of Energy (DOE); Argonne National Laboratory	Norman, RS (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC 29208 USA.	rsnorman@mailbox.sc.edu	Norman, Robert/ABC-5029-2021; Ross, Daniel/ABA-1747-2020	Norman, Robert/0000-0003-4766-4376; Marshall, Christopher/0000-0001-6669-3231	U.S. Department of Energy, Advanced Research Project Agency-Energy [DE-AR0000089]	U.S. Department of Energy, Advanced Research Project Agency-Energy(United States Department of Energy (DOE))	Funding was provided by the U.S. Department of Energy, Advanced Research Project Agency-Energy (award DE-AR0000089).; Funding was provided by the U.S. Department of Energy, Advanced Research Project Agency-Energy (award DE-AR0000089). We would like to thank JGI and Barbara Campbell (Clemson University) for permission to utilize the Sulfurospirillum sp. Am-N assembled contigs in our comparative genome analysis. These sequence data were produced by the US Department of Energy Joint Genome Institute (http://www.jgi.doe.gov/) in collaboration with the user community. We would also like to thank the editor and reviewers of the manuscript for the helpful comments.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Betz JN, 2015, BIOCHEMISTRY-US, V54, P1807, DOI 10.1021/bi501205e; Bothe H, 2007, BIOL NITROGEN CYCLE, V427; Buttet GF, 2013, APPL ENVIRON MICROB, V79, P6941, DOI 10.1128/AEM.02312-13; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campbell BJ, 2001, APPL ENVIRON MICROB, V67, P4566, DOI 10.1128/AEM.67.10.4566-4572.2001; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Dell'Acqua S, 2011, J BIOL INORG CHEM, V16, P183, DOI 10.1007/s00775-011-0753-3; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Finster K, 1997, INT J SYST BACTERIOL, V47, P1212, DOI 10.1099/00207713-47-4-1212; Frohlich KU, 2000, FEBS LETT, V473, P6, DOI 10.1016/S0014-5793(00)01474-5; Galardini M, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-11; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Goris T, 2014, ENVIRON MICROBIOL, V16, P3562, DOI 10.1111/1462-2920.12589; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; He JZ, 2006, ENVIRON SCI TECHNOL, V40, P4429, DOI 10.1021/es052508d; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Hino T, 2012, BBA-BIOENERGETICS, V1817, P680, DOI 10.1016/j.bbabio.2011.09.021; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Hubert C, 2007, APPL ENVIRON MICROB, V73, P2644, DOI 10.1128/AEM.02332-06; Jensen A, 2005, ANTON LEEUW INT J G, V87, P339, DOI 10.1007/s10482-004-6839-y; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Ju XF, 2007, ENVIRON MICROBIOL, V9, P1078, DOI 10.1111/j.1462-2920.2006.01199.x; Karnholz A, 2002, APPL ENVIRON MICROB, V68, P1005, DOI 10.1128/AEM.68.2.1005-1009.2002; Kern M, 2007, MICROBIOL-SGM, V153, P3739, DOI 10.1099/mic.0.2007/009928-0; Kodama Y, 2007, INT J SYST EVOL MICR, V57, P827, DOI 10.1099/ijs.0.64823-0; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Konstantinidis KT, 2009, P NATL ACAD SCI USA, V106, P15909, DOI 10.1073/pnas.0902000106; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LaBelle EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109935; LEFAOU A, 1990, FEMS MICROBIOL LETT, V75, P351, DOI 10.1016/S0168-6445(05)80005-1; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lohmayer R, 2014, APPL ENVIRON MICROB, V80, P3141, DOI 10.1128/AEM.04220-13; Lu CL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0381-3; Luijten MLGC, 2003, INT J SYST EVOL MICR, V53, P787, DOI 10.1099/ijs.0.02417-0; Luijten MLGC, 2004, FEMS MICROBIOL ECOL, V49, P145, DOI 10.1016/j.femsec.2004.01.015; Marshall CW, 2013, ENVIRON SCI TECHNOL, V47, P6023, DOI 10.1021/es400341b; Marshall CW, 2012, APPL ENVIRON MICROB, V78, P8412, DOI 10.1128/AEM.02401-12; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; Miura T, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00236-15; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parks DH, 2014, CHECKM ASSESSING QUA; Peters John W., 2009, V6, P179, DOI [10.1039/BK9781847559159-00179, 10.1039/9781847559159-00179]; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rosenbaum MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030827; Ross DE, 2015, GENOME ANNOUNC, V3; Rowland HAL, J ENVIRON QUAL, V38, P1598, DOI [10.2134/jeg2008.0223, DOI 10.2134/JEG2008.0223]; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; SCHOLZMURAMATSU H, 1995, ARCH MICROBIOL, V163, P48, DOI 10.1007/BF00262203; SCHUMACHER W, 1992, ARCH MICROBIOL, V158, P287, DOI 10.1007/BF00245247; Sercu B, 2013, MICROB ECOL, V65, P39, DOI 10.1007/s00248-012-0092-0; Shartau SLC, 2010, APPL ENVIRON MICROB, V76, P4977, DOI 10.1128/AEM.00596-10; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Sikorski J, 2010, STAND GENOMIC SCI, V2, P149, DOI 10.4056/sigs.671209; Simon J, 2004, FEBS LETT, V569, P7, DOI 10.1016/j.febslet.2004.05.060; Simon J, 2003, MOL MICROBIOL, V49, P69, DOI 10.1046/j.1365-2958.2003.03544.x; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stolz JF, 1999, INT J SYST BACTERIOL, V49, P1177, DOI 10.1099/00207713-49-3-1177; Tan B, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01034-14; Tang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033535; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; UEDA Y, 1991, J BIOCHEM, V109, P728, DOI 10.1093/oxfordjournals.jbchem.a123448; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Ye RW, 2001, CURR OPIN MICROBIOL, V4, P307, DOI 10.1016/S1369-5274(00)00208-3; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00110	85	16	16	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151214	10.1371/journal.pone.0151214	http://dx.doi.org/10.1371/journal.pone.0151214			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26983005	Green Submitted, Green Published, gold			2022-12-27	WOS:000372574900069
J	Ruggeri, P; Splendiani, A; Di Muri, C; Fioravanti, T; Santojanni, A; Leonori, I; De Felice, A; Biagiotti, I; Carpi, P; Arneri, E; Cerioni, PN; Giovannotti, M; Barucchi, VC				Ruggeri, Paolo; Splendiani, Andrea; Di Muri, Cristina; Fioravanti, Tatiana; Santojanni, Alberto; Leonori, Iole; De Felice, Andrea; Biagiotti, Ilaria; Carpi, Piera; Arneri, Enrico; Cerioni, Paola Nisi; Giovannotti, Massimo; Barucchi, Vincenzo Caputo			Coupling Demographic and Genetic Variability from Archived Collections of European Anchovy (Engraulis encrasicolus)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; POLYMORPHIC MICROSATELLITE LOCI; SMALL PELAGIC FISH; ALLELE FREQUENCY; SARDINA-PILCHARDUS; RE-IMPLEMENTATION; DNA ISOLATION; ADRIATIC SEA; BOTTLENECK; DIVERSITY	It is well known that temporal fluctuations in small populations deeply influence evolutionary potential. Less well known is whether fluctuations can influence the evolutionary potentials of species with large census sizes. Here, we estimated genetic population parameters from as survey of polymorphic microsatellite DNA loci in archived otoliths from Adriatic European anchovy (Engraulis encrasicolus), a fish with large census sizes that supports numerous local fisheries. Stocks have fluctuated greatly over the past few decades, and the Adriatic fishery collapsed in 1987. Our results show a significant reduction of mean genetic parameters as a consequence of the population collapse. In addition, estimates of effective population size (N-e) are much smaller than those expected in a fishes with large population census sizes (N-c). Estimates of N-e indicate low effective population sizes, even before the population collapse. The ratio N-e/N-e ranged between 10(-6) and 10(-8), indicating a large discrepancy between the anchovy gene pool and population census size. Therefore, anchovy populations may be more vulnerable to fishery effort and environmental change than previously thought.	[Ruggeri, Paolo; Splendiani, Andrea; Di Muri, Cristina; Fioravanti, Tatiana; Cerioni, Paola Nisi; Giovannotti, Massimo; Barucchi, Vincenzo Caputo] Univ Politecn Marche, Dipartimento Sci Vita Ambiente, Via Brecce Bianche, I-60131 Ancona, Italy; [Santojanni, Alberto; Leonori, Iole; De Felice, Andrea; Biagiotti, Ilaria; Carpi, Piera; Barucchi, Vincenzo Caputo] CNR, Ist Scienze Marine, Sez Pesca Marittima, Largo Fiera Pesca, I-60125 Ancona, Italy; [Arneri, Enrico] FAO FIRF, Dept Fisheries & Aquaculture, AdriaMed Project, Viale Terme Caracalla, I-00153 Rome, Italy	Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Barucchi, VC (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita Ambiente, Via Brecce Bianche, I-60131 Ancona, Italy.; Barucchi, VC (corresponding author), CNR, Ist Scienze Marine, Sez Pesca Marittima, Largo Fiera Pesca, I-60125 Ancona, Italy.	v.caputo@univpm.it	Giovannotti, Massimo/AAZ-3563-2020; De+Felice, Andrea/AHA-1500-2022; Leonori, Iole/AAF-6681-2020; De Felice, Andrea/L-9465-2014; Leonori, Iole/AAD-7901-2020; Di Muri, Cristina/ABF-5993-2021; Di Muri, Cristina/GSN-8197-2022; Biagiotti, Ilaria/C-8893-2014	De+Felice, Andrea/0000-0002-0051-2052; Leonori, Iole/0000-0001-7673-1684; De Felice, Andrea/0000-0002-0051-2052; Leonori, Iole/0000-0001-7673-1684; Di Muri, Cristina/0000-0003-4072-0662; Di Muri, Cristina/0000-0003-4072-0662; Biagiotti, Ilaria/0000-0002-5395-6896; Giovannotti, Massimo/0000-0001-7622-3583; NISI CERIONI, Paola/0000-0001-5074-9843; SANTOJANNI, ALBERTO/0000-0003-4947-3004; Ruggeri, Paolo/0000-0002-5433-508X; Carpi, Piera/0000-0002-9306-5385	RITMARE National Flagship Project (Italian Ministry for University and Research) [SP2_WP1_AZ4_UO02]; Universita Politecnica delle Marche (Ancona, Italy)	RITMARE National Flagship Project (Italian Ministry for University and Research); Universita Politecnica delle Marche (Ancona, Italy)	This work was supported by the RITMARE National Flagship Project (Italian Ministry for University and Research) SP2_WP1_AZ4_UO02. Annual funds are provided by Universita Politecnica delle Marche (Ancona, Italy) to Vincenzo Caputo Barucchi.; Special thanks are provided to Stewart Grant, Erik Sotka and two anonymous reviewers who greatly helped us to improve this manuscript and allowed us to tackle the major criticisms and a huge thank you to Tara Baris who helpfully edited an early draft of the manuscript to improve readability. This research was mainly supported by Universita Politecnica delle Marche (Ancona, Italy).	Alheit J, 2014, J MARINE SYST, V131, P21, DOI 10.1016/j.jmarsys.2013.11.002; Allendorf F, 2013, CONSERV GENET, V2nd; Allendorf FW, 2014, MOL ECOL, V23, P23, DOI 10.1111/mec.12574; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Azzali M, 2002, MAR ECOL-P S Z N I, V23, P78, DOI 10.1111/j.1439-0485.2002.tb00009.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Benbouza Halima, 2006, Biotechnologie Agronomie Societe et Environnement, V10, P77; Berthier P, 2002, GENETICS, V160, P741; Bonanomi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15395; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Carpi P, 2015, SCI MAR, V79, P57, DOI 10.3989/scimar.03903.29A; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cuveliers EL, 2011, MOL ECOL, V20, P3555, DOI 10.1111/j.1365-294X.2011.05196.x; Cuveliers EL, 2009, MOL ECOL RESOUR, V9, P725, DOI 10.1111/j.1755-0998.2009.02516.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Falush D, 2003, GENETICS, V164, P1567; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Gaggiotti OE, 1999, CAN J FISH AQUAT SCI, V56, P1376, DOI 10.1139/cjfas-56-8-1376; Ganias K, 2014, REPROD POTENTIAL BIO; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Habel JC, 2014, BIOL REV, V89, P484, DOI 10.1111/brv.12068; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Hoarau G, 2005, P ROY SOC B-BIOL SCI, V272, P497, DOI 10.1098/rspb.2004.2963; Hood G., 2009, POPTOOLS V 3 1 0; Hutchinson WF, 1999, MOL ECOL, V8, P893; Jasper JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081916; Kauer MO, 2003, GENETICS, V165, P1137; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Landi M, 2005, MOL ECOL NOTES, V5, P266, DOI 10.1111/j.1471-8286.2005.00892.x; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Laurent V, 2007, BIOL J LINN SOC, V90, P591, DOI 10.1111/j.1095-8312.2007.00747.x; Leonori I, 2011, DTA06 MAR RES CNR; Leonori I, 2012, ACTA ADRIAT, V53, P389; Lin L, 2011, GENET MOL RES, V10, P764, DOI 10.4238/vol10-2gmr1085; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Marty L, 2015, EVOL APPL, V8, P47, DOI 10.1111/eva.12220; Morello EB, 2009, OCEANOGR MAR BIOL, V47, P209; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nielsen EE, 2008, FISH FISH, V9, P450, DOI 10.1111/j.1467-2979.2008.00304.x; O'Leary SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066126; Pakaki V, 2009, MOL ECOL RESOUR, V9, P1406, DOI 10.1111/j.1755-0998.2009.02681.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; POLLAK E, 1983, GENETICS, V104, P531; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruggeri P, 2012, CAN J FISH AQUAT SCI, V69, P1698, DOI 10.1139/F2012-092; Santojanni A, 2003, SCI MAR, V67, P327, DOI 10.3989/scimar.2003.67n3327; Santojanni A., 2006, Biologia Marina Mediterranea, V13, P98; Santojanni A, 2006, CLIM RES, V31, P181, DOI 10.3354/cr031181; Schaerlaekens DG, 2011, J EXP MAR BIOL ECOL, V398, P56, DOI 10.1016/j.jembe.2010.12.010; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Speller CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051122; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; Van Beveren E, 2014, MAR BIOL, V161, P1809, DOI 10.1007/s00227-014-2463-1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Waples RS, 2007, GENETICS, V175, P219, DOI 10.1534/genetics.106.065300; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	70	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0151507	10.1371/journal.pone.0151507	http://dx.doi.org/10.1371/journal.pone.0151507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982808	gold, Green Submitted, Green Published			2022-12-27	WOS:000372574900089
J	Tayao, M; Andrici, J; Farzin, M; Clarkson, A; Sioson, L; Watson, N; Chua, TC; Sztynda, T; Samra, JS; Gill, AJ				Tayao, Michael; Andrici, Juliana; Farzin, Mahtab; Clarkson, Adele; Sioson, Loretta; Watson, Nicole; Chua, Terence C.; Sztynda, Tamara; Samra, Jaswinder S.; Gill, Anthony J.			Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							EXTRAHEPATIC CHOLANGIOCARCINOMA; MUTATIONS PREDISPOSE; MESOTHELIOMA; IMMUNOHISTOCHEMISTRY; EPIDEMIOLOGY; PERITONEAL; PROTEIN-1; LANDSCAPE; DIAGNOSIS; TUMORS	Background Pancreatic cancer is both common and highly lethal and therefore new biomarkers or potential targets for treatment are needed. Loss of BRCA associated protein-1 (BAP1) expression has been found in up to a quarter of intrahepatic cholangiocarcinomas. Given the close anatomical relationship between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma, we therefore sought to investigate the frequency of loss of BAP1 expression in pancreatic ductal adenocarcinoma. Methods The records of the department of Anatomical Pathology Royal North Shore Hospital, Sydney, Australia, were searched for cases of pancreatic ductal adenocarcinoma diagnosed between 1992 and 2014 with material available in archived formalin fixed paraffin embedded tissue blocks. Immunohistochemistry for BAP1 was performed on tissue microarray sections and if staining was equivocal or negative it was confirmed on whole sections. Negative staining for BAP1 was defined as loss of expression in all neoplastic nuclei, with preserved expression in non-neoplastic cells which acted as an internal positive control. Results Loss of BAP1 expression was found in only 1 of 306 (0.33%) pancreatic ductal adenocarcinomas. This case was confirmed to demonstrate diffuse loss of expression throughout all neoplastic cells in multiple blocks, consistent with BAP1 loss being an early clonal event. All other cases demonstrated positive expression of BAP1. Conclusion We conclude that, in contrast to intrahepatic cholangiocarcinoma, loss of expression of BAP1 occurs very rarely in pancreatic ductal adenocarcinoma. Therefore BAP1 inactivation is unlikely to be a frequent driver abnormality in pancreatic adenocarcinoma.	[Tayao, Michael; Andrici, Juliana; Farzin, Mahtab; Clarkson, Adele; Sioson, Loretta; Watson, Nicole; Gill, Anthony J.] Royal N Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Res Grp, St Leonards, NSW 2065, Australia; [Tayao, Michael; Sztynda, Tamara] Univ Technol Sydney, Sch Life Sci, Ultimo, NSW 2007, Australia; [Andrici, Juliana; Samra, Jaswinder S.; Gill, Anthony J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Andrici, Juliana; Farzin, Mahtab; Clarkson, Adele; Sioson, Loretta; Gill, Anthony J.] Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW 2065, Australia; [Chua, Terence C.; Samra, Jaswinder S.] Royal N Shore Hosp, Dept Gastrointestinal Surg, St Leonards, NSW 2065, Australia; [Chua, Terence C.; Samra, Jaswinder S.] Univ Sydney, Discipline Surg, Sydney, NSW 2006, Australia; [Chua, Terence C.; Samra, Jaswinder S.] Macquarie Univ, Macquarie Univ Hosp, N Ryde, NSW, Australia; [Gill, Anthony J.] Royal N Shore Hosp, Sydney Vital Translat Res Ctr, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Technology Sydney; University of Sydney; Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Macquarie University; Royal North Shore Hospital	Andrici, J (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Res Grp, St Leonards, NSW 2065, Australia.; Andrici, J (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.; Andrici, J (corresponding author), Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW 2065, Australia.	iand7910@uni.sydney.edu.au	Gill, Anthony/D-4215-2015; Gill, Anthony J./M-5015-2019	Gill, Anthony/0000-0002-9447-1967; CHUA, TERENCE/0000-0002-4263-1017	Sydney Vital, Translational Cancer Research, through a Cancer Institute NSW competitive grant	Sydney Vital, Translational Cancer Research, through a Cancer Institute NSW competitive grant	This project was supported by the Sydney Vital, Translational Cancer Research, through a Cancer Institute NSW competitive grant to AJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Andrici J, 2015, LOSS EXPRESSION BAP1; Andrici J, 2016, HUM PATHOL, V51, P9, DOI 10.1016/j.humpath.2015.12.012; Andrici J, 2015, MODERN PATHOL, V28, P1360, DOI 10.1038/modpathol.2015.87; Arzt L, 2014, PATHOL ONCOL RES, V20, P145, DOI 10.1007/s12253-013-9677-2; Battaglia A, 2014, CLIN MED INSIGHTS-ON, V8, P37, DOI 10.4137/CMO.S15239; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Cardinale V, 2010, WORLD J GASTRO ONCOL, V2, P407, DOI 10.4251/wjgo.v2.i11.407; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chang DK, 2014, CURR OPIN GENET DEV, V24, P74, DOI 10.1016/j.gde.2013.12.001; Cigognetti M, 2015, MODERN PATHOL, V28, P1043, DOI 10.1038/modpathol.2015.65; de la Fouchardiere A, 2014, CLIN GENET, V1, P1; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Farzin M, 2015, PATHOLOGY, V47, P302, DOI 10.1097/PAT.0000000000000250; Frampton AE, 2013, FUTURE ONCOL, V9, P31, DOI [10.2217/FON.12.175, 10.2217/fon.12.175]; Giovinazzo F, 2012, SURG ONCOL, V21, pE171, DOI 10.1016/j.suronc.2012.07.004; Gonzalez-Perez A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r106; Graham JS, 2015, CLIN GENET, V88, P213, DOI 10.1111/cge.12536; Haugk B, 2010, HISTOPATHOLOGY, V57, P503, DOI 10.1111/j.1365-2559.2010.03610.x; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Ho TH, 2015, UROL ONCOL, V33, pe9, DOI DOI 10.1016/J.UR0L0NC.2014.10.014; Hwang HC, 2016, AM J SURG PATHOL, V40; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Joseph RW, 2016, J UROLOGY, V195, P180, DOI 10.1016/j.juro.2015.07.113; Khan SA, 2008, HPB, V10, P77, DOI 10.1080/13651820801992641; Koopmans AE, 2014, MODERN PATHOL, V27, P1321, DOI 10.1038/modpathol.2014.43; McGregor SM, 2015, HUM PATHOL, V46, P1670, DOI 10.1016/j.humpath.2015.06.024; Mochel MC, 2015, AM J CLIN PATHOL, V143, P901, DOI 10.1309/AJCPG8LFJC0DHDQT; Murali R, 2013, PATHOLOGY, V45, P116, DOI 10.1097/PAT.0b013e32835d0efb; Pins A, 2015, HUM PATHOL, V46, P239, DOI 10.1016/j.humpath.2014.10.015; Popova T, 2013, AM J HUM GENET, V92, P974, DOI 10.1016/j.ajhg.2013.04.012; Porpodis K, 2013, J THORAC DIS, V5, pS397, DOI 10.3978/j.issn.2072-1439.2013.08.08; Putra J, 2015, EXP MOL PATHOL, V99, P240, DOI 10.1016/j.yexmp.2015.07.005; Reid MD, 2014, AM J CLIN PATHOL, V141, P168, DOI 10.1309/AJCP0FKDP7ENVKEV; Rusch A, 2015, LUNG CANCER, V87, P77, DOI 10.1016/j.lungcan.2014.10.017; Shah AA, 2013, PATHOLOGY, V45, P651, DOI 10.1097/PAT.0000000000000002; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singhi AD, 2016, MODERN PATHOL, V29, P14, DOI 10.1038/modpathol.2015.121; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wiesner T, 2012, AM J SURG PATHOL, V36, P818, DOI 10.1097/PAS.0b013e3182498be5; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Yoshikawa Y, 2012, CANCER SCI, V103, P868, DOI 10.1111/j.1349-7006.2012.02223.x	44	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150338	10.1371/journal.pone.0150338	http://dx.doi.org/10.1371/journal.pone.0150338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1WF	26982343	gold, Green Published, Green Submitted			2022-12-27	WOS:000372574900035
J	Yang, C; Srinivasan, P				Yang, Chao; Srinivasan, Padmini			Life Satisfaction and the Pursuit of Happiness on Twitter	PLOS ONE			English	Article							DEPRESSION; ASSOCIATIONS; HEALTH	Life satisfaction refers to a somewhat stable cognitive assessment of one's own life. Life satisfaction is an important component of subjective well being, the scientific term for happiness. The other component is affect: the balance between the presence of positive and negative emotions in daily life. While affect has been studied using social media datasets (particularly from Twitter), life satisfaction has received little to no attention. Here, we examine trends in posts about life satisfaction from a two-year sample of Twitter data. We apply a surveillance methodology to extract expressions of both satisfaction and dissatisfaction with life. A noteworthy result is that consistent with their definitions trends in life satisfaction posts are immune to external events (political, seasonal etc.) unlike affect trends reported by previous researchers. Comparing users we find differences between satisfied and dissatisfied users in several linguistic, psychosocial and other features. For example the latter post more tweets expressing anger, anxiety, depression, sadness and on death. We also study users who change their status over time from satisfied with life to dissatisfied or vice versa. Noteworthy is that the psychosocial tweet features of users who change from satisfied to dissatisfied are quite different from those who stay satisfied over time. Overall, the observations we make are consistent with intuition and consistent with observations in the social science research. This research contributes to the study of the subjective well being of individuals through social media.	[Yang, Chao; Srinivasan, Padmini] Univ Iowa, Comp Sci, Iowa City, IA USA	University of Iowa	Yang, C (corresponding author), Univ Iowa, Comp Sci, Iowa City, IA USA.	chao.yang.us@gmail.com		Srinivasan, Padmini/0000-0001-8791-403X				Allisio L., 2013, P 1 INT WORKSH EM SE, V1096, P95; [Anonymous], 2015, TWITTER DIGITAL SOCI; Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Argyle M., 2013, PSYCHOL HAPPINESS, DOI [10.4324/9781315812212, DOI 10.4324/9781315812212]; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Bollen J, 2009, P 5 INT AAAI C WEBL; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; De Choudhury Munmun, 2013, AAAI; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; Ferriss AL., 2002, J HAPPINESS STUD, V3, P199; Frank M R, 2013, SCI REPORTS; Greeley A., 2006, TRUTH CONSERVATIVE C, V1, P150; Guney S, 2010, PROCD SOC BEHV, V2, P1210, DOI 10.1016/j.sbspro.2010.03.174; HADAWAY CK, 1978, SOC FORCES, V57, P636, DOI 10.2307/2577686; Hart W., 2011, ART LIVING VIPASSANA; Inglehart, 2010, INT DIFFERENCES WELL, V351, P397, DOI DOI 10.1093/ACPROF:OSO/9780199732739.003.0012; Koivumaa-Honkanen H, 2004, SOC PSYCH PSYCH EPID, V39, P994, DOI 10.1007/s00127-004-0833-6; Kovecses Z., 2008, COLLEGIUM, P131; Kramer ADI, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P287; Kross E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069841; Lee YC, 2013, J HAPPINESS STUD, V14, P571, DOI 10.1007/s10902-012-9343-5; Lewinsohn PM., 1991, SUBJECTIVE WELL BEIN, V21, P141; Lim C, 2010, AM SOCIOL REV, V75, P914, DOI 10.1177/0003122410386686; Mahmud J., 2014, P INT AAAI C WEB SOC, V8; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Palmore Erdman, 1972, J HLTH SOCIAL BEHAV, P68; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pennebaker J. W., 2007, DEV PSYCHOMETRIC PRO; Quercia D., 2012, CSCW 12; Ruiz D. M., 2010, 4 AGREEMENTS PRACTIC; Schwartz H. A, 2013, P 7 INT AAAI C WEBL; Seligman M.E., 2012, FLOURISH VISIONARY N; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Van der Zanden R, 2014, J AFFECT DISORDERS, V160, P10, DOI 10.1016/j.jad.2014.01.005; Wan CK, 1996, J MARRIAGE FAM, V58, P502, DOI 10.2307/353513; Wang D, 2014, KEY ENG MATER, V589-590, P23, DOI 10.4028/www.scientific.net/KEM.589-590.23; Wang N, 2012, VALIDATION FACEBOOKS, P1; Yang Chao, 2014, P 2014 ACM C WEB SCI, P4	40	26	28	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2016	11	3							e0150881	10.1371/journal.pone.0150881	http://dx.doi.org/10.1371/journal.pone.0150881			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1WF	26982323	Green Published, gold			2022-12-27	WOS:000372574900055
J	Ha, H; Kim, GB; Kweon, J; Huh, HK; Lee, SJ; Koo, HJ; Kang, JW; Lim, TH; Kim, DH; Kim, YH; Kim, N; Yang, DH				Ha, Hojin; Kim, Guk Bae; Kweon, Jihoon; Huh, Hyung Kyu; Lee, Sang Joon; Koo, Hyun Jung; Kang, Joon-Won; Lim, Tae-Hwan; Kim, Dae-Hee; Kim, Young-Hak; Kim, Namkug; Yang, Dong Hyun			Turbulent Kinetic Energy Measurement Using Phase Contrast MRI for Estimating the Post-Stenotic Pressure Drop: In Vitro Validation and Clinical Application	PLOS ONE			English	Article							DIRECT NUMERICAL-SIMULATION; BLOOD-FLOW; FLUCTUATING VELOCITIES; AORTIC-STENOSIS; STENOTIC FLOWS; QUANTIFICATION; INTENSITY; GRADIENTS; VALVES	Background Although the measurement of turbulence kinetic energy (TKE) by using magnetic resonance imaging (MRI) has been introduced as an alternative index for quantifying energy loss through the cardiac valve, experimental verification and clinical application of this parameter are still required. Objectives The goal of this study is to verify MRI measurements of TKE by using a phantom stenosis with particle image velocimetry (PIV) as the reference standard. In addition, the feasibility of measuring TKE with MRI is explored. Methods MRI measurements of TKE through a phantom stenosis was performed by using clinical 3T MRI scanner. The MRI measurements were verified experimentally by using PIV as the reference standard. In vivo application of MRI-driven TKE was explored in seven patients with aortic valve disease and one healthy volunteer. Transvalvular gradients measured by MRI and echocardiography were compared. Results MRI and PIV measurements of TKE are consistent for turbulent flow (0.666 < R-2 < 0.738) with a mean difference of -11.13 J/m(3) (SD = 4.34 J/m(3)). Results of MRI and PIV measurements differ by 2.76 +/- 0.82 cm/s (velocity) and -11.13 +/- 4.34 J/m(3) (TKE) for turbulent flow (Re > 400). The turbulence pressure drop correlates strongly with total TKE (R-2 = 0.986). However, in vivo measurements of TKE are not consistent with the transvalvular pressure gradient estimated by echocardiography. Conclusions These results suggest that TKE measurement via MRI may provide a potential benefit as an energy-loss index to characterize blood flow through the aortic valve. However, further clinical studies are necessary to reach definitive conclusions regarding this technique.	[Ha, Hojin] Pohang Univ Sci & Technol, POSTECH Biotech Ctr, Pohang, South Korea; [Kim, Guk Bae] Univ Ulsan, Coll Med, Asan Inst Life Sci, Asan Med Ctr, Seoul, South Korea; [Kweon, Jihoon; Kim, Dae-Hee; Kim, Young-Hak] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea; [Huh, Hyung Kyu; Lee, Sang Joon] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, South Korea; [Koo, Hyun Jung; Kang, Joon-Won; Lim, Tae-Hwan; Kim, Namkug; Yang, Dong Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Namkug] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); University of Ulsan; University of Ulsan; Asan Medical Center; Pohang University of Science & Technology (POSTECH); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Yang, DH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.	donghyun.yang@gmail.com	Lee, Sang Joon/AAG-2448-2019; Kim, Namkug/E-3843-2012	Kim, Namkug/0000-0002-3438-2217; Kim, Dae-Hee/0000-0002-8275-4871; Koo, Hyun Jung/0000-0001-5640-3835; Kweon, Jihoon/0000-0003-1831-7615	National Research Foundation of Korea (NRF); Korean government (MSIP) [NRF-2015R1A2A2A04003034, NRF-2013R1A1A1058711, 2008-0061991]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP)	This work was supported by grants from the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP) (NRF-2015R1A2A2A04003034, NRF-2013R1A1A1058711 and no. 2008-0061991).	Abbas AE, 2015, ECHOCARDIOGR-J CARD, V32, P372, DOI 10.1111/echo.12712; Arzani A, 2012, ANN BIOMED ENG, V40, P860, DOI 10.1007/s10439-011-0447-6; Binter C, 2013, MAGN RESON MED, V69, P1337, DOI 10.1002/mrm.24370; Bock J, 2011, MAGN RESON MED, V66, P1079, DOI 10.1002/mrm.22907; Casas B, 2016, MAGN RESON MED, V75, P1808, DOI 10.1002/mrm.25772; Dyverfeldt P, 2008, J MAGN RESON IMAGING, V28, P655, DOI 10.1002/jmri.21475; Dyverfeldt P, 2006, MAGN RESON MED, V56, P850, DOI 10.1002/mrm.21022; Dyverfeldt P, 2013, JACC-CARDIOVASC IMAG, V6, P64, DOI 10.1016/j.jcmg.2012.07.017; Dyverfeldt P, 2011, J MAGN RESON IMAGING, V33, P582, DOI 10.1002/jmri.22407; Dyverfeldt P, 2009, MAGN RESON IMAGING, V27, P913, DOI 10.1016/j.mri.2009.05.004; Garcia D, 2003, J AM COLL CARDIOL, V41, P435, DOI 10.1016/S0735-1097(02)02764-X; Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765; Ha HJ, 2014, MED ENG PHYS, V36, P1106, DOI 10.1016/j.medengphy.2014.06.004; Ha H, 2014, MED ENG PHYS, V36, P119, DOI 10.1016/j.medengphy.2013.10.008; Knobloch V, 2014, MAGN RESON MED, V71, P1405, DOI 10.1002/mrm.24785; Munson B.R., 1990, FUNDAMENTALS FLUID M; Petersson S, 2015, MAGN RESON MED; Petersson S, 2010, MAGN RESON MED, V64, P1039, DOI 10.1002/mrm.22494; STAMM RB, 1983, J AM COLL CARDIOL, V2, P707, DOI 10.1016/S0735-1097(83)80311-8; STEIN PD, 1976, CIRC RES, V39, P58, DOI 10.1161/01.RES.39.1.58; Varghese SS, 2007, J FLUID MECH, V582, P253, DOI 10.1017/S0022112007005848; Varghese SS, 2007, J FLUID MECH, V582, P281, DOI 10.1017/S0022112007005836; Vetel J, 2008, J FLUID MECH, V607, P351, DOI 10.1017/S0022112008002188; Vitarelli A, 2002, AM J MED, V113, P127, DOI 10.1016/S0002-9343(02)01157-9	24	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151540	10.1371/journal.pone.0151540	http://dx.doi.org/10.1371/journal.pone.0151540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	26978529	Green Published, gold, Green Submitted			2022-12-27	WOS:000372572800085
J	Tiainen, M; Tiippana, K; Vainio, M; Peromaa, T; Komeilipoor, N; Vainio, L				Tiainen, Mikko; Tiippana, Kaisa; Vainio, Martti; Peromaa, Tarja; Komeilipoor, Naeem; Vainio, Lari			Selective Influences of Precision and Power Grips on Speech Categorization	PLOS ONE			English	Article							PERCEPTION; GRASP; LANGUAGE; MOUTH	Recent studies have shown that articulatory gestures are systematically associated with specific manual grip actions. Here we show that executing such actions can influence performance on a speech-categorization task. Participants watched and/or listened to speech stimuli while executing either a power or a precision grip. Grip performance influenced the syllable categorization by increasing the proportion of responses of the syllable congruent with the executed grip (power grip-[ke] and precision grip-[te]). Two follow-up experiments indicated that the effect was based on action-induced bias in selecting the syllable.	[Tiainen, Mikko; Tiippana, Kaisa; Peromaa, Tarja; Komeilipoor, Naeem; Vainio, Lari] Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland; [Vainio, Martti] Univ Helsinki, Inst Behav Sci, Phonet & Speech Synth Res Grp, Helsinki, Finland	University of Helsinki; University of Helsinki	Tiainen, M (corresponding author), Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland.	mikko.o.tiainen@helsinki.fi	Tiippana, Kaisa/AFQ-7636-2022	Tiippana, Kaisa/0000-0002-2305-8104; Peromaa, Tarja/0000-0001-6290-111X; Vainio, Martti/0000-0003-2570-0196; Tiainen, Mikko/0000-0003-3245-9337; Vainio, Lari/0000-0001-7754-9745	Academy of Finland [1265610]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (http://www.aka.fi/) under Grant 1265610, reveived by MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; D'Ausilio A, 2012, CORTEX, V48, P882, DOI 10.1016/j.cortex.2011.05.017; Daar M, 2008, CORTEX, V44, P400, DOI 10.1016/j.cortex.2007.12.003; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Gentilucci M, 2004, EUR J NEUROSCI, V19, P190, DOI 10.1111/j.1460-9568.2004.03104.x; Gentilucci M, 2003, EUR J NEUROSCI, V17, P179, DOI 10.1046/j.1460-9568.2003.02438.x; Gentilucci M, 2001, J NEUROPHYSIOL, V86, P1685, DOI 10.1152/jn.2001.86.4.1685; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Green DM, 1966, SIGNAL DETECTION THE; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Loetscher T, 2010, CURR BIOL, V20, pR264, DOI 10.1016/j.cub.2010.01.015; Macmillan N. A., 1991, DETECTION THEORY USE; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Mochida T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068619; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Sams M, 2005, COGNITIVE BRAIN RES, V23, P429, DOI 10.1016/j.cogbrainres.2004.11.006; Sato M, 2013, EXP BRAIN RES, V227, P275, DOI 10.1007/s00221-013-3510-8; Smalle EHM, 2015, CEREB CORTEX, V25, P3690, DOI 10.1093/cercor/bhu218; Symes E, 2008, J EXP PSYCHOL HUMAN, V34, P854, DOI 10.1037/0096-1523.34.4.854; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Vainio L, 2014, EXP BRAIN RES, V232, P2359, DOI 10.1007/s00221-014-3932-y; Vainio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053061; Witt JK, 2015, PERCEPTION, V44, P289, DOI 10.1068/p7908	29	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0151688	10.1371/journal.pone.0151688	http://dx.doi.org/10.1371/journal.pone.0151688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1VK	26978074	Green Published, gold			2022-12-27	WOS:000372572800099
J	Turowski, V; Sperling, B; Hanczaruk, MA; Gobel, TW; Viertlboeck, BC				Turowski, Vanessa; Sperling, Beatrice; Hanczaruk, Matthias A.; Goebel, Thomas W.; Viertlboeck, Birgit C.			Chicken TREM-B1, an Inhibitory Ig-Like Receptor Expressed on Chicken Thrombocytes	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; IMMUNE-RESPONSES; MULTIGENE FAMILY; COMPLEX ENCODES; B-LYMPHOCYTES; CUTTING EDGE; FC-RECEPTOR; NK CELLS; T-CELLS; TRANSCRIPT-1	Triggering receptors expressed on myeloid cells (TREM) form a multigene family of immunoregulatory Ig-like receptors and play important roles in the regulation of innate and adaptive immunity. In chickens, three members of the TREM family have been identified on chromosome 26. One of them is TREM-B1 which possesses two V-set Ig-domains, an uncharged transmembrane region and a long cytoplasmic tail with one ITSM and two ITIMs indicating an inhibitory function. We generated specific monoclonal antibodies by immunizing a Balb/c mouse with a TREM-B1-FLAG transfected BWZ.36 cell line and tested the hybridoma supernatants on TREM-B1-FLAG transfected 2D8 cells. We obtained two different antibodies specific for TREM-B1, mab 7E8 (mouse IgG1) and mab 1E9 (mouse IgG2a) which were used for cell surface staining. Single and double staining of different tissues, including whole blood preparations, revealed expression on thrombocytes. Next we investigated the biochemical properties of TREM-B1 by using the specific mab 1E9 for immunoprecipitation of either lysates of surface biotinylated peripheral blood cells or stably transfected 2D8 cells. Staining with streptavidin coupled horse radish peroxidase revealed a glycosylated monomeric protein of about 50 kDa. Furthermore we used the stably transfected 2D8 cell line for analyzing the cytoplasmic tyrosine based signaling motifs. After pervanadate treatment, we detected phosphorylation of the tyrosine residues and subsequent recruitment of the tyrosine specific protein phosphatase SHP-2, indicating an inhibitory potential for TREM-B1. We also showed the inhibitory effect of TREM-B1 in chicken thrombocytes using a CD107 degranulation assay. Crosslinking of TREM-B1 on activated primary thrombocytes resulted in decreased CD107 surface expression of about 50-70%.	[Turowski, Vanessa; Sperling, Beatrice; Hanczaruk, Matthias A.; Goebel, Thomas W.; Viertlboeck, Birgit C.] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Hanczaruk, Matthias A.] Bundeswehr Inst Microbiol, Munich, Germany	University of Munich; Bundeswehr Institute of Microbiology (IMB)	Viertlboeck, BC (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	Birgit.Viertlboeck@lmu.de			Deutsche Forschungsgemeinschaft (DFG) [VI459/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grant VI459/2-2 www.dfg.de to BCV.	Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; Arnon TI, 2008, J MOL BIOL, V381, P1012, DOI 10.1016/j.jmb.2008.06.082; Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; CHEN CLH, 1986, J EXP MED, V164, P375, DOI 10.1084/jem.164.1.375; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Dennis G, 2000, P NATL ACAD SCI USA, V97, P13245, DOI 10.1073/pnas.230442897; Derive M, 2012, J IMMUNOL, V188, P5585, DOI 10.4049/jimmunol.1102674; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gattis JL, 2006, J BIOL CHEM, V281, P13396, DOI 10.1074/jbc.M600489200; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Jansen CA, 2010, DEV COMP IMMUNOL, V34, P759, DOI 10.1016/j.dci.2010.02.009; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KASPERS B, 1993, VET IMMUNOL IMMUNOP, V36, P333, DOI 10.1016/0165-2427(93)90029-4; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Laun K, 2006, PLOS GENET, V2, P707, DOI 10.1371/journal.pgen.0020073; Lu YT, 2006, HYBRIDOMA, V25, P20, DOI 10.1089/hyb.2006.25.20; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Neulen ML, 2015, DEV COMP IMMUNOL, V49, P72, DOI 10.1016/j.dci.2014.11.012; Neulen ML, 2012, IMMUNOGENETICS, V64, P389, DOI 10.1007/s00251-011-0591-z; PECK R, 1982, J IMMUNOL, V129, P4; Puehler F, 2003, J IMMUNOL METHODS, V274, P229, DOI 10.1016/S0022-1759(02)00515-X; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rothwell CJ, 1996, VET IMMUNOL IMMUNOP, V55, P225, DOI 10.1016/S0165-2427(96)05635-8; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Seliger C, 2012, VET IMMUNOL IMMUNOP, V145, P86, DOI 10.1016/j.vetimm.2011.10.010; Sperling B, 2015, DEV COMP IMMUNOL, V50, P121, DOI 10.1016/j.dci.2015.02.004; St Paul M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043381; Straub C, 2014, DEV COMP IMMUNOL, V42, P159, DOI 10.1016/j.dci.2013.09.007; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; Viertboeck BC, 2009, J IMMUNOL, V182, P1533, DOI 10.4049/jimmunol.182.3.1533; Viertlboeck BC, 2007, VET IMMUNOL IMMUNOP, V119, P137, DOI 10.1016/j.vetimm.2007.06.017; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Viertlboeck BC, 2004, J IMMUNOL, V173, P7385, DOI 10.4049/jimmunol.173.12.7385; Viertlboeck BC, 2006, IMMUNOGENETICS, V58, P180, DOI 10.1007/s00251-006-0091-8; Viertlboeck BC, 2008, MOL IMMUNOL, V45, P2097, DOI 10.1016/j.molimm.2007.10.012; Viertlboeck BC, 2008, MOL IMMUNOL, V45, P1398, DOI 10.1016/j.molimm.2007.08.024; Viertlboeck BC, 2007, P NATL ACAD SCI USA, V104, P11718, DOI 10.1073/pnas.0702011104; Viertlboeck BC, 2013, DEV COMP IMMUNOL, V41, P403, DOI 10.1016/j.dci.2013.04.017; Viertlboeck BC, 2011, VET IMMUNOL IMMUNOP, V144, P1, DOI 10.1016/j.vetimm.2011.07.001; Viertlboeck BC, 2010, DEV COMP IMMUNOL, V34, P866, DOI 10.1016/j.dci.2010.03.007; Viertlboeck BC, 2009, J IMMUNOL, V182, P6985, DOI 10.4049/jimmunol.0803060; Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175; Washington AV, 2004, BLOOD, V104, P1042, DOI 10.1182/blood-2004-01-0315; Washington AV, 2002, BLOOD, V100, P3822, DOI 10.1182/blood-2002-02-0523; YAMADA E, 2008, CURR PROTOC IMMUNOL, pCH1; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Zechmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081942; Zhu YW, 2011, IMMUNITY, V34, P466, DOI 10.1016/j.immuni.2011.04.008	56	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151513	10.1371/journal.pone.0151513	http://dx.doi.org/10.1371/journal.pone.0151513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	26967520	Green Published, Green Submitted, gold			2022-12-27	WOS:000371989200060
J	Li, LG; Vogel, J; He, ZL; Zou, XM; Ruan, HH; Huang, W; Wang, JS; Bianchi, TS				Li, Liguang; Vogel, Jason; He, Zhenli; Zou, Xiaoming; Ruan, Honghua; Huang, Wei; Wang, Jiashe; Bianchi, Thomas S.			Association of Soil Aggregation with the Distribution and Quality of Organic Carbon in Soil along an Elevation Gradient on Wuyi Mountain in China	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; SEASONAL-VARIATION; MICROBIAL BIOMASS; ALTITUDE GRADIENT; DENSITY FRACTIONS; CLIMATE-CHANGE; MATTER; STORAGE; FOREST; DECOMPOSITION	Forest soils play a critical role in the sequestration of atmospheric CO2 and subsequent attenuation of global warming. The nature and properties of organic matter in soils have an influence on the sequestration of carbon. In this study, soils were collected from representative forestlands, including a subtropical evergreen broad-leaved forest (EBF), a coniferous forest (CF), a subalpine dwarf forest (DF), and alpine meadow (AM) along an elevation gradient on Wuyi Mountain, which is located in a subtropical area of southeastern China. These soil samples were analyzed in the laboratory to examine the distribution and speciation of organic carbon (OC) within different size fractions of water-stable soil aggregates, and subsequently to determine effects on carbon sequestration. Soil aggregation rate increased with increasing elevation. Soil aggregation rate, rather than soil temperature, moisture or clay content, showed the strongest correlation with OC in bulk soil, indicating soil structure was the critical factor in carbon sequestration of Wuyi Mountain. The content of coarse particulate organic matter fraction, rather than the silt and clay particles, represented OC stock in bulk soil and different soil aggregate fractions. With increasing soil aggregation rate, more carbon was accumulated within the macroaggregates, particularly within the coarse particulate organic matter fraction (250-2000 mu m), rather than within the microaggregates (53-250 mu m) or silt and clay particles (<53 mu m). In consideration of the high instability of macroaggregates and the liability of SOC within them, further research is needed to verify whether highly-aggregated soils at higher altitudes are more likely to lose SOC under warmer conditions.	[Li, Liguang; Zou, Xiaoming; Ruan, Honghua] Nanjing Forestry Univ, Coll Biol & Environm, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing 210037, Jiangsu, Peoples R China; [Li, Liguang; He, Zhenli] Univ Florida, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL 34945 USA; [Vogel, Jason] Texas A&M Univ, Dept Ecosyst Sci & Management, 2126 TAMU, College Stn, TX 77843 USA; [Zou, Xiaoming; Huang, Wei] Univ Puerto Rico, Inst Trop Ecosyst Studies, POB 70377, San Juan, PR 00936 USA; [Wang, Jiashe] Adm Bur Wuyishan Natl Nat Reserve, Wuyishan 354300, Fujian, Peoples R China; [Bianchi, Thomas S.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	Nanjing Forestry University; State University System of Florida; University of Florida; Texas A&M University System; Texas A&M University College Station; University of Puerto Rico; University of Puerto Rico Rio Piedras; State University System of Florida; University of Florida	Ruan, HH (corresponding author), Nanjing Forestry Univ, Coll Biol & Environm, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing 210037, Jiangsu, Peoples R China.	hhruan@njfu.edu.cn	Bianchi, Thomas S/L-4060-2014; Zou, Xiaoming/GWV-5608-2022; He, Zhenli/A-4773-2008; He, Zhenli/R-1494-2016; Li, Liguang/Q-2916-2019	Bianchi, Thomas S/0000-0002-3068-2933; Zou, Xiaoming/0000-0001-9023-3067; 	National Basic Research Program of China (973 Program) [2012CB416904]; National Natural Science Foundation of China [31170417]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was funded by the National Basic Research Program of China (973 Program, 2012CB416904), http://www.973.gov.cn/English/AreaList.aspx, to H.H.R.; the National Natural Science Foundation of China (No. 31170417), http://www.nsfc.gov.cn/, to H.H.R.; and the Priority Academic Program Development of Jiangsu Higher Education Institutions, to H.H.R.	Angers DA, 1997, EUR J SOIL SCI, V48, P295, DOI 10.1111/j.1365-2389.1997.tb00549.x; Bachmann J, 2008, J PLANT NUTR SOIL SC, V171, P14, DOI 10.1002/jpln.200700054; BIRDSEY RA, 1993, FOREST ECOL MANAG, V58, P33, DOI 10.1016/0378-1127(93)90129-B; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Bu XL, 2012, APPL SOIL ECOL, V52, P42, DOI 10.1016/j.apsoil.2011.10.005; Bu XL, 2011, EUR J SOIL BIOL, V47, P102, DOI 10.1016/j.ejsobi.2010.11.009; Bu XL, 2010, GEODERMA, V159, P139, DOI 10.1016/j.geoderma.2010.07.005; Chen JF, 2000, CHINESE J SOIL SCI, V31, P97; Chenu C, 2006, EUR J SOIL SCI, V57, P596, DOI 10.1111/j.1365-2389.2006.00834.x; CHRISTENSEN BT, 1985, ACTA AGR SCAND, V35, P175, DOI 10.1080/00015128509435773; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Djukic I, 2010, J PLANT NUTR SOIL SC, V173, P30, DOI 10.1002/jpln.200900027; Garten CT, 2006, GEODERMA, V136, P342, DOI 10.1016/j.geoderma.2006.03.049; Garten CT, 2011, GEODERMA, V167-68, P30, DOI 10.1016/j.geoderma.2011.08.007; GOLCHIN J, 1994, P HAZ WAST REMED, P187; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Gregorich EG, 2006, SOIL SCI SOC AM J, V70, P975, DOI 10.2136/sssaj2005.0116; Gregorich EG, 2003, GEODERMA, V113, P237, DOI 10.1016/S0016-7061(02)00363-4; Griffiths RP, 2009, FOREST ECOL MANAG, V257, P1, DOI 10.1016/j.foreco.2008.08.010; Gruneberg E, 2013, FOREST ECOL MANAG, V303, P1, DOI 10.1016/j.foreco.2013.03.014; Gupta VVSR, 2015, SOIL BIOL BIOCHEM, V80, pA3, DOI 10.1016/j.soilbio.2014.09.002; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; He JY, 1994, NATURAL RESOURCE SER, P39; He Rong, 2009, Shengtaixue Zazhi, V28, P394; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; Mao DH, 2015, BIOGEOSCIENCES, V12, P1635, DOI 10.5194/bg-12-1635-2015; Plante AF, 2011, SOIL BIOL BIOCHEM, V43, P1051, DOI 10.1016/j.soilbio.2011.01.024; Pulleman MM, 2005, EUR J SOIL SCI, V56, P453, DOI 10.1111/j.1365-2389.2004.00696.x; Rasmussen C, 2005, SOIL SCI SOC AM J, V69, P1711, DOI 10.2136/sssaj2005.0040; Schwendenmann L, 2006, PLANT SOIL, V288, P217, DOI 10.1007/s11104-006-9109-0; Shi Zheng, 2008, Yingyong Shengtai Xuebao, V19, P2357; Shrestha BM, 2007, SOIL SCI SOC AM J, V71, P1194, DOI 10.2136/sssaj2006.0405; Singh S, 1996, BIOL FERT SOILS, V22, P76, DOI 10.1007/BF00384436; Six J, 2002, SOIL SCI SOC AM J, V66, P1981, DOI 10.2136/sssaj2002.1981; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Six J, 2000, SOIL SCI SOC AM J, V64, P1042, DOI 10.2136/sssaj2000.6431042x; Smith P, 2008, ADV AGRON, V97, P1, DOI 10.1016/S0065-2113(07)00001-6; Smith R, 2015, AGR ECOSYST ENVIRON, V201, P92, DOI 10.1016/j.agee.2014.12.002; Spielvogel S, 2008, EUR J SOIL SCI, V59, P674, DOI 10.1111/j.1365-2389.2008.01030.x; Steffens M, 2009, EUR J SOIL SCI, V60, P198, DOI 10.1111/j.1365-2389.2008.01104.x; Virto I, 2008, GEODERMA, V146, P326, DOI 10.1016/j.geoderma.2008.05.021; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; Wan J, 2007, GEOCHIM COSMOCHIM AC, V71, P5439, DOI 10.1016/j.gca.2007.07.030; Wang SJ, 2010, ECOL RES, V25, P1113, DOI 10.1007/s11284-010-0736-9; Wang SJ, 2009, SOIL BIOL BIOCHEM, V41, P891, DOI 10.1016/j.soilbio.2008.12.016; Wiesmeier M, 2015, GLOBAL CHANGE BIOL, V21, P3836, DOI 10.1111/gcb.12957; Xie XL, 2004, PEDOSPHERE, V14, P491; Xu Xia, 2008, Yingyong Shengtai Xuebao, V19, P539; Zhou Xiao-yu, 2010, Yingyong Shengtai Xuebao, V21, P1867	50	107	117	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2016	11	3							e0150898	10.1371/journal.pone.0150898	http://dx.doi.org/10.1371/journal.pone.0150898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3TL	26751695	Green Published, Green Submitted, gold			2022-12-27	WOS:000371993000074
J	Kunutsor, SK; Whitehouse, MR; Blom, AW; Beswick, AD				Kunutsor, Setor K.; Whitehouse, Michael R.; Blom, Ashley W.; Beswick, Andrew D.		INFORM Team	Patient-Related Risk Factors for Periprosthetic Joint Infection after Total Joint Arthroplasty: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SURGICAL SITE INFECTION; TOTAL KNEE ARTHROPLASTY; REVISION TOTAL KNEE; TOTAL HIP; CARDIOVASCULAR-DISEASE; FINANCIAL ANALYSIS; ECONOMIC BURDEN; DEEP INFECTION; REPLACEMENT; PREVENTION	Background Periprosthetic joint infections (PJIs) are dreaded complications of total joint arthroplasties. The risk of developing PJIs is likely to be influenced by several patient factors such as sociodemographic characteristics, body mass index (BMI), and medical and surgical histories. However, the nature and magnitude of the long-term longitudinal associations between these patient-related factors and risk of developing PJIs are uncertain. Objective To conduct a systematic review and meta-analysis to assess the associations between several patient-related factors and PJI. Data Sources MEDLINE, EMBASE, Web of Science, Cochrane Library, and reference lists of relevant studies from inception to September 2015. Study Selection Longitudinal studies with at least one-year of follow-up for PJIs after total joint arthroplasty. Data Extraction and Synthesis Two investigators extracted data on study characteristics, methods, and outcomes. A consensus was reached with involvement of a third. The relative risk (RR) with 95% confidence intervals was used as the summary measure of association across studies. Study-specific RRs with 95% confidence intervals were meta-analysed using random effect models and were grouped by study-level characteristics. Results Sixty-six observational (23 prospective cohort and 43 retrospective cohort or case-control) studies with data on 512,508 participants were included. Comparing males to females and smokers to non-smokers, the pooled RRs for PJI were 1.36 (1.18-1.57) and 1.83 (1.24-2.70) respectively. There was no evidence of any significant associations of PJI with age and high alcohol intake. Comparing BMI >= 30 versus < 30 kg/m(2); >= 35 versus < 35 kg/m(2); and >= 40 versus < 40 kg/m(2); the pooled RRs were 1.60 (1.29-1.99); 1.53 (1.22-1.92); and 3.68 (2.25-6.01) respectively. Histories of diabetes, rheumatoid arthritis, depression, steroid use, and previous joint surgery were also associated with increased risk of PJI. The results remained similar when grouped by relevant study level characteristics. Conclusions Several potentially modifiable patient-related factors are associated with the risk of developing PJIs. Identifying patients with these risk factors who are due to have arthroplasty surgery and modulating these risk factors might be essential in reducing the incidence of PJI. Further research is however warranted to assess the potential clinical utility of these risk factors as risk assessment tools for PJI.	[Kunutsor, Setor K.; Whitehouse, Michael R.; Blom, Ashley W.; Beswick, Andrew D.; INFORM Team] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Southmead Hosp, Learning & Res Bldg,Level 1,Southmead Rd, Bristol BS10 5NB, Avon, England	Southmead Hospital; University of Bristol	Kunutsor, SK (corresponding author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Southmead Hosp, Learning & Res Bldg,Level 1,Southmead Rd, Bristol BS10 5NB, Avon, England.	skk31@cantab.net	Kunutsor, Setor K/H-9807-2019; Whitehouse, Michael/AAR-3898-2020	Kunutsor, Setor K/0000-0002-2625-0273; Whitehouse, Michael/0000-0003-2436-9024; MacGowan, Alasdair/0000-0002-6720-5268; Garfield, Kirsty/0000-0002-8301-3602; Gooberman-Hill, Rachael/0000-0003-3353-2882; Beswick, Andrew/0000-0002-7032-7514; Blom, Ashley/0000-0002-9940-1095; Lenguerrand, Erik/0000-0002-0371-731X; Noble, Sian/0000-0002-8011-0722	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research program [RP-PG-1210-12005]; National Institute for Health Research [NF-SI-0515-10048, RP-PG-1210-12005, CL-2010-25-006] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research program(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research program (RP-PG-1210-12005). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AE, 2010, AM J INFECT CONTROL, V38, P711, DOI 10.1016/j.ajic.2010.03.017; Baek SH, 2014, WORLD J ORTHOP, V5, P362, DOI 10.5312/wjo.v5.i3.362; Berbari EF, 2012, INFECT CONT HOSP EP, V33, P774, DOI 10.1086/666641; Berry DJ, 2002, J BONE JOINT SURG AM, V84A, P171, DOI 10.2106/00004623-200202000-00002; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P570, DOI 10.2106/JBJS.D.02121; Cahill J L, 2008, J Orthop Surg (Hong Kong), V16, P58; Chen J, 2013, ARCH ORTHOP TRAUM SU, V133, P675, DOI 10.1007/s00402-013-1723-8; Chene G, 1996, AM J EPIDEMIOL, V144, P610; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dowsey MM, 2009, CLIN ORTHOP RELAT R, V467, P1577, DOI 10.1007/s11999-008-0551-6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evangelista V, 2005, THROMB HAEMOSTASIS, V93, P8, DOI 10.1160/TH04-07-0453; Fortin PR, 1999, ARTHRITIS RHEUM, V42, P1722, DOI 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-R; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; HUNTER G, 1977, J BONE JOINT SURG BR, V59, P293, DOI 10.1302/0301-620X.59B3.893507; Kallala RF, 2015, BONE JOINT J, V97B, P197, DOI 10.1302/0301-620X.97B2.33707; Kapadia BH, 2016, LANCET, V387, P386, DOI 10.1016/S0140-6736(14)61798-0; Kerkhoffs GMMJ, 2012, J BONE JOINT SURG AM, V94A, P1839, DOI 10.2106/JBJS.K.00820; Kunutsor SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139166; Kunutsor SK, 2015, INT J CANCER, V136, P1162, DOI 10.1002/ijc.29084; Kunutsor SK, 2014, ATHEROSCLEROSIS, V236, P7, DOI 10.1016/j.atherosclerosis.2014.06.006; Kunutsor SK, 2015, EUR J EPIDEMIOL, V30, P599, DOI 10.1007/s10654-015-0058-x; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5; Kwong LM, 2012, EXPERT OPIN PHARMACO, V13, P333, DOI 10.1517/14656566.2012.652087; Liabaud B, 2013, J ARTHROPLASTY, V28, P563, DOI 10.1016/j.arth.2012.07.037; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moon HK, 2008, YONSEI MED J, V49, P129, DOI 10.3349/ymj.2008.49.1.129; Oduwole KO, 2010, KNEE SURG SPORT TR A, V18, P945, DOI 10.1007/s00167-010-1074-8; Ong KL, 2006, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.blo.0000214439.95268.59; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P3022, DOI 10.1007/s11999-011-1971-2; Patel A, 2015, BONE JOINT J, V97B, P1076, DOI 10.1302/0301-620X.97B8.35170; Peersman G, 2001, CLIN ORTHOP RELAT R, P15, DOI 10.1097/00003086-200111000-00003; Ravi B, 2014, ARTHRITIS RHEUMATOL, V66, P254, DOI 10.1002/art.38231; Reusch JEB, 2003, J CLIN INVEST, V112, P986, DOI 10.1172/JCI200319902; Ritter MA, 1995, J ARTHROPLASTY, V10, P737, DOI 10.1016/S0883-5403(05)80068-3; Seneviratne CJ, 2013, ARCH ORAL BIOL, V58, P1327, DOI 10.1016/j.archoralbio.2013.06.017; SILVERSTEIN P, 1992, AM J MED, V93, pS22, DOI 10.1016/0002-9343(92)90623-J; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Soderman P, 2000, ACTA ORTHOP SCAND, V71, P354, DOI 10.1080/000164700317393330; Sorensen LT, 2012, ARCH SURG-CHICAGO, V147, P373, DOI 10.1001/archsurg.2012.5; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Toma O, 2011, ANESTH ANALG, V113, P730, DOI 10.1213/ANE.0b013e31821fff74; Tsang STJ, 2013, BONE JOINT J, V95B, P1474, DOI 10.1302/0301-620X.95B11.31716; Vanhegan IS, 2012, J BONE JOINT SURG BR, V94B, P619, DOI 10.1302/0301-620X.94B5.27073; Wells G.A., NEWCASTLE OTTAWA SCA; Yuan K, 2013, INT J SURG, V11, P383, DOI 10.1016/j.ijsu.2013.02.018; Zhou XD, 2015, GENE, V563, P76, DOI 10.1016/j.gene.2015.03.005; Zhu Y, 2015, J HOSP INFECT, V89, P82, DOI 10.1016/j.jhin.2014.10.008	54	286	303	8	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2016	11	3							e0150866	10.1371/journal.pone.0150866	http://dx.doi.org/10.1371/journal.pone.0150866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0EB	26938768	Green Submitted, gold, Green Published			2022-12-27	WOS:000371735200152
J	Wang, C; Lin, X; Li, L; Lin, SJ				Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie			Differential Growth Responses of Marine Phytoplankton to Herbicide Glyphosate	PLOS ONE			English	Article							DISSOLVED ORGANIC PHOSPHORUS; TRANSPORTER GENE PHND; FRESH-WATER POND; PSEUDOMONAS SP; ACUTE TOXICITY; ROUNDUP; LIMITATION; COMMUNITY; IMPACT; DEGRADATION	Glyphosate is a globally popular herbicide to kill weeds and its wide applications may lead to accumulation in coastal oceans as a source of phosphorus (P) nutrient or growth inhibitor of phytoplankton. We studied the physiological effects of glyphosate on fourteen species representing five major coastal phytoplankton phyla (haptophyta, bacillariophyta, dinoflagellata, raphidophyta, and chlorophyta). Based on growth responses to different concentrations of glyphosate under contrasting dissolved inorganic phosphorus (DIP) conditions, we found that phytoplankton species could be classified into five groups. Group I (Emiliania huxleyi, Skeletonema costatum, Phaeodactylum tricornutum) could utilize glyphosate as sole P-source to support growth in axenic culture, but in the presence of DIP, they were inhibited by both 36-mu M and 360-mu M glyphosate. Group II (Karenia mikimotoi, Prorocentrum minimum, Dunaliella tertiolecta, Symbiodinium sp., Heterosigma akashiwo and Alexandrium catenella) could not utilize glyphosate as sole P-source to support growth, and in the presence of DIP growth was not affected by 36-mu M but inhibited by 360-mu M glyphosate. Glyphosate consistently enhanced growth of Group III (Isochrysis galbana) and inhibited Group IV (Thalassiosira weissflogii, Thalassiosira pseudonana and Chattonella marina) regardless of DIP condition. Group V (Amphidinium carterae) exhibited no measurable response to glyphosate regardless of DIP condition. This grouping is not congruent with the phylogenetic relationships of the phytoplankton species suggesting functional differentiation driven by environmental pressure. We conclude that glyphosate could be used as P-source by some species while is toxic to some other species and yet has no effects on others. The observed differential effects suggest that the continued use of glyphosate and increasing concentration of this herbicide in the coastal waters will likely exert significant impact on coastal marine phytoplankton community structure.	[Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, Coll Ocean & Marine Biodivers, Xiamen, Fujian, Peoples R China; [Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, Global Change Res Ctr, Xiamen, Fujian, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Xiamen University; Xiamen University; Xiamen University; University of Connecticut	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Xiamen Univ, Coll Ocean & Marine Biodivers, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Xiamen Univ, Global Change Res Ctr, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016	CHEN, SHYR-CHYR/0000-0002-5858-3013; LIU, KAO-LANG/0000-0003-4100-8909; WANG, CHIH-HUNG/0000-0003-0802-7825; WU, YAO-MING/0000-0002-1720-7863; YANG, JUSTIN CHENG-TA/0000-0001-8256-2477; LIEN, WAN-CHING/0000-0001-9448-5093	National Natural Science Foundation of China (NSFC) [41176091, 41330959]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC), 41176091 and 41330959. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1978, CAN J BOT, V56, P2196, DOI 10.1139/b78-263; Annett R, 2014, J APPL TOXICOL, V34, P458, DOI 10.1002/jat.2997; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arunakumara K. K. I. U., 2013, African Journal of Microbiology Research, V7, P4084; Baylis AD, 2000, PEST MANAG SCI, V56, P299, DOI 10.1002/(SICI)1526-4998(200004)56:4<299::AID-PS144>3.0.CO;2-K; BERNER T, 1989, J PHYCOL, V25, P70, DOI 10.1111/j.0022-3646.1989.00070.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BOWMER KH, 1982, PESTIC SCI, V13, P623, DOI 10.1002/ps.2780130609; Busse MD, 2001, SOIL BIOL BIOCHEM, V33, P1777, DOI 10.1016/S0038-0717(01)00103-1; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; DICK RE, 1995, APPL MICROBIOL BIOT, V43, P545, DOI 10.1007/BF00218464; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Duke SO, 2011, J AGR FOOD CHEM, V59, P5835, DOI 10.1021/jf102704x; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Edge CB, 2013, SCI TOTAL ENVIRON, V444, P145, DOI 10.1016/j.scitotenv.2012.11.045; FENG JC, 1990, J AGR FOOD CHEM, V38, P1118, DOI 10.1021/jf00094a046; Fiori E, 2014, AQUAT TOXICOL, V147, P112, DOI 10.1016/j.aquatox.2013.12.014; FOLMAR LC, 1979, ARCH ENVIRON CON TOX, V8, P269, DOI 10.1007/BF01056243; Forlani G, 2008, PLANT CELL PHYSIOL, V49, P443, DOI 10.1093/pcp/pcn021; Forlani G, 2015, NEW PHYTOL, V205, P160, DOI 10.1111/nph.13022; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; Giesy JP, 2000, REV ENVIRON CONTAM T, V167, P35; Gimsing AL, 2004, APPL SOIL ECOL, V27, P233, DOI 10.1016/j.apsoil.2004.05.007; GOLDSBOROUGH LG, 1989, ARCH ENVIRON CON TOX, V18, P537, DOI 10.1007/BF01055020; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; HERNANDO F, 1989, J PLANT PHYSIOL, V134, P26, DOI 10.1016/S0176-1617(89)80197-X; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hove-Jensen B, 2014, MICROBIOL MOL BIOL R, V78, P176, DOI 10.1128/MMBR.00040-13; Ilikchyan IN, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00135; Ilikchyan IN, 2009, ENVIRON MICROBIOL, V11, P1314, DOI 10.1111/j.1462-2920.2009.01869.x; Kamlow M, 2013, THESIS NORWEGIAN U S; Karl DM, 2000, NATURE, V406, P31, DOI 10.1038/35017683; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; KREUTZWEISER DP, 1989, B ENVIRON CONTAM TOX, V42, P331, DOI 10.1007/BF01699957; Kryuchkova YV, 2014, MICROBIOL RES, V169, P99, DOI 10.1016/j.micres.2013.03.002; Krzysko-Lupicka T, 2008, CHEMOSPHERE, V71, P1386, DOI 10.1016/j.chemosphere.2007.11.006; Labry C, 2002, J PLANKTON RES, V24, P97, DOI 10.1093/plankt/24.2.97; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; LeGresley M, 2010, COUNTING CHAMBER MET; Lin X, 2011, J PHYCOL, V47, P1110, DOI 10.1111/j.1529-8817.2011.01038.x; Lipok J, 2010, ECOTOX ENVIRON SAFE, V73, P1681, DOI 10.1016/j.ecoenv.2010.08.017; LIU CM, 1991, APPL ENVIRON MICROB, V57, P1799, DOI 10.1128/AEM.57.6.1799-1804.1991; Ma J, 2003, B ENVIRON CONTAM TOX, V71, P594, DOI 10.1007/s00128-003-8521-x; MITCHELL DG, 1987, B ENVIRON CONTAM TOX, V39, P1028, DOI 10.1007/BF01689594; Modesto KA, 2010, CHEMOSPHERE, V81, P781, DOI 10.1016/j.chemosphere.2010.07.005; Mohr S, 2008, ENVIRON POLLUT, V152, P530, DOI 10.1016/j.envpol.2007.07.010; Mohr S, 2007, AQUAT TOXICOL, V82, P73, DOI 10.1016/j.aquatox.2007.02.001; MOORE JK, 1983, APPL ENVIRON MICROB, V46, P316, DOI 10.1128/AEM.46.2.316-320.1983; Nandula V. K., 2005, Outlooks on Pest Management, V16, P183, DOI 10.1564/16aug11; ORRETT K, 1987, LIMNOL OCEANOGR, V32, P383, DOI 10.4319/lo.1987.32.2.0383; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Perez GL, 2007, ECOL APPL, V17, P2310, DOI 10.1890/07-0499.1; Peruzzo PJ, 2008, ENVIRON POLLUT, V156, P61, DOI 10.1016/j.envpol.2008.01.015; PIPKE R, 1988, APPL ENVIRON MICROB, V54, P1293, DOI 10.1128/AEM.54.5.1293-1296.1988; PIPKE R, 1987, EUR J BIOCHEM, V165, P267, DOI 10.1111/j.1432-1033.1987.tb11437.x; QUINN JP, 1989, APPL MICROBIOL BIOT, V31, P283, DOI 10.1007/BF00258410; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Sandrini JZ, 2013, AQUAT TOXICOL, V130, P171, DOI 10.1016/j.aquatox.2013.01.006; Saxton MA, 2011, J GREAT LAKES RES, V37, P683, DOI 10.1016/j.jglr.2011.07.004; Schaffer JD, 2004, B ENVIRON CONTAM TOX, V72, P1032, DOI 10.1007/s00128-004-0347-7; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SCHULZ A, 1985, FEMS MICROBIOL LETT, V28, P297, DOI 10.1111/j.1574-6968.1985.tb00809.x; SERVIZI JA, 1987, B ENVIRON CONTAM TOX, V39, P15, DOI 10.1007/BF01691783; Shi XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071232; Stachowski-Haberkorn S, 2008, AQUAT TOXICOL, V89, P232, DOI 10.1016/j.aquatox.2008.07.004; Stalikas CD, 2001, J CHROMATOGR A, V907, P1, DOI 10.1016/S0021-9673(00)01009-8; Sun YY, 2009, BIOTECHNOL BIOPROC E, V14, P225, DOI 10.1007/s12257-008-0013-8; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Suzumura M, 1998, LIMNOL OCEANOGR, V43, P1553, DOI 10.4319/lo.1998.43.7.1553; TALBOT HW, 1984, CURR MICROBIOL, V10, P255, DOI 10.1007/BF01577137; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963; Vendrell E, 2009, B ENVIRON CONTAM TOX, V82, P538, DOI 10.1007/s00128-009-9674-z; Vera MS, 2010, ECOTOXICOLOGY, V19, P710, DOI 10.1007/s10646-009-0446-7; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; Webster TMU, 2014, ENVIRON SCI TECHNOL, V48, P1271, DOI 10.1021/es404258h; Winer BJ, 1971, STAT PRINCIPLES EXPT; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	84	118	126	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151633	10.1371/journal.pone.0151633	http://dx.doi.org/10.1371/journal.pone.0151633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985828	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300099
J	Wang, CH; Wu, CY; Yang, JCT; Lien, WC; Wang, HP; Liu, KL; Wu, YM; Chen, SC				Wang, Chih-Hung; Wu, Cheng-Yi; Yang, Justin Cheng-Ta; Lien, Wan-Ching; Wang, Hsiu-Po; Liu, Kao-Lang; Wu, Yao-Ming; Chen, Shyr-Chyr			Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center	PLOS ONE			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; SURGICAL-PATIENTS; MANAGEMENT; DIAGNOSIS; BRIDGE; TRIAL; BILE	Background Percutaneous cholecystostomy tube (PCT) has been effectively used for the treatment of acute cholecystitis (AC) for patients unsuitable for early cholecystectomy. This retrospective study investigated the recurrence rate after successful PCT treatment and factors associated with recurrence. Methods We reviewed patients treated with PCT for AC from October 2004 through December 2013. Patients with successful PCT treatment were those who were free from persistent PCT drainage. We used multivariable logistic regression analysis sequentially to identify factors associated with each outcome. Results The study included 184 patients (mean age: 70.1 years). The average duration for parenteral antibiotics was 14.4 days and 20.0 days for PCT drainage. The one-year recurrence rate was 9.2% (17/184) with most recurrences occurring within two months (6.5%, 12/184) of the procedure. Complicated cholecystitis (odds ratio [OR]: 4.67; 95% confidence interval [CI]: 1.44-15.70; P = 0.01) and PCT drainage duration >32 days (OR: 4.92; 95% CI: 1.03-23.53; P = 0.05) positively correlated with one-year recurrence; parenteral antibiotics duration > 10 days (OR: 0.21; 95% CI: 0.05-0.68; P = 0.01) was inversely associated with one-year recurrence. Conclusions The recurrence rate was low for patients after successful PCT treatment. Predictors for recurrence included the severity of initial AC and subsequently provided treatments.	[Wang, Chih-Hung; Wu, Cheng-Yi; Chen, Shyr-Chyr] Natl Taiwan Univ, Dept Emergency Med, Taipei 10764, Taiwan; [Wang, Chih-Hung; Wu, Cheng-Yi; Yang, Justin Cheng-Ta; Wang, Hsiu-Po; Liu, Kao-Lang; Wu, Yao-Ming; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, Justin Cheng-Ta; Liu, Kao-Lang] Natl Taiwan Univ, Dept Med Imaging, Taipei 10764, Taiwan; [Lien, Wan-Ching] Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsinchu, Taiwan; [Lien, Wan-Ching] Natl Taiwan Univ, Hsinchu, Taiwan; [Wang, Hsiu-Po] Natl Taiwan Univ, Dept Internal Med, Taipei 10764, Taiwan; [Wu, Yao-Ming] Natl Taiwan Univ, Dept Surg, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Lien, WC (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsinchu, Taiwan.; Lien, WC (corresponding author), Natl Taiwan Univ, Hsinchu, Taiwan.	wanchinglien@ntu.edu.tw	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016	CHEN, SHYR-CHYR/0000-0002-5858-3013; LIU, KAO-LANG/0000-0003-4100-8909; WANG, CHIH-HUNG/0000-0003-0802-7825; WU, YAO-MING/0000-0002-1720-7863; YANG, JUSTIN CHENG-TA/0000-0001-8256-2477; LIEN, WAN-CHING/0000-0001-9448-5093				Browning P D, 1993, J Vasc Interv Radiol, V4, P531, DOI 10.1016/S1051-0443(93)71915-6; Chang YR, 2014, SURGERY, V155, P615, DOI 10.1016/j.surg.2013.12.026; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chok KSH, 2010, ANZ J SURG, V80, P280, DOI 10.1111/j.1445-2197.2009.05105.x; Crnich CJ, 2012, INFECT DIS CLIN N AM, V26, P143, DOI 10.1016/j.idc.2011.09.007; Davis CA, 1999, ARCH SURG-CHICAGO, V134, P727, DOI 10.1001/archsurg.134.7.727; de Mestral C, 2013, J TRAUMA ACUTE CARE, V74, P175, DOI 10.1097/TA.0b013e31827890e1; Decker G, 2001, ACTA CHIR BELG, V101, P294; Gomi H, 2013, J HEPATO-BIL-PAN SCI, V20, P60, DOI 10.1007/s00534-012-0572-0; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Hatjidakis AA, 1998, CARDIOVASC INTER RAD, V21, P36, DOI 10.1007/s002709900208; HOUGHTON PWJ, 1985, BRIT J SURG, V72, P220, DOI 10.1002/bjs.1800720327; HUBER DF, 1983, AM J SURG, V146, P719, DOI 10.1016/0002-9610(83)90326-4; Kiviniemi H, 1998, INT SURG, V83, P299; Kortram K, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-7; Leveau P, 2008, SCAND J GASTROENTERO, V43, P593, DOI 10.1080/00365520701851673; Li M, 2013, AM SURGEON, V79, P524; MARGIOTTA SJ, 1988, AM SURGEON, V54, P34; McGillicuddy EA, 2012, BRIT J SURG, V99, P1254, DOI 10.1002/bjs.8836; Miura F, 2013, J HEPATO-BIL-PAN SCI, V20, P47, DOI 10.1007/s00534-012-0563-1; MORRIS CR, 1952, SURGERY, V32, P673; Okamoto K, 2013, J HEPATO-BIL-PAN SCI, V20, P55, DOI 10.1007/s00534-012-0562-2; Pessaux P, 2001, SURG LAPARO ENDO PER, V11, P252, DOI 10.1097/00129689-200108000-00005; RADDER RW, 1980, DIAGN IMAGING, V49, P330; ROSLYN JJ, 1980, AM J SURG, V140, P126, DOI 10.1016/0002-9610(80)90428-6; Sanjay P, 2013, HPB, V15, P511, DOI 10.1111/j.1477-2574.2012.00610.x; Smith TJ, 2013, ANN SURG, V257, P1112, DOI 10.1097/SLA.0b013e318274779c; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; VANDERLINDEN W, 1970, AM J SURG, V120, P7, DOI 10.1016/S0002-9610(70)80133-7; Venara A, 2014, J VISC SURG, V151, P435, DOI 10.1016/j.jviscsurg.2014.06.003; Wang CH, 2014, WORLD J SURG, V38, P347, DOI 10.1007/s00268-013-2311-3; WERBEL GB, 1989, ARCH SURG-CHICAGO, V124, P782; Winbladh A, 2009, HPB, V11, P183, DOI 10.1111/j.1477-2574.2009.00052.x; Wise JN, 2005, AM J ROENTGENOL, V184, P1647, DOI 10.2214/ajr.184.5.01841647; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Zerem E, 2014, SURG LAPARO ENDO PER, V24, P187, DOI 10.1097/SLE.0b013e31828fa45e	36	118	126	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148017	10.1371/journal.pone.0148017	http://dx.doi.org/10.1371/journal.pone.0148017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26985828	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528400058
J	Li, L; Tian, JH; Long, MKW; Chen, Y; Lu, JF; Zhou, CM; Wang, TL				Li, Li; Tian, Jinghua; Long, Mitchell King-Wei; Chen, Yong; Lu, Jianfei; Zhou, Changman; Wang, Tianlong			Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; GUILLAIN-BARRE-SYNDROME; LOCAL HEALTH DISTRICT; CELL-DEATH; HYPERBARIC-OXYGEN; NEURON DEATH; DISEASE; BRAIN; SPHINGOLIPIDS; WITHDRAWAL	Ganglioside GM1, which is particularly abundant in the central nervous system (CNS), is closely associated with the protection against several CNS disorders. However, controversial findings have been reported on the role of GM1 following ischemic stroke. In the present study, using a rat middle cerebral artery occlusion (MCAO) model, we investigated whether GM1 can protect against ischemic brain injury and whether it targets the autophagy pathway. GM1 was delivered to Sprague-Dawley male rats at 3 doses (25 mg/kg, 50 mg/kg, 100 mg/kg) by intraperitoneal injection soon after reperfusion and then once daily for 2 days. The same volume of saline was given as a control. Tat-Beclin-1, a specific autophagy inducer, was administered by intraperitoneal injection at 24 and 48 hours post-MCAO. Infarction volume, mortality and neurological function were assessed at 72 hours after ischemic insult. Immunofluorescence and Western blotting were performed to determine the expression of autophagy-related proteins P62, LC3 and Beclin-1 in the penumbra area. No significant changes in mortality and physiological variables (heart rate, blood glucose levels and arterial blood gases) were observed between the different groups. However, MCAO resulted in enhanced conversion of LC3-I into LC3-II, P62 degradation, high levels of Beclin-1, a large area infarction (26.3 +/- 3.6%) and serious neurobehavioral deficits. GM1 (50 mg/kg) treatment significantly reduced the autophagy activation, neurobehavioral dysfunctions, and infarction volume (from 26.3% to 19.5%) without causing significant adverse side effects. However, this biological function could be abolished by Tat-Beclin-1. In conclusion: GM1 demonstrated safe and robust neuroprotective effects that are associated with the inhibition of autophagy following experimental stroke.	[Li, Li; Wang, Tianlong] Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Tian, Jinghua] Heze Med Coll, Dept Anat, Jinan, Shandong, Peoples R China; [Long, Mitchell King-Wei] Des Moines Univ, Osteopath Med, Des Moines, IA USA; [Chen, Yong] Peoples Hosp Deyang City, Dept Neurol, Chengdu, Sichuan, Peoples R China; [Lu, Jianfei; Zhou, Changman] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Anat & Histol, Beijing 100871, Peoples R China	Capital Medical University; Peking University	Li, L (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing, Peoples R China.	lili2009kaoyan@163.com; w_tl5595@hotmail.com	Bianchi, Thomas S/L-4060-2014; Zou, Xiaoming/GWV-5608-2022; He, Zhenli/A-4773-2008; He, Zhenli/R-1494-2016; Li, Liguang/Q-2916-2019	Bianchi, Thomas S/0000-0002-3068-2933; Zou, Xiaoming/0000-0001-9023-3067; 	National Natural Science Foundation of China [81500996, 31271280]; Beijing Postdoctoral Research Foundation; Beijing Municipal Administration of Hospitals' Ascent Plan [DFL 20150802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Postdoctoral Research Foundation(China Postdoctoral Science Foundation); Beijing Municipal Administration of Hospitals' Ascent Plan	This work was supported by the National Natural Science Foundation of China No. 81500996 to LL and 31271280 to CZ (http://www.nsfc.gov.cn/), Beijing Postdoctoral Research Foundation (2015) to LL (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml), and Beijing Municipal Administration of Hospitals' Ascent Plan (DFL 20150802) to TW (http://www.bjah.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER M, 1994, STROKE, V25, P1141; Baek SH, 2009, AUTOPHAGY, V5, P277, DOI 10.4161/auto.5.2.7641; Baxter P, 2014, TRANSL STROKE RES, V5, P136, DOI 10.1007/s12975-013-0283-0; Bu QX, 2014, BRAIN RES, V1558, P100, DOI 10.1016/j.brainres.2014.02.034; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; FIGUERAS A, 1992, BRIT MED J, V305, P1330, DOI 10.1136/bmj.305.6865.1330; Gao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046092; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Giraldi C, 1990, Acta Neurol (Napoli), V12, P214; Govoni V, 1997, BRAIN, V120, P1123, DOI 10.1093/brain/120.7.1123; Govoni V, 2003, J NEUROL SCI, V216, P99, DOI 10.1016/S0022-510X(03)00215-6; Gupta G, 2010, FEBS LETT, V584, P1634, DOI 10.1016/j.febslet.2009.11.070; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Iwabuchi K, 2010, FEBS LETT, V584, P1642, DOI 10.1016/j.febslet.2009.10.043; Jiang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048672; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang S, 2014, GENE, V539, P181, DOI 10.1016/j.gene.2014.02.017; Kashiwagi A, 2015, ANESTHESIOLOGY, V122, P1075, DOI 10.1097/ALN.0000000000000561; KAWAMURA S, 1991, ACTA NEUROCHIR, V109, P126, DOI 10.1007/BF01403007; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; LENZI GL, 1994, STROKE, V25, P1552, DOI 10.1161/01.STR.25.8.1552; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Ohmi Y, 2009, P NATL ACAD SCI USA, V106, P22405, DOI 10.1073/pnas.0912336106; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rong X, 2013, ACTA NEUROBIOL EXP, V73, P379; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Schneider JS, 2010, J NEUROL SCI, V292, P45, DOI 10.1016/j.jns.2010.02.009; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; SVENNERHOLM L, 1994, LIFE SCI, V55, P2125, DOI 10.1016/0024-3205(94)00393-9; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005; Whitehead SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020808; Wolinski P, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/727189; Yin W, 2002, BRAIN RES, V926, P165, DOI 10.1016/S0006-8993(01)03304-2; Yu RK, 2010, FEBS LETT, V584, P1694, DOI 10.1016/j.febslet.2009.08.026; Zamfir AD, 2014, ADV EXP MED BIOL, V806, P153, DOI 10.1007/978-3-319-06068-2_8; ZHU Y, 2013, BMC EVOL BIOL, V13, DOI DOI 10.1186/1477-7819-11-19	46	107	117	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2016	11	1							e0144219	10.1371/journal.pone.0144219	http://dx.doi.org/10.1371/journal.pone.0144219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CA	26751695	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888100009
